Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" CHL1 "CALL, FLJ44930, L1CAM2, MGC132578" ENSG00000134121 "Cell adhesion molecule L1 like" O00533 3 196763-409417 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.8" "Cell type enhanced" "Detected in many" "Astrocytes: 223.6;Excitatory neurons: 423.8;Inhibitory neurons: 320.7;Oligodendrocyte precursor cells: 918.4" "Cancer enhanced" "Detected in many" "glioma: 15.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 33 "memory B-cell: 2.7;naive B-cell: 3.7" "Lineage enriched" "Detected in single" 38 "B-cells: 3.7" "Group enriched" "Detected in some" 5 "SK-MEL-30: 91.8;WM-115: 29.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003345, CAB026120" Enhanced "Secreted in brain" NA NA 5800000000 "Cluster 37: B-cells - Transcription" "Cluster 10: Brain - Neuronal signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "CAB026120: , HPA003345: AB_1078516" "unprognostic (5.54e-2)" "unprognostic (2.08e-1)" "unprognostic (7.45e-2)" "unprognostic (7.14e-3)" "unprognostic (1.16e-3)" "unprognostic (1.12e-1)" "unprognostic (3.10e-2)" "unprognostic (2.22e-1)" "unprognostic (5.14e-1)" "unprognostic (1.06e-1)" "unprognostic (7.81e-2)" "unprognostic (3.51e-1)" "prognostic favorable (1.21e-6)" "unprognostic (1.11e-1)" "unprognostic (6.07e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" 13.6 4.1 18.6 8.6 33.9 0.3 8.5 2.3 35.5 3.3 0.0 14.7 4.4 3.4 1.6 8.9 2.6 4.8 11.5 35.8 26.7 17.8 0.8 5.1 6.2 12.5 5.3 16.3 1.7 0.5 2.6 0.0 5.7 3.7 7.9 15.9 6.9 6.3 0.3 12.9 6.2 5.4 10.0 3.0 4.0 1.5 10.6 0.7 0.9 1.4 2.9 3.1 5.3 5.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 91.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 29.6 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 33.9 2.3 35.5 35.8 26.7 12.5 5.3 5.7 10.0 10.6 5.0 4.1 0.0 0.0 223.6 8.8 22.9 0.6 2.8 56.9 1.2 0.6 13.6 18.0 1.5 15.8 11.0 0.0 0.0 0.1 0.0 11.7 0.0 2.0 2.9 0.1 2.3 0.0 0.0 423.8 0.0 0.0 33.5 0.0 1.9 1.3 106.2 1.4 1.3 0.0 1.7 320.7 0.0 0.0 0.3 4.4 1.4 2.8 0.6 3.6 22.5 0.0 58.7 0.0 918.4 11.6 0.2 0.0 0.0 1.4 6.2 0.0 19.7 17.8 2.7 0.0 2.7 11.2 3.0 1.3 15.6 12.1 0.0 1.1 12.4 0.0 0.8 CNTN6 NB-3 ENSG00000134115 "Contactin 6" Q9UQ52 3 1092658-1404217 "Predicted membrane proteins" "Cell adhesion, Notch signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 11.0;thyroid gland: 9.7" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 35.3;Excitatory neurons: 127.6;Inhibitory neurons: 75.9;Oligodendrocyte precursor cells: 52.8" "Group enriched" "Detected in some" 15 "renal cancer: 2.7;thyroid cancer: 3.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.1;SH-SY5Y: 2.3;SuSa: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA016645 Uncertain NA NA 4700000 "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA016645: AB_1847149" "unprognostic (1.09e-1)" "unprognostic (3.70e-1)" "unprognostic (2.27e-1)" "unprognostic (3.99e-1)" "unprognostic (3.16e-1)" "unprognostic (1.05e-4)" "unprognostic (1.45e-1)" "unprognostic (1.86e-1)" "unprognostic (3.80e-2)" "unprognostic (2.61e-2)" "unprognostic (4.65e-2)" "unprognostic (1.26e-3)" "unprognostic (5.45e-2)" "unprognostic (5.23e-2)" "unprognostic (1.15e-1)" "unprognostic (4.46e-2)" 0.0 3.2 1.3 0.0 2.4 0.0 0.1 11.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 1.4 0.1 0.0 3.2 0.0 2.2 2.2 0.0 0.0 0.0 0.3 2.0 2.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 3.7 0.0 9.7 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.4 11.0 2.3 1.1 1.4 2.2 2.2 2.7 1.9 3.7 1.3 0.0 35.3 3.6 15.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.5 0.0 3.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.0 127.6 0.0 0.2 3.3 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 75.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 7.5 0.0 0.0 0.0 52.8 6.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 1.1 0.0 0.0 CNTN4 BIG-2 ENSG00000144619 "Contactin 4" Q8IWV2 3 2098813-3057959 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 22.6" "Cell type enhanced" "Detected in many" "Early spermatids: 411.7;Excitatory neurons: 960.7;Inhibitory neurons: 1048.5;Oligodendrocyte precursor cells: 248.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 8.3;CACO-2: 9.0;HEK 293: 5.5;SH-SY5Y: 16.5;WM-115: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 170000000 "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (1.64e-1)" "unprognostic (7.17e-3)" "unprognostic (9.85e-2)" "unprognostic (5.75e-2)" "unprognostic (9.94e-2)" "unprognostic (1.33e-1)" "unprognostic (3.85e-1)" "unprognostic (1.08e-1)" "unprognostic (2.21e-1)" "unprognostic (2.60e-2)" "unprognostic (7.38e-3)" "unprognostic (2.41e-2)" "prognostic favorable (1.00e-4)" "unprognostic (1.22e-2)" "unprognostic (2.88e-2)" "unprognostic (2.10e-1)" "unprognostic (2.13e-1)" 3.4 0.5 2.2 1.1 6.4 0.0 2.5 13.5 12.3 8.7 0.0 4.6 1.8 8.3 1.9 3.1 4.2 5.1 2.5 1.8 2.7 4.2 2.9 2.4 1.1 0.5 5.4 1.0 1.6 22.6 1.9 7.9 1.2 4.3 3.3 19.8 0.9 5.6 0.7 0.7 4.1 4.5 4.2 1.0 3.6 13.4 7.7 2.2 10.3 4.0 2.6 3.6 1.7 4.0 0.0 0.0 1.1 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 16.5 0.0 0.0 0.1 1.2 0.1 0.2 0.0 0.0 1.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 6.4 13.5 12.3 1.8 2.7 0.5 5.4 1.2 4.2 7.7 4.0 0.4 9.6 3.6 26.8 0.1 0.8 1.3 0.0 1.8 96.5 2.0 1.8 1.4 7.2 5.6 0.0 0.0 0.1 0.0 1.8 0.0 4.4 411.7 0.3 9.1 1.9 7.8 0.0 960.7 0.0 0.1 18.1 0.0 0.3 0.0 6.9 0.7 0.4 0.3 101.0 1048.5 2.0 0.0 0.3 0.7 156.3 5.0 0.4 1.8 31.9 0.0 27.5 0.0 248.3 14.7 0.0 1.6 5.3 0.4 0.4 3.7 3.7 0.0 5.9 6.6 0.5 8.3 4.5 4.9 0.9 0.0 0.3 0.1 0.1 3.5 0.2 IL5RA "CD125, CDw125, IL5R" ENSG00000091181 "Interleukin 5 receptor subunit alpha" Q01344 3 3066324-3126613 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 9.0;fallopian tube: 10.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 28.0;granulocytes: 19.0;Plasma cells: 9.9;Respiratory ciliated cells: 13.9" "Cancer enhanced" "Detected in some" "prostate cancer: 1.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 192 "basophil: 178.4;eosinophil: 355.1" "Lineage enriched" "Detected in many" 255 "granulocytes: 355.1" "Cell line enriched" "Detected in some" 28 "HMC-1: 71.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA 910000 "Cluster 2: Granulocytes - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.38e-3)" "unprognostic (2.26e-2)" "unprognostic (2.66e-1)" "unprognostic (6.13e-3)" "unprognostic (2.66e-1)" "unprognostic (1.54e-3)" "unprognostic (7.79e-3)" "unprognostic (8.42e-2)" "unprognostic (2.83e-1)" "unprognostic (1.67e-1)" "unprognostic (9.84e-4)" "unprognostic (4.32e-3)" "unprognostic (3.08e-2)" "unprognostic (6.95e-2)" "unprognostic (2.20e-1)" "unprognostic (7.49e-2)" "unprognostic (4.93e-2)" 0.2 0.2 0.8 0.6 0.7 0.6 1.0 0.6 0.3 1.0 9.0 0.7 1.7 0.4 0.2 0.5 10.7 0.7 1.0 0.8 1.2 0.4 0.1 2.7 0.4 5.0 4.6 0.1 0.4 0.0 1.5 0.1 3.2 1.8 1.1 0.0 0.7 0.1 0.4 0.1 1.6 0.3 4.5 1.8 1.1 1.1 1.2 0.5 0.2 0.0 1.5 1.7 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 2.5 71.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 178.4 0.1 355.1 0.9 0.1 0.1 0.4 1.0 0.7 0.1 1.3 0.3 0.7 1.0 0.0 0.1 0.1 0.1 0.7 0.8 0.7 0.6 0.3 0.8 1.2 5.0 4.6 3.2 4.5 1.2 0.9 0.2 0.0 2.5 0.0 4.8 0.1 0.0 0.3 0.0 0.0 0.0 0.0 2.3 1.5 1.4 0.0 0.0 0.1 2.8 0.0 0.0 0.0 2.4 28.0 0.3 0.1 0.0 0.8 0.7 0.0 0.0 0.2 0.0 0.5 19.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.3 5.7 0.0 0.1 5.4 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 9.9 0.8 0.0 0.1 13.9 0.0 0.0 0.0 0.3 0.9 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.1 TRNT1 "CCA1, CGI-47, MtCCA" ENSG00000072756 "TRNA nucleotidyl transferase 1" Q96Q11 3 3126933-3150879 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Nucleotidyltransferase, RNA-binding, Transferase" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036938 Uncertain Supported Mitochondria Yes No "Cluster 46: Basophils - DNA binding" "Cluster 7: Kidney - Transmembrane transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Mitochondria "HPA036938: AB_10670566" "unprognostic (6.39e-3)" "unprognostic (1.58e-1)" "unprognostic (2.38e-3)" "unprognostic (4.69e-2)" "unprognostic (4.92e-2)" "unprognostic (2.41e-1)" "unprognostic (1.39e-2)" "unprognostic (2.68e-1)" "unprognostic (6.22e-2)" "unprognostic (5.65e-2)" "unprognostic (4.62e-2)" "unprognostic (1.41e-2)" "unprognostic (1.24e-2)" "unprognostic (6.50e-2)" "unprognostic (1.09e-1)" "unprognostic (3.78e-1)" "unprognostic (1.02e-1)" 9.7 10.0 7.2 8.9 7.2 3.5 8.5 7.9 8.0 7.8 7.0 8.1 4.4 8.8 5.5 9.4 7.6 8.3 8.4 7.4 7.2 17.2 10.0 8.4 9.7 7.1 7.3 8.3 8.4 8.3 10.3 10.5 7.1 11.3 7.6 4.0 7.7 6.3 9.3 6.4 7.9 8.3 7.3 10.7 9.1 6.5 7.4 9.8 11.3 7.6 10.9 13.1 7.9 8.0 20.0 29.6 18.2 9.8 24.1 21.5 20.5 19.9 17.4 21.6 20.9 25.0 20.9 35.6 12.8 22.4 32.0 12.6 24.6 18.6 26.5 24.6 13.3 28.7 25.3 24.9 31.4 32.2 20.8 17.9 25.0 20.2 6.8 15.0 21.0 24.1 25.1 9.8 35.9 37.2 22.0 21.4 15.2 29.2 19.0 20.5 28.1 32.5 26.1 25.8 10.8 15.9 31.6 20.6 18.5 26.3 18.7 16.3 14.8 22.8 18.7 23.6 25.7 12.6 31.4 43.4 17.2 27.6 25.0 49.4 12.4 36.4 16.4 18.1 16.0 25.8 20.8 18.1 16.8 15.7 22.7 20.1 16.6 19.8 19.0 15.6 18.6 11.2 7.2 7.2 7.9 8.0 7.4 7.2 7.1 7.3 7.1 7.3 7.4 8.0 20.7 16.0 13.4 15.3 30.2 14.8 29.0 19.9 24.5 13.5 12.1 11.0 14.3 2.8 16.3 18.4 14.6 25.8 23.5 10.6 45.0 19.1 2.3 15.8 19.0 21.1 8.4 16.6 23.8 9.9 17.8 19.9 23.4 12.0 22.8 20.7 12.5 9.2 13.3 10.1 27.0 10.7 16.2 11.0 13.3 2.9 10.8 13.3 7.2 23.4 20.3 17.1 18.6 23.6 34.7 10.6 9.2 8.6 30.7 30.9 11.0 32.7 11.4 15.7 0.0 14.9 17.4 20.8 17.9 23.4 13.1 28.3 22.0 24.7 13.5 23.9 CRBN "MRT2, MRT2A" ENSG00000113851 Cereblon Q96SW2 3 3144628-3179727 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" "Disease variant, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 314.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045910 Approved NA NA "Cluster 10: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 16: U-266 - Nucleosome" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA045910: AB_10960409" "unprognostic (1.26e-1)" "unprognostic (4.14e-2)" "unprognostic (4.27e-2)" "unprognostic (4.05e-2)" "unprognostic (1.85e-2)" "unprognostic (3.31e-2)" "unprognostic (1.21e-1)" "unprognostic (6.40e-3)" "unprognostic (2.15e-1)" "unprognostic (2.38e-1)" "unprognostic (1.23e-1)" "unprognostic (4.79e-2)" "unprognostic (2.17e-3)" "unprognostic (1.70e-1)" "unprognostic (5.95e-2)" "unprognostic (2.28e-2)" "unprognostic (1.47e-2)" 25.1 20.9 25.6 17.1 30.2 44.0 33.8 32.7 41.6 22.9 42.0 21.4 21.8 26.2 23.9 20.6 21.7 21.0 30.9 29.2 28.5 31.0 35.4 24.4 28.6 33.7 26.8 32.1 21.9 29.9 11.1 29.5 35.5 23.5 22.9 26.8 36.3 23.6 41.8 24.8 22.8 24.8 22.9 30.6 22.9 48.2 29.1 23.5 31.9 38.5 21.6 20.0 14.6 48.1 12.9 10.5 32.5 14.4 38.8 37.3 13.6 14.3 23.9 18.4 24.6 15.6 18.7 13.9 19.4 17.8 22.3 12.2 19.9 24.1 20.0 24.0 30.9 35.9 20.1 19.4 26.0 32.5 22.4 28.7 31.1 19.9 15.1 36.1 25.2 29.9 21.5 29.4 16.1 18.7 28.6 32.5 27.3 17.8 24.8 25.9 19.5 30.5 21.8 20.0 16.3 23.7 15.9 21.6 35.7 24.1 28.9 24.0 16.3 18.8 9.8 30.0 18.6 33.2 55.8 35.2 29.2 29.5 23.5 314.2 44.3 99.3 61.6 53.6 65.2 46.4 82.6 66.8 39.8 36.9 84.3 72.4 28.1 103.6 58.1 21.4 63.0 96.1 25.6 30.2 32.7 41.6 29.2 28.5 33.7 26.8 35.5 22.9 29.1 48.1 89.7 44.8 39.1 30.3 46.5 36.1 35.5 70.9 33.0 61.5 30.6 43.4 73.5 38.6 45.2 38.6 27.1 52.6 81.2 21.4 72.4 33.3 184.2 23.9 31.7 72.0 15.6 54.5 72.6 21.2 35.3 47.9 17.3 22.3 140.4 50.2 68.6 35.0 36.0 43.7 74.1 24.6 54.9 52.7 33.4 56.6 62.7 54.8 33.8 28.1 68.8 66.4 121.5 42.7 74.0 20.4 33.5 66.5 34.1 26.0 53.4 73.2 36.4 64.5 59.2 58.0 46.2 206.2 96.2 19.2 38.5 50.2 70.9 49.4 30.5 24.7 SUMF1 "FGE, UNQ3037" ENSG00000144455 "Sulfatase modifying factor 1" Q8NBK3 3 3700814-4467273 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 116.4;hTERT-RPE1: 117.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038025 Uncertain "Intracellular and membrane" NA NA 2800000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 1: Thyroid gland - Transcription" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "HPA038025: AB_10675624" "unprognostic (5.02e-2)" "unprognostic (2.30e-1)" "unprognostic (1.08e-1)" "unprognostic (8.99e-3)" "unprognostic (5.66e-2)" "unprognostic (1.11e-1)" "unprognostic (8.34e-3)" "unprognostic (3.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.05e-1)" "unprognostic (2.65e-2)" "unprognostic (2.28e-1)" "prognostic favorable (4.79e-7)" "unprognostic (5.12e-2)" "unprognostic (2.58e-1)" "unprognostic (1.45e-1)" "unprognostic (7.86e-2)" 20.7 19.5 10.4 13.1 12.0 10.2 29.2 10.9 12.2 21.3 15.6 23.9 13.3 15.8 26.8 28.7 25.6 19.7 12.5 10.2 12.2 39.3 27.4 23.0 12.6 12.2 11.7 17.4 18.9 46.8 14.5 18.8 11.4 22.1 29.6 3.4 22.8 17.7 4.3 20.3 14.1 20.5 11.4 16.8 23.8 5.1 13.1 10.6 28.4 7.6 13.4 20.0 18.5 13.1 25.0 20.6 11.4 6.3 116.4 61.3 21.9 34.4 53.9 16.2 18.2 9.6 78.9 3.7 20.3 63.0 24.3 13.3 5.0 39.0 25.2 12.0 10.1 5.4 18.9 26.2 30.0 6.1 14.4 56.6 43.2 18.2 5.3 117.9 44.8 8.9 9.1 8.4 45.8 40.2 3.4 9.1 12.0 22.8 23.4 6.3 17.0 16.0 86.6 28.0 2.2 12.6 24.6 56.8 20.4 19.5 75.7 15.6 41.4 32.5 4.2 25.3 21.0 10.4 22.8 1.7 63.2 13.5 24.7 66.1 100.5 35.6 38.9 81.8 35.2 26.6 31.2 32.9 86.6 30.7 39.4 32.0 36.2 42.0 78.2 45.9 16.9 90.2 10.4 12.0 10.9 12.2 10.2 12.2 12.2 11.7 11.4 11.4 13.1 13.1 12.8 19.2 20.1 36.9 13.8 12.7 18.8 32.9 21.1 5.6 29.5 23.2 5.5 18.6 16.7 38.6 6.2 29.8 9.7 16.5 11.7 39.3 26.1 14.2 14.1 13.7 8.4 11.1 53.2 19.1 23.3 25.8 21.4 21.9 17.1 10.4 17.5 18.7 28.2 3.3 57.0 19.7 4.1 37.1 12.0 10.7 16.4 24.3 19.6 62.8 43.9 6.8 11.3 56.8 85.5 14.0 16.4 17.3 11.5 13.7 10.5 23.8 19.4 6.2 6.6 21.2 16.5 4.8 5.1 25.9 11.8 24.4 11.6 11.1 25.6 18.3 LRRN1 FIGLER3 ENSG00000175928 "Leucine rich repeat neuronal 1" Q6UXK5 3 3799431-3849834 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2" "Cell type enriched" "Detected in many" 6 "Oligodendrocyte precursor cells: 418.2" "Cancer enhanced" "Detected in many" "glioma: 20.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 106.6;CAPAN-2: 37.9;HAP1: 32.3;NTERA-2: 62.7;SuSa: 104.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011071 Enhanced NA NA 2400000 "Cluster 49: Eosinophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "HPA011071: AB_1853355" "unprognostic (1.27e-2)" "unprognostic (4.87e-1)" "unprognostic (1.32e-2)" "unprognostic (3.30e-3)" "unprognostic (2.01e-2)" "unprognostic (3.02e-2)" "unprognostic (2.10e-1)" "unprognostic (1.98e-2)" "unprognostic (3.34e-1)" "unprognostic (2.96e-1)" "unprognostic (2.85e-2)" "unprognostic (2.70e-1)" "unprognostic (1.39e-3)" "unprognostic (1.86e-3)" "unprognostic (1.67e-1)" "unprognostic (1.75e-1)" "unprognostic (7.25e-2)" 0.8 0.1 7.7 0.4 13.1 1.2 4.2 6.5 7.2 3.6 0.2 0.2 0.9 2.4 1.1 0.8 1.3 2.4 0.1 6.6 5.0 0.5 0.2 1.0 0.3 13.7 14.1 5.3 1.9 4.5 2.0 0.2 12.8 4.0 0.3 1.3 5.2 4.2 5.7 1.3 1.2 1.5 5.9 1.2 1.3 6.0 18.2 2.9 2.4 2.8 0.8 3.7 0.8 3.9 0.0 0.0 106.6 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 37.9 0.0 0.0 0.0 0.0 0.0 32.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 19.9 0.0 4.7 0.0 8.1 0.0 0.0 1.1 0.0 62.7 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 7.0 0.0 0.0 0.0 104.4 4.0 0.0 0.0 0.0 12.5 0.0 1.2 11.1 23.3 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.7 13.1 6.5 7.2 6.6 5.0 13.7 14.1 12.8 5.9 18.2 3.9 0.4 3.2 0.0 63.0 3.5 2.2 1.8 8.7 1.8 3.0 7.6 13.3 0.4 10.0 6.6 0.0 0.0 0.1 0.7 0.4 0.0 1.6 3.2 0.5 1.5 1.0 0.0 0.4 52.7 2.2 0.2 3.0 2.0 1.2 2.5 1.1 0.0 0.0 0.1 0.0 48.1 1.0 0.0 0.0 0.8 1.1 2.5 0.3 1.8 1.9 0.0 3.4 1.0 418.2 5.3 9.9 2.5 0.7 2.9 2.4 0.3 0.7 3.0 0.5 0.0 14.9 0.9 0.0 0.9 0.5 0.3 0.0 0.6 0.1 1.4 1.0 SETMAR metnase ENSG00000170364 "SET domain and mariner transposase fusion gene" Q53H47 3 4303304-4317567 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 25.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA057999 Supported Nucleoli NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoli "HPA057999: AB_2683574" "unprognostic (1.59e-1)" "unprognostic (1.22e-2)" "unprognostic (5.24e-3)" "unprognostic (4.89e-2)" "unprognostic (7.73e-2)" "unprognostic (4.73e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.58e-2)" "unprognostic (1.54e-2)" "unprognostic (3.29e-1)" "unprognostic (1.19e-3)" "unprognostic (1.19e-1)" "prognostic favorable (6.61e-6)" "unprognostic (5.42e-1)" "unprognostic (3.06e-2)" "unprognostic (1.08e-1)" "unprognostic (1.26e-3)" 6.5 3.7 2.6 2.2 4.3 2.6 8.5 4.2 3.3 8.4 1.9 3.9 2.7 10.3 4.6 4.5 8.5 5.3 3.4 3.0 2.3 6.4 3.3 2.7 2.9 3.6 2.8 12.1 5.1 3.4 3.7 3.7 3.4 7.9 4.3 2.1 5.7 6.1 3.8 4.8 3.1 10.4 2.5 2.8 3.7 4.2 4.0 6.0 7.4 5.1 2.8 5.5 5.2 6.5 3.7 3.2 9.8 2.1 23.1 7.6 9.9 4.1 1.2 3.9 3.7 3.5 2.9 9.9 4.2 2.3 7.2 3.1 8.9 6.1 4.3 6.8 7.6 12.5 6.1 5.6 2.7 5.9 5.1 9.1 4.7 3.0 0.9 3.6 5.7 11.2 8.3 3.6 6.2 5.2 8.9 3.7 9.5 2.4 5.7 10.3 9.6 4.1 3.6 5.1 7.8 11.4 4.9 6.1 5.3 6.2 5.9 3.4 3.8 5.8 8.0 4.9 5.4 4.9 12.3 24.1 2.1 6.7 4.9 0.7 0.4 0.5 0.8 1.2 0.7 1.0 1.0 1.1 0.4 1.3 1.6 2.0 0.0 0.2 0.8 0.6 0.7 0.6 2.6 4.3 4.2 3.3 3.0 2.3 3.6 2.8 3.4 2.5 4.0 6.5 4.8 0.0 5.0 4.9 2.4 2.4 8.0 12.0 10.8 5.8 6.6 13.7 6.6 2.8 10.8 0.0 0.0 25.5 1.9 2.7 13.7 11.2 0.7 3.8 6.3 5.6 3.6 5.5 6.4 13.4 12.1 8.9 5.6 4.4 1.3 13.9 4.2 2.6 5.7 0.0 6.9 2.8 10.2 2.1 1.5 1.9 9.6 2.7 0.0 4.7 4.1 4.6 2.1 7.1 11.7 6.6 4.4 13.2 1.8 4.4 2.0 6.0 6.7 2.8 6.6 7.0 8.1 7.5 6.4 6.0 0.6 16.3 2.8 16.9 5.6 3.6 ITPR1 "ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29" ENSG00000150995 "Inositol 1,4,5-trisphosphate receptor type 1" Q14643 3 4493345-4847840 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 290.2;Inhibitory neurons: 183.1;Microglial cells: 84.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 49.9" "Immune cell enhanced" "Detected in many" "naive B-cell: 13.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 76.4;HEL: 41.1;HeLa: 74.9;HMC-1: 40.0;U-87 MG: 56.7" "Region enhanced" "Detected in all" "cerebellum: 697.2" "Region enhanced" "Detected in all" "cerebellum: 208.8" "HPA014765, HPA016487" Approved Approved Vesicles NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "HPA014765: AB_1851843, HPA016487: AB_1851842" "unprognostic (1.92e-1)" "unprognostic (5.04e-2)" "unprognostic (1.34e-1)" "unprognostic (1.75e-1)" "unprognostic (2.16e-2)" "unprognostic (3.61e-2)" "unprognostic (1.60e-1)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.17e-2)" "unprognostic (1.92e-2)" "unprognostic (2.08e-1)" "unprognostic (2.77e-2)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.43e-4)" "unprognostic (2.40e-1)" 10.6 12.0 1.8 11.8 12.0 7.2 17.3 49.9 20.1 11.5 15.6 19.5 4.5 36.5 10.0 10.6 27.1 14.1 10.1 5.9 0.0 13.9 3.9 13.7 11.2 0.0 0.5 25.3 6.7 45.3 16.0 8.0 0.0 21.7 6.3 3.9 16.1 27.9 3.0 5.0 11.5 24.5 0.0 9.2 11.1 4.5 0.0 10.3 31.7 5.3 10.5 27.9 11.8 6.1 0.4 4.1 1.0 3.0 27.7 1.9 11.8 0.9 0.5 1.3 0.8 1.3 1.2 14.5 0.6 1.9 6.5 0.1 2.2 2.6 2.1 76.4 3.2 41.1 74.9 3.5 27.4 17.7 40.0 9.2 4.0 5.8 1.1 7.6 7.2 8.4 7.9 13.9 3.7 1.8 7.2 3.0 2.1 0.5 9.7 4.2 1.0 1.1 1.7 5.5 0.7 19.5 5.4 4.3 4.3 0.9 2.6 20.6 13.5 1.8 4.3 3.7 2.3 17.7 12.0 9.6 56.7 17.0 2.7 5.8 2.0 1.5 2.3 0.9 1.7 6.7 1.6 1.6 2.2 13.4 2.7 1.6 1.8 1.8 0.9 4.7 1.4 1.1 1.8 12.0 49.9 20.1 5.9 0.0 0.0 0.5 0.0 0.0 0.0 6.1 30.1 0.0 31.4 24.8 49.7 3.8 6.1 6.3 11.4 4.0 40.0 29.7 8.0 2.8 11.2 9.2 0.0 0.5 17.8 0.3 3.9 2.4 5.4 9.1 11.9 31.2 3.5 8.4 290.2 5.1 0.5 21.5 20.4 12.7 26.5 22.6 36.0 2.0 4.7 1.7 183.1 1.3 2.0 12.9 17.4 7.9 30.1 23.9 7.2 84.3 14.2 4.3 6.2 25.1 12.7 1.5 1.2 52.6 8.8 5.4 0.3 3.9 13.1 1.5 39.5 8.8 28.2 1.5 2.9 4.9 3.1 1.0 25.7 22.0 0.8 3.3 BHLHE40 "BHLHB2, Clast5, DEC1, SHARP2, STRA13" ENSG00000134107 "Basic helix-loop-helix family member e40" O14503 3 4979437-4985323 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 386.7;granulocytes: 439.2;Squamous epithelial cells: 517.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 101.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 488.2;Karpas-707: 228.4;U-87 MG: 218.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028922 Uncertain Supported "Nuclear bodies" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 44: HDLM-2 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" "Nuclear bodies" "HPA028922: AB_2672828" "unprognostic (8.64e-3)" "unprognostic (5.21e-2)" "unprognostic (1.03e-2)" "unprognostic (1.39e-1)" "unprognostic (8.58e-3)" "unprognostic (7.95e-2)" "unprognostic (2.90e-1)" "unprognostic (2.88e-3)" "unprognostic (1.31e-1)" "unprognostic (2.52e-2)" "prognostic unfavorable (8.74e-4)" "unprognostic (5.45e-2)" "unprognostic (3.36e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "unprognostic (5.95e-2)" "unprognostic (7.03e-3)" 154.1 99.0 38.5 52.9 38.4 188.2 200.0 36.1 48.7 141.6 41.4 67.9 30.8 67.6 34.6 353.2 61.5 100.4 153.4 38.1 32.8 151.4 187.9 112.1 52.4 52.0 47.5 76.0 79.8 67.5 92.6 72.2 39.3 98.1 47.4 118.3 117.3 32.5 251.7 207.2 42.6 65.2 40.5 26.9 43.5 14.1 49.6 40.6 82.7 46.8 50.7 172.1 272.3 37.0 40.4 53.4 0.1 14.7 30.8 23.8 78.6 7.5 19.7 7.7 30.2 3.4 39.7 0.2 19.6 14.2 118.9 31.5 6.6 108.0 13.2 488.2 4.7 9.8 39.6 11.9 29.7 25.5 192.8 55.1 63.3 88.9 25.4 53.4 30.0 1.7 53.9 228.4 20.3 28.4 3.9 10.8 2.9 45.6 87.1 0.7 17.6 23.0 74.4 7.9 0.8 1.7 132.6 34.2 40.0 45.9 78.6 38.8 39.7 30.4 29.3 28.9 50.0 175.9 82.8 1.6 218.0 19.8 15.3 101.4 9.7 54.5 24.7 4.9 24.9 7.7 13.1 16.6 15.2 4.5 2.9 10.1 14.3 54.9 0.5 19.9 0.9 11.9 38.5 38.4 36.1 48.7 38.1 32.8 52.0 47.5 39.3 40.5 49.6 37.0 172.5 67.3 191.3 32.3 24.9 165.4 112.8 330.5 373.3 15.4 136.6 74.7 65.0 40.0 297.7 46.0 0.0 32.0 159.8 52.9 11.7 75.2 0.3 210.2 69.6 161.6 10.7 2.5 36.6 72.5 89.3 102.6 68.3 386.7 439.2 0.5 75.0 56.5 38.3 10.1 4.5 32.6 136.3 52.1 354.0 1.7 7.2 117.9 108.5 27.2 42.9 95.1 44.3 11.1 3.3 138.8 37.9 3.8 38.0 61.1 8.8 23.1 102.1 11.5 6.6 55.3 94.4 0.2 0.4 517.2 262.0 158.4 97.8 0.3 24.4 129.4 ARL8B "ARL10C, FLJ10702, Gie1" ENSG00000134108 "ADP ribosylation factor like GTPase 8B" Q9NVJ2 3 5122249-5180911 "Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Langerhans cells: 249.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038759, HPA040515, HPA045924" Approved NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 43: THP-1 - Innate immune response" "Cluster 41: Macrophages - Immune response" "HPA038759: AB_2676193, HPA040515: AB_2677017, HPA045924: AB_2679500" "unprognostic (1.37e-2)" "unprognostic (1.22e-1)" "unprognostic (3.90e-2)" "unprognostic (3.59e-1)" "unprognostic (1.12e-1)" "unprognostic (3.08e-1)" "prognostic unfavorable (3.68e-6)" "unprognostic (1.62e-1)" "unprognostic (1.48e-1)" "unprognostic (2.21e-2)" "unprognostic (6.27e-3)" "unprognostic (1.96e-1)" "prognostic favorable (4.84e-6)" "unprognostic (5.90e-3)" "unprognostic (1.89e-1)" "unprognostic (1.57e-1)" "unprognostic (1.95e-2)" 41.7 51.1 53.6 36.1 58.4 59.7 42.4 55.4 73.2 39.5 38.3 33.8 30.7 45.1 39.8 65.8 31.1 38.7 55.2 59.7 58.6 53.8 43.9 43.6 38.7 57.2 54.3 38.9 27.5 48.1 0.1 49.8 59.2 45.0 34.8 34.3 28.6 41.8 50.7 54.8 34.3 47.0 60.3 33.9 34.1 32.2 59.5 35.8 62.1 59.9 47.5 49.7 0.3 61.7 49.5 44.1 38.5 20.7 118.4 103.8 71.7 67.8 75.5 64.0 75.8 33.6 44.9 52.6 29.4 65.7 141.4 30.6 61.9 60.1 73.2 58.3 35.8 86.2 34.3 48.4 162.5 73.9 97.0 96.7 179.5 80.9 56.2 67.4 72.2 47.2 76.6 55.0 96.2 45.1 63.0 56.1 36.2 44.6 65.2 43.5 52.2 46.7 63.9 73.8 22.1 41.9 57.7 112.5 96.2 42.7 66.0 219.7 61.6 66.5 55.8 91.9 62.3 50.8 88.0 143.9 94.4 102.7 54.9 42.9 37.8 24.5 18.8 33.0 22.4 19.8 19.6 18.8 31.7 16.7 20.0 20.0 17.0 22.1 27.4 14.2 20.3 27.7 53.6 58.4 55.4 73.2 59.7 58.6 57.2 54.3 59.2 60.3 59.5 61.7 35.8 80.1 63.7 52.9 42.9 128.1 60.5 40.4 74.6 23.3 44.4 31.4 55.6 31.5 45.2 35.0 10.4 42.4 30.4 38.9 19.6 37.2 33.7 45.9 39.8 35.9 13.1 35.1 61.6 37.6 80.1 48.7 33.6 88.5 56.4 25.3 19.2 42.4 97.8 8.4 68.3 19.5 24.4 68.3 249.6 42.0 23.0 109.3 55.2 47.8 103.3 37.2 23.7 47.7 86.0 61.5 26.7 33.8 45.4 71.5 23.2 46.1 40.6 22.7 72.3 31.7 45.7 34.5 24.0 109.5 164.7 173.1 36.8 23.8 16.6 123.3 EDEM1 "EDEM, KIAA0212" ENSG00000134109 "ER degradation enhancing alpha-mannosidase like protein 1" Q92611 3 5187646-5219958 "Plasma proteins, Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 79.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 100.7;Langerhans cells: 194.0;Plasma cells: 135.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 184.4;U-698: 162.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029565 Uncertain Enhanced "Endoplasmic reticulum,Aggresome" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Endoplasmic reticulum" Aggresome "HPA029565: AB_10602032" "unprognostic (3.03e-1)" "unprognostic (3.02e-2)" "unprognostic (3.57e-3)" "unprognostic (4.30e-3)" "unprognostic (1.37e-1)" "unprognostic (2.60e-2)" "unprognostic (6.29e-2)" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (6.49e-2)" "unprognostic (5.72e-3)" "unprognostic (1.51e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "unprognostic (2.34e-2)" "unprognostic (1.37e-1)" "unprognostic (3.09e-1)" 11.2 11.3 5.5 31.3 6.6 66.5 14.4 3.7 6.2 11.6 4.4 15.6 14.1 11.9 12.6 16.7 10.7 12.2 7.2 5.2 5.6 12.5 59.3 29.8 41.4 6.5 5.2 13.1 24.9 17.2 9.4 14.0 4.9 12.4 16.9 5.6 13.3 10.7 5.7 17.2 18.7 12.5 5.4 24.4 17.7 10.5 6.7 79.1 17.6 5.4 42.5 16.7 13.2 6.4 18.0 17.8 11.1 11.1 14.3 31.6 35.1 28.8 38.8 19.5 25.5 8.2 23.4 95.9 15.2 28.6 42.3 13.9 12.1 39.8 29.6 184.4 7.1 32.7 16.9 18.7 66.2 39.0 91.8 28.7 47.4 41.6 45.5 26.4 39.2 122.1 8.7 128.2 24.4 10.6 78.9 14.9 5.6 8.2 13.4 113.2 19.6 90.0 22.4 37.0 1.4 14.5 20.8 29.6 44.4 9.8 15.2 123.3 38.7 37.2 25.7 32.1 33.6 75.1 49.4 162.3 61.8 37.1 31.8 2.9 2.6 3.1 4.0 3.7 5.7 6.7 5.9 4.4 3.3 4.4 5.2 4.1 3.0 2.1 4.6 7.5 6.7 2.0 5.5 6.6 3.7 6.2 5.2 5.6 6.5 5.2 4.9 5.4 6.7 6.4 11.8 60.9 100.7 10.7 51.1 20.6 7.0 15.5 10.2 5.3 17.2 11.0 3.1 20.0 19.9 16.5 10.4 10.0 29.1 23.8 0.0 7.0 14.4 11.4 14.8 12.6 8.4 12.6 17.4 12.2 32.8 11.3 20.9 20.0 23.5 8.1 12.8 76.2 17.0 1.7 15.4 26.4 14.2 32.9 194.0 63.1 8.4 44.3 16.0 14.0 43.1 3.3 12.3 11.1 10.3 15.2 4.7 9.1 135.5 12.5 16.1 8.5 11.0 4.0 0.0 9.4 13.6 7.8 5.5 23.1 27.3 40.9 25.5 5.1 12.3 20.7 GRM7 "GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87" ENSG00000196277 "Glutamate metabotropic receptor 7" Q14831 3 6770001-7741533 "G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Cardiomyopathy, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1;parathyroid gland: 4.4" "Group enriched" "Detected in some" 14 "Excitatory neurons: 773.1;Inhibitory neurons: 597.7;Oligodendrocyte precursor cells: 1189.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SH-SY5Y: 4.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015964 Uncertain Cytosol NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "HPA015964: " "unprognostic (2.04e-2)" "unprognostic (7.03e-3)" "unprognostic (1.43e-1)" "unprognostic (9.37e-2)" "unprognostic (8.48e-3)" "unprognostic (2.58e-1)" "unprognostic (7.30e-2)" "unprognostic (3.50e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-1)" "unprognostic (1.46e-2)" "unprognostic (2.54e-1)" "unprognostic (6.84e-6)" "unprognostic (1.45e-1)" "unprognostic (2.82e-2)" "unprognostic (5.43e-2)" "unprognostic (2.59e-2)" 0.2 2.0 2.8 0.0 2.9 0.0 0.1 0.1 3.8 0.9 0.0 0.1 0.2 0.9 0.0 0.0 0.2 0.0 0.0 3.9 5.1 0.0 0.1 0.1 0.0 2.0 3.0 0.1 0.0 4.4 0.0 0.1 1.7 0.3 0.1 1.1 0.7 0.3 0.0 0.0 0.0 2.3 3.7 0.1 0.0 1.1 5.0 0.3 0.1 0.0 0.0 0.2 0.1 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.9 0.1 3.8 3.9 5.1 2.0 3.0 1.7 3.7 5.0 1.7 0.1 0.0 0.0 29.4 0.0 0.1 1.2 0.1 0.0 24.1 0.1 0.5 1.1 4.3 0.7 0.0 8.4 0.0 0.1 0.0 1.9 0.0 32.7 0.1 2.7 0.2 0.0 0.0 773.1 0.0 0.1 1.6 0.0 0.1 1.3 0.1 0.0 0.0 0.1 1.7 597.7 0.0 0.0 0.0 1.2 41.7 0.3 0.4 0.0 13.1 0.1 1.3 0.0 1189.3 56.9 0.0 0.0 0.0 0.0 0.7 0.0 0.1 8.0 3.5 6.6 0.7 0.4 2.7 0.8 0.0 0.0 0.0 0.1 0.5 0.0 0.7 LMCD1 ENSG00000071282 "LIM and cysteine rich domains 1" Q9NZU5 3 8501807-8574668 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 573.4" "Cell type enhanced" "Detected in many" "Adipocytes: 287.6;Ductal cells: 122.0;Endothelial cells: 161.9;Pancreatic endocrine cells: 114.1;Smooth muscle cells: 112.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "T-reg: 20.5" "Lineage enriched" "Detected in many" 6 "T-cells: 20.5" "Cell line enhanced" "Detected in many" "HHSteC: 88.9;HSkMC: 124.9;hTEC/SVTERT24-B: 93.8;U-2197: 83.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024059 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" No No 6600 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Cytosol" "Plasma membrane, Cell Junctions" "HPA024059: AB_1852950" "unprognostic (2.46e-1)" "unprognostic (1.79e-1)" "unprognostic (5.13e-3)" "unprognostic (1.30e-1)" "unprognostic (2.28e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (2.96e-1)" "unprognostic (8.21e-3)" "unprognostic (4.29e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (8.66e-5)" "unprognostic (3.80e-2)" "unprognostic (1.33e-1)" "unprognostic (1.01e-3)" "unprognostic (3.68e-3)" 131.4 14.3 9.5 45.6 9.5 0.1 97.5 13.5 10.8 27.2 38.8 18.1 9.0 90.3 18.4 36.1 57.8 67.2 90.6 14.0 9.7 33.0 9.7 131.7 17.3 14.0 11.0 65.8 37.7 30.0 8.7 54.5 12.1 34.8 7.0 15.2 42.2 16.8 573.4 28.8 20.1 63.3 13.2 55.6 46.4 11.3 12.6 4.7 18.5 260.9 10.2 110.6 31.5 14.8 9.4 52.0 8.6 6.6 62.0 34.6 8.9 37.9 19.4 20.5 50.0 38.8 11.5 0.0 4.2 44.2 8.8 0.8 4.9 9.9 8.4 16.0 3.6 11.6 3.5 7.6 88.9 0.0 1.1 124.9 0.2 93.8 0.7 11.9 10.1 0.0 0.0 0.0 26.8 6.7 0.0 0.1 16.8 12.0 2.3 0.2 28.2 0.1 19.1 3.6 0.3 21.3 6.4 31.1 20.6 23.9 40.7 0.1 5.0 20.4 40.3 83.0 25.9 5.1 6.2 2.6 4.1 2.9 27.0 0.0 0.0 0.0 0.0 0.4 0.1 2.0 2.9 0.6 3.3 0.3 0.0 0.1 0.0 0.0 0.0 1.0 20.5 0.3 9.5 9.5 13.5 10.8 14.0 9.7 14.0 11.0 12.1 13.2 12.6 14.8 287.6 9.6 10.7 2.0 2.1 31.6 42.1 7.4 9.6 13.0 20.4 17.0 14.7 14.3 13.5 5.5 10.4 3.9 1.7 1.4 3.9 122.0 1.1 9.6 77.7 161.9 12.1 0.0 0.8 48.5 4.2 64.5 7.1 4.8 10.2 44.2 30.7 12.6 3.4 97.6 1.2 2.4 4.1 0.8 47.0 2.3 11.5 3.2 53.4 29.0 9.0 38.9 1.0 4.0 8.7 114.1 0.9 32.4 8.0 8.4 0.3 45.5 12.0 8.0 0.0 57.0 112.9 6.4 9.1 29.0 27.1 4.4 5.3 21.5 4.7 7.5 SSUH2 "C3orf32, fls485, ssu-2" ENSG00000125046 "Ssu-2 homolog" Q9Y2M2 3 8619400-8745040 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 2.5;intestine: 3.7;testis: 3.9" "Group enriched" "Detected in some" 4 "Early spermatids: 61.7;Late spermatids: 43.6;Proximal enterocytes: 16.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 27 "Hep G2: 26.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA049777 Approved NA NA "Cluster 45: Intestine - Brush border" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 29: Early spermatids - Spermatogenesis" "HPA049777: AB_2680876" "unprognostic (2.49e-1)" "unprognostic (7.62e-2)" "unprognostic (9.65e-2)" "unprognostic (1.68e-1)" "unprognostic (2.46e-1)" "unprognostic (8.86e-2)" "unprognostic (1.46e-3)" "unprognostic (9.79e-2)" "unprognostic (1.53e-1)" "unprognostic (4.09e-1)" "unprognostic (7.97e-3)" "unprognostic (1.52e-1)" "unprognostic (3.15e-3)" "unprognostic (1.31e-1)" "unprognostic (3.65e-2)" "unprognostic (4.96e-2)" "unprognostic (7.50e-2)" 0.5 0.1 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.2 0.0 0.5 3.7 0.2 0.0 0.2 0.2 0.4 2.5 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.1 0.1 3.3 0.1 0.0 1.6 0.3 3.9 0.0 0.0 0.8 0.1 0.1 0.2 0.2 0.1 0.0 0.5 0.6 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 9.9 0.0 0.0 1.3 0.0 0.3 0.1 0.1 0.0 0.0 0.3 0.8 1.8 0.0 0.1 0.0 0.0 0.0 0.1 3.1 0.0 0.0 61.7 1.7 0.1 3.0 0.0 0.0 4.5 0.0 0.0 0.1 0.0 0.2 0.0 0.7 2.2 0.0 0.0 0.0 1.9 1.8 0.0 0.0 0.4 43.6 1.2 0.2 1.8 1.0 0.0 0.0 0.0 2.0 1.4 0.1 1.2 0.4 0.0 0.1 16.1 0.9 4.0 0.0 0.0 0.4 0.7 0.5 1.1 0.3 0.1 0.0 0.1 0.5 0.8 0.2 CAV3 "LGMD1C, LQT9, VIP-21, VIP21" ENSG00000182533 "Caveolin 3" P56539 3 8733802-8841808 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skeletal muscle: 182.7;tongue: 72.8" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 22.9;Early spermatids: 4.2;Sertoli cells: 6.6;Skeletal myocytes: 11.0" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RH-30: 94.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017518, CAB018557, HPA054488" Enhanced Approved "Vesicles,Plasma membrane" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "Plasma membrane" Vesicles "CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504" "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-2)" "unprognostic (6.43e-2)" "unprognostic (8.79e-2)" "unprognostic (3.05e-3)" "unprognostic (8.38e-3)" "unprognostic (9.79e-2)" "unprognostic (1.36e-1)" 0.4 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 5.7 0.1 0.1 27.4 0.1 0.1 0.0 0.0 0.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.9 0.1 0.0 2.5 0.2 182.7 0.2 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.2 0.1 72.8 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 11.0 2.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 OXTR ENSG00000180914 "Oxytocin receptor" P30559 3 8750381-8769628 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 14.7;breast: 54.1" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 122.6;Excitatory neurons: 25.8;Oligodendrocyte precursor cells: 21.1;Respiratory ciliated cells: 57.1" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 421.2;BJ hTERT+: 127.9;BJ hTERT+ SV40 Large T+: 119.4;fHDF/TERT166: 424.5;HBF TERT88: 92.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.18e-1)" "unprognostic (7.94e-2)" "unprognostic (4.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.02e-2)" "unprognostic (2.02e-1)" "unprognostic (1.46e-2)" "unprognostic (2.56e-3)" "unprognostic (2.12e-1)" "unprognostic (3.42e-1)" "unprognostic (2.76e-1)" "unprognostic (3.80e-2)" "unprognostic (4.24e-4)" "unprognostic (8.25e-2)" "unprognostic (4.60e-2)" "unprognostic (2.71e-1)" "unprognostic (1.84e-1)" 0.4 0.2 4.0 0.1 8.1 0.6 54.1 3.3 4.1 0.5 0.3 0.2 0.1 3.5 0.3 1.6 3.0 0.3 0.5 3.1 13.7 0.5 0.2 0.9 0.2 14.7 12.4 3.1 0.1 0.1 0.3 0.5 6.6 0.8 0.1 2.7 0.2 0.8 0.2 0.2 0.2 0.5 12.0 0.3 0.2 0.3 13.7 0.3 0.3 0.1 0.1 0.8 0.2 3.7 1.1 4.6 2.5 0.5 0.5 1.2 0.8 421.2 127.9 119.4 63.4 0.6 11.3 0.3 0.9 424.5 1.7 0.9 2.0 0.9 92.4 3.9 2.1 1.1 1.9 0.7 2.2 1.0 1.0 0.7 0.5 1.7 0.9 36.1 0.2 1.3 0.2 0.8 67.5 0.3 0.9 3.3 2.7 1.4 18.7 0.9 1.6 25.5 4.5 0.4 0.7 0.8 0.7 0.9 0.2 8.1 0.3 0.6 0.6 5.9 1.5 1.2 1.2 0.7 1.2 0.2 0.6 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.0 8.1 3.3 4.1 3.1 13.7 14.7 12.4 6.6 12.0 13.7 3.7 1.3 9.6 1.1 3.3 0.3 0.4 0.6 1.0 0.0 0.8 2.3 122.6 1.5 1.5 6.5 0.0 0.0 0.2 0.4 0.3 0.0 2.7 1.4 4.7 0.6 0.7 0.0 0.0 25.8 0.0 0.1 2.0 0.0 0.9 0.0 4.3 1.4 0.0 0.2 0.0 14.0 0.0 2.0 0.0 0.0 2.0 0.0 3.1 0.0 5.6 0.1 7.9 0.0 21.1 15.4 1.2 0.1 0.4 0.2 2.2 0.0 0.1 57.1 0.2 0.0 2.0 16.9 1.0 1.8 0.0 0.1 0.0 0.3 3.1 0.1 0.3 RAD18 RNF73 ENSG00000070950 "RAD18 E3 ubiquitin protein ligase" Q9NS91 3 8775402-8963773 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006716, HPA006724, HPA008752" Supported Approved Enhanced "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 2: Granulocytes - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nuclear bodies" "HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129" "unprognostic (1.26e-1)" "unprognostic (1.07e-1)" "unprognostic (4.45e-2)" "unprognostic (1.25e-3)" "unprognostic (2.73e-2)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.01e-1)" "unprognostic (9.76e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (3.73e-4)" "prognostic unfavorable (3.65e-5)" "unprognostic (1.97e-2)" "unprognostic (1.51e-1)" "unprognostic (7.92e-2)" "unprognostic (1.89e-2)" 2.7 2.3 1.2 3.3 1.5 5.2 5.3 1.3 1.7 3.2 0.5 3.8 10.1 2.8 1.9 3.4 2.3 3.1 1.8 1.5 0.9 1.6 2.7 2.7 4.6 1.6 1.0 2.8 1.7 2.0 1.3 3.0 1.5 3.2 4.9 2.6 3.2 1.6 1.3 4.5 6.5 2.8 1.2 3.5 2.2 2.9 1.1 5.8 3.7 1.0 4.4 2.5 2.9 2.3 16.2 15.2 12.3 7.4 3.0 6.4 14.9 25.0 8.5 23.5 16.1 13.7 10.1 19.8 4.7 14.2 13.8 5.6 13.1 13.0 23.8 12.2 17.2 16.9 16.1 8.2 1.9 22.7 13.9 2.4 4.6 23.3 15.7 6.3 7.7 17.1 18.2 19.0 20.9 18.6 22.9 15.9 17.2 12.7 28.5 18.0 13.6 15.6 6.9 12.2 5.1 11.5 11.2 10.5 8.2 9.7 11.0 9.8 6.4 19.4 10.5 16.8 21.7 9.6 16.1 43.7 14.3 24.5 14.6 6.4 1.6 5.1 1.5 1.7 2.8 1.9 2.1 2.7 2.0 1.9 2.2 1.6 0.7 2.8 1.1 3.6 3.0 0.8 1.2 1.5 1.3 1.7 1.5 0.9 1.6 1.0 1.5 1.2 1.1 2.3 5.7 16.0 9.8 6.2 7.7 11.1 7.5 6.4 5.7 4.6 7.3 11.7 2.2 4.3 7.5 3.7 2.1 9.0 8.6 5.2 1.9 9.6 4.2 4.0 5.8 4.6 1.8 7.2 20.9 8.2 12.4 6.8 3.6 4.9 13.9 14.8 6.1 3.1 7.1 3.3 15.7 6.5 2.0 5.2 5.6 3.0 4.1 4.6 3.6 14.0 7.1 3.2 8.2 16.1 14.3 10.2 4.3 2.6 8.7 6.4 4.0 3.1 4.1 2.3 6.6 4.3 6.9 26.2 14.0 6.0 11.8 6.7 7.5 9.3 6.3 3.6 SRGAP3 "ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP" ENSG00000196220 "SLIT-ROBO Rho GTPase activating protein 3" O43295 3 8980591-9363053 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.1;retina: 14.8" "Cell type enhanced" "Detected in many" "Astrocytes: 201.8;Bipolar cells: 217.5;Cone photoreceptor cells: 273.1;Endometrial ciliated cells: 166.0;Excitatory neurons: 223.1;Horizontal cells: 228.8;Inhibitory neurons: 281.2;Oligodendrocyte precursor cells: 159.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.3;HBEC3-KT: 8.2;hTCEpi: 7.8;RT4: 10.9;T-47d: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036959, HPA044074, HPA078079" Enhanced Approved Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 30: Epithelial cell lines - Translation" "Cluster 62: Horizontal cells - Visual perception" Cytosol "HPA036959: AB_10672784, HPA044074: AB_2678799, HPA078079: " "unprognostic (3.63e-3)" "unprognostic (1.12e-3)" "unprognostic (7.61e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (3.53e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (9.55e-2)" "unprognostic (6.66e-3)" "unprognostic (2.70e-2)" "unprognostic (5.58e-2)" "unprognostic (1.18e-3)" "unprognostic (6.10e-2)" "unprognostic (3.77e-1)" "unprognostic (2.75e-2)" "unprognostic (6.39e-3)" 0.7 3.3 12.3 0.7 13.9 0.3 1.5 22.1 16.9 5.2 0.3 1.0 0.7 2.2 1.5 2.3 10.9 1.0 1.8 14.5 9.1 3.2 0.5 1.0 1.1 5.1 9.8 3.7 1.1 0.6 6.1 0.7 7.4 4.5 1.1 14.8 4.2 1.4 1.3 3.7 0.9 0.7 5.6 0.7 1.5 3.5 11.9 1.8 2.6 2.1 0.9 4.1 1.7 10.0 0.5 0.5 9.3 0.4 0.6 1.2 1.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.0 0.1 4.8 0.2 8.2 0.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 5.0 0.7 7.8 0.6 0.8 0.2 0.0 2.1 0.0 0.0 0.0 0.1 0.2 2.0 0.9 1.6 0.7 1.1 0.0 0.0 3.8 10.9 1.0 1.2 0.2 2.8 0.1 2.2 10.5 0.0 0.0 0.0 0.3 0.1 0.1 2.7 0.1 0.0 0.8 1.7 0.3 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 12.3 13.9 22.1 16.9 14.5 9.1 5.1 9.8 7.4 5.6 11.9 10.0 1.0 3.2 5.6 201.8 2.3 4.1 28.7 36.3 23.3 217.5 7.9 9.8 9.6 0.0 40.6 77.3 273.1 2.4 3.5 1.4 5.9 3.2 24.1 166.0 6.0 4.2 3.0 0.8 223.1 0.5 0.8 4.9 8.2 93.8 1.3 5.4 0.7 2.1 13.2 228.8 281.2 6.2 12.2 18.6 6.0 20.2 2.5 9.4 1.8 37.5 3.3 80.6 1.0 159.8 132.2 0.6 0.5 1.2 1.4 12.3 0.5 1.4 59.4 94.8 0.0 2.9 3.9 6.1 7.1 17.2 5.8 1.4 14.7 12.0 3.1 31.2 THUMPD3 DKFZP434F091 ENSG00000134077 "THUMP domain containing 3" Q9BV44 3 9362971-9386791 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 270.0;Late spermatids: 145.3;Spermatocytes: 183.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036170, HPA036171" Approved Enhanced Nucleoli,Cytosol No No "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol Nucleoli "HPA036170: AB_10671836, HPA036171: AB_2674985" "unprognostic (2.13e-2)" "unprognostic (8.30e-2)" "unprognostic (1.74e-3)" "unprognostic (4.25e-2)" "unprognostic (2.66e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.25e-7)" "unprognostic (6.54e-2)" "unprognostic (1.09e-1)" "unprognostic (2.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "prognostic favorable (1.03e-4)" "unprognostic (1.41e-1)" "unprognostic (4.53e-2)" "unprognostic (4.05e-2)" "unprognostic (1.59e-2)" 14.5 15.5 10.1 15.0 11.5 33.0 18.0 12.7 11.0 18.1 14.0 19.1 16.8 16.3 16.7 20.9 14.7 13.6 24.6 9.9 11.7 20.0 23.4 14.2 18.8 11.2 10.6 14.7 15.5 25.8 12.1 15.1 12.0 19.5 19.0 22.0 15.9 17.9 26.9 13.6 14.3 14.4 11.6 14.3 14.1 59.4 10.9 18.3 23.1 26.4 17.7 16.4 9.6 15.2 40.0 53.0 36.4 18.7 46.5 44.4 146.3 47.2 38.3 47.1 35.8 40.2 41.0 41.0 35.8 43.5 74.1 26.0 66.4 48.3 47.9 45.6 39.1 51.0 51.2 35.3 44.8 66.0 35.3 36.2 53.7 55.7 58.1 38.0 31.5 65.1 80.2 58.2 62.9 55.3 78.9 27.2 69.3 44.0 50.1 49.4 62.7 57.9 29.7 60.4 15.5 48.9 39.6 27.5 43.5 37.2 45.2 42.1 22.8 45.0 38.9 54.9 53.1 73.1 186.7 129.2 55.0 60.5 65.7 19.1 17.8 17.6 20.5 23.4 26.2 17.2 17.6 21.9 20.8 20.0 28.0 21.5 3.6 17.7 29.0 20.5 18.4 14.1 10.1 11.5 12.7 11.0 9.9 11.7 11.2 10.6 12.0 11.6 10.9 15.2 14.9 25.6 21.8 10.1 14.0 10.7 29.3 42.6 16.5 21.6 19.5 23.2 45.3 17.2 34.6 22.0 16.7 34.7 13.1 10.0 52.8 39.2 270.0 19.2 26.8 14.9 3.0 9.7 9.7 29.4 28.4 22.3 12.2 20.9 28.4 21.9 13.2 25.3 27.4 38.7 13.2 15.5 38.7 14.8 6.8 145.3 20.5 18.0 12.4 9.4 20.2 31.4 18.6 18.1 12.5 28.2 9.8 25.9 16.2 32.6 10.9 32.6 20.1 35.2 6.6 28.5 24.5 183.5 52.9 18.9 12.9 27.5 18.4 49.2 20.0 20.9 SETD5 FLJ10707 ENSG00000168137 "SET domain containing 5" Q9C0A6 3 9397615-9479240 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Autism, Autism spectrum disorder, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 263.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017093, HPA035574" Approved Enhanced Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 51: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "CAB017093: , HPA035574: AB_2674681" "unprognostic (6.46e-2)" "unprognostic (1.64e-1)" "unprognostic (3.44e-1)" "unprognostic (1.13e-1)" "unprognostic (1.22e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (6.21e-4)" "unprognostic (5.52e-2)" "unprognostic (2.29e-1)" "unprognostic (3.22e-1)" "unprognostic (1.65e-1)" "unprognostic (4.04e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (6.65e-2)" "unprognostic (1.67e-1)" "unprognostic (4.04e-2)" "unprognostic (5.15e-3)" 24.9 28.1 22.3 19.3 22.0 14.9 25.4 33.7 24.9 29.5 20.9 30.5 15.2 27.6 30.2 25.0 30.2 18.8 23.0 23.5 22.3 18.3 27.6 33.5 23.1 20.5 20.3 33.2 28.5 18.0 26.5 24.0 21.1 25.6 20.9 33.9 28.3 20.4 23.9 32.8 25.6 23.2 18.6 26.1 23.9 17.8 22.2 25.5 30.5 21.5 26.7 26.5 28.1 24.2 25.3 28.6 57.8 27.0 36.5 33.6 138.5 24.9 30.2 31.6 35.4 29.1 30.2 53.5 14.3 33.4 29.8 20.0 50.6 29.8 35.5 38.4 27.6 50.6 56.4 29.8 36.7 42.0 31.9 35.0 52.2 49.3 55.1 37.3 35.7 35.6 50.0 40.0 32.6 36.4 35.7 38.1 42.2 19.5 23.9 37.7 47.6 26.2 29.6 37.7 22.3 34.6 34.2 29.8 22.6 52.6 39.7 30.8 41.6 35.3 41.6 21.0 28.9 27.4 34.2 83.6 26.9 30.4 33.2 0.4 0.4 0.2 0.9 0.2 0.8 0.7 0.6 0.7 0.3 0.7 0.5 0.5 1.1 1.1 0.2 0.8 0.1 0.1 22.3 22.0 33.7 24.9 23.5 22.3 20.5 20.3 21.1 18.6 22.2 24.2 51.5 41.7 50.6 136.1 53.6 93.9 54.4 28.5 86.6 110.6 45.1 26.2 25.5 41.5 50.0 42.3 114.7 38.9 50.4 39.1 3.9 37.3 7.9 45.9 60.3 62.5 62.4 34.3 175.0 34.0 41.3 62.2 45.9 49.4 48.1 60.6 63.1 50.1 24.4 55.5 188.5 51.9 26.4 32.4 70.7 11.7 66.8 30.8 44.4 108.7 39.7 33.4 39.1 263.9 131.7 44.2 46.2 53.8 67.7 88.2 39.4 12.8 52.9 60.9 13.1 65.3 52.8 50.6 37.8 75.2 91.5 57.3 49.6 56.2 47.8 84.2 LHFPL4 GARLH4 ENSG00000156959 "LHFPL tetraspan subfamily member 4" Q7Z7J7 3 9498361-9553822 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 15.5;pituitary gland: 12.2;retina: 9.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 42.4;Cone photoreceptor cells: 18.8;Excitatory neurons: 60.0;Inhibitory neurons: 67.2;Oligodendrocyte precursor cells: 34.2;Rod photoreceptor cells: 17.4" "Group enriched" "Detected in some" 4 "glioma: 6.8;testis cancer: 5.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 13.5;NTERA-2: 4.4;SCLC-21H: 10.0;SH-SY5Y: 12.5;U-266/84: 11.3;WM-115: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041421 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" Nucleoplasm "HPA041421: AB_10796673" "unprognostic (6.81e-2)" "unprognostic (3.65e-2)" "unprognostic (4.50e-1)" "unprognostic (6.62e-3)" "unprognostic (1.82e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-1)" "unprognostic (5.65e-2)" "unprognostic (6.59e-2)" "unprognostic (1.12e-2)" "unprognostic (3.77e-1)" "unprognostic (1.90e-2)" "unprognostic (6.78e-2)" "unprognostic (2.99e-1)" "unprognostic (3.03e-3)" "unprognostic (8.21e-2)" 0.0 2.0 11.1 0.0 11.4 0.0 0.0 7.1 15.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.3 12.7 0.0 0.0 0.0 0.0 10.4 7.4 0.0 0.5 0.1 12.2 0.0 10.2 0.0 0.2 9.3 0.0 0.0 0.0 0.1 0.2 0.0 3.3 0.0 0.2 0.7 12.1 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.5 0.0 0.0 0.0 0.0 0.0 0.0 10.0 12.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 2.9 0.0 11.3 0.0 0.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.1 11.4 7.1 15.5 11.3 12.7 10.4 7.4 10.2 3.3 12.1 9.8 0.4 0.0 0.0 4.6 0.5 0.0 2.9 0.0 0.0 42.4 0.4 0.3 0.8 0.0 0.0 0.0 18.8 0.6 0.6 0.6 0.0 0.3 0.6 0.7 1.1 0.8 1.2 0.0 60.0 0.2 1.4 0.6 0.0 1.3 1.3 0.5 4.2 0.2 0.3 15.2 67.2 0.7 0.0 0.3 0.0 0.7 0.0 0.8 0.0 1.0 0.1 2.0 3.1 34.2 5.6 0.4 1.7 0.0 0.0 6.3 0.8 0.2 0.0 17.4 0.0 2.7 0.4 1.7 1.1 0.0 0.0 1.4 0.4 0.3 0.8 2.5 MTMR14 "C3orf29, FLJ22405, FLJ90311, hEDTP, hJumpy" ENSG00000163719 "Myotubularin related protein 14" Q8NCE2 3 9649433-9702393 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054063 Approved "Intracellular and membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 28: BEWO - Transcription regulation" "Cluster 3: Monocytes - Immune response regulation" "HPA054063: AB_2682365" "unprognostic (9.50e-2)" "unprognostic (5.60e-3)" "unprognostic (9.28e-2)" "unprognostic (1.31e-1)" "unprognostic (8.81e-3)" "unprognostic (2.34e-2)" "prognostic unfavorable (3.95e-4)" "unprognostic (2.42e-1)" "unprognostic (2.00e-1)" "unprognostic (3.51e-3)" "unprognostic (7.04e-2)" "unprognostic (1.37e-1)" "prognostic favorable (2.74e-4)" "unprognostic (1.25e-2)" "unprognostic (1.89e-1)" "unprognostic (1.29e-1)" "unprognostic (1.01e-3)" 18.3 18.0 15.7 22.1 16.4 56.0 15.5 15.6 15.7 12.4 28.1 18.5 17.7 12.7 11.2 15.9 13.5 13.4 34.4 14.8 16.3 18.4 19.5 21.6 37.3 16.4 16.0 13.9 11.8 14.9 10.2 20.1 16.8 12.1 18.4 9.2 13.9 10.7 45.3 19.8 17.9 13.4 15.9 27.8 16.5 16.9 16.6 24.4 15.3 35.6 41.6 18.3 12.7 18.8 18.9 29.1 19.1 11.1 25.6 17.1 106.4 15.0 28.6 29.3 33.6 22.1 27.7 38.2 16.0 24.2 37.8 11.3 23.4 34.2 24.7 34.5 32.5 40.0 24.4 31.9 45.6 35.3 70.6 31.9 22.9 36.9 38.4 19.9 33.2 28.6 25.0 34.0 20.5 60.4 26.1 28.9 31.3 28.2 23.8 27.0 23.1 41.1 26.4 32.6 10.2 28.7 16.7 21.6 29.3 26.0 28.9 57.3 26.0 13.7 21.5 24.9 21.5 37.0 63.3 49.6 31.0 44.0 18.2 116.9 139.9 107.1 44.7 148.1 44.5 76.5 43.3 45.5 177.8 63.4 39.6 40.6 87.7 58.0 145.1 97.2 55.5 113.7 15.7 16.4 15.6 15.7 14.8 16.3 16.4 16.0 16.8 15.9 16.6 18.8 19.3 16.0 6.4 21.5 41.7 10.8 12.2 22.6 8.0 0.0 13.2 12.1 23.8 18.6 14.8 9.2 0.0 47.6 34.2 22.0 29.4 38.3 13.8 10.4 10.5 20.0 12.5 24.8 12.2 28.2 39.0 13.0 27.0 19.6 19.7 15.0 26.4 16.7 67.7 0.0 10.3 14.6 22.4 65.3 28.3 12.8 13.1 55.8 12.4 28.1 68.4 0.0 22.6 9.5 19.9 41.9 25.9 13.2 25.0 15.2 33.2 37.3 10.1 0.0 6.6 15.2 14.0 39.0 40.0 14.7 18.0 64.7 27.0 40.5 16.8 12.7 CPNE9 KIAA4217 ENSG00000144550 "Copine family member 9" Q8IYJ1 3 9703826-9729908 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "brain: 69.2" "Cell type enhanced" "Detected in some" "Early spermatids: 12.9;Excitatory neurons: 28.2;Inhibitory neurons: 8.0;Late spermatids: 61.3" "Cancer enriched" "Detected in single" 4 "testis cancer: 1.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "intermediate monocyte: 1.0" "Lineage enhanced" "Detected in single" "monocytes: 1.0" "Cell line enhanced" "Detected in some" "Daudi: 2.3;U-937: 2.0" "Low region specificity" "Detected in all" HPA060813 Approved "Plasma membrane,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "Plasma membrane" "HPA060813: " "unprognostic (2.96e-1)" "unprognostic (4.75e-2)" "unprognostic (1.34e-1)" "unprognostic (5.04e-3)" "unprognostic (1.10e-1)" "unprognostic (1.96e-1)" "unprognostic (2.13e-3)" "unprognostic (1.03e-2)" "unprognostic (3.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.20e-4)" "unprognostic (2.67e-2)" "unprognostic (5.44e-4)" "unprognostic (1.47e-2)" "unprognostic (8.59e-2)" "unprognostic (3.45e-1)" "unprognostic (7.48e-2)" 0.1 2.1 10.9 0.2 7.1 1.2 0.1 12.1 23.6 0.1 0.0 0.4 0.3 0.1 0.0 0.1 0.1 0.1 0.1 5.8 19.6 0.2 0.0 0.3 0.2 69.2 19.8 0.1 0.1 0.1 5.3 0.1 65.0 0.1 0.1 1.1 0.1 0.2 0.0 1.7 0.3 0.2 4.2 0.2 0.3 1.3 39.6 0.1 0.1 0.0 0.1 0.1 0.1 12.9 0.0 0.3 0.1 0.0 0.3 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 2.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.2 0.3 0.3 0.0 0.3 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.2 0.6 0.5 0.0 0.0 0.2 0.4 0.7 0.9 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.4 0.3 2.0 0.1 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.1 10.9 7.1 12.1 23.6 5.8 19.6 69.2 19.8 65.0 4.2 39.6 12.9 0.1 0.0 0.0 2.0 0.0 0.3 0.0 0.0 0.6 0.8 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.9 0.1 0.1 0.1 0.0 0.0 28.2 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.4 0.0 1.9 0.0 8.0 0.0 0.0 0.8 0.3 61.3 0.0 0.8 0.0 3.7 0.0 0.7 0.0 2.0 2.2 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.2 0.9 0.7 0.2 0.4 0.0 0.1 0.0 0.1 0.0 BRPF1 BR140 ENSG00000156983 "Bromodomain and PHD finger containing 1" P55201 3 9731729-9748015 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 82.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003359 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 28: BEWO - Transcription regulation" "Cluster 10: Non-specific - Unknown function" "Plasma membrane, Cytosol" "HPA003359: AB_1078217" "unprognostic (4.18e-2)" "unprognostic (2.21e-2)" "unprognostic (6.47e-2)" "unprognostic (9.10e-2)" "unprognostic (3.42e-1)" "unprognostic (2.33e-2)" "prognostic unfavorable (3.20e-5)" "unprognostic (3.00e-1)" "unprognostic (3.72e-1)" "unprognostic (3.26e-3)" "unprognostic (4.27e-2)" "prognostic unfavorable (5.28e-4)" "unprognostic (1.51e-3)" "unprognostic (4.86e-2)" "unprognostic (3.55e-1)" "unprognostic (6.87e-2)" "unprognostic (9.67e-3)" 8.0 7.1 4.7 6.9 6.9 23.5 7.7 9.9 7.4 8.2 3.8 8.3 4.8 9.5 4.4 8.6 8.8 5.5 7.3 6.7 3.8 6.2 5.5 7.9 8.9 4.7 4.2 9.3 7.3 7.7 6.7 6.5 4.3 7.5 4.0 4.0 9.1 5.0 9.5 10.9 8.3 5.4 3.1 10.5 7.5 14.4 5.2 11.9 9.0 6.8 7.6 7.9 7.8 5.5 9.9 17.2 12.5 8.2 8.9 8.6 82.4 12.6 7.5 14.3 10.2 12.1 8.3 18.6 6.0 11.6 13.5 8.2 15.3 12.0 9.0 20.1 17.9 21.4 33.8 9.8 11.4 30.6 20.0 8.5 9.8 19.8 13.1 7.2 10.8 17.5 25.2 15.9 8.3 24.3 19.8 25.7 20.6 6.7 15.9 28.7 10.6 12.3 6.7 14.5 8.9 15.2 12.7 9.0 10.1 8.2 9.8 31.4 14.1 15.9 13.6 14.5 24.0 13.4 18.1 31.5 13.1 25.9 15.1 1.0 0.9 1.4 1.3 0.8 2.0 0.6 0.9 1.2 0.8 0.5 1.1 1.3 0.8 4.2 0.7 1.9 0.7 0.8 4.7 6.9 9.9 7.4 6.7 3.8 4.7 4.2 4.3 3.1 5.2 5.5 7.9 16.0 10.0 2.6 6.8 14.1 5.1 3.9 8.0 4.6 9.2 7.0 3.7 2.8 6.2 7.3 6.2 4.2 13.0 9.4 0.0 4.1 3.9 4.2 6.9 9.7 10.2 9.7 3.4 5.5 5.5 5.8 7.7 7.0 8.8 7.3 11.0 3.5 6.4 8.4 2.4 5.0 2.0 5.6 9.2 1.2 6.5 6.9 1.8 2.8 6.3 5.2 5.2 4.0 2.9 6.1 3.1 6.0 7.9 5.1 4.9 2.1 4.3 5.1 6.6 11.3 7.7 16.6 13.9 9.9 18.5 3.7 10.8 5.6 6.1 6.8 OGG1 "HMMH, HOGG1, MUTM, OGH1" ENSG00000114026 "8-oxoguanine DNA glycosylase" O15527 3 9749944-9788219 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 86.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027514, CAB047301" Approved Enhanced Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "CAB047301: , HPA027514: AB_10602189" "unprognostic (6.95e-2)" "unprognostic (7.82e-3)" "unprognostic (7.19e-2)" "unprognostic (1.24e-3)" "unprognostic (9.69e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (5.77e-5)" "unprognostic (7.83e-2)" "unprognostic (2.45e-2)" "unprognostic (3.43e-3)" "unprognostic (9.66e-3)" "unprognostic (4.23e-2)" "prognostic favorable (2.65e-4)" "unprognostic (2.06e-2)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.59e-1)" 12.6 13.8 18.6 13.2 18.3 12.2 12.8 20.5 19.6 18.2 12.5 14.8 18.9 17.1 10.3 9.6 16.9 8.4 11.8 19.6 15.8 30.3 20.7 10.7 26.2 18.8 16.7 22.5 10.6 6.6 10.8 8.6 17.9 15.7 8.1 12.1 12.2 10.1 7.2 9.6 17.2 9.8 16.2 15.2 12.4 8.6 17.5 13.5 13.1 8.0 21.2 15.3 14.3 17.4 11.3 20.7 20.3 13.1 19.9 22.3 38.4 14.5 14.8 21.6 25.6 19.9 10.8 68.5 9.5 18.3 34.1 10.8 12.1 15.9 9.0 25.1 17.6 33.9 32.5 29.3 20.7 13.3 20.9 22.3 20.0 37.4 16.0 17.4 27.3 9.6 11.0 10.9 20.9 21.3 10.7 13.2 11.0 10.3 29.3 7.8 13.7 22.4 12.4 5.7 9.0 15.9 18.4 15.2 11.5 10.4 23.7 22.9 17.5 21.9 22.7 17.2 24.0 10.7 16.9 35.9 17.4 37.9 13.7 15.1 10.9 20.7 18.7 9.0 18.4 13.9 15.8 15.3 9.8 16.5 12.1 11.5 2.9 27.0 7.3 15.9 21.0 10.9 18.6 18.3 20.5 19.6 19.6 15.8 18.8 16.7 17.9 16.2 17.5 17.4 9.5 0.0 3.4 15.3 16.7 5.5 8.9 8.3 9.1 20.9 6.7 7.4 2.3 10.0 4.9 9.2 35.5 6.4 16.5 9.0 11.7 7.7 0.9 5.0 12.2 10.4 18.0 22.3 11.2 6.7 10.1 11.7 6.1 4.4 2.5 10.0 10.0 11.8 18.0 8.4 9.2 8.8 6.1 9.0 5.8 1.8 14.3 9.3 7.2 10.3 15.8 11.3 27.8 13.0 9.9 8.8 11.0 13.5 10.0 5.2 47.1 86.3 4.1 34.7 26.3 11.1 10.3 10.2 21.5 5.0 4.5 4.0 12.9 12.0 14.0 5.4 CAMK1 "CaMKI, CaMKI-alpha" ENSG00000134072 "Calcium/calmodulin dependent protein kinase I" Q14012 3 9757347-9769992 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Differentiation, Neurogenesis" "Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 58.3;Hofbauer cells: 76.2;Macrophages: 71.2;Sertoli cells: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "eosinophil: 280.5" "Lineage enriched" "Detected in many" 7 "granulocytes: 280.5" "Cell line enriched" "Detected in many" 4 "HMC-1: 403.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031904, HPA051409" Approved Approved Cytosol NA NA 110000 "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" Cytosol "CAB031904: AB_630964, HPA051409: AB_2681473" "unprognostic (4.43e-2)" "unprognostic (3.05e-1)" "unprognostic (1.68e-1)" "unprognostic (1.29e-1)" "unprognostic (1.11e-1)" "unprognostic (3.06e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (5.53e-2)" "unprognostic (3.32e-1)" "unprognostic (9.74e-2)" "unprognostic (1.37e-3)" "unprognostic (2.17e-1)" "unprognostic (1.14e-3)" "unprognostic (7.76e-2)" "unprognostic (1.72e-1)" "unprognostic (3.67e-2)" "unprognostic (3.01e-1)" 52.4 99.7 50.1 17.2 48.9 5.1 37.2 39.9 61.0 27.0 31.8 33.6 9.2 31.8 13.7 8.0 37.0 11.1 20.5 61.2 46.3 24.9 36.4 23.9 11.1 37.8 41.7 41.2 8.4 14.4 21.6 6.7 38.8 31.1 10.6 5.9 9.8 19.7 7.1 7.9 16.5 26.0 36.8 16.7 21.7 29.8 46.9 4.3 19.5 7.8 15.0 28.4 18.3 46.1 0.5 16.4 12.6 0.0 64.7 24.3 32.6 38.4 21.1 43.1 40.4 24.1 3.0 1.1 9.0 26.0 6.2 2.7 0.0 5.0 27.0 0.4 95.4 53.5 32.1 34.1 35.9 4.5 403.3 25.3 4.1 60.6 6.7 35.4 36.8 0.9 7.2 1.2 16.3 10.3 0.3 38.8 9.0 0.4 25.7 0.3 0.4 1.1 25.9 2.8 4.2 16.7 6.6 0.7 4.0 5.3 4.1 67.2 19.6 19.8 24.4 28.0 48.7 0.4 0.3 1.0 41.5 14.7 3.0 17.8 21.3 280.5 0.3 42.2 0.1 0.1 0.4 0.2 14.1 0.2 0.3 0.1 1.0 3.6 43.0 0.4 2.0 4.7 50.1 48.9 39.9 61.0 61.2 46.3 37.8 41.7 38.8 36.8 46.9 46.1 58.3 0.0 3.1 17.9 2.8 5.0 19.2 3.4 5.7 9.9 5.2 4.6 0.1 12.8 2.1 11.0 2.1 0.4 3.0 2.6 9.8 14.4 1.8 1.8 14.9 22.8 6.0 4.8 25.6 4.0 1.2 23.3 5.6 3.1 30.5 16.7 30.4 23.5 76.2 0.0 14.5 2.3 0.0 46.4 40.2 7.2 36.1 71.2 5.4 8.4 36.7 39.4 3.1 6.6 2.7 5.5 2.9 45.1 0.2 17.5 3.6 47.4 1.3 7.7 59.2 12.2 42.7 1.5 3.7 1.5 3.8 0.8 7.1 6.6 7.6 11.0 TADA3 "ADA3, FLJ20221, FLJ21329, hADA3, NGG1, TADA3L" ENSG00000171148 "Transcriptional adaptor 3" O75528 3 9779860-9793011 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042250 Approved Supported Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA042250: AB_10794043" "unprognostic (5.77e-2)" "unprognostic (1.72e-2)" "unprognostic (2.78e-1)" "unprognostic (2.00e-3)" "unprognostic (6.83e-2)" "unprognostic (4.70e-2)" "unprognostic (9.15e-3)" "unprognostic (2.71e-1)" "unprognostic (4.90e-2)" "unprognostic (1.33e-1)" "unprognostic (1.47e-2)" "unprognostic (6.56e-2)" "prognostic favorable (5.47e-5)" "unprognostic (1.10e-2)" "unprognostic (2.03e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-3)" 32.5 60.1 51.3 36.9 51.4 34.8 32.5 48.8 57.0 37.9 43.2 44.8 31.4 44.3 23.2 34.2 44.1 32.0 47.2 51.0 54.4 41.6 50.8 34.0 46.3 54.0 53.5 56.8 29.0 35.5 45.0 22.2 50.5 49.6 27.1 18.1 35.5 40.8 59.8 28.6 33.8 32.5 52.4 38.9 39.4 54.5 56.6 32.8 39.3 40.0 37.9 41.6 31.9 48.4 48.0 49.7 78.2 44.2 67.1 61.3 167.6 50.0 83.6 64.3 80.3 50.7 55.1 52.8 59.1 107.7 84.3 28.4 43.9 65.3 29.2 66.0 53.7 118.0 60.6 55.3 95.5 44.6 185.5 62.6 83.3 91.5 65.8 85.0 43.3 75.0 80.6 63.4 80.0 136.0 43.2 44.5 73.5 62.8 47.8 22.2 39.6 67.2 66.3 47.6 30.5 88.5 42.9 23.1 81.5 43.2 80.6 106.2 62.9 88.0 70.4 47.1 70.0 50.3 61.3 92.4 126.0 76.5 74.0 62.8 44.0 126.0 58.2 68.4 30.6 33.8 40.7 48.1 49.6 30.4 35.9 39.2 51.6 53.0 88.9 31.5 54.5 55.2 51.3 51.4 48.8 57.0 51.0 54.4 54.0 53.5 50.5 52.4 56.6 48.4 26.1 12.8 12.8 22.5 37.0 16.8 88.3 66.2 32.5 28.6 43.4 45.7 8.6 41.5 30.2 33.1 14.6 47.3 59.1 80.2 66.5 65.2 93.3 28.7 32.9 24.4 35.5 41.6 9.9 64.2 53.5 34.4 32.1 22.6 47.0 31.9 35.0 43.1 65.0 25.2 10.9 63.0 44.7 50.3 25.4 75.6 36.7 48.8 32.0 6.5 92.8 96.9 146.2 5.0 10.0 67.1 68.2 42.9 31.9 43.1 64.9 70.3 25.2 29.3 72.3 33.9 42.2 86.9 81.2 32.7 16.6 36.8 50.2 41.0 52.7 53.0 ARPC4 "ARC20, p20-Arc" ENSG00000241553 "Actin related protein 2/3 complex subunit 4" P59998 3 9792495-9807101 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 468.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 5900000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 3: Monocytes - Immune response regulation" "unprognostic (2.54e-1)" "unprognostic (4.69e-2)" "unprognostic (8.93e-2)" "unprognostic (2.97e-2)" "unprognostic (2.49e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.79e-1)" "unprognostic (6.43e-2)" "unprognostic (2.05e-1)" "unprognostic (3.57e-1)" "unprognostic (2.99e-2)" "unprognostic (1.18e-1)" "unprognostic (5.20e-2)" "unprognostic (4.83e-2)" "unprognostic (7.89e-2)" "prognostic favorable (2.34e-4)" 100.8 97.8 136.1 135.3 136.2 148.5 84.2 128.9 146.3 86.3 121.5 126.1 98.7 93.2 66.7 139.0 82.6 68.8 71.3 150.5 138.1 118.7 81.7 91.7 171.5 136.1 137.2 69.9 58.4 76.9 54.3 77.5 138.3 69.9 117.7 18.2 69.7 70.9 91.8 101.0 98.0 113.0 136.7 143.3 83.5 38.0 144.9 132.6 69.6 61.2 205.1 121.7 84.9 138.4 151.7 168.9 150.2 95.5 189.9 157.8 402.2 225.1 238.2 204.5 177.6 106.8 199.3 106.2 126.6 326.5 201.1 95.8 102.9 182.7 183.6 202.2 67.2 315.6 156.0 120.7 209.9 291.8 410.6 173.7 166.9 245.6 149.4 171.5 239.0 59.1 165.5 92.2 327.0 302.3 244.2 261.1 278.5 201.9 200.2 209.9 105.9 160.8 248.6 198.0 62.9 209.9 137.1 155.9 161.5 128.3 189.5 450.6 243.8 188.8 87.8 194.2 329.4 60.8 197.1 293.0 272.7 224.2 286.4 300.2 377.6 431.4 279.8 469.0 230.7 210.3 232.4 230.4 314.4 194.9 161.7 218.0 639.5 218.0 457.8 432.2 274.6 480.6 136.1 136.2 128.9 146.3 150.5 138.1 136.1 137.2 138.3 136.7 144.9 138.4 91.1 16.0 42.0 0.0 104.0 68.2 79.5 37.7 17.6 12.9 56.2 38.4 24.3 44.3 32.2 58.8 8.4 117.4 228.5 213.3 72.4 136.0 9.8 42.8 70.9 79.5 112.9 56.8 0.0 126.1 240.3 59.7 44.9 62.1 104.1 69.4 81.4 54.7 340.3 23.5 0.0 151.8 30.5 237.1 155.8 7.4 49.4 210.3 78.2 0.0 468.8 40.7 300.7 0.0 0.0 171.2 182.6 66.2 31.7 75.3 118.8 136.2 29.1 13.3 39.5 43.8 82.4 12.9 32.0 33.9 65.8 169.1 132.1 103.1 154.4 87.9 ARPC4-TTLL3 ENSG00000250151 "ARPC4-TTLL3 readthrough" 3 9793082-9835401 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.4;B-cells: 1.8;Basal squamous epithelial cells: 1.8;Erythroid cells: 3.0;Gastric mucus-secreting cells: 2.0;Macrophages: 1.5;Plasma cells: 1.7;T-cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 43: THP-1 - Innate immune response" "Cluster 59: Non-specific - Transcription" "unprognostic (9.59e-3)" "unprognostic (7.61e-2)" "unprognostic (6.22e-2)" "unprognostic (2.65e-1)" "unprognostic (3.55e-3)" "unprognostic (2.86e-2)" "unprognostic (1.95e-2)" "unprognostic (2.78e-1)" "unprognostic (4.13e-2)" "unprognostic (3.31e-1)" "unprognostic (6.67e-2)" "unprognostic (1.82e-1)" "unprognostic (3.42e-4)" "unprognostic (5.49e-2)" "unprognostic (4.06e-1)" "unprognostic (2.58e-1)" "unprognostic (2.37e-4)" 2.0 1.6 1.4 2.9 1.4 6.7 1.5 1.4 3.2 2.0 1.4 1.5 2.2 1.2 0.6 2.0 1.4 1.3 1.5 1.4 1.6 1.6 1.0 1.9 2.2 1.7 1.5 1.5 0.8 1.0 1.6 1.1 1.5 1.3 0.9 0.6 1.3 0.7 1.6 2.0 2.0 1.5 1.4 3.2 1.3 1.6 1.9 2.3 1.3 0.5 2.1 1.6 1.6 1.7 2.9 0.4 3.0 1.2 3.1 4.6 8.0 3.1 3.3 2.1 2.3 1.4 1.0 3.8 1.4 9.6 4.2 1.5 3.1 2.5 2.6 6.8 1.5 6.1 1.5 0.9 4.3 6.1 9.4 5.6 3.5 5.5 2.4 2.8 3.1 5.8 4.7 4.1 3.1 0.0 3.8 4.9 3.3 1.7 2.1 5.6 2.5 0.1 4.0 3.1 1.6 2.6 2.1 4.3 3.1 1.7 0.8 13.4 4.0 1.8 2.1 3.7 4.5 4.6 6.7 9.6 3.9 5.7 3.9 0.8 2.9 3.0 2.7 2.8 1.7 1.3 1.8 1.4 3.0 1.3 1.4 1.5 3.2 1.3 3.3 2.7 1.4 3.8 1.4 1.4 1.4 3.2 1.4 1.6 1.7 1.5 1.5 1.4 1.9 1.7 0.1 0.0 2.4 0.0 1.8 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.1 0.3 0.0 3.0 0.2 0.0 0.1 1.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 0.0 0.0 1.5 0.0 0.0 0.1 TTLL3 "DKFZP434B103, HOTTL" ENSG00000214021 "Tubulin tyrosine ligase like 3" Q9Y4R7 3 9808086-9855138 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 63.9" "Low region specificity" "Detected in all" HPA051413 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 35: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA051413: AB_2681476" "unprognostic (1.51e-2)" "unprognostic (1.91e-1)" "unprognostic (7.23e-3)" "unprognostic (2.08e-1)" "unprognostic (4.96e-1)" "unprognostic (4.04e-4)" "unprognostic (3.14e-2)" "unprognostic (4.39e-2)" "unprognostic (7.71e-2)" "unprognostic (6.83e-2)" "unprognostic (5.46e-3)" "unprognostic (1.08e-2)" "prognostic unfavorable (6.45e-6)" "unprognostic (1.77e-2)" "unprognostic (2.09e-1)" "unprognostic (2.82e-1)" "prognostic favorable (9.51e-6)" 32.2 23.7 24.3 12.4 25.6 30.9 27.5 22.1 30.7 54.5 29.3 31.3 11.5 29.0 16.5 15.9 37.3 25.3 25.6 22.8 25.3 25.2 9.9 24.8 23.0 28.7 28.0 63.0 17.5 11.0 37.5 12.7 26.7 39.7 13.1 8.5 20.1 30.4 11.8 41.0 22.8 20.4 25.6 29.4 19.4 40.8 26.5 13.2 27.2 12.6 15.1 30.8 40.0 30.9 2.0 5.1 10.9 2.1 19.2 36.4 63.9 6.7 6.5 3.6 4.9 8.7 7.7 11.7 5.8 12.5 3.6 3.0 6.9 1.3 2.2 13.6 19.7 14.2 17.6 8.9 6.6 12.9 24.1 23.6 9.2 6.9 2.7 20.8 6.2 17.6 14.0 28.0 8.0 7.0 2.3 20.3 1.4 1.3 2.9 6.7 4.4 5.2 5.4 14.9 5.1 4.6 3.4 1.8 5.8 5.3 4.9 8.9 20.2 9.6 12.4 9.2 3.2 17.8 8.6 16.8 8.0 18.9 3.4 5.9 2.1 6.6 2.3 5.9 1.1 2.8 1.6 1.2 2.7 2.7 1.8 1.5 8.5 2.3 3.5 3.0 2.9 0.9 24.3 25.6 22.1 30.7 22.8 25.3 28.7 28.0 26.7 25.6 26.5 30.9 11.7 12.8 9.1 0.0 5.6 5.2 5.1 6.7 9.1 11.1 6.0 6.5 3.3 1.5 8.5 9.2 25.0 5.4 12.0 11.7 0.0 4.3 29.1 16.5 14.2 10.1 12.0 1.7 0.0 6.7 5.4 14.9 27.0 10.5 8.2 13.6 9.3 1.6 5.3 6.7 0.0 11.9 2.0 14.4 5.7 17.8 22.7 9.2 10.6 0.0 7.9 9.4 11.3 0.0 0.0 7.4 8.2 12.4 4.0 6.6 3.0 2.2 28.7 13.8 13.1 11.6 8.8 15.1 6.7 4.1 4.7 5.1 7.5 9.5 8.5 7.3 RPUSD3 MGC29784 ENSG00000156990 "RNA pseudouridine synthase D3" Q6P087 3 9837849-9844602 "Predicted intracellular proteins" "mRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 100.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 249.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037551, HPA037552" Uncertain Approved Nucleoplasm NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA037551: AB_2675538, HPA037552: AB_10672600" "unprognostic (1.57e-1)" "unprognostic (8.88e-2)" "unprognostic (5.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.05e-2)" "unprognostic (2.35e-1)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.31e-1)" "unprognostic (2.36e-1)" "unprognostic (3.00e-2)" "unprognostic (2.56e-2)" "unprognostic (1.48e-1)" "unprognostic (5.17e-3)" "unprognostic (2.02e-1)" "unprognostic (2.16e-1)" "unprognostic (2.94e-2)" "unprognostic (8.83e-2)" 18.8 28.8 25.1 13.2 25.4 21.3 19.8 24.3 31.3 20.3 22.0 25.3 17.6 21.5 14.7 32.3 20.0 8.7 37.2 26.5 25.4 24.7 30.7 16.1 17.4 23.8 24.1 17.8 24.5 26.1 20.3 16.7 23.8 19.9 16.5 15.5 19.9 17.4 72.7 27.4 20.1 16.7 21.6 21.0 22.8 54.3 25.3 15.2 16.0 48.2 21.3 24.2 21.0 26.0 30.5 44.8 33.6 21.7 55.1 40.5 249.3 25.9 36.7 41.9 44.3 39.4 30.6 52.4 31.6 29.0 61.7 25.6 75.2 46.3 33.2 40.7 78.9 69.8 39.6 42.5 43.1 43.5 42.3 50.0 63.3 48.9 56.5 34.2 55.9 69.3 52.7 35.4 41.9 72.0 59.6 78.9 36.4 44.4 66.3 41.5 27.5 88.5 46.2 23.0 25.9 21.5 32.6 41.0 69.9 47.9 70.3 46.3 33.6 16.7 30.0 29.8 38.4 52.3 67.4 70.0 35.1 81.3 39.5 35.4 51.0 26.5 44.1 38.2 45.7 50.3 41.4 42.3 46.8 41.9 46.3 41.7 12.3 84.9 26.7 45.0 64.9 41.5 25.1 25.4 24.3 31.3 26.5 25.4 23.8 24.1 23.8 21.6 25.3 26.0 11.8 19.2 9.6 10.1 19.5 8.0 21.4 27.8 13.1 22.8 17.1 21.5 25.4 21.5 20.8 14.7 20.9 44.3 19.8 16.4 46.9 31.1 80.3 6.9 13.7 15.8 13.2 24.6 9.9 31.6 48.6 16.3 15.8 9.7 21.0 20.1 22.1 28.3 39.1 11.8 10.6 17.0 12.2 14.7 7.3 59.5 21.5 15.2 16.0 3.7 27.2 20.6 54.6 8.0 6.3 25.8 20.6 21.4 18.8 19.5 28.1 55.4 12.9 22.2 6.6 13.3 17.2 100.7 20.6 22.3 12.8 17.2 20.5 33.9 28.6 16.2 CIDEC "CIDE-3, FLJ20871, Fsp27" ENSG00000187288 "Cell death inducing DFFA like effector c" Q96AQ7 3 9866711-9880255 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 740.3;breast: 492.9" "Cell type enriched" "Detected in some" 7 "Proximal enterocytes: 219.4" "Group enriched" "Detected in many" 5 "breast cancer: 4.5;colorectal cancer: 1.4;liver cancer: 2.4;pancreatic cancer: 4.6;stomach cancer: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "ASC diff: 1683.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018837, HPA020553" Uncertain NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 45: Enterocytes - Digestion" "HPA018837: AB_1846767, HPA020553: AB_1846769" "unprognostic (1.83e-2)" "unprognostic (3.08e-2)" "unprognostic (2.32e-1)" "unprognostic (1.83e-1)" "unprognostic (1.19e-1)" "unprognostic (7.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.26e-5)" "unprognostic (9.03e-2)" "unprognostic (1.81e-1)" "unprognostic (5.48e-3)" "unprognostic (8.14e-2)" "unprognostic (5.37e-5)" "unprognostic (9.47e-3)" "unprognostic (2.02e-1)" "unprognostic (7.46e-3)" "unprognostic (2.94e-2)" 740.3 5.6 0.1 1.1 0.2 0.0 492.9 0.0 0.4 1.2 0.0 15.9 68.9 4.6 0.3 0.7 2.2 5.0 9.5 0.1 0.1 2.1 10.0 0.2 1.2 0.1 0.2 0.4 7.4 0.1 0.2 0.0 0.2 2.3 3.9 0.0 16.2 3.7 6.1 18.1 89.8 1.6 0.1 0.2 7.4 0.9 0.2 1.5 3.9 11.6 0.0 13.3 4.8 0.2 0.0 0.2 0.0 0.0 1683.2 376.0 1.2 0.1 0.0 0.0 0.0 7.5 9.1 0.0 0.2 0.6 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 19.1 2.8 0.0 0.0 228.9 0.4 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.1 0.6 0.0 0.3 0.0 0.6 1.6 0.0 0.0 1.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.4 0.1 0.1 0.1 0.2 0.2 0.1 0.2 0.2 2.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 2.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 30.0 1.9 0.0 0.5 0.2 0.1 0.1 3.5 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.1 8.4 0.0 0.0 0.4 1.0 2.5 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 14.5 0.4 0.0 0.4 219.4 1.1 0.0 0.0 0.0 0.5 0.6 0.6 0.4 0.0 0.0 0.0 0.2 0.1 3.8 0.3 JAGN1 "FLJ14602, GL009" ENSG00000171135 "Jagunal homolog 1" Q8N5M9 3 9890574-9894349 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067610 Approved Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Vesicles "HPA067610: " "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (1.86e-3)" "unprognostic (1.97e-2)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" "unprognostic (2.92e-3)" "unprognostic (1.57e-1)" "unprognostic (2.37e-2)" "unprognostic (6.36e-3)" "unprognostic (9.93e-3)" "unprognostic (2.70e-1)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.65e-2)" "unprognostic (2.49e-1)" 29.6 43.5 21.3 15.7 22.3 12.1 26.6 23.8 28.9 21.9 24.6 26.3 27.0 23.4 39.7 19.4 25.7 16.4 22.9 21.6 23.1 30.1 62.6 17.4 19.2 22.5 22.3 25.5 40.2 31.5 17.8 20.6 22.5 20.9 30.2 19.9 24.0 20.8 36.1 27.6 26.4 20.5 22.9 17.6 30.8 14.1 22.7 24.0 17.8 30.1 23.6 23.0 21.0 23.6 32.7 54.0 39.8 23.9 116.9 121.5 128.3 43.8 65.2 49.4 49.6 40.6 43.1 51.4 19.6 44.2 54.0 28.1 63.1 59.5 48.9 38.4 65.7 62.4 55.7 73.7 99.4 45.6 37.3 115.3 89.4 63.6 73.2 51.0 47.0 45.8 65.0 34.5 59.2 99.0 37.8 80.5 50.1 65.3 74.3 31.0 32.5 64.4 73.3 45.9 25.0 46.4 29.6 31.8 58.1 35.8 50.4 56.8 39.9 26.2 28.1 29.3 35.4 60.2 94.5 60.7 33.1 55.7 44.9 100.9 61.8 31.1 48.1 48.6 50.5 52.5 46.8 45.9 57.4 53.3 50.9 48.0 24.9 51.9 37.9 58.1 54.7 67.9 21.3 22.3 23.8 28.9 21.6 23.1 22.5 22.3 22.5 22.9 22.7 23.6 28.7 32.1 17.5 5.2 38.6 27.5 47.8 84.1 30.7 27.3 53.0 58.8 14.1 55.8 43.5 38.6 10.4 74.7 30.8 49.5 21.5 80.6 3.2 33.0 33.5 36.3 25.8 30.9 4.8 98.1 80.1 37.9 30.1 22.9 8.2 36.5 42.8 52.4 55.8 23.5 5.7 55.2 59.0 40.7 22.5 6.8 39.4 29.8 37.4 4.7 75.3 52.3 50.4 8.0 8.0 73.5 55.7 38.7 35.3 66.2 114.2 55.9 40.6 23.3 46.0 31.6 31.7 66.0 51.2 35.8 36.8 52.9 31.3 48.8 58.3 39.2 IL17RE FLJ23658 ENSG00000163701 "Interleukin 17 receptor E" Q8NFR9 3 9902612-9916402 "Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 20.8;skin 1: 31.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 92.6;Gastric mucus-secreting cells: 58.1;Intestinal goblet cells: 52.1;Paneth cells: 37.7;Proximal enterocytes: 74.4;Undifferentiated cells: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 15.5;ASC TERT1: 38.5;hTCEpi: 16.5;T-47d: 19.4" "Region enhanced" "Detected in single" "cerebellum: 1.5" HPA019011 Uncertain "Intracellular and membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA019011: AB_1851667" "unprognostic (1.08e-2)" "unprognostic (7.58e-2)" "unprognostic (2.06e-1)" "unprognostic (1.43e-3)" "unprognostic (1.09e-1)" "unprognostic (9.81e-2)" "unprognostic (1.50e-1)" "unprognostic (8.43e-2)" "unprognostic (6.69e-2)" "unprognostic (6.31e-2)" "unprognostic (3.55e-3)" "unprognostic (4.15e-2)" "unprognostic (3.34e-2)" "unprognostic (1.10e-1)" "unprognostic (1.32e-1)" "unprognostic (5.96e-2)" "unprognostic (2.85e-2)" 6.1 0.4 0.5 1.4 1.6 0.0 5.9 2.2 1.0 4.5 0.3 16.6 20.8 1.8 2.7 7.5 2.5 6.8 1.2 0.4 0.9 2.8 0.8 8.1 0.4 1.5 0.4 0.6 9.7 4.2 1.6 1.1 2.3 4.8 13.8 0.1 6.3 3.3 0.4 31.0 20.4 1.4 0.4 1.0 16.7 0.2 0.3 2.8 3.2 0.2 1.7 1.7 6.6 0.4 2.6 0.3 0.0 0.1 15.5 38.5 11.3 1.0 1.4 0.3 0.9 2.9 2.3 0.0 0.6 2.7 0.0 7.1 0.0 6.2 0.1 0.1 0.1 0.8 0.2 6.8 0.4 0.0 3.2 2.4 16.5 0.0 0.1 0.0 0.1 2.5 0.1 0.0 0.7 3.1 0.4 11.3 0.1 8.1 0.8 0.0 0.0 0.1 2.8 3.2 0.6 0.2 0.0 6.5 0.0 0.3 19.4 0.3 1.5 0.1 0.0 0.3 0.2 0.2 0.1 0.0 0.4 6.5 0.2 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 2.2 1.0 0.4 0.9 1.5 0.4 2.3 0.4 0.3 0.4 3.4 6.4 1.1 3.3 1.0 14.5 11.9 2.3 14.2 3.0 8.4 8.3 0.9 15.7 2.0 16.5 0.0 4.3 0.8 92.6 7.9 2.7 0.2 1.4 2.0 1.3 33.6 9.0 2.4 4.8 1.8 4.9 58.1 1.3 0.0 1.2 1.8 15.4 2.6 1.7 1.9 52.1 2.0 2.2 3.5 0.4 2.1 1.6 5.4 0.0 1.0 4.7 2.1 2.0 0.6 2.5 37.7 3.4 0.8 6.1 74.4 8.0 1.0 1.0 19.7 1.8 7.2 1.6 2.3 11.8 14.8 0.8 2.8 1.0 40.8 4.6 IL17RC IL17-RL ENSG00000163702 "Interleukin 17 receptor C" Q8NAC3 3 9917074-9933630 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.7;myeloid DC: 2.1" "Group enriched" "Detected in many" 18 "dendritic cells: 2.1;monocytes: 1.7" "Cell line enhanced" "Detected in many" "ASC diff: 71.2;ASC TERT1: 43.6;HSkMC: 40.7;T-47d: 41.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019885, CAB026255" Approved "Intracellular and membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 45: Enterocytes - Digestion" "CAB026255: , HPA019885: AB_1851664" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "unprognostic (1.38e-1)" "prognostic favorable (1.38e-4)" "unprognostic (2.58e-2)" "unprognostic (1.45e-3)" "unprognostic (8.60e-2)" "unprognostic (7.11e-2)" "unprognostic (1.38e-2)" "unprognostic (5.27e-2)" "unprognostic (4.30e-2)" "unprognostic (5.98e-2)" "unprognostic (9.35e-3)" "unprognostic (2.40e-1)" "unprognostic (2.63e-1)" "unprognostic (1.48e-1)" "unprognostic (2.83e-1)" 17.5 32.2 5.5 4.2 5.5 3.8 18.8 5.0 7.1 16.6 6.0 21.4 15.0 15.0 4.9 23.6 14.8 7.4 19.9 5.7 6.6 15.7 63.7 9.2 1.8 6.2 5.9 12.9 15.3 17.0 27.9 2.9 4.9 31.3 4.7 1.1 23.7 12.6 16.9 32.2 15.5 6.9 6.6 5.9 16.8 1.7 7.0 1.9 13.9 15.7 2.4 17.9 19.4 5.0 7.3 4.6 1.5 4.5 71.2 43.6 10.8 10.0 23.4 12.3 19.5 1.6 19.9 0.0 11.8 15.8 8.7 5.1 2.0 10.7 4.1 4.7 6.0 1.9 13.6 6.6 22.0 0.1 0.0 40.7 8.7 14.9 3.3 5.7 10.6 0.0 0.8 9.1 9.8 11.3 0.2 0.4 0.9 2.6 31.4 4.5 5.1 2.6 9.1 4.1 4.0 6.4 6.1 13.7 10.8 0.4 41.2 0.8 8.9 13.4 6.4 5.9 6.7 0.1 0.3 0.0 21.0 0.9 9.8 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 5.5 5.5 5.0 7.1 5.7 6.6 6.2 5.9 4.9 6.6 7.0 5.0 10.1 0.0 0.5 18.9 2.0 10.8 18.6 11.2 12.5 2.1 30.2 24.1 3.4 18.6 11.7 1.8 0.0 5.8 2.6 22.4 3.9 15.1 0.5 8.0 8.7 7.8 14.4 6.5 3.8 21.1 4.7 15.7 15.8 10.0 0.0 14.0 11.4 43.9 11.0 1.7 4.8 25.3 16.2 6.0 7.8 1.4 19.0 6.0 14.2 4.7 3.4 25.5 1.0 7.1 0.9 13.2 29.8 17.0 1.7 25.7 53.2 17.7 6.9 1.6 19.7 12.8 12.4 0.8 0.5 13.3 19.9 2.9 2.1 11.9 20.0 16.6 CRELD1 "AVSD2, CIRRIN" ENSG00000163703 "Cysteine rich with EGF like domains 1" Q96HD1 3 9933816-9945406 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 110.3;hTERT-RPE1: 77.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026964 Uncertain Approved Nucleoli,Cytosol "Intracellular and membrane" NA NA 19000000 "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Cytosol Nucleoli "HPA026964: AB_10602210" "unprognostic (3.06e-2)" "unprognostic (1.08e-1)" "unprognostic (2.69e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.07e-4)" "unprognostic (3.03e-1)" "unprognostic (3.59e-1)" "unprognostic (2.85e-2)" "unprognostic (1.24e-2)" "unprognostic (1.19e-1)" "unprognostic (1.92e-2)" "unprognostic (4.59e-2)" "unprognostic (1.14e-2)" "unprognostic (6.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.89e-1)" "unprognostic (3.78e-2)" 32.7 37.3 63.6 11.4 63.5 9.3 24.8 69.1 94.4 27.7 59.1 57.5 14.0 31.3 17.0 18.0 34.9 16.5 73.2 63.9 65.7 43.0 57.1 27.5 12.4 64.7 63.0 32.5 27.6 22.7 70.9 17.9 66.3 47.6 12.1 16.4 26.3 34.5 48.9 20.1 25.9 22.2 58.6 28.6 35.6 23.6 65.5 10.5 67.6 26.4 9.2 33.6 24.4 68.2 6.4 8.1 19.3 8.8 30.1 17.6 110.3 26.7 8.0 6.1 11.7 11.1 20.7 8.4 57.6 17.7 27.7 4.5 10.4 17.6 4.9 15.2 9.2 7.3 15.2 28.2 68.7 3.3 29.3 21.7 32.3 15.2 13.6 77.2 28.8 11.1 9.5 10.4 6.1 15.5 3.6 19.3 5.7 30.1 6.6 4.8 3.1 21.6 25.9 9.9 6.9 26.7 12.6 10.3 24.3 27.5 27.9 17.0 21.7 12.1 19.5 16.2 6.3 10.7 14.2 15.2 27.3 7.8 13.0 12.3 10.2 9.3 11.9 9.8 12.2 7.9 8.9 11.5 6.9 8.7 11.3 10.4 1.8 13.8 12.9 12.3 7.2 9.5 63.6 63.5 69.1 94.4 63.9 65.7 64.7 63.0 66.3 58.6 65.5 68.2 24.7 19.2 17.5 43.4 14.1 9.7 26.2 48.5 15.9 21.5 17.5 15.0 41.9 31.5 24.0 16.5 16.7 23.7 15.1 10.9 7.9 19.6 6.8 10.3 7.0 20.2 27.0 7.8 38.0 4.4 11.5 20.1 19.4 12.9 21.0 18.8 19.2 14.9 20.6 32.0 37.1 19.1 38.7 8.8 9.0 10.1 32.0 10.0 12.4 15.0 13.9 18.3 27.8 14.6 21.7 8.7 20.4 26.4 15.3 31.4 18.8 11.1 13.2 15.8 26.3 11.0 17.1 68.0 26.5 9.6 12.4 22.2 15.4 11.2 15.4 20.2 PRRT3 FLJ33674 ENSG00000163704 "Proline rich transmembrane protein 3" Q5FWE3 3 9945542-9952408 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 11.6;fallopian tube: 7.6;parathyroid gland: 15.3;pituitary gland: 11.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 17.2;MCF7: 23.1;SK-BR-3: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035127, HPA035128, HPA069859" Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 83000 "Cluster 32: T-cells - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" "Plasma membrane" Nucleoplasm "HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: " "unprognostic (1.55e-1)" "unprognostic (8.41e-2)" "unprognostic (3.42e-1)" "unprognostic (2.38e-3)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.15e-4)" "unprognostic (2.27e-3)" "unprognostic (1.37e-2)" "unprognostic (2.76e-2)" "unprognostic (2.20e-3)" "unprognostic (3.60e-1)" "unprognostic (1.01e-4)" "unprognostic (2.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (2.09e-1)" 0.9 1.8 3.9 1.1 5.0 1.5 1.2 10.1 11.6 1.3 0.3 1.3 0.4 1.2 1.2 1.2 7.6 1.1 1.1 4.4 1.1 1.3 0.4 0.9 1.2 5.1 1.9 1.3 1.8 15.3 11.0 0.3 5.3 2.5 0.3 2.2 2.3 1.7 1.4 2.3 0.9 0.9 0.0 0.9 1.1 2.1 3.6 1.3 2.2 0.2 1.3 1.8 1.1 4.8 0.4 1.0 3.6 4.7 17.2 2.3 1.2 1.8 3.4 2.0 4.5 0.3 3.4 2.0 0.4 4.2 2.1 0.3 1.3 4.5 0.9 9.8 2.0 0.7 1.9 0.2 1.7 0.4 1.7 4.4 0.3 1.7 0.7 9.7 0.8 6.0 1.0 4.7 2.5 23.1 4.4 0.4 8.5 0.1 2.1 2.8 0.4 1.9 1.0 0.4 6.6 4.4 1.8 33.6 0.7 1.4 9.1 0.4 0.7 0.4 4.6 0.9 1.3 6.1 6.6 0.6 10.9 0.3 1.3 0.5 0.2 0.2 1.2 0.1 1.4 0.5 1.3 1.2 0.0 0.6 1.4 1.3 0.3 0.7 0.1 0.6 0.2 0.4 3.9 5.0 10.1 11.6 4.4 1.1 5.1 1.9 5.3 0.0 3.6 4.8 3.3 0.0 2.0 3.9 2.9 2.7 3.8 3.7 3.4 22.8 7.4 6.2 3.0 7.2 3.4 11.0 14.6 0.7 4.4 4.5 3.9 2.9 4.3 5.0 5.4 3.3 11.3 2.1 14.7 5.0 0.5 5.2 5.6 4.9 1.3 7.9 2.2 2.9 3.8 15.2 10.8 5.4 2.0 2.5 2.6 3.5 5.6 2.2 1.8 2.8 11.3 8.6 11.3 5.5 3.7 3.1 1.0 2.6 2.2 4.2 6.4 8.0 12.4 21.6 0.0 7.2 5.3 10.4 6.4 3.4 2.3 0.4 5.6 7.8 4.7 3.0 EMC3 TMEM111 ENSG00000125037 "ER membrane protein complex subunit 3" Q9P0I2 3 9962537-10011116 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 360.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042372 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 51: Myeloid cells - Hemostasis" "HPA042372: AB_10795609" "unprognostic (1.31e-1)" "unprognostic (2.36e-2)" "unprognostic (2.50e-2)" "unprognostic (1.51e-1)" "unprognostic (2.07e-1)" "unprognostic (8.02e-2)" "unprognostic (1.59e-3)" "unprognostic (2.90e-2)" "unprognostic (2.05e-3)" "unprognostic (2.46e-2)" "unprognostic (1.35e-1)" "unprognostic (1.91e-1)" "prognostic favorable (2.81e-6)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.71e-2)" "unprognostic (5.58e-2)" 71.1 41.1 26.5 28.9 27.6 65.7 33.3 28.5 29.9 26.1 29.7 40.6 37.4 23.2 26.9 46.1 28.9 27.9 34.3 29.2 29.4 40.3 65.7 36.1 22.7 31.0 29.5 22.5 43.6 70.5 17.2 20.3 30.4 25.8 36.0 24.2 42.8 32.0 78.5 33.6 37.3 32.0 28.3 23.1 35.3 48.5 28.8 27.2 39.9 46.7 28.5 40.7 25.1 30.4 48.9 100.7 37.4 22.5 232.6 90.3 125.1 98.1 84.6 60.1 64.8 69.5 75.6 38.7 69.8 111.9 115.2 66.7 64.2 58.3 61.7 105.2 64.3 63.6 69.9 46.5 100.4 71.8 68.2 107.4 102.5 104.9 60.1 76.5 75.6 41.8 82.0 109.2 90.2 119.5 38.3 35.6 41.5 103.2 68.7 49.0 52.4 115.7 72.8 86.7 26.4 53.1 69.9 103.3 63.4 39.1 87.5 58.0 87.6 59.8 49.6 65.0 100.8 58.3 165.6 79.0 126.2 52.0 76.4 119.7 115.1 108.5 64.5 93.6 66.8 65.6 63.7 74.5 88.3 71.2 45.8 61.5 103.5 77.3 95.3 79.1 107.3 156.1 26.5 27.6 28.5 29.9 29.2 29.4 31.0 29.5 30.4 28.3 28.8 30.4 59.1 54.5 72.9 19.9 45.3 50.6 59.9 178.0 24.5 40.6 43.0 39.9 108.1 57.2 121.4 46.0 39.6 49.5 52.7 58.6 46.9 100.6 360.7 61.6 50.2 59.2 21.1 240.2 25.4 119.9 51.8 51.1 38.7 64.0 34.1 36.5 46.1 105.0 97.8 23.5 21.1 40.2 109.9 51.0 66.6 109.3 50.4 101.7 58.7 9.4 97.5 65.2 57.7 21.1 17.8 107.4 71.3 37.6 55.6 58.7 92.6 76.9 99.1 63.5 59.2 44.7 60.7 199.7 63.0 49.6 60.7 85.8 52.7 60.6 52.0 80.2 FANCD2 "FA-D2, FACD, FAD, FANCD" ENSG00000144554 "FA complementation group D2" Q9BXW9 3 10026414-10101932 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 25.2;Spermatocytes: 62.5;Spermatogonia: 30.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 120.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB016117, HPA063742" Approved Supported "Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol" No No "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nucleoli, Nuclear bodies, Cytosol" "CAB016117: AB_2278211, HPA063742: AB_2685110" "unprognostic (3.25e-2)" "unprognostic (1.09e-1)" "unprognostic (6.21e-2)" "unprognostic (1.12e-2)" "unprognostic (2.92e-1)" "unprognostic (3.36e-2)" "unprognostic (1.08e-5)" "unprognostic (2.96e-2)" "unprognostic (1.59e-3)" "prognostic unfavorable (5.00e-5)" "unprognostic (1.23e-2)" "unprognostic (9.14e-2)" "unprognostic (4.41e-10)" "unprognostic (9.11e-3)" "unprognostic (3.99e-1)" "unprognostic (7.76e-2)" "unprognostic (2.89e-2)" 1.1 0.7 2.7 7.7 2.1 17.8 3.4 1.6 5.3 1.5 1.1 4.0 3.2 2.0 0.7 2.5 2.6 2.0 0.5 3.4 1.6 0.9 1.1 1.9 12.2 3.9 1.4 3.6 0.8 0.8 0.5 4.7 3.0 1.9 6.4 3.1 4.9 1.0 4.8 4.5 4.0 2.0 2.4 6.4 3.5 11.8 2.3 9.8 1.9 0.4 13.0 2.3 1.3 5.1 24.1 25.4 46.5 13.2 2.4 3.5 120.7 22.0 9.8 31.3 25.4 18.8 23.0 46.7 9.8 7.0 25.1 20.2 48.8 16.7 31.0 22.6 33.0 63.6 39.6 17.9 0.4 48.1 37.9 1.2 2.6 34.1 18.4 4.2 18.4 39.3 39.6 51.6 23.1 27.2 40.6 17.9 56.1 18.1 17.6 43.4 37.7 32.5 10.3 26.7 13.0 25.3 26.4 20.1 8.3 33.5 31.0 29.4 10.6 24.6 28.4 15.1 31.5 21.7 46.4 77.2 14.1 47.7 43.2 2.7 0.6 1.9 0.6 0.5 0.6 2.4 0.9 0.5 0.4 3.2 1.1 0.9 1.5 1.0 1.4 1.8 1.5 0.5 2.7 2.1 1.6 5.3 3.4 1.6 3.9 1.4 3.0 2.4 2.3 5.1 0.7 0.0 0.5 0.7 12.5 4.6 3.5 2.9 2.8 3.1 4.5 2.7 2.0 1.5 1.9 1.8 10.4 12.7 5.6 3.1 0.0 1.9 5.9 2.6 1.5 2.1 1.2 25.2 3.0 3.5 15.2 2.6 2.0 3.4 1.3 11.8 3.3 1.5 5.7 0.0 2.6 3.2 6.1 3.8 7.0 8.0 2.1 3.7 3.6 1.9 4.9 0.6 1.0 1.5 2.4 1.8 3.6 1.5 8.1 2.2 0.5 0.7 2.0 5.6 19.7 2.6 2.1 62.5 30.2 4.1 2.7 7.0 5.2 1.6 7.6 3.1 FANCD2OS "C3orf24, MGC40179" ENSG00000163705 "FANCD2 opposite strand" Q96PS1 3 10081317-10108255 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 33 "testis: 61.6" "Group enriched" "Detected in some" 59 "Early spermatids: 565.0;Late spermatids: 852.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 1.8" "Immune cell enriched" "Detected in some" 5 "neutrophil: 5.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "CACO-2: 1.3;MCF7: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA076166 Approved Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 74: Testis - Spermatogenesis" "Cluster 39: CACO-2 - Unknown function" "Cluster 34: Spermatids - Unknown function" Vesicles "HPA076166: " "unprognostic (5.99e-2)" "unprognostic (4.33e-3)" "unprognostic (8.04e-2)" "unprognostic (1.11e-3)" "unprognostic (3.51e-1)" "unprognostic (2.63e-2)" "unprognostic (4.78e-2)" "unprognostic (3.49e-1)" "unprognostic (2.53e-3)" "unprognostic (3.91e-2)" "unprognostic (9.45e-2)" "unprognostic (2.11e-7)" "unprognostic (2.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.3 0.0 0.1 1.0 0.0 1.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 61.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.4 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.5 0.4 0.3 0.2 0.4 0.3 0.3 0.4 0.2 0.1 0.8 0.3 0.3 5.4 0.2 1.0 0.3 0.1 0.1 0.3 0.1 1.8 0.4 0.2 0.1 0.3 0.2 0.3 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 565.0 0.4 0.0 0.3 0.0 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 852.8 7.2 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.9 0.0 4.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BRK1 "C3orf10, HSPC300, MDS027" ENSG00000254999 "BRICK1 subunit of SCAR/WAVE actin nucleating complex" Q8WUW1 3 10115675-10127190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 2544.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060391 Approved "Nuclear speckles,Cell Junctions" NA NA 170000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Nuclear speckles" "Cell Junctions" "HPA060391: AB_2684272" "unprognostic (4.99e-2)" "unprognostic (3.48e-2)" "unprognostic (2.64e-1)" "unprognostic (3.83e-2)" "unprognostic (2.91e-1)" "unprognostic (9.60e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.49e-2)" "unprognostic (2.89e-1)" "unprognostic (1.09e-1)" "unprognostic (1.89e-1)" "unprognostic (1.37e-1)" "unprognostic (7.14e-3)" "unprognostic (1.12e-1)" "unprognostic (9.40e-2)" "unprognostic (4.35e-2)" "unprognostic (7.75e-3)" 165.2 120.7 167.4 109.9 169.3 163.5 161.3 163.9 201.1 157.7 166.2 186.4 101.2 150.9 171.6 175.7 152.6 118.1 154.3 173.0 174.0 176.6 154.4 135.2 157.3 165.7 165.3 152.5 116.7 154.5 111.5 109.3 165.5 138.0 133.2 62.1 137.8 130.3 185.7 153.8 123.4 155.3 168.9 131.2 150.9 142.1 172.4 151.7 134.0 167.3 180.3 174.1 147.6 169.0 179.1 210.4 218.0 114.1 358.2 389.0 516.5 259.0 258.1 238.9 235.6 145.5 203.9 205.1 120.5 301.0 208.2 91.0 159.7 263.9 260.5 227.3 220.8 282.7 233.5 219.9 203.4 272.1 204.2 256.8 250.4 267.9 193.0 312.2 339.2 168.9 187.3 231.9 366.4 393.0 177.1 216.7 252.1 251.9 263.6 168.8 224.5 224.2 315.9 292.5 84.6 146.8 208.6 179.3 217.2 216.0 291.8 233.8 307.9 237.9 182.2 281.4 234.8 131.9 385.1 460.6 343.9 368.5 200.4 303.2 334.5 357.1 238.7 337.0 213.8 304.7 228.6 226.9 380.0 307.9 205.9 223.5 337.5 228.7 345.8 404.8 287.9 469.9 167.4 169.3 163.9 201.1 173.0 174.0 165.7 165.3 165.5 168.9 172.4 169.0 224.7 64.1 79.3 16.6 198.4 263.8 307.2 560.2 137.7 41.6 332.8 352.2 125.5 233.1 291.4 204.1 20.9 254.2 220.3 149.0 493.1 375.7 1034.0 145.6 152.2 273.7 298.7 191.2 33.5 361.6 282.9 223.2 119.3 127.3 173.3 152.3 272.4 255.0 442.7 47.1 20.7 211.3 307.2 373.9 380.3 2544.4 247.3 295.5 354.0 28.1 556.8 208.4 375.9 13.6 21.7 479.4 202.9 253.9 130.2 338.3 274.7 887.5 204.6 38.7 236.7 158.7 254.6 212.0 160.1 264.4 315.4 213.2 185.9 267.4 235.4 418.7 VHL VHL1 ENSG00000134086 "Von Hippel-Lindau tumor suppressor" P40337 3 10141778-10153667 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Congenital erythrocytosis, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 146.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031631, HPA031632, HPA068954" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 57: B-cells - Immune response" Nucleoplasm Cytosol "HPA031631: AB_2673968, HPA031632: AB_2673969, HPA068954: " "prognostic unfavorable (9.02e-5)" "unprognostic (1.10e-1)" "unprognostic (4.46e-3)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (3.55e-1)" "unprognostic (3.03e-2)" "unprognostic (4.36e-2)" "unprognostic (5.82e-3)" "unprognostic (1.81e-2)" "unprognostic (2.51e-1)" "prognostic favorable (7.84e-4)" "unprognostic (1.46e-1)" "unprognostic (2.92e-2)" "unprognostic (1.28e-3)" 14.0 13.7 11.5 21.1 11.0 27.9 14.7 13.6 12.1 11.8 6.7 14.8 15.7 14.1 9.8 12.3 13.4 11.5 7.9 11.8 14.9 12.6 14.1 11.8 29.6 9.4 9.4 12.6 12.7 11.7 9.0 14.1 9.3 14.0 15.7 8.9 14.5 10.2 11.4 14.2 17.2 12.8 9.6 22.5 16.0 13.4 16.6 23.4 15.8 7.7 29.7 12.5 10.9 12.5 19.5 18.2 39.9 24.6 36.0 27.7 146.5 16.8 24.0 21.1 24.5 21.5 23.7 67.9 22.2 23.0 29.9 16.4 37.2 23.6 25.7 33.0 33.7 52.7 30.5 30.6 34.3 47.3 41.3 28.1 26.3 28.0 35.1 28.4 24.6 42.5 48.3 50.3 21.1 35.0 45.5 40.9 26.7 21.1 23.4 57.3 34.6 34.6 25.5 48.7 15.0 49.4 35.0 18.7 21.0 23.9 37.0 59.1 21.3 20.8 27.7 19.6 26.8 35.7 78.1 105.6 23.2 55.3 19.4 4.6 3.2 2.3 2.6 2.2 1.9 2.5 1.8 2.2 2.0 3.3 1.7 1.8 5.6 3.0 2.0 2.3 1.7 1.2 11.5 11.0 13.6 12.1 11.8 14.9 9.4 9.4 9.3 9.6 16.6 12.5 12.4 12.8 12.5 9.1 38.7 14.7 17.8 14.3 24.5 14.7 10.7 6.1 6.1 20.0 9.6 16.5 18.8 16.8 21.9 10.7 7.9 11.8 9.6 13.1 26.1 14.8 14.4 30.5 15.9 5.1 18.7 12.8 20.9 19.9 5.1 18.4 18.9 14.3 14.9 18.5 14.2 11.3 16.2 27.1 45.8 7.3 14.0 32.3 12.4 7.5 31.9 9.1 28.8 12.1 14.9 10.7 11.7 11.3 33.3 23.8 12.3 9.5 9.7 15.3 6.6 17.4 11.9 15.4 24.0 26.7 20.5 17.2 23.5 21.4 10.2 25.9 IRAK2 ENSG00000134070 "Interleukin 1 receptor associated kinase 2" O43187 3 10164919-10243745 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.3" "Cell type enhanced" "Detected in many" "Langerhans cells: 43.7;Oligodendrocytes: 34.3;Prostatic glandular cells: 23.4;Urothelial cells: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 33.2;BJ hTERT+: 35.2;CAPAN-2: 35.6;GAMG: 62.6;RT4: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013483, HPA050520" Uncertain Approved Vesicles NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 41: Macrophages - Immune response" Vesicles "CAB013483: , HPA050520: AB_2681154" "unprognostic (1.31e-1)" "unprognostic (2.04e-2)" "unprognostic (1.46e-2)" "unprognostic (4.61e-3)" "unprognostic (8.71e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (8.35e-4)" "unprognostic (1.89e-2)" "unprognostic (8.01e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.24e-1)" "unprognostic (3.10e-2)" "unprognostic (7.22e-2)" "unprognostic (4.38e-2)" "unprognostic (3.91e-2)" "prognostic favorable (6.60e-5)" 6.4 3.6 4.0 6.0 3.9 23.3 4.6 3.9 8.0 2.9 1.7 2.1 2.0 2.0 0.7 7.2 1.8 4.4 1.9 3.2 5.1 3.4 10.8 10.4 3.8 5.1 4.1 1.0 1.9 1.0 1.2 2.2 5.6 3.3 1.7 1.5 3.6 1.8 17.0 5.2 5.4 1.4 3.4 4.5 3.4 1.3 4.2 3.9 3.1 4.3 11.5 16.1 4.5 8.0 2.7 7.6 0.3 1.0 8.1 6.7 33.2 2.9 35.2 4.7 4.5 3.6 35.6 0.1 0.9 4.3 62.6 0.8 0.8 9.0 6.3 2.3 2.5 0.8 1.7 9.9 3.9 0.0 1.1 4.1 1.5 17.3 22.4 12.4 9.7 0.3 1.8 10.7 5.7 0.1 0.0 1.8 0.3 4.2 7.5 1.7 0.0 0.6 10.3 49.2 0.5 0.3 3.3 0.1 0.3 0.8 0.8 1.7 10.1 10.7 0.9 6.5 7.0 3.6 11.3 2.1 22.9 4.7 1.9 0.2 1.0 0.1 5.8 0.7 6.0 4.2 1.7 3.3 1.0 3.2 1.2 3.0 2.1 7.4 0.2 0.0 0.7 2.2 4.0 3.9 3.9 8.0 3.2 5.1 5.1 4.1 5.6 3.4 4.2 8.0 3.9 0.0 4.1 1.6 8.3 8.0 20.8 9.9 5.2 0.9 1.6 1.3 2.0 0.0 6.1 0.0 0.0 0.2 3.8 1.3 0.0 9.8 4.1 4.3 2.4 12.3 0.0 0.0 6.3 4.2 0.7 4.3 7.7 16.7 0.0 0.1 0.7 4.8 3.4 0.0 7.0 0.7 4.1 2.9 43.7 1.5 0.9 20.9 5.4 13.1 1.9 2.1 7.2 7.1 34.3 15.7 0.3 0.0 7.4 23.4 2.6 1.1 1.3 0.0 0.0 4.2 2.0 0.7 0.9 4.7 7.4 1.0 3.9 0.2 0.5 30.4 TATDN2 KIAA0218 ENSG00000157014 "TatD DNase domain containing 2" Q93075 3 10248023-10281218 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA036822 Approved Approved "Nuclear speckles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" "HPA036822: AB_10671972" "unprognostic (4.51e-2)" "unprognostic (2.66e-3)" "unprognostic (2.75e-1)" "unprognostic (4.23e-2)" "unprognostic (9.88e-2)" "unprognostic (1.58e-2)" "unprognostic (2.57e-3)" "unprognostic (8.43e-2)" "unprognostic (3.78e-1)" "unprognostic (1.63e-1)" "prognostic favorable (4.66e-4)" "unprognostic (3.25e-1)" "unprognostic (1.87e-1)" "unprognostic (2.55e-2)" "unprognostic (1.70e-1)" "unprognostic (3.33e-1)" "unprognostic (2.48e-2)" 15.5 15.8 19.8 14.8 20.9 34.4 15.4 18.0 21.4 19.9 17.0 15.5 12.7 17.4 15.5 19.9 15.6 10.3 16.2 20.8 17.3 17.8 14.0 17.3 21.6 17.6 17.2 24.7 19.9 17.9 17.8 9.8 17.3 20.9 14.7 9.0 17.7 12.3 15.0 20.7 18.8 13.5 17.4 23.9 16.7 8.6 19.5 32.5 20.8 10.9 22.1 16.6 18.4 18.3 19.4 32.1 16.9 14.3 21.2 22.9 73.3 23.2 22.5 28.8 18.8 23.6 17.0 45.6 17.0 32.1 30.7 14.3 29.1 20.9 22.5 29.5 36.5 24.3 30.8 24.9 13.7 34.6 24.8 17.6 22.9 40.2 13.6 18.8 23.6 28.3 27.9 40.7 26.4 37.2 45.4 29.6 23.9 25.2 31.9 24.8 18.0 26.5 18.2 26.8 18.7 22.6 19.4 21.8 10.9 15.6 22.2 32.4 18.8 33.1 21.6 28.1 41.6 25.5 43.6 80.6 30.0 35.6 23.1 1.3 0.6 0.5 1.6 1.0 1.6 0.8 1.4 1.3 0.5 1.4 1.4 2.1 0.5 0.9 0.5 1.3 1.7 0.9 19.8 20.9 18.0 21.4 20.8 17.3 17.6 17.2 17.3 17.4 19.5 18.3 6.3 6.4 11.0 4.9 8.2 12.6 4.6 4.8 9.1 4.4 9.4 6.3 6.9 7.2 4.3 11.0 6.2 3.8 9.3 12.7 1.9 5.1 2.0 4.1 7.0 7.9 16.8 6.1 8.8 9.2 4.0 6.8 5.1 5.9 5.1 9.1 7.9 10.2 10.3 5.0 5.9 8.7 2.0 15.6 21.0 1.8 7.2 9.1 14.2 6.5 9.0 5.2 18.6 4.5 5.0 8.6 3.1 7.5 8.8 9.3 8.0 5.4 2.4 2.8 6.6 5.8 4.7 2.1 5.6 6.4 12.4 2.5 10.7 8.7 10.8 7.1 GHRL "ghrelin, MTLRP, obestatin" ENSG00000157017 "Ghrelin and obestatin prepropeptide" Q9UBU3 3 10285666-10292947 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 19 "stomach 1: 356.1" "Cell type enriched" "Detected in many" 52 "Gastric mucus-secreting cells: 1123.8" "Cancer enhanced" "Detected in some" "stomach cancer: 3.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 17.5;classical monocyte: 11.0;eosinophil: 12.4;myeloid DC: 41.8;neutrophil: 25.7;plasmacytoid DC: 28.5" "Group enriched" "Detected in many" 6 "dendritic cells: 41.8;granulocytes: 25.7;monocytes: 11.0" "Cell line enhanced" "Detected in many" "Karpas-707: 14.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA014246, CAB022731" Enhanced "Secreted to blood" NA NA 2580000 350000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 4: Stomach - Digestion" "Cluster 2: Karpas-707 - Immune response" "Cluster 16: Pancreatic endocrine cells - Mixed function" "CAB022731: , HPA014246: AB_1849659" "unprognostic (1.74e-2)" "unprognostic (3.01e-4)" "unprognostic (3.75e-1)" "unprognostic (1.05e-2)" "unprognostic (2.94e-2)" "unprognostic (1.60e-3)" "unprognostic (2.12e-1)" "unprognostic (1.06e-3)" "unprognostic (3.85e-1)" "unprognostic (5.45e-3)" "unprognostic (1.54e-3)" "unprognostic (2.71e-2)" "unprognostic (1.64e-3)" "unprognostic (4.52e-2)" "unprognostic (8.56e-2)" "unprognostic (2.14e-1)" "unprognostic (1.79e-4)" 0.5 0.5 3.5 3.1 4.1 4.4 1.5 4.0 7.6 0.5 3.0 2.2 19.0 0.7 4.8 1.8 0.7 2.3 1.3 3.3 2.8 0.9 1.4 1.0 7.4 3.2 2.8 1.3 4.1 0.7 0.7 0.5 3.5 1.0 0.6 2.0 1.4 0.3 2.0 2.1 3.1 0.9 2.0 2.5 356.1 1.1 2.7 1.3 1.3 0.2 3.1 1.4 0.5 2.9 0.6 0.2 2.6 2.0 1.8 0.0 4.8 2.4 0.0 0.7 0.2 2.9 0.5 1.5 0.9 0.1 2.1 0.4 0.0 0.6 0.0 0.4 2.9 3.1 2.1 6.3 0.0 3.2 5.3 0.3 0.0 0.0 0.1 0.2 0.5 1.9 1.3 14.4 0.0 0.7 1.2 4.3 1.3 0.5 5.3 0.8 0.2 0.8 0.0 2.4 1.9 0.3 1.6 1.1 0.1 1.7 1.1 3.8 2.6 1.2 0.7 1.1 1.7 1.7 2.6 2.9 0.4 3.5 0.5 17.5 11.0 12.4 0.2 5.5 0.1 2.1 0.2 0.0 41.8 1.0 0.3 0.1 25.7 4.4 0.4 28.5 0.2 3.8 3.5 4.1 4.0 7.6 3.3 2.8 3.2 2.8 3.5 2.0 2.7 2.9 0.6 0.0 1.1 1.3 4.9 1.3 4.6 0.2 0.0 7.8 0.8 0.6 0.3 0.0 0.2 1.8 10.4 1.7 10.5 0.5 0.0 1.0 0.3 0.2 0.7 1.5 0.0 0.0 1.0 1.3 1.5 1.0 1123.8 0.8 0.0 0.6 1.8 0.1 1.8 3.3 0.6 0.1 0.0 3.8 8.8 1.0 0.3 5.7 1.8 2.8 7.4 2.2 21.6 0.0 0.7 0.9 0.1 0.4 0.7 4.9 1.5 0.2 0.2 9.1 6.6 4.0 0.9 1.7 1.3 0.0 0.6 0.3 4.0 0.7 0.8 2.2 SEC13 "D3S1231E, npp-20, SEC13L1, SEC13R" ENSG00000157020 "SEC13 homolog, nuclear pore and COPII coat complex component" P55735 3 10293131-10321112 "Metabolic proteins, Predicted intracellular proteins, Transporters" "ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035292, HPA057943" Approved Supported Nucleoplasm,Vesicles NA NA 35000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 28: BEWO - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Vesicles" "HPA035292: AB_10959451, HPA057943: AB_2683560" "unprognostic (3.33e-3)" "unprognostic (6.16e-2)" "unprognostic (2.28e-2)" "unprognostic (4.95e-2)" "unprognostic (4.22e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.73e-4)" "unprognostic (2.43e-1)" "unprognostic (2.67e-1)" "unprognostic (1.69e-1)" "unprognostic (4.58e-1)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (4.60e-1)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" 62.1 71.5 51.0 61.8 55.6 58.4 58.9 55.9 57.6 83.7 59.2 68.8 114.7 66.4 59.4 72.6 57.4 47.5 71.1 52.2 57.2 67.4 92.1 64.3 54.6 54.6 54.6 52.6 85.2 64.6 109.2 68.5 55.2 53.8 65.7 21.2 96.2 64.9 111.5 62.7 96.6 76.6 54.3 59.4 67.3 39.4 54.2 70.3 57.6 87.3 65.4 69.9 59.2 58.2 122.6 182.1 142.9 55.2 228.0 251.6 474.4 243.8 296.1 279.3 319.8 150.3 97.6 110.7 109.6 390.1 156.8 49.0 186.4 218.3 142.4 97.8 194.5 136.2 137.3 363.7 311.8 156.7 115.5 224.7 173.1 292.6 181.5 205.6 337.0 146.2 148.4 159.8 219.5 250.2 153.8 169.9 160.9 158.0 218.7 148.1 102.4 198.2 172.4 90.2 80.3 99.4 107.3 98.7 101.3 119.3 127.5 150.8 253.6 114.2 130.2 172.6 213.3 131.7 198.4 258.6 215.5 217.5 193.0 127.3 163.2 106.6 84.4 144.9 94.6 96.5 83.6 82.1 222.5 82.6 68.0 71.2 105.8 93.9 116.4 198.3 106.1 176.5 51.0 55.6 55.9 57.6 52.2 57.2 54.6 54.6 55.2 54.3 54.2 58.2 23.9 48.1 61.9 14.0 45.8 39.4 50.4 73.6 31.3 16.2 29.5 26.4 40.2 30.0 68.3 27.6 10.4 119.9 36.5 60.1 66.5 79.3 25.6 31.8 44.0 51.0 41.4 33.0 17.3 109.2 166.6 74.1 73.9 47.1 43.1 35.5 33.9 57.3 104.9 11.8 13.7 108.2 50.8 33.0 46.7 10.2 53.4 45.0 26.6 12.2 64.2 37.4 35.0 11.6 12.6 81.8 56.1 52.6 203.2 52.4 187.5 112.0 64.5 21.1 13.1 37.7 63.6 54.9 38.9 43.7 40.2 168.6 36.5 35.8 74.2 62.3 ATP2B2 PMCA2 ENSG00000157087 "ATPase plasma membrane Ca2+ transporting 2" Q01814 3 10324023-10708007 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calmodulin-binding, Translocase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 104.0;choroid plexus: 43.0;salivary gland: 33.2;skeletal muscle: 37.4" "Cell type enhanced" "Detected in some" "Astrocytes: 117.5;Bipolar cells: 87.7;Excitatory neurons: 323.2;Horizontal cells: 104.3;Inhibitory neurons: 230.5;Oligodendrocyte precursor cells: 58.3" "Cancer enhanced" "Detected in some" "liver cancer: 7.7" "Region enhanced" "Detected in many" "cerebral cortex: 104.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 4.0;RPMI-8226: 11.9;SCLC-21H: 4.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005606 Enhanced NA NA "Cluster 47: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "CAB005606: AB_2243199" "unprognostic (2.04e-1)" "unprognostic (1.26e-2)" "unprognostic (6.84e-2)" "unprognostic (1.59e-2)" "unprognostic (3.59e-1)" "unprognostic (3.62e-1)" "unprognostic (4.09e-2)" "unprognostic (4.65e-1)" "unprognostic (5.61e-2)" "unprognostic (1.93e-1)" "unprognostic (2.32e-4)" "unprognostic (2.70e-1)" "unprognostic (1.46e-3)" "unprognostic (1.08e-3)" "unprognostic (1.33e-2)" "unprognostic (8.34e-2)" "unprognostic (7.95e-3)" 0.0 0.6 3.4 0.0 15.8 0.0 0.1 38.6 104.0 2.0 43.0 0.1 0.0 2.2 0.2 0.1 3.7 0.0 0.1 10.4 0.2 0.2 20.3 0.0 0.0 1.6 9.8 0.0 0.2 2.0 3.5 0.0 2.7 0.0 0.0 13.5 33.2 0.0 37.4 0.4 0.1 1.4 0.0 0.1 0.1 0.6 16.1 0.5 0.0 4.9 0.1 0.0 0.1 30.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 11.9 0.0 0.0 4.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 15.8 38.6 104.0 10.4 0.2 1.6 9.8 2.7 0.0 16.1 30.3 0.1 0.0 0.0 117.5 0.1 0.5 0.0 0.0 0.0 87.7 3.6 0.3 12.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 7.7 0.8 0.7 0.0 0.0 323.2 0.0 0.0 0.5 0.0 14.1 2.5 0.1 0.4 27.1 0.0 104.3 230.5 0.0 0.0 0.8 0.7 7.5 0.0 0.1 3.6 14.0 0.0 16.4 0.0 58.3 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.2 0.0 2.3 0.5 0.1 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.0 SLC6A11 GAT3 ENSG00000132164 "Solute carrier family 6 member 11" P48066 3 10816201-10940714 "Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 153.3" "Cell type enhanced" "Detected in some" "Astrocytes: 85.2;Excitatory neurons: 13.7;Inhibitory neurons: 25.8;Muller glia cells: 26.4;Oligodendrocyte precursor cells: 23.1" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 5.2;HaCaT: 13.5;Hep G2: 16.0;hTCEpi: 11.9;NTERA-2: 6.7;T-47d: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037981 Supported Supported Uncertain Nucleoplasm,Vesicles NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm Vesicles "HPA037981: AB_10671383" "unprognostic (6.04e-2)" "unprognostic (8.01e-2)" "unprognostic (1.21e-7)" "unprognostic (8.60e-2)" "unprognostic (8.68e-2)" "unprognostic (9.72e-3)" "unprognostic (6.39e-3)" "unprognostic (9.77e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (8.78e-2)" "unprognostic (1.51e-3)" "unprognostic (6.06e-2)" "unprognostic (4.44e-2)" "unprognostic (9.83e-2)" "unprognostic (2.31e-2)" 0.0 0.0 50.5 0.0 78.7 0.0 1.1 57.3 32.6 0.7 9.6 0.0 0.0 0.5 0.1 8.2 0.5 0.0 0.0 22.6 96.6 0.0 0.1 0.0 0.0 60.0 128.4 0.0 0.1 0.5 0.3 0.4 61.9 0.7 0.0 11.0 1.0 0.0 0.2 5.7 0.0 0.1 41.8 0.4 0.0 1.4 153.3 0.0 0.0 0.0 0.1 0.4 1.8 21.1 5.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 13.5 0.0 2.2 0.0 0.0 0.2 0.3 0.0 16.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.9 4.5 3.9 0.1 0.0 0.1 5.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.5 78.7 57.3 32.6 22.6 96.6 60.0 128.4 61.9 41.8 153.3 21.1 0.0 0.0 0.0 85.2 0.0 1.3 0.7 0.3 4.0 8.4 0.9 0.9 1.4 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 13.7 0.0 7.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 25.8 0.0 0.0 0.0 0.8 0.9 3.4 0.2 0.0 6.5 0.0 26.4 0.0 23.1 0.8 0.2 0.0 6.8 0.0 0.5 0.0 0.0 0.0 1.5 0.0 0.6 0.1 0.6 1.8 10.6 3.7 1.0 0.1 0.0 0.0 1.7 SLC6A1 "GABATHG, GABATR, GAT1" ENSG00000157103 "Solute carrier family 6 member 1" P30531 3 10992186-11039247 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.3;liver: 87.3;retina: 37.0" "Group enriched" "Detected in some" 4 "Astrocytes: 221.0;Inhibitory neurons: 332.3;Microglial cells: 108.7;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 107.9" "Group enriched" "Detected in some" 16 "glioma: 16.1;liver cancer: 24.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013341, CAB022293" Enhanced NA NA "Cluster 15: Liver - Metabolism" "Cluster 20: HeLa - Mitochondria" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB022293: , HPA013341: AB_1849509" "unprognostic (1.66e-3)" "unprognostic (1.30e-3)" "unprognostic (4.12e-3)" "unprognostic (1.70e-1)" "unprognostic (2.53e-1)" "unprognostic (2.53e-1)" "prognostic favorable (3.20e-4)" "unprognostic (1.05e-1)" "unprognostic (4.27e-2)" "unprognostic (8.26e-2)" "unprognostic (2.90e-1)" "unprognostic (2.69e-1)" "prognostic unfavorable (5.05e-6)" "unprognostic (7.32e-3)" "unprognostic (2.36e-1)" "unprognostic (1.35e-1)" "unprognostic (5.34e-2)" 1.9 0.8 51.5 0.4 56.0 2.2 1.0 45.4 67.1 3.3 0.0 1.1 0.4 1.2 2.9 9.1 1.2 1.2 4.1 35.8 53.6 2.9 87.3 2.0 0.5 39.4 63.5 2.1 0.3 15.9 3.6 0.8 34.8 2.4 0.5 37.0 0.4 4.0 2.7 1.7 0.9 0.5 43.0 0.7 0.5 4.1 71.3 17.6 0.7 0.8 0.4 0.9 2.6 39.4 0.2 0.2 0.5 0.3 0.4 0.1 0.3 0.2 0.0 0.2 0.3 0.4 0.3 0.4 0.1 0.1 0.5 0.4 0.6 0.2 0.2 0.0 0.5 0.4 1.6 0.8 0.2 0.6 0.6 0.3 0.0 0.0 0.3 0.1 0.1 0.5 0.3 1.0 0.0 0.3 0.2 0.5 0.2 0.3 0.4 0.3 0.0 0.0 0.1 0.5 0.2 0.0 0.2 0.2 0.0 0.3 0.3 0.3 0.1 0.2 0.1 0.2 0.2 0.3 0.1 0.3 0.2 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 51.5 56.0 45.4 67.1 35.8 53.6 39.4 63.5 34.8 43.0 71.3 39.4 0.3 0.0 0.5 221.0 0.0 0.3 0.0 0.0 6.2 26.6 0.1 0.0 2.1 14.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.1 2.6 0.0 0.0 3.7 0.0 0.0 1.4 0.0 0.0 2.5 0.2 0.0 25.2 0.0 0.0 332.3 0.0 0.0 0.8 0.0 1.6 5.6 0.2 0.0 108.7 0.0 36.6 0.0 130.2 107.9 0.0 0.0 10.1 0.0 0.0 0.0 0.2 0.0 3.7 13.1 9.4 6.8 3.8 0.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 HRH1 ENSG00000196639 "Histamine receptor H1" P35367 3 11137093-11263557 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 46.1;Distal enterocytes: 44.9;Glandular and luminal cells: 41.6;Suprabasal keratinocytes: 41.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029740 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 57: Non-specific - Angiogenesis" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 44: Endometrium - Transcription" "Plasma membrane" Cytosol "HPA029740: AB_10601578" "unprognostic (4.60e-3)" "unprognostic (3.41e-2)" "unprognostic (6.37e-3)" "unprognostic (9.55e-2)" "unprognostic (3.32e-2)" "unprognostic (1.07e-2)" "unprognostic (9.60e-3)" "unprognostic (4.00e-3)" "unprognostic (7.54e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (1.27e-5)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-2)" "unprognostic (7.19e-2)" "unprognostic (1.20e-1)" 5.7 3.0 5.5 3.1 6.2 0.1 3.4 1.7 6.5 5.0 2.1 8.8 2.7 4.3 4.8 3.3 7.4 7.1 1.5 6.1 5.3 4.2 0.7 4.1 1.2 4.6 2.9 5.9 0.6 0.9 0.5 3.9 3.6 2.4 5.1 0.2 1.8 3.5 0.9 5.1 4.3 5.4 3.2 1.0 1.7 0.8 5.8 1.2 1.2 2.2 1.4 14.3 5.0 4.1 2.6 6.1 0.0 0.0 2.7 28.5 4.2 4.6 15.3 13.3 8.8 1.1 21.8 0.0 13.4 10.6 13.5 17.3 0.0 6.3 17.7 10.1 0.0 1.4 9.7 0.0 8.4 4.5 2.4 10.0 3.7 30.4 10.5 18.4 19.1 0.2 0.0 0.1 5.8 0.0 0.0 1.9 0.0 2.6 5.4 0.4 1.6 0.6 23.2 3.6 0.2 0.0 6.6 4.6 0.0 0.2 0.0 3.5 28.8 14.8 9.4 15.3 23.4 0.0 1.7 0.1 22.5 3.9 13.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 5.5 6.2 1.7 6.5 6.1 5.3 4.6 2.9 3.6 3.2 5.8 4.1 11.5 6.4 1.1 33.3 0.1 46.1 8.9 7.4 6.8 0.0 0.5 0.5 0.5 0.0 19.3 1.8 0.0 0.2 0.0 44.9 0.0 0.6 0.3 20.5 6.9 20.2 3.5 0.0 34.6 0.7 1.0 16.7 8.6 41.6 2.5 28.8 2.5 0.0 27.2 0.0 19.1 15.1 4.1 12.5 12.3 0.2 3.7 9.8 0.0 2.8 0.1 0.0 0.0 2.0 1.1 14.0 21.0 0.0 0.0 6.2 29.1 0.7 5.0 0.2 0.0 6.8 2.8 1.8 3.3 2.2 41.5 0.5 1.0 0.2 15.8 19.3 ATG7 "APG7L, DKFZp434N0735, GSA7" ENSG00000197548 "Autophagy related 7" O95352 3 11272309-11557665 "Predicted intracellular proteins, Transporters" "Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 160.0;Excitatory neurons: 178.7;Inhibitory neurons: 176.4;Late spermatids: 119.1;Microglial cells: 132.1;Oligodendrocytes: 137.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 60.1;classical monocyte: 136.6;eosinophil: 88.4;intermediate monocyte: 79.4;myeloid DC: 82.4;neutrophil: 107.4;non-classical monocyte: 60.8" "Group enriched" "Detected in all" 5 "dendritic cells: 82.4;granulocytes: 107.4;monocytes: 136.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007639, CAB018771" Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 33000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "Nucleoplasm, Plasma membrane" "CAB018771: AB_2062165, HPA007639: AB_1845162" "unprognostic (3.97e-2)" "unprognostic (2.83e-2)" "prognostic favorable (9.66e-4)" "unprognostic (1.18e-2)" "unprognostic (2.79e-1)" "unprognostic (5.19e-2)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.82e-1)" "unprognostic (2.40e-1)" "unprognostic (1.80e-3)" "unprognostic (2.30e-2)" "unprognostic (2.67e-1)" "prognostic favorable (9.55e-4)" "unprognostic (1.61e-1)" "unprognostic (3.65e-2)" "unprognostic (1.16e-1)" "unprognostic (1.50e-1)" 16.8 13.5 11.2 25.0 13.1 47.6 18.0 7.3 21.8 14.5 17.0 17.3 13.0 14.9 16.7 16.7 18.7 16.6 10.8 12.4 9.5 13.7 13.2 20.9 23.9 15.0 15.0 12.2 10.9 21.2 7.5 21.0 13.1 11.6 19.2 10.3 12.2 11.9 13.0 18.0 13.8 20.0 12.4 16.4 14.4 22.5 15.4 13.1 13.0 13.5 25.0 20.3 12.0 21.3 48.5 37.1 16.7 9.2 28.0 36.7 80.4 44.5 56.8 43.1 49.9 16.0 42.5 22.1 26.5 39.2 45.1 14.5 18.3 62.0 73.8 19.8 23.5 16.0 33.6 19.6 36.9 46.8 50.8 38.0 28.2 83.6 52.0 45.4 60.5 14.0 24.1 17.9 60.6 31.3 13.7 21.3 13.0 22.2 47.9 17.1 19.6 19.9 32.5 34.2 14.6 14.5 31.6 26.4 17.5 20.1 28.8 44.7 42.5 36.0 25.7 23.6 63.2 11.1 31.8 38.1 57.8 43.1 49.9 60.1 136.6 88.4 15.9 79.4 12.3 13.0 12.9 15.1 82.4 12.3 11.7 13.7 107.4 21.3 60.8 14.7 12.4 56.8 11.2 13.1 7.3 21.8 12.4 9.5 15.0 15.0 13.1 12.4 15.4 21.3 6.4 0.0 9.8 160.0 11.4 11.1 7.3 21.6 9.6 18.1 7.4 3.6 4.2 4.3 12.5 7.3 18.8 16.5 7.9 8.3 7.9 12.3 44.2 10.6 9.5 14.6 11.4 9.5 178.7 12.9 16.8 11.0 10.7 13.2 14.7 12.4 19.6 9.0 57.6 20.2 176.4 7.6 22.4 25.8 12.1 119.1 10.2 28.8 3.6 132.1 30.6 8.1 13.4 99.0 137.2 17.4 7.3 9.8 10.8 6.4 8.4 6.8 16.5 12.5 6.6 11.7 10.6 22.4 11.9 9.8 7.7 19.2 10.1 9.9 7.6 7.4 VGLL4 KIAA0121 ENSG00000144560 "Vestigial like family member 4" Q14135 3 11556069-11771350 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038225, HPA038614" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" NA No "Cluster 18: Basophils - Vesicular transport" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 28: BEWO - Transcription regulation" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoli fibrillar center" Nucleoplasm "HPA038225: AB_10674549, HPA038614: AB_2676115" "unprognostic (1.21e-2)" "unprognostic (4.68e-3)" "unprognostic (3.29e-1)" "unprognostic (1.49e-1)" "unprognostic (3.75e-1)" "unprognostic (6.13e-2)" "unprognostic (1.24e-2)" "unprognostic (2.73e-1)" "unprognostic (1.66e-1)" "unprognostic (4.35e-3)" "unprognostic (2.01e-2)" "unprognostic (1.86e-1)" "prognostic favorable (1.32e-5)" "unprognostic (1.04e-1)" "unprognostic (8.81e-2)" "unprognostic (9.42e-2)" "unprognostic (1.26e-1)" 36.2 44.2 29.3 16.8 28.9 14.7 37.2 21.8 31.2 54.2 73.1 31.6 25.4 50.6 21.3 37.0 45.7 35.8 31.1 33.0 26.1 34.8 15.8 33.0 20.0 30.1 27.2 78.0 25.2 37.2 25.3 25.1 26.1 31.5 17.9 19.8 43.8 22.9 18.9 39.7 25.7 31.1 22.3 21.1 27.0 24.5 30.2 29.6 45.8 12.6 21.9 35.2 46.1 30.2 26.6 17.1 38.8 9.9 55.0 28.5 97.4 16.7 33.0 12.8 14.0 15.2 26.0 33.0 36.1 26.1 25.1 18.1 20.4 29.9 9.2 20.8 32.5 27.1 15.7 22.6 43.2 27.9 23.0 36.0 61.8 16.1 25.4 72.6 51.8 33.1 10.4 5.1 20.1 23.1 27.3 31.0 25.0 37.1 24.7 43.5 25.9 44.3 33.3 39.0 20.6 50.0 16.8 21.7 43.1 29.8 21.3 26.0 27.1 33.1 18.5 22.3 39.0 9.9 28.9 72.7 37.4 44.9 64.0 20.2 3.9 0.8 10.2 2.3 7.0 5.9 6.0 9.0 5.1 3.8 6.9 8.5 2.5 5.6 9.2 4.2 3.3 6.1 29.3 28.9 21.8 31.2 33.0 26.1 30.1 27.2 26.1 22.3 30.2 30.2 76.8 32.1 20.8 92.4 21.3 64.5 61.8 101.8 82.6 43.1 63.1 68.6 4.1 61.5 53.3 44.1 148.0 74.0 22.6 23.8 62.6 73.3 15.6 63.8 44.4 78.4 34.6 29.9 108.9 35.8 80.6 59.5 35.2 67.5 14.5 66.5 69.3 17.2 33.1 74.0 75.5 34.1 105.8 20.2 43.6 16.1 73.3 21.1 44.4 50.6 23.1 95.3 32.0 111.6 60.8 54.5 35.3 90.7 14.7 101.7 36.2 27.1 61.7 55.3 32.9 58.9 59.0 8.7 28.3 78.2 76.1 44.7 26.8 66.0 41.3 77.7 TAMM41 "C3orf31, DKFZp434E0519, MGC16471" ENSG00000144559 "TAM41 mitochondrial translocator assembly and maintenance homolog" Q96BW9 3 11790442-11846919 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036834, HPA044861" Uncertain Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "HPA036834: AB_10672270, HPA044861: AB_2679116" "unprognostic (2.40e-2)" "unprognostic (4.41e-2)" "prognostic favorable (1.23e-4)" "unprognostic (4.45e-2)" "unprognostic (1.44e-2)" "unprognostic (5.60e-2)" "unprognostic (2.03e-5)" "unprognostic (1.57e-1)" "unprognostic (2.35e-1)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (7.33e-3)" "unprognostic (3.78e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-1)" "unprognostic (7.34e-2)" "unprognostic (3.59e-3)" 8.3 7.4 5.8 5.6 6.2 4.3 8.0 6.4 8.5 8.0 2.6 6.5 4.9 7.2 9.7 9.0 6.9 4.1 8.0 5.3 6.9 6.7 5.5 5.0 7.1 3.9 4.1 11.0 5.6 5.8 5.6 4.1 4.0 5.2 4.9 6.3 6.8 4.5 9.2 10.1 6.2 6.2 2.8 6.5 6.0 5.7 5.4 6.5 6.0 5.2 7.8 8.4 8.2 6.2 6.2 11.3 13.5 9.4 14.3 18.0 24.9 9.3 6.6 13.9 13.8 13.6 9.9 23.4 13.3 9.8 6.2 7.4 22.9 13.9 17.9 8.8 21.6 14.0 10.6 15.9 16.7 25.8 7.1 10.3 20.3 13.1 14.6 9.1 21.8 18.3 20.8 7.0 18.0 17.8 14.6 19.2 10.9 9.6 23.8 14.4 7.7 20.7 21.6 14.8 6.2 5.4 8.1 10.3 16.6 15.1 13.5 11.6 5.7 7.2 8.3 21.8 13.5 5.4 14.2 12.1 8.8 21.8 6.7 1.9 4.5 7.1 5.7 3.2 7.6 7.5 9.1 5.8 7.8 7.1 8.4 8.8 0.2 6.9 6.7 5.8 7.7 4.8 5.8 6.2 6.4 8.5 5.3 6.9 3.9 4.1 4.0 2.8 5.4 6.2 9.4 6.4 7.0 24.5 11.4 4.2 8.1 15.7 5.7 11.5 5.5 8.3 8.9 0.0 8.7 3.7 12.5 12.2 8.6 3.3 9.8 10.1 2.2 5.4 9.2 7.6 3.0 9.4 34.5 9.3 11.0 7.2 6.6 4.4 2.5 10.5 5.7 5.8 9.2 10.1 34.7 8.1 12.2 6.4 6.4 1.5 7.8 6.8 3.6 14.0 5.9 11.0 10.3 34.7 32.0 7.9 3.4 6.4 7.1 6.7 4.2 10.3 11.8 14.7 0.0 8.6 8.7 7.4 12.4 6.6 4.1 7.0 9.5 10.8 7.3 5.9 SYN2 "SYNII, SYNIIa, SYNIIb" ENSG00000157152 "Synapsin II" Q92777 3 12004388-12192032 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Schizophrenia "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 96.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 338.3;Inhibitory neurons: 543.3;Oligodendrocyte precursor cells: 128.2" "Cancer enhanced" "Detected in many" "glioma: 4.5" "Group enriched" "Detected in many" 5 "amygdala: 67.0;basal ganglia: 77.7;cerebral cortex: 96.8;hippocampal formation: 92.9;white matter: 44.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.3;HMC-1: 4.5;NTERA-2: 3.3;SCLC-21H: 2.7;SH-SY5Y: 11.1;SuSa: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037012, CAB079005" Supported Approved Nucleoplasm NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "CAB079005: , HPA037012: AB_2675431" "unprognostic (1.62e-3)" "unprognostic (1.60e-2)" "unprognostic (7.54e-2)" "unprognostic (9.87e-3)" "unprognostic (1.73e-1)" "unprognostic (3.19e-1)" "unprognostic (6.32e-3)" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (3.68e-2)" "unprognostic (1.24e-1)" "unprognostic (9.77e-2)" "unprognostic (4.89e-4)" "unprognostic (9.94e-2)" "unprognostic (7.35e-2)" "unprognostic (1.78e-2)" 7.0 3.1 67.0 0.4 77.7 0.1 7.1 3.8 96.8 1.4 0.0 2.3 0.4 2.0 1.0 0.3 1.2 0.4 1.0 92.9 2.9 1.5 0.0 1.1 0.0 13.4 0.0 1.5 0.5 4.1 3.4 2.8 10.8 0.5 0.5 7.8 2.4 0.2 0.9 2.5 1.6 1.8 0.0 0.6 1.8 3.6 15.3 0.1 0.2 0.4 0.0 0.3 1.3 44.9 0.0 0.2 0.0 0.0 1.8 0.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.2 1.0 0.0 0.2 0.0 0.0 0.0 0.0 3.3 0.1 0.2 0.0 0.0 0.0 0.0 0.2 2.7 11.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.0 77.7 3.8 96.8 92.9 2.9 13.4 0.0 10.8 0.0 15.3 44.9 43.4 0.0 0.0 7.8 0.0 0.0 0.4 0.0 0.6 13.9 0.4 2.4 1.4 0.0 0.0 0.0 6.2 1.7 0.1 0.0 0.0 0.0 0.6 0.2 0.1 4.5 0.0 0.0 338.3 0.0 0.4 0.9 0.0 0.3 0.0 0.2 0.7 0.0 0.6 13.5 543.3 0.0 0.0 1.8 0.0 1.8 0.0 0.3 0.0 4.7 0.1 2.5 0.0 128.2 8.3 0.3 0.0 0.0 0.0 0.3 0.0 2.7 0.0 3.7 0.0 0.7 0.7 4.9 6.9 0.0 0.0 0.8 0.1 0.1 0.0 0.2 TIMP4 ENSG00000157150 "TIMP metallopeptidase inhibitor 4" Q99727 3 12153068-12158912 "Plasma proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 177.7;breast: 119.6" "Cell type enriched" "Detected in many" 10 "Adipocytes: 363.9" "Cancer enriched" "Detected in many" 13 "glioma: 66.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 212.9;ASC TERT1: 53.0;HSkMC: 91.9;NTERA-2: 50.7;U-87 MG: 53.6" "Region enhanced" "Detected in all" "cerebellum: 106.1" "Region enriched" "Detected in all" 9 "cerebellum: 47.7" "Secreted to extracellular matrix" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "unprognostic (2.99e-2)" "unprognostic (5.14e-3)" "unprognostic (1.02e-2)" "unprognostic (2.10e-1)" "unprognostic (2.09e-2)" "unprognostic (1.97e-4)" "unprognostic (9.33e-3)" "unprognostic (4.26e-3)" "unprognostic (1.36e-1)" "unprognostic (1.74e-2)" "unprognostic (3.78e-1)" "unprognostic (6.81e-2)" "unprognostic (4.99e-3)" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (6.66e-5)" "unprognostic (2.86e-1)" 177.7 8.3 7.7 3.9 8.4 0.6 119.6 49.6 7.2 9.3 3.9 12.1 1.4 8.1 1.0 2.9 6.8 4.4 31.0 6.8 8.8 2.8 1.1 6.6 0.6 13.7 8.6 3.8 4.0 1.4 12.3 9.9 11.7 5.5 4.3 1.0 8.9 2.3 16.7 7.7 11.0 4.4 11.3 3.4 9.2 0.7 7.1 2.0 23.1 30.1 0.1 9.8 8.7 11.6 0.7 24.2 0.7 0.0 212.9 53.0 26.4 0.8 8.9 1.0 1.3 0.5 0.1 0.0 2.2 0.9 0.8 0.9 0.0 0.8 0.4 1.0 0.0 0.0 12.7 0.9 33.2 0.0 0.1 91.9 2.2 5.8 0.2 1.6 0.0 0.0 0.5 17.3 0.2 0.6 0.0 0.0 50.7 0.0 6.0 0.0 0.0 0.4 0.0 0.1 0.3 0.0 5.0 0.0 0.0 6.1 0.0 0.0 1.0 0.1 0.0 0.6 0.9 0.0 0.1 0.0 53.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 8.4 49.6 7.2 6.8 8.8 13.7 8.6 11.7 11.3 7.1 11.6 363.9 0.0 0.0 0.0 0.4 0.1 1.3 0.3 0.6 0.4 12.4 2.8 7.0 0.0 0.2 0.0 0.0 0.4 1.4 1.3 0.0 0.6 1.6 0.2 2.1 33.6 6.6 5.3 0.1 2.6 2.7 15.7 0.0 0.0 0.0 0.2 22.5 0.0 3.4 0.0 0.2 2.8 0.0 1.2 0.3 7.5 12.2 0.8 3.6 0.0 0.0 0.7 0.0 9.0 0.1 4.6 4.8 2.6 0.0 4.2 2.7 0.5 5.5 0.0 32.9 3.1 29.1 0.1 0.0 0.2 0.1 0.1 0.4 0.2 2.0 2.2 PPARG "NR1C3, PPARG1, PPARG2, PPARgamma" ENSG00000132170 "Peroxisome proliferator activated receptor gamma" P37231 3 12287368-12434356 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 165.1" "Cell type enhanced" "Detected in many" "Adipocytes: 284.1;Extravillous trophoblasts: 217.8;Granulosa cells: 232.9;Urothelial cells: 239.6" "Cancer enhanced" "Detected in all" "urothelial cancer: 33.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 198.7;ASC TERT1: 113.7;BEWO: 247.5;CAPAN-2: 111.6;HSkMC: 118.9;PC-3: 112.0;RT4: 157.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB004282, HPA051239, HPA063663" Approved Enhanced Nucleoplasm,Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Vesicles" "CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081" "unprognostic (7.35e-3)" "unprognostic (3.27e-2)" "unprognostic (4.05e-2)" "unprognostic (8.37e-2)" "unprognostic (2.41e-2)" "unprognostic (5.27e-3)" "prognostic unfavorable (3.41e-5)" "unprognostic (9.13e-2)" "unprognostic (2.32e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.59e-8)" "unprognostic (1.51e-2)" "unprognostic (1.46e-1)" "unprognostic (9.68e-3)" "prognostic favorable (5.52e-5)" 165.1 3.9 4.0 8.7 3.0 3.0 74.3 3.2 4.7 9.7 0.6 48.7 23.6 7.0 1.2 6.2 7.0 10.5 14.6 4.0 2.7 14.3 17.1 28.5 4.9 3.7 3.5 14.5 2.8 7.9 0.5 43.6 3.4 5.5 40.6 1.0 5.7 1.7 5.2 6.2 15.1 8.7 3.2 12.0 35.5 6.9 3.5 4.1 13.2 8.1 2.1 67.7 9.1 5.0 44.0 38.6 0.0 0.2 198.7 113.7 247.5 3.7 44.7 5.4 2.1 7.8 111.6 0.0 0.1 4.0 72.9 17.3 14.4 0.7 1.0 106.4 20.3 0.0 8.1 10.3 51.8 0.2 0.1 118.9 9.7 9.8 37.5 20.6 0.7 1.0 0.0 0.0 8.3 11.0 0.1 0.8 0.7 99.2 112.0 0.0 0.0 0.2 30.6 157.5 0.1 1.2 18.8 6.7 2.2 6.7 0.0 34.2 35.0 7.8 10.6 4.6 0.2 0.0 0.1 0.3 3.2 0.5 1.2 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.0 3.0 3.2 4.7 4.0 2.7 3.7 3.5 3.4 3.2 3.5 5.0 284.1 3.2 7.2 1.6 0.6 1.0 50.5 0.4 4.6 0.9 1.9 2.8 9.2 1.5 2.5 5.5 0.0 110.4 1.8 93.4 1.9 1.1 4.9 5.2 1.4 26.1 8.4 0.0 39.3 0.7 217.8 12.3 83.1 20.8 8.9 232.9 25.7 3.4 49.9 0.0 74.1 21.3 0.0 19.4 4.8 2.2 4.1 19.1 3.6 38.4 1.8 0.6 0.0 6.6 1.2 17.3 84.1 0.0 1.6 42.1 17.0 14.3 1.5 0.2 13.1 1.9 31.3 10.9 22.8 4.6 1.1 88.9 2.2 0.8 24.5 239.6 TSEN2 "MGC2776, SEN2, SEN2L" ENSG00000154743 "TRNA splicing endonuclease subunit 2" Q8NCE0 3 12484421-12541549 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "mRNA processing, tRNA processing" Lyase "Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027120, HPA027125, HPA027268" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 30: Non-specific - Translation" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Centrosome, Cytosol" "HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347" "unprognostic (5.58e-2)" "unprognostic (4.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.71e-2)" "unprognostic (9.59e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (1.42e-1)" "unprognostic (5.66e-2)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "unprognostic (6.15e-2)" "unprognostic (1.41e-2)" "unprognostic (6.99e-2)" "unprognostic (4.90e-2)" "unprognostic (6.06e-2)" "prognostic favorable (3.49e-4)" 8.9 9.4 3.4 1.1 3.9 0.3 8.9 4.4 4.8 11.5 3.7 11.5 1.4 10.9 2.6 8.6 12.0 1.8 15.5 3.5 3.7 10.2 8.5 6.0 2.2 3.6 3.5 14.2 12.1 3.2 10.9 0.9 3.6 10.0 2.3 3.4 6.7 3.2 15.9 8.3 6.9 3.2 3.3 6.6 9.7 6.7 3.9 2.6 9.0 3.8 2.2 11.5 9.7 3.8 6.2 11.8 5.5 7.4 6.3 7.7 7.6 5.8 4.3 6.6 5.1 4.2 5.2 5.5 3.3 4.0 5.8 5.8 7.8 9.4 5.4 5.5 9.8 5.1 9.1 5.7 5.4 9.3 2.1 4.9 11.2 10.1 9.7 3.3 4.7 8.8 10.7 3.4 6.5 11.9 9.6 6.1 6.5 10.5 13.5 4.6 2.3 13.5 9.9 4.8 1.5 4.5 6.7 5.0 4.8 3.1 10.1 5.1 4.5 4.2 3.9 4.7 9.7 3.1 8.6 6.2 5.6 11.8 5.4 0.6 1.9 0.0 2.7 1.6 4.4 3.7 4.6 3.8 2.3 3.2 6.2 5.1 0.4 2.5 1.7 3.4 1.6 2.6 3.4 3.9 4.4 4.8 3.5 3.7 3.6 3.5 3.6 3.3 3.9 3.8 5.5 3.2 3.3 26.1 8.9 2.9 11.2 5.6 13.1 28.1 3.7 4.3 7.0 10.0 3.8 11.0 43.8 8.8 2.6 9.2 1.9 6.2 1.6 7.1 7.4 6.2 4.2 8.4 42.8 4.2 4.3 5.7 13.7 3.7 5.1 17.7 3.6 5.0 4.6 10.1 46.4 5.2 4.1 3.5 1.7 2.8 9.0 3.6 3.6 16.9 2.4 8.0 6.2 19.1 31.8 4.5 5.0 10.1 3.8 6.2 2.3 6.9 11.1 34.1 6.6 7.9 6.3 14.0 23.0 7.1 4.8 1.9 4.6 15.3 8.4 8.0 MKRN2OS "C3orf83, MKRN2-AS1" ENSG00000225526 "MKRN2 opposite strand" H3BPM6 3 12514934-12561059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 9.2;intestine: 8.0" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 6.6;Proximal enterocytes: 7.5;Respiratory ciliated cells: 4.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "cerebellum: 4.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.9;CAPAN-2: 13.8;HBEC3-KT: 3.4;MCF7: 3.2;RT4: 5.7;T-47d: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065586, HPA065753" Uncertain Approved "Golgi apparatus" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA065586: AB_2685514, HPA065753: AB_2685553" "unprognostic (2.53e-2)" "unprognostic (1.01e-2)" "unprognostic (3.89e-3)" "unprognostic (2.03e-3)" "unprognostic (3.81e-1)" "unprognostic (8.45e-2)" "unprognostic (2.24e-1)" "unprognostic (2.29e-1)" "unprognostic (5.26e-2)" "unprognostic (3.86e-2)" "unprognostic (1.58e-2)" "unprognostic (4.29e-3)" "unprognostic (2.53e-5)" "unprognostic (1.02e-1)" "unprognostic (2.48e-1)" "unprognostic (8.50e-3)" "unprognostic (3.17e-3)" 0.1 0.0 0.1 0.4 0.4 0.0 1.3 4.4 0.8 1.8 0.0 4.3 8.0 0.2 9.2 4.6 1.9 2.2 2.0 0.2 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.2 4.1 1.0 1.6 0.4 0.2 0.9 5.0 1.3 7.0 1.9 0.4 2.5 7.6 0.0 0.0 0.0 5.1 0.1 0.1 0.2 0.6 0.0 0.9 0.9 1.1 0.1 2.9 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 13.8 0.0 0.3 0.0 0.0 0.6 0.0 3.4 0.0 0.0 0.9 0.0 0.6 0.2 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.2 2.0 5.7 0.2 0.0 0.0 0.8 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 4.4 0.8 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 1.1 0.3 0.5 0.0 0.7 0.0 1.8 0.7 2.9 1.3 0.7 2.8 0.6 3.7 0.0 2.7 0.0 1.9 0.0 1.7 1.5 3.0 0.5 0.2 0.0 0.0 2.3 2.2 0.6 0.0 6.6 2.8 0.0 0.2 0.0 0.0 0.2 0.0 2.6 2.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.8 2.1 2.2 0.0 0.2 0.4 7.5 1.1 4.4 1.0 0.0 0.1 0.1 0.2 0.1 3.4 0.0 0.3 0.0 0.1 2.1 0.9 MKRN2 "HSPC070, RNF62" ENSG00000075975 "Makorin ring finger protein 2" Q9H000 3 12557057-12586208 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 10 "Early spermatids: 572.9;Late spermatids: 774.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037559, HPA037560" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Cytosol" "HPA037559: AB_10672460, HPA037560: AB_10696936" "unprognostic (4.17e-2)" "unprognostic (1.08e-1)" "unprognostic (1.59e-2)" "unprognostic (5.99e-2)" "unprognostic (3.89e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (4.38e-1)" "unprognostic (8.49e-2)" "unprognostic (2.86e-1)" "unprognostic (1.42e-1)" "unprognostic (2.56e-3)" "prognostic favorable (6.04e-4)" "unprognostic (3.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.33e-2)" "unprognostic (3.32e-2)" 16.3 11.5 15.1 10.9 15.1 3.5 13.8 16.9 17.6 15.7 13.5 16.3 13.0 16.6 12.0 17.9 14.7 11.6 32.5 15.1 17.0 16.0 15.1 13.4 14.5 15.5 15.9 21.7 24.1 23.9 12.8 16.7 16.1 12.5 13.5 11.4 14.0 14.0 32.0 14.5 12.2 18.9 16.7 10.7 13.7 56.3 16.7 21.4 21.1 24.5 17.3 15.3 14.3 17.6 20.6 18.8 24.5 17.4 45.2 44.3 40.6 30.0 35.5 41.7 34.1 19.2 18.8 26.7 16.9 37.7 18.8 10.9 38.4 33.1 37.1 30.9 29.2 40.3 19.1 31.1 51.9 38.8 14.4 46.8 30.6 47.6 30.2 34.8 34.9 39.1 39.7 30.8 37.7 25.9 51.4 17.8 16.5 21.7 40.4 45.9 26.0 32.2 30.4 24.8 14.8 26.4 28.4 12.8 30.4 17.3 29.7 38.0 31.1 23.0 23.0 28.5 43.0 26.6 62.8 60.8 28.8 49.5 41.1 20.9 17.9 32.9 20.7 16.4 26.4 21.3 21.4 22.0 19.8 16.5 22.8 20.8 13.2 27.8 23.3 15.9 24.5 20.2 15.1 15.1 16.9 17.6 15.1 17.0 15.5 15.9 16.1 16.7 16.7 17.6 15.4 19.2 9.6 9.8 13.8 9.6 9.9 13.5 10.2 13.8 8.5 8.9 14.7 1.5 14.2 5.5 4.2 19.7 20.8 7.6 19.6 16.1 572.9 9.7 13.8 14.1 2.4 5.0 15.9 16.8 19.6 11.4 5.1 10.1 19.0 17.3 7.9 5.8 15.5 11.8 15.5 10.0 6.1 7.2 9.1 774.2 20.5 9.6 16.0 6.5 20.1 19.1 20.6 14.1 11.1 16.0 10.8 20.7 14.7 9.5 12.0 11.6 14.2 13.2 13.1 11.3 17.4 66.5 38.4 8.1 9.2 16.1 15.7 23.6 10.1 9.8 RAF1 "c-Raf, CRAF, Raf-1" ENSG00000132155 "Raf-1 proto-oncogene, serine/threonine kinase" P04049 3 12583601-12664125 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 175.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 175.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002639, HPA002640, CAB019291" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 59: Non-specific - Translation" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane, Cytosol" "CAB019291: , HPA002639: , HPA002640: AB_1856047" "unprognostic (6.33e-2)" "unprognostic (1.29e-1)" "unprognostic (5.92e-2)" "unprognostic (2.17e-3)" "unprognostic (6.51e-3)" "unprognostic (7.66e-3)" "unprognostic (2.66e-3)" "unprognostic (1.53e-2)" "unprognostic (2.72e-1)" "unprognostic (7.66e-2)" "unprognostic (2.92e-2)" "unprognostic (1.29e-2)" "unprognostic (2.79e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-2)" "unprognostic (2.36e-2)" 42.4 34.2 36.7 33.8 37.9 77.4 39.2 42.6 37.4 47.6 40.4 46.8 40.5 45.6 34.0 55.5 43.2 31.0 89.6 36.9 35.8 46.7 68.9 44.7 36.3 38.3 36.9 52.0 50.6 63.6 28.3 39.1 37.0 41.9 42.0 37.4 39.6 38.0 194.9 56.0 43.4 45.5 36.7 48.3 55.5 26.8 38.1 52.8 48.8 122.5 47.7 46.1 46.2 39.8 49.9 57.9 85.5 66.6 74.3 59.6 168.0 73.9 129.1 100.1 112.5 46.6 41.3 52.7 34.6 120.1 51.6 31.9 93.4 67.5 103.8 91.4 70.2 72.0 69.4 42.9 74.2 70.1 64.7 55.3 67.8 102.3 82.0 67.6 73.1 78.2 52.6 136.0 98.3 88.6 91.1 47.8 86.5 64.0 76.4 72.6 75.7 66.4 60.9 76.9 26.1 56.2 61.1 59.8 40.9 66.1 99.1 91.5 51.1 65.6 62.5 55.7 85.0 103.3 178.4 112.3 57.2 80.4 73.9 40.4 32.7 62.5 22.3 32.6 22.5 19.5 21.9 22.3 30.3 20.4 21.9 22.8 175.1 29.8 34.2 13.5 28.3 28.2 36.7 37.9 42.6 37.4 36.9 35.8 38.3 36.9 37.0 36.7 38.1 39.8 28.5 22.4 37.6 47.7 36.1 34.4 35.2 22.1 27.9 56.7 27.5 22.6 29.0 35.8 25.7 27.6 66.7 40.0 41.5 31.3 13.7 25.6 8.8 33.2 37.1 32.7 29.3 46.7 46.1 37.0 46.8 32.3 27.5 43.8 34.2 78.7 36.0 41.2 28.6 43.7 52.9 31.0 30.5 39.3 43.4 4.6 39.1 34.7 26.6 44.0 49.5 31.9 51.5 65.4 64.0 35.5 29.9 41.3 43.3 46.9 47.3 20.1 31.2 81.9 32.9 56.2 39.1 28.3 33.6 31.8 43.5 62.3 40.8 35.6 31.2 47.1 TMEM40 FLJ11036 ENSG00000088726 "Transmembrane protein 40" Q8WWA1 3 12733528-12769457 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 219.8;skin 1: 64.7;vagina: 80.1" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 104.7;Cytotrophoblasts: 128.3;Macrophages: 121.3;Squamous epithelial cells: 116.5;Suprabasal keratinocytes: 201.9;Syncytiotrophoblasts: 656.6;Urothelial cells: 157.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 13.3;urothelial cancer: 12.1" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 6.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 6.0" "Cell line enhanced" "Detected in many" "HBEC3-KT: 244.9;hTCEpi: 56.1;hTERT-HME1: 68.0;RT4: 36.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA044165, HPA073122" Enhanced Approved Cytosol NA NA 2500000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 51: Myeloid cells - Hemostasis" Cytosol "HPA044165: AB_10961279, HPA073122: " "unprognostic (2.51e-3)" "unprognostic (1.96e-2)" "unprognostic (2.64e-3)" "unprognostic (8.25e-2)" "unprognostic (2.27e-1)" "unprognostic (1.92e-1)" "unprognostic (5.15e-4)" "unprognostic (5.96e-2)" "unprognostic (3.15e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-3)" "unprognostic (2.47e-1)" "unprognostic (1.20e-3)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (1.46e-2)" "unprognostic (6.77e-2)" 0.1 0.1 0.4 0.0 0.4 3.3 3.2 0.5 0.6 42.1 0.3 0.0 0.1 0.1 1.3 219.8 3.1 0.1 4.2 0.5 0.3 0.2 0.3 2.1 0.1 0.4 0.3 0.1 0.1 3.2 0.2 15.9 0.3 3.7 0.0 0.1 27.3 2.5 1.3 64.7 0.0 0.1 0.1 1.8 0.2 0.8 0.4 1.5 0.1 0.6 25.9 15.2 80.1 0.3 26.6 0.1 0.0 0.1 0.0 0.0 22.4 0.2 1.1 1.3 1.4 1.0 4.1 0.1 0.2 0.0 0.6 7.6 0.0 244.9 5.1 0.2 0.0 1.9 0.2 0.8 0.0 0.0 0.0 0.0 56.1 0.0 68.0 0.4 0.0 0.0 0.1 0.0 0.0 7.7 0.0 0.0 0.0 0.2 4.3 0.0 1.6 0.0 1.6 36.0 0.2 0.2 0.1 31.3 0.0 4.6 2.8 0.7 0.0 0.0 1.6 0.0 2.1 0.3 0.1 0.4 0.1 0.0 0.0 1.6 0.9 1.1 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 6.0 0.0 0.0 0.8 0.0 32.9 0.4 0.4 0.5 0.6 0.5 0.3 0.4 0.3 0.3 0.1 0.4 0.3 0.1 0.0 0.0 0.3 0.3 64.2 104.7 71.7 17.6 0.0 1.5 5.6 4.7 0.0 39.4 1.8 0.0 128.3 0.0 0.1 0.0 0.5 0.8 2.9 0.0 1.8 0.0 0.0 0.3 0.0 14.7 1.8 0.0 0.1 0.0 0.0 2.2 0.7 10.8 0.0 0.3 0.0 12.2 4.8 7.3 2.0 0.3 121.3 10.6 0.0 2.6 0.0 2.1 0.0 0.2 2.2 0.0 0.0 0.0 53.5 0.0 0.0 55.0 0.0 0.0 0.1 3.6 0.7 6.8 116.5 201.9 656.6 1.0 0.2 0.0 157.9 CAND2 "KIAA0667, TIP120B, Tp120b" ENSG00000144712 "Cullin associated and neddylation dissociated 2 (putative)" O75155 3 12796472-12871916 "Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 135.0" "Cell type enriched" "Detected in many" 4 "Early spermatids: 120.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 19.4;REH: 12.4;U-266/84: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005777 Approved Approved "Nuclear bodies,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear bodies" Cytosol "HPA005777: AB_2667431" "unprognostic (6.11e-3)" "unprognostic (3.44e-2)" "unprognostic (1.52e-3)" "unprognostic (6.09e-2)" "unprognostic (4.22e-1)" "unprognostic (2.35e-1)" "unprognostic (1.12e-2)" "unprognostic (1.67e-2)" "unprognostic (2.00e-2)" "unprognostic (9.03e-2)" "unprognostic (6.36e-3)" "unprognostic (1.03e-1)" "unprognostic (4.78e-5)" "unprognostic (1.31e-2)" "unprognostic (2.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.96e-3)" 3.0 3.2 7.9 0.5 7.9 1.0 1.9 6.4 8.7 4.8 7.6 6.5 0.9 6.4 2.2 2.4 6.2 1.7 25.3 8.0 9.6 2.4 1.6 2.4 0.8 8.0 7.4 5.0 2.4 5.4 8.3 0.8 8.3 3.6 0.7 2.2 3.3 3.0 135.0 1.4 2.3 3.4 6.6 2.2 3.3 15.7 8.8 0.8 3.1 36.2 0.6 4.4 2.7 8.6 0.8 1.6 5.6 0.2 0.2 0.1 0.3 1.4 0.6 3.4 4.1 0.9 0.3 1.0 1.9 0.9 0.9 0.2 6.4 0.1 2.6 1.8 19.4 1.5 2.9 1.4 5.2 0.2 0.1 1.2 0.3 3.1 0.1 3.3 0.7 7.2 5.3 1.0 1.0 3.3 2.6 0.8 3.8 0.4 2.0 12.4 1.2 1.0 0.2 1.5 3.9 4.6 0.1 0.9 1.2 1.1 1.6 6.3 0.4 1.0 0.9 1.0 1.4 1.3 9.9 8.4 0.6 1.2 2.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.1 7.9 7.9 6.4 8.7 8.0 9.6 8.0 7.4 8.3 6.6 8.8 8.6 0.9 3.2 1.1 5.9 0.2 0.4 0.8 0.6 1.8 16.0 0.4 0.5 4.8 1.5 0.7 1.8 10.4 0.2 0.2 0.1 0.0 0.9 120.6 0.4 1.4 1.8 0.0 0.4 19.3 0.0 0.2 2.6 0.5 0.3 0.0 5.6 3.3 2.0 4.2 13.5 25.3 0.0 0.0 0.0 0.8 23.2 4.7 0.4 0.0 4.7 0.0 2.9 1.0 12.1 7.2 0.0 0.0 10.1 0.2 0.5 0.0 0.7 0.3 3.1 0.0 4.1 4.0 1.4 5.3 0.4 0.1 0.1 1.0 9.2 0.0 0.4 RPL32 L32 ENSG00000144713 "Ribosomal protein L32" P62910 3 12834485-12841582 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047501, HPA051994" Enhanced Approved "Endoplasmic reticulum,Cytosol" NA NA 45000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "HPA047501: AB_2680070, HPA051994: AB_2681686" "unprognostic (6.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.25e-1)" "unprognostic (1.21e-2)" "unprognostic (1.88e-2)" "unprognostic (2.55e-1)" "unprognostic (4.58e-3)" "unprognostic (2.03e-1)" "unprognostic (1.51e-1)" "unprognostic (1.68e-2)" "unprognostic (2.20e-1)" "unprognostic (6.93e-2)" "unprognostic (1.94e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (8.36e-2)" "unprognostic (1.44e-2)" 1907.8 1194.0 1183.6 985.6 1234.6 2971.9 2518.6 1157.9 1625.9 2186.9 1121.8 1558.0 888.8 1458.5 2020.0 1799.9 1857.7 928.0 1266.4 1148.0 1212.7 1252.7 1295.7 1185.9 2346.7 1206.9 1168.5 3697.3 2765.5 775.2 986.3 974.3 1231.2 1537.4 1561.1 523.9 1561.0 780.3 2422.9 2644.1 1380.3 1321.4 1242.7 1511.9 1420.5 567.9 1204.2 1741.0 1134.2 1544.1 2984.9 1566.9 1867.1 1268.7 1494.9 1746.7 1497.4 1918.8 2298.7 4080.5 4927.7 1200.0 2217.5 2476.7 1684.5 2327.2 1482.5 2572.0 1066.1 1735.3 812.9 909.5 1718.2 2495.2 2023.2 1198.1 2874.3 1501.4 2099.3 2562.1 3427.6 2450.0 1456.5 3696.3 5338.3 1895.4 3629.5 2438.7 2198.5 1863.5 1879.0 2323.9 2054.2 4479.6 2773.8 4208.3 2534.9 2129.5 3285.7 2180.2 1344.1 3390.6 2540.9 2434.9 945.7 1887.9 807.8 2141.2 2740.7 1329.5 3137.0 4624.7 1280.6 1066.6 1359.4 1419.3 2254.0 1557.7 2671.2 4640.8 1357.9 3466.6 1629.6 1259.1 2347.0 621.3 2399.6 1800.7 4325.6 5980.2 4749.7 3485.2 3077.9 5413.0 6661.3 5216.7 320.4 2897.7 1489.1 3049.5 3940.9 9478.6 1183.6 1234.6 1157.9 1625.9 1148.0 1212.7 1206.9 1168.5 1231.2 1242.7 1204.2 1268.7 3508.6 1070.5 1834.7 48.6 7663.9 9224.7 7932.7 5817.1 6926.2 342.4 9401.1 14609.2 488.6 3061.2 2689.8 1460.3 166.8 4947.7 4337.7 1512.3 4560.6 3028.0 1986.6 1422.0 4295.9 4075.7 2307.8 4056.3 39.3 6515.0 7623.3 3321.2 2414.9 1972.5 2387.6 3801.4 4734.3 3694.7 4285.0 180.0 41.2 5268.2 1723.2 5797.3 8513.9 7985.2 6662.4 3978.7 4845.2 43.1 6310.8 1703.6 4092.7 18.1 47.3 4383.7 3899.5 2998.1 3398.6 7138.0 3381.8 6786.8 1088.2 684.5 1965.6 5442.0 4616.2 1064.1 1260.6 8612.8 10963.5 4878.3 6299.1 5026.8 5534.7 8006.9 IQSEC1 "ARF-GEP100, BRAG2, GEP100, KIAA0763" ENSG00000144711 "IQ motif and Sec7 domain ArfGEF 1" Q6DN90 3 12897043-13283281 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 183.0;Cone photoreceptor cells: 193.9;Excitatory neurons: 191.3;Horizontal cells: 235.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 66.5;U-266/84: 64.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038143, HPA038144" Uncertain Supported "Nucleoli,Nucleoli rim,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoli, Nucleoli rim, Vesicles" "HPA038143: AB_10697241, HPA038144: AB_2675860" "prognostic unfavorable (3.03e-5)" "unprognostic (1.80e-1)" "unprognostic (6.32e-2)" "unprognostic (3.01e-1)" "unprognostic (8.19e-3)" "unprognostic (2.64e-3)" "unprognostic (5.60e-2)" "unprognostic (1.67e-1)" "unprognostic (3.00e-1)" "unprognostic (1.14e-2)" "prognostic favorable (9.07e-4)" "unprognostic (4.42e-1)" "prognostic favorable (3.58e-6)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (1.00e-3)" "unprognostic (4.65e-2)" 26.8 38.7 37.0 19.3 49.4 54.9 19.7 13.9 85.6 20.5 0.0 19.6 7.0 19.6 7.4 9.2 19.5 11.0 35.3 42.7 19.9 16.8 30.9 28.4 24.6 48.1 14.2 21.1 19.3 30.9 18.5 19.0 50.6 22.4 7.1 56.3 15.3 13.7 34.4 12.8 22.3 12.3 4.3 46.6 17.7 10.8 17.6 14.0 16.1 27.0 16.4 19.6 15.3 55.1 10.2 13.3 11.4 12.5 9.6 12.8 66.5 10.8 9.1 7.2 5.5 9.1 8.1 21.2 12.0 20.1 7.9 5.8 9.0 5.7 5.3 14.1 19.0 12.6 8.0 38.0 10.3 0.2 5.1 13.0 10.6 14.7 8.3 9.6 6.7 8.6 36.0 20.6 5.1 31.6 8.2 13.1 12.3 7.6 26.4 11.3 3.9 29.6 4.4 12.8 9.5 18.2 7.4 27.5 6.5 10.4 11.6 8.6 17.5 7.5 19.2 6.4 1.5 43.6 64.7 8.1 14.2 6.0 6.1 4.5 2.7 3.9 2.5 2.9 1.9 5.0 1.7 1.9 1.4 4.3 1.7 2.0 8.3 1.3 2.8 4.9 1.3 2.1 37.0 49.4 13.9 85.6 42.7 19.9 48.1 14.2 50.6 4.3 17.6 55.1 29.1 3.2 17.9 59.7 45.6 11.5 7.9 7.8 12.0 110.1 16.1 15.9 183.0 21.5 10.7 3.7 193.9 9.9 48.5 3.4 7.9 6.8 2.9 7.3 13.2 29.8 10.2 46.3 191.3 12.9 42.2 22.8 8.2 5.0 15.2 21.6 24.7 42.7 22.0 235.6 128.4 13.3 4.1 60.4 42.4 4.8 16.8 34.2 7.2 78.7 36.3 16.6 45.3 67.3 78.8 7.8 3.8 22.6 23.3 19.0 3.0 5.8 29.1 123.1 26.3 24.9 30.6 2.2 1.7 3.5 7.7 21.8 24.8 45.2 8.5 13.2 NUP210 "FLJ22389, GP210, KIAA0906, POM210" ENSG00000132182 "Nucleoporin 210" Q8TEM1 3 13316235-13420322 "Metabolic proteins, Predicted membrane proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 53.4;lymphoid tissue: 41.7" "Cell type enhanced" "Detected in many" "dendritic cells: 57.7;Granulosa cells: 70.0;NK-cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 232.7;U-266/84: 261.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066888 Approved NA NA 78000 "Cluster 39: Non-specific - mRNA processing" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 40: Granulosa cells - Unknown function" "HPA066888: AB_2685741" "unprognostic (3.17e-2)" "unprognostic (2.09e-1)" "unprognostic (2.53e-1)" "unprognostic (3.60e-2)" "unprognostic (2.33e-1)" "unprognostic (9.72e-3)" "prognostic unfavorable (6.03e-6)" "unprognostic (1.30e-1)" "unprognostic (3.15e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (5.87e-2)" "unprognostic (1.96e-3)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.59e-2)" "unprognostic (1.63e-2)" 2.0 5.2 5.3 23.2 5.8 53.4 5.4 7.8 6.5 2.3 4.8 6.4 7.3 2.6 8.4 7.1 4.1 4.6 2.3 5.0 6.2 8.8 19.8 7.6 41.3 6.1 6.7 1.2 13.0 9.7 13.5 6.4 5.5 5.4 5.6 4.8 6.4 2.8 5.2 5.6 22.2 2.4 5.2 32.5 8.5 9.2 5.8 41.7 8.1 1.8 29.0 5.8 2.2 7.3 41.5 72.0 34.8 90.8 0.0 0.0 138.1 0.6 0.0 8.6 0.4 37.2 66.3 167.7 55.6 0.1 3.9 23.8 77.5 0.0 3.2 135.9 57.9 65.2 81.1 39.6 0.0 210.8 22.7 0.0 0.0 0.0 0.0 6.3 0.1 124.1 102.5 174.9 0.0 103.8 112.6 83.4 40.2 12.8 14.8 0.2 0.2 232.7 16.9 38.4 39.8 39.8 51.3 67.7 21.0 15.5 64.8 172.6 0.5 0.1 11.7 0.2 31.8 176.1 261.0 144.9 0.1 116.0 0.3 0.0 2.5 0.9 7.3 3.2 5.8 5.4 5.2 7.2 5.4 3.1 4.3 5.8 0.1 5.5 2.0 5.6 4.8 3.7 5.3 5.8 7.8 6.5 5.0 6.2 6.1 6.7 5.5 5.2 5.8 7.3 0.7 16.0 5.4 16.6 37.3 1.7 1.3 0.5 0.0 25.4 9.6 5.3 11.6 8.6 4.1 5.5 14.6 17.6 57.7 2.9 3.9 5.7 19.2 4.3 1.0 1.0 8.3 41.8 17.9 4.4 5.6 1.1 3.6 8.3 5.1 70.0 3.6 17.0 16.7 35.3 23.4 8.8 4.1 11.3 4.9 23.5 0.6 14.9 1.8 10.3 16.7 3.0 69.0 30.2 17.7 2.6 0.8 0.4 43.7 2.6 2.1 4.5 3.0 19.4 0.0 2.1 1.1 6.4 10.0 3.5 2.4 4.9 37.2 17.8 11.5 1.9 HDAC11 ENSG00000163517 "Histone deacetylase 11" Q96DB2 3 13479724-13506424 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 122.7" "Group enriched" "Detected in many" 6 "Early spermatids: 357.7;Late spermatids: 692.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 47.7;T-47d: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (5.22e-2)" "unprognostic (3.58e-2)" "unprognostic (1.83e-1)" "unprognostic (5.69e-3)" "unprognostic (1.76e-1)" "unprognostic (4.71e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (4.50e-2)" "unprognostic (5.67e-3)" "unprognostic (1.78e-2)" "unprognostic (9.87e-2)" "unprognostic (3.94e-1)" "prognostic favorable (7.88e-10)" "unprognostic (3.63e-2)" "unprognostic (1.65e-1)" "unprognostic (1.46e-1)" "unprognostic (1.39e-3)" 7.7 10.1 92.5 3.9 115.5 0.8 9.4 89.2 98.4 16.9 62.8 18.0 12.2 11.8 6.5 17.6 13.3 9.1 31.4 82.5 90.5 25.1 6.6 9.1 2.8 95.2 100.1 16.7 38.1 23.2 22.8 4.6 87.4 15.9 6.9 6.2 17.4 12.2 51.5 18.7 13.4 7.3 83.9 5.3 12.8 84.2 100.5 4.9 16.5 15.5 4.1 14.7 14.4 122.7 12.0 8.0 8.0 6.6 11.9 10.4 6.5 7.5 5.4 7.8 5.1 4.0 10.4 1.0 9.3 11.6 12.3 8.9 4.7 14.6 5.0 5.1 4.4 2.4 3.7 11.3 12.6 0.2 4.1 9.0 26.6 8.7 6.8 14.2 5.8 7.6 5.0 2.1 7.7 12.2 1.5 1.7 2.1 8.1 20.9 1.7 11.8 3.4 16.6 9.0 1.3 6.2 12.1 47.7 21.8 6.6 42.6 2.8 5.3 6.7 13.0 13.0 4.7 1.5 4.5 0.2 2.1 1.8 4.1 0.1 2.6 5.8 3.3 1.6 2.3 1.1 3.1 2.6 1.8 0.4 3.0 2.1 1.0 9.6 0.6 1.7 2.6 1.9 92.5 115.5 89.2 98.4 82.5 90.5 95.2 100.1 87.4 83.9 100.5 122.7 5.2 9.6 5.0 11.4 0.9 11.5 7.7 11.0 8.6 8.5 10.6 8.0 84.6 8.6 8.9 11.0 0.0 18.9 2.8 23.1 19.6 14.6 357.7 8.6 5.2 6.3 8.9 0.8 6.9 11.4 3.1 9.7 9.7 7.8 1.3 5.0 7.1 2.8 6.0 10.1 7.1 14.4 18.3 3.5 3.8 692.3 16.1 3.6 8.8 1.0 4.6 21.8 2.1 12.5 46.9 11.1 13.6 15.4 0.7 5.1 36.1 24.9 12.0 5.6 0.0 5.6 9.5 15.3 7.3 10.1 10.5 5.7 3.3 3.1 20.0 6.8 FBLN2 ENSG00000163520 "Fibulin 2" P98095 3 13549125-13638422 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 292.8" "Cell type enhanced" "Detected in many" "Adipocytes: 92.7;Endometrial stromal cells: 84.4;Fibroblasts: 458.4;Leydig cells: 170.9;Peritubular cells: 227.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 6.7;naive CD8 T-cell: 3.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 384.0;fHDF/TERT166: 264.3;HMC-1: 311.6;HSkMC: 221.9;U-2197: 139.2" "Group enriched" "Detected in many" 4 "olfactory bulb: 12.4;white matter: 3.1" "Low region specificity" "Detected in all" "HPA001934, CAB018622" Enhanced Supported "Plasma membrane" "Secreted to extracellular matrix" NA NA 35000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "CAB018622: AB_2294196, HPA001934: AB_1078827" "unprognostic (1.19e-1)" "unprognostic (7.76e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (2.82e-2)" "unprognostic (1.05e-1)" "prognostic favorable (3.17e-4)" "unprognostic (8.02e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "unprognostic (2.57e-1)" "unprognostic (4.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.89e-2)" "unprognostic (2.82e-2)" "unprognostic (2.61e-2)" "unprognostic (1.41e-1)" 157.3 7.6 5.9 12.7 7.7 1.0 97.3 5.2 9.0 63.4 6.4 32.7 6.2 31.1 3.2 42.4 26.8 46.2 292.8 7.0 4.9 8.7 3.7 29.2 8.4 5.3 5.3 5.8 8.6 3.0 2.3 80.3 4.8 29.1 11.8 0.6 39.4 8.8 47.7 72.5 19.8 14.7 4.1 6.0 22.3 46.7 6.9 14.2 63.7 48.9 5.6 79.6 56.7 4.4 0.0 1.4 50.9 0.0 384.0 51.7 23.8 124.9 98.2 122.4 80.4 8.1 0.3 0.0 5.9 264.3 0.2 0.2 0.0 0.5 22.9 0.1 0.1 100.7 1.9 0.0 26.0 0.2 311.6 221.9 2.0 19.3 0.0 0.2 0.0 8.6 0.8 0.9 0.6 0.3 5.2 0.6 12.2 0.0 0.7 0.2 0.0 0.5 0.9 0.1 3.0 2.4 0.5 90.3 0.1 13.6 0.2 0.3 0.1 0.1 0.1 139.2 0.1 0.2 0.0 0.0 1.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.2 6.7 1.3 0.0 3.7 0.0 0.2 0.0 0.5 0.0 0.9 5.9 7.7 5.2 9.0 7.0 4.9 5.3 5.3 4.8 4.1 6.9 4.4 92.7 0.0 1.5 1.6 3.6 30.8 0.8 10.5 2.2 0.0 1.7 1.9 8.8 0.0 12.3 7.3 2.1 7.8 1.9 0.1 0.0 0.0 3.8 2.9 84.4 43.8 0.0 1.7 0.6 0.2 4.8 458.4 6.1 2.7 23.6 0.6 47.8 0.4 3.6 0.0 0.6 0.0 0.0 1.9 49.8 12.1 170.9 4.5 39.2 26.2 0.3 1.2 0.0 30.7 0.3 0.3 0.0 227.2 1.6 1.2 2.7 0.1 1.4 0.4 13.1 29.7 26.4 3.4 13.5 2.0 28.8 6.2 5.3 0.2 0.0 1.1 WNT7A Wnt-7a ENSG00000154764 "Wnt family member 7A" O00755 3 13816258-13880071 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1;gallbladder: 2.3;placenta: 2.7" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 68.7;Extravillous trophoblasts: 147.5;Pancreatic endocrine cells: 98.8;Syncytiotrophoblasts: 185.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.2;ovarian cancer: 11.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Cell line enhanced" "Detected in some" "BEWO: 59.8;EFO-21: 56.0;PC-3: 19.9;RPTEC TERT1: 100.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015719, CAB025894" Approved "Secreted to extracellular matrix" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 38: Extravillous trophoblasts - Unknown function" "CAB025894: , HPA015719: AB_1858856" "unprognostic (1.26e-2)" "unprognostic (4.60e-1)" "unprognostic (2.98e-1)" "prognostic unfavorable (2.96e-5)" "unprognostic (3.02e-1)" "unprognostic (1.14e-3)" "unprognostic (2.49e-1)" "unprognostic (3.32e-4)" "unprognostic (2.20e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.03e-6)" "unprognostic (7.89e-2)" "unprognostic (3.78e-2)" "unprognostic (6.49e-4)" "unprognostic (1.90e-1)" "unprognostic (3.74e-1)" "unprognostic (8.88e-3)" 0.0 0.0 3.6 0.1 3.1 0.1 0.0 1.0 3.7 0.2 0.3 0.0 0.0 1.1 0.2 0.4 0.1 2.3 0.0 2.4 2.1 0.2 0.0 2.0 0.2 5.1 1.9 0.0 0.1 0.0 0.0 2.7 2.5 0.1 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 3.4 1.3 0.0 1.3 2.5 0.0 0.0 0.0 0.1 0.3 0.1 2.8 8.6 0.0 0.8 0.0 0.0 0.0 59.8 0.0 0.0 0.0 0.0 0.0 7.6 0.0 56.0 0.0 0.1 11.2 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.9 0.0 0.0 1.7 100.3 0.9 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 3.6 3.1 1.0 3.7 2.4 2.1 5.1 1.9 2.5 3.4 2.5 2.8 0.0 12.8 0.0 8.5 0.0 5.9 2.8 2.6 0.0 0.0 0.0 0.0 0.7 8.6 1.4 0.0 0.0 68.7 0.0 0.0 0.0 13.8 17.3 14.5 0.4 0.6 0.0 0.0 4.0 9.1 147.5 0.4 0.0 17.9 0.0 0.0 0.0 0.0 7.4 0.0 2.4 0.0 0.0 0.0 0.0 5.6 0.0 0.1 0.0 1.0 0.0 0.0 0.0 4.5 0.3 98.8 0.0 0.0 0.0 3.3 0.0 0.1 0.2 0.0 0.0 0.0 0.2 6.0 2.3 0.0 1.3 185.7 1.5 0.0 0.0 6.0 CHCHD4 "FLJ31709, MIA40, TIMM40" ENSG00000163528 "Coiled-coil-helix-coiled-coil-helix domain containing 4" Q8N4Q1 3 14112077-14124870 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 84.1;Proximal tubular cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034688, HPA063727" Uncertain Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA034688: AB_10696361, HPA063727: AB_2685103" "unprognostic (3.89e-3)" "unprognostic (8.82e-2)" "unprognostic (1.50e-2)" "unprognostic (7.34e-2)" "unprognostic (1.11e-2)" "unprognostic (9.12e-2)" "unprognostic (2.63e-3)" "unprognostic (1.02e-1)" "unprognostic (1.82e-1)" "unprognostic (5.55e-2)" "unprognostic (3.59e-2)" "unprognostic (1.43e-1)" "prognostic favorable (8.63e-5)" "unprognostic (1.53e-1)" "unprognostic (2.34e-1)" "unprognostic (9.65e-2)" "unprognostic (7.85e-3)" 12.2 14.0 12.3 8.6 12.9 3.3 11.5 12.8 16.4 9.8 13.3 19.5 14.6 8.9 10.1 12.4 9.6 5.8 25.8 12.4 14.4 20.9 18.8 7.6 8.9 13.0 13.8 10.4 11.1 22.9 9.6 8.5 13.0 10.8 15.5 11.4 10.1 11.8 34.1 10.3 11.5 8.8 12.5 10.3 13.6 8.7 12.7 9.4 9.6 29.0 12.7 15.1 9.9 13.3 19.1 39.2 19.8 19.8 16.9 18.9 57.5 20.3 18.7 24.4 21.4 23.3 15.3 40.9 19.4 15.5 24.7 15.3 41.5 41.8 29.8 25.7 41.6 47.9 28.5 31.3 28.2 32.5 19.9 16.6 43.5 40.0 63.5 17.3 27.7 32.4 50.6 35.6 26.3 40.7 41.0 19.6 30.6 59.5 52.1 29.3 19.9 87.5 27.8 20.7 16.3 20.1 22.6 72.2 30.1 17.0 34.6 32.8 10.0 22.3 16.2 27.8 37.4 19.8 56.1 40.6 21.9 49.5 16.6 12.0 15.6 10.7 7.8 24.0 14.0 15.0 13.2 12.1 25.7 22.0 16.8 11.5 6.9 21.8 24.8 10.5 16.3 11.6 12.3 12.9 12.8 16.4 12.4 14.4 13.0 13.8 13.0 12.5 12.7 13.3 6.7 16.0 8.6 2.9 10.6 9.4 14.5 17.9 13.1 7.9 13.3 11.4 24.5 11.5 8.8 9.2 0.0 21.6 3.5 12.2 84.1 18.8 2.6 6.7 8.3 9.0 4.9 20.8 3.2 13.4 22.3 8.9 5.6 5.4 10.8 7.6 3.9 20.4 21.0 5.0 3.8 13.3 16.2 10.0 6.6 5.3 11.5 9.7 8.8 1.9 11.4 9.9 15.5 2.5 3.5 13.1 10.0 10.1 13.2 25.3 22.4 62.2 5.9 7.2 6.6 9.9 11.8 24.7 40.4 20.8 11.8 13.0 7.3 12.0 17.9 11.6 TMEM43 "ARVD5, DKFZp586G1919, LUMA, MGC3222" ENSG00000170876 "Transmembrane protein 43" Q9BTV4 3 14125015-14143680 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Cardiomyopathy, Disease variant, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 137.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019198 Approved NA NA 34000 "Cluster 5: Granulocytes - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA019198: AB_1858118" "unprognostic (3.65e-3)" "unprognostic (2.52e-1)" "unprognostic (4.03e-2)" "unprognostic (4.66e-1)" "unprognostic (5.45e-3)" "unprognostic (1.72e-1)" "unprognostic (1.28e-3)" "unprognostic (1.08e-1)" "unprognostic (2.57e-1)" "unprognostic (1.50e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (5.77e-2)" "unprognostic (5.45e-2)" "unprognostic (1.35e-3)" "unprognostic (2.19e-1)" "unprognostic (9.78e-2)" "unprognostic (1.18e-1)" 75.4 34.3 23.1 36.8 23.8 21.0 61.3 23.0 25.3 66.8 23.5 56.7 23.5 89.1 31.0 69.5 63.9 47.1 64.7 23.2 25.0 27.7 19.6 58.1 30.2 27.5 25.1 82.6 27.3 25.6 30.6 57.6 25.9 43.3 29.4 15.9 37.9 65.2 60.8 108.7 40.0 82.5 23.6 31.2 34.8 15.2 25.5 26.0 47.0 45.8 33.7 56.1 66.4 25.2 41.5 45.7 44.1 58.3 173.4 180.6 104.6 80.1 164.8 129.9 93.0 37.5 54.1 19.5 55.7 201.3 64.3 88.3 47.1 70.9 92.9 48.7 38.0 35.3 45.6 53.8 109.3 51.4 40.4 136.0 173.6 107.9 133.0 103.6 94.8 36.2 56.1 47.8 76.6 54.3 23.4 43.2 48.4 62.8 75.3 32.2 46.8 78.2 59.4 70.4 12.9 35.5 101.0 59.3 66.5 37.3 37.5 74.3 86.4 118.7 63.7 120.6 76.0 32.1 54.3 25.1 89.3 68.4 108.7 81.3 51.5 100.3 68.7 45.5 64.0 36.8 66.8 62.7 67.4 31.6 44.5 49.0 157.2 79.9 49.2 42.6 65.7 69.7 23.1 23.8 23.0 25.3 23.2 25.0 27.5 25.1 25.9 23.6 25.5 25.2 44.2 137.8 46.8 17.9 16.8 43.7 32.2 31.0 39.9 6.2 19.9 29.7 13.4 15.7 52.9 18.4 14.6 31.2 43.2 9.3 0.0 34.9 0.6 17.3 58.1 37.4 4.9 22.5 24.1 10.0 65.6 68.0 20.9 34.4 28.4 16.1 23.6 8.9 17.8 6.7 20.6 8.3 8.2 16.1 33.5 3.9 43.2 19.8 30.2 15.9 26.8 8.4 16.5 30.2 23.9 22.4 9.7 70.7 15.6 35.8 8.8 9.0 16.2 8.6 32.9 43.6 39.3 5.6 12.0 44.1 45.5 37.5 32.1 17.6 11.5 30.2 XPC "RAD4, XPCC" ENSG00000154767 "XPC complex subunit, DNA damage recognition and repair factor" Q01831 3 14145147-14178621 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009932, HPA035707, HPA069673" Supported Enhanced "Nucleoplasm,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Plasma membrane" "CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167" "unprognostic (7.46e-2)" "unprognostic (2.52e-2)" "unprognostic (4.50e-2)" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (2.54e-2)" "unprognostic (1.97e-1)" "unprognostic (5.65e-2)" "unprognostic (1.50e-1)" "unprognostic (7.13e-3)" "unprognostic (4.39e-2)" "unprognostic (2.07e-1)" "prognostic favorable (4.14e-7)" "unprognostic (1.59e-1)" "unprognostic (7.88e-2)" "unprognostic (7.62e-2)" "prognostic favorable (2.46e-4)" 22.9 17.2 14.3 16.4 17.3 10.2 22.9 15.6 14.6 27.2 15.2 20.1 19.0 24.9 17.6 16.1 25.3 16.6 13.1 12.9 17.3 24.8 24.2 20.7 24.5 16.8 17.4 34.6 21.6 24.0 25.8 15.6 17.4 22.9 15.6 15.2 18.5 23.6 21.3 31.9 24.0 17.5 15.2 24.2 17.4 12.4 16.0 21.2 26.7 9.8 21.7 22.9 20.3 18.3 14.3 33.8 36.7 22.6 51.0 35.8 124.8 33.6 88.7 29.9 22.3 11.8 14.7 46.6 14.5 37.5 14.7 15.6 23.6 49.3 23.6 21.5 24.7 24.9 35.7 21.7 45.0 16.8 42.2 50.1 56.4 39.7 77.4 34.2 34.5 19.0 31.2 22.5 32.5 27.2 17.9 16.3 23.5 20.4 21.2 19.3 17.9 33.7 36.2 36.9 8.8 29.9 36.1 27.2 23.5 54.6 29.9 13.8 57.1 11.2 32.1 18.4 15.4 54.5 46.4 25.4 26.5 19.4 41.6 41.4 20.2 26.8 23.2 16.6 22.7 27.1 26.7 23.5 17.9 25.0 28.3 20.8 73.1 24.3 23.3 17.4 24.7 16.9 14.3 17.3 15.6 14.6 12.9 17.3 16.8 17.4 17.4 15.2 16.0 18.3 26.0 60.9 63.2 16.6 39.9 13.8 20.4 25.5 59.2 35.6 19.0 25.9 11.8 31.5 47.7 16.5 39.6 42.5 38.9 13.4 35.2 19.3 2.3 32.2 44.8 29.9 16.3 20.8 18.0 19.2 20.3 29.2 15.3 25.5 47.4 25.0 22.9 40.5 18.2 26.9 22.0 13.9 20.3 23.9 14.9 2.7 30.7 19.6 8.8 15.0 40.1 24.9 54.6 17.1 27.5 19.5 15.0 28.2 29.1 18.9 32.7 66.1 55.0 51.0 26.3 43.3 27.7 28.7 54.9 21.4 11.1 32.0 42.3 26.3 18.1 10.5 LSM3 "SMX4, USS2, YLR438C" ENSG00000170860 "LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated" P62310 3 14178817-14201122 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 752.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044966 Approved Approved Nucleoplasm,Nucleoli NA NA 30000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoli Nucleoplasm "HPA044966: AB_2679159" "unprognostic (3.84e-3)" "unprognostic (7.00e-3)" "unprognostic (3.61e-2)" "unprognostic (2.87e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-1)" "unprognostic (2.94e-3)" "unprognostic (5.01e-2)" "unprognostic (2.70e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-2)" "unprognostic (8.07e-3)" "unprognostic (4.93e-3)" "unprognostic (5.57e-2)" "unprognostic (2.88e-1)" "unprognostic (1.46e-1)" "unprognostic (1.89e-3)" 12.6 10.8 12.1 11.0 12.6 18.9 12.6 13.2 16.6 8.7 12.1 12.1 12.4 9.1 10.4 12.1 8.2 6.5 17.4 12.6 12.7 23.3 18.4 8.2 12.9 12.3 12.0 9.4 9.5 11.0 9.0 10.3 12.5 9.8 11.2 10.7 9.2 8.3 30.1 10.1 12.9 8.1 12.4 9.7 10.5 12.3 12.6 16.8 10.7 22.4 11.8 10.3 8.7 13.2 36.0 28.6 30.1 31.3 13.8 16.0 76.3 29.0 19.3 36.6 34.8 32.6 27.6 39.5 23.5 20.3 25.7 16.4 34.5 28.4 36.0 37.5 42.3 41.8 38.1 31.5 7.1 47.3 29.0 12.0 20.2 36.8 15.6 16.4 19.1 34.0 45.9 30.7 27.4 41.5 50.4 64.2 52.1 40.2 38.5 27.4 37.3 43.5 34.6 36.7 16.8 27.2 33.2 46.1 28.6 34.3 53.2 59.7 17.3 23.3 37.2 28.3 50.6 21.4 67.3 73.6 29.5 45.9 33.8 44.1 18.9 30.0 14.8 23.7 17.7 27.3 17.1 17.5 18.3 21.7 18.4 19.7 17.8 21.9 20.3 28.7 22.9 25.7 12.1 12.6 13.2 16.6 12.6 12.7 12.3 12.0 12.5 12.4 12.6 13.2 114.2 67.3 94.3 11.4 118.2 97.8 135.4 328.8 115.5 52.5 124.2 171.4 263.4 155.8 164.6 126.9 18.8 391.8 114.2 158.2 485.2 220.4 337.8 111.2 97.8 104.5 104.7 111.9 8.3 265.5 409.6 120.0 67.8 115.2 138.2 142.4 128.8 234.8 235.5 55.5 8.3 195.4 175.0 132.9 115.0 153.1 140.1 119.6 97.8 5.6 202.4 180.7 170.0 7.1 13.3 219.2 196.7 139.9 154.2 110.2 203.9 752.2 122.3 68.2 105.2 111.5 117.9 288.5 295.5 150.8 101.2 318.4 93.6 144.6 205.7 177.2 SLC6A6 TAUT ENSG00000131389 "Solute carrier family 6 member 6" P31641 3 14402576-14489349 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 68.5" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 571.3;Rod photoreceptor cells: 547.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "neutrophil: 59.2" "Lineage enriched" "Detected in all" 6 "granulocytes: 59.2" "Cell line enhanced" "Detected in many" "HeLa: 66.6;RPTEC TERT1: 111.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015028, HPA016488" Enhanced Approved "Cell Junctions,Cytosol" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 9: Photoreceptor cells - Phototransduction" "Cell Junctions, Cytosol" "HPA015028: AB_1857200, HPA016488: AB_1857202" "unprognostic (8.25e-2)" "unprognostic (7.29e-3)" "unprognostic (2.63e-2)" "prognostic favorable (5.22e-5)" "prognostic unfavorable (5.75e-8)" "unprognostic (4.14e-2)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.58e-1)" "unprognostic (2.56e-1)" "unprognostic (3.81e-1)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-2)" "unprognostic (9.65e-2)" "unprognostic (1.90e-1)" 10.9 25.6 1.7 8.4 6.9 54.7 8.5 5.0 7.7 11.3 0.0 3.9 0.9 10.4 0.0 6.7 6.7 9.4 24.4 3.5 3.8 12.2 1.5 20.5 7.5 9.6 6.6 28.9 2.3 2.5 7.4 7.9 6.7 4.3 2.4 68.5 17.1 7.2 30.9 18.3 17.1 6.9 1.7 15.6 9.4 3.7 11.0 4.5 9.3 8.7 9.1 8.1 6.1 6.8 4.1 18.4 4.6 10.1 11.6 5.7 15.9 4.3 26.4 8.4 6.2 8.8 5.6 12.6 4.5 10.9 11.7 4.3 4.5 10.1 16.5 3.7 9.7 8.8 66.6 24.2 0.0 3.7 22.3 1.9 2.6 7.8 1.6 7.7 14.5 6.2 10.1 3.5 18.6 8.1 9.4 20.3 6.1 7.1 10.8 6.1 7.3 24.9 111.8 28.5 7.2 4.6 3.1 3.2 0.6 36.8 11.5 4.5 15.3 9.7 3.9 5.2 6.2 3.9 6.0 7.1 19.3 6.6 23.2 5.6 9.2 8.6 2.5 7.3 1.3 4.0 2.7 3.0 2.8 2.1 0.5 0.6 59.2 1.8 9.4 1.4 8.7 4.6 1.7 6.9 5.0 7.7 3.5 3.8 9.6 6.6 6.7 1.7 11.0 6.8 42.7 6.4 21.5 1.3 16.4 49.3 17.1 51.5 43.9 126.1 9.5 6.9 4.2 7.2 52.8 20.2 571.3 3.0 14.5 0.5 0.0 12.0 19.6 82.1 23.0 29.4 14.4 9.4 17.4 8.2 15.8 13.5 29.0 126.9 13.3 2.5 11.7 0.6 27.2 10.1 18.5 3.5 46.8 60.1 59.5 16.6 17.4 58.8 17.8 32.8 110.9 30.8 10.3 3.0 23.9 31.1 12.6 17.3 13.3 17.6 51.3 23.3 69.5 547.8 0.0 11.4 8.3 0.4 1.3 15.7 23.9 5.1 25.5 46.8 3.6 16.8 GRIP2 KIAA1719 ENSG00000144596 "Glutamate receptor interacting protein 2" Q9C0E4 3 14489107-14556075 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 13.3;skeletal muscle: 35.8;tongue: 12.5" "Cell type enriched" "Detected in many" 4 "Inhibitory neurons: 89.0" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.9;NTERA-2: 2.1;PC-3: 6.1;SCLC-21H: 3.4;U-2 OS: 2.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035673 Approved Cytosol NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA035673: AB_10669776" "unprognostic (1.48e-1)" "unprognostic (6.26e-3)" "unprognostic (2.43e-2)" "unprognostic (3.13e-2)" "unprognostic (5.51e-2)" "unprognostic (1.14e-3)" "unprognostic (1.87e-1)" "unprognostic (8.19e-2)" "unprognostic (9.14e-2)" "unprognostic (2.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.54e-1)" "unprognostic (2.44e-1)" "unprognostic (1.40e-1)" "unprognostic (1.90e-1)" "unprognostic (5.82e-1)" "unprognostic (4.01e-1)" 1.1 1.1 3.0 0.7 2.7 0.0 1.0 0.0 6.2 1.1 0.0 0.8 0.4 1.1 0.4 2.2 0.8 1.2 13.3 0.2 3.5 2.3 0.3 0.4 0.4 2.9 5.8 3.4 0.5 0.3 1.0 3.9 2.1 0.9 1.0 0.3 0.9 0.4 35.8 2.0 1.0 1.0 1.7 1.6 4.5 0.7 9.6 0.3 0.8 12.5 0.7 1.0 1.2 1.8 0.1 0.9 0.0 0.0 0.3 0.2 0.0 0.3 3.1 0.3 1.9 1.2 0.0 0.0 0.7 0.2 0.5 0.2 0.7 0.0 0.0 0.0 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 1.5 6.1 0.0 0.0 0.0 0.0 0.0 3.4 0.6 0.3 0.0 1.0 1.1 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.7 0.0 6.2 0.2 3.5 2.9 5.8 2.1 1.7 9.6 1.8 2.3 0.0 0.5 2.3 0.1 0.0 0.1 0.0 1.2 14.9 0.1 1.3 8.5 0.0 0.6 0.0 14.6 0.0 0.7 0.1 0.0 0.0 3.0 2.1 1.4 0.8 4.2 0.0 3.0 0.2 0.0 2.0 2.0 4.9 0.0 0.0 1.1 0.0 0.1 0.0 89.0 0.1 0.0 0.0 0.0 5.2 4.1 0.7 0.0 2.8 0.0 0.5 0.0 0.5 0.9 0.0 0.0 2.2 0.3 0.1 0.0 0.2 0.0 21.9 19.7 4.3 14.7 0.1 0.8 0.2 0.0 0.1 0.3 1.1 0.0 0.0 CCDC174 "C3orf19, FLJ33839" ENSG00000154781 "Coiled-coil domain containing 174" Q6PII3 3 14651746-14672659 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 152.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043468, HPA060129" Approved Enhanced Nucleoplasm NA NA "Cluster 10: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 28: BEWO - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA043468: AB_2678493, HPA060129: AB_2684208" "unprognostic (6.10e-2)" "unprognostic (7.96e-2)" "unprognostic (2.92e-1)" "unprognostic (3.26e-2)" "unprognostic (6.58e-3)" "unprognostic (5.06e-2)" "unprognostic (6.48e-3)" "unprognostic (1.13e-1)" "unprognostic (1.52e-1)" "unprognostic (5.29e-2)" "unprognostic (3.86e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.15e-2)" "unprognostic (2.30e-3)" "unprognostic (2.04e-1)" "unprognostic (2.64e-1)" "prognostic favorable (3.81e-5)" 9.5 7.0 7.7 7.0 8.5 17.2 9.2 8.8 8.5 10.9 6.8 9.8 9.4 10.4 7.5 8.9 9.4 6.8 8.2 7.7 8.0 8.9 8.7 7.1 9.6 8.1 8.4 14.7 10.1 11.9 8.6 8.6 8.1 9.7 7.3 6.7 8.6 8.0 11.1 9.7 9.5 7.9 7.5 10.6 10.3 9.1 8.2 11.6 9.0 10.7 10.2 9.6 9.5 9.6 6.2 6.7 10.0 10.7 13.6 11.1 25.3 8.1 11.6 10.0 7.8 7.5 7.0 12.8 5.8 7.2 6.8 5.3 7.3 6.8 7.8 9.7 8.9 13.0 8.1 8.1 19.7 12.9 14.5 12.9 17.0 13.5 16.5 14.0 8.6 13.4 13.2 11.4 7.6 10.9 13.6 11.3 13.5 10.1 10.9 10.1 9.3 10.6 10.4 10.8 4.8 13.1 9.5 7.4 13.4 11.6 11.2 18.1 8.0 8.0 7.8 7.4 9.5 15.0 14.3 14.7 8.0 9.8 11.1 25.4 10.7 22.2 12.9 11.3 15.2 17.4 16.1 15.1 9.7 16.4 17.4 13.8 20.5 18.8 12.2 10.9 12.5 10.0 7.7 8.5 8.8 8.5 7.7 8.0 8.1 8.4 8.1 7.5 8.2 9.6 29.5 9.6 34.5 11.4 48.0 16.2 31.3 38.0 26.7 32.8 25.0 28.4 37.0 32.9 35.7 12.9 20.9 32.1 42.3 27.3 56.7 34.7 152.5 27.3 35.4 31.0 18.5 43.4 12.8 34.9 25.2 33.7 20.4 34.7 52.0 22.0 38.6 29.3 26.5 15.2 16.6 34.1 32.6 27.2 16.5 59.1 33.5 30.5 14.2 5.6 45.2 22.2 34.0 11.1 15.8 38.2 34.9 40.3 34.9 28.8 36.8 46.4 31.1 24.9 32.9 28.4 37.2 78.7 33.5 19.9 13.5 65.7 41.6 23.5 23.1 31.8 C3orf20 DKFZP434N1817 ENSG00000131379 "Chromosome 3 open reading frame 20" Q8ND61 3 14675141-14773036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 15 "testis: 6.6" "Cell type enhanced" "Detected in some" "Astrocytes: 5.9;Early spermatids: 19.3;Excitatory neurons: 8.4;Inhibitory neurons: 6.9;Late spermatids: 34.6;Oligodendrocytes: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Daudi: 4.0;HEL: 8.2;U-698: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA039584 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 36: HEL - Hemostasis" "Cluster 25: Spermatids - Spermatogenesis" "Plasma membrane, Cytosol" "HPA039584: AB_10795152" "unprognostic (1.23e-1)" "unprognostic (2.82e-1)" "unprognostic (5.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.76e-3)" "unprognostic (1.81e-1)" "unprognostic (7.82e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (9.08e-2)" "unprognostic (4.74e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-4)" 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.6 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 8.2 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.2 0.5 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.2 0.1 0.1 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 34.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 2.5 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FGD5 "FLJ00274, FLJ39957, ZFYVE23" ENSG00000154783 "FYVE, RhoGEF and PH domain containing 5" Q6ZNL6 3 14810853-14934571 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 51.3;Endothelial cells: 44.7;Hepatic stellate cells: 55.6;Microglial cells: 25.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 94.9;TIME: 81.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014436, HPA014536, HPA019191" Uncertain Supported "Plasma membrane" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" "HPA014436: , HPA014536: AB_1848518, HPA019191: AB_1848519" "unprognostic (2.57e-1)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (3.28e-2)" "unprognostic (2.02e-2)" "unprognostic (1.03e-3)" "unprognostic (1.08e-1)" "unprognostic (4.10e-2)" "unprognostic (6.34e-2)" "unprognostic (5.53e-2)" "unprognostic (1.46e-1)" "unprognostic (9.39e-2)" "unprognostic (6.84e-3)" "unprognostic (1.71e-2)" "unprognostic (3.46e-1)" "unprognostic (1.32e-2)" "prognostic favorable (7.50e-4)" 19.8 4.4 4.8 5.6 4.3 0.3 15.0 4.1 4.9 10.4 3.4 5.3 9.2 11.3 2.3 5.7 8.5 11.9 11.5 3.0 2.9 10.1 3.1 20.6 4.2 4.5 11.5 5.3 2.2 3.5 3.2 17.7 4.8 5.3 4.6 0.2 3.7 4.4 6.8 5.4 7.0 11.4 3.2 25.0 4.6 4.3 6.7 2.0 7.5 13.4 3.6 7.7 5.6 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 94.9 0.1 0.0 0.0 0.0 0.0 0.4 0.2 5.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.6 0.4 0.0 81.1 0.0 6.6 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 4.3 4.1 4.9 3.0 2.9 4.5 11.5 4.8 3.2 6.7 3.0 51.3 0.0 4.6 0.0 0.9 3.1 0.2 0.0 1.2 0.1 1.3 1.9 4.4 1.5 0.6 0.0 0.0 0.3 0.4 0.1 1.9 0.2 7.3 0.4 5.3 44.7 0.0 5.3 3.4 0.2 0.1 11.3 1.1 0.3 0.0 0.0 55.6 1.3 10.5 0.0 8.6 0.2 0.0 2.2 5.9 9.9 11.5 3.3 1.8 25.3 0.0 0.0 1.0 0.5 0.3 4.8 2.5 4.5 0.0 0.3 1.0 7.0 0.0 0.2 0.0 4.9 2.4 0.2 3.6 0.1 1.8 0.5 0.7 2.3 0.5 0.2 NR2C2 "hTAK1, TAK1, TR2R1, TR4" ENSG00000177463 "Nuclear receptor subfamily 2 group C member 2" P49116 3 14947584-15053600 "Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 92.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006313 Approved Enhanced Nucleoplasm NA NA "Cluster 10: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA006313: AB_1079503" "unprognostic (1.32e-1)" "unprognostic (3.87e-1)" "unprognostic (3.98e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "prognostic favorable (1.51e-5)" "unprognostic (1.03e-2)" "unprognostic (1.34e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-1)" "unprognostic (1.29e-1)" "unprognostic (5.95e-2)" "unprognostic (1.02e-1)" "unprognostic (2.26e-1)" "unprognostic (1.25e-1)" "unprognostic (2.82e-2)" "unprognostic (5.82e-3)" 14.1 12.4 11.4 18.0 12.0 19.1 13.6 21.6 13.3 15.7 2.5 16.9 18.4 17.1 9.8 12.4 15.3 11.3 15.7 12.4 9.0 13.9 13.0 16.8 18.0 7.6 6.1 18.6 14.2 14.2 19.2 9.7 4.6 13.7 11.7 36.2 13.5 11.5 20.1 19.5 18.8 12.8 4.7 19.9 14.8 20.7 8.7 22.4 24.3 17.9 15.7 14.4 13.7 13.5 18.3 20.2 22.8 17.7 15.8 18.8 52.0 25.8 20.7 20.5 21.0 13.0 17.4 28.0 13.2 23.3 17.9 17.9 21.2 13.3 21.2 37.1 30.0 36.8 45.8 12.0 13.4 27.3 27.3 15.0 17.2 25.9 13.4 17.1 23.5 27.2 26.6 18.7 18.3 16.2 41.9 21.3 15.1 8.6 20.7 33.4 27.1 18.8 9.9 27.1 14.5 36.1 23.5 19.4 23.2 17.9 19.5 26.7 30.5 31.6 37.2 29.1 35.6 28.4 40.0 30.4 22.7 25.6 28.2 2.7 0.9 0.7 1.6 1.2 1.5 0.8 0.9 1.0 0.9 1.8 1.2 1.1 1.2 1.0 1.1 1.5 0.9 0.6 11.4 12.0 21.6 13.3 12.4 9.0 7.6 6.1 4.6 4.7 8.7 13.5 14.0 22.4 12.2 35.9 15.7 3.7 11.1 1.0 17.1 17.4 15.1 9.7 6.2 11.5 4.7 7.3 14.6 7.8 15.2 16.5 5.9 6.6 58.8 8.0 10.3 13.4 25.1 20.4 35.5 7.2 7.3 11.5 14.3 9.1 9.5 17.2 18.9 8.2 7.8 13.5 39.9 10.2 0.0 20.1 2.3 65.4 19.3 14.2 5.4 52.5 13.6 13.9 9.2 50.8 92.2 12.3 12.4 20.7 14.2 19.6 13.0 6.8 13.7 17.2 0.0 18.8 10.3 33.9 22.2 13.3 3.1 14.9 15.3 17.0 10.4 18.4 MRPS25 "DKFZp313H0817, FLJ00023, MRP-S25, RPMS25" ENSG00000131368 "Mitochondrial ribosomal protein S25" P82663 3 15042460-15065317 "Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 367.5;Late spermatids: 1316.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043490 Approved Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" Mitochondria "HPA043490: AB_10794888" "unprognostic (3.98e-2)" "unprognostic (5.36e-2)" "unprognostic (4.58e-3)" "unprognostic (1.24e-2)" "unprognostic (4.66e-2)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (4.93e-3)" "unprognostic (2.23e-1)" "unprognostic (2.10e-1)" "unprognostic (6.29e-2)" "unprognostic (2.68e-3)" "prognostic favorable (3.60e-7)" "unprognostic (2.84e-2)" "unprognostic (1.93e-1)" "unprognostic (5.06e-2)" "unprognostic (2.91e-3)" 20.5 23.7 14.4 18.1 14.2 12.5 19.1 15.0 15.3 21.7 23.6 33.0 29.7 20.0 11.0 25.4 22.7 8.2 68.0 13.4 13.9 33.4 46.5 22.7 17.6 13.2 13.9 25.9 21.1 19.1 32.1 10.3 13.8 22.6 20.8 43.4 19.6 13.6 54.8 22.2 29.8 12.6 11.8 26.0 26.3 35.2 14.0 9.7 43.5 28.8 17.6 25.9 21.9 12.4 18.0 26.1 20.9 29.2 21.7 18.4 66.8 24.1 9.3 19.0 16.3 29.9 19.1 46.8 12.5 10.6 12.6 22.8 30.5 22.8 16.3 18.8 42.9 38.9 60.2 37.6 15.1 34.7 28.5 22.4 21.2 29.9 9.1 12.9 17.9 31.2 42.0 27.3 14.3 57.3 27.3 33.5 21.7 41.6 41.1 36.5 18.1 48.7 23.9 30.7 16.5 24.9 17.6 33.0 35.9 12.8 44.7 29.9 22.1 17.1 25.2 23.7 30.6 26.3 30.1 33.7 17.3 43.8 16.3 3.3 27.2 7.2 17.4 34.6 20.2 39.4 16.2 18.0 29.3 35.2 25.6 21.0 1.8 13.8 37.2 24.0 14.2 18.1 14.4 14.2 15.0 15.3 13.4 13.9 13.2 13.9 13.8 11.8 14.0 12.4 22.8 51.3 34.6 47.3 49.4 38.5 61.0 76.2 31.9 58.2 37.2 39.9 271.5 44.3 57.7 36.8 164.7 94.6 30.5 78.5 223.0 50.0 367.5 31.1 45.1 31.0 54.0 36.6 37.7 34.0 74.6 40.0 51.0 28.3 26.0 45.5 21.0 101.0 93.4 67.3 43.9 81.3 54.9 29.8 36.6 1316.8 46.0 35.3 37.4 8.4 41.0 25.7 43.3 32.2 29.3 47.4 49.5 30.1 41.6 74.4 152.8 201.6 40.7 106.2 72.3 35.6 43.0 139.1 30.0 56.1 48.6 72.7 28.4 97.4 125.8 73.9 RBSN ZFYVE20 ENSG00000131381 "Rabenosyn, RAB effector" Q9H1K0 3 15070073-15099163 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044878 Approved Supported Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 59: Non-specific - Transcription" Vesicles "HPA044878: AB_10967610" "unprognostic (6.76e-2)" "unprognostic (2.18e-1)" "unprognostic (3.00e-3)" "unprognostic (1.00e-1)" "unprognostic (8.06e-2)" "unprognostic (3.79e-3)" "unprognostic (1.09e-3)" "unprognostic (1.72e-2)" "unprognostic (3.57e-1)" "unprognostic (1.90e-2)" "unprognostic (2.00e-2)" "unprognostic (9.34e-2)" "unprognostic (2.38e-3)" "unprognostic (4.45e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-1)" "unprognostic (1.78e-1)" 9.0 7.0 12.5 6.7 12.5 18.2 7.7 10.2 13.0 9.1 1.1 10.7 4.7 9.3 7.1 8.9 8.7 5.4 9.8 13.4 11.4 5.4 8.4 8.4 6.6 12.1 12.5 12.7 5.9 9.7 6.1 7.9 11.1 7.4 5.3 13.6 5.9 9.0 13.1 10.2 7.1 9.0 12.8 7.7 7.8 6.6 13.0 5.5 11.2 9.9 6.1 9.1 7.5 11.8 11.2 16.0 12.8 16.6 13.8 10.2 33.9 12.0 11.5 14.1 12.7 9.7 6.5 7.8 6.8 15.9 8.2 7.0 16.5 14.5 12.4 9.9 14.6 8.9 19.7 8.0 9.5 9.0 9.4 11.1 16.1 18.1 12.0 8.3 11.6 8.7 13.5 8.9 10.8 14.7 4.9 4.5 11.0 7.1 12.7 6.4 14.6 8.6 7.3 12.6 3.4 12.0 14.7 8.9 10.7 9.4 22.8 6.5 14.2 12.7 13.3 12.5 17.1 7.9 12.6 9.2 12.2 10.0 12.2 8.1 4.6 11.1 4.4 6.4 3.9 4.4 6.1 5.5 3.8 7.4 7.7 5.2 11.7 3.1 5.6 3.6 4.3 2.7 12.5 12.5 10.2 13.0 13.4 11.4 12.1 12.5 11.1 12.8 13.0 11.8 10.4 16.0 19.0 19.6 9.2 0.0 6.7 0.0 6.8 21.6 7.6 7.0 20.4 8.6 9.9 3.7 22.9 10.4 8.4 6.0 5.9 8.4 17.4 6.4 11.1 12.4 1.2 9.5 21.8 9.6 9.6 14.6 10.2 8.8 10.1 16.4 14.6 14.0 10.7 21.9 23.9 6.9 0.0 15.8 0.0 18.0 19.0 12.1 0.0 8.4 10.5 15.5 7.2 16.1 25.2 9.6 5.1 14.7 12.1 12.6 8.1 6.9 8.0 23.1 6.6 17.5 10.4 12.4 14.0 11.0 0.0 12.9 9.9 10.6 5.4 10.0 CAPN7 PalBH ENSG00000131375 "Calpain 7" Q9Y6W3 3 15206152-15252916 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004745, HPA046617" Uncertain Approved Centrosome,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 28: BEWO - Transcription regulation" "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol Centrosome "HPA004745: , HPA046617: AB_2679721" "unprognostic (2.70e-2)" "unprognostic (2.79e-1)" "prognostic favorable (4.85e-5)" "unprognostic (1.85e-1)" "unprognostic (1.69e-2)" "unprognostic (1.41e-2)" "unprognostic (2.22e-3)" "unprognostic (2.72e-1)" "unprognostic (1.42e-1)" "unprognostic (2.76e-1)" "unprognostic (1.39e-1)" "unprognostic (5.29e-2)" "unprognostic (1.12e-3)" "unprognostic (3.24e-2)" "unprognostic (7.84e-2)" "unprognostic (5.66e-2)" "unprognostic (1.05e-2)" 13.9 11.9 4.6 11.6 5.9 13.2 16.6 12.5 5.4 16.9 9.3 12.1 12.9 16.1 14.9 11.4 14.4 11.1 11.6 4.1 8.1 15.2 19.1 12.1 14.3 5.9 5.7 19.8 15.3 20.1 9.2 12.9 5.5 14.1 12.2 28.5 13.9 12.7 25.3 11.6 13.6 13.8 6.0 11.4 14.0 12.1 6.8 16.9 23.5 16.5 15.7 10.2 9.8 9.7 14.3 18.5 15.1 9.5 26.0 20.1 51.4 18.1 20.8 22.1 16.7 13.3 10.0 24.6 12.3 20.7 13.6 9.7 22.5 23.3 19.0 23.7 17.5 30.8 24.8 17.7 19.3 25.1 15.0 13.9 33.2 28.7 14.1 20.9 15.9 23.3 30.3 25.1 21.6 20.8 17.9 10.5 14.5 20.7 17.7 10.2 25.1 17.1 16.4 25.8 12.2 15.8 29.5 15.7 20.8 19.2 27.9 25.8 14.4 19.8 14.9 25.9 21.4 17.2 37.1 12.4 18.1 18.0 17.5 4.6 3.0 5.1 3.3 2.5 5.3 3.5 3.6 2.8 2.9 3.1 4.9 4.6 1.8 3.6 4.4 2.4 3.0 3.0 4.6 5.9 12.5 5.4 4.1 8.1 5.9 5.7 5.5 6.0 6.8 9.7 15.8 12.8 23.6 44.1 35.0 21.4 13.5 10.6 47.3 42.7 20.3 16.0 33.2 8.6 20.6 1.8 56.3 21.2 21.7 11.2 9.8 12.6 15.5 32.2 31.5 19.0 20.9 14.9 60.2 16.9 12.6 27.6 30.1 29.9 15.8 28.9 14.6 20.8 12.2 55.5 65.8 11.3 4.1 11.9 23.0 14.8 24.8 20.9 21.4 49.6 18.4 31.2 10.3 73.9 86.0 13.0 6.9 26.4 52.8 20.0 16.7 15.2 34.9 98.1 39.5 31.5 24.8 26.8 17.8 29.7 23.2 26.1 34.2 21.1 11.8 14.3 SH3BP5 Sab ENSG00000131370 "SH3 domain binding protein 5" O60239 3 15254353-15341368 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 200.5" "Cell type enhanced" "Detected in many" "Adipocytes: 195.9;Early spermatids: 192.2;Extravillous trophoblasts: 356.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 349.3;MCF7: 118.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036445, HPA057988" Uncertain Enhanced "Nucleoplasm,Nuclear bodies" No No "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Nuclear bodies" "HPA036445: AB_10670106, HPA057988: AB_2683572" "unprognostic (1.28e-3)" "unprognostic (2.99e-2)" "unprognostic (9.50e-2)" "unprognostic (6.97e-2)" "unprognostic (4.68e-2)" "unprognostic (1.56e-2)" "unprognostic (7.74e-2)" "unprognostic (7.81e-3)" "unprognostic (4.80e-2)" "unprognostic (4.09e-2)" "unprognostic (2.76e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (8.17e-4)" "unprognostic (4.76e-2)" "unprognostic (3.06e-2)" "unprognostic (4.34e-2)" "unprognostic (2.03e-1)" 78.3 200.5 21.2 35.2 22.7 72.6 72.0 38.4 26.1 71.1 16.0 27.4 15.7 77.5 13.5 26.9 85.6 45.7 24.1 23.3 21.0 52.8 17.3 73.2 59.9 21.4 20.0 116.2 15.9 47.9 35.7 40.8 22.4 25.0 8.4 27.4 49.9 34.1 71.7 25.6 27.0 37.3 20.8 30.9 16.1 30.9 20.9 37.4 51.1 19.1 35.7 33.0 50.6 35.1 27.4 16.5 6.4 14.1 53.1 46.8 349.3 13.6 10.9 9.3 10.4 10.8 13.4 21.3 6.2 40.8 16.1 3.6 2.9 14.2 5.9 19.5 12.8 15.7 72.3 1.9 21.9 4.4 8.6 36.9 9.3 41.6 7.9 34.2 116.0 31.3 18.4 8.5 10.3 118.1 57.6 23.2 13.6 3.5 20.6 1.1 27.2 115.6 8.8 53.5 16.8 7.8 18.6 19.2 21.7 21.6 18.1 10.9 84.3 22.8 29.5 21.9 12.0 3.3 7.6 15.2 44.7 16.3 31.5 8.1 7.8 9.1 52.9 2.5 15.9 19.1 24.1 36.1 8.9 24.3 12.9 16.6 13.9 25.4 4.6 3.9 11.1 20.4 21.2 22.7 38.4 26.1 23.3 21.0 21.4 20.0 22.4 20.8 20.9 35.1 195.9 0.0 16.3 2.3 115.2 17.0 6.0 8.2 11.4 41.3 23.5 32.1 0.7 5.7 13.9 68.0 14.6 12.5 73.7 0.6 3.9 2.7 192.2 13.1 33.0 150.7 2.4 7.0 49.5 8.7 356.3 97.5 3.6 13.7 2.5 28.1 165.0 7.0 33.1 65.6 38.4 2.5 12.2 87.2 133.3 97.8 49.0 113.1 33.8 26.2 33.3 5.1 167.9 12.5 60.6 3.2 1.1 118.5 67.1 8.5 4.7 36.2 7.5 44.4 6.6 56.8 13.4 3.0 4.5 14.2 12.1 173.2 51.5 81.6 1.4 10.2 METTL6 MGC24132 ENSG00000206562 "Methyltransferase like 6" Q8TCB7 3 15381275-15440566 "Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 223.0;Late spermatids: 121.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035166 Uncertain Approved Vesicles No No "Cluster 40: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles "HPA035166: AB_10602709" "unprognostic (2.73e-1)" "unprognostic (3.53e-1)" "unprognostic (2.60e-1)" "unprognostic (1.29e-2)" "unprognostic (6.60e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.66e-6)" "unprognostic (3.98e-1)" "unprognostic (1.82e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (2.19e-2)" "unprognostic (1.68e-2)" "unprognostic (1.27e-2)" "unprognostic (2.81e-1)" "unprognostic (3.77e-2)" "unprognostic (2.46e-1)" 7.9 7.0 13.7 7.5 13.8 5.3 9.7 13.9 15.9 9.0 6.5 6.1 6.2 8.9 8.8 8.2 9.5 6.2 7.8 14.4 13.3 6.9 6.3 6.7 9.2 11.0 10.9 12.2 6.5 9.2 8.3 9.2 11.4 8.5 7.1 13.2 5.7 9.1 7.0 8.1 5.8 10.3 11.6 7.5 7.0 18.0 14.0 10.2 9.5 7.7 10.0 7.6 6.5 16.8 13.5 21.4 23.4 20.2 21.0 23.7 59.3 24.0 24.5 28.4 29.9 12.9 17.2 22.3 16.1 22.7 24.2 11.0 23.3 20.8 30.0 15.9 25.6 21.4 20.6 19.9 39.7 20.5 18.5 21.3 25.6 34.1 17.1 22.9 26.6 22.8 22.5 22.4 28.6 28.0 22.7 17.0 23.7 14.2 25.6 17.4 29.0 22.0 17.1 18.6 10.1 18.7 20.9 19.1 19.8 16.9 27.9 17.6 18.1 22.0 14.1 22.3 22.0 24.1 43.9 26.7 23.6 19.5 21.1 7.2 8.1 12.2 9.7 10.7 9.6 7.6 9.1 9.7 9.2 9.6 9.1 10.0 4.7 11.8 10.5 12.4 9.1 6.9 13.7 13.8 13.9 15.9 14.4 13.3 11.0 10.9 11.4 11.6 14.0 16.8 5.6 3.2 5.5 20.5 6.8 4.0 8.0 13.9 10.2 17.4 5.9 6.5 5.5 1.5 7.8 9.2 6.2 9.2 5.0 1.3 5.9 10.2 223.0 5.9 10.7 7.7 1.8 6.3 37.4 13.5 21.5 8.2 4.1 5.4 5.1 14.2 5.3 2.3 9.0 20.2 38.2 2.3 4.1 4.4 4.2 121.3 9.0 6.8 5.4 9.4 8.0 11.9 13.4 17.1 22.0 9.2 2.7 9.1 10.3 5.5 4.6 4.9 9.3 15.9 6.6 8.7 8.6 31.3 17.6 6.3 2.8 11.6 8.2 11.4 3.7 5.3 EAF1 ENSG00000144597 "ELL associated factor 1" Q96JC9 3 15427598-15450635 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 57.1" "Group enriched" "Detected in all" 6 "Early spermatids: 268.7;Late spermatids: 389.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 137.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059516, HPA060569, HPA069538" Supported Approved "Nucleoplasm,Nuclear bodies,Vesicles" NA No "Cluster 16: MAIT-cells - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nuclear bodies" Vesicles "HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147" "unprognostic (1.26e-1)" "unprognostic (1.61e-2)" "unprognostic (6.37e-2)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (5.47e-2)" "unprognostic (3.14e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (3.22e-1)" "unprognostic (3.16e-2)" "unprognostic (3.22e-1)" "unprognostic (8.45e-2)" "unprognostic (2.06e-2)" "unprognostic (5.17e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-1)" 12.9 9.0 9.2 10.5 8.9 57.1 9.1 7.2 9.4 7.2 7.7 9.0 10.6 7.9 7.6 9.8 7.0 10.4 5.1 10.3 11.1 11.2 19.0 8.3 10.7 9.6 10.3 5.6 9.8 11.8 8.6 10.2 12.3 10.0 9.9 7.7 6.9 6.8 5.3 10.7 10.0 8.3 7.8 9.8 11.4 7.3 10.6 10.6 10.5 5.8 11.1 11.5 5.8 7.9 10.3 16.6 17.1 17.6 9.8 8.3 137.4 14.7 10.5 16.7 16.3 22.7 11.4 28.7 9.3 10.9 10.9 8.6 22.5 13.2 19.2 23.6 16.2 24.8 14.5 20.8 22.1 23.6 19.2 11.0 22.8 24.3 16.2 12.8 16.8 23.1 26.9 20.6 14.1 21.2 23.6 13.2 30.7 19.3 16.9 21.3 14.2 16.0 14.5 17.8 17.6 30.6 18.2 16.7 17.6 21.9 25.2 18.5 16.6 17.5 12.8 15.6 21.8 27.1 58.3 29.7 17.0 27.7 21.1 8.0 7.1 4.6 11.1 5.4 14.3 4.9 9.1 8.7 4.2 3.6 5.4 8.7 6.5 8.1 6.9 9.8 10.9 4.4 9.2 8.9 7.2 9.4 10.3 11.1 9.6 10.3 12.3 7.8 10.6 7.9 11.5 9.6 17.3 6.8 14.2 46.9 9.1 6.0 14.2 8.1 15.8 7.7 4.8 15.7 9.0 12.9 6.2 8.0 29.1 15.5 9.8 8.6 268.7 10.8 16.0 11.8 34.3 7.8 16.4 8.2 14.6 13.9 16.3 14.1 10.2 9.9 12.1 30.4 15.8 21.9 14.0 12.5 12.2 30.7 31.6 389.5 11.5 37.6 23.2 3.7 19.4 5.5 22.6 5.5 10.7 15.6 10.3 12.0 12.2 16.1 16.0 29.7 8.6 6.4 26.3 13.6 11.0 21.5 11.6 17.7 54.3 35.8 22.0 4.3 12.8 19.9 COLQ EAD ENSG00000206561 "Collagen like tail subunit of asymmetric acetylcholinesterase" Q9Y215 3 15450133-15521751 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Neurotransmitter degradation" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 17.9" "Cell type enhanced" "Detected in many" "Astrocytes: 17.3;Excitatory neurons: 45.1;Inhibitory neurons: 46.3;Late spermatids: 16.6;NK-cells: 15.5;Oligodendrocyte precursor cells: 18.1;Oligodendrocytes: 18.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "MAIT T-cell: 60.9" "Lineage enriched" "Detected in many" 34 "T-cells: 60.9" "Group enriched" "Detected in some" 6 "BEWO: 11.5;HDLM-2: 3.8;U-937: 5.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045876 Approved "Plasma membrane,Cell Junctions" "Secreted to blood" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "Cell Junctions" "HPA045876: AB_2679479" "unprognostic (4.08e-3)" "unprognostic (2.61e-2)" "unprognostic (2.13e-3)" "unprognostic (2.37e-1)" "unprognostic (2.11e-1)" "unprognostic (4.62e-2)" "unprognostic (1.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (1.28e-3)" "unprognostic (4.68e-1)" "unprognostic (7.00e-5)" "unprognostic (6.58e-2)" "unprognostic (1.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.30e-4)" 2.5 2.3 3.1 0.7 3.2 0.8 2.2 3.9 4.6 4.6 11.9 3.7 1.0 3.4 1.6 0.9 8.8 1.1 17.9 3.7 2.7 2.9 3.4 2.5 3.9 4.8 3.2 3.6 1.7 3.6 5.7 0.3 2.8 4.6 0.5 0.6 1.5 0.8 10.8 1.6 2.6 0.7 2.6 7.2 2.4 5.0 2.3 2.6 2.6 5.1 3.0 2.2 2.4 2.9 0.1 0.0 0.7 0.0 0.0 0.3 11.5 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 3.8 0.4 0.2 0.5 0.0 0.0 0.1 0.3 0.4 0.0 0.3 0.1 0.2 0.3 0.5 0.0 0.3 0.2 0.2 0.1 0.3 0.0 0.0 0.5 0.2 0.1 0.1 0.1 0.0 0.2 1.0 0.0 0.0 0.2 0.5 0.6 0.0 0.0 0.1 0.2 0.2 0.1 0.8 0.4 0.0 0.0 5.2 0.1 0.0 0.6 0.0 9.9 0.0 60.9 0.0 5.3 7.4 0.0 0.0 0.5 0.6 0.0 1.8 0.0 0.4 0.3 3.5 3.1 3.2 3.9 4.6 3.7 2.7 4.8 3.2 2.8 2.6 2.3 2.9 0.6 0.0 0.6 17.3 0.5 0.3 0.2 0.1 0.0 0.3 0.4 0.6 0.7 0.0 1.4 0.0 0.0 0.3 7.7 0.0 0.0 0.1 4.1 6.5 1.4 0.4 1.2 0.4 45.1 0.0 0.2 0.6 1.1 0.8 0.0 3.3 1.8 0.8 0.2 6.7 46.3 0.2 2.0 0.6 0.0 16.6 1.8 0.4 0.0 7.5 0.4 0.3 15.5 18.1 18.3 0.2 0.1 4.5 2.0 0.2 0.0 0.2 4.3 0.7 0.0 0.5 0.7 1.5 0.5 0.0 0.1 2.3 4.1 1.4 0.3 0.1 HACL1 "2-HPCL, HPCL, PHYH2" ENSG00000131373 "2-hydroxyacyl-CoA lyase 1" Q9UJ83 3 15560699-15601852 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "basophil: 117.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 117.3" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035496, HPA035497, HPA073760" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles Nucleoplasm "HPA035496: AB_10601328, HPA035497: AB_2674653, HPA073760: AB_2686633" "unprognostic (6.64e-3)" "unprognostic (2.82e-2)" "unprognostic (2.24e-3)" "unprognostic (3.82e-1)" "unprognostic (4.08e-2)" "unprognostic (1.77e-1)" "unprognostic (2.96e-2)" "unprognostic (6.31e-2)" "unprognostic (8.27e-3)" "unprognostic (5.23e-2)" "unprognostic (3.30e-2)" "unprognostic (1.44e-1)" "prognostic favorable (2.63e-5)" "unprognostic (6.62e-2)" "unprognostic (2.66e-1)" "unprognostic (3.23e-2)" "unprognostic (9.07e-2)" 14.4 12.0 7.5 8.2 7.8 11.6 14.6 10.4 10.5 9.1 7.9 10.0 56.6 8.3 16.6 7.5 10.8 8.8 11.0 7.6 7.0 26.0 51.8 9.7 14.1 7.4 7.2 7.5 15.2 20.0 7.8 7.8 7.0 10.8 12.0 12.2 9.1 9.1 17.6 10.6 27.7 9.5 7.4 11.4 13.2 26.7 6.8 13.9 20.4 10.6 14.5 10.3 6.4 10.0 15.1 28.6 8.2 30.7 13.4 12.4 82.3 14.2 22.0 26.6 26.3 27.3 14.3 14.6 9.7 18.7 10.5 10.4 18.7 25.3 23.8 13.6 36.4 25.4 17.7 24.7 20.3 30.5 23.1 13.7 16.2 37.9 16.6 8.3 31.4 18.3 24.0 21.2 22.9 28.7 14.0 12.6 19.7 19.7 29.7 14.4 21.5 19.6 26.4 20.2 9.6 12.3 22.4 19.0 25.2 12.8 8.5 25.4 22.5 14.1 14.6 17.4 24.7 27.2 50.9 28.5 27.1 26.4 17.2 117.3 16.0 18.3 14.4 20.1 21.2 15.4 15.5 18.0 16.0 21.2 14.8 16.1 3.4 24.1 24.2 10.2 19.8 13.0 7.5 7.8 10.4 10.5 7.6 7.0 7.4 7.2 7.0 7.4 6.8 10.0 12.4 9.6 17.3 34.9 22.1 10.3 12.0 13.5 20.5 19.3 9.1 10.2 6.4 14.3 15.6 11.0 29.2 27.2 15.7 6.1 13.7 16.0 66.6 12.6 6.0 12.3 9.1 8.2 67.4 25.2 18.0 12.0 11.2 5.4 13.3 12.7 8.9 24.3 13.2 13.5 55.8 7.5 10.2 9.3 8.1 56.8 23.3 8.8 12.4 25.3 19.3 24.8 8.2 40.7 38.8 14.5 11.2 15.4 21.4 9.0 41.9 39.7 29.8 38.3 6.6 9.0 11.2 51.1 24.4 8.6 7.1 18.9 19.4 15.1 10.6 7.9 BTD ENSG00000169814 Biotinidase P43251 3 15601341-15722311 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 95.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052275 Uncertain "Secreted to blood" NA NA 2800000000 "Cluster 2: Granulocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA052275: AB_2681782" "unprognostic (6.04e-2)" "unprognostic (2.42e-1)" "unprognostic (9.37e-3)" "unprognostic (5.84e-2)" "unprognostic (2.13e-1)" "unprognostic (1.95e-2)" "unprognostic (6.37e-3)" "unprognostic (4.26e-2)" "unprognostic (3.29e-2)" "unprognostic (1.23e-2)" "unprognostic (1.05e-2)" "unprognostic (1.29e-1)" "prognostic favorable (2.60e-9)" "unprognostic (2.44e-2)" "unprognostic (4.90e-2)" "unprognostic (1.67e-3)" "unprognostic (3.73e-2)" 25.3 16.7 10.7 8.0 12.7 13.1 16.4 20.2 12.6 13.7 11.0 15.9 46.1 13.2 62.4 9.9 18.3 19.9 10.2 11.5 10.3 37.6 95.9 15.9 9.6 12.0 10.0 25.3 44.1 27.7 5.9 17.0 12.6 19.5 17.0 35.2 16.0 21.1 7.8 9.5 30.7 14.1 10.3 11.3 24.4 18.2 9.9 10.6 26.8 11.4 10.4 14.3 7.5 19.1 9.2 22.0 7.8 7.3 51.7 15.3 39.6 15.4 18.4 16.2 28.3 10.1 21.5 4.1 16.3 31.6 7.1 9.7 5.3 16.7 18.7 7.6 11.7 12.9 28.8 24.8 12.7 8.8 14.7 18.3 16.9 42.9 5.1 39.7 30.5 5.9 8.7 32.3 44.7 11.1 4.5 8.2 8.5 16.9 13.0 5.9 18.4 27.9 16.5 17.7 5.3 11.8 17.9 5.2 24.4 15.1 19.9 11.3 24.3 20.5 13.6 19.1 10.1 8.9 11.4 4.1 21.4 7.7 14.4 74.1 20.7 44.9 22.9 19.6 21.0 14.7 23.3 19.2 21.4 13.1 19.7 15.4 19.8 15.0 15.8 24.9 28.8 16.5 10.7 12.7 20.2 12.6 11.5 10.3 12.0 10.0 12.6 10.3 9.9 19.1 14.9 6.4 11.0 11.8 11.7 5.9 12.4 25.0 6.2 13.5 9.1 7.9 6.0 45.8 16.7 18.4 18.8 25.3 19.7 9.9 5.9 21.1 31.0 9.5 6.0 9.1 7.2 4.0 6.6 28.5 22.4 14.5 9.7 5.7 5.1 8.9 20.3 63.3 14.9 5.0 12.2 8.5 16.2 8.2 5.9 17.9 32.3 9.2 10.6 5.6 8.7 19.2 6.2 27.2 23.9 12.0 17.9 18.0 16.6 6.3 52.1 32.0 19.8 54.1 13.1 8.5 8.6 45.3 7.5 7.7 5.5 23.1 13.6 17.4 8.9 9.5 ANKRD28 "CFAP79, FAP79, KIAA0379, PITK, PP6-ARS-A, PPP1R65" ENSG00000206560 "Ankyrin repeat domain 28" O15084 3 15667236-15859771 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Melanocytes: 282.8;Oligodendrocyte precursor cells: 364.4;Oligodendrocytes: 284.4;Plasma cells: 733.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 27 "basophil: 17.0" "Lineage enriched" "Detected in single" 27 "granulocytes: 17.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (4.72e-2)" "unprognostic (8.71e-2)" "unprognostic (1.91e-3)" "unprognostic (1.48e-2)" "unprognostic (9.73e-2)" "unprognostic (4.29e-3)" "unprognostic (1.38e-1)" "unprognostic (1.27e-1)" "unprognostic (8.04e-2)" "unprognostic (2.04e-1)" "unprognostic (5.39e-3)" "unprognostic (7.71e-2)" "prognostic favorable (2.85e-4)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "unprognostic (4.43e-2)" "unprognostic (1.06e-1)" 13.2 7.0 8.1 5.7 9.1 11.6 13.4 12.3 12.6 11.3 6.8 10.0 9.6 9.0 27.7 7.8 7.6 9.9 5.8 8.1 8.4 10.3 13.5 9.0 5.8 9.5 7.9 11.3 13.8 15.7 5.6 6.4 8.9 6.8 9.7 14.0 8.2 7.8 23.9 10.7 7.8 6.3 7.9 7.1 10.7 11.9 7.5 10.3 13.5 20.1 8.9 9.1 10.1 10.7 16.3 10.7 11.6 7.9 38.4 31.7 37.7 20.6 28.9 26.0 29.8 6.5 16.3 31.6 7.0 20.8 20.4 6.5 9.6 17.0 26.4 6.9 13.5 15.0 14.5 10.7 62.7 23.4 10.0 46.4 11.7 24.6 25.6 32.4 27.5 17.4 11.5 41.4 67.6 11.0 19.7 15.1 23.8 10.8 8.8 17.1 21.8 26.9 24.9 16.2 5.9 10.5 15.3 15.4 63.9 10.4 9.2 18.3 21.8 32.9 20.2 25.1 20.3 25.2 31.2 18.8 24.6 16.8 25.5 17.0 0.0 0.0 0.3 0.0 0.4 0.2 0.6 0.3 0.1 0.2 0.2 0.3 0.1 0.2 0.0 0.3 0.2 0.2 8.1 9.1 12.3 12.6 8.1 8.4 9.5 7.9 8.9 7.9 7.5 10.7 39.2 32.1 51.2 63.6 69.9 42.6 20.8 17.0 17.6 27.9 37.7 16.0 18.9 18.6 39.9 7.3 139.7 8.9 71.6 19.5 9.8 14.4 95.5 25.5 55.0 61.4 19.8 37.6 175.4 20.7 9.3 73.4 36.7 42.0 196.7 17.3 21.0 45.1 41.0 52.2 144.5 18.1 22.4 59.7 181.3 92.2 34.8 87.5 282.8 47.8 16.7 43.2 19.6 364.4 284.4 14.8 14.8 10.9 733.4 35.1 12.7 11.3 45.2 41.3 0.0 45.6 29.3 24.4 10.5 25.3 33.5 3.4 195.5 10.2 20.5 21.5 GALNT15 "GALNT7, GALNTL2, pp-GalNAc-T15" ENSG00000131386 "Polypeptide N-acetylgalactosaminyltransferase 15" Q8N3T1 3 16174680-16231992 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 157.4;brain: 141.7" "Cell type enhanced" "Detected in many" "Adipocytes: 103.9;Astrocytes: 34.6;Early spermatids: 26.6;Endothelial cells: 26.9;Hepatic stellate cells: 41.7;Muller glia cells: 47.4;Oligodendrocytes: 69.3" "Cancer enriched" "Detected in many" 5 "glioma: 21.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "ASC diff: 133.0;ASC TERT1: 128.8;HSkMC: 102.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017076 Uncertain Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA 40000 "Cluster 15: NK-cells - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" Cytosol "HPA017076: AB_1849458" "unprognostic (3.87e-1)" "unprognostic (4.84e-4)" "unprognostic (6.39e-2)" "unprognostic (8.77e-3)" "unprognostic (2.77e-1)" "unprognostic (2.52e-1)" "unprognostic (7.40e-4)" "unprognostic (4.24e-1)" "unprognostic (2.24e-1)" "unprognostic (8.28e-6)" "unprognostic (5.13e-2)" "unprognostic (2.58e-1)" "unprognostic (2.66e-2)" "unprognostic (1.37e-3)" "unprognostic (1.88e-1)" "unprognostic (8.51e-2)" "unprognostic (1.78e-3)" 157.4 4.9 45.1 1.7 55.8 2.7 87.2 62.5 49.3 12.3 14.4 21.7 3.0 11.4 11.9 12.4 24.9 5.6 18.1 47.9 90.8 11.8 4.0 9.4 4.1 137.6 60.4 22.3 3.6 2.4 3.5 32.3 130.8 6.0 3.9 13.4 25.5 4.7 36.3 41.7 21.2 7.0 102.4 12.3 15.3 9.1 62.8 4.0 18.3 35.3 1.3 33.0 22.8 141.7 0.4 1.3 0.9 1.0 133.0 128.8 0.3 3.4 2.5 0.4 1.3 0.0 0.5 0.5 1.9 7.8 2.3 0.8 0.5 1.4 2.0 0.6 1.4 1.1 1.9 0.0 7.4 1.5 0.4 102.8 0.0 1.2 1.8 2.4 2.8 0.7 0.2 3.0 1.1 1.9 0.0 2.1 0.5 0.8 1.1 0.3 1.1 24.1 0.5 0.5 0.4 0.3 0.4 1.0 0.6 0.6 0.7 1.8 3.9 0.6 4.3 26.8 0.6 1.4 5.1 1.4 2.5 0.4 0.4 0.5 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.2 0.1 0.3 0.1 0.0 45.1 55.8 62.5 49.3 47.9 90.8 137.6 60.4 130.8 102.4 62.8 141.7 103.9 0.0 1.7 34.6 0.1 0.5 0.4 0.0 0.0 3.8 1.1 0.9 2.8 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 26.6 0.5 3.3 26.9 0.0 0.0 4.9 0.0 0.1 24.7 0.0 1.0 1.3 0.1 41.7 1.8 0.1 0.0 3.9 0.0 0.0 0.8 2.1 16.7 1.8 0.5 0.0 22.5 0.1 47.4 0.0 5.0 69.3 0.2 0.0 0.7 1.8 2.1 0.0 0.1 0.0 3.2 0.0 7.3 2.1 25.5 0.5 0.1 0.9 0.0 0.2 0.3 0.0 0.3 DPH3 "DELGIP, DELGIP1, DESR1, DPH3A, KTI11, MGC20197, ZCSL2" ENSG00000154813 "Diphthamide biosynthesis 3" Q96FX2 3 16257061-16264969 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035287 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm Cytosol "HPA035287: AB_10604113" "unprognostic (2.49e-2)" "unprognostic (8.80e-2)" "unprognostic (2.84e-2)" "unprognostic (3.30e-2)" "unprognostic (1.52e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (1.22e-1)" "unprognostic (2.83e-1)" "unprognostic (5.06e-2)" "unprognostic (5.83e-2)" "unprognostic (4.13e-1)" "unprognostic (5.90e-3)" "unprognostic (1.82e-2)" "unprognostic (1.55e-1)" "unprognostic (1.19e-2)" "unprognostic (6.44e-2)" 14.2 11.9 12.7 9.6 13.5 8.4 10.3 14.3 14.3 10.2 13.6 11.5 10.7 10.0 11.0 9.4 8.9 10.2 13.9 12.2 15.6 13.1 15.3 11.1 8.9 15.4 14.4 6.1 7.8 9.0 8.5 13.2 15.0 9.3 8.7 13.4 5.7 11.1 29.4 4.9 13.3 15.2 14.7 9.1 9.4 8.5 13.6 11.5 12.4 20.1 8.1 12.4 5.8 15.5 10.5 14.6 31.9 18.9 58.9 39.7 24.8 29.9 24.4 28.0 31.3 18.1 5.8 10.0 9.3 37.5 24.0 6.2 29.4 17.7 32.6 50.5 20.4 16.6 11.5 21.0 36.7 24.5 15.6 28.6 23.6 36.0 15.2 17.6 25.5 17.4 26.9 16.4 39.9 14.1 19.0 16.5 25.6 15.9 14.7 12.9 20.7 15.4 24.9 8.0 7.2 20.2 13.8 6.7 35.4 25.6 12.5 23.9 29.9 22.9 15.0 41.7 24.0 12.6 44.5 12.8 33.6 27.2 20.7 27.1 16.7 25.7 11.3 22.8 14.0 10.1 11.9 13.8 15.9 9.9 9.9 11.9 35.5 10.7 21.6 6.2 11.9 12.7 12.7 13.5 14.3 14.3 12.2 15.6 15.4 14.4 15.0 14.7 13.6 15.5 32.3 19.2 22.4 10.1 31.0 51.6 42.9 41.0 29.0 11.6 32.9 34.7 34.9 25.8 32.4 16.5 12.5 47.9 28.1 43.0 41.1 49.5 109.1 27.5 35.3 32.5 17.9 32.0 12.0 57.2 80.6 34.4 30.1 33.3 52.0 11.2 26.7 41.6 101.6 6.7 10.3 22.6 26.4 45.5 61.7 63.3 20.5 46.4 28.4 3.7 71.5 24.8 29.9 6.6 9.2 66.6 32.4 15.8 42.2 42.6 79.1 45.4 33.9 15.1 13.1 33.4 36.7 80.4 40.1 31.3 52.4 80.9 34.5 18.7 19.0 47.1 OXNAD1 MGC15763 ENSG00000154814 "Oxidoreductase NAD binding domain containing 1" Q96HP4 3 16265160-16350299 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 67.0;Inhibitory neurons: 62.8;T-cells: 90.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 81.0" "Lineage enriched" "Detected in all" 4 "T-cells: 81.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036830, HPA059160" Approved Approved Nucleoplasm "Intracellular and membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 58: T-cells - T-cell receptor" Nucleoplasm "HPA036830: AB_2675338, HPA059160: AB_2683936" "unprognostic (4.49e-2)" "unprognostic (7.41e-3)" "unprognostic (2.71e-3)" "unprognostic (2.38e-3)" "unprognostic (4.65e-2)" "unprognostic (3.23e-2)" "unprognostic (1.46e-1)" "unprognostic (2.31e-2)" "unprognostic (1.23e-2)" "unprognostic (8.05e-2)" "unprognostic (1.46e-1)" "unprognostic (8.08e-2)" "prognostic favorable (1.00e-7)" "unprognostic (2.22e-2)" "unprognostic (1.03e-1)" "unprognostic (6.95e-3)" "prognostic favorable (7.63e-4)" 5.8 4.0 2.0 11.4 3.3 8.9 4.8 2.4 3.7 2.7 3.7 8.5 12.2 3.0 2.5 5.4 3.4 5.0 9.0 1.8 2.4 8.7 16.9 4.2 17.0 2.3 2.4 3.0 3.7 7.3 2.4 3.6 2.5 2.9 7.2 4.6 4.4 2.6 14.9 4.1 14.1 2.8 1.3 7.1 7.3 4.4 2.8 18.1 5.6 10.1 12.1 5.4 3.3 3.4 8.3 12.0 7.6 12.0 8.8 7.8 29.7 8.8 6.5 11.8 9.5 17.2 8.2 11.8 5.4 5.5 6.5 5.9 15.9 14.3 11.2 21.6 10.5 17.4 9.6 9.3 9.1 28.3 10.2 5.8 10.5 19.2 9.2 3.7 9.3 12.0 24.1 27.3 5.2 14.7 16.6 14.8 16.3 12.4 13.8 14.6 9.3 20.7 8.0 9.9 5.4 7.5 9.8 16.3 14.0 8.2 10.4 16.1 4.2 7.7 9.8 8.5 14.4 9.9 19.0 19.0 9.1 24.3 10.5 0.1 3.8 3.1 22.6 5.4 30.3 5.5 34.6 24.5 6.0 4.3 81.0 61.8 3.4 19.3 5.4 4.6 20.4 19.3 2.0 3.3 2.4 3.7 1.8 2.4 2.3 2.4 2.5 1.3 2.8 3.4 4.9 0.0 8.6 35.6 8.9 2.4 5.4 7.9 6.2 5.8 5.7 3.4 12.8 7.2 4.7 7.3 6.2 10.2 29.4 8.9 31.3 9.8 40.2 3.9 5.5 4.4 3.0 16.2 67.0 6.2 8.1 5.1 11.2 3.9 20.8 5.8 3.9 23.3 8.5 3.3 62.8 7.6 6.1 5.2 3.6 31.7 3.1 6.3 5.4 17.8 10.2 5.8 41.2 36.2 42.1 7.5 2.9 1.9 20.8 5.0 21.2 15.7 7.2 11.7 6.6 6.1 6.8 9.0 11.7 7.5 3.4 5.1 90.0 7.8 11.5 6.5 RFTN1 "FLJ23866, KIAA0084, MIG2, Raftlin" ENSG00000131378 "Raftlin, lipid raft linker 1" Q14699 3 16313574-16514026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 117.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 87.6;monocytes: 143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 151.7;Daudi: 122.9;HDLM-2: 177.5;SH-SY5Y: 132.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048725 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 3: Monocytes - Immune response regulation" "HPA048725: AB_2680502" "unprognostic (1.98e-1)" "unprognostic (5.82e-2)" "unprognostic (1.44e-1)" "unprognostic (1.61e-1)" "unprognostic (5.92e-2)" "unprognostic (1.19e-2)" "unprognostic (1.87e-1)" "unprognostic (7.55e-3)" "unprognostic (9.99e-3)" "unprognostic (7.24e-2)" "unprognostic (2.75e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.29e-7)" "unprognostic (6.19e-2)" "unprognostic (1.49e-2)" "unprognostic (2.88e-2)" "unprognostic (2.81e-1)" 57.2 11.2 15.1 44.7 18.3 13.3 33.2 13.6 22.7 28.2 15.8 15.2 9.3 36.6 4.9 14.5 26.0 15.4 44.7 18.3 20.2 18.4 24.8 46.9 117.0 21.7 14.9 30.4 4.7 9.0 7.4 51.0 16.1 16.4 14.1 11.4 11.3 10.3 25.5 17.1 22.8 31.3 13.9 45.5 11.8 7.0 15.2 73.2 53.4 26.6 117.4 26.2 14.5 17.5 0.1 2.9 5.3 0.0 151.7 75.7 7.7 38.8 65.9 19.3 15.6 21.5 1.0 122.9 18.6 71.2 4.3 0.6 0.1 51.4 25.5 177.5 9.0 19.8 4.9 0.3 78.6 14.7 10.8 111.3 3.4 60.7 19.0 67.5 40.5 19.8 0.5 0.4 47.0 6.6 31.3 5.0 3.5 0.0 1.4 29.6 60.8 15.0 8.0 0.1 0.1 132.6 1.3 1.3 7.2 7.4 0.2 12.2 59.9 47.3 23.0 47.8 16.8 0.4 0.5 82.5 22.0 38.6 19.2 56.0 19.6 13.2 35.3 46.4 18.1 16.3 27.2 37.6 33.6 32.0 18.4 27.8 1.2 80.1 81.7 25.8 60.4 38.3 15.1 18.3 13.6 22.7 18.3 20.2 21.7 14.9 16.1 13.9 15.2 17.5 37.9 22.4 40.0 8.1 51.2 6.5 0.3 2.3 0.0 3.2 0.7 1.5 14.3 5.7 6.9 0.0 0.0 6.2 61.1 0.1 0.0 7.2 38.0 2.6 51.8 34.4 1.2 10.3 87.6 0.9 1.1 32.4 3.1 2.0 24.7 2.1 36.0 7.2 10.5 0.0 16.5 0.0 0.0 17.6 63.6 12.2 18.6 27.0 10.6 19.7 143.8 37.2 64.9 3.0 2.4 0.9 0.1 8.6 43.2 0.6 0.0 0.4 3.3 3.2 0.0 28.2 35.2 2.8 2.4 0.8 5.1 2.5 39.5 12.6 0.3 0.4 DAZL "DAZH, DAZL1, DAZLA, MGC26406, SPGYLA" ENSG00000092345 "Deleted in azoospermia like" Q92904 3 16586792-16670306 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "testis: 79.6" "Cell type enhanced" "Detected in some" "Early spermatids: 64.1;Late spermatids: 41.2;Spermatocytes: 257.9;Spermatogonia: 143.1" "Cancer enriched" "Detected in single" 51 "testis cancer: 13.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "HAP1: 18.8" "HPA019777, HPA047113" Enhanced NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA019777: AB_1847495, HPA047113: AB_2679936" "unprognostic (5.61e-2)" "unprognostic (5.27e-3)" "unprognostic (2.80e-1)" "unprognostic (5.85e-2)" "unprognostic (2.32e-3)" "unprognostic (2.60e-2)" "unprognostic (6.34e-2)" "unprognostic (4.91e-2)" "unprognostic (9.69e-2)" "unprognostic (7.79e-2)" "unprognostic (2.04e-1)" "unprognostic (3.47e-1)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.4 79.6 0.0 0.0 0.0 0.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 41.2 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 257.9 143.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PLCL2 "KIAA1092, PLCE2" ENSG00000154822 "Phospholipase C like 2" Q9UPR0 3 16802651-17090604 "Metabolic proteins, Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 27.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 212.5;Extravillous trophoblasts: 73.0;Inhibitory neurons: 163.7;Microglial cells: 124.6;Oligodendrocyte precursor cells: 121.7;Oligodendrocytes: 72.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 21.1;Daudi: 24.7;HAP1: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047616, HPA061728" Enhanced NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA047616: AB_2680105, HPA061728: " "unprognostic (2.95e-2)" "unprognostic (8.09e-2)" "unprognostic (3.96e-2)" "unprognostic (6.35e-2)" "unprognostic (1.59e-1)" "unprognostic (3.83e-3)" "unprognostic (1.83e-1)" "unprognostic (9.31e-2)" "unprognostic (3.22e-2)" "unprognostic (8.72e-2)" "unprognostic (5.93e-3)" "unprognostic (1.29e-2)" "prognostic favorable (2.98e-10)" "unprognostic (2.01e-1)" "unprognostic (1.78e-1)" "unprognostic (2.70e-1)" "unprognostic (9.97e-2)" 7.8 11.8 2.8 5.8 5.0 10.0 5.9 13.7 4.0 4.2 1.1 5.6 6.6 6.6 2.5 1.3 4.3 4.1 21.1 3.3 1.6 7.4 5.6 4.8 10.2 3.6 1.7 12.5 6.7 0.8 6.0 3.8 4.1 3.1 5.7 2.1 2.8 1.4 27.1 1.9 8.3 4.2 0.8 12.9 5.4 3.9 1.7 5.9 3.7 7.7 7.7 2.6 3.1 2.9 0.0 1.9 2.5 0.0 9.3 21.1 2.0 1.8 5.0 0.8 2.0 0.0 1.8 24.7 0.0 1.6 1.0 0.0 24.8 0.9 1.8 11.8 5.2 0.0 2.6 0.0 0.3 3.8 2.7 3.4 0.2 6.9 0.0 1.5 4.3 8.1 5.8 9.4 0.0 0.0 4.3 0.4 5.0 0.0 2.6 9.4 0.0 13.5 0.0 0.4 8.0 3.6 1.0 3.0 0.7 1.7 0.0 4.0 4.4 1.2 1.7 1.1 4.2 8.9 0.0 15.7 1.3 5.2 0.9 0.9 0.8 1.9 2.1 0.9 2.6 1.4 2.0 2.9 1.0 1.3 1.9 2.1 1.8 6.5 1.2 0.5 1.5 1.1 2.8 5.0 13.7 4.0 3.3 1.6 3.6 1.7 4.1 0.8 1.7 2.9 8.6 0.0 2.2 8.1 17.5 1.0 0.9 1.1 1.2 11.5 0.6 0.4 38.6 11.5 1.1 3.7 4.2 2.5 34.1 12.5 7.9 2.6 1.1 7.5 4.1 6.6 3.6 7.0 212.5 9.2 73.0 7.8 17.3 2.1 2.5 5.6 5.7 6.4 7.8 16.8 163.7 9.8 0.0 8.7 4.6 1.5 19.6 13.8 0.0 124.6 12.3 1.2 39.1 121.7 72.2 2.9 22.6 19.2 18.2 0.5 9.5 10.9 1.3 1.8 6.6 9.6 5.0 2.5 5.4 0.3 0.6 49.8 24.2 6.5 5.4 0.6 TBC1D5 KIAA0210 ENSG00000131374 "TBC1 domain family member 5" Q92609 3 17157162-18444817 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Astrocytes: 226.6;Excitatory neurons: 333.2;Inhibitory neurons: 350.5;Microglial cells: 324.2;Oligodendrocyte precursor cells: 341.8;Oligodendrocytes: 565.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035125, HPA035126" Uncertain Supported "Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "Golgi apparatus" "HPA035125: AB_2674479, HPA035126: AB_10670696" "unprognostic (1.87e-1)" "unprognostic (3.57e-1)" "unprognostic (2.86e-2)" "unprognostic (3.19e-1)" "unprognostic (1.60e-1)" "unprognostic (4.30e-3)" "unprognostic (3.07e-2)" "unprognostic (3.31e-1)" "unprognostic (3.56e-2)" "unprognostic (6.27e-2)" "unprognostic (2.05e-1)" "unprognostic (1.42e-1)" "prognostic favorable (1.75e-7)" "unprognostic (1.25e-1)" "unprognostic (1.56e-1)" "unprognostic (5.72e-2)" "unprognostic (7.07e-2)" 17.9 17.4 13.7 17.0 21.1 25.2 18.6 18.2 15.5 20.1 6.0 13.5 10.8 17.6 12.1 16.8 22.5 19.2 15.8 13.8 16.1 19.9 14.7 18.0 23.1 21.9 17.7 28.1 18.3 25.7 8.5 17.5 22.8 14.0 13.9 10.9 14.1 16.4 9.3 14.0 13.8 18.3 18.3 24.0 13.8 18.9 16.0 20.3 30.0 11.3 23.2 14.8 10.1 29.9 26.3 28.8 23.2 22.0 45.0 65.5 25.4 27.6 39.7 17.7 15.3 14.0 23.2 48.5 29.1 56.3 27.1 8.0 20.6 33.6 36.6 43.0 7.9 46.6 11.1 16.5 28.8 45.7 39.0 42.6 39.3 38.5 23.2 39.8 40.9 28.3 29.6 43.6 43.5 17.6 22.5 10.5 19.1 16.8 30.0 48.9 29.6 34.7 26.3 20.0 8.8 41.0 52.5 12.2 18.6 21.7 34.6 37.6 44.7 48.7 21.6 25.6 30.4 25.2 36.6 46.7 37.5 42.3 46.5 11.7 8.1 11.9 5.8 6.5 7.5 10.3 4.4 4.2 9.2 11.3 3.2 3.8 10.4 4.3 6.3 5.8 5.2 4.8 13.7 21.1 18.2 15.5 13.8 16.1 21.9 17.7 22.8 18.3 16.0 29.9 40.4 16.0 35.0 226.6 56.0 18.4 20.0 15.8 42.7 20.3 23.0 19.9 18.6 25.8 27.8 14.7 10.4 17.1 28.9 9.2 5.9 17.7 64.1 19.6 28.9 30.7 13.1 31.3 333.2 9.9 16.7 32.5 20.4 28.2 18.9 31.5 34.6 19.9 21.4 35.3 350.5 13.4 10.2 35.6 22.9 40.2 30.7 34.9 14.2 324.2 23.2 26.6 32.0 341.8 565.6 12.3 9.1 30.5 20.7 9.8 13.7 15.9 16.3 22.3 6.6 34.0 20.4 20.7 25.5 28.4 17.0 8.2 30.0 35.5 14.5 17.6 SATB1 ENSG00000182568 "SATB homeobox 1" Q01826 3 18345377-18445588 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "lymphoid tissue: 374.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 180.2;Inhibitory neurons: 283.4;Oligodendrocyte precursor cells: 168.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "naive CD4 T-cell: 113.7" "Group enriched" "Detected in all" 4 "NK-cells: 63.4;T-cells: 113.7" "Cell line enhanced" "Detected in many" "HDLM-2: 455.3;JURKAT: 213.3;MOLT-4: 107.7;REH: 126.5;THP-1: 192.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051769, CAB056144, HPA070534" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Nuclear bodies" "CAB056144: AB_10584780, HPA051769: AB_2681600, HPA070534: " "unprognostic (2.16e-1)" "unprognostic (3.99e-1)" "unprognostic (7.13e-2)" "unprognostic (3.58e-1)" "unprognostic (9.15e-2)" "unprognostic (4.22e-3)" "unprognostic (2.16e-1)" "unprognostic (1.62e-3)" "unprognostic (2.90e-2)" "unprognostic (6.14e-2)" "prognostic favorable (8.97e-4)" "unprognostic (1.66e-1)" "prognostic favorable (1.96e-7)" "unprognostic (1.92e-2)" "unprognostic (2.18e-1)" "unprognostic (2.79e-2)" "unprognostic (1.47e-3)" 16.1 10.3 13.4 28.8 19.1 42.8 13.2 0.8 32.2 11.4 2.6 29.9 16.0 13.6 24.0 12.2 17.9 17.6 26.0 23.4 0.4 10.8 15.4 15.7 38.1 0.3 6.1 13.8 28.8 32.4 22.5 4.9 0.0 22.5 18.5 29.8 44.0 25.9 89.5 21.4 21.0 11.8 1.4 27.4 18.5 6.7 0.9 374.2 24.5 49.0 27.8 24.6 12.3 11.0 2.1 0.0 12.7 0.0 17.2 16.6 1.4 3.4 12.3 2.9 9.8 0.5 22.9 4.7 0.4 4.1 1.0 0.2 46.4 5.4 5.9 455.3 28.0 0.1 1.1 0.0 2.5 26.7 3.8 7.4 4.0 0.1 0.6 35.1 3.3 213.3 0.6 24.3 2.2 0.4 107.7 33.9 18.5 1.5 1.5 126.5 6.2 4.9 4.8 15.7 5.9 34.5 0.0 3.9 0.3 10.0 98.5 192.7 1.7 12.6 7.9 5.9 3.7 1.3 0.4 10.0 10.3 101.3 5.7 21.1 1.9 4.6 44.2 2.0 78.6 1.6 29.9 23.0 3.5 13.0 113.7 69.5 4.1 63.4 1.1 4.0 6.0 26.6 13.4 19.1 0.8 32.2 23.4 0.4 0.3 6.1 0.0 1.4 0.9 11.0 19.3 25.6 29.6 48.3 44.6 14.3 12.3 10.9 12.0 12.1 33.2 18.0 70.0 22.8 15.0 31.3 87.6 0.5 71.1 11.0 1.9 16.9 8.2 31.6 15.3 17.0 32.4 22.5 180.2 12.5 0.2 16.4 8.6 11.6 23.4 20.6 35.0 20.9 9.3 0.0 283.4 30.8 4.1 41.5 36.4 4.3 8.4 45.5 10.6 41.2 23.0 15.5 56.7 168.9 28.8 10.5 23.6 8.2 20.6 21.7 24.6 9.1 50.9 63.1 6.6 8.3 10.2 3.2 9.3 20.5 22.0 0.3 84.0 16.8 25.7 19.7 KCNH8 "elk3, Kv12.1" ENSG00000183960 "Potassium voltage-gated channel subfamily H member 8" Q96L42 3 19148510-19535642 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.0;pituitary gland: 10.7" "Group enriched" "Detected in some" 63 "Oligodendrocyte precursor cells: 331.7;Oligodendrocytes: 989.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.4" "Lineage enriched" "Detected in single" 4 "B-cells: 1.4" "Cell line enhanced" "Detected in some" "HAP1: 1.0;OE19: 1.9;SH-SY5Y: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA016586, HPA077537, HPA077773" Approved Supported "Plasma membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane" "HPA016586: AB_1852127, HPA077537: , HPA077773: " "unprognostic (6.68e-3)" "unprognostic (1.68e-1)" "unprognostic (2.99e-2)" "unprognostic (8.56e-6)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.88e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (1.69e-1)" "unprognostic (5.04e-3)" "unprognostic (2.90e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (3.89e-2)" "unprognostic (8.71e-5)" "unprognostic (1.72e-1)" 0.0 1.8 7.3 0.3 11.9 0.2 0.5 6.5 16.0 0.3 2.8 0.6 0.4 0.1 0.1 0.1 0.2 0.4 0.2 6.4 8.8 0.1 0.1 0.0 0.8 8.4 8.8 0.0 1.5 0.1 10.7 0.0 8.2 0.7 0.5 3.4 1.1 0.2 0.0 0.4 1.1 0.1 5.8 1.1 1.4 1.7 9.7 0.4 0.2 0.0 0.7 0.1 0.3 15.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.3 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 7.3 11.9 6.5 16.0 6.4 8.8 8.4 8.8 8.2 5.8 9.7 15.4 0.0 0.0 0.0 2.0 9.7 0.5 1.6 0.0 0.0 4.2 1.1 2.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 3.2 0.1 0.1 0.1 3.6 0.0 9.3 0.6 0.0 0.1 2.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 10.4 1.5 0.0 0.0 0.0 1.9 0.0 0.1 3.6 1.0 0.0 3.4 0.0 331.7 989.4 0.5 0.2 0.0 0.1 1.5 0.0 0.0 0.0 1.0 0.0 0.2 0.5 1.2 3.4 0.0 0.0 0.1 0.3 0.1 0.6 0.4 EFHB "CFAP21, FLJ25200" ENSG00000163576 "EF-hand domain family member B" Q8N7U6 3 19879472-19947025 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.5;fallopian tube: 17.1;testis: 15.5" "Group enriched" "Detected in many" 4 "Early spermatids: 77.2;Endometrial ciliated cells: 49.9;Late spermatids: 25.7;Respiratory ciliated cells: 93.6;Spermatocytes: 32.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "RPTEC TERT1: 19.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA034835 Approved Vesicles,Cytosol NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" Cytosol Vesicles "HPA034835: " "unprognostic (9.70e-2)" "unprognostic (2.71e-2)" "unprognostic (2.37e-1)" "unprognostic (2.33e-2)" "unprognostic (1.20e-2)" "unprognostic (9.56e-3)" "unprognostic (1.51e-5)" "unprognostic (4.43e-2)" "unprognostic (3.66e-1)" "unprognostic (1.51e-1)" "unprognostic (4.92e-2)" "unprognostic (5.47e-2)" "unprognostic (6.06e-2)" "unprognostic (2.13e-2)" "unprognostic (9.35e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" 0.5 0.7 1.6 0.1 1.5 0.2 0.9 1.0 1.4 0.9 2.6 0.2 0.0 1.1 0.6 0.4 17.1 0.6 0.2 1.4 1.6 1.0 0.2 2.0 0.2 6.5 5.0 1.5 0.2 0.4 0.4 0.4 3.4 0.4 0.3 0.8 0.2 0.5 0.2 0.4 0.2 0.5 3.7 0.5 0.2 15.5 1.6 0.3 0.5 0.2 0.3 0.3 0.2 2.2 0.0 0.5 0.2 0.2 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 19.5 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.6 1.5 1.0 1.4 1.4 1.6 6.5 5.0 3.4 3.7 1.6 2.2 1.0 0.0 1.1 5.5 0.3 0.1 0.5 1.9 0.6 0.8 1.8 1.4 0.3 5.7 12.4 3.7 2.1 0.9 1.6 0.5 5.9 0.3 77.2 49.9 1.8 0.7 1.2 3.6 1.7 0.2 0.5 1.3 0.0 1.8 3.8 1.8 1.8 0.6 0.5 1.7 2.2 0.2 4.1 1.3 0.3 25.7 2.5 1.0 0.0 1.9 0.2 5.3 0.0 3.0 1.7 0.6 0.1 2.2 0.0 0.3 1.2 8.3 93.6 0.8 0.0 3.6 1.7 32.7 4.3 0.1 0.1 0.8 0.3 1.0 0.4 0.3 RAB5A RAB5 ENSG00000144566 "RAB5A, member RAS oncogene family" P20339 3 19947097-19985175 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Endocytosis, Phagocytosis, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004567, HPA049354" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Vesicles" "CAB004567: AB_628191, HPA049354: AB_2680725" "unprognostic (2.49e-3)" "unprognostic (1.95e-1)" "unprognostic (2.58e-2)" "unprognostic (4.72e-1)" "unprognostic (3.85e-1)" "unprognostic (5.58e-2)" "unprognostic (1.40e-2)" "unprognostic (6.75e-2)" "unprognostic (7.12e-2)" "unprognostic (5.97e-2)" "unprognostic (1.83e-3)" "unprognostic (4.68e-2)" "unprognostic (2.10e-2)" "unprognostic (1.93e-1)" "unprognostic (1.33e-1)" "unprognostic (2.45e-1)" "unprognostic (8.36e-2)" 35.7 27.3 39.2 27.0 39.9 41.4 33.2 42.1 49.5 30.5 36.6 29.7 29.6 22.7 42.4 42.3 21.1 32.2 36.3 38.6 43.1 33.6 42.8 29.5 24.3 42.7 42.5 19.9 27.2 53.8 20.5 49.2 42.2 30.7 30.5 35.4 35.8 28.8 29.1 36.0 28.2 28.0 44.0 24.2 32.6 18.0 41.1 28.9 41.1 30.3 29.1 35.4 29.7 46.1 29.8 26.8 38.5 26.4 65.8 57.8 38.9 51.3 59.7 47.8 55.0 31.9 45.7 21.8 30.3 56.7 27.6 18.4 29.0 38.2 55.7 37.9 24.1 31.9 24.9 31.1 82.2 45.0 38.1 53.6 71.0 56.1 81.9 59.9 61.6 28.5 37.1 34.1 57.9 46.2 34.8 31.9 48.4 40.8 42.6 25.8 27.2 32.2 98.9 38.8 12.0 39.6 36.9 45.3 60.3 57.0 35.4 35.8 61.6 34.5 30.1 44.4 44.2 42.0 73.5 28.6 55.0 40.4 57.1 28.7 18.0 31.3 7.9 19.6 10.6 7.9 9.3 9.6 18.1 5.8 8.5 8.1 36.0 20.3 26.3 11.8 10.9 11.5 39.2 39.9 42.1 49.5 38.6 43.1 42.7 42.5 42.2 44.0 41.1 46.1 114.8 60.9 45.1 33.0 43.6 170.0 129.5 48.8 62.0 34.0 57.0 35.9 57.0 27.1 52.6 42.3 31.3 74.7 44.2 68.7 103.7 52.2 21.2 45.9 44.4 72.4 62.0 55.3 33.7 45.3 67.2 65.2 66.3 72.0 85.0 39.1 41.7 39.3 54.2 15.2 31.4 59.4 65.1 44.4 158.8 15.9 36.7 60.9 83.6 28.1 43.1 86.1 41.2 65.9 44.1 65.2 55.9 35.3 50.7 109.7 49.4 62.3 48.1 36.8 52.6 86.5 72.4 24.6 27.1 65.0 188.0 164.3 60.6 37.1 41.5 151.0 PP2D1 "C3orf48, FLJ25449" ENSG00000183977 "Protein phosphatase 2C like domain containing 1" A8MPX8 3 19979961-20012267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "bone marrow: 2.0;testis: 7.4" "Group enriched" "Detected in some" 106 "Early spermatids: 420.0;Late spermatids: 301.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036870, HPA066083" Enhanced Uncertain "Nucleoplasm,Intermediate filaments" NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Intermediate filaments" "HPA036870: AB_10671246, HPA066083: AB_2685611" "unprognostic (1.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (2.04e-1)" "unprognostic (3.76e-1)" "unprognostic (6.27e-4)" "unprognostic (3.29e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (3.40e-1)" "unprognostic (4.35e-2)" "unprognostic (6.00e-2)" "unprognostic (3.50e-1)" "unprognostic (8.77e-2)" "unprognostic (1.87e-1)" "unprognostic (4.93e-3)" "unprognostic (1.04e-1)" 0.2 0.1 0.0 0.1 0.0 2.0 0.1 0.5 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.1 7.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.2 0.4 0.0 0.0 0.1 0.4 0.0 0.6 0.3 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.4 0.4 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 420.0 0.2 0.3 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 301.8 2.5 0.2 0.0 0.0 0.0 0.1 0.0 2.0 0.9 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.1 3.4 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 KAT2B "GCN5, GCN5L, P/CAF, PCAF" ENSG00000114166 "Lysine acetyltransferase 2B" Q92831 3 20040446-20154404 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 165.2;Oligodendrocyte precursor cells: 418.2;Oligodendrocytes: 175.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002470, CAB004526, HPA055839, HPA073897" Supported Enhanced Nucleoplasm,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm Cytosol "CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: " "unprognostic (2.91e-2)" "unprognostic (6.85e-3)" "unprognostic (9.05e-2)" "unprognostic (2.25e-1)" "unprognostic (2.66e-2)" "unprognostic (3.01e-3)" "unprognostic (2.44e-1)" "unprognostic (3.83e-3)" "unprognostic (2.44e-2)" "unprognostic (1.03e-1)" "unprognostic (5.23e-3)" "unprognostic (7.13e-2)" "unprognostic (7.03e-2)" "unprognostic (2.26e-2)" "unprognostic (1.59e-1)" "unprognostic (5.16e-2)" "unprognostic (4.63e-2)" 17.9 9.9 38.7 15.4 46.5 48.0 10.3 39.1 40.3 14.9 33.8 13.8 17.7 12.3 8.1 27.4 11.7 12.6 35.9 34.4 42.2 16.6 39.3 16.2 22.4 41.7 44.9 27.7 18.7 51.0 10.2 13.7 43.0 14.5 12.5 33.9 37.6 13.0 60.2 14.3 21.5 13.6 37.1 19.8 13.9 2.7 42.2 23.6 14.4 56.1 20.1 11.9 15.1 45.1 2.7 6.9 3.8 6.2 15.1 14.2 8.8 8.8 13.0 9.1 13.3 2.1 4.5 24.0 3.6 16.7 11.5 2.0 9.4 2.8 7.6 21.8 9.0 21.0 10.7 0.7 7.1 3.2 26.2 6.1 5.0 7.9 5.1 16.0 8.8 5.8 13.7 32.9 13.0 3.3 7.0 6.4 1.6 6.7 6.8 9.1 7.1 5.1 12.4 14.2 1.9 4.1 4.9 7.9 30.5 5.9 8.2 14.2 8.5 15.3 6.1 5.8 10.1 12.3 27.6 5.7 13.9 13.8 33.0 0.6 0.4 1.3 1.5 0.7 1.5 0.4 1.3 1.1 0.4 0.8 0.4 0.8 2.4 0.5 0.5 1.2 2.2 0.3 38.7 46.5 39.1 40.3 34.4 42.2 41.7 44.9 43.0 37.1 42.2 45.1 15.5 32.1 20.8 165.2 11.9 8.5 11.3 2.2 3.4 14.6 5.5 5.0 64.1 4.3 10.4 5.5 4.2 7.3 19.5 16.6 11.7 3.8 3.8 6.4 5.7 14.6 11.5 52.2 22.4 4.4 1.1 11.7 3.6 13.1 10.8 12.3 20.7 33.6 7.7 15.2 32.1 7.3 4.1 22.8 23.3 1.8 6.5 16.0 17.8 52.5 11.1 14.8 14.4 418.2 175.4 3.3 2.4 5.3 19.9 7.1 24.7 6.2 12.7 11.9 6.6 25.2 9.0 0.8 1.4 10.0 12.9 9.9 23.5 2.9 3.8 8.0 SGO1 "NY-BR-85, SGOL1" ENSG00000129810 "Shugoshin 1" Q5FBB7 3 20160593-20186206 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.7;lymphoid tissue: 13.0;testis: 6.7" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 16.5;Extravillous trophoblasts: 42.6;Granulosa cells: 20.3;Hofbauer cells: 10.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "basophil: 10.0;memory B-cell: 8.8;naive B-cell: 8.9;plasmacytoid DC: 4.1;T-reg: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035501, HPA069302, HPA069857" Enhanced Enhanced Nucleoplasm,Kinetochore,Cytosol Yes Yes "Cluster 37: B-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Kinetochore, Cytosol" "HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214" "unprognostic (6.87e-3)" "unprognostic (5.01e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-3)" "unprognostic (2.51e-2)" "unprognostic (4.10e-2)" "unprognostic (2.55e-6)" "unprognostic (9.49e-3)" "unprognostic (2.45e-2)" "unprognostic (3.69e-2)" "unprognostic (1.65e-4)" "unprognostic (1.52e-2)" "unprognostic (0.00e+0)" "unprognostic (2.29e-2)" "unprognostic (4.95e-2)" "unprognostic (4.14e-1)" "unprognostic (1.64e-1)" 0.3 0.1 0.3 3.3 0.7 8.7 0.5 0.9 0.5 0.4 0.0 2.1 2.3 0.4 0.0 1.9 0.1 0.4 0.1 0.3 0.4 0.3 0.6 0.3 6.2 0.8 0.6 0.2 0.1 0.2 0.0 1.7 0.6 0.2 2.8 0.1 0.4 0.1 0.1 1.1 2.5 1.0 0.3 1.4 1.5 6.7 0.6 13.0 0.2 0.0 6.6 0.9 0.7 1.2 20.3 23.9 29.9 18.5 1.4 2.6 20.2 21.3 10.1 31.2 33.6 16.5 24.0 30.7 10.6 8.6 21.2 11.4 28.7 11.3 37.6 40.9 19.6 34.6 15.6 12.8 0.2 32.0 28.8 0.3 0.9 33.3 13.1 4.0 18.5 34.9 31.3 52.2 24.6 19.4 52.4 15.4 30.0 20.3 17.0 31.8 38.4 17.7 7.5 14.9 14.2 15.4 23.6 27.2 13.1 22.7 18.2 21.3 4.7 22.5 27.3 20.5 43.3 22.8 57.4 35.2 12.5 31.1 35.0 10.0 0.1 1.4 0.2 0.2 0.1 8.8 0.6 0.7 0.3 8.9 0.2 0.3 1.4 0.3 0.2 4.1 2.6 0.6 0.3 0.7 0.9 0.5 0.3 0.4 0.8 0.6 0.6 0.3 0.6 1.2 0.1 0.0 0.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 2.0 3.4 0.0 0.0 0.0 1.8 0.0 16.5 1.5 0.0 0.0 1.1 0.0 2.3 1.6 1.2 0.0 0.0 0.0 1.8 42.6 3.3 0.0 2.9 1.3 20.3 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 4.9 1.0 4.3 0.0 0.0 ZNF385D "FLJ22419, ZNF659" ENSG00000151789 "Zinc finger protein 385D" Q9H6B1 3 21412218-22373321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 44.0;testis: 15.1" "Cell type enriched" "Detected in many" 5 "Inhibitory neurons: 1766.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in all" 8 "cerebellum: 44.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 4.8;hTERT-RPE1: 5.4;LHCN-M2: 5.3;PC-3: 5.3;RPTEC TERT1: 15.1;U-87 MG: 21.1" "Low region specificity" "Detected in all" HPA036190 Uncertain NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA036190: AB_10602355" "unprognostic (4.07e-2)" "unprognostic (1.26e-1)" "unprognostic (5.44e-2)" "unprognostic (3.23e-2)" "unprognostic (1.64e-1)" "unprognostic (1.74e-1)" "unprognostic (8.20e-2)" "unprognostic (6.60e-2)" "unprognostic (7.84e-2)" "unprognostic (3.73e-1)" "unprognostic (2.35e-1)" "unprognostic (9.01e-2)" "unprognostic (3.49e-7)" "unprognostic (8.70e-3)" "unprognostic (5.38e-2)" "unprognostic (7.76e-3)" "unprognostic (2.15e-5)" 3.8 0.2 2.6 1.4 4.5 0.3 2.2 44.0 5.4 1.8 0.0 0.8 0.3 1.1 0.5 2.0 0.7 2.7 1.8 1.7 2.5 1.4 0.1 0.6 0.8 3.3 4.5 0.6 0.6 0.2 0.1 0.0 3.6 1.3 0.5 7.3 0.7 1.1 1.0 0.7 0.5 1.7 1.5 0.3 0.4 15.1 3.1 0.7 0.5 3.3 1.0 2.7 1.2 5.3 0.0 0.0 0.3 0.0 2.0 4.3 0.1 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.2 0.0 5.4 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.0 0.0 15.1 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.1 0.1 0.0 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 2.6 4.5 44.0 5.4 1.7 2.5 3.3 4.5 3.6 1.5 3.1 5.3 82.2 12.8 13.4 17.3 1.4 9.7 0.7 6.2 1.8 58.8 1.5 6.3 3.6 1.5 19.2 1.8 8.4 0.3 1.4 0.9 27.4 0.6 174.9 0.2 1.9 89.0 0.0 12.6 267.5 0.7 0.2 20.5 0.0 0.3 5.1 1.8 2.2 5.8 0.4 323.0 1766.6 0.7 0.0 0.0 14.0 274.5 16.8 4.9 12.4 64.6 0.6 114.3 1.0 159.3 12.7 1.4 0.6 13.5 0.3 1.7 2.3 6.6 4.4 31.0 13.1 22.0 20.2 50.4 2.0 0.6 7.7 0.1 1.5 34.3 0.7 1.0 UBE2E2 "FLJ25157, UbcH8" ENSG00000182247 "Ubiquitin conjugating enzyme E2 E2" Q96LR5 3 23203020-23591794 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 652.7;Inhibitory neurons: 399.4;Microglial cells: 402.8;Oligodendrocyte precursor cells: 513.2;Oligodendrocytes: 845.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 41.7;intermediate monocyte: 50.3;memory B-cell: 35.1;myeloid DC: 57.6;naive B-cell: 40.1;non-classical monocyte: 54.4;plasmacytoid DC: 74.0" "Group enriched" "Detected in all" 6 "B-cells: 40.1;dendritic cells: 74.0;monocytes: 54.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003303, HPA028872, HPA030445, CAB073417" Approved Approved Nucleoplasm No No "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 68: Epididymis - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "CAB073417: , HPA003303: AB_1858521, HPA028872: AB_10966277, HPA030445: AB_10669599" "unprognostic (2.20e-1)" "unprognostic (2.30e-1)" "unprognostic (1.52e-2)" "unprognostic (3.68e-3)" "unprognostic (3.74e-2)" "unprognostic (1.70e-1)" "unprognostic (9.19e-3)" "unprognostic (3.11e-3)" "unprognostic (1.32e-1)" "unprognostic (1.20e-1)" "unprognostic (4.20e-1)" "unprognostic (4.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.44e-2)" "unprognostic (2.68e-2)" "unprognostic (3.11e-2)" "unprognostic (6.11e-3)" 23.9 8.9 14.3 10.6 17.2 7.0 18.3 14.5 28.1 22.9 9.4 18.2 4.6 18.2 25.7 17.4 13.7 15.4 19.9 20.2 16.8 17.1 13.4 17.8 16.4 13.2 12.8 16.2 7.0 13.5 12.0 7.4 14.4 14.7 4.8 16.6 11.9 13.3 16.0 16.8 8.3 18.9 12.6 14.3 11.6 15.1 13.7 18.1 13.9 12.4 12.6 16.2 17.8 28.4 36.7 12.9 33.3 0.6 29.0 32.1 30.3 22.6 38.2 20.8 29.0 3.6 29.2 31.7 15.1 19.9 28.5 3.5 24.5 35.2 26.5 0.2 24.6 0.0 15.3 4.3 20.8 0.0 24.5 25.6 36.2 30.0 50.0 21.1 20.2 24.5 1.9 32.4 19.0 5.9 16.8 7.2 23.7 20.7 18.6 34.9 13.0 36.8 20.4 0.8 8.5 17.7 24.8 14.4 0.4 23.8 30.7 20.9 17.8 20.4 29.1 13.8 25.7 31.2 10.9 49.4 19.2 14.2 5.8 0.1 41.7 0.2 0.7 50.3 0.9 35.1 1.4 0.6 57.6 40.1 9.1 3.5 1.1 2.5 54.4 74.0 0.7 15.7 14.3 17.2 14.5 28.1 20.2 16.8 13.2 12.8 14.4 12.6 13.7 28.4 13.3 22.4 9.8 159.3 48.4 25.6 12.2 77.2 34.7 24.0 31.3 27.1 38.2 15.7 28.1 31.3 16.7 34.8 24.2 0.9 68.4 12.0 24.2 9.6 30.8 24.6 1.8 8.2 652.7 29.2 43.1 42.1 5.6 18.8 0.0 38.5 14.6 41.4 47.7 32.0 399.4 1.1 67.1 47.3 73.9 16.0 39.4 49.2 78.2 402.8 40.5 14.8 1.0 513.2 845.2 13.9 1.2 53.0 32.8 64.6 0.0 152.7 17.3 3.6 32.9 14.9 67.3 36.3 91.0 44.1 42.3 38.6 4.6 15.1 0.7 8.6 UBE2E1 UbcH6 ENSG00000170142 "Ubiquitin conjugating enzyme E2 E1" P51965 3 23805955-23891640 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030445, CAB073413" Approved Approved Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 25: RPMI-8226 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "CAB073413: , HPA030445: AB_10669599" "unprognostic (7.50e-2)" "unprognostic (2.78e-2)" "unprognostic (7.91e-3)" "unprognostic (7.13e-2)" "unprognostic (6.74e-3)" "unprognostic (1.74e-1)" "prognostic unfavorable (9.97e-7)" "unprognostic (3.69e-2)" "unprognostic (3.53e-2)" "unprognostic (1.34e-2)" "unprognostic (5.36e-3)" "unprognostic (2.70e-2)" "unprognostic (2.40e-2)" "unprognostic (1.94e-1)" "unprognostic (2.94e-1)" "unprognostic (2.75e-1)" "unprognostic (1.93e-1)" 68.6 54.9 84.5 67.1 91.0 123.2 89.5 91.5 121.1 74.7 83.9 76.9 50.6 66.6 68.3 80.9 63.5 61.8 62.6 82.4 94.1 69.3 71.2 71.2 102.4 92.5 88.7 79.3 53.9 103.7 34.4 96.1 93.8 71.3 79.0 73.1 64.6 73.6 89.4 63.8 51.4 77.5 93.2 73.8 60.9 51.7 87.2 98.5 61.4 94.9 108.1 92.5 65.1 101.8 199.3 101.7 202.1 99.1 129.2 170.3 151.5 141.0 256.8 172.7 234.0 80.1 235.8 182.6 121.2 166.3 146.8 65.6 232.5 208.6 228.2 202.2 201.4 235.5 75.8 97.3 177.0 260.2 138.8 172.6 162.8 230.4 324.9 207.1 278.6 118.9 177.2 210.8 136.0 86.7 188.6 235.8 268.0 117.8 255.3 201.6 80.7 531.0 262.0 129.3 54.3 176.0 146.7 131.5 215.5 202.5 146.4 329.1 183.1 132.2 144.2 85.9 109.5 154.9 99.8 363.6 152.2 231.9 110.9 1.7 4.2 3.7 1.8 4.7 2.9 3.0 2.4 1.8 3.8 2.8 3.2 2.0 1.5 4.3 2.8 4.0 2.0 2.1 84.5 91.0 91.5 121.1 82.4 94.1 92.5 88.7 93.8 93.2 87.2 101.8 30.7 44.8 28.9 66.3 52.7 72.3 62.6 89.0 59.2 31.3 37.9 24.9 68.2 31.5 59.5 18.4 4.2 97.3 27.9 56.7 56.7 90.4 25.6 37.0 28.7 58.4 46.3 41.0 47.1 78.0 99.4 43.2 25.5 32.7 40.6 40.2 43.5 22.5 98.8 20.2 50.6 37.9 150.5 69.4 156.5 55.3 40.7 61.5 97.8 127.4 98.9 81.6 36.0 90.5 102.8 71.8 61.9 48.5 40.8 78.0 21.5 43.4 60.1 27.7 52.6 47.1 63.0 35.4 59.5 61.7 90.2 72.1 35.7 27.6 52.2 72.6 NKIRAS1 "kappaB-Ras1, KBRAS1" ENSG00000197885 "NFKB inhibitor interacting Ras like 1" Q9NYS0 3 23889951-23946591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 64.6;Rod photoreceptor cells: 59.7;Spermatocytes: 68.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 64.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077387 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 29: U-266 - Adaptive immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Endoplasmic reticulum, Cytosol" "HPA077387: " "unprognostic (1.36e-2)" "unprognostic (1.88e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.31e-4)" "unprognostic (1.08e-2)" "unprognostic (4.25e-2)" "unprognostic (5.30e-2)" "prognostic favorable (3.69e-4)" "unprognostic (3.69e-3)" "unprognostic (8.07e-3)" "unprognostic (1.19e-2)" "unprognostic (3.37e-2)" "prognostic favorable (7.71e-13)" "unprognostic (1.98e-1)" "unprognostic (4.90e-2)" "unprognostic (1.18e-1)" "unprognostic (2.63e-3)" 10.0 13.4 23.0 4.5 23.4 8.0 8.7 23.9 29.9 9.0 16.0 9.4 3.4 8.7 8.4 8.4 7.9 6.2 16.4 24.1 25.1 16.4 25.0 6.2 4.4 22.8 22.9 11.9 5.2 37.8 14.9 6.3 23.9 9.5 4.0 47.3 6.9 13.1 32.8 4.9 4.1 9.2 20.9 5.9 6.2 22.9 22.1 3.8 9.8 27.2 4.5 6.6 6.1 21.7 13.3 12.9 11.0 11.7 31.6 14.6 11.4 32.4 19.8 23.5 18.9 10.9 3.6 7.0 14.4 18.8 13.9 7.0 20.4 14.1 20.0 28.7 13.8 3.4 10.2 10.5 17.1 6.0 3.4 12.1 19.1 30.3 13.9 21.3 7.0 6.6 6.7 26.6 26.1 6.4 4.5 5.5 15.2 8.2 15.6 6.7 17.3 6.0 16.2 5.2 4.3 21.6 11.0 14.5 23.4 11.4 11.7 9.9 12.6 10.9 11.8 28.2 26.5 57.1 64.0 4.2 14.4 10.3 9.0 13.9 5.1 6.7 8.9 4.1 9.8 6.1 6.2 8.5 5.1 8.1 9.6 7.8 2.4 4.3 4.3 3.6 5.3 4.5 23.0 23.4 23.9 29.9 24.1 25.1 22.8 22.9 23.9 20.9 22.1 21.7 5.7 6.4 8.2 7.5 5.3 11.2 10.3 18.0 13.6 34.1 9.0 8.3 22.3 4.3 13.1 5.5 64.6 12.2 6.0 3.0 15.6 7.5 27.5 18.0 12.0 5.5 1.2 3.0 15.3 4.5 9.7 11.6 3.1 21.0 7.0 5.7 6.1 13.3 7.3 13.5 16.9 2.2 14.2 3.2 12.9 7.7 7.5 6.8 10.6 5.6 4.6 44.0 3.1 11.6 10.7 5.3 2.4 9.1 4.2 8.1 4.1 23.2 17.2 59.7 13.1 7.3 12.9 68.6 41.1 7.9 9.9 10.4 6.7 10.7 3.0 7.2 RPL15 "EC45, L15, RPL10, RPLY10, RPYL10" ENSG00000174748 "Ribosomal protein L15" P61313 3 23916591-23924374 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 290000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "unprognostic (8.73e-3)" "unprognostic (3.13e-2)" "unprognostic (1.06e-2)" "unprognostic (5.77e-3)" "unprognostic (1.16e-2)" "unprognostic (8.40e-2)" "unprognostic (1.76e-3)" "unprognostic (4.43e-2)" "unprognostic (1.65e-1)" "unprognostic (1.41e-1)" "unprognostic (3.54e-2)" "unprognostic (6.15e-2)" "unprognostic (1.53e-2)" "unprognostic (1.32e-1)" "unprognostic (1.65e-1)" "unprognostic (1.78e-1)" "unprognostic (2.17e-2)" 1235.0 974.6 932.8 988.5 948.8 3173.3 1985.3 910.8 1017.8 1476.6 865.3 1256.2 916.2 1233.3 1364.2 1590.2 1684.8 1032.7 1064.9 889.6 947.1 924.1 963.9 881.7 2139.0 956.2 935.2 3508.3 2314.0 1132.0 875.3 999.3 954.7 1056.4 1082.2 492.2 2541.7 933.6 1204.2 1598.4 944.7 1146.3 1028.4 1135.6 1189.7 543.9 985.7 2145.3 1420.4 1470.7 1967.5 1622.0 1298.3 983.7 1884.4 1672.6 1865.3 2205.4 2938.4 4771.0 2306.5 1735.1 3111.2 2614.8 2272.5 1911.8 2160.2 3773.1 1663.6 2599.8 1395.8 1246.8 2257.1 3847.8 1873.7 1781.3 3198.5 1482.3 1665.5 2318.9 3919.5 2624.0 1883.9 4784.3 5359.8 2903.6 4909.4 3783.5 3360.8 2616.7 1920.5 3044.4 2731.4 2598.3 3423.7 3345.9 3254.1 2354.3 2745.2 2980.8 1645.5 4025.3 2762.8 2203.8 987.6 2402.2 1020.5 4416.6 3791.8 1655.3 2958.9 5102.2 1849.1 1569.5 2056.3 1645.1 3196.8 2579.1 3758.6 3500.8 1570.9 3483.4 1852.3 897.2 2250.3 454.1 1698.4 1878.9 2960.6 3476.6 2599.4 2357.9 2917.1 3310.7 3182.8 2831.7 263.1 2346.0 1602.6 2369.7 2475.9 6597.8 932.8 948.8 910.8 1017.8 889.6 947.1 956.2 935.2 954.7 1028.4 985.7 983.7 1499.2 746.8 1100.3 44.7 3602.1 7074.5 6959.4 8223.9 3122.1 541.8 6066.8 6379.1 385.1 2546.4 3484.1 1029.9 181.4 4812.5 2798.4 1007.2 4187.0 3163.6 3239.1 1167.3 1989.0 2798.6 1720.1 2338.9 63.9 4491.5 6879.4 2261.8 1083.6 1607.8 1478.8 2969.2 2682.2 1755.9 3583.6 277.6 77.7 2855.1 3013.0 3552.7 6451.3 4965.7 3662.3 2601.6 3966.5 50.6 4609.7 1412.2 2856.9 45.8 91.3 3499.5 2558.2 2337.3 2291.1 7001.0 1750.8 3801.2 1422.6 570.1 1360.8 2679.8 4368.3 1786.6 962.8 4001.9 8678.9 5061.5 2967.3 3017.0 3549.9 7926.6 NR1D2 "BD73, EAR-1r, Hs.37288, HZF2, REVERBB, REVERBbeta, RVR" ENSG00000174738 "Nuclear receptor subfamily 1 group D member 2" Q14995 3 23945286-23980617 "Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 135.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053868, HPA054798" Approved Approved Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA053868: AB_2682284, HPA054798: AB_2616453" "unprognostic (8.64e-2)" "unprognostic (9.96e-3)" "unprognostic (2.27e-1)" "unprognostic (2.46e-1)" "unprognostic (8.67e-2)" "unprognostic (2.09e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (2.60e-1)" "unprognostic (6.79e-3)" "unprognostic (2.21e-1)" "unprognostic (5.73e-2)" "prognostic favorable (4.47e-7)" "unprognostic (2.36e-3)" "unprognostic (1.23e-1)" "unprognostic (1.08e-1)" "unprognostic (1.59e-1)" 15.4 16.0 14.1 10.9 13.7 15.3 20.9 26.8 21.5 13.7 8.7 13.7 13.6 24.9 13.8 15.8 16.8 14.5 31.7 14.2 14.8 21.8 29.5 14.1 14.7 13.1 15.2 31.2 17.0 52.8 11.9 8.7 13.7 17.5 11.3 34.4 32.4 24.7 54.5 14.0 13.9 13.3 13.7 18.7 14.8 7.4 17.3 12.2 54.2 50.4 14.2 10.6 12.4 18.8 22.5 5.0 11.5 10.9 11.8 12.6 7.1 32.7 42.7 17.8 19.7 3.7 21.6 16.0 10.7 46.0 27.8 14.7 14.6 21.4 36.9 5.8 16.9 2.6 11.3 4.5 24.6 8.6 2.3 16.9 22.1 21.7 55.4 32.9 12.3 9.3 5.8 56.3 14.2 12.9 4.7 2.7 12.5 18.2 24.8 4.1 18.6 11.1 9.9 30.6 11.8 26.2 23.9 13.6 29.2 18.5 11.9 7.4 24.5 46.2 47.0 30.2 37.6 27.4 39.4 7.4 26.3 12.6 27.5 0.0 0.3 0.0 1.4 1.1 2.6 1.0 1.6 1.3 0.4 0.7 1.1 1.1 0.1 0.5 0.6 0.4 1.0 0.4 14.1 13.7 26.8 21.5 14.2 14.8 13.1 15.2 13.7 13.7 17.3 18.8 51.8 12.8 7.5 51.6 39.6 33.3 34.7 14.5 59.2 82.5 29.7 23.9 39.5 17.2 17.5 20.2 39.6 11.1 43.0 17.1 7.9 11.3 10.0 77.5 49.8 38.9 28.5 3.8 58.6 15.1 2.5 47.7 35.7 135.2 8.2 33.2 15.4 33.1 9.6 95.9 62.0 18.2 26.4 12.8 32.0 11.3 34.2 26.8 28.4 32.8 12.6 62.8 11.3 44.2 57.5 19.8 10.3 42.5 28.5 41.4 17.9 11.9 16.0 53.6 32.9 46.8 45.5 7.6 10.9 42.0 33.5 6.8 44.4 37.0 12.1 31.1 THRB "ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2" ENSG00000151090 "Thyroid hormone receptor beta" P10828 3 24117153-24495756 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Deafness, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 199.2;Cone photoreceptor cells: 164.7;Excitatory neurons: 688.0;Inhibitory neurons: 631.3;Oligodendrocyte precursor cells: 329.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "amygdala: 7.7;basal ganglia: 15.1;cerebral cortex: 17.6;hippocampal formation: 18.5;white matter: 6.7" "Group enriched" "Detected in some" 5 "basophil: 7.2;naive B-cell: 2.2" "Group enriched" "Detected in many" 15 "B-cells: 2.2;granulocytes: 7.2" "Cell line enhanced" "Detected in many" "K-562: 45.6;RT4: 32.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002008, CAB002009, HPA061035" Approved Supported "Nuclear bodies" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear bodies" "CAB002008: , CAB002009: , HPA061035: AB_2684422" "unprognostic (1.82e-1)" "unprognostic (4.22e-1)" "unprognostic (2.83e-1)" "unprognostic (2.20e-6)" "unprognostic (3.37e-1)" "unprognostic (2.66e-2)" "unprognostic (1.93e-2)" "unprognostic (1.73e-1)" "unprognostic (5.78e-3)" "unprognostic (2.95e-2)" "unprognostic (4.43e-1)" "unprognostic (2.01e-2)" "prognostic favorable (9.46e-8)" "unprognostic (1.32e-3)" "unprognostic (6.75e-2)" "unprognostic (2.73e-2)" "unprognostic (3.34e-2)" 11.1 4.9 7.7 1.7 15.1 1.0 10.0 0.0 17.6 2.8 0.0 11.7 2.5 7.0 1.8 6.4 3.8 2.2 7.7 18.5 2.0 12.1 20.1 5.0 1.5 0.0 0.0 2.3 9.0 7.3 15.7 4.4 0.0 7.5 8.4 20.1 6.2 7.7 23.6 6.8 3.9 7.0 0.0 5.7 8.3 0.7 1.4 3.6 4.4 27.0 1.4 8.9 4.2 6.7 10.3 3.1 0.6 0.1 17.4 8.8 6.7 0.5 2.1 1.5 3.2 6.7 9.7 0.1 2.5 6.8 1.1 15.4 10.8 3.9 1.0 0.0 6.4 0.0 2.5 8.9 0.5 0.0 0.0 16.0 7.3 0.2 1.2 3.5 0.0 0.0 45.6 0.0 1.5 0.6 0.0 0.0 6.5 0.6 3.4 0.0 0.0 0.0 10.0 32.7 1.7 0.6 16.5 8.9 0.2 4.6 9.7 0.0 0.9 3.9 3.0 0.0 1.9 0.1 0.5 0.0 2.7 0.1 0.3 7.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 2.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.2 7.7 15.1 0.0 17.6 18.5 2.0 0.0 0.0 0.0 0.0 1.4 6.7 3.0 3.2 11.4 199.2 3.3 9.9 29.5 13.2 1.8 17.9 24.5 18.7 11.6 8.6 14.1 23.9 164.7 12.4 0.0 39.9 1.9 2.4 2.3 3.4 0.5 6.0 25.2 3.8 688.0 12.5 23.2 13.7 16.3 5.7 0.0 0.3 7.5 37.7 1.7 0.0 631.3 8.1 10.2 11.3 11.7 2.4 0.6 4.6 1.8 97.4 0.2 11.7 0.0 329.2 32.4 10.3 17.5 2.2 0.1 40.1 4.8 8.1 10.3 21.8 6.6 12.0 7.5 0.3 0.7 5.1 23.9 5.5 1.0 0.4 9.8 81.3 RARB "HAP, NR1B2, RRB2" ENSG00000077092 "Retinoic acid receptor beta" P10826 3 25174332-25597932 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Disease variant, FDA approved drug targets, Microphthalmia, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 41.4;Excitatory neurons: 66.8;Inhibitory neurons: 92.6;Microglial cells: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 13.7;HEK 293: 16.0;hTERT-RPE1: 82.3;WM-115: 36.5" "Region enriched" "Detected in all" 9 "basal ganglia: 109.2" "CAB002617, HPA004174" Enhanced Enhanced Nucleoplasm NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "CAB002617: , HPA004174: AB_1079744" "unprognostic (2.04e-2)" "unprognostic (3.53e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (2.70e-2)" "unprognostic (2.43e-1)" "unprognostic (4.71e-2)" "unprognostic (1.62e-1)" "unprognostic (2.86e-1)" "prognostic favorable (3.43e-5)" "unprognostic (9.24e-3)" "unprognostic (2.28e-1)" "unprognostic (9.99e-2)" "unprognostic (6.56e-3)" 4.1 7.0 3.5 2.6 15.0 0.0 6.9 2.2 6.6 9.3 7.2 6.0 1.7 7.4 6.7 7.9 6.0 5.3 14.0 3.5 1.4 15.1 6.5 5.3 6.7 3.4 1.7 11.5 1.3 6.0 7.5 14.4 0.9 12.5 2.2 13.6 13.1 11.2 2.4 1.1 2.0 5.9 1.4 4.9 3.9 0.6 2.4 1.2 9.1 5.3 4.2 7.2 6.1 3.7 0.0 1.9 1.2 6.4 13.7 3.6 0.0 1.6 0.8 0.0 0.6 0.3 0.1 0.1 0.2 2.5 0.3 0.4 0.0 0.3 0.0 0.1 16.0 0.1 0.1 1.1 0.3 0.2 0.1 7.1 0.0 0.0 0.0 82.3 13.4 0.1 0.1 5.6 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.6 8.3 0.0 0.2 0.1 9.1 0.0 0.1 0.0 1.1 0.1 2.1 7.0 0.2 0.0 0.1 5.6 0.2 36.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 15.0 2.2 6.6 3.5 1.4 3.4 1.7 0.9 1.4 2.4 3.7 2.4 0.0 0.5 41.4 0.3 0.1 18.0 6.4 1.8 4.5 1.7 7.5 12.0 12.8 14.9 11.0 25.0 0.2 0.8 0.0 0.0 1.6 1.5 8.3 4.2 10.5 0.0 0.0 66.8 0.9 0.1 6.8 7.7 3.0 0.0 0.1 22.1 2.1 0.4 5.0 92.6 0.0 2.0 1.9 0.4 1.2 0.0 0.3 0.0 29.0 0.0 24.8 0.0 19.6 2.9 1.4 0.0 0.0 0.2 10.2 0.6 0.6 9.2 6.3 0.0 2.9 9.7 0.2 1.0 6.6 0.1 0.3 0.5 0.2 0.2 9.7 TOP2B ENSG00000077097 "DNA topoisomerase II beta" Q02880 3 25597905-25664907 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA-binding, Isomerase, Topoisomerase" "Autism spectrum disorder, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 569.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004601, HPA024120, HPA050441" Supported Enhanced Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127" "unprognostic (2.90e-2)" "unprognostic (5.17e-2)" "unprognostic (7.21e-3)" "unprognostic (2.42e-1)" "unprognostic (1.60e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.86e-7)" "unprognostic (7.86e-2)" "unprognostic (1.89e-1)" "unprognostic (2.84e-1)" "unprognostic (7.14e-2)" "unprognostic (1.08e-1)" "prognostic favorable (2.43e-4)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" "unprognostic (1.49e-1)" "unprognostic (7.93e-2)" 27.1 25.5 15.3 38.9 17.6 49.1 34.7 25.2 16.5 36.2 12.0 30.1 28.8 42.9 25.5 34.1 29.7 26.2 38.5 15.3 16.0 32.1 27.7 28.0 50.4 13.5 16.2 40.6 28.8 53.2 11.7 34.4 15.1 38.7 33.3 112.3 27.1 34.2 29.9 32.4 28.6 34.2 16.4 36.4 32.1 19.5 14.6 82.5 45.8 36.7 46.6 43.7 18.5 25.3 57.6 58.6 125.9 155.3 41.1 51.7 50.1 54.4 69.6 49.4 53.9 30.1 44.6 176.9 37.1 79.2 30.5 47.7 105.6 60.5 82.5 85.5 56.7 268.5 71.2 50.6 28.9 212.8 137.4 37.1 29.7 55.3 48.2 49.8 81.7 118.6 92.0 84.3 64.4 64.0 138.5 52.5 95.9 38.5 44.1 569.9 71.0 82.6 43.9 199.5 63.2 109.7 81.1 57.4 49.9 72.2 59.7 187.1 78.7 68.3 52.6 55.2 58.9 129.6 78.6 185.1 44.9 155.6 46.5 3.2 1.4 2.8 3.0 1.7 3.3 2.0 2.9 3.1 2.2 2.5 3.3 3.0 1.0 3.9 2.6 2.8 2.3 1.1 15.3 17.6 25.2 16.5 15.3 16.0 13.5 16.2 15.1 16.4 14.6 25.3 36.4 64.1 62.7 65.3 47.3 39.1 47.9 30.9 31.3 62.4 44.4 31.9 121.5 34.3 36.1 25.8 56.3 47.8 65.8 29.9 13.7 34.3 3.6 48.0 58.8 36.6 59.3 65.6 77.8 33.4 24.5 40.2 28.5 45.1 34.1 71.4 25.0 35.1 26.2 60.6 89.8 32.3 20.3 40.7 50.1 6.0 39.1 45.3 23.2 43.1 49.8 51.3 68.0 76.4 113.0 35.5 22.2 33.4 46.0 56.2 20.6 25.6 39.2 95.7 32.9 56.5 51.0 94.9 44.0 57.9 37.6 46.7 53.7 48.4 39.2 64.3 NGLY1 "FLJ11005, PNG-1, PNG1" ENSG00000151092 "N-glycanase 1" Q96IV0 3 25718944-25790039 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 594.1;Late spermatids: 963.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036825 Approved "Intracellular and membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "HPA036825: AB_10672231" "unprognostic (3.65e-2)" "unprognostic (8.65e-2)" "prognostic favorable (1.17e-5)" "unprognostic (2.96e-2)" "unprognostic (1.72e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (1.96e-6)" "unprognostic (2.20e-1)" "unprognostic (2.34e-1)" "unprognostic (3.73e-3)" "unprognostic (2.55e-1)" "unprognostic (4.23e-2)" "unprognostic (4.92e-3)" "unprognostic (1.07e-2)" "unprognostic (2.47e-1)" "unprognostic (9.08e-2)" "unprognostic (1.89e-2)" 10.8 13.7 6.9 15.1 7.1 25.6 15.6 10.0 9.2 12.3 10.5 17.9 14.6 9.7 16.2 12.3 11.5 9.8 16.1 7.5 8.0 17.8 22.4 11.4 25.9 8.1 9.2 11.8 15.9 11.6 5.9 11.9 8.2 14.2 20.6 13.5 14.9 9.9 49.5 9.8 15.4 12.1 6.7 15.5 15.3 55.8 9.1 27.4 13.6 38.1 25.3 16.1 9.9 8.6 27.6 24.2 12.8 27.4 23.5 22.7 15.0 21.6 20.4 29.7 25.5 14.8 20.9 64.3 24.5 19.9 28.3 12.1 45.5 14.0 39.2 27.8 18.5 49.9 15.1 24.8 29.0 48.3 25.7 20.3 17.5 33.6 31.5 32.2 31.3 32.8 47.9 49.1 30.3 11.7 60.7 26.8 17.4 33.2 43.5 54.2 16.5 54.6 27.1 31.1 8.3 9.5 35.1 33.3 23.3 24.0 31.1 40.6 15.7 15.5 20.1 27.5 29.9 60.4 60.7 48.8 25.1 52.8 18.1 48.8 19.7 27.8 22.9 19.4 26.0 42.2 23.2 23.5 31.6 33.4 21.8 23.6 18.3 45.0 16.0 65.1 19.0 20.7 6.9 7.1 10.0 9.2 7.5 8.0 8.1 9.2 8.2 6.7 9.1 8.6 24.3 19.2 17.3 34.0 84.1 12.6 23.7 25.0 16.5 22.3 19.8 16.8 30.3 27.1 21.4 5.5 12.5 40.5 74.7 25.0 35.2 30.6 594.1 20.0 19.4 20.9 7.2 26.9 51.7 44.2 31.7 19.2 17.3 19.2 20.8 77.7 17.5 25.1 23.4 11.8 64.2 29.3 14.2 22.2 63.6 963.6 14.9 33.6 24.9 31.9 30.0 20.7 45.3 54.3 59.4 27.2 27.3 15.8 87.1 27.8 26.0 38.2 25.2 22.7 0.0 26.0 17.9 105.7 52.7 18.8 13.8 56.6 41.1 26.3 30.3 20.6 OXSM "CEM1, FASN2D, FLJ20604, KS" ENSG00000151093 "3-oxoacyl-ACP synthase, mitochondrial" Q9NWU1 3 25782917-25794534 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 59.5;Spermatocytes: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021293, HPA021300, HPA021337" Enhanced Approved Mitochondria,Cytosol No No "Cluster 24: B-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Mitochondria, Cytosol" "HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776" "unprognostic (2.20e-2)" "unprognostic (3.28e-1)" "prognostic favorable (1.35e-4)" "prognostic favorable (5.51e-4)" "unprognostic (1.01e-1)" "unprognostic (8.17e-2)" "unprognostic (2.15e-3)" "unprognostic (1.41e-1)" "unprognostic (1.76e-1)" "unprognostic (2.83e-2)" "unprognostic (3.06e-2)" "unprognostic (1.20e-1)" "prognostic favorable (4.18e-9)" "unprognostic (1.79e-2)" "unprognostic (2.42e-1)" "unprognostic (3.10e-1)" "unprognostic (1.73e-2)" 6.1 11.0 3.1 5.5 3.4 4.0 9.3 3.5 4.6 4.9 5.3 11.1 9.4 4.6 13.9 8.5 6.8 3.9 12.9 3.3 3.6 13.7 22.0 4.9 7.9 3.3 3.3 4.9 10.5 10.0 5.8 5.9 3.4 5.9 12.3 10.2 10.1 5.9 14.6 7.7 7.8 5.2 3.5 7.9 8.2 11.7 3.5 7.1 8.6 15.6 8.8 5.5 5.3 3.4 11.0 18.1 3.8 10.5 10.7 11.6 10.9 8.6 12.4 15.8 11.2 13.8 12.9 20.4 11.5 8.0 9.2 11.3 15.7 16.6 14.9 12.3 16.0 22.5 15.2 16.9 13.1 18.4 13.7 11.0 20.4 12.7 13.3 10.3 13.8 18.9 23.5 16.0 13.7 16.6 13.6 14.4 0.7 8.8 20.6 17.8 9.9 33.7 23.3 6.8 5.4 9.7 13.8 23.6 18.3 6.0 25.5 16.9 8.5 10.0 11.9 13.1 12.7 15.1 18.8 6.6 13.9 16.0 10.4 2.1 5.1 3.7 8.6 6.0 10.1 7.9 8.8 10.8 8.4 8.9 10.2 10.7 0.8 11.4 6.8 8.8 6.0 6.3 3.1 3.4 3.5 4.6 3.3 3.6 3.3 3.3 3.4 3.5 3.5 3.4 5.9 0.0 9.4 3.9 9.3 3.1 5.9 23.0 4.0 6.5 8.7 13.2 13.3 10.0 12.0 11.0 4.2 19.5 7.1 5.4 11.7 13.5 59.5 7.8 7.2 4.9 2.4 2.1 4.5 6.8 16.9 5.9 4.6 6.4 10.1 13.0 7.5 17.4 8.5 5.0 5.1 9.8 14.2 3.8 3.2 15.1 7.2 6.8 5.4 1.0 5.2 9.1 6.2 3.5 3.8 7.5 8.9 4.1 7.8 6.5 10.6 18.4 9.2 7.4 0.0 5.3 5.8 48.0 12.6 7.2 4.4 14.1 5.9 19.2 8.8 3.6 LRRC3B LRP15 ENSG00000179796 "Leucine rich repeat containing 3B" Q96PB8 3 26622806-26717537 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 28.0;choroid plexus: 8.7;skeletal muscle: 9.5" "Cell type enhanced" "Detected in some" "Astrocytes: 256.9;Early spermatids: 115.3;Inhibitory neurons: 50.0;Oligodendrocyte precursor cells: 38.2" "Group enriched" "Detected in some" 9 "endometrial cancer: 0.7;glioma: 2.6;ovarian cancer: 1.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.5;SuSa: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA015568 Approved NA NA "Cluster 70: Brain - Nervous system development" "Cluster 5: NTERA-2 - Transcription" "Cluster 64: Astrocytes - Nervous system maintenance" "HPA015568: AB_1853282" "unprognostic (1.22e-2)" "unprognostic (2.94e-1)" "unprognostic (1.87e-1)" "unprognostic (7.42e-2)" "unprognostic (8.82e-4)" "unprognostic (2.84e-2)" "unprognostic (1.55e-1)" "unprognostic (2.77e-1)" "unprognostic (1.91e-4)" "unprognostic (3.31e-2)" "unprognostic (2.63e-1)" "unprognostic (1.60e-1)" "unprognostic (2.82e-1)" 0.3 0.1 18.7 0.0 21.2 0.0 0.4 28.0 24.4 0.3 8.7 0.5 0.0 0.7 0.0 0.4 0.4 0.0 0.3 23.1 16.2 0.1 0.1 0.0 0.0 17.9 18.4 1.5 0.0 0.0 1.5 0.0 17.6 0.1 0.5 1.1 0.4 0.1 9.5 0.1 0.2 0.4 20.7 0.1 0.5 7.2 18.9 0.7 0.1 0.2 0.0 4.8 0.2 16.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 21.2 28.0 24.4 23.1 16.2 17.9 18.4 17.6 20.7 18.9 16.1 0.8 0.0 0.0 256.9 0.0 0.1 0.0 0.0 0.0 1.6 1.2 4.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 115.3 0.2 3.2 0.3 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 50.0 0.0 0.0 0.0 0.0 11.6 0.6 0.1 0.0 9.4 0.0 0.8 0.0 38.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 4.6 0.0 1.6 0.6 0.0 0.1 0.0 0.1 0.1 0.0 0.1 NEK10 FLJ32685 ENSG00000163491 "NIMA related kinase 10" Q6ZWH5 3 27110085-27369460 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Ciliopathy, Disease variant, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 36.6;tongue: 20.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 87.6;Early spermatids: 123.5;Endometrial ciliated cells: 59.3;Excitatory neurons: 131.4;Inhibitory neurons: 130.2;Late spermatids: 61.7;Respiratory ciliated cells: 104.2" "Cancer enriched" "Detected in single" 5 "breast cancer: 1.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 6.0;LHCN-M2: 8.2;U-2 OS: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA038941 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" Vesicles Nucleoplasm "HPA038941: AB_10673600" "prognostic favorable (4.20e-4)" "unprognostic (2.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.15e-2)" "unprognostic (3.37e-2)" "unprognostic (3.02e-1)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-2)" "unprognostic (2.20e-3)" "unprognostic (1.37e-1)" "unprognostic (7.67e-2)" "unprognostic (1.33e-2)" "unprognostic (1.38e-2)" "unprognostic (1.57e-3)" "unprognostic (2.14e-1)" 0.2 0.3 3.0 0.3 5.3 0.3 14.0 0.0 9.4 1.4 3.3 2.0 2.5 0.8 8.3 1.8 11.0 1.4 3.3 9.6 5.0 1.7 2.5 2.4 0.5 3.3 5.7 0.7 0.7 0.4 3.4 0.1 2.7 1.7 0.5 6.2 0.3 1.2 12.4 0.3 0.8 0.3 2.3 0.4 1.0 36.6 6.1 0.5 0.7 20.0 0.6 1.2 0.2 0.9 0.8 1.6 0.8 0.9 0.6 1.5 0.3 6.0 0.9 1.6 1.4 0.0 0.4 0.5 1.4 2.5 1.1 0.1 0.4 0.4 1.7 1.1 0.6 0.1 3.4 2.9 0.1 0.3 0.8 1.8 0.4 2.5 0.1 2.0 1.1 3.4 0.1 0.6 8.2 0.1 0.6 0.4 0.5 0.2 0.2 0.8 0.3 0.2 3.0 0.5 0.1 0.2 0.9 0.3 0.4 0.5 4.8 0.3 0.7 4.3 6.8 0.2 0.6 0.2 0.2 0.4 3.6 0.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 5.3 0.0 9.4 9.6 5.0 3.3 5.7 2.7 2.3 6.1 0.9 1.5 6.4 0.0 11.4 0.3 0.3 0.3 3.2 0.0 14.5 25.8 7.4 12.9 4.3 9.3 1.8 87.6 0.0 0.8 0.2 0.0 0.4 123.5 59.3 1.3 2.4 0.0 0.0 131.4 0.0 0.3 3.1 0.0 7.7 0.0 1.1 0.7 1.3 0.2 0.0 130.2 0.4 12.2 1.0 0.8 61.7 1.8 1.1 0.0 32.8 0.1 1.0 1.0 20.6 12.9 0.2 2.7 1.2 0.1 1.9 2.1 0.3 104.2 19.1 0.0 14.9 2.4 32.2 2.2 0.1 0.4 0.0 1.1 3.7 0.6 0.4 SLC4A7 "NBC3, SBC2, SLC4A6" ENSG00000033867 "Solute carrier family 4 member 7" Q9Y6M7 3 27372721-27484420 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 57.6;retina: 72.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 733.9;Rod photoreceptor cells: 704.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "hTERT-HME1: 78.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022494, HPA035857" Enhanced Supported "Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane" "Focal adhesion sites, Cytosol" "CAB022494: , HPA035857: AB_10795135" "unprognostic (2.94e-2)" "unprognostic (6.34e-2)" "unprognostic (1.80e-3)" "unprognostic (1.91e-1)" "unprognostic (8.48e-3)" "unprognostic (2.68e-1)" "unprognostic (6.79e-4)" "unprognostic (4.13e-2)" "unprognostic (1.40e-1)" "unprognostic (1.64e-1)" "unprognostic (1.83e-1)" "unprognostic (8.58e-3)" "prognostic unfavorable (7.91e-6)" "unprognostic (1.09e-2)" "unprognostic (6.68e-2)" "unprognostic (1.93e-1)" "unprognostic (7.26e-2)" 8.6 5.1 3.2 9.0 5.2 4.0 18.7 3.4 16.9 10.5 1.6 16.2 57.6 6.4 8.2 8.6 6.0 13.7 7.8 19.3 2.5 12.7 3.9 8.3 11.2 0.5 3.2 6.8 3.4 1.7 3.4 5.8 0.6 7.9 7.4 72.9 5.8 8.7 5.0 4.6 17.4 6.6 1.8 7.0 6.0 7.1 4.4 5.8 4.9 27.2 10.3 12.1 8.8 2.6 13.0 23.8 21.0 9.8 9.6 17.2 15.0 43.3 20.0 16.3 12.6 6.5 6.6 29.4 3.6 16.8 15.7 5.5 20.2 21.1 25.7 25.1 6.6 13.5 15.4 7.1 16.5 30.9 11.3 13.7 9.0 24.8 78.9 34.2 27.1 19.0 9.1 10.1 33.8 4.7 31.1 7.2 13.8 1.6 23.4 21.0 16.7 5.9 38.1 9.2 5.3 13.1 19.7 14.4 6.9 17.9 32.9 11.8 19.0 38.2 10.6 26.7 33.7 3.8 4.3 16.6 33.3 21.4 17.8 0.0 0.2 0.0 1.0 0.2 0.7 0.4 1.3 1.4 0.5 0.5 0.5 0.9 0.0 1.0 0.3 0.7 1.2 0.3 3.2 5.2 3.4 16.9 19.3 2.5 0.5 3.2 0.6 1.8 4.4 2.6 30.0 0.0 11.2 10.7 37.5 29.3 39.5 23.4 11.4 130.2 72.4 30.4 23.1 21.5 22.8 62.5 733.9 5.8 51.8 5.5 9.8 15.5 10.2 73.6 40.7 53.6 38.2 7.2 46.2 7.1 29.3 52.2 15.8 124.1 23.5 24.6 17.5 6.2 17.0 6.7 88.7 58.5 36.7 48.4 61.6 7.6 9.0 46.5 35.6 185.5 26.7 45.7 20.6 60.8 20.9 19.1 23.4 9.8 27.8 93.1 142.5 10.2 9.6 704.2 39.5 56.4 43.7 40.0 21.7 21.7 30.7 8.1 56.1 19.0 26.7 35.2 EOMES TBR2 ENSG00000163508 Eomesodermin O95936 3 27715949-27722711 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 8.4;lymphoid tissue: 15.0" "Cell type enhanced" "Detected in some" "dendritic cells: 43.6;Erythroid cells: 16.8;NK-cells: 93.7;T-cells: 31.5" "Cancer enhanced" "Detected in many" "testis cancer: 5.8" "Region enriched" "Detected in single" 13 "cerebellum: 8.4" "Group enriched" "Detected in many" 7 "gdT-cell: 16.5;MAIT T-cell: 26.2;memory CD8 T-cell: 19.5;naive CD8 T-cell: 11.9;NK-cell: 33.0" "Group enriched" "Detected in many" 107 "NK-cells: 33.0;T-cells: 26.2" "Cell line enhanced" "Detected in some" "HDLM-2: 7.4;JURKAT: 8.3;SCLC-21H: 3.9" "Region enriched" "Detected in many" 8 "olfactory bulb: 77.5" "Group enriched" "Detected in some" 27 "cerebellum: 30.2;olfactory bulb: 12.7" HPA028896 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Golgi apparatus, Cytosol" "HPA028896: AB_10601370" "unprognostic (1.53e-4)" "unprognostic (5.95e-3)" "unprognostic (3.01e-2)" "unprognostic (1.60e-4)" "unprognostic (4.13e-2)" "unprognostic (9.63e-4)" "unprognostic (4.29e-4)" "unprognostic (3.14e-3)" "unprognostic (1.24e-1)" "unprognostic (2.82e-2)" "unprognostic (9.96e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (9.45e-6)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (6.32e-3)" "unprognostic (1.49e-2)" 1.0 0.6 0.2 3.2 0.1 1.8 0.6 8.4 0.4 0.4 0.4 0.7 0.4 0.8 0.8 0.3 0.4 1.6 0.3 0.2 0.3 0.4 2.4 2.2 15.0 0.2 0.3 0.5 0.3 0.1 0.2 0.4 0.6 0.5 0.8 1.6 0.9 0.1 0.1 0.2 1.4 0.4 0.3 12.8 1.3 0.4 0.2 1.5 0.5 0.1 5.4 1.3 0.4 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.6 1.3 0.0 7.4 1.1 0.0 0.0 0.5 0.0 0.9 0.0 0.0 0.8 0.0 0.9 0.3 0.0 8.3 0.2 0.0 0.0 2.0 2.0 0.0 0.2 0.2 0.9 1.3 0.0 0.0 0.6 0.0 3.9 0.0 0.0 0.0 0.9 0.3 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 16.5 0.0 26.2 0.0 3.0 19.5 0.0 0.0 0.2 11.9 0.2 33.0 0.1 0.1 0.0 2.9 0.2 0.1 8.4 0.4 0.2 0.3 0.2 0.3 0.6 0.3 0.2 0.4 0.3 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.4 0.2 0.3 0.8 1.5 0.0 0.0 0.0 0.0 43.6 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 16.8 0.0 0.0 0.0 0.3 0.5 0.1 0.0 0.0 2.2 1.6 0.2 0.0 0.0 0.0 0.0 3.1 0.7 0.0 0.3 1.3 1.8 1.0 1.1 0.1 93.7 0.0 0.0 0.0 0.0 0.4 9.8 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.7 0.0 2.0 0.0 0.1 0.0 31.5 0.0 0.0 0.0 CMC1 "C3orf68, MGC61571" ENSG00000187118 "C-X9-C motif containing 1" Q7Z7K0 3 28241584-28325142 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 418.8;NK-cells: 694.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "NK-cell: 162.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043333 Approved NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 63: NK-cells & T-cells - Immune response" "HPA043333: AB_10797139" "unprognostic (1.16e-1)" "unprognostic (8.01e-3)" "unprognostic (6.90e-3)" "unprognostic (8.88e-2)" "unprognostic (1.83e-1)" "unprognostic (1.02e-1)" "unprognostic (3.81e-2)" "unprognostic (3.64e-1)" "unprognostic (1.26e-1)" "unprognostic (3.80e-3)" "unprognostic (3.09e-1)" "unprognostic (2.30e-2)" "prognostic favorable (6.81e-4)" "unprognostic (3.54e-1)" "unprognostic (8.12e-2)" "unprognostic (4.55e-1)" "prognostic favorable (5.52e-4)" 15.9 18.7 9.4 4.8 9.4 4.9 11.8 9.6 14.3 10.6 9.7 14.7 7.6 10.1 5.3 11.9 11.4 4.0 34.6 9.1 9.8 24.2 24.8 11.5 4.3 9.4 9.4 10.5 11.8 5.0 16.9 6.5 9.6 11.4 4.0 3.2 9.3 4.5 24.8 9.1 9.9 3.4 9.3 12.3 14.7 4.2 9.6 4.1 9.6 13.7 2.9 12.2 11.4 9.5 15.2 24.7 6.8 7.1 18.5 18.5 17.4 20.0 6.1 8.5 8.5 7.3 21.0 13.5 24.8 3.3 14.2 7.1 8.7 18.7 5.1 30.4 21.9 14.5 22.1 16.2 19.1 9.3 10.9 9.9 13.8 8.6 10.8 19.2 10.7 34.0 14.2 19.3 6.9 13.7 13.6 25.1 7.9 15.2 27.0 12.7 7.9 11.0 10.9 6.7 6.7 12.5 14.7 9.1 44.9 9.4 18.8 27.4 12.9 9.1 11.2 13.8 13.1 8.9 22.0 19.7 24.1 20.5 19.2 24.2 21.9 17.1 40.2 28.9 57.7 18.4 25.4 69.6 29.9 17.1 18.8 41.9 6.7 162.2 32.9 30.4 27.2 29.4 9.4 9.4 9.6 14.3 9.1 9.8 9.4 9.4 9.6 9.3 9.6 9.5 51.5 38.5 33.0 26.4 28.3 21.2 38.0 68.6 23.9 16.2 40.0 53.5 202.8 30.0 42.3 31.3 10.4 68.4 418.8 68.2 221.1 61.3 226.4 67.2 38.5 42.1 28.2 128.6 51.5 58.6 42.4 39.4 24.5 42.5 36.7 25.9 50.3 88.7 64.5 3.3 61.2 71.7 67.1 61.7 26.2 31.1 49.4 36.4 30.2 41.2 53.8 37.4 694.1 53.8 63.3 66.1 71.3 39.1 32.7 42.9 56.2 134.4 56.0 25.4 39.5 31.2 71.6 26.3 49.3 28.6 32.8 31.5 222.5 58.2 67.9 42.2 AZI2 "AZ2, FLJ21939, NAP1" ENSG00000163512 "5-azacytidine induced 2" Q9H6S1 3 28315003-28349050 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035258 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" "HPA035258: AB_10602329" "unprognostic (1.86e-2)" "unprognostic (2.17e-2)" "unprognostic (2.11e-3)" "unprognostic (1.05e-1)" "unprognostic (2.38e-1)" "unprognostic (3.60e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (3.76e-2)" "unprognostic (1.44e-1)" "unprognostic (7.48e-3)" "unprognostic (2.72e-1)" "unprognostic (1.17e-1)" "unprognostic (3.30e-3)" "unprognostic (1.66e-1)" "unprognostic (3.34e-1)" "unprognostic (2.92e-3)" "prognostic unfavorable (2.77e-4)" 27.1 11.6 17.1 9.1 17.4 20.8 12.7 17.5 19.8 12.5 18.4 10.4 12.0 12.0 10.7 9.7 10.6 13.1 14.7 16.2 19.0 14.9 11.3 12.5 9.9 17.1 17.2 13.1 11.2 12.8 13.9 12.3 17.6 12.4 9.8 13.6 17.8 10.5 14.1 9.8 11.3 11.8 16.3 10.0 10.9 16.5 18.8 14.0 14.0 12.0 8.6 11.7 8.6 17.8 20.5 20.6 27.4 16.4 43.0 69.0 40.3 25.5 52.6 44.3 52.7 18.3 20.2 12.6 15.5 36.0 29.7 8.4 21.2 42.4 35.9 34.2 23.7 23.8 20.6 25.4 64.4 24.6 14.5 69.9 57.1 35.7 61.9 28.9 24.6 26.6 36.0 22.9 41.1 19.4 31.3 19.4 19.1 13.5 30.0 14.6 29.5 13.0 19.3 11.5 14.6 35.8 22.3 25.6 52.3 24.7 17.7 25.6 17.0 29.4 24.2 24.9 31.3 26.5 27.6 18.3 31.1 51.4 27.2 74.7 37.8 26.3 13.3 31.2 16.1 6.3 12.6 15.5 16.7 8.4 12.0 11.0 10.4 11.0 28.1 13.5 18.9 19.1 17.1 17.4 17.5 19.8 16.2 19.0 17.1 17.2 17.6 16.3 18.8 17.8 31.6 64.1 49.5 21.9 17.0 24.9 34.4 53.6 34.7 29.3 33.0 28.6 23.1 24.3 46.9 23.9 37.5 32.4 34.9 33.1 45.0 26.4 26.9 49.0 46.8 28.1 26.9 31.8 28.2 28.2 57.0 55.6 16.8 30.2 19.6 27.5 32.9 38.3 33.7 15.2 43.6 29.0 38.7 63.0 11.0 28.1 46.9 57.6 8.8 16.9 61.8 30.5 22.6 32.6 32.6 30.5 28.8 41.0 32.8 28.8 34.8 50.0 57.9 30.9 46.0 44.4 34.6 68.0 61.3 32.0 34.7 62.7 28.7 32.0 24.5 28.3 ZCWPW2 ZCW2 ENSG00000206559 "Zinc finger CW-type and PWWP domain containing 2" Q504Y3 3 28348721-28538122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 9.9" "Cell type enhanced" "Detected in many" "Astrocytes: 35.6;Early spermatids: 95.0;Excitatory neurons: 33.7;Inhibitory neurons: 34.9;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 31.7;Spermatocytes: 68.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035035, HPA039839" Uncertain Approved "Nuclear speckles" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" "HPA035035: AB_10602256, HPA039839: AB_2676708" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.34e-1)" "unprognostic (2.41e-1)" "unprognostic (4.59e-3)" "unprognostic (6.53e-2)" "unprognostic (6.09e-4)" "unprognostic (3.21e-1)" "unprognostic (2.70e-2)" "unprognostic (1.73e-3)" "unprognostic (1.12e-1)" "unprognostic (1.10e-4)" "unprognostic (1.06e-2)" "unprognostic (7.88e-2)" "unprognostic (1.40e-2)" "unprognostic (2.38e-2)" 1.5 1.7 1.8 0.9 1.5 0.8 1.8 1.6 1.9 1.4 0.2 1.4 1.2 2.1 2.1 1.3 1.0 2.0 2.7 1.7 1.1 1.6 1.2 1.3 1.2 0.8 1.0 2.4 1.9 1.5 1.2 1.2 1.0 2.2 1.1 1.6 2.3 1.1 6.2 1.9 0.9 1.0 0.8 1.1 1.8 9.9 1.2 0.6 2.5 4.5 1.0 0.8 0.8 1.6 0.3 0.2 0.8 0.3 1.2 2.8 1.2 1.1 0.8 0.3 0.3 0.2 0.9 0.7 0.5 0.6 0.8 0.4 0.2 0.2 0.3 0.4 0.4 0.3 1.1 0.3 0.6 0.5 0.6 1.2 0.5 0.3 0.5 1.3 0.5 1.5 0.3 1.0 1.5 0.3 0.2 0.6 0.3 0.1 1.1 0.3 0.3 0.6 1.2 0.1 0.3 0.9 0.2 0.4 0.7 0.8 0.4 2.6 1.0 0.8 0.4 0.7 0.6 0.3 0.2 0.3 2.8 0.5 1.0 1.0 0.7 1.1 0.3 0.7 0.2 0.1 0.3 0.2 0.3 0.2 0.5 0.7 1.0 0.2 0.2 0.4 0.3 0.2 1.8 1.5 1.6 1.9 1.7 1.1 0.8 1.0 1.0 0.8 1.2 1.6 1.6 0.0 2.0 35.6 0.4 0.6 2.7 3.7 1.2 3.0 1.6 2.7 13.6 0.0 4.3 0.0 0.0 2.4 0.1 0.4 5.9 0.5 95.0 1.2 1.2 1.0 1.2 0.0 33.7 0.9 1.4 4.3 0.0 0.6 2.5 0.8 1.4 0.5 1.3 3.3 34.9 1.9 8.2 0.6 0.7 17.7 4.7 1.3 0.0 13.1 0.7 3.7 1.0 32.2 31.7 0.6 0.3 4.9 0.3 1.1 0.6 2.6 1.7 2.0 0.0 4.4 4.5 68.7 5.8 1.1 1.6 1.2 0.6 1.3 0.7 1.3 RBMS3 ENSG00000144642 "RNA binding motif single stranded interacting protein 3" Q6XE24 3 28574791-30010391 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 331.1;Inhibitory neurons: 655.9;Microglial cells: 1013.7;Oligodendrocyte precursor cells: 229.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 5.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 9 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 9 "dendritic cells: 3.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 20.7;WM-115: 24.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034719 Uncertain Approved Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA034719: AB_10670172" "unprognostic (8.39e-2)" "unprognostic (2.54e-2)" "unprognostic (1.02e-1)" "unprognostic (7.08e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-1)" "unprognostic (3.13e-2)" "unprognostic (4.95e-2)" "unprognostic (1.08e-1)" "unprognostic (3.90e-2)" "unprognostic (1.90e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (1.85e-4)" "unprognostic (2.25e-3)" "unprognostic (3.81e-2)" "unprognostic (8.48e-2)" "unprognostic (3.24e-4)" 15.8 8.6 6.5 2.1 7.2 0.1 12.2 9.5 5.8 9.9 12.0 8.1 1.4 6.2 6.7 3.1 9.8 6.7 14.3 2.1 21.4 5.1 3.7 12.6 2.7 12.6 15.7 11.6 2.0 4.9 3.2 10.4 9.0 6.4 2.6 0.4 4.7 8.7 6.4 3.8 4.0 4.5 6.3 6.6 4.3 2.2 11.1 5.5 15.3 10.8 1.7 8.1 7.3 2.6 2.2 0.2 10.2 0.1 19.6 12.5 0.0 5.7 3.6 5.9 6.8 0.0 0.4 0.0 6.1 20.7 1.8 0.2 0.5 3.8 10.9 0.0 1.1 5.9 8.7 0.0 19.9 0.1 0.0 11.8 2.6 10.5 12.3 8.4 7.9 0.0 0.0 0.0 7.4 0.0 0.1 0.0 0.3 0.0 0.4 0.4 7.5 0.0 2.2 0.0 0.0 19.4 13.7 0.0 0.7 4.6 0.0 0.0 17.1 11.1 11.6 13.5 11.7 0.0 0.0 0.8 1.5 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.9 0.3 0.0 6.5 7.2 9.5 5.8 2.1 21.4 12.6 15.7 9.0 6.3 11.1 2.6 100.9 118.6 18.8 331.1 0.6 8.3 25.5 23.0 2.2 0.4 2.7 19.8 16.2 31.5 21.3 9.2 0.0 16.4 5.9 0.0 0.0 5.3 35.1 2.8 7.0 54.4 0.0 0.0 20.7 1.2 3.0 96.8 2.0 4.6 5.1 19.8 129.9 1.9 2.8 0.0 655.9 0.0 6.1 30.3 14.1 18.8 159.7 2.7 7.2 1013.7 0.6 0.0 0.0 229.2 8.9 0.4 0.0 110.6 0.1 24.3 0.0 2.9 10.5 0.0 111.7 154.6 73.5 1.2 1.5 2.4 7.2 9.6 2.9 22.4 0.0 4.7 TGFBR2 "MFS2, TBR-ii, TBRII" ENSG00000163513 "Transforming growth factor beta receptor 2" P37173 3 30606601-30694142 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Apoptosis, Differentiation, Growth regulation" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 391.5;Endothelial cells: 236.4;Hepatic stellate cells: 478.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 313.6;ASC TERT1: 472.3;HSkMC: 430.0;LHCN-M2: 381.7;TIME: 418.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB073537 Supported "Plasma membrane" NA NA 810000 "Cluster 5: Granulocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" "CAB073537: " "unprognostic (1.74e-1)" "unprognostic (1.84e-2)" "unprognostic (3.70e-1)" "unprognostic (3.02e-2)" "unprognostic (1.92e-1)" "unprognostic (2.26e-1)" "unprognostic (1.96e-1)" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (2.24e-2)" "unprognostic (7.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.65e-2)" "unprognostic (4.72e-2)" "unprognostic (1.81e-2)" "unprognostic (8.81e-2)" "unprognostic (8.02e-2)" 230.0 56.1 16.5 73.8 12.9 29.4 145.7 13.8 19.3 90.0 30.6 96.0 44.2 69.1 18.2 44.9 69.6 91.9 95.2 10.6 13.4 67.9 59.1 148.0 70.1 17.6 16.5 26.6 52.0 59.0 16.9 81.6 16.7 44.1 54.1 2.1 49.2 60.8 31.1 39.1 77.7 107.2 17.3 111.1 63.4 7.8 21.5 49.7 91.8 62.2 60.7 98.0 55.1 17.2 16.6 100.2 5.3 0.1 313.6 472.3 15.9 83.9 116.1 28.5 27.7 22.9 86.6 2.2 298.2 117.2 32.2 33.3 4.0 125.4 42.0 7.0 8.9 10.1 10.7 104.5 128.5 14.9 76.6 430.0 93.6 126.3 114.4 117.0 296.0 10.9 1.8 0.0 381.7 1.3 16.2 10.5 2.2 75.7 39.8 14.1 36.4 2.1 113.5 40.5 0.1 5.6 24.9 6.1 22.0 6.6 0.0 14.0 418.6 134.7 33.2 61.4 32.0 2.8 0.3 12.5 80.1 16.1 55.8 9.0 3.0 11.5 3.4 3.1 3.3 4.5 4.8 3.3 2.6 6.4 16.6 7.3 13.1 1.9 8.0 6.6 0.7 3.8 16.5 12.9 13.8 19.3 10.6 13.4 17.6 16.5 16.7 17.3 21.5 17.2 391.5 144.2 99.7 0.7 77.0 37.3 18.9 23.5 39.9 5.1 23.7 24.1 84.5 50.1 39.5 27.6 0.0 6.8 85.3 10.5 3.9 13.1 2.5 28.3 57.5 236.4 8.4 20.4 0.4 15.8 5.1 129.2 39.3 30.8 29.8 0.7 478.0 55.5 30.4 0.0 1.0 12.4 22.4 147.0 58.0 3.8 32.9 67.9 30.2 170.5 47.5 0.2 56.7 6.0 2.4 37.6 12.1 47.4 37.5 8.6 13.6 7.2 14.7 1.2 32.9 60.8 53.4 0.3 1.2 8.0 30.5 3.7 68.2 1.7 14.5 10.8 GADL1 ENSG00000144644 "Glutamate decarboxylase like 1" Q6ZQY3 3 30726200-30894765 "Enzymes, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "skeletal muscle: 25.8;tongue: 11.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 1.4;Club cells: 1.3;Collecting duct cells: 1.8;Fibroblasts: 5.9;Late spermatids: 1.8;Skeletal myocytes: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.7;TIME: 2.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039160, HPA040229" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 2: Karpas-707 - Immune response" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane, Cytosol" "HPA039160: AB_10796222, HPA040229: AB_10796118" "unprognostic (4.96e-2)" "unprognostic (1.30e-2)" "unprognostic (9.83e-2)" "unprognostic (1.39e-2)" "unprognostic (5.60e-2)" "unprognostic (7.32e-2)" "unprognostic (5.05e-3)" "unprognostic (8.37e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-3)" "unprognostic (1.63e-1)" "unprognostic (1.98e-5)" "unprognostic (8.81e-2)" "unprognostic (4.54e-2)" "unprognostic (4.39e-1)" "unprognostic (1.06e-1)" 0.3 0.4 2.2 0.4 2.1 1.2 0.4 2.6 2.5 0.1 0.1 0.2 0.2 0.3 0.6 0.6 0.2 0.3 0.6 1.8 0.8 0.7 0.3 0.3 0.4 0.9 0.5 0.6 0.4 0.2 0.2 0.3 0.9 0.6 0.2 1.7 0.4 0.1 25.8 0.9 0.2 0.2 0.1 0.6 0.3 0.5 1.0 0.1 0.9 11.3 0.3 0.2 0.0 2.3 0.4 0.0 0.2 0.4 0.3 0.1 0.5 0.2 0.1 0.0 0.0 0.5 0.5 0.4 0.2 0.0 0.2 0.3 4.7 0.1 0.1 0.6 0.1 0.5 0.8 0.2 0.0 0.3 1.3 0.1 0.1 0.2 0.1 0.4 0.1 0.3 0.5 1.7 0.2 0.3 0.2 0.5 0.5 0.1 0.1 0.7 0.9 0.4 0.2 0.6 0.5 0.3 0.2 0.3 1.3 0.3 0.4 0.3 2.4 0.6 0.5 0.8 0.2 0.6 0.3 0.3 0.2 0.2 0.6 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 2.2 2.1 2.6 2.5 1.8 0.8 0.9 0.5 0.9 0.1 1.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.6 0.0 1.3 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.3 0.0 0.0 0.5 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 1.8 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 1.6 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 STT3B "FLJ90106, SIMP, STT3-B" ENSG00000163527 "STT3 oligosaccharyltransferase complex catalytic subunit B" Q8TCJ2 3 31532638-31637616 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 264.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036448, HPA036646" Approved Supported "Endoplasmic reticulum" NA NA 17000 "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "Endoplasmic reticulum" "HPA036448: AB_2675129, HPA036646: AB_10673472" "unprognostic (2.17e-2)" "unprognostic (2.23e-1)" "prognostic favorable (7.91e-5)" "unprognostic (1.60e-1)" "unprognostic (3.11e-1)" "unprognostic (2.74e-2)" "unprognostic (2.02e-2)" "unprognostic (1.44e-1)" "unprognostic (1.04e-1)" "unprognostic (2.60e-1)" "unprognostic (3.26e-3)" "unprognostic (3.68e-2)" "unprognostic (3.86e-2)" "unprognostic (9.18e-2)" "unprognostic (1.42e-1)" "unprognostic (6.71e-3)" "unprognostic (1.02e-1)" 42.8 59.9 21.1 52.2 29.5 63.7 57.1 23.3 27.0 62.1 30.9 59.7 47.9 51.8 90.3 44.8 45.3 60.2 49.4 22.6 30.7 49.6 74.8 49.3 59.9 24.3 23.1 105.5 45.7 76.6 24.8 60.3 23.9 56.3 61.4 38.6 49.9 51.3 62.1 44.7 49.1 57.7 25.4 44.2 55.1 94.3 26.1 71.8 80.7 57.8 58.8 56.6 32.1 27.6 77.9 128.0 115.4 121.7 142.0 142.3 249.7 142.3 124.9 104.2 119.9 117.7 164.5 134.0 67.8 130.0 85.8 63.9 108.1 123.5 135.9 377.1 70.2 115.0 120.7 126.4 109.4 252.0 131.1 109.8 129.7 148.8 186.7 160.7 107.1 168.3 62.8 209.6 144.0 44.4 246.8 154.8 92.9 129.6 70.7 252.3 62.6 196.0 122.0 110.7 48.7 59.4 141.3 207.2 84.5 98.3 93.4 132.8 209.3 139.8 88.6 139.7 127.3 129.0 166.4 111.4 126.9 170.0 117.6 2.1 3.3 6.2 3.1 3.9 5.0 2.4 5.6 4.4 2.9 2.7 5.3 4.3 1.2 6.1 2.9 5.5 3.0 2.0 21.1 29.5 23.3 27.0 22.6 30.7 24.3 23.1 23.9 25.4 26.1 27.6 32.1 86.6 57.7 34.6 69.6 68.1 58.4 34.1 74.6 51.0 57.2 29.5 71.1 54.3 76.0 44.1 68.8 67.3 65.3 41.8 13.7 34.1 162.8 25.0 65.9 42.0 45.1 50.9 61.5 45.3 100.5 49.6 45.3 43.5 31.1 43.6 37.9 68.2 54.8 45.4 59.4 57.5 36.7 58.0 76.0 264.9 36.4 71.5 51.6 53.4 49.1 34.2 56.7 60.3 73.3 36.5 50.0 32.7 144.2 74.1 50.5 31.5 42.2 37.4 26.3 39.0 53.3 90.9 55.2 65.0 61.8 95.4 78.3 68.4 66.1 69.4 OSBPL10 ENSG00000144645 "Oxysterol binding protein like 10" Q9BXB5 3 31657912-32077580 "Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 440.2;Late spermatids: 1206.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 17 "memory B-cell: 11.5;naive B-cell: 6.7" "Lineage enriched" "Detected in single" 22 "B-cells: 11.5" "Cell line enhanced" "Detected in many" "hTERT-HME1: 93.3;RPTEC TERT1: 118.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003636 Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Plasma membrane, Cytosol" "HPA003636: AB_1079529" "unprognostic (5.28e-3)" "unprognostic (2.06e-2)" "unprognostic (4.21e-2)" "unprognostic (1.44e-2)" "unprognostic (1.98e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-2)" "unprognostic (3.63e-2)" "unprognostic (8.55e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.15e-1)" "prognostic favorable (1.51e-4)" "unprognostic (5.86e-2)" "unprognostic (7.64e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (4.85e-4)" 8.3 2.6 3.1 7.8 3.0 1.2 6.0 0.1 3.6 10.2 6.5 6.5 3.7 8.4 6.6 13.0 5.9 11.4 2.9 4.8 2.7 13.3 2.2 5.8 12.9 1.2 4.9 3.1 1.6 1.6 6.7 22.3 3.0 11.8 7.8 5.5 6.8 20.9 1.6 4.9 6.7 11.1 0.3 9.5 6.1 25.0 1.3 2.8 3.5 2.2 17.8 20.3 5.9 2.6 19.3 10.6 2.0 39.3 4.2 7.4 63.1 5.2 6.1 4.9 6.8 27.0 14.3 45.6 48.8 1.1 17.0 11.5 8.9 45.1 6.0 0.3 8.2 0.1 26.4 18.3 2.7 0.1 0.2 7.7 39.7 7.8 93.3 18.2 23.4 0.2 0.1 0.2 22.7 16.0 0.2 0.1 24.9 64.9 26.5 0.5 0.8 0.9 118.3 7.8 3.0 0.5 8.9 17.0 5.4 36.9 11.1 0.2 15.2 6.1 61.7 0.5 26.2 4.1 3.0 42.6 8.6 0.1 39.3 0.2 0.0 0.1 0.0 0.0 0.0 11.5 0.0 0.0 0.0 6.7 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.2 3.1 3.0 0.1 3.6 4.8 2.7 1.2 4.9 3.0 0.3 1.3 2.6 20.5 9.6 3.9 2.9 50.6 10.8 7.5 10.1 4.6 7.3 13.8 6.6 2.3 4.3 7.3 7.3 0.0 15.3 2.4 7.9 9.8 1.8 440.2 11.0 26.5 21.1 15.0 5.7 70.5 4.9 25.9 10.4 6.1 26.4 0.0 1.3 18.2 0.6 2.5 0.0 129.9 4.6 6.1 0.9 6.3 1206.2 11.1 2.2 8.8 17.8 1.7 45.7 1.0 12.1 2.3 16.2 9.0 4.1 21.0 18.3 6.1 24.8 6.9 2.3 19.7 4.8 15.6 7.0 4.1 14.4 12.4 30.2 3.5 1.0 8.8 16.3 ZNF860 ENSG00000197385 "Zinc finger protein 860" A6NHJ4 3 31981750-31991723 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 4.2" "Cell type enhanced" "Detected in some" "B-cells: 14.0;Extravillous trophoblasts: 3.8;Respiratory ciliated cells: 4.3;Syncytiotrophoblasts: 4.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 49 "memory B-cell: 7.0;naive B-cell: 5.2" "Lineage enriched" "Detected in single" 56 "B-cells: 7.0" "Cell line enriched" "Detected in many" 4 "BEWO: 44.8" HPA063386 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 57: B-cells - Immune response" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA063386: AB_2684999" "unprognostic (1.19e-1)" "unprognostic (2.46e-2)" "unprognostic (2.88e-1)" "unprognostic (1.64e-2)" "unprognostic (1.51e-1)" "unprognostic (8.01e-2)" "unprognostic (1.23e-2)" "unprognostic (1.94e-2)" "unprognostic (3.15e-1)" "unprognostic (4.15e-3)" "unprognostic (1.51e-2)" "unprognostic (6.38e-2)" "unprognostic (1.30e-4)" "unprognostic (9.51e-2)" "unprognostic (1.59e-1)" "unprognostic (8.74e-2)" "unprognostic (3.75e-3)" 0.3 0.2 0.2 1.4 0.2 0.1 1.4 0.0 0.2 1.5 0.5 0.6 0.2 0.9 2.3 1.7 1.0 0.6 0.2 0.4 0.3 1.0 0.0 0.7 3.1 0.1 0.6 0.6 0.1 0.0 1.4 1.3 0.3 2.8 0.8 0.7 1.4 1.2 0.1 1.2 1.2 0.7 0.0 1.6 0.6 1.0 0.3 0.4 0.9 0.2 4.2 1.1 0.8 0.1 3.0 0.9 0.0 2.3 0.0 0.1 44.8 0.2 0.1 0.2 0.3 3.0 3.5 3.3 3.3 0.0 1.4 2.8 1.0 4.5 0.3 0.0 0.4 0.0 4.4 1.5 0.0 0.0 0.0 0.2 2.0 0.3 8.6 0.3 0.8 0.0 0.0 0.0 0.4 2.6 0.0 0.0 1.2 8.1 4.7 0.0 0.0 0.1 10.2 1.2 0.2 0.0 0.6 5.3 0.0 2.1 4.0 0.0 1.7 0.3 3.5 0.0 0.3 0.0 0.0 5.2 0.4 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.2 0.4 0.3 0.1 0.6 0.3 0.0 0.3 0.1 0.5 0.0 0.0 0.0 14.0 0.9 0.5 0.7 0.6 0.6 1.9 0.8 0.6 0.0 3.1 0.0 0.0 1.7 0.1 0.2 0.0 0.1 0.1 1.2 0.7 1.1 3.5 0.0 1.6 0.5 3.8 0.7 1.5 1.6 0.0 0.0 0.4 0.0 0.3 0.0 1.7 0.5 2.0 0.0 0.5 0.3 0.6 0.3 0.0 1.0 0.0 3.0 0.0 0.0 0.0 0.3 0.2 0.4 0.7 0.8 0.5 1.2 4.3 0.0 0.0 0.2 0.7 0.1 0.2 2.4 0.3 4.2 0.4 0.0 0.5 0.6 GPD1L KIAA0089 ENSG00000152642 "Glycerol-3-phosphate dehydrogenase 1 like" Q8N335 3 32105689-32168709 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Brugada syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 158.4;tongue: 253.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 154.1;Distal enterocytes: 75.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 136.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (1.23e-1)" "unprognostic (3.12e-2)" "prognostic favorable (7.05e-4)" "unprognostic (2.63e-1)" "unprognostic (9.67e-3)" "unprognostic (2.24e-1)" "prognostic unfavorable (1.35e-5)" "prognostic favorable (5.71e-5)" "unprognostic (2.49e-2)" "unprognostic (1.74e-1)" "unprognostic (2.00e-1)" "unprognostic (1.53e-1)" "prognostic favorable (3.33e-15)" "unprognostic (1.50e-1)" "unprognostic (1.99e-1)" "unprognostic (2.31e-3)" "unprognostic (5.51e-3)" 39.0 44.7 18.2 8.3 20.1 6.9 30.6 17.2 21.2 22.8 27.1 40.1 26.5 11.6 9.8 40.9 19.1 9.2 124.8 21.2 20.5 34.2 2.8 31.3 9.0 19.2 18.6 16.6 21.6 32.8 5.9 20.8 19.3 59.9 36.7 9.8 22.0 41.2 158.4 10.3 29.0 16.6 20.5 12.8 29.7 6.1 18.3 6.8 40.3 253.1 10.2 31.0 12.9 21.9 11.1 10.0 3.5 15.3 49.3 11.9 136.1 8.8 3.1 9.2 7.1 10.7 5.2 19.4 13.2 6.2 11.3 12.6 23.4 9.3 11.6 8.3 21.4 11.3 13.2 16.8 12.4 29.4 39.3 35.5 12.1 8.9 12.5 9.4 16.3 15.7 8.0 6.1 7.3 15.1 12.6 11.0 2.1 27.6 44.8 23.1 15.7 40.0 14.6 66.8 15.1 15.0 6.7 61.1 25.0 4.8 38.7 14.1 8.6 10.5 4.9 16.3 23.6 4.3 2.0 19.3 24.0 22.3 6.0 0.5 2.8 5.7 3.3 3.2 8.0 1.5 4.1 4.0 5.6 1.2 2.5 3.7 1.4 7.4 2.1 4.4 8.8 2.8 18.2 20.1 17.2 21.2 21.2 20.5 19.2 18.6 19.3 20.5 18.3 21.9 10.2 28.9 41.8 1.3 4.1 4.6 5.3 3.5 8.6 4.1 20.3 10.7 154.1 2.8 18.6 9.2 2.1 36.4 10.8 75.2 39.2 2.0 8.0 5.3 4.4 10.5 7.8 6.9 23.1 3.7 6.1 10.5 17.3 9.2 39.3 9.8 13.2 0.7 10.0 1.7 23.7 21.3 26.4 6.3 5.7 20.7 5.9 4.4 8.8 24.4 2.3 32.9 7.2 3.0 11.1 4.3 21.6 12.8 8.7 13.8 33.9 18.4 15.0 3.9 0.0 8.0 8.7 0.8 2.1 32.3 7.0 27.1 10.4 3.3 26.9 8.5 CMTM8 CKLFSF8 ENSG00000170293 "CKLF like MARVEL transmembrane domain containing 8" Q8IZV2 3 32238679-32370321 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 47.7" "Cell type enhanced" "Detected in many" "Adipocytes: 94.7;Cytotrophoblasts: 107.6;Granulosa cells: 129.9;Syncytiotrophoblasts: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "BEWO: 208.4;SK-BR-3: 59.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055077, HPA073258" Approved Approved Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA055077: AB_2682691, HPA073258: AB_2686591" "unprognostic (9.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-1)" "unprognostic (1.14e-1)" "unprognostic (3.33e-2)" "unprognostic (9.46e-2)" "unprognostic (5.67e-2)" "unprognostic (8.85e-2)" "unprognostic (1.29e-1)" "unprognostic (7.59e-2)" "unprognostic (2.56e-1)" "prognostic favorable (2.80e-4)" "unprognostic (1.78e-2)" "unprognostic (2.14e-1)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" 14.8 12.9 6.0 3.3 5.8 1.2 15.5 4.9 6.7 5.9 5.9 7.0 7.3 4.4 17.4 3.5 8.4 3.4 13.6 5.5 5.0 10.2 41.2 17.9 3.9 6.2 5.4 1.4 47.7 12.0 3.6 17.4 6.3 11.7 7.4 1.1 19.7 6.0 4.7 9.2 6.2 2.5 5.5 1.3 14.9 1.0 7.0 9.5 13.6 5.1 4.1 4.8 3.7 4.9 10.6 10.8 2.1 13.5 9.5 14.7 208.4 0.1 0.3 1.1 1.2 15.0 14.9 0.0 21.8 0.0 0.0 5.8 17.2 3.5 0.9 0.0 31.5 6.8 2.1 25.2 0.6 2.8 5.3 28.8 10.8 1.5 10.4 5.2 8.4 11.2 0.1 0.0 10.7 7.8 8.9 1.0 4.4 16.4 9.9 12.4 2.5 2.1 13.1 12.1 3.7 3.0 1.7 59.3 5.8 2.5 17.0 1.4 7.6 0.0 15.5 0.0 3.2 0.5 0.4 0.1 0.0 4.8 3.7 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 6.0 5.8 4.9 6.7 5.5 5.0 6.2 5.4 6.3 5.5 7.0 4.9 94.7 38.5 36.3 1.0 2.8 11.6 35.2 4.6 18.8 0.1 75.4 45.6 2.2 17.2 16.1 0.0 0.0 107.6 2.3 13.7 11.7 18.1 13.0 22.1 5.6 51.9 22.2 5.7 2.2 37.0 67.5 17.7 32.1 29.2 0.0 129.9 54.7 79.5 9.8 0.0 41.6 40.7 16.2 5.3 15.0 2.4 2.5 3.6 5.4 36.5 1.2 35.6 0.0 17.6 1.0 25.8 17.7 1.2 1.4 64.9 21.3 24.3 9.9 2.7 0.0 2.2 12.3 3.5 3.7 12.1 6.5 116.2 18.6 10.9 21.0 49.7 CMTM7 "CKLFSF7, FLJ30992" ENSG00000153551 "CKLF like MARVEL transmembrane domain containing 7" Q96FZ5 3 32391698-32483067 "Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 102.3;Ductal cells: 105.6;Hofbauer cells: 120.3;Kupffer cells: 110.7;Langerhans cells: 102.8;monocytes: 108.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 135.4;hTERT-RPE1: 135.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077409 Approved "Plasma membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 25: RPMI-8226 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "Plasma membrane" "HPA077409: AB_2686838" "unprognostic (2.27e-3)" "unprognostic (3.16e-2)" "unprognostic (3.98e-2)" "unprognostic (1.15e-1)" "unprognostic (5.42e-2)" "unprognostic (3.16e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (3.03e-2)" "unprognostic (3.92e-2)" "unprognostic (2.60e-1)" "unprognostic (6.55e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (1.00e-6)" "unprognostic (5.86e-2)" "unprognostic (2.51e-1)" "unprognostic (3.79e-1)" "unprognostic (3.12e-2)" 22.8 10.4 7.5 20.7 7.7 43.7 32.6 8.6 12.9 15.2 8.7 8.4 5.3 11.1 10.9 3.9 38.7 16.0 10.1 7.3 8.2 22.1 10.1 33.0 32.2 8.9 8.3 5.5 19.9 4.0 3.7 19.2 9.2 12.1 9.3 0.6 13.1 19.9 4.0 10.1 18.3 10.5 8.7 49.3 13.4 8.6 9.5 46.1 20.5 3.1 31.4 24.1 7.2 10.8 0.4 15.8 32.8 40.2 29.8 29.0 93.4 15.5 18.0 26.5 24.3 18.0 135.4 0.1 46.7 18.1 33.0 17.4 40.6 69.1 23.2 0.0 32.8 18.5 0.1 40.6 120.8 4.7 29.0 31.0 9.0 27.2 42.6 135.1 60.0 0.2 15.8 40.9 19.6 0.4 0.2 42.9 39.7 7.0 71.7 90.5 12.3 85.0 37.7 30.9 1.6 33.9 2.0 2.6 80.8 13.9 21.3 48.7 36.2 25.3 25.5 27.9 54.4 11.6 4.6 0.2 9.3 57.9 54.2 32.4 198.7 110.8 21.3 196.8 12.7 44.2 72.1 44.2 106.8 34.7 76.5 54.1 77.3 21.6 173.6 45.0 164.1 112.6 7.5 7.7 8.6 12.9 7.3 8.2 8.9 8.3 9.2 8.7 9.5 10.8 10.3 25.6 16.7 1.0 65.5 9.8 20.2 102.3 1.8 0.5 63.4 86.0 2.1 28.6 51.9 18.4 0.0 22.2 25.0 2.0 0.0 105.6 0.2 17.4 12.8 24.2 17.3 11.6 0.5 15.5 10.0 15.2 26.0 33.1 29.8 29.0 20.7 1.3 120.3 1.7 1.4 4.4 40.7 110.7 102.8 1.2 1.5 77.2 24.9 20.6 108.1 1.4 12.3 1.0 0.3 91.8 8.1 1.2 62.9 42.0 1.2 27.5 23.3 0.2 6.6 1.2 13.5 1.2 10.4 0.9 5.5 6.8 57.4 6.1 2.8 16.3 CMTM6 "CKLFSF6, FLJ20396" ENSG00000091317 "CKLF like MARVEL transmembrane domain containing 6" Q9NX76 3 32481312-32502852 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 815.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026980, HPA063491" Enhanced Approved Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 41: Macrophages - Immune response" Vesicles "HPA026980: AB_10602801, HPA063491: " "unprognostic (1.32e-2)" "unprognostic (3.04e-1)" "unprognostic (3.34e-2)" "unprognostic (1.81e-2)" "unprognostic (7.25e-2)" "unprognostic (8.20e-2)" "unprognostic (2.95e-2)" "unprognostic (1.99e-1)" "unprognostic (2.44e-3)" "unprognostic (2.95e-1)" "unprognostic (1.04e-3)" "unprognostic (6.79e-2)" "unprognostic (2.27e-1)" "unprognostic (7.23e-2)" "unprognostic (6.58e-2)" "unprognostic (3.74e-2)" "unprognostic (1.55e-3)" 40.3 26.2 11.6 69.0 11.4 97.3 54.4 11.7 13.5 50.4 24.8 47.7 26.7 46.3 41.0 40.3 176.6 50.3 18.5 10.8 13.4 40.0 132.4 54.3 53.9 14.5 12.5 18.6 23.5 41.6 9.2 70.1 14.3 48.6 58.4 13.0 33.2 39.9 5.0 49.4 29.5 41.6 14.5 55.4 46.9 40.4 13.5 47.8 61.7 13.6 78.3 79.0 18.9 14.7 107.4 34.2 66.5 50.1 112.1 111.0 292.4 77.5 110.4 79.7 91.5 36.6 174.4 63.5 86.1 104.6 53.8 67.6 47.0 128.9 108.2 285.4 57.3 80.4 22.8 54.5 79.6 135.3 153.0 110.5 81.3 92.0 68.6 128.2 130.3 60.9 39.8 116.0 103.0 33.4 81.9 70.0 59.3 88.6 50.0 68.6 51.7 49.9 111.1 147.9 15.3 44.3 70.5 39.5 76.1 66.9 58.3 133.5 117.8 88.0 57.9 86.7 94.1 59.6 63.9 58.6 61.4 116.8 112.1 176.8 84.4 208.0 29.1 133.4 32.8 54.4 38.1 28.3 72.7 42.2 22.0 24.7 313.4 65.1 210.2 38.6 46.3 108.6 11.6 11.4 11.7 13.5 10.8 13.4 14.5 12.5 14.3 14.5 13.5 14.7 57.0 35.3 49.9 12.4 243.7 96.0 82.4 159.3 55.2 13.9 233.0 57.5 5.8 60.1 112.0 95.6 12.5 253.6 122.5 88.0 33.2 113.8 12.3 129.1 68.3 70.7 132.1 41.2 14.2 83.0 101.7 74.9 63.2 180.9 126.8 186.5 124.9 305.2 156.5 50.5 19.2 117.6 118.0 310.1 815.8 8.4 39.4 326.0 81.8 30.0 425.8 130.1 71.1 18.1 9.4 136.7 46.1 42.9 104.7 147.1 23.8 63.4 183.0 17.3 39.5 32.9 74.3 36.1 20.2 89.7 126.6 261.7 120.9 50.3 64.6 110.3 DYNC1LI1 DNCLI1 ENSG00000144635 "Dynein cytoplasmic 1 light intermediate chain 1" Q9Y6G9 3 32525974-32570858 "Predicted intracellular proteins" "Cell cycle, Cell division, Host-virus interaction, Mitosis, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 192.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035013 Approved Supported Centrosome,Cytosol NA NA 23000 "Cluster 14: Monocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Centrosome, Cytosol" "HPA035013: AB_10600807" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "unprognostic (1.78e-2)" "unprognostic (2.25e-2)" "unprognostic (1.55e-1)" "unprognostic (5.38e-2)" "prognostic unfavorable (9.19e-9)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (7.26e-3)" "unprognostic (5.02e-2)" "unprognostic (1.05e-2)" "unprognostic (2.21e-2)" "unprognostic (2.14e-2)" "unprognostic (5.51e-2)" "unprognostic (4.58e-2)" "unprognostic (2.27e-2)" 17.9 11.3 16.3 17.8 17.3 37.4 21.3 23.9 23.2 15.3 12.9 15.6 13.6 18.6 12.4 15.7 16.3 16.1 48.6 17.0 20.7 21.2 18.7 19.2 20.4 19.2 17.0 16.6 17.8 21.4 13.6 13.0 22.7 20.6 15.7 39.7 11.8 13.8 46.6 35.0 15.0 22.4 14.8 19.5 14.3 40.8 18.2 22.7 14.5 35.2 20.6 19.9 14.1 17.5 40.1 42.2 64.5 40.7 36.2 42.4 177.7 60.4 82.8 106.4 86.9 45.2 33.7 49.7 39.9 61.5 50.6 20.1 65.4 47.3 100.8 47.7 45.5 66.2 28.9 40.7 44.4 75.6 36.9 34.5 37.1 75.3 58.4 38.8 69.8 55.9 75.8 44.6 57.9 32.0 58.2 33.7 66.8 38.1 56.1 50.7 34.4 51.8 44.2 36.0 27.6 41.1 42.4 52.1 47.0 51.2 43.7 43.9 52.3 58.2 48.9 51.2 61.6 32.0 87.1 80.7 32.7 64.5 46.6 33.1 29.5 26.6 10.3 35.4 11.0 13.0 11.1 11.7 33.0 13.4 7.8 10.3 62.7 16.4 59.0 18.0 13.7 28.9 16.3 17.3 23.9 23.2 17.0 20.7 19.2 17.0 22.7 14.8 18.2 17.5 48.6 25.6 28.3 20.5 49.4 43.0 30.9 40.7 40.5 48.0 30.9 28.8 95.7 11.5 40.2 14.7 18.8 34.9 53.8 14.2 46.9 50.5 102.6 65.8 54.9 39.3 30.9 48.8 43.6 46.5 36.6 37.6 25.0 66.8 17.1 29.2 23.6 28.8 39.4 65.6 55.0 23.0 26.4 35.9 54.2 39.9 26.1 50.7 28.4 28.1 80.0 37.2 34.0 25.6 33.5 56.1 20.0 28.6 28.7 23.4 18.9 61.9 44.3 81.9 46.0 36.7 44.9 192.0 169.5 23.7 50.2 11.1 40.8 39.9 16.8 15.0 CNOT10 "FLJ12890, FLJ13165" ENSG00000182973 "CCR4-NOT transcription complex subunit 10" Q9H9A5 3 32685145-32773875 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 181.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035614, HPA041450" Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Centrosome" Cytosol "HPA035614: AB_10669975, HPA041450: AB_2677487" "unprognostic (3.75e-1)" "unprognostic (4.57e-2)" "unprognostic (4.45e-3)" "unprognostic (6.01e-2)" "unprognostic (9.88e-2)" "unprognostic (4.60e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.88e-1)" "unprognostic (1.50e-1)" "unprognostic (5.09e-3)" "unprognostic (1.80e-1)" "unprognostic (1.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.44e-2)" "unprognostic (1.84e-2)" "unprognostic (8.75e-3)" "unprognostic (3.43e-1)" 8.4 7.8 5.9 11.4 6.5 17.4 12.6 7.8 7.1 10.9 7.2 11.6 9.8 10.7 11.5 9.8 14.1 8.7 7.7 5.7 6.7 10.6 12.5 9.8 14.6 6.1 5.8 12.2 9.4 13.0 10.3 8.5 6.2 9.1 13.8 6.5 8.5 7.5 9.5 13.2 10.6 10.1 6.1 14.5 9.1 39.8 6.3 19.7 12.3 5.8 16.5 9.8 8.7 7.5 24.4 26.7 27.2 25.9 12.9 14.8 181.2 20.1 20.0 28.0 31.3 20.5 20.5 39.6 13.0 14.4 18.1 20.9 32.5 26.5 27.8 34.5 33.3 51.0 23.2 20.0 37.6 42.3 18.9 10.9 23.3 30.9 40.4 18.7 23.2 36.4 54.1 30.1 16.6 20.1 38.0 20.4 41.2 28.0 25.3 37.9 18.5 39.8 18.0 28.1 15.5 29.9 29.5 41.1 24.4 19.3 40.0 47.4 14.3 17.3 24.6 23.0 33.7 30.8 67.8 39.6 17.7 31.7 21.4 18.5 12.0 17.7 11.4 17.1 12.4 15.3 18.6 13.7 15.1 17.4 18.1 16.0 9.6 10.2 25.2 8.4 16.0 12.3 5.9 6.5 7.8 7.1 5.7 6.7 6.1 5.8 6.2 6.1 6.3 7.5 11.6 16.0 22.8 28.4 19.6 10.5 7.2 13.0 9.1 16.8 9.4 9.0 13.2 14.3 15.3 14.7 33.3 14.8 21.0 15.3 5.9 12.9 60.3 23.4 12.9 14.1 15.6 21.2 37.7 13.5 17.1 12.0 15.3 14.1 10.8 17.2 12.8 9.8 11.9 15.2 36.5 10.6 10.2 18.8 14.3 34.3 9.6 14.5 12.4 20.6 37.2 7.4 10.3 29.1 35.3 11.7 16.4 10.5 17.5 6.6 15.2 7.0 29.9 20.9 6.6 14.9 12.5 63.0 33.1 10.2 14.5 8.2 20.1 17.8 14.4 7.3 TRIM71 "LIN-41, LIN41" ENSG00000206557 "Tripartite motif containing 71" Q2Q1W2 3 32817997-32897824 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "RNA-mediated gene silencing, Ubl conjugation pathway" "Developmental protein, RNA-binding, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 4.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Extravillous trophoblasts: 15.6;Inhibitory neurons: 4.5;Oligodendrocyte precursor cells: 4.5;Spermatogonia: 13.7" "Cancer enriched" "Detected in some" 28 "testis cancer: 28.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 31.4;BEWO: 94.5;Hep G2: 63.8;NTERA-2: 84.3;SuSa: 76.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA038141, HPA038142" Uncertain Approved "Plasma membrane,Actin filaments,Focal adhesion sites" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 5: NTERA-2 - Transcription" "Cluster 38: Extravillous trophoblasts - Unknown function" "Plasma membrane, Actin filaments, Focal adhesion sites" "HPA038141: AB_2675857, HPA038142: AB_10697240" "unprognostic (2.93e-2)" "unprognostic (4.29e-3)" "unprognostic (1.70e-1)" "unprognostic (1.02e-2)" "unprognostic (2.58e-2)" "unprognostic (3.27e-2)" "unprognostic (2.09e-2)" "unprognostic (1.25e-1)" "unprognostic (3.16e-2)" "unprognostic (3.04e-1)" "unprognostic (1.11e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-6)" "unprognostic (3.92e-2)" "unprognostic (9.27e-2)" "unprognostic (8.17e-2)" "unprognostic (4.65e-2)" 0.0 0.0 1.0 0.0 1.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.8 0.9 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 31.4 0.0 0.0 0.0 94.5 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 1.6 0.0 63.8 0.0 1.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.4 0.0 0.0 0.6 6.9 84.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 76.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.0 0.8 0.9 0.8 0.1 0.1 0.1 0.0 0.8 0.2 0.0 9.6 4.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.0 2.7 0.0 1.8 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.2 0.0 0.0 3.1 0.0 15.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 4.5 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 1.0 0.1 0.0 0.0 4.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 3.6 0.7 0.5 0.0 0.0 0.1 0.3 13.7 0.0 0.0 4.0 0.1 0.0 0.0 0.0 CCR4 "CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5" ENSG00000183813 "C-C motif chemokine receptor 4" P51679 3 32951644-32956349 "CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 13.0;urinary bladder: 5.4" "Cell type enhanced" "Detected in some" "granulocytes: 2.5;Horizontal cells: 5.0;Plasma cells: 2.1;Spermatogonia: 1.8;T-cells: 7.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 5 "T-reg: 60.9" "Lineage enriched" "Detected in many" 41 "T-cells: 60.9" "Cell line enriched" "Detected in some" 17 "HDLM-2: 206.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA031613 Approved Supported "Plasma membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 3: T-cells - Adaptive immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" "HPA031613: AB_10601096" "unprognostic (4.63e-3)" "unprognostic (8.70e-3)" "unprognostic (2.82e-3)" "unprognostic (2.64e-3)" "unprognostic (1.18e-1)" "unprognostic (4.59e-7)" "unprognostic (3.02e-1)" "unprognostic (5.05e-3)" "unprognostic (1.53e-2)" "unprognostic (1.69e-2)" "unprognostic (1.75e-1)" "unprognostic (2.17e-1)" "unprognostic (9.88e-3)" "unprognostic (2.04e-1)" "unprognostic (5.53e-4)" "unprognostic (1.54e-1)" "unprognostic (1.40e-1)" 0.5 0.2 0.3 8.6 0.3 1.7 0.6 0.8 0.7 0.6 0.2 0.9 0.6 0.4 0.3 1.2 0.2 3.3 0.2 0.4 0.4 0.3 0.6 1.7 7.0 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.4 0.8 1.2 0.1 0.5 0.1 2.0 2.1 1.5 0.6 0.0 3.2 1.4 0.8 0.2 13.0 0.3 0.1 8.0 5.4 0.2 0.7 0.3 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.3 0.4 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.0 206.5 0.0 12.2 0.7 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.2 0.0 5.8 3.2 0.8 0.0 0.0 1.8 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.5 0.0 0.1 0.7 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.3 0.4 0.3 0.2 0.1 0.2 0.2 0.2 0.0 1.4 0.3 0.3 0.4 0.3 0.4 0.3 11.5 3.4 0.1 0.4 0.3 0.3 1.1 0.3 0.3 0.4 60.9 1.7 0.3 0.3 0.8 0.7 0.4 0.4 0.2 0.1 0.4 0.0 0.2 0.7 0.1 0.0 0.6 0.0 0.4 0.4 0.7 0.0 0.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 2.5 0.0 0.4 0.1 0.1 5.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.7 0.0 0.0 0.7 0.8 0.0 0.5 0.2 0.0 1.8 0.0 0.1 0.0 7.8 0.0 0.0 0.6 GLB1 "EBP, ELNR1" ENSG00000170266 "Galactosidase beta 1" P16278 3 32996609-33097202 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Gangliosidosis, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 857.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008382, HPA040610, HPA069503" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 2700000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 4: Macrophages - Innate immune response" Vesicles "Golgi apparatus" "CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142" "unprognostic (1.51e-2)" "unprognostic (3.66e-2)" "unprognostic (5.02e-3)" "unprognostic (9.66e-3)" "unprognostic (9.61e-3)" "unprognostic (1.04e-1)" "unprognostic (2.31e-3)" "unprognostic (1.32e-1)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (2.08e-1)" "prognostic favorable (1.14e-5)" "unprognostic (3.05e-1)" "unprognostic (2.33e-1)" "unprognostic (2.20e-1)" "unprognostic (5.85e-2)" 22.0 36.1 12.1 27.8 13.0 21.9 20.5 12.5 14.8 33.4 16.0 43.5 43.0 21.9 103.6 15.4 28.2 32.0 15.5 12.5 14.8 46.0 48.2 42.7 25.8 14.3 12.9 21.4 30.8 59.4 18.5 53.8 15.4 23.2 45.6 14.9 25.3 29.3 7.7 15.8 31.0 30.6 12.4 24.4 35.5 13.5 13.5 17.5 52.8 10.8 23.0 31.8 16.2 15.1 37.4 63.6 39.8 48.3 241.9 123.7 857.2 59.1 157.6 73.7 95.1 91.3 86.5 17.9 50.9 120.9 53.9 35.1 38.1 75.5 53.7 104.9 33.0 69.9 35.3 47.4 124.3 50.5 69.9 144.9 70.2 67.0 39.2 144.1 116.5 24.7 64.3 67.0 81.8 44.6 29.6 31.6 26.4 78.0 27.0 24.7 26.4 86.6 78.4 54.4 12.0 40.3 75.0 120.2 74.4 69.3 80.3 130.2 67.7 46.8 32.2 65.2 50.1 53.2 87.9 5.9 99.6 71.2 36.7 43.9 146.2 86.4 29.2 125.8 40.4 37.9 34.3 31.8 166.5 35.6 17.9 21.8 56.6 26.0 92.1 35.1 77.1 91.9 12.1 13.0 12.5 14.8 12.5 14.8 14.3 12.9 15.4 12.4 13.5 15.1 8.7 19.2 25.3 39.2 18.6 6.0 13.6 60.1 10.8 11.3 11.5 7.5 9.1 34.3 43.3 27.6 6.2 100.1 14.1 41.9 27.4 53.5 24.8 18.7 16.0 17.4 16.9 20.6 46.7 35.4 55.3 29.2 26.0 27.1 26.6 20.6 19.6 39.7 79.5 5.0 46.0 23.5 40.7 43.9 13.9 5.0 15.2 41.7 14.2 23.4 64.6 16.5 10.3 27.2 24.2 28.1 43.4 21.1 19.8 9.9 36.2 33.1 31.0 16.2 13.1 12.9 16.3 1.0 6.6 10.1 3.4 49.1 18.7 51.0 32.0 12.1 TMPPE FLJ45032 ENSG00000188167 "Transmembrane protein with metallophosphoesterase domain" Q6ZT21 3 33090421-33097146 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 5.5" "Cell type enhanced" "Detected in some" "Rod photoreceptor cells: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "BEWO: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027019 Approved Approved Nucleoplasm,Mitochondria Yes No "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Mitochondria" "HPA027019: AB_1848942" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (1.00e-1)" "unprognostic (1.37e-1)" "unprognostic (5.03e-2)" "unprognostic (2.96e-2)" "unprognostic (6.34e-3)" "unprognostic (8.14e-2)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (1.25e-3)" "unprognostic (9.58e-2)" "unprognostic (1.60e-7)" "unprognostic (1.61e-1)" "unprognostic (5.40e-2)" "unprognostic (2.13e-1)" "unprognostic (4.33e-2)" 0.6 0.5 0.8 1.4 0.7 5.5 0.6 0.7 1.2 0.6 4.3 1.0 1.2 0.5 0.6 0.6 0.9 0.6 0.4 1.5 0.5 1.0 0.6 1.1 1.1 1.4 1.4 0.6 0.7 1.9 0.3 1.2 1.6 0.5 1.2 2.8 0.7 0.6 0.2 1.1 1.1 0.8 0.2 1.5 1.3 0.3 1.7 0.5 1.0 0.3 1.3 0.8 0.4 0.2 1.4 1.9 1.0 1.7 1.2 1.0 27.2 0.6 1.0 1.6 0.9 2.7 3.8 0.8 1.2 1.7 0.9 1.4 1.7 1.5 2.6 4.2 0.6 3.4 1.9 2.1 0.9 3.0 4.7 1.1 1.2 2.0 1.4 0.8 1.9 1.7 2.6 2.9 1.2 1.3 1.2 1.3 1.0 0.4 1.1 1.5 0.6 1.9 1.5 1.9 0.2 0.6 0.9 2.6 0.6 1.3 1.4 4.2 2.7 2.4 3.0 1.3 2.6 2.3 1.6 0.4 3.0 2.2 1.7 0.0 1.1 0.3 0.1 2.4 0.6 0.3 0.2 0.0 1.0 0.1 0.0 0.0 1.9 0.0 1.1 0.2 0.2 0.4 0.8 0.7 0.7 1.2 1.5 0.5 1.4 1.4 1.6 0.2 1.7 0.2 0.3 0.0 1.3 0.0 0.8 0.8 0.1 0.0 0.0 1.2 0.4 0.4 0.4 0.0 0.2 0.0 0.0 1.1 1.9 1.4 0.0 0.4 0.0 0.8 0.6 0.4 0.0 0.4 0.0 0.8 1.7 0.3 0.0 1.1 0.0 0.4 0.4 0.6 0.9 1.7 0.0 0.2 2.0 1.3 1.2 0.0 0.0 1.1 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.5 1.4 0.4 1.0 0.2 1.4 0.3 0.4 2.2 0.0 0.2 0.7 0.0 0.0 1.5 0.9 0.4 0.6 0.5 0.6 0.2 CRTAP "CASP, LEPREL3, P3H5" ENSG00000170275 "Cartilage associated protein" O75718 3 33114014-33147773 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Disease variant, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "classical monocyte: 377.6" "Group enriched" "Detected in all" 5 "dendritic cells: 306.9;monocytes: 377.6" "Cell line enhanced" "Detected in all" "ASC diff: 795.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043598, HPA044150" Approved Approved "Intermediate filaments,Actin filaments,Cytosol" "Secreted to blood" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Intermediate filaments, Actin filaments, Cytosol" "HPA043598: AB_10960991, HPA044150: AB_10959594" "unprognostic (5.29e-2)" "unprognostic (2.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.85e-3)" "unprognostic (7.36e-2)" "unprognostic (4.73e-3)" "unprognostic (4.28e-2)" "unprognostic (1.87e-1)" "unprognostic (9.97e-2)" "unprognostic (4.62e-2)" "unprognostic (3.70e-1)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-1)" "unprognostic (9.93e-2)" "unprognostic (1.28e-3)" 157.2 106.5 65.2 38.7 69.2 43.2 123.9 51.9 54.8 211.2 52.9 145.1 35.0 170.1 57.1 58.7 138.3 80.5 83.9 49.6 64.9 67.9 44.6 92.3 37.3 65.2 62.4 131.4 36.0 45.7 22.8 69.9 63.9 90.7 51.6 19.3 54.0 106.5 54.4 84.1 65.6 115.0 67.5 48.2 78.9 25.0 65.3 23.7 77.2 68.9 38.1 142.7 135.8 69.5 64.1 123.3 37.8 119.2 795.0 516.6 219.0 136.1 294.0 160.6 151.9 42.1 35.1 44.4 147.6 259.3 129.9 80.2 68.0 103.9 115.5 110.1 106.0 69.2 87.6 43.7 237.4 45.4 54.8 415.3 208.5 145.0 183.2 311.7 172.0 27.0 60.3 82.1 164.6 54.7 16.5 46.3 45.5 67.5 165.7 59.4 111.0 86.1 127.8 42.0 7.9 61.0 92.0 79.8 201.1 87.3 85.9 109.3 113.0 209.1 89.1 115.4 145.9 59.0 214.3 6.7 164.3 89.7 117.1 13.4 377.6 28.5 35.8 147.7 52.5 39.9 51.4 40.2 306.9 39.2 29.2 27.8 30.5 42.1 46.0 82.5 74.0 200.5 65.2 69.2 51.9 54.8 49.6 64.9 65.2 62.4 63.9 67.5 65.3 69.5 74.0 9.6 42.8 15.3 29.0 60.4 41.1 39.5 150.8 17.9 32.7 43.7 34.7 25.8 22.0 38.6 8.4 49.0 37.1 14.8 11.7 25.0 1.2 17.4 135.7 72.7 6.0 46.0 10.0 32.0 81.6 142.3 29.0 31.2 48.1 58.4 122.4 53.2 107.0 35.3 14.5 26.0 10.2 181.1 91.1 6.3 142.9 108.6 80.0 10.3 134.1 15.9 22.6 17.1 11.6 18.4 16.3 144.8 58.1 24.5 24.4 52.7 6.8 10.1 111.7 78.4 120.9 1.6 15.9 95.1 46.7 28.0 26.5 89.9 36.1 30.0 SUSD5 KIAA0527 ENSG00000173705 "Sushi domain containing 5" O60279 3 33150043-33218810 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Excitatory neurons: 15.4;Inhibitory neurons: 10.5;Oligodendrocyte precursor cells: 61.3;Sertoli cells: 32.9;Smooth muscle cells: 29.0" "Cancer enhanced" "Detected in many" "melanoma: 5.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 31.1;HUVEC TERT2: 78.5;LHCN-M2: 30.4;TIME: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052788 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA 17000000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus, Vesicles" "HPA052788: AB_2681948" "unprognostic (1.81e-1)" "unprognostic (1.52e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-3)" "unprognostic (1.39e-3)" "unprognostic (4.05e-2)" "unprognostic (3.72e-1)" "unprognostic (6.28e-2)" "unprognostic (2.77e-1)" "unprognostic (2.24e-2)" "unprognostic (1.69e-1)" "unprognostic (2.15e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-3)" "unprognostic (6.45e-2)" "unprognostic (8.46e-2)" "unprognostic (1.89e-2)" 4.6 1.4 2.9 0.9 3.0 0.1 1.9 2.2 4.6 6.3 4.4 1.7 0.8 4.6 2.2 1.3 5.2 5.5 1.5 3.1 4.4 1.5 0.5 1.7 2.3 3.4 3.4 3.8 0.6 1.0 0.8 0.2 3.4 1.3 1.2 0.6 0.7 6.3 1.6 1.9 1.9 4.8 3.8 2.5 1.8 2.1 4.7 0.1 3.2 3.3 5.3 1.5 2.4 3.5 0.0 1.1 1.2 0.7 1.7 0.2 0.1 9.6 3.4 31.1 10.5 0.1 0.0 0.0 8.8 2.5 9.5 0.1 13.7 4.5 12.9 0.3 15.3 0.0 2.0 0.0 0.2 0.1 0.1 1.3 2.4 19.9 3.9 15.2 78.5 0.0 0.0 0.1 30.4 0.0 0.0 0.1 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.0 1.0 0.1 0.1 2.5 0.7 1.8 1.9 31.3 0.0 14.4 1.2 4.7 0.0 0.7 0.0 0.3 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.9 3.0 2.2 4.6 3.1 4.4 3.4 3.4 3.4 3.8 4.7 3.5 0.1 0.0 0.0 0.3 0.0 1.0 0.1 0.0 0.0 1.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 2.2 0.5 0.0 0.0 15.4 0.0 0.1 1.4 0.0 0.9 0.0 0.2 0.4 0.0 0.0 3.3 10.5 0.0 0.0 2.1 2.0 0.3 0.0 0.1 1.8 0.0 0.0 0.5 0.0 61.3 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.7 32.9 3.6 29.0 0.1 2.6 0.1 1.0 0.0 0.2 0.1 0.0 0.1 FBXL2 "FBL2, FBL3" ENSG00000153558 "F-box and leucine rich repeat protein 2" Q9UKC9 3 33277025-33403662 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 48.8;Excitatory neurons: 125.0;Inhibitory neurons: 92.8;Late spermatids: 50.7;Oligodendrocyte precursor cells: 55.8;Oligodendrocytes: 49.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 5.7;LHCN-M2: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003240, HPA061783" Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA003240: , HPA061783: AB_2684605" "unprognostic (5.73e-2)" "unprognostic (4.47e-2)" "unprognostic (7.92e-2)" "unprognostic (7.21e-2)" "unprognostic (3.68e-1)" "unprognostic (1.59e-1)" "unprognostic (1.10e-2)" "unprognostic (2.09e-1)" "unprognostic (3.16e-1)" "unprognostic (2.00e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "prognostic favorable (3.35e-4)" "unprognostic (3.30e-3)" "unprognostic (9.72e-2)" "unprognostic (4.28e-2)" "unprognostic (5.90e-2)" 0.9 1.3 3.6 0.4 3.8 0.3 1.0 2.2 4.0 1.1 4.2 1.1 0.7 1.0 2.1 0.4 1.5 0.6 0.9 3.5 3.7 1.4 0.2 1.2 0.3 2.9 2.6 1.4 1.1 2.7 2.7 1.4 3.0 1.0 0.2 4.2 0.8 1.6 0.2 0.6 0.5 0.8 1.6 0.5 0.8 1.1 3.3 0.2 2.3 0.0 0.2 0.8 0.9 2.7 2.7 0.7 1.0 1.0 1.5 2.4 0.4 2.0 1.6 1.8 2.6 0.5 3.1 0.1 0.6 1.3 0.8 0.5 0.9 2.1 1.2 0.2 1.1 0.4 2.3 0.5 1.8 0.2 0.4 0.9 1.6 1.1 0.8 5.7 3.3 1.9 0.5 0.2 6.2 0.2 0.5 0.3 0.7 0.3 0.6 0.1 0.6 0.1 4.6 0.7 1.1 1.1 0.9 0.5 0.8 1.7 1.3 0.7 2.5 0.8 0.7 0.6 1.1 0.2 0.1 0.1 0.8 0.2 0.6 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.0 3.6 3.8 2.2 4.0 3.5 3.7 2.9 2.6 3.0 1.6 3.3 2.7 2.7 3.2 7.3 22.2 1.0 1.1 7.6 5.6 1.8 15.3 3.0 3.7 2.4 2.8 4.8 5.5 25.0 0.5 0.4 0.1 3.9 3.9 48.8 18.8 3.6 3.8 0.0 0.0 125.0 0.4 1.5 5.0 5.6 6.2 0.0 6.2 2.2 0.1 0.5 18.5 92.8 0.3 8.2 0.8 2.4 50.7 1.5 0.5 1.8 22.5 0.1 6.6 0.0 55.8 49.6 4.2 0.1 4.1 0.3 4.2 0.2 3.2 16.5 17.7 6.6 3.6 3.9 21.3 8.6 0.7 1.1 0.7 1.5 3.5 0.1 3.8 UBP1 LBP-1a ENSG00000153560 "Upstream binding protein 1" Q9NZI7 3 33388336-33441371 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003967 Supported Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 14: B-cells - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA003967: AB_10601829" "unprognostic (3.11e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.81e-4)" "unprognostic (4.64e-2)" "unprognostic (9.35e-2)" "unprognostic (3.92e-2)" "prognostic unfavorable (9.45e-4)" "unprognostic (6.67e-3)" "unprognostic (3.92e-2)" "unprognostic (1.11e-2)" "unprognostic (2.01e-1)" "unprognostic (7.48e-3)" "unprognostic (1.23e-1)" "unprognostic (3.14e-2)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" "unprognostic (1.88e-2)" 23.6 21.4 18.6 31.2 20.8 24.5 24.4 24.3 22.9 23.9 14.2 34.7 29.7 28.7 26.8 29.6 23.2 24.4 31.3 21.2 19.9 23.4 32.4 30.5 44.1 15.0 16.6 29.2 31.0 24.6 22.9 22.2 15.5 25.7 34.6 28.5 23.5 39.5 23.0 26.5 28.7 37.0 17.0 32.6 27.0 16.9 20.0 43.6 26.5 27.6 43.8 35.6 23.0 18.4 48.9 58.6 44.3 74.0 66.1 48.0 21.6 57.7 64.0 67.8 68.4 57.1 42.5 91.2 33.1 85.2 48.6 33.1 133.3 67.6 82.9 50.2 40.7 97.9 57.0 68.7 46.2 71.8 40.5 40.0 54.4 65.7 66.3 55.5 82.5 49.6 90.7 49.0 66.1 46.5 57.5 42.5 105.4 38.6 59.7 59.8 32.4 84.7 47.9 72.8 30.5 36.3 45.9 78.8 50.3 58.5 59.6 86.2 68.8 59.4 45.7 67.8 81.1 38.8 74.9 92.4 51.4 82.7 45.0 3.5 1.6 1.7 2.1 1.7 2.0 1.1 2.1 2.1 2.5 0.8 2.4 2.0 0.4 2.2 2.4 2.0 1.4 1.6 18.6 20.8 24.3 22.9 21.2 19.9 15.0 16.6 15.5 17.0 20.0 18.4 18.0 6.4 20.9 29.7 15.4 25.5 9.7 13.6 19.9 24.6 35.3 17.8 29.3 18.6 10.0 11.0 14.6 7.9 22.2 30.0 3.9 11.8 1.6 12.8 23.5 23.5 12.1 21.7 58.3 14.5 9.4 15.8 17.9 18.4 2.5 27.2 21.4 41.6 14.8 23.5 50.9 27.8 10.2 27.3 27.6 3.5 9.9 25.5 26.6 29.0 27.3 7.7 20.6 34.2 35.5 14.3 17.1 17.7 15.7 17.1 17.3 10.9 8.1 17.8 13.1 15.6 19.7 14.3 13.8 26.8 31.1 5.5 20.5 24.9 28.4 13.2 CLASP2 KIAA0627 ENSG00000163539 "Cytoplasmic linker associated protein 2" O75122 3 33496245-33718356 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 176.6;retina: 126.4" "Cell type enhanced" "Detected in all" "Astrocytes: 294.5;Excitatory neurons: 514.2;Inhibitory neurons: 526.3;Oligodendrocyte precursor cells: 739.9;Oligodendrocytes: 1315.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067071 Supported "Golgi apparatus,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" Cytosol "HPA067071: AB_2685775" "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (7.24e-3)" "unprognostic (5.46e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (1.27e-2)" "unprognostic (4.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-2)" "unprognostic (2.60e-3)" "unprognostic (3.25e-2)" "prognostic favorable (1.48e-6)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "unprognostic (1.07e-2)" "unprognostic (5.72e-2)" 14.0 25.1 43.4 12.1 84.1 12.3 15.8 100.7 79.1 21.4 0.0 16.9 9.9 20.5 11.3 17.9 16.0 17.7 40.4 44.8 57.5 18.1 10.8 15.3 15.4 69.0 49.9 27.3 11.5 17.7 33.3 15.6 85.9 16.6 13.1 126.4 8.8 20.7 64.9 13.0 11.0 19.4 67.8 14.5 11.2 11.8 60.0 16.1 14.1 63.4 15.9 14.5 11.5 176.6 13.5 29.4 32.9 27.8 20.9 20.4 23.6 24.8 23.2 28.5 30.6 17.2 13.8 44.4 14.1 19.6 18.3 11.5 43.0 19.7 34.4 36.0 30.5 43.7 24.6 15.4 9.9 43.6 35.8 12.7 19.3 30.9 29.2 16.5 28.0 27.0 43.3 24.8 31.1 7.6 32.5 18.6 24.5 13.5 18.4 34.5 30.9 24.1 17.9 15.2 27.4 46.4 28.7 22.1 24.7 26.5 20.9 38.1 27.0 22.3 19.4 16.9 27.7 17.3 34.6 36.5 20.2 29.6 28.8 3.7 4.6 2.6 3.3 4.5 5.1 6.1 2.9 3.2 6.5 3.7 3.9 3.6 0.9 9.1 7.0 6.1 3.5 4.8 43.4 84.1 100.7 79.1 44.8 57.5 69.0 49.9 85.9 67.8 60.0 176.6 19.7 6.4 11.7 294.5 29.9 21.0 8.6 8.8 18.8 103.3 26.0 13.8 37.4 15.7 12.7 14.7 156.4 12.3 36.2 9.9 1.9 6.4 2.8 20.8 15.6 16.1 14.4 12.2 514.2 7.0 8.1 19.2 26.5 27.9 12.0 17.8 16.1 13.9 15.0 92.5 526.3 8.8 8.2 32.3 26.6 2.9 14.3 26.0 16.0 128.4 19.5 32.0 22.6 739.9 1315.9 8.0 5.6 13.5 28.8 12.3 6.1 12.2 13.8 120.6 6.6 34.2 22.9 11.1 14.4 19.3 30.7 12.9 25.6 15.5 11.2 8.8 PDCD6IP "AIP1, Alix, Hp95" ENSG00000170248 "Programmed cell death 6 interacting protein" Q8WUM4 3 33798571-33869707 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 299.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA011905, CAB016212, HPA051604" Approved Approved Vesicles,Centrosome "Intracellular and membrane" NA NA 4100000 "Cluster 27: Non-specific - Gene expression" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles Centrosome "CAB016212: AB_673819, HPA011905: AB_1855111, HPA051604: " "unprognostic (1.53e-1)" "unprognostic (2.63e-1)" "prognostic favorable (1.16e-4)" "unprognostic (2.17e-1)" "unprognostic (2.75e-1)" "unprognostic (5.12e-2)" "unprognostic (7.76e-3)" "unprognostic (1.23e-2)" "unprognostic (3.29e-1)" "unprognostic (2.86e-1)" "unprognostic (3.88e-3)" "unprognostic (4.49e-2)" "prognostic favorable (3.90e-9)" "unprognostic (9.61e-2)" "unprognostic (1.89e-1)" "unprognostic (4.78e-1)" "unprognostic (1.11e-1)" 33.1 27.6 16.3 24.5 17.9 21.2 32.9 18.4 23.3 35.0 23.0 46.4 36.2 35.1 26.4 46.0 30.9 25.9 30.5 17.6 19.7 35.0 33.2 35.2 26.1 25.2 18.1 34.3 25.0 40.6 22.8 31.2 26.4 30.0 41.5 30.5 29.7 23.7 33.9 39.8 38.8 31.8 18.6 27.5 37.2 23.8 18.8 24.4 34.2 22.1 30.1 26.9 35.9 21.4 47.2 46.4 30.2 25.1 78.5 80.6 34.3 67.2 56.2 50.9 52.2 33.3 43.8 75.9 33.8 77.7 32.2 45.5 47.8 61.4 57.8 27.4 39.5 56.7 37.4 28.2 50.8 56.5 57.6 62.2 69.5 57.6 67.8 60.5 77.1 32.4 50.3 26.2 74.4 27.0 36.3 31.8 29.9 43.5 57.8 32.8 36.5 43.8 64.6 39.2 14.7 26.8 61.6 67.8 30.7 48.9 62.0 51.4 101.1 59.5 28.2 50.1 46.9 26.6 37.6 55.6 56.7 62.6 28.8 6.8 13.5 11.0 8.0 18.1 8.7 12.0 8.9 8.1 12.4 10.8 7.7 7.5 6.8 12.1 18.0 5.0 9.4 10.0 16.3 17.9 18.4 23.3 17.6 19.7 25.2 18.1 26.4 18.6 18.8 21.4 78.5 86.6 84.8 85.8 76.1 41.7 62.6 62.7 51.8 28.6 42.5 34.0 53.4 62.9 80.6 64.4 52.1 53.0 58.5 299.9 37.2 67.2 85.3 121.6 84.0 68.8 36.1 40.6 83.5 78.3 52.8 54.3 96.8 77.8 53.7 53.0 54.3 57.3 60.6 25.2 69.2 97.1 63.1 93.0 44.7 50.4 74.0 85.0 28.4 75.9 71.0 23.1 42.2 96.0 161.7 122.5 127.1 80.5 46.9 56.5 130.2 61.0 130.9 49.9 46.0 42.3 50.4 93.0 48.4 61.5 43.2 96.6 55.2 47.7 86.7 70.3 ARPP21 "ARPP-21, R3HDM3, TARPP" ENSG00000172995 "CAMP regulated phosphoprotein 21" Q9UBL0 3 35638945-35794496 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 260.8;lymphoid tissue: 170.1;skeletal muscle: 85.6" "Group enriched" "Detected in some" 6 "Excitatory neurons: 861.9;Oligodendrocyte precursor cells: 624.8" "Cancer enriched" "Detected in single" 5 "glioma: 1.3" "Region enhanced" "Detected in many" "basal ganglia: 260.8" "Immune cell enriched" "Detected in single" 30 "plasmacytoid DC: 10.1" "Lineage enriched" "Detected in single" 30 "dendritic cells: 10.1" "Cell line enhanced" "Detected in some" "JURKAT: 111.4;MOLT-4: 68.4;REH: 37.3;RH-30: 20.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 254.3" HPA017303 Enhanced Supported Approved Nucleoli,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 10: Brain - Neuronal signaling" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoli Cytosol "HPA017303: AB_1845049" "unprognostic (1.72e-4)" "unprognostic (2.35e-1)" "unprognostic (1.10e-2)" "unprognostic (6.61e-2)" "unprognostic (6.30e-3)" "unprognostic (8.90e-2)" "unprognostic (2.42e-3)" "unprognostic (1.27e-1)" "unprognostic (7.42e-4)" "unprognostic (1.32e-1)" "unprognostic (2.35e-1)" "unprognostic (1.52e-1)" 0.2 0.2 34.8 0.4 260.8 4.5 0.1 85.2 69.9 0.0 0.0 0.4 0.2 0.0 0.0 2.6 0.0 0.0 0.2 48.5 15.7 1.1 2.3 0.1 0.1 14.3 7.8 0.0 0.1 0.0 12.6 0.0 15.6 1.1 0.4 2.9 2.1 0.2 85.6 0.2 0.3 0.0 0.0 0.2 0.2 0.0 9.1 170.1 0.5 48.6 0.4 0.0 0.0 44.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.6 0.0 5.2 0.0 0.0 0.0 0.6 0.0 111.4 0.0 0.2 2.6 0.0 68.4 0.0 0.1 0.0 2.7 37.3 20.6 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.1 0.0 0.0 34.8 260.8 85.2 69.9 48.5 15.7 14.3 7.8 15.6 0.0 9.1 44.5 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 1.8 0.0 0.2 0.2 0.0 0.0 861.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 108.2 0.0 0.0 0.0 0.0 3.5 0.3 0.1 0.0 21.5 0.1 0.0 0.0 624.8 85.7 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.5 0.0 21.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 STAC STAC1 ENSG00000144681 "SH3 and cysteine rich domain" Q99469 3 36380503-36548007 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 13.8" "Cell type enhanced" "Detected in some" "Distal tubular cells: 5.9;Early spermatids: 5.2;granulocytes: 6.3;Granulosa cells: 12.5;Late spermatids: 5.3;Muller glia cells: 21.6;Smooth muscle cells: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 1.5;NK-cell: 1.3;T-reg: 1.5" "Group enriched" "Detected in many" 5 "granulocytes: 1.5;NK-cells: 1.3;T-cells: 1.5" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 46.8;HaCaT: 34.1;SH-SY5Y: 49.1;U-251 MG: 30.3;U-87 MG: 48.1" "Low region specificity" "Detected in many" HPA035143 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Plasma membrane" "HPA035143: AB_10603892" "unprognostic (5.29e-2)" "unprognostic (7.61e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-6)" "unprognostic (4.24e-2)" "unprognostic (1.83e-2)" "unprognostic (3.06e-2)" "unprognostic (3.89e-1)" "unprognostic (2.02e-1)" "unprognostic (3.31e-3)" "unprognostic (1.77e-3)" "unprognostic (5.82e-2)" "unprognostic (8.07e-2)" "unprognostic (1.73e-4)" "unprognostic (8.93e-2)" "unprognostic (1.95e-1)" "unprognostic (7.94e-3)" 2.8 5.1 1.4 0.6 1.9 0.4 1.9 3.6 3.9 7.0 5.0 3.6 0.1 1.4 0.3 2.1 3.2 2.7 0.7 0.8 4.3 2.5 0.9 11.1 0.4 2.3 2.5 2.5 0.1 10.1 1.1 0.3 6.9 13.8 0.7 5.8 1.3 4.4 1.6 1.2 0.4 3.4 1.9 0.6 0.9 1.9 2.1 0.7 0.5 5.3 0.2 3.7 2.2 0.5 7.7 3.3 1.6 0.0 6.5 2.1 0.1 19.9 0.4 4.0 4.6 0.0 0.0 0.0 7.8 46.8 13.0 34.1 2.4 8.2 4.1 0.0 7.2 1.1 10.0 0.2 0.0 20.3 0.4 2.4 0.2 0.1 0.7 27.6 0.0 1.8 0.0 0.4 0.5 0.0 4.1 0.2 13.8 0.0 3.0 0.0 0.0 0.0 10.8 0.0 6.2 49.1 7.9 5.2 0.1 13.6 0.0 2.0 8.5 0.5 19.1 0.6 30.3 0.0 0.0 0.0 48.1 7.9 8.3 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.5 0.0 1.4 1.9 3.6 3.9 0.8 4.3 2.3 2.5 6.9 1.9 2.1 0.5 0.9 0.0 0.5 0.3 0.0 0.0 0.0 0.5 0.0 0.7 2.3 0.8 0.9 0.0 1.3 0.0 0.0 0.0 0.1 0.0 5.9 0.2 5.2 0.9 0.5 0.4 0.0 2.1 0.6 0.0 0.1 1.5 0.0 2.1 6.3 12.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 2.2 5.3 0.0 4.8 0.0 0.0 0.0 21.6 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.4 5.0 1.8 0.1 0.0 0.3 0.0 0.4 0.0 0.0 0.0 DCLK3 "DCAMKL3, DCDC3C, KIAA1765" ENSG00000163673 "Doublecortin like kinase 3" Q9C098 3 36712422-36764349 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;testis: 2.8" "Cell type enriched" "Detected in some" 6 "Early spermatids: 53.8" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.2" "Region enhanced" "Detected in some" "basal ganglia: 3.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040685, HPA053234" Approved Approved Vesicles,Cytosol NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" Cytosol Vesicles "HPA040685: AB_2732487, HPA053234: " "unprognostic (9.09e-3)" "unprognostic (1.41e-3)" "unprognostic (2.75e-1)" "unprognostic (2.66e-2)" "unprognostic (2.41e-1)" "unprognostic (1.80e-1)" "unprognostic (1.40e-2)" "unprognostic (1.08e-2)" "unprognostic (1.96e-2)" "unprognostic (1.86e-2)" "unprognostic (2.05e-1)" "unprognostic (7.07e-2)" "unprognostic (6.11e-5)" "unprognostic (7.94e-3)" "unprognostic (5.80e-2)" "unprognostic (3.25e-3)" "unprognostic (1.36e-2)" 0.5 0.1 0.9 0.4 3.9 0.1 0.2 0.1 1.8 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.8 0.7 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.2 1.0 0.3 0.0 0.0 0.1 1.5 0.1 0.0 0.9 0.1 0.1 0.3 1.4 0.0 0.0 2.8 0.7 1.3 0.3 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.9 0.1 1.8 0.8 0.7 0.3 0.2 0.0 1.4 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 53.8 0.1 0.1 0.5 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 2.0 0.0 0.9 0.0 0.0 0.0 0.4 8.9 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.5 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.1 3.3 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRANK1 "KIAA0342, LBA1" ENSG00000168016 "Tetratricopeptide repeat and ankyrin repeat containing 1" O15050 3 36826819-36945057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 45.0" "Cell type enhanced" "Detected in many" "Excitatory neurons: 56.5;Granulosa cells: 73.0;Inhibitory neurons: 91.8;Microglial cells: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 7 "neutrophil: 115.1" "Lineage enriched" "Detected in all" 7 "granulocytes: 115.1" "Cell line enhanced" "Detected in many" "Daudi: 67.9;HMC-1: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035508 Approved Approved Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA035508: AB_10671105" "unprognostic (7.11e-3)" "unprognostic (1.55e-2)" "unprognostic (3.05e-2)" "unprognostic (2.34e-1)" "unprognostic (4.84e-2)" "unprognostic (2.04e-3)" "unprognostic (9.13e-2)" "unprognostic (3.22e-1)" "unprognostic (1.76e-1)" "unprognostic (8.59e-2)" "unprognostic (3.83e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (2.52e-5)" "unprognostic (1.31e-1)" "unprognostic (3.69e-1)" "unprognostic (1.82e-3)" "unprognostic (1.07e-3)" 7.4 4.6 1.7 14.0 2.5 10.0 6.4 5.2 7.5 24.6 0.0 14.8 11.1 18.0 5.2 3.2 45.0 9.6 6.2 1.8 2.3 3.4 9.9 8.8 18.7 1.9 0.5 15.6 2.4 3.2 6.7 5.2 1.8 16.5 13.4 1.4 6.8 6.3 1.1 2.3 16.7 8.8 3.4 13.1 8.2 2.4 3.3 17.5 6.2 2.5 20.8 16.6 10.0 0.7 1.4 1.7 0.4 0.0 4.5 17.9 0.0 1.4 9.1 3.9 8.0 0.0 7.2 67.9 2.8 5.3 13.5 0.5 0.2 1.0 0.7 3.7 0.1 11.6 4.8 0.0 5.5 3.1 26.1 5.7 3.5 3.1 0.2 1.1 5.4 7.6 9.5 9.9 2.4 0.1 8.9 1.3 0.5 0.0 1.9 2.5 0.3 1.4 1.5 3.3 0.6 0.0 7.2 1.9 0.7 0.8 1.2 3.8 3.7 3.4 1.3 0.2 1.2 9.3 2.2 15.8 0.6 2.6 0.4 7.3 2.0 11.5 14.9 2.9 10.7 10.9 12.3 15.3 1.4 17.5 11.0 10.6 115.1 8.5 3.9 0.2 11.6 3.0 1.7 2.5 5.2 7.5 1.8 2.3 1.9 0.5 1.8 3.4 3.3 0.7 5.4 16.0 7.8 18.3 18.8 0.8 1.3 1.7 6.8 4.4 1.6 2.3 3.6 1.5 4.0 3.7 2.1 1.3 16.5 40.9 0.0 3.1 0.4 6.1 15.1 5.5 5.4 12.6 56.5 1.8 1.6 7.1 18.8 8.8 6.3 73.0 5.7 17.7 5.0 0.0 91.8 16.7 0.0 6.6 0.8 0.0 4.4 7.4 5.4 52.5 8.7 1.6 26.8 23.6 13.2 3.2 16.9 6.0 21.9 1.6 16.7 0.9 5.2 0.7 0.0 2.6 5.2 0.3 0.3 2.6 0.9 0.7 21.8 3.7 4.0 1.5 EPM2AIP1 "FLJ11207, KIAA0766" ENSG00000178567 "EPM2A interacting protein 1" Q7L775 3 36985043-36993131 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "unprognostic (7.24e-2)" "prognostic favorable (2.70e-4)" "unprognostic (6.24e-2)" "unprognostic (5.96e-2)" "unprognostic (2.60e-2)" "unprognostic (1.17e-2)" "unprognostic (2.28e-1)" "unprognostic (5.32e-3)" "unprognostic (1.71e-2)" "unprognostic (4.07e-2)" "unprognostic (1.22e-2)" "unprognostic (7.73e-2)" "unprognostic (4.30e-3)" "unprognostic (1.03e-2)" "unprognostic (1.35e-1)" "unprognostic (3.91e-2)" "unprognostic (2.25e-3)" 8.1 11.1 12.0 11.2 11.0 13.5 12.2 18.7 13.1 12.4 9.8 9.0 7.8 14.0 16.3 7.1 12.4 6.7 13.1 10.8 18.0 9.5 10.2 10.1 12.5 13.4 12.0 18.0 8.0 13.1 14.4 8.1 13.6 15.0 8.8 28.4 9.7 10.5 12.6 8.7 10.1 10.4 10.8 14.4 8.7 8.1 15.9 15.3 21.4 10.5 11.9 8.6 10.0 14.9 5.8 5.5 26.6 0.1 11.7 16.6 6.2 12.7 8.4 9.0 10.7 4.8 10.0 17.1 5.3 9.5 10.2 12.2 7.7 7.9 10.7 8.7 7.4 13.5 30.2 10.3 7.4 15.9 7.9 18.9 7.1 10.5 6.3 14.3 9.0 18.9 13.5 34.4 12.7 5.7 9.8 11.5 3.9 4.6 6.6 7.7 18.8 9.1 8.5 14.2 11.1 14.0 14.9 18.6 4.1 8.8 31.6 9.9 10.8 13.5 11.1 10.2 9.4 18.7 12.0 10.6 9.1 12.1 7.8 5.7 2.9 5.6 3.0 3.9 3.6 4.4 4.7 2.8 3.1 4.9 4.4 3.8 2.8 4.9 8.7 4.6 2.9 1.4 12.0 11.0 18.7 13.1 10.8 18.0 13.4 12.0 13.6 10.8 15.9 14.9 24.9 41.7 34.3 5.5 50.0 20.3 33.1 15.9 26.7 68.4 26.8 23.0 39.9 31.5 23.7 35.0 41.7 20.3 36.5 16.6 11.7 10.2 7.6 14.2 35.3 25.7 34.3 24.8 7.5 10.0 7.4 36.2 16.8 14.5 26.0 40.4 30.4 28.4 13.0 69.0 10.6 21.7 22.4 29.5 32.8 6.4 41.0 29.9 24.9 5.6 24.7 45.9 44.3 6.6 9.8 9.0 16.6 37.2 42.2 25.0 15.4 12.9 17.0 61.0 13.1 47.2 32.9 25.5 18.5 24.2 26.9 8.9 39.7 43.5 19.0 18.6 MLH1 "COCA2, FCC2, HNPCC, HNPCC2" ENSG00000076242 "MutL homolog 1" P40692 3 36993350-37050846 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013294, HPA052707, HPA060714, CAB070868" Supported Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "CAB013294: AB_2533406, CAB070868: , HPA052707: AB_2681923, HPA060714: AB_2684348" "unprognostic (1.26e-2)" "unprognostic (3.88e-3)" "unprognostic (2.36e-2)" "unprognostic (1.82e-1)" "unprognostic (3.33e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (8.24e-5)" "unprognostic (3.36e-2)" "unprognostic (2.18e-1)" "unprognostic (1.32e-1)" "unprognostic (8.54e-2)" "unprognostic (8.63e-3)" "unprognostic (2.10e-3)" "unprognostic (4.37e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (8.86e-2)" 15.6 17.9 7.3 17.4 8.0 22.1 15.4 7.1 9.1 17.4 7.6 17.4 12.0 16.3 14.0 14.3 14.9 11.1 35.4 6.9 8.3 16.0 19.1 15.8 21.9 8.6 7.4 15.1 16.6 22.4 22.7 14.8 7.6 16.2 14.5 9.6 12.1 14.0 49.1 13.4 13.4 19.2 7.1 18.8 15.5 25.4 7.7 28.4 19.2 42.2 24.3 17.2 14.0 9.0 37.1 56.7 66.7 0.2 25.9 34.5 30.7 54.7 44.4 64.1 62.3 43.4 40.1 92.2 25.0 44.1 33.6 24.7 65.2 45.8 68.5 42.2 32.1 68.1 42.3 54.9 23.2 81.9 40.5 28.4 29.0 54.8 57.8 21.9 37.6 55.0 86.0 32.0 66.2 27.6 81.0 22.2 49.4 38.4 31.6 4.6 90.6 40.2 35.1 39.3 14.2 36.1 52.1 56.9 32.7 33.3 79.9 55.6 28.8 46.0 50.5 44.0 65.9 29.1 93.7 88.1 37.8 71.9 45.7 12.6 12.5 15.1 12.7 22.6 9.8 11.3 7.7 11.4 14.3 9.7 8.4 9.6 2.6 7.8 29.2 5.9 15.0 11.0 7.3 8.0 7.1 9.1 6.9 8.3 8.6 7.4 7.6 7.1 7.7 9.0 10.8 25.6 15.8 22.9 18.5 7.1 12.4 18.7 7.4 18.5 9.6 9.7 41.8 12.8 15.8 11.0 10.4 33.4 16.0 6.1 19.6 14.6 31.3 12.5 11.3 10.7 5.4 19.0 18.5 14.7 26.9 14.4 12.2 9.5 7.6 13.0 13.6 14.9 20.1 3.3 21.6 8.6 16.2 16.3 8.9 13.2 11.1 13.8 8.8 10.3 18.2 15.9 11.3 27.2 31.3 9.3 7.4 13.9 22.1 6.4 5.3 12.9 16.5 18.1 13.1 10.0 14.0 58.6 29.3 9.3 5.5 20.0 15.9 14.8 8.4 6.5 LRRFIP2 HUFI-2 ENSG00000093167 "LRR binding FLII interacting protein 2" Q9Y608 3 37052626-37183689 "Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 516.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035956, HPA042023" Uncertain Approved "Plasma membrane,Actin filaments" NA NA 150000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane, Actin filaments" "HPA035956: AB_10671238, HPA042023: AB_2677802" "unprognostic (2.03e-3)" "prognostic favorable (6.31e-4)" "unprognostic (1.16e-2)" "unprognostic (7.90e-2)" "unprognostic (2.48e-1)" "unprognostic (2.97e-1)" "unprognostic (5.41e-2)" "unprognostic (1.82e-1)" "unprognostic (3.09e-2)" "unprognostic (2.56e-2)" "unprognostic (4.99e-3)" "unprognostic (1.98e-1)" "unprognostic (4.13e-3)" "unprognostic (2.62e-1)" "unprognostic (1.37e-1)" "unprognostic (4.84e-3)" "unprognostic (3.76e-2)" 23.4 24.0 43.7 20.1 46.9 44.3 22.3 43.6 49.0 46.0 33.6 38.3 35.4 31.8 19.7 52.6 25.8 22.0 75.8 38.8 44.4 24.0 48.5 27.0 18.1 43.4 42.0 27.4 19.2 33.3 18.6 20.8 44.8 41.0 34.2 36.0 28.5 24.3 97.9 37.0 36.2 31.5 41.0 45.0 26.5 71.8 46.4 18.8 27.5 45.3 23.2 24.2 40.9 60.9 56.6 30.8 34.9 27.7 45.5 69.3 30.5 149.9 148.2 82.6 94.3 29.0 25.3 22.2 24.0 145.4 40.8 28.8 25.8 74.2 134.3 49.7 20.2 39.8 44.0 28.6 64.8 31.9 23.3 31.1 52.1 107.8 110.4 45.8 58.2 34.0 32.3 37.8 69.5 14.4 27.2 17.0 23.0 23.0 39.2 13.0 99.2 22.6 58.4 21.7 12.6 19.9 57.9 53.0 49.4 28.0 30.6 32.6 56.5 63.1 42.6 93.4 71.5 29.1 57.1 33.9 37.1 28.1 91.4 20.5 21.4 33.8 8.8 14.9 11.3 9.7 9.3 9.5 14.1 8.5 6.8 8.3 19.2 16.9 26.9 7.9 13.0 11.7 43.7 46.9 43.6 49.0 38.8 44.4 43.4 42.0 44.8 41.0 46.4 60.9 47.8 28.9 36.5 98.6 29.1 136.1 143.0 41.3 113.8 36.3 64.7 53.2 123.1 38.6 53.7 23.9 29.2 29.2 28.7 117.2 64.6 89.8 516.2 78.9 44.0 59.9 54.0 60.0 169.8 94.3 46.1 57.4 37.8 127.3 52.6 29.4 56.7 58.8 24.9 122.8 197.7 45.6 28.5 35.6 128.3 330.7 42.3 48.2 74.7 62.8 67.7 51.9 30.9 130.7 309.0 109.9 90.1 57.6 45.8 325.6 125.8 46.1 36.2 51.9 39.5 32.4 72.8 159.9 73.4 139.3 170.5 39.3 34.1 90.0 66.0 303.2 GOLGA4 "GCP2, GOLG, golgin-240, p230" ENSG00000144674 "Golgin A4" Q13439 3 37243177-37366751 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 683.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035102, HPA040675" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus" Nucleoplasm "HPA035102: AB_10601472, HPA040675: " "unprognostic (9.46e-2)" "unprognostic (1.55e-1)" "unprognostic (1.18e-2)" "unprognostic (5.67e-2)" "unprognostic (1.44e-1)" "unprognostic (1.54e-1)" "unprognostic (5.61e-2)" "unprognostic (1.38e-1)" "unprognostic (5.79e-3)" "unprognostic (3.90e-2)" "unprognostic (5.62e-2)" "unprognostic (8.55e-2)" "prognostic favorable (3.62e-6)" "unprognostic (7.16e-2)" "unprognostic (1.04e-1)" "unprognostic (3.92e-2)" "unprognostic (1.33e-1)" 38.6 36.3 18.3 19.5 26.7 21.2 28.8 26.6 22.3 27.6 58.3 28.1 38.8 20.0 23.5 37.3 21.1 19.3 63.7 17.6 20.8 34.5 60.8 25.7 17.0 27.2 24.6 23.4 48.0 33.5 40.6 36.1 27.5 29.6 28.1 56.8 38.4 20.7 118.8 48.2 36.9 19.5 21.8 24.1 38.2 44.3 22.3 17.6 47.2 102.3 19.6 25.0 28.9 29.9 62.6 42.3 21.4 27.1 55.2 47.2 54.4 78.3 65.2 30.2 36.3 36.5 33.9 21.4 19.9 67.1 34.7 35.9 34.4 55.5 62.3 27.4 25.2 28.9 37.9 58.5 55.2 30.9 20.3 25.4 51.8 47.7 92.1 48.8 44.4 15.8 35.9 32.6 49.1 26.8 23.7 13.4 23.4 31.7 39.9 5.4 64.8 22.8 37.4 64.4 13.7 18.1 48.6 51.8 61.4 40.8 76.3 22.4 54.0 30.7 35.6 60.0 56.7 39.8 30.1 18.3 54.4 26.6 36.8 30.7 6.6 15.5 16.2 7.6 14.0 9.9 10.3 11.9 5.5 11.6 10.7 8.1 8.9 15.7 15.2 11.8 7.6 4.3 18.3 26.7 26.6 22.3 17.6 20.8 27.2 24.6 27.5 21.8 22.3 29.9 85.4 237.2 312.9 142.0 98.2 158.3 134.0 70.2 128.1 171.9 97.0 84.1 683.5 84.4 147.4 46.0 358.6 112.7 126.4 154.3 29.4 117.5 240.7 131.6 141.8 102.2 89.6 127.1 154.5 120.2 117.8 128.0 140.2 242.7 62.0 112.9 63.1 147.5 92.0 188.4 168.6 166.2 65.1 73.1 73.9 46.7 119.9 80.3 69.4 107.7 91.9 145.8 132.8 133.7 223.2 136.4 109.1 113.6 150.2 169.7 181.2 64.5 82.4 361.0 85.5 161.8 95.7 435.6 227.2 98.5 175.7 249.6 97.2 125.7 139.3 189.2 ITGA9 "ALPHA-RLC, ITGA4L, RLC" ENSG00000144668 "Integrin subunit alpha 9" Q13797 3 37452115-37823507 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 82.0;Hepatic stellate cells: 54.3;Inhibitory neurons: 61.0;Leydig cells: 41.3;Microglial cells: 53.4;Oligodendrocyte precursor cells: 93.5;Peritubular cells: 74.9" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 23.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 10.1;HEL: 8.1;SH-SY5Y: 11.8;SuSa: 16.9;WM-115: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030609 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 500000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "Nucleoplasm, Plasma membrane, Cell Junctions" "HPA030609: AB_10600815" "unprognostic (2.35e-2)" "unprognostic (3.36e-2)" "unprognostic (5.58e-2)" "unprognostic (3.94e-2)" "unprognostic (4.48e-2)" "unprognostic (2.85e-2)" "unprognostic (3.10e-1)" "unprognostic (8.87e-3)" "unprognostic (3.23e-1)" "unprognostic (2.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.51e-1)" "unprognostic (1.78e-2)" "unprognostic (1.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.72e-2)" "unprognostic (3.16e-2)" 8.8 15.5 1.9 4.5 1.8 8.5 5.9 0.0 6.2 21.8 3.6 9.6 6.3 10.6 4.0 15.5 5.4 9.4 20.1 7.8 0.7 4.0 14.8 8.9 4.1 0.9 1.3 5.0 1.8 2.6 1.7 9.8 0.4 12.5 6.8 0.7 4.2 10.8 2.8 3.0 9.1 15.8 0.7 22.6 7.5 6.9 5.0 1.8 20.7 9.8 2.4 6.5 4.5 1.2 0.2 0.0 4.3 0.3 0.0 0.2 0.1 0.1 0.0 0.0 0.0 10.1 0.0 3.2 1.4 0.0 0.1 0.2 3.8 0.0 0.0 0.1 0.6 8.1 0.1 0.2 0.2 0.0 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.4 0.3 0.0 0.2 0.5 11.8 0.1 0.5 0.7 16.9 0.0 3.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.1 0.2 6.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.8 0.0 6.2 7.8 0.7 0.9 1.3 0.4 0.7 5.0 1.2 20.8 0.0 14.7 16.0 0.1 2.5 1.1 0.1 1.2 1.2 1.1 2.9 12.9 2.8 3.1 1.8 0.0 0.2 0.0 0.0 0.0 0.1 1.5 1.4 4.9 21.6 0.0 3.0 82.0 0.0 0.5 7.5 0.0 0.9 6.3 36.2 54.3 1.3 2.8 0.0 61.0 0.1 0.0 31.9 2.2 4.2 41.3 5.7 3.6 53.4 0.1 0.6 0.0 93.5 6.2 0.0 0.0 74.9 0.4 0.2 0.0 0.1 0.0 0.0 0.0 3.2 3.3 0.6 0.9 0.0 1.7 0.3 1.8 25.9 0.4 0.3 CTDSPL "C3orf8, HYA22, PSR1, RBSP3, SCP3" ENSG00000144677 "CTD small phosphatase like" O15194 3 37861880-37984469 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 170.4;Excitatory neurons: 189.3;Inhibitory neurons: 126.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 132.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048325 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles Nucleoplasm "HPA048325: AB_2680359" "unprognostic (7.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.21e-1)" "unprognostic (6.48e-3)" "unprognostic (1.73e-1)" "unprognostic (3.35e-2)" "unprognostic (1.66e-3)" "unprognostic (4.30e-2)" "unprognostic (1.96e-1)" "unprognostic (2.55e-1)" "unprognostic (2.98e-3)" "unprognostic (1.20e-1)" "prognostic favorable (6.22e-14)" "unprognostic (3.48e-2)" "unprognostic (6.84e-2)" "unprognostic (1.94e-1)" "unprognostic (2.67e-2)" 21.1 9.2 19.4 6.3 20.6 10.0 28.1 24.3 23.2 20.3 17.1 33.4 14.3 20.2 14.0 23.8 17.9 29.3 29.4 18.8 17.3 39.7 21.5 27.2 4.1 19.2 17.7 19.6 15.8 12.0 10.7 31.7 16.6 26.5 30.2 3.2 27.1 31.3 21.2 52.9 17.6 23.2 18.1 17.3 31.7 10.6 19.5 7.2 14.0 19.9 5.5 26.4 19.1 17.3 44.5 18.9 7.6 24.0 29.2 41.0 57.2 30.0 37.0 20.1 23.5 27.4 35.3 0.2 17.9 36.9 8.4 36.3 19.2 56.1 16.0 0.1 15.1 27.2 18.8 63.1 26.4 0.0 6.4 21.5 132.3 21.2 25.5 22.4 28.2 12.0 8.9 0.0 33.7 13.7 11.1 0.1 31.5 17.7 2.7 12.3 14.9 0.2 63.3 28.7 6.3 19.9 16.5 28.7 33.5 30.5 28.1 7.3 23.2 14.4 20.4 27.3 19.1 0.6 0.2 0.2 15.8 14.8 27.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 2.1 19.4 20.6 24.3 23.2 18.8 17.3 19.2 17.7 16.6 18.1 19.5 17.3 26.8 67.3 27.6 170.4 1.2 30.1 17.0 17.7 27.9 10.1 25.7 59.4 42.2 65.8 25.7 23.9 0.0 34.7 1.0 35.6 23.5 14.2 21.5 7.6 17.6 22.4 45.2 7.8 189.3 4.7 9.9 32.4 10.2 27.2 1.3 15.7 22.9 18.1 7.2 10.1 126.3 18.5 2.0 13.3 6.5 51.3 71.7 11.3 8.8 22.5 1.4 9.5 1.0 87.4 48.8 14.2 17.9 98.2 0.4 15.5 9.1 19.7 12.4 1.7 26.3 55.4 40.4 10.0 16.9 17.7 28.7 9.4 2.0 65.8 42.0 14.4 VILL ENSG00000136059 "Villin like" O15195 3 37988059-38007188 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "intestine: 61.9;stomach 1: 97.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 221.7;Gastric mucus-secreting cells: 192.7;Paneth cells: 139.0;Proximal enterocytes: 165.6" "Cancer enhanced" "Detected in many" "pancreatic cancer: 22.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 25.0;OE19: 78.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA035675, HPA035676" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Cytosol" "Nucleoli fibrillar center" "HPA035675: AB_10671223, HPA035676: " "unprognostic (7.86e-3)" "unprognostic (7.37e-3)" "unprognostic (1.43e-1)" "unprognostic (2.03e-2)" "prognostic unfavorable (1.35e-4)" "prognostic favorable (1.75e-4)" "unprognostic (1.69e-1)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.03e-2)" "unprognostic (2.95e-2)" "unprognostic (3.66e-3)" "unprognostic (5.55e-2)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (7.43e-3)" 5.4 3.7 8.7 11.0 9.0 12.6 6.4 6.6 10.6 9.5 6.4 46.8 61.9 5.7 1.5 7.2 6.7 15.7 6.4 8.6 7.8 5.3 1.4 7.7 9.8 8.3 8.4 6.8 3.4 1.2 5.1 4.1 8.0 16.0 26.6 1.2 5.7 4.0 1.2 9.1 61.7 4.1 8.0 11.8 97.5 5.4 8.2 10.2 7.4 1.4 6.3 17.5 7.4 7.2 8.2 0.1 0.2 0.4 2.8 2.2 0.8 2.3 1.9 2.3 2.2 6.1 25.0 3.9 3.5 1.6 0.0 1.9 1.8 0.2 0.5 0.8 0.0 7.3 0.1 0.6 3.4 7.7 9.5 3.3 2.2 2.2 0.0 0.0 4.5 16.1 7.3 2.3 2.6 0.1 12.4 8.7 0.2 78.4 0.0 4.8 0.0 2.0 0.8 9.8 0.1 0.3 0.0 0.5 1.8 0.0 0.7 12.4 2.8 1.0 0.3 3.0 0.0 1.4 3.1 1.2 0.6 10.9 5.0 0.0 3.2 0.0 6.8 2.0 7.4 3.5 4.4 3.9 2.1 4.6 5.6 4.2 0.1 3.4 1.4 3.8 5.8 4.1 8.7 9.0 6.6 10.6 8.6 7.8 8.3 8.4 8.0 8.0 8.2 7.2 4.9 9.6 7.4 10.4 7.2 2.3 5.7 25.5 6.8 0.9 3.3 2.9 1.9 8.6 46.1 0.0 0.0 3.0 13.3 221.7 0.0 3.4 6.2 1.5 2.7 4.5 9.6 6.1 5.5 16.9 3.4 6.7 192.7 1.5 8.2 6.1 5.3 0.3 2.4 1.7 3.0 64.4 14.2 1.9 2.4 19.9 3.7 4.0 1.8 3.7 4.2 28.1 7.2 2.5 1.2 38.7 139.0 2.6 4.4 6.2 165.6 1.6 40.5 0.8 0.0 4.3 7.1 5.4 3.4 3.1 1.4 1.0 8.1 5.6 50.5 33.4 PLCD1 ENSG00000187091 "Phospholipase C delta 1" P51178 3 38007496-38029642 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 89.5;Theca cells: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 25.3;fHDF/TERT166: 26.3;hTCEpi: 31.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009913, HPA020107, HPA021677" Approved Approved Microtubules NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" Microtubules "CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319" "unprognostic (1.75e-3)" "unprognostic (1.01e-2)" "unprognostic (4.29e-2)" "unprognostic (1.45e-2)" "unprognostic (3.44e-1)" "unprognostic (9.67e-3)" "unprognostic (1.55e-1)" "unprognostic (7.25e-3)" "unprognostic (3.95e-1)" "unprognostic (1.45e-1)" "unprognostic (2.80e-1)" "unprognostic (2.24e-1)" "prognostic favorable (9.25e-11)" "unprognostic (1.50e-1)" "unprognostic (7.71e-2)" "unprognostic (2.93e-1)" "unprognostic (7.88e-2)" 14.8 12.9 14.3 4.6 16.1 4.3 10.6 15.4 15.6 15.9 9.7 15.7 4.9 11.5 4.2 26.2 9.8 5.6 7.2 12.8 19.0 10.1 5.4 11.3 6.6 20.3 18.5 12.7 6.0 3.9 9.3 3.8 19.6 9.1 10.1 2.8 13.0 8.8 2.9 18.5 8.3 5.6 19.4 7.2 8.3 32.6 16.9 9.1 8.3 4.1 6.6 15.7 19.0 21.9 1.0 2.7 9.4 2.6 25.3 22.2 2.8 2.8 11.1 4.2 6.4 1.0 2.3 0.6 1.4 26.3 2.9 15.0 4.8 3.0 1.3 3.9 1.2 0.5 1.7 4.7 14.7 0.0 1.6 18.0 31.6 12.9 1.7 9.4 8.2 2.2 16.3 1.3 9.6 1.2 2.2 1.1 2.4 5.5 2.7 0.9 1.3 3.6 5.1 5.0 0.1 2.6 0.8 12.4 3.2 3.1 2.7 1.2 4.4 2.5 6.3 6.7 0.1 5.2 2.2 0.6 6.4 0.1 1.3 14.6 2.7 0.2 13.0 3.7 15.2 1.3 16.9 12.8 3.8 0.6 10.1 7.9 9.9 5.9 2.2 2.0 16.6 7.4 14.3 16.1 15.4 15.6 12.8 19.0 20.3 18.5 19.6 19.4 16.9 21.9 5.2 3.2 7.5 22.9 3.6 2.8 12.4 9.6 8.0 0.9 5.4 6.1 4.7 8.6 7.3 9.2 2.1 1.8 4.2 89.5 3.9 11.4 1.7 3.3 11.3 8.1 4.9 3.6 1.9 3.0 5.1 10.2 6.6 3.8 4.5 3.6 20.0 4.1 4.0 3.3 2.3 28.3 10.2 3.8 14.5 3.6 12.8 4.3 1.8 3.7 3.4 13.3 1.0 7.1 2.2 4.1 34.7 14.3 5.9 13.2 10.0 5.8 6.2 1.7 6.6 5.4 7.2 3.1 3.7 12.6 5.8 0.8 7.4 53.4 11.3 14.7 DLEC1 "CFAP81, DLC1, FAP81" ENSG00000008226 "DLEC1 cilia and flagella associated protein" Q9Y238 3 38039205-38124025 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 14.7;fallopian tube: 27.9;testis: 13.2" "Group enriched" "Detected in many" 4 "Endometrial ciliated cells: 45.0;Respiratory ciliated cells: 74.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019077 Enhanced Supported Cytosol NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA019077: AB_1847724" "unprognostic (1.24e-4)" "unprognostic (3.60e-3)" "unprognostic (2.11e-1)" "unprognostic (1.09e-3)" "unprognostic (2.32e-1)" "unprognostic (1.76e-3)" "unprognostic (2.50e-3)" "unprognostic (8.54e-3)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (9.53e-2)" "unprognostic (7.62e-2)" "unprognostic (8.70e-4)" "unprognostic (1.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.89e-2)" "unprognostic (1.94e-4)" 1.2 0.3 2.3 0.3 2.1 0.9 0.4 1.6 1.2 3.5 14.7 0.3 0.4 0.5 4.1 0.1 27.9 0.6 0.2 2.5 2.9 0.3 0.1 4.8 0.4 6.6 8.6 0.9 0.1 0.1 9.6 0.1 4.7 0.9 0.4 0.0 0.9 0.5 0.0 0.4 0.4 0.1 5.3 0.5 0.3 13.2 3.2 0.1 1.1 0.0 0.3 0.2 0.1 2.5 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 2.1 1.6 1.2 2.5 2.9 6.6 8.6 4.7 5.3 3.2 2.5 0.0 3.2 3.0 2.9 0.4 0.5 0.5 3.0 1.2 1.2 0.4 0.4 0.7 0.0 14.1 0.0 0.0 0.1 0.4 1.2 0.0 0.1 4.5 45.0 1.2 0.6 1.2 0.8 1.1 0.2 0.1 1.3 0.0 1.4 2.5 0.2 0.0 0.3 0.5 0.0 0.9 0.7 6.1 0.6 1.2 6.6 0.9 1.1 0.0 2.8 0.8 0.2 2.1 0.5 0.3 0.1 1.4 0.0 2.8 0.5 0.7 0.5 74.4 0.8 0.0 0.7 1.5 6.7 1.3 1.0 0.3 0.1 1.3 0.4 0.2 0.4 ACAA1 ENSG00000060971 "Acetyl-CoA acyltransferase 1" P09110 3 38103129-38137242 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 212.6;liver: 659.3" "Cell type enhanced" "Detected in all" "Distal enterocytes: 356.8;Hepatocytes: 686.0;Proximal enterocytes: 441.1;Proximal tubular cells: 721.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 224.0;SK-BR-3: 342.9" "Low region specificity" "Detected in all" "HPA006764, HPA007244" Enhanced Supported Peroxisomes NA NA 4700000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Peroxisomes "HPA006764: AB_1078085, HPA007244: AB_1078084" "prognostic favorable (3.00e-4)" "unprognostic (5.57e-2)" "unprognostic (4.54e-2)" "prognostic favorable (7.53e-4)" "unprognostic (2.63e-1)" "prognostic favorable (1.23e-4)" "unprognostic (9.35e-3)" "unprognostic (2.91e-2)" "unprognostic (8.11e-2)" "unprognostic (2.22e-1)" "unprognostic (2.24e-1)" "unprognostic (4.90e-1)" "prognostic favorable (6.99e-9)" "unprognostic (1.72e-1)" "unprognostic (1.99e-1)" "unprognostic (2.50e-2)" "unprognostic (1.65e-2)" 42.8 54.1 47.5 24.0 54.4 44.7 41.2 54.3 49.5 28.3 42.3 56.9 101.0 20.8 44.6 56.7 19.4 29.8 84.8 44.6 48.7 212.6 659.3 34.9 26.1 54.2 50.4 20.9 59.3 47.9 24.8 17.2 53.0 55.1 51.2 4.9 38.9 25.3 48.2 30.7 89.5 18.7 50.9 41.3 42.1 15.5 53.6 28.0 32.1 53.8 30.0 43.7 33.5 54.9 35.5 39.8 13.0 40.7 55.6 32.2 44.6 32.2 47.0 36.3 34.5 52.8 38.8 21.1 22.6 52.0 17.4 24.5 34.9 54.0 20.0 31.0 37.2 27.0 35.4 155.5 35.3 63.3 59.8 59.0 39.3 31.2 22.5 23.9 49.9 49.7 26.2 24.2 41.3 49.2 60.3 45.3 13.3 224.0 47.0 13.9 25.0 34.3 103.4 110.4 10.9 16.5 31.7 342.9 23.7 18.0 35.1 48.9 36.8 21.9 21.1 43.2 44.2 31.9 21.7 16.1 34.8 54.4 34.7 79.9 114.4 130.4 48.8 159.1 41.2 33.9 45.7 47.4 178.1 36.0 45.2 42.5 76.3 71.9 187.7 104.5 77.2 82.1 47.5 54.4 54.3 49.5 44.6 48.7 54.2 50.4 53.0 50.9 53.6 54.9 30.7 41.7 38.7 50.6 45.6 33.3 56.5 57.6 40.9 36.9 48.7 37.1 3.2 98.7 44.3 66.2 14.6 91.6 61.7 356.8 166.3 98.0 4.5 40.7 38.6 25.4 55.1 40.4 25.6 78.4 64.5 34.4 76.5 39.1 19.0 32.5 37.1 686.0 81.7 8.4 24.7 73.1 48.8 93.5 86.8 9.6 35.8 83.2 58.7 14.0 89.5 43.1 53.5 12.5 30.9 100.9 270.6 33.1 44.5 60.6 441.1 721.8 26.3 16.7 32.9 28.5 27.4 19.8 11.7 48.1 35.5 99.3 44.4 186.7 84.3 87.0 MYD88 ENSG00000172936 "MYD88 innate immune signal transduction adaptor" Q99836 3 38138478-38143022 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Kupffer cells: 75.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 172.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009104 Approved Supported Vesicles,Mitochondria,Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "Vesicles, Mitochondria" "CAB009104: AB_2146724" "prognostic favorable (8.45e-4)" "unprognostic (1.19e-1)" "unprognostic (4.31e-2)" "unprognostic (2.51e-2)" "unprognostic (4.77e-2)" "unprognostic (4.38e-3)" "unprognostic (4.37e-2)" "unprognostic (3.63e-1)" "unprognostic (1.67e-1)" "unprognostic (7.28e-2)" "unprognostic (1.01e-2)" "unprognostic (7.30e-2)" "unprognostic (2.11e-2)" "unprognostic (4.41e-1)" "unprognostic (4.17e-2)" "unprognostic (1.65e-1)" "unprognostic (2.08e-2)" 20.1 14.2 6.9 43.5 7.4 51.8 15.0 7.2 7.5 15.2 8.0 30.3 32.2 12.1 18.6 36.6 14.4 23.5 9.4 6.7 7.7 13.7 61.1 42.6 35.2 9.5 7.5 11.4 11.6 11.6 9.2 22.6 8.0 14.3 31.7 2.1 18.0 12.0 3.2 17.7 32.2 24.5 8.6 40.7 27.6 7.7 9.2 38.3 9.4 8.8 41.6 47.4 20.3 8.5 25.1 34.2 5.9 33.2 25.0 32.0 10.8 23.6 39.0 68.1 72.9 22.7 30.9 52.8 13.8 44.7 15.8 30.9 43.2 24.2 22.1 39.5 8.7 28.5 16.6 36.6 21.4 36.2 72.0 38.4 26.6 39.2 15.3 13.2 39.9 40.3 13.3 22.3 36.8 25.7 61.3 12.2 22.1 52.8 35.7 24.8 7.0 23.1 37.6 58.9 3.0 12.0 33.4 172.1 22.3 4.8 25.8 40.8 35.5 13.8 7.9 60.6 24.0 28.9 32.9 38.5 25.0 63.0 28.9 288.5 236.9 296.9 67.2 333.6 58.1 43.7 60.6 69.3 203.6 35.2 42.1 59.5 284.7 54.6 436.1 99.9 87.4 257.3 6.9 7.4 7.2 7.5 6.7 7.7 9.5 7.5 8.0 8.6 9.2 8.5 13.4 6.4 15.2 2.0 19.5 14.4 13.5 12.7 14.2 1.0 11.3 10.8 1.6 5.7 16.4 5.5 0.0 14.6 35.3 40.8 7.9 24.5 1.4 10.9 30.2 15.9 9.6 9.7 0.2 27.3 24.4 10.8 23.9 18.6 24.1 10.0 10.4 33.2 32.2 0.0 0.4 14.9 10.2 75.4 40.5 0.9 13.7 61.5 3.6 1.9 58.1 4.1 28.8 2.5 0.3 64.0 34.8 10.5 12.9 16.0 28.0 12.2 12.1 0.1 13.1 4.3 7.2 8.6 0.6 15.1 17.2 12.0 19.6 10.2 15.9 49.4 OXSR1 "KIAA1101, OSR1" ENSG00000172939 "Oxidative stress responsive kinase 1" O95747 3 38165089-38255484 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008237, CAB017181" Supported Enhanced Cytosol NA NA 300000 "Cluster 38: Basophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 41: Macrophages - Immune response" Cytosol "CAB017181: , HPA008237: AB_1079540" "unprognostic (2.16e-1)" "unprognostic (2.36e-2)" "unprognostic (1.79e-2)" "unprognostic (4.55e-3)" "unprognostic (9.89e-2)" "unprognostic (1.97e-2)" "unprognostic (3.53e-3)" "unprognostic (4.05e-2)" "unprognostic (4.44e-1)" "unprognostic (6.06e-2)" "unprognostic (3.95e-3)" "unprognostic (1.88e-2)" "unprognostic (1.87e-3)" "unprognostic (1.56e-1)" "unprognostic (3.14e-2)" "unprognostic (1.71e-1)" "unprognostic (6.99e-3)" 18.4 17.2 9.7 15.7 10.0 33.8 15.6 13.6 12.5 17.8 13.0 18.3 15.2 14.8 15.6 34.1 12.8 15.1 16.9 9.9 10.8 21.5 18.6 15.5 18.5 11.0 11.0 16.1 12.1 26.3 11.5 16.5 11.1 16.5 19.7 13.0 15.2 16.3 36.7 19.5 15.7 17.6 10.2 15.0 16.8 14.1 11.0 25.1 14.8 35.4 23.4 26.7 21.1 11.2 48.5 21.9 42.5 29.8 29.0 33.3 48.2 41.9 57.1 59.2 63.8 28.3 30.8 53.4 20.8 50.5 25.4 29.4 57.8 43.1 77.5 57.6 24.5 58.6 46.1 31.1 34.6 36.6 34.2 26.6 49.6 54.8 87.8 55.7 37.5 67.7 45.2 29.9 102.7 13.7 71.1 26.4 44.8 31.2 26.1 24.2 35.7 41.4 36.4 36.4 22.0 34.0 45.9 114.2 29.0 46.3 37.7 23.7 34.4 37.0 36.6 56.8 63.0 22.7 29.0 38.7 50.7 44.6 75.3 6.8 1.6 3.9 1.8 2.8 1.9 1.0 2.2 1.7 2.6 1.2 1.7 2.1 3.2 3.1 2.5 1.4 2.8 0.9 9.7 10.0 13.6 12.5 9.9 10.8 11.0 11.0 11.1 10.2 11.0 11.2 19.0 12.8 25.8 46.7 27.3 44.1 35.5 25.3 26.7 13.3 19.4 16.5 32.6 4.3 27.6 27.6 20.9 12.1 27.4 44.0 19.6 28.4 3.9 39.9 32.1 19.0 24.1 29.7 59.6 14.5 21.0 18.4 90.7 91.2 15.8 24.9 14.6 20.5 14.9 21.9 51.9 24.5 10.2 29.8 79.0 2.3 9.6 58.0 7.2 29.0 35.2 8.0 18.6 44.7 42.8 46.5 29.4 12.8 19.5 56.5 27.0 22.5 16.1 7.0 13.1 23.7 22.6 15.1 18.5 41.9 51.9 33.0 29.6 19.6 21.6 115.3 SLC22A13 "OAT10, OCTL1, OCTL3, ORCTL3" ENSG00000172940 "Solute carrier family 22 member 13" Q9Y226 3 38265812-38278757 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "kidney: 9.0" "Group enriched" "Detected in some" 12 "Excitatory neurons: 2.3;Inhibitory neurons: 1.8;Proximal tubular cells: 7.1" "Cancer enriched" "Detected in single" 7 "renal cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA035603, HPA035962" Enhanced NA NA "Cluster 35: T-regs - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA035603: AB_10672869, HPA035962: AB_2674890" "unprognostic (2.73e-2)" "unprognostic (6.70e-2)" "unprognostic (2.80e-1)" "unprognostic (5.68e-2)" "unprognostic (7.13e-3)" "unprognostic (3.50e-3)" "unprognostic (6.83e-2)" "unprognostic (1.49e-1)" "unprognostic (3.48e-1)" "unprognostic (2.09e-1)" "unprognostic (3.04e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-5)" "unprognostic (3.39e-1)" "unprognostic (1.96e-2)" "unprognostic (5.24e-2)" "unprognostic (2.74e-1)" 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.4 0.8 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC22A14 "OCTL2, ORCTL4" ENSG00000144671 "Solute carrier family 22 member 14" Q9Y267 3 38282294-38318575 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 11.6" "Group enriched" "Detected in some" 7 "Early spermatids: 70.1;Late spermatids: 101.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 78: Testis - Spermatogenesis" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (6.26e-2)" "unprognostic (6.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.17e-1)" "unprognostic (6.25e-2)" "unprognostic (4.78e-2)" "unprognostic (2.33e-1)" "unprognostic (1.52e-1)" "unprognostic (1.07e-1)" "unprognostic (4.97e-2)" "unprognostic (4.81e-2)" "unprognostic (1.69e-1)" "unprognostic (3.57e-4)" "unprognostic (2.19e-1)" "unprognostic (4.02e-2)" "unprognostic (1.69e-1)" "unprognostic (2.35e-1)" 0.1 0.0 0.6 0.0 0.6 0.3 0.1 0.7 2.1 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.6 0.0 0.6 0.2 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.3 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 11.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.1 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.6 0.7 2.1 0.6 0.0 0.5 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.1 0.0 1.0 0.2 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 70.1 0.5 0.2 0.1 0.0 0.0 11.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.1 1.7 8.3 0.0 0.0 0.0 0.0 101.8 0.9 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.7 0.5 0.0 0.0 0.1 0.3 0.1 0.3 0.0 0.1 0.0 0.1 0.2 1.4 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 XYLB "FLJ10343, FLJ12539" ENSG00000093217 Xylulokinase O75191 3 38346760-38421348 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Xylose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 33.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 39.3;Hepatocytes: 49.3;Inhibitory neurons: 35.9;Proximal tubular cells: 31.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 5.4" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA037863, HPA038415" Uncertain Approved "Nuclear speckles" NA NA 12000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nuclear speckles" "HPA037863: AB_10672729, HPA038415: AB_10672592" "unprognostic (2.48e-1)" "unprognostic (9.72e-2)" "unprognostic (3.42e-2)" "unprognostic (6.25e-2)" "unprognostic (7.52e-2)" "unprognostic (5.19e-2)" "unprognostic (5.82e-2)" "unprognostic (1.26e-3)" "unprognostic (6.55e-2)" "unprognostic (2.22e-1)" "unprognostic (6.91e-3)" "unprognostic (4.63e-2)" "prognostic favorable (8.57e-4)" "unprognostic (3.26e-1)" "unprognostic (2.06e-1)" "unprognostic (5.78e-2)" "unprognostic (3.37e-2)" 1.4 2.3 1.3 1.5 1.0 2.2 3.0 5.4 2.0 1.6 0.0 4.1 5.8 1.9 0.8 1.9 1.1 1.6 0.5 0.9 0.7 11.4 33.4 0.7 1.0 0.9 0.2 2.2 2.5 1.1 0.8 0.9 1.1 1.6 4.6 2.1 5.3 0.9 0.6 1.5 6.4 1.4 0.0 1.0 3.5 1.0 0.9 1.6 0.7 0.5 0.8 1.2 1.3 0.6 3.5 6.4 2.8 6.7 4.2 4.3 6.3 5.9 2.0 4.5 4.4 8.2 3.6 3.7 1.4 7.6 5.4 2.5 8.1 2.5 5.6 5.0 6.2 7.5 5.0 24.1 2.2 10.1 7.7 3.0 5.2 5.8 2.7 1.9 4.7 8.5 18.0 6.2 5.0 2.4 8.3 1.4 3.8 8.9 7.9 4.2 5.5 5.0 0.6 6.3 3.6 3.2 3.7 16.0 12.7 2.4 7.2 6.1 2.6 9.0 7.3 15.6 2.5 3.5 6.6 8.5 5.4 9.1 7.2 1.4 0.9 2.0 0.6 1.6 0.5 0.2 0.5 0.3 1.7 0.3 0.6 0.6 1.9 0.5 1.4 0.6 1.5 0.4 1.3 1.0 5.4 2.0 0.9 0.7 0.9 0.2 1.1 0.0 0.9 0.6 1.0 0.0 1.3 14.0 0.9 0.9 2.1 1.8 6.8 3.2 3.0 3.4 1.1 2.8 1.5 0.0 0.0 4.3 1.7 3.8 1.9 1.0 0.5 0.4 3.5 1.8 0.0 3.4 39.3 3.0 3.8 2.3 8.6 1.0 0.0 1.3 1.1 49.3 4.0 0.0 35.9 5.7 2.0 1.0 3.7 1.0 1.5 2.0 0.0 17.8 1.0 0.4 0.0 17.1 17.7 1.3 5.8 1.9 1.6 1.7 13.0 31.7 1.3 5.1 0.0 2.4 1.4 0.5 2.7 4.1 0.9 1.4 0.8 1.8 5.1 2.1 ACVR2B ActR-IIB ENSG00000114739 "Activin A receptor type 2B" Q13705 3 38453890-38493142 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Heterotaxy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "testis cancer: 5.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.9;NTERA-2: 25.9;SuSa: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025115, HPA040384" Approved NA No "Cluster 54: Non-specific - Microtubule organization" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "CAB025115: , HPA040384: AB_2732484" "unprognostic (5.11e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-1)" "unprognostic (8.73e-2)" "unprognostic (9.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.32e-2)" "unprognostic (1.25e-2)" "unprognostic (1.88e-1)" "unprognostic (1.53e-2)" "unprognostic (5.14e-2)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (1.64e-1)" "unprognostic (1.98e-1)" "unprognostic (1.83e-1)" "unprognostic (4.75e-1)" 1.1 2.8 3.2 0.6 3.2 0.2 1.7 5.2 2.8 1.9 1.0 1.5 0.9 1.7 1.7 0.7 1.9 0.6 1.4 2.6 3.0 1.8 2.2 1.3 0.7 2.6 3.2 2.9 2.5 3.3 2.0 2.5 2.6 1.3 1.1 6.5 1.7 1.3 6.0 0.7 1.1 0.9 2.3 1.0 1.5 2.5 2.9 4.1 1.6 2.8 0.6 1.4 1.4 3.6 1.1 1.8 20.9 1.8 0.8 0.5 11.2 0.4 0.7 0.4 0.9 3.1 1.4 0.1 1.6 0.5 0.6 1.3 8.1 1.3 1.1 3.2 5.2 5.6 3.5 4.6 1.0 4.0 2.0 0.8 1.2 0.6 2.3 1.3 1.4 8.0 9.4 1.8 0.4 1.7 6.9 2.5 25.9 1.1 0.9 2.2 7.0 1.4 1.3 2.6 4.9 8.5 0.6 3.2 3.0 14.7 1.7 5.2 1.2 0.7 3.3 0.5 1.8 5.0 7.3 1.2 0.7 3.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 3.2 3.2 5.2 2.8 2.6 3.0 2.6 3.2 2.6 2.3 2.9 3.6 7.0 6.4 6.1 9.4 0.7 4.0 4.6 2.1 4.0 23.0 5.2 5.0 15.0 2.8 3.6 0.0 22.9 8.5 1.3 3.1 0.0 3.6 11.3 8.7 7.0 7.5 7.2 0.4 12.6 3.8 7.6 3.8 2.6 5.3 1.3 17.9 7.9 8.7 2.6 21.9 17.0 4.1 0.0 2.2 6.4 15.8 11.8 2.4 7.2 5.6 0.7 7.6 0.0 15.1 17.2 3.2 5.3 7.9 1.4 5.2 4.8 3.1 7.1 25.4 0.0 9.7 7.7 11.4 17.9 1.8 4.0 6.2 2.6 7.4 4.4 3.9 EXOG "ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b" ENSG00000157036 "Exo/endonuclease G" Q9Y2C4 3 38496127-38542161 "Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 59.8;Rod photoreceptor cells: 78.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012531, HPA071050" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA "Cluster 37: B-cells - Transcription" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA012531: AB_2732403, HPA071050: " "unprognostic (2.88e-1)" "unprognostic (5.81e-3)" "unprognostic (3.55e-3)" "unprognostic (2.77e-1)" "unprognostic (8.32e-3)" "unprognostic (8.90e-3)" "unprognostic (4.78e-4)" "unprognostic (3.59e-2)" "unprognostic (3.99e-2)" "unprognostic (3.10e-2)" "prognostic favorable (1.92e-5)" "prognostic unfavorable (4.90e-4)" "unprognostic (6.51e-2)" "unprognostic (1.64e-2)" "unprognostic (4.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.78e-2)" 3.9 5.1 5.5 4.0 5.4 3.9 3.4 7.9 7.0 5.2 3.4 4.9 2.0 4.7 3.5 2.6 3.8 3.5 12.9 5.9 5.1 3.7 3.4 3.8 6.0 5.1 5.7 3.9 3.9 3.3 5.6 2.9 4.5 4.8 3.2 5.3 3.2 3.6 3.2 1.9 4.4 4.5 4.1 5.5 3.6 3.9 5.9 5.0 4.5 3.2 4.7 4.4 3.5 6.4 4.3 7.6 8.7 7.6 5.7 8.4 3.5 13.9 8.7 11.6 12.9 6.8 4.3 15.1 3.5 5.5 3.3 4.3 11.0 4.7 9.8 17.5 10.2 11.4 12.7 7.6 7.0 12.7 9.5 6.4 5.2 10.3 5.4 5.5 16.2 8.6 5.2 9.9 18.2 2.9 8.6 4.2 8.3 3.7 9.8 5.8 4.6 6.7 6.0 5.5 4.0 2.0 8.5 2.1 3.8 3.9 2.9 6.1 13.3 9.5 7.2 10.8 11.2 5.7 10.3 13.3 7.4 10.9 7.1 0.9 10.0 4.5 26.6 9.8 23.8 60.3 25.8 26.4 7.2 47.1 25.9 25.2 0.6 27.8 11.6 14.4 12.9 5.5 5.5 5.4 7.9 7.0 5.9 5.1 5.1 5.7 4.5 4.1 5.9 6.4 9.8 6.4 4.5 15.3 24.9 2.9 6.5 13.4 8.0 49.9 4.4 3.7 33.0 7.2 5.8 11.0 56.3 12.3 23.8 5.4 0.0 8.5 3.7 3.2 9.7 12.9 16.9 13.7 23.5 5.3 2.1 10.8 4.6 3.6 1.3 14.0 9.7 5.7 7.0 40.4 29.1 7.5 10.2 8.3 6.2 3.7 27.1 6.0 12.4 15.0 16.0 13.0 59.8 31.7 23.5 6.4 7.4 17.7 19.1 5.5 4.3 4.0 8.0 78.3 13.1 11.6 9.5 36.5 28.0 4.6 1.0 1.9 22.9 14.0 9.7 6.3 SCN5A "CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1" ENSG00000183873 "Sodium voltage-gated channel alpha subunit 5" Q14524 3 38548057-38649687 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel" "Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease variant, FDA approved drug targets, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "heart muscle: 42.8" "Cell type enriched" "Detected in some" 5 "Cardiomyocytes: 77.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "LHCN-M2: 27.6;RH-30: 22.8" "Group enriched" "Detected in many" 5 "amygdala: 3.1;basal ganglia: 10.1;hypothalamus: 6.0" "Region enhanced" "Detected in many" "basal ganglia: 5.4" HPA063346 Supported "Nucleoplasm,Nucleoli,Plasma membrane" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 43: Cardiomyocytes - Nuclear processes" "Plasma membrane" "Nucleoplasm, Nucleoli" "HPA063346: " "unprognostic (9.29e-4)" "unprognostic (4.05e-2)" "unprognostic (9.95e-2)" "unprognostic (1.74e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (1.48e-1)" "unprognostic (7.36e-2)" "unprognostic (8.48e-2)" "unprognostic (7.12e-3)" "unprognostic (5.28e-2)" "unprognostic (1.16e-4)" "unprognostic (4.85e-3)" "unprognostic (1.09e-1)" "unprognostic (5.35e-2)" "unprognostic (4.95e-3)" 0.2 0.1 1.9 0.1 1.2 0.2 0.2 0.0 0.7 1.7 0.0 0.2 0.2 0.7 0.0 0.1 0.3 0.1 42.8 0.2 1.5 0.0 0.0 0.1 0.0 0.0 0.7 0.5 0.0 0.0 0.4 0.2 0.0 0.3 0.1 2.0 0.2 0.5 1.6 0.1 0.2 0.3 0.2 0.1 0.1 0.3 2.6 0.0 0.2 1.0 0.0 0.4 0.7 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.4 0.1 0.0 0.2 3.6 0.0 0.0 0.0 1.0 0.5 2.7 0.0 0.4 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.4 0.0 2.1 2.8 0.4 0.0 0.0 27.6 1.4 0.0 0.0 2.6 0.0 0.0 0.0 22.8 0.0 0.0 3.2 0.4 3.1 0.0 0.0 0.0 0.8 0.0 0.0 5.7 0.0 5.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.7 0.2 1.5 0.0 0.7 0.0 0.2 2.6 0.2 0.1 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 2.7 0.0 0.3 77.1 0.0 0.1 0.0 14.6 0.2 0.0 0.0 0.0 0.1 1.2 0.1 3.2 2.8 0.0 0.0 0.5 0.0 0.3 3.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 6.3 0.3 0.6 0.2 0.0 3.7 0.0 0.6 0.0 1.5 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.9 0.0 7.3 3.1 0.2 1.0 0.0 0.0 0.0 0.1 0.1 0.0 1.4 SCN10A "hPN3, Nav1.8, PN3, SNS" ENSG00000185313 "Sodium voltage-gated channel alpha subunit 10" Q9Y5Y9 3 38696802-38816286 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (6.57e-2)" "unprognostic (7.85e-2)" "unprognostic (2.09e-4)" "unprognostic (1.42e-1)" "unprognostic (2.69e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCN11A "NaN, Nav1.9, SCN12A, SNS-2" ENSG00000168356 "Sodium voltage-gated channel alpha subunit 11" Q9UI33 3 38845764-39052157 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.0;placenta: 1.9" "Cell type enhanced" "Detected in some" "Adipocytes: 5.4;Astrocytes: 7.8;Early spermatids: 7.0;Sertoli cells: 6.6;Spermatocytes: 4.4;Spermatogonia: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HDLM-2: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036746, HPA036747" Uncertain NA NA "Cluster 64: Macrophages - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA036746: AB_10696785, HPA036747: AB_2675287" "unprognostic (6.11e-2)" "unprognostic (5.16e-1)" "unprognostic (1.66e-1)" "unprognostic (4.75e-2)" "unprognostic (4.21e-2)" "unprognostic (2.34e-2)" "unprognostic (2.79e-2)" "unprognostic (5.66e-2)" "unprognostic (4.44e-2)" "unprognostic (5.21e-2)" "unprognostic (2.30e-4)" "unprognostic (1.91e-2)" "unprognostic (5.43e-2)" "unprognostic (5.02e-2)" "unprognostic (2.95e-1)" "unprognostic (3.12e-2)" "unprognostic (8.30e-4)" 0.5 0.1 0.4 0.2 0.2 0.0 0.3 0.2 0.3 0.1 0.1 0.6 0.3 0.0 0.4 0.0 0.1 0.1 0.0 0.4 0.3 0.5 0.2 0.1 0.2 0.3 0.4 0.1 0.1 0.0 0.3 1.9 0.3 0.1 0.6 0.1 0.0 0.1 0.1 0.4 0.5 0.3 0.3 3.0 0.1 1.3 0.5 0.2 0.1 0.0 0.1 0.8 0.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.3 0.4 0.3 0.3 0.4 0.3 0.3 0.5 0.4 5.4 0.0 0.0 7.8 0.1 0.8 0.9 0.0 0.0 0.2 0.2 0.3 1.2 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 7.0 0.4 0.5 2.5 0.0 2.7 1.6 0.2 0.1 0.6 0.0 0.2 0.0 1.1 1.4 0.4 0.3 0.0 1.0 0.0 0.0 0.3 1.6 2.1 0.0 0.2 1.8 0.0 0.1 0.5 0.0 1.5 2.4 0.1 0.0 0.0 0.1 0.7 0.0 0.2 2.3 0.5 6.6 1.0 0.4 4.4 6.3 0.0 0.9 0.3 0.6 0.7 0.0 0.8 WDR48 "KIAA1449, P80, SPG60" ENSG00000114742 "WD repeat domain 48" Q8TAF3 3 39052013-39096671 "Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038421, HPA058015" Approved Supported Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles "HPA038421: AB_10670780, HPA058015: AB_2683580" "unprognostic (1.95e-1)" "unprognostic (2.14e-1)" "unprognostic (2.99e-2)" "unprognostic (3.78e-1)" "unprognostic (7.68e-2)" "unprognostic (2.34e-3)" "unprognostic (6.14e-3)" "unprognostic (9.87e-3)" "unprognostic (8.02e-2)" "unprognostic (2.22e-2)" "unprognostic (2.28e-1)" "unprognostic (2.14e-2)" "prognostic favorable (1.63e-7)" "unprognostic (2.41e-1)" "unprognostic (2.94e-2)" "unprognostic (1.43e-1)" "unprognostic (1.69e-2)" 14.1 15.5 20.7 13.3 22.2 35.1 17.7 20.3 25.7 17.7 17.1 14.3 15.1 20.0 14.1 14.0 15.7 13.2 16.2 21.9 22.9 21.4 16.1 13.9 17.6 21.2 21.8 21.1 16.1 22.0 4.4 20.8 21.3 16.0 15.1 17.9 15.4 20.9 11.5 14.1 15.1 16.9 21.6 16.1 14.2 47.9 22.8 26.8 24.8 17.1 19.4 16.8 6.3 24.2 11.6 16.4 32.9 23.6 23.8 27.2 14.4 14.4 20.6 17.6 22.5 11.5 12.7 27.8 10.0 20.2 15.7 13.8 30.3 18.7 20.5 70.3 38.8 26.1 22.8 19.0 10.8 18.8 13.7 18.1 21.2 19.0 21.9 31.9 21.8 20.1 30.7 27.8 16.3 9.9 24.6 20.1 36.3 16.8 19.8 9.6 17.3 24.1 21.9 24.2 24.1 29.0 14.7 29.8 25.4 29.0 15.6 26.7 18.8 15.9 12.0 14.7 16.2 30.2 48.6 22.7 18.5 16.9 15.5 13.3 6.0 7.5 9.2 7.9 9.1 9.4 10.6 10.7 8.7 10.9 10.7 9.3 8.0 15.1 13.0 7.2 12.6 8.9 20.7 22.2 20.3 25.7 21.9 22.9 21.2 21.8 21.3 21.6 22.8 24.2 27.0 16.0 22.0 45.4 26.6 17.6 13.3 9.2 20.5 21.6 18.1 16.6 23.2 7.2 15.5 11.0 16.7 15.9 26.0 14.4 17.6 13.9 77.2 20.2 28.5 20.6 22.1 17.9 35.3 12.4 12.2 18.0 9.7 29.7 24.1 25.5 16.1 13.0 8.6 21.9 37.0 13.7 4.1 11.4 15.9 71.9 18.6 16.2 14.2 26.2 19.8 23.6 13.4 38.7 41.1 12.0 12.9 16.6 20.9 21.9 17.3 13.4 17.8 17.9 26.3 21.9 19.2 104.5 59.9 16.7 21.2 21.5 25.7 23.0 12.3 19.5 GORASP1 "FLJ23443, GOLPH5, GRASP65, P65" ENSG00000114745 "Golgi reassembly stacking protein 1" Q9BQQ3 3 39096599-39107863 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 98.9;Late spermatids: 56.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056283 Supported Supported "Golgi apparatus" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Golgi apparatus" "HPA056283: AB_2683085" "unprognostic (1.06e-1)" "unprognostic (8.31e-2)" "unprognostic (1.05e-1)" "prognostic favorable (6.92e-6)" "unprognostic (2.77e-1)" "unprognostic (1.98e-2)" "prognostic unfavorable (5.13e-4)" "unprognostic (2.13e-2)" "unprognostic (8.79e-3)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (1.73e-3)" "prognostic favorable (1.91e-6)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (1.44e-1)" "unprognostic (3.24e-3)" 16.9 13.5 35.4 12.8 36.4 11.5 18.6 38.7 35.7 25.2 30.3 23.6 13.6 18.8 16.6 20.0 22.2 15.6 21.3 34.1 35.9 26.9 26.3 19.6 13.4 41.7 36.9 13.3 24.5 22.5 15.4 21.0 38.0 22.1 26.0 20.6 26.2 30.7 16.3 16.4 18.5 24.0 42.0 21.5 19.1 10.5 38.8 11.8 18.4 19.0 17.4 17.9 14.8 46.6 15.6 19.0 18.0 17.8 42.8 28.1 16.6 27.1 31.1 27.5 24.6 11.3 18.4 16.8 15.7 41.4 17.2 24.7 20.7 32.2 19.3 22.4 14.3 23.8 18.7 16.0 19.3 20.0 25.8 22.0 43.8 28.5 28.0 30.6 38.2 6.0 19.8 20.3 26.3 22.6 5.6 18.9 13.1 35.7 23.1 6.0 10.7 23.8 27.4 28.1 7.1 14.0 25.7 51.4 16.1 24.4 33.2 20.7 29.0 15.4 14.3 37.0 15.0 14.1 14.8 4.1 18.3 16.7 23.0 6.5 12.0 7.0 3.3 12.7 4.5 11.7 4.1 3.1 12.8 9.3 4.7 3.4 6.9 2.8 17.2 7.2 6.7 8.0 35.4 36.4 38.7 35.7 34.1 35.9 41.7 36.9 38.0 42.0 38.8 46.6 21.1 3.2 9.8 23.2 8.7 4.1 10.6 6.5 8.0 8.5 12.9 9.7 8.7 12.8 7.2 12.9 0.0 14.0 3.4 21.4 11.7 10.7 98.9 15.5 11.4 13.4 11.4 5.5 7.7 8.7 11.1 8.9 24.5 16.3 1.3 8.8 8.9 11.4 9.5 8.4 9.2 15.3 8.2 7.2 9.8 56.1 7.2 9.5 12.4 9.4 7.0 7.3 0.0 9.0 9.6 11.0 8.0 6.4 5.7 11.4 14.2 6.0 10.7 11.1 0.0 8.8 10.0 10.1 6.8 8.0 5.8 19.8 4.4 6.5 15.1 12.6 TTC21A "IFT139A, STI2" ENSG00000168026 "Tetratricopeptide repeat domain 21A" Q8NDW8 3 39107704-39138903 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 21.2" "Cell type enhanced" "Detected in many" "Early spermatids: 82.3;Late spermatids: 84.7;Respiratory ciliated cells: 56.0;Spermatocytes: 59.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035510, HPA035511" Enhanced Approved Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA035510: AB_2674659, HPA035511: AB_10671514" "unprognostic (1.85e-3)" "unprognostic (6.95e-3)" "unprognostic (7.74e-3)" "prognostic favorable (1.79e-4)" "unprognostic (1.55e-1)" "unprognostic (1.58e-5)" "unprognostic (2.29e-2)" "unprognostic (4.93e-2)" "unprognostic (1.33e-1)" "unprognostic (1.15e-1)" "unprognostic (3.01e-4)" "unprognostic (2.19e-2)" "unprognostic (1.29e-3)" "unprognostic (6.54e-2)" "unprognostic (3.35e-1)" "unprognostic (9.76e-2)" "unprognostic (3.91e-4)" 0.1 0.1 0.6 0.4 0.6 0.1 0.2 0.4 1.1 0.2 1.8 0.1 0.2 0.3 0.0 0.1 1.0 0.1 0.1 0.5 0.6 0.1 0.1 0.2 0.3 0.7 0.9 0.3 1.1 0.2 0.1 0.1 0.6 0.2 0.1 0.4 0.3 0.1 0.1 0.2 0.1 0.0 0.5 0.2 0.1 21.2 0.5 0.2 0.2 0.1 0.3 0.1 0.1 0.6 0.1 0.3 0.1 0.2 0.0 0.2 0.2 0.3 0.2 0.2 0.1 0.0 0.1 0.7 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.3 0.1 0.0 0.3 0.0 0.3 0.3 0.2 0.2 0.2 0.0 0.4 0.2 0.0 0.2 0.0 1.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.1 0.3 0.8 0.3 0.0 0.8 0.0 0.2 0.0 0.1 0.7 0.1 0.7 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.4 1.1 0.5 0.6 0.7 0.9 0.6 0.5 0.5 0.6 3.7 0.0 3.0 20.2 10.4 0.6 4.4 4.0 0.6 5.3 2.6 2.4 6.4 4.3 5.4 1.8 8.4 1.7 1.8 2.5 0.0 2.1 82.3 24.0 3.6 3.0 4.2 0.4 15.0 1.8 1.7 2.1 4.1 5.2 1.3 3.2 5.0 1.3 1.6 5.0 13.3 2.5 0.0 2.2 0.9 84.7 7.2 1.6 3.6 4.7 2.6 3.4 0.0 5.0 3.2 1.7 2.0 6.0 3.7 2.1 2.3 1.2 56.0 15.3 6.6 7.8 2.7 59.8 3.4 0.1 0.6 3.7 1.3 2.1 2.4 2.3 CSRNP1 "AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1" ENSG00000144655 "Cysteine and serine rich nuclear protein 1" Q96S65 3 39141855-39154562 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 193.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 17.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 64.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045207, HPA058463" Supported Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "HPA045207: AB_10967202, HPA058463: AB_2683726" "unprognostic (2.90e-2)" "unprognostic (6.89e-2)" "unprognostic (3.00e-1)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (1.46e-1)" "unprognostic (3.78e-2)" "unprognostic (1.90e-2)" "unprognostic (1.81e-2)" "unprognostic (1.34e-1)" "unprognostic (3.46e-1)" "unprognostic (1.39e-1)" "prognostic favorable (1.07e-4)" "prognostic unfavorable (6.47e-4)" "unprognostic (2.42e-2)" "unprognostic (1.98e-1)" "unprognostic (1.51e-1)" 88.9 55.8 13.6 34.0 13.7 193.1 51.7 17.2 22.5 34.7 15.4 35.6 12.0 30.2 6.4 61.7 79.8 67.5 49.9 12.8 18.0 29.2 67.3 80.8 14.9 21.3 16.2 41.5 39.4 23.5 43.3 25.0 15.7 32.7 15.4 5.8 21.3 18.5 36.9 57.1 26.4 64.1 18.3 20.3 48.0 14.7 17.1 34.9 33.8 19.0 8.7 51.6 27.7 15.4 4.4 9.7 2.5 4.8 4.7 4.9 7.8 15.9 22.1 13.0 10.6 13.7 4.0 14.4 3.3 12.1 9.3 4.9 3.0 21.0 6.4 21.6 4.0 16.4 8.0 10.5 5.8 4.1 15.7 2.3 11.3 20.4 3.2 11.6 17.8 3.9 12.7 24.9 10.7 13.9 0.8 6.7 11.4 7.4 8.1 6.8 10.4 23.7 10.3 15.9 7.0 1.1 8.7 64.2 5.5 14.5 7.2 7.5 9.0 6.6 28.2 5.6 11.9 6.3 5.8 6.6 14.4 5.2 8.4 0.1 3.0 3.8 1.7 5.9 2.1 3.6 1.6 2.0 3.3 3.7 2.0 1.3 17.1 2.6 11.0 4.2 2.7 2.3 13.6 13.7 17.2 22.5 12.8 18.0 21.3 16.2 15.7 18.3 17.1 15.4 200.8 48.1 66.3 6.8 75.0 103.2 88.1 40.2 153.1 1.4 121.1 95.8 15.8 37.1 31.2 11.0 0.0 19.7 86.3 77.3 9.8 37.6 54.4 119.6 65.2 92.8 59.3 13.2 3.5 38.5 43.0 98.1 75.4 199.4 96.5 4.2 73.9 40.7 38.7 0.0 1.5 54.7 22.4 36.7 165.2 46.8 1.5 94.5 69.4 4.7 14.8 7.6 7.2 1.5 1.3 49.2 60.9 4.1 74.3 49.4 54.1 6.0 21.0 1.7 13.1 154.4 103.9 0.6 4.7 85.7 79.6 90.7 132.4 8.9 38.0 38.9 XIRP1 "CMYA1, DKFZp451D042, Xin" ENSG00000168334 "Xin actin binding repeat containing 1" Q702N8 3 39183210-39192596 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "heart muscle: 682.0;skeletal muscle: 383.4" "Cell type enriched" "Detected in some" 15 "Cardiomyocytes: 850.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.0" "Region enhanced" "Detected in some" "cerebellum: 2.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 4.4;LHCN-M2: 1.1;RH-30: 3.0" "Not detected" "Not detected" "HPA016750, HPA018458, CAB026391" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Cluster 38: Heart - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "Plasma membrane, Actin filaments" Nucleoplasm "CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885" "unprognostic (2.19e-1)" "unprognostic (6.40e-2)" "unprognostic (1.13e-1)" "unprognostic (9.75e-2)" "unprognostic (2.76e-1)" "unprognostic (2.43e-2)" "unprognostic (4.94e-2)" "unprognostic (2.66e-3)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (5.30e-2)" "unprognostic (6.26e-2)" "unprognostic (1.02e-5)" "unprognostic (2.08e-2)" "unprognostic (2.78e-2)" "unprognostic (6.86e-4)" "unprognostic (4.12e-2)" 1.1 0.3 0.0 1.2 0.0 0.0 0.2 2.0 0.3 0.0 0.1 0.7 0.0 0.2 0.0 5.6 0.0 1.0 682.0 1.1 0.1 0.1 0.1 1.7 0.0 0.6 0.2 0.1 1.2 0.0 0.5 0.7 0.2 3.4 0.0 0.0 5.1 0.0 383.4 0.5 0.5 0.4 0.2 0.6 0.3 0.0 0.1 0.5 0.2 96.4 0.0 3.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.3 1.1 0.1 0.6 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 850.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 3.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 CX3CR1 "CCRL1, CMKBRL1, CMKDR1, GPR13, V28" ENSG00000168329 "C-X3-C motif chemokine receptor 1" P49238 3 39263495-39281735 "Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity" "G-protein coupled receptor, Receptor, Transducer" "Age-related macular degeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.4" "Group enriched" "Detected in some" 5 "Microglial cells: 177.1;NK-cells: 350.1" "Cancer enriched" "Detected in many" 4 "glioma: 21.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 449.2" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 21 "RPMI-8226: 589.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032478, HPA046587" Approved Approved "Plasma membrane" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 25: RPMI-8226 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "CAB032478: AB_638830, HPA046587: AB_2679708" "unprognostic (2.00e-1)" "unprognostic (5.12e-2)" "unprognostic (2.65e-1)" "unprognostic (2.42e-2)" "unprognostic (6.52e-2)" "unprognostic (3.01e-3)" "unprognostic (2.64e-1)" "unprognostic (1.16e-2)" "unprognostic (3.98e-2)" "unprognostic (1.57e-3)" "unprognostic (1.13e-2)" "unprognostic (1.04e-1)" "unprognostic (3.05e-2)" "unprognostic (1.36e-2)" "unprognostic (8.59e-2)" "unprognostic (7.71e-3)" "unprognostic (1.12e-1)" 2.3 3.8 6.2 6.9 6.4 1.1 5.1 8.6 6.0 2.7 1.7 1.1 1.2 2.7 4.2 0.8 6.1 2.6 2.4 7.7 8.4 2.5 2.0 9.9 2.1 17.3 14.8 1.6 0.7 4.5 1.0 4.6 18.9 3.5 1.1 0.5 7.6 7.2 6.5 2.3 0.9 3.5 21.5 11.9 1.4 1.8 17.4 2.0 2.4 2.2 5.3 2.4 0.3 26.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.2 6.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 24.5 0.0 0.2 0.2 0.5 0.1 0.0 0.0 0.2 0.1 589.8 0.0 0.0 0.1 0.1 0.0 8.1 0.0 0.2 0.1 16.5 0.0 0.0 0.1 0.1 0.0 0.5 1.0 0.1 0.0 28.6 0.0 7.7 99.6 1.8 264.0 261.2 3.4 0.8 55.9 145.2 94.4 0.7 19.0 122.4 20.8 39.7 449.2 7.1 1.5 232.7 6.2 6.4 8.6 6.0 7.7 8.4 17.3 14.8 18.9 21.5 17.4 26.4 0.8 0.0 0.5 0.7 0.7 0.5 0.0 0.0 0.0 0.0 0.8 3.8 0.4 0.0 0.6 0.0 0.0 0.0 44.3 0.0 0.0 0.0 0.2 0.2 0.1 3.5 0.0 2.1 0.3 0.0 0.0 0.3 0.0 0.0 5.1 0.1 0.7 0.3 4.1 0.0 0.6 0.0 0.0 15.0 28.0 0.3 0.3 43.2 0.0 177.1 50.3 0.1 350.1 2.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 0.4 0.7 0.2 6.6 0.4 1.3 0.7 0.2 0.0 0.6 0.0 22.6 0.1 0.1 0.0 CCR8 "CDw198, CKR-L1, CMKBR8, CMKBRL2, CY6, GPR-CY6, TER1" ENSG00000179934 "C-C motif chemokine receptor 8" P51685 3 39329709-39333680 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "lymphoid tissue: 7.7" "Cell type enhanced" "Detected in single" "T-cells: 1.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 6 "T-reg: 25.7" "Lineage enriched" "Detected in single" 32 "T-cells: 25.7" "Cell line enriched" "Detected in some" 22 "HDLM-2: 99.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA042383 Enhanced NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 63: T-cells - Adaptive immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA042383: AB_2732497" "unprognostic (2.16e-1)" "unprognostic (2.12e-2)" "unprognostic (2.91e-2)" "unprognostic (1.04e-1)" "unprognostic (2.38e-2)" "unprognostic (7.63e-4)" "unprognostic (3.31e-1)" "unprognostic (1.27e-1)" "unprognostic (2.30e-3)" "unprognostic (3.37e-2)" "unprognostic (7.40e-2)" "unprognostic (2.99e-1)" "unprognostic (4.65e-8)" "unprognostic (7.96e-2)" "unprognostic (2.24e-2)" "unprognostic (2.56e-1)" "unprognostic (4.14e-1)" 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.5 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.6 0.3 0.0 0.0 7.7 0.1 0.0 0.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.3 2.7 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 2.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 25.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 SLC25A38 FLJ20551 ENSG00000144659 "Solute carrier family 25 member 38" Q96DW6 3 39383370-39397351 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 73.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041027 Approved NA NA "Cluster 46: Basophils - DNA binding" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" "HPA041027: AB_10794403" "unprognostic (3.82e-2)" "unprognostic (3.27e-2)" "unprognostic (1.96e-1)" "unprognostic (6.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.58e-1)" "unprognostic (1.25e-1)" "unprognostic (1.21e-2)" "unprognostic (3.94e-2)" "unprognostic (1.94e-1)" "unprognostic (1.26e-2)" "unprognostic (5.54e-2)" "prognostic favorable (1.58e-5)" "unprognostic (1.73e-1)" "unprognostic (1.47e-1)" "unprognostic (2.06e-1)" "prognostic favorable (7.29e-4)" 19.1 35.4 22.2 18.8 23.3 70.0 21.0 25.9 26.8 23.8 33.6 28.1 25.3 27.3 27.6 14.5 27.3 19.4 20.7 22.9 26.3 28.7 58.0 21.0 36.2 24.2 24.1 44.1 45.6 38.7 30.7 15.4 25.3 29.2 36.9 23.0 22.5 23.9 48.2 16.7 25.2 20.3 22.6 27.2 33.8 18.7 26.0 33.6 52.0 35.7 35.4 27.8 19.1 23.3 24.3 38.3 24.3 41.2 56.4 46.4 30.8 33.6 46.1 48.3 43.7 26.3 5.6 67.8 19.6 31.6 40.7 18.4 55.2 40.1 36.0 43.6 45.0 52.0 33.5 40.2 75.6 37.7 33.9 58.8 46.1 46.2 93.2 44.6 31.5 52.8 47.7 40.6 36.4 35.2 44.7 67.0 66.2 35.9 44.3 16.2 26.4 47.7 37.5 45.4 24.3 31.1 11.9 65.9 34.0 44.5 33.5 35.0 26.9 38.3 26.4 56.2 48.9 54.7 93.1 41.9 29.3 48.3 24.7 30.7 9.6 18.1 38.8 5.7 44.7 50.8 39.1 43.3 14.9 37.8 41.7 40.5 1.0 57.0 8.4 18.5 55.3 29.2 22.2 23.3 25.9 26.8 22.9 26.3 24.2 24.1 25.3 22.6 26.0 23.3 10.4 22.4 27.4 8.5 35.6 11.5 13.0 12.5 28.5 13.2 26.1 22.6 16.8 22.8 9.6 27.6 6.2 35.2 33.1 21.9 21.5 15.7 6.5 26.6 16.3 11.1 12.6 73.7 8.9 16.9 32.6 13.7 16.8 38.5 22.2 24.0 9.7 27.0 15.2 5.0 10.1 25.6 12.2 7.0 13.7 12.9 15.5 9.8 12.4 1.9 11.2 18.9 29.9 7.1 6.2 13.4 22.2 13.5 23.3 17.7 23.1 31.3 12.3 12.6 6.6 15.2 14.9 11.0 7.8 19.4 10.2 19.4 36.6 32.8 26.7 8.4 RPSA "37LRP, LAMR1, LRP, p40, SA" ENSG00000168028 "Ribosomal protein SA" P08865 3 39406716-39412542 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor, Ribonucleoprotein, Ribosomal protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB009561 Approved Supported "Plasma membrane,Cytosol" NA NA 1200000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Plasma membrane, Cytosol" "CAB009561: AB_2182543" "unprognostic (3.67e-3)" "unprognostic (2.92e-1)" "unprognostic (3.97e-2)" "unprognostic (3.72e-2)" "unprognostic (5.38e-2)" "unprognostic (5.10e-2)" "unprognostic (5.84e-3)" "unprognostic (2.54e-1)" "unprognostic (1.69e-1)" "unprognostic (2.36e-2)" "unprognostic (8.56e-2)" "unprognostic (7.50e-2)" "unprognostic (2.91e-2)" "unprognostic (3.18e-1)" "unprognostic (2.77e-1)" "unprognostic (1.73e-1)" "unprognostic (1.46e-1)" 1063.0 929.1 813.4 685.7 824.8 1574.8 1068.4 782.0 979.1 1260.0 761.8 1158.4 605.8 1022.1 351.0 1922.5 1128.3 372.5 783.9 778.6 794.3 905.9 972.5 894.3 1281.4 817.8 809.6 2153.7 2616.3 605.5 813.4 468.8 812.9 1212.6 872.2 273.3 1039.7 446.9 1087.1 1529.4 1133.1 718.3 842.4 1525.8 1209.3 358.0 831.9 1259.9 862.6 730.4 1466.4 1127.5 1293.1 821.5 1800.4 1646.5 1367.5 2265.9 1203.3 2661.2 2155.0 1251.2 2005.9 2775.9 1611.8 1811.6 1513.7 3949.6 737.0 2535.3 747.6 695.4 2983.8 2945.7 2402.3 1459.6 1599.6 1783.6 1390.5 1750.2 2322.7 2546.4 1649.2 3043.3 4729.8 2147.2 3475.3 2030.8 2942.7 2343.5 1909.3 1883.8 2031.1 1282.1 3031.0 1960.4 4574.2 2756.9 2755.1 1412.2 1958.4 2974.8 2004.4 814.2 985.3 1989.0 674.8 5156.5 2202.9 1843.5 1509.0 3544.5 1156.6 845.2 1545.8 1422.3 3102.3 1440.6 2363.4 2437.5 1355.7 2481.7 1143.9 98.3 240.5 56.7 572.9 294.6 993.1 1010.3 942.1 758.8 654.2 951.8 1036.2 936.1 34.3 726.0 247.5 723.6 765.5 1499.7 813.4 824.8 782.0 979.1 778.6 794.3 817.8 809.6 812.9 842.4 831.9 821.5 532.1 519.2 800.2 10.7 2802.5 1802.5 2606.9 1585.5 2040.3 270.4 1864.7 1423.4 64.0 1095.2 906.4 325.5 95.9 2852.5 1768.9 625.4 992.0 1598.4 144.3 536.7 1178.5 891.2 1033.6 1733.9 21.3 3417.4 4473.1 927.1 821.6 747.7 778.4 1654.5 937.3 717.7 1608.4 173.3 21.5 1847.0 455.7 1304.9 1469.6 283.7 1240.5 1086.9 738.2 12.2 1605.2 621.1 1858.9 19.1 29.3 1889.5 1184.2 747.4 1501.8 2136.7 724.4 1257.1 476.2 364.4 473.3 1053.5 1002.2 352.2 1255.8 2879.8 1916.2 2420.7 2100.0 1539.2 2442.4 2884.6 MOBP ENSG00000168314 "Myelin associated oligodendrocyte basic protein" Q13875 3 39467198-39529479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "brain: 918.8" "Cell type enriched" "Detected in some" 14 "Oligodendrocytes: 1607.0" "Cancer enriched" "Detected in single" 63 "glioma: 4.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 50 "HAP1: 18.6" "Low region specificity" "Detected in all" HPA035152 Enhanced Supported "Cytoplasmic bodies" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Cytoplasmic bodies" "HPA035152: AB_10603020" "unprognostic (1.76e-2)" "unprognostic (2.34e-1)" "unprognostic (3.53e-2)" "unprognostic (7.35e-2)" "unprognostic (5.67e-2)" "unprognostic (3.60e-2)" "unprognostic (7.47e-2)" "unprognostic (2.82e-1)" "unprognostic (7.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.01e-1)" "unprognostic (2.07e-1)" "unprognostic (2.04e-5)" "unprognostic (2.28e-1)" "unprognostic (8.98e-2)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" 0.2 0.1 366.9 0.1 539.9 0.0 0.1 443.3 488.6 0.2 112.1 0.7 0.0 0.5 0.0 0.0 1.5 0.1 0.2 308.8 382.8 0.3 0.1 0.7 0.0 836.4 490.3 0.8 0.1 2.5 0.4 0.0 714.6 0.1 0.2 0.2 0.3 0.0 0.2 0.2 0.1 0.1 565.7 0.0 0.1 5.5 519.1 0.0 0.1 0.0 0.0 0.3 0.1 918.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 366.9 539.9 443.3 488.6 308.8 382.8 836.4 490.3 714.6 565.7 519.1 918.8 0.1 0.0 0.0 3.3 0.0 0.6 0.1 0.0 0.0 0.1 0.2 0.3 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 105.1 1.5 0.1 0.2 0.0 0.0 6.1 0.0 0.0 0.2 0.0 0.8 11.4 40.9 0.0 0.0 0.0 0.0 3.8 0.2 0.0 0.0 1.6 113.0 1.5 0.2 0.0 1.0 0.0 0.2 0.0 4.0 1607.0 0.1 0.4 0.7 0.0 0.1 0.0 0.0 1.1 0.4 0.0 0.1 0.5 41.8 6.1 0.0 0.4 0.0 0.1 0.0 0.4 0.0 MYRIP "DKFZp586F1018, exophilin-8, SLAC2-C, SLAC2C" ENSG00000170011 "Myosin VIIA and Rab interacting protein" Q8NFW9 3 39808914-40260321 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 295.6;Inhibitory neurons: 507.3;Microglial cells: 210.8;Oligodendrocyte precursor cells: 98.0" "Cancer enhanced" "Detected in many" "liver cancer: 4.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.1;HUVEC TERT2: 15.6;REH: 3.7;SCLC-21H: 3.2;SH-SY5Y: 9.4;T-47d: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006433 Approved "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus" "HPA006433: AB_10603023" "unprognostic (1.87e-2)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.89e-2)" "unprognostic (2.36e-1)" "unprognostic (6.03e-2)" "unprognostic (2.57e-3)" "unprognostic (1.34e-3)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (1.91e-1)" "prognostic favorable (3.96e-8)" "unprognostic (7.12e-2)" "unprognostic (2.40e-1)" "unprognostic (8.92e-2)" "unprognostic (6.16e-2)" 4.1 1.0 16.8 1.3 13.3 0.0 3.7 11.1 18.4 5.7 15.4 2.7 1.7 3.2 2.2 1.3 2.8 2.7 2.4 17.3 7.7 1.5 11.5 0.8 1.6 9.2 17.8 3.1 8.9 2.1 2.9 0.1 13.0 2.0 2.6 4.3 12.5 0.8 1.7 1.2 2.4 2.3 4.2 7.2 5.6 0.9 12.0 0.5 1.5 0.5 1.7 1.4 2.6 15.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.2 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.0 0.1 3.7 0.0 0.0 0.4 2.0 3.2 9.4 0.0 0.0 0.0 0.0 3.8 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 13.3 11.1 18.4 17.3 7.7 9.2 17.8 13.0 4.2 12.0 15.0 15.8 0.0 3.2 36.2 0.4 0.8 0.1 0.0 1.2 2.7 0.5 0.3 2.4 5.7 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.1 19.9 1.1 0.7 21.3 0.0 1.7 295.6 2.8 0.0 1.6 3.1 6.2 2.5 14.0 42.8 17.4 0.0 5.0 507.3 11.9 0.0 2.8 0.7 6.1 0.9 0.1 0.0 210.8 0.0 6.6 0.0 98.0 24.5 0.6 0.1 0.0 0.0 1.4 0.1 1.8 0.1 4.2 0.0 0.3 0.7 3.1 0.6 0.1 0.6 0.0 0.3 0.1 0.7 0.1 EIF1B GC20 ENSG00000114784 "Eukaryotic translation initiation factor 1B" O60739 3 40309707-40312424 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 362.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 39: Non-specific - Basic cellular processes" "unprognostic (1.54e-1)" "unprognostic (1.06e-2)" "unprognostic (1.31e-2)" "unprognostic (3.20e-3)" "unprognostic (7.64e-2)" "unprognostic (7.91e-2)" "prognostic unfavorable (1.94e-5)" "unprognostic (3.16e-2)" "unprognostic (9.87e-2)" "unprognostic (3.02e-2)" "unprognostic (1.13e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.33e-1)" "unprognostic (1.23e-1)" "unprognostic (1.82e-1)" "unprognostic (8.87e-2)" 81.6 92.0 88.1 47.8 90.5 221.8 66.7 97.3 134.4 64.2 76.7 78.2 41.2 66.8 59.9 41.9 75.1 61.3 362.7 90.7 123.2 118.4 92.4 73.9 67.7 110.8 98.4 103.3 60.3 77.2 91.0 53.0 106.6 52.3 42.2 94.5 47.9 56.5 157.4 47.7 55.5 59.1 93.3 62.6 70.9 83.3 92.3 62.7 59.2 146.5 59.8 89.9 53.7 99.7 41.1 33.1 110.0 62.9 130.2 127.0 65.6 82.1 107.6 79.8 103.0 52.1 54.1 83.7 44.5 56.4 47.8 27.3 75.9 40.4 80.8 127.6 76.9 135.5 33.4 120.4 206.3 82.4 66.8 93.0 121.8 70.2 119.2 112.5 85.2 55.9 115.5 100.5 93.2 26.1 66.7 89.2 149.5 36.3 87.0 45.4 61.4 68.1 78.3 51.6 46.7 76.5 59.4 34.1 238.6 103.4 43.6 82.8 65.8 45.8 47.3 93.6 58.5 92.5 177.2 121.4 57.3 89.7 66.6 93.0 48.5 138.1 36.4 57.8 43.6 95.1 44.4 47.0 45.3 83.8 51.8 45.8 133.2 40.9 55.7 73.2 58.4 41.0 88.1 90.5 97.3 134.4 90.7 123.2 110.8 98.4 106.6 93.3 92.3 99.7 178.9 93.0 63.1 15.7 216.5 190.0 226.5 133.8 227.1 108.6 94.7 119.0 454.8 81.5 83.3 88.3 54.2 113.9 125.0 114.3 293.5 97.2 167.3 139.6 146.0 115.5 117.5 294.1 45.2 114.6 120.2 207.4 69.8 141.5 130.0 104.3 102.1 75.1 128.5 149.7 50.9 82.1 99.7 172.0 135.4 71.5 109.0 192.1 149.4 20.6 138.0 157.5 118.4 23.1 33.4 85.0 183.6 91.7 76.9 119.8 138.7 292.1 81.5 189.8 92.1 161.7 187.6 493.0 268.2 137.8 147.8 115.6 143.4 80.9 88.7 206.7 ENTPD3 "CD39L3, HB6, NTPDase-3" ENSG00000168032 "Ectonucleoside triphosphate diphosphohydrolase 3" O75355 3 40387184-40428744 "Enzymes, Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8;cervix: 21.3;salivary gland: 22.4" "Cell type enriched" "Detected in many" 4 "Inhibitory neurons: 92.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "plasmacytoid DC: 3.5" "Lineage enriched" "Detected in single" 7 "dendritic cells: 3.5" "Cell line enhanced" "Detected in some" "HaCaT: 3.6;HBEC3-KT: 13.0;hTCEpi: 8.4;RT4: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 15: RT4 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (1.00e-1)" "unprognostic (1.54e-2)" "unprognostic (2.75e-2)" "unprognostic (9.84e-3)" "unprognostic (2.27e-2)" "unprognostic (2.04e-1)" "unprognostic (1.80e-1)" "unprognostic (1.18e-2)" "unprognostic (8.40e-2)" "unprognostic (9.88e-3)" "unprognostic (4.72e-2)" "unprognostic (2.08e-1)" "unprognostic (3.25e-1)" "unprognostic (6.53e-2)" "unprognostic (5.99e-2)" "unprognostic (1.68e-1)" "unprognostic (1.23e-1)" 4.2 1.3 3.4 1.1 20.8 0.1 2.4 2.0 6.5 21.3 0.8 3.5 1.3 3.1 2.4 6.5 0.9 2.0 0.6 4.5 4.5 2.6 0.1 3.9 0.4 6.2 4.0 1.7 15.8 0.5 2.9 0.5 6.1 3.4 2.8 2.6 22.4 4.0 1.2 2.9 1.4 1.9 2.2 4.2 6.8 0.5 5.3 0.9 5.5 2.5 1.7 13.0 3.6 4.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 3.6 0.0 13.0 0.3 0.4 0.4 0.5 0.2 0.0 0.0 0.0 0.0 0.1 8.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.2 1.0 0.0 0.0 0.0 1.5 18.4 1.8 0.2 0.4 1.1 0.2 0.3 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.5 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.4 0.0 3.5 0.2 0.0 3.4 20.8 2.0 6.5 4.5 4.5 6.2 4.0 6.1 2.2 5.3 4.7 5.5 3.2 4.2 4.9 0.2 2.3 1.3 2.3 8.0 0.7 6.1 0.3 0.5 0.0 5.1 0.0 0.0 0.0 1.3 1.0 0.0 2.7 0.4 7.6 2.5 0.7 2.4 0.0 22.6 22.5 0.0 0.4 2.6 14.9 0.0 0.0 0.0 0.0 0.1 0.0 92.6 0.1 0.0 0.0 0.8 0.0 0.3 0.3 0.0 1.9 0.0 3.7 0.0 7.1 5.9 6.9 0.0 0.7 0.1 1.4 0.0 0.0 1.9 0.8 19.7 0.6 19.9 0.2 0.1 14.5 2.3 0.0 0.2 0.1 0.2 4.7 RPL14 "CTG-B33, hRL14, L14, RL14" ENSG00000188846 "Ribosomal protein L14" P50914 3 40457292-40468587 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004136 Approved Supported "Endoplasmic reticulum,Cytosol" NA NA 270000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "HPA004136: AB_1079839" "unprognostic (1.36e-3)" "unprognostic (2.91e-1)" "unprognostic (2.48e-2)" "unprognostic (2.35e-1)" "unprognostic (3.92e-2)" "unprognostic (2.54e-1)" "unprognostic (1.69e-2)" "unprognostic (2.42e-1)" "unprognostic (1.02e-1)" "unprognostic (4.94e-2)" "unprognostic (1.93e-2)" "unprognostic (1.20e-1)" "unprognostic (2.11e-1)" "unprognostic (1.54e-1)" "unprognostic (2.90e-2)" "unprognostic (6.14e-3)" "unprognostic (1.15e-1)" 193.3 125.9 50.3 29.2 53.0 64.2 199.2 53.9 66.4 280.8 49.7 204.9 39.0 173.8 28.5 178.6 203.5 25.3 89.8 49.2 53.3 157.1 133.0 157.7 45.3 54.0 50.7 401.6 236.4 45.5 161.1 40.7 52.9 180.5 39.8 37.0 173.9 58.2 165.5 226.7 125.3 33.5 54.0 126.1 193.3 27.8 53.7 59.1 161.1 62.9 56.0 210.4 214.5 49.9 53.1 23.4 116.6 55.7 103.6 281.6 80.4 85.8 140.4 152.1 110.9 48.9 18.5 205.9 64.9 64.6 76.4 17.2 78.1 103.7 104.9 79.7 80.6 115.3 43.1 44.7 149.4 153.1 53.2 172.9 301.8 70.6 143.1 220.9 168.3 179.7 111.7 30.1 117.1 38.1 53.4 111.8 44.8 172.9 75.7 26.9 65.6 95.4 140.3 33.2 46.3 75.2 43.2 40.2 102.6 128.0 58.5 74.5 93.3 50.8 41.5 67.4 102.5 90.9 129.3 125.0 22.9 106.1 47.5 15.4 49.1 19.2 76.5 46.0 118.9 98.6 110.8 98.1 62.1 89.8 133.6 126.9 6.5 56.9 38.0 54.4 97.1 236.2 50.3 53.0 53.9 66.4 49.2 53.3 54.0 50.7 52.9 54.0 53.7 49.9 1374.3 830.1 1146.4 29.7 2884.7 3113.4 5120.8 2595.4 3076.6 225.8 3891.2 6163.2 346.3 1634.2 1633.6 676.8 102.2 3352.5 2285.9 971.2 2529.8 2063.4 290.0 898.3 1997.2 1471.6 1228.6 2245.7 39.0 4163.8 4729.5 1652.6 1184.6 1362.2 1565.2 1640.0 1678.7 1340.0 2207.8 101.0 45.7 2528.3 805.6 2102.2 2691.6 617.6 2160.3 1804.6 1782.2 32.8 2894.7 491.4 2368.7 23.1 41.3 2772.7 2061.9 1084.8 1855.0 4343.4 2359.1 3658.8 667.3 328.8 966.3 2109.4 2212.8 265.0 405.3 4161.2 3418.2 3314.5 2819.7 1921.9 2787.9 4891.9 ZNF619 FLJ90764 ENSG00000177873 "Zinc finger protein 619" Q8N2I2 3 40477113-40491053 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045094 Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Intermediate filaments" "HPA045094: AB_10959900" "unprognostic (7.16e-2)" "unprognostic (5.94e-1)" "unprognostic (8.38e-3)" "unprognostic (5.42e-2)" "unprognostic (8.16e-3)" "unprognostic (1.32e-2)" "unprognostic (5.59e-2)" "unprognostic (1.85e-1)" "unprognostic (5.46e-2)" "unprognostic (2.65e-1)" "unprognostic (7.99e-2)" "unprognostic (6.15e-3)" "unprognostic (8.28e-6)" "unprognostic (1.94e-1)" "unprognostic (1.69e-1)" "unprognostic (6.56e-2)" "unprognostic (1.38e-2)" 1.7 1.6 2.3 2.0 3.5 3.1 2.9 3.0 2.8 2.0 2.5 2.0 2.3 2.0 2.1 1.4 2.5 1.3 1.8 2.2 2.6 2.2 2.4 2.0 2.4 3.0 3.0 2.6 2.5 3.1 1.2 2.0 3.0 2.1 2.6 4.1 2.7 2.2 2.5 2.4 2.0 2.3 2.2 2.9 2.4 1.1 3.0 1.5 3.0 2.2 2.9 1.7 1.5 4.6 1.9 2.5 2.9 2.8 4.5 4.3 1.3 2.7 3.1 4.5 3.9 0.9 2.6 0.2 1.4 2.2 2.2 2.1 3.2 5.0 4.8 3.6 1.1 6.1 2.2 1.4 4.6 4.2 5.0 3.4 3.9 4.7 6.6 3.9 3.8 0.2 3.9 2.9 2.9 2.3 0.1 2.1 1.6 2.2 2.8 1.2 3.0 3.3 2.1 4.2 2.1 2.2 2.4 4.1 2.0 2.9 3.4 2.7 3.6 3.3 2.7 2.0 2.8 1.6 2.2 0.2 2.1 2.6 3.7 0.8 0.7 1.1 0.7 0.9 0.7 0.7 0.6 0.8 1.0 0.8 0.6 0.9 0.8 1.3 1.0 0.6 1.2 0.7 2.3 3.5 3.0 2.8 2.2 2.6 3.0 3.0 3.0 2.2 3.0 4.6 1.5 0.0 1.1 1.0 2.3 0.3 0.8 0.6 1.2 3.6 1.0 1.0 1.3 0.0 0.3 3.7 2.1 1.4 1.0 0.7 0.0 1.4 0.1 1.4 1.6 1.6 0.0 2.1 0.5 1.5 0.9 1.2 1.5 1.1 0.0 2.4 1.8 0.9 1.1 0.0 1.0 1.3 0.0 1.6 0.4 0.0 1.2 1.2 0.0 2.8 1.6 2.5 2.1 1.0 2.3 0.6 0.2 0.4 1.7 0.5 1.6 1.3 1.0 3.6 0.0 2.0 1.1 1.2 1.4 1.7 0.1 0.4 1.5 2.5 0.8 0.6 ZNF620 MGC50836 ENSG00000177842 "Zinc finger protein 620" Q6ZNG0 3 40477131-40518736 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 7.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA031452, HPA059383" Uncertain Approved Centrosome NA NA "Cluster 44: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 44: Endometrium - Transcription" Centrosome "HPA031452: AB_10603939, HPA059383: AB_2732636" "unprognostic (1.42e-2)" "unprognostic (4.23e-2)" "unprognostic (1.14e-3)" "unprognostic (1.48e-2)" "unprognostic (5.62e-2)" "unprognostic (1.86e-1)" "unprognostic (3.04e-3)" "unprognostic (2.15e-2)" "unprognostic (7.73e-2)" "unprognostic (3.78e-2)" "unprognostic (1.71e-2)" "unprognostic (4.09e-2)" "unprognostic (1.21e-5)" "unprognostic (1.28e-1)" "unprognostic (4.78e-1)" "unprognostic (2.61e-2)" "unprognostic (9.19e-4)" 1.4 1.9 2.1 1.0 3.3 3.2 2.0 4.6 2.4 1.3 2.8 1.8 1.7 1.3 1.6 1.1 1.9 1.1 1.7 1.7 2.4 2.4 1.4 2.2 1.3 2.6 2.6 1.5 2.5 2.7 2.5 2.3 2.4 1.8 2.1 4.3 1.0 1.9 2.6 0.7 1.5 1.6 2.2 1.8 2.7 1.1 2.7 1.6 3.4 2.3 1.0 1.4 0.9 3.5 2.4 3.1 8.8 3.3 0.7 0.9 3.6 0.6 1.0 3.8 6.0 9.0 5.2 0.0 2.7 0.5 3.5 0.6 13.3 1.3 3.1 8.0 10.4 6.6 9.8 4.9 1.5 2.4 1.0 0.6 0.9 2.6 1.2 1.0 3.0 0.1 3.5 0.8 0.5 4.5 0.5 2.0 10.4 5.0 2.0 3.6 3.5 1.2 3.9 8.7 10.4 8.0 0.7 6.3 4.2 7.9 8.1 2.4 2.0 0.4 5.8 0.8 2.9 1.3 2.3 0.1 1.4 1.2 1.5 7.7 0.5 1.0 2.1 0.9 2.4 0.4 0.8 2.0 0.5 1.6 1.6 2.2 0.6 3.0 0.3 1.2 3.5 0.9 2.1 3.3 4.6 2.4 1.7 2.4 2.6 2.6 2.4 2.2 2.7 3.5 5.4 6.4 4.1 2.6 1.7 0.5 3.4 1.6 0.6 10.5 3.3 2.9 2.1 4.3 3.2 0.0 4.2 8.5 3.6 2.3 5.9 6.1 0.1 4.3 2.0 5.4 9.0 8.6 1.6 2.9 1.8 2.1 3.1 9.2 7.0 7.8 5.0 2.1 1.4 3.3 2.2 4.2 8.2 1.9 1.2 0.7 0.3 1.6 0.0 0.0 11.0 9.0 7.2 3.0 6.2 2.2 4.8 0.4 0.5 2.8 2.3 3.5 2.1 11.6 0.0 4.5 4.6 7.8 6.7 0.8 0.1 1.9 2.7 5.0 4.3 1.4 ZNF621 FLJ45246 ENSG00000172888 "Zinc finger protein 621" Q6ZSS3 3 40524878-40574685 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065518, HPA071440" Enhanced "Nuclear speckles" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "HPA065518: AB_2685501, HPA071440: AB_2686395" "unprognostic (1.09e-1)" "unprognostic (1.60e-1)" "unprognostic (4.20e-2)" "unprognostic (1.95e-1)" "unprognostic (2.45e-2)" "unprognostic (1.52e-3)" "unprognostic (9.50e-3)" "unprognostic (3.06e-2)" "unprognostic (3.14e-2)" "unprognostic (2.62e-1)" "unprognostic (4.04e-1)" "unprognostic (6.75e-3)" "unprognostic (2.19e-1)" "unprognostic (5.33e-2)" "unprognostic (8.76e-2)" "unprognostic (2.50e-2)" "unprognostic (2.01e-3)" 13.0 10.0 15.7 5.9 18.9 7.1 12.9 15.0 16.5 12.7 13.4 11.2 5.3 11.2 8.1 9.5 11.5 5.7 9.4 13.2 17.1 15.2 12.4 13.2 6.2 19.4 16.3 12.0 12.2 7.7 14.6 5.5 19.4 14.4 5.7 7.4 12.1 6.9 7.2 10.0 11.7 6.1 17.0 12.7 10.7 7.6 17.5 5.5 13.2 5.6 6.1 11.0 11.5 21.0 8.9 5.0 12.2 12.0 7.8 13.4 6.9 9.5 11.1 11.7 11.6 11.1 4.8 3.7 6.9 12.4 8.8 3.1 12.2 7.2 13.7 14.9 15.1 12.4 20.8 10.1 13.6 11.6 11.8 10.4 14.9 12.2 19.0 12.7 9.9 4.4 13.3 10.8 10.1 5.6 2.9 13.8 7.7 3.5 10.2 1.1 8.2 4.4 6.1 11.0 4.3 10.9 10.2 6.9 12.0 11.7 11.4 9.4 13.1 20.2 9.8 10.2 13.4 16.1 17.4 8.3 9.9 8.6 12.5 2.5 1.0 0.9 1.3 1.3 0.8 2.3 1.3 1.8 0.9 3.3 1.6 1.2 1.2 1.8 0.7 1.3 1.3 0.7 15.7 18.9 15.0 16.5 13.2 17.1 19.4 16.3 19.4 17.0 17.5 21.0 13.2 9.6 12.3 22.5 9.6 1.5 5.2 2.3 9.1 13.8 6.3 5.0 12.1 10.0 7.7 11.0 12.5 5.5 9.5 4.9 5.9 7.7 10.8 11.1 16.4 12.0 10.2 12.4 4.1 5.6 3.5 9.0 7.7 12.2 3.8 15.0 5.0 5.6 3.7 15.2 4.2 7.1 4.1 8.1 3.0 7.9 7.5 6.9 3.6 11.2 9.4 7.1 10.3 19.1 26.1 7.5 4.9 12.0 8.8 6.6 6.7 3.2 4.6 16.7 0.0 13.6 9.1 10.6 6.3 7.5 1.8 5.5 8.1 12.9 5.8 4.4 CTNNB1 "armadillo, beta-catenin, CTNNB" ENSG00000168036 "Catenin beta 1" P35222 3 41194741-41260096 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation, Wnt signaling pathway" Activator "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 539.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000108, CAB001950, HPA029159, HPA029160" Supported Enhanced "Plasma membrane" NA NA 2000000 "Cluster 39: Non-specific - mRNA processing" "Cluster 37: Intestine - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 41: Macrophages - Immune response" "Plasma membrane" "CAB000108: , CAB001950: , HPA029159: AB_10599619, HPA029160: AB_10600996" "unprognostic (2.47e-1)" "unprognostic (3.48e-2)" "prognostic favorable (7.54e-4)" "unprognostic (1.61e-1)" "unprognostic (9.55e-2)" "unprognostic (1.05e-2)" "unprognostic (3.20e-3)" "unprognostic (2.79e-1)" "unprognostic (1.57e-1)" "unprognostic (1.80e-2)" "unprognostic (1.88e-2)" "unprognostic (9.05e-2)" "unprognostic (1.97e-3)" "unprognostic (1.82e-2)" "unprognostic (1.17e-1)" "unprognostic (2.61e-1)" "unprognostic (9.79e-2)" 130.8 112.2 106.7 98.7 85.3 162.4 194.3 147.8 87.5 179.4 94.7 141.2 136.9 149.4 84.4 113.7 131.0 121.8 109.9 88.1 105.3 106.5 147.9 132.9 81.9 101.3 112.9 173.9 93.3 137.2 84.7 200.0 94.0 132.3 134.5 88.8 110.9 126.3 87.3 99.0 142.9 178.4 104.9 92.5 81.8 59.5 129.4 95.6 140.6 89.9 99.5 158.3 109.3 108.4 161.6 210.0 423.6 242.8 226.9 184.7 333.8 179.6 249.7 288.2 284.3 146.3 224.0 131.7 157.8 314.1 129.0 119.6 315.8 510.0 306.2 123.3 215.7 215.5 261.0 523.7 169.5 121.8 99.1 271.6 226.7 345.5 208.7 235.7 258.1 63.0 153.7 80.3 324.1 161.8 87.3 68.3 397.2 211.0 159.3 64.9 281.9 88.3 177.9 494.8 102.9 172.4 296.2 147.1 809.4 509.8 242.1 248.6 340.8 217.1 163.6 139.3 264.0 50.7 82.7 138.4 221.5 150.5 369.7 4.7 7.3 6.4 9.2 12.3 10.9 7.7 8.6 10.1 11.8 8.0 8.6 9.4 6.6 9.6 12.6 10.0 10.8 5.6 106.7 85.3 147.8 87.5 88.1 105.3 101.3 112.9 94.0 104.9 129.4 108.4 171.7 137.8 179.5 58.1 71.7 213.5 130.1 75.3 116.1 40.7 232.5 168.1 84.7 90.1 119.2 62.5 33.3 318.9 99.0 251.6 35.2 132.2 11.0 90.3 125.9 187.3 93.8 43.8 50.9 78.5 115.6 116.8 53.0 95.5 116.6 137.0 139.2 172.5 115.1 13.5 82.4 145.9 42.7 154.6 228.1 9.5 59.7 161.1 202.7 124.6 98.3 89.2 49.4 70.9 62.9 139.8 249.5 86.9 55.5 128.3 160.3 93.2 96.1 62.0 46.0 175.6 137.3 78.4 40.1 70.9 174.9 539.5 77.0 245.6 189.6 127.9 ULK4 "FAM7C1, FLJ20574, REC01035" ENSG00000168038 "Unc-51 like kinase 4" Q96C45 3 41246599-41962130 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 23.4" "Cell type enhanced" "Detected in many" "Early spermatids: 352.3;Excitatory neurons: 108.6;Inhibitory neurons: 99.2;Late spermatids: 405.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017930 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 18: U-2197 - ECM organization" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Mitochondria, Cytosol" "HPA017930: AB_1858615" "unprognostic (3.16e-2)" "unprognostic (2.98e-3)" "unprognostic (9.72e-3)" "unprognostic (3.46e-2)" "unprognostic (2.58e-1)" "unprognostic (8.68e-2)" "unprognostic (1.87e-1)" "unprognostic (3.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "unprognostic (3.75e-3)" "unprognostic (3.43e-1)" "unprognostic (1.91e-2)" "unprognostic (5.46e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (6.12e-2)" 2.7 3.1 1.6 2.9 2.1 8.5 2.5 0.4 1.7 8.5 16.9 1.6 1.2 6.6 4.5 1.5 9.0 1.9 8.6 2.3 2.5 3.9 2.1 3.5 3.0 6.9 7.6 2.1 2.0 8.0 2.9 2.7 3.9 2.2 1.7 6.0 1.7 2.4 0.4 2.1 2.0 3.5 5.6 2.0 2.4 23.4 2.5 3.0 4.9 0.4 2.7 1.9 3.7 2.1 8.3 2.9 2.8 3.8 1.1 1.7 4.8 2.7 2.7 3.2 3.0 1.0 2.3 9.5 1.6 6.3 3.5 4.1 3.7 2.1 2.9 1.5 1.0 2.1 5.7 3.3 4.1 6.5 1.8 1.6 2.3 16.1 3.2 4.4 2.2 6.4 2.1 7.5 2.3 6.4 8.1 4.9 3.4 2.1 3.4 1.7 9.1 4.5 7.2 7.6 1.6 10.3 3.1 1.3 2.8 1.8 3.1 2.0 6.6 2.0 2.4 14.2 2.5 4.5 9.0 3.9 11.5 6.3 2.5 3.7 3.7 4.0 5.0 4.3 4.1 3.7 5.3 4.5 3.3 4.7 4.0 5.7 6.6 1.8 2.3 3.3 7.7 3.0 1.6 2.1 0.4 1.7 2.3 2.5 6.9 7.6 3.9 5.6 2.5 2.1 6.4 9.6 6.9 84.9 11.2 2.0 3.0 4.0 5.2 5.6 5.7 4.6 14.8 4.3 5.1 3.7 54.2 3.1 9.9 2.0 0.0 3.4 352.3 45.3 27.4 6.0 1.8 2.1 108.6 2.4 4.1 8.7 10.2 7.5 1.3 49.6 1.8 6.6 7.3 11.8 99.2 1.2 2.0 3.1 4.0 405.2 6.5 6.9 0.0 80.6 5.9 10.4 3.1 49.8 62.0 3.0 0.7 4.1 5.1 0.9 1.1 5.9 47.3 26.7 6.6 4.4 10.5 38.9 9.6 3.3 3.7 4.2 10.8 3.6 1.9 1.2 TRAK1 "KIAA1042, MILT1, OIP106" ENSG00000182606 "Trafficking kinesin protein 1" Q9UPV9 3 42013802-42225890 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 168.9;skeletal muscle: 262.4;tongue: 202.6" "Cell type enhanced" "Detected in all" "Astrocytes: 173.0;Cardiomyocytes: 262.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RT4: 165.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005853, HPA011367" Approved Approved "Nucleoplasm,Endoplasmic reticulum" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 15: RT4 - Unknown function" "Cluster 46: Photoreceptor cells - Phototransduction" "Endoplasmic reticulum" Nucleoplasm "HPA005853: AB_1854778, HPA011367: AB_2668495" "unprognostic (5.55e-2)" "unprognostic (1.38e-2)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.80e-2)" "unprognostic (1.95e-1)" "unprognostic (1.39e-1)" "unprognostic (2.13e-2)" "unprognostic (3.01e-2)" "unprognostic (3.56e-3)" "prognostic favorable (4.84e-8)" "unprognostic (3.65e-2)" "unprognostic (1.70e-1)" "unprognostic (1.00e-2)" "unprognostic (4.61e-3)" 26.0 13.1 23.0 17.1 26.2 18.2 18.0 28.5 27.7 13.7 27.8 27.1 34.5 12.2 10.4 29.3 19.8 26.9 168.9 24.2 19.5 20.1 15.3 24.1 22.8 24.4 30.3 8.5 13.1 32.2 17.7 15.3 21.6 15.4 25.4 96.7 44.1 13.1 262.4 45.1 42.0 16.8 19.1 22.2 61.0 12.1 26.0 17.9 31.4 202.6 22.6 33.8 18.4 21.4 22.2 19.2 37.9 16.4 25.6 24.9 48.9 29.5 33.5 19.0 20.6 12.8 30.7 43.9 15.1 75.2 20.4 10.7 26.5 68.8 20.6 39.6 18.8 30.4 19.9 35.6 12.8 34.6 22.9 21.4 28.9 41.9 38.0 28.1 38.6 11.6 15.7 34.4 24.4 9.2 3.7 18.1 16.4 60.4 14.8 16.1 14.1 36.8 26.3 165.3 23.8 27.9 11.3 16.3 16.2 31.4 14.6 29.3 39.6 16.6 19.2 99.0 17.4 25.7 23.0 38.9 18.2 30.2 16.4 0.9 1.3 0.5 0.6 2.4 0.5 2.4 0.9 0.7 1.5 3.6 0.3 0.9 0.6 1.0 1.4 2.5 0.4 0.7 23.0 26.2 28.5 27.7 24.2 19.5 24.4 30.3 21.6 19.1 26.0 21.4 27.4 32.1 32.4 173.0 23.9 38.0 16.3 32.1 30.1 22.7 18.5 17.7 262.0 24.3 38.1 14.7 100.1 23.0 13.9 61.4 1.9 10.8 1.1 53.3 21.8 23.9 22.8 6.5 62.0 12.3 18.3 14.0 81.1 70.0 10.8 11.5 6.8 10.3 15.7 33.7 81.3 39.5 26.4 15.7 33.4 3.0 1.8 23.3 24.9 97.4 17.9 27.8 4.1 105.1 64.8 24.2 37.1 2.6 5.4 18.5 97.9 10.2 80.6 139.9 32.9 15.9 29.9 1.0 3.9 27.5 43.2 15.7 7.5 4.6 35.6 27.0 CCK ENSG00000187094 Cholecystokinin P06307 3 42257825-42266185 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 317.9;choroid plexus: 89.5;intestine: 115.7" "Cell type enhanced" "Detected in many" "Astrocytes: 40.1;Excitatory neurons: 154.8;Fibroblasts: 42.5;Inhibitory neurons: 157.7;Melanocytes: 40.9;Oligodendrocytes: 40.9;Prostatic glandular cells: 63.8" "Group enriched" "Detected in many" 5 "glioma: 4.0;pancreatic cancer: 1.8;prostate cancer: 3.5;stomach cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "OE19: 236.5" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebral cortex: 74.4" "HPA045039, HPA069515" Enhanced Supported "Secreted to blood" NA NA 43700000 "Cluster 10: Brain - Neuronal signaling" "Cluster 21: OE19 - Mitochondria" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA045039: , HPA069515: AB_2732135" "unprognostic (3.36e-1)" "unprognostic (1.58e-1)" "unprognostic (1.92e-1)" "unprognostic (1.40e-3)" "unprognostic (1.04e-1)" "unprognostic (1.70e-1)" "unprognostic (2.39e-3)" "unprognostic (1.97e-2)" "unprognostic (3.91e-1)" "unprognostic (8.77e-2)" "unprognostic (1.35e-1)" "unprognostic (2.42e-1)" "unprognostic (1.37e-1)" "unprognostic (5.10e-2)" 0.2 0.9 134.4 0.5 202.6 0.0 0.2 85.8 317.9 0.0 89.5 4.4 115.7 0.0 0.0 0.3 0.5 0.0 0.1 160.1 96.9 1.2 0.4 3.4 0.0 99.9 103.4 0.1 0.4 0.0 18.4 1.1 94.5 19.5 0.1 4.4 0.2 0.2 0.2 0.4 17.0 0.2 93.9 0.0 2.1 2.3 123.9 0.2 0.1 0.0 0.0 0.1 0.1 143.7 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 9.7 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 236.5 0.1 0.0 0.0 1.1 25.0 0.1 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 134.4 202.6 85.8 317.9 160.1 96.9 99.9 103.4 94.5 93.9 123.9 143.7 0.4 0.0 0.0 40.1 0.2 5.7 1.3 0.3 0.6 6.8 1.3 1.9 0.3 0.0 0.2 5.5 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 2.5 0.0 0.0 154.8 0.4 0.1 42.5 5.1 0.4 0.0 0.0 1.4 0.0 0.1 0.0 157.7 11.4 2.0 0.3 3.0 0.3 0.0 0.6 40.9 34.7 0.0 36.7 0.0 34.7 40.9 0.7 0.0 0.0 0.0 63.8 0.6 0.1 0.0 3.5 0.0 0.8 6.4 0.1 1.7 0.0 1.3 10.5 0.0 0.0 0.5 8.7 LYZL4 "LYC4, MGC26768" ENSG00000157093 "Lysozyme like 4" Q96KX0 3 42397083-42410610 "Predicted secreted proteins" Fertilization "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 46 "testis: 52.1" "Group enriched" "Detected in some" 46 "Early spermatids: 386.3;Late spermatids: 158.8" "Not detected" "Not detected" "Region enhanced" "Detected in single" "basal ganglia: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "OE19: 3.8" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA038806 Approved "Secreted in male reproductive system" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 21: OE19 - Mitochondria" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA038806: AB_10674841" "unprognostic (4.03e-1)" "unprognostic (5.68e-1)" "unprognostic (1.06e-1)" 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 52.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 386.3 0.0 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 158.8 3.1 0.3 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 5.9 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 VIPR1 "HVR1, RDC1, VPAC1, VPAC1R" ENSG00000114812 "Vasoactive intestinal peptide receptor 1" P32241 3 42489299-42537573 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 132.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 71.8;Intestinal goblet cells: 48.6;Paneth cells: 96.2;Proximal enterocytes: 58.6" "Cancer enhanced" "Detected in many" "prostate cancer: 10.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 22 "dendritic cells: 2.1;monocytes: 1.8;T-cells: 2.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 60.8;OE19: 36.2;RT4: 44.0;SK-BR-3: 24.7;WM-115: 79.0" "Group enriched" "Detected in many" 4 "amygdala: 6.3;basal ganglia: 4.5;cerebral cortex: 9.6;hippocampal formation: 7.7;white matter: 2.5" "Low region specificity" "Detected in all" HPA026777 Approved NA NA "Cluster 32: T-cells - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 17: WM-115 - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA026777: AB_10604003" "unprognostic (9.02e-2)" "unprognostic (9.34e-3)" "unprognostic (3.70e-1)" "unprognostic (1.57e-1)" "unprognostic (1.28e-1)" "unprognostic (1.47e-2)" "unprognostic (8.89e-4)" "unprognostic (4.00e-3)" "unprognostic (1.03e-1)" "unprognostic (2.95e-2)" "unprognostic (1.28e-2)" "unprognostic (2.72e-1)" "unprognostic (1.82e-3)" "unprognostic (7.70e-2)" "unprognostic (1.69e-1)" "unprognostic (1.03e-2)" "unprognostic (1.05e-2)" 17.5 2.6 10.1 3.4 12.7 2.3 16.9 13.5 15.2 2.9 5.1 28.0 34.5 1.2 6.6 5.3 1.3 6.0 6.5 13.0 5.5 2.7 32.4 132.1 4.6 5.3 4.8 0.6 2.5 4.2 1.9 2.8 6.3 25.0 27.7 4.2 22.7 8.9 1.2 29.8 30.0 1.3 4.4 5.7 6.1 1.4 4.7 1.9 15.1 4.9 2.4 8.7 5.0 12.1 0.1 2.4 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.4 2.2 60.8 0.2 3.1 0.0 0.0 2.4 0.0 1.6 0.1 0.0 5.2 3.8 1.8 0.0 0.3 0.0 0.5 0.0 3.8 0.2 1.2 0.0 0.7 0.6 0.0 0.0 0.0 5.2 0.0 0.3 3.8 36.2 0.2 0.5 0.0 2.8 0.0 44.0 1.3 0.0 0.0 24.7 0.0 7.1 15.2 0.5 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 79.0 0.0 1.8 0.0 0.2 1.5 1.0 0.0 2.4 1.0 2.1 0.0 2.7 0.8 0.0 0.0 1.3 0.0 0.4 0.9 10.1 12.7 13.5 15.2 13.0 5.5 5.3 4.8 6.3 4.4 4.7 12.1 16.0 3.2 6.0 3.3 1.3 7.6 4.5 2.2 22.2 0.2 19.2 21.5 2.6 5.7 2.1 1.8 8.4 0.1 0.4 71.8 0.0 0.3 3.0 0.2 0.1 2.8 4.8 0.0 26.9 0.9 1.0 1.0 16.3 0.6 0.0 0.3 19.6 0.4 0.7 0.0 1.5 48.6 0.0 8.7 4.0 0.6 0.0 5.9 0.0 3.7 8.9 1.4 0.0 3.0 1.7 1.2 96.2 0.0 1.5 6.3 58.6 0.1 1.0 5.4 32.9 0.2 20.8 0.1 0.1 4.1 7.7 0.3 2.9 0.1 24.0 3.9 SEC22C "MGC13261, MGC5373, SEC22L3" ENSG00000093183 "SEC22 homolog C, vesicle trafficking protein" Q9BRL7 3 42547969-42601080 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031242 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 6: T47d - Mammary gland" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" Nucleoplasm "HPA031242: " "unprognostic (1.68e-1)" "unprognostic (4.86e-2)" "unprognostic (1.01e-1)" "unprognostic (2.67e-1)" "unprognostic (9.37e-3)" "unprognostic (2.11e-1)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.15e-1)" "unprognostic (3.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.58e-2)" "unprognostic (2.57e-1)" "prognostic favorable (1.35e-7)" "unprognostic (2.59e-1)" "unprognostic (3.30e-1)" "unprognostic (7.51e-2)" "unprognostic (1.41e-3)" 35.7 23.4 37.3 14.1 40.8 36.5 33.2 39.1 46.8 28.2 33.8 31.1 31.9 29.8 27.4 17.2 27.2 18.9 24.3 34.1 38.0 26.2 16.4 33.1 19.0 41.4 40.3 29.3 29.6 26.4 26.6 19.3 42.0 37.3 15.6 25.6 23.3 25.9 22.2 19.4 32.6 26.3 37.5 20.4 28.3 27.5 39.2 18.2 24.2 26.1 16.4 25.7 23.1 48.1 24.0 22.2 35.9 30.5 72.4 68.1 7.6 43.8 46.7 46.1 47.9 15.5 37.9 24.5 17.6 50.1 28.2 12.6 24.1 39.8 40.7 32.8 28.5 41.7 40.0 21.0 55.4 19.2 39.5 38.3 53.1 51.4 62.5 46.5 51.1 38.7 37.0 46.5 45.8 16.6 27.1 22.3 19.8 16.0 31.9 11.7 21.4 22.9 40.6 21.1 18.5 27.8 30.9 28.0 34.5 26.5 48.4 20.9 42.9 35.1 27.8 63.8 43.1 36.8 55.6 23.5 41.7 26.6 34.0 11.7 11.5 22.0 13.2 9.0 19.6 11.5 17.6 16.3 10.8 9.4 14.9 13.2 7.1 10.2 9.3 11.3 16.3 10.1 37.3 40.8 39.1 46.8 34.1 38.0 41.4 40.3 42.0 37.5 39.2 48.1 31.4 25.6 27.6 27.1 23.2 15.0 18.3 25.3 25.0 16.6 31.6 29.6 18.8 24.3 17.2 11.0 29.2 20.5 28.1 1.9 41.1 29.7 61.2 17.5 19.5 30.5 9.0 48.2 18.9 32.9 20.3 31.8 21.9 12.7 49.4 25.1 32.2 14.5 31.3 26.9 18.4 4.9 32.6 19.0 14.4 15.0 32.6 17.6 40.9 21.5 35.5 39.2 24.7 12.5 44.1 28.8 1.0 42.9 23.0 24.0 36.9 29.6 19.4 39.9 39.5 26.6 31.1 96.9 49.8 11.3 10.2 10.5 34.6 20.3 6.6 9.4 SS18L2 KIAA-iso ENSG00000008324 "SS18 like 2" Q9UHA2 3 42581840-42596934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047377 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Cluster 13: T-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoli, Mitochondria" Nucleoplasm "HPA047377: AB_2680020" "unprognostic (4.09e-3)" "unprognostic (1.90e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-1)" "unprognostic (1.57e-1)" "unprognostic (1.64e-2)" "prognostic favorable (7.03e-4)" "unprognostic (6.55e-2)" "unprognostic (4.51e-2)" "unprognostic (2.62e-2)" "unprognostic (2.94e-2)" "unprognostic (1.09e-3)" "unprognostic (1.44e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (2.24e-3)" 21.0 17.1 27.6 18.5 28.6 33.9 21.9 28.8 37.1 19.8 26.7 17.5 19.0 12.6 17.8 21.2 15.7 10.4 18.7 28.2 28.4 24.5 32.4 19.6 35.4 28.2 27.8 19.1 21.6 13.5 25.1 9.9 28.3 35.9 13.6 13.7 19.1 8.6 16.2 24.9 25.6 7.4 28.4 31.6 22.7 10.1 27.8 23.6 20.4 11.0 30.2 19.4 18.5 31.5 32.3 14.0 29.0 26.4 34.9 27.8 17.3 20.6 22.4 28.7 32.2 27.1 29.1 43.3 18.2 13.6 31.6 17.9 33.9 28.0 30.9 21.7 40.5 46.9 28.9 45.3 25.4 62.5 36.2 22.1 17.7 23.7 21.9 20.6 31.4 39.1 43.2 65.4 23.1 29.3 44.8 76.4 45.9 42.7 34.2 23.6 20.6 61.2 32.3 38.2 16.2 23.0 17.6 27.2 29.8 30.2 35.8 57.4 19.5 18.0 29.0 42.8 38.0 46.5 76.3 73.5 26.3 66.1 17.0 60.4 56.4 84.9 88.4 66.0 121.0 120.3 116.3 106.2 62.1 104.3 99.5 101.1 75.8 83.0 50.9 74.5 139.2 90.4 27.6 28.6 28.8 37.1 28.2 28.4 28.2 27.8 28.3 28.4 27.8 31.5 39.3 12.8 16.7 5.5 96.3 107.1 70.1 101.5 91.0 16.2 78.6 77.8 19.3 42.9 46.1 27.6 8.4 57.1 102.9 39.2 56.7 43.4 4.3 47.0 37.9 37.0 55.1 67.3 13.6 49.2 75.8 39.0 39.8 71.9 45.7 39.6 32.5 61.0 66.8 23.5 11.2 51.1 79.3 38.6 51.2 3.7 34.5 43.0 51.6 6.5 69.3 38.1 88.6 3.0 25.8 50.6 58.9 15.8 72.4 75.6 121.4 85.2 28.2 26.8 13.1 26.4 32.5 19.4 24.7 84.5 138.1 37.4 103.2 34.5 53.7 99.2 NKTR p104 ENSG00000114857 "Natural killer cell triggering receptor" P30414 3 42600655-42648735 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022120, HPA051576" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Cluster 42: Non-specific - Transcription" "Cluster 51: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Plasma membrane, Cytosol" "HPA022120: AB_1854513, HPA051576: AB_2681540" "unprognostic (2.73e-3)" "unprognostic (3.11e-1)" "unprognostic (2.33e-1)" "unprognostic (2.06e-1)" "unprognostic (5.27e-3)" "prognostic favorable (1.26e-4)" "unprognostic (4.62e-2)" "unprognostic (5.65e-2)" "unprognostic (4.02e-2)" "unprognostic (1.61e-1)" "unprognostic (5.33e-2)" "prognostic unfavorable (6.01e-4)" "prognostic unfavorable (5.02e-4)" "unprognostic (3.82e-1)" "unprognostic (4.57e-1)" "unprognostic (1.40e-1)" "prognostic favorable (1.05e-5)" 17.4 19.2 16.4 17.6 18.7 46.5 19.3 22.3 17.1 28.4 17.9 17.7 13.2 18.4 22.4 17.0 23.0 11.4 17.8 15.0 20.3 18.2 21.1 23.9 22.1 20.5 16.4 29.0 22.1 10.6 36.5 11.1 17.6 23.2 13.4 41.3 17.5 10.5 19.5 32.6 25.4 10.7 14.0 36.7 16.3 18.0 18.2 15.4 25.4 10.4 20.0 18.3 22.6 27.8 15.1 7.7 32.3 15.6 16.6 19.3 14.9 22.8 6.8 9.9 12.9 14.7 13.3 25.9 10.7 9.1 9.0 12.6 16.1 8.4 19.2 11.0 13.1 31.4 30.5 24.6 7.3 25.4 19.9 9.6 12.2 18.4 10.5 19.1 17.4 7.1 30.3 20.2 18.6 6.9 17.8 35.5 23.1 7.6 12.3 17.3 12.0 10.5 15.7 12.7 9.4 8.5 24.1 11.1 4.8 16.3 17.5 17.8 28.0 18.0 13.1 21.4 23.2 17.2 21.7 17.7 10.1 30.0 11.3 7.8 3.6 7.5 5.7 4.6 5.3 5.5 5.6 4.9 2.9 5.3 5.6 4.9 5.3 7.0 6.8 5.1 5.3 2.3 16.4 18.7 22.3 17.1 15.0 20.3 20.5 16.4 17.6 14.0 18.2 27.8 221.8 109.0 141.4 169.4 129.5 59.0 60.3 57.8 66.0 200.0 76.3 69.8 68.7 65.8 73.2 88.3 246.0 72.5 156.0 60.3 17.6 47.3 23.9 114.4 125.5 166.2 71.8 76.6 143.5 38.8 51.1 83.3 86.6 132.4 96.8 210.0 110.7 58.6 45.9 132.9 170.0 70.2 61.1 53.8 70.2 21.8 167.7 78.9 51.6 194.9 97.4 101.9 163.7 180.0 267.2 47.6 59.2 134.3 131.3 77.5 106.8 17.0 53.3 279.9 92.1 103.5 88.9 246.2 186.1 42.4 57.3 31.3 164.4 104.5 75.0 54.2 ZBTB47 "DKFZp434N0615, KIAA1190, ZNF651" ENSG00000114853 "Zinc finger and BTB domain containing 47" Q9UFB7 3 42653697-42667580 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 112.5" "Cell type enhanced" "Detected in many" "Astrocytes: 21.9;Inhibitory neurons: 11.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 55.5;fHDF/TERT166: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074057 Enhanced Approved Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm "HPA074057: AB_2686657" "unprognostic (1.03e-1)" "unprognostic (1.15e-2)" "unprognostic (8.23e-2)" "unprognostic (3.99e-3)" "unprognostic (3.74e-2)" "unprognostic (1.95e-2)" "unprognostic (2.07e-1)" "unprognostic (1.23e-1)" "unprognostic (2.74e-1)" "unprognostic (2.00e-2)" "unprognostic (4.86e-2)" "unprognostic (8.99e-2)" "prognostic favorable (7.96e-5)" "unprognostic (5.77e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (7.10e-2)" 23.2 13.7 74.4 9.3 69.3 2.7 17.9 52.6 65.3 21.5 32.9 29.3 3.9 23.0 4.5 11.5 15.2 11.4 70.3 61.0 54.0 9.4 6.2 14.0 2.7 70.5 63.8 15.3 13.4 9.9 12.3 6.2 58.2 23.5 3.3 6.5 17.4 14.5 112.5 16.4 11.2 14.8 59.9 7.2 18.7 9.1 70.8 2.0 19.4 63.1 1.8 23.7 15.9 81.2 6.7 5.9 3.6 2.4 55.5 20.7 1.2 15.1 12.7 6.5 4.7 1.3 2.7 0.1 6.4 30.9 2.5 1.6 0.9 5.9 1.2 0.0 7.2 3.7 18.9 1.6 17.5 0.1 5.3 23.5 10.4 8.5 7.1 17.0 7.3 0.0 3.9 4.8 12.9 1.7 0.2 0.5 2.1 0.2 3.5 5.0 6.7 1.9 3.4 1.3 4.0 6.7 7.3 1.2 6.0 1.5 8.3 8.6 17.3 14.1 8.2 13.9 6.4 0.2 0.0 0.0 13.1 4.8 4.3 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.1 74.4 69.3 52.6 65.3 61.0 54.0 70.5 63.8 58.2 59.9 70.8 81.2 1.8 0.0 1.1 21.9 0.0 4.0 1.5 3.6 3.4 6.4 0.8 0.9 10.5 0.0 1.8 1.8 0.0 0.1 1.6 0.1 0.0 0.7 10.0 0.5 4.5 2.1 0.0 0.0 7.8 1.3 0.2 6.4 4.6 1.2 4.5 2.9 2.2 0.7 1.4 0.0 11.8 0.3 2.0 1.9 4.1 2.5 3.4 2.0 8.8 8.4 0.8 7.7 0.0 9.0 11.5 0.6 1.2 3.0 1.9 2.0 0.0 0.6 1.1 1.9 0.0 7.8 4.4 0.0 0.2 1.3 3.1 0.1 0.4 5.9 0.0 1.1 KLHL40 "KBTBD5, NEM8, SRYP" ENSG00000157119 "Kelch like family member 40" Q2TBA0 3 42685537-42692544 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Developmental protein" "Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 62 "skeletal muscle: 431.2;tongue: 162.3" "Group enriched" "Detected in some" 17 "Early spermatids: 5.0;Late spermatids: 10.7;Skeletal myocytes: 16.3" "Cancer enhanced" "Detected in single" "head and neck cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024463, HPA052201" Enhanced NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" "HPA024463: AB_1852095, HPA052201: AB_2681759" "unprognostic (1.13e-1)" "unprognostic (3.28e-2)" "unprognostic (1.19e-1)" "unprognostic (2.09e-1)" "unprognostic (7.85e-2)" "unprognostic (2.50e-1)" "unprognostic (4.04e-1)" 0.1 0.0 0.1 0.0 0.4 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 4.7 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.0 0.1 4.2 0.0 431.2 0.7 0.0 0.0 0.1 0.0 0.0 1.7 0.3 0.0 0.1 162.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.3 0.1 0.1 0.2 0.2 0.2 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.3 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HHATL "C3orf3, GUP1, KIAA1173, MBOAT3, MSTP002, OACT3" ENSG00000010282 "Hedgehog acyltransferase like" Q9HCP6 3 42692663-42702824 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 241.1;heart muscle: 521.2;skeletal muscle: 282.3;tongue: 154.2" "Group enriched" "Detected in some" 8 "Astrocytes: 59.1;Bipolar cells: 119.6;Cardiomyocytes: 65.2;Muller glia cells: 49.9;Oligodendrocytes: 168.0" "Cancer enhanced" "Detected in many" "melanoma: 14.2;thyroid cancer: 25.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA018174 Enhanced NA NA "Cluster 38: Heart - Muscle contraction" "Cluster 25: RPMI-8226 - Immune response" "Cluster 56: Bipolar cells - Visual perception" "HPA018174: AB_2116671" "unprognostic (1.72e-2)" "unprognostic (1.56e-1)" "unprognostic (5.20e-2)" "unprognostic (9.71e-2)" "unprognostic (7.94e-3)" "unprognostic (3.79e-2)" "unprognostic (8.80e-2)" "unprognostic (2.47e-1)" "unprognostic (5.98e-2)" "unprognostic (1.31e-1)" "unprognostic (3.16e-2)" "unprognostic (1.74e-1)" "unprognostic (9.68e-2)" "unprognostic (1.01e-1)" "unprognostic (2.89e-1)" "unprognostic (3.14e-1)" 0.5 0.7 77.5 0.0 163.6 0.0 1.3 124.7 110.1 0.5 34.3 0.3 0.0 0.9 0.4 4.0 1.8 0.4 521.2 76.0 109.5 0.3 0.3 0.7 0.3 152.8 152.1 0.1 1.3 2.9 3.8 0.1 149.3 1.7 0.1 37.8 10.7 0.2 282.3 1.3 0.2 0.2 101.0 0.2 0.2 1.1 127.8 2.2 21.4 154.2 0.1 0.1 0.3 241.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.5 163.6 124.7 110.1 76.0 109.5 152.8 152.1 149.3 101.0 127.8 241.1 0.0 0.0 0.0 59.1 0.0 0.4 0.0 0.0 0.0 119.6 0.0 0.0 65.2 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.5 2.2 0.1 1.2 0.0 0.0 4.8 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.7 11.1 0.0 0.0 0.0 0.7 0.2 0.0 0.0 5.4 2.8 0.0 49.9 0.0 1.5 168.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 10.2 0.0 5.5 0.5 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CCDC13 FLJ25467 ENSG00000244607 "Coiled-coil domain containing 13" Q8IYE1 3 42705756-42773253 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 2.4;choroid plexus: 2.5;fallopian tube: 2.9;retina: 4.3;testis: 5.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 28.0;Distal tubular cells: 17.6;Early spermatids: 18.1;Endometrial ciliated cells: 23.3;Late spermatids: 18.4;Respiratory ciliated cells: 53.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047429 Supported "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Cluster 77: Retina - Visual perception" "Cluster 49: Ciliated cells - Cilium organization" "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA047429: AB_2680043" "unprognostic (3.34e-2)" "unprognostic (3.72e-2)" "unprognostic (2.18e-2)" "unprognostic (1.67e-3)" "unprognostic (2.19e-2)" "unprognostic (5.35e-2)" "unprognostic (4.75e-2)" "unprognostic (8.06e-2)" "unprognostic (4.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.05e-2)" "unprognostic (2.31e-1)" "unprognostic (1.83e-7)" "unprognostic (6.21e-2)" "unprognostic (2.40e-1)" "unprognostic (5.71e-2)" "unprognostic (2.04e-2)" 0.2 0.1 1.0 0.0 1.9 0.0 0.1 1.1 1.4 0.5 2.5 0.3 0.0 0.2 0.3 0.1 2.9 0.0 0.4 1.1 0.9 0.4 0.8 0.8 0.0 1.9 2.1 0.0 0.2 0.0 0.7 0.0 1.6 0.3 0.1 4.3 0.1 0.0 0.3 0.0 0.2 0.0 1.5 0.1 0.3 5.9 1.4 0.0 0.6 0.0 0.0 0.2 0.2 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.9 1.1 1.4 1.1 0.9 1.9 2.1 1.6 1.5 1.4 2.4 0.3 0.0 0.6 7.2 0.4 1.0 0.4 2.8 0.6 28.0 0.8 0.5 1.2 1.5 5.6 3.7 4.2 0.1 0.3 0.9 17.6 0.9 18.1 23.3 2.1 0.6 0.0 0.0 6.0 0.2 0.5 0.8 0.0 1.1 1.3 0.2 0.4 0.4 2.6 0.0 4.0 0.4 0.0 1.6 2.8 18.4 1.5 1.4 1.8 3.7 2.7 1.8 1.0 2.0 4.6 0.2 2.4 0.7 0.0 1.0 0.0 4.6 53.4 5.4 0.0 0.0 1.7 13.3 3.7 0.1 1.1 0.0 0.5 1.0 0.1 0.7 AC006059.2 ENSG00000280571 "Novel protein" 3 42705756-42804518 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 2.2;retina: 7.6" "Cell type enriched" "Detected in single" 4 "Alveolar cells type 1: 3.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047429 Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Cluster 11: Alveolar cells - Smell perception" "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA047429: AB_2680043" "unprognostic (1.72e-1)" "unprognostic (4.20e-1)" "unprognostic (8.65e-2)" "unprognostic (2.65e-1)" "unprognostic (7.02e-2)" "unprognostic (8.28e-2)" "unprognostic (1.40e-1)" "unprognostic (1.72e-1)" "unprognostic (4.32e-2)" "unprognostic (5.96e-2)" "unprognostic (6.09e-3)" "unprognostic (2.99e-2)" "unprognostic (3.01e-2)" 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.1 0.0 0.0 0.7 0.0 0.0 7.6 0.1 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.2 0.6 0.4 0.7 0.7 0.6 0.7 0.7 0.5 2.2 0.0 3.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HIGD1A "DKFZP564K247, HIG1, RCF1A" ENSG00000181061 "HIG1 hypoxia inducible domain family member 1A" Q9Y241 3 42782908-42804490 "Predicted membrane proteins" "Electron transport, Respiratory chain, Stress response, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 638.8;Distal tubular cells: 632.0;Paneth cells: 610.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 509.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043336 Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 39: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria Nucleoplasm "HPA043336: AB_10795039" "unprognostic (6.46e-2)" "unprognostic (3.72e-3)" "prognostic favorable (2.12e-4)" "unprognostic (3.65e-2)" "unprognostic (8.87e-2)" "unprognostic (3.53e-1)" "unprognostic (3.70e-1)" "unprognostic (8.45e-2)" "unprognostic (6.14e-2)" "unprognostic (2.94e-1)" "unprognostic (1.24e-1)" "unprognostic (8.94e-2)" "prognostic favorable (3.99e-8)" "unprognostic (7.37e-2)" "unprognostic (3.01e-1)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" 121.3 130.0 134.6 75.3 140.6 53.8 81.4 151.4 198.8 90.2 135.4 295.2 162.2 65.9 95.2 162.8 62.6 79.3 323.1 139.4 155.1 198.9 343.5 66.5 50.9 148.1 148.8 39.4 60.8 111.4 90.5 64.6 153.5 101.5 300.1 152.7 75.1 96.3 174.2 68.8 134.8 96.2 156.1 48.9 145.9 63.7 145.6 52.8 115.5 316.7 80.0 99.5 120.1 174.0 159.9 67.0 182.9 165.2 420.3 244.3 195.2 205.1 151.0 168.4 165.8 132.8 166.7 95.8 120.5 161.8 114.0 92.9 143.0 203.0 225.6 135.5 145.9 301.0 127.6 257.4 191.8 180.4 131.4 274.0 233.7 129.0 181.4 94.7 159.8 135.1 299.7 110.3 247.3 51.1 96.1 61.1 162.7 133.7 176.5 80.9 138.0 72.1 454.1 361.1 82.7 108.2 187.6 142.0 207.0 182.9 145.0 130.0 166.1 127.4 105.2 341.1 219.1 89.7 184.1 207.2 165.2 185.7 100.6 115.7 66.2 130.5 72.9 115.4 65.8 56.6 71.5 73.6 77.2 43.6 60.3 70.5 70.0 65.6 143.2 509.4 99.4 171.5 134.6 140.6 151.4 198.8 139.4 155.1 148.1 148.8 153.5 156.1 145.6 174.0 50.1 54.5 82.4 32.3 39.7 131.2 153.1 244.8 59.2 35.7 86.4 62.0 351.5 80.1 133.0 138.0 10.4 114.1 99.5 638.8 632.0 113.3 8.4 87.3 41.2 50.8 82.0 126.8 32.8 145.0 202.7 98.1 100.9 63.6 93.3 49.7 59.6 197.9 77.1 28.6 27.3 193.5 343.8 46.9 113.3 13.0 30.7 63.4 176.1 21.5 82.7 232.5 43.3 14.1 32.9 279.4 610.7 52.3 65.5 193.5 122.4 296.4 106.0 41.2 78.9 28.8 119.8 186.1 78.7 94.2 204.6 299.9 50.7 101.5 168.0 254.2 ACKR2 "CCBP2, CCR10, CCR9, CMKBR9, D6" ENSG00000144648 "Atypical chemokine receptor 2" O00590 3 42804752-42887974 "G-protein coupled receptors, Predicted membrane proteins" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 9.4;placenta: 16.0" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 33.0;Extravillous trophoblasts: 106.2;Syncytiotrophoblasts: 73.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 3.9;NK-cell: 1.1" "Group enriched" "Detected in many" 7 "granulocytes: 3.9;NK-cells: 1.1" "Cell line enhanced" "Detected in some" "BEWO: 51.2;HEL: 17.1;SK-BR-3: 28.0;U-937: 10.7" "Group enriched" "Detected in many" 5 "amygdala: 2.2;basal ganglia: 7.9;cerebral cortex: 4.9;hippocampal formation: 2.4" "Low region specificity" "Detected in all" "HPA013819, HPA073493" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Vesicles, Cytosol" Nucleoplasm "HPA013819: AB_1846126, HPA073493: AB_2686610" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.90e-2)" "unprognostic (8.15e-2)" "unprognostic (7.51e-2)" "unprognostic (1.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.74e-1)" "unprognostic (2.99e-1)" "unprognostic (6.20e-2)" "unprognostic (8.47e-2)" "unprognostic (8.45e-2)" "unprognostic (1.13e-4)" "unprognostic (5.13e-3)" "unprognostic (3.22e-1)" "unprognostic (5.58e-3)" "unprognostic (6.09e-2)" 6.7 1.0 1.5 1.0 1.0 0.7 2.8 1.5 1.3 1.7 0.9 1.9 0.9 0.9 2.8 1.6 2.3 1.3 1.3 1.0 0.5 1.5 9.4 1.6 1.1 1.4 1.4 0.4 0.9 0.4 0.5 16.0 1.3 0.6 2.1 0.7 2.2 0.4 0.6 2.6 1.1 1.1 0.6 0.7 1.1 0.8 1.1 0.4 2.9 0.9 2.1 1.8 2.3 1.3 0.1 0.0 0.2 0.4 2.4 0.2 51.2 0.1 0.0 0.0 0.0 0.5 0.1 1.2 0.1 0.1 0.2 0.4 0.0 0.2 0.1 0.1 0.2 17.1 0.4 3.1 0.1 0.2 1.9 0.5 0.5 0.0 0.1 0.0 0.1 0.5 2.2 0.4 0.3 0.3 0.0 0.2 0.1 0.7 0.2 0.1 0.0 0.1 0.7 7.5 0.3 0.1 1.3 28.0 0.1 2.9 2.8 0.3 0.1 0.1 0.1 0.2 0.1 0.6 0.1 0.1 0.1 10.7 0.1 0.4 0.1 3.9 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.1 0.4 1.1 0.3 0.1 0.0 0.1 1.5 1.0 1.5 1.3 1.0 0.5 1.4 1.4 1.3 0.6 1.1 1.3 1.0 0.0 0.0 9.8 0.1 0.1 0.1 0.3 0.0 0.7 1.2 0.3 0.8 1.5 3.3 0.0 2.1 33.0 0.3 3.0 1.9 0.1 3.0 3.7 0.8 3.3 1.8 0.0 2.0 0.0 106.2 2.1 0.0 5.9 2.5 2.5 4.6 7.0 5.3 1.7 1.2 0.6 0.0 0.6 0.4 1.8 0.3 0.4 0.0 5.6 0.1 2.6 0.0 1.0 4.5 0.8 0.5 1.2 0.1 0.4 1.6 0.5 3.4 1.0 0.0 0.4 0.3 4.8 5.4 0.0 0.0 73.6 0.5 0.5 1.1 0.6 AC092042.3 ENSG00000273291 "Novel protein" 3 42809446-43055871 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 78: Testis - Spermatogenesis" "unprognostic (2.83e-2)" "unprognostic (2.13e-1)" "unprognostic (3.09e-1)" "unprognostic (3.69e-3)" "unprognostic (1.02e-1)" "unprognostic (3.74e-2)" "unprognostic (2.04e-1)" "unprognostic (6.65e-3)" "unprognostic (4.46e-2)" "unprognostic (8.42e-2)" "unprognostic (1.48e-1)" "unprognostic (1.73e-1)" "unprognostic (1.40e-2)" "unprognostic (2.54e-2)" "unprognostic (2.15e-1)" "unprognostic (4.20e-2)" "unprognostic (2.81e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRBOX1 ENSG00000240747 "KRAB box domain containing 1" C9JBD0 3 42809483-42942792 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 24 "testis: 197.8" "Cell type enhanced" "Detected in many" "Early spermatids: 250.9;Late spermatids: 111.3;Spermatocytes: 883.9;Spermatogonia: 176.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 22.2;CAPAN-2: 50.0;EFO-21: 22.6;GAMG: 35.2;hTEC/SVTERT24-B: 33.7;hTERT-HME1: 23.0;U-2197: 67.7" HPA046901 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 83: Testis - Spermatogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Golgi apparatus" "HPA046901: AB_2797232" "unprognostic (2.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-3)" "unprognostic (7.63e-3)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (2.27e-1)" "unprognostic (5.64e-2)" "unprognostic (2.95e-2)" "unprognostic (9.66e-2)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (1.31e-1)" "unprognostic (2.28e-1)" 3.4 4.7 2.9 0.2 2.9 0.5 3.9 3.1 3.8 5.8 2.8 4.9 1.7 5.3 8.1 4.3 3.9 1.2 3.8 3.0 3.0 6.0 0.6 1.5 0.9 3.1 2.9 6.9 3.9 0.8 4.0 1.3 2.9 3.6 2.0 1.9 2.3 5.3 1.6 5.1 1.8 4.7 2.9 1.2 2.7 197.8 2.9 1.5 5.2 1.1 1.6 3.8 3.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 8.7 22.2 0.2 0.0 0.1 50.0 0.0 22.6 1.8 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 9.7 0.0 33.7 23.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.9 0.0 0.0 0.0 0.0 0.0 17.0 0.0 67.7 0.0 7.4 2.6 0.0 3.8 0.0 1.4 0.0 0.3 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 4.0 0.7 1.0 0.3 0.0 2.9 2.9 3.1 3.8 3.0 3.0 3.1 2.9 2.9 2.9 2.9 3.1 2.2 0.0 2.6 1.6 0.1 0.0 2.6 0.0 0.6 8.8 4.2 11.3 5.6 2.8 1.8 5.5 2.1 12.0 0.2 0.4 19.6 4.2 250.9 4.4 7.7 1.6 0.0 0.0 0.8 12.0 10.1 6.1 0.0 2.5 0.0 3.8 1.4 1.0 2.2 1.7 1.4 1.4 0.0 0.0 0.0 111.3 20.2 1.0 0.0 1.0 0.0 18.3 1.0 1.5 1.0 6.8 3.2 13.5 0.0 1.8 1.2 3.1 0.7 8.8 13.1 5.2 6.9 883.9 176.0 0.6 0.0 9.0 0.2 14.3 2.8 1.0 CYP8B1 CYP12 ENSG00000180432 "Cytochrome P450 family 8 subfamily B member 1" Q9UNU6 3 42856005-42875898 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "liver: 404.5" "Cell type enriched" "Detected in some" 76 "Hepatocytes: 920.2" "Cancer enriched" "Detected in some" 46 "liver cancer: 69.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.4;SK-BR-3: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 62: Liver - Hemostasis" "Cluster 28: BEWO - Transcription regulation" "Cluster 2: Hepatocytes - Metabolism" "unprognostic (1.58e-2)" "unprognostic (5.41e-2)" "unprognostic (6.38e-2)" "unprognostic (1.15e-2)" "unprognostic (8.95e-2)" "unprognostic (1.42e-3)" "unprognostic (4.47e-3)" "unprognostic (1.49e-1)" "unprognostic (9.85e-2)" "unprognostic (4.04e-3)" "unprognostic (5.86e-3)" "unprognostic (2.74e-1)" "unprognostic (3.37e-1)" "unprognostic (1.03e-1)" "unprognostic (3.63e-1)" "unprognostic (3.19e-1)" "unprognostic (1.24e-1)" 0.3 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.2 0.1 0.5 0.1 0.2 0.1 14.4 404.5 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.4 0.1 0.0 0.0 0.2 0.1 0.1 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.2 1.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 8.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 5.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.9 920.2 0.1 0.0 0.0 0.0 0.0 10.7 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 ZNF662 FLJ45880 ENSG00000182983 "Zinc finger protein 662" Q6ZS27 3 42906142-42919334 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.4;SH-SY5Y: 3.2;THP-1: 3.3;U-2 OS: 4.6" "Low region specificity" "Detected in all" "HPA039116, HPA040377" Uncertain NA NA "Cluster 32: T-cells - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 52: Non-specific - Transcription" "HPA039116: AB_2676355, HPA040377: AB_2676949" "unprognostic (2.37e-2)" "unprognostic (2.71e-1)" "unprognostic (1.03e-1)" "unprognostic (5.82e-3)" "unprognostic (1.14e-1)" "unprognostic (2.55e-4)" "unprognostic (1.80e-3)" "unprognostic (1.09e-2)" "unprognostic (7.99e-2)" "unprognostic (2.96e-2)" "unprognostic (1.37e-1)" "unprognostic (2.69e-1)" "unprognostic (5.39e-3)" "unprognostic (7.18e-4)" "unprognostic (1.19e-1)" "unprognostic (3.60e-1)" "unprognostic (6.62e-2)" 5.9 4.8 3.5 1.4 3.9 0.9 7.3 6.8 6.5 11.3 5.2 7.3 2.0 9.2 4.5 5.8 8.2 2.6 5.1 3.4 3.6 6.9 5.1 4.3 1.6 3.6 3.3 14.2 10.7 1.3 7.2 2.0 3.6 10.4 3.4 11.1 8.3 4.0 3.5 10.9 4.4 4.1 3.0 4.7 6.2 7.4 3.4 1.1 8.2 2.8 1.5 7.9 8.1 5.2 0.1 0.0 0.2 0.0 0.0 0.0 2.4 1.0 0.0 0.7 0.5 2.4 1.4 0.2 1.7 1.1 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.5 0.5 0.0 0.9 0.1 0.4 2.3 0.1 1.3 0.0 0.1 0.0 0.0 0.1 0.3 2.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.7 0.1 1.7 3.2 0.0 1.1 0.0 0.6 0.0 3.3 0.1 0.8 4.6 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.4 0.2 0.1 0.2 0.0 0.1 0.3 0.2 0.1 0.4 0.3 1.3 1.3 0.4 0.5 0.1 0.4 0.2 0.2 3.5 3.9 6.8 6.5 3.4 3.6 3.6 3.3 3.6 3.0 3.4 5.2 4.2 12.8 4.6 7.2 0.2 2.4 2.5 0.2 2.2 6.5 4.4 3.9 2.9 4.3 3.9 1.8 6.2 1.9 0.2 1.4 1.9 1.8 2.0 1.3 5.6 3.4 5.4 1.3 4.3 3.2 2.4 4.6 12.2 2.3 0.0 9.7 3.6 3.4 0.1 6.7 6.5 2.4 2.0 0.8 2.6 4.4 11.5 0.8 5.4 6.5 0.0 4.1 0.0 16.1 8.0 2.9 1.2 4.5 0.1 1.9 0.4 1.7 1.3 10.9 13.1 6.0 3.3 18.5 11.0 0.9 1.8 2.9 0.4 2.2 4.0 2.1 GASK1A "C3orf41, DKFZP434B172, FAM198A" ENSG00000144649 "Golgi associated kinase 1A" Q9UFP1 3 42979267-43060211 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 1.4;Extravillous trophoblasts: 2.6;Fibroblasts: 1.8;Hofbauer cells: 3.9;Syncytiotrophoblasts: 2.7" "Cancer enhanced" "Detected in many" "glioma: 5.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.1;RPMI-8226: 3.4;SK-BR-3: 2.6;T-47d: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047726 Approved Supported Vesicles "Secreted - unknown location" NA NA 600000 "Cluster 15: Liver - Metabolism" "Cluster 6: T47d - Mammary gland" "Cluster 50: Fibroblasts - ECM organization" Vesicles "HPA047726: AB_10960554" "unprognostic (2.16e-3)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (2.93e-2)" "unprognostic (7.48e-2)" "unprognostic (2.18e-2)" "unprognostic (1.65e-2)" "unprognostic (5.79e-2)" "unprognostic (2.69e-1)" "unprognostic (6.21e-2)" "unprognostic (2.02e-1)" "unprognostic (1.50e-1)" "unprognostic (1.57e-4)" "unprognostic (4.45e-2)" "unprognostic (2.09e-2)" "unprognostic (3.49e-2)" "unprognostic (3.81e-1)" 5.5 2.1 4.9 2.5 6.4 0.0 4.2 6.3 3.8 10.6 4.9 3.4 0.7 9.8 2.2 1.8 11.3 5.3 1.7 4.1 5.9 1.0 13.1 3.1 0.7 8.8 7.7 6.8 2.0 0.1 3.0 2.0 7.6 2.6 1.0 3.9 2.6 2.2 1.4 1.7 2.1 6.0 6.3 0.9 3.4 2.9 10.0 0.6 2.1 0.8 0.3 3.2 3.9 5.2 0.0 0.0 0.0 3.1 0.1 0.0 1.1 0.2 0.3 0.0 0.0 0.1 0.9 0.0 1.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 1.9 0.7 0.0 0.0 0.6 0.4 1.2 0.8 0.0 0.4 0.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.8 0.0 1.9 0.0 0.0 0.0 0.0 3.4 0.0 0.5 0.1 0.3 0.0 2.6 0.0 0.1 6.7 0.9 0.0 0.4 0.6 1.4 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.9 6.4 6.3 3.8 4.1 5.9 8.8 7.7 7.6 6.3 10.0 5.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 POMGNT2 "AGO61, C3orf39, FLJ14566, GTDC2" ENSG00000144647 "Protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)" Q8NAT1 3 43079232-43106079 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034870, HPA040989" Uncertain "Intracellular and membrane" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 33: Fibroblasts - ECM organization" "HPA034870: AB_10602701, HPA040989: AB_2677238" "unprognostic (2.37e-3)" "unprognostic (8.22e-2)" "prognostic favorable (8.13e-5)" "unprognostic (2.57e-2)" "unprognostic (4.17e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.26e-5)" "unprognostic (8.71e-2)" "unprognostic (1.73e-2)" "unprognostic (7.43e-2)" "unprognostic (1.95e-2)" "unprognostic (4.01e-1)" "prognostic favorable (4.00e-7)" "unprognostic (4.98e-2)" "unprognostic (1.55e-1)" "unprognostic (3.26e-1)" "unprognostic (2.57e-1)" 11.0 13.5 22.1 4.2 21.0 20.7 9.9 22.6 23.1 19.4 19.8 14.9 3.6 50.7 11.3 7.5 30.9 9.0 19.1 22.6 20.8 12.8 9.2 10.2 3.1 21.7 21.0 30.4 15.3 17.7 19.1 5.5 24.9 15.2 2.9 9.0 13.8 14.5 31.5 11.7 7.1 19.7 18.1 6.0 13.8 14.8 26.7 5.5 11.8 18.6 2.3 15.2 13.6 17.8 20.0 14.9 8.5 26.0 32.0 8.2 13.5 5.6 10.0 19.5 22.7 18.2 13.7 0.0 20.6 10.2 23.6 0.4 14.0 16.3 8.5 0.1 39.2 14.0 11.1 17.4 12.1 9.9 15.9 9.5 11.9 13.2 7.7 7.7 7.6 29.7 11.6 0.1 7.6 11.8 18.1 2.6 18.7 12.4 27.7 7.0 6.0 12.3 11.6 14.4 13.4 12.2 11.8 9.4 10.9 5.7 17.8 8.6 3.6 15.7 21.9 23.3 23.3 14.5 23.2 0.1 20.2 19.6 17.0 0.0 0.5 0.5 3.0 0.4 2.7 1.9 1.9 1.9 0.6 0.9 2.3 1.9 0.0 1.0 0.4 0.6 1.7 1.0 22.1 21.0 22.6 23.1 22.6 20.8 21.7 21.0 24.9 18.1 26.7 17.8 4.1 3.2 2.0 11.8 2.6 8.0 2.8 3.8 6.8 15.3 8.2 7.5 17.0 10.0 3.4 14.7 8.4 3.4 3.2 2.4 5.9 9.9 10.4 6.9 6.6 3.9 6.0 28.4 13.2 10.7 5.3 14.3 4.6 2.5 0.0 12.6 5.0 6.6 6.2 10.1 14.1 1.9 4.1 4.2 4.8 24.5 19.9 3.7 5.4 3.7 1.1 10.1 5.2 15.6 7.4 5.5 2.0 29.3 3.1 4.4 1.4 5.2 9.2 5.2 13.1 8.5 8.3 10.0 19.0 6.0 11.6 1.8 3.6 3.2 2.7 2.2 SNRK "FLJ20224, HSNFRK, KIAA0096" ENSG00000163788 "SNF related kinase" Q9NRH2 3 43286512-43424764 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Sertoli cells: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 126.0;TIME: 74.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042163 Uncertain Approved "Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 48: Smooth muscle cells - ECM organization" "Vesicles, Plasma membrane, Cell Junctions" Nucleoplasm "HPA042163: AB_10794645" "prognostic favorable (9.28e-4)" "unprognostic (8.46e-2)" "unprognostic (2.79e-3)" "unprognostic (6.41e-2)" "unprognostic (1.14e-1)" "unprognostic (1.16e-3)" "unprognostic (2.00e-2)" "unprognostic (1.08e-1)" "unprognostic (2.63e-3)" "unprognostic (4.25e-1)" "unprognostic (2.32e-1)" "unprognostic (4.68e-2)" "prognostic favorable (9.41e-5)" "unprognostic (9.21e-3)" "unprognostic (2.04e-1)" "unprognostic (7.06e-3)" "unprognostic (7.38e-2)" 37.6 10.3 9.7 17.2 9.7 58.4 26.5 27.7 13.2 21.7 9.8 14.6 16.1 23.1 7.8 19.7 13.6 20.4 16.3 9.5 12.5 20.0 25.4 26.4 19.8 14.0 11.5 14.4 22.7 18.5 11.4 33.3 14.7 11.2 11.9 18.8 11.4 10.8 14.3 30.3 17.2 22.9 9.5 33.0 14.4 11.1 13.2 40.5 27.3 21.6 14.7 19.8 21.7 8.7 8.4 5.0 9.1 8.8 26.6 9.5 8.7 8.8 14.8 9.4 9.1 6.9 11.8 13.2 6.8 11.2 6.2 5.3 10.7 18.9 9.6 15.1 8.8 15.0 9.1 8.1 13.8 17.1 16.1 10.5 12.7 10.6 17.9 9.5 126.0 14.9 6.7 14.9 8.7 4.4 17.3 15.0 10.1 4.6 22.6 11.7 6.7 14.0 24.2 14.1 6.4 13.4 7.7 8.1 11.1 7.9 5.5 21.4 74.1 8.2 8.3 9.5 10.4 23.7 18.3 11.0 5.8 20.1 12.0 9.4 4.2 7.6 9.5 7.5 13.0 3.6 8.3 9.6 4.0 3.6 12.1 13.1 27.7 11.0 7.1 1.2 9.7 9.7 9.7 9.7 27.7 13.2 9.5 12.5 14.0 11.5 14.7 9.5 13.2 8.7 88.4 32.1 24.1 30.0 29.0 52.8 10.3 6.4 12.5 52.1 9.7 8.6 17.7 15.7 15.0 16.5 16.7 7.7 57.6 37.0 11.7 10.9 50.4 23.3 16.2 84.2 10.8 10.3 21.6 8.9 3.2 16.4 12.8 19.8 14.5 8.9 98.6 25.2 13.7 30.3 43.2 10.7 12.2 24.8 19.0 7.5 12.5 26.5 23.2 34.7 21.9 16.3 65.9 24.6 10.7 11.2 20.6 11.7 27.3 12.7 25.2 12.2 19.2 18.3 124.9 31.3 49.1 11.1 16.2 13.7 51.3 8.2 61.2 9.5 11.1 18.0 ANO10 "FLJ10375, MGC47890, SCAR10, TMEM16K" ENSG00000160746 "Anoctamin 10" Q9NW15 3 43354859-43691594 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 123.3;Excitatory neurons: 77.4;Inhibitory neurons: 97.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016624, HPA051569" Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" Vesicles "HPA016624: , HPA051569: AB_2681537" "unprognostic (1.51e-3)" "unprognostic (1.38e-2)" "prognostic favorable (6.70e-4)" "prognostic favorable (1.11e-4)" "unprognostic (4.23e-1)" "unprognostic (2.69e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (7.99e-3)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "prognostic favorable (6.41e-6)" "unprognostic (9.83e-3)" "unprognostic (1.22e-1)" "unprognostic (5.19e-3)" "unprognostic (5.71e-2)" 26.6 14.1 17.6 15.1 18.6 33.0 21.8 23.9 20.9 22.3 18.4 39.4 61.1 21.6 13.6 25.3 13.9 19.4 12.7 18.1 21.1 29.9 14.1 16.9 7.6 22.7 22.9 13.9 15.2 23.7 13.9 18.1 23.2 14.2 33.7 10.1 28.6 20.2 15.5 32.0 54.7 28.0 19.6 9.1 13.5 13.0 19.8 7.1 24.5 11.6 9.7 18.1 21.5 24.1 30.6 23.6 26.1 27.4 101.1 53.5 31.2 87.7 141.1 42.0 54.4 16.2 27.5 3.1 27.4 114.8 43.1 16.3 20.6 47.0 52.6 33.6 14.2 39.4 28.7 17.7 43.9 7.2 31.1 50.5 36.3 53.6 71.8 79.4 100.3 18.7 30.8 24.9 95.2 20.8 7.8 5.2 31.3 23.7 28.6 6.3 18.7 10.2 85.5 31.4 6.4 19.4 34.4 27.0 19.8 45.3 59.5 14.5 84.7 66.2 24.4 70.2 40.7 15.7 22.9 1.1 60.2 14.6 44.2 7.4 19.0 1.4 6.7 11.1 3.8 2.7 4.6 4.5 13.1 2.5 3.9 6.0 32.8 9.7 12.7 2.3 5.4 7.0 17.6 18.6 23.9 20.9 18.1 21.1 22.7 22.9 23.2 19.6 19.8 24.1 24.3 6.4 3.2 70.2 4.1 5.6 5.8 6.9 8.0 8.0 18.2 8.4 5.2 8.6 13.2 14.7 0.0 14.4 3.7 38.5 123.3 21.6 2.9 11.8 23.6 17.8 9.6 11.8 77.4 17.8 19.5 10.6 10.2 31.2 2.5 6.8 23.6 10.7 11.6 10.1 97.9 23.8 10.2 9.6 5.3 5.2 5.6 9.1 14.2 69.3 9.2 17.1 5.2 71.4 46.4 11.7 22.1 10.1 2.6 4.4 58.4 19.0 4.0 3.6 6.6 19.1 15.7 17.1 23.6 8.7 6.1 17.1 5.8 6.2 26.9 4.8 ABHD5 "CGI-58, NCIE2" ENSG00000011198 "Abhydrolase domain containing 5, lysophosphatidic acid acyltransferase" Q8WTS1 3 43690108-43734371 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Cataract, Deafness, Disease variant, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 205.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 67.8;neutrophil: 42.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 67.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020685, HPA035851, HPA035852" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Vesicles, Cytosol" Nucleoplasm "CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073" "unprognostic (2.58e-1)" "unprognostic (2.73e-1)" "prognostic favorable (8.89e-4)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (2.26e-1)" "unprognostic (6.13e-2)" "unprognostic (2.40e-2)" "unprognostic (5.33e-2)" "unprognostic (3.50e-3)" "unprognostic (2.56e-2)" "unprognostic (4.13e-3)" "prognostic favorable (9.17e-5)" "unprognostic (2.48e-1)" "unprognostic (8.87e-2)" "unprognostic (4.18e-2)" "unprognostic (4.18e-2)" 38.8 12.5 6.7 8.5 8.6 39.6 27.9 10.5 8.9 9.8 6.0 12.3 9.9 5.7 4.1 31.1 5.1 11.6 13.4 6.8 7.4 12.0 21.7 16.4 3.4 9.2 8.2 4.6 16.0 12.2 5.6 10.2 9.1 7.1 7.5 6.3 27.4 8.4 15.0 38.0 10.5 9.3 9.3 9.4 12.1 10.8 8.4 6.8 15.5 18.5 7.9 16.7 16.9 11.9 18.9 6.8 8.2 9.7 32.0 12.8 17.1 77.4 27.1 18.8 14.9 9.4 6.4 16.2 10.9 23.2 15.8 5.8 16.5 18.5 22.6 58.4 13.2 36.6 24.4 7.5 15.7 9.2 13.2 13.0 64.6 31.3 28.5 18.8 33.3 10.8 23.9 14.2 46.9 11.0 7.6 6.9 22.8 16.7 20.4 3.1 24.1 8.6 27.9 40.4 10.6 13.6 36.9 20.5 9.8 9.8 18.9 8.9 19.3 18.1 13.6 35.0 34.5 11.1 34.0 7.7 20.3 17.3 16.0 67.8 14.7 9.5 2.3 7.9 1.7 3.5 1.7 2.7 6.8 4.0 1.6 2.5 42.5 2.0 5.7 1.9 4.8 5.3 6.7 8.6 10.5 8.9 6.8 7.4 9.2 8.2 9.1 9.3 8.4 11.9 117.5 25.6 51.8 12.7 44.8 39.9 27.5 25.9 88.8 11.9 149.9 116.2 10.3 14.3 49.6 27.6 27.1 16.7 80.3 65.0 33.2 57.5 19.5 47.5 49.0 34.6 36.2 69.0 24.1 61.5 24.9 53.7 67.8 114.0 16.5 8.8 18.2 12.7 18.0 3.3 24.1 23.7 34.6 44.1 17.4 17.1 5.3 79.8 7.2 11.2 35.9 11.0 12.3 18.1 28.8 75.2 49.8 5.7 41.8 25.5 98.5 39.8 19.1 17.4 0.0 32.0 46.4 47.3 41.9 111.7 40.9 205.4 42.6 15.2 21.9 71.6 TOPAZ1 "C3orf77, FLJ36157" ENSG00000173769 "Testis and ovary specific PAZ domain containing 1" Q8N9V7 3 44241886-44332098 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 35 "testis: 3.5" "Group enriched" "Detected in some" 5 "Spermatocytes: 122.4;Spermatogonia: 75.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA047431, HPA051034" Uncertain NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA047431: AB_2680045, HPA051034: AB_2681318" "unprognostic (1.68e-1)" "unprognostic (8.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 19.7 0.0 0.0 122.4 75.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCAIM "C3orf23, DKFZp313N0621, TOAG-1" ENSG00000179152 "T cell activation inhibitor, mitochondrial" Q8N3R3 3 44338119-44409451 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 42.9" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 90.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (1.50e-1)" "unprognostic (1.61e-1)" "unprognostic (1.31e-3)" "unprognostic (1.15e-1)" "unprognostic (9.21e-2)" "unprognostic (1.98e-1)" "unprognostic (4.24e-1)" "unprognostic (1.82e-1)" "unprognostic (8.55e-2)" "unprognostic (1.93e-3)" "unprognostic (5.07e-3)" "unprognostic (5.60e-2)" "prognostic favorable (2.19e-7)" "unprognostic (4.03e-1)" "unprognostic (1.49e-1)" "unprognostic (4.65e-2)" "prognostic favorable (2.81e-4)" 8.6 8.5 7.9 6.7 8.6 4.8 6.6 12.0 10.5 5.9 8.7 9.6 8.2 6.7 8.4 10.1 6.4 9.7 19.4 7.0 8.8 24.2 42.9 9.3 6.9 9.8 9.1 8.1 5.7 11.4 3.5 9.2 9.8 9.9 9.8 10.3 4.7 5.9 22.0 7.7 9.2 8.7 8.7 7.2 9.4 5.6 9.1 8.4 7.4 18.9 7.9 9.9 4.2 10.9 15.5 7.5 8.3 10.6 13.5 10.8 17.3 14.8 17.4 15.7 16.5 7.0 35.6 22.0 10.8 10.0 11.4 7.1 8.0 16.5 17.4 9.2 8.8 15.5 10.4 16.5 23.5 25.9 14.4 12.7 33.0 15.9 17.9 14.9 21.3 22.1 19.2 12.5 16.2 10.8 25.2 13.2 7.8 17.4 17.5 5.0 9.1 16.8 36.6 24.2 8.3 20.3 16.5 22.6 24.1 14.4 17.1 15.3 18.1 9.4 11.2 24.7 22.4 8.4 16.5 16.1 21.2 20.9 16.1 14.8 7.9 10.6 3.6 10.0 4.2 2.3 4.7 3.6 10.3 3.7 3.8 5.5 3.6 3.6 10.1 5.5 9.4 4.0 7.9 8.6 12.0 10.5 7.0 8.8 9.8 9.1 9.8 8.7 9.1 10.9 12.5 9.6 16.1 38.5 7.4 10.3 9.3 12.2 12.0 18.9 11.1 8.3 30.1 24.3 10.5 14.7 12.5 13.6 14.5 12.0 60.7 23.6 3.3 10.3 7.8 11.6 6.0 7.2 55.8 20.9 21.0 7.5 12.2 17.7 21.0 15.1 15.0 47.7 20.0 25.2 90.4 17.1 12.2 18.8 10.1 2.0 8.7 17.6 7.2 20.6 16.0 17.1 9.2 42.7 47.1 25.6 14.7 4.9 7.4 10.8 11.7 46.2 11.4 13.1 13.1 8.1 12.8 6.2 11.0 16.8 9.5 13.4 8.2 14.6 17.3 13.4 ZNF445 "ZKSCAN15, ZNF168, ZSCAN47" ENSG00000185219 "Zinc finger protein 445" P59923 3 44431705-44477670 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006678 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 72: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Mitochondria, Cytosol" "HPA006678: AB_10603329" "unprognostic (7.72e-2)" "unprognostic (2.55e-1)" "unprognostic (1.12e-2)" "unprognostic (1.42e-1)" "unprognostic (7.14e-2)" "unprognostic (1.67e-2)" "unprognostic (1.79e-2)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.62e-1)" "unprognostic (1.03e-2)" "unprognostic (4.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.76e-1)" "unprognostic (2.48e-1)" "unprognostic (4.40e-3)" "unprognostic (1.05e-1)" 4.2 3.0 2.3 1.8 2.5 1.3 3.9 4.3 2.4 6.0 1.1 4.7 1.4 5.1 2.0 2.7 5.0 1.6 3.6 2.4 2.4 3.3 4.9 4.1 1.9 2.1 2.1 7.0 4.4 2.8 5.0 2.0 2.2 4.4 1.7 4.2 3.6 2.1 4.4 3.7 3.5 2.2 1.7 3.9 3.9 3.1 2.2 3.3 3.8 2.7 2.1 4.1 4.4 2.9 1.9 2.1 6.4 5.1 3.5 3.6 2.9 2.5 2.1 3.7 3.7 3.2 1.6 3.3 1.5 2.6 2.3 1.5 4.4 1.7 4.5 3.6 1.6 6.1 4.7 3.2 2.2 7.8 4.9 2.5 2.1 4.2 2.6 3.1 2.6 4.6 4.8 2.4 3.0 1.2 7.5 5.2 4.4 1.2 1.9 3.3 4.0 1.6 2.0 3.8 3.2 3.9 3.9 2.0 1.0 4.7 3.7 3.4 3.2 5.2 4.6 3.2 3.2 1.9 1.5 2.7 1.9 3.8 3.2 1.0 0.3 0.6 0.3 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.3 0.2 1.0 0.5 0.8 0.3 0.1 0.1 2.3 2.5 4.3 2.4 2.4 2.4 2.1 2.1 2.2 1.7 2.2 2.9 11.7 12.8 17.4 19.2 8.4 4.1 4.4 2.9 9.6 36.0 4.8 4.4 11.1 5.7 7.6 11.0 37.5 4.1 15.7 3.8 1.9 5.8 2.5 6.3 14.1 9.7 7.2 10.3 21.7 8.4 1.7 9.0 7.1 6.8 11.4 26.6 13.2 10.1 5.7 28.6 24.3 6.3 2.0 16.4 4.7 2.2 9.3 10.5 0.0 9.4 11.6 10.1 22.6 11.6 19.5 4.9 6.0 9.8 9.5 5.6 4.3 2.8 9.6 28.4 13.1 14.5 10.6 6.7 6.9 5.6 2.6 1.4 9.8 9.3 7.2 3.8 ZNF852 ENSG00000178917 "Zinc finger protein 852" Q6ZMS4 3 44494847-44510636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 9.0;Oligodendrocytes: 9.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA048312, HPA071850" Uncertain Approved Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 43: Cardiomyocytes - Nuclear processes" Cytosol "HPA048312: AB_2680352, HPA071850: AB_2686458" "unprognostic (2.64e-1)" "unprognostic (2.62e-1)" "unprognostic (5.93e-3)" "unprognostic (1.73e-1)" "unprognostic (2.29e-2)" "unprognostic (1.30e-3)" "unprognostic (3.47e-2)" "unprognostic (2.55e-2)" "unprognostic (5.11e-2)" "unprognostic (1.43e-1)" "unprognostic (3.80e-2)" "unprognostic (1.03e-1)" "unprognostic (6.62e-4)" "unprognostic (4.70e-2)" "unprognostic (2.29e-1)" "unprognostic (8.05e-2)" "unprognostic (1.11e-2)" 1.3 1.4 0.7 2.5 0.6 1.6 2.1 3.4 0.9 2.0 3.6 1.9 1.7 2.2 1.7 0.9 1.6 1.3 0.5 0.8 1.1 1.7 1.7 1.8 2.5 0.9 0.7 2.5 2.1 2.9 0.8 2.3 1.1 2.6 3.1 0.9 3.7 2.1 0.5 2.5 2.0 1.9 0.3 2.7 3.0 1.3 1.2 2.9 1.7 0.9 3.2 1.1 0.8 0.7 1.0 1.4 3.9 6.6 0.8 2.3 2.4 1.0 1.3 2.1 3.1 2.1 1.1 3.2 0.7 0.8 0.9 0.8 4.3 1.1 2.8 2.8 1.5 3.1 6.5 1.9 1.2 3.3 5.7 0.8 1.9 2.7 1.1 2.2 1.7 3.3 3.7 1.4 2.5 0.2 3.0 3.8 2.4 1.2 0.8 1.5 4.3 1.9 1.6 3.2 3.0 2.5 2.2 0.9 0.7 6.6 2.2 3.5 2.8 2.6 2.5 1.4 1.0 2.4 1.9 1.9 1.1 2.6 1.7 0.0 0.4 0.7 0.2 0.5 0.3 1.1 0.5 0.3 0.2 0.9 0.5 0.7 0.6 0.4 0.2 1.4 0.2 0.1 0.7 0.6 3.4 0.9 0.8 1.1 0.9 0.7 1.1 0.3 1.2 0.7 2.0 0.0 5.4 5.9 2.3 3.3 0.8 0.9 1.2 2.1 1.5 1.5 1.8 2.8 1.4 0.0 2.1 0.8 5.1 0.8 3.9 1.9 0.3 2.6 1.6 2.0 0.0 3.2 5.7 1.4 0.9 1.4 1.1 1.5 1.3 1.8 2.2 1.4 0.7 1.7 6.8 0.9 2.0 0.3 1.0 0.4 0.6 1.4 1.8 1.9 1.4 2.8 3.1 9.0 9.2 1.5 0.1 1.2 6.8 1.1 1.0 1.0 4.2 1.6 0.0 2.4 1.6 2.0 1.6 0.5 1.8 0.3 2.3 1.6 0.8 0.9 ZKSCAN7 "FLJ12738, ZNF167, ZNF448, ZNF64, ZSCAN39" ENSG00000196345 "Zinc finger with KRAB and SCAN domains 7" Q9P0L1 3 44555193-44594173 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 15.4;Late spermatids: 17.1;Oligodendrocyte precursor cells: 10.6;Spermatocytes: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.0;NTERA-2: 3.1;SH-SY5Y: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048312, HPA049906, HPA071850" Uncertain Supported "Nuclear speckles,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "Nuclear speckles" "HPA048312: AB_2680352, HPA049906: AB_2680946, HPA071850: AB_2686458" "unprognostic (3.31e-2)" "unprognostic (4.49e-2)" "unprognostic (7.25e-2)" "unprognostic (5.78e-3)" "unprognostic (3.41e-2)" "unprognostic (1.21e-3)" "unprognostic (2.18e-1)" "unprognostic (2.31e-2)" "unprognostic (3.45e-2)" "unprognostic (1.06e-1)" "unprognostic (4.22e-4)" "unprognostic (5.91e-2)" "unprognostic (1.18e-3)" "unprognostic (2.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.54e-1)" "unprognostic (7.17e-3)" 1.5 2.7 0.8 1.0 0.8 0.3 1.6 1.8 1.0 2.8 1.2 1.9 0.4 2.8 2.3 0.8 2.5 0.9 2.1 0.7 0.8 2.7 2.2 1.3 1.3 0.7 0.7 4.2 3.0 0.8 4.2 0.7 0.6 2.4 0.7 3.0 1.6 1.3 1.0 0.6 1.7 1.4 0.4 2.0 1.7 4.1 0.7 2.2 2.6 0.6 1.2 2.4 1.5 0.9 0.0 0.0 2.6 4.0 0.8 0.3 0.0 1.3 1.1 1.4 1.5 0.0 0.0 0.0 0.4 0.9 0.4 0.0 0.0 0.8 1.7 0.0 0.0 0.1 0.9 1.1 2.4 0.0 0.0 1.8 0.9 0.7 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.2 0.0 0.7 0.3 1.9 4.8 0.0 0.1 0.0 2.9 0.0 1.9 0.4 0.8 0.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.5 0.2 0.3 0.8 0.1 0.2 0.3 0.5 0.6 0.2 0.7 0.3 0.7 0.4 0.6 0.3 0.6 0.5 0.3 0.8 0.8 1.8 1.0 0.7 0.8 0.7 0.7 0.6 0.4 0.7 0.9 0.3 0.0 0.5 5.2 1.4 0.1 0.4 0.9 0.6 6.6 0.9 1.1 4.8 0.0 0.4 1.8 0.0 0.0 3.3 0.2 0.0 2.1 15.4 0.6 1.8 0.9 3.0 1.3 4.3 0.5 0.1 2.1 0.0 0.4 0.0 3.1 0.4 1.4 1.1 3.3 4.7 0.3 0.0 0.3 0.4 17.1 0.9 0.7 0.0 1.0 1.4 3.8 6.2 10.6 6.4 0.9 0.0 2.6 0.4 0.5 0.4 1.3 0.3 4.2 0.0 1.0 1.1 10.8 3.6 0.5 0.4 0.1 1.0 2.9 0.6 0.2 ZNF660 FLJ36870 ENSG00000144792 "Zinc finger protein 660" Q6AZW8 3 44578223-44599694 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 27.9;Muller glia cells: 28.1;Rod photoreceptor cells: 25.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.4;HEL: 3.4;NTERA-2: 5.2;RH-30: 3.4;SuSa: 2.8" "Low region specificity" "Detected in all" HPA029705 Uncertain Uncertain "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" "Nucleoli fibrillar center, Cytosol" "HPA029705: AB_10602592" "unprognostic (5.43e-2)" "unprognostic (3.58e-2)" "unprognostic (1.07e-1)" "unprognostic (9.52e-3)" "unprognostic (1.25e-1)" "unprognostic (6.34e-2)" "unprognostic (1.22e-1)" "unprognostic (3.73e-2)" "unprognostic (2.46e-2)" "unprognostic (1.36e-2)" "unprognostic (2.91e-3)" "unprognostic (8.56e-2)" "unprognostic (2.79e-3)" "unprognostic (4.87e-3)" "unprognostic (1.60e-1)" "unprognostic (7.21e-2)" "unprognostic (1.94e-2)" 1.1 0.8 0.7 0.4 0.6 0.8 0.9 2.3 0.7 2.2 0.1 1.4 0.1 2.1 0.6 0.3 1.8 0.7 1.0 0.6 0.9 1.1 0.3 0.9 0.9 0.9 0.8 3.4 0.8 0.7 2.4 0.7 0.8 1.6 0.3 4.6 0.6 0.9 0.4 0.3 0.9 0.9 0.6 1.0 0.8 1.7 0.9 0.8 1.5 0.4 0.6 1.3 1.2 0.8 0.0 0.0 3.4 0.8 0.0 0.0 0.5 0.4 0.8 0.5 0.5 0.0 0.0 0.0 0.7 0.3 0.0 0.0 1.1 0.0 0.6 0.0 0.0 3.4 0.3 0.5 0.8 0.0 0.0 1.3 0.0 1.2 0.0 0.1 0.8 0.0 0.0 0.1 1.8 0.0 0.0 2.0 5.2 0.0 0.0 0.0 3.4 0.0 0.1 0.1 0.8 2.2 0.0 0.0 0.0 2.8 0.0 1.3 0.2 0.9 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.7 0.6 2.3 0.7 0.6 0.9 0.9 0.8 0.8 0.6 0.9 0.8 3.2 0.0 6.0 11.8 1.4 0.1 1.1 0.5 0.0 27.9 1.0 1.0 2.2 4.3 3.2 0.0 6.2 0.0 2.3 0.2 0.0 1.2 10.3 1.9 7.8 4.0 4.2 3.0 7.6 0.5 0.0 4.4 0.5 1.1 6.3 12.4 3.6 0.2 2.0 11.8 11.5 0.3 0.0 1.0 0.5 2.0 5.0 1.3 0.0 11.2 2.9 28.1 6.2 15.6 13.7 0.5 0.0 3.4 0.3 0.8 0.0 0.2 1.0 25.6 0.0 7.9 5.1 7.7 3.9 0.1 0.0 0.0 0.7 7.0 0.4 0.3 ZNF197 "D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41" ENSG00000186448 "Zinc finger protein 197" O14709 3 44584888-44648471 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054567 Uncertain Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA054567: AB_2682527" "unprognostic (1.06e-1)" "unprognostic (6.35e-2)" "unprognostic (6.10e-2)" "unprognostic (1.09e-1)" "unprognostic (5.49e-2)" "unprognostic (1.68e-2)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (7.49e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (1.49e-2)" "unprognostic (3.14e-1)" "unprognostic (7.83e-2)" "unprognostic (1.23e-1)" "unprognostic (2.85e-2)" 6.2 5.8 2.8 1.9 3.0 1.1 5.7 4.6 3.0 6.3 2.1 7.2 2.1 6.3 2.7 4.5 6.1 2.2 5.4 2.8 3.3 5.6 6.3 4.6 2.4 3.1 3.0 7.4 5.9 3.3 7.4 2.7 2.9 6.0 2.4 5.7 5.2 2.9 11.6 4.8 5.0 2.7 2.7 4.8 5.2 5.7 3.1 3.2 7.6 4.2 2.3 6.9 5.6 3.5 2.6 1.2 10.4 3.4 5.5 6.4 0.4 5.0 6.5 4.3 4.6 2.1 2.3 2.1 3.1 4.0 2.6 1.7 4.8 4.0 4.4 0.4 1.2 9.0 4.0 1.7 5.7 6.8 2.4 6.7 5.2 4.9 7.3 5.6 3.2 2.8 6.1 3.7 6.3 0.6 3.9 4.9 7.2 2.8 3.4 1.5 7.3 2.9 3.9 2.6 4.2 7.3 4.5 2.3 6.0 5.5 6.2 6.8 3.1 4.5 3.6 7.0 4.2 4.9 5.6 1.4 3.5 2.3 4.5 0.4 0.7 0.5 0.7 0.3 0.6 0.5 0.6 0.6 1.0 1.7 0.7 0.4 0.3 1.3 4.7 1.7 0.8 0.3 2.8 3.0 4.6 3.0 2.8 3.3 3.1 3.0 2.9 2.7 3.1 3.5 7.3 16.0 8.7 13.1 3.8 2.5 4.6 4.1 5.7 12.4 4.5 3.9 12.3 1.5 9.7 0.0 8.4 1.1 5.7 7.2 1.9 7.4 16.7 4.6 8.0 5.4 6.1 3.0 13.5 8.9 0.7 6.2 3.6 4.5 3.8 10.9 6.8 7.6 4.6 16.8 17.1 6.5 2.0 5.1 3.4 4.5 5.6 5.1 5.4 12.2 8.5 13.2 7.2 14.6 20.1 6.8 5.2 5.3 5.4 5.0 6.4 4.5 4.6 8.5 6.6 6.6 6.4 11.2 5.7 3.3 3.4 0.4 4.6 13.5 5.1 3.6 ZNF35 "HF.10, HF10, Zfp105" ENSG00000169981 "Zinc finger protein 35" P13682 3 44648732-44660791 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 30.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051859, HPA054738" Uncertain Approved Nucleoplasm NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA051859: AB_2681642, HPA054738: AB_2682588" "unprognostic (1.54e-1)" "unprognostic (1.81e-1)" "unprognostic (1.77e-2)" "unprognostic (1.41e-1)" "unprognostic (8.91e-3)" "unprognostic (9.91e-2)" "unprognostic (6.68e-2)" "unprognostic (1.48e-1)" "unprognostic (2.01e-2)" "unprognostic (4.54e-2)" "unprognostic (1.47e-2)" "unprognostic (1.69e-2)" "unprognostic (9.08e-3)" "unprognostic (1.23e-1)" "unprognostic (8.64e-2)" "unprognostic (1.60e-3)" "unprognostic (3.30e-1)" 3.9 2.7 2.2 1.6 2.4 1.9 3.1 2.9 2.5 3.1 1.4 4.1 1.3 4.3 2.8 3.9 2.8 1.7 4.0 2.3 2.4 3.5 2.0 2.8 1.4 2.3 2.5 2.3 2.8 2.0 3.5 1.4 2.4 3.4 1.6 2.5 3.1 2.1 3.8 3.3 2.9 3.2 2.1 3.1 3.2 7.1 2.3 1.3 3.1 2.3 2.4 3.6 3.3 2.9 3.2 2.4 6.2 8.0 4.0 3.2 1.1 3.9 5.4 6.7 6.4 4.3 1.4 2.8 1.7 5.4 2.9 2.2 0.3 5.6 6.9 0.1 2.2 9.3 4.3 0.2 3.6 9.3 6.8 3.3 4.1 6.0 5.3 3.3 5.4 0.0 6.3 2.6 7.4 1.9 0.2 3.0 13.9 2.3 6.7 0.1 6.6 4.9 3.6 9.0 3.4 8.8 4.9 3.0 0.8 5.1 8.0 5.7 5.7 7.1 5.2 3.9 7.8 7.1 11.8 1.6 6.1 4.5 5.6 0.0 1.7 0.7 0.9 1.9 0.6 1.5 0.2 1.0 1.8 1.9 0.4 0.5 0.1 2.3 1.8 0.7 0.1 1.0 2.2 2.4 2.9 2.5 2.3 2.4 2.3 2.5 2.4 2.1 2.3 2.9 6.6 6.4 8.7 6.8 5.3 2.8 3.9 3.0 1.8 4.9 4.8 3.4 3.2 2.8 3.3 1.8 0.0 0.3 3.7 2.8 1.9 8.1 10.2 2.2 4.2 9.3 2.4 3.8 7.5 8.7 0.1 5.8 2.6 3.5 0.0 5.7 5.0 1.5 3.8 6.7 8.5 2.4 10.2 2.8 1.4 6.5 1.2 3.2 1.8 4.7 3.6 4.4 7.2 8.0 11.2 10.3 3.3 4.5 4.0 4.3 2.0 3.8 3.4 6.4 0.0 4.8 5.5 30.7 11.7 3.0 2.8 0.4 2.6 5.7 3.0 3.3 ZNF502 "FLJ12515, FLJ14855" ENSG00000196653 "Zinc finger protein 502" Q8TBZ5 3 44712643-44723831 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 16.2;Spermatogonia: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA024761, HPA029557" Uncertain NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 5: NTERA-2 - Transcription" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "HPA024761: AB_10599830, HPA029557: AB_10601448" "unprognostic (1.80e-1)" "unprognostic (3.10e-2)" "unprognostic (4.53e-2)" "unprognostic (5.53e-2)" "unprognostic (1.25e-2)" "unprognostic (1.31e-2)" "unprognostic (6.75e-2)" "unprognostic (1.35e-3)" "unprognostic (8.23e-2)" "unprognostic (1.51e-1)" "unprognostic (8.72e-3)" "unprognostic (5.49e-2)" "prognostic favorable (4.51e-5)" "unprognostic (1.88e-1)" "unprognostic (3.14e-1)" "unprognostic (2.97e-1)" "prognostic favorable (2.06e-4)" 3.0 3.1 1.5 0.9 1.8 0.8 3.5 2.7 1.7 4.2 1.2 3.9 0.8 4.6 1.3 2.6 4.1 0.9 2.8 1.6 1.8 4.2 2.1 1.9 1.2 1.6 1.7 5.3 4.0 1.3 4.2 1.8 1.5 4.9 1.5 5.2 3.2 2.2 3.2 3.6 2.6 1.9 1.5 3.4 3.1 5.0 1.8 1.4 3.8 2.3 1.1 3.9 3.4 1.5 0.0 0.7 1.9 0.0 2.1 3.0 0.0 1.6 0.4 1.9 1.1 0.1 0.9 0.0 0.5 1.5 2.0 1.0 0.0 2.4 1.6 0.0 0.9 0.0 0.0 0.0 2.3 0.0 0.9 2.4 0.9 2.2 0.0 0.5 1.4 0.0 0.0 0.0 1.9 0.0 0.0 0.5 3.1 0.5 0.0 0.0 1.2 0.0 2.2 2.4 2.0 2.5 0.9 1.6 0.0 2.2 0.0 0.0 1.8 0.0 1.6 3.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.2 0.4 0.6 0.3 1.0 0.8 1.0 0.8 0.5 1.2 1.5 1.2 0.0 1.2 0.3 0.3 0.2 0.3 1.5 1.8 2.7 1.7 1.6 1.8 1.6 1.7 1.5 1.5 1.8 1.5 4.0 6.4 5.1 3.3 3.9 1.7 3.3 3.2 4.0 12.0 2.4 3.6 4.5 2.8 4.4 3.7 14.6 2.5 3.3 1.4 0.0 3.2 3.1 1.0 3.4 5.4 4.9 1.7 3.0 3.0 1.3 3.2 1.5 1.5 2.5 5.6 4.2 1.6 1.1 10.1 5.9 1.6 4.1 0.8 0.7 2.9 4.7 1.0 0.0 3.7 2.1 11.5 2.1 3.0 2.6 2.7 1.1 6.8 0.5 3.4 2.0 1.6 3.1 16.2 0.0 4.6 2.8 14.1 17.8 2.6 2.6 1.5 1.9 4.3 3.0 1.9 ZNF501 "MGC21738, ZNF52" ENSG00000186446 "Zinc finger protein 501" Q96CX3 3 44729596-44737083 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 10.1;Spermatogonia: 11.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 3.5" HPA044161 Uncertain Approved "Endoplasmic reticulum" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Endoplasmic reticulum" "HPA044161: AB_2678841" "unprognostic (8.89e-2)" "unprognostic (5.04e-2)" "unprognostic (9.24e-2)" "unprognostic (3.03e-2)" "unprognostic (1.19e-2)" "unprognostic (3.46e-3)" "unprognostic (2.37e-1)" "unprognostic (2.25e-2)" "unprognostic (4.02e-2)" "unprognostic (1.61e-1)" "unprognostic (2.86e-1)" "unprognostic (2.81e-1)" "unprognostic (3.81e-4)" "unprognostic (1.18e-1)" "unprognostic (4.48e-1)" "unprognostic (1.09e-2)" "unprognostic (3.02e-2)" 1.6 0.5 1.0 0.7 1.2 0.1 1.8 1.4 1.1 1.4 0.3 1.9 0.4 2.0 0.5 0.9 1.6 0.6 1.2 0.9 1.0 1.4 0.4 0.9 0.8 1.0 1.1 2.1 1.4 0.5 0.8 1.2 1.0 1.7 0.8 2.0 1.1 1.4 1.2 1.1 1.0 1.3 1.1 1.1 1.1 1.9 1.1 0.8 1.3 1.2 0.9 1.6 1.2 1.0 0.0 0.0 1.1 0.0 2.0 3.5 0.4 1.3 1.2 1.4 1.6 0.5 0.5 1.0 0.0 0.6 1.0 0.4 0.0 0.5 1.3 0.0 0.7 0.0 0.1 1.0 2.8 0.0 0.0 2.0 1.3 1.6 0.1 0.4 0.9 0.0 0.0 0.0 0.4 0.0 0.4 0.0 2.6 0.6 0.0 0.7 0.0 0.5 1.1 0.7 1.4 0.9 0.8 0.8 0.5 2.1 0.0 0.1 0.5 0.0 1.2 1.3 1.0 2.2 1.6 0.0 0.0 0.0 1.7 0.5 0.2 0.9 0.7 0.2 0.9 0.8 0.6 0.7 0.3 1.0 0.9 0.6 0.3 0.8 0.3 0.3 0.7 0.3 1.0 1.2 1.4 1.1 0.9 1.0 1.0 1.1 1.0 1.1 1.1 1.0 3.5 0.0 0.5 3.6 2.4 0.9 1.5 1.5 2.8 3.5 2.0 1.8 3.5 1.5 1.8 3.7 2.1 1.9 0.9 0.5 0.0 2.9 1.1 1.3 2.5 2.3 1.2 3.4 1.3 1.9 2.0 3.2 3.1 1.1 0.0 3.1 2.2 1.0 1.6 10.1 3.3 1.0 2.0 1.3 0.8 1.9 1.5 0.9 0.0 1.0 1.5 9.0 5.2 3.5 3.9 1.9 0.4 1.5 3.1 0.9 0.7 1.1 0.9 4.0 6.6 3.1 3.8 7.0 11.3 1.8 1.6 0.3 1.8 2.5 1.3 0.8 KIAA1143 ENSG00000163807 KIAA1143 Q96AT1 3 44737661-44761619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 245.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045018, HPA061799" Approved Enhanced "Nucleoplasm,Cytokinetic bridge" Yes No "Cluster 49: Eosinophils - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 32: U-937 - Innate immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "Cytokinetic bridge" "HPA045018: AB_10964578, HPA061799: AB_2684614" "unprognostic (1.31e-1)" "unprognostic (2.74e-1)" "prognostic favorable (3.65e-4)" "unprognostic (2.25e-1)" "unprognostic (6.00e-2)" "unprognostic (3.01e-3)" "unprognostic (2.23e-3)" "unprognostic (6.17e-2)" "unprognostic (6.42e-2)" "unprognostic (1.57e-3)" "unprognostic (3.71e-1)" "unprognostic (4.08e-2)" "prognostic favorable (3.26e-6)" "unprognostic (1.82e-1)" "unprognostic (1.85e-1)" "unprognostic (3.19e-2)" "unprognostic (6.46e-2)" 9.2 7.4 3.6 4.9 4.5 4.4 8.2 3.9 4.7 7.7 2.1 8.9 4.5 10.4 3.5 6.5 7.8 5.4 9.8 3.4 4.0 7.0 4.9 5.7 6.4 4.4 4.3 11.0 7.5 8.1 4.7 6.4 4.4 9.0 5.1 5.8 7.0 6.2 17.4 7.0 6.5 7.4 3.7 6.4 7.0 3.1 4.1 9.2 8.4 9.0 7.2 8.1 6.5 6.0 8.3 5.3 14.7 10.2 9.8 15.1 7.3 9.3 13.1 11.7 11.9 5.3 7.2 20.2 6.9 9.8 5.6 5.6 17.5 9.9 15.4 11.2 5.9 14.7 9.6 6.5 6.7 18.6 9.9 10.9 11.7 12.0 11.3 13.0 9.9 12.3 21.2 10.8 11.6 4.7 20.9 13.1 13.9 8.7 6.8 8.5 14.0 11.5 7.5 7.0 7.3 12.5 10.9 8.3 7.5 9.8 13.9 15.8 11.5 6.5 5.8 17.2 10.7 6.9 21.1 12.1 12.0 17.8 9.7 2.6 2.3 4.0 2.8 2.5 2.4 2.5 2.4 2.2 2.2 2.3 2.5 2.4 2.3 3.1 3.8 1.5 2.1 1.9 3.6 4.5 3.9 4.7 3.4 4.0 4.4 4.3 4.4 3.7 4.1 6.0 35.8 38.5 39.4 5.9 32.9 34.5 31.6 44.1 25.0 20.0 24.5 24.0 28.4 32.9 43.6 23.9 8.4 40.6 32.5 18.8 68.4 45.5 245.7 29.0 32.4 34.6 15.6 27.3 5.4 62.6 55.8 28.9 18.3 29.3 38.6 17.6 37.1 26.4 35.0 15.2 6.0 24.6 26.4 42.9 27.3 84.4 37.6 30.3 14.2 5.6 37.7 44.8 41.2 5.5 10.1 48.9 24.0 49.2 19.1 51.0 23.5 45.2 30.5 14.0 0.0 43.3 28.3 53.8 40.5 22.3 27.8 57.2 35.3 25.7 25.7 46.7 KIF15 "HKLP2, KNSL7, NY-BR-62" ENSG00000163808 "Kinesin family member 15" Q9NS87 3 44761721-44873376 "Plasma proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 5.0;lymphoid tissue: 9.2;testis: 7.3" "Group enriched" "Detected in many" 4 "Early spermatids: 177.5;Late spermatids: 78.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035516, HPA035517, HPA061469" Approved NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA035516: AB_2674664, HPA035517: AB_10671935, HPA061469: " "unprognostic (2.26e-1)" "unprognostic (1.85e-1)" "prognostic favorable (3.12e-4)" "unprognostic (3.49e-2)" "unprognostic (2.69e-1)" "unprognostic (5.17e-3)" "unprognostic (6.68e-7)" "unprognostic (1.35e-2)" "unprognostic (1.51e-2)" "unprognostic (6.94e-2)" "unprognostic (3.14e-4)" "unprognostic (2.72e-2)" "unprognostic (0.00e+0)" "unprognostic (1.38e-2)" "unprognostic (1.83e-1)" "unprognostic (6.13e-2)" "unprognostic (3.58e-1)" 0.2 0.1 0.1 1.2 0.1 5.0 0.4 0.2 0.2 0.3 0.0 1.4 1.4 0.3 0.0 1.1 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.2 2.2 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 1.6 0.1 0.2 0.1 0.0 0.8 1.4 0.4 0.1 0.4 0.8 7.3 0.1 9.2 0.0 0.0 2.2 0.3 0.4 0.1 7.5 3.9 17.6 12.8 1.2 1.4 3.9 8.6 5.3 10.8 9.0 6.6 7.2 13.8 2.8 3.1 4.0 6.3 10.1 4.7 13.1 11.6 2.3 14.9 7.7 8.4 0.1 15.6 6.6 0.3 0.2 7.3 7.1 1.6 8.6 18.4 9.3 17.2 8.2 3.9 30.0 5.7 18.2 9.7 7.0 11.9 19.0 7.9 2.4 4.9 8.2 7.8 14.2 4.6 2.9 4.6 7.7 11.7 4.8 10.4 8.5 8.8 11.5 7.2 12.7 17.3 5.5 16.3 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 2.6 1.6 1.9 0.4 0.9 0.0 0.1 0.5 0.8 1.8 0.0 0.7 0.0 2.1 3.3 0.8 2.5 0.0 0.8 177.5 1.3 1.7 1.2 0.0 28.0 3.2 0.0 5.9 1.9 5.1 1.4 0.0 12.3 0.0 0.2 3.5 0.0 3.8 2.6 0.0 1.6 1.4 78.0 0.0 1.8 0.0 0.0 0.3 0.7 1.0 3.0 4.7 0.5 0.1 0.4 9.7 0.5 0.5 0.1 0.2 0.0 0.0 0.4 1.9 20.2 14.7 6.0 1.0 0.7 3.1 1.1 5.3 0.5 TMEM42 MGC29956 ENSG00000169964 "Transmembrane protein 42" Q69YG0 3 44861904-44865670 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 70.0;Late spermatids: 85.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052569 Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm Nucleoli "HPA052569: AB_2681871" "prognostic favorable (5.23e-4)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (3.73e-2)" "unprognostic (2.32e-1)" "unprognostic (7.93e-2)" "unprognostic (6.99e-3)" "unprognostic (1.64e-2)" "unprognostic (9.16e-2)" "unprognostic (9.23e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "prognostic favorable (1.10e-5)" "unprognostic (1.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" 14.8 21.8 15.4 2.2 16.5 2.1 13.6 16.2 18.0 16.9 14.8 11.4 2.4 12.3 11.3 11.4 12.9 3.5 15.1 15.4 16.5 19.7 22.8 11.5 4.7 15.8 16.2 18.5 14.1 7.3 25.8 3.8 16.2 17.5 3.5 4.3 11.7 5.1 20.7 13.2 10.1 3.8 16.4 14.2 13.6 26.4 16.2 9.4 20.2 8.8 4.2 13.6 14.1 17.0 6.0 6.1 1.8 3.5 22.4 17.7 0.2 4.9 7.0 5.9 6.0 1.4 11.9 4.1 9.3 9.8 2.6 4.1 0.4 7.5 6.1 6.3 0.1 2.6 8.1 6.7 23.7 3.0 0.2 18.4 19.3 6.2 13.7 12.7 10.3 10.3 0.1 8.4 9.2 4.8 2.7 5.0 3.3 7.4 2.4 2.1 1.0 1.0 13.3 2.4 1.9 2.3 5.9 2.0 2.5 5.7 4.4 5.2 6.8 5.2 0.6 7.6 5.5 2.8 2.2 1.2 10.4 3.6 2.4 5.8 9.0 4.7 7.6 8.7 8.4 15.4 11.6 7.2 11.5 13.0 15.7 12.7 1.7 10.7 11.9 12.6 10.0 9.7 15.4 16.5 16.2 18.0 15.4 16.5 15.8 16.2 16.2 16.4 16.2 17.0 8.0 22.4 7.7 0.0 14.0 6.1 14.4 31.5 19.4 8.9 17.5 21.2 11.3 18.6 13.0 33.1 2.1 22.5 15.1 4.5 13.7 19.9 70.0 16.0 14.0 10.5 12.0 12.0 0.0 10.2 14.0 18.3 7.1 13.0 3.8 24.7 13.2 18.5 22.7 18.5 0.0 10.2 24.4 10.6 6.0 85.6 27.4 11.7 7.2 0.0 11.2 21.5 10.3 0.0 0.0 14.3 9.3 19.5 6.2 19.1 11.7 21.7 19.9 15.8 6.6 15.4 9.0 33.8 19.9 13.0 8.9 9.7 12.8 29.2 10.7 9.4 TGM4 TGP ENSG00000163810 "Transglutaminase 4" P49221 3 44874608-44914990 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 377 "prostate: 434.4" "Cell type enriched" "Detected in some" 20 "Prostatic glandular cells: 226.6" "Cancer enriched" "Detected in single" 312 "prostate cancer: 75.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.9;hTERT-HME1: 1.3;NB-4: 2.7;RPMI-8226: 2.0;SH-SY5Y: 1.4" "Not detected" "Not detected" "CAB033571, HPA073290" Enhanced NA NA "Cluster 51: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 35: Glandular cells - Unknown function" "CAB033571: AB_2287329, HPA073290: " "unprognostic (4.40e-2)" "unprognostic (4.68e-2)" "unprognostic (1.92e-1)" "unprognostic (2.17e-3)" "unprognostic (2.84e-1)" "unprognostic (2.19e-2)" "unprognostic (1.37e-1)" "unprognostic (1.92e-1)" "unprognostic (2.41e-2)" "unprognostic (1.65e-1)" "unprognostic (8.56e-3)" "unprognostic (5.08e-2)" "unprognostic (1.44e-8)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (3.68e-1)" "unprognostic (6.41e-2)" 0.0 1.1 0.0 0.2 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 434.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.3 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.5 4.2 0.7 0.0 0.0 0.1 0.1 0.9 0.0 0.2 0.0 0.0 0.5 0.2 0.1 0.0 0.0 5.7 0.8 0.6 0.4 0.0 0.0 0.2 0.0 0.3 1.3 0.0 1.5 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 11.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.4 0.0 226.6 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.1 0.3 0.0 0.4 1.0 0.2 0.1 0.2 2.4 ZDHHC3 "DHHC3, GODZ, ZNF373" ENSG00000163812 "Zinc finger DHHC-type palmitoyltransferase 3" Q9NYG2 3 44915257-44976185 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 8 "Early spermatids: 570.7;Late spermatids: 1564.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012465, HPA016616" Approved Approved "Golgi apparatus" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "CAB012465: , HPA016616: AB_1859004" "unprognostic (2.80e-1)" "unprognostic (6.07e-2)" "prognostic favorable (3.43e-4)" "unprognostic (3.10e-2)" "unprognostic (2.47e-2)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.37e-4)" "unprognostic (4.20e-2)" "unprognostic (1.04e-1)" "unprognostic (6.37e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "prognostic favorable (1.81e-8)" "unprognostic (2.64e-1)" "unprognostic (1.49e-1)" "unprognostic (5.33e-2)" "unprognostic (4.26e-2)" 50.1 48.6 23.0 25.7 21.5 82.8 36.3 27.9 22.9 42.2 25.8 70.6 44.1 35.4 24.5 58.0 27.5 32.0 36.3 25.8 21.1 40.3 32.3 41.9 21.9 28.7 25.1 28.9 22.2 46.0 13.4 28.7 29.8 35.6 64.6 16.6 33.3 40.1 43.7 70.0 58.1 36.3 25.8 29.6 55.3 80.8 27.0 26.9 38.6 52.8 33.3 53.6 42.5 25.3 62.5 53.3 41.0 49.1 219.2 100.5 46.8 58.8 80.7 78.3 66.5 61.0 85.1 58.7 31.4 107.9 52.8 80.7 68.4 104.3 74.6 61.7 29.3 55.9 57.9 45.7 50.6 136.3 43.0 92.5 111.6 73.6 67.2 59.8 79.6 63.8 73.8 51.3 78.1 42.9 46.2 73.6 60.7 155.9 96.7 29.9 40.6 47.0 66.7 176.7 14.6 52.8 70.3 70.5 36.4 70.4 57.4 88.2 78.0 55.4 55.2 60.2 66.3 32.2 66.6 59.6 55.2 198.9 39.4 53.7 24.5 32.6 14.6 12.3 13.3 10.7 11.0 16.1 26.8 12.6 10.2 14.4 25.4 14.5 17.5 15.3 17.1 13.6 23.0 21.5 27.9 22.9 25.8 21.1 28.7 25.1 29.8 25.8 27.0 25.3 41.5 41.7 82.1 7.5 17.8 48.2 42.1 40.8 48.9 9.8 24.4 20.8 29.2 24.3 27.1 53.3 6.2 47.7 23.4 105.6 72.4 46.6 570.7 18.8 31.2 34.1 35.9 68.8 15.7 79.0 59.4 26.4 69.3 26.6 19.0 21.5 35.7 29.4 49.5 15.2 15.6 78.2 38.7 34.0 26.7 1564.3 51.9 37.4 24.9 18.7 35.6 25.1 34.0 15.1 11.2 115.8 73.1 44.8 26.2 73.7 112.9 30.1 20.9 10.6 19.7 15.6 31.9 104.5 45.3 70.5 60.2 101.7 25.0 26.1 72.8 128.9 EXOSC7 "EAP1, hRrp42p, KIAA0116, p8, RRP42, Rrp42p" ENSG00000075914 "Exosome component 7" Q15024 3 44975241-45036066 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036182, HPA057980" Approved Supported "Nuclear speckles" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles" "HPA036182: AB_10673346, HPA057980: AB_2683571" "unprognostic (1.69e-2)" "unprognostic (3.92e-3)" "unprognostic (1.84e-3)" "unprognostic (4.97e-2)" "unprognostic (3.00e-3)" "unprognostic (2.16e-1)" "unprognostic (2.34e-3)" "unprognostic (2.21e-2)" "unprognostic (2.96e-1)" "unprognostic (7.85e-2)" "unprognostic (1.20e-1)" "unprognostic (7.67e-3)" "prognostic favorable (2.69e-4)" "unprognostic (4.33e-1)" "unprognostic (7.30e-2)" "unprognostic (2.94e-1)" "unprognostic (1.20e-1)" 17.5 44.1 9.5 12.5 9.5 17.2 18.4 10.0 10.4 23.5 10.7 15.3 11.6 20.4 7.0 27.2 17.0 9.1 27.0 9.5 10.9 22.2 18.1 15.0 19.6 10.4 9.8 19.0 18.6 20.1 17.3 15.4 10.1 15.9 10.8 5.9 17.5 15.9 43.8 44.6 13.2 11.2 9.7 15.3 20.0 23.2 10.5 20.2 19.9 36.4 16.8 22.7 22.2 9.8 61.5 55.7 44.9 37.3 45.9 50.0 40.5 26.2 42.2 56.0 57.7 93.3 47.8 77.4 40.3 45.6 42.6 33.9 55.9 72.2 46.0 52.3 49.2 67.5 64.5 91.5 88.7 95.3 26.5 44.1 45.6 61.2 123.6 36.5 54.8 84.9 107.4 37.8 40.3 63.2 68.6 167.9 54.3 55.2 78.4 33.8 41.7 117.7 51.0 85.5 20.9 31.4 37.0 31.6 39.7 38.4 46.7 77.9 39.3 28.8 43.0 48.3 71.7 47.1 47.5 92.6 42.4 131.6 26.2 6.8 41.3 7.6 38.8 41.5 43.6 71.3 44.6 40.2 66.0 59.7 51.8 41.4 2.1 58.3 31.5 40.2 47.7 45.4 9.5 9.5 10.0 10.4 9.5 10.9 10.4 9.8 10.1 9.7 10.5 9.8 25.0 35.3 30.1 16.0 23.2 61.8 68.8 97.2 47.3 29.5 23.9 43.2 39.0 21.5 46.5 35.0 18.8 67.8 22.1 8.6 135.0 51.7 3.9 23.7 34.8 24.0 13.1 19.6 19.9 46.7 62.4 32.7 23.0 21.7 15.2 33.0 18.2 28.6 46.5 20.2 22.5 19.3 79.3 14.2 22.6 8.3 47.8 17.4 26.6 8.4 20.6 37.6 33.0 10.6 14.0 41.7 10.3 41.0 19.4 74.8 17.7 47.4 34.3 23.4 13.1 25.7 53.9 53.7 66.3 35.5 74.2 63.1 26.2 52.2 24.3 56.3 CLEC3B "TN, TNA" ENSG00000163815 "C-type lectin domain family 3 member B" P05452 3 45001548-45036071 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 420.3" "Cell type enhanced" "Detected in some" "Adipocytes: 76.3;Endothelial cells: 27.9;Fibroblasts: 126.4;Hepatic stellate cells: 57.5;Leydig cells: 30.1;Microglial cells: 69.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 297.9;ASC TERT1: 591.9;U-2197: 120.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002582, HPA034794" Approved "Secreted to blood" NA NA 6540000000 25000000000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "CAB002582: AB_564027, HPA034794: AB_2674332" "unprognostic (2.04e-1)" "unprognostic (1.80e-3)" "unprognostic (2.58e-1)" "unprognostic (4.57e-2)" "unprognostic (7.75e-2)" "prognostic favorable (1.53e-4)" "prognostic favorable (9.99e-9)" "unprognostic (1.75e-2)" "unprognostic (2.25e-1)" "unprognostic (4.02e-1)" "prognostic favorable (5.68e-4)" "unprognostic (9.33e-2)" "unprognostic (2.39e-2)" "unprognostic (7.46e-2)" "unprognostic (1.39e-1)" "unprognostic (5.54e-2)" "unprognostic (4.21e-2)" 420.3 51.0 44.4 9.3 46.4 1.7 214.8 45.5 66.6 89.4 50.9 83.9 31.6 60.4 17.1 49.9 41.1 35.6 259.9 43.0 42.9 131.4 29.0 201.2 33.1 51.3 56.1 26.0 14.6 14.3 27.7 142.8 48.0 33.5 37.4 0.7 49.8 19.1 74.8 149.7 78.2 25.5 44.8 264.5 43.5 113.2 50.7 10.1 88.4 68.0 8.2 100.9 74.9 43.0 0.0 0.0 0.1 0.2 297.9 591.9 0.0 40.1 62.9 1.2 6.2 0.0 0.0 0.1 0.1 3.1 0.0 0.1 0.0 0.1 0.1 0.3 0.9 0.6 0.1 0.1 0.5 0.1 0.7 47.5 0.1 0.3 0.1 0.4 0.5 0.3 0.0 1.7 0.5 0.2 0.0 2.2 0.0 0.0 0.6 0.0 0.1 2.2 0.0 0.0 0.3 1.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 4.5 0.2 120.6 0.1 1.0 1.2 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.4 46.4 45.5 66.6 43.0 42.9 51.3 56.1 48.0 44.8 50.7 43.0 76.3 0.0 0.0 1.6 0.3 3.4 0.0 0.0 1.8 0.0 0.7 0.3 0.8 1.5 0.0 0.0 0.0 0.0 0.5 0.0 3.9 0.0 4.0 0.3 16.9 27.9 0.0 2.7 0.8 0.2 0.0 126.4 3.1 0.3 0.0 0.0 57.5 0.3 0.9 0.0 0.6 0.0 0.0 1.2 9.5 19.5 30.1 2.2 3.6 69.3 0.7 0.4 0.0 1.5 0.7 0.1 0.0 6.4 0.5 0.0 0.0 0.0 0.0 0.3 0.0 1.0 12.3 0.0 0.0 0.7 3.8 0.1 0.7 0.4 0.0 0.0 CDCP1 "CD318, SIMA135" ENSG00000163814 "CUB domain containing protein 1" Q9H5V8 3 45082277-45146422 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 121.2;Basal respiratory cells: 92.6;Pancreatic endocrine cells: 137.1;Urothelial cells: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.3;NK-cell: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 94.9;HBEC3-KT: 109.0;hTEC/SVTERT24-B: 265.2;hTERT-HME1: 177.9;PC-3: 89.7;RPTEC TERT1: 81.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010978, HPA010979, CAB025637" Enhanced "Intracellular and membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "CAB025637: , HPA010978: AB_1846403, HPA010979: AB_1846401" "unprognostic (9.31e-2)" "unprognostic (4.50e-2)" "unprognostic (1.67e-2)" "unprognostic (2.66e-1)" "unprognostic (1.11e-2)" "unprognostic (1.51e-3)" "unprognostic (2.94e-2)" "prognostic unfavorable (1.41e-5)" "unprognostic (2.15e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (1.48e-4)" "unprognostic (2.14e-2)" "unprognostic (9.98e-3)" "unprognostic (3.59e-2)" "unprognostic (2.99e-1)" "unprognostic (1.21e-1)" "unprognostic (1.34e-1)" 2.3 0.5 0.4 4.4 0.7 0.9 5.6 0.4 1.2 8.5 12.8 17.4 17.7 3.2 9.2 37.2 4.0 6.2 0.5 0.7 0.7 4.8 0.8 8.2 0.8 1.4 0.8 0.3 7.9 1.4 1.2 2.2 1.3 5.1 17.0 0.2 12.6 5.6 0.3 23.3 15.1 3.1 1.1 0.7 16.5 0.6 3.6 0.6 7.7 0.0 5.8 9.7 16.4 2.6 52.2 15.1 0.0 0.2 0.1 2.4 12.1 9.7 1.6 4.4 4.1 21.3 94.9 0.0 11.8 2.9 2.5 40.5 0.3 109.0 8.9 0.0 0.1 0.1 16.4 0.1 8.1 0.1 3.6 3.7 56.1 265.2 177.9 16.0 1.0 0.1 31.1 0.2 13.8 0.1 0.1 0.9 7.4 24.7 89.7 0.0 0.0 8.6 81.1 40.7 3.4 0.1 20.1 5.0 0.1 4.8 22.9 0.4 4.6 0.2 0.2 3.3 0.2 0.1 0.1 0.1 1.5 1.1 1.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.1 0.0 0.9 4.2 0.0 0.0 0.0 0.2 0.4 0.7 0.4 1.2 0.7 0.7 1.4 0.8 1.3 1.1 3.6 2.6 0.1 3.2 13.1 0.3 0.3 121.2 83.3 92.6 50.7 0.0 12.9 6.6 0.5 14.3 57.7 9.2 0.0 5.8 0.3 76.6 0.0 78.6 0.1 36.5 6.3 1.9 37.6 0.4 2.0 71.6 7.5 4.6 37.8 59.3 8.8 0.1 0.0 0.0 10.8 0.0 0.4 37.9 18.3 7.9 37.6 0.5 3.1 13.4 3.6 0.0 10.7 0.0 0.0 1.0 0.3 137.1 34.9 0.0 2.5 75.8 30.8 0.0 56.6 0.0 0.0 0.4 3.6 0.0 0.4 59.8 75.0 3.3 1.8 13.5 28.9 117.4 TMEM158 "p40BBp, RIS1" ENSG00000249992 "Transmembrane protein 158" Q8WZ71 3 45224466-45226287 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.3;endometrium 1: 69.5" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 24.5;Breast myoepithelial cells: 24.5;Endometrial stromal cells: 61.0;Muller glia cells: 87.4" "Cancer enhanced" "Detected in many" "glioma: 38.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 336.1;GAMG: 111.9;U-138 MG: 138.9;U-87 MG: 455.3" "Region enhanced" "Detected in all" "basal ganglia: 95.5" "Low region specificity" "Detected in all" HPA074974 Approved NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 5: Muller glia cells - Visual perception" "HPA074974: AB_2732274" "unprognostic (3.84e-1)" "unprognostic (9.83e-3)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (3.77e-2)" "unprognostic (5.73e-2)" "unprognostic (3.31e-2)" "unprognostic (4.67e-3)" "unprognostic (6.23e-2)" "unprognostic (6.41e-2)" "unprognostic (1.84e-3)" "prognostic favorable (6.43e-5)" "prognostic unfavorable (5.42e-9)" "unprognostic (1.96e-1)" "unprognostic (1.71e-1)" "unprognostic (2.86e-2)" "unprognostic (4.49e-3)" 2.6 9.2 20.3 3.8 33.3 1.9 1.6 7.5 23.0 8.6 8.5 8.1 0.7 69.5 2.2 18.2 3.9 6.4 0.7 22.4 23.9 3.6 0.7 1.6 0.5 10.6 22.5 1.4 1.9 0.2 12.2 0.8 10.4 13.2 1.9 1.5 1.4 22.7 2.0 2.4 1.9 17.0 15.2 0.4 1.9 2.5 27.4 0.2 0.7 0.7 1.1 8.7 2.8 13.8 12.9 2.1 4.4 0.8 7.7 18.3 3.7 31.6 336.1 17.0 27.5 0.7 0.8 0.1 1.6 10.5 111.9 17.2 5.1 1.4 50.2 0.8 2.0 0.0 6.1 0.1 10.7 2.5 6.1 24.6 0.6 33.7 2.7 39.2 1.8 0.0 80.3 0.9 30.4 0.5 0.0 22.3 37.8 0.3 46.5 0.0 1.0 4.9 6.7 11.9 6.1 1.4 12.2 0.4 2.1 3.4 0.3 4.3 5.1 138.9 10.4 88.4 110.2 0.0 0.1 0.0 455.3 12.6 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 20.3 33.3 7.5 23.0 22.4 23.9 10.6 22.5 10.4 15.2 27.4 13.8 1.6 0.0 0.5 1.6 0.4 24.5 6.1 2.1 2.8 4.4 13.1 24.5 1.0 1.5 0.8 9.2 0.0 0.1 0.5 0.6 0.0 2.9 0.2 10.8 61.0 1.3 7.7 0.0 8.7 0.4 0.1 9.3 0.5 4.2 0.0 0.7 2.5 2.7 5.1 1.7 5.7 0.6 2.0 0.8 16.4 0.7 8.4 6.4 0.0 1.9 1.4 87.4 0.0 6.0 1.2 1.0 0.5 0.0 0.0 1.7 0.0 0.2 0.4 2.9 0.0 4.9 8.3 0.3 0.5 1.0 10.5 0.3 0.6 16.7 0.7 4.2 LARS2 "KIAA0028, LEURS, MGC26121, mtLeuRS" ENSG00000011376 "Leucyl-tRNA synthetase 2, mitochondrial" Q15031 3 45388561-45554726 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 28.7;Excitatory neurons: 35.4;Inhibitory neurons: 37.8;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035951, HPA045450, HPA066085" Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria Nucleoplasm "HPA035951: AB_10672997, HPA045450: AB_2679328, HPA066085: AB_2685612" "unprognostic (3.89e-1)" "unprognostic (3.89e-1)" "prognostic favorable (1.71e-4)" "unprognostic (3.02e-2)" "unprognostic (3.77e-1)" "unprognostic (1.45e-1)" "unprognostic (2.21e-3)" "unprognostic (9.19e-2)" "unprognostic (6.13e-2)" "unprognostic (2.86e-1)" "unprognostic (4.98e-1)" "unprognostic (4.37e-2)" "prognostic favorable (1.32e-11)" "unprognostic (2.81e-1)" "unprognostic (5.74e-2)" "unprognostic (9.90e-2)" "unprognostic (9.07e-2)" 3.3 4.7 9.5 3.4 10.3 2.4 3.9 10.1 11.7 3.7 9.2 6.9 3.9 4.6 4.3 4.2 4.5 3.0 5.5 9.3 10.5 7.5 8.1 2.9 4.3 9.5 10.2 3.8 2.4 12.3 3.7 4.2 9.5 4.3 6.9 4.2 3.6 4.2 6.2 3.6 2.9 4.4 9.2 3.2 3.6 2.2 11.5 6.9 4.5 6.4 4.8 5.0 3.7 8.5 6.3 11.2 10.7 9.3 11.8 13.0 11.1 11.6 15.7 24.7 16.2 20.3 8.8 13.8 8.9 18.0 18.2 5.8 49.0 30.4 16.0 9.5 12.7 12.9 13.6 18.4 12.1 20.9 4.4 19.0 16.8 26.0 12.5 13.1 14.9 19.5 25.1 5.5 19.0 9.7 21.1 11.6 28.4 15.0 21.9 8.9 9.8 16.9 23.6 18.8 7.6 9.7 17.3 7.9 11.8 13.5 14.6 14.7 9.1 12.1 8.3 8.5 12.3 5.3 12.3 15.4 14.0 16.9 9.5 0.0 0.6 0.6 1.2 0.9 1.5 1.0 0.7 1.1 1.2 0.5 0.8 1.0 0.3 1.9 0.8 1.0 0.6 0.7 9.5 10.3 10.1 11.7 9.3 10.5 9.5 10.2 9.5 9.2 11.5 8.5 3.9 0.0 2.0 28.7 4.8 1.1 1.5 1.8 3.4 5.5 3.2 2.8 9.0 1.5 1.8 5.5 4.2 5.0 3.5 4.4 5.9 2.9 0.6 7.6 5.7 4.2 4.8 5.2 35.4 2.7 5.2 3.2 6.6 4.9 1.3 9.8 2.2 7.7 5.4 1.7 37.8 4.5 0.0 2.9 1.3 1.2 1.2 2.6 1.8 19.7 2.3 4.0 2.1 22.6 25.2 3.2 7.0 2.2 5.0 1.9 2.6 2.4 2.9 4.7 0.0 3.1 2.9 0.7 2.4 4.8 1.3 2.9 3.2 8.3 6.8 1.7 LIMD1 ENSG00000144791 "LIM domains containing 1" Q9UGP4 3 45555394-45686341 "Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation" Repressor "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 74.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064220, HPA071736" Approved Supported "Nucleoplasm,Focal adhesion sites" NA NA 8100 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Focal adhesion sites" "HPA064220: AB_2685216, HPA071736: " "unprognostic (2.77e-1)" "unprognostic (3.22e-2)" "unprognostic (5.43e-2)" "unprognostic (7.78e-2)" "unprognostic (6.53e-2)" "unprognostic (2.07e-2)" "unprognostic (9.44e-2)" "unprognostic (1.53e-2)" "unprognostic (1.11e-1)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "unprognostic (2.11e-3)" "prognostic favorable (6.73e-5)" "unprognostic (8.02e-2)" "unprognostic (3.06e-2)" "unprognostic (2.86e-2)" "unprognostic (6.61e-3)" 7.1 3.8 4.3 7.8 4.7 6.0 5.4 3.5 4.8 5.4 9.5 7.3 7.1 6.6 4.6 5.6 6.1 7.2 9.7 3.5 3.8 3.7 11.1 17.1 10.6 8.3 5.4 4.1 10.2 9.0 2.8 6.4 6.6 6.2 7.5 2.8 9.8 4.8 17.4 6.5 7.9 5.5 4.7 10.8 8.2 2.5 6.9 8.0 12.2 8.6 8.6 6.0 4.8 6.9 13.3 24.7 8.8 11.9 7.6 14.7 17.7 12.4 17.0 12.7 11.0 11.7 6.8 1.7 8.1 11.4 26.1 8.8 18.8 10.0 10.5 28.1 11.7 14.7 20.5 9.7 7.7 13.3 18.2 6.2 8.3 19.1 10.0 9.2 11.3 14.7 12.4 40.0 12.6 8.7 16.2 8.3 14.2 10.4 23.7 7.9 10.3 20.2 6.8 23.3 4.1 8.0 10.5 18.8 12.4 9.0 11.4 11.8 20.7 14.3 12.9 14.5 13.4 38.1 52.7 6.5 30.9 11.7 16.0 3.8 0.9 1.1 1.0 2.0 0.6 2.4 0.8 0.8 0.9 4.0 0.8 0.8 1.0 0.7 4.0 5.8 0.8 0.8 4.3 4.7 3.5 4.8 3.5 3.8 8.3 5.4 6.6 4.7 6.9 6.9 5.0 38.5 27.4 17.6 17.8 2.9 5.7 4.3 4.0 1.6 5.2 3.8 16.5 21.5 12.4 7.3 2.1 6.4 23.9 8.0 1.9 7.2 1.2 7.9 10.2 5.9 6.7 10.3 1.4 5.3 12.8 9.0 9.7 10.7 3.8 11.1 9.7 22.9 17.1 6.7 3.6 15.9 10.2 17.0 10.1 0.9 11.8 13.5 5.4 18.7 11.1 4.8 12.3 74.4 22.5 6.2 6.9 3.4 9.7 9.1 5.9 2.9 11.9 1.5 6.6 8.2 15.2 1.0 3.5 4.1 2.3 5.3 7.9 2.5 9.6 5.4 SACM1L "KIAA0851, SAC1" ENSG00000211456 "SAC1 like phosphatidylinositide phosphatase" Q9NTJ5 3 45689056-45745409 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039573, HPA069869" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA 82000 "Cluster 48: NK-cells - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Golgi apparatus" "HPA039573: AB_10674983, HPA069869: AB_2686216" "unprognostic (2.07e-1)" "unprognostic (4.08e-1)" "unprognostic (1.36e-3)" "unprognostic (1.14e-1)" "unprognostic (2.31e-2)" "unprognostic (4.34e-2)" "unprognostic (2.82e-1)" "unprognostic (1.03e-2)" "unprognostic (8.54e-2)" "unprognostic (1.94e-2)" "unprognostic (1.22e-2)" "unprognostic (6.29e-3)" "prognostic favorable (5.47e-7)" "unprognostic (3.50e-1)" "unprognostic (1.62e-1)" "unprognostic (2.50e-1)" "unprognostic (1.33e-2)" 23.5 26.3 13.2 26.2 13.8 21.1 22.0 17.1 16.1 22.1 13.6 24.0 23.3 20.6 23.3 20.2 16.9 19.2 16.3 14.0 18.8 38.1 28.2 28.9 26.8 15.5 14.9 16.2 21.8 35.8 10.9 25.0 14.7 24.3 23.6 20.3 22.9 20.6 8.8 18.4 21.6 21.2 14.6 26.2 25.0 14.2 15.9 32.5 43.5 11.4 25.0 22.9 10.8 16.3 31.0 23.0 38.0 22.0 58.8 39.2 29.6 50.1 43.0 36.9 33.1 30.5 21.8 47.8 24.3 39.8 49.8 22.7 50.4 27.0 48.9 34.3 26.8 50.8 38.2 25.7 37.6 78.0 61.5 26.5 41.1 39.9 29.6 29.9 25.6 43.2 57.9 45.7 60.6 14.0 59.5 41.4 40.1 29.6 40.1 17.2 20.0 48.4 41.2 42.7 15.0 36.1 35.5 36.3 44.7 38.0 31.0 64.1 33.7 36.2 21.1 37.0 44.5 25.3 71.7 32.5 45.1 106.8 36.2 10.3 17.1 27.5 24.6 14.2 27.5 11.0 17.8 26.0 27.2 11.9 17.6 23.5 14.1 65.2 13.0 11.1 16.7 27.6 13.2 13.8 17.1 16.1 14.0 18.8 15.5 14.9 14.7 14.6 15.9 16.3 18.4 28.9 37.3 22.5 22.2 19.6 9.1 14.6 22.2 22.8 15.2 12.3 16.6 14.3 15.7 7.3 31.3 22.9 55.4 16.4 19.6 11.1 1.6 15.9 31.9 17.6 12.0 23.4 44.7 10.0 11.2 19.5 17.3 18.5 17.1 17.2 17.2 15.4 24.5 33.7 42.7 9.4 18.3 23.0 18.7 2.9 16.8 22.6 17.8 30.9 25.5 15.8 46.4 40.7 43.6 12.9 20.7 23.0 33.2 14.6 18.5 22.3 14.1 20.7 6.6 15.8 16.6 12.3 12.0 15.7 17.3 18.3 44.5 19.5 13.6 11.6 SLC6A20 "IMINO, SIT1, XT3, Xtrp3" ENSG00000163817 "Solute carrier family 6 member 20" Q9NP91 3 45755449-45796536 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "choroid plexus: 59.2;intestine: 24.2" "Cell type enriched" "Detected in some" 4 "Proximal enterocytes: 74.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 4.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.7;OE19: 3.9;SuSa: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" "unprognostic (1.57e-1)" "unprognostic (5.26e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-2)" "unprognostic (1.48e-1)" "unprognostic (9.43e-3)" "unprognostic (3.26e-2)" "unprognostic (4.33e-3)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (1.68e-3)" "unprognostic (1.46e-1)" "prognostic favorable (1.55e-5)" "unprognostic (2.87e-1)" "unprognostic (1.23e-1)" "unprognostic (7.55e-2)" "unprognostic (2.09e-2)" 0.2 0.1 0.4 0.7 1.7 0.4 0.4 1.8 4.7 1.3 59.2 0.5 24.2 0.8 0.1 0.1 0.2 6.9 0.2 2.0 0.2 1.9 0.1 1.9 0.3 0.3 0.3 0.1 3.0 0.1 1.3 0.1 0.4 0.4 0.2 0.5 0.7 0.1 0.8 0.7 17.6 0.3 0.3 0.1 5.2 0.4 0.7 0.9 0.1 0.5 0.1 0.0 0.1 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.7 0.1 0.5 0.0 0.2 1.7 0.0 0.0 0.1 0.0 0.1 0.2 0.7 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.4 3.9 0.1 0.2 0.0 0.2 0.1 0.1 0.1 0.2 0.8 0.1 0.0 1.1 0.1 0.0 0.0 0.2 0.2 0.2 0.1 0.4 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.4 1.7 1.8 4.7 2.0 0.2 0.3 0.3 0.4 0.3 0.7 0.6 0.1 0.0 5.0 0.0 0.1 0.5 0.6 0.6 0.0 0.3 0.7 0.4 1.2 17.2 2.7 0.0 0.0 0.1 0.2 3.5 0.0 13.7 0.6 1.7 0.5 0.1 0.0 0.0 1.4 0.2 0.1 0.7 17.9 2.1 0.0 0.2 0.4 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.1 9.4 1.2 1.2 0.4 2.3 74.7 3.5 1.4 0.3 0.0 0.6 0.3 0.2 0.2 0.0 0.3 0.0 0.3 0.1 7.0 4.2 LZTFL1 BBS17 ENSG00000163818 "Leucine zipper transcription factor like 1" Q9NQ48 3 45823316-45916042 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 119.0;Endometrial ciliated cells: 56.7;Respiratory ciliated cells: 142.2;Spermatocytes: 170.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043466, HPA048447" Enhanced Supported Cytosol NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA043466: AB_2678491, HPA048447: AB_2680398" "unprognostic (1.64e-2)" "unprognostic (1.34e-1)" "unprognostic (3.14e-2)" "unprognostic (1.26e-2)" "unprognostic (2.65e-2)" "unprognostic (5.42e-2)" "unprognostic (1.15e-2)" "unprognostic (2.26e-2)" "unprognostic (4.20e-2)" "unprognostic (2.94e-2)" "unprognostic (7.83e-2)" "unprognostic (5.32e-2)" "unprognostic (1.30e-3)" "unprognostic (6.27e-3)" "unprognostic (8.31e-2)" "unprognostic (4.27e-3)" "unprognostic (4.19e-1)" 5.2 6.2 7.1 4.5 8.2 6.0 12.4 5.8 10.1 12.4 17.5 5.7 7.0 13.2 15.0 5.5 18.9 6.9 4.6 8.7 7.7 12.0 10.0 9.0 4.7 6.7 7.3 11.4 5.6 14.2 11.7 5.9 6.5 7.9 6.2 15.8 7.2 8.8 2.8 6.0 5.7 8.4 6.6 6.0 5.8 25.4 7.1 30.7 18.9 3.5 5.7 4.7 4.1 6.9 10.1 5.0 7.8 5.1 7.2 17.9 4.0 5.3 10.0 12.2 15.8 2.4 7.5 2.7 3.1 7.5 15.2 6.4 9.5 8.6 15.9 0.2 6.1 2.6 6.7 4.5 9.4 9.9 2.8 9.3 29.6 16.8 10.8 7.8 6.0 16.5 8.9 6.7 5.9 1.6 34.1 9.6 8.1 6.7 4.2 3.7 0.8 10.7 14.7 4.7 5.4 11.0 7.0 6.0 13.2 8.7 7.1 18.3 9.9 4.5 3.1 12.2 7.1 18.3 10.0 0.1 14.3 11.7 3.7 0.0 0.9 0.4 1.3 1.2 1.7 4.3 1.1 1.2 2.3 2.4 1.8 1.7 1.0 1.5 0.8 2.5 2.0 1.6 7.1 8.2 5.8 10.1 8.7 7.7 6.7 7.3 6.5 6.6 7.1 6.9 7.6 28.9 25.2 7.8 10.8 13.5 10.5 14.9 12.0 7.9 16.9 14.9 7.6 11.5 23.6 14.7 14.6 3.1 8.4 3.7 15.6 13.3 119.0 56.7 10.5 10.2 11.4 11.6 22.3 6.9 5.1 13.3 6.1 12.3 8.2 10.1 11.7 13.5 6.6 23.5 9.9 10.4 10.2 7.3 7.0 19.2 9.9 5.3 8.8 5.6 10.8 17.8 7.2 6.6 12.2 5.6 5.6 13.5 11.6 5.9 3.2 23.0 142.2 14.6 13.1 15.7 9.2 170.0 24.1 8.4 9.9 2.1 10.5 14.2 8.9 5.6 CCR9 "CDw199, GPR-9-6, GPR28" ENSG00000173585 "C-C motif chemokine receptor 9" P51686 3 45886504-45903175 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "lymphoid tissue: 124.3" "Cell type enhanced" "Detected in some" "B-cells: 1.0;T-cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "memory B-cell: 24.0;naive B-cell: 15.6;T-reg: 8.1" "Group enriched" "Detected in many" 42 "B-cells: 24.0;T-cells: 8.1" "Cell line enriched" "Detected in some" 54 "MOLT-4: 112.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB006839 Uncertain NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "CAB006839: " "unprognostic (3.08e-3)" "unprognostic (3.37e-1)" "unprognostic (5.56e-2)" "unprognostic (1.78e-1)" "unprognostic (8.65e-3)" "unprognostic (7.88e-3)" "unprognostic (4.54e-1)" "unprognostic (2.94e-2)" "unprognostic (3.00e-1)" "unprognostic (1.77e-1)" "unprognostic (8.06e-2)" "unprognostic (1.16e-1)" "unprognostic (2.59e-2)" "unprognostic (1.88e-1)" "unprognostic (4.34e-1)" "unprognostic (2.27e-1)" "unprognostic (7.20e-3)" 0.0 0.0 0.0 1.1 0.1 0.5 0.0 0.0 0.1 0.0 0.4 0.2 3.8 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 5.4 0.0 0.2 1.0 0.2 0.0 0.1 124.3 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 112.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 24.0 2.8 2.4 0.3 15.6 0.4 0.1 0.0 0.0 0.0 0.3 8.1 2.7 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 FYCO1 "FLJ13335, ZFYVE7" ENSG00000163820 "FYVE and coiled-coil domain autophagy adaptor 1" Q9BQS8 3 45917899-45995824 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 263.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 89.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035526, HPA057966" Uncertain Enhanced Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 15: RT4 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" Vesicles "HPA035526: AB_10672867, HPA057966: AB_2683567" "unprognostic (2.45e-1)" "unprognostic (6.62e-2)" "unprognostic (6.97e-3)" "unprognostic (1.14e-3)" "unprognostic (7.65e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-2)" "unprognostic (4.53e-3)" "unprognostic (5.85e-2)" "unprognostic (8.85e-2)" "unprognostic (2.36e-1)" "unprognostic (2.98e-1)" "prognostic favorable (3.33e-11)" "unprognostic (2.90e-1)" "unprognostic (1.42e-1)" "unprognostic (2.89e-2)" "unprognostic (6.99e-2)" 16.7 13.0 10.5 9.7 12.0 6.5 13.4 9.6 9.4 23.1 11.3 42.0 8.0 25.6 10.3 21.3 15.4 18.7 66.8 8.6 10.3 10.7 10.8 14.7 8.6 15.5 10.8 23.1 12.7 20.3 7.6 8.2 14.8 19.3 10.7 33.0 14.9 22.9 263.3 19.3 14.4 28.2 15.1 10.2 20.4 3.3 11.9 10.5 16.5 104.6 8.2 39.6 16.9 15.1 10.8 10.3 3.0 13.0 27.9 21.8 4.9 10.2 23.7 13.1 14.6 5.6 9.3 7.9 5.6 14.2 12.7 7.9 8.5 17.0 15.7 3.3 9.0 11.4 8.7 6.3 19.0 8.8 7.9 24.3 16.7 21.1 20.5 20.3 26.7 13.4 7.4 11.3 9.5 6.7 9.0 5.5 4.5 8.8 9.8 3.1 8.3 4.4 15.9 37.2 2.2 3.4 6.4 20.0 17.6 4.4 9.7 5.7 20.8 5.0 5.9 17.0 5.7 6.4 4.4 2.7 17.2 11.1 9.6 0.7 0.5 0.3 2.0 0.5 2.7 0.2 1.2 2.1 0.2 0.2 0.5 0.7 0.4 1.5 0.3 1.3 1.2 0.7 10.5 12.0 9.6 9.4 8.6 10.3 15.5 10.8 14.8 15.1 11.9 15.1 9.5 28.9 13.7 12.4 4.8 4.1 4.8 5.6 3.4 11.2 8.5 4.8 89.3 8.6 13.0 16.5 35.5 4.3 8.7 6.8 3.9 8.8 0.1 6.4 8.9 9.3 9.6 6.9 0.8 8.3 2.2 14.0 12.8 11.2 2.5 14.9 11.4 9.2 4.1 0.0 0.8 7.6 2.0 5.8 4.6 1.6 12.8 5.1 10.6 10.3 4.0 20.0 6.2 8.0 21.2 11.0 2.5 17.7 3.0 17.3 8.7 6.2 18.6 37.1 6.6 20.8 12.8 2.3 0.8 8.4 4.1 2.9 12.7 6.1 6.2 7.9 CXCR6 "BONZO, CD186, STRL33, TYMSTR" ENSG00000172215 "C-X-C motif chemokine receptor 6" O00574 3 45940933-45948351 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.0" "Group enriched" "Detected in some" 6 "Extravillous trophoblasts: 74.1;T-cells: 58.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 445.8" "Lineage enriched" "Detected in many" 5 "T-cells: 445.8" "Cell line enhanced" "Detected in some" "BEWO: 2.9;CAPAN-2: 11.2;JURKAT: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (2.05e-3)" "prognostic favorable (4.92e-4)" "unprognostic (1.77e-3)" "prognostic favorable (6.74e-6)" "unprognostic (6.67e-2)" "prognostic favorable (2.16e-4)" "unprognostic (2.09e-2)" "unprognostic (1.51e-2)" "unprognostic (1.93e-2)" "unprognostic (3.65e-4)" "unprognostic (8.57e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (2.42e-5)" "unprognostic (2.25e-2)" "unprognostic (4.42e-2)" "unprognostic (3.46e-2)" "unprognostic (1.57e-2)" 1.7 1.7 0.4 7.1 1.3 1.6 3.3 0.5 0.6 2.8 0.8 4.1 4.4 1.1 1.6 2.7 2.3 5.9 1.0 0.5 1.3 0.9 4.0 4.0 17.0 2.3 0.7 2.1 1.5 0.3 0.4 10.8 2.2 1.5 3.7 2.7 1.9 0.8 10.2 0.7 9.5 1.1 1.6 13.3 8.7 0.5 1.2 4.9 1.4 0.0 10.8 7.2 1.6 2.4 0.2 0.0 0.0 0.2 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.8 11.2 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.2 0.3 0.0 0.2 0.6 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.2 0.7 0.0 1.4 0.2 0.6 0.3 1.0 0.5 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.5 0.2 92.8 0.2 445.8 0.3 26.5 112.1 0.1 0.2 1.3 16.0 0.8 89.8 0.4 0.6 87.0 24.7 0.4 1.3 0.5 0.6 0.5 1.3 2.3 0.7 2.2 1.6 1.2 2.4 0.3 0.0 0.0 0.0 1.1 1.0 0.1 0.0 0.0 1.1 0.2 0.1 0.7 0.0 0.0 0.0 2.1 8.4 4.2 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 5.3 0.0 0.0 74.1 1.2 1.5 0.1 1.3 0.0 1.4 0.8 0.8 0.0 0.0 0.2 0.0 2.8 1.8 0.0 0.0 0.8 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 5.5 0.1 0.0 0.1 0.0 4.7 0.0 0.2 0.3 0.0 0.0 0.1 1.1 10.3 58.5 0.0 0.1 0.1 XCR1 "CCXCR1, GPR5" ENSG00000173578 "X-C motif chemokine receptor 1" P46094 3 46017007-46027487 "G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 11.2" "Cell type enriched" "Detected in some" 5 "Langerhans cells: 10.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "myeloid DC: 3.8" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.8" "Cell line enhanced" "Detected in some" "HEL: 1.6;Karpas-707: 2.5;RT4: 2.0;U-266/84: 2.2;U-87 MG: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA013169 Uncertain NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 41: Macrophages - Immune response" "HPA013169: AB_1846211" "unprognostic (3.49e-3)" "unprognostic (4.23e-3)" "unprognostic (1.15e-2)" "unprognostic (5.91e-3)" "unprognostic (7.91e-2)" "unprognostic (8.53e-6)" "unprognostic (3.89e-6)" "unprognostic (9.27e-3)" "unprognostic (4.41e-3)" "unprognostic (3.40e-3)" "unprognostic (2.03e-2)" "unprognostic (1.30e-1)" "unprognostic (1.87e-1)" "unprognostic (5.98e-2)" "unprognostic (1.60e-2)" "unprognostic (1.30e-2)" "unprognostic (1.80e-1)" 0.9 0.1 0.1 3.8 0.2 3.0 0.6 0.8 0.7 0.7 0.5 1.1 1.7 0.5 4.5 1.9 0.5 3.0 0.5 0.5 0.1 0.3 1.1 1.4 11.2 0.3 0.1 0.9 0.1 0.1 0.0 4.3 0.3 0.6 1.1 0.6 0.2 0.6 0.1 2.7 1.7 1.5 0.0 7.2 1.2 0.4 0.3 8.8 0.5 0.4 4.6 1.6 0.2 0.7 0.0 0.8 0.3 0.0 0.0 0.0 0.7 0.3 0.8 0.0 0.0 0.7 0.0 0.7 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.4 0.0 0.0 0.4 0.3 0.5 2.5 0.0 0.8 0.4 0.0 0.0 0.4 0.0 0.3 0.0 0.3 0.3 2.0 0.1 0.0 0.0 0.2 0.0 0.7 0.2 0.0 0.0 0.4 0.9 0.2 0.1 1.2 2.2 0.7 1.7 0.0 0.2 0.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 3.8 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.3 0.1 0.2 0.8 0.7 0.5 0.1 0.3 0.1 0.3 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.8 10.2 1.5 0.0 2.0 1.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 CCR3 "CC-CKR-3, CD193, CKR3, CMKBR3" ENSG00000183625 "C-C motif chemokine receptor 3" P51677 3 46163604-46266706 "CD markers, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 2.6" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 1.2;granulocytes: 1.3;Melanocytes: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 25 "basophil: 3389.4;eosinophil: 2509.9" "Lineage enriched" "Detected in many" 109 "granulocytes: 3389.4" "Cell line enriched" "Detected in some" 10 "RPMI-8226: 29.6" "Not detected" "Not detected" "CAB003795, HPA069514" Uncertain Supported "Plasma membrane" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 47: Cytotrophoblasts - Unknown function" "Plasma membrane" "CAB003795: AB_562259, HPA069514: " "unprognostic (1.56e-2)" "unprognostic (6.65e-3)" "unprognostic (1.01e-1)" "unprognostic (3.98e-2)" "unprognostic (1.41e-1)" "unprognostic (3.25e-3)" "unprognostic (3.11e-7)" "unprognostic (4.36e-2)" "unprognostic (3.35e-2)" "unprognostic (3.43e-2)" "unprognostic (4.81e-2)" "unprognostic (3.94e-2)" "unprognostic (3.17e-6)" "unprognostic (1.35e-2)" "unprognostic (1.72e-2)" "unprognostic (2.41e-1)" "unprognostic (9.81e-2)" 0.1 0.0 0.2 1.6 0.3 0.4 0.0 0.1 0.5 0.1 1.7 0.8 1.3 0.0 0.0 0.2 0.1 0.7 0.0 0.1 0.2 0.1 0.1 0.6 0.5 0.4 0.0 0.0 0.3 0.0 0.0 0.7 0.4 0.0 0.7 0.0 0.0 0.1 1.7 0.8 2.6 0.9 0.0 1.5 1.2 0.2 0.1 0.1 0.1 0.1 0.1 1.2 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.8 2.6 0.1 0.8 0.0 0.9 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.1 0.3 0.1 0.0 0.0 0.3 0.0 29.6 0.0 2.4 0.1 0.0 0.1 0.8 0.0 0.8 0.0 0.7 0.0 0.1 0.2 0.0 0.1 3.0 2.6 0.0 0.0 0.5 0.0 3389.4 1.0 2509.9 0.5 1.5 0.8 1.2 2.6 1.4 1.1 0.7 0.3 0.9 115.8 0.5 1.4 3.5 31.1 7.6 0.2 0.3 0.1 0.5 0.1 0.2 0.4 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 CCR1 "CD191, CKR-1, CMKBR1, MIP1aR, SCYAR1" ENSG00000163823 "C-C motif chemokine receptor 1" P32246 3 46201711-46208313 "CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 42.5" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 81.2;Hofbauer cells: 117.4;Kupffer cells: 171.9;Macrophages: 74.2;monocytes: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Karpas-707: 330.3;RPMI-8226: 158.5;U-266/70: 57.7;U-266/84: 183.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 2: Karpas-707 - Immune response" "Cluster 4: Macrophages - Innate immune response" "unprognostic (3.95e-1)" "unprognostic (2.17e-1)" "unprognostic (1.20e-1)" "unprognostic (2.16e-1)" "unprognostic (1.05e-1)" "unprognostic (6.66e-2)" "unprognostic (1.16e-1)" "unprognostic (8.82e-2)" "unprognostic (4.91e-3)" "unprognostic (2.20e-3)" "unprognostic (1.09e-1)" "unprognostic (9.60e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (1.08e-1)" "unprognostic (5.52e-3)" "unprognostic (1.47e-1)" "unprognostic (2.38e-1)" 21.0 4.7 2.1 42.5 2.3 24.8 4.0 2.4 3.1 2.5 2.6 5.6 7.3 2.5 1.6 3.4 2.8 11.7 2.4 1.9 2.6 4.9 17.2 18.7 10.9 5.2 3.2 2.1 3.1 1.9 0.9 26.4 4.5 1.6 7.3 0.3 2.1 2.6 1.3 0.6 6.6 15.5 4.7 30.8 4.9 1.7 4.9 5.7 1.0 3.3 10.2 16.7 0.7 7.4 0.3 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.2 0.0 0.3 0.7 1.5 0.1 0.4 0.0 3.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.5 6.1 0.1 0.0 0.2 0.1 0.0 0.0 0.2 0.0 330.3 0.0 0.2 0.2 13.0 0.0 0.0 0.0 0.1 0.0 158.5 0.0 5.6 0.0 0.0 0.0 0.4 1.3 0.9 0.2 35.5 0.0 0.8 0.0 0.0 0.2 57.7 183.7 0.1 29.1 26.5 0.4 82.5 125.1 25.8 10.5 76.2 50.1 2.9 0.1 8.5 53.9 0.2 0.1 1.4 113.4 84.5 51.3 18.9 0.1 50.6 2.1 2.3 2.4 3.1 1.9 2.6 5.2 3.2 4.5 4.7 4.9 7.4 0.3 3.2 3.0 0.0 2.0 0.9 0.0 0.0 0.6 0.0 0.1 0.5 0.6 0.0 1.3 0.0 0.0 1.3 15.9 0.0 1.9 0.0 0.4 0.1 0.6 1.6 0.0 1.7 0.0 0.0 81.2 2.4 0.0 0.0 3.8 0.0 1.4 1.2 117.4 0.0 0.0 0.0 0.0 171.9 23.5 0.1 0.0 74.2 5.4 9.4 51.5 0.2 7.2 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 3.2 1.5 0.2 0.0 0.4 0.5 0.0 0.2 0.2 1.7 2.9 6.0 0.0 0.0 0.0 CCR2 "CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R" ENSG00000121807 "C-C motif chemokine receptor 2" P41597 3 46353744-46360940 "CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "Host-virus interaction, Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 25.9" "Cell type enhanced" "Detected in some" "dendritic cells: 40.4;Kupffer cells: 43.1;Macrophages: 25.2;monocytes: 34.9;Plasma cells: 26.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "basophil: 560.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Karpas-707: 185.5;THP-1: 89.8;U-266/70: 416.5;U-266/84: 177.7" "Not detected" "Not detected" "Region enhanced" "Detected in single" "spinal cord: 2.4" "CAB003793, HPA063255" Approved Supported "Nucleoli fibrillar center,Plasma membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane" "Nucleoli fibrillar center" "CAB003793: AB_344889, HPA063255: " "unprognostic (1.09e-2)" "unprognostic (6.28e-4)" "unprognostic (3.49e-2)" "unprognostic (6.35e-4)" "unprognostic (1.89e-2)" "unprognostic (4.16e-4)" "unprognostic (8.06e-2)" "prognostic favorable (5.87e-4)" "unprognostic (6.33e-2)" "unprognostic (3.27e-2)" "unprognostic (3.12e-1)" "unprognostic (1.56e-1)" "unprognostic (5.52e-3)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (4.88e-2)" "unprognostic (4.19e-1)" 2.6 1.9 0.1 25.9 0.1 1.9 3.1 0.1 0.2 1.6 0.3 4.6 7.5 1.2 0.9 1.2 1.2 3.4 1.1 0.1 0.1 1.2 2.1 5.8 11.6 0.4 0.2 1.1 0.8 0.3 0.2 0.8 0.2 1.2 5.1 0.0 3.1 1.7 0.5 1.9 5.7 7.1 0.3 20.4 5.2 1.0 0.2 4.3 1.1 0.5 7.2 5.5 1.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.1 0.0 0.0 2.7 0.0 185.5 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 89.8 0.0 0.0 0.0 0.0 0.3 416.5 177.7 0.0 0.1 3.3 0.1 560.9 146.2 2.6 11.9 12.8 89.2 7.9 24.3 20.2 145.2 1.8 0.6 0.7 3.8 14.0 0.4 113.6 11.4 81.6 0.1 0.1 0.1 0.2 0.1 0.1 0.4 0.2 0.2 0.3 0.2 0.3 0.1 0.0 1.3 0.0 5.8 0.3 0.0 0.0 0.6 0.0 0.1 0.1 0.3 1.5 0.0 0.0 0.0 0.1 40.4 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 4.4 0.0 0.0 0.0 0.4 1.1 0.1 0.0 0.0 1.8 0.9 0.8 0.0 0.0 0.0 0.0 43.1 10.5 0.7 0.0 25.2 0.0 0.0 34.9 0.0 1.0 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 8.2 0.1 0.1 0.0 CCR5 "CC-CKR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22" ENSG00000160791 "C-C motif chemokine receptor 5" P51681 3 46370854-46376206 "CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins" "Host-virus interaction" "G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.0" "Cell type enhanced" "Detected in some" "Kupffer cells: 5.5;Langerhans cells: 32.6;Macrophages: 12.8;T-cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 39.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "JURKAT: 1.4;Karpas-707: 6.8;U-266/84: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (4.32e-3)" "unprognostic (1.94e-3)" "unprognostic (1.89e-3)" "prognostic favorable (7.42e-5)" "unprognostic (1.80e-2)" "prognostic favorable (9.33e-5)" "unprognostic (3.38e-3)" "unprognostic (9.90e-3)" "unprognostic (7.65e-2)" "unprognostic (6.22e-2)" "unprognostic (1.36e-1)" "unprognostic (5.34e-2)" "unprognostic (1.14e-3)" "unprognostic (8.34e-2)" "unprognostic (4.69e-2)" "unprognostic (3.14e-2)" "unprognostic (2.42e-2)" 1.8 2.0 0.5 15.0 0.6 1.3 2.4 0.6 0.7 2.1 1.0 3.3 4.1 1.4 1.0 1.4 1.7 5.0 1.1 0.4 0.8 1.0 3.4 7.4 14.4 1.6 0.9 1.7 0.6 0.6 0.4 0.7 1.3 1.9 3.9 0.1 2.9 1.0 0.3 1.1 5.8 3.2 1.2 9.4 6.8 0.8 1.2 4.2 0.8 0.2 9.4 4.8 0.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 6.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 3.1 0.0 0.0 0.1 0.0 12.0 2.2 0.0 11.0 3.8 39.7 0.5 4.7 16.1 9.5 0.0 0.4 4.1 0.5 6.3 0.0 9.0 8.0 3.2 0.5 0.6 0.6 0.7 0.4 0.8 1.6 0.9 1.3 1.2 1.2 2.4 0.3 0.0 1.7 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.3 1.5 0.0 1.3 0.0 1.4 0.3 4.7 0.0 0.0 0.0 0.0 5.5 32.6 0.0 0.0 12.8 3.6 1.9 1.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 13.1 0.1 0.0 0.1 CCRL2 "ACKR5, CKRX, CRAM-A, CRAM-B, HCR" ENSG00000121797 "C-C motif chemokine receptor like 2" O00421 3 46407166-46412997 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 35.0;Erythroid cells: 26.5;Hofbauer cells: 42.7;Kupffer cells: 22.1;Langerhans cells: 36.5;Macrophages: 56.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 21.0;OE19: 8.4;PC-3: 15.3;RT4: 8.3;TIME: 15.4;U-266/84: 8.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043238 Approved NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 36: HEL - Hemostasis" "Cluster 41: Macrophages - Immune response" "HPA043238: AB_10794924" "unprognostic (3.94e-1)" "unprognostic (7.02e-2)" "prognostic favorable (3.72e-5)" "unprognostic (1.64e-1)" "unprognostic (2.67e-1)" "unprognostic (1.12e-1)" "unprognostic (1.46e-1)" "unprognostic (1.62e-1)" "unprognostic (4.10e-2)" "unprognostic (4.17e-2)" "unprognostic (9.73e-2)" "unprognostic (1.98e-2)" "unprognostic (5.17e-2)" "unprognostic (1.78e-1)" "unprognostic (3.04e-2)" "unprognostic (2.57e-1)" "prognostic favorable (9.67e-5)" 11.7 1.6 2.1 11.4 2.1 9.0 8.4 2.2 3.7 2.3 2.2 11.5 11.7 1.2 0.6 0.9 1.1 5.5 2.7 2.1 2.2 2.2 4.4 12.4 4.9 2.8 2.3 0.5 1.5 0.8 0.8 5.1 3.1 0.8 10.4 0.2 0.9 0.8 1.1 0.7 12.1 2.5 2.6 8.5 5.5 0.3 2.9 7.7 1.3 1.1 3.8 6.0 1.1 3.3 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 1.2 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.3 0.7 4.6 0.0 21.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 5.0 0.2 0.0 7.2 4.2 2.8 0.1 5.0 0.0 1.6 2.6 0.0 8.4 15.3 0.4 0.3 0.0 0.0 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.5 15.4 0.6 0.3 0.7 0.3 0.0 8.6 0.2 7.5 6.5 0.0 8.7 15.4 4.3 2.8 22.1 3.4 1.7 1.6 4.7 9.9 3.9 1.0 2.5 2.6 6.7 10.1 3.0 4.7 5.0 2.1 2.1 2.2 3.7 2.1 2.2 2.8 2.3 3.1 2.6 2.9 3.3 35.0 0.0 4.7 0.0 4.4 2.0 0.2 0.2 0.0 0.0 0.4 0.4 1.1 1.5 1.2 0.0 0.0 0.3 4.5 19.5 0.0 0.6 0.1 0.1 0.2 12.1 0.0 26.5 0.0 8.8 1.2 1.4 4.6 0.1 9.5 0.1 6.4 0.4 42.7 0.0 0.0 16.6 0.0 22.1 36.5 0.0 0.0 56.2 1.8 1.9 6.7 0.0 0.0 0.0 0.0 9.8 12.4 0.0 4.2 0.2 17.2 0.2 0.6 0.0 0.0 0.6 0.5 0.0 0.0 0.0 1.1 2.5 6.4 0.4 9.2 1.1 LTF HLF2 ENSG00000012223 Lactotransferrin P02788 3 46435645-46485234 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Immunity, Ion transport, Iron transport, Osteogenesis, Transcription, Transcription regulation, Transport" "Antibiotic, Antimicrobial, DNA-binding, Heparin-binding, Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 4255.5;salivary gland: 1162.5" "Cell type enriched" "Detected in many" 5 "Breast glandular cells: 1519.6" "Group enriched" "Detected in all" 5 "breast cancer: 239.0;endometrial cancer: 170.3;glioma: 152.6;prostate cancer: 195.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 23 "neutrophil: 5.4;non-classical monocyte: 17.0" "Group enriched" "Detected in many" 23 "granulocytes: 5.4;monocytes: 17.0" "Group enriched" "Detected in some" 11 "RPMI-8226: 43.2;TIME: 14.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB008646, CAB016201, HPA057177, HPA059976" Enhanced "Secreted to blood" NA NA 350000000 "Cluster 7: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 30: Mammary glandular cells - Lactation" "CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: AB_2683361, HPA059976: AB_2684185" "unprognostic (7.24e-3)" "unprognostic (2.43e-1)" "unprognostic (5.94e-2)" "unprognostic (3.41e-2)" "unprognostic (7.14e-3)" "unprognostic (3.45e-2)" "unprognostic (6.43e-3)" "unprognostic (2.52e-1)" "unprognostic (1.92e-1)" "unprognostic (4.21e-2)" "unprognostic (3.43e-1)" "unprognostic (1.04e-1)" "prognostic favorable (6.30e-5)" "unprognostic (1.66e-2)" "unprognostic (3.53e-1)" "unprognostic (2.05e-1)" "unprognostic (9.09e-3)" 6.9 1.2 2.5 36.1 3.4 4255.5 333.3 4.6 4.2 658.3 2.2 2.8 1.2 4.1 157.5 23.0 4.3 7.5 5.7 3.7 6.2 105.3 3.3 29.4 8.6 4.8 21.5 0.5 18.6 6.2 7.0 3.1 12.6 154.2 2.2 0.9 1162.5 378.9 1.7 11.8 5.1 1.9 7.1 70.5 331.6 0.4 14.5 29.8 10.1 1.6 345.7 2.4 1.2 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 1.9 0.5 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.7 0.1 0.1 0.0 0.1 0.6 43.2 0.2 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.0 14.3 0.0 0.3 1.2 0.1 0.6 0.0 0.1 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 17.0 0.4 0.0 29.5 2.5 3.4 4.6 4.2 3.7 6.2 4.8 21.5 12.6 7.1 14.5 9.9 15.5 0.0 2.8 0.7 4.3 1.1 8.6 82.8 0.0 0.0 1519.6 198.4 1.0 2.8 298.0 71.7 0.0 0.0 6.2 0.1 0.0 1.4 1.2 0.3 0.2 8.8 0.0 3.0 0.1 0.9 0.2 2.5 56.1 2.3 1.3 0.1 5.0 0.0 0.0 0.0 0.0 0.2 14.2 0.0 0.7 1.5 5.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.1 78.6 0.0 18.6 14.9 0.0 0.0 0.3 9.9 0.2 0.1 15.4 0.1 0.1 4.0 0.1 0.1 101.7 RTP3 "LTM1, TMEM7, Z3CXXC3" ENSG00000163825 "Receptor transporter protein 3" Q9BQQ7 3 46497976-46500950 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 130 "liver: 119.5" "Cell type enriched" "Detected in some" 40 "Hepatocytes: 89.6" "Cancer enriched" "Detected in some" 5 "liver cancer: 22.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SiHa: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075932 Uncertain Mitochondria NA NA "Cluster 62: Liver - Hemostasis" "Cluster 20: HeLa - Mitochondria" "Cluster 2: Hepatocytes - Metabolism" Mitochondria "HPA075932: " "unprognostic (2.09e-1)" "unprognostic (1.64e-1)" "prognostic favorable (3.11e-6)" "unprognostic (1.08e-1)" "unprognostic (1.58e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.6 119.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 89.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.4 1.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 LRRC2 ENSG00000163827 "Leucine rich repeat containing 2" Q9BYS8 3 46515385-46580099 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 45.3;skeletal muscle: 165.0;tongue: 94.1" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 198.4" "Cancer enhanced" "Detected in some" "thyroid cancer: 5.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 7.2;HEL: 4.2;LHCN-M2: 4.1;TIME: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039138, HPA064844" Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "Nuclear bodies, Cytosol" "HPA039138: AB_10795461, HPA064844: " "unprognostic (1.32e-4)" "unprognostic (3.44e-3)" "unprognostic (2.29e-2)" "unprognostic (3.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.44e-1)" "unprognostic (7.38e-3)" "unprognostic (1.61e-1)" "unprognostic (7.42e-2)" "unprognostic (1.45e-1)" "unprognostic (3.72e-3)" "unprognostic (2.17e-1)" "unprognostic (2.23e-2)" "unprognostic (1.09e-1)" "unprognostic (2.53e-1)" "unprognostic (1.96e-2)" "unprognostic (1.24e-1)" 2.4 0.7 1.5 0.7 3.6 0.8 1.9 1.1 2.8 3.5 0.2 1.9 0.7 4.8 2.4 1.4 2.4 3.0 45.3 2.7 0.1 4.5 5.6 1.2 0.5 0.4 0.4 5.2 1.1 0.9 1.2 0.9 0.3 2.1 1.6 0.3 2.2 0.3 165.0 1.9 0.8 4.0 0.2 2.8 1.8 0.8 0.1 3.2 22.1 94.1 0.7 2.3 2.0 1.4 0.1 0.0 0.1 0.1 0.6 1.4 0.1 0.5 1.0 0.3 0.5 0.0 0.1 0.2 0.1 7.2 0.0 0.1 2.5 0.0 0.9 0.3 0.0 4.2 0.3 0.0 0.1 0.1 0.0 0.1 0.0 2.8 0.0 2.3 0.1 0.5 0.0 0.2 4.1 0.0 0.5 0.1 1.0 0.3 0.1 0.1 0.0 0.2 0.0 0.2 0.3 0.8 0.5 0.1 1.0 0.7 0.1 0.5 3.2 0.1 0.3 1.6 1.1 0.2 0.2 1.9 0.1 0.1 0.9 0.6 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.5 0.2 0.1 0.1 0.5 0.1 1.5 3.6 1.1 2.8 2.7 0.1 0.4 0.4 0.3 0.2 0.1 1.4 1.6 9.6 1.1 2.0 0.2 1.9 1.1 0.6 0.6 0.1 0.8 1.3 198.4 7.2 0.0 1.8 0.0 0.1 0.0 0.2 9.8 0.6 2.3 0.3 1.6 4.0 3.0 0.0 12.5 1.0 0.0 11.9 3.1 0.4 10.2 2.5 5.0 10.2 2.0 0.0 11.2 1.8 0.0 0.8 5.7 2.9 0.6 0.6 10.6 3.7 0.0 0.4 0.0 3.5 0.7 1.0 0.4 0.0 3.0 0.6 0.0 0.8 0.7 0.2 0.0 32.7 2.6 0.6 0.7 0.0 2.4 0.1 2.1 7.9 1.9 0.4 TDGF1 "CR, CR-1, CRIPTO, Cripto-1" ENSG00000241186 "Teratocarcinoma-derived growth factor 1" P13385 3 46574534-46582457 "Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 23.4;lymphoid tissue: 20.9" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 121.3" "Cancer enriched" "Detected in many" 4 "testis cancer: 27.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 25.7;NTERA-2: 110.6;SuSa: 66.3" "Group enriched" "Detected in many" 5 "cerebellum: 11.2;pons and medulla: 8.7" "Low region specificity" "Detected in single" HPA051928 Uncertain Vesicles,Cytosol "Secreted in other tissues" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 39: Non-specific - Basic cellular processes" Vesicles Cytosol "HPA051928: " "unprognostic (7.84e-3)" "unprognostic (2.00e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (2.80e-2)" "unprognostic (1.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.93e-1)" "unprognostic (3.61e-1)" "unprognostic (1.72e-2)" "unprognostic (6.77e-2)" "unprognostic (1.74e-1)" "unprognostic (8.76e-3)" "unprognostic (2.01e-1)" "unprognostic (2.10e-2)" "unprognostic (1.75e-2)" "unprognostic (1.05e-1)" 0.4 3.4 2.4 0.5 1.9 0.3 0.3 2.1 4.8 0.7 1.4 2.6 0.7 1.0 2.0 0.1 0.1 0.6 0.6 1.8 1.7 23.4 1.3 0.4 0.4 2.1 1.8 7.7 0.4 0.1 0.1 0.2 2.2 0.4 4.6 0.4 1.0 0.3 1.5 0.3 0.5 1.2 1.7 20.9 2.7 0.5 3.1 15.1 0.8 1.5 0.1 0.2 0.1 1.9 0.1 0.2 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.0 1.8 0.0 0.2 0.0 0.0 25.7 0.2 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.2 110.6 4.0 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 66.3 0.1 0.1 1.8 0.2 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.2 0.7 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.9 0.3 0.1 0.1 0.0 0.0 2.4 1.9 2.1 4.8 1.8 1.7 2.1 1.8 2.2 1.7 3.1 1.9 0.9 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.5 0.0 0.0 0.0 0.9 121.3 0.2 5.0 0.3 0.1 8.2 2.4 0.0 0.0 0.0 0.0 0.3 8.2 0.2 0.0 14.3 0.4 1.4 0.1 0.0 0.0 5.5 0.0 0.0 0.0 1.0 0.3 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.3 0.6 0.0 0.2 0.0 0.1 0.3 0.1 0.3 0.0 0.0 0.0 0.1 17.7 6.1 0.0 FAM240A ENSG00000283473 "Family with sequence similarity 240 member A" A0A1B0GVK7 3 46612435-46626543 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.7" "Cell type enhanced" "Detected in single" "Breast glandular cells: 2.2" "Region enhanced" "Detected in single" "cerebral cortex: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 30: Mammary glandular cells - Lactation" 0.1 0.0 0.0 0.0 0.3 0.0 0.4 0.3 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALS2CL "DKFZp686I0110, FLJ36525, RN49018" ENSG00000178038 "ALS2 C-terminal like" Q60I27 3 46668995-46693704 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.5;kidney: 30.7;skin 1: 32.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 73.7;Gastric mucus-secreting cells: 41.3;Respiratory ciliated cells: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 31.6;HaCaT: 17.1;HBEC3-KT: 33.1;hTCEpi: 20.9;RT4: 15.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB046465, HPA048301" Uncertain NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "CAB046465: AB_10638285, HPA048301: AB_2680346" "unprognostic (6.38e-2)" "unprognostic (5.98e-2)" "unprognostic (2.38e-3)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.86e-2)" "unprognostic (1.04e-2)" "unprognostic (1.92e-1)" "unprognostic (8.60e-2)" "unprognostic (4.28e-2)" "unprognostic (1.42e-2)" "unprognostic (4.50e-2)" "unprognostic (1.04e-1)" "unprognostic (1.98e-3)" "unprognostic (4.45e-2)" "unprognostic (5.20e-2)" "unprognostic (6.79e-2)" "unprognostic (4.14e-3)" 4.7 2.2 0.8 1.6 0.9 0.8 5.1 1.8 2.0 10.1 0.5 5.6 3.5 2.2 0.1 37.5 4.4 2.7 10.1 0.6 0.8 30.7 7.2 10.8 1.7 1.5 0.6 1.8 5.8 0.5 4.3 1.3 1.4 4.5 1.0 0.0 11.0 2.2 5.3 32.3 4.7 0.8 0.5 6.5 3.5 0.8 0.6 1.1 15.6 1.9 1.4 4.8 19.5 0.6 9.8 2.2 0.0 0.0 0.0 0.0 0.1 0.7 1.1 0.0 0.3 0.1 31.6 0.0 8.9 0.8 0.5 17.1 0.0 33.1 0.1 0.1 0.0 0.8 3.7 0.0 0.3 0.0 0.0 0.0 20.9 0.0 3.2 0.2 0.9 2.0 0.0 0.2 0.0 0.9 0.0 0.1 0.3 4.7 1.9 0.1 0.0 12.0 7.7 15.8 0.3 0.2 12.6 9.7 0.0 0.5 2.2 0.2 6.6 0.1 1.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.8 0.9 1.8 2.0 0.6 0.8 1.5 0.6 1.4 0.5 0.6 0.6 17.5 73.7 15.3 2.3 0.5 15.2 8.4 21.8 12.0 0.3 4.7 5.5 10.2 18.6 29.9 11.0 0.0 1.5 0.1 29.0 0.0 10.1 0.6 5.1 1.8 13.1 0.0 0.0 8.0 13.5 7.3 4.5 41.3 5.5 1.3 0.1 7.1 7.6 2.7 0.0 2.9 6.4 24.4 0.3 4.1 0.2 0.3 1.4 1.8 10.3 0.8 0.1 0.0 0.0 0.3 26.3 12.0 0.0 0.1 17.7 5.9 0.4 46.9 0.1 19.7 5.6 8.5 1.3 2.7 22.3 16.3 2.1 1.3 0.3 11.8 27.7 TMIE DFNB6 ENSG00000181585 "Transmembrane inner ear" Q8NEW7 3 46694528-46710886 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.6;choroid plexus: 10.5;pituitary gland: 9.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.8;Spermatocytes: 2.6;Spermatogonia: 3.2" "Cancer enriched" "Detected in many" 5 "glioma: 6.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 2.4" "Lineage enriched" "Detected in single" 15 "T-cells: 2.4" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.1;EFO-21: 2.7;JURKAT: 10.7;SH-SY5Y: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038298 Uncertain Uncertain Vesicles,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 56: Bipolar cells - Visual perception" "Vesicles, Cytosol" "HPA038298: AB_10675792" "unprognostic (6.59e-2)" "unprognostic (1.11e-1)" "unprognostic (7.25e-3)" "unprognostic (2.48e-3)" "unprognostic (1.88e-2)" "unprognostic (5.40e-3)" "unprognostic (3.94e-2)" "unprognostic (8.80e-2)" "unprognostic (3.37e-2)" "unprognostic (6.65e-2)" "unprognostic (1.97e-1)" "unprognostic (5.35e-2)" "unprognostic (4.58e-2)" "unprognostic (1.23e-1)" "unprognostic (4.41e-2)" "unprognostic (5.29e-2)" "unprognostic (6.78e-2)" 0.7 6.2 14.2 0.5 14.1 0.0 0.4 14.0 18.0 0.7 10.5 1.0 0.4 0.5 0.7 1.5 0.6 0.2 0.7 14.1 19.3 2.3 0.8 1.0 0.8 19.6 15.7 1.5 0.2 0.1 9.9 0.4 19.2 0.5 0.3 0.7 0.5 1.0 3.6 0.7 0.5 0.4 16.0 0.7 0.3 1.5 18.7 0.5 0.9 1.2 0.8 0.6 0.9 14.9 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 3.1 0.0 2.7 0.0 0.5 0.1 0.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.5 10.7 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.7 0.1 1.2 0.0 0.3 0.1 0.1 0.3 2.3 0.3 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.1 0.0 2.4 0.4 0.0 0.0 0.0 0.0 0.4 0.4 14.2 14.1 14.0 18.0 14.1 19.3 19.6 15.7 19.2 16.0 18.7 14.9 1.9 0.0 0.0 0.3 0.0 0.8 0.2 0.5 0.0 3.8 0.2 0.6 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.1 1.9 0.4 0.5 0.2 0.0 0.7 0.0 0.0 1.7 0.4 0.1 0.4 0.0 0.1 0.0 0.1 0.4 0.1 0.6 0.0 0.8 0.0 0.0 0.0 0.4 1.5 0.6 0.3 0.0 1.9 0.1 1.4 0.0 0.0 0.3 1.2 0.0 0.4 0.0 0.3 0.0 0.0 0.6 0.5 0.0 1.1 1.0 2.6 3.2 0.0 0.9 0.1 0.2 0.1 0.0 0.2 AC109583.1 ENSG00000206549 "Novel protein identical to PRSS50" 3 46712115-46812574 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 4.8;thyroid gland: 6.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "ovarian cancer: 3.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA040768 Supported NA NA "Cluster 51: Non-specific - Unknown function" "HPA040768: AB_2677126" "unprognostic (1.19e-2)" "unprognostic (1.63e-1)" "unprognostic (1.63e-2)" "unprognostic (7.59e-3)" "unprognostic (4.32e-1)" "unprognostic (7.45e-2)" "unprognostic (9.24e-2)" "unprognostic (1.37e-1)" "unprognostic (6.77e-2)" "unprognostic (2.23e-1)" "unprognostic (8.91e-4)" "unprognostic (1.08e-1)" "unprognostic (1.46e-3)" "unprognostic (2.68e-2)" "unprognostic (1.79e-2)" "unprognostic (9.36e-2)" "unprognostic (3.66e-3)" 0.2 0.3 0.1 0.0 0.1 0.0 0.7 0.7 0.2 1.7 0.5 0.5 0.1 0.7 3.0 0.1 1.0 0.0 1.5 0.0 0.4 1.6 0.8 0.3 0.0 0.3 0.3 0.7 1.5 1.8 4.6 0.0 0.3 1.5 0.0 0.1 0.8 0.7 4.8 0.2 0.2 0.1 0.2 0.1 0.3 1.8 0.3 0.0 6.0 0.2 0.0 0.6 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.2 0.0 0.4 0.3 0.3 0.3 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS50 "CT20, TSP50" ENSG00000283706 "Serine protease 50" Q9UI38 3 46712117-46717869 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "pituitary gland: 17.2;testis: 52.0;thyroid gland: 16.5" "Group enriched" "Detected in some" 8 "Spermatocytes: 359.2;Spermatogonia: 303.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.4" HPA040768 Supported "Intracellular and membrane" NA NA "Cluster 43: Testis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA040768: AB_2677126" 0.5 1.2 0.9 0.0 0.9 0.1 1.9 2.3 1.5 4.5 0.7 1.6 0.0 1.5 2.9 0.4 2.3 0.1 4.1 1.1 1.2 5.4 2.7 0.7 0.0 1.2 0.9 2.2 4.6 1.4 17.2 0.1 1.0 4.5 0.0 0.2 1.9 2.1 1.2 0.4 0.5 0.2 1.2 0.3 1.0 52.0 1.1 0.2 16.5 0.0 0.0 1.7 2.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 2.3 1.5 1.1 1.2 1.2 0.9 1.0 1.2 1.1 0.9 0.0 0.0 0.0 1.6 0.0 0.1 0.5 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 3.1 0.2 0.0 1.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.1 0.1 39.5 0.2 0.0 359.2 303.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 PRSS45P "PRSS45, TESPL, TESSP5" ENSG00000188086 "Serine protease 45, pseudogene" Q7RTY3 3 46742092-46750891 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 6.4;skeletal muscle: 10.4" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA060284 Uncertain NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "HPA060284: AB_2684242" "unprognostic (4.55e-3)" "unprognostic (3.49e-2)" "unprognostic (1.07e-2)" "unprognostic (2.50e-1)" "unprognostic (6.07e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (6.20e-2)" "unprognostic (1.54e-1)" "unprognostic (1.30e-1)" "unprognostic (3.83e-4)" "unprognostic (2.33e-2)" "unprognostic (6.60e-3)" "unprognostic (1.27e-2)" "unprognostic (1.57e-2)" "unprognostic (2.15e-1)" "unprognostic (5.97e-3)" 0.3 0.2 0.3 0.0 0.3 0.0 1.1 0.5 0.4 1.6 1.0 0.5 0.1 0.3 6.4 0.2 0.9 0.0 3.5 0.2 0.7 1.7 1.3 0.6 0.1 0.6 0.7 0.4 2.1 2.8 1.9 0.1 0.7 1.4 0.0 0.2 0.9 1.0 10.4 0.3 0.3 0.1 0.5 0.3 0.3 2.2 0.6 0.2 4.9 0.9 0.0 0.7 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.4 0.2 0.7 0.6 0.7 0.7 0.5 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MYL3 "CMH8, MLC1SB, MLC1V, VLC1" ENSG00000160808 "Myosin light chain 3" P08590 3 46835111-46882172 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 9155.0;skeletal muscle: 5135.3;tongue: 2074.2" "Cell type enriched" "Detected in some" 53 "Cardiomyocytes: 3626.2" "Group enriched" "Detected in many" 4 "head and neck cancer: 3.0;prostate cancer: 3.4;renal cancer: 8.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 8.6;HSkMC: 8.7;RPTEC TERT1: 34.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA016564, CAB018662, HPA046859, HPA063034" Enhanced Approved Nucleoli,Mitochondria NA NA 7300000 "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoli, Mitochondria" "CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927" "unprognostic (3.11e-1)" "unprognostic (2.64e-2)" "unprognostic (5.55e-2)" "unprognostic (1.51e-1)" "unprognostic (1.77e-1)" "unprognostic (4.44e-2)" "unprognostic (9.67e-3)" "unprognostic (3.37e-2)" "unprognostic (4.72e-3)" "unprognostic (3.63e-2)" "unprognostic (1.08e-1)" "unprognostic (7.88e-2)" "prognostic favorable (1.22e-8)" "unprognostic (1.16e-3)" "unprognostic (9.45e-3)" "unprognostic (7.18e-5)" "unprognostic (2.53e-3)" 5.8 4.1 11.3 0.9 11.1 1.5 8.9 11.4 14.8 6.7 8.4 2.5 1.6 3.3 3.4 157.0 4.2 3.6 9155.0 11.0 12.8 50.3 4.1 5.7 3.3 15.2 13.0 5.2 2.7 1.3 1.7 4.7 12.1 25.1 0.8 1.9 19.6 1.5 5135.3 4.0 2.3 2.0 13.2 7.9 2.1 2.3 12.6 0.7 2.4 2074.2 0.5 2.4 4.7 13.2 0.5 0.7 0.4 0.3 4.4 1.5 3.6 0.7 0.4 0.4 0.6 8.6 0.8 1.6 1.4 0.1 0.2 0.5 0.4 0.1 0.7 0.3 0.1 0.8 2.6 0.3 0.7 0.9 0.8 8.7 0.2 0.3 0.1 0.2 0.1 0.5 0.4 1.2 0.2 1.2 0.3 0.5 1.0 0.4 0.4 0.9 0.3 0.1 34.2 1.3 0.6 0.4 0.3 0.7 0.1 0.7 0.3 0.5 0.2 1.0 0.8 0.6 0.3 0.5 0.4 0.7 0.3 0.8 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.1 0.1 0.3 0.0 0.1 0.4 0.0 0.0 11.3 11.1 11.4 14.8 11.0 12.8 15.2 13.0 12.1 13.2 12.6 13.2 0.7 0.0 0.0 1.0 0.0 0.8 0.2 0.0 0.0 0.2 2.3 0.1 3626.2 0.0 0.0 1.8 0.0 0.4 0.0 0.0 54.8 0.0 2.4 0.1 2.2 32.8 0.0 0.0 0.1 0.0 16.4 23.7 0.0 0.0 0.0 0.0 1.1 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.6 12.8 1.2 0.7 0.0 0.0 0.0 2.8 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 68.1 0.0 0.4 6.6 27.9 20.4 0.2 0.5 0.0 0.4 0.8 0.4 0.1 0.0 0.0 PTH1R "PTHR, PTHR1" ENSG00000160801 "Parathyroid hormone 1 receptor" Q03431 3 46877721-46903799 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "kidney: 586.8" "Cell type enhanced" "Detected in many" "Distal tubular cells: 95.9;Extravillous trophoblasts: 60.8;Proximal tubular cells: 324.8;Sertoli cells: 138.1" "Group enriched" "Detected in many" 4 "renal cancer: 18.8;testis cancer: 5.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "RPTEC TERT1: 116.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075879 Enhanced NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA075879: " "unprognostic (1.26e-1)" "unprognostic (7.09e-2)" "unprognostic (2.24e-5)" "unprognostic (7.46e-2)" "unprognostic (3.46e-1)" "unprognostic (5.02e-2)" "unprognostic (3.84e-3)" "unprognostic (5.47e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (7.51e-2)" "unprognostic (8.44e-2)" "prognostic favorable (6.79e-6)" "unprognostic (4.22e-3)" "unprognostic (1.50e-1)" "unprognostic (1.35e-4)" "unprognostic (6.62e-3)" 32.5 72.2 45.0 1.1 43.8 0.0 20.2 45.7 60.8 43.8 38.0 10.3 1.2 19.1 2.7 3.7 20.3 3.5 33.0 42.6 43.5 586.8 84.6 25.6 2.4 46.5 44.9 22.2 7.6 1.2 5.9 16.0 46.7 12.4 0.6 0.7 2.7 3.5 7.7 9.8 9.6 2.6 44.5 54.4 7.6 10.3 46.2 0.4 6.5 2.2 0.4 12.3 20.3 43.3 0.0 0.2 0.2 0.2 15.9 1.9 0.2 0.4 0.2 0.3 0.2 0.4 0.0 0.0 1.6 0.1 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 15.5 0.0 0.1 0.0 0.2 0.1 0.0 0.0 2.6 0.1 0.1 0.0 0.3 2.1 0.0 0.1 0.1 5.3 0.0 116.9 0.0 0.2 0.7 0.0 0.1 0.0 5.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.0 43.8 45.7 60.8 42.6 43.5 46.5 44.9 46.7 44.5 46.2 43.3 4.6 0.0 0.0 17.3 2.5 1.3 0.1 0.0 0.6 1.5 2.9 0.4 5.0 2.8 0.0 33.1 0.0 0.6 0.1 0.0 95.9 0.0 11.6 0.6 20.5 4.1 0.0 8.0 1.6 0.5 60.8 9.6 0.0 0.6 0.0 0.1 17.2 0.7 2.0 1.7 2.8 0.0 0.0 1.3 2.8 32.5 5.9 2.1 0.0 1.9 0.0 3.2 0.0 1.0 0.3 0.3 0.0 2.2 0.0 0.0 0.0 324.8 0.0 1.7 138.1 6.5 21.7 0.9 2.7 0.0 0.9 0.8 2.0 0.3 0.0 0.1 CCDC12 MGC23918 ENSG00000160799 "Coiled-coil domain containing 12" Q8WUD4 3 46921726-46982010 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056814, HPA060530" Approved Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 16: U-266 - Nucleosome" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA056814: AB_2683241, HPA060530: AB_2684309" "unprognostic (1.47e-2)" "unprognostic (1.79e-3)" "unprognostic (2.27e-1)" "unprognostic (1.32e-3)" "unprognostic (1.65e-1)" "unprognostic (4.24e-2)" "unprognostic (6.15e-2)" "unprognostic (4.27e-3)" "unprognostic (1.88e-1)" "unprognostic (4.35e-2)" "unprognostic (1.50e-2)" "unprognostic (4.08e-2)" "prognostic favorable (1.15e-4)" "unprognostic (2.06e-1)" "unprognostic (2.11e-1)" "unprognostic (8.86e-3)" "unprognostic (4.65e-2)" 39.1 55.5 40.1 38.3 40.7 57.9 40.2 41.8 45.3 48.4 39.2 44.4 39.7 45.2 22.1 75.2 33.4 22.1 53.5 39.8 40.4 53.3 46.1 39.4 51.0 40.9 40.0 40.4 40.9 33.7 35.2 26.7 40.7 38.4 21.3 19.1 42.3 22.9 80.6 72.5 42.8 21.1 40.7 48.9 46.9 30.1 40.9 41.4 43.2 30.1 33.4 39.2 55.6 41.4 63.7 52.5 60.4 31.7 33.4 27.1 46.5 63.1 32.1 46.6 34.0 68.5 53.5 123.9 56.1 38.2 66.3 35.1 51.6 58.6 19.6 122.3 39.3 136.0 77.8 104.6 45.5 147.1 93.1 37.2 54.6 59.2 52.2 36.9 45.7 78.0 148.3 59.6 23.1 77.0 114.6 139.0 78.7 62.5 42.9 48.0 46.9 79.6 49.2 65.5 32.0 62.1 77.0 62.8 62.7 26.7 47.8 143.9 94.6 31.1 61.4 63.5 101.4 77.5 185.8 155.1 43.5 102.2 45.6 50.0 132.0 122.0 139.3 142.8 109.8 209.7 106.6 122.8 126.9 222.4 90.8 107.3 40.4 123.7 155.8 202.1 148.8 118.9 40.1 40.7 41.8 45.3 39.8 40.4 40.9 40.0 40.7 40.7 40.9 41.4 58.0 80.1 54.7 15.0 119.1 79.2 146.0 146.6 73.4 53.4 55.9 47.1 53.3 82.9 97.4 80.9 54.2 137.0 132.2 137.2 111.6 103.7 4.3 64.4 54.8 66.1 79.1 38.7 15.9 124.8 112.5 53.5 85.6 89.4 82.4 52.4 55.6 54.1 100.0 58.9 14.6 104.4 87.5 70.8 75.6 9.8 58.4 58.6 46.2 16.9 112.7 68.8 213.1 15.1 21.0 103.5 132.4 48.2 73.9 124.1 147.7 90.5 71.1 90.7 39.5 82.8 55.6 21.7 57.5 97.1 108.8 166.9 98.6 82.0 112.6 209.0 NBEAL2 KIAA0540 ENSG00000160796 "Neurobeachin like 2" Q6ZNJ1 3 46979666-47009704 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.2" "Cell type enriched" "Detected in many" 4 "Gastric mucus-secreting cells: 144.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "HEL: 69.1;SK-BR-3: 64.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051969 Approved NA NA 31000 "Cluster 1: Neutrophils - Mixed function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA051969: " "unprognostic (3.83e-2)" "unprognostic (1.82e-1)" "unprognostic (1.68e-1)" "unprognostic (3.37e-2)" "unprognostic (5.99e-3)" "prognostic favorable (4.60e-4)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" "unprognostic (4.17e-1)" "unprognostic (6.27e-2)" "unprognostic (5.29e-2)" "unprognostic (1.06e-3)" "unprognostic (3.75e-1)" "unprognostic (6.63e-3)" "unprognostic (1.04e-1)" "unprognostic (2.80e-1)" "unprognostic (1.34e-2)" 16.7 16.0 4.0 23.3 3.6 92.1 19.3 3.3 5.7 34.3 4.4 21.5 12.8 10.5 4.6 103.2 14.7 11.0 15.2 3.3 3.4 36.9 11.2 54.0 20.9 4.2 3.8 7.9 40.7 6.7 11.3 4.8 4.5 21.5 8.4 0.8 35.6 8.4 6.5 86.0 31.0 5.6 3.8 70.0 42.5 6.3 4.6 11.2 14.7 2.9 15.8 16.6 56.8 3.7 20.2 22.1 4.0 11.3 2.3 0.8 12.9 2.8 1.7 3.8 2.5 19.4 14.2 17.4 7.7 2.4 3.7 13.0 8.3 9.0 1.9 15.4 12.4 69.1 27.8 12.2 2.2 11.9 48.5 1.9 14.8 3.9 6.0 4.6 34.2 36.2 14.6 26.3 1.9 31.2 20.5 32.7 10.6 31.9 10.0 21.6 0.5 23.0 9.1 41.1 6.1 9.9 2.4 64.4 5.7 4.9 31.5 19.9 25.3 0.3 11.7 5.1 8.9 20.1 20.7 16.3 5.1 55.0 2.9 0.2 0.6 0.4 0.5 0.6 0.1 0.0 0.2 0.5 0.1 0.0 0.1 0.1 4.4 0.4 0.4 0.1 0.2 0.3 4.0 3.6 3.3 5.7 3.3 3.4 4.2 3.8 4.5 3.8 4.6 3.7 15.0 12.8 9.4 7.8 10.0 3.3 5.5 2.4 5.7 1.3 16.3 18.2 4.3 8.6 9.3 33.1 18.8 2.2 30.8 15.1 1.9 22.9 1.4 20.0 4.1 9.8 7.2 10.3 4.0 23.1 1.1 3.0 144.3 23.9 6.3 5.1 11.7 1.2 11.1 0.0 1.5 11.5 4.1 12.9 8.3 1.0 1.2 27.9 0.0 6.5 14.6 1.5 26.8 1.0 1.4 31.4 5.6 0.0 14.2 6.2 3.4 1.3 6.6 1.9 13.1 3.4 3.5 0.5 2.4 33.6 8.0 1.9 26.3 4.5 15.1 21.0 SETD2 "FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A" ENSG00000181555 "SET domain containing 2, histone lysine methyltransferase" Q9BYW2 3 47016429-47164113 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase" "Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042451 Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Cytosol "HPA042451: AB_10806239" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (6.08e-2)" "unprognostic (1.01e-1)" "unprognostic (3.37e-2)" "unprognostic (1.37e-2)" "unprognostic (1.40e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (8.19e-4)" "unprognostic (6.19e-2)" "unprognostic (2.45e-1)" "unprognostic (7.84e-2)" "prognostic favorable (7.99e-6)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (8.79e-2)" "unprognostic (5.43e-2)" 9.9 6.5 8.2 10.7 10.5 23.8 10.3 24.1 8.3 12.6 10.8 9.7 9.1 13.3 6.1 9.8 11.0 8.5 7.2 6.2 6.7 10.8 10.0 9.4 13.5 8.3 8.5 15.3 13.3 16.2 2.2 11.4 8.4 10.2 11.0 10.6 9.6 9.7 11.1 9.0 10.3 11.9 8.1 11.4 10.7 13.1 7.9 19.2 15.5 14.5 13.3 9.8 4.0 12.8 21.1 13.2 25.4 14.5 15.3 18.9 11.3 17.9 17.0 20.8 19.9 15.4 13.8 43.5 11.6 25.5 20.0 12.4 29.5 17.6 27.6 27.5 12.2 47.3 24.8 12.4 11.7 34.1 26.5 15.2 17.3 20.7 24.6 15.3 20.1 22.8 29.9 16.6 17.8 9.5 26.7 8.5 20.6 9.4 15.4 17.5 25.6 23.2 12.4 26.6 10.9 17.6 29.5 11.8 12.0 17.2 12.9 27.5 26.7 24.6 18.1 21.5 29.9 22.0 25.4 43.7 14.2 19.6 14.6 1.3 1.2 2.9 2.0 1.1 1.1 2.2 1.2 1.6 1.4 2.5 1.7 1.6 3.3 3.6 1.1 1.5 0.6 0.6 8.2 10.5 24.1 8.3 6.2 6.7 8.3 8.5 8.4 8.1 7.9 12.8 50.5 48.1 58.8 115.9 58.3 33.3 22.6 15.6 54.1 40.5 31.0 29.1 67.2 27.1 53.2 11.0 41.7 20.3 58.2 32.6 11.7 20.9 26.1 62.8 63.0 41.2 22.1 38.9 131.4 22.4 12.7 39.2 56.6 66.2 58.8 68.9 23.6 29.8 16.8 26.9 129.4 28.2 14.2 28.8 26.5 35.1 30.4 42.7 17.8 148.9 37.9 22.7 43.3 113.1 143.2 23.7 22.3 33.1 54.0 31.2 24.6 11.5 49.7 39.9 13.1 56.1 42.6 71.0 29.3 60.2 35.7 18.5 65.3 57.1 29.5 34.7 KIF9 MGC104186 ENSG00000088727 "Kinesin family member 9" Q9HAQ2 3 47228395-47283451 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 64.4" "Cell type enhanced" "Detected in all" "Early spermatids: 690.3;Endometrial ciliated cells: 398.0;Respiratory ciliated cells: 359.0;Spermatocytes: 328.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022031, HPA022033, HPA030429" Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" "HPA022031: AB_1852502, HPA022033: AB_1852504, HPA030429: AB_10601921" "unprognostic (1.93e-2)" "unprognostic (6.37e-2)" "prognostic favorable (2.26e-4)" "unprognostic (1.17e-3)" "unprognostic (8.86e-2)" "unprognostic (1.13e-1)" "unprognostic (2.80e-3)" "unprognostic (1.70e-1)" "unprognostic (2.94e-2)" "unprognostic (4.59e-2)" "unprognostic (7.47e-2)" "unprognostic (1.14e-1)" "prognostic favorable (5.95e-6)" "unprognostic (4.21e-2)" "unprognostic (2.03e-1)" "unprognostic (9.17e-2)" "unprognostic (1.23e-1)" 6.5 7.4 9.3 3.1 10.1 11.8 10.6 8.8 14.4 7.6 23.1 9.1 6.1 7.9 20.5 5.8 26.3 6.4 14.1 10.1 9.8 26.8 6.0 8.6 2.6 12.0 12.9 5.0 12.7 10.1 16.4 3.7 11.4 7.7 8.1 18.7 8.9 4.8 9.4 8.4 5.6 4.5 11.0 5.7 9.3 64.4 10.0 2.3 21.0 5.7 3.1 6.8 5.4 9.5 19.4 21.7 7.6 19.1 3.6 8.7 6.2 5.9 6.1 8.8 7.8 8.4 23.0 12.8 7.3 7.6 11.8 12.0 22.6 15.3 8.7 6.6 14.6 11.9 16.5 26.9 3.4 25.3 3.8 4.5 15.3 12.8 9.6 7.4 19.0 13.5 26.5 5.1 6.6 15.5 13.7 37.6 21.7 44.4 30.5 8.6 5.3 18.3 36.7 10.9 10.8 19.9 6.8 13.0 21.8 3.9 8.4 17.6 9.0 5.1 11.0 8.3 13.6 4.4 19.7 16.1 18.9 25.1 11.3 2.5 3.6 2.1 1.5 2.6 3.0 3.5 1.4 2.3 5.7 0.6 1.7 1.9 6.3 3.5 2.3 3.3 1.0 1.3 9.3 10.1 8.8 14.4 10.1 9.8 12.0 12.9 11.4 11.0 10.0 9.5 34.5 19.2 18.4 4.2 6.7 20.1 53.7 44.3 20.5 7.2 61.4 74.5 28.2 38.6 51.9 64.4 35.5 10.7 7.5 23.8 109.5 45.5 690.3 398.0 17.8 29.3 58.9 20.0 16.6 32.7 11.1 12.1 34.1 38.5 29.1 11.3 17.9 20.7 9.2 5.0 10.3 40.1 52.9 7.2 7.1 160.6 14.0 8.0 16.0 2.8 3.8 17.2 3.1 2.5 3.2 26.0 15.7 13.2 5.7 37.6 15.1 198.1 359.0 44.0 13.1 42.2 16.7 328.8 37.3 17.2 20.2 8.2 7.8 21.8 37.8 37.4 KLHL18 "FLJ13703, KIAA0795" ENSG00000114648 "Kelch like family member 18" O94889 3 47282917-47346816 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035027, HPA035028" Approved Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "Nuclear bodies" "HPA035027: AB_10602340, HPA035028: AB_10669899" "unprognostic (1.96e-1)" "unprognostic (1.61e-1)" "unprognostic (1.20e-1)" "unprognostic (3.82e-2)" "unprognostic (2.26e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.22e-1)" "unprognostic (9.01e-2)" "unprognostic (3.05e-1)" "unprognostic (9.60e-2)" "unprognostic (3.23e-3)" "unprognostic (2.88e-3)" "unprognostic (3.13e-2)" "unprognostic (2.61e-1)" "unprognostic (1.07e-1)" "unprognostic (4.67e-1)" 5.9 6.2 6.5 6.2 6.9 15.9 4.6 5.9 7.7 5.7 3.9 5.8 4.4 5.3 5.1 8.7 4.6 5.4 6.2 6.8 6.3 6.1 3.7 6.2 6.9 4.9 6.0 3.9 5.5 7.2 6.0 5.5 5.1 5.1 4.6 20.2 4.4 6.2 6.7 13.8 5.6 6.6 5.5 8.8 4.9 6.3 6.7 5.1 7.0 5.6 7.5 6.7 6.7 6.3 11.6 14.6 11.1 16.5 12.0 8.6 7.9 15.6 8.1 15.5 12.6 15.6 7.0 22.6 8.6 13.1 14.2 7.0 33.7 16.5 15.9 18.0 11.3 33.3 20.9 14.3 12.3 17.9 14.7 10.0 12.5 22.4 20.8 8.7 17.5 12.1 41.0 9.2 12.6 9.6 13.7 10.3 20.4 9.4 29.2 9.4 7.3 13.2 14.6 21.6 7.6 10.1 10.9 13.2 7.9 11.3 7.8 9.7 18.4 14.3 14.8 16.6 19.9 10.3 21.9 19.5 9.2 20.5 15.4 6.1 12.1 3.7 2.0 10.7 2.9 3.8 1.6 3.9 7.8 2.4 1.3 2.0 4.9 1.3 18.6 2.0 1.7 5.7 6.5 6.9 5.9 7.7 6.8 6.3 4.9 6.0 5.1 5.5 6.7 6.3 19.6 12.8 13.7 13.1 24.4 11.3 10.6 8.1 12.0 65.2 17.4 13.0 62.1 4.3 7.5 3.7 20.9 10.6 26.1 15.2 21.5 15.5 3.0 15.5 24.8 16.1 9.5 21.7 24.2 14.8 11.9 9.3 12.2 27.5 36.1 11.0 14.3 19.7 29.6 13.5 23.0 11.1 4.1 28.8 14.9 3.5 5.9 26.7 0.0 18.7 22.4 13.9 8.2 15.1 17.4 17.7 10.6 8.2 12.0 9.3 9.8 28.2 6.3 54.2 6.6 19.5 13.5 13.9 14.8 14.8 21.0 14.1 20.8 15.4 10.3 13.0 PTPN23 "DKFZP564F0923, HD-PTP, KIAA1471" ENSG00000076201 "Protein tyrosine phosphatase non-receptor type 23" Q9H3S7 3 47381011-47413435 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Hydrolase, Protein phosphatase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016845 Approved Supported "Nucleoplasm,Nuclear bodies,Vesicles" Yes No "Cluster 10: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nuclear bodies" Vesicles "HPA016845: AB_1855926" "unprognostic (1.17e-3)" "unprognostic (8.68e-2)" "unprognostic (2.56e-1)" "unprognostic (1.26e-1)" "unprognostic (1.63e-1)" "unprognostic (6.24e-2)" "unprognostic (1.07e-3)" "unprognostic (2.07e-2)" "unprognostic (9.55e-2)" "unprognostic (7.12e-2)" "unprognostic (5.67e-2)" "unprognostic (4.34e-2)" "prognostic favorable (1.82e-4)" "unprognostic (3.05e-2)" "unprognostic (4.40e-1)" "unprognostic (9.53e-2)" "unprognostic (4.68e-2)" 18.5 19.1 6.2 12.6 9.2 14.7 17.4 5.8 10.5 23.3 5.1 16.3 14.3 20.9 7.5 19.0 19.2 8.4 13.2 7.1 7.2 17.5 14.0 18.7 9.1 8.8 7.2 23.5 20.2 23.5 30.9 11.6 8.5 18.7 6.5 8.5 20.0 11.4 30.0 26.4 18.4 8.8 5.5 20.0 16.1 15.6 7.7 8.0 27.1 8.9 7.3 18.5 20.4 14.4 21.5 29.9 16.4 21.4 21.0 16.0 15.8 19.2 18.9 17.5 14.8 25.0 20.7 15.1 17.2 21.9 31.2 19.0 14.3 20.8 8.5 14.3 15.1 21.0 22.2 24.0 23.0 12.3 27.5 21.4 20.9 22.9 23.2 12.4 21.7 12.5 15.9 20.3 19.0 30.2 11.5 10.4 17.5 14.9 20.1 7.2 7.9 18.5 13.2 40.9 8.6 20.6 17.1 35.6 13.6 9.8 20.3 12.0 22.4 26.7 22.2 37.7 27.5 28.8 20.4 8.7 29.0 11.6 19.5 0.8 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.3 0.3 6.2 9.2 5.8 10.5 7.1 7.2 8.8 7.2 8.5 5.5 7.7 14.4 11.1 9.6 7.0 17.0 8.2 8.0 5.2 6.9 13.6 11.7 9.5 8.0 8.7 8.6 9.5 5.5 14.6 10.6 11.0 15.7 1.9 10.5 2.1 10.3 13.7 12.4 7.3 2.5 9.8 8.9 7.9 9.1 26.5 21.1 2.5 14.9 11.4 12.7 13.9 16.8 12.0 16.3 20.3 10.4 5.5 3.1 19.3 9.5 12.4 7.5 8.7 8.8 6.2 9.5 14.3 13.5 10.4 13.5 15.4 9.3 14.6 9.4 12.6 14.2 6.6 10.2 8.8 13.6 13.3 13.2 10.9 9.3 8.9 9.4 12.8 8.2 SCAP KIAA0199 ENSG00000114650 "SREBF chaperone" Q12770 3 47413681-47477126 "Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 135.2" "Cell type enhanced" "Detected in many" "Theca cells: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004713 Approved NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" "HPA004713: AB_1079868" "unprognostic (4.02e-2)" "unprognostic (2.56e-1)" "unprognostic (1.91e-1)" "unprognostic (4.74e-2)" "unprognostic (1.51e-1)" "unprognostic (1.26e-1)" "unprognostic (8.74e-2)" "unprognostic (3.85e-2)" "unprognostic (1.28e-2)" "unprognostic (7.10e-2)" "prognostic favorable (7.14e-4)" "unprognostic (4.07e-2)" "prognostic favorable (4.33e-5)" "unprognostic (3.15e-2)" "unprognostic (1.39e-1)" "unprognostic (1.34e-1)" "unprognostic (7.06e-3)" 23.4 135.2 30.2 15.8 27.7 17.1 25.8 35.3 37.5 29.0 35.2 36.8 24.5 31.4 17.4 37.5 28.2 14.5 29.8 27.8 26.2 33.3 73.7 22.2 15.9 32.1 27.5 35.4 34.1 28.3 34.0 18.2 30.1 29.1 21.8 27.5 25.1 18.6 27.5 47.0 34.3 20.5 18.8 37.1 32.3 39.2 34.0 18.6 30.6 19.3 15.6 31.7 29.3 26.0 19.7 28.2 28.8 45.6 51.6 26.4 51.3 18.8 27.9 30.0 28.3 38.0 31.9 31.5 26.7 30.4 30.7 20.3 41.1 38.8 31.7 23.6 29.0 54.1 37.7 40.9 51.4 33.4 32.5 33.2 40.1 36.4 42.2 24.9 26.1 32.0 38.5 21.4 24.8 28.9 37.1 49.2 30.7 39.7 40.1 20.1 25.9 37.5 24.4 37.1 19.0 35.1 27.1 33.8 18.8 36.8 29.5 37.6 22.0 27.2 33.1 39.7 26.8 21.2 24.6 18.3 27.6 30.2 20.9 6.0 5.9 6.5 6.6 4.9 8.7 5.5 5.4 6.0 7.0 5.3 6.1 6.1 15.8 6.7 4.2 5.4 7.3 5.0 30.2 27.7 35.3 37.5 27.8 26.2 32.1 27.5 30.1 18.8 34.0 26.0 15.0 0.0 16.0 34.0 11.6 11.6 9.8 14.5 19.9 23.2 20.2 18.9 14.6 11.5 16.2 20.2 29.2 27.6 9.8 55.3 0.0 13.9 13.0 11.5 12.8 12.9 12.0 10.1 39.3 15.1 15.8 16.9 26.5 16.3 7.0 53.5 7.9 46.0 16.3 53.8 39.7 20.7 10.2 13.4 8.3 28.6 19.6 10.4 24.9 15.0 7.7 18.6 14.4 27.6 30.2 10.6 33.8 21.4 18.5 10.2 40.6 9.7 17.9 34.7 32.9 14.0 22.3 14.6 25.0 19.6 11.6 79.1 12.1 100.1 31.4 9.0 ELP6 "C3orf75, FLJ20211, TMEM103" ENSG00000163832 "Elongator acetyltransferase complex subunit 6" Q0PNE2 3 47495640-47513712 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation, tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046358, HPA064545" Uncertain Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Cytosol" Centrosome "HPA046358: AB_10961011, HPA064545: AB_2685282" "unprognostic (2.00e-3)" "unprognostic (2.27e-1)" "unprognostic (7.41e-3)" "unprognostic (2.41e-2)" "unprognostic (2.67e-1)" "unprognostic (8.62e-2)" "unprognostic (4.24e-3)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (1.24e-2)" "unprognostic (2.07e-2)" "unprognostic (5.38e-2)" "prognostic favorable (3.42e-6)" "unprognostic (1.54e-1)" "unprognostic (9.05e-2)" "unprognostic (2.30e-1)" "unprognostic (6.29e-2)" 13.5 27.0 21.3 14.3 22.8 11.5 15.8 23.6 23.6 14.5 24.3 16.2 15.2 17.2 23.1 15.5 16.9 14.7 19.6 21.0 21.6 17.5 21.3 12.1 21.9 22.8 22.2 21.7 14.8 21.1 15.1 14.4 22.7 19.4 13.9 8.7 16.4 17.7 35.6 16.6 13.4 18.0 22.2 15.7 15.7 21.1 22.9 24.6 19.3 29.0 20.5 16.0 13.3 23.7 37.6 36.4 45.3 46.8 34.9 32.0 26.5 43.4 29.7 54.2 48.6 35.1 38.4 68.7 27.1 37.6 51.3 22.1 43.6 62.5 33.0 39.9 34.4 62.6 55.5 40.4 38.5 49.1 38.5 34.9 33.2 61.4 38.3 31.5 47.3 58.8 67.1 21.7 54.1 44.0 59.8 56.7 55.1 35.4 57.9 29.2 22.3 42.2 38.4 33.9 40.3 40.9 36.9 29.8 25.8 36.0 40.8 41.1 32.8 57.3 41.9 28.9 56.9 44.8 63.5 64.9 28.4 58.8 58.4 19.7 20.4 15.1 31.8 18.9 25.2 33.4 29.4 32.9 25.9 35.2 28.3 28.9 2.8 35.3 13.7 33.9 38.5 25.6 21.3 22.8 23.6 23.6 21.0 21.6 22.8 22.2 22.7 22.2 22.9 23.7 19.3 6.4 12.3 8.8 24.9 8.4 15.2 35.7 19.4 21.7 20.3 22.4 23.0 24.3 20.0 33.1 14.6 44.0 27.8 16.0 60.7 28.1 8.3 15.3 19.4 22.6 17.4 30.3 9.4 23.6 39.6 23.4 17.9 14.0 22.2 56.3 30.0 28.5 28.6 38.7 11.9 15.0 40.7 14.5 8.3 14.5 23.0 17.4 16.0 9.4 21.7 43.7 48.4 5.5 11.7 21.3 12.7 30.5 23.1 10.9 22.9 51.1 15.7 26.0 6.6 14.2 22.6 47.2 22.4 15.6 8.4 26.8 23.9 58.4 21.7 10.4 CSPG5 NGC ENSG00000114646 "Chondroitin sulfate proteoglycan 5" O95196 3 47562238-47580792 "Predicted membrane proteins" "Differentiation, Growth regulation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "brain: 83.2;choroid plexus: 65.2;retina: 28.3" "Group enriched" "Detected in some" 4 "Astrocytes: 67.6;Muller glia cells: 94.7;Oligodendrocyte precursor cells: 233.7" "Cancer enriched" "Detected in many" 19 "glioma: 48.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 32.6;HEK 293: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049529, HPA067818, HPA071779" Enhanced Approved Nucleoplasm,Mitochondria No No "Cluster 65: Brain - Ion transport" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm Mitochondria "HPA049529: AB_2680805, HPA067818: AB_2685905, HPA071779: AB_2686446" "unprognostic (2.68e-1)" "unprognostic (2.11e-1)" "unprognostic (8.87e-2)" "unprognostic (3.12e-2)" "unprognostic (2.88e-1)" "unprognostic (7.66e-2)" "unprognostic (5.05e-4)" "unprognostic (1.40e-1)" "unprognostic (3.82e-1)" "prognostic favorable (2.14e-4)" "unprognostic (1.17e-1)" "unprognostic (1.13e-1)" "unprognostic (3.41e-4)" "unprognostic (8.08e-2)" "unprognostic (1.01e-1)" "unprognostic (1.43e-1)" "unprognostic (2.10e-1)" 0.9 0.8 58.3 0.2 62.4 0.1 0.6 33.6 83.2 0.3 65.2 1.1 0.0 0.3 0.1 0.3 0.3 0.1 0.5 62.5 49.7 0.2 0.2 3.2 0.2 41.2 45.6 0.2 0.3 0.3 1.7 0.8 45.8 0.4 0.2 28.3 0.3 0.0 0.5 1.1 0.3 0.4 37.0 0.0 0.4 1.9 48.0 0.1 0.4 0.0 0.1 0.1 0.2 46.1 0.3 1.7 32.6 5.7 0.6 0.0 0.9 0.6 0.1 1.2 0.3 0.3 2.0 0.1 2.5 0.1 2.4 0.5 2.7 0.3 0.3 0.0 8.8 0.5 1.4 0.0 0.0 0.4 1.4 0.0 1.1 0.1 0.0 0.9 0.1 1.1 6.6 0.3 0.1 1.5 0.2 0.4 3.1 2.4 3.3 0.5 0.2 0.7 1.4 1.1 3.4 1.5 2.1 4.1 0.1 0.9 1.6 3.1 0.3 0.1 6.5 0.1 1.9 0.8 0.8 0.0 0.5 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.3 62.4 33.6 83.2 62.5 49.7 41.2 45.6 45.8 37.0 48.0 46.1 0.7 3.2 2.0 67.6 0.1 0.8 0.1 0.0 0.0 28.6 2.2 1.8 1.3 0.0 0.0 0.0 6.2 0.2 0.0 0.5 0.0 0.2 2.0 0.6 0.6 0.3 1.8 0.0 18.6 0.0 0.2 0.5 0.0 2.0 0.0 6.1 0.0 0.5 0.2 6.7 25.0 0.3 0.0 0.0 0.2 0.6 0.3 0.2 0.0 7.5 0.0 94.7 0.0 233.7 9.9 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 22.7 0.0 0.8 0.8 13.5 3.3 0.0 0.6 0.1 0.2 0.2 0.4 0.1 SMARCC1 "BAF155, CRACC1, Rsc8, SRG3" ENSG00000173473 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1" Q92922 3 47585269-47782106 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011576, CAB016336, HPA024352, HPA026853" Supported Enhanced Nucleoplasm NA NA 31000 "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030" "unprognostic (3.47e-1)" "unprognostic (1.65e-1)" "prognostic favorable (3.34e-4)" "unprognostic (2.54e-1)" "unprognostic (1.83e-2)" "unprognostic (3.70e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (1.33e-2)" "unprognostic (4.28e-3)" "unprognostic (6.92e-2)" "unprognostic (5.53e-2)" "unprognostic (2.78e-2)" "unprognostic (1.66e-2)" "unprognostic (7.99e-2)" "unprognostic (3.84e-1)" "unprognostic (2.31e-2)" "unprognostic (2.45e-1)" 12.2 8.1 19.6 18.6 21.1 21.2 23.5 16.2 19.6 19.3 17.0 23.0 14.7 18.3 15.6 20.1 13.1 11.8 9.4 15.9 17.7 20.0 13.8 13.1 22.2 18.3 19.8 17.8 19.5 14.3 8.3 22.2 18.8 22.4 21.9 9.6 17.0 17.1 19.0 24.1 16.9 16.3 19.7 16.3 16.9 16.7 18.9 34.8 17.7 10.3 30.3 21.0 15.9 20.9 45.1 23.4 95.7 74.9 21.0 35.7 64.3 35.1 32.7 44.5 45.1 42.3 46.6 104.3 27.7 44.4 25.8 37.7 91.2 54.3 64.6 50.3 54.1 102.4 38.4 57.7 31.4 94.8 45.3 30.1 47.0 50.1 55.2 33.1 52.8 68.7 87.5 34.4 48.4 33.4 124.4 48.9 126.8 43.2 35.4 55.1 55.5 92.0 47.2 58.0 42.6 85.5 54.5 52.7 38.9 66.5 45.8 87.1 42.7 29.6 41.7 33.9 58.0 41.9 57.1 122.0 21.6 88.1 42.5 1.9 1.6 1.7 2.7 2.6 2.4 3.9 3.0 3.7 2.1 2.6 2.8 3.3 1.9 2.0 1.9 2.2 3.1 1.9 19.6 21.1 16.2 19.6 15.9 17.7 18.3 19.8 18.8 19.7 18.9 20.9 30.4 41.7 45.9 56.5 61.7 53.0 60.5 37.4 71.7 29.3 60.3 45.5 31.5 34.3 58.9 57.0 37.5 79.7 43.7 30.1 13.7 67.9 88.9 60.2 72.3 38.3 91.6 76.9 47.3 46.7 113.0 32.7 49.5 115.7 24.6 103.8 22.1 37.8 30.2 20.2 52.2 64.5 34.6 32.3 36.9 113.1 25.4 41.6 23.2 42.2 57.7 18.9 52.5 98.0 104.9 58.8 29.0 28.6 65.3 83.7 24.1 38.0 34.0 33.0 39.5 44.7 60.1 59.4 108.3 86.0 66.8 72.5 52.4 77.6 61.8 62.4 DHX30 "DDX30, FLJ11214, KIAA0890" ENSG00000132153 "DExH-box helicase 30" Q7L2E3 3 47802909-47850195 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034806 Supported Supported Mitochondria,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria Cytosol "HPA034806: AB_10601364" "unprognostic (2.00e-1)" "unprognostic (8.37e-2)" "unprognostic (3.27e-1)" "unprognostic (2.14e-2)" "unprognostic (3.04e-1)" "unprognostic (1.62e-1)" "unprognostic (1.27e-3)" "unprognostic (1.14e-1)" "unprognostic (1.16e-1)" "unprognostic (1.74e-1)" "unprognostic (1.10e-3)" "unprognostic (1.42e-2)" "prognostic favorable (1.37e-6)" "unprognostic (4.12e-2)" "unprognostic (1.43e-1)" "unprognostic (2.81e-1)" "unprognostic (2.22e-1)" 22.6 24.6 23.7 17.1 23.3 22.2 22.9 21.4 26.3 26.4 24.8 26.8 16.2 27.6 10.4 23.6 24.8 14.9 28.8 23.5 22.4 26.8 25.2 21.3 20.1 24.0 23.5 27.9 24.1 28.9 32.1 17.5 24.6 26.6 10.9 12.7 21.6 18.2 37.1 27.6 22.3 15.9 20.3 27.3 25.2 54.2 23.8 23.3 24.8 21.0 14.3 25.2 22.8 24.2 21.9 52.3 54.5 56.2 24.6 20.2 35.3 39.0 33.4 65.1 46.5 56.9 42.6 66.4 32.0 37.0 51.2 30.3 73.7 52.1 23.1 49.6 86.1 59.6 76.0 58.6 40.7 56.0 58.3 33.0 33.4 68.1 49.7 28.4 44.0 57.5 82.0 40.6 31.8 57.1 82.2 59.3 60.7 30.2 84.0 44.6 30.6 62.2 32.0 53.6 41.6 61.6 39.6 54.1 31.1 25.0 38.5 58.8 32.2 40.6 51.0 46.7 73.9 56.2 75.3 61.8 42.8 48.3 49.9 14.1 10.7 7.8 16.2 10.6 12.4 10.4 12.4 16.3 13.9 8.7 11.7 12.7 1.6 9.6 11.6 7.9 15.3 14.7 23.7 23.3 21.4 26.3 23.5 22.4 24.0 23.5 24.6 20.3 23.8 24.2 31.1 38.5 46.7 30.7 34.7 18.1 25.7 38.7 39.3 49.0 34.6 35.6 38.1 32.9 34.1 51.5 43.8 41.7 33.1 37.6 66.5 37.8 129.5 59.2 31.7 32.4 40.1 38.5 32.8 36.3 22.8 26.7 42.3 33.2 23.5 40.7 27.5 50.8 35.9 58.9 36.6 25.8 40.7 29.6 17.6 123.8 24.8 24.4 19.6 13.1 32.5 46.3 28.8 22.1 28.7 46.0 41.0 30.1 39.9 28.6 40.5 83.5 49.9 52.8 32.9 27.3 28.6 145.4 50.2 33.5 19.9 29.6 29.7 36.6 38.5 26.3 MAP4 ENSG00000047849 "Microtubule associated protein 4" P27816 3 47850690-48089272 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 743.9" "Cell type enhanced" "Detected in all" "Bipolar cells: 392.2;Cardiomyocytes: 921.5;Cone photoreceptor cells: 625.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038149, HPA038150" Enhanced Approved "Plasma membrane,Microtubules,Cytosol" NA NA 880000 "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Microtubules, Cytosol" "Plasma membrane" "HPA038149: AB_10672471, HPA038150: AB_10672505" "unprognostic (2.51e-1)" "unprognostic (4.48e-1)" "unprognostic (2.72e-1)" "unprognostic (1.95e-2)" "unprognostic (3.36e-1)" "unprognostic (4.57e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (6.82e-2)" "unprognostic (1.46e-2)" "unprognostic (5.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.30e-2)" "unprognostic (2.25e-2)" "unprognostic (8.89e-2)" "unprognostic (6.45e-2)" "unprognostic (1.88e-1)" "unprognostic (1.21e-3)" 127.4 55.7 475.5 50.4 483.4 16.1 98.0 433.2 406.8 118.0 215.5 193.2 35.1 111.7 69.7 90.7 94.7 52.9 380.9 351.2 408.7 88.3 66.0 105.0 35.0 567.9 490.6 90.0 71.4 31.4 56.1 64.8 509.2 92.7 47.6 149.0 71.4 88.1 743.9 120.6 80.6 94.5 526.1 64.0 93.9 80.0 552.3 42.1 61.1 491.0 37.8 135.5 115.2 533.2 121.9 95.7 117.1 89.3 168.6 298.5 49.5 222.6 241.2 184.1 204.9 81.3 74.4 102.3 50.7 337.9 172.8 79.2 151.4 201.6 204.7 148.7 63.8 69.3 102.8 106.0 228.6 48.6 53.9 251.4 246.4 224.0 271.6 167.1 245.1 70.6 91.2 115.3 146.9 69.1 69.5 58.9 70.9 59.9 195.0 36.6 110.1 128.1 118.2 100.1 46.4 72.3 171.0 68.3 118.6 163.0 50.1 44.8 334.5 172.7 132.3 182.9 144.4 80.4 66.9 47.8 222.2 58.6 167.3 10.5 6.6 3.7 15.6 10.6 7.5 12.3 10.2 12.7 7.1 11.5 4.9 7.6 2.6 13.4 27.3 10.8 13.0 9.7 475.5 483.4 433.2 406.8 351.2 408.7 567.9 490.6 509.2 526.1 552.3 533.2 147.9 70.5 48.2 124.4 45.1 74.8 55.4 53.1 42.7 392.2 34.7 36.2 921.5 48.6 53.4 80.9 625.5 33.8 54.6 43.7 27.4 97.8 116.2 78.2 143.2 110.4 28.8 21.6 63.7 65.3 81.0 105.5 39.8 93.4 27.8 81.6 50.0 57.3 38.0 47.1 71.2 31.7 34.6 28.3 50.5 38.8 77.0 40.0 78.2 95.5 72.0 82.8 47.4 77.9 167.2 92.0 28.0 103.0 47.2 89.0 37.1 39.2 43.6 97.5 72.3 149.0 119.0 65.6 64.3 58.7 69.6 22.4 60.5 137.4 39.5 44.7 CDC25A ENSG00000164045 "Cell division cycle 25A" P30304 3 48157146-48188417 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.3;lymphoid tissue: 8.8;testis: 13.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 111.2;Early spermatids: 18.3;Late spermatids: 31.8;Spermatogonia: 16.3" "Cancer enhanced" "Detected in many" "testis cancer: 19.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005855, HPA008803" Approved "Nucleoplasm,Golgi apparatus" NA Yes "Cluster 43: B-cells - Humoral immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "Golgi apparatus" "HPA005855: AB_1846364, HPA008803: " "unprognostic (1.49e-1)" "unprognostic (8.13e-2)" "unprognostic (1.20e-2)" "unprognostic (1.43e-3)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (7.05e-7)" "unprognostic (1.35e-2)" "unprognostic (4.32e-3)" "unprognostic (8.92e-3)" "unprognostic (4.41e-2)" "unprognostic (9.09e-2)" "unprognostic (4.41e-3)" "unprognostic (1.57e-3)" "unprognostic (1.07e-1)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" 0.7 0.9 0.8 3.3 0.8 15.3 1.1 0.7 1.0 0.6 0.7 3.5 2.0 0.6 0.9 2.4 0.2 0.3 0.4 0.8 2.0 0.7 0.8 0.3 4.4 1.1 1.9 2.2 0.7 0.8 0.8 2.6 1.7 0.6 3.9 2.0 0.8 0.6 0.4 0.6 1.8 1.1 0.8 2.0 0.9 13.3 2.0 8.8 1.8 0.3 5.6 0.9 0.9 0.7 22.2 10.7 50.0 27.2 1.7 3.2 34.2 29.9 11.3 36.7 29.6 46.8 11.2 64.9 11.4 8.0 23.4 16.3 86.6 20.6 38.6 21.4 45.1 83.8 19.0 23.1 1.7 59.4 23.4 1.7 3.1 45.8 19.6 4.6 14.1 47.8 67.6 33.6 20.1 11.8 74.8 46.6 73.4 20.2 24.2 33.2 32.9 35.1 9.5 20.7 23.5 28.8 18.6 21.6 9.5 31.7 11.3 41.9 7.2 18.0 27.7 20.3 41.4 16.7 54.2 101.5 13.5 65.2 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.7 1.0 0.8 2.0 1.1 1.9 1.7 0.8 2.0 0.7 0.3 0.0 0.0 1.0 1.1 0.4 0.4 0.8 1.8 0.5 1.2 1.0 111.2 0.0 0.1 0.0 2.1 4.2 0.2 2.4 0.0 0.4 18.3 0.5 0.9 2.7 1.2 8.0 0.2 0.9 7.4 1.5 1.5 1.3 0.0 4.6 1.4 0.3 3.1 0.0 0.5 2.0 0.0 0.6 0.9 31.8 1.5 0.5 0.0 0.0 0.1 1.1 0.0 0.5 0.0 1.1 0.8 1.9 13.0 0.7 0.4 0.4 0.2 0.4 0.0 0.1 2.2 14.5 16.3 4.3 0.0 0.3 0.6 2.4 4.1 0.5 CAMP "CAP18, FALL-39, FALL39, LL37" ENSG00000164047 "Cathelicidin antimicrobial peptide" P49913 3 48223347-48225491 "Plasma proteins, Predicted secreted proteins, Transporters" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "bone marrow: 2914.5" "Cell type enhanced" "Detected in some" "Early spermatids: 16.3;Fibroblasts: 6.9;Late spermatids: 17.4;Prostatic glandular cells: 9.4;Spermatocytes: 5.0;Spermatogonia: 7.2" "Cancer enriched" "Detected in many" 4 "testis cancer: 10.1" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "eosinophil: 84.4;neutrophil: 335.4" "Lineage enriched" "Detected in many" 12 "granulocytes: 335.4" "Cell line enhanced" "Detected in some" "Daudi: 27.3;hTCEpi: 19.0;U-698: 77.5" "Not detected" "Not detected" "CAB015949, CAB016522, HPA029874" Enhanced "Secreted to blood" NA NA 617000000 28000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" "CAB015949: , CAB016522: , HPA029874: AB_10600859" "unprognostic (2.14e-2)" "prognostic favorable (5.73e-4)" "unprognostic (4.59e-2)" "unprognostic (2.62e-1)" "unprognostic (9.41e-2)" "unprognostic (4.57e-5)" "unprognostic (3.09e-1)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.65e-2)" "unprognostic (1.32e-1)" "unprognostic (8.08e-4)" "unprognostic (1.23e-2)" "unprognostic (2.55e-1)" "unprognostic (1.71e-1)" "unprognostic (1.80e-2)" "unprognostic (1.03e-2)" 0.8 0.1 0.1 1.6 0.1 2914.5 0.5 0.1 0.5 0.6 0.1 0.3 0.0 0.6 339.9 0.4 0.1 0.3 1.4 0.1 0.1 0.4 3.9 7.4 6.8 0.2 0.1 0.2 0.1 0.1 0.5 2.4 0.2 0.5 0.1 0.0 15.2 0.6 0.2 3.7 1.7 0.1 0.1 23.2 0.4 1.9 0.1 10.7 5.7 0.2 2.9 0.4 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 27.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 19.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.1 1.0 1.4 0.1 0.0 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 77.5 0.0 3.4 0.1 37.9 5.5 84.4 0.0 9.8 0.0 2.3 0.0 0.0 7.7 2.4 0.0 0.0 335.4 2.6 28.1 4.7 0.0 86.9 0.1 0.1 0.1 0.5 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.9 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.3 0.9 0.3 0.2 0.0 2.1 0.0 0.2 0.0 6.9 0.5 1.4 0.0 0.0 0.4 0.0 3.2 0.0 0.0 0.0 0.0 1.3 1.1 17.4 0.9 3.6 1.8 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.8 9.4 0.0 0.1 0.7 0.0 0.0 0.0 0.1 5.0 7.2 0.0 0.0 0.0 1.0 0.0 0.4 0.6 ZNF589 SZF1 ENSG00000164048 "Zinc finger protein 589" Q86UQ0 3 48241100-48299253 "Predicted intracellular proteins, Transcription factors" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 20.9" "Cancer enhanced" "Detected in all" "testis cancer: 15.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HAP1: 44.1;NTERA-2: 71.1" HPA003145 Uncertain Supported Nucleoplasm NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm "HPA003145: AB_1080738" "unprognostic (2.49e-3)" "prognostic favorable (2.50e-4)" "unprognostic (9.14e-2)" "unprognostic (7.34e-3)" "unprognostic (1.18e-1)" "prognostic favorable (1.71e-4)" "unprognostic (3.01e-5)" "prognostic favorable (6.45e-5)" "unprognostic (2.64e-2)" "unprognostic (9.67e-2)" "prognostic favorable (1.21e-4)" "unprognostic (8.02e-2)" "unprognostic (1.46e-1)" "unprognostic (1.32e-2)" "unprognostic (3.45e-2)" "unprognostic (9.57e-3)" "unprognostic (2.19e-2)" 7.2 8.5 9.6 6.7 9.7 5.8 6.9 14.9 11.2 11.2 2.3 8.3 3.8 7.6 20.1 10.2 8.8 4.6 6.2 11.0 9.3 7.1 3.7 10.1 12.3 7.9 7.9 13.6 6.5 5.9 7.8 3.0 7.7 18.3 6.6 14.8 6.6 15.7 6.1 9.8 16.1 6.0 7.2 24.1 7.9 6.6 8.9 8.1 16.6 4.2 12.2 8.5 10.7 10.2 4.5 3.2 12.7 10.8 15.8 8.7 16.1 4.6 3.5 5.2 6.9 6.8 6.0 17.8 3.3 4.7 4.0 3.9 44.1 11.2 4.2 11.5 10.5 22.5 14.9 5.4 2.9 5.4 5.6 2.8 7.5 6.4 4.3 5.7 9.0 13.7 15.4 4.5 2.8 4.5 6.8 4.1 71.1 4.3 6.6 3.3 4.6 6.8 4.0 4.4 4.9 9.1 3.4 3.7 13.7 18.8 6.0 8.0 14.0 3.0 5.8 7.2 3.5 8.9 12.0 14.6 4.0 12.6 9.3 1.2 2.2 1.6 2.8 2.0 3.5 3.1 3.4 3.8 2.3 1.9 3.8 3.8 1.2 1.2 2.8 10.9 3.1 1.9 9.6 9.7 14.9 11.2 11.0 9.3 7.9 7.9 7.7 7.2 8.9 10.2 2.0 0.0 5.4 4.2 5.5 1.1 1.4 0.9 3.4 15.3 2.4 1.5 4.1 0.0 2.8 9.2 20.9 2.2 13.7 1.3 3.9 1.4 1.5 7.3 3.5 2.7 1.8 2.1 9.8 1.0 1.2 4.3 1.5 11.7 0.0 3.9 2.5 1.0 3.3 1.7 11.5 2.5 0.0 5.5 3.0 2.0 2.1 7.3 1.8 3.7 3.7 5.3 1.0 9.5 11.0 1.0 1.7 4.5 5.3 1.5 1.4 1.6 2.4 13.1 6.6 4.1 3.0 1.4 3.1 2.9 1.3 0.0 4.4 7.0 2.5 0.9 NME6 "IPIA-ALPHA, NM23-H6" ENSG00000172113 "NME/NM23 nucleoside diphosphate kinase 6" O75414 3 48290722-48301685 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017909 Approved Approved Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Vesicles "HPA017909: AB_1854530" "unprognostic (7.31e-3)" "unprognostic (1.87e-1)" "unprognostic (8.19e-3)" "unprognostic (2.09e-2)" "unprognostic (8.52e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.17e-7)" "unprognostic (1.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.00e-3)" "unprognostic (1.32e-1)" "unprognostic (2.98e-1)" "prognostic favorable (3.18e-5)" "unprognostic (1.98e-2)" "unprognostic (1.57e-2)" "unprognostic (1.23e-1)" "unprognostic (9.50e-2)" 8.7 7.7 6.3 10.4 6.4 8.1 12.1 9.2 6.3 10.2 8.7 11.6 13.2 9.3 8.5 12.1 14.8 8.9 13.5 7.1 6.5 11.1 10.3 10.2 12.2 5.9 6.3 12.4 11.6 12.4 6.0 14.2 5.7 9.5 11.5 7.6 10.9 8.7 17.7 10.0 10.4 12.4 4.9 9.6 11.5 6.2 6.4 9.4 12.2 17.2 13.7 9.6 9.0 6.3 30.0 19.1 24.3 18.3 18.2 23.4 22.1 27.2 18.3 37.5 27.3 30.5 26.5 30.1 14.0 20.5 36.5 10.1 21.9 27.2 24.1 36.1 21.3 17.9 24.1 26.6 25.7 24.3 20.7 19.7 33.8 34.4 42.9 19.3 19.8 21.1 33.9 23.6 14.0 13.9 21.4 11.3 22.3 19.5 23.3 12.7 22.9 25.3 21.2 23.6 7.7 12.7 19.8 21.0 26.1 17.8 23.9 22.5 22.1 8.3 33.0 21.2 39.4 27.0 40.9 26.1 16.3 31.9 18.4 47.3 33.4 76.4 40.9 36.0 36.6 43.5 37.4 35.2 39.9 38.0 28.1 27.2 37.3 40.4 42.1 34.5 33.5 25.1 6.3 6.4 9.2 6.3 7.1 6.5 5.9 6.3 5.7 4.9 6.4 6.3 13.1 28.9 20.7 2.3 16.4 5.0 8.5 18.2 9.6 11.9 14.1 13.6 10.4 15.7 19.4 9.2 14.6 49.5 18.4 8.2 39.2 24.8 2.6 16.1 17.5 12.8 4.2 8.0 2.5 30.1 41.6 12.4 11.7 11.8 10.1 22.8 7.9 7.9 34.4 10.1 3.2 10.8 12.2 9.3 9.7 1.7 11.8 13.7 16.0 1.9 23.4 17.6 18.6 2.5 2.7 31.3 8.3 7.2 10.8 12.8 16.6 16.4 30.6 11.5 13.1 7.7 12.2 9.3 15.0 12.4 4.1 19.7 14.7 15.1 12.8 7.1 SPINK8 ENSG00000229453 "Serine peptidase inhibitor Kazal type 8 (putative)" P0C7L1 3 48306842-48328341 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "bone marrow: 11.5;breast: 44.1" "Group enriched" "Detected in some" 5 "Breast glandular cells: 22.1;Breast myoepithelial cells: 9.9" "Group enriched" "Detected in some" 10 "breast cancer: 8.6;glioma: 9.6;prostate cancer: 2.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "eosinophil: 1.3;neutrophil: 1.7" "Lineage enriched" "Detected in single" 12 "granulocytes: 1.7" "Cell line enriched" "Detected in some" 60 "SK-BR-3: 73.2" "Region enriched" "Detected in many" 9 "hippocampal formation: 73.7" "Low region specificity" "Detected in all" HPA053151 Uncertain "Secreted to blood" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 5: Breast - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 30: Mammary glandular cells - Lactation" "HPA053151: AB_2682059" "prognostic unfavorable (8.47e-4)" "unprognostic (1.98e-1)" "unprognostic (1.75e-2)" "unprognostic (1.99e-1)" "unprognostic (1.15e-1)" "unprognostic (1.20e-1)" 0.0 0.0 2.2 0.0 2.2 11.5 44.1 2.6 4.5 0.0 0.4 0.0 0.1 0.0 2.5 2.8 0.2 0.0 0.0 3.0 1.8 0.0 0.0 0.1 0.0 2.9 1.5 0.0 0.4 0.0 0.1 0.2 2.6 0.5 0.0 0.3 2.1 0.3 0.0 0.1 0.0 0.0 1.8 0.6 0.0 0.3 2.6 0.0 0.0 0.0 0.0 0.1 0.2 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 73.2 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 2.2 2.2 2.6 4.5 3.0 1.8 2.9 1.5 2.6 1.8 2.6 2.9 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 22.1 9.9 0.0 0.0 0.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.1 0.1 0.0 1.2 0.0 0.0 2.7 1.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 2.0 0.0 0.0 0.7 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.0 1.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.6 FBXW12 "Fbw12, FBXO35" ENSG00000164049 "F-box and WD repeat domain containing 12" Q6X9E4 3 48372219-48401259 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "pancreas: 6.1" "Group enriched" "Detected in some" 4 "Early spermatids: 12.4;Late spermatids: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037491, HPA037492" Uncertain Approved Vesicles,Cytosol NA NA "Cluster 25: Pancreas - Digestion" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol Vesicles "HPA037491: AB_2675504, HPA037492: AB_2675505" "unprognostic (5.38e-2)" "unprognostic (1.90e-1)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-2)" "unprognostic (8.56e-2)" "unprognostic (2.17e-1)" "unprognostic (9.48e-2)" "unprognostic (2.95e-1)" "unprognostic (1.21e-3)" "unprognostic (6.96e-3)" "unprognostic (2.36e-1)" "unprognostic (6.29e-3)" "unprognostic (1.43e-1)" "unprognostic (1.29e-1)" "unprognostic (8.81e-3)" 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.1 6.1 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.5 0.6 0.4 0.1 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.4 0.6 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 1.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 PLXNB1 "KIAA0407, PLXN5, SEP" ENSG00000164050 "Plexin B1" O43157 3 48403854-48430086 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 121.1;Oligodendrocytes: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040586 Enhanced "Intracellular and membrane" NA NA 95000000 "Cluster 70: Brain - Nervous system development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 64: Astrocytes - Nervous system maintenance" "HPA040586: AB_10794034" "unprognostic (1.31e-3)" "unprognostic (7.09e-2)" "unprognostic (9.63e-2)" "unprognostic (8.13e-2)" "unprognostic (3.65e-1)" "prognostic favorable (5.03e-4)" "unprognostic (1.06e-1)" "unprognostic (4.29e-2)" "unprognostic (3.45e-2)" "unprognostic (1.01e-2)" "unprognostic (4.20e-3)" "unprognostic (1.18e-2)" "prognostic favorable (2.77e-5)" "unprognostic (4.01e-2)" "unprognostic (1.61e-1)" "unprognostic (6.98e-2)" "prognostic favorable (7.60e-4)" 9.0 2.8 26.6 3.3 54.5 1.0 13.7 34.3 28.6 17.1 33.0 19.5 9.7 19.5 5.6 22.9 25.3 10.3 10.4 22.0 28.3 27.6 28.9 11.4 1.6 42.9 43.9 19.1 26.0 6.1 17.9 6.8 41.5 22.9 5.4 4.2 17.3 15.8 1.7 24.6 13.0 7.5 26.5 6.5 14.7 3.9 40.4 5.0 35.8 1.4 2.0 16.3 21.4 61.0 5.5 9.2 16.7 9.9 6.1 4.9 34.1 4.6 2.6 2.6 1.7 11.3 20.7 0.0 16.6 3.2 1.7 16.3 3.6 37.0 0.5 9.7 0.7 0.0 19.9 21.5 8.9 7.5 3.1 8.8 31.5 0.6 7.5 10.1 4.3 3.7 1.4 0.8 2.5 9.5 1.3 6.5 29.7 12.0 2.0 8.4 3.6 1.3 15.6 24.5 8.5 18.4 5.9 34.6 5.3 4.4 18.5 6.2 8.5 2.6 7.8 3.8 5.3 0.3 0.0 0.2 0.5 2.2 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.6 54.5 34.3 28.6 22.0 28.3 42.9 43.9 41.5 26.5 40.4 61.0 3.2 35.3 24.3 121.1 0.7 11.5 15.8 26.1 32.5 2.6 23.3 31.5 17.7 30.0 27.5 46.0 2.1 23.7 0.2 36.2 5.9 18.5 4.3 54.2 9.3 5.0 52.7 3.2 1.4 15.8 2.4 7.2 26.5 41.8 0.0 11.2 5.3 59.7 2.9 3.3 2.6 21.2 30.5 3.1 1.2 5.1 15.2 1.0 1.8 4.7 0.7 24.3 0.0 21.6 70.1 21.9 21.8 15.4 0.3 11.4 21.5 12.7 56.5 5.7 0.0 6.1 13.0 1.4 2.7 22.3 9.7 9.9 1.3 0.5 28.3 11.6 CCDC51 FLJ12436 ENSG00000164051 "Coiled-coil domain containing 51" Q96ER9 3 48432164-48440456 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 43.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010980, HPA011408" Supported Supported Nucleoplasm,Centrosome,Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Mitochondria" Centrosome "HPA010980: AB_1846155, HPA011408: AB_2072212" "unprognostic (1.24e-2)" "unprognostic (5.23e-2)" "unprognostic (5.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-1)" "unprognostic (2.75e-3)" "unprognostic (4.71e-3)" "unprognostic (1.26e-2)" "unprognostic (3.04e-1)" "unprognostic (3.26e-2)" "unprognostic (7.70e-2)" "unprognostic (1.47e-3)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" 10.1 13.7 10.7 7.3 10.9 5.0 8.7 10.8 11.6 8.3 22.2 12.2 11.0 8.0 10.1 13.8 8.8 5.4 11.9 11.1 10.6 13.9 13.0 6.7 9.6 11.3 10.8 7.7 5.4 9.4 6.1 8.2 11.3 6.7 13.6 7.7 7.0 9.0 15.5 10.1 8.6 9.0 10.7 12.6 7.6 7.8 11.7 9.9 10.3 11.7 11.8 9.0 9.5 10.7 22.7 26.7 15.7 18.7 23.1 24.2 43.6 14.6 13.4 28.6 23.2 42.9 36.9 48.6 20.5 11.7 21.6 32.2 39.5 47.8 17.4 22.9 25.6 41.4 44.1 32.7 35.3 20.4 18.2 18.4 106.8 35.6 38.8 15.7 16.7 28.0 23.4 13.7 27.7 21.4 24.1 26.5 34.8 48.2 42.8 16.5 18.6 37.7 39.3 27.8 13.1 27.2 24.2 26.2 39.9 14.7 28.2 31.3 12.6 16.5 22.3 41.6 28.5 22.0 34.8 25.5 22.0 43.8 16.0 3.0 14.1 7.0 15.5 14.9 15.8 28.1 14.5 19.7 25.5 23.0 14.8 17.4 6.0 16.5 9.1 21.1 19.8 14.6 10.7 10.9 10.8 11.6 11.1 10.6 11.3 10.8 11.3 10.7 11.7 10.7 7.1 12.8 2.6 2.6 5.9 4.7 3.7 28.8 17.6 7.3 6.6 8.1 8.2 15.7 12.8 9.2 0.0 40.1 5.0 12.6 23.5 15.1 3.3 19.4 7.3 5.9 5.4 5.9 2.4 12.4 22.0 10.0 6.6 16.5 3.8 10.1 4.6 13.1 15.9 8.4 2.4 7.6 14.2 3.8 3.3 2.7 12.2 4.4 14.2 1.9 9.1 11.0 11.3 3.5 3.2 15.2 8.0 13.2 5.1 5.4 21.6 43.4 9.3 10.7 6.6 4.0 6.2 7.2 16.3 13.0 4.7 6.7 4.8 20.0 13.4 3.4 TMA7 "CCDC72, HSPC016" ENSG00000232112 "Translation machinery associated 7 homolog" Q9Y2S6 3 48440257-48444208 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047397 Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Nucleoli rim" "Nucleoplasm, Nuclear bodies" "HPA047397: AB_2680029" "unprognostic (1.26e-3)" "unprognostic (1.21e-1)" "unprognostic (9.10e-2)" "unprognostic (1.18e-2)" "unprognostic (2.06e-1)" "unprognostic (5.02e-2)" "unprognostic (3.55e-2)" "prognostic favorable (8.33e-4)" "unprognostic (1.14e-2)" "unprognostic (3.85e-3)" "unprognostic (1.92e-2)" "unprognostic (2.55e-2)" "unprognostic (1.14e-2)" "unprognostic (9.31e-3)" "unprognostic (3.13e-2)" "unprognostic (1.14e-1)" "unprognostic (8.64e-3)" 252.5 276.8 498.7 220.7 507.8 434.6 241.9 504.6 588.9 236.5 500.2 253.3 192.8 179.4 344.5 310.5 181.7 117.9 355.4 502.2 514.7 317.6 273.2 208.0 279.3 511.7 510.0 259.6 230.3 309.8 302.0 146.6 505.9 239.6 229.3 295.4 215.9 142.7 511.6 215.1 220.4 132.7 513.0 272.9 235.5 216.0 511.9 388.3 232.4 287.4 297.7 213.3 239.3 514.5 565.0 398.8 634.2 456.6 514.0 497.1 435.6 454.1 355.7 425.1 419.3 326.3 395.9 365.2 315.3 397.8 553.6 215.5 559.8 512.5 471.6 452.6 475.5 689.4 910.3 845.8 399.0 792.2 443.0 459.7 538.2 402.6 388.8 414.2 546.0 641.1 376.6 379.0 615.3 581.2 929.4 1071.2 847.1 607.0 637.3 262.2 397.0 620.4 746.0 748.7 207.8 526.1 511.0 369.3 736.1 583.6 356.7 1156.3 412.1 358.0 650.8 560.5 902.6 626.1 1001.6 902.8 459.1 754.2 379.9 1923.2 1058.7 2195.0 1127.1 1022.5 1237.6 1412.6 1486.0 1377.1 1150.8 1172.2 1464.7 1408.1 2036.5 943.8 1028.9 1521.6 1652.1 2663.7 498.7 507.8 504.6 588.9 502.2 514.7 511.7 510.0 505.9 513.0 511.9 514.5 518.8 240.4 370.4 20.9 615.0 716.3 534.0 1308.9 618.6 219.6 866.8 1111.2 633.4 513.3 616.2 901.2 106.3 785.4 797.4 948.2 1717.8 566.9 653.6 524.8 511.4 474.5 635.3 609.1 25.8 1032.9 830.9 443.7 356.3 646.1 454.4 376.5 574.7 1098.6 854.5 119.5 25.4 985.5 695.8 652.4 790.5 1123.9 646.8 544.3 777.3 18.7 850.3 522.8 1080.3 10.1 28.3 872.9 980.3 464.6 593.9 584.6 1211.0 1438.8 466.4 321.9 355.0 393.6 448.4 547.4 689.4 805.5 898.4 440.1 757.1 351.9 937.2 572.2 ATRIP "FLJ12343, MGC20625, MGC21482, MGC26740" ENSG00000164053 "ATR interacting protein" Q8WXE1 3 48446710-48467645 "Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 14.9" "Low cell type specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033109, HPA047590" Approved Supported Nucleoplasm NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 23: Testis - Cell cycle regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB033109: AB_634993, HPA047590: AB_2680094" "unprognostic (5.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.85e-1)" "unprognostic (8.87e-2)" "unprognostic (2.34e-1)" "unprognostic (4.79e-3)" "unprognostic (4.72e-2)" "unprognostic (8.88e-3)" "unprognostic (2.66e-1)" "unprognostic (7.94e-2)" "unprognostic (2.53e-2)" "unprognostic (7.05e-2)" "unprognostic (2.01e-1)" "unprognostic (8.89e-2)" "unprognostic (2.59e-1)" "unprognostic (1.40e-2)" "unprognostic (8.52e-2)" 3.8 2.6 2.0 3.7 2.1 5.0 3.8 3.9 2.3 3.9 2.2 3.1 2.4 3.4 1.4 3.7 3.0 2.0 2.4 2.0 1.7 3.1 2.5 3.6 3.6 2.0 1.9 3.6 2.7 4.0 1.8 3.2 1.9 3.0 3.5 2.7 2.5 3.6 4.7 4.4 2.6 3.0 1.6 3.0 2.8 14.9 2.0 4.9 5.4 3.0 4.9 3.3 3.5 2.3 8.7 3.7 9.7 7.4 5.6 9.5 10.2 13.1 6.0 15.7 12.8 5.1 6.3 19.3 5.9 5.4 7.3 9.2 10.9 10.2 15.1 11.5 5.6 14.9 19.1 3.7 3.2 15.0 9.7 3.8 3.1 8.5 4.0 3.5 7.0 7.1 12.0 9.6 14.7 4.9 12.6 5.4 7.5 4.4 10.5 8.5 8.7 13.7 5.3 4.3 4.7 6.9 10.4 10.5 3.9 8.5 8.8 5.7 8.1 10.7 7.0 13.0 15.3 11.6 20.0 13.6 5.7 11.2 6.0 0.2 0.7 0.0 1.1 0.3 0.1 0.3 0.9 0.5 0.5 0.2 0.7 1.0 0.5 0.5 0.6 1.1 1.2 0.7 2.0 2.1 3.9 2.3 2.0 1.7 2.0 1.9 1.9 1.6 2.0 2.3 4.3 0.0 1.5 2.0 0.9 2.9 0.0 0.9 0.0 1.0 4.1 4.7 1.6 0.0 2.0 0.0 2.1 0.2 4.4 2.4 0.0 3.6 0.0 3.8 6.4 2.3 0.0 0.4 3.2 3.9 0.1 2.2 1.5 5.8 0.0 5.5 0.0 0.0 0.1 1.7 3.2 1.7 2.0 0.0 0.5 0.0 0.0 2.5 0.0 1.9 1.6 0.5 3.1 2.0 3.3 4.1 1.1 0.0 0.7 0.0 0.0 2.1 3.6 2.1 0.0 0.0 4.5 0.0 0.0 0.0 3.8 0.1 2.2 4.2 1.3 0.0 TREX1 "AGS1, DRN3" ENSG00000213689 "Three prime repair exonuclease 1" Q9NSU2 3 48465811-48467645 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Exonuclease, Hydrolase, Nuclease" "Aicardi-Goutieres syndrome, Disease variant, Neurodegeneration, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 53.6;Club cells: 24.5;Ionocytes: 40.7;Langerhans cells: 22.6;Melanocytes: 24.9;Respiratory ciliated cells: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 67.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035437, HPA046721" Supported Supported Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol "HPA035437: AB_10672092, HPA046721: AB_2732531" 9.9 14.3 32.7 16.5 33.4 28.7 12.2 33.2 42.1 13.8 39.8 12.4 11.1 7.7 11.4 19.2 15.5 13.8 10.7 33.0 32.7 12.2 12.8 13.8 26.6 33.0 34.2 7.4 13.1 11.3 20.6 8.4 34.3 16.6 9.9 1.9 36.5 15.4 9.7 26.4 12.0 7.0 33.8 25.0 13.7 4.0 33.5 18.1 8.4 13.8 18.1 13.1 10.4 33.7 19.2 18.1 13.3 10.3 18.1 17.5 0.0 6.7 29.5 46.9 67.5 0.3 21.8 23.8 11.7 24.4 44.8 21.4 0.9 27.2 6.7 19.9 1.6 13.5 58.1 0.5 20.1 12.8 9.3 16.2 2.5 25.9 9.8 9.8 20.4 16.9 0.0 32.6 20.7 0.4 17.3 8.6 0.1 11.0 11.2 14.4 4.9 43.2 13.4 3.8 0.1 8.1 21.8 29.6 15.4 0.9 0.8 20.3 22.2 8.5 9.2 21.8 14.2 26.4 16.9 10.4 21.5 25.4 7.5 7.7 142.3 11.0 32.6 119.2 18.7 86.8 43.0 31.4 125.9 87.5 40.3 33.8 82.2 30.9 94.6 99.1 43.3 78.6 32.7 33.4 33.2 42.1 33.0 32.7 33.0 34.2 34.3 33.8 33.5 33.7 0.0 0.0 0.5 6.8 2.1 9.1 0.0 53.6 0.6 0.0 0.0 0.0 6.3 0.0 24.5 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 4.6 0.0 1.7 2.3 0.0 0.0 4.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.8 40.7 0.0 22.6 0.0 0.0 2.0 24.9 5.6 0.0 0.0 0.0 1.0 5.9 0.0 1.1 0.0 3.9 0.0 0.0 0.0 29.9 0.0 0.0 0.0 4.2 0.0 0.0 2.7 13.9 0.0 2.6 0.0 1.5 0.0 SHISA5 "hShisa5, SCOTIN" ENSG00000164054 "Shisa family member 5" Q8N114 3 48467798-48504826 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 279.7;Extravillous trophoblasts: 229.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042295 Approved NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA042295: AB_10794794" "unprognostic (3.52e-3)" "unprognostic (4.79e-2)" "unprognostic (1.71e-1)" "unprognostic (3.98e-2)" "unprognostic (8.58e-3)" "unprognostic (2.48e-1)" "prognostic unfavorable (3.72e-6)" "unprognostic (3.82e-3)" "unprognostic (8.76e-3)" "unprognostic (1.21e-3)" "unprognostic (1.39e-1)" "unprognostic (1.75e-1)" "prognostic unfavorable (8.64e-5)" "unprognostic (1.11e-1)" "unprognostic (6.08e-3)" "unprognostic (3.81e-3)" "unprognostic (1.74e-2)" 97.5 71.8 74.2 68.3 71.9 65.0 82.2 58.8 92.2 99.6 113.0 82.1 60.6 91.4 45.3 140.6 94.9 70.6 75.0 72.3 88.9 94.3 115.0 101.7 80.1 76.8 73.6 86.3 58.3 48.0 70.2 138.4 72.0 107.9 39.5 13.7 69.1 69.8 22.8 60.1 74.5 67.1 70.8 114.3 73.5 35.5 87.6 84.4 76.8 31.7 66.9 116.8 98.3 65.2 71.0 141.9 82.4 132.0 153.1 194.7 417.7 115.3 209.0 254.3 187.9 157.4 175.6 97.7 123.2 200.9 240.9 91.7 91.5 148.3 70.7 116.4 63.6 89.2 91.2 128.2 256.7 61.9 164.0 200.9 169.3 205.7 141.7 141.7 193.2 129.0 56.6 115.6 138.2 154.1 70.4 111.1 150.4 101.2 113.0 48.2 36.7 133.4 130.5 446.6 24.6 13.8 74.9 79.1 155.6 136.8 91.5 91.2 153.6 90.5 100.8 155.2 112.0 87.0 76.3 85.8 128.2 118.3 90.2 205.9 301.6 252.5 320.7 267.5 283.4 165.0 264.1 293.8 167.3 222.6 210.9 219.4 910.2 138.7 306.9 126.7 345.7 500.0 74.2 71.9 58.8 92.2 72.3 88.9 76.8 73.6 72.0 70.8 87.6 65.2 69.8 41.7 39.4 12.1 55.8 27.8 73.0 52.2 114.4 22.7 29.6 29.8 17.3 51.5 37.6 64.4 16.7 279.7 56.3 43.0 11.7 79.4 4.2 29.2 49.8 79.4 37.8 22.9 10.8 104.3 229.9 57.4 36.2 31.2 34.8 41.5 66.0 88.0 103.0 6.7 11.0 48.3 14.2 57.5 27.3 5.7 49.0 47.7 46.2 18.7 46.5 30.1 101.0 10.6 10.4 80.2 31.2 39.1 54.5 50.2 64.9 43.3 38.0 5.0 32.9 22.1 43.9 5.1 8.8 85.9 32.1 120.5 74.0 49.9 40.3 50.5 PFKFB4 ENSG00000114268 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4" Q16877 3 48517684-48562015 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 40.3;Proximal enterocytes: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 12.5;eosinophil: 21.9;intermediate monocyte: 13.8;neutrophil: 40.4;non-classical monocyte: 25.1" "Group enriched" "Detected in many" 6 "granulocytes: 40.4;monocytes: 25.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 52.5;U-87 MG: 83.9;WM-115: 74.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047719, HPA066058" Uncertain Approved Nucleoli NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 58: Brain - Synaptic function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoli "HPA047719: AB_2680129, HPA066058: AB_2685606" "unprognostic (7.60e-2)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (3.90e-3)" "unprognostic (7.96e-2)" "unprognostic (1.72e-6)" "unprognostic (1.65e-1)" "unprognostic (3.75e-2)" "unprognostic (6.78e-2)" "unprognostic (3.78e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.91e-8)" "unprognostic (2.04e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-3)" "unprognostic (3.35e-2)" 1.8 2.5 5.1 4.0 5.5 14.8 1.9 6.1 6.3 3.3 3.4 3.3 18.4 2.0 18.0 7.3 1.6 1.6 1.5 5.1 6.5 3.5 1.7 4.2 1.5 6.8 6.4 3.3 11.2 3.2 5.2 10.2 6.9 3.6 3.4 16.1 2.7 1.3 5.4 3.8 20.8 2.4 5.9 10.3 1.3 24.0 7.7 1.3 1.6 3.4 1.1 2.0 5.8 6.7 12.0 3.9 8.3 8.1 2.8 4.0 16.6 6.1 10.4 11.9 29.3 6.0 4.2 5.5 5.8 4.6 28.4 3.5 3.6 10.6 10.6 3.5 2.9 12.3 9.3 6.7 2.5 2.3 5.1 4.2 15.6 19.4 1.9 52.5 2.9 6.7 4.4 4.5 9.7 2.8 0.8 17.3 5.0 2.3 8.0 0.9 4.1 5.9 4.5 11.4 2.5 5.4 6.6 3.0 23.6 8.2 6.3 5.3 0.9 12.0 4.7 1.6 36.7 21.6 4.4 3.2 83.9 4.3 74.8 0.0 12.5 21.9 0.4 13.8 0.1 0.3 0.6 0.1 5.1 0.2 1.0 0.3 40.4 0.5 25.1 0.6 0.0 4.9 5.1 5.5 6.1 6.3 5.1 6.5 6.8 6.4 6.9 5.9 7.7 6.7 0.1 0.0 1.3 13.1 0.3 3.2 0.3 7.0 1.8 6.3 1.6 1.3 1.0 2.8 2.1 0.0 2.1 13.8 0.2 1.3 0.0 2.9 2.8 1.9 2.4 0.8 4.2 0.4 4.5 1.5 40.3 1.2 0.5 3.3 1.3 2.0 1.1 1.0 6.0 6.7 7.3 13.0 2.0 7.8 0.5 2.6 0.9 7.3 1.8 3.7 3.5 3.3 1.0 6.0 13.9 2.9 1.4 0.7 1.8 0.4 43.6 0.2 2.7 4.4 0.0 0.1 1.5 0.5 0.8 2.5 1.7 5.5 0.9 1.3 3.7 0.1 UCN2 "SRP, UCN-II, UCNI, URP" ENSG00000145040 "Urocortin 2" Q96RP3 3 48561718-48563781 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 13.1;vagina: 4.5" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 2.9;Basal respiratory cells: 1.4" "Cancer enriched" "Detected in many" 5 "melanoma: 18.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 18.8;hTCEpi: 27.3;hTEC/SVTERT24-B: 21.5;SiHa: 19.1;U-251 MG: 20.7;WM-115: 55.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA066841 Uncertain Approved Vesicles "Secreted to blood" NA NA 98600 "Cluster 31: Skin - Epidermis development" "Cluster 17: WM-115 - Nervous system development" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles "HPA066841: AB_2685735" "unprognostic (7.98e-2)" "unprognostic (1.35e-1)" "unprognostic (4.80e-2)" "unprognostic (1.96e-2)" "unprognostic (2.39e-2)" "unprognostic (4.26e-2)" "unprognostic (1.92e-3)" "unprognostic (2.02e-3)" "unprognostic (1.62e-1)" "unprognostic (2.93e-3)" "unprognostic (2.52e-3)" "unprognostic (1.09e-1)" "unprognostic (3.34e-14)" "unprognostic (4.39e-2)" "unprognostic (2.75e-1)" "unprognostic (1.36e-1)" "unprognostic (2.88e-2)" 0.1 0.0 0.2 0.3 0.1 0.1 0.4 0.3 0.4 2.3 0.1 0.2 0.1 1.2 0.7 3.4 0.2 0.4 0.3 0.2 0.4 1.4 0.0 0.2 0.0 0.3 0.3 0.2 0.0 0.0 0.3 0.2 0.3 3.1 0.0 0.0 1.6 0.4 0.3 13.1 0.2 0.2 0.2 0.7 0.2 1.4 0.3 0.0 0.0 0.0 0.1 0.5 4.5 0.2 0.0 3.1 0.5 0.1 1.8 1.1 2.6 9.7 12.1 5.9 4.4 0.0 0.0 0.0 0.4 2.3 7.0 1.9 0.0 11.6 3.2 9.2 0.2 0.2 18.8 1.5 2.0 0.0 0.5 1.3 27.3 21.5 4.3 4.1 0.0 0.2 0.0 0.2 0.9 0.0 0.0 1.8 0.8 0.0 0.2 0.2 0.3 0.0 1.8 0.0 0.0 0.0 19.1 0.0 14.5 1.7 0.3 0.4 0.0 2.6 1.8 0.3 20.7 0.1 0.3 0.0 8.8 0.1 55.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.4 0.2 0.4 0.3 0.3 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 2.9 0.3 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 COL7A1 "EBD1, EBDCT, EBR1" ENSG00000114270 "Collagen type VII alpha 1 chain" Q02388 3 48564073-48595329 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Protease inhibitor, Serine protease inhibitor" "Disease variant, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 98.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 72.5;Basal respiratory cells: 59.3;Basal squamous epithelial cells: 67.2;Endometrial stromal cells: 45.3" "Cancer enhanced" "Detected in all" "head and neck cancer: 41.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 65.7;HaCaT: 63.5;HBEC3-KT: 100.6;HDLM-2: 97.8;HeLa: 146.2;SiHa: 82.8" "CAB016357, HPA018877, HPA042420" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" NA NA 6000 "Cluster 41: Basophils - Cellular respiration" "Cluster 31: Skin - Epidermis development" "Cluster 20: HeLa - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Endoplasmic reticulum" Vesicles "CAB016357: AB_2229746, HPA018877: , HPA042420: AB_2677990" "unprognostic (2.69e-2)" "unprognostic (4.11e-1)" "unprognostic (1.35e-1)" "unprognostic (3.47e-1)" "unprognostic (4.93e-2)" "prognostic favorable (6.31e-4)" "unprognostic (7.56e-2)" "unprognostic (1.25e-2)" "unprognostic (5.59e-2)" "unprognostic (2.98e-1)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.74e-2)" "unprognostic (0.00e+0)" "unprognostic (1.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (3.86e-2)" 0.8 1.1 1.4 3.8 1.0 0.1 4.9 2.8 2.1 24.3 0.4 2.9 1.7 12.1 6.7 21.8 6.4 4.0 3.2 0.3 6.5 7.4 1.3 1.7 1.2 7.0 3.2 3.4 0.4 0.0 2.5 1.6 3.0 34.2 0.9 1.4 11.5 12.2 3.5 98.2 4.1 2.5 2.6 6.5 2.1 3.6 6.5 1.2 0.5 0.6 1.3 6.6 29.2 0.6 0.2 25.4 1.2 0.5 9.2 12.3 31.0 65.7 40.8 16.9 10.0 0.4 0.5 0.1 2.0 15.0 15.4 63.5 0.0 100.6 3.1 97.8 0.5 0.2 146.2 4.3 25.6 0.0 0.4 19.9 58.8 34.4 26.8 23.1 0.0 0.7 0.5 0.7 2.0 0.3 0.0 0.9 3.1 1.3 1.3 0.5 2.2 0.2 9.2 0.2 0.2 0.2 82.8 0.1 0.8 3.7 1.3 0.3 0.0 5.6 3.2 3.2 50.1 1.8 1.8 0.1 49.0 0.4 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.0 2.8 2.1 0.3 6.5 7.0 3.2 3.0 2.6 6.5 0.6 0.4 0.0 0.0 10.7 0.2 72.5 24.1 59.3 67.2 17.7 1.0 10.2 6.6 0.0 10.6 11.0 10.4 1.4 0.1 0.6 0.0 0.9 11.8 3.1 45.3 1.4 1.8 0.0 6.8 0.7 1.0 8.3 1.1 4.0 0.0 0.8 0.4 0.7 1.6 8.4 11.6 0.7 0.0 0.3 4.2 6.3 5.0 0.8 8.8 8.4 0.1 2.6 0.0 4.0 4.4 15.6 0.1 5.7 0.0 5.7 0.2 0.3 2.5 12.9 0.0 2.0 13.4 2.6 1.5 11.3 24.2 1.2 0.8 5.0 0.2 5.8 UQCRC1 "D3S3191, QCR1, UQCR1" ENSG00000010256 "Ubiquinol-cytochrome c reductase core protein 1" P31930 3 48599002-48610976 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 766.7;tongue: 882.7" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 662.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002815, HPA003525, CAB033782" Enhanced Supported Mitochondria NA NA 250000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "CAB033782: AB_2213631, HPA002815: AB_1080486, HPA003525: AB_1080484" "unprognostic (1.29e-1)" "unprognostic (3.15e-3)" "unprognostic (6.91e-3)" "unprognostic (1.06e-1)" "unprognostic (1.66e-1)" "unprognostic (9.91e-2)" "unprognostic (8.53e-2)" "unprognostic (1.99e-1)" "unprognostic (3.11e-2)" "unprognostic (9.14e-2)" "unprognostic (3.37e-1)" "unprognostic (7.20e-2)" "prognostic favorable (2.35e-10)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "unprognostic (1.02e-1)" "unprognostic (6.72e-2)" 66.0 58.2 93.7 46.9 97.1 62.4 55.0 117.3 110.1 50.7 127.2 156.9 156.3 35.5 50.4 78.9 66.2 33.9 387.7 96.7 115.0 131.3 149.0 42.1 42.8 111.0 101.7 36.1 87.4 192.2 30.6 56.0 114.6 51.8 129.6 52.9 105.9 77.5 766.7 78.6 125.4 62.8 99.3 41.0 103.3 52.1 111.6 72.7 48.4 882.7 58.0 63.5 40.0 101.4 118.2 169.6 136.7 145.0 147.5 117.0 225.2 129.4 206.1 196.5 178.9 272.8 107.1 193.4 94.4 143.2 274.1 123.6 171.6 280.9 91.7 138.3 173.8 214.7 186.7 317.1 186.9 164.4 152.2 150.9 293.6 183.2 274.6 167.5 172.5 173.7 110.5 107.1 152.5 192.0 156.7 241.6 157.6 229.6 324.2 103.4 138.1 273.5 235.8 178.7 84.4 107.5 182.8 218.7 211.8 92.0 163.1 178.0 112.5 107.7 153.7 179.5 272.4 124.8 121.4 136.5 192.7 233.9 319.0 251.3 643.7 325.4 204.7 665.7 193.7 260.0 203.5 206.1 593.3 227.7 177.1 175.2 158.2 194.4 608.0 235.0 258.1 988.2 93.7 97.1 117.3 110.1 96.7 115.0 111.0 101.7 114.6 99.3 111.6 101.4 31.5 57.7 50.4 17.3 59.0 117.6 164.6 339.4 103.6 41.9 59.3 46.1 662.2 140.2 139.2 121.4 29.2 334.4 28.0 550.2 365.9 163.7 155.0 64.0 41.6 53.4 144.5 80.6 16.9 166.3 311.1 78.2 167.7 61.5 82.4 72.5 49.6 188.0 238.2 40.4 22.0 319.6 223.8 118.1 85.4 331.9 58.4 107.7 119.2 12.2 129.1 67.1 51.5 14.6 12.5 163.5 333.3 70.7 117.6 78.4 553.4 398.4 104.7 65.0 59.2 61.2 153.0 110.3 74.7 173.0 105.4 336.7 50.8 172.1 416.8 153.4 TMEM89 ENSG00000183396 "Transmembrane protein 89" A2RUT3 3 48620759-48621769 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 24.8" "Group enriched" "Detected in some" 16 "Early spermatids: 329.4;Late spermatids: 228.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA053577 Uncertain NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA053577: AB_2682196" "unprognostic (1.61e-1)" "unprognostic (2.50e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" "unprognostic (1.07e-1)" "unprognostic (1.94e-3)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (7.12e-2)" "unprognostic (2.02e-2)" "unprognostic (6.31e-3)" "unprognostic (5.90e-3)" "unprognostic (3.35e-2)" "unprognostic (3.83e-2)" "unprognostic (8.41e-2)" "unprognostic (2.71e-1)" "unprognostic (3.86e-2)" 0.1 0.0 0.1 0.0 0.1 1.7 0.1 0.1 0.4 0.1 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.3 0.6 0.1 0.0 0.1 0.5 24.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.3 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.1 0.0 0.3 0.0 0.4 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.3 0.4 0.9 0.4 0.1 0.2 0.1 0.5 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 329.4 0.0 0.0 0.1 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 228.6 2.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 17.3 1.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 SLC26A6 DKFZp586E1422 ENSG00000225697 "Solute carrier family 26 member 6" Q9BXS9 3 48625723-48635493 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Anion exchange, Antiport, Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 69.7;Intestinal goblet cells: 34.0;Paneth cells: 40.9;Proximal enterocytes: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048363 Approved NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA048363: AB_2680371" "unprognostic (1.54e-1)" "unprognostic (4.94e-2)" "unprognostic (3.34e-1)" "unprognostic (3.15e-2)" "unprognostic (2.15e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (3.92e-4)" "unprognostic (2.39e-1)" "unprognostic (2.35e-1)" "unprognostic (2.04e-1)" "unprognostic (4.09e-1)" "unprognostic (9.66e-3)" "prognostic unfavorable (1.53e-5)" "unprognostic (1.39e-2)" "unprognostic (1.17e-1)" "unprognostic (1.55e-1)" "unprognostic (3.58e-2)" 5.6 6.8 4.8 5.2 5.2 18.1 5.5 5.1 6.5 9.3 5.4 28.0 8.2 7.4 3.6 5.2 6.6 3.7 8.1 4.7 5.0 19.6 7.6 9.5 3.9 5.6 5.1 7.3 11.4 3.6 5.5 5.5 5.9 12.4 21.6 4.1 5.8 4.2 9.5 6.7 22.4 5.6 5.2 12.5 26.8 5.6 5.6 3.8 6.3 6.1 3.2 6.6 7.9 6.2 8.5 8.9 13.2 15.0 39.9 19.8 11.2 13.7 17.7 25.8 27.4 17.6 7.6 12.0 4.6 11.6 28.7 11.2 12.1 12.5 7.2 9.3 12.0 10.8 29.6 34.3 29.4 5.2 16.5 27.4 44.0 17.7 12.4 22.1 8.0 12.4 8.6 13.2 6.2 9.8 10.4 27.0 18.5 23.0 17.9 5.2 4.8 14.5 18.8 7.9 3.3 6.2 17.7 21.3 25.2 17.9 11.2 19.2 6.9 11.6 9.2 15.0 31.7 15.7 17.8 5.6 9.7 20.5 28.4 6.8 11.1 2.3 3.0 10.8 2.7 0.9 1.8 1.9 9.0 0.2 1.0 1.5 1.5 0.6 10.1 5.1 3.4 5.0 4.8 5.2 5.1 6.5 4.7 5.0 5.6 5.1 5.9 5.2 5.6 6.2 4.3 3.2 5.9 10.7 2.1 3.2 2.6 8.0 5.7 2.1 3.8 2.7 6.6 1.5 3.8 1.8 14.6 9.3 2.4 69.7 0.0 2.9 1.2 1.3 3.2 5.1 20.4 4.0 2.0 6.3 15.0 4.0 13.3 2.7 0.0 3.1 4.2 6.3 7.0 5.0 2.1 34.0 10.2 5.3 7.4 0.9 3.7 6.3 5.4 1.9 5.8 1.6 6.2 2.5 2.5 5.8 40.9 9.4 5.8 2.0 43.6 6.2 3.7 6.9 0.0 1.3 4.5 2.9 6.9 2.4 3.4 10.5 3.8 13.5 26.8 1.0 CELSR3 "ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2" ENSG00000008300 "Cadherin EGF LAG seven-pass G-type receptor 3" Q9NYQ7 3 48636463-48662886 "G-protein coupled receptors, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 7.3;pituitary gland: 7.3;retina: 3.8;testis: 2.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 16.9;Cone photoreceptor cells: 16.7;Enteroendocrine cells: 9.0;Excitatory neurons: 10.1;Horizontal cells: 30.3;Inhibitory neurons: 10.8;Rod photoreceptor cells: 10.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 16.9;HeLa: 16.2;SH-SY5Y: 18.4;SiHa: 16.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062866 Approved NA NA "Cluster 58: Brain - Synaptic function" "Cluster 20: HeLa - Mitochondria" "Cluster 62: Horizontal cells - Visual perception" "HPA062866: AB_2684886" "unprognostic (7.80e-2)" "unprognostic (3.80e-2)" "unprognostic (4.89e-1)" "unprognostic (9.12e-4)" "unprognostic (1.51e-1)" "unprognostic (1.59e-6)" "unprognostic (3.61e-6)" "unprognostic (1.86e-1)" "unprognostic (1.46e-3)" "unprognostic (5.07e-2)" "unprognostic (2.13e-3)" "unprognostic (2.87e-3)" "unprognostic (3.26e-3)" "unprognostic (9.53e-2)" "unprognostic (1.42e-1)" "unprognostic (3.86e-2)" "unprognostic (1.73e-1)" 0.2 1.2 2.4 0.3 2.9 0.6 0.2 7.3 5.6 0.2 0.0 0.3 0.3 0.3 0.3 0.1 0.2 0.1 0.1 2.8 0.7 0.1 0.1 0.2 0.4 0.0 0.0 0.2 0.8 0.2 7.3 0.2 0.0 0.2 0.3 3.8 0.1 0.2 0.1 0.4 0.4 0.2 0.0 0.3 0.6 2.2 0.0 0.1 0.2 0.0 0.2 0.1 0.2 1.1 5.0 3.7 6.0 3.6 0.7 1.1 1.6 0.3 0.7 0.8 1.1 7.0 3.7 1.1 0.9 0.2 3.1 0.6 1.9 0.3 0.4 16.9 1.0 1.7 16.2 2.5 1.1 1.6 2.6 0.5 4.7 0.4 8.5 0.2 0.1 3.5 0.6 5.0 1.2 5.4 0.1 0.1 3.4 1.8 1.6 0.4 0.8 5.2 0.0 3.4 13.5 18.4 16.6 0.3 0.6 0.8 8.1 3.2 0.1 5.9 5.6 7.8 2.9 0.4 9.5 4.4 4.2 1.2 9.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.4 2.9 7.3 5.6 2.8 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 0.5 0.7 0.7 0.4 0.1 0.3 1.2 16.9 1.8 2.0 2.7 0.0 0.1 0.0 16.7 0.2 0.8 1.0 0.0 0.2 3.5 0.7 0.9 0.8 9.0 2.1 10.1 0.0 0.3 0.3 0.5 2.5 1.3 0.5 0.4 0.6 0.2 30.3 10.8 1.9 0.0 0.0 0.3 2.3 0.3 0.3 0.0 0.0 0.1 1.0 0.0 1.5 3.6 0.2 0.1 0.0 0.9 0.2 0.2 0.1 0.2 10.9 0.0 0.3 0.7 5.7 3.9 0.6 0.4 0.1 0.6 0.5 0.5 0.1 NCKIPSD "AF3P21, DIP1, ORF1, SPIN90, WASLBP, WISH" ENSG00000213672 "NCK interacting protein with SH3 domain" Q9NZQ3 3 48673844-48686364 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 121.9" "Cell type enhanced" "Detected in many" "Peritubular cells: 47.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019267, HPA050005" Enhanced "Plasma membrane" NA NA 110000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 20: HeLa - Mitochondria" "Cluster 43: Cardiomyocytes - Nuclear processes" "Plasma membrane" "CAB019267: , HPA050005: AB_2680988" "unprognostic (1.55e-2)" "unprognostic (2.02e-1)" "unprognostic (2.15e-1)" "unprognostic (1.79e-1)" "unprognostic (9.64e-3)" "unprognostic (5.50e-3)" "prognostic unfavorable (8.57e-4)" "unprognostic (1.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (2.40e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.20e-5)" "unprognostic (1.60e-2)" "unprognostic (1.55e-1)" "unprognostic (3.73e-2)" "unprognostic (2.09e-2)" 18.6 17.7 25.5 6.3 28.5 5.9 17.0 16.4 47.6 14.9 2.4 13.7 10.0 12.9 11.4 11.1 16.3 12.4 37.5 26.3 23.0 19.3 14.3 16.5 8.5 23.1 16.4 31.1 11.8 121.9 20.1 11.1 22.5 17.5 9.8 11.3 14.1 15.8 12.6 19.8 12.5 11.7 13.1 11.5 11.6 16.4 23.7 6.3 13.6 10.0 7.0 12.6 14.6 29.3 20.9 18.0 18.0 18.6 24.0 14.5 25.0 20.5 22.8 22.2 28.2 26.6 12.4 15.3 10.9 12.2 25.4 13.8 23.2 27.1 12.7 17.3 28.3 27.4 73.2 21.5 20.9 18.8 29.6 14.0 23.3 30.9 19.3 25.2 12.8 19.1 9.5 19.8 18.1 15.3 17.1 15.8 21.0 20.6 31.5 8.6 8.3 25.8 12.3 21.2 18.7 15.1 21.4 19.9 17.4 16.3 17.7 22.7 7.2 19.0 21.3 22.8 27.5 17.7 14.1 17.0 21.7 24.6 29.8 0.6 2.9 0.1 2.1 3.4 1.5 2.9 2.4 2.4 3.6 1.4 3.5 2.4 0.2 3.4 1.8 5.2 2.9 2.9 25.5 28.5 16.4 47.6 26.3 23.0 23.1 16.4 22.5 13.1 23.7 29.3 15.9 0.0 6.9 7.2 2.9 2.5 3.7 8.1 1.8 9.2 3.8 5.5 17.0 5.7 4.0 1.8 12.5 9.6 4.5 10.8 5.9 7.0 2.4 4.7 5.5 8.1 8.4 4.8 11.8 4.6 10.5 5.4 6.6 5.8 5.7 7.6 23.6 6.4 8.6 11.8 10.9 6.0 6.1 6.5 6.1 2.5 18.3 6.4 1.8 1.9 4.5 3.5 0.0 2.5 8.3 7.5 6.2 47.4 3.9 2.3 13.8 7.6 3.9 6.3 13.1 4.0 6.4 5.6 18.4 2.8 1.7 8.2 3.3 8.6 8.7 2.3 IP6K2 IHPK2 ENSG00000068745 "Inositol hexakisphosphate kinase 2" Q9UHH9 3 48688003-48740353 "Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007532, HPA070811" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 50: Non-specific - Ribosome" "Cluster 20: HeLa - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA007532: AB_1851542, HPA070811: AB_2732165" "prognostic favorable (1.25e-4)" "unprognostic (2.55e-2)" "unprognostic (8.86e-2)" "unprognostic (6.69e-3)" "unprognostic (1.01e-1)" "unprognostic (1.49e-2)" "unprognostic (1.76e-3)" "prognostic favorable (2.95e-4)" "unprognostic (6.57e-3)" "unprognostic (1.56e-1)" "unprognostic (1.92e-3)" "unprognostic (1.99e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.64e-1)" "unprognostic (3.50e-2)" "prognostic favorable (1.83e-4)" 57.6 96.3 53.1 39.5 57.2 130.1 80.1 84.6 57.8 117.2 52.8 106.0 79.8 101.8 108.4 95.4 78.3 47.9 62.3 53.7 58.4 106.9 83.5 55.4 53.7 56.2 53.3 99.1 91.2 48.0 121.8 44.8 55.1 111.6 88.0 63.7 88.7 42.2 45.8 145.4 89.1 43.1 49.7 78.9 79.5 55.5 55.2 72.2 108.8 31.5 43.5 66.7 113.4 64.2 25.9 49.5 100.6 71.2 55.5 69.3 72.6 48.0 54.0 54.0 62.2 41.1 67.0 45.5 38.7 45.5 67.8 65.3 50.6 72.1 50.0 54.1 44.9 52.2 172.7 89.5 45.0 50.3 48.9 65.7 103.0 73.3 59.7 71.8 76.2 143.8 39.5 55.4 63.9 57.3 107.4 68.3 77.4 50.0 90.4 44.4 33.3 50.0 73.7 121.7 62.4 94.6 103.9 69.5 53.0 79.6 67.7 83.3 54.8 58.3 57.4 37.0 48.7 50.6 65.4 64.2 53.3 57.7 52.4 158.1 50.5 92.7 63.4 50.8 57.6 60.8 55.1 60.4 50.1 60.2 51.1 52.7 80.3 67.5 65.3 52.0 84.2 46.8 53.1 57.2 84.6 57.8 53.7 58.4 56.2 53.3 55.1 49.7 55.2 64.2 63.3 70.5 52.9 38.5 41.3 83.1 87.2 182.5 174.2 66.5 69.9 77.5 12.9 38.6 109.1 99.3 39.6 114.3 39.4 157.4 76.3 58.7 43.8 50.8 64.8 46.1 110.2 40.1 31.1 47.4 73.9 73.7 64.2 56.9 54.5 60.3 32.5 25.1 41.4 20.2 40.6 108.6 150.5 16.6 33.5 16.4 81.1 24.5 26.6 22.5 30.3 32.4 44.3 50.8 52.6 60.5 105.7 68.4 34.0 59.0 84.7 65.5 68.4 56.0 52.6 31.5 50.6 71.6 57.9 90.3 83.0 124.0 43.3 87.9 89.8 89.3 PRKAR2A PRKAR2 ENSG00000114302 "Protein kinase cAMP-dependent type II regulatory subunit alpha" P13861 3 48744597-48847874 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 82.7;testis: 82.5" "Group enriched" "Detected in all" 8 "Early spermatids: 788.7;Late spermatids: 1370.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005023, HPA038268" Uncertain NA NA 210000 "Cluster 14: Monocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 34: Spermatids - Unknown function" "CAB005023: AB_562330, HPA038268: AB_2675921" "unprognostic (2.81e-2)" "unprognostic (3.59e-1)" "prognostic favorable (4.27e-5)" "unprognostic (1.60e-1)" "unprognostic (4.01e-2)" "unprognostic (6.17e-3)" "prognostic unfavorable (1.97e-4)" "unprognostic (4.77e-2)" "unprognostic (2.65e-1)" "unprognostic (1.47e-1)" "unprognostic (1.13e-1)" "unprognostic (9.18e-2)" "prognostic favorable (2.07e-4)" "unprognostic (3.59e-2)" "unprognostic (3.54e-1)" "unprognostic (1.46e-3)" "unprognostic (1.08e-2)" 19.0 14.8 8.3 11.6 7.4 18.5 13.0 8.1 9.1 10.4 11.7 23.5 12.9 9.9 9.3 18.5 17.6 8.3 17.2 7.9 14.3 18.1 15.8 12.5 8.9 12.4 10.1 10.7 12.5 16.5 6.8 11.4 11.7 14.3 19.6 15.8 17.1 14.4 82.7 13.8 13.9 16.2 11.8 9.3 14.2 82.5 10.8 4.9 17.2 39.4 12.5 11.8 10.0 12.0 39.2 25.9 21.2 16.4 31.1 31.4 23.8 44.0 21.8 37.7 23.7 34.4 17.1 34.3 30.1 45.7 24.4 17.6 61.0 38.4 50.4 28.3 22.6 45.8 44.7 25.4 22.8 48.6 28.3 26.2 29.5 48.5 35.4 14.1 40.2 11.5 52.3 21.4 35.9 15.2 0.4 15.7 15.1 28.6 28.4 14.7 26.9 43.6 24.2 42.4 21.0 21.6 43.2 50.8 29.1 22.8 34.2 37.1 51.5 33.0 26.3 54.2 61.0 36.2 76.4 32.5 44.5 52.5 25.4 8.0 6.5 8.0 6.7 6.1 6.6 6.0 5.8 5.8 6.3 5.0 3.9 4.0 9.2 7.0 12.0 3.9 5.5 5.2 8.3 7.4 8.1 9.1 7.9 14.3 12.4 10.1 11.7 11.8 10.8 12.0 61.5 19.2 62.2 42.1 36.5 41.9 25.5 26.9 48.9 44.2 51.0 34.9 70.8 50.1 33.1 46.0 68.8 25.0 61.2 92.3 21.5 41.3 788.7 64.2 60.4 48.8 42.0 22.9 62.4 60.3 34.6 37.6 43.8 41.3 13.3 29.4 55.0 121.4 48.8 62.2 73.1 42.5 34.6 52.2 45.3 1370.7 55.0 48.0 30.2 38.4 48.3 24.8 39.1 42.7 90.9 66.4 46.9 55.7 48.6 34.0 45.2 41.2 50.3 46.2 52.6 51.8 46.6 82.1 61.0 79.0 62.8 23.5 54.1 32.8 87.9 26.6 SLC25A20 "CAC, CACT" ENSG00000178537 "Solute carrier family 25 member 20" O43772 3 48856926-48898904 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 148.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 42.2;Hepatocytes: 64.2;Proximal enterocytes: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 96.1;RPMI-8226: 138.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016862, HPA029863" Approved Approved Mitochondria,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Mitochondria, Cytosol" "HPA016862: AB_1857028, HPA029863: AB_10602893" "unprognostic (1.02e-1)" "unprognostic (1.84e-1)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (5.18e-2)" "unprognostic (3.97e-2)" "unprognostic (1.03e-1)" "unprognostic (5.96e-3)" "unprognostic (4.06e-1)" "unprognostic (1.73e-1)" "unprognostic (1.36e-2)" "unprognostic (2.51e-1)" "unprognostic (3.71e-3)" "unprognostic (3.34e-1)" "unprognostic (5.12e-1)" "unprognostic (4.22e-2)" "unprognostic (3.49e-2)" 20.7 29.9 16.3 11.9 18.2 10.7 17.9 18.6 16.4 8.3 15.3 26.5 65.6 10.4 4.6 9.1 12.8 15.7 62.8 15.5 17.9 25.6 148.3 15.6 14.6 17.7 17.4 5.9 30.4 17.3 11.6 7.3 17.8 11.7 23.5 4.5 19.9 9.0 66.5 10.4 52.7 15.1 17.4 20.6 21.0 9.1 17.5 17.3 11.4 61.1 16.1 11.3 8.4 18.4 4.1 12.8 9.7 13.8 30.1 11.8 1.9 22.3 11.8 15.2 15.8 16.3 19.1 19.0 15.6 35.1 18.7 4.1 24.5 9.8 11.6 47.9 11.8 26.4 19.2 20.4 14.0 27.8 48.1 14.9 11.2 20.6 3.8 6.1 20.2 28.1 24.1 96.1 20.2 10.9 30.4 13.7 5.1 22.9 27.6 10.6 5.9 138.4 16.4 10.1 3.9 13.6 20.7 0.2 11.4 13.6 30.5 12.9 16.6 17.2 3.2 25.5 16.4 35.6 27.0 21.8 24.5 19.5 23.3 60.8 101.1 215.2 97.4 79.7 62.2 36.8 53.1 71.2 97.5 33.0 41.2 69.1 48.6 64.6 83.7 120.5 60.7 112.3 16.3 18.2 18.6 16.4 15.5 17.9 17.7 17.4 17.8 17.4 17.5 18.4 7.5 6.4 2.7 13.1 7.0 1.8 2.5 4.6 3.4 1.1 4.0 3.6 42.2 4.3 4.4 0.0 6.2 2.3 13.6 28.4 3.9 3.5 1.3 2.3 4.6 5.5 7.3 16.4 2.2 4.3 2.3 6.1 9.2 2.1 1.3 3.8 7.5 64.2 16.9 0.0 3.8 12.7 2.0 13.4 4.5 1.8 10.5 10.0 1.8 1.0 31.3 2.9 32.0 1.0 6.0 3.7 16.4 12.4 12.6 3.9 51.8 16.7 5.9 1.3 0.0 5.4 5.3 8.3 7.1 4.1 1.3 1.2 14.4 27.7 16.6 2.9 ARIH2 TRIAD1 ENSG00000177479 "Ariadne RBR E3 ubiquitin protein ligase 2" O95376 3 48918821-48986382 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067381, HPA069715, HPA070963" Enhanced Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA067381: AB_2685827, HPA069715: AB_2686182, HPA070963: AB_2686329" "unprognostic (7.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.26e-1)" "unprognostic (2.74e-1)" "unprognostic (2.55e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.90e-2)" "unprognostic (4.01e-2)" "unprognostic (5.01e-2)" "prognostic favorable (7.31e-4)" "unprognostic (5.01e-3)" "prognostic favorable (6.60e-4)" "unprognostic (1.15e-1)" "unprognostic (7.04e-2)" "unprognostic (1.27e-2)" "unprognostic (1.39e-2)" 20.6 22.9 21.4 16.0 24.5 23.0 19.8 24.2 23.7 21.4 24.7 29.4 11.7 24.5 33.8 19.5 21.3 15.0 53.9 21.3 23.4 22.7 21.3 19.7 20.7 22.9 22.9 20.7 24.1 24.4 26.0 18.4 23.8 23.1 17.7 32.4 18.6 21.9 100.4 16.5 21.2 24.4 22.0 24.3 22.5 27.0 22.8 26.1 22.0 79.6 21.4 23.6 17.4 27.7 40.4 39.6 37.6 53.2 54.3 29.7 52.4 46.3 53.5 56.5 62.1 42.0 35.0 84.1 21.4 49.8 82.0 23.5 77.9 47.2 68.7 57.0 48.1 85.3 51.7 34.5 48.9 63.4 39.5 31.9 70.2 70.9 94.9 32.2 43.1 38.3 68.4 54.6 50.7 27.8 65.4 25.8 64.3 43.3 59.5 23.5 42.8 70.2 32.9 54.1 16.4 44.8 47.7 56.1 45.0 44.1 28.6 43.8 41.4 34.1 49.4 52.5 74.0 72.8 148.1 103.3 37.3 51.9 43.7 53.1 34.6 39.9 44.2 32.2 30.5 28.8 28.2 37.1 32.3 34.2 29.2 37.3 25.6 25.8 20.9 29.9 35.5 39.3 21.4 24.5 24.2 23.7 21.3 23.4 22.9 22.9 23.8 22.0 22.8 27.7 37.0 35.3 31.4 54.9 50.2 50.9 51.5 27.3 68.3 57.0 35.5 35.3 74.6 32.9 44.0 29.5 87.6 36.4 76.0 31.3 29.4 33.8 15.3 33.5 48.3 38.4 16.7 76.2 50.0 43.2 36.2 40.1 42.3 38.1 45.5 42.3 28.5 44.6 26.6 57.2 59.1 26.2 14.2 32.8 35.7 11.3 41.7 44.6 30.2 38.4 45.2 42.2 95.8 42.3 128.6 42.1 23.0 43.2 85.0 78.9 20.8 34.3 30.6 82.5 26.3 51.5 48.6 165.7 89.7 59.4 54.0 53.4 66.8 37.7 31.6 67.0 P4HTM "EGLN4, FLJ20262, HIFPH4, P4H-TM, PH-4, PH4, PHD4" ENSG00000178467 "Prolyl 4-hydroxylase, transmembrane" Q9NXG6 3 48989889-49007153 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 155.3;Respiratory ciliated cells: 169.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007199 Supported Uncertain Vesicles,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 25: RPMI-8226 - Immune response" "Cluster 49: Ciliated cells - Cilium organization" "Vesicles, Cytosol" "HPA007199: AB_1855272" "unprognostic (1.95e-2)" "unprognostic (3.12e-2)" "unprognostic (9.47e-2)" "prognostic favorable (8.18e-4)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (6.47e-2)" "unprognostic (2.02e-2)" "unprognostic (1.89e-2)" "unprognostic (3.78e-2)" "unprognostic (2.51e-3)" "unprognostic (1.54e-2)" "prognostic favorable (3.28e-5)" "unprognostic (1.10e-2)" "unprognostic (3.51e-1)" "unprognostic (2.60e-2)" "unprognostic (9.65e-3)" 13.3 37.1 50.6 4.9 53.3 5.9 12.4 44.3 67.9 18.4 89.7 14.7 12.1 17.6 18.7 8.2 39.8 11.2 26.2 53.5 57.3 29.8 11.9 15.7 6.5 52.2 49.6 20.0 38.5 39.4 75.9 11.0 51.5 18.5 7.4 16.4 19.6 16.8 15.2 10.1 13.0 7.4 45.8 10.7 25.1 23.6 53.3 5.5 26.5 11.3 3.8 12.8 13.1 49.6 8.6 27.9 4.8 0.1 15.5 17.6 0.4 16.8 24.6 13.2 14.8 6.3 55.6 8.1 15.8 21.6 10.5 4.8 12.5 6.6 4.1 30.4 19.5 0.0 42.1 0.0 38.6 8.3 0.2 11.0 6.3 13.4 1.1 51.4 15.0 0.1 0.0 37.9 6.5 48.1 1.2 1.0 6.8 52.6 31.2 0.0 0.0 53.5 24.4 15.9 20.9 0.2 17.7 25.0 0.1 1.1 20.1 13.1 9.9 8.0 6.1 19.9 14.5 50.0 28.6 0.1 54.9 0.7 7.1 8.0 9.0 5.9 6.7 3.5 9.6 8.4 12.3 11.7 9.4 15.9 13.0 8.3 0.8 5.9 4.5 1.6 17.0 6.0 50.6 53.3 44.3 67.9 53.5 57.3 52.2 49.6 51.5 45.8 53.3 49.6 15.1 22.4 17.3 36.2 16.1 9.2 34.6 41.1 12.5 72.9 28.7 23.0 12.0 41.5 44.0 46.0 87.6 31.4 13.4 27.4 19.6 38.3 138.4 106.4 23.7 12.6 80.9 12.4 55.7 39.1 9.9 28.1 48.9 31.2 22.9 31.6 15.4 8.5 16.8 117.8 48.6 40.4 65.1 6.3 12.8 155.3 30.4 13.0 12.4 20.6 11.3 58.4 14.4 17.1 32.3 23.6 51.8 25.9 28.9 24.4 56.2 30.4 169.4 72.5 19.7 32.9 24.7 32.5 7.0 12.9 10.4 26.1 25.0 23.9 40.9 31.2 WDR6 ENSG00000178252 "WD repeat domain 6" Q9NNW5 3 49007062-49015953 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042622 Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 35: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Cytosol "Plasma membrane" "HPA042622: AB_10966784" "unprognostic (2.41e-2)" "unprognostic (2.03e-1)" "unprognostic (2.14e-1)" "unprognostic (1.26e-2)" "unprognostic (4.80e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.97e-6)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (1.01e-3)" "unprognostic (1.94e-2)" "prognostic favorable (4.52e-5)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.87e-1)" "unprognostic (1.61e-2)" 67.5 148.8 108.7 51.9 106.3 41.8 69.8 104.9 124.5 153.1 120.1 130.1 66.5 122.8 83.1 65.1 129.8 59.7 82.7 105.8 116.3 113.7 97.7 77.8 61.2 105.1 112.8 205.9 136.7 91.0 207.4 46.1 108.1 159.3 50.9 49.4 99.2 74.1 71.4 63.7 105.4 68.1 102.0 112.9 93.3 61.2 120.9 54.7 178.2 37.8 53.5 118.8 90.5 107.2 61.4 82.4 133.7 113.7 87.8 71.1 90.1 89.4 73.1 98.7 79.4 73.9 86.2 98.3 55.5 143.2 75.8 68.1 107.8 125.0 70.0 78.3 71.8 93.1 223.0 98.8 88.8 97.3 40.3 128.5 87.3 91.1 68.4 136.2 73.0 101.8 54.0 102.4 90.6 121.7 113.5 109.8 119.1 55.7 75.9 65.5 57.3 61.8 117.6 179.3 64.9 121.0 66.8 54.1 40.6 96.9 94.8 76.7 98.4 72.7 116.1 71.3 121.1 177.3 82.7 84.3 98.7 122.2 53.4 6.4 11.5 12.8 19.0 15.5 21.1 13.0 13.9 14.4 13.5 12.8 15.8 12.2 3.9 14.6 8.0 17.0 12.6 16.8 108.7 106.3 104.9 124.5 105.8 116.3 105.1 112.8 108.1 102.0 120.9 107.2 16.0 22.4 48.5 67.9 28.0 17.8 24.3 32.0 27.9 26.0 48.1 43.1 3.1 42.9 38.5 47.8 47.9 46.5 21.4 18.4 9.8 30.7 4.3 34.6 32.3 20.8 72.3 16.6 9.3 26.0 21.0 24.1 36.7 39.2 29.1 66.7 26.0 44.7 26.8 37.0 17.5 32.3 28.5 19.2 20.2 7.0 38.2 18.7 12.4 22.5 24.7 39.0 12.3 27.2 23.3 28.0 23.5 28.2 29.9 26.2 30.8 31.3 26.2 46.4 26.3 20.0 21.0 43.0 34.9 15.5 11.4 56.5 25.9 44.7 36.4 19.9 DALRD3 FLJ10496 ENSG00000178149 "DALR anticodon binding domain containing 3" Q5D0E6 3 49015488-49022293 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 158.9;Late spermatids: 306.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036862 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "Nuclear bodies, Cytosol" "HPA036862: AB_10673507" "unprognostic (2.76e-2)" "unprognostic (8.44e-3)" "unprognostic (3.56e-1)" "prognostic favorable (9.03e-4)" "unprognostic (3.77e-1)" "unprognostic (1.52e-1)" "unprognostic (3.33e-3)" "unprognostic (1.19e-2)" "unprognostic (5.33e-2)" "unprognostic (9.52e-2)" "unprognostic (8.07e-2)" "unprognostic (1.11e-1)" "prognostic favorable (2.79e-5)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" "unprognostic (1.15e-2)" "unprognostic (2.18e-1)" 11.8 18.5 11.2 6.0 10.9 5.4 14.2 10.6 12.4 14.1 14.5 10.1 7.8 9.8 13.1 18.3 36.9 10.5 10.0 10.8 10.8 21.4 9.0 9.9 9.1 11.5 12.6 15.2 38.7 13.9 14.4 9.6 10.9 10.2 7.9 6.5 11.6 9.5 11.0 18.8 9.6 6.9 12.0 10.8 14.7 51.0 11.2 9.4 19.2 6.9 12.3 10.7 11.5 10.8 12.0 16.6 10.2 20.0 28.5 37.8 12.4 9.9 27.5 16.5 15.8 11.7 14.9 4.9 13.7 27.3 14.3 7.8 13.4 26.1 11.5 7.0 9.1 5.3 13.9 22.0 18.7 15.0 10.5 25.7 26.6 20.9 46.1 42.0 26.0 11.2 4.3 12.0 16.4 20.8 6.6 10.1 16.8 25.3 15.5 3.5 1.5 35.7 44.4 19.0 6.5 21.1 10.9 30.1 23.7 16.8 21.3 16.2 15.9 6.4 9.7 22.6 9.2 37.8 21.9 3.0 24.2 8.3 12.9 12.0 11.1 5.5 13.9 13.7 25.0 23.9 22.4 17.1 11.7 21.1 18.7 12.5 10.9 22.6 12.8 8.1 29.5 12.8 11.2 10.9 10.6 12.4 10.8 10.8 11.5 12.6 10.9 12.0 11.2 10.8 26.8 16.0 12.2 8.5 27.3 25.6 21.6 28.5 22.8 30.2 35.5 40.5 1.2 27.1 20.8 27.6 18.8 28.2 30.0 25.0 37.2 40.7 158.9 61.2 21.5 16.3 19.1 11.1 10.7 39.4 40.0 19.8 28.5 24.6 24.7 32.4 15.0 5.9 19.2 40.4 9.5 22.3 20.3 12.9 24.5 306.6 24.2 16.8 21.4 2.8 23.5 25.8 13.4 6.6 5.5 21.5 21.3 18.4 18.2 10.0 50.4 49.9 75.3 58.4 46.0 19.1 19.0 110.7 33.4 26.5 34.1 18.3 27.1 29.7 30.0 17.3 NDUFAF3 "2P1, C3orf60, DKFZP564J0123, E3-3, MGC10527" ENSG00000178057 "NADH:ubiquinone oxidoreductase complex assembly factor 3" Q9BU61 3 49020459-49023495 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 329.8" "Group enriched" "Detected in all" 4 "Distal tubular cells: 475.4;Early spermatids: 1124.6;Late spermatids: 1303.4;Proximal tubular cells: 658.1;Spermatocytes: 913.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035376, HPA035377" Enhanced NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 43: Testis - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA035376: AB_2674597, HPA035377: AB_10673219" "unprognostic (2.90e-2)" "unprognostic (2.72e-2)" "unprognostic (6.88e-2)" "unprognostic (3.03e-2)" "unprognostic (3.57e-2)" "unprognostic (2.61e-1)" "unprognostic (6.28e-3)" "unprognostic (4.12e-2)" "unprognostic (1.55e-1)" "unprognostic (1.64e-2)" "unprognostic (8.62e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.86e-5)" "unprognostic (7.97e-2)" "unprognostic (1.73e-1)" "unprognostic (8.02e-2)" "unprognostic (1.60e-1)" 69.0 121.9 112.1 36.4 119.9 51.7 60.7 124.3 123.6 58.4 117.3 43.5 34.9 58.6 47.7 48.5 61.7 32.3 166.0 109.4 117.8 88.6 85.2 52.2 45.3 121.2 116.5 59.4 48.8 84.1 99.0 29.9 120.2 57.2 27.0 26.2 70.7 51.5 127.0 33.1 41.4 30.7 120.5 53.9 49.8 329.8 118.0 52.0 71.2 99.6 37.7 51.1 45.7 126.8 47.7 68.4 60.6 59.9 78.5 66.6 35.0 59.6 57.5 82.8 64.5 98.9 75.1 55.1 68.5 92.1 113.4 34.9 43.3 95.4 29.6 72.9 76.8 109.5 129.9 124.8 110.4 92.2 50.8 68.5 72.5 116.6 85.8 98.9 73.0 169.4 31.4 136.0 90.8 73.9 134.1 46.5 20.1 78.1 183.0 41.1 24.3 169.3 136.7 97.4 52.9 61.6 55.0 115.1 59.1 27.3 66.5 177.6 64.4 76.4 52.0 108.0 100.1 110.8 79.3 86.6 93.2 48.4 121.8 144.3 164.6 143.9 157.6 175.3 168.4 244.1 172.6 160.6 144.9 234.0 223.3 170.2 51.8 154.9 201.2 297.8 180.5 250.4 112.1 119.9 124.3 123.6 109.4 117.8 121.2 116.5 120.2 120.5 118.0 126.8 117.4 93.0 95.2 7.2 95.3 53.3 143.7 113.6 66.0 60.4 119.4 125.5 198.0 104.4 109.6 150.8 2.1 135.2 81.9 124.6 475.4 171.7 1124.6 123.4 81.8 104.3 132.0 118.2 7.2 155.7 128.0 121.2 50.0 58.2 117.3 73.1 114.9 150.6 217.8 69.0 8.3 118.1 103.7 114.1 73.8 1303.4 170.2 129.5 136.9 11.2 149.6 171.5 103.0 6.6 19.6 139.5 148.0 120.7 151.1 175.5 176.9 658.1 199.2 52.8 72.3 87.5 106.4 913.0 88.6 108.4 54.8 106.9 91.2 105.6 109.4 154.9 IMPDH2 ENSG00000178035 "Inosine monophosphate dehydrogenase 2" P12268 3 49024325-49029447 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "GMP biosynthesis, Purine biosynthesis" "DNA-binding, Oxidoreductase, RNA-binding" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001400, CAB020717" Approved Supported "Cytosol,Rods & Rings" NA NA 340000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" Cytosol "Rods & Rings" "CAB020717: , HPA001400: AB_1079139" "unprognostic (2.09e-2)" "unprognostic (2.91e-1)" "unprognostic (5.96e-2)" "unprognostic (1.20e-1)" "unprognostic (7.31e-3)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (1.30e-1)" "unprognostic (2.65e-1)" "unprognostic (2.17e-1)" "unprognostic (5.44e-2)" "unprognostic (4.24e-2)" "unprognostic (1.30e-1)" "unprognostic (3.85e-1)" "unprognostic (5.80e-2)" "unprognostic (2.24e-1)" "unprognostic (4.47e-2)" 109.1 89.3 42.1 68.0 43.0 105.3 188.6 44.2 41.6 169.6 37.3 100.8 75.3 113.5 48.2 169.0 199.3 64.9 70.0 39.5 45.2 67.5 63.5 83.3 78.7 46.9 43.2 331.0 313.9 55.7 65.0 81.0 46.6 97.6 121.2 22.0 87.9 66.4 272.8 180.0 74.1 100.9 45.1 68.6 93.4 36.1 43.8 95.9 75.1 124.4 122.0 119.7 137.5 48.9 271.8 150.6 201.6 211.3 309.2 558.4 200.6 180.8 298.2 425.5 361.0 265.8 235.2 485.7 128.2 220.7 119.5 183.1 433.6 369.8 371.1 119.9 135.3 362.2 205.0 257.8 264.4 388.4 139.0 497.7 403.1 414.6 756.5 331.8 313.5 337.7 221.7 266.2 354.1 213.4 327.0 258.9 269.0 255.4 300.2 143.5 218.4 487.9 251.7 166.2 130.2 128.9 198.1 216.5 341.3 170.2 277.3 166.1 151.4 181.0 347.7 449.5 468.8 253.3 193.3 227.3 214.1 421.9 188.1 21.8 27.8 10.7 43.6 46.8 81.9 79.7 58.4 47.7 51.1 79.6 84.9 71.6 10.9 60.5 41.6 38.0 40.2 45.2 42.1 43.0 44.2 41.6 39.5 45.2 46.9 43.2 46.6 45.1 43.8 48.9 40.5 64.1 60.9 3.9 92.2 202.7 255.0 253.8 229.9 16.1 202.7 231.8 32.3 74.4 122.4 36.8 14.6 327.3 34.5 51.1 80.3 133.6 2.7 49.0 120.5 60.9 60.7 112.5 2.9 187.1 280.6 104.4 70.3 51.2 66.1 98.0 52.8 24.9 95.3 15.2 4.1 124.4 114.0 55.9 105.4 6.7 123.3 50.0 88.9 1.0 67.3 26.5 24.7 4.0 5.2 108.8 70.8 71.1 64.6 160.1 47.4 92.0 53.7 15.8 39.5 149.4 215.1 22.6 62.5 195.7 195.6 314.0 52.3 166.8 266.5 157.2 QRICH1 "AB-DIP, FLJ20259, VERBRAS" ENSG00000198218 "Glutamine rich 1" Q2TAL8 3 49029707-49094363 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, Unfolded protein response" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037677, HPA037678" Approved Enhanced Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA037677: AB_10671883, HPA037678: AB_2675603" "unprognostic (2.38e-2)" "unprognostic (2.05e-1)" "unprognostic (8.29e-2)" "unprognostic (1.67e-1)" "unprognostic (2.41e-1)" "unprognostic (3.14e-2)" "unprognostic (2.77e-3)" "unprognostic (6.94e-2)" "unprognostic (2.82e-2)" "prognostic favorable (7.46e-4)" "unprognostic (1.12e-1)" "unprognostic (1.40e-2)" "unprognostic (2.17e-3)" "unprognostic (5.06e-2)" "unprognostic (3.84e-1)" "unprognostic (1.76e-1)" "unprognostic (1.06e-1)" 29.8 27.9 15.4 30.5 17.0 61.0 27.8 25.3 20.2 25.8 16.0 25.9 26.3 28.6 25.9 30.0 27.6 25.2 26.0 16.9 14.8 21.3 23.5 27.8 40.1 14.7 13.2 34.0 26.0 33.2 24.8 27.0 14.6 25.8 25.2 30.4 28.3 26.3 34.8 35.4 31.0 28.9 13.2 35.8 25.9 44.5 13.3 51.9 25.7 32.4 41.9 26.8 23.7 16.9 41.4 39.6 78.6 35.6 48.2 45.8 48.2 48.4 60.3 75.6 70.7 44.3 50.8 65.6 29.1 58.9 62.8 33.5 69.0 63.0 64.8 57.8 45.1 65.5 52.9 37.8 43.1 57.9 75.0 53.3 47.4 74.8 46.6 46.2 60.3 62.7 45.0 58.6 51.6 31.8 84.9 41.4 62.3 43.7 48.9 43.3 40.3 55.4 47.6 63.2 29.9 58.9 54.9 47.7 39.7 59.3 42.4 65.5 52.5 49.0 55.1 43.7 69.8 54.2 66.6 82.2 44.0 55.2 57.2 21.3 15.6 19.1 18.1 18.9 21.5 16.6 17.3 20.6 18.5 16.6 18.3 22.0 11.7 18.1 33.0 13.5 19.8 14.3 15.4 17.0 25.3 20.2 16.9 14.8 14.7 13.2 14.6 13.2 13.3 16.9 21.8 9.6 18.9 19.6 30.5 22.2 13.7 16.0 17.1 13.6 20.6 17.7 21.1 14.3 17.9 20.2 22.9 25.7 28.2 16.6 1.9 15.9 15.8 19.8 20.7 19.6 25.9 22.5 37.9 14.0 27.8 20.3 23.9 27.5 16.5 20.0 18.9 20.4 19.7 11.8 39.1 20.6 10.2 25.3 18.3 10.9 22.4 19.5 12.4 14.0 22.3 12.5 15.5 24.6 25.5 18.6 10.5 30.9 39.7 18.0 14.4 10.1 15.2 17.6 6.6 21.9 25.3 52.4 27.8 24.5 22.6 36.8 28.5 17.0 16.8 15.5 QARS1 QARS ENSG00000172053 "Glutaminyl-tRNA synthetase 1" P47897 3 49095932-49105130 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Epilepsy, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 55.5;Cytotrophoblasts: 193.9;Extravillous trophoblasts: 156.7;Hofbauer cells: 96.1;Syncytiotrophoblasts: 187.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036986, HPA036987" Enhanced Enhanced Cytosol No No 58000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA036986: AB_10672344, HPA036987: AB_2675418" "prognostic favorable (1.43e-4)" "unprognostic (1.96e-1)" "unprognostic (7.31e-2)" "unprognostic (1.10e-2)" "unprognostic (5.13e-3)" "unprognostic (6.62e-3)" "unprognostic (6.53e-3)" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (2.51e-1)" "unprognostic (4.33e-1)" "unprognostic (9.14e-2)" "prognostic favorable (5.60e-6)" "unprognostic (2.73e-3)" "unprognostic (1.65e-1)" "unprognostic (2.74e-2)" "unprognostic (3.11e-1)" 61.1 58.8 20.0 57.2 21.3 96.6 89.5 23.5 18.5 58.3 34.2 104.8 101.6 45.5 58.5 102.5 71.0 48.3 72.0 18.4 21.1 57.1 51.1 52.3 75.8 23.8 21.0 69.0 73.9 78.1 33.0 76.7 23.0 60.4 121.0 21.4 103.2 61.1 156.1 105.0 84.6 60.2 22.7 60.1 75.0 30.0 23.0 92.3 53.2 146.2 118.8 72.8 58.1 24.6 95.9 97.8 128.0 197.4 146.4 180.8 159.2 90.5 188.2 160.5 152.9 123.0 113.5 257.1 61.4 136.7 95.3 119.9 166.3 137.8 111.4 78.2 148.0 206.4 156.0 216.1 91.2 187.2 130.9 184.8 123.1 127.4 108.1 175.3 184.7 144.6 95.3 112.4 118.0 89.2 130.7 154.9 116.1 159.0 122.9 76.0 123.7 200.6 108.5 163.9 48.7 161.6 85.4 211.0 147.8 122.7 184.4 205.5 137.6 82.8 127.3 131.7 117.9 111.9 176.5 142.9 88.4 156.3 60.3 30.7 84.3 25.8 44.5 104.1 57.4 62.2 54.1 47.0 127.0 49.9 46.6 49.0 8.0 71.8 94.5 57.4 82.1 81.2 20.0 21.3 23.5 18.5 18.4 21.1 23.8 21.0 23.0 22.7 23.0 24.6 15.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 0.0 0.0 0.0 0.0 193.9 11.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 156.7 14.7 0.0 0.0 0.0 0.0 0.0 0.0 96.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 187.0 2.0 0.0 0.0 0.0 USP19 "KIAA0891, ZMYND9" ENSG00000172046 "Ubiquitin specific peptidase 19" O94966 3 49108046-49120938 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 16: U-266 - Nucleosome" "Cluster 10: Non-specific - Unknown function" "unprognostic (3.23e-2)" "unprognostic (2.12e-1)" "unprognostic (5.91e-2)" "unprognostic (1.37e-1)" "unprognostic (1.92e-2)" "unprognostic (3.90e-3)" "unprognostic (2.99e-2)" "unprognostic (3.00e-3)" "unprognostic (2.69e-1)" "unprognostic (3.65e-2)" "unprognostic (2.31e-2)" "unprognostic (1.26e-1)" "prognostic favorable (7.05e-9)" "unprognostic (2.99e-1)" "unprognostic (2.11e-1)" "unprognostic (1.72e-3)" "unprognostic (7.54e-2)" 20.3 25.5 16.4 19.4 18.7 26.8 19.6 19.0 18.6 21.9 24.4 26.2 22.4 24.3 19.1 19.7 24.3 15.5 26.8 17.4 16.8 18.9 18.6 17.7 21.5 19.0 17.5 22.8 21.2 31.0 17.5 16.5 17.9 19.4 15.9 14.3 29.6 24.4 75.6 26.5 21.9 18.9 16.7 22.9 21.6 20.8 18.4 27.4 23.6 45.0 16.8 23.3 19.6 19.5 20.2 26.3 28.6 42.1 36.8 24.1 38.7 23.1 26.1 35.1 28.7 28.7 27.3 41.6 22.2 24.4 36.2 24.1 40.3 29.1 16.0 32.7 32.1 42.5 56.4 22.8 36.1 45.7 40.5 33.8 22.7 36.9 24.1 25.9 24.2 33.8 30.8 28.4 18.9 23.9 42.6 43.0 58.2 27.4 44.1 19.4 24.3 45.7 22.3 37.4 16.5 51.4 33.3 38.1 34.9 26.1 26.0 55.4 21.8 24.5 30.5 36.7 33.7 77.7 97.1 38.0 32.8 34.3 32.6 9.7 3.7 5.3 4.5 3.6 4.2 2.8 3.7 5.2 4.6 2.9 3.3 3.9 7.5 2.9 4.4 1.9 2.7 4.3 16.4 18.7 19.0 18.6 17.4 16.8 19.0 17.5 17.9 16.7 18.4 19.5 7.8 12.8 14.5 10.4 7.2 6.2 3.8 8.5 8.6 12.7 8.7 7.4 13.1 5.7 9.9 7.3 18.8 9.6 9.2 17.1 5.9 7.7 3.6 14.8 8.7 7.6 9.1 10.3 8.4 7.8 5.3 7.7 14.3 9.5 2.5 8.1 7.9 13.6 9.0 13.5 8.0 11.6 10.2 8.7 4.7 4.9 13.1 6.8 3.6 2.8 6.5 8.7 3.1 8.0 7.7 11.5 13.9 12.4 7.4 4.2 16.3 7.7 14.9 11.4 13.1 12.3 11.1 16.2 13.2 9.1 5.4 13.5 8.0 9.8 13.4 3.1 LAMB2 "LAMS, NPHS5" ENSG00000172037 "Laminin subunit beta 2" P55268 3 49121114-49133118 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 151.8;Leydig cells: 146.3;Peritubular cells: 140.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 299.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000053, HPA001895, HPA050033, CAB078160" Supported Approved Vesicles,Cytosol "Secreted to extracellular matrix" NA NA 25000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Vesicles Cytosol "CAB000053: AB_2313665, CAB078160: AB_2665799, HPA001895: AB_1079227, HPA050033: " "unprognostic (1.12e-2)" "unprognostic (4.40e-2)" "unprognostic (5.14e-3)" "unprognostic (1.10e-1)" "unprognostic (4.08e-1)" "unprognostic (4.01e-1)" "unprognostic (5.59e-2)" "unprognostic (6.80e-2)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (1.26e-1)" "unprognostic (4.96e-2)" "unprognostic (1.21e-3)" "unprognostic (1.78e-1)" "unprognostic (4.38e-2)" "unprognostic (6.20e-2)" "unprognostic (1.24e-2)" 75.2 73.2 12.8 18.2 14.2 2.6 58.2 15.1 14.9 68.0 47.7 63.1 24.6 72.7 25.5 31.9 63.8 62.2 169.1 13.1 14.5 41.3 31.7 55.1 16.9 20.0 14.8 94.4 32.7 104.7 15.4 99.0 15.4 50.4 18.0 11.7 40.3 81.0 67.5 40.9 32.5 80.2 14.1 29.8 48.4 21.4 17.3 6.7 60.2 70.0 12.8 52.2 55.9 13.5 15.7 38.7 34.4 122.0 196.3 201.5 31.1 131.9 161.8 73.8 75.7 18.3 52.0 0.2 44.4 299.0 38.3 49.3 30.0 47.6 52.3 0.1 9.5 6.9 63.4 32.1 132.5 0.3 0.3 176.9 69.4 61.6 62.1 184.3 75.9 0.0 4.1 0.1 61.4 30.3 0.1 0.3 15.1 20.7 32.0 0.2 16.6 0.5 53.5 19.1 0.2 20.4 74.9 42.9 68.3 57.5 93.4 0.9 126.9 82.2 34.9 28.5 35.4 0.1 0.4 0.4 39.1 0.3 57.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.8 14.2 15.1 14.9 13.1 14.5 20.0 14.8 15.4 14.1 17.3 13.5 83.7 118.6 53.5 26.1 2.4 31.2 13.9 33.6 33.0 1.7 39.4 40.5 151.8 37.1 43.6 55.2 6.2 11.3 0.9 3.6 5.9 26.4 3.5 15.4 24.4 77.8 0.0 0.4 0.2 9.4 6.4 120.1 50.4 27.2 1.3 88.9 94.9 49.9 10.4 8.4 0.4 3.1 32.6 10.1 31.1 12.3 146.3 7.5 42.7 15.9 3.5 46.7 2.1 1.0 0.6 14.1 14.9 140.7 0.5 10.2 16.4 28.6 11.2 2.6 118.3 80.8 92.3 4.3 8.6 14.2 24.4 9.4 3.8 27.6 5.6 9.3 CCDC71 FLJ12800 ENSG00000177352 "Coiled-coil domain containing 71" Q8IV32 3 49162535-49166331 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047547 Uncertain Approved "Nuclear membrane" No No "Cluster 22: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear membrane" "HPA047547: AB_2680083" "unprognostic (1.06e-2)" "unprognostic (6.02e-2)" "unprognostic (3.43e-3)" "unprognostic (3.67e-1)" "unprognostic (1.15e-1)" "unprognostic (3.68e-2)" "unprognostic (6.71e-3)" "unprognostic (7.20e-3)" "unprognostic (2.16e-1)" "unprognostic (5.77e-2)" "unprognostic (9.03e-3)" "unprognostic (7.20e-2)" "prognostic favorable (9.65e-9)" "unprognostic (3.53e-2)" "unprognostic (1.53e-1)" "unprognostic (2.00e-2)" "unprognostic (7.14e-2)" 13.0 15.4 5.0 9.6 5.4 7.3 14.5 5.4 6.2 13.6 4.9 9.9 8.3 14.9 9.6 13.8 16.4 9.1 12.2 5.0 5.9 10.6 12.6 11.1 13.5 5.3 5.4 18.2 9.5 13.6 9.6 10.1 5.4 12.0 7.6 3.4 12.5 10.5 14.8 13.0 10.7 10.0 5.3 13.3 10.5 12.2 5.4 13.0 16.1 9.5 9.5 12.9 11.9 5.3 12.6 16.9 19.4 18.8 21.8 15.8 18.6 15.2 21.8 26.1 22.9 17.6 19.8 11.2 13.0 26.2 20.9 13.0 19.3 40.7 9.3 24.9 14.0 22.7 22.0 17.9 25.7 18.3 16.5 26.9 31.4 31.0 23.7 19.4 25.8 26.7 23.1 4.6 21.1 26.9 31.8 11.2 30.2 18.8 18.1 11.5 10.8 10.5 24.8 24.0 9.8 21.3 15.5 16.3 18.5 15.6 21.7 30.2 17.1 18.3 19.4 18.3 20.0 17.5 8.2 15.6 13.3 17.2 20.7 0.0 1.0 0.4 0.9 1.7 1.4 0.5 0.8 1.2 0.9 1.3 1.2 0.8 0.9 4.8 1.3 0.3 1.0 0.6 5.0 5.4 5.4 6.2 5.0 5.9 5.3 5.4 5.4 5.3 5.4 5.3 5.1 6.4 1.5 1.6 7.9 2.7 12.5 23.8 6.8 1.5 7.5 8.5 1.4 5.7 11.2 7.3 0.0 23.3 4.1 8.3 25.4 21.3 9.3 2.4 3.5 8.0 8.4 11.8 2.1 11.8 16.5 7.7 7.1 1.8 2.5 6.5 16.1 9.3 20.1 0.0 2.0 8.4 24.4 5.6 2.1 10.2 11.8 5.3 5.4 6.5 8.8 3.6 12.3 1.0 1.0 15.2 9.3 13.5 9.3 10.8 10.4 14.1 7.1 1.2 13.1 4.1 7.0 10.6 18.4 9.2 2.7 22.4 5.8 6.6 8.2 11.5 KLHDC8B MGC35097 ENSG00000185909 "Kelch domain containing 8B" Q8IXV7 3 49171598-49176486 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 128.7" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 60.7;Sertoli cells: 98.6;Theca cells: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 28.8" "Group enriched" "Detected in many" 10 "granulocytes: 28.8;monocytes: 8.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008463, HPA014467" Approved Enhanced Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Cytosol "HPA008463: AB_1852563, HPA014467: AB_1852565" "unprognostic (1.66e-2)" "unprognostic (1.42e-1)" "unprognostic (5.31e-2)" "unprognostic (8.50e-3)" "unprognostic (2.66e-1)" "unprognostic (5.03e-3)" "unprognostic (1.71e-3)" "prognostic favorable (1.47e-4)" "unprognostic (6.80e-2)" "unprognostic (1.23e-1)" "unprognostic (1.52e-1)" "unprognostic (4.30e-2)" "unprognostic (1.02e-3)" "unprognostic (4.78e-2)" "unprognostic (5.60e-2)" "unprognostic (1.86e-2)" "unprognostic (1.61e-2)" 29.1 128.7 13.5 5.6 14.0 6.1 24.9 9.4 14.8 20.2 24.8 56.1 7.2 26.2 10.6 31.1 26.5 16.7 70.5 12.4 21.2 16.3 12.6 17.3 9.9 12.4 14.2 70.1 9.4 10.4 10.1 12.3 16.1 16.9 3.6 2.3 14.1 13.5 29.6 28.1 14.0 14.2 11.6 13.2 16.7 15.5 19.1 4.3 26.6 13.4 6.8 29.4 22.5 10.3 2.5 5.5 22.4 11.4 13.5 8.0 6.9 8.4 4.7 8.2 6.6 3.6 7.4 0.0 4.6 14.0 2.3 0.1 5.6 5.1 2.1 4.6 1.5 15.1 15.2 9.6 25.6 0.0 8.5 13.3 23.9 10.6 0.8 18.4 21.2 5.3 23.7 0.2 6.3 0.7 1.6 16.7 7.4 1.3 13.1 2.3 2.1 0.7 6.1 1.3 0.9 25.2 6.7 0.2 17.0 4.7 6.8 7.3 9.3 6.2 17.1 11.2 2.6 2.1 0.7 0.3 4.5 0.0 3.1 0.0 5.4 28.8 1.0 8.0 0.4 0.0 0.5 0.7 0.5 0.1 1.8 1.0 9.7 0.0 8.3 0.8 0.2 2.4 13.5 14.0 9.4 14.8 12.4 21.2 12.4 14.2 16.1 11.6 19.1 10.3 14.1 9.6 10.9 5.9 0.9 7.6 11.5 16.4 10.8 2.2 10.8 9.0 60.7 11.5 14.3 7.3 2.1 10.9 2.4 1.0 17.6 14.3 7.2 6.8 6.9 20.5 6.7 6.5 3.8 5.9 8.5 22.3 2.6 3.3 1.3 7.7 37.1 7.5 41.7 0.0 4.6 3.0 18.3 12.0 2.2 7.7 15.2 10.5 12.4 6.5 2.5 29.4 0.0 3.5 0.7 8.6 1.7 14.3 0.6 8.3 0.7 13.4 4.0 2.7 98.6 28.3 31.1 9.2 8.6 15.5 9.8 49.8 1.5 55.5 1.7 7.9 C3orf84 ENSG00000236980 "Chromosome 3 open reading frame 84" H3BNL1 3 49177634-49191858 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 7.2" "Group enriched" "Detected in some" 109 "Early spermatids: 112.3;Late spermatids: 84.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 112.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 84.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IHO1 "CCDC36, CT74, FLJ25320, LELA1" ENSG00000173421 "Interactor of HORMAD1 1" Q8IYA8 3 49198428-49258106 "Predicted intracellular proteins" "Differentiation, DNA recombination, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "choroid plexus: 7.5;testis: 26.5" "Cell type enhanced" "Detected in some" "Adipocytes: 1.7;Cardiomyocytes: 1.4;Fibroblasts: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.9;hTEC/SVTERT24-B: 9.2;LHCN-M2: 4.0;NTERA-2: 2.5;U-2197: 5.1;WM-115: 2.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA045690, HPA069534" Approved Approved Nucleoplasm NA NA "Cluster 17: Basophils - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "HPA045690: AB_10964634, HPA069534: AB_2686146" "unprognostic (1.54e-1)" "unprognostic (9.53e-3)" "unprognostic (2.16e-1)" "unprognostic (5.05e-2)" "unprognostic (3.84e-2)" "unprognostic (1.86e-2)" "unprognostic (1.36e-2)" "unprognostic (1.49e-2)" "unprognostic (9.94e-3)" "unprognostic (2.62e-1)" "unprognostic (1.38e-1)" "unprognostic (1.36e-2)" "unprognostic (5.51e-4)" "unprognostic (3.11e-2)" "unprognostic (2.95e-1)" "unprognostic (3.59e-2)" "unprognostic (6.33e-2)" 3.2 1.4 0.2 0.3 0.2 0.2 1.8 0.9 0.5 1.3 7.5 1.1 0.2 1.2 0.4 0.4 1.3 0.7 1.1 0.4 0.0 0.3 0.1 0.5 0.3 0.1 0.3 3.8 0.2 0.1 0.2 0.9 0.1 0.4 0.1 0.7 0.3 0.5 0.9 0.6 0.4 1.0 0.1 0.5 0.3 26.5 0.5 0.1 1.0 0.8 0.1 0.8 0.6 0.1 0.0 0.1 0.0 0.0 1.9 2.2 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.1 1.7 0.0 9.2 0.0 0.0 1.2 0.0 0.0 0.1 4.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 5.1 0.0 0.0 0.0 0.0 0.0 0.1 2.6 0.7 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.9 0.5 0.4 0.0 0.1 0.3 0.1 0.1 0.5 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 C3orf62 FLJ43654 ENSG00000188315 "Chromosome 3 open reading frame 62" Q6ZUJ4 3 49268596-49277232 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 8 "neutrophil: 40.0" "Lineage enriched" "Detected in many" 8 "granulocytes: 40.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043328 Approved "Nuclear speckles" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 71: Testis - DNA repair" "Cluster 30: Epithelial cell lines - Translation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" "HPA043328: AB_10795613" "prognostic favorable (3.93e-4)" "unprognostic (4.87e-3)" "unprognostic (3.70e-3)" "unprognostic (2.35e-2)" "unprognostic (9.51e-2)" "prognostic favorable (9.72e-4)" "prognostic unfavorable (5.20e-4)" "prognostic favorable (8.88e-4)" "unprognostic (1.28e-1)" "unprognostic (9.40e-3)" "prognostic favorable (8.15e-4)" "unprognostic (7.23e-2)" "unprognostic (3.27e-2)" "prognostic favorable (3.29e-5)" "unprognostic (2.46e-1)" "unprognostic (4.79e-1)" "prognostic favorable (1.62e-5)" 6.5 10.5 3.0 4.5 3.6 8.5 5.5 4.4 5.5 6.1 7.0 7.6 3.1 5.6 4.5 6.9 7.9 4.8 6.5 3.5 4.0 5.7 5.6 7.3 4.9 3.8 3.4 11.3 3.2 3.1 7.8 2.7 4.2 7.5 2.6 9.0 4.2 2.1 3.9 5.7 5.5 2.7 2.2 11.7 4.0 17.3 5.0 4.2 6.0 3.6 3.4 6.4 6.1 4.4 4.3 2.5 5.9 7.4 4.7 4.0 3.3 2.5 4.2 2.2 3.2 3.6 3.2 8.5 3.8 3.9 4.6 3.3 2.9 2.8 2.4 7.5 3.4 5.6 5.8 4.0 1.4 8.0 10.0 3.3 8.1 3.2 6.0 3.8 2.5 4.9 6.5 6.3 1.8 2.7 5.9 5.8 4.2 3.6 3.6 4.4 3.1 4.5 3.6 9.8 4.5 6.1 6.8 5.2 9.1 4.3 2.6 8.8 3.1 3.0 7.3 5.2 4.7 5.5 10.2 7.1 2.2 7.4 4.2 1.0 5.1 5.3 1.2 1.7 1.0 1.9 1.1 1.2 0.6 1.2 0.8 1.0 40.0 0.3 1.7 2.5 1.4 1.3 3.0 3.6 4.4 5.5 3.5 4.0 3.8 3.4 4.2 2.2 5.0 4.4 8.6 9.6 16.1 4.6 4.4 6.8 3.5 7.9 1.8 12.6 5.7 6.0 9.1 7.2 10.3 11.0 22.9 7.0 7.8 7.6 0.0 4.9 12.4 6.6 9.2 8.1 5.4 7.0 7.3 3.9 4.3 7.3 5.6 10.1 2.5 8.5 9.7 6.3 9.8 5.0 6.1 9.8 2.0 18.0 7.1 17.3 8.7 11.3 8.8 9.4 14.2 7.3 9.2 4.5 7.0 6.0 3.8 8.6 4.6 7.0 4.9 5.2 11.1 13.7 0.0 14.9 6.4 51.8 6.8 4.2 8.7 4.1 6.9 12.1 7.4 2.7 USP4 "UNP, Unph" ENSG00000114316 "Ubiquitin specific peptidase 4" Q13107 3 49277144-49340712 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 131.8;Late spermatids: 104.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018499 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 34: Spermatids - Unknown function" "Plasma membrane, Cytosol" "HPA018499: AB_1858689" "unprognostic (2.34e-3)" "unprognostic (1.52e-1)" "unprognostic (2.22e-3)" "unprognostic (6.12e-2)" "unprognostic (3.51e-1)" "unprognostic (4.33e-2)" "unprognostic (9.42e-2)" "prognostic favorable (4.46e-5)" "unprognostic (3.54e-1)" "unprognostic (9.07e-3)" "unprognostic (2.78e-2)" "unprognostic (1.70e-3)" "prognostic favorable (4.29e-5)" "unprognostic (7.30e-2)" "unprognostic (1.00e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 25.2 20.3 24.2 26.5 26.3 53.7 24.9 24.5 28.2 27.7 27.1 25.4 18.3 24.4 21.6 26.0 22.4 18.3 26.5 23.7 23.4 21.8 20.2 29.5 30.9 23.9 24.4 24.5 19.0 24.1 16.4 23.3 23.9 23.7 23.4 26.9 21.0 21.7 31.6 31.4 22.5 24.0 22.4 33.7 20.2 28.0 24.8 37.0 23.0 28.8 33.7 25.8 25.0 24.5 14.2 15.8 21.6 28.8 38.7 40.1 14.7 36.4 32.9 46.7 41.3 16.8 34.8 27.1 14.4 53.9 27.4 18.9 28.6 52.6 42.5 42.1 8.4 60.3 31.9 19.6 57.0 32.5 34.0 42.8 23.3 51.0 41.5 34.3 55.0 29.9 21.6 41.6 42.1 24.5 38.3 55.8 18.7 17.7 26.9 15.6 13.3 23.9 37.5 29.2 17.5 24.0 27.2 19.3 14.0 21.6 13.5 51.2 50.1 31.1 17.2 39.6 22.5 33.6 17.3 38.6 28.6 50.1 36.5 70.1 83.6 94.8 48.1 69.2 53.7 51.0 50.2 48.9 74.6 41.4 47.7 42.2 179.2 72.4 81.2 28.4 59.7 78.0 24.2 26.3 24.5 28.2 23.7 23.4 23.9 24.4 23.9 22.4 24.8 24.5 24.3 41.7 25.1 28.1 24.7 18.7 17.9 17.2 22.2 17.5 10.9 10.3 17.9 10.0 23.2 20.2 20.9 22.7 27.9 13.6 21.5 16.5 131.8 17.3 18.3 22.1 10.7 31.6 30.8 13.6 14.3 17.9 27.5 21.1 33.6 21.4 17.5 14.6 24.0 11.8 26.4 13.8 16.2 38.6 21.0 104.9 15.5 34.2 16.0 16.9 36.0 13.9 23.7 25.6 20.2 18.9 7.6 19.2 29.2 17.6 14.5 13.4 28.6 20.5 13.1 18.4 17.0 35.3 14.5 17.9 18.5 24.2 29.4 17.0 13.9 14.5 GPX1 ENSG00000233276 "Glutathione peroxidase 1" P07203 3 49357176-49358353 "Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 3273.8;Kupffer cells: 3971.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 1534.3;granulocytes: 1010.7;monocytes: 1337.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011582, HPA044758" Approved Supported Cytosol NA NA 3100000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 15: Liver - Metabolism" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 51: Myeloid cells - Hemostasis" Cytosol "CAB011582: AB_2112120, HPA044758: AB_2679076" "unprognostic (1.50e-2)" "unprognostic (4.34e-3)" "unprognostic (1.25e-1)" "prognostic favorable (7.78e-4)" "unprognostic (1.26e-1)" "unprognostic (1.83e-1)" "unprognostic (6.73e-3)" "unprognostic (5.03e-2)" "unprognostic (3.40e-2)" "unprognostic (2.48e-1)" "unprognostic (5.46e-2)" "unprognostic (1.53e-1)" "unprognostic (7.64e-3)" "unprognostic (9.14e-3)" "unprognostic (3.16e-2)" "unprognostic (5.72e-3)" "unprognostic (7.64e-3)" 321.4 200.0 178.3 151.9 186.6 246.7 151.5 190.2 298.9 90.9 247.3 86.9 122.2 82.2 17.8 134.3 86.5 91.1 95.5 173.1 198.9 152.9 281.6 168.3 174.3 234.0 213.0 61.9 74.4 35.2 85.7 121.2 208.3 107.0 42.7 8.3 113.1 53.9 157.1 70.4 113.6 70.4 218.0 195.9 92.9 31.5 217.6 75.3 82.1 61.7 86.6 116.8 94.9 256.3 322.8 189.2 72.6 95.4 113.5 205.9 225.9 217.7 114.7 151.5 80.1 157.8 229.7 0.6 301.6 139.8 181.7 93.2 98.8 660.3 31.6 200.2 271.6 224.8 190.2 397.4 575.6 161.0 594.4 455.9 267.6 292.4 221.5 190.0 341.5 78.6 0.5 179.3 125.9 0.8 51.2 407.0 441.3 147.4 510.5 190.8 93.8 120.3 258.2 385.6 87.7 178.5 249.5 1.5 287.3 75.7 1.5 559.5 546.5 209.7 236.0 385.8 453.6 1.1 127.9 116.3 390.5 436.3 507.8 1010.7 1337.0 707.6 69.8 483.7 100.9 314.2 127.7 83.7 1093.1 276.8 118.4 116.2 136.4 107.4 275.8 1534.3 233.3 1401.2 178.3 186.6 190.2 298.9 173.1 198.9 234.0 213.0 208.3 218.0 217.6 256.3 0.0 109.0 323.5 6.2 148.1 249.7 432.8 985.0 92.2 32.1 0.0 0.0 0.0 220.2 616.7 0.0 10.4 499.9 491.5 229.5 0.0 0.0 300.7 0.0 0.0 227.8 251.3 364.1 12.8 0.0 830.3 131.0 73.4 0.0 480.6 0.0 585.7 888.1 3273.8 1.7 17.9 285.0 386.6 3971.6 965.7 1102.9 134.5 1305.5 273.9 41.2 828.6 63.4 138.0 8.0 7.6 0.0 179.0 67.0 82.4 481.0 349.9 0.0 490.0 14.6 210.4 150.6 151.8 12.7 169.4 112.1 154.1 278.8 112.2 0.0 367.3 517.0 RHOA "ARH12, ARHA, Rho12, RHOH12" ENSG00000067560 "Ras homolog family member A" P61586 3 49359139-49412998 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle, Cell division, Host-virus interaction" Hydrolase "Cancer-related genes, Disease variant, Ectodermal dysplasia, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005052 Approved Supported "Plasma membrane,Cytosol" NA NA 1500000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 52: Non-specific - Ribosome" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 10: Non-specific - Unknown function" "Plasma membrane, Cytosol" "CAB005052: AB_562216" "unprognostic (1.50e-1)" "unprognostic (3.38e-1)" "prognostic favorable (3.08e-4)" "unprognostic (8.75e-2)" "unprognostic (1.63e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.15e-4)" "unprognostic (1.39e-1)" "unprognostic (8.83e-2)" "unprognostic (9.44e-3)" "unprognostic (2.21e-2)" "unprognostic (4.29e-2)" "prognostic favorable (3.21e-6)" "unprognostic (5.14e-2)" "unprognostic (7.50e-2)" "unprognostic (1.57e-1)" "unprognostic (4.52e-2)" 452.4 315.0 234.6 357.9 258.6 473.4 360.0 257.1 274.1 310.4 237.4 351.9 274.6 293.8 298.6 362.6 269.2 267.1 269.6 220.8 271.2 286.9 274.5 430.9 396.3 282.9 245.8 297.2 225.3 269.4 164.3 396.8 287.2 244.5 369.3 113.3 238.0 315.6 331.0 281.3 281.0 416.9 259.3 329.1 292.1 154.1 257.5 387.7 326.3 298.5 454.9 358.2 273.6 292.5 470.4 406.1 500.9 512.7 569.9 858.9 370.8 930.1 735.7 790.3 722.4 347.6 527.4 721.8 251.6 1404.1 448.8 259.5 560.4 630.6 817.6 505.7 323.3 678.8 488.0 416.0 604.2 647.9 472.8 668.2 437.8 643.2 508.1 799.7 1038.0 391.9 361.1 437.9 967.5 254.3 717.3 739.0 441.4 548.2 497.1 325.5 451.4 610.5 701.9 559.6 167.7 387.3 599.0 464.5 495.4 499.4 301.7 819.6 972.1 558.4 483.2 737.2 725.7 388.0 775.6 754.8 567.9 691.6 678.3 716.9 1105.5 1160.5 480.1 1358.8 423.8 432.7 415.6 479.6 806.9 379.3 314.5 397.1 1282.7 440.9 1398.1 645.5 554.9 1884.8 234.6 258.6 257.1 274.1 220.8 271.2 282.9 245.8 287.2 259.3 257.5 292.5 502.8 387.8 265.2 20.5 374.6 270.9 260.0 236.1 251.6 47.1 239.4 223.1 141.1 178.7 220.9 180.3 6.2 355.8 373.1 447.2 340.4 339.5 48.2 174.2 243.7 413.8 234.4 319.3 26.1 347.8 709.8 386.2 313.9 201.0 257.3 141.6 312.7 173.2 760.0 82.4 27.0 344.9 191.2 771.9 495.8 55.6 335.2 683.7 327.3 52.5 710.0 219.9 389.3 24.6 51.4 398.0 354.6 407.7 375.7 334.1 341.3 350.8 201.1 40.8 276.1 354.1 450.1 264.4 253.6 390.8 279.6 525.2 359.5 299.1 347.7 371.4 TCTA ENSG00000145022 "T cell leukemia translocation altered" P57738 3 49412206-49416475 "Disease related genes, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007342 Approved Approved Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 59: Non-specific - Transcription" Cytosol "HPA007342: AB_2202399" "unprognostic (5.58e-2)" "unprognostic (4.33e-2)" "unprognostic (6.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.17e-2)" "unprognostic (3.35e-2)" "unprognostic (2.18e-1)" "prognostic favorable (6.76e-4)" "unprognostic (3.74e-1)" "unprognostic (3.38e-3)" "unprognostic (1.82e-3)" "unprognostic (1.03e-1)" "prognostic favorable (5.00e-15)" "unprognostic (1.68e-1)" "unprognostic (1.96e-1)" "unprognostic (3.43e-1)" "unprognostic (6.41e-3)" 21.7 48.0 49.1 13.1 52.3 12.3 21.5 50.1 52.9 23.2 47.0 24.7 18.9 23.1 60.6 15.6 26.1 16.6 22.6 48.4 50.6 51.0 41.9 23.5 15.8 51.6 51.6 27.1 24.1 39.8 48.8 14.5 52.3 34.5 28.8 14.0 21.8 25.1 19.6 14.2 23.1 21.8 48.8 25.9 23.3 15.7 52.1 20.1 45.3 13.8 16.0 25.4 15.9 51.5 12.8 15.5 9.8 14.8 42.5 18.5 12.9 26.0 19.2 25.8 21.6 9.1 13.6 15.2 18.6 61.5 29.6 14.4 19.3 26.2 21.0 22.9 13.4 25.4 19.6 11.9 25.8 10.9 31.9 40.2 26.8 28.7 22.9 24.7 27.0 12.0 9.4 33.8 63.8 11.7 13.4 9.8 8.0 24.1 35.5 8.1 10.6 36.0 44.5 16.7 26.3 8.7 30.9 33.8 28.6 19.7 28.8 10.2 24.5 19.3 11.9 40.4 9.8 18.4 26.1 10.4 45.4 19.3 27.2 20.4 17.8 23.2 19.1 34.2 11.1 12.0 12.0 14.7 10.1 13.7 14.9 15.5 20.1 23.0 47.5 15.6 17.8 22.4 49.1 52.3 50.1 52.9 48.4 50.6 51.6 51.6 52.3 48.8 52.1 51.5 15.5 25.6 15.6 8.8 19.3 2.7 10.0 10.3 14.2 10.2 19.9 18.0 14.1 20.0 12.9 27.6 12.5 25.9 20.5 34.0 46.9 15.3 8.0 15.5 15.0 14.7 17.5 9.0 12.3 11.6 11.5 17.6 53.5 17.0 5.7 7.1 11.4 31.8 24.8 10.1 11.0 19.1 20.3 18.6 6.0 14.3 15.5 19.2 14.2 11.2 15.5 26.3 26.8 11.1 16.8 15.1 28.6 16.1 13.2 13.4 34.9 50.3 22.8 11.3 6.6 13.7 16.6 8.2 6.1 10.4 4.5 20.0 21.6 22.1 16.6 7.9 AC104452.1 ENSG00000283189 "Novel protein" 3 49416777-49429314 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Collecting duct cells: 1.8;granulocytes: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 60: Granulocytes - Receptor signaling" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 AMT "GCST, NKH" ENSG00000145020 Aminomethyltransferase P48728 3 49416778-49422685 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 49.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 42.4;Proximal enterocytes: 33.3;Undifferentiated cells: 31.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 17.1;Hep G2: 47.5;NTERA-2: 8.0;SH-SY5Y: 14.9;SuSa: 9.0" HPA005566 Supported Supported Nucleoplasm,Mitochondria NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria Nucleoplasm "HPA005566: AB_1844811" "unprognostic (2.10e-2)" "unprognostic (1.65e-2)" "unprognostic (1.82e-1)" "unprognostic (9.14e-3)" "unprognostic (4.04e-1)" "unprognostic (1.11e-2)" "unprognostic (2.81e-1)" "unprognostic (2.17e-3)" "unprognostic (1.94e-1)" "unprognostic (3.29e-1)" "unprognostic (7.17e-3)" "unprognostic (1.88e-1)" "prognostic favorable (3.90e-8)" "unprognostic (4.40e-1)" "unprognostic (1.91e-1)" "unprognostic (3.60e-1)" "unprognostic (1.98e-3)" 4.7 12.8 9.8 1.2 10.3 8.8 5.6 10.7 11.7 11.8 13.1 12.2 13.8 6.8 8.2 3.5 10.1 5.8 21.6 9.4 9.6 23.2 49.1 5.4 2.1 9.8 10.2 12.5 19.5 14.2 11.9 2.3 9.8 11.3 11.8 6.5 10.6 8.5 3.1 4.8 12.1 3.7 9.9 6.3 11.1 3.0 10.0 3.8 5.8 4.2 1.5 8.0 6.4 9.9 0.1 0.7 1.4 0.4 0.6 0.0 17.1 0.0 0.4 0.1 0.3 0.5 0.6 0.0 0.2 0.4 0.0 0.3 0.1 0.7 0.1 0.3 0.0 0.0 0.5 47.5 1.8 0.0 0.0 0.6 1.8 0.0 0.7 1.3 0.6 0.2 0.0 0.0 0.2 0.4 0.1 0.1 8.0 0.0 0.2 0.0 0.5 1.0 0.8 0.4 0.0 14.9 0.2 0.0 1.1 9.0 0.1 0.3 0.6 0.1 0.0 0.3 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 3.2 0.0 1.7 0.0 0.5 0.0 0.0 4.2 0.2 1.2 0.9 0.1 7.9 0.5 0.3 0.0 1.3 9.8 10.3 10.7 11.7 9.4 9.6 9.8 10.2 9.8 9.9 10.0 9.9 1.2 3.2 9.2 11.4 3.6 2.8 12.1 3.1 3.4 17.4 1.2 1.3 21.8 14.3 6.3 0.0 20.9 25.6 1.4 13.8 0.0 0.8 2.5 0.7 1.6 3.2 12.7 8.8 8.7 0.7 8.8 4.5 15.8 1.0 7.6 2.0 3.9 42.4 5.0 8.4 8.5 18.4 2.0 3.8 2.9 1.6 10.5 2.6 5.4 7.5 1.8 26.0 7.2 6.0 6.6 0.6 18.9 6.4 1.1 6.7 33.3 1.1 6.6 19.3 6.6 5.2 3.1 1.9 0.3 2.2 2.7 10.3 3.8 1.0 31.6 10.9 NICN1 MGC12936 ENSG00000145029 "Nicolin 1" Q9BSH3 3 49422333-49429326 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 24.3;Late spermatids: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058014 Supported Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA058014: AB_2683579" "unprognostic (4.10e-2)" "unprognostic (1.08e-2)" "unprognostic (7.31e-2)" "unprognostic (1.33e-3)" "unprognostic (1.14e-1)" "unprognostic (1.31e-2)" "unprognostic (1.31e-2)" "unprognostic (4.50e-3)" "unprognostic (1.04e-2)" "unprognostic (2.88e-2)" "prognostic favorable (1.11e-4)" "unprognostic (2.46e-1)" "prognostic favorable (8.81e-7)" "unprognostic (3.11e-2)" "unprognostic (2.37e-1)" "unprognostic (1.03e-2)" "unprognostic (2.96e-2)" 7.8 11.2 20.1 4.6 22.5 2.6 7.8 16.9 24.0 9.7 15.6 11.7 4.3 10.5 8.1 5.8 10.2 5.5 11.5 21.8 18.0 16.9 10.5 8.3 6.9 18.8 18.2 11.1 7.6 9.9 11.6 4.5 20.4 11.5 4.0 9.0 9.1 6.8 12.5 6.7 7.9 6.6 17.8 9.9 9.7 11.8 20.0 10.6 13.6 9.9 6.5 9.1 8.1 21.6 3.7 10.9 11.8 9.6 5.1 6.1 3.8 4.6 4.0 3.8 5.2 2.6 10.9 10.8 4.0 9.1 8.0 3.1 6.4 5.6 4.3 18.2 4.2 10.6 12.2 13.0 9.5 4.2 6.6 13.0 7.2 8.7 3.1 19.8 5.8 22.6 6.5 0.2 4.2 3.5 6.7 6.3 3.5 4.1 3.4 5.9 3.8 13.5 7.0 2.1 1.9 4.6 3.8 3.1 8.0 22.1 5.9 2.1 12.2 3.1 3.2 3.0 1.7 13.7 4.1 3.7 9.3 11.6 5.1 5.3 3.7 3.1 4.1 3.1 2.7 5.0 2.4 5.0 3.3 2.1 3.1 3.7 0.8 4.1 5.2 4.2 6.2 3.8 20.1 22.5 16.9 24.0 21.8 18.0 18.8 18.2 20.4 17.8 20.0 21.6 0.0 0.0 1.1 4.9 3.7 4.1 5.6 7.6 1.8 6.8 0.0 0.0 14.3 5.7 3.3 0.0 10.4 6.2 4.0 2.3 0.0 0.0 24.3 0.0 0.0 2.9 12.1 6.5 4.4 0.0 2.2 3.3 8.6 0.0 1.3 0.0 3.9 5.5 5.8 3.3 4.9 4.2 0.0 5.2 3.0 52.7 9.6 1.7 3.6 1.9 1.0 6.2 9.2 3.0 2.9 0.0 1.6 6.0 3.5 2.2 5.4 0.0 3.0 6.8 6.6 4.7 2.8 11.0 2.3 3.3 3.3 3.3 3.8 0.1 3.4 4.6 DAG1 "156DAG, A3a, AGRNR, DAG" ENSG00000173402 "Dystroglycan 1" Q14118 3 49468703-49535618 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 207.9;Skeletal myocytes: 326.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 280.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001960, CAB016353, HPA070563" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 84000000 "Cluster 14: Monocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Plasma membrane" Nucleoplasm "CAB001960: , CAB016353: AB_627292, HPA070563: " "unprognostic (1.58e-1)" "unprognostic (5.14e-1)" "unprognostic (6.71e-3)" "unprognostic (3.32e-1)" "unprognostic (7.39e-2)" "unprognostic (9.91e-2)" "unprognostic (1.67e-1)" "unprognostic (3.27e-2)" "unprognostic (8.18e-2)" "unprognostic (3.91e-2)" "unprognostic (5.70e-3)" "unprognostic (1.10e-1)" "prognostic favorable (2.59e-4)" "unprognostic (9.22e-2)" "unprognostic (1.99e-2)" "unprognostic (7.43e-2)" "unprognostic (1.57e-2)" 25.2 22.0 31.5 17.9 32.6 5.4 26.6 30.7 30.7 26.2 25.5 38.8 24.0 32.1 16.2 28.3 31.8 26.4 68.9 30.1 28.9 28.1 43.0 31.8 9.4 33.3 31.4 24.6 51.4 44.3 18.6 77.0 28.6 29.5 30.6 9.8 31.8 37.9 93.8 28.5 24.0 45.9 30.2 12.6 32.0 26.9 34.1 10.5 25.5 95.7 14.3 27.8 22.0 31.2 92.3 92.4 61.9 152.3 80.3 38.8 280.9 63.9 93.7 108.0 69.0 74.2 96.0 13.0 62.2 103.2 87.6 168.4 55.6 81.2 67.2 12.7 18.6 9.6 84.3 87.2 35.5 11.2 17.4 33.3 72.5 100.3 33.3 96.7 97.1 15.3 14.5 9.8 31.2 75.5 10.1 8.1 66.4 110.0 31.2 5.5 60.5 22.3 82.5 126.4 21.8 45.2 74.8 206.0 105.5 170.3 171.6 22.8 51.8 39.1 63.9 76.0 91.4 11.0 24.2 8.1 50.4 12.6 245.9 2.3 1.2 0.7 1.1 1.3 1.2 1.2 0.9 0.9 0.7 1.0 1.0 1.0 2.2 1.1 2.5 1.3 0.7 1.4 31.5 32.6 30.7 30.7 30.1 28.9 33.3 31.4 28.6 30.2 34.1 31.2 19.0 54.5 18.4 32.0 4.0 14.3 8.0 31.7 17.1 7.4 36.1 46.4 56.6 30.0 20.6 35.0 4.2 116.4 5.8 37.3 1.9 32.4 30.0 30.2 17.3 20.9 33.0 14.3 15.6 79.6 118.4 26.1 37.8 37.9 7.0 207.9 16.8 59.9 21.2 3.3 16.5 29.7 14.2 8.6 7.0 20.0 21.5 6.3 33.8 9.4 5.6 27.1 5.2 19.6 10.7 57.2 21.4 36.9 5.1 14.4 18.9 7.6 23.2 8.7 46.0 326.1 36.2 7.1 19.9 19.0 17.0 95.9 5.9 10.0 29.2 10.2 BSN ZNF231 ENSG00000164061 "Bassoon presynaptic cytomatrix protein" Q9UPA5 3 49554477-49671549 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 33.6" "Cell type enhanced" "Detected in some" "Excitatory neurons: 76.6;Horizontal cells: 25.2;Inhibitory neurons: 50.1;Oligodendrocyte precursor cells: 22.6" "Cancer enhanced" "Detected in some" "glioma: 1.4" "Region enhanced" "Detected in many" "cerebral cortex: 33.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 2.0;SCLC-21H: 4.4;SH-SY5Y: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034757 Enhanced NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA034757: AB_10671233" "unprognostic (8.57e-2)" "unprognostic (3.45e-1)" "unprognostic (7.31e-2)" "unprognostic (3.50e-4)" "unprognostic (7.40e-2)" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (5.46e-3)" "unprognostic (1.14e-1)" "unprognostic (1.70e-1)" "unprognostic (6.21e-5)" "unprognostic (2.50e-3)" "unprognostic (5.38e-5)" "unprognostic (9.33e-2)" "unprognostic (3.03e-1)" "unprognostic (2.30e-1)" "unprognostic (7.34e-2)" 0.1 1.4 8.2 0.1 17.6 0.0 0.1 0.1 33.6 0.2 0.0 0.2 0.1 0.3 3.0 0.0 0.1 0.0 0.2 17.2 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.3 0.6 0.3 5.3 0.1 0.0 0.2 0.0 3.4 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.3 3.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 4.9 0.1 0.2 1.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 1.2 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.5 0.1 0.4 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.7 2.0 0.2 0.0 0.4 0.2 0.1 0.8 0.1 0.5 0.0 0.1 0.2 0.0 0.2 4.4 2.7 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 17.6 0.1 33.6 17.2 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.1 0.0 0.0 9.4 0.0 0.0 0.1 0.0 0.0 15.0 0.2 0.5 2.5 0.0 0.0 0.0 6.2 0.1 0.0 0.1 0.0 0.0 7.8 0.4 0.3 0.5 0.0 0.0 76.6 0.5 0.1 0.3 0.0 0.3 0.0 0.6 0.7 0.4 0.1 25.2 50.1 0.1 0.0 0.3 0.0 11.7 1.2 0.1 1.8 9.4 0.0 3.9 2.1 22.6 6.3 0.1 0.0 0.4 0.0 0.1 0.1 0.3 0.0 8.8 0.0 1.0 1.3 6.7 8.0 0.0 0.1 0.1 0.0 0.2 0.2 0.1 APEH "D3F15S2, D3S48E, DNF15S2" ENSG00000164062 "Acylaminoacyl-peptide hydrolase" P13798 3 49674014-49683971 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029700, HPA029701, HPA029702, HPA029703" Enhanced Enhanced Cytosol No No 2300000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 3: HMC-1 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348" "unprognostic (4.93e-2)" "unprognostic (5.42e-2)" "unprognostic (6.04e-3)" "unprognostic (2.71e-1)" "unprognostic (9.32e-2)" "unprognostic (8.20e-2)" "unprognostic (3.65e-2)" "unprognostic (2.48e-1)" "unprognostic (5.89e-2)" "unprognostic (8.03e-2)" "unprognostic (3.21e-1)" "unprognostic (4.30e-2)" "prognostic favorable (3.32e-10)" "unprognostic (2.11e-2)" "unprognostic (1.12e-1)" "unprognostic (4.34e-2)" "unprognostic (7.67e-2)" 21.7 43.6 18.0 30.7 18.0 42.3 26.8 17.9 22.8 24.8 27.7 48.5 48.6 19.7 24.7 40.2 33.7 22.3 40.6 17.7 19.9 65.8 63.3 26.8 35.2 19.2 21.3 24.6 34.8 63.0 38.3 31.9 24.3 31.0 51.7 12.9 34.0 29.5 103.8 32.8 35.1 28.1 16.8 27.2 35.5 18.7 20.0 37.3 48.6 103.9 43.4 35.0 21.2 16.7 101.2 79.2 84.2 110.8 71.3 48.3 113.6 64.2 79.3 87.4 91.2 130.1 101.7 127.1 70.0 71.7 78.9 89.8 95.1 143.4 64.2 61.9 41.0 138.8 123.4 105.1 72.0 145.5 204.7 55.0 106.5 49.2 101.4 85.5 78.7 86.4 86.6 59.8 86.0 90.8 105.3 76.6 50.4 140.5 75.3 38.4 72.8 165.1 169.9 226.7 40.4 71.2 72.4 166.7 78.9 61.0 112.1 77.2 36.1 53.8 93.0 83.6 86.8 69.8 54.5 77.7 91.7 104.1 78.7 57.9 43.0 52.8 44.8 47.6 34.8 33.3 36.3 41.9 43.6 27.6 37.9 37.4 13.6 39.0 47.6 35.1 50.4 51.9 18.0 18.0 17.9 22.8 17.7 19.9 19.2 21.3 24.3 16.8 20.0 16.7 5.4 41.7 25.3 7.5 20.1 8.7 23.3 50.2 11.4 6.8 20.8 15.9 46.8 30.0 39.4 27.6 12.5 83.7 16.5 83.2 43.0 44.4 6.4 16.6 13.8 9.0 26.5 43.8 4.8 34.7 64.8 16.4 41.8 20.5 23.5 20.0 13.2 74.7 51.1 8.4 4.7 47.1 63.1 35.9 11.9 10.9 15.2 23.2 21.4 2.8 26.8 30.4 27.8 3.0 2.0 39.0 35.8 13.5 39.4 18.0 85.4 80.7 19.4 11.1 13.1 10.6 25.2 33.2 28.5 30.6 9.2 62.1 23.9 28.5 74.0 23.7 MST1 "D3F15S2, DNF15S2, HGFL, MSP, NF15S2" ENSG00000173531 "Macrophage stimulating 1" 3 49683947-49689501 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 10 "liver: 927.9" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 362.8" "Cancer enriched" "Detected in many" 7 "liver cancer: 42.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 84.6;NB-4: 17.3;U-266/70: 21.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024036 Approved "Secreted to blood" NA NA "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" "HPA024036: AB_1854147" "unprognostic (5.13e-3)" "unprognostic (1.45e-1)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (2.00e-2)" "unprognostic (1.16e-2)" "unprognostic (9.42e-3)" "unprognostic (8.24e-2)" "unprognostic (2.97e-1)" "prognostic favorable (7.14e-4)" "unprognostic (3.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.11e-1)" "unprognostic (2.48e-1)" "unprognostic (8.03e-2)" "unprognostic (1.68e-3)" 29.3 28.0 8.1 1.0 8.3 6.3 8.2 8.8 14.0 12.6 8.1 5.1 50.6 8.9 11.3 7.3 10.5 7.4 4.9 8.1 8.4 96.9 927.9 5.9 3.6 8.4 8.4 12.5 16.4 9.4 29.3 5.8 8.3 12.9 2.1 5.3 8.1 5.1 3.6 14.8 31.1 2.1 8.1 13.9 8.8 34.9 8.2 2.2 36.4 2.9 1.7 6.0 6.9 8.3 0.2 0.4 1.2 2.0 3.7 7.6 3.7 1.1 1.4 0.6 0.8 3.9 1.2 0.3 2.6 1.3 0.5 0.8 0.6 1.5 0.6 1.3 0.7 0.6 2.6 84.6 5.8 0.0 1.6 10.2 2.6 0.7 2.1 14.1 1.4 3.5 0.7 9.9 1.9 0.6 0.5 17.3 0.2 1.1 1.0 0.4 0.5 2.2 4.2 0.6 0.2 2.8 0.0 1.6 0.4 2.5 1.5 5.7 0.9 1.9 0.6 0.1 0.2 21.8 2.9 0.5 2.2 3.2 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.1 8.3 8.8 14.0 8.1 8.4 8.4 8.4 8.3 8.1 8.2 8.3 3.1 6.4 3.9 10.1 3.5 2.9 4.6 5.8 6.8 8.2 6.1 10.2 2.2 45.8 5.4 27.6 8.4 4.8 1.0 5.1 62.6 6.9 7.6 2.3 3.5 3.4 8.3 29.7 1.1 3.9 19.7 5.2 9.2 3.2 1.3 36.9 10.0 362.8 1.4 1.7 2.0 8.9 6.1 10.7 1.4 2.6 3.1 1.2 3.6 2.8 0.1 8.9 0.0 3.0 2.9 2.1 7.2 1.9 1.6 1.3 57.0 61.9 6.7 6.9 0.0 2.3 10.9 21.8 9.2 2.6 4.7 5.1 2.1 22.8 13.7 3.4 RNF123 "FLJ12565, KPC1" ENSG00000164068 "Ring finger protein 123" Q5XPI4 3 49689538-49721529 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 156.1;tongue: 112.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065983, HPA071879" Supported Approved Cytosol NA NA 140000 "Cluster 37: B-cells - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 6: Erythroid cells - Oxygen transport" Cytosol "HPA065983: AB_2685592, HPA071879: AB_2686468" "unprognostic (2.68e-1)" "unprognostic (3.34e-1)" "unprognostic (2.67e-1)" "unprognostic (1.04e-1)" "unprognostic (2.21e-1)" "unprognostic (9.51e-2)" "unprognostic (2.04e-1)" "unprognostic (3.75e-1)" "unprognostic (4.08e-1)" "unprognostic (1.07e-1)" "unprognostic (7.51e-2)" "unprognostic (5.03e-3)" "prognostic favorable (1.33e-8)" "unprognostic (5.69e-2)" "unprognostic (1.74e-1)" "unprognostic (7.22e-2)" "unprognostic (3.83e-1)" 13.0 19.0 18.9 9.0 19.2 34.6 12.5 18.5 23.9 13.1 21.0 17.8 19.5 14.7 10.5 13.4 12.5 9.7 27.8 19.6 16.5 22.0 57.7 12.3 10.4 17.5 16.9 11.6 13.5 16.3 17.4 9.4 17.2 14.6 6.8 6.0 14.4 9.2 156.1 14.5 18.2 9.3 14.7 17.9 17.9 23.7 18.0 13.7 14.6 112.0 7.3 14.2 12.0 17.9 9.7 12.6 15.5 16.2 23.2 13.9 17.1 12.1 15.9 15.0 16.0 14.1 16.1 23.2 10.9 17.6 13.3 11.8 11.6 18.1 10.0 15.8 15.0 19.7 27.8 31.6 23.1 19.3 19.8 17.6 17.9 14.4 16.5 14.8 16.2 23.0 20.0 20.0 13.2 14.1 19.8 30.7 8.2 11.5 21.0 9.3 9.7 24.4 21.5 16.4 10.6 20.8 16.4 14.4 18.7 8.7 15.4 33.0 16.2 13.4 16.3 11.9 14.9 26.4 28.4 9.5 19.2 23.6 20.5 8.9 6.9 5.6 6.7 6.2 4.0 7.1 4.5 4.1 5.5 7.0 5.3 5.0 4.0 5.5 6.8 7.9 3.6 3.8 18.9 19.2 18.5 23.9 19.6 16.5 17.5 16.9 17.2 14.7 18.0 17.9 7.1 9.6 5.3 16.3 6.5 2.3 3.1 4.7 1.8 8.6 7.1 6.1 1.1 11.5 5.8 3.7 4.2 6.8 9.3 10.4 5.9 5.3 13.3 8.1 5.8 5.9 6.7 52.4 18.0 5.5 4.6 5.9 11.2 7.5 7.0 9.5 10.0 29.8 5.6 6.7 14.6 6.1 10.2 9.6 1.4 16.5 7.5 6.0 3.6 5.6 6.3 5.4 7.2 7.5 7.2 7.2 6.3 5.7 7.0 5.0 19.2 10.2 5.4 8.9 0.0 7.6 5.6 10.7 8.9 4.6 3.0 8.5 6.0 7.5 6.9 4.1 AMIGO3 ENSG00000176020 "Adhesion molecule with Ig like domain 3" Q86WK7 3 49716829-49719684 "Metabolic proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 1.3;Enteroendocrine cells: 1.2;Microglial cells: 1.0;NK-cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 11.0" "Lineage enriched" "Detected in many" 10 "dendritic cells: 11.0" "Cell line enhanced" "Detected in many" "CACO-2: 3.4;HeLa: 4.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 20: HeLa - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (5.33e-2)" "unprognostic (5.15e-2)" "unprognostic (2.54e-2)" "unprognostic (4.61e-1)" "unprognostic (2.46e-2)" "unprognostic (4.83e-3)" "unprognostic (3.92e-3)" "unprognostic (3.75e-3)" "unprognostic (1.20e-1)" "unprognostic (2.30e-1)" "unprognostic (7.56e-2)" "unprognostic (7.85e-3)" "unprognostic (3.10e-1)" "unprognostic (2.78e-1)" "unprognostic (2.78e-1)" "unprognostic (2.84e-1)" "unprognostic (3.58e-3)" 0.6 0.8 0.5 0.2 0.4 1.5 0.5 1.4 0.8 0.7 0.1 0.5 0.4 0.7 0.5 1.0 0.8 0.2 0.9 0.3 0.7 0.6 1.9 0.9 0.5 1.0 0.3 1.0 1.6 0.0 3.1 0.1 0.3 1.1 0.0 0.1 0.9 0.3 3.4 3.0 0.8 0.0 0.0 1.1 1.0 1.7 0.4 0.3 0.9 0.0 0.1 0.5 0.6 0.5 0.4 0.4 0.3 0.6 1.9 0.2 1.3 0.3 0.0 0.2 0.1 3.4 0.5 0.0 0.4 0.7 0.1 1.8 0.0 0.2 0.0 1.9 1.0 0.0 4.2 2.2 0.0 1.0 2.7 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.6 0.6 0.0 1.7 1.6 1.7 0.4 0.5 0.5 0.4 0.6 0.4 0.0 1.9 1.5 2.5 1.0 0.2 0.5 0.0 0.2 0.5 1.1 0.3 1.8 1.2 0.3 2.2 1.4 0.5 0.0 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.2 0.9 0.1 0.1 0.3 0.6 0.0 1.0 0.0 11.0 0.5 0.3 0.5 0.4 1.4 0.8 0.3 0.7 1.0 0.3 0.3 0.0 0.4 0.5 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 GMPPB KIAA1851 ENSG00000173540 "GDP-mannose pyrophosphorylase B" Q9Y5P6 3 49716844-49723973 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 130.2;Syncytiotrophoblasts: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014657 Uncertain NA NA 38000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" "HPA014657: AB_1849852" "unprognostic (3.48e-2)" "unprognostic (9.84e-2)" "unprognostic (2.77e-2)" "prognostic favorable (6.19e-6)" "unprognostic (1.01e-2)" "unprognostic (5.11e-3)" "unprognostic (1.54e-2)" "unprognostic (4.01e-3)" "unprognostic (1.04e-1)" "unprognostic (1.99e-2)" "unprognostic (5.01e-3)" "unprognostic (5.73e-2)" "prognostic favorable (3.17e-4)" "unprognostic (1.60e-1)" "unprognostic (1.79e-1)" "unprognostic (1.67e-1)" "unprognostic (1.22e-1)" 14.5 30.1 6.1 16.1 6.0 11.8 15.3 5.7 6.6 20.8 9.2 23.1 14.5 18.6 14.5 26.3 19.5 9.5 18.2 6.0 6.3 17.5 44.2 21.4 13.0 6.7 6.5 14.0 57.4 10.1 39.4 7.5 6.1 27.9 12.2 4.1 35.4 14.7 13.4 14.9 21.8 9.4 6.1 27.9 26.2 9.6 6.8 9.3 26.3 5.7 13.0 15.9 16.8 5.9 31.8 27.0 21.0 12.3 15.6 10.8 21.7 36.1 17.1 29.0 26.1 18.7 21.5 17.6 15.8 18.1 22.2 16.7 18.6 29.0 10.6 17.2 14.5 13.5 27.2 21.5 31.1 19.0 19.6 8.2 15.1 40.0 34.8 11.3 24.8 20.2 10.4 32.0 16.3 20.3 27.3 11.7 12.2 22.5 34.3 9.2 12.5 30.4 16.3 24.0 13.8 16.0 15.7 36.5 12.5 10.6 20.6 13.9 21.9 25.7 25.0 33.4 38.8 33.7 11.1 13.6 25.4 14.7 28.6 22.1 15.6 6.7 18.3 21.3 18.6 22.7 15.9 19.3 14.7 22.5 11.8 14.6 4.0 11.3 21.8 61.8 12.0 14.8 6.1 6.0 5.7 6.6 6.0 6.3 6.7 6.5 6.1 6.1 6.8 5.9 7.3 9.6 17.2 1.6 35.4 0.8 22.8 0.7 2.8 3.7 34.1 14.1 4.5 15.7 3.8 18.4 2.1 28.5 28.5 43.6 29.4 39.8 10.0 18.3 14.3 10.7 16.7 9.9 0.8 50.6 67.2 15.5 34.7 17.8 0.0 11.2 9.3 28.4 39.0 6.7 0.8 55.9 0.0 10.7 1.7 10.0 15.5 13.7 1.8 1.0 40.9 5.8 19.6 1.0 0.4 31.9 27.1 7.5 130.2 40.9 29.2 25.7 14.4 6.2 0.0 5.3 12.2 22.9 12.6 14.7 1.7 79.5 14.7 13.1 32.8 37.1 IP6K1 "IHPK1, KIAA0263" ENSG00000176095 "Inositol hexakisphosphate kinase 1" Q92551 3 49724294-49786542 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040825 Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 43: Testis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "HPA040825: AB_10960426" "unprognostic (6.18e-2)" "unprognostic (1.33e-1)" "unprognostic (3.58e-2)" "unprognostic (4.71e-2)" "unprognostic (1.99e-1)" "prognostic favorable (2.08e-4)" "unprognostic (9.97e-3)" "unprognostic (8.45e-2)" "unprognostic (1.16e-1)" "unprognostic (2.11e-1)" "prognostic favorable (6.85e-4)" "unprognostic (1.29e-2)" "prognostic favorable (5.77e-5)" "unprognostic (8.75e-2)" "unprognostic (1.67e-1)" "unprognostic (9.24e-2)" "unprognostic (1.64e-2)" 17.9 20.2 32.4 12.1 33.6 12.5 17.2 27.6 34.9 21.5 17.2 24.1 12.1 25.6 12.2 20.0 19.4 12.9 15.8 35.9 27.7 21.3 14.6 17.5 13.3 26.4 28.2 25.5 19.8 22.8 21.5 16.4 27.4 18.1 11.3 18.3 17.4 17.2 12.6 23.1 17.8 16.9 24.5 21.9 18.5 32.2 30.7 17.2 16.2 11.4 13.2 19.1 16.0 29.0 20.6 24.5 27.9 33.1 28.6 21.8 22.5 26.6 27.8 42.7 37.3 31.9 20.9 17.3 16.8 29.7 28.8 14.9 39.8 24.2 24.0 35.6 30.6 40.5 36.1 21.8 31.4 25.0 26.7 25.6 29.4 46.4 27.8 24.0 36.1 20.3 26.7 20.3 21.4 18.2 30.6 25.6 30.2 16.1 37.6 19.1 19.8 35.7 27.7 30.8 15.0 29.8 33.4 21.8 30.6 16.0 17.6 36.2 32.8 23.9 23.6 33.1 31.0 24.3 35.6 18.8 21.9 28.4 24.9 4.7 7.3 12.1 11.7 5.4 11.4 6.0 10.4 12.8 5.6 8.4 12.6 12.7 33.3 10.3 7.0 4.1 11.8 9.5 32.4 33.6 27.6 34.9 35.9 27.7 26.4 28.2 27.4 24.5 30.7 29.0 17.1 25.6 12.3 24.5 25.0 15.6 14.7 7.4 11.4 38.4 19.7 15.0 8.8 18.6 10.1 12.9 89.6 19.2 27.6 22.0 5.9 14.5 88.2 24.9 19.9 19.0 27.6 24.2 42.3 13.0 16.1 14.7 14.8 17.3 19.7 19.6 19.6 12.2 12.8 30.3 46.6 14.1 10.2 15.0 14.2 23.7 21.1 17.8 19.6 31.9 15.9 19.6 35.0 43.7 39.8 19.2 8.8 16.6 28.9 19.6 14.6 12.5 21.8 78.3 19.7 16.2 18.3 24.6 21.9 13.7 18.8 27.5 27.6 30.5 12.8 20.4 CDHR4 "CDH29, VLLR9392" ENSG00000187492 "Cadherin related family member 4" A6H8M9 3 49790732-49799873 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "fallopian tube: 59.4" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 74.2;Respiratory ciliated cells: 160.4" "Cancer enriched" "Detected in some" 6 "endometrial cancer: 6.8" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.3;HeLa: 1.5" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 1.2" HPA076277 Enhanced "Intracellular and membrane" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "HPA076277: AB_2732306" "unprognostic (1.50e-4)" "unprognostic (4.87e-2)" "unprognostic (6.00e-2)" "unprognostic (2.00e-3)" "unprognostic (2.37e-2)" "unprognostic (2.45e-3)" "unprognostic (6.35e-7)" "unprognostic (1.17e-1)" "unprognostic (1.13e-2)" "unprognostic (1.12e-1)" "unprognostic (9.61e-2)" "unprognostic (2.35e-1)" "unprognostic (9.07e-11)" "unprognostic (2.65e-1)" "unprognostic (3.70e-2)" "unprognostic (1.13e-2)" "unprognostic (2.37e-1)" 0.5 0.1 0.6 0.1 0.6 0.2 0.2 0.4 0.3 5.5 1.0 0.5 0.1 1.7 0.4 0.1 59.4 0.1 0.2 0.6 0.7 0.2 0.1 7.4 0.0 2.7 6.1 0.2 0.0 0.0 0.1 0.1 3.4 0.3 0.1 0.0 0.2 0.2 0.2 1.3 0.1 0.2 1.2 0.0 0.1 7.5 0.8 0.0 0.2 0.0 0.0 0.2 0.3 1.0 0.1 0.5 0.1 0.0 0.1 1.3 0.1 0.1 0.0 0.2 0.3 0.0 0.8 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.2 1.5 0.3 0.0 0.1 0.1 0.2 0.4 0.2 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.2 0.7 0.0 0.6 0.4 0.0 1.9 2.0 0.2 0.1 0.7 0.1 0.2 0.1 0.1 0.7 0.4 0.1 0.1 1.0 0.5 0.1 0.2 0.1 3.9 0.6 0.6 0.4 0.3 0.6 0.7 2.7 6.1 3.4 1.2 0.8 1.0 0.2 0.0 3.4 0.0 0.0 0.1 0.1 4.3 0.0 0.0 0.1 0.1 0.4 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 74.2 0.9 0.5 0.0 0.0 0.1 0.2 0.1 0.9 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 20.3 0.0 0.0 4.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.1 160.4 0.0 0.0 0.2 1.7 4.8 0.8 0.0 0.0 0.0 0.2 0.1 0.2 0.1 INKA1 "C3orf54, FAM212A" ENSG00000185614 "Inka box actin regulator 1" 3 49803261-49805030 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 24.1" "Cell type enhanced" "Detected in some" "Adipocytes: 19.9;Breast myoepithelial cells: 9.7;Endothelial cells: 8.4;Hofbauer cells: 54.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 59.6;memory B-cell: 65.9;naive B-cell: 64.4" "Group enriched" "Detected in many" 7 "B-cells: 65.9;granulocytes: 59.6" "Cell line enhanced" "Detected in many" "HEL: 68.5;HMC-1: 45.1;NB-4: 38.5;THP-1: 42.1;U-937: 34.9" "Low region specificity" "Detected in all" HPA041879 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 32: U-937 - Innate immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Vesicles" "HPA041879: AB_10797269" "unprognostic (1.36e-1)" "unprognostic (2.99e-2)" "unprognostic (6.97e-2)" "unprognostic (7.95e-2)" "unprognostic (1.34e-1)" "prognostic favorable (1.96e-4)" "unprognostic (2.70e-2)" "unprognostic (4.35e-2)" "unprognostic (7.28e-2)" "unprognostic (2.94e-1)" "unprognostic (3.35e-3)" "unprognostic (4.61e-2)" "unprognostic (1.90e-3)" "unprognostic (4.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.45e-1)" "unprognostic (1.40e-2)" 5.1 2.3 4.8 2.0 5.0 3.5 4.1 5.2 7.6 6.2 2.8 3.2 0.8 4.7 1.4 19.7 2.8 1.5 5.2 5.3 5.5 5.8 1.1 5.4 4.1 6.2 5.3 2.2 1.3 0.5 2.1 3.1 5.7 6.4 0.5 0.2 4.9 2.1 11.7 24.1 4.3 1.8 5.8 6.7 2.4 2.9 6.5 1.6 2.1 2.3 3.9 5.5 10.3 7.0 1.3 1.1 1.5 1.1 1.8 4.1 0.0 3.0 1.9 1.4 1.7 0.1 0.0 14.9 0.4 2.2 1.5 8.7 0.5 10.4 0.1 2.6 0.0 68.5 0.7 0.2 2.6 10.4 45.1 5.4 14.5 2.9 2.6 0.9 6.1 1.0 4.7 1.2 1.2 0.6 0.9 38.5 1.1 0.0 5.8 13.9 0.8 3.3 0.1 16.9 0.8 5.3 2.7 0.5 1.5 0.4 0.3 42.1 3.8 7.3 0.9 3.4 1.3 1.7 1.7 1.2 3.2 34.9 1.8 59.6 2.4 11.6 1.3 5.9 0.3 65.9 1.5 1.8 0.7 64.4 2.2 3.6 1.3 0.0 8.5 9.3 1.6 6.4 4.8 5.0 5.2 7.6 5.3 5.5 6.2 5.3 5.7 5.8 6.5 7.0 19.9 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 1.0 9.7 0.0 0.0 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.7 0.0 0.5 1.6 8.4 0.0 0.0 0.0 1.2 0.7 3.0 0.0 0.1 0.0 0.1 0.0 0.0 54.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 3.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.1 0.4 0.5 0.0 0.0 UBA7 "D8, UBA1B, UBE1L, UBE2" ENSG00000182179 "Ubiquitin like modifier activating enzyme 7" P41226 3 49805209-49813953 "Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 52.5;granulocytes: 83.0;Proximal enterocytes: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 56.7;HEL: 55.7;HMC-1: 103.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB015444, HPA058182" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA 370000 "Cluster 49: Eosinophils - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Vesicles" Cytosol "CAB015444: AB_793598, HPA058182: AB_2683631" "prognostic favorable (1.55e-4)" "unprognostic (7.07e-3)" "unprognostic (1.59e-2)" "unprognostic (1.61e-2)" "unprognostic (3.77e-1)" "unprognostic (2.31e-2)" "unprognostic (5.08e-3)" "unprognostic (3.61e-2)" "unprognostic (6.33e-2)" "unprognostic (2.00e-1)" "unprognostic (1.40e-1)" "unprognostic (2.17e-1)" "prognostic unfavorable (1.04e-5)" "unprognostic (9.11e-2)" "unprognostic (3.81e-2)" "unprognostic (1.57e-1)" "prognostic favorable (1.48e-4)" 21.6 21.4 10.1 32.7 10.6 40.2 20.7 10.4 12.1 25.6 10.4 29.0 43.4 22.5 15.6 18.7 23.8 27.7 17.9 9.8 10.5 25.6 23.0 35.4 51.2 13.7 11.1 32.8 17.2 2.9 14.1 19.4 12.1 34.8 26.1 1.2 42.3 22.4 9.1 20.5 48.6 20.6 12.3 65.6 27.5 5.8 12.2 39.8 31.8 10.3 33.6 23.1 23.3 13.8 11.6 0.1 0.9 0.3 30.2 31.7 3.5 6.1 27.0 42.7 56.7 0.0 23.9 0.4 4.8 22.4 18.3 6.2 0.1 10.9 3.7 29.9 0.1 55.7 0.6 3.5 22.3 5.3 103.7 49.0 0.7 16.9 1.0 29.6 21.7 2.0 0.1 3.4 10.0 0.3 11.6 13.7 0.1 0.0 1.2 14.6 1.0 1.9 8.8 22.3 0.0 0.9 7.4 10.7 3.8 0.6 1.1 36.8 9.7 8.3 1.1 3.7 2.4 0.1 0.2 0.3 23.2 19.8 2.0 20.7 22.5 38.5 16.4 32.9 14.3 17.1 15.0 14.5 21.3 18.1 13.4 12.4 6.8 17.1 27.6 7.6 15.9 22.0 10.1 10.6 10.4 12.1 9.8 10.5 13.7 11.1 12.1 12.3 12.2 13.8 17.3 32.1 20.3 11.4 28.0 3.8 6.3 10.5 6.8 0.2 9.2 9.1 6.9 17.2 16.6 12.9 0.0 5.2 15.5 28.7 0.0 9.5 6.9 5.8 3.0 13.5 9.5 8.0 0.2 7.8 3.5 11.8 52.5 6.5 83.0 13.2 16.1 7.6 21.6 0.0 0.1 21.7 8.2 20.1 6.4 34.1 11.1 32.5 0.0 15.0 16.8 2.4 19.6 1.0 0.1 5.2 21.7 11.3 14.1 4.4 51.8 5.6 12.8 1.2 6.6 5.8 8.1 0.9 0.3 7.3 4.7 2.9 17.7 6.9 20.2 6.6 TRAIP "RNF206, TRIP" ENSG00000183763 "TRAF interacting protein" Q9BWF2 3 49828601-49856574 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 8.2;Spermatocytes: 15.6;Spermatogonia: 9.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "basal ganglia: 10.8" "HPA036261, HPA036262" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Cluster 37: B-cells - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane, Cytosol" "HPA036261: AB_10673348, HPA036262: AB_2675029" "unprognostic (5.30e-3)" "unprognostic (9.41e-2)" "unprognostic (1.48e-1)" "unprognostic (6.50e-3)" "unprognostic (1.88e-1)" "unprognostic (7.68e-3)" "prognostic unfavorable (8.77e-5)" "unprognostic (4.61e-2)" "unprognostic (1.52e-2)" "unprognostic (8.61e-2)" "unprognostic (1.24e-2)" "unprognostic (7.97e-2)" "unprognostic (9.01e-5)" "unprognostic (5.84e-2)" "unprognostic (4.24e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" 1.5 1.0 1.6 1.8 2.5 6.8 1.9 0.7 1.8 2.0 0.4 2.3 1.5 1.7 1.4 2.9 1.8 1.0 0.9 1.6 0.9 0.8 0.8 0.9 4.6 0.6 0.6 2.1 1.0 0.8 1.2 1.6 0.7 1.4 2.9 2.3 1.2 0.9 2.0 4.2 2.0 2.1 0.6 1.9 1.2 7.9 1.3 5.3 1.4 1.2 4.4 1.3 1.9 0.9 10.4 12.4 17.4 17.6 1.6 2.4 14.4 12.4 5.8 25.3 24.0 15.2 11.6 25.5 8.5 7.1 17.7 13.4 18.5 14.0 18.8 14.7 12.2 19.2 16.3 13.6 0.7 15.8 15.4 1.6 2.0 20.4 10.7 3.0 6.7 22.3 14.0 17.8 11.4 15.1 26.5 20.1 14.0 12.3 20.3 14.4 11.7 14.8 4.6 14.2 8.4 14.4 13.6 11.3 8.8 12.4 10.2 22.4 5.2 16.1 19.0 22.5 24.4 13.0 33.7 27.3 8.1 21.2 14.6 0.0 0.6 0.3 0.9 0.3 0.9 2.9 0.5 2.1 0.6 1.5 0.7 1.1 0.1 1.2 1.3 0.7 0.3 0.6 1.6 2.5 0.7 1.8 1.6 0.9 0.6 0.6 0.7 0.6 1.3 0.9 0.6 3.2 0.6 1.0 1.8 1.1 0.6 1.5 2.2 2.8 1.2 1.4 2.6 0.0 0.3 3.7 0.0 4.2 1.2 1.8 0.0 2.0 4.3 0.6 0.9 0.8 0.0 3.8 1.4 1.0 8.2 2.0 1.5 0.9 0.0 5.7 1.1 0.7 3.5 0.0 0.9 2.0 0.0 0.8 0.4 4.8 2.5 0.7 1.8 1.0 1.8 1.7 0.0 0.5 0.6 1.1 0.3 1.2 4.3 0.8 0.9 0.3 0.5 3.3 0.0 1.4 1.7 15.6 9.1 2.3 0.3 1.0 1.2 1.2 4.6 0.2 CAMKV "MGC8407, VACAMKL" ENSG00000164076 "CaM kinase like vesicle associated" Q8NCB2 3 49857988-49869935 "Enzymes, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 91.8" "Cell type enhanced" "Detected in some" "Bipolar cells: 12.2;Early spermatids: 6.3;Excitatory neurons: 32.7;Inhibitory neurons: 27.0;Late spermatids: 7.8" "Group enriched" "Detected in some" 11 "glioma: 4.0;testis cancer: 5.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 7.6;CACO-2: 6.1;HAP1: 10.3;NTERA-2: 34.1;RPMI-8226: 6.9;SCLC-21H: 17.7;SH-SY5Y: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007656, CAB034931" Enhanced Supported Approved "Nucleoplasm,Cytokinetic bridge" Yes NA "Cluster 10: Brain - Neuronal signaling" "Cluster 5: NTERA-2 - Transcription" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "Cytokinetic bridge" "CAB034931: AB_2068550, HPA007656: AB_1078391" "unprognostic (9.47e-4)" "unprognostic (5.65e-3)" "unprognostic (1.42e-1)" "unprognostic (2.70e-7)" "unprognostic (2.76e-1)" "unprognostic (7.95e-4)" "unprognostic (3.09e-2)" "unprognostic (2.61e-1)" "unprognostic (1.48e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (8.11e-2)" "unprognostic (1.00e-3)" "unprognostic (7.61e-2)" "unprognostic (9.51e-2)" "unprognostic (1.67e-3)" 0.0 0.8 66.5 0.0 91.8 0.0 0.0 0.0 84.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.3 19.0 0.1 0.0 0.0 0.0 0.2 8.7 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.1 0.1 0.0 12.9 0.0 0.1 2.0 37.2 0.0 0.0 0.0 0.0 0.0 0.0 39.2 0.0 0.2 7.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.8 0.0 0.0 0.1 0.9 0.2 34.1 0.0 0.2 1.3 0.0 6.9 0.0 0.0 17.7 8.3 0.0 0.0 0.0 1.3 0.0 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 66.5 91.8 0.0 84.9 73.3 19.0 0.2 8.7 0.0 12.9 37.2 39.2 0.0 0.0 0.0 3.9 0.0 0.3 0.0 0.0 0.0 12.2 0.1 0.1 0.7 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 1.2 0.0 32.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 27.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 4.7 0.0 0.2 0.0 2.5 3.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.3 0.0 0.0 0.1 0.0 MST1R "CD136, CDw136, PTK8, RON, SEA" ENSG00000164078 "Macrophage stimulating 1 receptor" Q04912 3 49887002-49903873 "CD markers, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 62.3;stomach 1: 42.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 25.6;Distal enterocytes: 53.9;Gastric mucus-secreting cells: 108.6;Intestinal goblet cells: 25.7;Pancreatic endocrine cells: 31.2;Paneth cells: 30.3;Proximal enterocytes: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 39.3;CAPAN-2: 98.8;HaCaT: 56.3;HBEC3-KT: 59.4;hTCEpi: 83.4;RT4: 67.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA007657, HPA008180, CAB008972" Enhanced Approved Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291" "unprognostic (3.84e-3)" "unprognostic (3.86e-1)" "unprognostic (1.92e-1)" "unprognostic (7.33e-3)" "unprognostic (3.82e-2)" "unprognostic (2.32e-1)" "unprognostic (8.07e-3)" "unprognostic (1.54e-2)" "unprognostic (4.12e-2)" "unprognostic (2.15e-1)" "unprognostic (1.24e-3)" "unprognostic (2.28e-1)" "unprognostic (8.08e-3)" "unprognostic (2.38e-1)" "unprognostic (2.18e-1)" "unprognostic (8.00e-3)" "prognostic favorable (2.33e-5)" 5.1 0.3 1.1 5.1 1.1 0.2 3.8 1.1 1.7 5.7 1.3 26.5 25.2 1.3 1.2 17.5 1.7 11.4 3.2 1.1 0.9 3.4 1.1 9.5 2.5 0.9 0.8 1.0 5.8 0.1 2.7 0.8 0.9 4.7 20.1 0.2 5.4 1.0 1.3 62.3 23.9 2.0 0.8 1.6 42.6 8.4 0.9 8.8 3.4 0.7 5.6 9.2 11.5 1.0 39.3 14.4 0.1 0.6 0.0 0.0 2.2 0.5 0.1 0.0 0.0 4.1 98.8 1.7 8.8 0.5 0.1 56.3 0.0 59.4 0.0 0.9 1.0 0.1 25.9 0.9 0.9 0.0 1.2 0.3 83.4 0.2 11.7 0.2 0.1 0.2 0.8 0.3 0.0 5.1 0.1 0.1 0.3 33.1 34.6 2.9 0.0 1.1 35.8 67.9 1.0 0.1 11.5 22.6 0.2 0.1 17.7 0.9 0.3 0.0 0.3 0.3 0.1 0.5 0.2 0.2 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 1.1 1.1 1.7 1.1 0.9 0.9 0.8 0.9 0.8 0.9 1.0 1.6 25.6 10.3 0.7 1.0 8.8 2.2 14.2 6.8 0.0 2.8 2.5 1.0 0.0 10.6 0.0 0.0 0.1 0.2 53.9 0.0 6.4 15.4 2.9 0.8 0.6 4.2 0.0 1.1 10.0 0.4 0.8 108.6 5.3 0.0 0.1 0.0 0.0 0.1 0.0 1.1 25.7 2.0 0.0 1.4 10.5 0.3 0.5 0.0 1.0 0.6 0.0 1.0 2.0 0.1 31.2 30.3 0.0 0.5 2.2 27.6 0.1 7.6 0.0 0.0 0.5 0.9 1.3 1.5 3.2 4.7 0.0 0.5 0.0 20.1 6.2 MON1A "MGC13272, SAND1" ENSG00000164077 "MON1 homolog A, secretory trafficking associated" Q86VX9 3 49907160-49930173 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053752, HPA058032" Uncertain Approved Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 45: Intestine - Brush border" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA053752: AB_2682250, HPA058032: AB_2683584" "unprognostic (1.81e-2)" "unprognostic (6.34e-2)" "unprognostic (1.48e-1)" "unprognostic (1.14e-2)" "unprognostic (1.26e-2)" "unprognostic (3.51e-2)" "unprognostic (3.29e-2)" "unprognostic (2.34e-2)" "unprognostic (2.28e-1)" "unprognostic (2.13e-2)" "prognostic favorable (3.30e-4)" "unprognostic (5.23e-2)" "unprognostic (2.07e-1)" "unprognostic (1.46e-1)" "unprognostic (1.03e-1)" "unprognostic (3.86e-2)" "unprognostic (1.55e-1)" 6.2 8.2 15.1 3.1 15.4 2.1 5.5 12.9 18.1 6.1 9.7 10.0 15.2 7.1 1.3 7.7 4.4 1.9 8.8 14.8 13.7 7.6 11.8 5.3 2.7 13.7 14.1 4.7 7.1 3.1 9.5 2.3 14.2 6.8 1.7 1.6 4.8 3.0 14.6 6.7 9.8 2.8 13.3 5.4 7.0 13.7 14.0 3.8 7.7 5.3 2.1 7.9 6.2 14.3 5.7 4.7 2.8 8.9 8.9 5.2 4.0 8.0 3.9 7.6 8.5 7.0 3.7 17.4 7.2 7.5 6.6 7.1 6.2 10.1 3.2 14.5 15.6 7.6 5.5 9.2 11.0 8.9 10.5 7.3 10.8 14.8 5.1 3.9 11.1 7.3 11.9 5.9 5.8 9.4 10.2 13.1 6.4 12.4 23.9 6.3 3.2 13.4 5.4 4.1 8.1 5.0 3.4 6.6 8.4 1.9 5.1 6.0 8.9 5.0 6.0 14.0 13.0 12.3 13.2 10.7 7.7 13.7 7.6 0.2 8.0 4.3 13.8 6.2 15.9 12.2 11.6 14.3 9.8 5.2 14.1 11.6 2.5 17.7 5.2 4.9 13.1 10.4 15.1 15.4 12.9 18.1 14.8 13.7 13.7 14.1 14.2 13.3 14.0 14.3 8.8 3.2 5.4 5.2 3.5 14.9 2.5 6.1 9.1 3.3 4.5 3.6 7.3 1.5 4.2 1.8 4.2 4.6 5.0 5.9 1.9 4.8 14.9 2.5 3.8 6.1 6.7 7.8 5.1 6.7 3.3 3.9 8.2 2.1 4.5 2.8 4.6 14.3 5.4 0.0 5.1 5.6 6.1 3.5 4.2 33.4 3.4 2.4 5.4 1.9 3.0 4.5 7.2 4.5 4.2 12.9 5.9 5.7 8.1 6.0 15.9 13.1 3.6 2.9 0.0 4.5 7.3 16.2 7.2 11.1 9.1 4.0 6.1 6.5 7.1 2.6 RBM6 "3G2, DEF-3, DEF3, g16, NY-LU-12" ENSG00000004534 "RNA binding motif protein 6" P78332 3 49940007-50100045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026272, HPA027164" Enhanced Approved "Nuclear speckles,Cytoplasmic bodies" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 72: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "Cytoplasmic bodies" "HPA026272: AB_1847592, HPA027164: AB_1847593" "unprognostic (3.81e-3)" "unprognostic (2.13e-1)" "unprognostic (3.52e-2)" "unprognostic (2.40e-2)" "unprognostic (4.53e-2)" "unprognostic (2.88e-2)" "unprognostic (1.40e-2)" "unprognostic (7.97e-3)" "unprognostic (8.84e-3)" "unprognostic (5.09e-2)" "prognostic favorable (1.41e-4)" "unprognostic (4.31e-2)" "prognostic unfavorable (8.83e-4)" "unprognostic (7.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.45e-1)" "prognostic favorable (5.13e-5)" 65.2 75.5 51.4 43.7 50.5 45.8 58.3 56.9 96.4 108.2 53.0 81.5 43.4 70.0 34.5 51.7 81.7 27.6 74.3 51.0 54.8 74.3 78.1 64.7 59.8 53.6 51.0 96.2 89.7 36.7 72.8 30.3 50.0 98.2 39.5 64.3 50.3 36.0 44.0 54.3 78.0 42.2 48.1 103.5 69.3 66.1 53.1 48.6 74.9 25.7 50.1 67.2 68.5 51.7 28.6 18.0 73.0 48.1 70.8 38.4 25.9 47.8 41.0 40.8 42.7 31.0 31.4 147.2 27.0 47.0 41.1 23.6 61.2 40.9 51.3 57.3 23.2 68.6 46.1 41.3 40.0 71.3 69.4 36.0 50.5 45.7 50.9 76.4 52.2 37.0 57.0 36.0 39.3 26.9 66.8 106.0 57.9 34.7 32.0 26.1 31.0 38.0 40.4 57.0 28.8 51.6 43.7 31.0 30.9 62.9 25.3 55.7 48.8 41.2 48.0 33.3 48.6 49.7 123.7 84.9 23.7 58.6 40.6 16.4 8.5 5.2 13.3 4.6 11.2 12.3 9.3 8.2 8.8 11.5 9.3 10.2 5.6 7.2 8.8 9.6 7.0 6.1 51.4 50.5 56.9 96.4 51.0 54.8 53.6 51.0 50.0 48.1 53.1 51.7 76.0 57.7 75.2 172.4 87.4 54.0 43.0 34.2 67.7 120.1 43.5 33.8 35.7 40.0 45.9 62.5 102.2 38.2 91.9 46.4 11.7 33.4 31.9 51.2 69.5 57.2 47.3 51.9 195.6 28.0 33.0 53.9 64.7 46.3 43.0 93.0 45.7 36.0 27.8 92.5 216.8 44.5 36.7 56.1 82.2 25.2 65.6 50.1 60.5 161.1 66.1 43.4 62.8 154.3 177.9 34.3 32.4 60.5 106.9 51.2 60.9 17.7 49.1 145.7 46.0 55.6 63.7 135.3 56.7 46.7 45.3 36.3 66.4 66.3 39.5 35.2 RBM5 "H37, LUCA-15, LUCA15" ENSG00000003756 "RNA binding motif protein 5" P52756 3 50088919-50119021 "Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017335, HPA018011" Approved Enhanced Nucleoplasm NA NA "Cluster 38: Basophils - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA017335: AB_1856134, HPA018011: AB_1856135" "unprognostic (4.11e-3)" "unprognostic (1.19e-1)" "unprognostic (6.12e-2)" "unprognostic (4.00e-2)" "unprognostic (2.07e-1)" "unprognostic (2.61e-3)" "prognostic unfavorable (9.77e-4)" "prognostic favorable (6.46e-4)" "unprognostic (1.16e-2)" "unprognostic (2.85e-1)" "prognostic favorable (7.58e-4)" "unprognostic (5.58e-2)" "unprognostic (1.49e-2)" "unprognostic (1.93e-1)" "unprognostic (1.58e-1)" "unprognostic (2.41e-1)" "unprognostic (3.89e-3)" 70.6 53.9 42.2 44.2 45.4 63.5 69.8 48.4 49.6 96.2 47.9 74.8 37.4 74.6 64.0 57.5 85.8 40.1 58.0 41.1 52.5 66.2 58.1 61.8 66.8 46.5 42.5 120.2 73.1 45.2 84.7 60.1 46.2 85.2 47.7 90.5 63.9 47.2 63.6 81.6 72.1 53.7 40.9 95.2 64.8 62.9 44.1 62.5 80.8 36.4 69.5 66.6 73.2 62.5 31.1 37.3 132.6 58.2 54.3 78.1 31.3 91.9 54.8 67.0 46.9 37.6 34.7 72.4 31.0 60.3 65.6 26.8 90.4 44.5 71.5 67.5 33.2 91.0 136.5 34.2 66.7 84.1 71.0 70.1 49.8 72.7 71.3 114.5 71.9 72.5 63.3 47.4 63.7 27.3 85.6 56.9 47.9 52.3 42.3 46.3 57.9 37.6 48.7 152.1 19.0 43.8 75.6 32.8 46.2 89.5 30.2 79.9 82.0 44.3 45.9 61.7 53.7 64.8 103.2 76.4 32.9 50.8 52.3 54.3 21.4 29.2 24.8 22.2 23.3 20.5 22.2 25.9 18.4 19.6 27.9 22.3 39.0 22.9 22.6 13.9 28.5 17.0 42.2 45.4 48.4 49.6 41.1 52.5 46.5 42.5 46.2 40.9 44.1 62.5 70.1 70.5 103.3 108.7 69.9 32.0 39.8 31.1 27.3 94.4 43.9 44.2 44.5 25.8 68.2 38.6 183.5 52.5 77.0 51.3 11.7 27.3 128.2 52.4 67.9 67.9 73.5 40.2 100.8 20.9 26.2 54.4 74.5 47.8 68.9 85.1 60.3 40.0 32.4 94.2 107.1 53.7 50.8 42.2 48.4 246.2 64.3 56.4 44.4 96.5 66.9 43.2 75.2 117.6 136.0 30.8 45.8 57.9 64.5 49.5 42.4 11.3 84.0 126.1 32.9 62.4 57.1 57.8 33.0 31.1 34.0 81.7 68.1 52.2 44.7 55.5 SEMA3F "Sema4, SEMAK" ENSG00000001617 "Semaphorin 3F" Q13275 3 50155045-50189075 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 100.8" "Cell type enhanced" "Detected in many" "Adipocytes: 40.2;Bipolar cells: 23.4;Endothelial cells: 24.4;Hepatic stellate cells: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 108.1;HUVEC TERT2: 187.0;RT4: 112.3;SK-BR-3: 170.2;TIME: 338.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA035008 Approved "Secreted to blood" NA NA 1700000 7900000 "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA035008: AB_10604091" "unprognostic (8.17e-2)" "unprognostic (2.01e-1)" "unprognostic (1.12e-2)" "unprognostic (1.87e-2)" "unprognostic (5.52e-3)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.71e-1)" "unprognostic (9.05e-2)" "unprognostic (4.20e-1)" "unprognostic (9.55e-2)" "unprognostic (3.01e-1)" "unprognostic (2.23e-2)" "unprognostic (6.19e-2)" "unprognostic (8.56e-2)" "unprognostic (3.88e-3)" "unprognostic (6.87e-3)" 33.8 9.0 8.8 8.6 5.7 2.7 31.9 5.1 8.1 28.3 12.0 10.5 13.4 14.5 5.4 100.8 15.6 10.8 22.6 5.0 9.2 49.2 4.8 46.2 3.7 10.2 12.7 3.6 6.7 5.5 11.1 30.4 8.7 32.7 6.3 22.0 24.6 32.5 10.4 75.1 12.5 9.1 6.3 50.7 17.3 2.4 21.8 6.1 27.1 6.1 12.6 27.0 55.4 4.7 13.9 3.1 0.7 14.2 0.2 1.3 3.0 8.0 24.2 6.5 10.2 5.4 6.1 0.5 77.9 1.1 0.7 47.5 6.9 100.7 2.4 0.1 1.8 0.8 108.1 18.5 5.7 1.7 3.2 6.2 55.3 15.1 45.4 90.7 187.0 1.2 2.9 0.1 1.3 12.4 1.5 7.5 8.6 6.2 10.1 11.8 0.0 0.5 7.2 112.3 1.1 2.6 12.8 170.2 0.3 10.4 67.2 7.3 338.6 4.2 31.9 29.7 5.5 0.2 0.0 0.9 0.3 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 5.7 5.1 8.1 5.0 9.2 10.2 12.7 8.7 6.3 21.8 4.7 40.2 0.0 1.1 0.0 0.2 6.8 3.0 9.2 5.7 23.4 10.7 6.0 9.2 1.5 6.6 18.4 10.4 11.2 0.6 5.5 0.0 0.3 0.0 6.5 2.4 24.4 0.0 0.0 0.7 0.8 0.5 1.1 16.3 6.9 0.0 0.2 25.4 0.6 1.4 6.7 1.1 10.7 0.0 0.3 0.8 0.3 0.3 0.2 0.0 3.7 0.0 8.7 0.0 0.0 0.1 6.8 3.8 0.0 0.0 2.5 5.7 0.7 5.4 19.8 0.0 0.5 2.5 0.0 0.4 17.7 8.9 6.3 0.4 0.2 5.2 8.6 GNAT1 CSNBAD3 ENSG00000114349 "G protein subunit alpha transducin 1" P11488 3 50191610-50197696 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Transducer "Congenital stationary night blindness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 904 "retina: 1120.2" "Cell type enriched" "Detected in some" 5 "Rod photoreceptor cells: 2275.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "hippocampal formation: 6.5" "Not detected" "Not detected" HPA045393 Enhanced NA NA "Cluster 79: Retina - Phototransduction" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA045393: AB_2679310" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "unprognostic (8.56e-3)" "unprognostic (3.32e-2)" "unprognostic (2.13e-1)" "unprognostic (7.72e-2)" "unprognostic (2.82e-3)" "unprognostic (6.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.87e-1)" "unprognostic (3.02e-1)" "unprognostic (9.48e-3)" 0.1 0.1 0.3 0.1 0.2 0.7 0.2 0.9 0.4 0.1 0.0 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 1120.2 0.0 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 1.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.9 0.4 0.2 0.1 0.2 0.2 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 222.9 0.1 0.1 0.4 0.0 0.0 0.0 241.8 0.0 0.0 0.0 0.0 0.0 14.1 0.1 0.1 13.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 90.9 0.0 0.0 0.0 0.0 0.0 38.2 0.6 0.0 0.0 0.0 0.0 397.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2275.4 0.0 0.0 0.0 4.7 2.1 0.7 0.0 0.1 0.0 0.1 0.1 0.1 SLC38A3 "G17, SN1" ENSG00000188338 "Solute carrier family 38 member 3" Q99624 3 50205246-50221486 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "liver: 331.6;retina: 172.9" "Group enriched" "Detected in many" 6 "Bipolar cells: 88.3;Cone photoreceptor cells: 187.7;Hepatocytes: 114.6;Muller glia cells: 80.1;Rod photoreceptor cells: 124.0" "Cancer enriched" "Detected in many" 9 "liver cancer: 140.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.9" "Group enriched" "Detected in some" 5 "Hep G2: 49.8;SCLC-21H: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031871 Approved Microtubules,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol Microtubules "HPA031871: AB_2674080" "unprognostic (2.14e-1)" "unprognostic (2.10e-1)" "unprognostic (8.60e-2)" "unprognostic (6.19e-4)" "unprognostic (7.37e-2)" "unprognostic (9.61e-2)" "unprognostic (2.34e-2)" "unprognostic (2.30e-2)" "unprognostic (4.68e-3)" "unprognostic (1.46e-1)" "unprognostic (2.06e-1)" "unprognostic (5.71e-2)" "unprognostic (1.23e-3)" "unprognostic (1.90e-1)" "unprognostic (2.37e-1)" "unprognostic (1.52e-1)" "unprognostic (1.96e-1)" 1.4 0.1 30.8 0.1 33.8 1.0 1.4 38.7 42.1 0.5 27.4 0.2 1.3 0.3 0.4 1.1 0.6 0.4 5.6 29.8 30.8 5.1 331.6 0.2 0.5 35.8 40.5 6.3 37.2 7.9 4.6 1.2 34.9 0.5 0.1 172.9 1.8 0.1 35.8 0.8 0.6 0.2 32.4 0.2 1.9 1.9 36.4 0.0 1.3 35.8 0.3 0.1 0.4 35.0 0.0 0.0 1.2 7.0 0.1 0.0 1.7 0.0 0.0 1.3 0.6 4.1 0.0 0.1 1.1 0.0 0.3 0.0 1.9 0.0 0.9 0.1 0.6 0.0 1.0 49.8 0.1 0.5 0.0 0.1 0.0 0.1 0.0 5.6 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.5 0.5 0.0 0.2 0.2 15.4 1.3 0.7 0.2 0.0 2.1 2.0 0.3 0.0 0.2 1.2 0.0 1.0 0.3 0.0 0.1 0.2 0.3 0.1 2.9 0.2 0.3 0.2 0.0 0.1 0.3 0.1 0.1 0.0 0.2 0.2 0.2 0.8 0.4 0.0 0.2 0.1 0.1 30.8 33.8 38.7 42.1 29.8 30.8 35.8 40.5 34.9 32.4 36.4 35.0 0.3 0.0 0.0 17.6 0.4 0.0 0.1 0.0 0.6 88.3 3.2 1.7 3.3 17.2 0.0 0.0 187.7 0.2 0.0 0.0 0.0 1.8 0.3 0.4 0.0 3.9 3.5 2.7 0.2 2.2 0.1 0.2 0.0 0.5 0.0 0.1 2.2 114.6 0.1 8.4 0.6 0.2 0.0 2.6 0.0 0.0 2.1 0.1 0.0 7.5 0.6 80.1 0.0 4.5 3.7 0.6 0.0 0.4 0.0 0.0 0.0 4.2 0.0 124.0 0.0 0.6 0.3 2.9 3.3 0.9 0.0 1.4 0.2 0.0 0.2 0.0 GNAI2 "GIP, GNAI2B" ENSG00000114353 "G protein subunit alpha i2" P04899 3 50226292-50259362 "Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 656.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007704 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA 4000000 "Cluster 52: Eosinophils - Transcription" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" Cytosol "Nucleoplasm, Plasma membrane" "HPA007704: AB_1849230" "prognostic favorable (1.03e-4)" "unprognostic (3.89e-1)" "unprognostic (3.35e-2)" "unprognostic (8.40e-3)" "unprognostic (2.58e-1)" "unprognostic (2.32e-2)" "unprognostic (2.59e-2)" "unprognostic (3.23e-1)" "unprognostic (1.08e-3)" "unprognostic (6.01e-2)" "unprognostic (7.00e-3)" "unprognostic (1.12e-1)" "unprognostic (6.24e-3)" "unprognostic (1.44e-1)" "unprognostic (4.30e-2)" "unprognostic (4.33e-2)" "unprognostic (1.38e-1)" 210.2 100.3 155.2 217.9 167.3 367.1 152.8 166.3 181.6 146.0 120.2 142.1 69.9 141.7 66.9 124.4 136.9 152.5 157.1 144.3 184.6 79.4 126.5 214.5 251.3 199.8 170.2 147.7 64.1 66.9 99.2 241.8 194.8 103.6 64.3 35.6 71.9 156.9 69.3 87.0 103.0 154.0 173.6 262.1 73.6 69.6 173.3 160.3 101.3 89.4 170.4 169.7 108.4 193.2 128.2 63.0 186.3 197.6 220.7 277.5 35.5 271.1 399.6 354.9 361.1 70.4 173.2 149.1 119.2 567.0 193.4 100.1 132.8 350.3 222.8 331.2 50.9 364.8 158.0 110.2 219.8 329.2 479.8 270.3 152.9 319.1 129.8 289.6 837.8 124.1 26.1 307.1 357.5 155.7 313.6 433.0 109.7 59.0 302.4 185.0 89.8 219.7 232.6 130.9 48.4 86.1 189.5 57.1 124.4 150.4 94.3 346.1 792.3 330.9 187.5 309.2 274.7 199.4 278.3 127.0 373.6 466.9 398.1 16.6 59.3 113.7 33.7 80.9 20.2 28.8 26.8 34.3 57.3 26.1 20.2 25.8 145.2 23.5 74.5 47.2 34.0 27.3 155.2 167.3 166.3 181.6 144.3 184.6 199.8 170.2 194.8 173.6 173.3 193.2 656.8 41.7 32.1 25.1 119.5 56.7 59.7 32.3 45.5 29.0 61.6 83.8 22.9 55.8 26.6 44.1 14.6 79.5 311.4 11.7 5.9 124.3 203.3 57.8 115.7 340.3 92.2 52.1 12.4 60.5 84.4 101.9 21.9 71.8 89.9 150.0 221.3 79.7 336.0 6.7 14.8 24.6 18.3 342.7 291.7 302.0 90.7 386.1 83.6 58.1 356.6 292.6 151.4 26.7 45.4 160.3 40.9 95.5 104.8 46.1 30.3 24.5 24.4 21.9 52.6 85.3 163.1 16.6 22.6 37.6 62.9 116.4 164.9 156.3 20.5 70.1 SEMA3B "LUCA-1, SemA, sema5, SEMAA, semaV" ENSG00000012171 "Semaphorin 3B" Q13214 3 50267558-50277546 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 174.5;brain: 184.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 163.5;Distal enterocytes: 129.1;Gastric mucus-secreting cells: 208.0;Oligodendrocytes: 157.8;Proximal enterocytes: 336.4;Syncytiotrophoblasts: 111.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 73.7;Hep G2: 105.7;SK-BR-3: 54.5;WM-115: 173.1" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 5 "spinal cord: 27.9" HPA030651 Uncertain "Secreted in other tissues" NA NA 790000 "Cluster 49: Eosinophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 17: WM-115 - Nervous system development" "Cluster 45: Enterocytes - Digestion" "HPA030651: AB_10602224" "prognostic favorable (1.27e-4)" "unprognostic (6.48e-2)" "unprognostic (5.40e-2)" "unprognostic (1.07e-1)" "unprognostic (1.68e-1)" "unprognostic (4.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.83e-2)" "unprognostic (2.21e-2)" "unprognostic (2.28e-1)" "unprognostic (1.85e-2)" "unprognostic (4.27e-1)" "unprognostic (7.99e-2)" "unprognostic (7.78e-2)" "unprognostic (3.89e-1)" "unprognostic (8.87e-3)" "unprognostic (1.69e-2)" 33.6 174.5 50.2 9.0 124.4 0.2 17.3 87.7 78.2 46.2 35.2 53.6 41.3 45.7 2.2 9.1 37.0 10.0 40.3 53.1 66.4 70.9 6.1 49.2 0.3 125.7 101.9 24.5 41.4 10.6 10.4 35.3 98.6 34.0 10.5 2.0 12.7 20.6 7.4 7.9 62.8 14.2 76.2 5.1 56.8 14.8 110.4 0.6 24.2 8.7 0.3 19.6 32.3 184.2 12.7 8.2 0.8 8.0 0.6 1.0 2.0 16.3 22.3 4.7 7.9 5.5 29.7 0.0 14.3 15.3 0.0 1.8 0.4 26.2 1.8 0.2 0.7 0.0 73.7 105.7 16.8 0.0 0.8 5.1 0.5 5.4 4.1 19.9 0.0 0.1 0.2 2.2 0.8 22.4 0.0 0.7 1.1 23.4 4.5 0.3 1.2 0.6 7.4 1.4 1.0 3.8 4.2 54.5 9.2 2.4 3.6 0.1 0.5 1.3 15.4 4.3 5.3 4.4 0.2 0.2 7.9 0.2 173.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.2 124.4 87.7 78.2 53.1 66.4 125.7 101.9 98.6 76.2 110.4 184.2 6.5 163.5 18.6 45.1 1.8 0.0 8.3 0.0 6.2 3.7 19.3 8.5 14.5 44.3 18.6 64.4 0.0 3.6 1.2 129.1 1.9 38.3 11.2 29.8 11.6 6.1 10.3 0.0 0.6 23.1 1.0 35.3 208.0 73.1 11.4 11.4 5.7 1.2 1.9 0.0 0.8 45.7 0.0 1.6 0.0 21.4 4.1 2.8 0.0 12.2 0.7 17.3 0.0 3.0 157.8 32.5 79.9 3.0 0.6 14.1 336.4 40.4 5.1 1.6 6.6 19.0 7.5 6.6 11.4 2.0 0.0 111.6 2.4 0.2 31.5 32.7 LSMEM2 "C3orf45, FLJ38608" ENSG00000179564 "Leucine rich single-pass membrane protein 2" Q8N112 3 50279087-50288114 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 23.9;skeletal muscle: 16.5" "Cell type enriched" "Detected in some" 6 "Late spermatids: 283.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA079523 Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 38: Heart - Muscle contraction" "Cluster 25: Spermatids - Spermatogenesis" "Plasma membrane" Nucleoplasm "HPA079523: " "unprognostic (2.84e-3)" "unprognostic (6.54e-2)" "unprognostic (2.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (2.65e-1)" "unprognostic (3.17e-2)" "unprognostic (2.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.46e-2)" "unprognostic (2.48e-1)" "unprognostic (6.49e-3)" "unprognostic (1.71e-1)" 0.4 0.4 2.9 0.1 4.8 0.4 0.3 3.1 3.7 1.3 1.8 0.5 0.3 0.7 0.2 0.5 0.7 0.2 23.9 3.2 3.2 0.8 0.2 0.4 0.0 3.7 3.7 1.2 0.2 0.0 0.1 0.1 3.4 0.4 0.1 0.3 0.2 0.4 16.5 0.2 0.3 0.4 2.7 0.2 0.3 3.9 3.8 0.0 0.2 5.5 0.0 0.4 0.8 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 4.8 3.1 3.7 3.2 3.2 3.7 3.7 3.4 2.7 3.8 6.0 1.0 0.0 0.6 0.7 0.3 1.0 0.2 0.2 0.0 0.2 1.5 0.9 4.4 0.0 0.8 1.8 0.0 0.1 0.3 0.9 0.0 0.1 40.5 3.3 0.6 0.8 0.0 0.0 0.2 0.2 0.1 0.4 0.0 10.1 5.1 0.2 0.0 0.3 0.1 0.0 0.2 0.3 0.0 0.3 0.4 283.1 1.2 0.3 1.8 0.0 0.0 0.5 0.0 0.0 2.8 0.2 0.0 0.7 0.0 0.4 1.5 0.1 0.2 0.2 0.0 1.4 4.7 1.8 1.1 0.4 1.3 0.1 0.2 0.1 0.7 0.1 IFRD2 "IFNRP, SKMc15, SM15" ENSG00000214706 "Interferon related developmental regulator 2" Q12894 3 50287732-50292918 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 139.9;Prostatic glandular cells: 153.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068560 Approved Approved Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA068560: AB_2686005" "prognostic favorable (7.22e-4)" "unprognostic (5.19e-2)" "unprognostic (2.08e-2)" "unprognostic (8.61e-3)" "unprognostic (3.88e-1)" "unprognostic (2.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.24e-1)" "unprognostic (1.62e-1)" "unprognostic (2.01e-1)" "unprognostic (1.91e-2)" "unprognostic (7.78e-3)" "prognostic favorable (2.50e-4)" "unprognostic (3.07e-2)" "unprognostic (1.03e-1)" "unprognostic (1.58e-1)" "unprognostic (1.13e-1)" 39.4 44.9 16.7 13.9 17.8 15.6 33.9 17.4 20.9 24.4 19.2 33.2 20.1 26.8 11.8 44.3 28.2 10.9 69.4 16.2 16.6 39.3 97.0 30.7 14.1 18.0 17.7 23.1 87.3 17.8 22.1 9.3 17.2 45.1 15.0 3.6 33.7 16.7 109.6 25.4 28.1 14.9 17.9 28.3 67.9 17.4 18.0 8.4 31.9 44.6 12.5 36.1 23.6 18.0 70.1 70.5 19.1 60.3 19.2 22.0 44.0 52.4 28.2 62.8 44.3 58.3 69.5 47.3 37.7 36.3 53.9 40.0 40.2 83.8 32.3 45.4 80.7 68.4 93.5 69.5 37.9 70.1 41.4 20.4 70.6 65.7 81.9 20.7 54.0 41.8 44.2 37.9 37.6 65.1 46.5 82.0 48.1 86.1 135.4 29.8 27.7 108.1 38.0 41.3 33.7 32.5 33.2 90.4 34.4 18.3 43.1 66.4 39.5 52.2 65.6 91.3 107.9 26.5 48.9 41.8 41.4 91.1 77.9 11.7 24.1 3.6 33.1 34.4 47.5 32.4 35.0 32.3 35.2 34.0 36.7 33.3 2.3 39.0 19.7 35.0 30.9 30.5 16.7 17.8 17.4 20.9 16.2 16.6 18.0 17.7 17.2 17.9 18.0 18.0 36.9 19.2 24.6 5.9 26.8 67.3 71.7 51.7 31.9 17.3 48.5 37.1 1.7 32.9 36.4 20.2 20.9 35.3 23.8 22.1 29.4 68.8 67.2 11.3 27.8 30.3 15.6 93.6 7.1 89.6 49.5 24.8 62.7 13.1 7.6 28.6 13.9 50.7 31.2 18.5 6.7 29.6 34.6 13.7 28.4 139.9 13.7 15.2 35.6 2.8 16.5 13.3 25.7 4.5 7.3 68.2 26.8 14.3 31.9 153.3 31.3 58.6 10.4 12.0 0.0 30.8 34.9 21.9 19.1 43.1 68.6 30.4 19.2 40.3 56.3 76.8 HYAL3 "LUCA-3, LUCA14, Minna14" ENSG00000186792 "Hyaluronidase 3" O43820 3 50292831-50299405 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 36.4" "Group enriched" "Detected in many" 17 "Early spermatids: 79.7;Late spermatids: 268.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 33.2;eosinophil: 54.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 54.6" "Cell line enhanced" "Detected in all" "HEL: 58.8;HMC-1: 101.1;THP-1: 107.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" HPA049402 Uncertain "Secreted to blood" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" "HPA049402: AB_2680746" "unprognostic (1.21e-3)" "unprognostic (2.55e-2)" "unprognostic (5.45e-2)" "unprognostic (8.19e-2)" "unprognostic (3.07e-1)" "unprognostic (1.65e-2)" "unprognostic (7.98e-3)" "unprognostic (7.36e-2)" "unprognostic (1.58e-1)" "unprognostic (3.41e-2)" "unprognostic (5.40e-2)" "unprognostic (5.71e-2)" "unprognostic (2.61e-1)" "unprognostic (8.09e-2)" "unprognostic (1.28e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (2.12e-5)" 2.1 2.8 5.1 1.3 5.4 36.4 1.8 6.7 8.3 2.0 2.9 1.9 1.7 1.6 1.1 3.9 1.6 1.8 1.8 5.1 4.0 2.6 5.1 2.1 1.2 7.4 4.0 1.5 1.9 0.9 1.9 1.5 7.3 3.2 1.0 1.1 3.5 2.4 1.0 2.1 1.8 2.2 3.9 1.7 4.5 13.9 5.4 1.6 1.7 0.9 1.6 1.8 2.7 5.8 6.0 6.9 3.8 4.3 7.6 3.9 2.3 6.5 5.8 8.0 6.1 9.3 6.2 5.2 3.1 7.5 12.4 6.5 7.0 15.2 3.0 12.3 3.6 58.8 18.8 7.6 5.5 6.4 101.1 8.1 11.5 8.1 5.2 5.8 8.4 5.8 4.6 6.3 3.8 3.6 2.4 37.4 2.9 7.0 17.2 2.6 5.1 9.5 9.5 2.6 4.7 5.4 9.6 7.5 5.1 4.4 4.9 107.2 11.1 6.8 4.9 22.2 3.8 3.0 7.0 4.4 6.0 22.5 5.8 33.2 4.1 54.6 1.3 2.3 2.2 1.6 4.1 1.9 8.2 2.9 1.1 1.5 1.4 2.1 1.4 2.0 2.6 2.4 5.1 5.4 6.7 8.3 5.1 4.0 7.4 4.0 7.3 3.9 5.4 5.8 2.5 3.2 1.1 0.3 0.8 3.1 2.8 8.1 2.8 1.5 2.2 2.8 0.4 1.5 5.0 3.7 4.2 2.8 0.2 0.8 9.8 5.6 79.7 2.0 1.6 3.5 4.2 9.2 2.4 0.7 5.3 1.2 4.1 2.1 7.0 1.1 7.1 2.1 2.1 5.0 1.6 1.9 6.1 1.9 4.4 268.2 1.8 2.0 3.6 1.0 5.9 1.5 0.0 0.5 0.3 3.6 0.4 2.6 1.9 2.2 0.5 2.7 1.8 0.8 6.6 1.2 1.8 4.3 4.6 3.7 3.7 3.0 2.2 1.6 1.8 3.5 NAA80 "FUS2, NAT6" ENSG00000243477 "N-alpha-acetyltransferase 80, NatH catalytic subunit" Q93015 3 50296402-50299416 "Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 65.5" "Cell type enhanced" "Detected in many" "Adipocytes: 6.5;Exocrine glandular cells: 8.8;monocytes: 9.3;Pancreatic endocrine cells: 6.5;Proximal tubular cells: 7.5;Theca cells: 6.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "eosinophil: 56.3" "Lineage enriched" "Detected in all" 5 "granulocytes: 56.3" "Cell line enhanced" "Detected in all" "HMC-1: 60.5" "Low region specificity" "Detected in all" HPA039576 Approved NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "HPA039576: AB_10794750" "prognostic favorable (3.62e-4)" "unprognostic (1.02e-2)" "unprognostic (6.04e-2)" "unprognostic (1.42e-2)" "unprognostic (2.19e-1)" "unprognostic (7.78e-2)" "unprognostic (7.49e-2)" "unprognostic (4.62e-2)" "unprognostic (1.89e-1)" "unprognostic (1.39e-1)" "unprognostic (1.50e-2)" "unprognostic (4.38e-2)" "prognostic favorable (1.71e-4)" "unprognostic (1.88e-1)" "unprognostic (1.01e-1)" "unprognostic (9.16e-2)" "unprognostic (2.55e-1)" 13.4 12.2 8.2 7.6 9.2 32.4 13.9 10.9 15.2 16.8 3.1 12.3 6.4 13.3 7.0 15.4 15.4 6.3 17.2 8.8 6.5 19.3 14.6 15.5 10.3 11.6 8.0 17.5 15.1 9.0 14.3 5.8 11.9 19.1 7.7 3.8 13.8 10.6 18.0 22.5 13.4 6.8 5.3 16.5 17.7 65.5 7.3 8.2 14.4 7.2 9.7 13.1 15.9 8.9 8.0 6.2 9.0 9.5 10.7 12.3 6.0 7.4 14.6 11.5 9.9 5.4 15.0 24.6 5.5 12.9 9.4 9.9 5.3 24.2 4.7 15.6 9.0 49.2 37.7 12.3 9.4 8.3 60.5 14.8 16.8 19.3 13.3 17.0 14.1 13.2 4.4 22.7 10.5 8.3 9.9 37.7 5.0 3.6 19.9 6.4 3.2 29.9 19.4 3.9 6.3 8.9 8.4 17.5 3.5 5.5 7.6 23.4 11.7 9.2 9.2 11.4 7.3 15.4 8.9 6.1 15.9 15.5 8.8 13.7 3.1 56.3 7.1 4.2 10.3 10.4 9.7 8.6 5.2 7.5 7.6 6.4 0.9 9.8 2.7 2.6 9.4 5.5 8.2 9.2 10.9 15.2 8.8 6.5 11.6 8.0 11.9 5.3 7.3 8.9 6.5 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 3.8 4.1 0.0 0.0 0.0 3.7 0.0 5.4 4.5 0.0 3.9 4.8 0.0 3.1 3.4 2.1 0.0 0.0 0.0 8.8 5.1 2.1 0.0 3.2 0.0 3.6 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 6.5 0.0 0.0 2.4 0.0 0.0 7.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 5.1 2.1 6.4 0.0 0.0 HYAL1 "HYAL-1, LUCA1" ENSG00000114378 "Hyaluronidase 1" Q12794 3 50299890-50312381 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Disease variant, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 201.6;lymphoid tissue: 95.1" "Cell type enhanced" "Detected in many" "Cholangiocytes: 30.0;Hepatic stellate cells: 33.2;Hepatocytes: 137.1;Proximal tubular cells: 58.2" "Cancer enhanced" "Detected in all" "liver cancer: 37.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "Hep G2: 100.9;SK-BR-3: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002112 Uncertain "Secreted to blood" NA NA 590000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA002112: AB_1857412" "unprognostic (1.39e-1)" "unprognostic (8.68e-2)" "prognostic favorable (2.07e-4)" "unprognostic (5.23e-2)" "unprognostic (3.18e-1)" "unprognostic (8.71e-2)" "unprognostic (9.35e-2)" "unprognostic (3.59e-2)" "unprognostic (6.56e-2)" "unprognostic (1.31e-1)" "unprognostic (6.65e-3)" "unprognostic (1.16e-1)" "prognostic favorable (1.56e-11)" "unprognostic (4.51e-2)" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.90e-2)" 11.4 21.5 5.0 2.8 4.5 0.3 9.2 6.4 6.3 10.8 18.3 6.8 3.4 8.2 0.8 5.5 7.3 13.2 68.2 4.5 4.0 49.4 201.6 30.7 1.8 5.4 4.8 3.0 9.4 19.9 3.3 2.4 5.6 4.6 2.9 3.1 7.3 2.9 15.0 21.1 6.0 5.9 3.5 95.1 19.4 1.7 5.8 0.8 8.3 19.0 1.2 4.8 12.3 4.7 2.9 1.8 0.4 0.9 0.6 0.7 0.5 0.1 0.3 0.1 0.4 11.4 3.1 0.0 0.8 0.6 0.6 6.6 0.2 0.4 0.0 0.1 0.0 0.3 8.6 100.9 4.4 0.7 0.7 3.9 13.8 0.1 0.4 0.8 2.9 0.3 0.3 0.5 0.4 0.6 0.1 0.3 0.6 7.1 0.6 0.0 0.2 0.3 5.9 0.4 0.2 2.1 0.2 28.0 0.3 2.4 2.0 0.3 1.9 0.6 0.6 0.6 0.3 0.2 0.3 0.4 0.4 0.6 0.3 1.3 0.4 1.5 0.3 0.1 0.8 0.4 0.3 0.4 0.2 0.5 0.6 0.4 3.1 0.3 0.3 0.5 0.4 0.1 5.0 4.5 6.4 6.3 4.5 4.0 5.4 4.8 5.6 3.5 5.8 4.7 18.1 19.2 18.5 1.6 0.3 2.9 0.4 3.3 0.0 1.0 0.3 0.1 20.8 30.0 2.0 11.0 4.2 0.1 0.0 2.5 23.5 16.5 8.2 0.2 0.9 25.8 1.8 2.7 3.1 14.4 0.1 3.3 19.4 0.2 0.0 0.6 33.2 137.1 0.1 0.0 3.1 1.4 0.0 4.4 0.9 7.7 2.1 0.9 0.0 7.5 0.0 0.4 0.0 1.5 1.6 12.1 0.3 1.2 0.0 0.2 0.4 58.2 0.9 0.5 6.6 1.2 4.3 0.4 1.1 0.9 3.1 0.7 0.9 7.4 0.9 1.7 HYAL2 "LuCa-2, LUCA2" ENSG00000068001 "Hyaluronidase 2" Q12891 3 50317790-50322782 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 282.8" "Group enriched" "Detected in many" 5 "Adipocytes: 497.6;Endothelial cells: 216.3;Hepatic stellate cells: 253.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in all" 4 "HUVEC TERT2: 363.3;TIME: 502.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036436 Uncertain NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA036436: AB_10670104" "unprognostic (9.97e-3)" "unprognostic (2.60e-1)" "unprognostic (1.44e-1)" "unprognostic (5.10e-3)" "unprognostic (3.44e-1)" "unprognostic (7.41e-2)" "unprognostic (7.93e-2)" "unprognostic (4.70e-1)" "unprognostic (1.44e-1)" "unprognostic (6.76e-2)" "unprognostic (2.36e-1)" "unprognostic (3.01e-1)" "unprognostic (2.63e-3)" "unprognostic (7.36e-2)" "unprognostic (2.72e-1)" "unprognostic (7.02e-3)" "unprognostic (5.62e-2)" 97.4 62.6 24.7 29.1 23.0 3.1 93.9 24.9 28.3 51.6 24.3 34.0 17.9 66.1 10.3 39.7 55.6 47.5 92.2 22.3 24.8 85.1 32.2 186.8 40.0 26.0 24.9 29.1 27.9 25.7 41.6 87.4 27.5 37.2 11.5 3.3 37.5 22.0 30.9 37.1 38.7 37.4 27.1 282.8 38.6 22.0 28.1 9.5 80.9 35.7 14.6 47.0 45.8 24.9 26.8 38.5 63.0 64.1 38.2 32.9 39.6 29.8 41.2 42.0 32.6 44.6 77.3 7.0 102.4 43.6 82.5 27.4 24.6 58.7 12.0 14.2 19.6 9.7 34.9 69.2 33.0 8.1 24.4 51.9 48.8 42.1 13.8 38.1 363.3 18.2 17.6 8.0 35.4 37.0 17.7 16.6 72.0 23.2 55.7 15.5 12.4 26.1 52.4 24.2 16.6 53.3 30.4 31.2 31.8 21.2 34.4 20.3 502.9 50.0 49.7 33.5 47.5 13.9 24.1 21.6 29.4 25.5 73.0 0.0 9.5 10.7 1.4 14.1 3.0 1.1 1.3 3.8 5.3 1.5 0.4 0.7 9.2 2.8 13.6 4.0 1.9 3.3 24.7 23.0 24.9 28.3 22.3 24.8 26.0 24.9 27.5 27.1 28.1 24.9 497.6 19.2 9.9 5.2 3.6 13.0 28.6 45.2 11.4 7.8 17.6 16.6 7.3 32.9 30.9 33.1 6.2 33.6 4.1 13.5 11.7 53.0 4.7 8.5 19.8 216.3 7.3 10.1 1.6 38.7 38.4 26.6 16.8 13.8 0.0 31.5 253.1 9.1 46.2 8.4 1.9 13.0 42.7 12.6 9.3 5.0 24.5 9.4 17.8 15.9 7.6 19.7 5.2 4.0 3.4 45.6 13.5 22.2 4.2 45.3 16.1 11.8 11.0 6.1 39.5 11.2 26.0 11.2 56.0 24.9 12.6 32.7 4.1 50.0 16.6 33.3 TUSC2 "C3orf11, FUS1, PAP, PDAP2" ENSG00000114383 "Tumor suppressor 2, mitochondrial calcium regulator" O75896 3 50320027-50328251 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 351.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030116 Approved Vesicles,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 31: Spermatids - Spermatogenesis" Cytosol Vesicles "HPA030116: AB_10602253" "unprognostic (1.58e-2)" "unprognostic (1.55e-1)" "unprognostic (1.73e-1)" "unprognostic (8.46e-2)" "unprognostic (2.73e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (2.84e-4)" "unprognostic (2.53e-3)" "unprognostic (2.87e-1)" "unprognostic (1.20e-2)" "unprognostic (3.47e-2)" "unprognostic (1.99e-2)" "prognostic favorable (8.70e-7)" "unprognostic (9.22e-3)" "unprognostic (1.98e-1)" "unprognostic (3.15e-1)" "unprognostic (6.34e-3)" 17.7 25.4 53.4 14.9 54.1 12.4 17.0 51.0 56.2 16.3 43.9 25.2 12.8 17.7 28.2 18.9 20.6 11.5 35.4 54.8 55.5 29.2 25.9 18.4 17.1 54.6 56.2 15.8 27.4 34.8 21.5 17.3 55.6 22.1 16.6 36.0 18.4 17.8 50.9 13.8 20.3 13.7 50.5 23.7 26.9 22.6 56.1 20.4 23.1 36.4 20.5 20.5 14.2 50.8 24.7 20.2 27.5 30.1 29.8 15.4 30.1 19.3 26.5 36.3 30.7 35.6 22.0 41.8 21.0 18.3 37.4 15.5 33.9 25.7 31.7 24.8 31.2 20.6 18.6 38.7 26.1 36.7 34.8 16.8 40.7 36.5 18.1 25.5 38.0 32.8 25.4 19.6 21.1 18.8 38.7 46.5 37.6 30.4 28.9 13.3 13.4 34.4 36.9 26.4 14.7 30.3 14.4 25.4 29.9 27.2 24.2 44.3 30.3 10.8 26.6 24.8 40.2 47.6 79.7 29.4 24.2 24.1 17.4 16.7 21.2 34.6 24.0 19.6 24.3 23.0 20.8 25.2 14.2 24.6 23.5 25.2 30.2 22.4 18.1 26.3 25.2 32.3 53.4 54.1 51.0 56.2 54.8 55.5 54.6 56.2 55.6 50.5 56.1 50.8 39.8 12.8 17.0 3.9 41.7 57.5 36.8 60.7 37.0 55.5 61.0 44.2 39.6 55.8 37.9 57.0 22.9 62.9 54.4 46.5 115.4 73.9 123.1 55.6 15.8 39.2 50.4 40.4 12.9 74.1 55.5 24.9 25.0 28.4 29.9 16.4 40.4 72.7 76.6 74.0 11.4 46.1 73.2 46.1 51.1 351.8 27.1 37.7 55.2 5.6 57.6 69.0 59.8 4.0 7.8 74.0 61.0 24.8 45.8 67.8 72.0 178.6 71.5 45.5 13.1 18.0 38.5 54.1 49.2 47.4 91.2 69.6 38.7 28.9 46.1 63.7 RASSF1 "123F2, NORE2A, RDA32, REH3P21" ENSG00000068028 "Ras association domain family member 1" Q9NS23 3 50329782-50340980 "Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 116.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 252.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040735 Approved NA Yes "Cluster 46: Basophils - DNA binding" "Cluster 82: Adipose tissue - ECM organization" "Cluster 24: NB-4 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA040735: AB_10671692" "unprognostic (5.02e-2)" "prognostic favorable (2.64e-4)" "unprognostic (3.05e-1)" "unprognostic (2.95e-2)" "unprognostic (1.00e-3)" "prognostic favorable (2.60e-4)" "prognostic unfavorable (9.77e-4)" "unprognostic (3.80e-2)" "unprognostic (2.11e-1)" "unprognostic (1.07e-2)" "unprognostic (1.54e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (8.58e-5)" "unprognostic (4.27e-2)" "unprognostic (2.29e-1)" "unprognostic (1.11e-1)" "unprognostic (9.71e-2)" 50.1 18.9 19.2 23.2 19.5 84.3 46.0 19.6 20.1 44.1 18.1 28.4 15.6 29.7 11.1 26.2 35.4 21.5 47.7 18.4 19.2 39.0 24.7 61.2 39.5 20.8 20.0 31.2 35.3 7.5 22.2 25.8 20.4 31.6 11.6 6.1 30.2 11.8 28.5 38.9 39.6 18.1 20.7 72.3 31.7 38.5 20.4 16.3 29.7 14.3 25.5 32.3 37.4 22.1 37.4 15.1 11.1 18.5 25.0 33.8 16.2 62.5 40.9 52.6 41.8 34.7 27.3 18.0 9.4 67.3 23.6 19.6 23.3 26.1 28.3 44.6 15.2 61.8 51.9 18.4 28.6 61.2 65.2 26.1 18.1 52.0 18.4 15.4 23.7 21.8 26.2 40.7 24.1 13.1 23.3 81.9 14.7 31.2 44.9 19.0 11.4 41.4 15.7 10.8 13.0 23.9 55.6 37.2 41.5 11.2 22.3 59.2 22.9 36.1 27.2 52.0 31.3 16.5 11.7 39.4 20.3 75.6 66.1 252.6 23.3 79.5 77.0 41.5 48.3 44.3 24.6 55.3 24.9 33.6 15.7 37.7 18.4 64.6 59.1 18.5 27.5 42.0 19.2 19.5 19.6 20.1 18.4 19.2 20.8 20.0 20.4 20.7 20.4 22.1 76.6 16.0 8.1 4.6 50.7 73.8 36.3 22.6 34.1 11.6 32.7 22.9 14.3 12.8 14.4 1.8 14.6 27.5 116.1 12.2 5.9 23.1 2.4 16.5 16.3 47.4 16.7 33.2 3.8 26.5 28.1 29.1 27.0 17.6 57.1 9.0 26.0 4.3 38.6 3.3 3.8 19.4 22.4 27.7 43.8 10.4 19.0 28.7 90.7 9.4 23.2 6.1 93.7 2.0 6.0 40.9 17.4 14.7 63.8 24.7 12.1 10.2 7.7 10.1 26.3 19.3 50.4 33.1 11.0 19.2 50.2 16.6 67.2 9.0 15.2 21.3 ZMYND10 "BLU, CILD22, DNAAF7" ENSG00000004838 "Zinc finger MYND-type containing 10" O75800 3 50341110-50345732 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "fallopian tube: 120.2;testis: 258.5" "Group enriched" "Detected in many" 11 "Early spermatids: 309.4;Endometrial ciliated cells: 221.8;Late spermatids: 415.3;Respiratory ciliated cells: 390.8;Spermatocytes: 529.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "T-47d: 5.6;U-87 MG: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035255 Approved "Plasma membrane,Cytosol" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" Cytosol "HPA035255: AB_10601928" "unprognostic (2.93e-3)" "unprognostic (2.98e-3)" "unprognostic (1.15e-2)" "unprognostic (3.85e-3)" "unprognostic (4.44e-1)" "unprognostic (7.78e-3)" "unprognostic (4.71e-2)" "unprognostic (6.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (6.73e-2)" "prognostic favorable (6.75e-5)" "unprognostic (8.25e-2)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" 0.3 0.1 5.0 0.2 5.0 0.7 1.1 3.5 2.8 4.3 29.2 0.2 0.2 1.7 1.6 0.2 120.2 0.5 0.2 4.3 6.7 2.1 0.9 11.1 0.2 12.5 15.6 0.6 1.1 3.7 5.9 0.1 9.4 0.7 0.1 3.2 0.3 0.4 0.4 0.5 0.4 0.5 10.4 0.6 0.3 258.5 7.3 0.5 1.9 0.2 0.1 0.2 0.3 9.2 1.6 0.6 0.2 0.5 0.6 0.9 0.3 0.2 0.9 1.6 0.5 0.0 1.0 0.7 0.6 1.0 0.2 0.2 1.5 0.0 0.1 0.4 0.6 1.5 1.2 0.0 0.0 0.5 0.8 0.0 0.1 2.0 0.1 1.5 0.1 1.3 0.5 0.1 0.2 1.0 0.3 2.7 0.0 0.2 0.7 0.7 0.0 0.5 2.0 0.0 1.8 0.5 0.1 0.5 0.0 0.0 5.6 0.6 0.0 0.3 0.4 0.9 0.1 1.0 0.4 0.1 3.9 2.2 0.1 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.1 0.1 0.0 0.0 0.1 5.0 5.0 3.5 2.8 4.3 6.7 12.5 15.6 9.4 10.4 7.3 9.2 0.5 3.2 5.1 1.3 0.7 0.5 0.4 24.2 1.2 1.2 2.3 1.7 0.8 0.0 33.1 1.8 4.2 0.1 1.7 0.2 0.0 1.1 309.4 221.8 2.4 1.2 0.0 3.2 0.5 0.0 0.2 1.1 0.0 3.6 0.0 0.3 0.7 0.4 0.6 0.0 0.3 0.7 22.4 0.0 0.4 415.3 9.0 1.3 1.8 1.0 0.9 1.2 2.1 0.5 1.3 0.1 0.0 5.7 0.9 0.6 0.0 1.0 390.8 7.6 0.0 0.9 9.8 529.7 9.1 1.1 0.4 0.1 1.7 0.2 0.3 0.1 NPRL2 "NPR2, NPR2L, TUSC4" ENSG00000114388 "NPR2 like, GATOR1 complex subunit" Q8WTW4 3 50347330-50350826 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Disease variant, Epilepsy, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 94.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038196, HPA038197" Approved NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 63: NK-cells & T-cells - Immune response" "HPA038196: AB_10675631, HPA038197: AB_10671523" "unprognostic (7.25e-3)" "unprognostic (2.01e-2)" "unprognostic (3.41e-2)" "unprognostic (2.81e-1)" "unprognostic (6.44e-2)" "unprognostic (2.11e-2)" "unprognostic (3.06e-3)" "prognostic favorable (1.59e-4)" "unprognostic (7.86e-2)" "unprognostic (1.22e-2)" "unprognostic (1.60e-3)" "unprognostic (5.69e-2)" "unprognostic (4.28e-2)" "unprognostic (4.55e-2)" "unprognostic (3.14e-1)" "unprognostic (4.49e-1)" "unprognostic (3.06e-2)" 4.9 9.2 9.4 5.0 9.7 5.1 7.4 10.0 11.0 9.0 9.4 8.3 5.3 5.3 11.1 6.8 8.8 6.2 10.3 10.0 11.1 9.3 12.9 5.1 8.0 9.7 10.7 7.8 16.4 12.1 9.0 5.7 10.1 7.7 8.5 5.7 12.1 8.1 14.7 7.5 5.6 6.9 10.0 6.8 7.2 7.8 9.9 9.6 8.3 18.0 9.2 5.8 5.3 10.3 12.2 11.9 7.9 14.5 22.5 11.8 8.2 6.4 16.5 17.1 16.8 9.3 11.0 13.9 9.5 11.9 8.6 6.7 18.1 18.5 12.3 10.0 12.9 16.6 10.0 18.2 20.2 20.7 21.9 14.3 19.3 21.8 15.0 11.5 16.8 20.2 9.5 13.6 14.7 2.4 19.3 14.8 8.7 37.2 33.4 7.1 5.0 34.5 19.7 12.1 6.0 14.1 7.3 11.1 12.5 8.2 17.5 10.4 6.0 7.2 9.2 13.8 11.7 16.8 22.0 11.8 14.6 25.5 7.3 40.6 17.4 46.7 72.7 18.1 63.4 23.2 36.4 62.7 20.6 21.1 30.8 48.5 22.9 64.1 20.8 16.6 49.8 50.7 9.4 9.7 10.0 11.0 10.0 11.1 9.7 10.7 10.1 10.0 9.9 10.3 13.4 9.6 11.9 7.8 19.0 12.0 9.8 26.7 14.8 18.4 18.2 19.9 13.2 15.7 16.3 14.7 20.9 27.4 31.4 15.8 37.2 15.9 94.6 8.1 9.4 11.3 11.9 30.3 7.2 15.0 21.5 12.9 18.3 7.1 19.0 12.6 11.7 14.8 14.7 25.2 7.9 20.9 38.7 13.2 10.3 66.6 19.3 7.4 12.4 2.8 15.0 15.0 68.0 5.0 6.5 12.2 12.8 15.1 19.4 7.7 30.7 30.0 15.6 26.4 6.6 11.1 22.1 16.8 14.9 15.4 12.5 9.0 29.3 16.0 18.8 7.7 CYB561D2 "101F6, TSP10" ENSG00000114395 "Cytochrome b561 family member D2" O14569 3 50350845-50358460 "Enzymes, Predicted membrane proteins" "Electron transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071862 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA071862: " "unprognostic (4.89e-2)" "unprognostic (3.25e-1)" "unprognostic (2.02e-1)" "unprognostic (6.98e-2)" "unprognostic (5.15e-2)" "unprognostic (2.72e-2)" "unprognostic (2.28e-3)" "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (5.41e-2)" "prognostic favorable (1.86e-4)" "unprognostic (3.26e-1)" "prognostic favorable (6.16e-5)" "unprognostic (4.33e-2)" "unprognostic (1.89e-1)" "unprognostic (2.18e-1)" "unprognostic (7.57e-2)" 13.3 20.7 8.1 16.7 9.8 22.0 13.9 9.7 9.2 10.6 10.5 19.7 22.0 7.6 25.8 14.6 9.7 14.6 10.1 8.3 8.6 19.8 34.3 14.1 22.2 9.8 9.6 7.0 19.5 18.2 13.8 11.1 9.8 16.3 18.0 3.1 20.3 11.5 10.0 9.8 22.7 7.1 9.6 24.7 21.7 10.5 9.2 13.2 20.3 3.5 15.3 12.3 9.3 11.3 16.2 33.5 8.4 15.8 17.2 14.7 19.2 27.4 20.4 24.5 28.0 24.1 25.3 25.3 29.3 33.8 29.8 16.5 12.8 25.2 10.7 38.5 31.9 23.7 40.7 22.5 24.2 26.3 52.3 23.0 11.3 29.3 13.5 12.4 21.1 19.1 10.5 32.3 19.7 30.3 17.0 22.9 13.4 24.6 52.1 11.6 5.8 50.2 26.3 27.0 8.4 23.7 13.7 56.1 17.5 8.4 19.8 30.9 23.1 22.5 18.9 37.6 35.8 24.6 26.2 16.8 30.2 32.1 24.4 145.8 113.9 176.1 144.3 140.1 95.6 88.4 96.1 115.7 86.3 79.3 67.1 99.6 110.8 109.3 136.2 89.0 114.7 112.4 8.1 9.8 9.7 9.2 8.3 8.6 9.8 9.6 9.8 9.6 9.2 11.3 13.3 6.4 21.7 5.5 24.4 5.0 12.0 37.4 8.6 6.8 26.5 12.3 0.0 0.0 30.9 25.8 6.2 35.0 40.2 47.1 11.7 44.9 19.9 19.7 14.7 9.1 31.8 6.7 6.7 68.1 46.0 13.0 31.1 18.4 21.5 8.4 0.0 0.0 57.3 8.4 5.8 47.0 46.8 0.0 12.3 9.1 8.7 29.1 19.6 6.5 36.2 22.2 45.3 6.0 13.3 43.3 49.4 7.9 36.7 17.9 55.6 22.3 38.4 8.2 13.1 8.0 15.6 6.1 14.1 14.0 7.4 55.1 32.9 15.9 28.1 18.4 Z84492.1 ENSG00000272104 "Novel protein" 3 50350892-50367923 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 4.8;Karpas-707: 6.5" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 2: Karpas-707 - Immune response" "unprognostic (2.51e-1)" "unprognostic (9.06e-2)" 1.7 0.5 2.4 0.9 2.2 1.1 1.7 1.9 3.7 1.5 1.0 2.8 4.6 0.8 4.0 1.2 1.6 0.8 0.3 1.5 3.2 2.5 0.4 0.5 4.5 1.8 1.6 3.0 3.5 1.2 0.7 0.2 1.7 2.7 1.1 0.4 4.3 1.0 0.6 4.4 4.7 0.5 1.4 2.6 3.6 1.3 2.4 1.2 3.2 0.1 1.8 0.6 0.0 1.7 1.6 0.0 0.0 1.0 1.1 0.0 0.3 1.7 1.1 0.3 1.3 0.0 1.0 0.9 1.5 0.0 0.1 0.9 0.0 0.6 0.9 1.8 0.4 0.0 1.3 0.0 0.4 0.0 4.8 0.0 0.8 0.6 0.0 0.2 0.0 2.4 0.3 6.5 0.0 0.6 1.8 0.0 0.6 1.6 0.0 0.6 0.3 2.6 0.3 0.0 1.2 3.0 0.0 1.2 0.2 0.3 1.1 0.0 0.0 0.3 0.1 0.0 0.5 1.6 2.5 1.1 0.0 0.4 0.0 4.8 0.1 3.6 5.8 0.3 8.4 8.3 10.5 8.6 0.1 9.3 14.2 8.2 0.5 10.4 0.7 1.6 15.4 3.0 2.4 2.2 1.9 3.7 1.5 3.2 1.8 1.6 1.7 1.4 2.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM115 PL6 ENSG00000126062 "Transmembrane protein 115" Q12893 3 50354750-50359521 "Plasma proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006319, HPA015497" Supported Supported "Golgi apparatus" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "CAB006319: AB_425880, HPA015497: AB_1858076" "unprognostic (1.62e-2)" "unprognostic (2.37e-1)" "unprognostic (1.59e-2)" "unprognostic (1.65e-3)" "unprognostic (2.32e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.73e-5)" "unprognostic (7.00e-2)" "unprognostic (6.00e-2)" "unprognostic (2.05e-2)" "unprognostic (1.75e-3)" "unprognostic (2.65e-2)" "prognostic favorable (1.04e-7)" "unprognostic (4.88e-3)" "unprognostic (3.00e-1)" "unprognostic (1.18e-1)" "unprognostic (1.75e-1)" 29.4 34.3 23.5 12.0 24.4 11.7 28.6 24.6 26.5 25.2 26.9 29.5 23.4 33.3 17.6 27.2 26.3 15.6 31.9 23.3 23.1 28.9 32.3 26.6 11.3 25.7 24.1 25.4 29.9 32.0 20.3 22.8 24.7 30.7 12.8 6.7 29.1 20.6 27.1 42.6 27.1 17.0 23.2 24.3 31.2 17.0 24.4 10.8 34.6 18.2 9.6 28.0 25.6 24.0 26.6 31.9 20.4 33.6 56.9 45.2 26.4 40.3 59.3 50.2 38.3 24.0 30.4 12.9 33.1 53.1 46.2 27.8 24.7 32.7 14.1 23.9 42.9 19.5 27.8 32.9 79.7 21.4 27.2 68.4 41.6 41.5 30.1 43.3 38.6 15.7 21.3 21.7 37.9 24.5 14.8 33.8 36.4 17.4 49.9 7.2 16.3 28.8 38.3 24.7 22.7 48.7 24.5 26.9 34.5 17.8 22.3 22.4 40.4 45.3 22.8 48.1 42.9 32.0 19.9 7.3 41.6 23.3 30.5 52.5 27.9 41.4 26.5 25.1 17.5 18.2 17.5 21.2 23.2 18.5 18.7 18.2 37.9 27.3 24.5 26.1 24.1 23.8 23.5 24.4 24.6 26.5 23.3 23.1 25.7 24.1 24.7 23.2 24.4 24.0 24.0 16.0 12.4 4.2 14.3 30.2 19.7 26.1 29.6 17.1 25.3 24.9 7.0 25.8 15.8 11.0 6.2 58.8 15.9 39.9 3.9 44.7 1.1 17.9 17.2 22.9 15.7 18.5 2.9 26.5 42.2 31.5 20.4 16.3 11.4 23.6 26.0 19.5 36.3 18.5 3.7 26.6 28.5 11.4 12.4 1.2 29.2 15.5 10.6 2.8 20.4 25.7 13.4 6.6 4.4 35.6 32.5 25.2 18.8 33.8 43.9 26.9 14.3 15.1 26.3 19.3 26.5 17.0 8.0 17.5 34.9 92.8 14.3 36.4 24.9 25.6 CACNA2D2 KIAA0558 ENSG00000007402 "Calcium voltage-gated channel auxiliary subunit alpha2delta 2" Q9NY47 3 50362613-50504244 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 49.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 76.9;Alveolar cells type 2: 182.3;Inhibitory neurons: 36.0" "Cancer enhanced" "Detected in many" "testis cancer: 20.4" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 192.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034771, HPA071829" Enhanced Approved Vesicles NA NA 9700000 "Cluster 35: T-regs - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 11: Alveolar cells - Smell perception" Vesicles "HPA034771: AB_10603555, HPA071829: AB_2686454" "unprognostic (2.06e-1)" "unprognostic (2.37e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (7.62e-5)" "unprognostic (6.59e-2)" "unprognostic (6.37e-2)" "unprognostic (6.91e-2)" "unprognostic (6.57e-3)" "unprognostic (4.39e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.21e-4)" "unprognostic (2.71e-2)" "unprognostic (1.57e-4)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (3.55e-1)" "unprognostic (4.22e-2)" 1.0 0.6 4.7 1.3 5.2 1.2 1.2 9.9 6.9 1.4 0.3 1.6 1.2 1.6 0.9 0.6 1.1 0.7 8.4 0.7 13.9 2.3 0.3 49.1 1.2 8.3 8.4 2.1 4.3 2.5 7.1 1.8 14.0 3.0 1.9 8.6 1.3 1.1 1.8 2.6 1.6 1.2 4.8 1.4 4.1 6.5 11.4 1.0 2.2 1.5 0.5 0.5 0.7 2.1 0.0 0.1 3.0 6.6 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.6 0.0 0.6 0.2 24.8 0.0 0.1 0.1 1.8 0.2 0.2 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.4 0.0 1.1 0.1 0.2 7.9 0.2 0.5 0.2 0.0 0.7 0.0 0.0 18.6 192.7 0.6 0.4 0.0 5.5 1.5 0.0 0.0 0.1 1.8 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.0 0.9 0.7 0.9 0.7 0.0 0.5 1.2 0.7 0.0 0.9 0.0 0.1 1.2 0.4 4.7 5.2 9.9 6.9 0.7 13.9 8.3 8.4 14.0 4.8 11.4 2.1 0.4 76.9 182.3 4.2 0.4 1.5 0.4 0.0 1.8 21.5 2.5 1.7 4.6 0.0 2.5 1.8 20.9 0.0 6.8 0.8 0.0 0.2 0.7 0.1 0.4 0.6 1.2 2.7 7.8 0.0 0.0 1.5 3.1 0.2 20.3 0.3 0.4 0.0 0.1 0.0 36.0 11.0 0.0 0.0 0.4 4.0 0.3 0.4 0.0 1.9 0.1 4.3 15.5 6.0 0.9 0.4 0.3 1.9 2.9 0.7 0.2 0.7 2.2 9.8 13.1 2.4 2.4 2.6 11.2 0.2 0.6 0.3 2.9 3.4 0.6 0.3 C3orf18 G20 ENSG00000088543 "Chromosome 3 open reading frame 18" Q9UK00 3 50558025-50571027 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 29.3;Early spermatids: 54.2;Late spermatids: 62.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 2.2;NK-cells: 2.0;T-cells: 6.3" "Cell line enhanced" "Detected in many" "HDLM-2: 48.8" "Group enriched" "Detected in all" 4 "cerebellum: 28.2;olfactory bulb: 27.5" "Low region specificity" "Detected in all" HPA012105 Approved Approved Cytosol No No "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 39: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 34: Spermatids - Unknown function" Cytosol "HPA012105: AB_1845717" "unprognostic (9.29e-3)" "unprognostic (1.46e-2)" "unprognostic (6.96e-2)" "unprognostic (5.00e-2)" "unprognostic (8.19e-2)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (1.05e-2)" "unprognostic (1.64e-1)" "unprognostic (1.76e-1)" "unprognostic (2.10e-3)" "unprognostic (1.29e-2)" "prognostic favorable (2.80e-9)" "unprognostic (7.65e-2)" "unprognostic (4.49e-1)" "unprognostic (2.18e-1)" "unprognostic (1.59e-1)" 6.1 8.7 23.0 2.9 23.6 0.9 5.6 30.0 24.0 10.8 25.8 11.9 1.8 10.6 4.4 3.5 9.3 3.6 33.3 22.2 25.6 9.4 4.9 3.7 3.8 23.6 24.9 12.6 6.6 27.3 12.5 2.1 23.2 9.2 2.6 28.4 7.1 9.8 36.2 3.1 5.3 9.5 22.8 5.2 10.1 19.7 25.1 3.1 9.0 26.8 3.6 9.5 6.4 22.1 1.8 2.7 3.1 0.6 10.1 9.0 1.0 11.1 17.2 9.9 7.2 0.2 2.8 2.3 2.6 15.2 9.3 0.2 0.0 4.3 5.2 48.8 0.3 5.0 6.9 0.8 5.0 0.0 6.0 8.9 0.6 9.6 0.5 7.9 1.9 7.2 1.1 2.2 5.9 0.4 0.4 1.5 3.8 1.9 12.3 1.0 0.3 2.7 0.6 0.4 3.4 16.1 2.9 0.6 0.3 3.5 3.4 1.3 0.6 9.9 7.7 18.1 1.4 2.8 2.5 0.3 14.0 5.1 0.2 0.0 0.4 0.7 5.1 0.1 6.3 2.2 4.3 4.8 0.4 1.4 5.0 6.1 0.0 2.0 0.1 0.8 2.2 2.5 23.0 23.6 30.0 24.0 22.2 25.6 23.6 24.9 23.2 22.8 25.1 22.1 1.8 0.0 1.1 8.1 2.2 1.1 1.1 0.9 1.2 10.2 1.8 2.0 29.3 0.0 1.4 1.8 8.4 0.4 1.3 0.3 3.9 2.1 54.2 1.1 2.3 2.6 1.8 0.0 5.6 1.8 0.8 4.9 1.5 0.5 0.0 3.1 2.5 2.2 1.6 1.7 8.3 0.7 0.0 1.3 0.3 62.6 4.7 1.1 0.0 3.7 8.9 12.4 3.1 3.0 3.3 0.7 0.1 4.1 1.6 0.5 0.1 3.5 1.2 17.3 13.1 5.6 5.3 2.7 2.5 0.1 0.4 0.1 3.0 2.7 0.3 0.2 HEMK1 MTQ1 ENSG00000114735 "HemK methyltransferase family member 1" Q9Y5R4 3 50569152-50596168 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 149.9;Late spermatids: 151.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 58.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034701, HPA034702" Uncertain NA NA "Cluster 44: Non-specific - Transcription" "Cluster 43: Testis - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 34: Spermatids - Unknown function" "HPA034701: AB_10601429, HPA034702: AB_10673101" "unprognostic (1.27e-2)" "unprognostic (6.96e-2)" "unprognostic (2.49e-1)" "unprognostic (4.11e-2)" "unprognostic (2.43e-1)" "unprognostic (7.95e-3)" "unprognostic (9.39e-2)" "unprognostic (3.51e-3)" "unprognostic (1.45e-1)" "unprognostic (3.04e-1)" "unprognostic (5.33e-3)" "unprognostic (2.54e-3)" "unprognostic (1.58e-2)" "unprognostic (4.16e-2)" "unprognostic (4.53e-2)" "unprognostic (6.23e-2)" "unprognostic (2.44e-3)" 12.2 18.6 12.9 11.3 13.6 9.1 13.1 13.4 17.1 19.1 18.5 16.4 11.6 14.4 10.8 14.7 17.4 8.6 17.6 12.6 13.3 23.0 29.7 13.9 15.0 13.9 13.9 21.7 22.3 15.4 19.4 10.5 13.8 22.8 10.7 5.7 21.2 11.7 9.8 10.1 15.0 11.0 13.6 19.3 18.9 27.0 13.3 15.3 25.2 12.5 11.5 17.4 15.2 14.7 11.8 7.0 10.5 10.2 23.6 18.3 14.8 13.6 11.1 13.0 16.1 6.0 18.7 11.7 10.6 18.9 13.8 13.3 8.0 31.2 5.6 58.4 6.5 13.4 11.7 8.1 19.9 14.1 9.2 13.9 24.1 13.8 15.8 22.9 15.9 22.3 11.9 11.9 12.4 10.4 24.1 14.9 4.6 13.5 18.6 7.9 5.2 23.2 15.5 13.9 3.8 11.9 5.1 15.1 15.6 13.8 12.1 21.2 7.2 13.8 11.9 11.0 17.2 10.6 5.7 6.6 20.6 18.0 8.1 24.5 12.4 12.3 18.7 9.0 16.8 19.8 14.8 15.6 17.1 17.5 16.1 17.2 2.0 16.1 5.7 22.0 10.8 13.3 12.9 13.6 13.4 17.1 12.6 13.3 13.9 13.9 13.8 13.6 13.3 14.7 5.9 12.8 13.4 9.4 14.0 4.5 13.2 11.1 6.2 11.2 12.5 10.0 14.8 8.6 14.8 7.3 0.0 25.7 14.9 11.3 11.7 13.5 149.9 10.3 7.6 6.4 0.0 8.6 2.1 8.2 18.9 12.3 11.2 8.0 17.1 16.0 16.1 15.2 19.9 6.7 2.6 19.7 12.2 8.1 4.6 151.1 11.5 9.1 8.8 4.7 17.4 12.7 16.5 2.0 4.1 9.7 10.3 8.2 12.5 8.2 19.2 20.0 22.0 20.0 19.7 10.8 8.3 27.3 8.7 9.1 3.4 13.7 13.8 7.8 16.0 10.0 CISH "CIS, CIS-1, G18, SOCS" ENSG00000114737 "Cytokine inducible SH2 containing protein" Q9NSE2 3 50606489-50611774 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 60.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 38.5;Distal tubular cells: 58.7;Proximal tubular cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "HDLM-2: 316.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB034039, HPA040812" Approved Approved "Microtubules,Cytokinetic bridge" Yes No "Cluster 32: T-cells - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" Microtubules "Cytokinetic bridge" "CAB034039: AB_2080282, HPA040812: AB_2677148" "unprognostic (2.36e-3)" "unprognostic (7.60e-3)" "unprognostic (2.89e-2)" "prognostic favorable (1.13e-5)" "unprognostic (8.54e-2)" "unprognostic (9.38e-2)" "prognostic favorable (6.98e-4)" "unprognostic (6.97e-3)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "prognostic favorable (9.65e-4)" "unprognostic (1.30e-2)" "prognostic favorable (3.53e-12)" "unprognostic (2.50e-1)" "unprognostic (1.76e-1)" "unprognostic (1.15e-1)" "unprognostic (1.78e-2)" 19.0 4.8 1.0 8.7 1.0 7.6 24.5 1.1 1.3 10.0 1.9 9.9 10.2 9.4 3.1 9.6 9.8 4.5 26.5 0.9 1.4 47.6 60.7 28.0 8.5 2.8 1.9 14.5 20.2 22.1 14.3 23.2 2.2 7.5 8.9 0.3 13.1 8.9 40.0 13.3 8.8 4.9 1.7 9.9 10.4 2.3 1.6 9.7 36.4 5.2 6.7 5.9 10.0 1.5 2.4 0.8 2.8 5.9 0.7 3.4 2.5 0.6 0.6 0.3 0.4 2.3 0.6 0.0 2.0 0.9 1.3 2.8 4.7 3.8 0.3 316.3 0.8 18.7 1.8 2.5 2.1 2.5 22.0 14.2 1.6 0.7 1.3 0.2 0.6 2.0 75.6 0.6 0.6 14.8 4.1 17.4 2.7 8.7 2.9 1.8 1.2 19.4 6.3 2.7 1.4 4.7 1.0 37.7 0.7 0.8 20.9 15.4 0.5 0.8 2.2 2.8 1.4 0.3 0.4 0.0 0.5 22.7 0.4 21.3 10.2 13.7 33.8 6.2 51.1 0.9 54.0 41.6 7.0 0.4 40.5 40.6 8.6 2.0 3.9 4.6 35.3 19.6 1.0 1.0 1.1 1.3 0.9 1.4 2.8 1.9 2.2 1.7 1.6 1.5 7.1 3.2 38.5 0.0 1.8 8.0 7.4 1.9 10.2 0.7 18.3 12.1 14.3 0.0 6.7 18.4 0.0 9.1 14.1 8.9 58.7 11.7 2.6 6.6 4.3 3.5 2.4 11.6 0.1 16.4 4.0 11.6 3.6 8.5 1.3 16.9 2.2 7.0 12.7 0.0 0.0 9.6 2.0 8.4 10.0 0.6 8.4 12.8 1.8 1.0 17.3 0.1 14.4 0.0 0.0 7.2 6.7 3.8 4.0 3.0 6.5 58.2 0.8 0.2 13.1 7.6 8.8 1.0 1.3 7.3 8.9 15.9 31.0 3.4 12.1 3.6 MAPKAPK3 "3pK, MAPKAP3, MK-3, MK3" ENSG00000114738 "MAPK activated protein kinase 3" Q16644 3 50611520-50649291 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "bone marrow: 106.5;heart muscle: 256.3;skeletal muscle: 224.2;tongue: 284.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 226.6;Hofbauer cells: 102.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 142.8;granulocytes: 126.3;monocytes: 341.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058275 Supported Nucleoplasm NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 32: U-937 - Innate immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "HPA058275: AB_2683663" "unprognostic (6.46e-3)" "unprognostic (1.84e-1)" "prognostic favorable (8.08e-5)" "unprognostic (1.17e-1)" "unprognostic (1.93e-1)" "unprognostic (9.96e-2)" "unprognostic (8.77e-3)" "unprognostic (7.68e-3)" "unprognostic (1.11e-1)" "unprognostic (5.87e-2)" "unprognostic (2.19e-3)" "unprognostic (1.01e-1)" "prognostic favorable (1.90e-8)" "unprognostic (2.15e-2)" "unprognostic (1.22e-1)" "unprognostic (1.86e-1)" "unprognostic (1.69e-1)" 15.3 43.3 18.0 29.8 19.6 106.5 15.8 19.2 19.2 15.0 21.3 19.7 30.2 11.3 10.3 49.6 15.1 12.1 256.3 18.0 19.7 40.0 18.7 28.2 21.7 23.6 20.5 14.2 36.2 47.2 23.5 13.9 22.5 18.4 20.0 4.7 27.7 12.6 224.2 53.4 24.2 15.9 21.6 25.3 27.6 9.2 21.1 42.0 41.2 284.3 24.2 20.3 22.2 21.6 99.6 30.3 12.4 35.9 18.4 45.7 27.9 23.8 33.7 35.7 30.3 47.1 90.2 39.8 23.5 79.5 88.5 34.6 85.9 92.7 31.9 88.3 22.3 209.5 40.6 43.5 36.8 152.1 106.4 36.9 57.0 83.1 112.2 35.6 31.9 70.2 59.7 25.4 76.1 40.5 65.3 153.3 46.4 34.6 127.0 28.5 29.9 60.1 165.5 56.2 23.0 16.5 21.3 58.9 27.7 20.6 37.8 93.4 23.8 28.1 64.5 146.4 59.5 17.2 33.7 33.1 148.3 234.7 11.8 45.3 169.5 126.3 27.6 271.6 27.3 15.1 30.9 32.1 142.8 8.8 23.9 27.8 104.4 42.1 341.5 91.2 28.0 132.6 18.0 19.6 19.2 19.2 18.0 19.7 23.6 20.5 22.5 21.6 21.1 21.6 3.5 9.6 14.0 8.5 8.6 11.3 26.9 14.0 19.4 1.1 15.3 12.3 226.6 15.7 10.4 11.0 0.0 6.0 38.1 16.2 64.6 45.6 34.5 3.4 2.7 7.1 6.0 19.1 0.3 30.4 7.4 14.9 11.7 5.4 36.2 8.3 5.3 14.2 102.1 0.0 0.7 15.4 10.2 68.0 23.9 86.2 7.2 59.4 7.2 0.0 76.6 17.1 41.2 0.5 2.0 76.2 15.6 3.4 12.7 30.9 30.7 35.4 5.7 2.3 26.3 9.7 12.0 4.1 4.6 34.2 20.2 5.1 24.3 22.0 28.2 33.5 DOCK3 "KIAA0299, MOCA, PBP" ENSG00000088538 "Dedicator of cytokinesis 3" Q8IZD9 3 50674927-51384198 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.5;thyroid gland: 12.2" "Group enriched" "Detected in some" 11 "Astrocytes: 223.6;Excitatory neurons: 777.2;Inhibitory neurons: 837.1;Oligodendrocyte precursor cells: 445.4;Oligodendrocytes: 814.7" "Group enriched" "Detected in many" 4 "glioma: 2.7;thyroid cancer: 7.6" "Group enriched" "Detected in many" 8 "amygdala: 9.9;basal ganglia: 12.8;cerebral cortex: 17.5;hippocampal formation: 13.4;white matter: 17.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.1;GAMG: 5.9;HMC-1: 4.9;JURKAT: 5.8;U-87 MG: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037543, HPA037544" Enhanced Supported Enhanced Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA037543: AB_10672495, HPA037544: AB_10670383" "unprognostic (1.02e-1)" "unprognostic (1.11e-1)" "unprognostic (1.78e-3)" "unprognostic (6.35e-8)" "unprognostic (2.63e-1)" "unprognostic (3.02e-2)" "unprognostic (4.64e-2)" "unprognostic (3.67e-1)" "unprognostic (1.91e-1)" "unprognostic (7.99e-2)" "unprognostic (2.36e-3)" "unprognostic (1.34e-2)" "unprognostic (1.45e-2)" "unprognostic (5.83e-5)" "unprognostic (7.96e-2)" "unprognostic (6.19e-2)" "unprognostic (1.24e-1)" 0.8 3.3 9.9 0.2 12.8 0.2 0.3 0.9 17.5 0.9 0.0 3.1 0.2 0.7 0.7 2.1 0.8 0.3 2.9 13.4 0.8 0.8 0.1 0.5 0.3 1.3 0.4 0.4 0.4 5.3 6.4 0.1 1.2 2.0 0.3 10.1 1.5 1.9 1.9 2.4 0.8 1.0 0.0 0.5 1.4 5.9 1.7 0.0 12.2 1.8 0.3 2.0 0.6 17.2 0.1 0.2 0.2 6.1 0.0 0.0 2.6 0.1 0.1 0.3 0.2 0.1 0.4 0.0 0.5 1.9 5.9 0.4 4.1 0.0 0.1 3.7 4.3 0.1 1.2 0.1 0.0 0.1 4.9 0.0 0.1 0.2 0.0 0.3 0.0 5.8 0.0 0.1 0.5 0.2 0.0 0.0 2.0 0.3 1.9 0.0 0.6 0.0 0.3 0.6 3.7 0.0 0.3 3.4 0.0 4.1 0.1 0.0 0.4 0.2 1.6 0.2 2.2 0.3 0.0 0.0 7.9 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.0 9.9 12.8 0.9 17.5 13.4 0.8 1.3 0.4 1.2 0.0 1.7 17.2 0.0 0.0 0.6 223.6 0.0 0.0 0.2 0.0 0.0 22.0 0.3 0.4 7.5 0.0 0.7 0.0 2.1 0.1 0.4 0.1 1.9 0.0 11.4 0.3 0.2 0.4 0.0 0.0 777.2 0.0 0.2 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.5 33.7 837.1 0.0 0.0 0.0 0.0 6.0 0.0 0.4 0.0 52.5 0.0 3.1 1.0 445.4 814.7 0.3 0.0 0.0 0.5 0.1 0.0 0.2 0.1 5.1 0.0 1.1 1.2 6.0 4.1 0.4 0.1 0.0 1.1 0.1 0.0 0.1 MANF "ARMET, ARP" ENSG00000145050 "Mesencephalic astrocyte derived neurotrophic factor" P55145 3 51385291-51389397 "Plasma proteins, Predicted secreted proteins" "Stress response, Unfolded protein response" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 426.1;Syncytiotrophoblasts: 459.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 109.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011175 Approved Supported "Endoplasmic reticulum" "Secreted to blood" NA NA 7500000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA011175: AB_1845039" "unprognostic (2.90e-2)" "unprognostic (5.24e-2)" "unprognostic (1.11e-2)" "unprognostic (2.51e-2)" "unprognostic (5.84e-2)" "prognostic unfavorable (9.58e-6)" "prognostic unfavorable (7.48e-4)" "unprognostic (7.37e-2)" "unprognostic (1.25e-1)" "unprognostic (1.12e-3)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (1.21e-2)" "unprognostic (1.46e-1)" "unprognostic (1.99e-2)" "unprognostic (1.27e-1)" "unprognostic (5.10e-2)" 39.4 36.7 34.4 70.9 34.5 35.3 41.8 37.8 50.5 59.4 44.2 55.4 42.5 48.2 169.3 53.2 42.8 32.1 51.1 34.8 42.7 48.6 109.2 44.3 50.5 38.4 35.7 28.7 81.1 38.8 56.4 59.9 37.2 51.3 58.8 17.7 51.0 50.5 12.4 36.6 39.5 47.2 36.2 56.1 59.5 43.2 37.9 47.7 117.8 20.8 76.1 67.8 35.5 38.1 128.6 61.2 164.7 207.7 107.8 139.4 173.8 200.2 160.6 194.0 184.5 99.6 292.6 271.6 162.6 121.9 449.8 77.7 201.4 200.0 187.3 128.9 92.2 220.2 93.5 230.3 349.8 108.2 137.1 60.6 168.5 201.3 271.7 189.9 252.7 112.3 48.3 299.5 181.6 75.5 184.8 215.6 144.6 298.0 237.6 76.4 105.3 288.7 162.8 86.9 64.4 201.6 165.3 104.2 130.3 175.8 83.7 141.2 129.3 117.4 112.1 140.4 222.6 247.9 105.0 186.5 195.4 217.5 221.2 73.2 15.3 9.4 28.8 13.0 35.5 17.4 20.2 27.5 16.0 12.1 14.9 16.0 8.5 26.0 8.3 109.8 13.4 16.9 34.4 34.5 37.8 50.5 34.8 42.7 38.4 35.7 37.2 36.2 37.9 38.1 55.9 32.1 21.5 5.2 134.1 163.1 223.7 232.5 31.3 15.1 50.5 40.5 69.3 61.5 104.0 55.2 6.2 188.1 142.8 75.7 43.0 172.6 99.0 73.3 101.9 88.3 116.6 26.1 5.8 124.6 387.0 101.2 71.9 99.4 62.9 77.9 79.6 156.1 179.5 11.8 8.5 235.9 118.0 36.1 170.6 123.3 60.0 63.0 181.5 7.5 79.1 39.6 117.4 5.0 9.5 167.8 90.5 51.6 426.1 245.0 47.7 78.9 71.1 19.1 65.7 59.7 194.2 176.8 91.1 42.8 160.5 459.0 94.8 40.6 120.9 202.0 RBM15B "HUMAGCGB, OTT3" ENSG00000259956 "RNA binding motif protein 15B" Q8NDT2 3 51391285-51397908 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036645, HPA058136" Approved Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "HPA036645: AB_10671965, HPA058136: AB_2683618" "unprognostic (2.65e-3)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (1.39e-1)" "unprognostic (5.29e-1)" "unprognostic (5.28e-2)" "unprognostic (3.13e-3)" "unprognostic (1.70e-1)" "unprognostic (5.25e-2)" "unprognostic (3.11e-1)" "unprognostic (3.39e-1)" "unprognostic (3.01e-2)" "prognostic favorable (1.84e-5)" "unprognostic (1.35e-1)" "unprognostic (1.69e-1)" "unprognostic (1.89e-1)" "unprognostic (3.84e-1)" 13.0 10.3 10.2 10.6 9.5 11.1 12.3 8.8 10.5 12.0 7.4 14.4 10.4 16.9 10.6 17.0 12.0 9.3 10.4 9.9 9.5 9.7 9.9 11.5 11.2 9.9 10.1 14.6 17.8 13.8 10.7 8.0 8.9 10.9 11.9 8.2 12.3 11.0 6.1 16.5 13.0 12.2 9.3 11.4 14.6 11.4 9.7 19.7 10.8 7.0 12.2 13.0 10.5 9.6 19.2 16.7 38.2 40.1 33.7 26.2 23.3 17.4 32.2 27.2 22.3 20.8 13.6 27.5 14.1 31.5 30.0 17.3 22.0 31.3 13.1 22.2 17.3 23.9 26.2 17.9 19.7 31.4 13.0 28.6 38.2 25.0 29.5 29.6 28.5 44.3 18.1 18.2 23.6 20.4 54.8 19.8 30.5 17.6 25.9 19.4 16.8 23.5 24.5 45.5 24.7 35.5 22.4 29.5 20.6 25.2 23.4 36.7 26.0 27.7 24.1 23.6 33.3 26.6 25.9 30.3 22.6 24.8 30.2 0.0 1.9 0.7 1.8 2.7 1.9 1.0 2.2 1.9 2.1 2.4 2.2 1.3 0.4 1.7 2.7 2.3 1.1 1.6 10.2 9.5 8.8 10.5 9.9 9.5 9.9 10.1 8.9 9.3 9.7 9.6 16.7 3.2 5.4 4.2 15.2 25.4 38.9 12.6 16.5 18.2 24.9 20.2 17.3 20.0 12.5 14.7 10.4 15.2 19.8 19.9 11.7 19.4 22.4 17.6 17.2 19.1 12.6 19.0 4.4 23.2 20.7 16.7 21.4 19.6 5.1 31.0 17.9 20.5 18.4 15.2 5.1 21.0 12.2 33.1 20.9 10.6 15.8 15.1 7.2 2.8 16.3 14.2 22.6 3.5 5.0 28.2 13.4 15.1 16.4 32.8 15.2 16.5 11.2 15.5 26.3 26.0 21.1 14.9 7.9 28.0 28.1 19.7 16.3 21.0 24.4 36.7 DCAF1 "KIAA0800, MGC102804, VPRBP" ENSG00000145041 "DDB1 and CUL4 associated factor 1" Q9Y4B6 3 51395867-51500002 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.4" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 17.9;Granulosa cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036142, HPA052445, HPA053203" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" No No "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nucleoli fibrillar center" "HPA036142: AB_10669666, HPA052445: AB_2681835, HPA053203: AB_2682080" "unprognostic (7.51e-2)" "unprognostic (3.19e-1)" "unprognostic (3.71e-3)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (9.75e-2)" "unprognostic (2.58e-2)" "unprognostic (1.24e-1)" "unprognostic (8.75e-2)" "unprognostic (2.15e-1)" "unprognostic (2.89e-2)" "unprognostic (2.21e-2)" "prognostic favorable (7.45e-5)" "unprognostic (5.49e-2)" "unprognostic (5.00e-1)" "unprognostic (6.81e-2)" "unprognostic (1.64e-1)" 11.4 11.3 7.6 11.7 8.8 15.9 11.2 11.2 9.4 9.4 9.8 11.0 7.9 10.3 9.4 10.6 8.9 7.4 9.5 7.8 9.3 11.0 11.5 10.0 14.8 8.4 8.8 10.3 10.4 18.9 8.6 10.3 8.6 9.7 10.9 19.7 11.3 9.6 27.9 13.5 11.4 9.2 8.0 11.3 10.3 53.4 8.5 18.6 14.6 16.1 15.9 11.2 10.0 9.0 19.9 23.9 22.8 20.7 20.1 15.9 21.6 21.8 16.2 23.1 22.5 26.4 18.8 48.1 11.7 17.2 35.3 17.1 43.3 19.5 29.6 33.7 21.5 41.2 32.4 22.8 14.7 54.4 28.7 10.6 22.2 29.8 21.6 15.0 18.2 26.1 24.5 30.3 18.3 20.3 41.8 22.0 24.0 23.5 26.0 17.5 24.4 32.0 18.0 30.5 11.8 21.0 24.1 22.0 13.2 16.7 15.0 22.8 22.9 18.8 25.1 31.4 33.9 20.5 29.7 48.2 21.9 36.6 15.7 2.5 3.0 2.4 6.5 3.3 7.4 5.1 5.6 5.6 4.8 4.9 6.0 5.1 0.7 5.8 5.0 3.8 6.7 4.9 7.6 8.8 11.2 9.4 7.8 9.3 8.4 8.8 8.6 8.0 8.5 9.0 11.1 3.2 10.6 0.0 3.6 0.0 0.0 0.0 0.0 0.0 11.3 9.4 0.0 0.0 6.8 3.7 0.0 7.6 9.7 0.0 1.9 7.0 0.0 11.2 10.3 5.6 0.0 0.0 0.0 6.7 5.7 3.0 0.0 17.9 6.3 13.1 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 2.6 0.0 0.0 0.0 0.0 7.5 0.0 0.0 2.8 0.0 0.0 6.1 5.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 10.5 5.0 7.4 0.0 0.0 RAD54L2 "ARIP4, KIAA0809, SRISNF2L" ENSG00000164080 "RAD54 like 2" Q9Y4B4 3 51541144-51668667 "Enzymes, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035004, HPA039992, HPA077351" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: " "unprognostic (1.46e-2)" "unprognostic (3.67e-2)" "unprognostic (2.61e-1)" "unprognostic (5.01e-2)" "unprognostic (1.15e-1)" "unprognostic (4.38e-2)" "unprognostic (1.63e-1)" "unprognostic (1.45e-2)" "unprognostic (9.24e-2)" "unprognostic (2.76e-1)" "unprognostic (1.59e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.71e-5)" "unprognostic (3.72e-2)" "unprognostic (3.19e-1)" "unprognostic (3.30e-2)" "unprognostic (6.63e-2)" 4.6 4.8 5.6 3.7 6.1 6.1 4.6 6.5 5.6 4.8 2.9 5.8 2.5 5.6 4.2 4.0 4.6 2.7 4.4 5.0 5.2 4.0 7.8 4.9 4.2 5.5 5.7 5.3 5.3 3.8 4.5 4.8 5.5 4.4 3.4 7.5 4.5 3.9 7.1 5.5 5.0 4.1 5.3 5.2 5.2 5.0 6.3 6.2 4.6 5.3 5.2 4.8 4.3 6.2 6.6 5.1 12.8 12.7 7.0 5.0 6.7 5.5 7.8 7.4 6.9 9.1 3.8 17.4 1.5 9.7 7.8 5.0 20.5 6.8 9.1 9.2 4.6 14.9 11.5 6.0 6.4 16.8 8.5 5.8 5.4 11.3 10.9 4.6 8.3 14.8 10.3 9.1 5.9 5.1 15.0 7.6 10.2 3.2 5.5 6.9 9.9 2.3 3.8 8.4 5.2 10.0 8.7 8.2 5.7 7.7 5.4 9.9 10.9 7.7 8.9 8.0 10.8 9.8 10.7 16.8 8.3 9.2 10.0 3.1 2.2 2.2 3.3 2.6 3.5 1.8 2.9 2.8 2.3 2.9 1.9 2.3 0.9 3.0 3.5 2.3 2.9 2.2 5.6 6.1 6.5 5.6 5.0 5.2 5.5 5.7 5.5 5.3 6.3 6.2 10.8 9.6 14.4 31.3 11.3 9.2 8.6 6.7 3.4 33.8 8.7 8.0 11.0 15.7 7.8 9.2 31.3 19.3 12.2 7.7 1.9 9.3 7.5 9.5 12.0 15.1 16.3 3.8 54.9 10.4 8.7 9.6 9.2 19.8 18.3 14.2 10.4 21.9 8.9 47.1 54.3 8.1 4.1 9.1 8.4 3.1 15.2 9.4 14.2 26.2 13.2 9.1 30.9 42.7 42.3 13.9 9.7 17.0 11.3 12.4 4.6 4.4 9.5 29.9 13.1 17.1 11.6 43.9 36.4 5.5 8.9 29.7 12.5 10.1 7.9 12.5 TEX264 "FLJ13935, ZSIG11" ENSG00000164081 "Testis expressed 264, ER-phagy receptor" Q9Y6I9 3 51662693-51704323 "Plasma proteins, Predicted intracellular proteins" "Autophagy, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 374.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005002, HPA017739" Enhanced Approved Nucleoli,Cytosol "Intracellular and membrane" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 43: Testis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoli, Cytosol" "CAB005002: AB_425976, HPA017739: AB_1857910" "unprognostic (2.80e-3)" "unprognostic (1.05e-2)" "unprognostic (2.69e-1)" "unprognostic (2.79e-3)" "unprognostic (8.11e-2)" "unprognostic (8.26e-3)" "unprognostic (2.05e-1)" "unprognostic (3.06e-3)" "unprognostic (2.30e-1)" "unprognostic (5.19e-2)" "prognostic favorable (5.67e-4)" "unprognostic (1.83e-1)" "prognostic favorable (7.95e-9)" "unprognostic (4.99e-2)" "unprognostic (3.65e-1)" "unprognostic (3.17e-1)" "unprognostic (4.67e-2)" 34.7 73.4 43.5 23.1 46.5 22.3 35.6 48.7 51.7 39.0 53.1 41.5 39.0 34.2 41.2 41.1 44.0 39.7 41.4 43.8 47.2 67.6 65.3 29.8 33.5 47.2 45.5 31.3 54.3 88.5 26.2 29.4 46.4 45.1 34.5 20.4 58.7 46.9 34.2 69.3 37.6 26.3 46.3 40.9 46.7 111.5 45.9 29.1 48.7 29.6 26.3 35.9 34.9 48.4 36.5 65.5 11.6 59.3 116.8 56.4 23.5 31.0 72.0 50.1 50.1 35.2 84.2 51.6 21.9 44.1 84.2 34.7 32.7 61.6 23.7 42.0 51.9 49.6 40.2 47.8 104.0 31.5 53.6 74.8 96.9 56.3 57.1 45.3 36.9 39.0 26.6 87.7 51.9 42.1 50.9 73.3 12.6 59.8 72.7 24.3 15.3 98.7 79.7 50.1 16.5 26.8 37.4 101.5 48.0 15.7 49.6 66.0 27.3 49.8 20.8 53.0 41.2 61.0 71.3 26.4 61.5 65.9 50.9 99.2 110.1 69.3 119.7 115.6 120.3 98.6 122.6 113.6 104.6 102.4 100.9 103.1 23.5 76.1 115.6 92.4 159.9 139.9 43.5 46.5 48.7 51.7 43.8 47.2 47.2 45.5 46.4 46.3 45.9 48.4 63.6 35.3 21.9 12.4 36.7 34.8 46.7 123.9 45.5 33.5 69.9 68.2 24.4 65.8 68.2 99.3 58.4 142.9 52.3 70.3 62.6 83.1 57.7 44.9 31.8 54.8 32.9 24.8 6.5 75.7 88.9 41.4 29.0 48.2 16.5 45.3 38.9 63.1 105.4 42.1 9.1 56.5 118.0 48.3 45.5 61.2 51.0 47.8 65.8 8.4 56.1 62.6 89.6 7.5 12.3 59.6 76.4 48.9 36.0 45.6 137.6 126.7 49.7 55.4 26.3 30.8 30.7 374.8 111.7 46.3 35.4 76.3 61.9 110.4 86.0 49.9 GRM2 "GPRC1B, mGlu2, MGLUR2" ENSG00000164082 "Glutamate metabotropic receptor 2" Q14416 3 51707068-51718613 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "brain: 6.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 2.6;Cone photoreceptor cells: 6.2;Excitatory neurons: 16.2;Spermatocytes: 3.5" "Cancer enriched" "Detected in single" 4 "testis cancer: 1.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SCLC-21H: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027868, HPA065166" Approved Supported NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA027868: , HPA065166: AB_2685425" "unprognostic (1.01e-1)" "unprognostic (8.61e-4)" "unprognostic (7.66e-2)" "unprognostic (7.29e-3)" "unprognostic (1.98e-1)" "unprognostic (3.68e-2)" "unprognostic (7.10e-2)" "unprognostic (1.27e-1)" "unprognostic (1.39e-2)" "unprognostic (2.05e-1)" "unprognostic (4.45e-1)" "unprognostic (1.74e-1)" "unprognostic (1.37e-2)" "unprognostic (1.35e-1)" "unprognostic (1.82e-1)" "unprognostic (2.93e-2)" "unprognostic (1.19e-2)" 0.3 0.0 1.6 0.0 2.2 0.4 0.1 0.0 2.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 1.7 0.7 0.0 0.0 0.1 0.0 4.9 0.1 0.0 0.1 0.0 0.1 0.0 6.0 0.1 0.0 0.4 0.1 0.0 0.3 0.5 0.1 0.0 0.0 0.2 0.0 0.6 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 2.2 0.0 2.3 1.7 0.7 4.9 0.1 6.0 0.0 0.4 0.3 0.4 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 2.6 0.5 0.9 1.1 0.0 0.0 0.0 6.2 0.0 0.3 0.1 0.0 0.0 0.3 0.1 0.1 1.5 0.0 0.0 16.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.0 0.0 0.4 0.0 1.0 0.8 0.0 0.0 0.4 0.0 0.3 0.0 0.1 0.0 2.0 0.0 0.2 0.1 3.5 1.1 0.2 0.3 0.0 0.1 0.2 0.0 0.1 IQCF6 ENSG00000214686 "IQ motif containing F6" A8MYZ5 3 51778561-51779241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "testis: 21.5" "Group enriched" "Detected in some" 218 "Early spermatids: 379.2;Late spermatids: 188.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "Karpas-707: 1.0;U-937: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "unprognostic (4.98e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 379.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 188.6 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC097636.1 ENSG00000285749 "Novel protein" 3 51798803-51833389 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.5;testis: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" NA NA "Cluster 20: HeLa - Mitochondria" 0.2 0.2 0.5 0.3 0.5 1.6 0.2 2.5 2.0 0.2 0.0 0.2 0.5 0.2 0.7 0.1 0.1 0.2 0.1 0.6 0.0 0.3 0.8 0.2 0.4 0.1 0.0 0.1 0.6 0.1 0.2 0.5 0.4 0.1 1.8 0.3 0.1 0.2 0.6 0.4 0.1 0.0 0.5 0.3 3.3 0.0 0.2 0.3 0.0 0.1 0.1 1.7 0.4 0.3 0.5 0.4 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.6 0.5 0.5 0.1 0.0 0.3 0.2 0.0 0.1 0.0 0.4 0.1 0.3 0.8 0.4 0.0 0.5 0.6 0.0 0.1 0.1 0.2 0.3 0.1 0.5 0.4 1.3 0.0 0.2 0.1 0.3 0.4 0.3 0.2 0.3 0.2 0.5 0.0 0.3 0.4 0.3 0.1 0.0 0.3 0.3 0.3 0.3 0.6 0.3 0.5 0.5 0.2 0.6 0.3 0.2 0.3 1.0 0.3 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.5 2.5 2.0 0.6 0.0 0.1 0.0 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCF3 ENSG00000229972 "IQ motif containing F3" P0C7M6 3 51826883-51830856 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 114 "testis: 105.8" "Group enriched" "Detected in some" 179 "Early spermatids: 1689.1;Late spermatids: 6153.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (2.83e-1)" 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 105.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.9 0.5 0.5 0.4 0.3 0.5 0.2 0.4 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1689.1 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6153.2 21.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 20.1 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCF2 ENSG00000184345 "IQ motif containing F2" Q8IXL9 3 51861615-51863424 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 89 "testis: 14.0" "Group enriched" "Detected in some" 187 "Early spermatids: 1040.3;Late spermatids: 2718.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 34: Spermatids - Unknown function" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1040.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2718.3 7.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCF5 ENSG00000214681 "IQ motif containing F5" A8MTL0 3 51873721-51875601 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 487 "testis: 104.4" "Group enriched" "Detected in some" 92 "Early spermatids: 926.1;Late spermatids: 2733.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (3.45e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 926.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2733.9 12.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 18.6 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCF1 MGC39725 ENSG00000173389 "IQ motif containing F1" Q8N6M8 3 51894876-51903353 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 242 "testis: 70.7" "Group enriched" "Detected in some" 170 "Early spermatids: 1222.4;Late spermatids: 3277.3" "Cancer enriched" "Detected in single" 30 "testis cancer: 1.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 34: Spermatids - Unknown function" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "unprognostic (2.76e-1)" "unprognostic (1.96e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1222.4 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3277.3 10.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RRP9 "RNU3IP2, U3-55K" ENSG00000114767 "Ribosomal RNA processing 9, U3 small nucleolar RNA binding protein" O43818 3 51933429-51941904 "Predicted intracellular proteins" "rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 66.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038798 Uncertain Supported Nucleoplasm NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA038798: AB_10672653" "unprognostic (5.57e-2)" "unprognostic (9.47e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-2)" "unprognostic (4.18e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (2.90e-5)" "unprognostic (1.24e-1)" "unprognostic (2.00e-1)" "unprognostic (1.63e-1)" "unprognostic (2.82e-2)" "unprognostic (8.25e-3)" "unprognostic (2.60e-3)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (4.15e-2)" "unprognostic (5.92e-2)" 20.5 20.1 9.8 13.7 10.7 12.4 17.3 9.9 12.1 17.1 8.2 13.2 10.9 16.4 5.3 17.7 15.8 6.8 14.5 10.4 9.8 17.7 16.2 13.9 15.7 10.1 10.0 15.8 14.2 10.4 10.5 9.1 9.5 14.6 7.6 5.6 11.6 9.0 28.9 17.8 12.5 9.1 9.3 14.6 13.1 10.8 10.5 9.2 12.6 13.2 10.5 19.1 15.5 10.6 35.8 50.0 23.5 56.2 33.8 18.8 59.5 38.4 20.9 63.7 40.3 85.5 39.6 102.7 15.9 27.3 86.5 32.3 81.9 59.4 25.5 47.1 35.8 69.5 30.6 77.5 67.9 76.6 55.6 39.0 43.0 80.1 75.3 15.5 24.9 35.8 67.0 25.2 28.5 56.7 65.3 76.2 92.6 54.7 126.9 39.7 26.7 78.6 31.4 52.1 28.9 34.1 34.8 38.5 38.8 20.0 20.1 49.2 24.1 44.3 59.4 111.0 160.8 43.0 75.6 96.2 39.5 94.2 71.4 2.1 9.1 0.5 16.4 13.2 17.5 16.4 14.1 14.5 17.0 13.5 10.9 13.2 0.6 18.8 6.5 18.0 12.5 10.0 9.8 10.7 9.9 12.1 10.4 9.8 10.1 10.0 9.5 9.3 10.5 10.6 9.2 0.0 10.5 3.6 15.2 66.8 27.1 29.7 13.1 12.9 11.2 10.3 4.1 10.0 14.0 5.5 4.2 26.8 14.8 8.3 15.6 24.3 8.1 11.2 12.7 12.7 8.4 7.2 1.9 13.4 40.5 12.6 9.7 9.3 15.2 14.4 5.0 7.0 23.4 16.8 1.3 7.2 22.4 5.3 13.4 6.6 8.7 8.7 21.4 1.0 12.9 10.6 16.5 2.0 1.6 20.0 10.3 9.1 11.6 34.2 6.2 22.2 11.9 10.7 6.6 15.6 36.7 8.0 23.8 15.0 50.4 16.7 12.5 16.4 18.9 14.6 PARP3 "ADPRT3, ADPRTL3, ARTD3, hPARP-3, IRT1, pADPRT-3" ENSG00000041880 "Poly(ADP-ribose) polymerase family member 3" Q9Y6F1 3 51942345-51948867 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020984, HPA067657" Supported Supported "Nucleoplasm,Nuclear bodies" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Nuclear bodies" "HPA020984: , HPA067657: AB_2685881" "prognostic favorable (6.39e-5)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (2.85e-2)" "unprognostic (7.31e-2)" "unprognostic (1.56e-1)" "unprognostic (4.13e-1)" "unprognostic (3.53e-2)" "unprognostic (2.26e-1)" "unprognostic (2.01e-1)" "unprognostic (7.44e-3)" "unprognostic (4.30e-1)" "prognostic favorable (1.25e-8)" "unprognostic (5.63e-2)" "unprognostic (1.77e-1)" "unprognostic (1.40e-2)" "unprognostic (4.65e-3)" 16.0 33.4 12.7 9.9 13.5 3.1 15.3 12.9 14.6 9.6 14.4 17.1 28.1 11.4 5.9 10.4 11.2 11.3 13.6 11.6 14.2 21.2 29.2 13.4 10.9 13.8 14.9 8.9 4.4 35.8 10.9 5.9 13.7 14.6 10.2 4.7 14.5 15.5 15.8 7.5 25.2 9.3 12.9 14.8 16.4 5.4 14.9 8.2 19.6 17.6 8.0 15.4 10.8 12.4 10.0 6.6 2.0 17.3 17.8 30.0 4.8 15.4 29.0 23.1 24.9 3.9 28.1 14.1 4.5 29.4 12.6 1.6 5.0 14.5 9.1 34.8 1.2 7.8 15.1 13.2 18.8 5.3 10.9 24.4 12.4 16.2 9.1 35.7 10.8 10.2 3.5 14.7 19.9 3.4 4.6 12.5 2.4 4.2 16.4 7.3 2.8 13.9 14.0 13.5 2.0 6.4 16.3 4.8 10.7 1.4 6.5 5.9 24.0 42.5 9.9 7.4 10.4 22.5 26.0 6.0 27.2 14.4 13.6 0.0 1.6 1.2 2.4 3.0 2.2 6.3 2.6 1.8 2.6 2.5 3.6 3.5 0.1 5.7 1.6 0.9 3.2 1.8 12.7 13.5 12.9 14.6 11.6 14.2 13.8 14.9 13.7 12.9 14.9 12.4 5.3 6.4 10.0 6.2 8.1 2.7 10.6 15.9 21.1 2.0 8.6 8.9 7.4 8.6 8.6 0.0 0.0 0.6 2.1 13.1 7.9 9.7 7.8 2.4 3.8 5.3 3.0 1.7 2.6 6.3 0.4 4.7 17.3 2.7 4.5 0.8 2.5 9.5 3.7 0.0 3.0 11.3 6.1 3.2 2.2 15.3 4.7 3.7 7.2 3.7 5.0 3.8 0.0 1.0 1.8 11.5 6.5 1.5 4.9 4.3 33.4 20.6 9.5 2.1 6.6 4.1 5.7 3.4 3.3 7.8 1.4 0.5 5.9 1.6 13.8 9.3 GPR62 ENSG00000180929 "G protein-coupled receptor 62" Q9BZJ7 3 51955381-51957499 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 34.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.0;Cone photoreceptor cells: 4.2;Horizontal cells: 5.0;Oligodendrocytes: 18.7" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SCLC-21H: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "unprognostic (9.56e-3)" "unprognostic (3.32e-3)" "unprognostic (2.21e-1)" "unprognostic (6.38e-2)" "unprognostic (7.98e-2)" "unprognostic (1.66e-2)" "unprognostic (9.02e-2)" "unprognostic (6.49e-2)" "unprognostic (2.03e-2)" "unprognostic (6.17e-2)" "unprognostic (3.05e-2)" "unprognostic (1.26e-1)" "unprognostic (1.82e-5)" "unprognostic (3.64e-2)" "unprognostic (2.45e-1)" "unprognostic (1.16e-2)" "unprognostic (1.77e-2)" 0.1 0.2 11.5 0.0 21.7 0.0 0.1 17.4 17.9 0.1 3.6 0.1 0.0 0.2 0.2 0.0 0.2 0.1 0.4 11.6 12.3 0.2 0.2 0.0 0.0 21.0 18.3 0.4 0.0 0.0 0.4 0.0 17.4 0.2 0.0 5.2 0.1 0.1 0.7 0.1 0.0 0.0 14.8 0.0 0.1 0.1 16.5 0.0 0.1 0.0 0.0 0.1 0.1 34.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 21.7 17.4 17.9 11.6 12.3 21.0 18.3 17.4 14.8 16.5 34.9 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 3.0 0.1 0.1 0.4 0.0 0.0 0.0 4.2 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 PCBP4 "LIP4, MCG10" ENSG00000090097 "Poly(rC) binding protein 4" P57723 3 51957454-51974016 "Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 391.4" "Group enriched" "Detected in many" 5 "Bipolar cells: 374.5;Cone photoreceptor cells: 654.7;Rod photoreceptor cells: 592.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 22 "B-cells: 5.2;granulocytes: 7.0;T-cells: 12.0" "Cell line enhanced" "Detected in all" "SH-SY5Y: 160.4;SK-MEL-30: 140.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057754 Supported Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 54: Non-specific - Microtubule organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol "HPA057754: AB_2683517" "unprognostic (7.17e-2)" "unprognostic (8.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.34e-2)" "unprognostic (4.94e-3)" "unprognostic (1.94e-2)" "unprognostic (4.97e-3)" "unprognostic (4.46e-2)" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (5.45e-2)" "unprognostic (1.62e-1)" "unprognostic (3.13e-2)" "unprognostic (6.79e-2)" "unprognostic (1.89e-1)" "unprognostic (3.59e-1)" "unprognostic (4.72e-2)" 25.7 26.9 86.3 9.2 111.6 2.6 27.7 100.8 106.8 41.6 75.1 40.2 18.3 39.3 13.4 16.0 31.9 13.0 68.4 87.7 92.1 30.1 20.0 31.2 8.3 116.1 106.6 33.8 20.1 24.1 48.7 8.6 101.9 55.5 9.3 391.4 24.7 22.1 154.1 21.7 24.1 16.8 91.3 22.3 33.3 24.4 106.5 5.7 35.0 96.3 6.5 38.2 30.4 139.9 35.1 11.8 46.3 67.8 20.6 36.6 7.9 78.7 38.1 46.4 29.8 44.2 12.4 1.1 11.5 62.6 41.0 8.1 43.4 27.5 21.7 55.4 7.0 4.4 41.3 46.1 33.2 4.5 32.7 49.8 50.6 29.6 12.9 57.5 23.5 20.1 2.2 15.2 75.3 16.5 1.9 5.4 22.5 22.2 31.5 24.5 22.4 6.2 16.5 24.7 90.3 160.4 21.5 11.6 140.2 12.2 21.5 17.0 47.2 49.3 92.6 15.7 42.8 10.1 7.0 7.2 57.2 9.9 73.5 7.0 0.1 3.8 11.1 0.0 7.8 5.2 10.6 10.9 0.3 2.6 4.8 3.7 0.0 0.1 0.0 0.1 12.0 3.4 86.3 111.6 100.8 106.8 87.7 92.1 116.1 106.6 101.9 91.3 106.5 139.9 14.9 3.2 3.2 27.7 3.8 8.7 16.2 14.2 9.1 374.5 12.4 15.7 7.3 1.5 5.6 9.2 654.7 1.5 6.3 7.7 17.6 31.4 49.8 2.2 15.8 17.3 62.0 0.4 15.0 23.4 1.2 13.0 6.6 4.2 1.3 7.8 15.7 3.6 1.1 42.1 20.8 9.4 16.2 1.0 5.1 101.2 22.4 1.5 23.2 5.6 0.9 88.8 9.2 40.7 65.0 42.3 16.6 16.1 5.3 19.8 21.2 10.7 1.5 592.7 6.6 11.6 17.9 1.4 6.0 4.4 11.8 0.5 9.6 3.6 6.1 11.1 ABHD14B "CIB, MGC15429" ENSG00000114779 "Abhydrolase domain containing 14B" Q96IU4 3 51968510-51983409 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 313.2;Proximal tubular cells: 265.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 190.8" "Low region specificity" "Detected in all" "HPA036444, HPA036642" Supported Approved Nucleoplasm,Nucleoli,Cytosol NA NA 2100000 "Cluster 44: Non-specific - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoli "Nucleoplasm, Cytosol" "HPA036444: AB_10672221, HPA036642: AB_10672225" "unprognostic (8.97e-2)" "prognostic favorable (6.92e-5)" "unprognostic (1.84e-1)" "prognostic favorable (5.42e-5)" "unprognostic (1.07e-1)" "unprognostic (2.21e-2)" "unprognostic (2.06e-3)" "unprognostic (1.35e-3)" "unprognostic (3.95e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-1)" "unprognostic (2.95e-2)" "prognostic favorable (2.93e-5)" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (9.70e-2)" "unprognostic (3.70e-2)" 69.2 81.9 21.3 26.1 22.3 37.4 66.0 21.4 25.3 49.7 29.9 60.0 81.5 39.3 44.7 46.1 58.3 35.2 31.0 20.2 21.4 97.3 155.6 37.8 48.3 22.2 22.2 51.2 65.2 51.3 36.5 15.4 22.7 48.5 55.3 40.4 64.8 36.6 25.1 42.7 74.8 26.9 22.4 47.1 51.0 9.6 22.9 39.0 57.1 22.6 43.1 47.9 42.9 22.3 37.6 32.9 2.7 37.3 100.6 91.3 9.2 14.5 18.4 27.2 32.5 25.3 72.6 41.7 11.4 54.2 12.6 18.5 23.5 22.2 21.0 57.6 27.2 66.6 30.6 106.6 55.3 37.8 64.9 115.1 74.4 27.8 36.9 41.9 34.0 64.2 39.1 66.8 55.8 40.5 16.8 29.9 3.5 43.6 88.5 42.1 5.2 190.8 51.8 16.7 15.2 16.6 37.3 68.0 121.8 5.7 97.7 25.8 31.5 13.8 64.8 32.3 8.7 82.1 41.6 17.4 30.4 118.9 24.8 41.7 24.3 10.9 42.2 19.9 63.3 58.3 53.0 52.0 38.1 42.9 52.4 49.2 1.9 24.5 12.9 28.4 42.4 37.5 21.3 22.3 21.4 25.3 20.2 21.4 22.2 22.2 22.7 22.4 22.9 22.3 40.4 6.4 26.2 7.8 69.4 30.2 62.4 68.5 38.1 12.7 88.1 81.0 4.7 72.9 28.7 69.9 14.6 16.7 50.7 79.6 146.8 34.8 1.4 19.6 22.4 36.8 75.9 41.2 10.1 46.8 19.0 43.4 35.2 20.9 50.8 14.8 39.7 122.1 55.4 8.4 10.8 97.1 42.7 60.7 36.3 2.4 65.0 39.0 55.2 14.0 37.7 14.8 50.4 4.5 9.4 30.0 74.5 46.6 37.4 39.6 313.2 265.3 25.2 39.9 39.5 34.7 35.6 0.4 3.9 57.1 30.4 11.8 63.9 47.7 127.9 64.4 ABHD14A "DKFZP564O243, DORZ1" ENSG00000248487 "Abhydrolase domain containing 14A" Q9BUJ0 3 51971426-51981199 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 124.3;Rod photoreceptor cells: 115.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 79.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038153, HPA056913" Approved Enhanced Vesicles NA NA 420000 "Cluster 20: T-cells - T-cell receptor" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "HPA038153: AB_2675868, HPA056913: AB_2683275" "unprognostic (4.15e-3)" "unprognostic (6.73e-2)" "unprognostic (1.98e-1)" "unprognostic (3.34e-2)" "unprognostic (2.71e-1)" "unprognostic (1.08e-2)" "unprognostic (8.92e-2)" "prognostic favorable (4.72e-4)" "unprognostic (3.96e-1)" "unprognostic (2.46e-2)" "unprognostic (5.52e-3)" "unprognostic (1.51e-2)" "unprognostic (1.97e-2)" "unprognostic (9.74e-2)" "unprognostic (2.17e-1)" "unprognostic (1.33e-1)" "unprognostic (1.30e-2)" 23.5 48.6 65.2 8.3 64.5 13.5 18.4 72.3 78.0 25.1 67.6 18.1 10.6 15.0 28.3 8.4 24.2 12.1 36.1 64.8 69.3 35.3 26.1 14.3 11.4 59.6 60.0 27.1 26.6 27.1 49.6 8.9 59.7 19.0 6.9 43.5 23.2 14.5 34.8 7.6 12.9 7.5 59.2 14.6 17.7 13.2 69.4 11.5 32.8 39.1 8.4 19.4 16.7 59.8 6.9 12.9 8.2 24.7 79.8 39.9 4.5 9.0 14.8 10.6 14.3 14.8 27.0 7.8 6.0 22.4 12.1 6.2 9.0 10.0 3.4 25.1 10.0 22.7 37.4 50.0 22.4 31.4 29.0 37.9 6.6 9.0 4.6 23.7 13.8 14.6 9.3 25.4 16.8 7.8 14.5 31.8 4.7 32.4 30.4 10.3 4.2 73.9 20.7 10.6 16.8 26.1 22.5 4.7 13.5 1.7 7.1 33.7 8.2 9.6 10.4 23.4 10.7 37.0 37.4 6.6 18.1 49.6 14.1 6.9 20.3 15.2 94.0 12.7 96.5 49.0 80.9 83.5 36.2 41.5 73.7 79.0 2.1 45.5 8.6 46.0 88.4 54.9 65.2 64.5 72.3 78.0 64.8 69.3 59.6 60.0 59.7 59.2 69.4 59.8 15.9 6.4 21.7 0.0 20.2 9.7 25.1 29.0 4.0 90.8 21.0 22.9 24.3 20.0 20.8 33.1 25.0 10.3 29.6 7.1 33.2 15.5 4.7 23.5 18.0 14.1 40.2 2.5 0.0 12.4 15.3 36.9 4.6 14.9 15.2 12.8 17.2 16.2 29.3 58.9 0.0 14.0 24.4 14.2 18.5 24.9 88.0 14.6 12.4 0.0 7.4 59.9 41.2 0.0 0.0 17.1 5.6 33.1 16.3 17.0 13.8 124.3 29.5 115.2 19.7 24.7 16.8 18.2 57.8 1.8 5.5 4.9 28.9 20.6 15.3 19.5 ABHD14A-ACY1 ENSG00000114786 "ABHD14A-ACY1 readthrough" 3 51974706-51989183 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 4.8;Collecting duct cells: 5.5;Distal tubular cells: 3.9;Proximal tubular cells: 16.8;Theca cells: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "HPA036174, HPA036175, HPA038153" Approved Uncertain Vesicles NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "HPA036174: AB_2674988, HPA036175: AB_2674989, HPA038153: AB_2675868" "unprognostic (8.40e-2)" "unprognostic (1.37e-1)" "unprognostic (4.90e-2)" "unprognostic (7.22e-3)" "unprognostic (3.83e-2)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (1.35e-1)" "unprognostic (6.23e-2)" "unprognostic (2.71e-1)" "unprognostic (1.10e-1)" "unprognostic (1.29e-2)" "unprognostic (9.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (7.11e-4)" 0.5 0.8 0.1 0.1 0.1 0.0 0.4 0.6 0.4 0.2 0.2 0.2 0.0 0.6 0.0 0.2 0.5 0.1 0.2 0.1 0.2 0.3 0.3 0.2 0.0 0.2 0.1 0.1 0.3 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.7 0.2 0.2 0.0 0.2 0.2 0.4 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.4 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.1 0.4 0.5 1.2 0.9 0.8 0.6 0.7 1.1 1.0 0.5 0.7 1.0 0.0 1.1 0.6 0.6 1.0 0.5 0.1 0.1 0.6 0.4 0.1 0.2 0.2 0.1 0.2 0.2 0.1 0.2 1.4 0.0 4.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.2 3.2 0.0 0.0 1.8 5.5 0.0 0.0 0.9 0.1 3.9 1.5 0.0 0.4 1.4 0.6 0.0 0.8 1.0 1.2 0.0 1.0 2.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.6 0.0 0.0 0.5 1.2 2.0 0.0 0.0 0.0 0.0 0.2 16.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 6.3 0.0 0.0 ACY1 ENSG00000243989 "Aminoacylase 1" Q03154 3 51983340-51989197 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "intestine: 181.5;kidney: 449.9;liver: 274.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 31.6;Gastric mucus-secreting cells: 32.6;Proximal enterocytes: 144.8;Proximal tubular cells: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 128.0" "CAB003695, HPA036174, HPA036175" Enhanced NA NA 23000000 "Cluster 27: Non-specific - Gene expression" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989" "unprognostic (4.28e-2)" "unprognostic (1.89e-1)" "unprognostic (2.10e-1)" "unprognostic (2.48e-3)" "unprognostic (3.15e-1)" "unprognostic (6.51e-2)" "unprognostic (2.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.05e-2)" "unprognostic (6.08e-2)" "unprognostic (2.36e-2)" "unprognostic (2.70e-2)" "prognostic favorable (2.93e-4)" "unprognostic (3.57e-1)" "unprognostic (3.75e-1)" "unprognostic (7.88e-2)" "prognostic favorable (6.77e-4)" 19.2 24.0 5.6 7.3 5.7 8.8 20.7 6.4 7.3 13.9 11.6 30.6 181.5 4.3 21.8 10.7 13.0 10.7 14.5 5.1 6.0 449.9 274.9 9.2 7.2 6.5 5.9 4.8 8.7 28.2 4.7 9.7 6.6 14.3 30.5 1.9 16.4 11.1 20.2 8.2 138.2 6.9 6.7 8.1 23.6 3.2 6.1 5.1 21.0 34.6 9.2 12.5 7.1 6.6 15.9 26.2 13.2 34.1 28.9 39.4 40.5 12.6 28.2 29.4 14.9 41.2 67.9 7.2 12.2 22.0 13.2 20.0 14.7 81.2 11.5 21.8 10.7 25.3 13.9 128.0 49.7 19.8 21.0 48.0 67.2 25.4 69.1 25.8 11.5 14.6 47.1 23.9 29.9 35.2 0.6 38.9 23.4 92.1 39.3 8.0 14.1 63.5 74.5 50.8 16.9 18.2 12.6 62.6 29.5 7.5 42.3 27.9 7.1 22.0 21.9 24.8 18.8 61.7 16.9 12.1 28.1 42.9 29.0 9.1 15.7 0.4 10.7 15.1 5.7 7.4 2.6 4.5 21.2 6.1 4.1 4.7 0.0 20.4 6.4 2.8 3.8 9.7 5.6 5.7 6.4 7.3 5.1 6.0 6.5 5.9 6.6 6.7 6.1 6.6 0.5 3.2 3.2 0.0 4.9 0.6 1.0 1.9 17.1 0.2 2.7 1.3 0.2 1.5 2.5 5.5 0.0 3.9 0.3 31.6 9.8 16.6 0.2 0.2 0.9 0.9 2.4 15.8 0.0 8.3 4.5 4.3 32.6 0.6 7.0 0.2 1.1 13.1 1.9 0.0 0.0 11.2 4.1 1.9 0.3 0.8 0.6 4.2 0.0 0.0 9.3 0.8 1.0 0.0 0.0 16.4 23.3 0.0 14.9 0.6 144.8 92.0 1.7 1.1 0.0 0.6 2.0 0.1 0.2 18.5 0.4 4.1 2.6 1.0 14.5 0.4 RPL29 "HIP, HUMRPL29, L29, RPL29P10" ENSG00000162244 "Ribosomal protein L29" P47914 3 51993522-51995895 "Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069064 Approved Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 190000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA069064: AB_2686077" "unprognostic (3.77e-3)" "unprognostic (2.72e-1)" "unprognostic (2.18e-1)" "unprognostic (2.32e-3)" "unprognostic (2.89e-3)" "unprognostic (5.46e-2)" "unprognostic (6.79e-3)" "unprognostic (1.79e-1)" "unprognostic (2.16e-1)" "unprognostic (5.06e-2)" "unprognostic (1.17e-1)" "unprognostic (1.40e-1)" "unprognostic (2.16e-2)" "unprognostic (1.98e-1)" "unprognostic (9.99e-2)" "unprognostic (6.25e-2)" "unprognostic (7.56e-2)" 1695.8 1400.7 669.4 719.9 687.1 2111.2 1659.2 668.9 816.3 1854.9 645.4 1352.4 866.4 1208.8 657.8 1772.7 1470.3 645.8 1073.9 646.1 673.9 1112.9 1155.6 972.4 1348.0 697.9 665.1 2740.8 2740.5 537.5 708.8 534.7 696.9 1307.1 624.9 229.3 1478.4 550.2 2689.5 2458.5 1155.7 567.4 721.7 1239.3 1341.7 440.2 684.7 1075.5 982.6 1287.3 991.6 1339.6 1643.6 729.6 1208.7 1467.7 1123.3 1808.9 1933.5 3007.1 1603.5 1299.2 1540.3 1693.7 1396.9 1757.3 1831.7 3226.6 553.5 1292.3 1044.1 1084.1 1622.7 2689.1 802.7 1335.2 2202.3 1689.2 1892.1 3037.1 2287.6 2548.8 1630.1 3714.1 3735.4 1254.5 2210.9 1936.9 1920.9 1420.6 1338.0 2536.8 1264.3 2629.0 2238.9 3210.8 1965.5 1755.6 2463.0 1038.1 1267.3 3258.5 2211.8 2509.3 948.0 1820.6 969.6 2279.1 2378.1 706.9 1710.1 4227.3 1745.3 1001.3 1324.5 1559.7 2006.9 1615.8 2498.1 2399.9 1326.2 2953.0 1357.6 556.4 1184.0 333.4 895.8 882.9 1488.2 1886.9 1446.6 1149.2 1356.0 1749.9 1662.7 1421.4 145.3 1115.6 724.8 1154.7 1444.1 3507.7 669.4 687.1 668.9 816.3 646.1 673.9 697.9 665.1 696.9 721.7 684.7 729.6 2092.1 189.1 415.6 35.3 3749.3 3975.7 5198.9 3485.6 4465.8 234.8 4763.1 7627.1 82.4 1611.4 1245.9 711.7 102.2 2537.2 2453.7 1497.3 2181.5 1773.3 1117.1 1158.9 3170.1 1957.3 1430.9 2176.2 28.2 4573.5 5119.4 1862.6 1826.2 1529.2 694.4 3951.5 2026.4 1661.0 2373.7 107.7 33.6 3051.9 1043.6 2693.9 3423.6 4294.3 3611.5 2216.3 2218.0 37.5 2893.8 989.3 2520.1 18.1 49.2 3180.2 2816.5 1583.5 2556.8 5203.2 3720.1 3760.6 507.1 405.3 1143.9 2535.7 2110.2 564.9 465.2 5714.8 5075.9 2455.2 2765.1 5917.8 3455.9 5933.8 DUSP7 "MKP-X, PYST2" ENSG00000164086 "Dual specificity phosphatase 7" Q16829 3 52048919-52056571 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 117.3;Squamous epithelial cells: 51.6;Suprabasal keratinocytes: 135.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "hTCEpi: 109.8;hTERT-HME1: 92.6" "Low region specificity" "Detected in all" HPA073007 Approved NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 28: Keratinocytes - Keratinization" "HPA073007: " "unprognostic (1.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (6.16e-3)" "unprognostic (2.32e-2)" "unprognostic (2.75e-1)" "unprognostic (1.44e-1)" "unprognostic (8.67e-3)" "unprognostic (7.38e-3)" "unprognostic (7.74e-3)" "prognostic unfavorable (8.84e-6)" "unprognostic (4.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.29e-2)" "unprognostic (9.46e-2)" 13.1 10.0 23.3 7.6 28.4 3.6 11.5 19.5 27.5 27.0 7.5 8.4 4.1 14.6 3.9 64.1 10.1 8.7 22.2 24.2 21.2 10.6 5.2 24.9 10.2 25.8 27.2 8.7 7.0 6.2 7.2 14.1 22.3 11.5 3.8 2.6 13.2 7.9 23.1 65.6 7.9 6.7 19.5 26.2 9.1 12.0 27.2 8.1 9.1 20.5 10.8 13.5 45.5 38.4 21.3 4.4 5.2 11.9 16.4 14.1 6.2 21.0 39.8 20.4 14.7 5.8 10.6 5.8 5.7 31.3 10.3 24.6 19.8 76.0 13.8 5.0 8.1 27.8 10.9 10.3 13.3 25.1 16.2 14.8 109.8 26.5 92.6 14.1 19.8 16.8 16.2 16.4 16.5 5.9 18.7 35.2 12.9 5.9 37.6 15.5 4.5 15.6 8.5 9.1 6.5 19.0 9.4 8.5 14.9 4.2 3.0 59.4 26.0 39.1 25.3 41.7 65.4 7.9 7.9 9.3 21.7 41.5 12.7 0.9 3.4 1.7 5.3 10.3 7.2 0.9 6.3 3.8 4.7 0.5 4.5 4.1 1.3 2.5 10.3 7.1 4.5 1.7 23.3 28.4 19.5 27.5 24.2 21.2 25.8 27.2 22.3 19.5 27.2 38.4 17.0 9.6 1.1 0.0 2.9 117.3 31.5 13.5 21.1 4.9 6.6 7.2 18.9 0.0 5.2 0.0 0.0 0.6 13.4 1.6 1.9 3.1 1.7 2.9 8.1 18.7 2.4 1.7 5.5 2.6 4.3 7.8 0.5 2.8 0.0 1.3 23.6 0.9 8.1 0.0 4.4 2.5 0.0 16.7 12.0 0.5 8.7 9.0 21.4 5.6 10.3 0.9 9.2 5.5 20.2 12.1 1.3 4.9 1.6 17.5 0.6 1.3 1.5 1.0 26.3 3.3 8.6 3.5 5.5 51.6 135.2 1.2 7.3 4.1 3.4 29.3 POC1A "DKFZP434C245, WDR51A" ENSG00000164087 "POC1 centriolar protein A" Q8NBT0 3 52075226-52154690 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Dwarfism, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 12.8;testis: 17.6" "Cell type enhanced" "Detected in many" "Early spermatids: 47.9;Extravillous trophoblasts: 33.8;Late spermatids: 73.4;Spermatocytes: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040600 Approved NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "HPA040600: AB_10672837" "unprognostic (2.68e-1)" "unprognostic (7.17e-2)" "prognostic favorable (1.78e-4)" "unprognostic (5.08e-2)" "unprognostic (3.61e-1)" "unprognostic (1.31e-1)" "unprognostic (1.02e-3)" "unprognostic (2.41e-2)" "unprognostic (7.23e-3)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (3.89e-2)" "prognostic unfavorable (9.43e-7)" "unprognostic (9.90e-3)" "unprognostic (1.96e-1)" "unprognostic (3.62e-2)" "unprognostic (2.32e-2)" 1.4 4.1 1.5 4.0 1.5 11.1 2.2 1.4 1.8 1.5 1.1 5.9 4.8 1.0 1.0 4.7 1.7 1.1 1.4 1.7 1.6 2.1 5.2 1.9 5.4 1.9 1.6 0.7 0.9 1.1 0.7 4.1 1.8 1.3 6.0 0.4 1.3 1.0 1.5 2.6 4.0 2.9 1.5 2.8 2.8 17.6 1.6 12.8 1.0 1.0 7.0 2.0 1.8 1.8 30.1 25.2 25.0 33.5 5.1 6.5 33.9 30.0 28.7 62.8 48.7 22.1 31.0 31.3 8.8 23.9 48.6 18.3 38.0 33.9 45.3 26.0 16.0 21.4 26.3 23.9 1.4 24.5 13.0 3.6 7.3 49.6 25.9 8.7 29.0 46.2 18.8 32.9 37.5 23.8 45.6 44.2 19.1 33.7 41.0 19.6 19.7 30.0 14.2 21.0 11.6 16.7 24.0 23.7 18.3 26.0 29.2 45.7 9.7 28.6 27.6 46.3 49.3 27.8 49.1 26.6 19.2 42.6 29.1 0.0 1.6 0.0 1.2 2.2 0.1 0.9 0.8 0.4 1.9 0.5 0.7 0.4 0.5 1.4 1.6 1.9 2.6 1.1 1.5 1.5 1.4 1.8 1.7 1.6 1.9 1.6 1.8 1.5 1.6 1.8 0.9 0.0 1.3 0.3 2.5 1.7 1.6 4.7 0.0 0.7 2.1 2.2 0.7 0.0 1.4 1.8 0.0 21.8 0.9 4.4 0.0 1.8 47.9 4.5 1.0 2.9 1.8 15.6 2.3 3.0 33.8 3.4 2.0 1.5 0.0 11.3 1.8 4.2 12.9 1.7 1.4 5.4 0.0 2.6 3.4 73.4 1.2 2.6 1.8 1.9 2.7 0.8 1.0 0.0 2.7 2.1 2.2 0.4 12.9 1.3 3.0 3.2 4.2 0.0 0.0 1.1 3.4 40.1 21.2 4.9 1.8 7.5 1.6 4.4 8.4 2.1 ALAS1 "ALAS, ALAS3" ENSG00000023330 "5'-aminolevulinate synthase 1" P13196 3 52198086-52214327 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Heme biosynthesis" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 720.5;liver: 548.8" "Cell type enhanced" "Detected in all" "Hepatocytes: 243.1;Syncytiotrophoblasts: 309.2;Theca cells: 187.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 233.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 233.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017498, HPA035860" Enhanced Supported Nucleoplasm,Mitochondria NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 15: RT4 - Unknown function" "Cluster 15: Hepatocytes - Hemostasis" Mitochondria Nucleoplasm "CAB017498: AB_2225629, HPA035860: AB_10672992" "unprognostic (1.17e-1)" "unprognostic (1.65e-1)" "unprognostic (1.50e-1)" "unprognostic (7.09e-2)" "unprognostic (2.33e-1)" "unprognostic (6.21e-2)" "prognostic favorable (1.82e-5)" "unprognostic (3.98e-2)" "unprognostic (1.26e-1)" "unprognostic (2.31e-2)" "unprognostic (9.86e-2)" "unprognostic (5.64e-2)" "prognostic favorable (6.06e-7)" "unprognostic (8.45e-2)" "unprognostic (3.91e-2)" "unprognostic (1.07e-1)" "unprognostic (1.75e-2)" 34.5 720.5 24.8 23.9 25.1 176.7 28.7 37.9 82.5 20.5 35.7 43.6 44.9 19.0 28.1 36.4 15.3 32.7 116.2 26.6 28.1 45.7 548.8 47.8 22.9 27.2 25.4 17.1 19.6 60.3 15.7 36.8 33.2 23.1 41.6 20.6 42.8 27.2 110.9 24.3 39.3 23.9 24.9 19.5 45.9 18.6 31.8 23.5 22.1 106.6 28.2 73.8 23.5 28.3 36.2 55.0 38.0 35.4 57.9 43.1 103.1 51.8 47.7 67.6 65.3 73.6 66.2 33.6 12.7 36.4 137.0 20.9 55.1 42.6 54.7 65.9 21.6 43.2 41.2 56.4 81.8 70.8 83.0 54.0 39.1 107.7 35.7 25.0 62.8 57.7 25.8 27.0 62.4 29.5 33.9 107.3 33.0 41.1 93.4 20.0 23.9 53.3 59.8 213.9 20.2 13.3 83.9 40.9 47.2 30.5 23.5 99.9 45.7 37.6 37.1 78.5 76.2 39.5 73.8 50.5 42.1 75.5 61.1 233.9 33.4 103.2 22.9 42.9 37.4 23.1 23.9 26.0 29.8 21.5 21.1 23.3 49.6 30.9 39.0 17.1 35.7 25.1 24.8 25.1 37.9 82.5 26.6 28.1 27.2 25.4 33.2 24.9 31.8 28.3 28.4 35.3 60.3 5.2 14.9 17.3 17.2 36.1 15.9 16.6 28.6 19.6 107.5 25.8 37.7 23.9 4.2 81.9 25.1 68.5 56.7 35.5 10.2 20.2 9.3 27.6 34.6 11.2 6.2 31.3 28.2 19.6 42.3 25.3 95.4 13.1 18.5 243.1 69.1 11.8 6.2 24.3 34.6 13.0 20.8 4.1 13.4 36.4 5.4 8.4 49.1 9.7 11.3 4.0 8.4 42.3 28.1 16.6 14.0 16.0 35.6 36.1 40.6 9.2 13.1 9.1 27.5 25.5 22.3 21.4 16.2 309.2 25.1 187.2 24.3 26.4 TLR9 CD289 ENSG00000239732 "Toll like receptor 9" Q9NR96 3 52221080-52225645 "CD markers, FDA approved drug targets, Human disease related genes, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.1;lymphoid tissue: 6.0" "Group enriched" "Detected in some" 5 "B-cells: 3.3;Microglial cells: 1.0;Paneth cells: 1.1;Plasma cells: 1.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 7 "plasmacytoid DC: 166.9" "Lineage enriched" "Detected in many" 7 "dendritic cells: 166.9" "Group enriched" "Detected in some" 8 "Daudi: 53.5;RPMI-8226: 52.4;U-698: 27.6" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "unprognostic (6.03e-2)" "unprognostic (5.08e-2)" "unprognostic (3.58e-3)" "unprognostic (6.69e-7)" "unprognostic (1.16e-1)" "unprognostic (1.89e-2)" "unprognostic (2.69e-1)" "unprognostic (1.58e-1)" "unprognostic (7.02e-2)" "unprognostic (1.89e-1)" "unprognostic (4.40e-2)" "unprognostic (7.60e-2)" "unprognostic (2.65e-3)" "unprognostic (2.44e-2)" "unprognostic (3.70e-1)" "unprognostic (2.27e-1)" "unprognostic (7.91e-3)" 0.5 0.2 0.9 2.6 1.0 1.3 0.4 2.2 6.1 1.2 0.7 0.9 0.4 0.7 0.0 0.3 0.9 0.6 0.3 1.1 0.8 0.3 0.3 0.6 6.0 1.1 1.0 1.5 0.1 0.0 0.3 0.2 1.7 0.7 0.1 0.0 0.7 0.2 1.2 0.3 1.3 0.1 0.9 3.0 0.5 0.4 0.9 1.5 0.6 0.4 4.1 0.7 0.8 1.2 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 53.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.7 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 5.4 1.1 0.0 0.0 0.0 1.0 0.0 52.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.2 0.0 0.1 0.0 0.0 3.6 1.7 27.6 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.2 2.7 23.5 0.9 0.6 0.3 12.8 0.2 0.2 0.5 0.0 0.0 166.9 2.5 1.8 0.9 1.0 2.2 6.1 1.1 0.8 1.1 1.0 1.7 0.9 0.9 1.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC097637.1 ENSG00000173366 "Novel twinfilin, actin-binding protein, homolog 2 (Drosophila) (TWF2) and toll-like receptor 9 (TLR9) protein" 3 52221081-52231190 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.8;lymphoid tissue: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 64: Macrophages - Immune response" "unprognostic (4.08e-2)" "unprognostic (9.63e-2)" 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.7 0.1 1.8 0.0 0.0 2.6 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TWF2 "A6r, A6RP, PTK9L" ENSG00000247596 "Twinfilin actin binding protein 2" Q6IBS0 3 52228612-52246788 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 183.4" "Cell type enhanced" "Detected in many" "Hofbauer cells: 205.0;monocytes: 202.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053874 Uncertain Uncertain "Plasma membrane" NA NA 5900000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 3: Monocytes - Immune response regulation" "Plasma membrane" "HPA053874: AB_2682287" "unprognostic (4.24e-2)" "unprognostic (8.61e-2)" "unprognostic (2.18e-1)" "unprognostic (2.62e-2)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (5.46e-3)" "unprognostic (2.76e-1)" "unprognostic (6.56e-2)" "unprognostic (1.97e-1)" "unprognostic (2.58e-2)" "unprognostic (5.07e-2)" "unprognostic (4.31e-3)" "unprognostic (4.40e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-1)" "unprognostic (7.07e-2)" 50.3 32.0 16.6 28.1 16.4 28.3 39.0 12.9 26.5 35.7 13.2 32.4 21.8 35.4 0.6 44.5 27.9 17.2 94.8 17.3 15.4 31.2 29.3 34.9 33.3 15.5 13.7 29.5 17.3 6.8 18.3 15.8 16.0 29.1 4.8 0.9 36.7 18.7 183.4 32.4 33.6 14.1 15.4 54.8 24.5 14.2 14.7 21.3 23.8 4.3 15.1 36.2 36.4 18.0 24.9 59.8 10.7 28.6 29.1 47.5 35.7 56.0 55.9 49.1 43.4 32.3 51.6 89.9 36.5 27.1 39.2 37.5 11.9 60.0 4.2 52.4 34.0 89.6 38.0 78.9 49.1 54.3 139.6 46.4 28.8 50.4 12.8 21.9 82.9 50.1 21.0 36.0 20.7 21.7 65.0 117.1 30.4 15.2 171.9 27.0 22.0 92.0 22.3 38.4 13.6 59.7 19.7 74.7 109.2 4.2 19.3 40.5 105.9 55.1 68.4 50.4 47.4 37.4 35.9 45.6 125.9 143.8 73.7 97.5 167.8 143.4 107.7 169.1 95.0 109.1 112.4 114.6 159.7 83.1 86.5 108.9 242.0 93.7 181.6 150.6 141.9 149.6 16.6 16.4 12.9 26.5 17.3 15.4 15.5 13.7 16.0 15.4 14.7 18.0 44.3 6.4 7.8 2.0 50.7 17.2 29.5 59.2 12.5 14.0 29.9 28.2 28.8 27.1 23.7 12.9 0.0 42.4 77.0 64.4 37.2 86.8 3.1 34.2 27.5 35.9 22.1 17.7 7.5 100.8 84.3 34.0 18.8 86.3 40.6 28.4 31.1 13.3 205.0 6.7 4.2 20.2 30.5 108.8 56.7 2.7 35.1 111.8 33.8 3.7 202.4 14.9 97.9 3.5 3.5 103.2 55.7 33.8 25.2 20.3 65.5 25.4 12.2 5.1 52.6 16.1 38.6 1.7 25.1 27.2 15.3 22.6 64.4 53.7 23.9 31.3 PPM1M "FLJ32332, PP2Ceta" ENSG00000164088 "Protein phosphatase, Mg2+/Mn2+ dependent 1M" Q96MI6 3 52245759-52250599 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 42.2;Kupffer cells: 39.0;Macrophages: 31.1;NK-cells: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 54.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036905, HPA062291" Uncertain Approved "Nuclear bodies" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear bodies" "HPA036905: AB_10602818, HPA062291: AB_2684740" "unprognostic (4.26e-3)" "prognostic favorable (7.73e-4)" "unprognostic (2.55e-2)" "unprognostic (4.85e-3)" "unprognostic (5.64e-2)" "unprognostic (4.88e-3)" "unprognostic (1.70e-2)" "prognostic favorable (6.69e-4)" "unprognostic (4.63e-2)" "unprognostic (1.69e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.61e-5)" "unprognostic (1.49e-1)" "unprognostic (4.14e-2)" "unprognostic (9.27e-2)" "unprognostic (4.37e-2)" 19.5 9.4 12.7 20.3 13.7 24.6 15.5 9.9 13.6 25.9 12.2 18.7 6.0 18.3 9.9 12.3 18.1 14.1 11.4 13.6 14.2 10.9 5.6 23.5 29.6 12.8 11.4 18.6 8.0 11.2 9.1 11.6 12.2 16.7 8.7 2.2 11.6 15.2 3.7 10.7 13.1 18.0 12.0 30.1 11.4 8.8 15.5 27.6 13.8 7.8 28.2 17.5 18.2 12.9 0.9 5.4 3.2 7.6 46.1 45.7 5.2 12.2 26.2 17.0 13.1 3.2 4.2 9.0 3.6 32.0 9.5 1.5 10.9 2.3 6.9 11.0 2.7 20.5 14.6 3.3 33.6 3.1 18.7 37.8 5.2 18.9 11.9 27.3 22.2 40.5 3.6 14.5 20.2 2.2 13.7 0.9 4.1 4.0 14.7 3.0 1.6 20.0 7.3 2.6 2.3 9.3 9.0 2.2 11.1 6.8 7.6 7.9 15.5 6.5 10.7 3.8 1.6 54.3 11.2 9.9 12.7 5.4 8.0 1.8 24.1 13.3 20.6 19.3 15.9 6.8 16.1 19.2 14.4 7.4 15.2 19.0 28.9 11.7 29.6 8.5 20.5 17.5 12.7 13.7 9.9 13.6 13.6 14.2 12.8 11.4 12.2 12.0 15.5 12.9 6.8 0.0 5.4 1.3 15.4 5.1 6.5 0.7 8.0 1.6 5.9 7.2 1.8 5.7 2.0 1.8 0.0 3.3 25.9 0.7 3.9 1.8 9.7 4.7 8.9 7.0 1.2 3.0 1.5 1.1 5.8 11.9 3.1 11.0 5.7 7.3 12.5 3.7 42.2 1.7 0.6 0.4 2.0 39.0 17.0 18.0 12.8 31.1 5.4 4.7 29.1 5.1 30.9 1.5 0.7 1.3 3.2 9.8 11.4 2.3 0.9 3.0 0.9 0.7 19.7 5.2 7.3 0.7 4.2 11.9 3.8 1.9 25.1 3.1 1.0 3.5 WDR82 "MST107, MSTP107, PRO2730, PRO34047, SWD2, TMEM113, WDR82A" ENSG00000164091 "WD repeat domain 82" Q6UXN9 3 52254434-52288020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 185.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040427 Supported "Nucleoli rim" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoli rim" "HPA040427: AB_2676979" "unprognostic (7.43e-2)" "unprognostic (3.20e-1)" "unprognostic (1.03e-2)" "unprognostic (2.15e-3)" "unprognostic (1.78e-1)" "unprognostic (1.38e-2)" "unprognostic (1.77e-2)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-1)" "unprognostic (2.15e-3)" "unprognostic (2.92e-3)" "unprognostic (9.32e-2)" "unprognostic (2.04e-1)" "unprognostic (8.54e-2)" "unprognostic (1.26e-1)" 40.3 37.8 36.5 46.8 37.0 55.6 33.9 38.1 36.5 48.6 35.9 37.5 33.8 56.2 30.1 46.7 43.8 35.3 48.0 37.9 40.2 28.7 32.6 36.0 57.8 31.4 34.1 54.6 28.1 35.4 22.0 43.3 33.4 41.2 39.1 35.5 31.2 48.7 65.5 37.0 33.6 52.2 34.3 49.1 31.4 33.3 42.7 73.1 40.4 67.0 60.8 47.4 36.1 34.6 46.0 54.3 100.4 75.5 93.7 77.3 50.3 76.6 63.3 74.0 61.1 63.9 44.9 121.4 29.2 82.4 64.8 40.7 139.3 82.2 86.2 88.5 53.3 155.9 67.3 65.8 64.9 148.2 78.6 78.1 79.6 87.3 79.3 68.8 79.0 97.7 70.8 84.8 72.4 46.3 115.6 58.1 91.1 60.0 104.2 58.7 67.0 90.8 77.2 83.1 23.9 100.3 82.1 24.5 47.8 67.4 46.4 58.8 81.6 69.0 78.2 72.9 89.3 82.3 129.1 120.6 59.0 110.6 77.3 9.4 7.4 10.1 15.3 7.5 18.5 8.8 13.9 15.0 6.5 7.0 15.8 16.2 14.2 8.9 12.0 6.1 12.9 9.8 36.5 37.0 38.1 36.5 37.9 40.2 31.4 34.1 33.4 34.3 42.7 34.6 45.9 28.9 42.8 12.1 43.0 51.5 33.9 23.5 34.1 54.6 40.7 41.4 53.1 32.9 26.3 14.7 20.9 28.8 66.2 45.4 13.7 17.4 45.3 62.6 71.0 42.7 44.3 41.2 20.4 18.9 31.2 38.3 31.1 91.5 15.2 51.0 40.0 42.9 32.5 62.2 22.0 35.2 12.2 61.9 40.2 185.1 58.4 43.2 37.4 21.5 50.2 36.5 63.8 15.1 18.1 30.4 30.8 62.8 33.4 40.8 26.0 21.7 21.4 35.0 52.6 53.3 36.6 21.5 30.7 41.5 56.8 30.8 62.5 42.9 40.5 40.3 GLYCTK "HBEBP2, HBEBP4" ENSG00000168237 "Glycerate kinase" Q8IVS8 3 52287089-52295257 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 275.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 183.0;Proximal enterocytes: 105.2;Proximal tubular cells: 83.0" "Cancer enriched" "Detected in all" 6 "liver cancer: 52.7" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006913 Approved Approved "Golgi apparatus,Cytosol,Rods & Rings" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 21: OE19 - Mitochondria" "Cluster 2: Hepatocytes - Metabolism" Cytosol "Golgi apparatus, Rods & Rings" "HPA006913: AB_1078993" "unprognostic (1.51e-2)" "unprognostic (2.55e-1)" "unprognostic (1.25e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "prognostic favorable (1.64e-4)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (7.73e-3)" "unprognostic (1.82e-1)" "unprognostic (3.36e-3)" "unprognostic (2.15e-1)" "unprognostic (3.30e-2)" "unprognostic (3.42e-1)" "unprognostic (3.77e-1)" "unprognostic (3.82e-2)" "unprognostic (9.00e-3)" 14.8 8.3 1.0 4.5 0.9 6.7 9.3 0.5 1.5 2.9 0.9 11.4 22.4 3.2 0.6 3.8 2.7 2.2 4.4 0.9 1.2 24.9 275.1 4.2 4.6 1.4 0.9 2.4 5.9 2.5 2.9 2.2 1.2 3.7 3.6 0.6 3.1 1.0 3.6 1.9 21.7 1.6 0.4 8.9 8.5 2.3 1.2 2.3 4.1 1.0 3.2 3.3 2.5 1.2 2.9 5.8 3.4 1.2 15.7 2.4 1.8 2.4 2.6 4.6 3.9 12.1 2.4 6.7 1.6 2.7 3.7 1.6 1.7 7.8 0.8 2.0 1.8 9.3 7.5 16.2 1.7 2.8 5.0 2.4 3.5 7.6 3.2 2.1 10.2 5.2 2.4 4.5 3.6 1.9 5.9 2.7 1.5 14.2 4.2 1.9 2.5 11.1 5.8 3.9 1.9 1.9 2.6 1.4 3.0 1.0 3.2 1.7 3.8 3.5 4.1 2.4 6.1 5.1 3.9 5.4 2.7 4.9 2.2 2.2 5.2 6.6 5.6 2.8 2.6 4.4 4.2 4.9 5.6 2.6 3.3 4.3 4.4 3.6 3.5 3.4 6.6 3.7 1.0 0.9 0.5 1.5 0.9 1.2 1.4 0.9 1.2 0.4 1.2 1.2 5.4 6.4 3.2 0.7 8.2 0.4 3.2 4.1 1.8 1.6 2.1 1.4 1.6 18.6 3.0 9.2 0.0 7.9 9.2 18.4 19.6 5.4 0.3 4.4 2.7 8.3 23.4 26.5 0.6 6.2 5.3 2.9 27.0 8.6 1.3 3.4 14.6 183.0 13.2 0.0 0.4 15.8 2.0 16.6 2.4 0.0 1.2 9.1 3.6 1.0 7.7 1.2 9.2 0.5 0.7 4.0 40.6 0.0 13.5 2.8 105.2 83.0 2.4 1.5 0.0 2.7 2.7 1.8 8.3 2.1 1.3 11.1 9.3 7.7 24.9 4.3 DNAH1 "DNAHC1, HDHC7, HL-11, HL11, XLHSRF-1" ENSG00000114841 "Dynein axonemal heavy chain 1" Q9P2D7 3 52316319-52400491 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 21.5;Respiratory ciliated cells: 35.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.6" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "midbrain: 3.4" "HPA036805, HPA036806" Uncertain NA NA "Cluster 40: Neutrophils - Inflammatory response" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "HPA036805: AB_10670924, HPA036806: AB_10670849" "unprognostic (8.34e-3)" "unprognostic (3.60e-2)" "unprognostic (9.60e-4)" "unprognostic (1.54e-2)" "unprognostic (2.99e-1)" "unprognostic (6.59e-4)" "unprognostic (1.62e-1)" "unprognostic (1.43e-2)" "unprognostic (1.19e-1)" "unprognostic (1.49e-1)" "unprognostic (4.79e-2)" "unprognostic (4.98e-4)" "unprognostic (1.84e-3)" "unprognostic (8.66e-3)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (9.80e-5)" 2.1 1.4 0.2 2.1 0.7 6.2 1.7 0.0 1.1 1.4 2.1 1.4 1.3 1.5 1.3 1.3 4.0 1.6 1.0 0.3 0.5 1.5 2.4 2.4 3.1 1.3 1.7 1.9 1.5 1.4 1.8 1.0 0.8 1.6 1.3 2.5 1.5 0.7 1.1 1.7 2.9 1.7 0.3 2.9 1.6 4.1 0.6 1.9 1.5 0.5 2.4 1.1 1.1 1.8 0.1 0.7 1.0 1.0 1.2 4.6 0.5 0.6 1.0 0.2 0.2 0.0 0.6 0.3 0.6 0.8 0.1 0.1 0.0 0.2 0.4 0.8 1.4 2.0 0.1 0.2 0.6 1.5 1.3 2.0 0.3 0.8 1.0 2.1 0.8 0.8 0.2 1.7 0.8 0.2 0.4 1.4 0.5 0.1 0.9 0.7 0.0 0.6 0.3 0.8 0.1 0.5 1.0 0.1 0.7 0.3 0.2 2.4 1.0 0.3 0.2 0.9 0.2 1.8 1.8 0.5 0.3 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 1.1 0.3 0.5 1.3 1.7 0.8 0.3 0.6 1.8 2.2 6.4 3.7 9.1 3.2 0.5 0.4 2.0 0.6 1.8 1.7 1.8 4.4 0.0 2.7 0.0 4.2 0.6 3.1 2.3 0.0 0.3 9.7 6.9 1.6 2.1 5.4 2.7 13.8 0.6 0.2 1.2 8.2 3.8 3.8 3.2 2.2 3.9 1.2 5.0 10.0 2.6 8.2 3.5 1.6 21.5 1.2 3.2 1.8 3.7 3.4 0.9 4.1 2.5 10.7 0.3 2.1 0.4 2.4 0.9 4.8 0.9 35.5 5.2 0.0 1.4 1.9 6.9 1.5 1.1 0.3 0.8 3.3 1.7 2.2 0.6 BAP1 "hucep-6, KIAA0272, UCHL2" ENSG00000163930 "BRCA1 associated protein 1" Q92560 3 52401008-52410008 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Chromatin regulator, Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 103.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004322, HPA028814, HPA028815, HPA055560" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm Cytosol "CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850" "unprognostic (1.52e-1)" "unprognostic (7.96e-2)" "unprognostic (1.96e-2)" "unprognostic (6.04e-2)" "unprognostic (1.74e-1)" "unprognostic (2.55e-2)" "unprognostic (9.41e-3)" "unprognostic (8.53e-3)" "unprognostic (1.33e-1)" "unprognostic (3.15e-1)" "unprognostic (4.64e-3)" "unprognostic (3.30e-3)" "prognostic favorable (3.29e-7)" "unprognostic (6.37e-2)" "unprognostic (1.91e-1)" "unprognostic (5.54e-2)" "unprognostic (2.92e-1)" 45.2 63.5 97.6 25.0 99.2 73.9 42.9 78.9 135.5 39.1 71.4 47.7 21.6 40.5 23.1 59.3 36.0 25.7 57.0 114.1 83.3 57.3 65.2 46.0 29.4 81.2 85.7 43.9 52.7 40.2 36.9 24.6 81.7 50.0 24.1 20.1 43.0 22.5 74.7 73.4 43.4 23.8 79.9 54.2 48.1 140.0 89.2 33.1 49.1 43.5 27.9 44.6 41.7 90.5 39.1 43.1 52.2 44.8 50.1 31.4 59.3 37.8 50.1 62.4 48.0 52.5 35.8 55.7 18.3 54.7 69.3 31.4 55.7 63.0 37.9 55.1 51.4 68.6 94.4 53.2 45.7 65.6 58.5 48.0 80.1 68.5 36.1 33.3 50.3 107.7 59.9 48.3 44.5 33.7 79.1 89.5 58.0 31.0 52.8 33.7 41.7 55.8 37.4 61.2 19.8 63.6 46.1 13.7 56.9 29.2 37.7 90.6 52.5 54.1 49.3 66.0 70.9 71.7 101.6 81.2 58.5 68.2 66.1 2.9 3.2 5.4 5.4 2.8 2.6 3.2 4.3 4.4 2.2 4.1 3.1 4.0 7.4 2.2 2.2 5.6 4.2 2.7 97.6 99.2 78.9 135.5 114.1 83.3 81.2 85.7 81.7 79.9 89.2 90.5 13.5 0.0 16.0 8.1 12.2 31.6 10.5 13.2 23.3 16.6 16.4 12.6 23.6 11.5 10.2 25.8 0.0 14.0 17.7 23.2 11.7 13.5 103.4 9.2 12.4 14.7 10.8 8.2 7.5 16.7 15.8 13.6 14.8 13.6 21.0 18.1 14.6 29.2 12.6 10.1 7.7 16.6 6.1 17.4 10.7 48.0 10.2 12.0 12.4 5.6 15.2 16.1 16.5 7.1 6.7 15.8 16.5 11.7 16.2 11.7 13.3 18.5 8.2 12.3 19.7 14.7 14.2 37.8 13.9 23.0 23.4 12.0 12.2 15.9 19.8 9.6 PHF7 "HSPC226, NYD-SP6" ENSG00000010318 "PHD finger protein 7" Q9BWX1 3 52410660-52423641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 212 "testis: 1216.7" "Cell type enhanced" "Detected in many" "Early spermatids: 2630.6;Late spermatids: 8698.5;Spermatocytes: 1456.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 14.8;U-266/70: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA036283, HPA070305" Enhanced Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "Golgi apparatus" "HPA036283: AB_10795026, HPA070305: AB_2686248" "prognostic favorable (7.38e-5)" "unprognostic (4.57e-2)" "unprognostic (6.97e-3)" "prognostic favorable (9.44e-5)" "unprognostic (3.63e-1)" "unprognostic (2.61e-3)" "unprognostic (7.44e-2)" "unprognostic (5.78e-2)" "unprognostic (2.98e-1)" "unprognostic (6.38e-3)" "unprognostic (1.55e-3)" "unprognostic (1.12e-1)" "prognostic favorable (1.05e-6)" "unprognostic (2.07e-2)" "unprognostic (1.82e-1)" "unprognostic (2.34e-2)" "unprognostic (6.79e-2)" 4.8 2.8 0.6 1.3 0.6 4.1 5.0 0.9 1.3 2.1 0.6 4.3 2.7 1.6 3.3 2.6 2.0 1.1 1.9 0.6 0.7 2.9 4.7 2.4 2.1 0.8 0.8 1.4 4.4 5.7 1.7 2.0 0.8 4.3 4.6 0.6 3.5 1.7 2.3 5.0 4.2 1.4 0.7 3.2 2.5 1216.7 0.7 2.8 2.2 0.9 2.2 2.4 2.3 0.8 2.2 0.6 1.6 6.8 1.1 1.6 2.8 2.1 2.2 1.7 2.1 1.1 0.9 3.6 0.2 1.6 1.0 1.2 1.2 3.4 2.9 4.5 1.6 4.1 0.6 2.5 1.1 4.6 7.5 1.0 3.7 1.6 3.5 0.5 2.5 8.3 2.5 14.8 1.3 1.0 5.4 1.7 0.7 0.7 4.6 2.4 1.5 4.5 1.8 0.9 1.1 1.3 2.0 0.1 1.6 2.0 1.0 2.3 1.8 2.8 1.9 3.0 4.5 17.4 9.0 2.1 1.2 10.4 1.7 0.3 1.1 1.8 0.9 1.2 1.1 3.4 1.0 1.6 0.5 1.8 0.7 1.5 0.2 1.1 0.6 1.1 2.5 0.9 0.6 0.6 0.9 1.3 0.6 0.7 0.8 0.8 0.8 0.7 0.7 0.8 4.3 3.2 4.6 15.7 7.8 4.6 4.8 3.5 13.6 11.2 6.2 5.0 9.7 4.3 1.3 7.3 8.4 3.5 5.8 7.7 13.7 3.6 2630.6 5.3 3.1 6.7 11.5 14.7 10.9 2.8 2.0 5.7 6.1 2.1 7.0 3.7 3.3 4.5 4.2 13.5 12.4 4.2 2.0 4.1 2.3 8698.5 77.0 7.9 8.8 1.9 4.4 8.1 7.2 5.5 16.3 3.7 2.4 63.2 7.6 1.7 12.7 7.3 6.0 15.3 52.6 6.0 4.5 1456.7 71.6 7.6 3.0 0.5 5.5 7.2 10.2 2.2 SEMA3G "FLJ00014, sem2" ENSG00000010319 "Semaphorin 3G" Q9NS98 3 52433035-52445103 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 80.1;breast: 64.2" "Cell type enriched" "Detected in many" 6 "Adipocytes: 151.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 15 "T-reg: 1.4" "Lineage enriched" "Detected in single" 15 "T-cells: 1.4" "Cell line enhanced" "Detected in some" "ASC diff: 26.1;Hep G2: 7.1;HUVEC TERT2: 7.4;THP-1: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001761 Uncertain "Secreted to blood" NA NA 5600000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA001761: AB_1079902" "unprognostic (2.10e-2)" "unprognostic (1.49e-1)" "unprognostic (7.08e-2)" "unprognostic (1.47e-2)" "unprognostic (2.85e-1)" "unprognostic (5.79e-4)" "unprognostic (5.20e-3)" "unprognostic (9.14e-2)" "unprognostic (5.54e-2)" "unprognostic (5.64e-2)" "unprognostic (1.34e-3)" "unprognostic (4.14e-1)" "prognostic favorable (8.86e-5)" "unprognostic (5.63e-2)" "unprognostic (2.93e-2)" "unprognostic (1.32e-1)" "unprognostic (1.14e-1)" 80.1 1.9 9.9 3.4 9.4 0.1 64.2 18.9 11.4 5.1 6.2 6.8 3.0 5.9 1.3 4.5 5.2 5.9 18.6 8.4 9.0 19.8 1.3 23.9 1.6 10.8 10.0 3.2 3.1 1.8 2.4 26.7 11.3 4.6 3.7 0.4 10.6 2.5 12.8 12.7 9.6 3.9 9.9 8.0 5.7 1.3 12.1 1.7 7.7 18.6 1.8 8.3 7.8 9.1 0.0 0.1 0.1 0.2 26.1 0.2 2.5 0.0 0.0 0.0 0.0 0.7 0.3 3.3 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 1.2 3.9 0.2 7.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 7.4 2.6 0.0 0.4 0.0 0.3 0.2 4.3 1.2 0.7 0.1 0.0 0.0 4.1 0.0 0.3 0.5 0.5 0.0 0.4 0.5 0.1 1.9 6.5 2.9 0.1 2.4 0.0 0.0 0.5 2.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 9.9 9.4 18.9 11.4 8.4 9.0 10.8 10.0 11.3 9.9 12.1 9.1 151.5 3.2 1.3 0.0 0.3 0.4 0.1 0.1 0.0 1.7 5.1 5.5 10.7 0.0 0.0 3.7 0.0 1.7 0.9 0.3 0.0 0.0 3.0 2.8 1.6 20.4 9.6 0.0 0.0 0.0 0.2 3.6 1.1 5.8 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 1.3 5.0 0.3 0.5 0.0 24.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 1.2 0.2 0.0 9.4 0.0 0.1 0.2 0.0 4.1 3.0 0.1 0.1 0.5 0.1 7.5 0.4 0.1 0.2 0.0 TNNC1 TNNC ENSG00000114854 "Troponin C1, slow skeletal and cardiac type" P63316 3 52451100-52454041 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 36 "heart muscle: 8734.3;skeletal muscle: 21081.1;tongue: 12403.9" "Cell type enriched" "Detected in many" 10 "Cardiomyocytes: 3550.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 27.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 6 "T-cells: 1.2" "Cell line enhanced" "Detected in many" "CACO-2: 68.2;CAPAN-2: 33.5;EFO-21: 65.2;HeLa: 49.1;Hep G2: 46.1;HSkMC: 67.2;U-2 OS: 97.7" "Region enriched" "Detected in all" 4 "cerebral cortex: 87.0" "Group enriched" "Detected in some" 6 "midbrain: 7.6;spinal cord: 7.1" "CAB002450, HPA044848, HPA056897" Enhanced Approved "Nucleoplasm,Actin filaments,Mitochondria" NA NA 990000 "Cluster 13: T-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 9: U-2 OS - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Actin filaments, Mitochondria" "CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269" "unprognostic (2.18e-2)" "unprognostic (1.70e-1)" "unprognostic (8.66e-2)" "unprognostic (3.43e-1)" "unprognostic (4.00e-2)" "unprognostic (1.88e-2)" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.15e-2)" "unprognostic (4.95e-2)" "unprognostic (2.31e-1)" "unprognostic (4.15e-2)" "unprognostic (4.86e-1)" 8.4 10.9 0.7 0.8 0.8 0.7 19.1 2.7 1.1 7.7 7.3 4.0 1.1 2.8 41.7 387.3 2.8 3.3 8734.3 1.2 0.7 19.2 4.0 78.5 3.9 0.8 0.9 2.4 6.8 1.6 17.6 5.2 1.0 170.1 4.1 0.4 120.8 2.2 21081.1 18.9 3.3 0.8 0.8 2.8 5.7 10.6 0.8 4.3 14.4 12403.9 1.6 5.3 5.4 0.7 0.7 5.2 3.6 0.6 0.2 0.5 8.0 0.4 0.3 0.3 0.4 68.2 33.5 0.5 65.2 9.9 0.1 0.4 0.1 0.3 0.0 1.2 1.6 0.5 49.1 46.1 0.3 0.3 0.1 67.2 1.2 0.0 0.7 0.6 0.0 2.0 0.2 5.1 2.0 0.1 0.2 0.8 0.5 15.1 0.7 0.1 2.9 2.3 3.3 13.0 0.2 0.0 0.5 6.7 0.1 3.9 26.7 0.5 0.0 0.1 97.7 0.8 0.2 2.8 1.3 0.9 0.3 0.7 0.1 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.8 0.1 0.7 0.8 2.7 1.1 1.2 0.7 0.8 0.9 1.0 0.8 0.8 0.7 0.2 125.0 12.6 0.0 0.3 1.5 1.7 4.0 0.6 0.2 0.5 0.3 3550.1 5.7 7.9 3.7 2.1 59.0 0.1 1.6 27.4 11.8 0.7 66.4 6.7 39.8 330.7 0.4 0.0 13.0 5.1 52.7 0.5 98.8 0.0 0.8 0.7 0.7 4.9 0.0 0.0 1.7 2.0 0.0 1.4 5.8 22.4 2.6 5.4 0.0 0.1 1.2 0.0 0.0 0.0 6.5 0.3 177.6 0.1 0.8 0.5 1.3 2.8 0.1 0.0 241.8 36.0 2.1 1.0 0.1 0.9 31.1 2.8 1.3 2.0 6.8 NISCH "I-1, IRAS, KIAA0975" ENSG00000010322 Nischarin Q9Y2I1 3 52455118-52493068 "FDA approved drug targets, Predicted intracellular proteins" Apoptosis Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Enteroendocrine cells: 169.3;Peritubular cells: 246.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023189 Approved Approved "Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol" Yes NA "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Nucleoplasm, Cytosol" "Vesicles, Microtubules, Cytokinetic bridge" "HPA023189: AB_1854495" "unprognostic (6.66e-2)" "unprognostic (1.58e-1)" "unprognostic (1.59e-3)" "unprognostic (4.11e-3)" "unprognostic (1.64e-1)" "unprognostic (8.08e-3)" "unprognostic (1.60e-2)" "unprognostic (6.56e-3)" "unprognostic (4.96e-2)" "unprognostic (8.33e-3)" "prognostic favorable (1.91e-4)" "unprognostic (1.40e-2)" "unprognostic (5.10e-2)" "unprognostic (1.19e-1)" "unprognostic (2.94e-2)" "unprognostic (1.47e-1)" "unprognostic (7.05e-3)" 55.2 69.8 46.5 28.7 55.5 38.7 60.5 78.2 56.6 105.8 22.2 68.5 24.3 76.2 34.0 51.3 72.0 29.9 48.5 56.3 38.7 54.6 45.6 56.2 32.5 20.9 32.6 93.0 54.1 32.5 181.8 39.1 32.9 107.5 20.6 19.0 53.6 51.6 36.3 80.7 55.3 33.0 9.1 54.1 52.7 84.5 35.2 30.1 60.8 16.3 23.3 78.1 71.6 35.2 15.6 16.0 48.8 40.1 35.7 39.2 40.0 32.8 21.5 25.7 26.0 24.2 22.8 21.7 9.0 45.6 21.0 20.4 26.1 35.7 15.1 22.3 28.2 39.2 65.2 23.9 32.4 23.2 33.6 61.9 28.2 27.7 23.5 54.0 42.0 42.4 21.1 23.4 24.3 22.2 41.8 51.2 30.1 19.8 27.1 24.5 13.4 25.4 29.2 30.6 20.6 35.9 35.6 9.3 23.1 42.3 28.9 38.5 46.3 36.0 34.1 36.9 24.1 38.7 23.8 27.3 24.7 37.3 22.4 5.2 4.5 3.5 3.0 4.0 3.1 2.5 2.6 4.0 2.3 2.8 3.1 3.3 1.5 3.2 0.6 3.4 3.0 3.6 46.5 55.5 78.2 56.6 56.3 38.7 20.9 32.6 32.9 9.1 35.2 35.2 26.1 25.6 32.3 34.0 14.9 27.5 14.6 23.3 40.5 40.9 29.2 37.1 20.4 8.6 19.1 14.7 8.4 32.4 24.2 20.5 9.8 12.1 10.3 14.5 26.7 22.1 169.3 4.6 64.9 9.4 14.0 23.4 23.4 18.9 25.3 40.2 46.1 15.3 30.5 28.6 44.0 19.1 22.4 50.5 14.5 25.9 88.3 24.3 19.6 15.0 13.0 12.1 17.5 21.1 26.1 10.0 14.2 246.0 12.4 12.6 16.5 15.6 15.2 22.4 26.3 17.2 24.8 31.2 18.0 16.7 22.3 24.2 18.4 47.6 15.7 11.7 STAB1 "CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1" ENSG00000010327 "Stabilin 1" Q9NY15 3 52495338-52524495 "Predicted membrane proteins, Transporters" "Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 439.5" "Cell type enriched" "Detected in many" 4 "Hepatic stellate cells: 745.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 59 "classical monocyte: 9.4;intermediate monocyte: 5.7;myeloid DC: 2.5" "Group enriched" "Detected in many" 60 "dendritic cells: 2.5;monocytes: 9.4" "Group enriched" "Detected in some" 46 "HUVEC TERT2: 103.1;NB-4: 146.9;TIME: 128.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005434 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 96000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 4: Macrophages - Innate immune response" Cytosol "Nucleoplasm, Plasma membrane" "HPA005434: AB_1080097" "unprognostic (1.18e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (7.59e-4)" "unprognostic (3.63e-2)" "unprognostic (1.21e-1)" "unprognostic (1.49e-2)" "unprognostic (1.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.38e-1)" "unprognostic (4.00e-3)" "unprognostic (2.66e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (3.88e-7)" "unprognostic (3.16e-2)" "unprognostic (9.40e-2)" "unprognostic (4.70e-2)" "unprognostic (1.08e-1)" 194.2 160.4 41.0 50.4 42.9 13.8 84.5 41.4 58.3 54.4 62.8 87.7 29.6 45.3 8.5 29.2 79.3 25.8 74.6 41.9 44.4 85.6 102.1 104.7 12.9 50.0 48.4 32.2 32.2 5.0 52.0 55.4 53.7 57.6 31.0 0.6 45.7 16.0 25.9 24.0 95.1 33.8 43.0 439.5 53.2 21.0 65.3 6.8 55.1 4.6 8.2 105.7 48.6 47.8 0.1 0.0 0.1 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.7 0.2 0.2 0.6 0.0 0.0 1.8 0.1 0.0 0.1 0.0 103.1 0.1 0.3 0.1 0.0 0.0 0.0 146.9 0.0 0.2 0.2 0.1 0.1 0.3 0.0 0.0 0.4 0.4 0.0 0.3 0.0 0.1 0.0 0.0 128.8 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.0 9.4 0.0 0.0 5.7 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 41.0 42.9 41.4 58.3 41.9 44.4 50.0 48.4 53.7 43.0 65.3 47.8 31.3 0.0 3.8 0.0 5.5 6.0 0.6 0.0 1.8 1.0 1.5 2.7 2.4 11.5 0.0 3.7 0.0 1.7 1.9 0.0 0.0 0.0 0.5 0.4 0.5 43.0 1.2 21.5 0.3 0.0 2.0 3.3 0.5 0.3 18.3 0.0 745.0 19.7 130.7 0.0 0.3 0.0 0.0 185.4 30.3 2.9 4.4 147.0 12.4 30.0 21.9 0.5 2.1 0.5 0.1 0.0 0.0 20.3 2.0 0.2 0.0 0.8 0.0 0.1 19.7 2.0 1.4 0.9 2.2 1.5 4.8 2.2 2.3 0.5 0.0 0.2 NT5DC2 FLJ12442 ENSG00000168268 "5'-nucleotidase domain containing 2" Q9H857 3 52524385-52535054 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 69.2;Peritubular cells: 135.4;Sertoli cells: 111.7;Smooth muscle cells: 83.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050683 Approved NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 48: Smooth muscle cells - ECM organization" "HPA050683: AB_2681215" "unprognostic (1.40e-1)" "unprognostic (1.43e-1)" "unprognostic (1.92e-1)" "unprognostic (2.99e-2)" "unprognostic (7.82e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.16e-4)" "unprognostic (6.14e-2)" "unprognostic (1.35e-1)" "unprognostic (5.15e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (2.99e-3)" "unprognostic (1.44e-1)" "unprognostic (2.30e-1)" "unprognostic (1.50e-1)" "unprognostic (2.07e-2)" 30.3 73.2 26.0 18.6 25.2 15.5 27.9 38.6 29.8 48.0 43.2 18.3 13.7 36.3 27.5 69.4 29.5 12.1 117.5 26.0 30.2 30.6 7.8 33.6 16.3 41.8 46.6 45.3 15.6 16.5 50.8 32.7 64.0 74.9 12.7 8.5 43.5 39.3 10.3 49.0 16.2 20.8 26.8 18.6 16.4 49.7 27.6 9.9 26.3 10.9 22.9 40.7 38.7 25.9 138.8 73.7 238.9 128.4 186.2 252.3 188.3 139.6 121.2 95.4 78.0 216.5 66.8 174.4 15.1 177.9 76.0 47.3 194.9 179.8 90.0 71.0 123.8 104.1 122.1 337.4 274.9 0.1 88.8 333.0 40.9 162.9 49.4 175.4 203.0 125.2 194.9 57.5 112.0 145.5 72.7 179.2 318.1 125.6 234.6 104.6 100.3 168.8 52.7 35.5 111.1 323.3 54.7 101.2 71.8 178.6 96.0 98.5 95.1 123.7 153.8 123.8 298.9 25.9 47.3 129.4 369.4 0.7 152.1 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.1 0.0 1.1 0.0 0.1 26.0 25.2 38.6 29.8 26.0 30.2 41.8 46.6 64.0 26.8 27.6 25.9 20.9 9.6 11.5 2.6 12.9 7.8 26.6 15.2 30.1 18.4 54.6 69.2 14.0 5.7 13.0 12.9 0.0 3.4 3.3 3.1 17.6 10.1 6.9 5.3 20.0 12.6 12.6 8.0 0.9 2.3 24.8 24.8 8.6 10.8 18.4 36.4 11.0 1.2 10.4 1.7 1.2 6.0 10.2 10.1 8.8 19.7 49.7 7.8 16.0 1.9 2.8 36.6 1.0 5.0 1.5 7.0 0.6 135.4 21.4 23.4 0.6 9.3 2.7 4.7 111.7 18.6 83.4 6.2 37.9 23.5 13.8 2.3 2.8 15.8 7.2 12.7 SMIM4 C3orf78 ENSG00000168273 "Small integral membrane protein 4" Q8WVI0 3 52534013-52579237 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 121.9;skeletal muscle: 130.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 252.4;Distal tubular cells: 213.2;Proximal tubular cells: 215.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047771 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Mitochondria" "HPA047771: AB_2680150" "unprognostic (3.76e-3)" "unprognostic (3.19e-2)" "unprognostic (4.54e-2)" "unprognostic (4.89e-1)" "unprognostic (2.40e-1)" "unprognostic (1.48e-2)" "unprognostic (9.89e-2)" "prognostic favorable (1.78e-5)" "unprognostic (3.25e-2)" "unprognostic (4.25e-2)" "prognostic favorable (5.00e-4)" "unprognostic (6.35e-2)" "prognostic favorable (1.63e-4)" "unprognostic (8.72e-3)" "unprognostic (2.28e-1)" "unprognostic (1.67e-1)" "unprognostic (1.09e-2)" 22.6 121.9 14.6 12.9 15.3 7.4 22.1 21.8 20.5 16.0 20.5 19.1 12.3 14.3 10.4 16.3 14.5 3.7 100.3 15.3 15.5 37.3 20.2 20.3 10.5 15.6 18.2 41.5 25.7 31.6 56.4 6.1 16.9 26.2 10.4 13.9 28.9 13.6 130.3 20.1 15.0 5.0 15.0 15.8 20.4 17.3 15.4 6.6 48.6 50.2 8.7 20.2 13.3 18.0 58.7 19.0 22.9 58.5 26.5 13.7 47.0 25.9 12.0 29.2 25.3 24.6 15.4 25.1 11.6 10.9 29.4 30.2 7.6 20.9 11.8 16.9 60.1 23.6 58.2 50.2 40.1 28.4 31.6 29.6 12.7 24.6 17.7 15.8 26.8 27.0 31.9 36.4 19.9 25.4 26.4 39.4 39.1 31.9 42.4 18.1 22.2 50.1 17.0 25.2 24.9 31.4 50.6 16.5 52.6 12.9 17.0 23.6 24.0 16.0 53.1 76.4 53.5 42.3 50.6 57.3 87.9 52.2 22.5 8.1 44.1 17.3 19.1 35.8 18.8 24.6 27.3 23.9 49.7 22.7 29.1 27.0 1.6 22.5 15.2 26.5 29.6 20.0 14.6 15.3 21.8 20.5 15.3 15.5 15.6 18.2 16.9 15.0 15.4 18.0 35.4 48.1 46.3 1.3 30.3 27.1 37.3 52.2 41.5 17.6 80.9 84.1 252.4 60.1 63.1 53.3 12.5 42.9 26.6 58.3 213.2 52.9 21.9 71.9 30.6 32.8 79.3 22.1 1.9 86.1 24.7 36.0 34.1 48.9 59.5 16.9 55.6 160.4 116.4 3.3 2.1 62.9 30.5 80.8 46.7 15.1 65.0 51.1 37.4 0.0 28.5 102.8 15.5 2.5 3.2 57.8 39.9 101.2 19.7 19.7 89.5 215.6 52.1 15.3 46.0 22.8 56.8 9.8 14.2 34.8 34.5 27.6 25.8 44.3 73.5 23.6 PBRM1 "BAF180, PB1" ENSG00000163939 "Polybromo 1" Q86U86 3 52545352-52685917 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015629, HPA059373" Uncertain Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA015629: AB_1855012, HPA059373: AB_2683994" "unprognostic (1.87e-1)" "unprognostic (1.73e-1)" "unprognostic (1.91e-2)" "unprognostic (2.00e-1)" "unprognostic (6.15e-2)" "unprognostic (1.34e-2)" "unprognostic (1.02e-2)" "unprognostic (9.54e-2)" "unprognostic (1.87e-2)" "unprognostic (1.43e-1)" "unprognostic (1.99e-2)" "unprognostic (4.32e-2)" "unprognostic (2.89e-3)" "unprognostic (3.06e-1)" "unprognostic (1.96e-1)" "unprognostic (1.53e-2)" "unprognostic (1.06e-1)" 21.4 12.9 6.4 20.8 11.0 24.6 16.6 18.5 8.9 21.1 13.2 17.9 15.4 22.1 16.4 22.5 19.4 16.9 18.5 6.0 11.9 11.2 18.2 17.6 22.1 10.7 9.9 29.4 12.0 14.3 8.7 20.9 11.8 18.6 18.5 20.2 13.1 17.4 15.5 17.3 14.2 25.4 8.6 18.9 16.0 14.1 10.3 42.0 26.7 22.8 22.0 20.0 12.0 19.8 32.5 20.5 71.9 35.4 34.7 35.0 50.4 44.5 29.9 49.5 43.0 23.3 21.5 78.7 6.2 51.8 40.8 21.8 63.1 33.1 59.6 85.5 34.6 74.6 38.1 18.1 49.6 62.7 54.6 33.2 37.3 55.4 35.4 38.9 48.4 60.6 43.7 41.7 50.3 11.0 103.9 18.8 43.8 22.0 34.4 53.8 45.1 40.1 20.4 62.5 48.7 53.8 52.7 12.4 41.6 43.4 23.4 35.7 56.5 46.1 34.8 40.1 54.4 30.0 51.3 73.6 28.5 49.8 46.9 9.0 4.0 9.9 3.6 2.6 3.8 2.9 3.6 4.0 4.0 5.3 5.7 3.6 2.3 3.6 8.0 8.7 3.9 1.6 6.4 11.0 18.5 8.9 6.0 11.9 10.7 9.9 11.8 8.6 10.3 19.8 49.1 41.7 61.3 95.3 44.0 40.5 35.8 28.3 43.9 45.6 40.7 30.4 61.7 30.0 39.8 23.9 47.9 36.0 67.7 36.8 19.6 37.7 39.1 61.4 54.5 47.7 35.2 82.9 76.4 46.2 36.9 39.8 42.8 46.8 29.1 61.9 33.5 47.9 53.0 30.3 84.5 35.3 28.5 61.7 47.7 17.1 34.2 65.6 48.0 80.6 67.6 29.1 49.4 87.9 135.5 49.7 29.2 58.3 76.9 37.5 18.7 18.4 58.2 44.3 26.3 54.3 69.2 48.6 35.8 43.7 51.6 50.9 50.4 45.8 39.8 37.0 GNL3 "C77032, E2IG3, MGC800, NS" ENSG00000163938 "G protein nucleolar 3" Q9BVP2 3 52681156-52694497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020770, HPA036742, HPA036743" Enhanced Enhanced "Nucleoli rim,Nuclear bodies,Mitotic chromosome" Yes No 13000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli rim" "Nuclear bodies, Mitotic chromosome" "CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283" "unprognostic (4.40e-1)" "unprognostic (9.30e-2)" "unprognostic (4.10e-3)" "unprognostic (2.21e-1)" "unprognostic (5.11e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.46e-1)" "unprognostic (3.29e-3)" "unprognostic (1.14e-2)" "unprognostic (1.67e-3)" "prognostic unfavorable (6.11e-4)" "prognostic unfavorable (5.69e-5)" "unprognostic (1.33e-1)" "unprognostic (9.25e-2)" "unprognostic (1.03e-3)" "unprognostic (1.06e-2)" 47.2 47.1 17.1 42.1 17.0 27.4 68.8 18.4 24.4 38.8 18.7 40.0 38.8 33.8 25.6 65.0 28.2 28.0 29.6 17.9 19.4 33.4 50.3 29.7 51.5 17.9 17.7 35.8 60.7 27.1 35.9 36.4 17.8 46.7 46.0 16.0 46.4 26.3 78.2 39.1 29.6 32.2 16.9 34.0 41.0 26.8 17.9 35.9 28.6 42.9 64.9 92.3 41.3 19.1 110.4 79.1 114.4 125.3 105.6 105.1 178.1 133.0 101.5 135.4 100.6 121.3 80.8 255.4 42.2 100.1 104.6 78.2 189.1 125.1 180.5 156.3 134.6 196.8 139.0 189.3 218.1 283.7 138.0 96.1 216.5 147.8 224.1 90.3 107.8 99.7 214.8 136.2 93.8 77.7 170.6 162.1 195.6 153.4 151.2 99.3 93.0 315.0 108.9 153.9 81.4 105.6 82.1 190.5 193.6 101.7 74.7 155.8 86.6 92.8 100.0 139.2 281.7 147.6 252.0 387.0 96.9 203.5 148.4 1.2 15.2 3.3 19.9 16.7 34.1 28.7 26.8 24.1 26.1 23.9 30.4 29.4 1.8 26.1 12.9 40.7 18.8 20.2 17.1 17.0 18.4 24.4 17.9 19.4 17.9 17.7 17.8 16.9 17.9 19.1 34.6 22.4 48.2 5.2 84.3 163.7 146.0 111.9 77.4 19.0 72.6 46.4 51.3 25.8 144.9 12.9 10.4 73.2 78.5 42.8 41.1 105.1 54.4 44.7 76.5 53.4 47.8 51.5 11.6 104.6 117.5 92.9 47.9 53.0 63.1 47.5 23.2 41.9 40.9 21.9 11.1 71.7 67.1 24.2 77.6 28.2 51.9 43.0 78.2 5.6 59.5 17.7 38.1 7.1 9.4 99.9 34.4 34.3 122.3 126.1 19.1 47.2 56.5 14.8 6.6 106.2 79.1 37.9 74.4 59.4 153.7 90.3 63.0 74.5 85.8 135.7 GLT8D1 "AD-017, FLJ14611" ENSG00000016864 "Glycosyltransferase 8 domain containing 1" Q68CQ7 3 52694486-52706032 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 149.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010588 Approved Approved Mitochondria NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 23: Testis - Cell cycle regulation" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria "HPA010588: AB_1078098" "unprognostic (1.37e-1)" "unprognostic (2.96e-1)" "unprognostic (1.38e-2)" "prognostic favorable (2.76e-4)" "unprognostic (3.17e-2)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (1.82e-3)" "unprognostic (7.12e-2)" "unprognostic (9.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.07e-1)" "unprognostic (5.82e-3)" "unprognostic (2.42e-3)" "unprognostic (3.97e-1)" "unprognostic (3.34e-2)" "unprognostic (6.21e-2)" 33.1 39.8 25.4 22.5 26.6 9.3 35.6 25.2 29.3 47.5 35.6 27.7 25.9 35.0 41.3 18.3 54.4 29.8 32.6 26.2 26.7 40.4 69.5 29.6 25.3 24.0 26.9 53.8 35.7 46.0 64.8 48.2 25.5 30.5 32.3 32.2 29.9 32.7 20.8 22.6 23.4 32.2 25.9 24.6 28.9 64.5 26.4 29.2 64.0 24.6 26.8 31.6 28.6 28.6 28.7 33.2 65.7 52.0 142.6 179.8 36.8 70.3 107.8 60.6 69.1 15.5 52.6 24.0 19.7 122.7 73.3 31.9 42.1 72.0 79.5 43.5 30.6 22.8 61.4 71.7 68.3 34.0 68.5 104.1 62.9 52.1 66.8 139.8 91.3 40.6 29.4 53.6 80.6 29.2 23.4 51.8 33.8 49.8 61.5 17.4 37.3 81.9 71.3 30.8 26.9 46.5 58.6 27.9 48.9 61.2 47.7 44.2 67.1 43.7 33.9 63.9 39.6 60.2 73.7 26.4 76.0 53.2 56.2 38.4 13.0 21.8 19.1 8.5 18.3 14.1 22.2 20.0 11.8 9.8 22.3 15.6 6.9 30.3 9.3 23.1 16.8 10.9 25.4 26.6 25.2 29.3 26.2 26.7 24.0 26.9 25.5 25.9 26.4 28.6 25.8 0.0 9.6 16.0 16.0 12.1 16.1 40.3 13.6 41.5 18.1 19.7 15.3 17.2 23.8 18.4 12.5 58.4 26.5 9.4 23.5 34.4 71.4 38.5 38.4 22.7 18.6 8.6 17.9 27.1 63.5 59.2 14.8 15.2 5.7 35.6 34.2 38.2 26.9 21.9 16.8 21.1 30.5 13.6 12.0 23.0 53.7 12.3 24.9 8.4 26.5 37.0 34.0 15.6 14.6 23.3 16.9 48.5 39.1 14.7 22.8 21.5 44.4 21.3 26.3 31.6 25.2 149.5 50.0 10.3 8.0 26.1 21.4 74.2 17.3 10.0 SPCS1 "HSPC033, SPC1, SPC12, YJR010C-A" ENSG00000114902 "Signal peptidase complex subunit 1" Q9Y6A9 3 52704955-52711148 "Metabolic proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1177.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046091, HPA055273" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 16: U-266 - Nucleosome" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA046091: AB_10959614, HPA055273: AB_2682768" "unprognostic (5.47e-2)" "unprognostic (4.04e-1)" "prognostic favorable (9.28e-4)" "unprognostic (5.93e-2)" "unprognostic (6.88e-2)" "unprognostic (1.10e-2)" "unprognostic (3.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (5.56e-2)" "unprognostic (3.89e-1)" "unprognostic (1.15e-1)" "prognostic favorable (2.90e-4)" "unprognostic (5.96e-2)" "unprognostic (1.80e-1)" "unprognostic (3.58e-1)" "unprognostic (3.09e-2)" 95.3 154.7 75.1 64.1 76.6 61.3 100.5 80.7 101.1 97.4 88.7 110.1 94.8 101.0 110.8 117.0 92.1 48.4 119.7 75.4 83.9 137.3 172.8 87.8 71.2 82.3 80.5 91.1 231.2 89.5 141.1 59.4 82.1 96.3 84.7 124.6 145.2 79.1 142.2 109.0 103.9 53.0 81.7 105.6 151.1 153.2 81.4 66.6 113.2 49.7 87.1 103.0 94.7 84.9 114.6 102.2 113.4 139.3 164.9 134.4 157.2 157.6 144.5 139.4 128.4 108.1 171.0 114.6 65.7 145.4 142.5 110.2 109.9 142.5 149.1 154.3 115.8 138.6 169.2 164.6 175.1 213.3 229.1 104.7 190.5 148.5 174.4 130.5 117.4 147.5 118.8 418.0 151.8 105.5 168.8 207.2 195.8 317.2 203.9 67.9 95.7 608.6 232.7 148.3 73.6 157.4 148.7 178.1 224.2 102.4 188.1 248.1 106.2 127.3 119.1 226.3 192.1 406.2 654.1 169.8 196.5 209.4 169.8 292.7 129.9 258.2 131.1 137.0 155.1 202.0 158.5 144.2 143.9 149.3 146.8 152.1 100.1 119.6 152.5 620.5 177.1 253.8 75.1 76.6 80.7 101.1 75.4 83.9 82.3 80.5 82.1 81.7 81.4 84.9 172.5 64.1 104.2 23.8 282.3 156.5 227.9 470.7 136.1 465.4 289.0 351.0 148.7 221.6 283.6 310.8 118.9 373.5 488.1 195.2 361.9 353.8 597.8 286.4 180.8 157.6 167.7 143.9 27.1 339.4 399.8 181.9 119.8 181.5 211.6 138.7 131.4 301.8 311.0 102.6 34.4 291.3 325.5 202.9 189.9 1177.6 216.3 192.5 380.6 13.1 321.9 296.9 213.1 21.1 53.2 274.8 274.1 191.8 888.8 295.0 405.5 665.1 374.1 251.3 164.3 152.6 335.5 746.4 504.5 195.8 184.4 351.2 220.8 283.6 267.7 285.3 NEK4 "NRK2, pp12301, STK2" ENSG00000114904 "NIMA related kinase 4" P51957 3 52708444-52770946 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 46.0" "Cell type enhanced" "Detected in all" "Spermatocytes: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015750, HPA058543" Enhanced Supported Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "HPA015750: AB_1854367, HPA058543: AB_2732623" "unprognostic (1.32e-1)" "unprognostic (1.57e-1)" "prognostic favorable (2.69e-5)" "unprognostic (9.65e-3)" "unprognostic (3.42e-1)" "unprognostic (6.64e-2)" "unprognostic (8.75e-3)" "unprognostic (2.27e-1)" "unprognostic (7.85e-2)" "unprognostic (5.52e-2)" "unprognostic (1.46e-1)" "unprognostic (1.32e-1)" "unprognostic (3.74e-3)" "unprognostic (5.11e-2)" "unprognostic (2.85e-1)" "unprognostic (1.51e-2)" "unprognostic (8.39e-2)" 6.3 8.2 6.1 7.4 6.7 7.0 9.4 9.1 7.4 8.5 8.6 7.3 6.5 8.7 8.9 6.7 13.6 6.2 6.1 5.9 7.8 9.7 10.8 6.7 8.3 6.8 8.9 13.3 8.1 11.5 7.3 7.6 6.3 7.7 8.2 16.9 7.3 9.0 8.0 3.5 5.6 8.1 6.9 7.2 9.6 46.0 7.8 9.5 13.5 6.1 9.4 7.9 4.9 5.9 19.9 15.2 20.5 16.2 18.2 13.1 22.1 13.9 18.6 25.3 25.4 13.5 14.4 20.4 6.4 13.6 27.9 9.2 25.2 16.3 33.8 20.4 10.6 16.0 18.4 17.3 11.4 39.4 15.4 8.1 14.8 32.5 21.5 13.5 9.6 17.4 20.2 16.1 16.1 17.1 21.4 14.4 17.7 20.9 14.9 18.5 17.8 15.1 14.3 28.3 15.0 9.0 29.1 17.7 14.1 15.7 16.5 23.4 8.9 16.9 17.1 27.3 26.0 17.8 27.9 19.7 19.3 18.2 18.7 13.6 9.8 5.0 3.5 6.1 3.7 2.8 3.0 3.6 5.2 3.5 3.6 3.1 1.4 4.0 4.2 2.6 2.6 5.2 6.1 6.7 9.1 7.4 5.9 7.8 6.8 8.9 6.3 6.9 7.8 5.9 6.2 12.8 8.2 19.2 11.8 4.1 5.3 3.4 4.6 14.1 10.6 6.2 4.6 2.8 11.6 5.5 12.5 7.0 4.8 6.5 9.8 7.0 20.7 24.0 10.6 7.3 4.8 13.3 30.5 9.6 8.1 7.8 12.8 9.9 7.6 14.0 6.8 14.5 8.2 6.7 29.4 9.3 6.1 16.8 4.6 19.5 14.6 10.4 1.8 7.5 14.0 19.4 10.3 16.6 19.3 8.5 2.9 12.4 10.6 5.3 5.4 17.1 22.4 18.9 6.6 12.6 7.3 75.9 27.9 6.9 4.1 6.7 5.8 11.8 9.1 5.2 ITIH1 "H1P, IATIH, ITIH" ENSG00000055957 "Inter-alpha-trypsin inhibitor heavy chain 1" P19827 3 52777595-52792068 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 782 "liver: 1504.9" "Cell type enriched" "Detected in some" 34 "Hepatocytes: 1087.0" "Cancer enriched" "Detected in some" 598 "liver cancer: 329.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 5.3;Hep G2: 1.7;HL-60: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041639, HPA042049" Approved Approved Vesicles "Secreted to blood" NA NA 4490000 59000000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 62: Liver - Hemostasis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 15: Hepatocytes - Hemostasis" Vesicles "HPA041639: AB_10796349, HPA042049: AB_10797379" "unprognostic (1.87e-4)" "unprognostic (1.31e-3)" "unprognostic (2.38e-1)" "unprognostic (8.55e-2)" "unprognostic (1.03e-1)" "unprognostic (2.64e-3)" "prognostic favorable (1.89e-5)" "unprognostic (2.27e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (2.91e-2)" "unprognostic (8.45e-2)" "unprognostic (4.53e-4)" "unprognostic (4.02e-3)" "unprognostic (5.70e-3)" "unprognostic (2.08e-1)" "unprognostic (2.24e-2)" 0.8 0.3 0.0 0.5 0.0 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.2 1504.9 0.1 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.0 1.9 0.4 0.4 0.0 0.4 0.0 0.1 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.1 0.0 29.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.5 1087.0 0.1 0.0 0.0 0.0 0.0 20.2 0.0 1.7 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 1.4 0.0 0.0 0.1 ITIH3 H3P ENSG00000162267 "Inter-alpha-trypsin inhibitor heavy chain 3" Q06033 3 52794768-52809009 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 97 "liver: 792.7" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 1183.8" "Cancer enriched" "Detected in some" 247 "liver cancer: 273.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 24 "Hep G2: 17.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA017373 Approved "Secreted to blood" NA NA 9100000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" "HPA017373: AB_1851954" "unprognostic (2.07e-2)" "unprognostic (5.79e-2)" "unprognostic (1.89e-1)" "unprognostic (3.30e-4)" "unprognostic (4.28e-2)" "unprognostic (3.26e-2)" "unprognostic (5.97e-2)" "unprognostic (6.07e-2)" "unprognostic (1.49e-1)" "unprognostic (7.05e-2)" "unprognostic (1.04e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (4.49e-8)" "unprognostic (2.09e-4)" "unprognostic (1.70e-1)" "unprognostic (2.55e-2)" "unprognostic (9.31e-2)" 5.0 0.7 0.5 0.9 0.7 0.0 2.1 0.5 0.8 5.3 0.4 1.1 0.3 3.5 1.7 1.3 3.4 1.2 0.7 0.5 0.4 0.7 792.7 3.0 2.5 0.4 0.4 2.8 0.3 0.1 0.3 1.7 0.5 1.1 1.0 0.1 0.4 2.4 0.6 1.3 1.2 1.2 0.4 8.1 1.2 3.5 0.4 0.2 1.2 0.4 1.7 1.4 2.3 0.5 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.5 0.8 0.5 0.4 0.4 0.4 0.5 0.4 0.4 0.5 0.1 0.0 0.0 0.0 21.6 0.1 0.0 0.0 0.0 0.5 0.1 1.4 0.8 78.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.1 0.1 3.5 0.0 90.9 0.0 0.0 0.1 2.1 0.0 0.0 0.0 12.3 66.4 1183.8 0.0 0.0 0.0 0.0 0.0 85.1 0.3 132.0 1.2 0.1 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 9.1 0.4 0.3 0.0 0.1 0.3 3.6 19.2 0.0 0.1 ITIH4 "H4P, IHRP, ITIHL1" ENSG00000055955 "Inter-alpha-trypsin inhibitor heavy chain 4" Q14624 3 52812962-52830688 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 38 "liver: 1863.4" "Group enriched" "Detected in many" 5 "Early spermatids: 119.2;Hepatocytes: 134.6;Late spermatids: 126.5" "Cancer enriched" "Detected in single" 27 "liver cancer: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.4;JURKAT: 2.0;U-266/70: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001835, HPA003948, CAB072872" Enhanced Approved Vesicles "Secreted to blood" NA NA 3060000 58000000000 "Cluster 15: NK-cells - Transcription" "Cluster 62: Liver - Hemostasis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 15: Hepatocytes - Hemostasis" Vesicles "CAB072872: AB_2665724, HPA001835: AB_1079432, HPA003948: AB_1079433" "unprognostic (6.08e-2)" "unprognostic (4.45e-2)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "unprognostic (2.64e-1)" "unprognostic (1.96e-1)" "unprognostic (5.86e-2)" "unprognostic (1.98e-2)" "unprognostic (5.64e-2)" "unprognostic (1.02e-1)" "unprognostic (2.47e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-14)" "unprognostic (1.71e-3)" "unprognostic (2.96e-2)" "unprognostic (1.52e-1)" "unprognostic (4.21e-5)" 4.2 18.5 4.1 1.2 4.2 10.0 3.0 3.7 5.0 4.2 3.5 3.6 1.0 2.9 1.7 1.4 3.8 1.1 3.2 3.9 3.6 5.4 1863.4 4.9 1.7 3.9 3.8 2.4 48.9 0.1 4.3 0.7 3.9 4.0 1.0 3.3 2.1 1.8 40.3 2.5 3.4 1.5 3.6 7.4 3.9 1.8 3.8 2.2 5.2 2.8 1.2 5.3 3.3 3.9 0.0 0.1 0.4 0.9 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.2 0.1 0.4 0.0 0.0 0.2 2.4 0.1 1.0 0.0 1.2 0.4 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.0 0.3 0.8 0.0 0.1 0.2 0.3 0.4 0.1 0.0 0.8 0.3 0.0 0.2 0.3 0.0 0.4 0.3 0.0 0.1 0.4 0.5 0.3 0.1 0.0 0.4 0.4 0.0 3.0 1.4 0.2 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.0 4.1 4.2 3.7 5.0 3.9 3.6 3.9 3.8 3.9 3.6 3.8 3.9 0.7 0.0 1.1 22.5 0.9 0.8 0.3 0.3 0.0 10.0 0.6 1.3 1.1 2.8 0.8 0.0 12.5 0.0 0.4 0.1 0.0 0.3 119.2 0.7 0.7 0.8 0.0 8.4 11.6 2.6 0.0 0.6 1.1 0.4 0.0 2.7 2.5 134.6 0.5 5.0 8.6 0.2 0.0 2.2 1.0 126.5 1.2 1.3 0.0 5.6 1.9 2.3 2.1 3.0 3.1 2.3 0.5 1.9 0.7 0.2 0.0 0.3 0.3 6.0 6.6 6.2 2.4 1.3 1.5 0.0 0.3 0.3 1.2 3.2 0.1 0.1 MUSTN1 Mustang ENSG00000272573 "Musculoskeletal, embryonic nuclear protein 1" Q8IVN3 3 52833114-52835019 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 1689.2" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 1.3;Skeletal myocytes: 1.0;Smooth muscle cells: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.7;Hep G2: 8.0;HSkMC: 4.8;RH-30: 4.4" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 80: Striated muscle - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 48: Smooth muscle cells - ECM organization" "unprognostic (2.79e-2)" "unprognostic (3.73e-2)" "unprognostic (4.11e-1)" "unprognostic (2.60e-2)" "unprognostic (2.34e-2)" "unprognostic (6.21e-3)" "unprognostic (2.78e-1)" "unprognostic (1.13e-2)" "unprognostic (1.66e-2)" "unprognostic (1.04e-1)" "unprognostic (1.65e-3)" "unprognostic (6.00e-2)" "unprognostic (1.79e-1)" "unprognostic (8.11e-2)" "unprognostic (1.88e-2)" 86.1 10.1 107.0 9.3 118.7 6.5 46.4 106.9 177.9 89.1 105.7 27.2 8.4 44.6 49.0 44.9 52.1 42.5 142.5 104.2 105.8 17.5 12.5 31.0 5.4 107.2 107.4 37.6 6.6 1.6 12.1 4.5 110.3 43.8 21.2 0.8 26.3 59.3 1689.2 28.7 26.7 30.6 99.9 10.9 22.1 4.3 118.5 5.7 31.1 305.6 3.9 54.5 65.7 105.1 0.0 0.0 4.7 0.0 0.5 2.1 1.9 0.0 0.5 0.2 0.5 0.0 0.5 0.0 0.0 1.4 0.2 0.4 0.6 1.3 0.4 0.1 0.5 0.0 1.4 8.0 0.3 1.0 0.4 4.8 1.0 0.6 0.7 0.9 1.2 0.9 0.0 0.0 0.3 0.1 0.4 1.6 0.1 0.6 1.0 0.3 4.4 0.0 0.9 0.0 0.2 0.3 0.3 0.4 0.4 2.0 0.1 2.6 0.0 0.6 0.2 1.0 0.2 0.0 0.0 0.3 0.5 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 107.0 118.7 106.9 177.9 104.2 105.8 107.2 107.4 110.3 99.9 118.5 105.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STIMATE-MUSTN1 TMEM110-MUSTN1 ENSG00000248592 "STIMATE-MUSTN1 readthrough" 3 52833121-52897562 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "liver: 14.9;skeletal muscle: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 8.8;Karpas-707: 5.8;PC-3: 6.5" HPA051855 Uncertain Approved Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 2: Karpas-707 - Immune response" Cytosol "HPA051855: AB_2681639" "unprognostic (4.19e-2)" "unprognostic (3.85e-2)" "unprognostic (5.95e-2)" "unprognostic (7.28e-2)" "unprognostic (5.35e-2)" "unprognostic (3.11e-4)" "unprognostic (4.73e-2)" "unprognostic (2.66e-2)" "unprognostic (1.59e-2)" "unprognostic (2.51e-2)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.01e-6)" "unprognostic (5.49e-2)" "unprognostic (7.31e-2)" "unprognostic (4.55e-2)" "unprognostic (5.09e-5)" 3.6 1.7 0.9 0.5 1.4 1.4 2.6 1.4 2.0 2.9 1.6 1.3 0.0 2.1 0.3 2.1 1.2 0.1 4.4 0.9 0.4 3.1 14.9 2.3 0.1 1.5 1.2 1.6 3.2 0.0 1.4 0.0 1.6 1.4 0.1 0.1 1.6 0.0 9.9 2.0 1.7 0.1 1.9 2.4 2.0 1.4 2.0 0.2 2.1 0.6 0.1 2.5 2.7 2.3 1.8 0.5 0.0 4.0 0.3 0.0 1.1 4.1 0.6 0.1 0.1 0.0 0.5 1.8 0.8 0.0 1.3 1.7 1.0 0.7 0.0 8.8 4.4 2.1 0.0 0.0 0.1 2.8 2.7 0.0 0.2 0.1 0.7 0.0 0.1 2.4 1.6 5.8 0.0 0.6 1.9 0.9 1.4 0.1 6.5 0.8 0.0 1.3 0.0 0.0 0.4 0.7 0.9 0.5 1.9 0.2 0.3 0.9 1.1 0.4 2.2 0.8 2.3 5.0 4.2 0.8 0.9 2.9 1.3 0.0 0.0 0.3 0.0 0.4 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.9 1.4 1.4 2.0 0.9 0.4 1.5 1.2 1.6 1.9 2.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STIMATE "MGC52022, TMEM110" ENSG00000213533 "STIM activating enhancer" Q86TL2 3 52836219-52897548 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 7.3;Endometrial ciliated cells: 24.2;Extravillous trophoblasts: 6.9;Hofbauer cells: 9.7;Proximal tubular cells: 15.4;Respiratory ciliated cells: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" HPA051855 Uncertain Approved Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 32: U-937 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA051855: AB_2681639" "unprognostic (1.45e-1)" "unprognostic (7.93e-3)" "unprognostic (2.19e-1)" "unprognostic (2.49e-2)" "unprognostic (2.29e-3)" "unprognostic (3.87e-2)" "unprognostic (9.31e-2)" "unprognostic (7.55e-4)" "unprognostic (3.34e-1)" "unprognostic (6.55e-2)" "unprognostic (3.10e-1)" "unprognostic (4.04e-2)" "unprognostic (1.33e-2)" "unprognostic (1.00e-1)" "unprognostic (1.76e-1)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" 9.0 9.7 8.1 8.1 7.9 23.2 7.9 7.0 8.0 10.1 4.2 9.1 5.9 10.6 5.6 6.6 12.8 6.9 6.3 6.9 5.9 7.1 30.6 12.1 9.5 8.6 8.0 8.7 11.7 6.0 6.1 5.3 7.5 7.6 4.8 4.6 10.7 7.9 17.5 8.3 8.0 9.4 6.9 11.1 8.6 6.9 7.8 10.3 8.8 5.1 8.2 10.9 7.7 7.8 9.6 8.2 12.6 22.1 27.9 17.7 24.8 13.3 15.5 18.5 17.0 10.2 10.0 9.2 2.6 16.1 17.8 8.7 15.1 13.7 12.8 20.3 10.6 15.3 10.3 15.9 18.4 23.0 11.3 13.8 18.6 20.7 9.3 11.7 15.4 15.2 5.2 9.3 15.8 7.9 12.7 12.9 11.3 8.0 15.8 6.7 8.5 6.4 8.8 12.5 2.7 9.1 14.1 9.5 12.9 6.9 8.2 20.3 15.5 14.8 8.4 19.7 16.5 16.8 11.9 9.0 13.0 23.2 11.5 0.0 1.6 0.9 1.0 3.1 0.9 0.9 1.6 1.2 2.0 0.7 0.8 0.6 0.1 0.4 2.9 1.1 2.4 0.8 8.1 7.9 7.0 8.0 6.9 5.9 8.6 8.0 7.5 6.9 7.8 7.8 2.4 0.0 2.7 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.6 1.0 0.0 0.0 0.6 7.3 0.0 1.8 1.8 0.0 1.9 2.4 0.0 24.2 1.7 0.5 0.0 0.0 0.0 2.9 6.9 0.8 0.0 1.6 0.0 1.4 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 2.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.7 0.0 0.0 15.4 9.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.9 1.2 4.6 0.0 0.0 SFMBT1 "DKFZp434L243, RU1, SFMBT" ENSG00000163935 "Scm like with four mbt domains 1" Q9UHJ3 3 52903572-53046750 "Predicted intracellular proteins" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.6" "Cell type enhanced" "Detected in many" "Spermatocytes: 136.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036152, HPA064564" Enhanced Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA036152: AB_2674972, HPA064564: AB_2685288" "unprognostic (2.78e-2)" "unprognostic (9.96e-2)" "unprognostic (1.35e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (1.69e-1)" "unprognostic (2.71e-2)" "unprognostic (1.28e-2)" "unprognostic (9.39e-2)" "unprognostic (6.79e-2)" "unprognostic (3.55e-2)" "unprognostic (2.36e-1)" "unprognostic (2.57e-2)" "unprognostic (3.57e-3)" "unprognostic (7.15e-2)" "unprognostic (1.45e-1)" "unprognostic (2.19e-2)" "unprognostic (3.55e-2)" 3.2 2.4 2.6 5.6 3.1 6.9 5.8 5.5 3.4 3.6 3.8 7.3 4.8 2.3 5.0 6.6 5.4 3.6 7.2 3.0 3.5 6.3 7.8 4.2 7.6 3.2 3.1 1.3 9.0 11.9 5.3 4.6 3.2 3.7 7.6 6.4 7.4 2.8 13.0 5.2 5.2 3.5 2.7 3.9 6.3 45.6 2.9 5.1 5.9 8.7 8.5 5.1 3.1 3.5 25.6 6.8 10.9 19.8 2.3 1.7 22.3 5.5 5.2 16.3 20.1 14.1 21.5 13.2 6.3 3.4 17.8 2.1 11.0 7.0 19.7 23.8 6.9 11.0 14.9 6.4 3.7 17.4 10.9 1.6 10.1 11.2 7.5 1.8 3.0 14.8 3.8 18.9 5.4 8.0 11.1 7.0 5.7 9.7 7.2 9.8 10.2 7.3 2.2 27.1 12.8 8.1 23.6 9.6 11.8 1.2 6.3 16.0 1.9 7.2 16.2 12.5 17.2 9.0 34.1 27.3 6.6 7.1 12.4 1.3 1.5 9.1 2.5 0.7 3.3 6.2 3.9 2.3 0.6 5.2 3.6 4.0 2.4 2.9 0.7 0.7 1.9 1.9 2.6 3.1 5.5 3.4 3.0 3.5 3.2 3.1 3.2 2.7 2.9 3.5 2.5 9.6 9.4 42.7 22.7 11.6 8.6 5.1 9.6 15.4 11.7 6.2 17.0 10.0 6.0 1.8 45.9 10.0 7.3 11.0 7.9 8.2 56.2 5.1 3.5 4.1 6.0 16.0 37.1 13.4 8.7 6.2 10.7 5.1 8.9 8.2 3.6 16.8 6.5 8.4 47.3 8.3 0.0 6.7 7.9 58.5 2.1 6.9 0.0 46.9 3.6 6.2 17.5 60.3 41.8 9.4 6.9 7.5 11.5 9.1 6.0 7.6 11.1 23.2 6.6 5.2 4.2 136.6 27.0 9.8 8.7 5.3 14.4 8.4 12.2 5.3 RFT1 CDG1N ENSG00000163933 "RFT1 homolog" Q96AA3 3 53088483-53130453 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 39.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060327, HPA069022" Approved Approved Vesicles NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "HPA060327: AB_2684253, HPA069022: AB_2732126" "unprognostic (5.74e-2)" "unprognostic (1.31e-1)" "unprognostic (1.35e-3)" "unprognostic (5.16e-3)" "unprognostic (2.08e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (1.09e-1)" "unprognostic (1.22e-1)" "unprognostic (2.70e-1)" "unprognostic (2.81e-2)" "unprognostic (9.26e-2)" "unprognostic (6.48e-2)" "unprognostic (1.96e-1)" "unprognostic (1.22e-1)" "unprognostic (5.06e-2)" "unprognostic (3.54e-2)" 11.8 12.5 5.7 14.5 6.2 8.3 12.5 5.5 6.6 9.0 4.9 11.8 10.3 9.1 13.0 12.1 12.4 10.5 9.0 6.1 5.3 8.7 14.0 9.2 16.7 5.6 5.2 12.5 22.3 15.6 6.2 13.8 5.9 9.3 13.2 4.3 18.0 10.4 5.1 9.9 10.5 11.2 5.5 9.9 10.4 13.5 5.4 14.2 14.6 6.7 15.8 12.6 8.8 8.0 39.1 36.3 24.3 39.0 27.9 29.5 50.6 34.8 32.3 59.2 53.7 35.9 74.6 51.0 21.3 33.5 55.6 40.7 55.4 56.8 51.9 48.4 24.5 50.6 24.8 36.0 48.8 46.7 28.4 31.4 46.8 79.6 57.1 26.2 37.9 52.7 27.1 45.2 39.4 39.6 44.2 27.3 48.8 67.5 47.3 18.1 23.5 77.5 32.8 26.1 13.8 18.7 43.0 30.9 31.2 26.2 23.3 65.5 25.5 54.3 35.2 37.7 69.1 28.6 37.1 38.4 38.9 58.8 58.3 50.2 40.2 18.4 22.2 40.5 22.5 21.2 20.6 22.9 42.9 35.5 23.7 23.7 13.4 23.1 29.4 48.9 20.1 25.7 5.7 6.2 5.5 6.6 6.1 5.3 5.6 5.2 5.9 5.5 5.4 8.0 6.0 3.2 3.7 8.8 8.7 5.0 10.8 18.3 5.2 4.6 7.6 5.5 7.4 11.5 12.6 9.2 4.2 39.4 6.0 5.1 1.9 17.4 1.9 5.6 9.5 8.1 2.4 17.7 9.4 21.1 33.1 9.2 4.1 5.7 2.5 17.8 10.4 10.7 22.0 5.0 8.9 6.4 10.2 9.9 5.0 2.3 8.7 9.8 7.2 9.4 11.7 5.8 3.1 7.5 11.3 12.2 8.8 6.0 19.3 9.1 5.7 5.6 8.3 6.4 0.0 7.0 8.7 10.1 8.9 8.0 4.3 24.2 7.7 22.0 11.7 8.1 PRKCD ENSG00000163932 "Protein kinase C delta" Q05655 3 53156009-53192717 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 7 "dendritic cells: 57.0;granulocytes: 52.9;monocytes: 73.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 267.7;THP-1: 194.0" "Group enriched" "Detected in all" 5 "basal ganglia: 121.4;thalamus: 334.6" "Low region specificity" "Detected in all" "HPA001863, HPA001890, CAB010469, CAB013225" Enhanced Enhanced "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA 30000 "Cluster 52: Eosinophils - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "Endoplasmic reticulum, Golgi apparatus" "CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628" "unprognostic (3.59e-1)" "unprognostic (4.85e-2)" "unprognostic (2.66e-2)" "unprognostic (1.90e-1)" "unprognostic (1.17e-1)" "unprognostic (6.97e-2)" "prognostic unfavorable (2.24e-4)" "prognostic favorable (9.01e-4)" "unprognostic (1.95e-2)" "unprognostic (1.42e-1)" "unprognostic (1.79e-1)" "unprognostic (2.89e-1)" "unprognostic (2.05e-1)" "unprognostic (1.73e-1)" "unprognostic (2.48e-2)" "unprognostic (2.06e-3)" "unprognostic (2.95e-3)" 46.1 59.7 10.4 45.4 11.1 90.3 28.9 4.4 11.7 25.9 7.3 43.5 54.8 9.1 39.1 32.7 42.3 32.8 19.6 12.8 11.0 25.6 8.8 44.3 46.8 9.9 8.5 13.6 33.2 20.7 8.2 20.5 7.5 39.3 41.5 2.2 25.9 31.9 6.8 34.0 55.7 16.2 9.5 54.2 65.1 20.8 9.0 16.3 41.8 9.2 62.1 44.2 23.2 12.3 33.5 14.4 5.2 8.7 35.9 21.6 46.2 20.4 25.7 24.5 23.7 34.4 31.9 86.5 8.3 45.6 42.9 14.5 34.1 49.8 20.6 75.2 23.6 50.1 18.3 32.0 23.6 64.8 103.4 17.1 35.8 25.6 23.2 21.8 22.4 9.3 9.7 11.8 36.1 85.0 7.0 81.0 13.0 51.5 23.0 7.6 13.6 20.6 25.5 72.8 8.3 6.5 15.4 267.7 39.6 24.0 22.6 194.0 31.5 11.7 14.4 15.4 19.2 18.1 33.6 45.9 27.6 116.4 22.6 51.8 73.7 50.1 3.6 71.3 2.2 6.2 2.1 2.5 57.0 8.2 2.2 2.0 52.9 6.9 47.7 16.3 2.6 24.1 10.4 11.1 4.4 11.7 12.8 11.0 9.9 8.5 7.5 9.5 9.0 12.3 4.3 3.2 23.5 2.0 25.7 29.2 26.3 8.0 23.9 0.3 11.8 4.3 6.4 14.3 16.1 14.7 0.0 3.1 24.7 61.8 3.9 8.9 34.5 18.5 4.4 2.7 26.5 5.2 3.4 10.7 16.0 6.7 54.0 17.8 5.7 8.9 3.3 2.3 44.8 1.7 4.2 37.1 4.1 47.4 43.0 75.6 9.0 41.5 10.6 20.6 44.9 2.0 8.2 1.0 0.5 13.2 55.4 6.8 25.8 19.7 64.5 13.1 16.5 0.2 6.6 6.5 12.1 23.1 3.7 23.9 27.8 8.8 10.0 10.4 23.0 34.6 TKT ENSG00000163931 Transketolase P29401 3 53224712-53256052 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 667.0" "Cell type enhanced" "Detected in all" "Kupffer cells: 696.7;monocytes: 624.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "classical monocyte: 447.9;eosinophil: 274.4;intermediate monocyte: 199.0;myeloid DC: 203.8;neutrophil: 375.3;non-classical monocyte: 242.6" "Group enriched" "Detected in all" 9 "dendritic cells: 203.8;granulocytes: 375.3;monocytes: 447.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029480, HPA029481" Enhanced Enhanced Nucleoplasm NA NA 150000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 20: HeLa - Mitochondria" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm "HPA029480: AB_10599307, HPA029481: AB_10601895" "unprognostic (5.05e-2)" "unprognostic (3.34e-2)" "unprognostic (1.02e-2)" "unprognostic (1.77e-2)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (7.21e-6)" "unprognostic (6.78e-2)" "unprognostic (1.70e-1)" "unprognostic (4.73e-2)" "unprognostic (3.06e-3)" "unprognostic (1.36e-2)" "unprognostic (2.08e-1)" "unprognostic (2.99e-1)" "unprognostic (1.07e-1)" "unprognostic (3.29e-1)" "unprognostic (9.90e-3)" 152.2 93.2 78.0 66.2 80.0 667.0 71.9 93.2 82.3 59.7 60.5 73.2 84.2 44.7 19.2 168.5 53.7 97.2 27.4 72.3 96.9 68.2 58.1 93.4 69.2 89.2 89.9 87.7 154.0 41.4 45.6 61.2 93.8 48.8 48.8 21.7 54.9 50.9 12.8 47.0 58.1 51.6 77.4 99.8 66.1 20.2 87.9 82.9 116.1 15.2 67.4 130.9 85.5 97.2 313.0 1542.9 216.0 241.5 470.8 570.8 439.5 206.2 353.8 348.8 330.8 430.1 779.3 388.5 96.8 302.9 673.3 438.3 377.9 775.8 102.4 131.0 210.3 259.6 1022.2 655.2 573.9 321.4 168.1 416.0 437.5 418.5 213.7 949.2 444.9 323.8 188.3 164.7 144.5 381.6 338.6 358.1 737.1 603.0 367.9 201.1 98.5 726.2 550.3 520.2 139.6 103.7 383.4 605.3 365.1 656.7 188.8 437.4 335.9 107.2 164.2 320.0 401.9 94.5 190.3 235.7 234.4 321.0 203.8 51.5 447.9 274.4 17.8 199.0 22.8 39.7 25.8 20.6 203.8 21.1 26.6 20.7 375.3 30.8 242.6 34.4 36.7 312.4 78.0 80.0 93.2 82.3 72.3 96.9 89.2 89.9 93.8 77.4 87.9 97.2 79.5 134.6 125.6 46.7 92.1 79.4 384.6 325.3 287.4 41.0 99.3 80.5 14.9 75.8 149.5 62.5 29.2 349.0 69.7 139.1 80.3 197.7 6.5 87.4 79.6 81.8 52.6 150.3 16.9 269.8 249.8 80.2 168.7 95.5 62.7 123.6 75.0 83.4 256.0 37.0 23.9 149.6 142.4 696.7 110.5 8.9 157.2 333.3 76.5 17.8 624.4 88.8 46.4 17.1 39.3 193.6 81.4 106.8 109.4 337.7 141.5 219.1 99.2 46.3 52.6 35.9 102.1 16.8 30.6 409.3 67.1 413.6 78.8 427.2 276.7 413.6 DCP1A "HSA275986, SMAD4IP1, SMIF" ENSG00000272886 "Decapping mRNA 1A" Q9NPI6 3 53283429-53347586 "Plasma proteins, Predicted intracellular proteins, Transporters" "Nonsense-mediated mRNA decay" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013202 Approved Supported "Cytoplasmic bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" "Cytoplasmic bodies" "HPA013202: AB_1857287" "unprognostic (2.10e-1)" "unprognostic (7.61e-2)" "prognostic favorable (9.01e-4)" "unprognostic (9.79e-3)" "unprognostic (7.68e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.25e-5)" "unprognostic (2.90e-1)" "unprognostic (1.42e-1)" "unprognostic (3.24e-2)" "unprognostic (1.86e-1)" "unprognostic (8.37e-2)" "unprognostic (7.33e-3)" "unprognostic (9.14e-2)" "unprognostic (3.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.95e-1)" 9.3 8.2 4.3 8.7 4.9 29.9 8.9 11.3 6.8 8.5 5.5 8.5 6.1 11.7 5.8 7.9 9.1 8.2 8.0 4.6 4.9 6.0 6.4 7.7 10.3 4.6 4.6 14.9 6.3 10.3 6.3 10.2 4.8 7.9 8.4 8.6 6.1 6.9 9.5 7.4 7.3 10.4 4.1 9.2 6.8 8.2 5.2 14.2 8.7 9.5 9.8 9.0 7.0 6.3 8.3 8.3 19.4 15.8 13.1 13.5 26.3 9.5 12.5 20.5 19.0 24.7 14.5 18.9 3.7 12.0 12.3 6.8 25.3 9.7 17.8 16.9 11.3 18.5 11.8 12.9 11.4 23.0 24.6 10.7 9.4 18.5 15.0 12.6 15.1 13.2 16.4 20.2 10.1 5.0 30.6 11.2 13.1 8.6 12.1 14.0 12.9 13.2 8.6 18.2 10.1 16.7 16.3 10.7 14.3 14.4 7.0 17.8 16.3 9.8 14.1 10.3 14.5 12.9 11.9 21.9 12.0 12.8 17.8 46.9 25.0 43.0 41.0 25.5 50.4 38.9 41.4 47.8 27.1 48.7 49.6 46.8 26.0 54.3 52.3 31.4 30.9 38.5 4.3 4.9 11.3 6.8 4.6 4.9 4.6 4.6 4.8 4.1 5.2 6.3 28.6 28.9 30.7 26.4 43.6 57.5 48.5 32.4 48.9 27.5 32.7 25.5 26.4 15.7 24.7 7.3 47.9 41.1 34.5 25.5 3.9 29.2 10.8 21.5 33.4 33.5 51.8 20.2 43.4 35.1 52.3 33.6 18.3 34.0 36.8 34.8 24.7 13.2 19.9 28.6 40.5 27.6 24.4 27.6 48.9 26.3 24.8 29.2 10.6 20.6 35.2 18.3 30.9 40.7 44.2 45.0 19.6 25.9 31.8 48.4 22.3 13.5 14.2 30.3 13.1 39.2 32.5 12.8 19.1 27.4 41.2 64.0 39.1 27.7 27.9 62.1 CACNA1D "CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2" ENSG00000157388 "Calcium voltage-gated channel subunit alpha1 D" Q01668 3 53328963-53813733 "Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Cancer-related genes, Deafness, Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 251.2;Inhibitory neurons: 354.1;Microglial cells: 126.5;Oligodendrocyte precursor cells: 197.5" "Cancer enhanced" "Detected in many" "prostate cancer: 5.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 10 "basophil: 3.7" "Lineage enriched" "Detected in single" 21 "granulocytes: 3.7" "Cell line enhanced" "Detected in some" "HMC-1: 22.7;RPMI-8226: 55.5;SK-BR-3: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020215 Uncertain Approved "Nuclear membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear membrane" "HPA020215: AB_1845860" "unprognostic (5.85e-2)" "unprognostic (4.90e-3)" "unprognostic (5.09e-2)" "unprognostic (2.24e-2)" "unprognostic (7.55e-2)" "unprognostic (1.77e-2)" "unprognostic (1.92e-1)" "unprognostic (2.32e-2)" "unprognostic (2.95e-1)" "unprognostic (4.42e-2)" "unprognostic (3.90e-3)" "unprognostic (1.53e-1)" "prognostic favorable (8.34e-8)" "unprognostic (1.14e-1)" "unprognostic (3.05e-2)" "unprognostic (8.09e-3)" "unprognostic (6.70e-3)" 0.1 6.6 7.0 0.2 4.3 0.7 1.8 2.3 10.4 6.0 0.0 1.5 1.7 3.7 7.3 0.5 7.7 2.0 0.6 3.6 0.8 2.2 1.0 3.7 0.1 0.0 1.2 0.5 2.8 1.2 3.5 0.6 0.4 3.0 1.5 4.3 0.5 1.8 0.2 0.7 2.4 0.7 3.5 1.8 0.8 1.6 6.1 0.2 2.9 0.2 0.1 0.6 0.1 6.0 0.0 0.5 0.1 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 2.7 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 2.1 0.1 0.0 0.4 0.9 0.0 0.0 0.2 55.5 0.5 3.6 4.7 2.1 0.3 10.1 1.1 0.0 2.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 3.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.0 4.3 2.3 10.4 3.6 0.8 0.0 1.2 0.4 3.5 6.1 6.0 0.6 3.2 36.2 7.8 0.6 0.9 0.8 4.6 2.2 33.3 7.2 1.8 2.3 10.0 9.1 1.8 35.5 0.9 0.5 3.0 0.0 7.2 4.9 4.3 40.1 2.4 59.4 2.7 251.2 2.3 0.2 3.4 5.1 3.3 12.6 1.7 0.0 3.4 0.2 8.4 354.1 3.8 2.0 0.8 4.0 8.3 4.4 2.1 5.4 126.5 0.5 4.0 0.0 197.5 29.9 3.8 5.6 27.1 0.1 1.7 9.5 2.7 9.5 12.9 0.0 0.2 8.6 1.0 3.7 0.5 1.0 0.3 1.7 9.6 7.6 0.9 CHDH ENSG00000016391 "Choline dehydrogenase" Q8NE62 3 53812335-53846419 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 37.6;liver: 35.8" "Cell type enhanced" "Detected in many" "Cholangiocytes: 52.9;Hepatocytes: 51.8;Proximal enterocytes: 70.1;Proximal tubular cells: 87.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "basophil: 3.1;T-reg: 1.3" "Group enriched" "Detected in many" 17 "granulocytes: 3.1;T-cells: 1.3" "Cell line enhanced" "Detected in many" "CACO-2: 11.4;Hep G2: 35.8;OE19: 25.3;T-47d: 11.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036633, HPA058130" Enhanced NA NA "Cluster 10: Basophils - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA036633: AB_10670841, HPA058130: AB_2683615" "unprognostic (3.40e-3)" "unprognostic (1.17e-2)" "unprognostic (2.26e-3)" "unprognostic (7.17e-3)" "unprognostic (9.15e-2)" "unprognostic (1.17e-3)" "unprognostic (1.10e-1)" "unprognostic (1.97e-2)" "unprognostic (2.75e-1)" "unprognostic (4.35e-3)" "unprognostic (4.57e-2)" "unprognostic (5.12e-2)" "prognostic favorable (1.88e-8)" "unprognostic (3.37e-2)" "unprognostic (2.42e-1)" "unprognostic (8.26e-2)" "unprognostic (2.29e-2)" 0.6 2.8 13.6 1.8 14.3 0.6 7.3 12.5 11.4 3.7 16.5 8.9 8.4 2.7 1.4 0.9 2.6 2.7 2.4 11.3 10.9 37.6 35.8 2.4 1.0 14.5 13.9 1.3 16.4 8.3 7.8 0.4 10.1 5.8 9.2 1.5 15.0 1.0 3.9 2.4 14.7 0.9 10.3 0.5 8.0 6.9 15.9 0.2 2.6 1.2 1.2 0.4 0.9 12.0 0.4 4.6 1.2 0.1 0.0 0.0 5.2 0.3 0.5 0.0 0.0 11.4 0.8 0.4 0.8 0.8 0.1 0.0 7.4 0.0 0.0 0.0 4.0 0.0 1.7 35.8 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.6 0.0 0.0 5.7 0.7 0.0 6.9 0.0 0.1 7.2 25.3 0.8 0.0 1.8 8.2 5.1 4.0 3.0 4.0 1.8 0.1 0.0 0.9 11.2 0.1 0.0 0.0 0.8 0.2 1.0 1.0 1.6 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 13.6 14.3 12.5 11.4 11.3 10.9 14.5 13.9 10.1 10.3 15.9 12.0 0.6 3.2 6.8 19.6 1.3 6.6 5.6 1.1 1.2 23.8 23.5 19.8 11.3 52.9 5.9 11.0 14.6 3.7 0.4 16.6 7.9 19.4 28.9 3.2 11.0 1.4 47.9 0.0 2.4 13.8 2.3 2.3 21.4 9.4 7.0 2.2 1.4 51.8 0.3 1.7 3.5 38.9 0.0 1.9 2.5 46.2 5.9 2.6 3.6 1.0 0.1 18.8 0.0 27.2 5.2 8.0 15.1 15.4 5.3 19.8 70.1 87.8 3.8 13.4 0.0 1.0 3.4 15.1 2.3 0.7 5.3 0.8 2.4 2.0 45.4 2.2 IL17RB "CRL4, EVI27, IL17BR, IL17RH1" ENSG00000056736 "Interleukin 17 receptor B" Q9NRM6 3 53846568-53865794 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.9;kidney: 59.8;liver: 33.3" "Cell type enhanced" "Detected in many" "Astrocytes: 48.3;Enteroendocrine cells: 29.2;Oligodendrocyte precursor cells: 37.7;Proximal tubular cells: 78.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 20.2;Hep G2: 59.5;OE19: 46.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005482 Enhanced Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 7: Kidney - Transmembrane transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Vesicles, Plasma membrane" "HPA005482: AB_1234567" "unprognostic (1.85e-3)" "unprognostic (4.22e-3)" "unprognostic (1.60e-3)" "unprognostic (2.86e-2)" "unprognostic (1.42e-2)" "unprognostic (6.20e-3)" "unprognostic (1.62e-2)" "unprognostic (6.09e-3)" "unprognostic (1.30e-1)" "unprognostic (5.41e-2)" "unprognostic (4.75e-2)" "unprognostic (4.27e-2)" "prognostic favorable (6.61e-4)" "unprognostic (8.10e-2)" "unprognostic (6.97e-2)" "unprognostic (5.29e-1)" "unprognostic (7.15e-3)" 0.9 2.0 20.2 2.3 21.4 0.5 5.7 22.7 28.9 18.1 16.6 6.8 5.8 5.1 0.7 1.7 3.3 2.4 2.7 19.4 20.2 59.8 33.3 3.8 2.5 18.7 19.9 1.5 7.8 1.1 4.2 0.9 19.0 2.4 6.9 4.8 4.9 0.6 1.3 2.2 5.9 0.8 18.9 1.2 3.6 2.5 23.2 0.3 2.9 0.2 0.7 0.8 1.3 23.6 1.5 3.1 4.5 3.4 0.1 0.0 7.1 3.1 0.1 0.1 0.0 20.2 1.4 4.6 1.0 1.0 1.7 0.8 12.2 0.0 0.0 1.6 3.5 6.0 6.1 59.5 0.0 5.6 3.2 0.0 0.0 0.0 0.0 3.8 0.0 1.6 4.9 2.1 0.1 4.2 0.9 2.3 12.1 46.2 2.6 1.7 1.9 5.3 1.4 5.3 6.4 3.7 10.1 2.4 1.9 3.3 9.2 2.0 2.5 3.0 3.3 2.6 3.9 4.7 5.6 2.9 2.7 3.3 1.7 1.3 0.2 0.0 0.2 0.2 0.1 0.1 0.6 0.2 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.3 0.9 0.1 20.2 21.4 22.7 28.9 19.4 20.2 18.7 19.9 19.0 18.9 23.2 23.6 0.2 0.0 4.1 48.3 0.2 0.3 2.0 0.0 0.0 0.1 8.2 4.4 4.1 17.2 1.3 0.0 0.0 1.4 0.3 4.3 9.8 4.8 1.0 0.5 1.0 0.2 29.2 0.0 0.5 1.6 1.0 0.6 4.6 1.7 2.5 0.4 0.4 13.1 0.1 0.0 2.5 8.7 2.0 0.0 1.1 0.7 1.2 1.2 0.0 1.9 0.0 4.4 0.0 37.7 4.3 1.8 3.0 0.4 0.0 4.4 2.9 78.0 0.0 0.1 0.0 0.3 0.5 0.4 1.0 0.0 0.1 0.4 0.9 0.0 10.2 0.6 ACTR8 "ARP8, INO80N" ENSG00000113812 "Actin related protein 8" Q9H981 3 53867066-53882152 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 44.3;Late spermatids: 85.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 56.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065236 Supported Nucleoplasm,Centrosome NA NA "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Centrosome "HPA065236: AB_2685442" "unprognostic (9.05e-2)" "unprognostic (2.06e-1)" "prognostic favorable (2.21e-4)" "unprognostic (2.97e-1)" "unprognostic (5.67e-2)" "unprognostic (1.88e-1)" "prognostic unfavorable (5.11e-6)" "unprognostic (2.24e-2)" "unprognostic (4.68e-2)" "unprognostic (1.02e-1)" "unprognostic (2.82e-1)" "unprognostic (5.68e-2)" "prognostic favorable (7.88e-9)" "unprognostic (3.68e-1)" "unprognostic (3.35e-1)" "unprognostic (2.84e-1)" "unprognostic (1.15e-1)" 8.4 6.8 7.8 9.8 8.6 9.4 9.3 10.5 9.0 9.2 13.0 9.3 7.4 9.8 9.0 9.2 9.0 8.1 18.5 8.3 9.3 13.0 8.7 9.2 13.9 8.6 9.6 10.3 9.4 14.7 7.2 11.0 8.5 9.0 12.0 7.6 8.8 8.6 9.0 9.2 7.2 11.0 8.8 9.4 9.6 21.5 9.3 13.4 12.1 12.6 14.8 11.5 7.3 9.6 11.9 14.4 27.5 22.9 22.2 27.6 20.6 27.4 34.8 36.3 28.7 22.6 14.1 36.1 7.9 37.9 26.7 9.9 21.0 18.8 34.1 14.7 8.7 35.2 21.9 24.3 26.1 38.6 30.8 21.8 19.1 37.6 23.4 28.0 28.4 18.9 16.4 12.2 37.0 13.8 12.9 23.0 25.7 17.0 22.7 16.8 17.3 21.8 27.5 32.7 8.1 23.5 17.8 15.4 16.1 25.9 9.9 21.1 19.7 27.5 17.8 25.6 25.2 33.9 46.4 36.3 20.4 27.7 17.6 56.2 8.2 10.5 9.2 12.0 9.2 9.8 8.5 8.8 10.7 6.1 8.9 9.6 4.3 15.1 7.4 7.8 15.0 8.0 7.8 8.6 10.5 9.0 8.3 9.3 8.6 9.6 8.5 8.8 9.3 9.6 6.3 3.2 7.7 6.5 9.4 7.8 6.0 12.3 5.7 6.8 5.4 5.1 19.5 10.0 8.6 3.7 4.2 12.7 11.6 5.7 21.5 15.1 44.3 5.9 12.0 8.8 10.8 7.8 7.1 15.6 11.3 7.8 12.2 7.6 5.7 10.9 8.2 5.4 11.5 1.7 8.5 10.6 12.2 7.6 6.9 85.9 10.8 10.0 5.4 4.7 11.9 7.6 13.4 8.0 6.2 15.5 3.5 9.8 13.6 6.3 5.9 24.1 5.0 5.3 0.0 5.5 20.8 27.6 20.3 7.3 6.5 10.3 11.5 13.5 6.3 6.5 SELENOK SELK ENSG00000113811 "Selenoprotein K" Q9Y6D0 3 53884417-53891962 "Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 373.5;Proximal tubular cells: 415.0;Syncytiotrophoblasts: 350.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "basophil: 471.4" "Lineage enriched" "Detected in all" 7 "granulocytes: 471.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA008196 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "HPA008196: AB_1856665" "unprognostic (1.29e-2)" "unprognostic (1.18e-2)" "unprognostic (3.85e-1)" "prognostic favorable (7.18e-4)" "unprognostic (9.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.02e-2)" "prognostic favorable (3.76e-4)" "unprognostic (2.75e-1)" "unprognostic (5.21e-2)" "unprognostic (8.34e-2)" "unprognostic (1.14e-1)" "unprognostic (3.40e-2)" "unprognostic (8.43e-2)" "unprognostic (8.12e-2)" "unprognostic (9.35e-2)" "unprognostic (2.56e-3)" 39.6 51.9 52.3 27.0 53.0 70.1 35.8 55.2 67.9 29.8 52.3 35.9 23.3 29.1 64.4 27.8 33.9 23.4 90.1 52.0 55.8 42.1 74.2 38.3 23.7 55.0 53.7 48.6 51.7 55.7 62.8 26.5 55.5 34.6 29.3 86.5 29.7 28.5 86.7 24.1 30.4 18.7 55.7 32.3 39.6 32.0 53.3 26.7 43.0 61.2 29.4 35.5 26.1 58.4 22.4 14.9 34.3 23.3 52.1 32.8 36.8 32.0 40.5 43.4 48.9 33.4 33.1 33.8 13.8 23.4 48.7 13.8 40.7 24.5 37.8 59.6 50.3 21.1 61.4 77.6 49.1 28.3 48.6 19.8 40.3 30.1 39.4 25.2 35.3 25.1 20.1 86.3 38.5 24.7 18.5 33.5 33.4 27.5 55.1 11.5 20.9 61.9 51.3 37.1 17.5 49.5 21.9 29.4 32.7 37.5 19.6 44.0 20.6 24.4 28.7 62.2 45.7 62.8 76.3 31.4 36.8 37.3 38.2 471.4 41.7 110.7 69.5 47.2 67.5 60.3 63.0 70.0 36.6 49.0 55.0 63.0 94.1 52.2 56.6 66.3 72.1 82.6 52.3 53.0 55.2 67.9 52.0 55.8 55.0 53.7 55.5 55.7 53.3 58.4 223.1 134.6 103.9 0.0 173.5 0.0 0.0 0.0 0.0 0.0 233.7 237.5 0.0 0.0 53.9 149.0 0.0 162.3 373.5 0.0 189.8 258.5 0.0 150.1 113.5 62.7 0.0 0.0 0.0 199.6 239.6 86.9 0.0 237.9 237.1 59.1 0.0 0.0 162.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 161.6 0.0 0.0 74.9 0.0 0.0 0.0 0.0 282.5 0.0 0.0 110.6 0.0 0.0 415.0 53.9 0.0 0.0 0.0 86.0 0.0 0.0 0.0 0.0 350.1 155.9 94.7 0.0 0.0 CACNA2D3 HSA272268 ENSG00000157445 "Calcium voltage-gated channel auxiliary subunit alpha2delta 3" Q8IZS8 3 54122547-55074557 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.8;skeletal muscle: 9.9;tongue: 10.7" "Cell type enhanced" "Detected in many" "Astrocytes: 160.9;Excitatory neurons: 828.3;Inhibitory neurons: 456.4;Oligodendrocyte precursor cells: 317.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.1;HAP1: 1.9;HeLa: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030849 Uncertain Nucleoplasm NA NA 69000 "Cluster 47: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "HPA030849: " "unprognostic (6.92e-2)" "unprognostic (1.35e-2)" "unprognostic (1.89e-1)" "unprognostic (4.34e-5)" "unprognostic (5.53e-3)" "unprognostic (2.64e-3)" "unprognostic (3.24e-1)" "unprognostic (1.17e-2)" "unprognostic (5.84e-3)" "unprognostic (7.22e-3)" "unprognostic (1.14e-2)" "unprognostic (2.43e-1)" "unprognostic (2.00e-1)" "unprognostic (1.47e-3)" "unprognostic (2.19e-1)" "unprognostic (3.62e-2)" "unprognostic (6.95e-2)" 0.2 4.1 8.8 0.1 11.6 0.0 0.2 0.0 15.8 0.3 0.0 0.7 0.1 0.1 1.3 0.5 0.4 0.2 2.6 9.4 8.4 1.3 0.0 0.5 0.5 2.1 10.2 2.5 0.0 0.3 0.8 0.5 1.3 1.0 0.3 2.9 0.4 1.5 9.9 0.1 0.3 0.6 0.0 0.2 0.4 1.4 3.5 0.1 0.4 10.7 0.5 0.1 0.4 9.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.1 0.1 9.2 0.0 0.5 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 11.6 0.0 15.8 9.4 8.4 2.1 10.2 1.3 0.0 3.5 9.9 0.5 0.0 0.0 160.9 0.6 0.3 0.4 0.2 7.4 10.8 0.2 0.5 30.2 0.0 0.7 0.0 8.4 9.9 5.5 0.1 7.9 0.0 83.4 0.9 0.8 0.6 0.0 1.3 828.3 0.6 3.2 3.4 1.5 1.8 0.0 1.1 0.4 0.0 5.9 0.0 456.4 0.0 2.0 8.9 2.7 56.1 2.8 11.0 0.0 97.4 22.2 5.0 0.0 317.7 11.3 1.2 0.0 1.5 0.1 0.4 0.0 0.2 0.8 1.4 6.6 1.7 1.9 5.7 2.9 3.4 0.1 68.0 0.7 0.8 0.0 0.4 LRTM1 HT017 ENSG00000144771 "Leucine rich repeats and transmembrane domains 1" Q9HBL6 3 54918231-54967088 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "retina: 78.9;skeletal muscle: 25.8" "Cell type enriched" "Detected in some" 12 "Bipolar cells: 389.8" "Cancer enhanced" "Detected in single" "urothelial cancer: 0.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HEL: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 42: Non-specific - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 36: HEL - Hemostasis" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (2.28e-1)" "unprognostic (1.58e-2)" "unprognostic (9.56e-2)" "unprognostic (2.16e-1)" "unprognostic (1.87e-3)" 0.1 0.0 2.7 0.0 4.0 0.0 0.5 0.8 3.7 0.2 3.2 0.3 0.0 0.0 0.2 4.0 0.1 0.0 0.1 2.5 3.9 0.0 0.3 0.2 0.1 1.1 1.6 0.0 0.1 0.1 0.0 0.5 1.4 1.1 0.1 78.9 1.0 0.5 25.8 0.0 0.2 0.0 0.5 6.6 0.1 0.5 1.4 0.1 0.3 2.5 0.1 0.1 0.0 3.3 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.4 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.0 0.4 0.1 0.2 0.0 1.1 0.3 0.2 0.0 0.0 0.2 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.1 0.0 0.5 0.0 0.1 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 2.7 4.0 0.8 3.7 2.5 3.9 1.1 1.6 1.4 0.5 1.4 3.3 0.2 0.0 0.0 5.9 0.0 0.4 0.6 0.1 0.0 389.8 0.0 0.0 0.5 0.0 0.0 1.8 16.7 9.3 0.0 0.1 0.0 0.0 3.0 0.1 0.2 1.0 0.0 0.0 27.1 0.4 1.3 1.2 0.0 0.3 0.0 0.2 0.0 0.0 0.7 1.7 10.9 0.0 0.0 0.0 0.6 0.7 5.9 0.1 0.0 1.9 0.1 17.2 0.0 4.0 0.5 2.0 0.0 4.5 0.0 0.6 0.0 0.0 0.0 30.8 0.0 3.2 1.6 3.1 3.7 0.0 0.4 22.2 0.1 0.5 0.0 0.4 WNT5A hWNT5A ENSG00000114251 "Wnt family member 5A" P41221 3 55465715-55490539 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Wnt signaling pathway" "Developmental protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 27.4;salivary gland: 34.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 51.3;Basal squamous epithelial cells: 34.7;Club cells: 31.3;Endometrial stromal cells: 101.6;Oligodendrocyte precursor cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 227.2;BJ hTERT+: 315.4;HeLa: 242.1;SiHa: 354.2;U-87 MG: 248.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted to extracellular matrix" NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" "unprognostic (2.34e-3)" "unprognostic (1.35e-1)" "prognostic favorable (2.94e-5)" "unprognostic (1.37e-1)" "unprognostic (3.45e-3)" "unprognostic (1.14e-1)" "unprognostic (2.16e-2)" "unprognostic (3.91e-2)" "unprognostic (5.89e-2)" "unprognostic (9.58e-2)" "unprognostic (8.34e-3)" "unprognostic (1.10e-1)" "unprognostic (4.81e-3)" "unprognostic (9.70e-3)" "unprognostic (2.40e-1)" "unprognostic (5.42e-3)" "unprognostic (3.63e-2)" 2.3 0.8 1.9 3.1 1.9 0.1 4.9 1.7 1.8 5.7 0.6 3.1 3.5 27.4 3.1 16.9 6.7 7.2 1.6 2.5 3.2 2.7 2.6 4.9 2.2 3.9 4.3 9.1 4.3 1.0 1.8 10.8 3.0 4.6 3.2 1.2 34.4 8.3 2.0 2.4 3.8 5.9 3.8 4.0 3.5 1.8 3.1 2.4 2.8 1.7 5.1 18.7 12.1 5.4 0.0 0.4 20.8 0.2 15.8 37.7 0.0 227.2 315.4 46.3 80.4 1.3 0.0 6.6 0.6 132.2 19.5 0.2 10.0 0.2 48.2 0.0 6.2 6.4 242.1 0.1 35.1 0.0 0.4 25.0 5.9 139.2 7.6 22.5 0.1 0.2 0.0 109.5 113.3 0.0 0.1 0.1 11.1 0.5 13.6 0.0 14.1 1.0 6.2 7.6 0.0 1.0 354.2 43.1 0.0 18.0 0.1 0.0 0.0 76.1 13.2 70.0 18.2 25.8 0.0 2.4 248.5 0.3 35.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.9 1.7 1.8 2.5 3.2 3.9 4.3 3.0 3.8 3.1 5.4 1.1 51.3 23.2 4.2 0.0 1.5 1.6 1.4 34.7 13.2 12.1 4.4 4.3 0.0 31.3 12.9 0.0 3.0 0.0 0.2 0.0 0.2 15.8 13.3 101.6 4.3 0.0 0.0 3.0 0.2 0.6 19.9 0.0 13.9 2.5 8.5 1.1 2.6 1.3 0.0 9.0 0.3 10.2 2.4 1.3 4.2 19.6 2.6 0.0 5.6 4.2 1.6 0.0 31.2 0.1 0.4 2.5 30.1 0.1 0.9 2.3 1.0 1.9 1.4 0.0 1.6 7.7 0.1 1.1 17.5 1.6 1.5 1.5 6.5 1.6 9.6 ERC2 "CAST, CAST1, ELKSL, KIAA0378, SPBC110, Spc110" ENSG00000187672 "ELKS/RAB6-interacting/CAST family member 2" O15083 3 55508311-56468467 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 11.7" "Group enriched" "Detected in some" 5 "Excitatory neurons: 818.5;Inhibitory neurons: 674.8;Oligodendrocyte precursor cells: 304.6" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Group enriched" "Detected in many" 32 "amygdala: 7.9;basal ganglia: 11.7;cerebral cortex: 11.1;hippocampal formation: 7.6;white matter: 3.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 2.4;HUVEC TERT2: 2.1;Karpas-707: 7.9;SH-SY5Y: 2.0;U-266/70: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073739 Enhanced NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 2: Karpas-707 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA073739: AB_2732240" "unprognostic (2.13e-2)" "unprognostic (1.39e-1)" "unprognostic (9.10e-2)" "unprognostic (1.93e-2)" "unprognostic (2.62e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (4.50e-2)" "unprognostic (2.95e-2)" "unprognostic (1.22e-1)" "unprognostic (3.06e-2)" "unprognostic (2.69e-1)" "unprognostic (1.75e-2)" "unprognostic (1.46e-2)" "unprognostic (1.24e-2)" "unprognostic (4.49e-2)" "unprognostic (9.09e-2)" 0.0 0.3 7.9 0.0 11.7 0.0 0.1 0.0 11.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 7.6 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.8 0.2 0.0 1.7 0.1 0.0 0.3 0.0 2.6 0.2 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 3.1 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 2.1 0.0 0.0 7.9 0.0 0.8 0.0 0.0 1.7 0.0 0.2 0.0 0.1 0.0 1.6 0.0 0.9 2.0 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.7 0.0 0.2 6.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 11.7 0.0 11.1 7.6 0.0 0.0 0.2 0.0 0.0 0.0 3.1 0.1 3.2 0.5 22.9 0.0 0.1 0.2 0.0 1.2 11.3 0.4 0.5 3.4 0.0 1.3 0.0 25.0 0.0 0.0 0.0 0.0 0.4 6.2 0.4 0.3 0.5 0.0 0.0 818.5 0.6 0.1 0.6 0.0 1.2 0.0 0.9 0.0 0.0 0.7 5.0 674.8 0.0 0.0 0.0 0.0 2.5 1.5 0.2 0.0 30.9 0.0 1.3 0.0 304.6 102.4 1.6 0.0 0.7 0.0 0.8 0.0 0.6 1.5 10.8 0.0 0.1 0.1 1.5 2.9 0.4 0.1 0.0 0.0 1.2 0.0 0.3 CCDC66 DKFZp686C0433 ENSG00000180376 "Coiled-coil domain containing 66" A2RUB6 3 56557161-56621837 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 202.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044185, HPA051937" Approved Supported "Cell Junctions,Midbody ring,Centriolar satellite,Cytosol" Yes No "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Centriolar satellite" "Cell Junctions, Midbody ring, Cytosol" "HPA044185: AB_10965852, HPA051937: " "unprognostic (2.28e-2)" "unprognostic (7.74e-2)" "unprognostic (7.37e-2)" "unprognostic (2.90e-1)" "unprognostic (5.28e-2)" "unprognostic (1.72e-2)" "unprognostic (7.26e-3)" "unprognostic (1.68e-3)" "unprognostic (2.05e-2)" "unprognostic (1.27e-1)" "unprognostic (3.05e-3)" "unprognostic (5.48e-3)" "unprognostic (6.85e-3)" "unprognostic (1.81e-1)" "unprognostic (6.57e-2)" "unprognostic (3.24e-1)" "unprognostic (6.81e-3)" 2.7 3.1 3.8 3.6 3.7 3.0 5.2 3.7 4.3 4.8 4.2 4.0 3.0 4.1 5.3 2.5 5.7 3.4 2.9 3.7 4.2 4.1 2.0 3.6 4.9 3.8 3.7 6.0 3.3 5.4 4.5 3.3 3.9 4.0 4.1 7.8 3.3 3.6 4.5 2.5 2.8 4.9 3.8 4.3 3.2 3.7 3.7 5.1 4.9 2.6 4.9 3.7 3.1 3.8 5.6 2.0 5.8 3.7 8.9 5.2 4.6 6.8 6.4 9.1 7.8 4.3 4.3 15.6 1.6 3.8 5.8 2.8 3.4 6.5 10.1 5.6 4.0 9.5 9.0 4.6 6.2 12.8 3.3 4.9 8.8 7.7 5.1 8.0 6.0 7.7 9.3 2.4 7.2 4.7 10.0 7.5 9.7 4.8 7.5 3.4 5.2 8.6 5.3 1.9 2.2 4.2 8.7 5.5 5.2 4.9 1.9 5.2 3.1 6.6 5.2 6.3 9.9 4.7 5.3 8.0 4.9 14.3 5.5 10.0 1.5 3.5 4.1 2.0 5.4 2.7 7.0 5.0 1.1 1.6 8.0 5.8 0.3 5.1 2.4 1.0 14.8 2.6 3.8 3.7 3.7 4.3 3.7 4.2 3.8 3.7 3.9 3.8 3.7 3.8 39.7 22.4 22.6 42.7 41.3 28.2 20.1 30.5 15.9 68.5 18.5 21.0 30.5 30.0 29.0 22.0 108.4 23.0 51.5 7.7 29.4 23.7 202.5 58.1 33.5 28.8 21.0 40.8 93.2 10.5 14.6 29.9 18.8 13.9 34.2 38.3 37.9 8.5 18.4 52.2 95.8 11.4 22.4 35.8 27.9 109.6 54.0 20.7 26.6 51.5 56.1 36.8 105.0 70.9 96.7 14.1 9.8 47.8 28.1 25.5 11.5 20.3 51.5 111.5 32.9 38.6 30.9 55.8 46.8 12.1 29.5 16.4 51.7 33.6 14.5 11.4 TASOR "C3orf63, FAM208A, KIAA1105, RAP140, se89-1, TASOR1" ENSG00000163946 "Transcription activation suppressor" Q9UK61 3 56620133-56683237 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 25.0;Cardiomyocytes: 31.4;Cytotrophoblasts: 14.5;dendritic cells: 12.1;Extravillous trophoblasts: 9.9;Fibroblasts: 10.7;Hofbauer cells: 20.7;Syncytiotrophoblasts: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006735, HPA017142" Uncertain Enhanced Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA006735: AB_1852384, HPA017142: AB_1852382" "unprognostic (1.46e-1)" "unprognostic (7.97e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-1)" "unprognostic (2.51e-2)" "unprognostic (2.30e-3)" "unprognostic (9.31e-2)" "unprognostic (3.91e-2)" "unprognostic (5.93e-2)" "unprognostic (1.51e-1)" "unprognostic (8.84e-2)" "unprognostic (1.73e-1)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (1.67e-1)" "unprognostic (2.74e-1)" 9.5 8.4 4.0 15.4 8.4 11.8 11.4 8.7 5.3 12.0 1.7 11.7 10.0 12.3 7.4 11.1 13.1 11.7 6.2 2.2 3.6 10.2 7.9 11.3 20.7 5.1 5.6 14.2 12.4 21.1 4.4 9.4 6.0 9.3 12.4 9.9 8.9 9.4 2.6 7.1 11.3 12.3 5.9 14.7 12.8 29.2 4.5 21.3 18.8 6.9 19.3 12.5 3.8 12.0 49.2 19.2 29.2 23.0 15.5 26.7 14.6 21.4 22.0 20.1 21.1 15.8 35.8 77.3 7.9 21.6 33.9 19.1 29.3 25.1 29.2 38.3 14.8 30.4 27.3 7.1 10.9 32.2 46.1 12.9 20.6 19.6 35.1 23.7 26.5 28.8 29.8 43.3 26.0 17.3 39.8 6.4 16.3 25.9 29.0 20.9 28.9 25.9 19.0 35.5 19.3 23.9 46.9 18.5 23.2 16.6 30.6 36.7 28.6 25.9 23.7 23.8 33.1 39.2 58.5 38.6 30.1 46.7 35.0 0.6 0.8 1.1 1.2 0.6 0.7 0.7 1.0 1.2 1.0 1.1 1.1 1.2 0.2 0.9 0.7 0.7 1.0 0.6 4.0 8.4 8.7 5.3 2.2 3.6 5.1 5.6 6.0 5.9 4.5 12.0 25.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 14.5 12.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 9.9 10.7 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 9.2 2.1 0.0 0.0 0.0 ARHGEF3 "DKFZP434F2429, GEF3, STA3, XPLN" ENSG00000163947 "Rho guanine nucleotide exchange factor 3" Q9NR81 3 56727418-57079329 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 157.8;NK-cells: 137.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 88.8;RPMI-8226: 92.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034715, HPA064945" Uncertain Approved Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "HPA034715: AB_10600780, HPA064945: AB_2685389" "unprognostic (1.84e-2)" "unprognostic (2.22e-2)" "unprognostic (1.62e-2)" "prognostic favorable (2.17e-4)" "unprognostic (8.25e-2)" "prognostic favorable (2.61e-4)" "unprognostic (9.42e-2)" "unprognostic (3.83e-2)" "unprognostic (9.67e-2)" "unprognostic (7.44e-2)" "unprognostic (6.90e-2)" "unprognostic (4.99e-2)" "prognostic favorable (1.96e-7)" "unprognostic (8.24e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-2)" 16.8 43.2 11.2 20.6 14.8 9.8 13.8 14.4 17.4 16.0 30.9 14.3 6.4 38.0 12.5 19.0 23.2 22.3 12.7 25.9 10.8 25.3 5.2 24.8 29.3 11.2 9.1 20.6 29.1 52.3 21.6 21.3 10.7 14.8 13.5 8.2 21.5 15.3 8.0 12.6 9.6 34.5 7.6 21.5 15.8 14.3 11.6 36.1 14.2 8.5 28.7 17.2 11.6 12.8 24.2 8.4 1.2 7.7 2.7 2.2 16.5 2.6 2.2 2.6 3.4 4.1 22.3 12.6 2.5 4.7 25.3 12.1 7.2 30.8 3.0 18.4 3.5 10.3 5.2 88.8 6.6 0.0 10.9 9.7 19.9 2.3 3.5 23.6 25.5 13.3 2.9 27.2 5.9 3.7 34.8 1.3 2.3 19.5 12.9 0.2 9.2 92.2 19.8 13.2 1.4 3.8 15.3 11.2 6.9 8.5 2.9 10.6 11.8 1.3 6.0 5.4 4.0 35.0 14.2 45.1 21.7 12.2 10.9 20.6 23.0 3.7 96.1 25.5 72.5 26.0 73.6 85.0 13.9 16.9 59.3 73.5 8.3 39.7 32.2 5.9 67.4 76.0 11.2 14.8 14.4 17.4 25.9 10.8 11.2 9.1 10.7 7.6 11.6 12.8 22.7 16.0 22.4 30.0 24.2 11.1 8.6 16.3 32.5 9.5 7.6 9.9 9.8 2.8 12.6 23.9 4.2 11.4 57.5 4.8 11.7 11.0 22.6 10.1 7.0 40.3 9.6 14.1 157.8 10.2 7.9 13.5 36.2 16.5 13.9 4.8 22.9 0.1 7.6 0.0 70.8 1.3 2.0 38.1 8.2 14.1 17.7 18.7 10.6 63.7 19.9 9.0 137.0 68.3 80.0 7.5 1.4 24.0 22.1 11.2 0.2 7.3 9.5 1.2 0.0 8.0 4.4 3.3 2.6 37.9 14.9 11.9 64.3 3.2 3.2 13.4 SPATA12 ENSG00000186451 "Spermatogenesis associated 12" Q7Z6I5 3 57060664-57075432 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 20.5" "Group enriched" "Detected in some" 145 "Early spermatids: 464.2;Late spermatids: 1195.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 1.9;RH-30: 1.1" "HPA043323, HPA075578" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Cluster 78: Testis - Spermatogenesis" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA043323: AB_10796792, HPA075578: " "unprognostic (2.31e-1)" "unprognostic (2.18e-4)" "unprognostic (3.47e-4)" "unprognostic (2.21e-2)" "unprognostic (2.66e-1)" "unprognostic (8.79e-3)" "unprognostic (1.69e-3)" "unprognostic (3.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.29e-1)" "unprognostic (6.80e-2)" "unprognostic (1.76e-2)" "unprognostic (4.71e-3)" "unprognostic (7.29e-2)" "unprognostic (1.62e-2)" "unprognostic (1.14e-1)" "unprognostic (2.44e-3)" 0.0 0.3 0.4 0.0 0.3 0.0 0.0 0.2 0.2 0.1 2.1 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.6 0.0 0.0 0.3 0.2 2.0 0.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.3 20.5 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.1 0.0 1.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.4 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.4 0.5 0.0 1.1 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.3 0.0 0.7 0.1 0.1 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.2 0.2 0.2 0.6 2.0 0.8 0.7 0.5 0.4 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.3 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.4 464.2 1.0 0.1 0.6 0.0 0.0 0.1 1.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 3.1 0.0 0.1 0.0 0.0 1.3 0.0 1195.5 5.0 0.5 0.0 1.0 0.0 0.0 0.0 1.0 0.7 1.4 0.1 5.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.8 2.8 0.3 0.0 0.0 0.3 0.0 0.2 0.5 IL17RD "FLJ35755, IL-17RD, IL17RLM, SEF" ENSG00000144730 "Interleukin 17 receptor D" Q8NFM7 3 57089982-57170306 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 28.0" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 14.0;Early spermatids: 17.9;Late spermatids: 23.7;Microglial cells: 15.0;Peritubular cells: 25.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 25.0;AN3-CA: 67.9;NTERA-2: 39.2;SH-SY5Y: 102.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039577, HPA043550" Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Golgi apparatus" Nucleoplasm "HPA039577: AB_2676580, HPA043550: AB_2678546" "unprognostic (4.67e-2)" "unprognostic (1.52e-1)" "unprognostic (2.31e-1)" "unprognostic (2.72e-2)" "unprognostic (1.33e-2)" "unprognostic (9.62e-2)" "unprognostic (1.17e-2)" "unprognostic (1.60e-1)" "unprognostic (3.72e-1)" "unprognostic (2.11e-3)" "unprognostic (4.79e-2)" "unprognostic (1.25e-1)" "prognostic favorable (2.92e-9)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (2.63e-3)" "unprognostic (9.58e-3)" 1.9 0.8 4.7 0.9 5.7 0.0 7.4 5.2 4.0 6.0 28.0 5.9 0.4 13.5 10.6 2.4 6.4 3.3 1.9 5.5 6.5 5.7 0.2 0.6 0.3 8.9 8.8 7.4 0.9 9.4 2.3 0.3 5.5 5.1 1.8 0.3 6.0 8.5 0.6 2.0 1.0 12.0 6.2 2.5 1.2 9.7 4.8 0.3 0.5 2.6 0.5 2.8 3.3 6.5 4.0 0.8 25.0 67.9 0.1 0.6 4.0 0.4 0.2 0.3 0.8 0.5 1.9 0.0 0.2 1.4 5.3 0.2 4.8 1.0 0.8 0.0 1.3 0.0 0.0 0.2 0.1 0.0 0.1 1.0 2.6 0.0 0.5 16.6 1.1 0.6 0.0 0.1 1.4 0.5 0.0 0.1 39.2 2.2 1.9 0.0 9.1 0.0 5.2 1.0 0.6 102.0 1.0 1.5 2.9 8.1 0.9 0.0 0.7 1.3 1.6 1.2 4.2 0.0 0.0 0.1 0.7 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 5.7 5.2 4.0 5.5 6.5 8.9 8.8 5.5 6.2 4.8 6.5 1.4 0.0 2.3 11.4 0.0 0.9 2.0 3.1 0.0 0.1 1.5 14.0 1.6 1.5 2.4 0.0 0.0 0.3 0.1 0.1 0.0 3.1 17.9 0.5 5.5 4.0 0.0 0.0 0.6 0.2 0.1 10.1 0.0 1.0 0.0 2.0 1.1 0.1 0.1 0.0 0.9 0.3 2.0 0.0 1.2 23.7 11.5 0.6 0.0 15.0 0.0 0.6 0.0 7.5 2.1 0.7 0.7 25.9 0.0 2.9 0.0 5.0 1.8 0.0 0.0 4.8 1.3 10.6 7.5 1.1 0.9 0.1 0.3 6.5 0.3 0.7 HESX1 "ANF, RPX" ENSG00000163666 "HESX homeobox 1" Q9UBX0 3 57197838-57227606 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Spermatocytes: 36.3" "Cancer enriched" "Detected in many" 4 "testis cancer: 6.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 73.5;U-266/84: 23.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024187 Approved Approved Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA024187: AB_1850620" "unprognostic (6.47e-2)" "unprognostic (1.66e-3)" "unprognostic (5.50e-2)" "unprognostic (1.19e-3)" "unprognostic (5.04e-2)" "unprognostic (2.83e-2)" "unprognostic (3.96e-1)" "unprognostic (3.21e-2)" "unprognostic (1.93e-1)" "unprognostic (3.46e-3)" "unprognostic (9.48e-2)" "unprognostic (2.79e-3)" "unprognostic (1.39e-3)" "unprognostic (4.17e-2)" "unprognostic (3.15e-2)" "unprognostic (4.50e-3)" "unprognostic (1.14e-1)" 1.3 1.8 1.7 1.0 1.7 5.9 2.6 2.2 2.2 1.2 1.4 1.0 1.1 0.9 3.4 1.0 1.1 1.6 1.1 1.7 1.7 2.1 3.8 1.4 1.8 1.9 1.7 1.4 1.8 1.6 1.8 1.1 1.9 1.5 0.8 2.0 1.1 2.0 0.8 4.2 1.0 0.6 1.8 2.2 1.9 6.3 1.8 1.3 2.5 0.6 1.3 0.9 1.0 1.9 1.3 1.2 2.6 4.3 0.4 1.6 0.8 0.1 0.5 0.8 1.4 0.6 3.9 3.4 0.6 0.1 1.0 0.2 1.2 1.4 1.0 2.0 2.9 5.0 1.8 0.4 2.9 1.6 0.5 4.1 1.2 0.4 2.8 2.1 0.7 7.2 0.8 4.3 0.3 0.3 2.2 9.1 73.5 1.1 0.8 0.8 1.6 1.7 3.6 0.7 1.1 3.5 1.0 1.4 2.7 1.2 1.0 7.0 0.5 3.3 1.3 1.0 1.4 12.2 23.7 10.1 1.2 3.1 1.6 0.5 0.8 0.4 0.2 1.6 0.0 0.6 0.2 0.1 0.5 0.5 0.2 0.1 1.4 0.7 0.2 1.8 0.0 0.2 1.7 1.7 2.2 2.2 1.7 1.7 1.9 1.7 1.9 1.8 1.8 1.9 1.0 0.0 0.5 6.5 0.9 0.4 0.6 1.4 0.0 0.3 1.3 1.8 0.8 1.5 0.4 1.8 0.0 1.5 1.7 0.9 0.0 0.4 0.5 1.7 0.7 1.2 0.0 0.0 1.7 0.2 1.1 0.6 0.5 0.4 0.0 1.0 1.4 1.0 2.1 1.7 1.5 0.1 2.0 1.6 0.6 0.4 0.9 2.0 0.0 6.5 1.1 1.6 0.0 3.0 5.1 0.5 0.2 0.4 0.2 0.7 0.7 1.2 0.9 2.6 0.0 0.8 0.5 36.3 7.6 0.3 1.1 0.5 0.7 2.7 0.7 0.4 APPL1 APPL ENSG00000157500 "Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1" Q9UKG1 3 57227726-57278105 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "naive B-cell: 28.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011138 Approved Approved "Vesicles,Plasma membrane,Actin filaments,Cytosol" NA No 10000 "Cluster 37: B-cells - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 32: U-937 - Innate immune response" "Cluster 57: B-cells - Immune response" "Vesicles, Plasma membrane" "Actin filaments, Cytosol" "HPA011138: AB_1844959" "unprognostic (1.39e-1)" "unprognostic (3.45e-2)" "unprognostic (1.06e-2)" "unprognostic (2.01e-1)" "unprognostic (3.68e-2)" "unprognostic (2.31e-3)" "unprognostic (1.30e-3)" "unprognostic (1.81e-2)" "unprognostic (1.05e-1)" "unprognostic (8.36e-2)" "unprognostic (9.05e-3)" "unprognostic (5.55e-2)" "prognostic favorable (7.26e-5)" "unprognostic (3.99e-2)" "unprognostic (8.76e-2)" "unprognostic (1.12e-2)" "unprognostic (1.55e-1)" 15.6 11.6 9.5 14.8 9.7 15.1 18.9 12.9 11.3 17.1 6.8 14.2 12.6 17.1 10.6 16.9 11.7 13.0 24.7 9.7 11.3 16.5 12.9 13.6 16.7 9.8 10.1 22.7 29.6 25.1 7.8 14.3 10.1 15.0 14.0 13.5 15.2 14.4 44.2 20.1 14.6 15.3 10.4 15.8 15.2 8.0 10.2 18.9 19.8 26.6 19.6 13.4 11.9 10.7 30.2 12.9 12.2 45.4 21.2 29.7 26.2 15.5 9.5 15.4 17.8 14.9 17.5 47.3 6.2 24.6 24.7 5.9 33.7 27.3 26.6 36.1 15.0 27.6 19.5 16.1 22.7 59.6 19.1 21.8 24.3 19.3 21.3 31.3 25.3 30.2 9.0 30.0 17.8 10.4 48.7 15.4 19.5 21.6 21.7 1.7 49.1 26.1 27.7 16.7 12.5 26.5 21.1 32.3 21.0 16.7 15.7 39.6 23.4 25.1 17.5 37.4 29.9 27.0 41.8 33.2 27.4 29.1 17.1 2.0 5.3 3.8 3.7 4.5 4.9 17.9 3.8 3.3 10.9 28.3 3.3 2.5 1.4 7.4 3.6 18.0 1.9 2.7 9.5 9.7 12.9 11.3 9.7 11.3 9.8 10.1 10.1 10.4 10.2 10.7 82.9 51.3 45.5 19.6 106.6 52.9 47.3 46.9 83.6 40.5 67.2 92.8 100.1 47.1 47.4 42.3 31.3 46.9 70.9 29.0 58.7 58.6 42.5 35.4 92.8 66.2 45.6 20.0 49.7 60.3 44.7 68.6 40.2 59.4 23.4 60.8 40.0 44.1 52.2 52.2 50.4 36.2 42.7 68.6 50.6 22.1 73.0 71.0 19.6 33.7 87.8 56.6 56.7 43.2 62.2 51.7 25.5 76.0 62.8 38.7 41.0 58.8 18.1 55.4 52.6 94.3 61.2 64.9 44.2 105.7 69.6 28.0 45.4 73.7 49.1 25.8 ASB14 DKFZp313L0121 ENSG00000239388 "Ankyrin repeat and SOCS box containing 14" A6NK59 3 57268342-57292685 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "skeletal muscle: 28.1;tongue: 18.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Cardiomyocytes: 8.2;Excitatory neurons: 4.8;Inhibitory neurons: 4.3;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 20: HeLa - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (2.14e-3)" "unprognostic (1.85e-1)" "unprognostic (3.64e-1)" "unprognostic (7.14e-2)" "unprognostic (9.76e-2)" "unprognostic (1.22e-1)" "unprognostic (2.37e-3)" "unprognostic (1.81e-4)" "unprognostic (1.11e-1)" "unprognostic (1.37e-1)" "unprognostic (1.24e-2)" "unprognostic (1.45e-2)" "unprognostic (6.69e-2)" "unprognostic (6.87e-2)" "unprognostic (9.68e-2)" "unprognostic (5.93e-2)" "unprognostic (5.71e-3)" 0.6 0.3 0.1 0.5 0.3 1.9 0.6 1.4 0.4 0.6 0.4 0.4 0.2 0.3 0.0 0.4 0.5 0.2 3.9 0.1 0.2 0.3 0.3 0.6 0.7 0.6 0.3 0.5 1.5 0.0 0.4 0.1 0.4 0.3 0.0 1.6 0.7 0.0 28.1 0.8 0.5 0.0 0.4 0.6 0.5 0.3 0.3 0.0 0.4 18.0 0.0 0.4 0.6 0.5 0.2 0.1 0.1 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.7 0.9 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.2 0.4 1.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.1 0.6 0.0 0.1 0.7 0.9 0.1 0.1 0.3 0.1 0.2 0.2 0.0 0.6 0.2 0.7 0.1 0.3 0.1 0.4 0.3 0.1 0.3 0.1 0.2 0.7 0.6 0.4 0.6 0.4 0.7 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 1.4 0.4 0.1 0.2 0.6 0.3 0.4 0.4 0.3 0.5 0.1 3.2 0.5 2.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.2 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.2 0.2 0.0 0.0 4.8 0.0 0.0 0.2 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.2 0.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 DNAH12 "DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19" ENSG00000174844 "Dynein axonemal heavy chain 12" Q6ZR08 3 57293699-57544344 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Motor protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 5.0;choroid plexus: 7.1;fallopian tube: 10.3;lung: 3.5;testis: 8.9" "Group enriched" "Detected in many" 5 "Endometrial ciliated cells: 230.5;Respiratory ciliated cells: 318.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 9.6" "HPA037493, HPA058203, HPA061365" Enhanced NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493" "unprognostic (4.85e-2)" "unprognostic (1.29e-2)" "unprognostic (2.23e-1)" "unprognostic (2.18e-3)" "unprognostic (2.96e-2)" "unprognostic (2.17e-1)" "unprognostic (2.80e-2)" "unprognostic (1.51e-3)" "unprognostic (3.06e-2)" "unprognostic (3.21e-1)" "unprognostic (4.40e-2)" "unprognostic (5.90e-2)" "unprognostic (3.43e-5)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (2.53e-2)" "unprognostic (5.47e-2)" 0.0 0.2 1.2 0.0 1.0 0.0 0.2 0.7 0.7 0.9 7.1 0.0 0.0 0.3 0.1 0.0 10.3 0.2 0.0 1.3 1.3 0.1 0.1 3.5 0.0 4.5 5.0 0.1 0.7 0.0 0.9 0.0 2.9 0.1 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 2.8 0.0 0.1 8.9 1.2 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 1.0 0.7 0.7 1.3 1.3 4.5 5.0 2.9 2.8 1.2 1.6 0.2 3.2 1.1 13.7 0.2 0.0 0.2 5.4 0.0 0.3 0.8 0.6 1.1 0.0 42.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 49.8 230.5 1.3 0.1 1.8 0.0 3.9 0.0 0.0 1.2 0.0 4.6 1.3 0.3 0.0 0.0 0.1 0.0 3.8 0.0 6.1 0.0 0.0 9.8 0.9 0.7 0.0 2.8 0.1 1.7 0.0 5.0 15.8 0.1 0.0 0.4 0.0 0.1 0.0 0.5 318.9 0.2 0.0 0.7 1.6 28.4 2.7 0.0 0.0 0.0 0.5 5.4 0.1 0.1 PDE12 "2'-PDE, 3635, DKFZp667B1218" ENSG00000174840 "Phosphodiesterase 12" Q6L8Q7 3 57556274-57566848 "Enzymes, Predicted intracellular proteins" "mRNA processing" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043171 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "HPA043171: AB_10794654" "unprognostic (2.79e-1)" "unprognostic (3.18e-1)" "prognostic favorable (2.85e-5)" "unprognostic (2.39e-1)" "unprognostic (1.48e-1)" "unprognostic (9.21e-2)" "unprognostic (1.58e-2)" "unprognostic (8.43e-3)" "unprognostic (1.27e-1)" "unprognostic (6.45e-2)" "unprognostic (2.10e-1)" "unprognostic (9.88e-3)" "prognostic favorable (3.63e-8)" "unprognostic (6.97e-3)" "unprognostic (1.32e-1)" "unprognostic (7.85e-2)" "unprognostic (2.62e-1)" 7.6 8.6 4.1 8.3 4.6 13.9 6.0 5.1 4.4 5.2 4.7 7.2 9.1 5.7 3.9 9.0 4.2 7.1 5.7 4.3 5.2 8.0 10.6 5.5 8.9 3.9 3.9 4.7 9.8 9.2 4.4 7.3 3.5 6.3 6.7 7.3 5.9 6.4 8.4 4.9 7.2 6.9 4.2 7.1 7.2 4.2 3.9 7.0 7.2 7.9 8.1 8.6 4.9 6.2 19.5 18.8 11.5 21.3 14.6 10.3 20.8 16.1 15.3 17.8 15.8 24.9 12.9 31.6 5.9 14.6 23.7 12.5 24.8 16.8 14.5 14.7 12.7 23.5 15.4 19.3 16.6 31.1 23.5 14.2 11.3 21.5 19.0 9.3 15.6 16.1 19.4 22.3 16.3 15.0 28.0 10.2 17.8 15.1 32.0 10.5 9.4 23.0 14.4 22.3 10.2 16.0 17.3 20.2 17.4 9.1 15.0 17.6 19.3 14.7 13.7 28.1 26.4 21.9 34.2 27.4 17.3 24.1 22.2 20.6 9.3 8.7 10.9 12.7 12.3 6.7 10.2 11.3 10.2 11.4 12.4 12.4 2.3 14.9 13.8 5.3 13.5 10.2 4.1 4.6 5.1 4.4 4.3 5.2 3.9 3.9 3.5 4.2 3.9 6.2 15.9 25.6 21.9 32.0 20.0 36.8 18.5 13.2 14.8 21.0 17.9 10.0 10.8 22.8 14.8 31.3 12.5 19.0 23.9 17.9 5.9 10.0 1.3 15.5 19.3 14.6 12.5 20.4 50.8 9.8 11.3 14.6 12.8 21.7 19.7 12.8 13.6 27.8 15.0 26.9 49.0 10.8 10.2 18.5 16.8 1.3 10.5 16.1 12.4 26.2 15.8 18.3 17.5 47.7 56.6 9.0 9.8 12.4 20.4 18.6 14.8 16.5 8.9 31.1 6.6 32.7 15.1 18.6 10.3 21.7 39.6 20.5 19.2 19.7 19.5 19.1 ARF4 ARF2 ENSG00000168374 "ADP ribosylation factor 4" P18085 3 57571363-57598220 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 3100000 "Cluster 38: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.75e-1)" "unprognostic (2.11e-2)" "unprognostic (8.22e-2)" "unprognostic (1.17e-1)" "unprognostic (2.32e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (7.29e-7)" "unprognostic (4.78e-1)" "unprognostic (1.14e-1)" "unprognostic (1.24e-2)" "unprognostic (1.76e-2)" "unprognostic (2.47e-2)" "unprognostic (4.22e-2)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (9.30e-4)" "unprognostic (4.98e-3)" 128.5 162.7 53.5 107.4 56.5 72.6 138.4 56.5 73.3 208.7 75.3 158.9 123.5 121.7 226.7 108.9 96.1 154.8 116.5 56.8 64.5 114.4 172.6 126.3 73.9 57.4 62.3 113.5 151.2 101.5 105.8 181.8 59.6 138.5 197.2 54.0 182.1 132.8 64.8 67.3 109.2 169.2 61.6 66.5 130.9 100.8 58.6 74.9 143.9 69.5 97.3 203.6 91.4 63.6 251.8 90.4 218.5 182.1 516.7 533.3 212.8 617.9 585.5 382.0 483.4 264.4 235.0 89.2 110.3 774.3 334.8 95.4 234.0 353.1 491.3 111.7 76.9 183.4 196.6 351.3 647.1 115.7 127.8 517.3 308.8 355.4 423.8 482.6 480.1 86.8 134.5 173.8 672.8 123.1 69.7 146.8 263.8 333.5 306.5 40.7 173.3 170.5 459.6 175.8 67.5 164.1 252.9 240.1 325.0 298.5 167.9 193.4 369.8 299.8 174.9 447.9 360.6 126.3 116.3 124.0 331.4 220.8 378.3 249.4 85.3 95.4 41.1 72.8 72.2 53.2 58.3 53.5 72.3 48.1 71.4 55.5 102.8 58.2 65.9 109.2 59.9 90.8 53.5 56.5 56.5 73.3 56.8 64.5 57.4 62.3 59.6 61.6 58.6 63.6 172.5 76.9 90.8 18.3 150.2 350.1 505.9 429.6 195.8 32.2 249.8 204.7 48.4 91.5 259.6 97.5 6.2 322.3 146.7 226.5 191.7 287.1 179.1 195.5 197.2 146.5 164.5 232.4 25.2 232.6 448.2 298.4 200.3 301.4 101.7 121.8 101.7 161.0 197.2 18.5 26.9 403.7 248.2 90.1 264.9 72.6 177.0 139.4 241.9 15.9 112.8 156.2 35.0 30.2 30.2 396.8 238.1 185.8 346.8 399.6 180.8 178.5 201.2 27.2 78.9 115.1 345.5 132.4 80.7 188.2 321.9 698.2 133.0 230.4 272.3 599.7 DENND6A "AFI1A, FAM116A, FLJ34969" ENSG00000174839 "DENN domain containing 6A" Q8IWF6 3 57625454-57693077 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 66.9;Inhibitory neurons: 65.4;Oligodendrocytes: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 18.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 18.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062618, HPA069725, HPA071711" Approved Supported Vesicles NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Vesicles "HPA062618: AB_2684809, HPA069725: AB_2686184, HPA071711: AB_2686435" "unprognostic (6.20e-2)" "unprognostic (3.86e-2)" "prognostic favorable (9.21e-4)" "unprognostic (1.76e-1)" "unprognostic (7.75e-2)" "unprognostic (3.17e-1)" "prognostic unfavorable (6.36e-4)" "unprognostic (7.16e-2)" "unprognostic (1.17e-2)" "unprognostic (2.28e-3)" "unprognostic (5.97e-3)" "unprognostic (1.12e-1)" "prognostic favorable (7.77e-6)" "unprognostic (3.06e-1)" "unprognostic (1.63e-1)" "unprognostic (3.61e-3)" "unprognostic (2.94e-1)" 11.6 7.3 3.4 8.8 4.6 12.6 12.9 12.9 7.1 11.8 3.8 10.7 7.1 12.7 9.9 11.4 10.3 8.3 8.0 3.0 5.5 8.9 7.7 10.5 12.6 4.2 4.8 20.9 5.3 11.4 6.6 11.8 5.3 9.9 9.2 10.0 8.4 11.7 7.1 8.6 9.2 11.3 4.7 12.9 9.7 8.0 4.7 11.8 14.0 9.8 10.5 10.7 10.5 8.4 16.8 13.5 18.0 11.0 9.4 10.6 10.2 8.6 11.0 10.5 8.2 8.7 18.4 19.9 3.6 8.9 9.2 8.8 14.4 18.2 8.9 5.1 12.9 15.7 15.1 6.7 9.0 12.1 8.9 11.3 13.0 7.2 18.7 10.6 15.2 21.1 10.8 21.1 7.6 7.3 26.2 14.9 10.2 10.6 9.3 10.9 10.7 14.8 12.8 28.1 6.1 22.0 17.1 13.9 12.5 7.7 9.1 14.7 16.7 12.7 6.8 13.6 22.8 15.7 22.2 20.7 14.8 19.9 18.9 18.7 1.0 1.4 2.4 1.1 2.9 0.8 2.3 2.4 1.3 1.2 3.4 2.6 1.5 1.9 1.4 1.0 1.3 1.0 3.4 4.6 12.9 7.1 3.0 5.5 4.2 4.8 5.3 4.7 4.7 8.4 28.8 19.2 8.2 31.3 14.5 12.9 11.8 10.6 12.0 16.2 9.9 9.1 20.8 11.5 10.0 5.5 8.4 6.4 21.4 5.7 3.9 8.1 22.2 10.1 25.6 16.0 3.0 16.2 66.9 10.9 4.4 15.7 10.2 17.1 2.5 24.1 20.7 11.1 11.1 10.1 65.4 5.5 12.2 34.3 9.9 11.3 11.8 16.8 3.6 47.8 16.8 10.2 20.6 42.3 74.3 18.9 3.5 14.3 9.5 8.4 6.5 8.9 8.0 14.5 6.6 19.2 18.3 13.3 5.0 14.1 10.7 2.3 19.6 16.7 6.1 13.0 SLMAP "KIAA1601, SLAP" ENSG00000163681 "Sarcolemma associated protein" Q14BN4 3 57755450-57930003 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 295.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002357, HPA002358" Enhanced Approved "Endoplasmic reticulum" NA NA 9200 "Cluster 49: Eosinophils - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" "Endoplasmic reticulum" "HPA002357: AB_1080023, HPA002358: AB_1080021" "unprognostic (3.70e-1)" "unprognostic (2.87e-2)" "unprognostic (1.82e-3)" "unprognostic (3.43e-2)" "unprognostic (3.34e-1)" "unprognostic (6.18e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (7.98e-4)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (2.59e-3)" "unprognostic (1.06e-1)" "prognostic favorable (1.58e-6)" "unprognostic (8.18e-2)" "unprognostic (1.93e-1)" "unprognostic (1.92e-2)" "unprognostic (6.08e-2)" 25.9 28.1 8.3 35.2 14.7 15.5 21.9 13.4 9.2 25.6 11.3 126.5 34.0 93.5 14.2 116.8 48.6 31.6 134.7 7.5 7.3 24.9 16.4 17.6 16.4 7.8 7.4 37.5 16.1 36.6 11.5 23.5 8.3 65.6 38.2 20.4 20.1 100.3 64.0 21.5 37.7 137.6 6.5 14.9 52.3 31.8 9.2 19.8 28.7 42.0 18.3 87.5 29.0 8.7 43.3 23.1 23.0 25.7 31.8 28.9 24.2 40.8 41.9 27.0 25.5 59.4 54.6 25.1 17.9 30.4 48.4 23.5 38.5 54.5 36.8 32.2 20.6 49.9 31.1 47.6 29.1 47.8 26.5 20.0 39.1 33.6 60.8 38.1 31.8 25.0 39.7 23.7 28.5 11.7 28.0 20.4 29.7 29.3 38.7 12.4 21.0 28.0 47.7 44.3 10.0 12.8 49.9 37.4 23.7 26.7 19.9 27.4 38.1 33.0 23.1 28.2 52.8 28.9 57.1 36.7 25.5 45.4 27.9 3.3 3.8 10.9 3.6 2.7 3.2 3.7 2.8 3.2 3.2 2.5 3.2 3.4 9.5 5.2 2.4 1.4 4.1 3.6 8.3 14.7 13.4 9.2 7.5 7.3 7.8 7.4 8.3 6.5 9.2 8.7 17.3 38.5 39.6 90.1 25.6 92.0 45.4 49.3 54.1 28.0 25.0 23.7 295.9 40.0 40.0 33.1 50.1 19.0 34.4 53.9 19.6 45.8 40.2 45.9 24.6 22.8 14.4 28.6 113.3 34.3 12.2 28.6 41.3 72.4 3.8 34.8 18.2 22.7 15.6 32.0 121.5 26.8 20.3 20.3 25.9 26.2 32.6 27.8 28.4 76.8 25.1 86.8 34.0 101.0 97.7 64.1 36.6 71.8 39.0 93.3 36.4 24.8 46.5 32.4 52.6 26.8 82.2 87.4 47.0 54.5 73.3 16.3 26.1 52.0 28.7 126.9 FLNB "ABP-278, FH1, FLN1L, LRS1, TABP, TAP" ENSG00000136068 "Filamin B" O75369 3 58008400-58172251 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Differentiation, Myogenesis" "Actin-binding, Developmental protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 344.9;Pancreatic endocrine cells: 385.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 17.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 523.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004747, HPA004886, CAB019322" Enhanced Supported "Golgi apparatus,Plasma membrane,Actin filaments,Cytosol" NA NA 20000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 1: Thyroid gland - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "Golgi apparatus, Actin filaments, Cytosol" "CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600" "unprognostic (1.29e-2)" "unprognostic (1.08e-2)" "unprognostic (5.97e-2)" "unprognostic (6.86e-2)" "unprognostic (1.26e-1)" "unprognostic (2.05e-1)" "unprognostic (6.52e-2)" "unprognostic (1.72e-1)" "unprognostic (9.61e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (8.45e-5)" "unprognostic (9.23e-2)" "prognostic favorable (3.45e-6)" "unprognostic (4.38e-2)" "unprognostic (1.36e-1)" "unprognostic (6.65e-3)" "unprognostic (2.33e-1)" 74.6 63.1 42.8 22.3 51.3 7.4 90.4 50.9 52.4 45.5 57.1 122.2 52.8 75.5 120.3 57.7 75.9 19.6 47.2 40.1 41.6 96.7 71.5 49.9 24.4 54.4 52.3 68.9 83.2 59.9 38.1 48.0 52.6 124.4 74.4 10.2 64.0 51.4 16.3 91.3 92.7 36.2 48.1 55.3 70.2 30.4 50.0 74.8 91.1 17.8 23.8 114.7 58.6 58.3 134.4 225.0 22.3 32.9 14.8 25.0 385.7 49.0 39.3 106.6 108.4 227.1 223.1 21.9 18.1 172.9 172.8 215.9 42.1 311.5 103.0 121.6 20.8 18.4 192.7 110.5 107.8 16.2 63.1 40.2 132.1 148.5 448.3 125.2 365.4 94.7 30.9 6.6 67.0 29.2 49.3 38.5 34.5 146.6 192.1 21.6 5.8 18.7 143.8 224.6 24.7 23.1 247.3 132.6 27.4 160.9 110.3 44.6 523.3 27.8 84.5 334.1 175.6 4.8 1.7 17.0 102.2 29.2 29.9 10.1 0.3 5.0 0.5 0.8 2.7 4.1 1.7 0.8 1.4 1.6 5.1 3.8 0.2 7.3 1.5 17.9 2.0 1.5 42.8 51.3 50.9 52.4 40.1 41.6 54.4 52.3 52.6 48.1 50.0 58.3 133.7 51.3 30.2 3.9 11.0 50.6 42.9 73.2 29.0 3.3 86.6 43.4 10.0 57.2 62.0 47.8 39.6 28.7 36.8 344.9 0.0 93.8 15.6 103.6 24.4 92.9 49.2 10.3 34.1 67.1 207.1 28.8 88.7 133.8 24.7 34.4 151.3 52.0 14.6 1.7 34.3 82.8 38.7 11.3 12.2 22.4 16.1 11.1 5.4 22.5 11.6 9.1 2.1 25.1 40.9 385.7 161.0 27.8 3.4 115.2 157.3 6.5 76.1 10.6 0.0 4.4 25.9 4.4 6.9 46.4 51.7 49.8 9.9 84.6 93.0 88.4 DNASE1L3 "DNAS1L3, LSD" ENSG00000163687 "Deoxyribonuclease 1 like 3" Q13609 3 58192257-58214697 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Necrosis" "Endonuclease, Hydrolase, Nuclease" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "liver: 271.4;lymphoid tissue: 263.5" "Cell type enriched" "Detected in many" 6 "Hepatic stellate cells: 1670.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 424.7" "Lineage enriched" "Detected in many" 20 "dendritic cells: 424.7" "Cell line enhanced" "Detected in some" "BEWO: 1.9;Karpas-707: 1.1;RPMI-8226: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA019955 Approved "Secreted to blood" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 25: RPMI-8226 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA019955: AB_1847805" "unprognostic (7.49e-3)" "unprognostic (3.08e-3)" "unprognostic (9.75e-3)" "unprognostic (3.92e-3)" "unprognostic (2.93e-3)" "unprognostic (1.01e-2)" "prognostic favorable (1.20e-6)" "unprognostic (4.74e-4)" "unprognostic (2.10e-1)" "unprognostic (9.71e-2)" "unprognostic (1.91e-3)" "unprognostic (6.95e-2)" "prognostic favorable (1.06e-7)" "unprognostic (7.57e-2)" "unprognostic (2.47e-1)" "unprognostic (1.57e-1)" "unprognostic (5.64e-3)" 20.6 41.0 0.6 38.0 0.5 2.9 10.3 1.5 0.7 4.4 5.4 31.4 29.7 1.7 1.5 16.9 2.8 7.9 14.7 0.6 0.5 47.7 271.4 18.0 38.7 0.6 0.5 1.1 1.1 1.7 20.3 7.1 0.8 1.8 42.2 0.5 8.7 1.4 1.0 4.5 42.5 3.5 0.5 263.5 5.9 3.8 0.8 22.6 16.5 0.3 54.0 12.0 9.4 1.2 0.0 0.2 0.1 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.7 0.0 0.3 0.1 0.0 0.3 0.0 0.1 0.0 0.7 0.0 0.2 1.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 2.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.3 0.2 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 20.4 0.1 0.1 40.4 20.7 0.1 0.0 0.6 0.5 0.2 424.7 0.0 3.4 0.6 0.5 1.5 0.7 0.6 0.5 0.6 0.5 0.8 0.5 0.8 1.2 126.6 0.0 9.8 0.3 25.7 9.2 0.3 1.1 12.0 0.1 0.9 1.4 1.2 35.8 2.0 0.0 0.0 0.1 76.3 0.5 3.9 0.0 1.9 0.4 0.2 239.9 0.0 85.5 0.1 0.4 1.2 6.1 0.0 0.8 1.3 0.1 1670.9 27.1 0.5 1.7 0.1 0.2 0.0 127.1 144.3 3.2 4.1 18.6 3.6 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.2 0.3 0.1 3.3 0.0 0.2 0.0 0.3 1.3 0.3 0.2 59.3 16.3 0.3 3.8 2.6 0.0 1.0 ABHD6 ENSG00000163686 "Abhydrolase domain containing 6, acylglycerol lipase" Q9BV23 3 58237532-58295693 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 64.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 60.6;Oligodendrocytes: 88.6;Proximal enterocytes: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017283, HPA073225" Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 45: Intestine - Brush border" "Cluster 3: HMC-1 - Innate immune response" "Cluster 2: Hepatocytes - Metabolism" Vesicles Nucleoplasm "HPA017283: AB_1844452, HPA073225: AB_2686583" "unprognostic (4.20e-2)" "unprognostic (7.92e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.35e-2)" "unprognostic (1.16e-2)" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (1.15e-2)" "unprognostic (9.54e-2)" "unprognostic (1.11e-3)" "unprognostic (1.34e-2)" "unprognostic (1.94e-1)" "prognostic favorable (1.11e-11)" "unprognostic (1.94e-1)" "unprognostic (2.41e-1)" "unprognostic (2.72e-1)" "unprognostic (6.31e-2)" 12.2 12.9 24.0 6.4 33.9 0.9 8.9 34.1 32.4 4.4 19.4 12.7 39.5 6.1 14.7 6.4 9.1 5.8 5.7 31.6 26.9 35.6 64.9 8.5 8.0 31.7 32.3 5.0 2.7 8.9 16.6 6.4 31.7 5.5 11.1 9.2 4.0 14.3 4.6 25.5 52.3 9.2 28.8 35.0 12.9 3.9 35.5 5.5 9.1 5.4 7.6 5.8 5.9 49.8 3.5 12.0 1.8 8.5 23.2 4.2 21.2 8.9 8.1 9.2 12.5 6.9 4.8 6.6 0.8 4.7 28.5 9.9 8.3 3.9 8.4 11.3 4.2 5.7 8.1 9.7 7.8 1.7 28.1 3.9 18.4 8.8 3.8 10.6 5.0 10.6 6.8 15.0 7.2 2.6 11.7 0.7 6.1 28.5 27.3 4.2 3.8 14.8 14.5 4.8 10.8 4.4 9.9 5.1 19.0 3.7 3.6 4.5 5.8 6.6 7.0 16.6 10.8 4.2 13.5 0.3 17.1 16.9 9.3 0.0 2.2 1.7 1.6 7.4 1.5 3.6 0.9 1.9 3.7 2.5 0.9 1.1 0.0 0.7 5.2 5.4 1.2 1.0 24.0 33.9 34.1 32.4 31.6 26.9 31.7 32.3 31.7 28.8 35.5 49.8 27.1 0.0 1.8 11.4 13.6 8.7 3.0 2.7 6.2 13.3 2.1 1.5 5.6 5.7 4.9 3.7 4.2 2.0 7.7 11.2 1.9 3.0 1.0 9.8 7.9 14.1 0.0 5.7 33.6 1.9 0.9 2.9 7.7 1.5 11.4 10.1 21.4 60.6 8.9 15.2 34.3 4.0 0.0 16.7 20.0 0.7 6.8 12.1 3.6 11.2 11.5 11.2 6.2 37.7 88.6 1.9 1.4 8.2 2.0 1.8 55.1 17.4 13.8 3.3 0.0 2.9 3.9 0.5 2.2 6.9 24.6 0.5 5.1 16.0 5.8 2.0 RPP14 P14 ENSG00000163684 "Ribonuclease P/MRP subunit p14" O95059 3 58306245-58324695 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 40.8;tongue: 39.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA036194 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Cytosol" "HPA036194: AB_10672082" "unprognostic (6.05e-2)" "unprognostic (2.02e-2)" "unprognostic (1.50e-3)" "unprognostic (1.36e-1)" "unprognostic (4.08e-3)" "unprognostic (2.51e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.95e-3)" "unprognostic (3.76e-2)" "prognostic favorable (3.07e-10)" "unprognostic (5.19e-3)" "unprognostic (2.36e-1)" "prognostic unfavorable (2.96e-4)" "unprognostic (5.78e-2)" 5.1 5.7 3.1 4.6 3.2 4.8 5.0 5.9 4.1 4.6 2.0 6.8 6.8 5.5 3.7 5.9 4.9 4.2 10.9 3.2 2.9 9.1 11.5 4.1 4.0 3.0 2.2 5.5 6.1 7.7 5.9 4.0 3.1 4.7 6.4 5.1 4.9 4.4 40.8 5.3 6.9 7.1 1.7 5.8 5.4 5.1 3.1 6.5 5.5 39.0 6.0 5.2 5.0 3.4 12.3 10.4 11.5 8.2 6.6 9.0 12.3 9.9 11.7 14.5 17.1 15.9 8.0 13.8 2.4 14.4 13.7 7.2 17.6 15.8 14.8 10.6 8.5 12.0 11.9 8.4 7.8 24.4 10.7 8.4 12.1 18.6 16.3 5.2 12.1 18.2 12.0 7.8 14.3 6.5 16.2 7.9 11.9 10.5 17.9 6.8 8.4 14.0 9.6 18.9 6.9 11.8 10.2 9.8 11.9 7.3 11.0 8.6 11.1 10.4 11.7 10.5 20.4 13.0 28.3 22.3 11.2 17.1 6.7 2.1 3.4 2.6 2.1 2.8 3.0 2.1 2.7 3.2 3.9 3.0 3.2 3.5 4.0 5.5 6.0 3.9 1.8 2.1 3.1 3.2 5.9 4.1 3.2 2.9 3.0 2.2 3.1 1.7 3.1 3.4 9.0 9.6 11.9 6.2 8.2 31.2 8.1 21.1 17.1 26.3 8.2 7.6 28.4 7.2 11.8 3.7 25.0 8.4 9.4 14.9 11.7 5.7 0.8 8.2 12.4 10.6 9.6 7.6 18.4 6.2 5.9 11.5 13.3 8.2 3.8 11.5 11.4 21.3 6.2 18.5 18.2 11.8 16.2 11.0 20.0 1.7 12.5 9.7 23.2 13.1 9.2 13.2 7.2 10.6 11.2 7.8 7.6 9.8 14.2 8.1 16.2 11.4 9.7 28.3 0.0 14.1 13.7 11.9 15.3 20.4 43.0 10.3 9.2 15.0 13.7 6.5 HTD2 ENSG00000255154 "Hydroxyacyl-thioester dehydratase type 2" P86397 3 58306262-58320193 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 44.1" "Cell type enhanced" "Detected in some" "Club cells: 1.3;granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066812, HPA077228" Approved Supported Nucleoli,Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 60: Granulocytes - Receptor signaling" Mitochondria Nucleoli "HPA066812: AB_2685727, HPA077228: " "unprognostic (1.95e-1)" "unprognostic (3.20e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "unprognostic (2.28e-2)" "unprognostic (2.01e-1)" "unprognostic (2.56e-1)" "unprognostic (2.05e-1)" "unprognostic (9.19e-3)" "unprognostic (1.11e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "unprognostic (7.50e-2)" "unprognostic (3.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-2)" 7.7 7.2 4.3 6.5 5.0 7.2 8.7 7.3 5.5 6.8 4.7 8.9 12.1 8.4 5.9 8.7 7.8 6.8 12.5 4.8 5.6 11.1 15.2 5.7 6.8 3.6 4.6 12.1 7.4 12.0 5.7 6.7 4.6 7.1 9.1 9.2 7.4 8.6 44.1 7.9 8.7 7.6 4.3 7.2 7.0 7.4 4.5 6.6 10.4 37.8 8.0 6.9 4.9 5.5 10.4 7.1 10.9 8.7 11.6 11.2 15.1 13.8 10.2 17.0 14.4 15.9 7.7 19.9 4.0 10.1 12.8 8.7 18.5 12.6 16.8 11.0 13.1 13.7 16.1 13.9 11.3 16.7 11.4 15.1 15.1 17.3 11.4 11.0 14.6 14.3 12.2 19.9 11.1 6.4 11.2 8.9 17.2 10.2 17.3 7.2 7.2 14.7 12.5 13.8 7.0 10.5 8.4 9.4 17.2 12.1 10.9 15.9 8.1 14.5 10.8 14.3 17.2 15.4 27.6 15.7 12.7 11.9 9.8 17.9 19.2 29.2 19.7 23.7 21.5 28.1 20.0 25.2 20.2 27.6 27.5 21.3 13.6 24.9 20.4 24.5 15.6 15.7 4.3 5.0 7.3 5.5 4.8 5.6 3.6 4.6 4.6 4.3 4.5 5.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PXK "FLJ20335, Slob" ENSG00000168297 "PX domain containing serine/threonine kinase like" Q7Z7A4 3 58332880-58426127 "Enzymes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 320.5" "Cell type enriched" "Detected in all" 9 "Oligodendrocytes: 732.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 159.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024068 Supported Supported "Plasma membrane,Centriolar satellite,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 32: U-937 - Innate immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "Plasma membrane, Centriolar satellite" "HPA024068: AB_1855967" "unprognostic (2.98e-2)" "unprognostic (3.29e-1)" "unprognostic (2.71e-3)" "unprognostic (1.61e-1)" "unprognostic (2.40e-1)" "unprognostic (6.62e-3)" "unprognostic (5.03e-3)" "prognostic favorable (5.68e-4)" "unprognostic (3.90e-1)" "unprognostic (8.09e-2)" "unprognostic (3.48e-2)" "unprognostic (1.21e-1)" "unprognostic (1.38e-3)" "unprognostic (2.14e-1)" "unprognostic (1.06e-1)" "unprognostic (1.03e-1)" "unprognostic (2.86e-2)" 19.9 16.7 71.6 31.5 161.3 73.1 15.8 112.3 109.2 46.7 20.4 23.3 10.6 23.5 8.4 11.3 17.5 15.5 17.8 84.1 115.0 18.2 11.6 20.6 43.0 158.2 131.3 18.3 15.7 21.2 13.4 29.7 154.1 12.8 10.5 35.6 14.8 11.7 18.8 14.3 19.3 18.7 82.1 25.2 16.3 12.4 119.0 13.7 63.1 14.3 44.9 19.5 30.2 320.5 13.7 6.9 6.8 12.0 79.7 70.0 17.8 22.6 42.5 19.7 27.3 4.0 3.1 74.7 5.1 33.6 28.4 4.2 18.7 13.2 21.8 18.5 12.5 13.1 11.3 5.8 87.5 112.8 22.5 57.4 31.6 24.6 42.0 72.5 17.8 49.1 15.7 26.1 35.7 5.3 26.2 122.2 7.8 4.1 19.7 40.7 9.4 13.4 12.6 8.0 6.0 4.0 14.2 11.0 19.0 10.7 34.8 122.9 17.9 24.9 11.0 48.5 23.9 19.4 21.6 73.7 36.2 159.3 10.7 39.5 44.6 69.1 23.8 37.2 20.7 62.6 17.1 20.3 41.8 69.6 15.3 17.5 73.5 21.6 57.1 32.1 21.1 32.0 71.6 161.3 112.3 109.2 84.1 115.0 158.2 131.3 154.1 82.1 119.0 320.5 20.1 9.6 6.3 28.4 59.8 14.1 5.8 5.6 7.4 31.0 5.9 7.1 13.1 7.2 6.0 23.9 20.9 19.7 31.7 8.3 33.2 7.1 69.7 9.1 33.0 14.2 7.8 19.3 33.8 5.7 6.8 41.5 6.1 16.0 19.7 15.2 16.4 7.5 13.6 20.2 53.7 5.0 2.0 24.5 31.1 38.3 30.7 25.2 17.8 30.0 28.6 32.7 30.9 79.4 732.6 3.0 5.5 25.2 17.6 6.0 8.7 12.2 6.4 22.2 19.7 18.7 18.2 16.8 21.9 10.1 13.1 35.2 16.9 18.3 5.0 3.9 PDHB PDHE1B ENSG00000168291 "Pyruvate dehydrogenase E1 subunit beta" P11177 3 58427630-58433857 "Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 299.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 300.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033794, HPA036744, HPA036745" Enhanced Supported Nucleoplasm,Mitochondria No No 61000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Nucleoplasm "CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285" "unprognostic (2.06e-2)" "unprognostic (1.79e-1)" "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (7.22e-2)" "unprognostic (1.42e-1)" "unprognostic (3.20e-2)" "unprognostic (6.13e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (3.98e-1)" "unprognostic (2.35e-1)" "prognostic favorable (2.79e-8)" "unprognostic (2.67e-1)" "unprognostic (8.37e-2)" "unprognostic (1.06e-2)" "unprognostic (9.85e-2)" 59.9 76.5 48.7 42.2 50.2 25.7 42.9 53.9 62.7 43.3 63.6 56.8 42.5 38.5 44.6 57.4 37.7 35.9 175.0 49.7 52.3 100.8 110.7 36.4 53.1 51.7 49.4 26.5 36.4 88.8 44.1 57.0 51.5 48.5 60.4 30.7 45.9 52.1 272.6 36.8 37.6 63.8 51.6 42.8 53.9 42.3 53.1 53.1 40.8 299.4 56.0 49.7 35.9 54.3 66.5 90.9 92.3 69.8 91.7 111.1 110.4 81.6 101.3 117.9 120.6 165.1 62.6 140.3 44.9 103.8 109.0 37.6 113.2 74.9 90.0 81.7 83.0 125.4 163.7 126.0 92.5 103.0 67.9 97.9 67.7 95.5 55.8 137.5 103.1 114.2 65.9 61.5 129.5 63.1 98.2 107.8 127.2 69.2 101.3 46.3 71.8 136.1 188.1 89.1 63.7 70.2 75.6 107.2 85.4 131.3 159.0 108.7 76.3 62.9 83.7 66.8 94.2 85.2 129.9 99.2 96.2 120.8 60.7 57.8 98.9 98.7 83.2 115.1 87.9 102.2 81.7 80.5 141.1 103.4 90.9 82.4 19.6 129.4 109.7 94.7 113.2 124.1 48.7 50.2 53.9 62.7 49.7 52.3 51.7 49.4 51.5 51.6 53.1 54.3 57.8 60.9 34.5 5.9 45.3 27.9 40.7 142.0 26.7 31.8 29.4 31.6 300.6 48.6 96.0 35.0 25.0 174.1 35.3 41.0 230.9 95.9 76.3 37.0 37.3 58.0 58.0 22.5 10.9 72.2 101.6 54.1 29.6 34.2 39.3 48.5 46.1 76.1 84.6 57.2 13.3 50.4 162.8 37.9 26.6 16.9 60.3 37.2 56.9 9.4 76.5 61.7 70.0 9.0 13.6 55.9 43.0 51.1 38.8 19.1 45.8 146.8 70.7 45.9 65.7 30.8 72.3 98.2 88.3 42.8 29.8 157.2 44.7 224.4 53.0 37.7 KCTD6 "KCASH3, MGC27385" ENSG00000168301 "Potassium channel tetramerization domain containing 6" Q8NC69 3 58492096-58502360 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 62.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036100, HPA036101" Uncertain Approved Nucleoli,Mitochondria NA NA "Cluster 38: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" "Nucleoli, Mitochondria" "HPA036100: AB_10673230, HPA036101: AB_2674941" "unprognostic (8.63e-3)" "unprognostic (1.28e-2)" "unprognostic (3.37e-2)" "unprognostic (5.71e-2)" "unprognostic (9.00e-3)" "unprognostic (2.45e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (3.19e-2)" "unprognostic (1.81e-1)" "unprognostic (4.67e-3)" "unprognostic (9.36e-3)" "unprognostic (7.48e-2)" "prognostic favorable (8.63e-4)" "unprognostic (1.56e-2)" "unprognostic (1.71e-1)" "unprognostic (3.48e-1)" "unprognostic (2.44e-2)" 9.7 9.3 32.4 5.2 34.1 17.1 12.8 41.4 40.7 13.6 35.5 12.5 6.6 13.8 30.9 14.1 13.7 9.9 10.2 37.5 30.2 20.9 17.1 7.7 8.6 32.7 33.9 14.7 8.2 11.2 20.5 12.8 32.2 11.1 9.0 45.8 7.7 10.2 8.7 8.6 8.0 12.6 31.4 11.1 8.3 6.8 31.1 8.5 14.0 12.5 8.8 9.7 14.5 43.0 10.2 9.5 27.8 12.0 23.9 16.9 10.4 12.0 10.7 17.4 20.3 9.2 5.5 20.0 3.9 8.6 20.3 5.4 22.8 7.0 15.4 20.7 10.4 9.3 24.4 11.2 11.3 7.1 7.2 10.4 10.8 13.8 8.7 41.0 11.6 6.9 5.2 9.2 15.2 9.6 11.0 11.3 20.4 9.1 17.8 10.9 7.7 14.3 16.7 4.7 15.5 13.6 6.6 15.5 8.7 21.2 62.9 5.3 6.3 15.6 14.4 20.1 18.4 10.1 16.9 23.6 13.7 14.8 12.2 27.2 16.3 11.4 14.5 17.0 16.9 14.3 10.6 13.8 23.1 11.3 11.9 10.1 5.3 9.6 12.5 8.9 11.4 8.2 32.4 34.1 41.4 40.7 37.5 30.2 32.7 33.9 32.2 31.4 31.1 43.0 5.7 3.2 2.7 30.3 6.9 8.9 10.5 4.1 8.6 20.8 6.7 4.6 8.8 10.0 8.0 9.2 25.0 10.1 10.7 4.2 19.6 8.5 5.0 3.8 6.8 8.7 9.1 8.6 14.8 4.0 6.8 11.9 2.0 3.9 0.0 52.2 8.9 6.9 6.7 25.2 19.7 4.4 10.2 9.1 14.3 2.2 10.8 6.5 12.4 5.6 11.7 23.2 10.3 14.1 19.6 3.7 5.8 12.0 3.7 9.3 4.5 28.4 3.7 19.2 0.0 9.3 8.2 13.8 22.9 11.5 10.1 8.8 5.0 12.9 6.4 4.0 ACOX2 "BRCACOX, BRCOX, THCCox" ENSG00000168306 "Acyl-CoA oxidase 2" Q99424 3 58505136-58537283 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 177.3" "Cell type enhanced" "Detected in many" "Hepatocytes: 89.0;Proximal enterocytes: 27.9;Proximal tubular cells: 51.0" "Cancer enhanced" "Detected in many" "liver cancer: 25.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 16.4;ASC TERT1: 25.9;fHDF/TERT166: 9.2;Hep G2: 10.8;HSkMC: 17.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA038280, HPA064845" Enhanced Approved Vesicles,Cytosol No No 29000 "Cluster 85: Liver - Metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 2: Hepatocytes - Metabolism" Vesicles Cytosol "HPA038280: AB_10672623, HPA064845: AB_2685368" "unprognostic (6.62e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-1)" "unprognostic (2.51e-2)" "unprognostic (8.34e-2)" "unprognostic (1.48e-2)" "unprognostic (8.67e-3)" "unprognostic (6.45e-2)" "unprognostic (1.00e-1)" "unprognostic (1.85e-1)" "unprognostic (1.70e-3)" "unprognostic (1.26e-2)" "unprognostic (1.68e-3)" "unprognostic (4.00e-3)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (5.63e-3)" 8.8 8.3 4.1 2.1 4.6 0.1 5.8 4.4 4.5 9.3 16.8 12.9 25.4 9.4 5.8 6.3 10.8 8.2 16.7 4.3 4.5 42.1 177.3 6.2 1.7 5.3 4.8 11.2 4.6 9.6 4.6 3.4 4.4 10.8 8.3 1.8 7.2 9.8 8.2 2.9 21.6 11.2 4.5 1.4 4.0 4.9 4.9 4.0 16.1 17.0 1.2 8.7 6.0 4.1 0.0 0.0 0.2 0.0 16.4 25.9 4.7 3.1 0.2 0.0 0.4 0.8 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 2.3 0.0 0.0 17.4 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 4.6 4.4 4.5 4.3 4.5 5.3 4.8 4.4 4.5 4.9 4.1 1.9 3.2 5.8 11.1 0.6 0.6 7.6 0.5 5.7 0.3 1.3 3.8 14.3 4.3 0.9 3.7 0.0 0.7 0.0 4.2 15.6 0.3 0.1 0.4 1.3 1.6 3.0 2.7 0.6 1.9 0.4 8.6 2.0 0.2 1.3 8.6 6.1 89.0 5.2 1.7 0.6 5.1 0.0 1.9 0.4 1.8 10.8 1.7 0.0 1.0 0.5 10.8 0.0 0.5 0.0 0.4 0.8 8.6 0.1 0.6 27.9 51.0 0.0 0.8 6.6 7.0 5.2 0.4 0.4 3.0 0.3 0.8 0.3 9.6 4.6 3.8 FAM107A "DRR1, TU3A" ENSG00000168309 "Family with sequence similarity 107 member A" O95990 3 58564117-58627610 "Predicted intracellular proteins" "Cell cycle, Growth regulation, Stress response" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "brain: 1923.8;choroid plexus: 1389.1" "Cell type enhanced" "Detected in many" "Adipocytes: 196.3;Astrocytes: 81.9;Endothelial cells: 121.3;Hepatic stellate cells: 150.6;Muller glia cells: 125.0" "Cancer enriched" "Detected in many" 6 "glioma: 110.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "ASC diff: 20.7;HUVEC TERT2: 64.9" "Low region specificity" "Detected in all" HPA055888 Enhanced Supported "Nuclear speckles" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear speckles" "HPA055888: AB_2682957" "unprognostic (1.20e-2)" "unprognostic (1.19e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (3.11e-1)" "unprognostic (7.80e-3)" "prognostic favorable (3.38e-4)" "unprognostic (1.92e-1)" "unprognostic (1.64e-1)" "unprognostic (5.73e-2)" "unprognostic (7.82e-3)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (1.33e-2)" "unprognostic (2.82e-1)" "unprognostic (1.92e-1)" "unprognostic (7.95e-3)" 73.2 7.5 1824.7 8.3 1801.2 0.3 58.6 1490.8 1923.8 34.5 1389.1 36.9 5.4 36.3 53.3 29.2 87.0 16.0 140.4 1745.7 1736.7 45.0 5.5 93.2 3.1 1611.9 1644.5 11.8 23.3 5.9 109.6 29.4 1613.0 80.5 16.0 85.1 40.6 38.0 26.3 23.3 45.2 42.5 1564.5 25.7 37.7 5.7 1698.7 43.9 51.4 32.8 8.6 68.9 41.6 1770.4 0.0 0.0 0.9 0.0 20.7 1.3 0.3 0.1 0.0 0.1 0.2 0.0 0.1 0.1 5.8 0.0 0.2 0.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 1.4 0.0 0.1 0.1 0.3 64.9 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.2 0.0 3.6 0.3 0.2 0.2 0.1 0.1 0.0 0.1 1.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1824.7 1801.2 1490.8 1923.8 1745.7 1736.7 1611.9 1644.5 1613.0 1564.5 1698.7 1770.4 196.3 6.4 5.5 81.9 0.5 2.2 50.8 0.3 2.2 5.2 2.3 1.3 26.5 4.3 3.2 38.6 52.1 0.1 0.4 0.0 9.8 1.1 14.5 23.2 2.4 121.3 3.6 2.7 1.4 0.2 0.0 18.4 0.0 39.3 1.3 5.9 150.6 1.6 0.0 3.3 5.3 0.0 0.0 2.2 3.7 32.4 32.9 1.9 5.4 14.0 0.0 125.0 0.0 2.0 0.6 0.3 0.0 11.7 1.3 7.3 0.2 4.5 2.3 50.2 6.6 6.6 10.4 0.7 0.4 0.4 2.7 0.0 1.0 0.5 0.0 2.2 FAM3D "EF7, OIT1" ENSG00000198643 "FAM3 metabolism regulating signaling molecule D" Q96BQ1 3 58633946-58666834 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 264.8;intestine: 488.7;salivary gland: 468.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 794.8;Intestinal goblet cells: 1150.1;Paneth cells: 776.7;Proximal enterocytes: 353.1;Undifferentiated cells: 760.0" "Cancer enriched" "Detected in many" 4 "colorectal cancer: 151.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 3.7" "Lineage enhanced" "Detected in single" "granulocytes: 3.7" "Cell line enriched" "Detected in some" 65 "OE19: 68.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA013844 Approved "Secreted to digestive system" NA NA 15000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA013844: AB_2668897" "prognostic favorable (7.51e-4)" "unprognostic (1.07e-1)" "unprognostic (2.08e-2)" "unprognostic (9.67e-2)" "unprognostic (5.51e-2)" "prognostic favorable (1.89e-4)" "unprognostic (7.97e-2)" "unprognostic (6.54e-2)" "unprognostic (7.43e-2)" "unprognostic (5.48e-2)" "unprognostic (2.23e-2)" "unprognostic (1.42e-1)" "unprognostic (8.68e-2)" "unprognostic (1.64e-1)" "unprognostic (2.00e-1)" "unprognostic (6.97e-4)" "unprognostic (2.34e-2)" 0.9 0.1 0.2 29.6 0.1 0.0 18.5 0.0 0.5 31.3 0.1 362.0 89.2 0.6 0.2 264.8 0.8 81.6 0.2 0.2 0.1 1.1 0.2 4.8 0.6 0.1 0.2 0.1 1.7 0.0 0.4 1.0 0.1 14.8 488.7 0.0 468.4 68.4 0.1 2.6 90.4 8.3 0.1 0.2 78.2 0.3 0.3 0.4 1.5 0.0 41.1 12.7 59.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.3 0.1 0.4 0.2 68.5 0.0 0.1 0.1 0.3 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.1 0.2 0.1 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.7 0.0 0.3 0.0 0.0 0.4 0.2 0.1 0.0 0.5 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.6 0.0 1.1 0.3 3.4 0.0 9.9 223.1 0.0 0.0 29.5 53.8 0.2 47.1 133.4 14.7 0.0 0.0 1.3 794.8 0.0 1.3 0.5 0.0 0.0 2.5 152.1 0.0 0.1 0.0 0.0 0.8 114.2 0.2 8.9 0.0 0.4 0.2 0.3 0.0 0.1 1150.1 18.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 776.7 0.0 0.2 68.2 353.1 1.2 43.1 0.0 0.0 0.0 4.9 0.1 0.6 7.9 0.1 0.4 2.0 0.0 760.0 245.0 CFAP20DC "C3orf67, FLJ42117, FLJ42930" ENSG00000163689 "CFAP20 domain containing" Q6ZVT6 3 58717365-59050084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "esophagus: 7.9;testis: 22.1" "Cell type enhanced" "Detected in some" "Extravillous trophoblasts: 1.9;Hofbauer cells: 1.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069696 Approved "Golgi apparatus" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA069696: AB_2686174" "unprognostic (4.59e-1)" "unprognostic (4.63e-3)" "unprognostic (1.99e-1)" "unprognostic (4.49e-5)" "unprognostic (1.91e-1)" "unprognostic (9.33e-3)" "unprognostic (1.67e-3)" "unprognostic (3.72e-1)" "unprognostic (2.43e-1)" "unprognostic (6.68e-3)" "unprognostic (8.95e-2)" "unprognostic (6.19e-2)" "unprognostic (4.28e-2)" "unprognostic (8.82e-2)" "unprognostic (3.06e-2)" "unprognostic (7.79e-2)" "unprognostic (2.81e-2)" 0.3 1.1 0.5 0.7 0.6 0.2 0.5 0.0 0.7 1.0 0.1 0.5 0.0 0.3 0.3 7.9 2.9 0.5 0.1 0.7 0.4 0.5 1.0 0.4 1.6 0.6 0.7 0.2 0.5 0.7 1.9 1.1 0.4 0.3 0.7 0.4 2.0 0.2 0.0 0.3 0.1 0.3 0.3 0.3 0.4 22.1 0.5 0.5 0.3 0.1 3.2 0.2 2.2 0.3 11.2 1.8 3.0 0.0 1.8 5.7 0.0 5.2 1.7 2.3 1.8 1.0 3.6 11.6 1.7 1.2 0.0 1.1 4.8 2.5 4.0 1.8 0.3 0.0 1.9 0.0 0.9 0.0 0.0 1.1 2.4 4.8 3.9 2.8 4.7 7.6 9.0 0.1 3.1 1.5 0.6 0.0 3.8 3.6 7.7 11.3 0.0 4.8 2.4 0.1 7.8 3.6 1.4 1.1 3.4 5.0 3.5 0.0 0.1 0.2 3.4 5.6 2.4 4.6 10.3 2.3 2.6 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.6 0.0 0.7 0.7 0.4 0.6 0.7 0.4 0.3 0.5 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 FHIT "AP3Aase, FRA3B" ENSG00000189283 "Fragile histidine triad diadenosine triphosphatase" P49789 3 59747277-61251459 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Hydrolase "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 94.0" "Cell type enhanced" "Detected in many" "Astrocytes: 609.8;Inhibitory neurons: 450.5;Microglial cells: 337.3;Oligodendrocyte precursor cells: 1086.7;Oligodendrocytes: 1111.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "naive CD4 T-cell: 87.6" "Lineage enriched" "Detected in all" 12 "T-cells: 87.6" "Cell line enhanced" "Detected in many" "RPMI-8226: 17.5;U-266/70: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002684, HPA018840, HPA018909" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane" NA NA 12000 "Cluster 32: T-cells - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoli fibrillar center, Plasma membrane" "CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537" "unprognostic (2.36e-3)" "unprognostic (6.38e-2)" "unprognostic (1.59e-1)" "unprognostic (4.42e-2)" "unprognostic (1.10e-1)" "unprognostic (1.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.16e-2)" "unprognostic (2.77e-2)" "unprognostic (8.49e-2)" "unprognostic (2.36e-1)" "unprognostic (6.77e-2)" "prognostic favorable (1.36e-4)" "unprognostic (1.54e-1)" "unprognostic (5.96e-2)" "unprognostic (1.29e-2)" "unprognostic (1.80e-2)" 5.6 24.4 13.7 6.2 18.3 8.0 9.0 13.0 17.3 5.4 94.0 6.9 6.4 3.5 6.9 5.0 6.6 9.8 15.8 19.7 16.4 24.9 9.6 4.7 7.6 18.9 17.0 6.8 13.0 18.1 7.9 3.0 18.9 5.3 5.8 7.6 8.5 4.7 10.6 8.1 5.3 4.7 15.0 5.0 8.6 5.5 15.9 12.1 11.7 7.2 5.3 6.7 4.2 19.8 0.1 0.0 1.4 0.0 0.6 0.1 2.5 0.1 0.2 0.1 0.0 2.7 4.2 4.0 0.7 0.1 3.0 0.0 12.7 3.2 0.0 2.2 5.0 3.3 2.0 6.4 3.3 8.7 0.1 9.1 5.2 0.2 6.9 0.3 0.0 3.7 2.5 11.9 0.2 3.6 15.2 6.7 1.2 12.2 0.9 11.3 0.0 17.5 15.3 2.0 2.9 4.3 1.5 9.9 10.1 5.3 0.4 0.2 0.0 1.7 0.4 0.1 2.4 34.6 11.3 0.0 4.0 0.1 1.9 6.8 4.6 0.5 2.2 2.9 1.4 4.1 17.2 1.8 5.7 3.1 87.6 15.6 0.8 7.2 1.3 5.8 20.5 11.9 13.7 18.3 13.0 17.3 19.7 16.4 18.9 17.0 18.9 15.0 15.9 19.8 4.1 6.4 10.6 609.8 19.7 7.6 20.7 30.0 46.7 12.6 41.2 31.2 10.0 38.6 17.5 27.6 58.4 42.0 12.4 6.9 78.2 19.1 45.8 14.6 7.9 7.0 7.7 17.7 276.6 4.7 8.5 10.1 18.3 19.0 5.7 25.7 14.6 23.4 20.9 30.3 450.5 12.9 22.4 10.2 7.1 163.0 19.3 12.9 12.4 337.3 8.6 19.7 6.2 1086.7 1111.0 9.7 15.0 9.8 23.8 12.0 20.7 126.6 12.4 20.7 0.0 10.7 6.2 19.1 7.5 33.7 11.2 32.7 11.5 23.0 20.1 18.8 PTPRG "PTPG, RPTPG" ENSG00000144724 "Protein tyrosine phosphatase receptor type G" P23470 3 61561569-62297609 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Astrocytes: 356.8;Excitatory neurons: 416.1;Inhibitory neurons: 684.3;Microglial cells: 771.0;Oligodendrocyte precursor cells: 920.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 81.7;HSkMC: 61.1" "Low region specificity" "Detected in all" "HPA000546, HPA064237" Uncertain Approved "Plasma membrane" NA NA 520000000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 68: Oligodendrocytes - Mixed function" "Plasma membrane" "HPA000546: , HPA064237: AB_2685221" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (3.26e-1)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (5.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.86e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.10e-6)" "unprognostic (9.91e-2)" "unprognostic (3.25e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" 18.0 13.2 7.6 4.6 7.8 0.0 12.8 4.9 10.4 11.9 23.4 8.2 3.7 10.6 8.4 4.1 9.0 8.3 10.0 13.7 6.2 14.4 5.8 12.8 1.8 8.4 7.2 12.0 3.9 26.6 5.2 9.9 5.9 7.8 6.1 8.6 5.2 8.4 7.4 4.5 5.9 13.0 10.0 7.0 5.8 7.7 9.1 2.1 13.1 10.4 1.7 7.0 6.7 5.0 0.0 5.3 27.3 0.0 81.7 41.6 13.5 17.6 28.5 18.2 24.4 13.2 0.5 0.6 10.1 20.7 14.5 0.2 13.4 13.6 28.3 1.5 7.7 1.4 0.1 15.0 27.5 7.5 0.1 61.1 5.3 25.9 30.9 5.8 19.7 2.0 0.0 17.3 16.3 7.6 0.0 0.1 17.0 0.1 0.0 11.9 8.6 0.6 18.2 8.2 2.1 4.5 4.3 0.1 6.9 11.2 0.2 0.3 46.0 25.4 24.1 41.0 14.7 5.5 6.8 0.0 19.2 3.2 31.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.6 7.8 4.9 10.4 13.7 6.2 8.4 7.2 5.9 10.0 9.1 5.0 45.3 12.8 32.4 356.8 2.2 9.2 6.4 5.0 13.1 98.5 9.6 6.3 12.5 8.6 5.8 22.0 6.2 10.5 0.9 12.1 5.9 9.6 3.6 14.4 31.9 55.5 24.6 0.0 416.1 1.8 0.8 47.7 4.1 30.5 0.0 64.6 90.3 32.7 19.7 154.8 684.3 8.9 22.4 2.9 8.8 4.3 66.5 1.1 17.8 771.0 0.6 40.8 2.1 920.3 11.8 5.3 5.6 56.8 4.2 10.9 13.9 18.2 2.8 5.7 72.3 81.1 60.6 2.0 8.6 2.1 4.8 12.6 2.3 20.0 12.1 2.7 C3orf14 HT021 ENSG00000114405 "Chromosome 3 open reading frame 14" Q9HBI5 3 62319015-62336213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 159.7;Spermatocytes: 173.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 28.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 408.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048286 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Plasma membrane" Cytosol "HPA048286: AB_2680340" "unprognostic (8.00e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "unprognostic (3.69e-3)" "unprognostic (6.91e-2)" "unprognostic (9.19e-2)" "unprognostic (5.76e-5)" "unprognostic (1.57e-3)" "unprognostic (2.67e-1)" "unprognostic (9.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "prognostic favorable (4.33e-5)" "unprognostic (8.19e-2)" "unprognostic (1.73e-2)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" 7.6 15.9 35.4 5.9 37.3 1.3 35.6 32.3 44.5 6.7 23.0 8.3 3.5 7.8 8.1 18.8 4.2 6.5 10.2 37.6 36.7 15.0 3.4 6.9 5.8 32.2 31.4 9.1 12.6 3.8 31.0 5.0 33.0 17.9 4.3 27.2 12.4 5.5 1.3 17.3 4.8 7.1 33.5 4.3 6.2 32.8 33.8 3.7 9.1 1.3 9.2 12.7 9.3 33.0 0.1 22.1 27.2 0.0 18.9 24.8 19.3 33.6 21.2 41.7 41.0 0.3 36.8 0.0 0.1 20.4 84.6 6.7 0.0 21.4 32.1 0.0 14.5 20.5 0.0 0.0 12.0 0.3 45.2 11.3 28.9 47.8 39.6 0.9 21.0 0.0 2.4 0.3 43.0 408.7 0.0 0.0 33.4 31.9 41.9 0.1 0.0 11.8 37.0 64.3 45.9 40.8 21.3 90.0 38.7 20.5 34.0 25.1 0.5 22.2 0.2 105.1 34.8 24.1 0.0 0.0 22.1 0.0 78.4 9.2 4.7 0.7 0.2 17.9 0.0 4.1 3.9 3.3 5.4 1.4 1.1 0.8 0.5 0.9 28.1 7.6 7.9 2.4 35.4 37.3 32.3 44.5 37.6 36.7 32.2 31.4 33.0 33.5 33.8 33.0 8.7 22.4 11.8 11.8 3.3 36.8 23.6 41.5 31.3 34.7 90.2 77.0 7.7 11.5 38.1 22.0 4.2 21.4 8.0 2.6 60.7 35.7 159.7 11.3 14.8 12.1 87.4 2.1 34.8 55.1 19.6 20.9 4.1 12.6 1.3 7.9 5.7 3.1 32.0 37.0 33.4 3.8 44.7 10.0 27.2 62.9 14.0 13.4 46.2 3.7 56.6 35.4 0.0 13.0 15.8 35.8 0.8 10.5 0.5 21.8 2.7 41.5 12.3 28.0 0.0 15.8 21.6 173.2 53.5 30.8 28.7 9.9 5.0 20.6 3.9 23.3 FEZF2 "FEZL, FKSG36, FLJ10142, TOF, Zfp312, ZNF312" ENSG00000153266 "FEZ family zinc finger 2" Q8TBJ5 3 62369681-62374324 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "brain: 179.0" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 51.5" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Group enriched" "Detected in all" 6 "cerebral cortex: 179.0;hippocampal formation: 60.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "AF22: 1.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 12.2;cerebral cortex: 12.1;hippocampal formation: 21.3" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 12: NES - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (2.37e-1)" "unprognostic (1.74e-2)" "unprognostic (1.70e-1)" 0.1 0.0 13.7 0.0 15.6 0.0 0.0 3.8 179.0 0.0 4.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.1 4.6 0.1 0.0 0.0 0.0 18.9 4.1 0.0 0.0 0.0 0.7 0.0 13.4 0.0 0.0 5.7 0.0 0.0 0.1 0.0 0.0 0.0 5.8 0.1 0.2 0.0 4.8 2.8 0.0 0.0 0.0 0.0 0.0 21.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 15.6 3.8 179.0 60.1 4.6 18.9 4.1 13.4 5.8 4.8 21.1 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 51.5 0.9 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 CADPS "CAPS, CAPS1, KIAA1121, UNC-31" ENSG00000163618 "Calcium dependent secretion activator" Q9ULU8 3 62398346-62875416 "Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 84.6;retina: 184.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 772.6;Cone photoreceptor cells: 627.6;Excitatory neurons: 830.8;Inhibitory neurons: 1152.7;Oligodendrocyte precursor cells: 266.9" "Cancer enhanced" "Detected in many" "glioma: 2.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 11.5;SCLC-21H: 19.7;SK-MEL-30: 9.0;U-698: 13.2;U-87 MG: 20.5" HPA059328 Enhanced Supported Approved Vesicles NA NA "Cluster 77: Retina - Visual perception" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA059328: AB_2683982" "unprognostic (3.46e-3)" "unprognostic (1.40e-2)" "unprognostic (1.61e-2)" "unprognostic (3.87e-2)" "unprognostic (1.14e-1)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (3.12e-2)" "unprognostic (9.27e-2)" "unprognostic (5.73e-2)" "unprognostic (2.08e-3)" "unprognostic (3.21e-1)" "unprognostic (4.20e-3)" "unprognostic (1.90e-2)" "unprognostic (2.04e-1)" "unprognostic (7.91e-3)" "unprognostic (5.35e-3)" 0.4 16.4 32.2 2.0 47.7 0.1 0.7 18.7 84.6 2.8 0.0 2.8 3.2 0.6 2.5 0.2 0.4 2.4 16.7 32.1 26.0 0.2 0.2 0.8 0.5 83.2 39.7 1.9 13.5 0.2 39.6 0.2 84.5 3.6 2.4 184.3 1.4 2.8 0.1 1.4 3.3 0.8 4.1 0.6 3.0 3.2 33.0 0.6 0.2 0.0 0.7 0.4 1.4 61.7 0.0 0.0 0.8 0.0 4.2 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.5 11.5 0.0 0.1 0.0 0.0 0.0 0.0 19.7 1.5 0.0 0.0 9.0 0.4 0.0 0.0 0.1 1.6 0.1 3.3 0.9 0.0 1.7 13.2 20.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.2 47.7 18.7 84.6 32.1 26.0 83.2 39.7 84.5 4.1 33.0 61.7 0.0 0.0 1.9 93.0 0.1 1.3 0.2 0.0 0.0 772.6 0.5 2.8 25.6 7.2 0.0 0.0 627.6 0.1 0.0 0.4 0.0 4.1 1.1 0.2 1.1 0.9 95.9 0.0 830.8 0.4 0.0 3.2 0.0 0.1 42.5 0.2 0.0 0.0 0.0 47.1 1152.7 5.0 0.0 0.0 1.6 2.1 15.2 0.0 8.8 30.0 0.0 21.3 0.0 266.9 27.0 0.9 1.3 2.6 0.0 0.3 0.7 0.1 0.0 64.7 0.0 3.2 1.2 0.2 0.7 0.0 0.1 0.0 0.4 36.9 1.8 0.2 SYNPR "MGC26651, SPO" ENSG00000163630 Synaptoporin Q8TBG9 3 63228315-63616924 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "brain: 123.6;retina: 38.8" "Cell type enriched" "Detected in some" 6 "Inhibitory neurons: 641.5" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.0" "Region enhanced" "Detected in all" "olfactory bulb: 743.6" "Low region specificity" "Detected in all" "HPA051368, HPA061671" Enhanced NA NA "Cluster 6: Brain - Smell perception" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA051368: AB_2681456, HPA061671: AB_2684582" "unprognostic (1.69e-1)" "unprognostic (3.77e-2)" "unprognostic (3.14e-3)" "unprognostic (3.02e-1)" "unprognostic (2.42e-1)" "unprognostic (1.93e-1)" "unprognostic (2.50e-1)" "unprognostic (5.32e-2)" "unprognostic (1.82e-1)" "unprognostic (1.89e-1)" 0.0 0.3 40.0 0.1 123.6 0.0 0.0 52.1 68.7 0.0 5.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 4.5 42.5 19.0 0.0 0.0 0.0 0.0 21.9 22.8 0.0 0.1 0.0 1.1 0.0 11.2 0.0 0.1 38.8 0.6 0.0 0.0 0.0 0.1 0.0 25.9 0.0 0.5 0.0 41.2 0.0 0.2 0.0 0.0 0.0 0.0 40.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.0 123.6 52.1 68.7 42.5 19.0 21.9 22.8 11.2 25.9 41.2 40.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 5.3 0.0 72.4 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 106.0 641.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 45.0 0.0 8.0 7.6 0.1 1.1 0.0 0.0 0.0 0.0 0.1 0.0 7.4 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 SNTN "FLJ44379, S100AL" ENSG00000188817 "Sentan, cilia apical structure protein" A6NMZ2 3 63652675-63679020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "fallopian tube: 173.4" "Group enriched" "Detected in some" 9 "Endometrial ciliated cells: 410.9;Respiratory ciliated cells: 726.5" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.0" "Cell line enhanced" "Detected in single" "MOLT-4: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA043322, HPA058399" Enhanced NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA043322: AB_10793945, HPA058399: AB_2683705" "unprognostic (9.70e-3)" "unprognostic (3.67e-1)" "unprognostic (4.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.34e-3)" "unprognostic (1.93e-1)" "unprognostic (4.52e-2)" "unprognostic (1.73e-1)" "unprognostic (2.07e-2)" "unprognostic (1.66e-1)" "unprognostic (8.43e-3)" 0.1 0.2 0.6 0.6 0.5 0.8 0.2 3.9 1.9 3.6 0.0 0.3 0.4 2.9 0.4 0.2 173.4 0.5 0.0 0.7 0.2 0.1 0.1 13.4 0.8 1.0 1.1 0.3 0.9 0.1 0.0 0.2 1.2 0.4 0.5 1.0 0.3 0.2 0.3 1.1 0.5 0.3 0.0 0.3 0.8 0.3 0.8 0.1 17.8 0.1 0.2 0.1 0.0 1.4 0.2 0.1 0.2 0.4 0.0 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.6 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.1 0.2 1.0 0.2 0.1 0.7 0.1 0.2 0.6 0.1 0.0 0.2 0.5 0.9 0.2 0.1 0.0 0.1 0.2 0.2 0.0 0.4 0.2 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.3 1.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.4 0.2 0.0 0.1 0.1 0.0 0.6 0.5 3.9 1.9 0.7 0.2 1.0 1.1 1.2 0.0 0.8 1.4 0.0 3.2 4.2 0.3 0.0 0.0 0.1 34.0 0.0 0.0 0.3 0.1 0.3 0.0 60.4 0.0 0.0 0.4 0.0 0.1 0.0 0.0 3.6 410.9 2.3 0.3 0.0 0.0 0.1 0.4 0.0 1.4 0.0 4.2 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 38.7 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 726.5 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.5 0.2 C3orf49 ENSG00000163632 "Chromosome 3 open reading frame 49" Q96BT1 3 63819299-63848636 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.7" "Group enriched" "Detected in some" 6 "Early spermatids: 19.5;Late spermatids: 34.4" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 2.0;MCF7: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA053582 Uncertain Approved Vesicles,Centrosome,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "Vesicles, Centrosome" "HPA053582: AB_2682199" "unprognostic (2.90e-1)" "unprognostic (2.63e-1)" "unprognostic (4.81e-2)" "unprognostic (1.64e-1)" "unprognostic (1.07e-1)" "unprognostic (5.27e-3)" "unprognostic (1.79e-1)" "unprognostic (2.14e-2)" "unprognostic (9.29e-3)" "unprognostic (1.72e-1)" "unprognostic (5.14e-2)" "unprognostic (9.47e-3)" "unprognostic (7.61e-3)" "unprognostic (1.02e-1)" "unprognostic (7.68e-2)" "unprognostic (5.79e-2)" "unprognostic (1.07e-1)" 0.0 0.2 0.1 0.2 0.4 0.6 0.0 1.2 1.7 0.1 0.0 0.1 0.6 0.3 0.0 0.7 0.1 0.2 0.3 0.2 0.0 0.1 0.3 0.3 0.3 0.0 0.0 0.5 0.6 0.0 0.0 0.1 0.0 0.1 0.0 1.4 0.3 0.0 1.1 0.9 0.3 0.0 0.0 0.2 0.2 1.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.1 0.2 0.7 0.4 0.4 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.7 0.3 1.0 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.5 0.6 0.8 2.0 0.2 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.4 0.0 1.8 0.4 0.4 0.5 0.4 0.1 0.6 0.4 0.9 0.0 0.4 0.4 0.3 0.1 0.9 0.1 0.1 0.2 0.3 0.5 0.3 0.4 0.6 0.7 0.2 0.9 0.1 0.9 1.4 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.4 1.2 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.0 0.2 0.1 0.5 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 19.5 0.2 0.2 0.1 0.0 0.0 3.9 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 34.4 0.3 0.0 0.0 1.0 0.1 0.2 0.0 1.5 1.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 0.3 0.2 0.3 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.3 THOC7 "FLJ23445, fSAP24, NIF3L1BP1" ENSG00000163634 "THO complex 7" Q6I9Y2 3 63833870-63863868 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 1032.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044143 Approved Supported "Nuclear speckles,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear speckles, Cytosol" "HPA044143: AB_10794892" "unprognostic (4.33e-2)" "unprognostic (9.68e-2)" "unprognostic (1.75e-2)" "unprognostic (1.30e-1)" "unprognostic (2.26e-2)" "unprognostic (2.86e-1)" "unprognostic (1.20e-3)" "unprognostic (3.53e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-2)" "unprognostic (2.86e-2)" "unprognostic (9.90e-2)" "unprognostic (3.26e-2)" "unprognostic (1.51e-2)" "unprognostic (5.18e-2)" "unprognostic (4.25e-2)" "unprognostic (2.31e-1)" 54.7 63.5 57.1 43.2 60.0 80.1 75.1 58.1 85.1 54.4 52.0 69.9 64.2 50.5 53.2 73.1 43.0 48.6 88.0 61.5 59.1 67.8 73.5 40.9 68.1 58.4 59.1 44.4 62.3 52.1 33.5 53.5 57.1 43.8 69.1 64.5 50.5 49.5 103.5 64.2 53.7 59.6 57.3 38.2 49.1 47.6 57.8 72.3 44.4 104.0 68.0 60.8 50.3 61.1 141.2 83.5 95.6 23.9 125.1 172.5 89.6 120.2 126.9 139.2 140.1 101.6 151.5 168.3 49.1 155.1 139.2 79.3 107.5 190.4 194.1 169.6 75.5 150.2 102.8 117.2 130.1 212.6 69.6 123.9 157.2 118.4 213.1 137.6 155.1 110.0 116.8 158.6 170.2 1032.4 186.4 186.9 120.4 304.8 65.5 132.3 89.7 227.4 245.4 128.0 47.3 107.8 105.0 147.6 171.6 93.9 93.6 289.6 113.6 100.8 105.9 125.1 216.3 101.3 162.3 204.1 125.3 268.3 133.5 73.1 40.4 33.1 38.7 47.7 54.0 46.7 47.9 53.2 59.0 31.5 40.5 43.4 23.4 55.6 41.9 54.0 61.7 35.6 57.1 60.0 58.1 85.1 61.5 59.1 58.4 59.1 57.1 57.3 57.8 61.1 82.6 89.8 45.0 14.4 59.2 61.6 91.2 179.9 70.6 53.5 70.9 121.3 143.8 81.5 102.9 84.6 18.8 180.3 66.0 62.1 207.4 145.2 84.7 100.7 75.6 57.8 55.2 159.7 26.8 126.9 166.1 65.4 47.4 73.8 54.4 74.3 44.6 78.1 111.6 48.8 26.4 106.3 101.7 75.6 58.9 89.7 88.9 70.2 67.6 14.0 173.1 82.5 93.7 12.5 18.9 127.6 86.7 71.5 53.3 96.6 108.8 241.2 102.1 73.1 52.6 66.9 83.4 244.9 54.5 116.6 71.6 213.4 68.0 80.7 133.2 95.7 ATXN7 "ADCAII, OPCA3, SCA7, SGF73" ENSG00000163635 "Ataxin 7" O15265 3 63863155-64003462 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 102.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 15.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034989 Approved Nucleoplasm,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 2: Karpas-707 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Cytosol" "HPA034989: AB_10602596" "unprognostic (1.51e-2)" "unprognostic (2.44e-1)" "unprognostic (5.98e-2)" "unprognostic (2.18e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.22e-4)" "unprognostic (9.65e-2)" "unprognostic (2.76e-2)" "unprognostic (2.46e-1)" "unprognostic (2.12e-1)" "unprognostic (7.82e-2)" "unprognostic (9.77e-3)" "unprognostic (2.56e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "unprognostic (3.45e-2)" 7.5 6.3 4.5 11.4 4.1 24.4 7.1 4.9 4.4 7.4 0.2 6.9 8.0 8.6 4.7 8.7 6.3 9.6 5.8 3.1 3.7 7.1 8.4 9.0 12.7 3.4 3.3 8.0 21.0 10.9 2.3 8.3 2.7 6.7 8.8 16.3 7.8 5.2 7.1 9.3 9.2 7.9 0.7 10.6 8.4 15.0 3.1 16.5 7.5 8.7 11.7 7.4 4.4 3.2 8.4 5.7 8.1 7.2 8.5 11.3 9.5 6.5 9.0 11.1 10.5 8.9 8.7 12.5 3.1 9.0 12.5 6.5 9.6 9.1 11.9 22.8 4.9 16.1 10.7 4.2 6.4 8.5 17.7 7.9 9.0 15.7 17.7 9.0 8.4 13.3 6.3 26.2 7.7 25.8 12.7 6.8 5.5 5.7 3.0 9.1 7.1 10.1 6.1 11.0 3.1 5.6 13.2 9.4 10.8 6.4 5.1 12.2 11.9 11.4 12.0 12.7 12.9 12.9 13.2 10.3 10.3 11.6 9.4 15.8 1.1 2.1 3.7 1.0 3.3 1.0 6.2 4.0 0.8 2.4 6.2 4.1 4.5 3.5 0.7 1.5 6.2 1.3 4.5 4.1 4.9 4.4 3.1 3.7 3.4 3.3 2.7 0.7 3.1 3.2 2.4 9.6 9.1 34.6 17.0 43.6 24.9 17.6 29.6 73.2 3.4 1.7 10.5 35.8 17.9 5.5 102.2 14.1 21.5 38.3 0.0 2.8 17.1 3.3 1.5 16.1 26.4 29.5 81.2 4.2 13.6 16.6 18.8 3.5 14.7 1.2 26.7 22.8 14.2 25.2 67.0 19.7 24.4 34.6 30.3 9.5 12.8 20.1 12.4 64.6 33.5 24.5 54.6 60.3 46.7 2.5 28.5 13.2 14.8 26.1 28.1 0.7 27.4 70.8 0.0 39.2 15.6 14.8 15.6 25.6 46.2 61.2 41.5 1.6 20.1 38.6 PSMD6 "KIAA0107, p44S10, Rpn7, S10" ENSG00000163636 "Proteasome 26S subunit, non-ATPase 6" Q15008 3 64010550-64024010 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 285.7" "Cell type enhanced" "Detected in all" "Early spermatids: 513.3;Late spermatids: 717.7;Spermatocytes: 336.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "MCF7: 1458.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036921, HPA036922" Uncertain NA NA 120000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "HPA036921: AB_2675383, HPA036922: AB_10670850" "unprognostic (3.44e-2)" "unprognostic (2.03e-1)" "unprognostic (4.76e-3)" "unprognostic (1.95e-1)" "unprognostic (2.43e-1)" "unprognostic (1.82e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (8.65e-2)" "unprognostic (1.38e-1)" "unprognostic (1.95e-3)" "unprognostic (6.69e-2)" "unprognostic (4.73e-2)" "unprognostic (4.06e-3)" "unprognostic (4.20e-2)" "unprognostic (1.89e-1)" "unprognostic (9.55e-2)" "unprognostic (8.22e-3)" 47.2 67.9 43.9 43.3 45.2 115.0 49.5 47.5 63.2 37.1 44.7 46.2 34.0 43.1 60.1 61.4 35.2 28.2 74.9 46.2 47.5 62.9 74.9 37.9 50.2 47.5 47.5 32.8 285.7 72.9 30.8 54.2 49.2 42.1 43.4 48.4 43.7 45.6 160.8 54.6 34.8 49.5 49.2 38.8 46.1 120.2 45.2 54.8 40.3 90.9 63.9 52.3 40.4 49.0 98.4 102.5 141.1 99.5 97.6 87.0 125.9 136.3 128.8 221.5 162.4 193.0 79.8 136.9 57.6 132.4 154.7 66.1 166.4 144.7 207.3 141.1 104.6 183.6 76.3 128.2 142.9 204.9 112.2 93.7 100.8 184.2 80.3 107.4 141.5 117.7 187.3 86.1 157.8 1458.7 141.0 125.3 180.7 157.3 71.9 117.2 101.1 132.4 177.1 140.7 52.1 85.0 101.6 85.4 136.2 123.4 74.3 125.0 125.7 98.1 106.5 145.2 217.1 108.2 171.0 204.1 144.3 190.8 116.1 99.2 113.9 140.3 103.4 133.0 107.3 124.7 114.0 112.9 120.1 120.3 113.6 110.5 139.4 111.5 139.8 84.0 137.1 167.2 43.9 45.2 47.5 63.2 46.2 47.5 47.5 47.5 49.2 49.2 45.2 49.0 46.4 32.1 43.2 7.5 48.7 62.1 71.7 152.5 27.9 37.0 33.9 34.9 100.0 22.8 86.4 44.1 22.9 197.8 47.3 27.6 86.1 104.0 513.3 49.0 42.3 55.3 25.8 99.9 11.7 133.7 102.3 47.6 27.0 48.9 45.6 46.7 28.9 47.4 92.2 33.7 10.9 27.3 73.2 38.1 40.5 717.7 51.9 51.7 48.0 4.7 71.0 81.8 39.1 10.1 15.4 87.1 30.4 51.1 58.1 44.7 29.7 95.9 73.0 41.2 59.2 41.3 145.8 336.9 131.3 53.4 69.9 290.6 50.4 68.7 35.8 66.1 PRICKLE2 DKFZp686D143 ENSG00000163637 "Prickle planar cell polarity protein 2" Q7Z3G6 3 64092236-64445476 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Epilepsy, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 114.3;Excitatory neurons: 185.5;Inhibitory neurons: 232.4;Microglial cells: 112.4;Oligodendrocyte precursor cells: 103.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 24.1;ASC TERT1: 14.9;HSkMC: 22.1;U-87 MG: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035493 Approved "Golgi apparatus,Vesicles" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Vesicles "HPA035493: AB_10696504" "unprognostic (2.87e-1)" "unprognostic (4.31e-1)" "unprognostic (4.45e-2)" "unprognostic (1.25e-1)" "unprognostic (3.40e-1)" "unprognostic (3.53e-3)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (1.92e-1)" "unprognostic (3.83e-2)" "unprognostic (3.03e-2)" "unprognostic (6.35e-2)" "unprognostic (1.32e-3)" "unprognostic (1.10e-2)" "unprognostic (1.91e-1)" "unprognostic (9.04e-3)" "unprognostic (1.77e-1)" 20.8 3.0 14.1 3.9 14.9 0.3 8.0 3.4 15.8 16.4 9.1 18.4 2.3 17.3 6.8 7.7 11.7 8.8 5.6 28.5 10.0 3.8 3.1 10.6 0.8 4.4 8.9 8.4 3.8 5.4 5.6 5.6 6.2 7.3 4.6 10.1 4.9 13.8 1.9 4.3 5.9 16.6 6.3 1.4 8.1 1.7 11.7 1.0 6.9 3.9 1.0 12.4 8.8 9.3 0.0 4.7 1.3 0.1 24.1 14.9 0.0 3.5 4.5 2.8 4.2 8.3 0.1 0.0 0.5 3.4 7.6 0.1 0.0 3.2 2.8 3.3 0.1 0.0 0.5 0.1 6.7 0.0 0.0 22.1 4.0 8.2 3.5 8.4 1.7 0.0 0.0 1.8 3.9 4.6 0.0 0.1 3.0 0.0 0.1 0.0 0.2 0.1 4.5 11.7 1.2 0.2 0.0 0.9 0.1 7.7 1.6 0.1 0.1 11.9 5.4 2.9 6.9 3.7 0.0 0.7 15.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 14.1 14.9 3.4 15.8 28.5 10.0 4.4 8.9 6.2 6.3 11.7 9.3 12.4 0.0 10.9 114.3 1.5 6.2 4.1 7.3 7.4 25.6 4.3 8.4 6.2 1.5 7.3 3.7 64.6 1.4 0.3 1.6 0.0 2.7 15.1 24.7 47.5 9.5 0.0 0.0 185.5 0.4 0.4 20.3 0.0 8.7 0.0 5.2 33.5 1.7 4.1 16.8 232.4 0.6 4.1 1.2 1.8 3.5 9.9 0.6 5.4 112.4 0.0 7.5 1.0 103.5 26.4 0.7 0.3 23.0 0.2 0.9 0.0 6.2 7.6 4.4 13.1 14.6 14.3 2.0 1.0 6.2 3.0 4.9 0.6 6.6 1.1 2.7 ADAMTS9 KIAA1312 ENSG00000163638 "ADAM metallopeptidase with thrombospondin type 1 motif 9" Q9P2N4 3 64515654-64688000 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "ER-Golgi transport, Protein transport, Transport" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 41.2" "Cell type enhanced" "Detected in many" "Adipocytes: 166.3;Astrocytes: 84.2;Basal prostatic cells: 87.2;Endometrial stromal cells: 179.1;Endothelial cells: 221.0;Prostatic glandular cells: 115.7;Smooth muscle cells: 94.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 23.6;RPTEC TERT1: 27.1;SH-SY5Y: 128.3;SuSa: 40.5;WM-115: 28.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028567, HPA028577, HPA028601" Approved Approved "Endoplasmic reticulum,Vesicles" "Secreted to extracellular matrix" No NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles "Endoplasmic reticulum" "HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: AB_2672694" "unprognostic (2.21e-1)" "unprognostic (1.06e-1)" "unprognostic (1.41e-1)" "unprognostic (4.83e-2)" "unprognostic (3.08e-1)" "unprognostic (1.37e-2)" "unprognostic (7.80e-3)" "unprognostic (5.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.64e-1)" "unprognostic (1.11e-1)" "unprognostic (7.67e-2)" "unprognostic (3.16e-3)" "unprognostic (1.46e-2)" "unprognostic (3.01e-1)" "unprognostic (1.98e-3)" "unprognostic (5.00e-3)" 41.2 4.8 4.0 12.2 5.0 0.1 19.0 5.5 5.3 16.2 7.9 8.1 1.2 13.2 1.1 5.3 10.2 7.8 15.6 4.4 5.6 9.5 2.7 13.6 1.9 10.8 8.1 7.3 9.8 6.3 2.2 31.7 8.5 7.9 2.7 1.4 3.2 3.7 7.4 2.6 3.7 12.1 8.0 4.1 4.7 0.8 8.1 1.0 7.3 7.3 1.1 22.5 9.0 6.4 0.0 1.2 13.9 0.0 0.6 0.1 1.3 0.2 0.0 0.0 0.0 1.9 0.0 0.0 2.3 0.3 0.4 0.0 1.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.9 0.0 8.8 2.6 0.0 0.0 0.5 0.0 23.6 0.0 0.5 0.0 0.3 0.1 0.0 0.0 7.5 1.1 0.0 0.0 2.4 0.1 27.1 0.3 0.1 128.3 0.0 0.0 0.0 40.5 0.0 0.7 5.4 0.8 0.4 0.0 0.8 0.0 0.0 0.0 0.5 0.0 28.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 5.0 5.5 5.3 4.4 5.6 10.8 8.1 8.5 8.0 8.1 6.4 166.3 3.2 4.8 84.2 0.0 17.5 87.2 0.0 4.6 0.0 6.9 15.9 6.6 2.8 2.6 38.6 2.1 1.0 0.2 1.1 0.0 69.7 0.9 13.2 179.1 221.0 1.2 0.0 4.2 3.3 0.6 31.4 1.5 33.8 0.0 8.4 27.1 0.3 7.5 0.0 14.3 1.1 0.0 0.3 20.1 0.4 2.5 2.7 26.6 21.5 0.0 0.2 0.0 26.7 0.6 45.5 1.0 2.2 0.0 115.7 0.0 10.8 0.1 0.1 0.0 20.7 94.8 0.3 0.7 1.3 13.5 1.6 3.2 12.1 0.9 36.7 MAGI1 "AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3" ENSG00000151276 "Membrane associated guanylate kinase, WW and PDZ domain containing 1" Q96QZ7 3 65353525-66038834 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 497.7;Inhibitory neurons: 809.8;Oligodendrocyte precursor cells: 368.4;Oligodendrocytes: 532.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031851, HPA031853, HPA077002" Supported Supported "Nucleoplasm,Cell Junctions" NA NA "Cluster 18: Non-specific - Mitochondria" "Cluster 36: HEL - Hemostasis" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Cell Junctions" Nucleoplasm "HPA031851: AB_10599289, HPA031853: AB_10602095, HPA077002: " "unprognostic (5.00e-2)" "unprognostic (9.84e-2)" "unprognostic (6.00e-3)" "unprognostic (1.73e-3)" "unprognostic (1.64e-1)" "unprognostic (2.17e-2)" "unprognostic (1.46e-3)" "unprognostic (9.46e-3)" "unprognostic (8.59e-2)" "unprognostic (2.19e-1)" "unprognostic (6.58e-2)" "unprognostic (2.05e-3)" "prognostic favorable (4.55e-8)" "unprognostic (3.51e-2)" "unprognostic (1.34e-1)" "unprognostic (1.68e-2)" "unprognostic (8.03e-2)" 11.3 5.0 3.7 1.3 4.8 0.0 12.5 6.3 5.9 5.5 3.9 9.7 5.0 6.2 2.0 8.0 5.8 5.3 9.0 4.7 5.3 10.2 13.4 8.8 1.1 3.7 3.8 2.7 12.6 5.9 7.7 5.3 2.6 7.1 4.2 7.0 11.6 4.9 3.8 12.5 6.4 3.1 2.7 11.9 14.7 10.3 4.1 2.0 13.4 4.1 1.8 5.4 7.2 4.9 4.1 2.2 12.3 1.3 2.4 1.7 5.5 7.0 5.9 2.6 4.0 15.1 3.5 0.0 1.0 8.3 2.1 1.2 3.4 2.4 4.1 0.0 1.9 36.1 4.3 10.2 1.5 0.0 1.1 2.7 2.0 8.9 1.8 6.8 6.0 4.7 15.6 0.0 2.8 3.1 0.0 0.0 16.6 12.2 2.1 0.0 3.5 0.9 3.1 13.5 3.9 10.8 2.7 3.3 0.1 8.0 6.4 0.0 1.6 8.2 6.0 2.1 2.9 0.0 0.0 0.0 4.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 4.8 6.3 5.9 4.7 5.3 3.7 3.8 2.6 2.7 4.1 4.9 102.8 76.9 29.8 204.7 1.3 22.3 17.7 7.9 26.2 98.3 46.5 37.5 35.6 102.9 22.5 23.9 75.0 20.2 0.5 51.0 3.9 44.3 179.1 35.8 35.5 55.5 36.5 2.7 497.7 31.8 2.4 9.6 47.4 50.8 1.3 78.4 82.5 60.9 4.8 232.2 809.8 40.3 12.2 5.0 3.6 27.0 6.5 1.8 5.4 170.5 0.6 15.2 0.0 368.4 532.1 40.3 25.4 8.6 0.2 14.7 33.2 12.2 40.3 26.4 32.9 7.0 17.5 44.7 12.3 12.7 18.8 5.1 2.7 27.1 26.3 11.9 SLC25A26 ENSG00000144741 "Solute carrier family 25 member 26" Q70HW3 3 66133610-66388116 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026887 Supported Supported Mitochondria NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA026887: AB_2189921" "unprognostic (1.93e-1)" "unprognostic (1.29e-1)" "unprognostic (1.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (7.83e-2)" "unprognostic (7.94e-2)" "unprognostic (5.38e-2)" "unprognostic (1.53e-1)" "unprognostic (3.54e-1)" "unprognostic (9.21e-2)" "unprognostic (8.43e-2)" "prognostic favorable (1.73e-5)" "unprognostic (4.73e-2)" "unprognostic (2.59e-1)" "unprognostic (1.33e-1)" "unprognostic (2.07e-1)" 15.8 16.0 9.6 5.6 9.9 12.9 15.0 8.7 11.0 12.7 6.8 18.1 7.8 13.3 9.4 15.9 12.7 7.8 28.3 10.1 8.7 18.5 25.9 11.6 10.7 9.1 9.3 16.5 15.5 14.9 10.2 7.7 9.2 13.5 9.5 8.5 16.1 9.0 42.4 22.0 13.3 7.8 9.3 13.5 17.4 14.3 11.1 8.6 15.8 21.0 9.6 17.5 14.1 11.3 10.7 10.4 6.5 12.4 13.9 13.1 13.9 9.0 15.7 10.7 10.2 13.5 13.9 12.3 5.5 15.1 14.3 7.6 7.3 15.8 11.7 11.5 16.8 16.3 8.1 19.2 14.7 22.5 13.4 17.7 29.6 8.4 21.3 11.2 8.9 21.5 9.2 12.8 12.9 12.5 9.9 28.3 20.8 23.2 6.8 10.0 11.7 19.4 10.1 8.3 5.4 14.6 12.4 11.8 21.4 10.9 9.8 19.7 10.4 12.7 11.0 15.9 16.6 21.1 30.6 15.1 17.4 21.1 14.7 1.8 9.9 6.1 15.4 10.8 14.5 19.3 16.9 16.4 18.3 16.2 20.5 17.5 0.9 18.1 6.7 17.5 17.7 13.4 9.6 9.9 8.7 11.0 10.1 8.7 9.1 9.3 9.2 9.3 11.1 11.3 11.6 32.1 22.2 22.9 29.5 35.8 38.6 45.7 28.5 17.7 36.1 34.0 106.9 30.0 25.0 18.4 12.5 36.8 27.3 14.1 35.2 28.8 33.3 17.2 13.6 20.5 18.6 9.2 55.5 45.1 44.6 26.1 17.3 19.1 19.6 21.1 13.2 39.1 30.3 11.8 51.4 29.2 28.5 22.3 26.5 28.6 16.1 15.8 37.4 31.9 21.4 26.5 32.0 32.2 63.9 27.6 20.8 21.8 18.7 49.1 30.8 57.7 16.2 24.5 19.7 31.7 22.1 29.4 32.9 28.2 36.8 32.7 39.6 22.3 33.3 37.8 LRIG1 "DKFZP586O1624, LIG-1, LIG1" ENSG00000144749 "Leucine rich repeats and immunoglobulin like domains 1" Q96JA1 3 66378797-66501263 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 144.4" "Cell type enriched" "Detected in many" 5 "Astrocytes: 331.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 1.1" "Cell line enhanced" "Detected in many" "Daudi: 79.7;hTEC/SVTERT24-B: 55.2;U-698: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011846 Approved Approved Cytosol NA NA 78000 "Cluster 35: T-regs - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 64: Astrocytes - Nervous system maintenance" Cytosol "HPA011846: AB_2668545" "unprognostic (6.41e-2)" "unprognostic (4.18e-2)" "unprognostic (4.35e-3)" "unprognostic (4.58e-2)" "unprognostic (2.12e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-1)" "prognostic favorable (3.01e-5)" "unprognostic (5.12e-1)" "unprognostic (7.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.18e-1)" "unprognostic (2.12e-1)" "unprognostic (8.79e-2)" "unprognostic (1.30e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (1.50e-4)" 31.0 1.8 33.1 17.0 29.2 4.0 27.2 15.1 21.0 29.9 0.0 38.6 16.8 21.9 3.0 13.5 26.7 20.9 37.0 21.4 26.7 3.6 11.2 17.6 7.9 29.4 39.2 17.1 144.4 5.2 6.5 4.7 17.2 24.8 14.7 5.0 19.2 7.2 37.2 11.7 13.4 30.5 14.3 3.9 36.5 12.5 51.0 3.5 16.2 32.9 9.6 5.9 5.2 17.7 1.4 1.3 27.6 0.5 7.6 4.8 2.8 4.9 26.6 4.6 14.0 23.6 0.3 79.7 13.1 2.2 6.1 0.0 5.5 10.0 10.1 0.0 16.8 0.0 4.1 2.0 1.8 0.7 16.7 6.0 5.4 55.2 9.0 18.8 24.3 0.3 0.3 0.0 1.0 3.6 0.0 0.1 22.8 2.3 0.0 14.1 8.7 3.7 5.1 0.0 3.9 1.0 4.6 4.1 0.2 4.6 25.6 6.7 8.2 13.9 6.3 27.9 12.9 6.2 3.2 59.5 24.3 0.0 5.0 0.0 0.0 0.3 0.1 0.0 0.6 0.1 0.4 0.4 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 1.1 0.1 33.1 29.2 15.1 21.0 21.4 26.7 29.4 39.2 17.2 14.3 51.0 17.7 12.5 38.5 50.2 331.1 4.3 11.3 7.8 8.0 14.2 2.1 51.9 35.8 32.0 11.5 25.0 0.0 8.4 0.2 5.8 9.6 1.9 5.6 1.6 29.1 9.7 9.2 26.5 0.0 10.6 17.1 0.1 17.1 19.9 58.8 1.3 14.9 6.4 20.7 2.0 8.4 15.6 26.2 12.2 1.9 7.7 2.1 11.5 2.4 10.6 57.1 1.7 39.8 0.0 37.7 58.3 6.0 10.2 17.3 8.7 15.6 5.7 1.2 33.7 6.8 0.0 65.5 19.9 1.6 20.0 8.9 11.5 0.1 15.2 2.1 22.8 5.0 KBTBD8 "KIAA1842, TA-KRP" ENSG00000163376 "Kelch repeat and BTB domain containing 8" Q8NFY9 3 66998307-67011210 "Predicted intracellular proteins" "Translation regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.9;lymphoid tissue: 20.7" "Cell type enhanced" "Detected in many" "B-cells: 31.9;Langerhans cells: 35.2;Macrophages: 20.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 62.6;Karpas-707: 28.4;U-698: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041285, HPA069190" Approved NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "HPA041285: AB_10796341, HPA069190: AB_2686101" "unprognostic (2.62e-2)" "unprognostic (3.64e-1)" "unprognostic (1.70e-4)" "unprognostic (1.99e-2)" "unprognostic (6.63e-2)" "unprognostic (8.23e-2)" "unprognostic (1.30e-2)" "unprognostic (5.94e-3)" "unprognostic (1.93e-1)" "unprognostic (8.14e-2)" "unprognostic (5.09e-2)" "unprognostic (1.26e-3)" "unprognostic (5.02e-2)" "unprognostic (1.25e-1)" "unprognostic (7.43e-2)" "unprognostic (2.96e-1)" "unprognostic (1.54e-1)" 1.4 1.1 1.4 6.9 2.0 13.9 1.0 1.7 3.2 0.7 3.8 2.4 1.8 0.4 0.2 1.3 0.4 1.8 3.8 1.7 1.1 0.6 1.3 2.2 20.4 0.7 0.7 0.4 0.9 0.3 0.5 3.2 0.7 1.0 1.9 1.3 0.9 0.4 1.6 0.5 2.8 1.2 0.8 5.7 2.2 7.8 0.9 3.6 0.8 2.2 20.7 1.9 0.3 1.4 1.2 1.4 2.5 2.9 1.7 1.1 5.3 3.1 1.1 2.3 1.6 5.7 0.6 62.6 0.8 0.9 1.3 1.7 14.5 3.4 3.6 10.7 4.7 23.0 0.7 2.9 2.2 14.8 23.9 1.9 1.5 4.6 4.0 0.7 1.7 12.4 5.7 28.4 1.6 2.4 11.9 2.5 10.5 2.3 1.1 6.8 2.5 8.5 0.7 1.9 8.6 3.1 1.2 1.0 2.1 3.1 0.6 4.2 4.8 7.7 1.8 16.8 6.0 16.4 27.6 43.3 2.1 11.7 2.6 0.0 1.1 0.4 1.1 3.0 0.6 6.2 1.3 1.2 2.4 6.7 1.2 0.8 0.0 1.1 2.6 0.3 2.4 1.2 1.4 2.0 1.7 3.2 1.7 1.1 0.7 0.7 0.7 0.8 0.9 1.4 2.3 0.0 1.8 0.3 31.9 5.2 0.4 0.1 5.7 1.3 1.9 2.5 11.6 1.5 0.7 0.0 2.1 4.0 7.5 2.1 0.0 0.5 1.4 0.3 0.3 1.6 1.2 3.0 4.5 0.9 1.4 1.3 1.1 0.4 4.5 0.1 2.2 0.5 3.8 3.3 2.7 1.2 2.0 1.9 35.2 1.3 0.0 20.9 0.0 1.9 1.3 1.7 0.0 2.0 1.8 1.2 1.5 0.4 11.0 0.3 0.9 0.5 0.2 0.7 0.0 3.5 2.5 9.9 5.3 5.1 5.5 2.5 9.1 0.8 1.4 0.5 SUCLG2 ENSG00000172340 "Succinate-CoA ligase GDP-forming subunit beta" Q96I99 3 67360460-67654612 "Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 278.0" "Cell type enhanced" "Detected in all" "Hepatocytes: 402.3;Proximal tubular cells: 354.4;Undifferentiated cells: 306.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046705, HPA051998" Enhanced Approved "Plasma membrane,Mitochondria" NA NA 300000 "Cluster 15: NK-cells - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "Plasma membrane" "HPA046705: AB_2679762, HPA051998: AB_2681687" "unprognostic (1.69e-1)" "unprognostic (2.31e-1)" "prognostic favorable (1.08e-4)" "unprognostic (2.12e-1)" "unprognostic (3.10e-1)" "unprognostic (5.32e-2)" "unprognostic (1.87e-2)" "unprognostic (1.69e-1)" "unprognostic (3.88e-1)" "unprognostic (3.26e-2)" "unprognostic (4.61e-3)" "unprognostic (5.59e-2)" "prognostic favorable (2.79e-10)" "unprognostic (3.08e-2)" "unprognostic (2.79e-1)" "unprognostic (1.07e-1)" "unprognostic (1.38e-1)" 66.7 44.9 16.1 36.7 17.9 18.6 48.7 17.1 19.6 42.1 22.4 169.7 136.6 32.6 32.2 50.5 39.1 48.4 85.5 14.2 17.6 147.3 278.0 34.0 39.3 19.0 17.3 39.0 47.8 34.6 10.2 28.1 19.5 49.3 146.1 7.3 46.8 42.3 154.0 26.1 132.2 40.0 17.7 44.8 110.6 10.4 18.1 24.7 49.3 130.6 35.5 39.3 24.0 18.8 43.8 37.4 36.3 44.6 59.7 102.5 44.2 51.3 74.4 58.9 65.4 41.7 95.1 55.7 16.3 72.5 38.8 22.0 28.5 70.8 75.9 23.8 19.5 50.5 31.2 65.5 76.8 67.2 33.9 77.3 60.3 46.2 105.2 73.0 63.6 41.8 39.1 49.5 129.9 30.6 25.5 21.2 34.1 199.2 23.0 17.6 56.1 83.8 100.0 66.9 7.1 24.5 81.5 92.7 68.8 24.3 71.6 42.5 55.9 58.2 38.2 64.5 61.8 33.4 52.2 39.0 85.5 51.6 70.0 17.3 36.3 13.0 30.8 44.3 37.6 45.5 44.6 39.5 24.6 42.5 68.4 53.1 1.6 68.0 37.4 9.8 45.4 48.5 16.1 17.9 17.1 19.6 14.2 17.6 19.0 17.3 19.5 17.7 18.1 18.8 40.2 35.3 50.8 66.6 48.5 37.1 44.7 38.9 21.1 2.9 54.1 29.1 172.0 84.4 51.7 80.9 8.4 55.4 31.7 223.5 244.6 85.1 3.2 49.6 43.4 40.1 58.2 17.2 6.2 80.9 44.9 47.5 90.7 46.8 30.4 31.4 45.0 402.3 56.5 5.0 5.3 212.1 40.7 68.6 49.2 5.4 41.3 36.3 42.7 90.9 35.5 29.2 36.0 72.4 60.0 59.2 164.0 47.4 30.3 41.2 222.2 354.4 58.7 4.5 32.9 41.6 50.5 1.6 6.3 55.6 49.3 38.0 48.6 78.5 306.6 50.9 TAFA1 "FAM19A1, TAFA-1" ENSG00000183662 "TAFA chemokine like family member 1" Q7Z5A9 3 68004247-68545621 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 15.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "glioma: 0.5" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in many" 6 "T-cells: 20.7" "Cell line enriched" "Detected in single" 10 "REH: 1.6" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 12.5;cerebral cortex: 35.6;hippocampal formation: 33.0" HPA013407 Approved "Secreted in brain" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 65: Brain - Ion transport" "Cluster 14: REH - Unknown function" "Cluster 24: Non-specific - Transcription regulation" "HPA013407: AB_1848386" "unprognostic (5.19e-2)" "unprognostic (4.64e-3)" "unprognostic (1.97e-2)" "unprognostic (1.86e-2)" "unprognostic (7.95e-2)" "unprognostic (6.40e-2)" "unprognostic (3.42e-3)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (2.41e-1)" "unprognostic (1.41e-2)" "unprognostic (7.87e-2)" "unprognostic (1.35e-3)" "unprognostic (2.11e-1)" "unprognostic (1.99e-1)" "unprognostic (3.50e-4)" "unprognostic (5.77e-2)" 0.2 1.1 4.1 0.3 7.3 0.0 0.0 0.0 13.9 0.0 1.6 0.2 1.3 0.2 1.1 0.1 0.0 0.7 0.1 13.9 9.1 0.3 0.3 0.1 0.6 12.4 1.0 0.0 0.0 0.0 0.4 0.0 15.4 1.4 0.1 0.3 0.1 3.8 0.1 0.0 0.2 0.3 0.4 0.4 0.1 0.2 8.6 0.0 0.1 0.2 0.2 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 20.7 0.0 15.9 0.0 16.6 11.1 0.0 0.0 11.9 15.9 0.4 3.7 0.0 0.1 8.4 3.3 4.1 7.3 0.0 13.9 13.9 9.1 12.4 1.0 15.4 0.4 8.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TAFA4 "FAM19A4, TAFA-4" ENSG00000163377 "TAFA chemokine like family member 4" Q96LR4 3 68731766-68953297 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "adrenal gland: 14.9;brain: 11.6;retina: 11.1;stomach 1: 4.9" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "testis cancer: 0.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.8;NTERA-2: 9.2;SCLC-21H: 1.0;SuSa: 2.5" "Region enriched" "Detected in many" 5 "thalamus: 13.5" "Low region specificity" "Detected in many" "Secreted in brain" NA NA "Cluster 77: Retina - Visual perception" "Cluster 5: NTERA-2 - Transcription" "unprognostic (1.92e-1)" "unprognostic (9.97e-3)" "unprognostic (2.28e-1)" "unprognostic (8.19e-3)" "unprognostic (8.78e-2)" "unprognostic (2.00e-2)" "unprognostic (3.01e-2)" "unprognostic (1.22e-1)" "unprognostic (3.66e-2)" "unprognostic (8.06e-2)" "unprognostic (2.50e-1)" 0.0 14.9 4.8 0.2 5.0 0.0 0.0 3.8 3.0 0.0 0.4 0.4 0.0 0.0 0.0 0.2 0.0 1.2 0.0 1.4 7.9 0.1 0.0 0.1 0.0 4.5 9.4 0.4 0.0 0.0 0.7 0.3 4.3 0.9 0.0 11.1 0.0 0.1 0.0 0.0 0.2 0.2 3.2 0.0 4.9 1.0 11.6 0.0 0.0 0.0 0.0 0.1 0.0 7.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 5.0 3.8 3.0 1.4 7.9 4.5 9.4 4.3 3.2 11.6 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EOGT "AER61, C3orf64, FLJ33770" ENSG00000163378 "EGF domain specific O-linked N-acetylglucosamine transferase" Q5NDL2 3 68975217-69013684 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Peritubular cells: 40.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 86.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019460 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 46: Fibroblasts - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nuclear membrane" Cytosol "HPA019460: AB_1844628" "unprognostic (2.62e-1)" "unprognostic (3.72e-1)" "unprognostic (1.07e-1)" "unprognostic (1.95e-2)" "unprognostic (8.96e-2)" "unprognostic (6.30e-2)" "unprognostic (2.18e-3)" "unprognostic (6.66e-2)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" "unprognostic (1.68e-1)" "unprognostic (3.57e-1)" "prognostic unfavorable (8.97e-5)" "unprognostic (7.41e-2)" "unprognostic (4.67e-1)" "unprognostic (3.44e-2)" "unprognostic (2.04e-1)" 19.4 9.1 7.2 12.8 7.2 5.9 19.5 6.7 10.9 14.0 22.4 25.8 7.4 29.9 9.8 17.5 18.5 17.8 28.5 7.1 7.0 10.2 5.7 28.7 8.2 7.7 7.6 11.6 12.6 5.0 9.3 22.3 8.0 27.9 8.6 8.8 16.4 33.7 20.0 9.7 11.4 25.4 7.8 10.0 15.5 8.9 7.8 11.1 7.9 15.2 8.8 24.7 13.7 7.5 19.0 7.1 12.5 14.4 16.6 32.2 8.6 25.4 31.5 16.0 21.0 9.1 10.2 1.1 3.8 28.1 13.6 6.0 8.3 32.3 19.9 62.3 5.6 20.2 15.5 13.5 18.7 11.5 8.2 26.8 29.4 20.6 25.1 19.4 86.2 0.8 5.9 11.1 53.7 5.5 2.0 3.8 13.5 6.2 3.5 0.8 12.4 8.2 13.9 43.4 1.2 6.3 29.1 1.7 23.5 12.8 6.0 15.9 44.6 40.6 13.4 5.1 24.3 6.0 20.5 9.3 16.3 17.1 23.8 5.4 1.5 0.0 2.0 1.4 2.3 1.1 3.0 4.3 2.4 0.7 2.5 2.7 0.2 2.4 0.5 0.4 6.6 1.3 7.2 7.2 6.7 10.9 7.1 7.0 7.7 7.6 8.0 7.8 7.8 7.5 29.6 12.8 10.3 14.0 3.5 7.1 11.4 13.2 16.5 2.2 7.5 11.7 20.7 4.3 14.5 1.8 16.7 0.9 3.1 5.1 0.0 4.6 16.5 15.3 7.5 23.7 6.0 3.8 11.2 8.2 5.3 9.3 9.2 15.4 0.0 9.4 20.3 3.6 6.7 0.0 21.4 4.5 2.0 6.8 9.8 15.1 3.1 8.6 8.8 30.9 6.5 1.4 1.0 9.5 12.2 12.4 3.4 40.6 5.4 8.3 2.1 1.9 13.2 5.6 0.0 26.8 15.2 5.5 2.5 14.8 4.5 0.8 7.0 6.9 3.4 8.6 TMF1 "ARA160, TMF" ENSG00000144747 "TATA element modulatory factor 1" P82094 3 69019827-69052339 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 508.1;Late spermatids: 544.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008729 Approved Supported "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA008729: AB_1080310" "unprognostic (2.71e-1)" "unprognostic (2.11e-2)" "unprognostic (8.02e-3)" "unprognostic (7.19e-2)" "unprognostic (2.74e-1)" "unprognostic (6.75e-3)" "unprognostic (6.73e-3)" "unprognostic (1.79e-1)" "unprognostic (4.62e-2)" "unprognostic (2.37e-2)" "unprognostic (1.08e-2)" "unprognostic (2.83e-2)" "unprognostic (1.50e-1)" "unprognostic (1.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.51e-2)" "unprognostic (1.01e-1)" 10.3 10.6 4.4 14.0 5.2 26.2 14.1 6.2 5.5 13.3 12.3 12.5 12.9 14.8 14.1 11.5 12.9 14.1 9.2 4.3 5.3 12.6 11.0 12.0 16.0 5.3 5.1 12.6 13.6 15.6 9.9 16.5 5.2 14.5 14.2 12.5 17.4 10.3 9.8 9.7 14.8 11.6 5.1 12.8 14.0 19.4 5.4 9.6 20.9 8.3 14.8 13.5 7.9 6.1 19.5 8.3 7.8 7.9 20.7 26.4 17.5 24.6 23.6 16.1 19.2 11.9 14.1 7.4 3.9 25.1 11.3 10.5 10.2 10.8 26.4 14.3 7.6 14.4 11.0 14.1 18.5 16.3 19.7 15.6 17.0 21.4 19.3 17.1 17.5 6.0 8.8 11.8 21.2 11.1 9.5 14.1 6.8 12.3 4.4 7.8 9.9 10.4 21.0 15.4 5.4 8.3 20.2 14.2 15.4 10.4 10.7 19.4 23.1 15.8 6.7 27.9 14.8 13.2 13.6 7.2 24.1 16.6 13.1 4.8 2.4 5.1 3.1 2.0 2.1 2.6 2.8 2.7 2.1 3.1 2.9 2.6 5.3 2.7 3.4 2.4 3.1 1.6 4.4 5.2 6.2 5.5 4.3 5.3 5.3 5.1 5.2 5.1 5.4 6.1 49.2 64.1 78.9 21.9 84.7 37.5 37.6 41.7 39.3 43.4 46.2 35.8 36.9 38.6 86.4 42.3 37.5 39.6 108.4 48.8 15.6 52.4 508.1 150.4 92.8 43.1 55.6 45.0 32.2 56.2 58.7 70.0 54.6 86.2 74.7 51.7 29.3 19.7 28.4 35.3 38.4 61.6 38.7 31.8 54.4 544.8 51.0 55.1 35.6 32.8 66.7 41.5 59.8 36.2 40.9 50.6 40.8 62.1 129.3 64.8 49.4 25.1 200.5 52.1 32.9 62.8 56.8 116.2 39.3 30.6 39.5 80.6 94.5 54.5 38.5 85.7 UBA3 "hUba3, NAE2, UBE1C" ENSG00000144744 "Ubiquitin like modifier activating enzyme 3" Q8TBC4 3 69054730-69080408 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 383.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034873, HPA034874, HPA065335" Supported Approved "Nucleoplasm,Plasma membrane,Centrosome,Cytosol" NA NA 35000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 44: HDLM-2 - Immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane, Cytosol" "Nucleoplasm, Centrosome" "HPA034873: AB_10670578, HPA034874: AB_2674368, HPA065335: AB_2685473" "unprognostic (2.31e-1)" "unprognostic (1.75e-1)" "unprognostic (5.56e-3)" "unprognostic (9.26e-2)" "unprognostic (9.35e-3)" "unprognostic (5.53e-2)" "prognostic unfavorable (8.57e-4)" "unprognostic (1.08e-1)" "unprognostic (6.18e-2)" "unprognostic (1.60e-3)" "unprognostic (9.40e-2)" "unprognostic (2.71e-2)" "unprognostic (1.39e-3)" "unprognostic (2.61e-3)" "unprognostic (9.24e-2)" "unprognostic (7.80e-3)" "unprognostic (2.52e-1)" 34.3 32.3 83.7 39.4 225.9 39.1 43.4 138.0 136.2 32.1 32.1 34.5 28.8 35.8 41.0 33.9 27.5 29.7 66.6 109.7 198.7 33.9 31.2 32.2 49.6 240.4 162.7 30.0 19.3 45.6 22.9 41.7 245.4 36.6 35.8 62.0 44.9 32.2 41.5 45.0 30.3 39.8 131.0 38.9 26.4 23.7 197.1 44.8 27.1 34.7 49.8 39.4 26.6 383.0 76.6 31.4 75.8 47.1 69.0 90.9 56.1 65.9 74.4 70.4 70.2 39.2 52.2 55.2 18.6 72.5 71.3 42.1 59.1 76.5 80.2 105.0 38.5 77.0 57.7 39.6 53.8 77.1 62.4 72.0 49.8 67.9 54.9 86.7 92.3 45.2 31.9 45.6 94.0 26.8 49.5 49.7 67.5 95.4 26.9 39.6 55.9 53.0 113.2 94.6 32.8 46.2 70.3 51.0 58.4 80.9 34.3 73.3 71.4 53.0 46.9 70.6 93.3 53.2 91.8 67.3 54.5 84.3 69.7 87.9 45.7 71.0 24.3 54.0 28.1 33.6 32.2 30.3 40.1 29.7 29.6 30.5 40.9 39.8 57.1 20.1 40.8 53.0 83.7 225.9 138.0 136.2 109.7 198.7 240.4 162.7 245.4 131.0 197.1 383.0 21.9 35.3 31.4 35.9 35.5 33.8 29.2 66.2 31.9 22.9 21.6 17.9 68.5 14.3 44.5 35.0 39.6 74.5 19.8 15.8 19.6 37.1 15.2 25.1 21.2 26.9 18.6 30.7 44.6 23.6 57.2 28.3 22.4 25.6 42.4 26.0 22.9 17.2 34.1 33.7 62.8 16.3 97.6 37.1 49.6 10.3 40.4 39.6 30.2 44.0 60.6 29.1 24.7 53.3 76.7 31.5 11.7 38.0 28.3 23.7 16.7 36.9 47.3 48.9 26.3 22.2 31.0 34.2 32.1 34.9 42.8 56.8 34.0 24.3 17.5 32.5 ARL6IP5 "DERP11, GTRAP3-18, HSPC127, JWA, PRAF3, Yip6b" ENSG00000144746 "ADP ribosylation factor like GTPase 6 interacting protein 5" O75915 3 69084937-69106092 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015540, CAB019321" Supported Approved "Endoplasmic reticulum" NA NA 1100000 "Cluster 44: Non-specific - Transcription" "Cluster 38: Heart - Muscle contraction" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 3: Monocytes - Immune response regulation" "Endoplasmic reticulum" "CAB019321: , HPA015540: AB_1852061" "unprognostic (8.01e-2)" "unprognostic (1.71e-1)" "unprognostic (8.09e-2)" "unprognostic (1.51e-3)" "unprognostic (2.65e-1)" "unprognostic (3.51e-1)" "unprognostic (1.65e-1)" "unprognostic (1.84e-1)" "unprognostic (3.06e-1)" "unprognostic (3.72e-3)" "unprognostic (1.31e-2)" "unprognostic (7.23e-2)" "unprognostic (2.05e-3)" "unprognostic (3.60e-1)" "unprognostic (4.44e-2)" "unprognostic (3.42e-2)" "unprognostic (1.31e-2)" 157.7 130.6 91.0 109.9 95.9 67.8 139.7 100.6 156.0 123.0 83.1 87.3 59.1 72.8 104.4 78.3 90.5 102.1 216.3 91.1 105.6 88.5 80.3 125.5 138.3 100.6 93.4 74.2 55.3 83.4 47.6 88.8 106.8 129.6 85.2 135.0 159.6 90.5 183.2 48.5 66.1 100.4 104.1 100.3 72.5 34.9 98.3 92.3 71.2 186.8 130.0 111.8 61.0 113.3 86.9 59.0 71.1 52.8 361.4 335.2 89.7 87.9 196.5 66.7 77.4 30.1 205.9 17.0 28.9 151.1 124.8 67.0 59.2 100.8 57.0 339.5 55.2 59.6 91.1 45.8 92.9 51.4 280.5 243.6 177.5 61.5 77.3 235.0 206.0 55.7 26.6 156.7 163.6 50.3 56.0 67.0 18.5 200.2 55.1 48.6 65.0 159.1 330.5 143.1 17.8 47.0 87.0 93.5 119.5 69.7 61.7 80.2 203.7 44.1 34.8 112.5 96.1 139.4 208.5 31.7 146.0 126.0 72.8 697.4 388.2 650.2 332.4 357.6 257.1 397.7 462.4 427.6 275.7 336.1 391.2 409.5 162.0 298.4 315.1 176.0 530.4 933.9 91.0 95.9 100.6 156.0 91.1 105.6 100.6 93.4 106.8 104.1 98.3 113.3 101.1 176.3 132.0 34.6 183.6 72.8 70.6 275.5 108.7 201.9 214.9 174.5 422.0 95.8 185.0 93.8 187.7 305.8 212.7 146.7 25.4 281.4 20.8 144.9 79.5 121.4 42.0 89.8 45.9 214.4 379.2 254.8 64.2 233.4 336.6 75.7 150.3 72.5 292.0 122.8 70.7 57.1 270.6 260.0 402.1 18.9 207.2 275.4 272.1 35.6 476.6 235.7 272.9 49.8 97.0 244.2 95.7 261.8 93.4 93.6 91.7 77.8 155.0 272.4 190.7 190.3 125.4 7.3 4.3 207.8 73.9 178.4 292.2 133.6 77.8 94.0 LMOD3 ENSG00000163380 "Leiomodin 3" Q0VAK6 3 69106065-69123032 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 111.2;skeletal muscle: 459.8;tongue: 228.2" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 278.1" "Cancer enriched" "Detected in single" 6 "head and neck cancer: 1.6" "Region enriched" "Detected in single" 4 "midbrain: 2.3" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 4 "HSkMC: 2.9" "Not detected" "Not detected" HPA036034 Uncertain NA NA "Cluster 46: Basophils - DNA binding" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA036034: AB_10673494" "unprognostic (1.66e-1)" "unprognostic (2.65e-1)" "unprognostic (1.04e-2)" "unprognostic (1.32e-2)" "unprognostic (1.93e-1)" "unprognostic (2.50e-3)" "unprognostic (1.96e-2)" "unprognostic (2.77e-2)" "unprognostic (1.39e-1)" "unprognostic (6.57e-2)" "unprognostic (3.63e-1)" "unprognostic (4.33e-1)" "unprognostic (2.98e-4)" "unprognostic (3.67e-3)" "unprognostic (1.29e-1)" "unprognostic (8.86e-2)" "unprognostic (2.96e-1)" 0.2 0.1 0.3 0.2 0.4 0.2 0.1 0.3 0.5 0.1 0.2 0.1 0.2 0.0 0.2 6.4 0.0 0.3 111.2 0.3 0.3 0.1 0.1 0.5 0.2 0.3 2.3 0.0 0.4 0.0 0.9 0.5 0.3 3.8 0.1 1.3 9.0 0.4 459.8 0.2 0.2 0.1 0.1 0.7 0.4 0.1 0.2 0.1 0.1 228.2 0.0 0.8 0.1 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.3 2.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.1 0.2 1.6 0.2 0.4 0.2 0.2 0.2 0.3 0.4 0.3 0.1 0.3 0.3 0.4 0.4 0.2 0.4 0.2 0.4 0.1 0.3 0.4 0.3 0.5 0.3 0.3 0.3 2.3 0.3 0.1 0.2 0.5 0.5 0.0 0.0 0.3 6.2 2.3 1.5 2.1 0.0 5.0 2.4 1.8 278.1 5.7 1.3 0.0 39.6 0.8 10.0 2.4 0.0 1.0 1.6 3.4 1.2 2.4 0.0 0.0 0.1 0.0 2.1 8.2 0.0 10.0 17.8 0.5 0.7 1.2 0.7 6.7 2.0 1.9 6.1 2.2 28.1 0.5 0.3 2.2 12.4 0.0 3.9 1.0 13.4 0.0 0.3 1.1 0.2 1.2 0.9 2.6 6.1 0.4 0.3 18.1 0.0 33.1 3.4 0.6 0.1 0.8 1.4 0.4 8.2 0.9 1.1 2.5 FRMD4B "GRSP1, KIAA1013" ENSG00000114541 "FERM domain containing 4B" Q9Y2L6 3 69168782-69542583 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.0" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1209.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 39.8;hTERT-HME1: 52.7;HUVEC TERT2: 55.1;TIME: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009705 Uncertain Supported Approved "Nucleoplasm,Golgi apparatus,Centriolar satellite" NA NA 17000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Centriolar satellite" "Nucleoplasm, Golgi apparatus" "HPA009705: AB_1849147" "unprognostic (1.36e-1)" "unprognostic (2.92e-1)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (4.59e-2)" "unprognostic (9.73e-2)" "unprognostic (1.49e-1)" "unprognostic (2.02e-1)" "unprognostic (2.40e-2)" "unprognostic (2.32e-1)" "unprognostic (1.09e-2)" "unprognostic (8.23e-2)" "prognostic favorable (5.01e-4)" "unprognostic (1.49e-1)" "unprognostic (7.54e-2)" "unprognostic (2.79e-1)" "unprognostic (4.39e-3)" 11.0 4.8 17.5 12.3 46.7 15.5 16.1 26.9 30.9 24.9 7.0 12.8 9.1 11.3 9.3 26.8 13.2 19.2 17.4 20.8 29.3 16.3 34.5 24.8 10.9 39.4 37.1 10.9 8.2 3.7 4.0 25.5 36.3 16.9 12.9 21.9 37.1 10.5 2.3 23.0 12.5 10.5 22.7 32.3 15.0 4.7 42.0 14.1 27.1 4.6 11.2 13.7 15.8 84.0 6.7 1.8 10.4 0.3 0.2 1.5 11.3 0.5 1.7 0.8 0.5 39.8 11.3 0.8 3.5 0.5 1.0 25.9 4.9 35.3 1.2 2.2 3.3 20.4 2.6 2.3 0.7 5.2 10.2 1.7 35.2 1.0 52.7 1.6 55.1 4.7 1.6 5.8 3.0 7.7 0.5 0.8 5.6 8.9 8.5 32.2 2.8 1.0 14.8 4.6 12.1 15.6 1.7 12.2 35.5 9.3 4.6 6.8 47.1 0.6 4.3 0.4 1.8 0.6 0.3 1.2 0.4 13.5 13.5 18.3 27.6 2.3 1.9 13.8 7.0 1.6 6.3 2.8 16.9 2.0 1.9 1.8 7.1 3.8 2.3 16.8 15.4 7.7 17.5 46.7 26.9 30.9 20.8 29.3 39.4 37.1 36.3 22.7 42.0 84.0 20.6 41.7 83.6 2.9 3.6 60.7 33.4 57.8 69.4 13.8 34.4 21.7 33.4 41.5 58.5 14.7 218.9 49.9 20.3 74.4 33.2 32.6 18.9 207.9 49.3 64.3 24.5 8.6 4.2 17.3 19.7 32.1 75.4 282.6 34.7 97.5 89.3 53.6 92.6 0.0 92.7 42.1 36.7 138.7 112.7 4.0 6.5 105.2 28.4 93.7 26.3 13.5 1.0 129.2 1209.1 24.5 67.0 18.4 6.9 61.1 10.7 55.6 38.2 109.2 6.6 11.8 21.0 0.0 3.5 79.9 51.4 58.3 44.6 32.1 32.2 172.8 MITF "bHLHe32, MI, WS2, WS2A" ENSG00000187098 "Melanocyte inducing transcription factor" O75030 3 69739464-69968336 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Albinism, Cancer-related genes, Deafness, Disease variant, Microphthalmia, Osteopetrosis, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 133.5;Melanocytes: 585.2;Oligodendrocyte precursor cells: 166.9;Oligodendrocytes: 240.3" "Cancer enriched" "Detected in all" 4 "melanoma: 39.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 5.2;classical monocyte: 9.4;intermediate monocyte: 3.3;myeloid DC: 6.1;non-classical monocyte: 5.9" "Group enriched" "Detected in many" 6 "dendritic cells: 6.1;granulocytes: 5.2;monocytes: 9.4" "Cell line enhanced" "Detected in many" "HMC-1: 89.1;SK-MEL-30: 254.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002578, HPA003259" Enhanced NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB002578: AB_564111, HPA003259: AB_1079381" "unprognostic (3.29e-1)" "unprognostic (4.26e-2)" "unprognostic (2.98e-2)" "unprognostic (6.04e-2)" "unprognostic (1.03e-1)" "unprognostic (3.25e-1)" "unprognostic (1.04e-2)" "unprognostic (1.09e-1)" "unprognostic (2.75e-1)" "unprognostic (5.31e-3)" "unprognostic (3.87e-3)" "unprognostic (1.94e-1)" "prognostic favorable (8.35e-10)" "unprognostic (6.37e-2)" "unprognostic (1.08e-1)" "unprognostic (2.04e-1)" "unprognostic (1.73e-1)" 13.8 4.4 5.1 3.8 9.2 1.7 10.0 9.4 6.3 51.3 21.2 18.8 2.8 46.2 4.5 8.9 10.3 16.8 31.1 5.2 9.3 20.0 2.2 9.7 3.4 12.5 9.5 18.7 4.2 16.8 3.8 3.3 10.4 8.4 4.5 1.2 5.1 14.1 50.6 11.0 5.8 46.0 7.0 2.0 9.4 2.3 10.3 2.2 7.6 43.3 1.5 10.6 16.6 13.8 17.2 12.2 1.3 5.1 18.8 0.3 2.0 16.9 9.9 7.8 4.8 6.1 0.8 0.0 4.0 0.3 21.6 8.6 3.7 9.4 8.6 0.0 2.5 37.1 24.5 0.3 4.5 0.8 89.1 15.3 3.9 2.2 8.6 29.1 2.4 0.0 12.3 5.2 5.4 1.2 0.7 1.0 0.7 0.7 8.3 0.1 1.9 7.7 45.2 9.0 0.4 1.9 8.8 3.1 254.1 2.0 0.7 2.3 0.1 3.8 13.3 5.1 3.5 0.6 1.0 0.1 7.7 2.6 9.2 5.2 9.4 0.0 0.0 3.3 0.0 0.0 0.0 0.1 6.1 0.0 0.0 0.0 0.7 1.1 5.9 0.5 0.0 3.1 5.1 9.2 9.4 6.3 5.2 9.3 12.5 9.5 10.4 7.0 10.3 13.8 4.6 28.9 6.8 34.3 0.2 42.8 3.6 16.7 7.4 1.6 1.8 1.8 109.5 11.5 18.2 14.7 0.0 1.3 0.6 0.4 50.9 14.7 1.6 24.5 94.3 7.4 1.2 8.6 14.7 8.8 1.0 38.3 9.7 71.2 106.8 10.9 4.6 2.1 45.8 6.7 133.5 0.3 12.2 30.8 30.9 3.4 44.4 24.3 585.2 50.6 10.6 1.4 0.0 166.9 240.3 7.7 0.0 50.4 0.4 5.2 0.2 24.3 12.5 0.2 13.1 17.8 22.6 4.0 6.3 7.2 18.9 1.1 3.8 5.5 0.6 7.1 MDFIC2 ENSG00000242120 "MyoD family inhibitor domain containing 2" A0A1B0GVS7 3 70194479-70312638 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebral cortex: 4.2" "Low region specificity" "Detected in many" NA NA 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FOXP1 "12CC4, hFKH1B, HSPC215, QRF1" ENSG00000114861 "Forkhead box P1" Q9H334 3 70954708-71583989 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "basal ganglia: 41.1" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTEC/SVTERT24-B: 95.0" "Low region specificity" "Detected in all" "HPA003876, CAB011501" Supported Supported Nucleoplasm NA NA "Cluster 30: Non-specific - Translation" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "CAB011501: AB_732428, HPA003876: AB_1078907" "unprognostic (2.31e-1)" "unprognostic (4.35e-3)" "unprognostic (2.09e-2)" "unprognostic (3.54e-2)" "unprognostic (2.69e-1)" "unprognostic (2.81e-3)" "unprognostic (1.68e-1)" "unprognostic (1.00e-1)" "unprognostic (1.23e-1)" "unprognostic (2.03e-1)" "unprognostic (4.38e-3)" "unprognostic (3.40e-1)" "unprognostic (6.14e-2)" "unprognostic (1.05e-1)" "unprognostic (8.65e-2)" "unprognostic (1.27e-1)" "unprognostic (6.05e-2)" 16.5 3.8 5.0 20.3 41.1 38.5 14.5 0.3 12.5 11.2 9.9 28.7 12.2 15.3 6.5 23.0 14.3 21.0 12.7 7.8 0.0 7.0 13.0 22.9 22.2 3.1 6.7 32.4 16.8 6.5 9.1 13.7 0.9 21.2 23.4 2.6 29.7 9.6 8.2 10.9 15.3 22.7 0.1 17.8 20.6 14.4 6.6 26.3 14.5 11.1 25.4 21.6 14.2 8.1 9.6 8.0 16.8 13.2 8.4 21.3 8.2 26.3 30.9 22.0 17.4 51.9 11.2 31.1 4.3 12.9 17.6 6.9 31.0 22.8 40.3 7.8 11.7 13.0 17.0 52.7 20.5 25.7 31.6 21.7 10.3 95.0 42.1 18.3 36.6 15.4 13.6 36.7 10.8 42.6 11.9 9.3 19.7 7.2 39.9 38.0 30.7 4.7 18.8 30.1 14.5 27.6 32.6 7.7 1.9 15.9 5.6 21.9 47.7 34.9 14.3 48.9 42.2 9.0 7.1 41.8 22.5 35.7 7.5 46.9 15.3 15.2 18.3 13.1 19.4 58.1 38.7 22.6 13.0 62.2 60.8 40.0 27.0 22.2 25.3 21.7 35.9 28.8 5.0 41.1 0.3 12.5 7.8 0.0 3.1 6.7 0.9 0.1 6.6 8.1 158.8 73.7 121.3 130.9 266.5 183.0 170.6 58.2 176.4 30.3 98.5 115.1 42.1 148.7 72.0 33.1 18.8 47.2 122.9 118.1 31.3 79.0 156.0 116.3 48.2 184.9 271.6 111.5 391.0 95.1 12.6 90.4 95.8 128.0 219.8 117.7 184.9 72.3 49.5 6.7 139.9 231.2 154.6 117.6 209.0 89.6 42.0 101.3 37.4 414.1 120.3 15.5 116.4 184.5 286.4 124.8 102.8 24.8 66.0 178.8 91.7 19.4 83.7 42.8 92.1 102.9 119.4 13.7 33.6 111.5 101.4 52.4 168.1 33.1 157.2 146.3 AC097634.4 ENSG00000285708 "Novel protein" 3 70959226-71754229 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in all" "basal ganglia: 102.6" HPA003876 Uncertain Approved Nucleoplasm NA NA "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "HPA003876: AB_1078907" 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EIF4E3 MGC39820 ENSG00000163412 "Eukaryotic translation initiation factor 4E family member 3" Q8N5X7 3 71675414-71754773 "Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 14.7" "Group enriched" "Detected in many" 7 "granulocytes: 14.7;monocytes: 4.2;T-cells: 5.7" "Cell line enhanced" "Detected in many" "HDLM-2: 28.0;Karpas-707: 36.3;U-937: 50.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058649, HPA076465" Approved Approved "Nucleoli fibrillar center" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 2: Karpas-707 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Nucleoli fibrillar center" "HPA058649: AB_2683785, HPA076465: " "unprognostic (3.16e-3)" "unprognostic (7.60e-3)" "unprognostic (4.28e-2)" "unprognostic (1.67e-2)" "unprognostic (1.89e-2)" "unprognostic (1.49e-1)" "unprognostic (1.31e-2)" "prognostic favorable (6.63e-4)" "unprognostic (3.10e-2)" "prognostic favorable (4.64e-5)" "unprognostic (3.16e-2)" "unprognostic (4.58e-2)" "prognostic favorable (6.99e-5)" "unprognostic (3.09e-1)" "unprognostic (1.85e-1)" "unprognostic (3.64e-2)" "unprognostic (1.83e-2)" 27.5 12.0 13.5 12.7 17.5 26.6 13.9 10.7 18.3 11.5 1.7 18.0 14.2 14.5 9.8 19.6 15.7 10.6 29.9 17.5 12.3 13.9 11.7 16.1 12.7 8.7 10.0 22.7 15.9 24.5 9.8 6.3 8.1 16.0 17.0 8.2 14.3 18.2 61.8 9.7 18.6 17.3 10.6 17.7 12.7 5.6 15.7 15.8 17.4 54.5 10.9 15.1 9.9 15.5 0.6 2.5 2.4 7.8 2.3 5.9 3.0 2.1 2.3 2.1 1.2 1.3 1.2 0.0 5.1 2.0 13.4 2.8 8.6 12.1 1.7 28.0 2.7 0.0 0.2 0.2 8.2 4.3 4.6 5.3 7.5 0.6 6.4 1.1 6.7 4.9 0.9 36.3 0.4 9.4 3.9 1.0 18.9 0.9 4.3 2.1 9.4 1.2 25.9 13.3 4.8 12.9 14.4 3.1 0.3 7.4 13.6 0.2 1.8 1.2 5.9 16.6 2.0 25.2 25.0 0.0 0.9 50.3 4.8 2.0 4.2 6.1 2.1 1.8 3.2 0.2 2.9 3.5 0.9 0.1 2.1 2.5 14.7 1.1 2.6 0.0 5.7 1.7 13.5 17.5 10.7 18.3 17.5 12.3 8.7 10.0 8.1 10.6 15.7 15.5 16.6 28.9 14.5 5.5 1.9 10.1 10.3 2.0 5.2 9.4 14.5 10.3 39.3 11.5 7.4 11.0 0.0 3.7 20.3 41.0 3.9 5.2 1.0 8.6 19.0 11.0 9.1 1.7 37.0 5.8 3.0 12.5 7.1 35.2 7.0 6.4 17.5 7.3 3.9 1.7 32.0 10.8 2.0 19.5 6.2 1.7 12.8 15.8 3.6 11.2 31.2 13.0 17.5 11.6 11.9 8.6 17.1 9.4 10.9 12.2 40.0 14.9 8.1 0.5 0.0 11.5 14.1 0.6 1.3 8.3 13.5 1.5 20.8 2.6 10.1 9.5 GPR27 SREB1 ENSG00000170837 "G protein-coupled receptor 27" Q9NS67 3 71753855-71756496 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 22.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 10.3;Breast myoepithelial cells: 7.5;Collecting duct cells: 12.9;Glandular and luminal cells: 8.1;monocytes: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "eosinophil: 2.8;neutrophil: 7.2" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.2" "Cell line enhanced" "Detected in some" "EFO-21: 17.9;HL-60: 17.5;MCF7: 14.6;NTERA-2: 28.9;RPTEC TERT1: 13.6;SH-SY5Y: 10.9;T-47d: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029395 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA029395: AB_10602907" "prognostic favorable (5.63e-4)" "unprognostic (2.99e-1)" "unprognostic (3.23e-2)" "unprognostic (3.22e-1)" "unprognostic (7.14e-3)" "unprognostic (1.50e-2)" "unprognostic (2.17e-2)" "unprognostic (1.18e-2)" "unprognostic (3.22e-1)" "prognostic favorable (1.21e-6)" "unprognostic (2.97e-3)" "unprognostic (4.97e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-2)" "unprognostic (2.71e-2)" "unprognostic (1.45e-2)" "unprognostic (6.79e-2)" 1.4 4.0 21.3 1.5 22.9 15.7 3.9 13.0 19.7 3.5 7.4 1.6 0.3 5.0 2.8 3.7 6.8 1.0 3.4 19.9 20.6 3.2 0.1 1.4 0.2 18.0 18.3 4.4 3.1 17.3 9.2 1.2 16.2 5.1 0.5 1.8 1.4 4.3 0.7 2.1 0.7 2.9 19.7 3.3 2.0 4.7 22.9 0.5 6.2 1.9 0.2 2.0 2.3 18.9 0.0 1.1 1.9 2.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 17.9 0.0 0.8 0.1 4.3 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.1 17.5 0.9 0.0 2.9 0.0 1.2 0.0 0.0 3.7 0.0 0.0 0.0 14.6 1.2 0.2 28.9 0.0 0.0 0.0 0.0 0.0 13.6 7.8 3.0 10.9 3.8 0.0 0.0 3.6 9.9 0.0 0.0 0.0 7.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 2.8 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 7.2 0.0 0.1 0.0 0.0 0.1 21.3 22.9 13.0 19.7 19.9 20.6 18.0 18.3 16.2 19.7 22.9 18.9 0.2 0.0 1.1 0.0 0.1 1.9 4.2 0.0 4.0 10.3 6.5 7.5 3.5 2.8 1.3 12.9 4.2 1.4 0.4 0.2 1.9 0.7 0.2 2.1 4.9 0.4 1.2 1.7 0.0 0.0 1.3 1.2 1.1 8.1 0.0 2.4 0.4 0.0 0.9 0.0 0.0 0.0 0.0 4.4 0.3 0.0 0.9 3.2 0.0 0.0 8.6 0.5 1.0 0.0 0.0 0.3 0.1 1.2 0.0 5.6 0.0 0.1 1.5 0.4 0.0 2.3 1.7 0.2 4.8 4.7 1.7 0.3 0.7 0.5 0.3 2.0 PROK2 "BV8, KAL4, MIT1, PK2" ENSG00000163421 "Prokineticin 2" Q9HC23 3 71771655-71785206 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Biological rhythms" Neuropeptide "Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 64.5;lymphoid tissue: 22.5" "Cell type enhanced" "Detected in some" "Erythroid cells: 5.9;Kupffer cells: 8.0;Macrophages: 11.3;monocytes: 6.9;Spermatocytes: 23.8" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.1" "Region enriched" "Detected in many" 7 "cerebral cortex: 13.3" "Immune cell enriched" "Detected in many" 50 "neutrophil: 414.4" "Lineage enriched" "Detected in many" 50 "granulocytes: 414.4" "Cell line enhanced" "Detected in some" "HL-60: 9.2;NB-4: 8.9;NTERA-2: 5.5;U-266/70: 12.0;U-266/84: 20.8;U-937: 8.3" "Group enriched" "Detected in some" 6 "basal ganglia: 2.7;hypothalamus: 1.1;olfactory bulb: 3.5" "Low region specificity" "Detected in all" HPA041408 Approved "Secreted to blood" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 16: U-266 - Nucleosome" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "HPA041408: AB_10964057" "unprognostic (5.24e-2)" "unprognostic (3.13e-3)" "unprognostic (3.51e-3)" "unprognostic (3.59e-2)" "unprognostic (1.89e-1)" "unprognostic (2.94e-1)" "unprognostic (2.97e-2)" "unprognostic (9.52e-2)" "unprognostic (4.29e-2)" "unprognostic (9.91e-3)" "unprognostic (6.89e-2)" "unprognostic (5.73e-1)" "unprognostic (1.59e-4)" "unprognostic (2.02e-2)" "unprognostic (1.48e-1)" "unprognostic (1.40e-2)" "unprognostic (2.16e-2)" 7.2 0.3 0.7 17.7 0.5 64.5 0.3 0.1 13.3 0.4 0.7 0.4 0.3 0.2 0.0 0.4 2.7 1.2 1.0 0.2 0.5 0.6 2.5 13.1 0.2 0.5 1.0 0.2 1.1 0.0 0.4 3.1 1.2 0.2 0.2 0.1 0.3 0.0 0.5 0.1 0.5 1.5 0.2 22.5 0.6 11.4 1.9 1.1 0.5 4.2 0.5 6.0 0.4 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.6 0.0 0.0 0.0 0.3 8.9 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 20.8 0.0 0.0 8.3 0.0 0.0 8.2 3.5 3.4 0.7 0.0 0.0 2.7 2.9 0.7 0.0 0.9 5.0 414.4 0.0 0.2 0.3 1.7 3.1 0.7 0.5 0.1 13.3 0.2 0.5 0.5 1.0 1.2 0.2 1.9 0.7 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.6 1.8 0.0 0.0 2.5 0.0 0.0 0.0 1.6 0.1 0.1 0.1 0.0 5.9 0.0 0.0 0.0 0.9 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 8.0 0.3 2.8 0.3 11.3 1.8 0.0 6.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 23.8 2.9 0.0 0.0 0.0 3.5 0.1 0.0 0.0 RYBP "AAP1, DEDAF, YEAF1" ENSG00000163602 "RING1 and YY1 binding protein" Q8N488 3 72371825-72446623 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 524.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053357 Approved Supported Nucleoplasm NA No "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA053357: AB_2682124" "unprognostic (6.80e-2)" "unprognostic (2.81e-1)" "unprognostic (6.40e-2)" "unprognostic (1.58e-1)" "unprognostic (7.60e-2)" "unprognostic (1.60e-3)" "unprognostic (1.44e-1)" "unprognostic (1.65e-1)" "unprognostic (1.14e-2)" "unprognostic (2.40e-2)" "unprognostic (3.84e-1)" "unprognostic (4.12e-2)" "prognostic favorable (2.50e-5)" "unprognostic (1.89e-1)" "unprognostic (4.24e-1)" "unprognostic (3.09e-2)" "unprognostic (4.22e-1)" 8.6 5.4 2.0 0.8 2.0 2.7 7.8 1.4 2.3 9.4 0.9 9.5 0.8 10.0 0.6 7.1 8.5 1.2 5.7 1.8 2.2 7.6 8.6 11.5 0.8 1.5 1.6 10.9 4.7 0.8 5.9 2.2 1.4 8.7 1.0 2.1 6.7 1.2 4.4 8.3 7.4 1.4 1.4 8.6 7.0 8.1 2.0 1.5 5.8 0.8 1.0 8.8 7.9 2.0 0.9 0.9 1.7 1.6 1.5 1.5 1.1 0.9 2.0 1.7 2.1 1.6 1.2 1.0 0.9 1.5 2.0 0.4 1.9 1.4 2.1 6.0 1.0 4.7 1.2 0.7 1.1 0.9 1.1 2.3 1.7 2.2 3.5 2.2 0.5 1.1 1.4 3.1 1.4 1.4 1.3 0.9 3.1 2.7 1.1 1.4 1.5 0.6 1.3 1.0 1.3 5.2 2.4 2.3 1.2 2.7 0.7 1.1 1.3 2.2 1.6 1.3 0.8 2.5 2.7 0.9 1.1 1.6 2.4 0.0 0.1 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.8 0.1 0.2 0.2 0.1 0.1 2.0 2.0 1.4 2.3 1.8 2.2 1.5 1.6 1.4 1.4 2.0 2.0 67.4 57.7 27.6 29.4 39.1 107.2 67.8 19.2 46.1 74.7 75.5 51.4 39.2 32.9 28.9 42.3 16.7 26.9 63.1 58.7 33.2 21.1 27.3 67.5 103.7 70.9 81.2 42.7 49.5 24.0 51.7 61.5 13.7 87.5 69.0 27.1 55.0 40.5 16.5 38.7 64.2 50.5 26.4 37.6 77.3 13.4 25.7 71.3 35.6 60.9 31.9 22.4 27.8 42.7 524.1 32.8 49.0 43.6 49.0 65.0 16.8 24.7 32.3 40.8 32.9 74.9 42.1 57.9 37.0 51.7 97.0 186.9 44.3 98.5 34.9 65.1 SHQ1 "FLJ10539, Shq1p" ENSG00000144736 "SHQ1, H/ACA ribonucleoprotein assembly factor" Q6PI26 3 72749277-72861914 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 113.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042792 Uncertain Supported Nucleoplasm NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA042792: AB_10959736" "unprognostic (1.10e-2)" "unprognostic (1.03e-1)" "prognostic favorable (2.83e-4)" "prognostic favorable (6.49e-4)" "unprognostic (2.05e-1)" "unprognostic (4.54e-3)" "unprognostic (9.21e-3)" "unprognostic (3.19e-2)" "unprognostic (8.89e-2)" "unprognostic (6.78e-3)" "unprognostic (3.76e-1)" "unprognostic (5.28e-2)" "unprognostic (7.30e-3)" "unprognostic (3.59e-3)" "unprognostic (3.21e-2)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" 5.9 7.0 7.3 8.1 10.1 9.2 8.1 7.1 7.6 6.7 6.1 8.8 6.7 7.1 11.4 6.4 10.7 5.6 10.1 5.1 6.6 7.4 8.0 6.2 8.9 7.1 7.0 7.6 7.0 8.5 4.6 5.3 7.4 5.7 8.7 5.5 5.7 6.0 9.1 7.5 6.1 8.0 5.2 7.0 6.4 10.0 8.0 15.3 8.2 8.6 10.0 8.4 5.1 10.4 13.5 18.1 12.0 20.3 15.7 19.2 12.1 21.8 15.8 22.4 24.6 14.5 10.7 22.4 10.2 15.2 18.2 10.9 24.9 20.5 27.5 20.1 19.6 23.3 14.1 17.3 15.9 39.7 18.8 19.2 15.4 33.1 13.6 10.4 21.2 35.8 19.0 13.5 18.5 20.2 113.4 14.1 33.9 41.5 22.7 27.1 18.8 17.3 19.7 17.6 7.6 30.4 20.3 14.3 10.6 16.0 14.7 14.9 15.1 18.0 17.5 30.1 19.5 24.9 53.8 32.7 16.1 32.0 18.3 0.9 11.9 4.3 14.2 13.5 19.1 13.7 15.8 15.4 12.3 13.3 17.7 15.4 0.5 24.2 12.3 17.6 14.4 14.5 7.3 10.1 7.1 7.6 5.1 6.6 7.1 7.0 7.4 5.2 8.0 10.4 5.9 12.8 6.9 8.8 8.3 13.3 4.3 6.9 5.7 7.5 7.2 5.3 9.5 4.3 6.5 5.5 0.0 6.1 9.9 4.3 7.9 8.6 6.9 11.5 9.6 9.1 4.2 10.3 12.1 6.1 7.9 7.1 5.6 8.0 15.2 6.6 11.4 7.6 6.9 3.3 13.5 6.8 4.1 6.6 6.2 1.9 5.9 5.7 5.4 20.6 4.1 3.2 2.1 16.1 33.9 6.5 4.3 5.7 6.1 5.1 4.7 5.7 16.2 5.4 0.0 8.0 5.9 9.1 19.5 10.8 10.2 5.7 7.6 14.8 9.3 3.9 GXYLT2 GLT8D4 ENSG00000172986 "Glucoside xylosyltransferase 2" A0PJZ3 3 72888046-72998138 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 47.9;Endometrial stromal cells: 45.4;Fibroblasts: 23.0;Late spermatids: 27.1;Oligodendrocytes: 61.3;Skeletal myocytes: 40.0;Theca cells: 22.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 22.3;JURKAT: 22.1;MOLT-4: 36.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA068429 Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Midbody ring" Yes No "Cluster 35: T-regs - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "Cytokinetic bridge, Midbody ring" "HPA068429: AB_2685988" "unprognostic (9.43e-2)" "unprognostic (8.87e-3)" "unprognostic (1.90e-1)" "unprognostic (4.77e-2)" "unprognostic (3.33e-2)" "unprognostic (7.04e-2)" "unprognostic (4.79e-3)" "unprognostic (5.29e-2)" "unprognostic (5.25e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (7.33e-2)" "prognostic unfavorable (1.46e-7)" "unprognostic (3.22e-3)" "unprognostic (4.70e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (2.42e-5)" 6.0 3.8 2.6 5.2 5.3 1.8 4.0 4.3 3.2 5.7 2.6 3.7 0.6 5.6 2.5 3.2 5.1 10.1 13.6 2.0 2.4 0.9 0.3 3.8 1.5 6.2 5.8 16.5 4.2 2.4 1.9 4.0 4.1 3.3 2.0 0.4 5.3 4.0 0.8 1.7 1.2 5.5 5.3 0.7 1.3 5.8 4.6 6.7 8.8 1.5 1.0 5.7 3.6 6.9 0.2 1.8 0.1 11.2 9.9 19.3 1.7 1.8 4.2 4.0 9.8 0.5 1.2 0.0 3.1 4.9 22.3 0.1 1.0 2.2 3.8 0.0 1.3 0.0 7.2 12.4 12.6 4.9 0.0 18.8 1.1 9.7 1.6 6.0 0.0 22.1 5.8 0.1 2.4 2.7 36.5 0.1 6.6 0.1 2.2 0.2 9.5 0.0 1.3 1.7 1.1 5.0 9.8 0.5 1.3 2.0 3.7 1.5 0.1 4.3 13.5 13.3 6.5 1.0 0.1 0.2 11.1 2.3 7.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.6 0.3 0.0 2.6 5.3 4.3 3.2 2.0 2.4 6.2 5.8 4.1 5.3 4.6 6.9 1.6 3.2 2.6 7.2 0.1 1.9 1.9 5.3 0.0 0.6 1.5 7.6 14.6 2.8 2.3 0.0 0.0 0.2 1.5 1.4 0.0 0.1 47.9 5.7 45.4 0.6 3.5 0.0 8.3 1.1 0.3 23.0 0.0 7.5 0.0 8.0 0.7 0.0 0.4 0.0 9.0 2.9 0.0 0.0 4.0 27.1 8.1 0.5 0.0 12.2 0.0 2.5 0.0 3.0 61.3 0.8 0.4 7.2 0.0 2.0 0.6 0.5 2.1 0.4 0.0 40.0 3.9 2.5 4.2 0.2 0.4 0.8 0.4 22.9 1.6 0.4 PPP4R2 ENSG00000163605 "Protein phosphatase 4 regulatory subunit 2" Q9NY27 3 72996803-73069198 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034695, HPA039837, HPA073758" Approved Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA034695: AB_10671231, HPA039837: AB_2676707, HPA073758: AB_2686632" "unprognostic (4.60e-2)" "unprognostic (2.75e-1)" "unprognostic (3.98e-3)" "unprognostic (5.62e-2)" "unprognostic (8.86e-2)" "unprognostic (4.64e-2)" "unprognostic (2.38e-1)" "unprognostic (1.95e-1)" "unprognostic (1.11e-1)" "unprognostic (2.13e-3)" "unprognostic (1.87e-2)" "unprognostic (2.86e-3)" "unprognostic (1.67e-2)" "unprognostic (4.63e-2)" "unprognostic (1.71e-1)" "unprognostic (1.23e-1)" "unprognostic (3.35e-1)" 27.2 23.2 16.9 26.8 22.9 101.2 22.7 22.6 25.3 27.9 21.7 26.9 24.7 24.7 19.0 23.0 27.7 23.3 25.8 17.3 17.7 23.6 53.6 18.0 26.3 19.7 19.1 22.9 23.0 25.4 11.0 28.6 21.5 18.3 23.8 24.4 20.7 15.7 25.8 16.7 22.3 18.8 18.9 21.6 21.4 27.1 20.1 36.2 24.8 24.8 25.8 24.0 15.3 38.7 33.6 38.5 80.9 48.2 41.7 35.9 48.8 66.2 46.7 59.0 61.3 56.1 39.8 63.3 37.3 39.7 56.0 23.6 63.6 36.8 76.0 96.6 23.8 71.1 43.6 67.8 45.8 105.7 70.6 40.9 53.6 71.3 58.3 40.9 41.4 62.9 63.6 70.6 49.5 49.3 88.3 45.8 74.8 50.0 31.8 82.0 45.9 58.9 50.0 89.4 18.1 47.7 77.3 49.9 62.1 57.9 45.9 58.7 47.0 52.4 62.4 61.3 57.3 43.1 97.4 125.5 36.9 79.9 60.4 7.9 5.9 14.8 12.5 3.4 13.8 6.9 12.9 13.1 5.1 7.8 11.1 10.0 21.3 11.3 5.7 18.0 17.6 4.3 16.9 22.9 22.6 25.3 17.3 17.7 19.7 19.1 21.5 18.9 20.1 38.7 56.8 57.7 32.4 19.2 58.5 117.1 110.1 115.8 69.4 50.1 53.2 55.5 54.7 47.1 74.0 27.6 14.6 74.8 62.8 72.4 19.6 63.4 58.1 86.3 76.0 61.9 53.8 61.0 45.6 53.1 72.0 61.6 38.2 142.7 30.9 49.1 40.4 76.4 43.1 50.5 34.8 55.5 77.3 39.2 78.1 12.7 53.4 61.6 56.9 41.2 52.6 53.9 54.6 42.3 101.8 71.4 58.3 48.5 69.7 115.7 44.3 45.8 64.0 39.0 39.5 73.9 60.4 100.6 77.1 54.6 109.1 138.3 69.4 59.1 54.5 128.1 EBLN2 ENSG00000255423 "Endogenous Bornavirus like nucleoprotein 2" Q6P2I7 3 73061659-73063337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA062510, HPA068795" Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" Nucleoplasm "HPA062510: AB_2684787, HPA068795: AB_2686038" "unprognostic (1.23e-2)" "unprognostic (3.34e-2)" "unprognostic (1.43e-1)" "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (1.29e-3)" "unprognostic (7.44e-2)" "unprognostic (3.94e-2)" "unprognostic (1.81e-2)" "unprognostic (5.24e-3)" "unprognostic (2.89e-1)" "unprognostic (8.19e-3)" "unprognostic (8.38e-6)" "unprognostic (1.54e-1)" "unprognostic (1.47e-1)" "unprognostic (6.06e-2)" "unprognostic (1.12e-1)" 2.3 1.2 0.5 2.3 1.7 15.4 2.3 1.0 1.1 2.5 1.9 1.8 1.3 2.6 2.4 1.6 2.6 1.3 1.9 0.6 1.2 0.9 1.7 2.7 2.0 1.7 0.9 3.7 2.2 0.7 1.2 2.0 1.9 1.5 2.4 2.7 2.7 0.8 1.4 2.2 2.1 1.5 0.8 2.4 1.9 1.1 1.3 1.5 2.1 0.3 1.7 1.8 2.5 4.4 0.6 0.4 2.6 2.3 0.6 1.4 1.9 1.0 0.2 0.6 0.5 1.3 2.1 1.7 0.4 1.4 0.6 0.9 1.0 1.1 1.3 0.6 0.6 1.1 3.0 1.1 0.3 2.2 2.4 1.4 0.8 1.3 1.3 1.2 0.9 1.4 0.8 2.5 0.7 1.4 1.0 3.0 1.6 0.5 0.7 2.7 0.6 1.0 0.7 2.8 0.6 1.2 0.6 1.1 0.3 1.8 1.7 0.8 1.7 0.7 1.4 2.0 1.6 2.5 1.3 1.3 0.7 2.3 1.3 0.1 0.7 3.3 1.6 0.2 1.3 0.7 1.4 1.4 0.2 1.2 1.2 1.7 1.5 0.5 0.3 1.0 1.9 0.1 0.5 1.7 1.0 1.1 0.6 1.2 1.7 0.9 1.9 0.8 1.3 4.4 4.3 0.0 2.2 0.0 5.8 5.7 12.6 6.7 1.8 5.3 3.2 3.0 1.1 12.8 6.2 3.7 8.4 9.7 5.9 6.8 0.0 3.2 1.8 4.0 4.4 4.6 4.2 6.1 0.0 1.6 6.2 3.9 4.1 7.4 1.3 9.2 10.8 5.1 2.8 3.3 0.0 4.0 4.1 5.1 11.5 0.8 8.4 5.4 1.8 0.0 5.2 2.0 5.2 0.0 0.0 3.9 4.1 3.8 5.2 9.3 6.2 0.5 6.3 6.0 6.6 8.0 4.8 3.5 5.0 1.1 6.3 14.6 6.8 6.7 5.1 13.2 PDZRN3 "KIAA1095, LNX3, SEMACAP3, SEMCAP3" ENSG00000121440 "PDZ domain containing ring finger 3" Q9UPQ7 3 73382431-73624941 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 256.0;Excitatory neurons: 183.1;Inhibitory neurons: 258.3;Microglial cells: 329.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 19 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 19 "dendritic cells: 1.9" "Cell line enhanced" "Detected in many" "AF22: 32.1;ASC diff: 57.0;ASC TERT1: 29.6;BJ hTERT+: 42.0;HSkMC: 41.4;U-87 MG: 30.4" "Group enriched" "Detected in many" 4 "amygdala: 15.1;basal ganglia: 8.1;cerebral cortex: 19.5;hippocampal formation: 16.1;white matter: 7.2" "Low region specificity" "Detected in many" "HPA038822, HPA061420" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol Nucleoplasm "HPA038822: AB_10675952, HPA061420: AB_2684512" "unprognostic (3.22e-2)" "unprognostic (1.32e-1)" "unprognostic (1.00e-2)" "prognostic favorable (3.35e-5)" "unprognostic (1.09e-1)" "unprognostic (5.54e-2)" "unprognostic (8.47e-2)" "unprognostic (3.67e-1)" "unprognostic (1.60e-1)" "unprognostic (7.51e-2)" "prognostic favorable (4.93e-4)" "unprognostic (8.38e-2)" "prognostic favorable (3.65e-7)" "unprognostic (8.63e-3)" "unprognostic (1.63e-1)" "unprognostic (3.72e-2)" "unprognostic (2.86e-3)" 29.9 35.7 14.9 10.2 16.3 0.0 24.0 8.5 20.9 45.2 58.0 84.0 9.2 64.1 24.5 27.8 26.7 27.4 48.0 16.7 10.6 10.7 2.1 14.9 4.5 13.0 11.8 69.4 6.9 0.8 4.6 17.5 11.0 31.7 13.9 6.3 20.9 29.0 91.8 17.3 24.4 38.4 13.1 2.4 38.7 6.4 17.1 2.9 3.6 22.4 1.4 46.7 32.0 13.2 0.0 0.0 32.1 0.1 57.0 29.6 0.1 16.9 42.0 5.0 3.2 16.2 0.0 0.1 0.1 22.8 0.8 0.0 0.0 0.0 4.8 0.0 2.2 0.0 0.0 0.0 9.5 0.0 0.1 41.4 0.0 13.8 0.1 6.0 0.0 0.0 0.0 0.0 4.9 2.1 0.0 0.2 4.6 0.0 0.2 0.0 8.4 0.1 0.0 0.0 3.7 10.5 0.0 7.8 12.7 9.2 4.5 0.0 0.0 20.6 1.5 23.6 2.2 0.7 0.0 0.2 30.4 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 14.9 16.3 8.5 20.9 16.7 10.6 13.0 11.8 11.0 13.1 17.1 13.2 5.9 0.0 0.0 256.0 0.5 2.4 9.7 0.0 1.8 19.3 7.5 7.6 65.0 0.0 0.0 5.5 6.2 0.5 2.7 1.0 1.9 0.0 0.4 2.1 45.2 2.3 21.1 0.0 183.1 0.4 0.5 25.2 2.0 3.3 0.0 35.0 0.0 0.0 0.8 0.0 258.3 9.1 0.0 0.0 2.9 1.3 23.3 0.7 16.0 329.8 0.0 22.5 0.0 21.6 5.5 0.3 0.9 28.2 0.1 10.9 0.1 7.1 0.0 1.9 0.0 4.6 19.6 0.5 6.2 2.9 1.8 0.8 0.5 12.4 3.9 6.3 CNTN3 "BIG-1, PANG" ENSG00000113805 "Contactin 3" Q9P232 3 74262568-74521140 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.1" "Group enriched" "Detected in many" 7 "Excitatory neurons: 274.0;Inhibitory neurons: 195.1;Oligodendrocyte precursor cells: 228.7" "Cancer enhanced" "Detected in many" "prostate cancer: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BJ: 7.1;fHDF/TERT166: 19.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003341 Approved "Intracellular and membrane" NA NA 130000000 "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA003341: AB_1078556" "unprognostic (1.66e-2)" "unprognostic (1.86e-1)" "unprognostic (2.35e-3)" "unprognostic (9.86e-2)" "unprognostic (1.82e-2)" "unprognostic (1.94e-5)" "unprognostic (4.25e-2)" "unprognostic (2.13e-3)" "unprognostic (8.42e-2)" "unprognostic (3.85e-2)" "unprognostic (1.50e-1)" "unprognostic (7.25e-2)" "unprognostic (9.30e-7)" "unprognostic (4.23e-2)" "unprognostic (1.63e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-2)" 2.7 3.0 5.0 0.4 6.4 0.0 1.4 0.0 10.1 2.4 0.7 3.2 0.4 0.9 1.7 0.4 7.6 2.0 2.1 6.2 0.7 3.7 3.1 0.8 0.1 1.3 3.0 1.3 2.0 0.2 4.0 0.1 1.9 5.8 2.8 1.3 0.8 4.2 0.2 0.8 0.5 0.4 0.0 1.8 1.4 0.7 1.3 0.9 1.6 0.2 0.5 4.3 0.5 1.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 7.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 2.4 0.0 1.4 0.0 0.1 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 6.4 0.0 10.1 6.2 0.7 1.3 3.0 1.9 0.0 1.3 1.0 0.2 3.2 1.7 21.9 0.0 0.6 0.8 0.3 0.0 6.2 2.2 1.3 3.5 10.0 4.2 9.2 0.0 0.0 0.0 3.3 1.9 1.9 2.9 32.7 1.8 0.7 1.2 0.0 274.0 0.5 0.0 4.5 0.0 10.8 0.0 0.4 5.7 6.6 0.1 21.9 195.1 6.4 0.0 0.0 2.1 1.8 0.0 0.1 0.0 3.7 0.0 0.2 0.0 228.7 9.8 0.9 3.9 0.0 0.0 4.0 0.6 7.4 4.8 0.9 0.0 2.3 0.9 0.1 1.1 0.0 0.3 0.0 0.5 0.1 7.1 1.9 FRG2C ENSG00000172969 "FSHD region gene 2 family member C" A6NGY1 3 75664330-75667220 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "Distal tubular cells: 27.4;Early spermatids: 13.9;Late spermatids: 30.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "HDLM-2: 12.7" "HPA039264, HPA047769" Uncertain NA NA "Cluster 44: HDLM-2 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "HPA039264: AB_2676420, HPA047769: AB_2680149" "unprognostic (3.47e-2)" "unprognostic (8.28e-2)" "unprognostic (9.57e-2)" "unprognostic (2.59e-1)" "unprognostic (6.46e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-1)" "unprognostic (4.56e-2)" "unprognostic (3.68e-2)" "unprognostic (1.54e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 27.4 0.0 13.9 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 30.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF717 "X17, ZNF838" ENSG00000227124 "Zinc finger protein 717" 3 75678660-75785583 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 35.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "K-562: 47.7" HPA044549 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Nuclear bodies" "Plasma membrane" "HPA044549: AB_10964630" "unprognostic (2.49e-1)" "unprognostic (4.44e-2)" "unprognostic (1.52e-1)" "unprognostic (2.49e-2)" "unprognostic (2.61e-1)" "unprognostic (1.00e-1)" "unprognostic (2.18e-1)" "unprognostic (3.80e-2)" "unprognostic (3.20e-1)" "unprognostic (2.16e-2)" "unprognostic (2.36e-1)" "unprognostic (1.45e-2)" "unprognostic (3.60e-6)" "unprognostic (3.88e-2)" "unprognostic (2.08e-2)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" 5.1 5.7 7.6 3.3 9.6 2.8 7.3 7.7 9.5 5.7 4.4 5.1 5.7 5.9 15.4 5.4 7.2 4.5 5.9 7.2 8.1 9.9 7.9 4.6 4.8 9.0 8.5 7.9 8.9 8.3 9.3 5.0 9.2 6.7 6.6 7.8 7.2 4.7 4.2 9.9 5.2 4.2 8.5 7.1 7.4 8.2 8.7 4.7 9.3 4.4 7.1 5.8 5.4 12.3 11.4 5.8 5.2 3.6 6.1 8.5 3.9 3.5 5.2 5.1 5.9 9.4 9.8 5.2 4.6 6.0 5.0 6.3 6.8 4.5 4.2 0.5 7.0 8.6 9.4 0.9 15.9 0.5 8.6 10.4 4.8 12.8 17.4 4.3 0.7 0.5 47.7 11.6 5.7 1.8 0.6 17.1 5.2 8.9 6.3 7.7 4.5 27.0 7.6 3.8 4.2 17.4 3.5 6.6 14.6 5.1 16.8 4.6 1.6 9.3 10.9 6.4 1.4 12.0 19.9 5.2 4.7 1.3 6.0 1.3 2.6 5.1 2.1 3.8 1.2 5.1 3.3 2.0 2.7 6.1 6.3 3.7 0.7 3.0 3.8 4.1 1.1 2.0 7.6 9.6 7.7 9.5 7.2 8.1 9.0 8.5 9.2 8.5 8.7 12.3 6.6 3.2 3.1 28.1 6.0 3.2 4.2 3.4 5.2 8.5 9.1 8.3 5.6 8.6 4.2 7.3 2.1 5.2 5.8 2.2 11.7 4.6 5.0 3.4 4.8 5.1 5.3 7.4 21.7 4.4 1.8 5.7 4.6 2.6 8.9 11.4 7.9 8.2 7.3 10.1 27.2 7.0 4.1 5.7 4.1 2.1 2.5 4.5 1.8 16.9 5.0 5.2 5.2 25.6 35.4 3.9 2.0 3.0 0.7 5.1 6.3 17.5 6.3 8.1 0.0 5.1 5.3 11.1 8.6 7.0 4.4 3.4 3.1 7.9 5.0 3.9 ROBO2 KIAA1568 ENSG00000185008 "Roundabout guidance receptor 2" Q9HCK4 3 75906695-77649964 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.7;retina: 15.4" "Group enriched" "Detected in many" 24 "Excitatory neurons: 3438.7;Inhibitory neurons: 4706.0" "Cancer enhanced" "Detected in many" "glioma: 3.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 29.8;HEL: 83.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013371, HPA013975" Approved Approved "Nucleoplasm,Plasma membrane,Centriolar satellite" NA NA 1900000 "Cluster 58: Brain - Synaptic function" "Cluster 36: HEL - Hemostasis" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "Nucleoplasm, Centriolar satellite" "HPA013371: AB_1856391, HPA013975: " "unprognostic (1.14e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-2)" "unprognostic (7.25e-3)" "unprognostic (1.82e-2)" "unprognostic (5.93e-3)" "unprognostic (3.87e-1)" "unprognostic (2.83e-3)" "unprognostic (4.07e-2)" "unprognostic (4.23e-1)" "unprognostic (2.90e-2)" "unprognostic (1.76e-1)" "unprognostic (3.08e-4)" "unprognostic (2.06e-1)" "unprognostic (1.07e-1)" "unprognostic (1.99e-2)" "unprognostic (9.65e-3)" 0.7 2.4 10.1 0.5 13.6 0.0 0.6 0.0 14.2 2.4 0.0 0.8 0.5 2.1 0.4 4.8 0.1 2.3 0.6 10.4 1.7 1.8 1.2 10.0 1.5 14.8 13.1 7.0 1.6 2.8 1.5 5.2 14.3 1.2 0.4 15.4 1.6 5.7 0.1 2.3 0.7 1.4 16.7 2.9 0.7 3.7 4.9 9.3 0.1 0.4 2.2 1.2 1.7 8.1 0.0 0.0 2.2 0.0 7.5 8.1 0.1 0.3 29.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 9.8 83.9 1.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.5 0.0 5.1 9.1 0.0 0.0 1.1 5.1 12.2 0.0 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.5 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 13.6 0.0 14.2 10.4 1.7 14.8 13.1 14.3 16.7 4.9 8.1 0.7 0.0 0.5 164.6 0.0 1.8 2.0 0.4 19.4 30.8 0.2 1.0 2.4 1.5 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.2 1.0 1.7 1.1 0.0 0.0 3438.7 0.0 0.1 10.6 0.0 3.2 0.0 2.3 3.3 0.7 0.1 52.2 4706.0 3.0 0.0 0.0 2.8 3.4 3.1 0.1 0.0 54.4 0.0 2.0 0.0 63.3 52.4 0.2 0.0 6.0 0.0 0.8 0.3 0.1 0.1 5.6 0.0 0.1 0.9 2.9 1.1 15.7 1.1 0.1 0.2 40.5 0.5 0.2 ROBO1 "DUTT1, FLJ21882, SAX3" ENSG00000169855 "Roundabout guidance receptor 1" Q9Y6N7 3 78597239-79767998 "Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 309.4;Inhibitory neurons: 1518.9;Oligodendrocyte precursor cells: 348.3;Oligodendrocytes: 479.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013524, HPA052968, HPA074461" Uncertain Enhanced "Plasma membrane" NA NA 16000000 "Cluster 32: T-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "CAB013524: , HPA052968: AB_2682001, HPA074461: AB_2732256" "unprognostic (2.89e-1)" "unprognostic (6.42e-2)" "unprognostic (2.29e-2)" "unprognostic (1.30e-1)" "unprognostic (4.77e-2)" "unprognostic (1.61e-3)" "prognostic unfavorable (9.88e-4)" "unprognostic (2.44e-1)" "unprognostic (2.92e-2)" "unprognostic (2.00e-1)" "unprognostic (6.40e-2)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (6.77e-2)" "unprognostic (1.91e-1)" "unprognostic (2.39e-2)" "unprognostic (1.16e-2)" 12.4 8.6 12.7 10.7 13.7 0.2 4.9 4.3 9.5 13.4 0.0 7.8 3.1 9.5 7.2 12.3 4.7 7.7 6.7 7.8 10.8 3.1 3.6 7.6 9.3 8.8 16.3 16.4 1.9 1.8 7.4 7.8 9.9 12.9 6.0 3.9 5.4 11.9 4.5 20.5 4.3 10.5 7.5 9.0 4.8 10.3 15.5 13.3 4.8 5.4 18.2 13.9 11.1 12.4 0.2 26.9 25.7 41.3 35.0 22.8 1.4 21.1 28.0 16.3 13.8 0.6 11.5 0.0 0.1 26.2 13.0 10.9 31.5 21.6 20.5 0.4 39.1 16.4 51.4 43.4 8.4 0.3 4.1 38.3 28.9 61.9 29.1 30.5 16.5 0.0 2.2 49.0 16.8 13.1 0.0 0.1 32.8 7.9 9.6 0.9 27.2 0.3 0.1 8.9 19.7 13.7 45.5 9.9 16.2 24.6 31.8 0.4 0.3 54.1 23.4 32.7 36.1 1.7 0.0 0.0 49.2 0.1 45.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 12.7 13.7 4.3 9.5 7.8 10.8 8.8 16.3 9.9 7.5 15.5 12.4 4.3 3.2 11.0 81.0 1.9 33.1 20.6 17.9 39.9 11.7 4.1 3.6 3.6 0.0 9.0 7.3 4.2 9.7 0.0 0.1 0.0 0.5 23.9 1.6 23.2 14.3 1.2 4.0 309.4 0.2 8.3 34.6 3.6 2.3 1.3 5.1 16.1 0.3 1.5 1.7 1518.9 1.4 22.4 2.6 10.0 65.9 19.9 1.5 14.2 51.5 1.9 5.7 0.0 348.3 479.3 0.2 5.1 24.5 1.3 20.5 4.9 0.4 2.9 1.0 13.1 24.7 16.8 2.7 7.0 30.3 33.8 5.6 0.9 71.1 2.6 52.7 GBE1 ENSG00000114480 "1,4-alpha-glucan branching enzyme 1" Q04446 3 81489703-81761645 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Glycosyltransferase, Transferase" "Disease variant, Glycogen storage disease, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 149.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 287.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038073, HPA038074, HPA038075" Enhanced Approved Cytosol NA NA 6500000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545" "unprognostic (3.10e-1)" "unprognostic (1.02e-3)" "unprognostic (6.76e-2)" "unprognostic (1.05e-2)" "unprognostic (3.48e-2)" "unprognostic (1.89e-1)" "unprognostic (9.01e-3)" "unprognostic (1.17e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (2.19e-2)" "unprognostic (5.68e-2)" "unprognostic (1.46e-1)" "unprognostic (5.36e-2)" "unprognostic (4.42e-1)" "unprognostic (2.83e-3)" "unprognostic (3.78e-3)" 73.9 53.8 4.5 14.9 5.7 19.7 38.6 7.1 8.2 14.2 14.2 11.8 13.2 17.3 14.2 18.1 13.8 13.0 55.6 6.2 8.2 41.4 108.6 17.2 8.6 10.7 18.7 14.2 14.2 19.1 10.4 25.6 10.3 13.2 13.8 22.0 15.5 14.9 149.1 14.4 11.5 21.8 7.0 12.0 11.1 7.9 7.4 11.4 19.6 56.6 13.2 19.2 13.9 7.4 61.3 36.2 11.9 168.7 287.6 216.8 21.5 99.1 140.1 58.1 97.6 7.1 15.6 67.9 42.7 122.5 34.5 7.1 9.9 45.7 135.4 32.3 6.4 21.2 70.0 22.8 197.5 72.2 17.8 161.2 33.2 93.5 95.5 144.9 130.5 8.0 17.0 38.0 191.1 17.8 12.5 92.7 12.0 16.8 58.0 22.9 53.6 81.1 41.4 20.5 6.0 7.9 64.6 18.7 20.9 17.2 13.3 58.9 183.4 118.9 28.1 84.7 92.8 174.8 21.4 24.6 194.1 47.8 49.8 7.5 11.8 15.6 5.2 10.8 5.1 11.6 5.6 5.7 13.8 12.5 6.4 6.6 11.4 13.5 11.8 4.8 5.1 6.5 4.5 5.7 7.1 8.2 6.2 8.2 10.7 18.7 10.3 7.0 7.4 7.4 49.7 16.0 12.4 31.3 14.9 30.7 22.2 36.8 27.3 18.6 7.5 5.5 60.2 15.7 21.9 31.3 0.0 30.3 8.4 9.5 41.1 32.1 36.2 16.3 15.2 32.0 22.1 4.6 52.4 25.4 74.0 34.9 6.6 14.7 43.1 16.0 15.4 75.2 26.3 30.3 47.4 8.7 12.2 12.9 21.3 16.9 17.4 17.3 24.9 87.1 16.3 10.4 7.2 49.3 63.0 37.8 5.8 13.2 12.8 17.7 11.3 50.8 25.0 17.8 32.9 45.8 26.7 6.9 7.3 20.6 21.3 54.9 8.7 34.2 8.3 14.5 CADM2 "IGSF4D, Necl-3, NECL3, SynCAM2" ENSG00000175161 "Cell adhesion molecule 2" Q8N3J6 3 84958989-86074429 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 14 "brain: 42.1;retina: 94.9" "Group enriched" "Detected in many" 6 "Astrocytes: 1985.3;Excitatory neurons: 4097.4;Inhibitory neurons: 3632.5;Oligodendrocyte precursor cells: 3613.6;Oligodendrocytes: 5060.4" "Cancer enriched" "Detected in some" 9 "glioma: 7.9" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "basophil: 6.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.0" "Cell line enhanced" "Detected in some" "AF22: 10.9;AN3-CA: 31.4;U-266/70: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010024 Enhanced NA NA 250000 "Cluster 34: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA010024: AB_2068039" "unprognostic (2.23e-2)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (1.90e-4)" "unprognostic (8.64e-2)" "unprognostic (2.27e-1)" "unprognostic (4.76e-3)" "unprognostic (1.28e-1)" "unprognostic (3.18e-1)" "unprognostic (1.90e-1)" "unprognostic (8.27e-2)" "unprognostic (1.31e-1)" "unprognostic (2.07e-5)" "unprognostic (9.82e-3)" "unprognostic (1.26e-2)" "unprognostic (4.17e-3)" "unprognostic (1.16e-2)" 4.7 4.6 10.8 0.4 20.7 0.0 1.7 12.8 42.1 0.6 0.0 3.5 0.3 0.2 0.5 1.0 3.0 0.9 2.7 20.7 13.0 0.1 0.8 0.5 0.1 15.2 17.4 0.6 0.7 0.4 2.9 0.2 16.3 1.7 1.0 94.9 0.6 4.4 3.9 0.3 0.9 0.4 7.0 0.2 1.8 0.5 21.1 0.2 0.4 4.1 0.1 0.9 0.9 14.6 0.0 0.1 10.9 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.5 0.0 0.0 0.0 0.0 3.6 2.3 0.9 0.0 0.0 0.0 0.0 0.0 1.1 3.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.0 0.3 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 20.7 12.8 42.1 20.7 13.0 15.2 17.4 16.3 7.0 21.1 14.6 57.3 0.0 1.1 1985.3 0.0 1.0 0.7 0.1 5.7 230.3 2.2 3.4 13.2 0.0 0.8 0.0 519.1 0.3 0.2 0.7 0.0 0.2 3.0 0.1 0.5 3.5 1.8 0.0 4097.4 0.2 0.2 3.6 0.0 0.1 0.0 0.3 2.9 0.0 0.4 94.2 3632.5 0.5 0.0 0.0 0.8 2.1 1.8 1.4 3.6 145.2 0.0 60.8 0.0 3613.6 5060.4 0.2 0.0 0.4 0.0 0.7 0.1 0.1 0.0 576.3 0.0 265.0 0.9 0.4 6.4 1.6 1.0 0.0 0.3 0.5 0.1 0.3 VGLL3 VGL-3 ENSG00000206538 "Vestigial like family member 3" A8MV65 3 86876388-86991149 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.1" "Cell type enhanced" "Detected in many" "Early spermatids: 138.1;Extravillous trophoblasts: 178.1;Late spermatids: 71.8;Leydig cells: 132.3;Peritubular cells: 149.3;Skeletal myocytes: 65.9;Syncytiotrophoblasts: 80.7" "Cancer enhanced" "Detected in many" "prostate cancer: 7.9;urothelial cancer: 6.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "U-2197: 518.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054983 Approved Approved Nucleoli,Cytosol NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 18: U-2197 - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nucleoli, Cytosol" "HPA054983: AB_2682663" "unprognostic (9.08e-2)" "unprognostic (4.47e-3)" "unprognostic (5.97e-2)" "unprognostic (1.54e-1)" "unprognostic (2.98e-2)" "unprognostic (1.13e-1)" "unprognostic (2.77e-2)" "unprognostic (3.86e-2)" "unprognostic (1.38e-2)" "unprognostic (4.94e-2)" "unprognostic (3.70e-2)" "unprognostic (3.44e-2)" "unprognostic (2.73e-8)" "unprognostic (3.85e-3)" "unprognostic (1.27e-1)" "unprognostic (5.42e-3)" "unprognostic (1.05e-1)" 21.0 1.5 5.7 3.3 1.8 0.4 7.4 0.5 2.1 5.4 6.8 6.7 1.1 8.0 1.4 3.0 5.4 9.6 4.3 1.9 6.9 1.5 0.6 15.9 2.3 0.9 2.3 14.2 4.0 1.2 0.3 40.1 1.0 11.0 2.2 1.1 1.6 4.1 1.7 4.1 2.2 9.0 0.6 2.0 2.6 3.4 2.7 0.5 3.0 1.5 0.8 9.3 4.0 0.5 8.1 13.1 69.5 0.2 90.5 112.2 1.1 48.6 34.0 40.8 50.8 15.2 3.1 0.0 0.1 76.9 4.6 6.9 4.8 4.6 55.9 28.4 0.1 3.6 4.8 0.3 41.3 0.5 0.2 86.6 7.6 60.1 26.9 21.8 6.1 0.1 0.0 0.1 51.5 0.1 0.5 0.4 1.4 0.1 0.3 0.1 91.7 0.4 0.0 8.3 0.2 0.1 20.8 0.7 0.1 2.4 0.2 0.3 2.8 90.3 13.4 518.3 1.6 0.2 0.2 0.0 16.8 0.0 3.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 5.7 1.8 0.5 2.1 1.9 6.9 0.9 2.3 1.0 0.6 2.7 0.5 2.5 3.2 2.2 0.0 0.0 8.0 11.1 2.1 4.0 0.0 0.9 4.6 1.2 1.5 3.3 11.0 0.0 35.6 0.1 0.0 0.0 13.4 138.1 1.3 31.0 1.7 0.0 0.0 0.4 2.6 178.1 33.4 1.1 1.2 0.0 0.1 2.5 0.0 7.5 0.0 2.0 0.0 2.0 0.0 10.3 71.8 132.3 0.7 3.6 6.5 0.0 17.1 0.0 0.0 1.4 13.2 0.0 149.3 0.0 17.7 0.0 0.1 3.2 0.3 13.1 65.9 21.8 1.1 1.4 1.8 5.3 80.7 0.5 23.1 0.0 4.5 CHMP2B "CHMP2.5, DKFZP564O123, VPS2B" ENSG00000083937 "Charged multivesicular body protein 2B" Q9UQN3 3 87227271-87255556 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 445.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035069, HPA052754" Uncertain Approved Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA035069: AB_10602798, HPA052754: AB_2681936" "unprognostic (7.83e-3)" "unprognostic (7.45e-2)" "unprognostic (2.01e-3)" "unprognostic (4.05e-2)" "unprognostic (1.51e-1)" "unprognostic (2.35e-1)" "unprognostic (1.02e-2)" "unprognostic (1.52e-2)" "unprognostic (9.78e-2)" "unprognostic (8.69e-2)" "prognostic unfavorable (2.11e-5)" "unprognostic (5.76e-2)" "prognostic favorable (1.74e-6)" "unprognostic (6.52e-2)" "unprognostic (2.29e-1)" "unprognostic (6.41e-3)" "unprognostic (1.21e-1)" 26.0 24.2 15.7 22.8 20.2 42.7 26.3 22.3 22.2 28.9 16.2 41.6 38.5 29.5 22.5 35.2 22.6 28.8 27.0 15.1 18.2 29.6 34.5 22.9 21.9 25.1 21.0 24.9 29.2 24.3 30.4 25.0 24.1 34.9 37.5 15.3 24.9 27.7 35.3 26.4 40.8 29.6 23.7 22.1 31.1 16.1 20.3 17.2 43.1 28.0 21.6 42.3 29.7 31.2 68.4 71.6 25.4 17.4 45.0 38.4 29.7 52.8 71.2 45.1 57.1 57.0 115.0 25.3 36.7 60.1 38.6 35.0 31.6 37.6 56.0 41.7 34.7 29.5 24.6 25.4 39.2 44.9 42.5 29.3 63.2 42.9 58.3 42.6 35.8 29.6 17.3 36.7 50.2 53.2 41.1 18.3 32.4 91.1 65.5 21.4 31.0 26.1 36.0 71.3 9.7 10.8 54.2 45.6 91.4 28.8 40.6 13.7 30.6 42.9 36.5 445.0 37.7 37.7 56.3 41.6 47.6 24.8 30.9 124.7 50.7 136.7 27.3 65.2 37.3 49.6 34.6 34.8 55.1 53.4 32.0 32.4 96.8 31.4 67.8 31.3 52.4 37.8 15.7 20.2 22.3 22.2 15.1 18.2 25.1 21.0 24.1 23.7 20.3 31.2 56.2 83.3 68.7 11.4 58.7 132.0 254.5 90.0 53.5 19.9 59.8 52.1 68.8 62.9 85.0 49.7 4.2 75.4 45.7 268.7 138.9 170.6 6.8 86.7 45.2 54.4 46.7 36.2 14.1 261.2 187.0 68.9 48.4 86.9 74.1 27.1 48.5 60.8 86.9 37.0 15.1 80.3 73.2 61.9 87.6 7.5 66.2 72.6 40.9 9.4 62.0 213.9 42.2 10.6 36.0 237.4 241.3 96.3 30.0 226.0 101.7 145.8 90.5 16.3 72.3 58.5 57.5 78.7 76.7 62.8 145.6 180.9 52.9 38.1 81.3 330.3 POU1F1 "GHF-1, PIT-1, PIT1, POU1F1a" ENSG00000064835 "POU class 1 homeobox 1" P28069 3 87259404-87276584 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 137 "pituitary gland: 59.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA041646, HPA050624" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Nucleoplasm, Cytosol" "HPA041646: AB_10794672, HPA050624: AB_2681192" "unprognostic (1.88e-1)" "unprognostic (2.06e-1)" "unprognostic (4.27e-1)" "unprognostic (1.44e-1)" "unprognostic (3.60e-1)" "unprognostic (2.93e-1)" "unprognostic (1.87e-2)" "unprognostic (7.63e-3)" "unprognostic (3.21e-1)" "unprognostic (1.50e-1)" "unprognostic (4.69e-3)" "unprognostic (1.55e-1)" "unprognostic (1.52e-2)" "unprognostic (1.87e-2)" "unprognostic (1.22e-1)" "unprognostic (1.05e-4)" 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 59.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 HTR1F "5-HT1F, HTR1EL" ENSG00000179097 "5-hydroxytryptamine receptor 1F" P30939 3 87792706-87993839 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 1.8;retina: 3.6" "Group enriched" "Detected in some" 7 "Excitatory neurons: 232.6;Inhibitory neurons: 79.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.3;LHCN-M2: 1.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA005555 Uncertain NA NA "Cluster 46: Basophils - DNA binding" "Cluster 77: Retina - Visual perception" "Cluster 1: K-562 - Erythropoiesis" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA005555: AB_1856708" "unprognostic (1.66e-1)" "unprognostic (2.62e-1)" "unprognostic (2.58e-1)" "unprognostic (9.03e-2)" "unprognostic (1.09e-1)" "unprognostic (1.01e-2)" "unprognostic (4.78e-1)" "unprognostic (1.58e-1)" "unprognostic (2.77e-2)" "unprognostic (2.24e-1)" "unprognostic (1.33e-1)" "unprognostic (9.80e-2)" "unprognostic (2.67e-6)" "unprognostic (1.25e-4)" "unprognostic (1.55e-2)" "unprognostic (3.33e-2)" "unprognostic (3.31e-2)" 0.7 0.2 0.0 0.0 0.1 0.6 0.4 0.0 1.5 0.4 0.0 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.2 0.0 0.3 0.1 0.0 0.4 0.1 0.3 0.1 0.3 1.8 0.0 0.1 0.0 3.6 0.0 0.3 0.1 0.1 0.0 0.4 0.0 0.6 0.0 0.1 0.0 0.3 0.5 0.1 0.2 0.2 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.5 2.2 0.0 0.0 4.6 0.0 0.4 0.0 0.0 0.0 0.1 0.8 0.3 0.2 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 2.2 0.0 3.0 232.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 79.0 0.1 0.0 0.6 0.5 0.2 0.0 0.4 1.8 13.1 0.2 20.4 0.0 2.5 3.9 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 1.5 19.7 0.1 12.7 0.3 1.9 0.0 0.0 0.0 0.2 0.2 0.1 0.1 CGGBP1 "CGGBP, p20-CGGBP" ENSG00000163320 "CGG triplet repeat binding protein 1" Q9UFW8 3 88051944-88149885 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 528.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035568, HPA037017" Supported Enhanced Nucleoplasm NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA035568: AB_10670022, HPA037017: AB_2675433" "unprognostic (2.87e-1)" "unprognostic (2.86e-1)" "unprognostic (2.43e-2)" "unprognostic (4.89e-2)" "unprognostic (1.30e-2)" "unprognostic (2.96e-2)" "unprognostic (6.76e-2)" "unprognostic (2.95e-2)" "unprognostic (8.30e-2)" "unprognostic (3.63e-1)" "unprognostic (1.65e-1)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" "unprognostic (3.35e-2)" "unprognostic (3.00e-1)" "prognostic favorable (7.79e-4)" 40.2 31.0 22.2 45.8 25.5 75.7 36.9 26.5 29.8 39.9 27.1 32.8 35.6 45.3 32.7 35.6 33.5 37.3 35.9 23.5 27.3 40.2 41.3 39.5 65.2 23.0 22.9 56.2 37.9 44.4 23.2 42.0 23.3 35.5 39.6 48.8 35.2 35.3 37.6 28.1 37.6 44.3 24.4 52.7 33.7 32.5 23.6 85.3 47.0 47.4 61.9 35.7 27.7 34.9 37.4 64.1 109.3 77.4 92.8 78.1 34.5 81.9 71.4 82.0 97.9 46.7 56.4 81.9 52.7 74.7 63.0 30.2 91.4 63.2 103.2 126.0 46.5 132.3 66.0 47.4 79.7 86.3 93.8 74.4 53.8 95.0 118.7 99.2 85.1 99.0 58.2 87.5 89.5 62.9 136.5 59.5 58.1 62.5 59.0 83.6 106.9 58.0 56.0 66.3 22.0 66.6 66.9 35.6 179.1 79.6 57.5 95.6 81.5 98.8 72.5 528.4 81.8 64.0 83.2 90.5 73.1 81.5 84.9 107.9 42.7 81.2 44.2 45.7 43.8 45.0 39.6 46.4 40.6 47.6 46.6 39.6 77.0 47.4 51.6 34.0 48.9 44.7 22.2 25.5 26.5 29.8 23.5 27.3 23.0 22.9 23.3 24.4 23.6 34.9 65.1 51.3 48.0 32.3 75.1 53.2 65.7 45.6 60.9 35.8 59.8 45.3 45.9 42.9 47.8 40.5 16.7 55.0 66.0 49.0 66.5 39.0 21.0 37.8 64.5 63.0 41.9 107.5 40.6 42.0 63.6 57.5 50.4 46.8 46.9 61.1 74.6 55.1 41.2 67.3 35.6 38.3 38.7 56.2 72.8 36.3 69.6 58.7 40.9 42.2 52.4 70.6 53.5 62.8 91.1 52.8 43.9 50.0 63.7 63.0 41.1 65.1 25.3 32.9 65.7 63.3 79.0 94.1 47.9 52.5 50.0 83.9 80.5 31.8 36.0 72.7 AC119733.1 ENSG00000288654 "Novel protein" 3 88058139-88058216 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 50 "skeletal muscle: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF654 "FLJ10997, FLJ21142" ENSG00000175105 "Zinc finger protein 654" 3 88059255-88144660 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 9.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 51.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036172, HPA036173, HPA049262, HPA077939" Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 44: Endometrium - Transcription" Microtubules "Nucleoplasm, Cytokinetic bridge, Mitotic spindle" "HPA036172: AB_10672081, HPA036173: AB_2674987, HPA049262: , HPA077939: AB_2732364" "unprognostic (2.54e-2)" "unprognostic (2.28e-1)" "unprognostic (6.89e-3)" "unprognostic (2.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.29e-2)" "unprognostic (5.74e-2)" "unprognostic (3.45e-2)" "unprognostic (7.65e-2)" "unprognostic (2.02e-1)" "unprognostic (5.72e-3)" "prognostic unfavorable (9.97e-6)" "unprognostic (1.29e-2)" "unprognostic (2.92e-1)" "unprognostic (1.73e-1)" "unprognostic (2.15e-2)" "unprognostic (2.50e-2)" 5.0 3.7 2.6 4.1 2.7 8.1 5.5 4.9 3.3 5.1 1.8 4.4 4.5 4.6 4.7 5.6 3.4 4.8 3.4 2.4 3.2 4.8 7.0 4.5 6.1 2.8 3.1 6.4 4.1 4.3 1.2 5.0 3.3 5.5 4.2 11.7 4.6 4.1 3.0 6.5 4.8 4.1 3.2 4.9 4.7 6.0 2.7 7.6 5.9 4.9 5.7 5.1 2.3 3.9 7.2 3.0 5.0 6.9 9.9 8.6 4.6 9.3 8.4 6.1 8.4 4.4 4.3 11.3 6.2 7.4 4.4 4.7 5.3 8.6 11.8 7.0 3.0 7.0 3.9 3.2 7.5 8.0 7.6 8.4 7.4 6.7 7.8 12.1 8.1 6.6 4.9 9.0 13.6 5.3 8.0 6.5 2.7 5.7 4.8 5.7 3.4 5.4 5.4 9.0 3.7 3.3 6.8 5.2 17.0 6.0 7.3 5.7 9.5 13.6 8.7 51.8 6.6 10.1 7.6 7.9 10.8 7.5 8.6 9.7 1.2 1.8 1.7 1.2 2.0 1.1 1.8 2.4 1.5 1.7 2.2 1.5 1.7 4.0 1.0 0.7 1.4 1.0 2.6 2.7 4.9 3.3 2.4 3.2 2.8 3.1 3.3 3.2 2.7 3.9 18.2 9.6 13.1 10.1 12.8 22.4 10.1 7.9 9.1 14.0 17.4 10.2 11.8 5.7 10.8 5.5 12.5 4.8 14.5 11.9 1.9 7.6 1.4 9.4 16.0 12.4 5.3 5.2 11.7 5.3 4.2 11.7 5.1 12.2 15.8 14.5 8.9 14.0 6.3 16.8 11.3 7.1 10.2 12.3 19.5 1.5 7.5 14.8 8.8 7.5 10.9 9.9 9.2 9.0 13.3 8.4 8.2 12.4 9.2 12.0 9.0 6.0 10.7 14.3 6.6 13.9 11.5 12.1 10.4 11.4 18.6 8.2 14.0 9.0 7.8 14.4 C3orf38 MGC26717 ENSG00000179021 "Chromosome 3 open reading frame 38" Q5JPI3 3 88149959-88168729 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 341.2;Late spermatids: 312.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 147.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034736, HPA034737" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 18: U-2197 - ECM organization" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Plasma membrane, Cytosol" Nucleoplasm "HPA034736: AB_2674307, HPA034737: AB_10671505" "unprognostic (1.93e-1)" "unprognostic (1.40e-1)" "unprognostic (3.75e-3)" "unprognostic (1.48e-2)" "unprognostic (1.74e-2)" "unprognostic (2.41e-2)" "unprognostic (2.26e-3)" "unprognostic (1.54e-1)" "unprognostic (1.80e-2)" "prognostic favorable (3.55e-4)" "unprognostic (9.28e-3)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.95e-2)" "unprognostic (2.88e-3)" "unprognostic (1.63e-1)" "unprognostic (4.57e-2)" "unprognostic (3.67e-2)" 10.2 8.8 7.1 11.1 9.2 42.1 12.4 11.2 11.5 10.7 6.8 11.1 9.7 9.1 10.9 12.1 10.6 9.7 9.9 7.8 8.6 10.4 14.1 10.1 17.7 8.0 7.5 11.6 7.8 10.7 4.8 12.4 8.6 10.1 11.0 7.7 8.8 9.5 8.0 8.2 10.0 10.9 8.7 13.2 10.4 32.8 7.8 20.9 12.0 10.8 18.4 12.5 5.2 12.8 16.6 17.4 32.5 17.7 22.5 19.8 15.0 26.3 31.5 38.6 51.9 19.5 22.5 22.8 23.1 24.5 18.4 11.8 23.7 19.2 33.1 40.1 11.7 27.1 12.3 16.9 30.8 37.9 22.5 27.7 20.1 26.1 21.8 25.2 23.1 23.7 18.0 25.1 43.4 19.4 38.3 16.9 40.0 31.0 18.8 23.9 11.4 21.5 25.7 22.6 10.1 14.6 24.1 14.2 42.2 26.2 25.5 30.0 20.6 24.2 25.7 147.7 29.8 22.6 36.2 33.0 18.8 29.8 23.0 47.8 22.3 24.1 16.8 32.4 21.4 26.0 15.3 17.2 23.5 22.3 15.1 15.6 9.7 23.4 27.4 16.2 20.5 21.6 7.1 9.2 11.2 11.5 7.8 8.6 8.0 7.5 8.6 8.7 7.8 12.8 13.3 19.2 7.5 5.9 30.9 11.7 18.8 19.9 14.2 21.6 11.0 9.5 6.9 8.6 16.7 5.5 22.9 21.6 24.4 13.9 19.6 16.7 341.2 14.4 13.3 10.8 16.2 23.5 9.7 13.7 22.7 17.3 11.7 10.2 14.0 14.2 11.4 7.5 26.7 6.7 9.1 13.3 14.2 23.9 25.1 312.0 16.4 24.0 16.0 6.5 28.0 23.2 23.7 10.1 15.0 15.3 19.3 15.1 17.5 18.6 16.1 14.5 21.2 24.8 13.1 14.9 16.6 75.7 12.2 14.9 14.1 25.6 24.6 18.1 11.1 22.5 CSNKA2IP ENSG00000283434 "Casein kinase 2 subunit alpha' interacting protein" A0A1B0GTH6 3 88338416-88467594 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 119 "testis: 23.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 74: Testis - Spermatogenesis" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EPHA3 "ETK, ETK1, HEK, HEK4, TYRO4" ENSG00000044524 "EPH receptor A3" P29320 3 89107621-89482134 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 31.5" "Group enriched" "Detected in some" 4 "Excitatory neurons: 70.6;Inhibitory neurons: 106.6;Microglial cells: 103.0;Oligodendrocytes: 48.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "AF22: 197.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010462, HPA069390" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol" "Intracellular and membrane" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nuclear membrane, Plasma membrane, Cytosol" "Nucleoplasm, Actin filaments" "CAB010462: AB_2099218, HPA069390: " "unprognostic (1.48e-3)" "unprognostic (2.30e-2)" "unprognostic (4.95e-2)" "unprognostic (1.90e-1)" "unprognostic (2.96e-2)" "unprognostic (1.47e-2)" "unprognostic (2.03e-1)" "unprognostic (9.10e-3)" "unprognostic (1.24e-3)" "unprognostic (7.43e-2)" "unprognostic (1.83e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (3.28e-7)" "unprognostic (3.63e-2)" "unprognostic (1.88e-2)" "unprognostic (4.05e-2)" "unprognostic (1.20e-2)" 5.4 1.0 2.1 1.8 1.3 0.0 2.3 0.2 3.8 12.3 0.1 3.8 2.3 5.5 0.2 3.2 1.3 18.8 8.2 2.2 0.7 1.3 4.9 2.4 3.6 3.3 0.9 4.1 2.1 1.0 0.9 20.1 4.0 31.5 6.2 8.0 2.2 7.1 0.8 0.7 2.4 7.9 0.8 0.9 2.5 1.0 1.7 1.0 11.0 6.3 3.2 14.3 6.4 2.2 0.0 0.0 197.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 11.2 0.2 0.7 0.0 2.4 0.0 0.0 11.8 0.0 0.0 1.7 2.0 0.0 3.9 0.0 0.0 0.6 0.0 2.5 0.1 0.3 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.1 0.0 0.5 0.1 0.1 36.1 0.1 0.0 0.0 1.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.3 0.2 3.8 2.2 0.7 3.3 0.9 4.0 0.8 1.7 2.2 2.2 0.0 0.0 5.5 0.0 0.5 0.3 0.0 0.6 6.4 0.0 0.1 2.4 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 1.8 0.0 0.5 1.8 0.0 0.0 70.6 0.0 0.1 18.1 0.5 0.0 0.0 0.0 1.1 0.0 0.1 20.2 106.6 0.0 0.0 0.0 0.7 1.6 2.1 0.1 0.0 103.0 0.0 4.7 0.0 2.5 48.0 0.0 0.0 8.2 0.0 0.1 0.0 0.0 0.0 18.7 6.6 0.7 19.2 0.1 0.0 0.3 0.3 0.5 0.2 1.3 0.0 0.1 PROS1 PROS ENSG00000184500 "Protein S" P07225 3 93873051-93980003 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis" "Disease variant, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "choroid plexus: 107.5;heart muscle: 116.6;liver: 283.1" "Cell type enhanced" "Detected in many" "Fibroblasts: 83.1;Hepatocytes: 307.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 64.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 112.3;ASC TERT1: 100.1;HSkMC: 78.2;SK-MEL-30: 157.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007724, HPA023974, CAB032610" Approved "Secreted to blood" NA NA 22500000000 5000000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 2: Hepatocytes - Metabolism" "CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738" "unprognostic (2.00e-2)" "unprognostic (2.81e-2)" "unprognostic (9.21e-2)" "unprognostic (8.03e-3)" "unprognostic (3.35e-2)" "unprognostic (2.41e-1)" "unprognostic (6.48e-2)" "unprognostic (3.07e-1)" "unprognostic (5.18e-2)" "unprognostic (3.12e-1)" "unprognostic (1.10e-1)" "unprognostic (1.91e-1)" "unprognostic (1.10e-1)" "prognostic unfavorable (8.35e-4)" "unprognostic (4.90e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.42e-5)" 33.6 8.7 1.7 8.1 1.3 0.3 24.7 1.6 2.7 14.9 107.5 17.3 13.5 16.4 2.0 16.6 19.4 33.7 116.6 3.2 2.2 37.7 283.1 39.2 4.7 2.1 2.4 32.6 5.6 13.5 8.5 32.0 2.2 8.4 21.6 4.6 12.3 10.3 4.9 20.5 20.6 19.2 1.6 11.2 10.5 5.0 2.3 1.5 17.0 16.9 3.7 18.5 15.1 1.7 0.4 2.7 3.0 27.1 112.3 100.1 1.6 4.6 9.4 1.0 6.6 12.7 1.4 0.0 30.0 3.0 18.8 0.0 1.4 0.9 1.8 0.1 7.3 51.4 1.4 29.8 8.7 1.5 1.2 78.2 0.4 4.0 0.6 63.0 7.2 3.7 32.8 0.1 49.2 0.0 0.1 0.0 3.1 2.7 6.5 0.3 1.2 0.0 27.7 0.0 7.6 19.8 5.0 0.0 157.0 0.6 0.0 19.9 9.4 14.8 2.8 8.2 1.7 0.0 0.0 0.0 60.4 30.4 27.8 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 3.2 1.7 1.3 1.6 2.7 3.2 2.2 2.1 2.4 2.2 1.6 2.3 1.7 55.9 64.1 33.8 17.9 1.9 14.8 3.6 2.1 4.0 0.5 1.7 14.0 44.6 14.3 7.5 1.8 10.4 0.6 0.5 7.5 3.9 9.8 3.2 2.1 30.7 47.1 15.7 16.4 28.4 4.4 0.7 83.1 2.0 1.1 30.9 5.0 65.7 307.1 12.8 1.7 19.7 11.6 0.0 31.5 20.6 6.3 28.6 14.6 19.6 27.2 1.3 22.8 0.0 10.6 4.6 5.6 19.3 36.9 0.3 4.5 1.9 42.2 56.6 8.1 13.1 32.4 28.4 0.4 0.7 11.8 33.2 1.6 2.1 10.8 12.6 2.3 ARL13B "ARL2L1, DKFZp761H079, JBTS8" ENSG00000169379 "ADP ribosylation factor like GTPase 13B" Q3SXY8 3 93980139-94055678 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 18.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 93.0;Rod photoreceptor cells: 102.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048926 Approved Uncertain Microtubules,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 77: Retina - Visual perception" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 46: Photoreceptor cells - Phototransduction" Microtubules Cytosol "HPA048926: AB_2680559" "unprognostic (2.29e-2)" "unprognostic (2.35e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (1.94e-1)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (2.97e-1)" "unprognostic (1.05e-2)" "unprognostic (1.19e-1)" "unprognostic (2.15e-2)" "unprognostic (1.00e-1)" "unprognostic (5.42e-3)" "unprognostic (8.86e-2)" "unprognostic (2.73e-1)" "unprognostic (5.41e-2)" "unprognostic (7.50e-2)" 3.4 2.5 1.3 2.9 1.6 0.8 2.3 1.2 2.5 4.1 8.7 1.9 0.8 4.6 1.0 3.3 4.1 4.0 2.0 1.2 1.1 3.6 2.6 4.1 2.1 1.5 1.8 3.2 1.5 3.6 2.0 2.7 1.6 2.0 1.4 18.2 1.5 2.6 0.7 1.4 1.9 4.2 1.5 2.9 1.6 3.5 1.2 2.5 4.3 1.7 1.7 3.1 1.7 2.0 8.3 12.5 7.9 4.3 13.3 3.5 3.6 7.8 4.8 11.8 15.9 8.0 4.4 5.9 11.3 6.9 7.1 5.1 7.2 5.3 16.2 10.5 6.4 12.7 5.6 5.4 6.0 15.2 6.9 5.2 2.1 12.3 19.0 4.5 4.0 8.7 12.5 7.3 6.7 3.1 12.3 1.2 2.9 4.3 7.5 7.2 25.8 2.0 5.7 1.2 18.0 4.6 15.9 0.9 9.4 2.9 2.1 3.5 7.7 11.6 11.0 6.8 9.6 1.8 2.0 11.7 8.5 8.8 8.5 6.4 3.4 2.9 3.7 4.2 3.8 3.9 3.3 3.0 3.0 3.4 3.3 3.1 2.0 4.3 4.8 4.8 2.9 1.8 1.3 1.6 1.2 2.5 1.2 1.1 1.5 1.8 1.6 1.5 1.2 2.0 27.2 93.0 39.6 31.6 11.3 46.8 28.1 8.6 10.2 19.0 11.0 16.8 8.1 12.8 19.7 1.8 41.7 1.9 7.1 1.3 15.6 17.1 14.8 30.1 25.2 31.7 22.1 6.5 58.4 11.8 6.3 48.5 10.2 11.2 45.6 9.2 17.5 7.7 12.1 15.2 41.5 3.1 12.2 7.0 21.6 6.4 23.9 10.7 16.0 38.4 6.0 26.9 6.2 29.7 49.8 11.4 3.8 25.6 8.0 13.9 1.8 18.7 71.9 102.0 6.6 59.4 33.8 43.1 14.5 12.7 58.7 0.8 13.2 16.5 3.1 10.6 STX19 MGC21382 ENSG00000178750 "Syntaxin 19" Q8N4C7 3 94014365-94028597 "Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 16.3;intestine: 13.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 39.4;Glandular and luminal cells: 19.7;Intestinal goblet cells: 31.7;Paneth cells: 38.0;Proximal enterocytes: 19.2" "Cancer enhanced" "Detected in many" "prostate cancer: 10.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.0;HaCaT: 1.3;hTCEpi: 4.0" "Not detected" "Not detected" HPA030604 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 27: Mucus-secreting cells - Mucin production" "Intermediate filaments" Cytosol "HPA030604: AB_10601268" "unprognostic (7.35e-2)" "unprognostic (1.91e-1)" "unprognostic (1.12e-1)" "unprognostic (5.17e-2)" "unprognostic (2.35e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-1)" "unprognostic (1.21e-1)" "unprognostic (9.42e-2)" "unprognostic (9.04e-2)" "unprognostic (1.29e-2)" "unprognostic (4.32e-2)" "unprognostic (7.00e-3)" "unprognostic (1.19e-2)" "unprognostic (1.96e-1)" "unprognostic (2.12e-1)" "unprognostic (4.87e-3)" 0.1 0.0 0.3 1.7 0.5 0.0 5.4 0.4 0.6 2.8 3.7 13.0 7.6 0.8 16.3 6.0 1.4 1.8 0.1 0.3 0.2 0.4 0.1 4.0 0.0 0.3 0.6 0.1 6.7 4.6 0.1 0.1 0.2 3.9 13.4 1.2 8.8 0.1 0.1 9.1 8.1 0.3 0.1 0.4 7.3 0.2 0.2 0.2 0.1 0.0 1.2 0.2 2.9 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 4.0 0.0 0.4 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.4 0.6 0.3 0.2 0.3 0.6 0.2 0.1 0.2 0.3 0.4 16.0 15.9 1.0 0.2 1.7 2.2 6.4 2.8 3.0 5.6 3.7 0.1 0.0 9.9 0.0 12.5 0.2 0.1 39.4 1.9 4.4 1.9 15.9 2.1 0.2 0.0 0.0 3.9 8.2 0.0 0.1 10.2 19.7 0.0 0.1 0.0 0.0 0.2 0.0 2.4 31.7 10.2 0.0 0.0 0.6 0.0 0.1 0.0 1.0 0.0 0.5 0.0 1.0 1.6 7.1 38.0 0.7 0.0 1.5 19.2 0.1 16.1 14.8 0.0 1.0 0.5 0.2 0.1 2.7 1.8 0.3 0.3 0.0 15.7 1.6 DHFR2 "DHFRL1, DHFRP4, FLJ16119" ENSG00000178700 "Dihydrofolate reductase 2" Q86XF0 3 94047836-94063389 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Ductal cells: 6.3;Respiratory ciliated cells: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 13 "hTERT-RPE1: 154.6" HPA051465 Uncertain Approved Mitochondria NA NA "Cluster 32: T-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA051465: AB_2681494" "unprognostic (1.16e-1)" "unprognostic (1.15e-1)" "unprognostic (1.10e-2)" "unprognostic (3.50e-2)" "unprognostic (2.07e-1)" "unprognostic (1.38e-1)" "unprognostic (5.92e-2)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (4.62e-2)" "unprognostic (2.95e-1)" "unprognostic (1.52e-1)" "prognostic favorable (2.30e-6)" "unprognostic (1.63e-1)" "unprognostic (1.79e-1)" "unprognostic (1.13e-1)" "unprognostic (2.96e-2)" 3.3 4.9 3.9 3.8 5.2 1.8 5.3 6.0 5.2 5.2 4.8 4.2 4.1 7.9 6.4 3.5 6.3 5.1 3.7 4.1 4.1 5.9 6.7 4.5 5.7 4.8 4.2 10.1 5.3 6.5 2.5 3.2 5.0 6.4 4.6 3.2 4.4 4.9 1.4 4.2 4.9 5.4 4.2 4.9 4.7 4.7 4.4 5.7 6.7 2.1 4.6 3.3 2.4 6.5 3.8 6.5 4.2 4.4 5.7 7.2 1.7 5.7 6.0 2.8 3.2 1.4 5.7 2.5 3.8 3.0 3.7 5.0 3.3 3.9 4.4 8.5 1.8 3.1 2.9 3.4 6.0 2.2 3.6 7.6 5.1 3.3 4.2 154.6 2.9 11.9 1.6 5.6 3.7 4.5 10.8 1.2 3.7 10.8 6.7 2.7 5.7 4.1 4.1 1.9 5.4 5.3 8.3 2.2 9.6 3.3 5.6 3.1 4.8 4.4 7.4 1.8 2.2 4.1 4.4 3.5 4.4 5.5 6.2 2.2 1.1 2.0 1.8 1.7 3.3 1.8 2.4 2.9 0.7 2.2 3.2 3.0 1.7 1.4 1.8 2.1 3.2 1.3 3.9 5.2 6.0 5.2 4.1 4.1 4.8 4.2 5.0 4.2 4.4 6.5 2.8 12.8 5.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.6 3.4 0.0 0.0 1.8 3.7 0.0 2.4 2.3 0.0 3.9 6.3 0.0 3.5 4.4 2.5 0.0 0.0 0.0 5.5 1.7 2.5 0.0 2.9 2.5 4.9 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.4 0.0 0.0 5.6 8.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 1.3 3.5 0.0 0.0 NSUN3 FLJ22609 ENSG00000178694 "NOP2/Sun RNA methyltransferase 3" Q9H649 3 94062980-94131832 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 79.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036181 Uncertain NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA036181: AB_10602715" "unprognostic (5.77e-2)" "unprognostic (1.08e-1)" "unprognostic (1.54e-2)" "unprognostic (6.00e-3)" "unprognostic (1.26e-2)" "unprognostic (4.13e-1)" "unprognostic (7.35e-4)" "unprognostic (1.44e-1)" "unprognostic (9.50e-2)" "unprognostic (1.22e-1)" "unprognostic (8.63e-3)" "unprognostic (6.94e-3)" "unprognostic (6.47e-2)" "unprognostic (2.67e-1)" "unprognostic (2.52e-1)" "unprognostic (3.92e-2)" "unprognostic (2.33e-2)" 2.5 2.8 2.0 2.7 2.6 3.7 2.9 2.7 2.9 2.7 1.1 3.5 3.1 2.8 3.2 2.3 2.6 2.3 2.4 1.8 1.8 2.4 3.1 2.7 3.2 1.5 1.5 3.2 3.1 2.3 2.3 2.2 1.7 2.7 3.9 3.4 2.7 2.0 1.1 3.3 3.0 2.5 1.3 3.5 3.2 3.3 1.8 3.3 3.0 1.4 2.8 2.6 2.5 2.5 2.5 2.9 3.5 2.9 2.1 3.0 1.5 3.5 2.7 3.9 4.3 1.7 2.3 3.9 4.1 2.4 2.7 3.3 3.9 2.8 5.4 6.1 2.7 6.1 4.0 2.8 2.4 6.5 5.2 2.8 3.1 3.1 3.1 3.5 3.2 4.0 2.5 5.3 3.5 2.5 5.8 3.4 3.2 2.9 3.6 4.8 6.0 3.8 3.4 2.3 6.5 4.8 3.6 2.6 3.8 2.4 4.3 4.0 3.5 3.1 3.1 1.8 4.2 4.3 5.2 6.6 4.1 5.7 4.6 5.5 1.9 2.0 2.2 1.9 2.3 2.0 2.0 2.1 1.6 1.8 2.1 2.5 3.3 2.9 2.9 2.3 2.3 1.3 2.0 2.6 2.7 2.9 1.8 1.8 1.5 1.5 1.7 1.3 1.8 2.5 8.5 6.4 3.2 34.3 13.9 3.1 7.3 11.3 9.6 8.3 5.2 3.6 4.5 4.3 12.4 7.3 10.4 6.4 11.6 11.9 5.9 8.1 79.3 9.9 9.8 8.0 2.4 32.2 27.1 7.8 3.8 7.4 13.3 7.1 2.5 10.2 7.1 6.3 6.4 11.8 29.6 9.4 12.2 10.7 4.6 26.2 4.4 9.9 3.6 30.0 10.4 13.2 10.3 38.2 42.9 8.1 9.9 4.1 7.1 5.0 12.6 9.5 12.7 7.2 6.6 5.4 7.2 8.7 8.4 6.1 3.4 4.0 10.8 9.3 6.9 7.9 MTRNR2L12 ENSG00000269028 "MT-RNR2 like 12" P0DMP1 3 96617188-96618236 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 125442.5;choroid plexus: 60537.0" "Cell type enriched" "Detected in many" 11 "Cardiomyocytes: 34487.4" "Cancer enhanced" "Detected in all" "stomach cancer: 14.6" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 23357.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 23357.3" "Cell line enhanced" "Detected in all" "HeLa: 19226.4" "Secreted to blood" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (3.79e-2)" "unprognostic (1.05e-1)" "unprognostic (1.88e-2)" "unprognostic (1.37e-1)" "unprognostic (1.09e-1)" "unprognostic (9.76e-3)" "unprognostic (1.69e-3)" "unprognostic (1.81e-2)" "unprognostic (7.77e-2)" "unprognostic (3.55e-2)" "unprognostic (2.08e-2)" "unprognostic (4.90e-2)" "unprognostic (9.59e-3)" "unprognostic (1.81e-2)" "unprognostic (2.61e-1)" "unprognostic (2.08e-1)" "unprognostic (1.85e-2)" 7057.6 9488.3 60539.4 1610.0 60538.6 2401.2 2897.2 60547.3 125442.5 1316.1 60537.0 7130.2 3200.8 1495.8 1887.7 3942.3 1591.4 2141.9 24682.6 62534.7 60541.4 11477.3 10961.9 1405.1 1111.1 63276.7 60541.2 1471.0 3698.8 5500.5 0.9 1862.5 61842.9 2592.6 5672.7 5513.6 4076.4 3320.1 36694.8 4024.2 3630.6 2282.8 60728.7 1990.0 5139.8 3848.1 60548.8 1093.2 1305.3 22600.1 1986.4 1741.0 0.7 60592.0 3129.7 3743.3 2766.3 9914.1 4165.4 2220.4 2507.6 3970.8 808.2 749.3 954.5 2070.2 4888.5 6887.0 3132.2 1502.3 436.5 8365.9 196.7 1668.9 1010.6 2008.1 3570.2 7299.3 19226.4 8838.4 1579.3 1469.9 3824.2 4061.3 1945.5 784.9 2127.7 4578.8 844.6 3040.7 5258.3 2276.0 2553.9 1634.8 1252.5 4510.6 808.3 1892.5 1113.4 1992.1 2667.8 2102.8 4420.6 2269.6 1246.8 2408.9 2618.4 2595.6 3524.2 2439.6 2667.3 4152.9 3817.7 3062.1 2505.1 3462.1 1143.3 1197.9 802.7 3365.5 1896.5 8908.3 850.3 10533.0 3473.8 6467.2 1043.1 1696.3 1353.8 2636.4 1309.8 1129.5 1256.2 2611.9 1648.9 1580.6 23357.3 1490.6 1781.5 2078.4 1275.7 2740.2 60539.4 60538.6 60547.3 125442.5 62534.7 60541.4 63276.7 60541.2 61842.9 60728.7 60548.8 60592.0 1081.2 2705.1 2934.5 0.0 291.8 112.5 420.7 10.3 3.4 0.0 702.7 1431.3 34487.4 147.3 1441.4 84.6 0.0 8.4 394.0 24.5 62.6 1.1 19.7 1096.7 707.4 1236.7 4.9 182.7 0.0 1.8 8.6 1698.5 29.6 1465.4 1715.6 334.8 100.3 171.7 12.3 0.0 0.0 7.1 4.1 126.9 333.5 49.0 42.9 633.1 193.9 0.0 29.8 0.0 28.8 0.0 0.0 1.4 8.4 23.0 213.1 337.3 6.6 521.0 1431.8 0.0 46.0 2907.6 1520.5 36.3 39.6 3.3 80.7 10.5 625.8 220.9 5.2 397.1 EPHA6 FLJ35246 ENSG00000080224 "EPH receptor A6" Q9UF33 3 96814581-97752460 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 24.2;ovary: 6.3;testis: 8.4" "Cell type enhanced" "Detected in some" "Astrocytes: 421.5;Early spermatids: 401.8;Excitatory neurons: 423.8;Inhibitory neurons: 879.2;Late spermatids: 208.7" "Cancer enhanced" "Detected in single" "prostate cancer: 0.7" "Region enhanced" "Detected in many" "cerebellum: 24.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HEK 293: 9.3;U-266/70: 28.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007397, HPA058047" Uncertain Enhanced Nucleoplasm NA NA "Cluster 6: Brain - Smell perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA007397: AB_2667821, HPA058047: AB_2683588" "unprognostic (9.87e-2)" "unprognostic (1.67e-2)" "unprognostic (3.42e-4)" "unprognostic (7.21e-5)" "unprognostic (8.51e-2)" "unprognostic (1.32e-1)" "unprognostic (1.82e-2)" "unprognostic (3.14e-1)" "unprognostic (1.87e-1)" "unprognostic (1.34e-1)" "unprognostic (2.22e-1)" "unprognostic (1.71e-4)" "unprognostic (1.93e-3)" "unprognostic (1.76e-1)" "unprognostic (1.48e-2)" "unprognostic (7.14e-3)" 0.2 0.0 6.5 0.0 12.7 0.0 0.2 24.2 10.9 0.8 0.0 3.2 0.1 0.9 0.3 0.8 1.9 0.9 0.3 11.4 0.0 0.4 0.0 0.1 0.0 0.0 0.2 6.3 0.5 0.1 0.1 0.0 1.1 1.0 0.7 1.1 0.1 0.6 0.0 0.0 0.3 1.4 0.1 0.0 0.6 8.4 3.5 0.2 2.0 0.1 0.1 1.4 0.6 0.0 0.0 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 9.3 0.0 2.2 0.0 0.0 2.3 0.0 0.0 0.4 0.0 0.9 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 2.4 0.0 0.9 28.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 12.7 24.2 10.9 11.4 0.0 0.0 0.2 1.1 0.1 3.5 0.0 0.0 0.0 0.0 421.5 0.1 0.3 0.3 0.0 5.2 1.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 401.8 0.1 1.4 0.1 0.0 0.0 423.8 0.0 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 879.2 0.0 0.0 0.0 0.0 208.7 3.1 0.2 0.0 30.0 0.0 1.0 0.0 31.2 9.0 0.1 0.0 1.5 0.0 0.1 0.0 1.7 0.0 0.3 0.0 0.2 0.1 14.7 2.7 6.0 0.0 0.1 0.0 0.4 0.0 0.1 ARL6 "BBS3, RP55" ENSG00000113966 "ADP ribosylation factor like GTPase 6" Q9H0F7 3 97764521-97801229 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 46.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 55.0;Inhibitory neurons: 51.5;Rod photoreceptor cells: 57.4;Spermatocytes: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SCLC-21H: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019361 Approved Approved Microtubules NA NA "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 46: Photoreceptor cells - Phototransduction" Microtubules "HPA019361: AB_1845028" "unprognostic (1.31e-1)" "unprognostic (2.82e-2)" "unprognostic (7.12e-2)" "unprognostic (4.66e-2)" "unprognostic (2.08e-1)" "unprognostic (1.02e-1)" "unprognostic (8.78e-3)" "unprognostic (2.88e-2)" "unprognostic (5.55e-3)" "unprognostic (9.43e-2)" "unprognostic (1.19e-1)" "unprognostic (3.31e-1)" "prognostic favorable (2.53e-7)" "unprognostic (9.49e-2)" "unprognostic (1.67e-1)" "unprognostic (2.16e-2)" "unprognostic (2.97e-1)" 3.6 5.2 4.1 2.2 4.8 0.8 3.3 4.2 5.2 3.4 3.8 2.4 1.5 4.4 3.9 3.0 7.2 3.7 3.6 5.7 4.9 7.5 2.6 5.0 2.5 3.5 3.7 3.5 2.9 12.8 4.1 2.8 3.7 3.9 2.5 46.3 5.8 3.5 1.6 3.1 1.8 4.2 3.9 3.0 2.8 6.6 3.8 2.3 5.5 2.2 2.2 3.2 2.1 3.7 10.1 5.2 4.9 4.1 11.5 7.6 1.3 6.2 5.5 5.6 6.7 2.2 3.6 5.8 6.1 3.1 8.5 4.6 6.1 6.8 10.4 6.3 3.7 1.5 3.9 2.2 5.4 7.6 3.5 4.1 4.9 7.4 1.7 4.5 6.1 7.0 1.8 1.1 8.1 3.1 4.1 3.2 6.1 4.9 7.5 1.9 5.9 4.0 6.5 2.8 26.0 14.4 5.4 3.4 11.2 3.1 4.3 2.4 5.3 5.2 4.7 4.5 8.7 4.2 5.3 6.4 9.5 4.0 6.4 0.2 0.2 0.1 1.0 0.4 2.1 0.8 0.9 1.1 0.4 1.6 1.6 1.3 0.0 1.8 0.5 0.4 1.7 0.7 4.1 4.8 4.2 5.2 5.7 4.9 3.5 3.7 3.7 3.9 3.8 3.7 3.2 3.2 3.6 31.6 2.2 3.2 3.2 4.8 5.2 12.7 3.2 3.0 2.4 1.5 5.0 9.2 27.1 1.2 0.8 0.6 3.9 3.4 25.7 20.3 4.4 3.7 2.4 2.1 55.0 2.5 2.3 5.1 4.6 2.2 0.0 2.4 4.6 2.9 1.8 5.0 51.5 1.0 6.1 1.3 1.1 5.6 4.1 1.5 1.8 15.0 0.4 8.2 2.1 15.1 27.6 1.7 2.0 4.1 3.7 1.3 0.2 10.1 27.2 57.4 6.6 3.3 4.6 39.6 6.7 4.4 2.0 0.7 2.7 4.6 1.3 2.0 CRYBG3 DKFZp667G2110 ENSG00000080200 "Crystallin beta-gamma domain containing 3" Q68DQ2 3 97822011-97944984 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 122.6;Bipolar cells: 123.6;Early spermatids: 121.4;Late spermatids: 131.8;Oligodendrocytes: 128.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.6" "Group enriched" "Detected in many" 8 "dendritic cells: 3.6;granulocytes: 1.5;monocytes: 1.4" "Cell line enhanced" "Detected in many" "SCLC-21H: 39.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075635 Approved "Plasma membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 57: Non-specific - Angiogenesis" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" "HPA075635: " "unprognostic (1.88e-1)" "unprognostic (7.62e-3)" "unprognostic (2.54e-1)" "unprognostic (4.56e-2)" "unprognostic (7.60e-2)" "unprognostic (2.70e-2)" "unprognostic (2.45e-2)" "unprognostic (7.10e-2)" "unprognostic (3.41e-3)" "unprognostic (6.59e-2)" "unprognostic (2.80e-2)" "unprognostic (7.86e-2)" "prognostic favorable (7.07e-4)" "unprognostic (1.78e-2)" "unprognostic (1.58e-1)" "unprognostic (1.14e-2)" "unprognostic (6.38e-3)" 10.6 2.8 5.3 5.5 12.6 0.8 7.7 9.2 8.0 8.0 3.4 7.0 3.6 6.6 2.7 8.9 5.6 5.3 6.5 5.3 10.6 4.9 3.2 5.7 3.4 15.5 10.0 3.5 5.4 3.7 1.2 10.7 16.0 5.0 7.6 7.8 6.3 4.1 7.5 12.9 4.5 6.4 11.3 4.0 5.3 14.0 10.0 2.8 26.6 9.9 4.5 7.5 4.6 17.2 16.5 6.1 3.5 4.2 11.1 11.8 6.2 5.8 5.3 4.2 6.3 0.4 5.4 0.1 1.9 10.1 6.2 10.5 7.0 4.9 8.0 20.4 3.8 4.1 2.7 2.1 5.8 6.1 1.0 7.7 4.9 5.3 5.8 6.9 8.2 1.3 0.3 3.0 7.4 0.2 2.2 0.7 3.0 4.5 5.5 0.0 12.3 2.1 6.1 10.9 39.2 3.0 12.2 4.8 3.9 2.2 4.2 6.8 10.9 8.9 6.9 5.2 7.1 5.0 0.1 3.7 9.3 3.5 5.8 1.5 1.4 0.0 0.1 0.9 0.2 0.1 0.2 0.2 1.4 0.2 0.1 0.1 0.0 0.0 1.0 3.6 0.0 0.3 5.3 12.6 9.2 8.0 5.3 10.6 15.5 10.0 16.0 11.3 10.0 17.2 122.6 32.1 19.6 48.0 4.2 5.1 7.0 3.7 23.9 123.6 13.7 9.3 37.6 1.5 16.9 18.4 6.2 4.0 13.8 6.0 1.9 8.8 121.4 32.6 48.9 52.1 12.7 2.5 37.5 13.1 11.3 38.0 18.3 22.7 0.0 68.0 15.0 5.1 6.6 13.5 23.0 8.3 2.0 17.4 3.0 131.8 8.4 18.9 8.8 37.5 22.1 29.4 1.0 10.6 128.3 13.2 8.7 4.5 12.0 7.1 2.5 2.8 21.3 9.6 39.5 29.2 18.2 49.6 9.5 24.5 6.1 2.3 3.0 14.0 5.2 7.0 RIOX2 "FLJ14393, JMJD10, mdig, MINA, MINA53, NO52" ENSG00000170854 "Ribosomal oxygenase 2" Q8IUF8 3 97941818-97972457 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 33.7;Distal tubular cells: 49.0;Endometrial ciliated cells: 25.7;Extravillous trophoblasts: 43.5;Syncytiotrophoblasts: 31.2;Theca cells: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 109.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007603, HPA008080, CAB013458" Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 8: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960" "prognostic unfavorable (4.41e-4)" "unprognostic (8.64e-2)" "unprognostic (1.59e-3)" "unprognostic (2.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.53e-3)" "unprognostic (1.64e-3)" "unprognostic (8.68e-2)" "unprognostic (9.68e-2)" "unprognostic (5.34e-2)" "unprognostic (1.56e-3)" "unprognostic (6.95e-2)" "unprognostic (1.35e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (3.44e-3)" "unprognostic (1.76e-1)" 14.6 9.7 9.8 14.5 11.3 2.2 13.9 9.5 11.2 11.6 8.3 12.4 6.9 10.7 10.6 22.3 10.4 7.3 10.1 9.5 12.3 14.4 14.3 11.0 14.2 12.4 12.4 10.4 18.2 10.8 10.2 15.6 12.0 10.4 12.3 16.8 19.8 9.6 32.0 17.8 10.3 10.4 12.9 8.4 12.8 6.7 10.9 6.9 46.4 11.3 15.0 16.4 15.5 13.6 42.6 27.8 9.1 17.4 20.5 30.3 22.8 20.1 14.3 22.0 18.5 18.6 22.8 59.7 21.2 25.1 34.3 24.3 28.9 28.2 32.5 109.9 13.8 19.2 13.5 19.1 33.4 37.1 7.0 24.5 38.8 17.6 44.4 13.1 23.9 26.4 26.2 23.3 22.1 11.5 29.7 14.5 19.9 47.3 34.4 0.0 32.2 58.7 21.4 24.1 49.6 17.6 25.7 28.7 34.4 10.1 24.7 15.3 16.3 22.9 24.0 13.7 39.9 37.7 18.3 55.5 29.1 37.8 23.8 1.9 13.2 0.7 10.3 11.9 15.8 15.9 14.9 12.0 16.9 13.3 15.0 12.5 0.8 10.8 15.8 26.0 15.2 10.5 9.8 11.3 9.5 11.2 9.5 12.3 12.4 12.4 12.0 12.9 10.9 13.6 18.3 9.6 14.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 14.9 11.2 0.0 0.0 10.5 7.3 0.0 33.7 5.7 0.0 49.0 16.4 0.0 25.7 14.9 5.8 0.0 0.0 0.0 13.2 43.5 7.3 0.0 12.6 2.5 20.2 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 7.2 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.5 0.0 0.0 11.6 13.8 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 31.2 2.2 24.8 0.0 0.0 GABRR3 ENSG00000183185 "Gamma-aminobutyric acid type A receptor subunit rho3" A8MPY1 3 97986673-98035304 "Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 85 "retina: 14.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 19.8;Rod photoreceptor cells: 11.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-698: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 79: Retina - Phototransduction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (3.22e-2)" "unprognostic (2.06e-3)" "unprognostic (5.65e-2)" "unprognostic (2.82e-1)" "unprognostic (1.43e-4)" "unprognostic (2.84e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.3 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5AC2 HSA1 ENSG00000196578 "Olfactory receptor family 5 subfamily AC member 2" Q9NZP5 3 98087173-98088102 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "Early spermatids: 2.2;Late spermatids: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 31: Spermatids - Spermatogenesis" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H1 "HSHTPCRX14, HTPCRX14" ENSG00000231192 "Olfactory receptor family 5 subfamily H member 1" A6NKK0 3 98130721-98138548 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "BEWO: 1.3" NA NA "Cluster 28: BEWO - Transcription regulation" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H14 ENSG00000236032 "Olfactory receptor family 5 subfamily H member 14" A6NHG9 3 98147479-98156614 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "B-cells: 1.0;Collecting duct cells: 1.8;Early spermatids: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 34: Spermatids - Unknown function" 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.7 0.5 0.3 0.1 0.1 0.1 0.2 0.0 0.2 0.5 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 OR5H15 ENSG00000233412 "Olfactory receptor family 5 subfamily H member 15" A6NDH6 3 98166696-98169774 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H6 ENSG00000230301 "Olfactory receptor family 5 subfamily H member 6" Q8NGV6 3 98263252-98265356 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "Early spermatids: 1.3;Late spermatids: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 31: Spermatids - Spermatogenesis" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5H2 ENSG00000197938 "Olfactory receptor family 5 subfamily H member 2" Q8NGV7 3 98282888-98283832 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5K4 ENSG00000196098 "Olfactory receptor family 5 subfamily K member 4" A6NMS3 3 98353854-98354819 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 23: Spermatids - Flagellum & Golgi organization" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5K3 ENSG00000206536 "Olfactory receptor family 5 subfamily K member 3" A6NET4 3 98390666-98391631 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5K1 "HSHTPCRX10, HTPCRX10" ENSG00000232382 "Olfactory receptor family 5 subfamily K member 1" Q8NHB7 3 98463201-98472924 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR5K2 ENSG00000231861 "Olfactory receptor family 5 subfamily K member 2" Q8NHB8 3 98497604-98498663 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.61e-2)" "unprognostic (1.21e-2)" "unprognostic (8.45e-3)" "unprognostic (1.69e-3)" "unprognostic (6.47e-3)" "unprognostic (7.17e-2)" "unprognostic (1.45e-1)" "unprognostic (3.61e-2)" "unprognostic (1.19e-2)" "unprognostic (6.57e-2)" "unprognostic (3.77e-2)" "unprognostic (5.93e-2)" 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.2 0.0 0.4 0.0 0.5 0.0 0.4 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.2 0.1 0.4 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.8 0.2 0.5 0.0 0.0 0.5 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLDND1 "C3orf4, Z38" ENSG00000080822 "Claudin domain containing 1" Q9NY35 3 98497912-98523066 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "brain: 1093.8;choroid plexus: 316.7" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 575.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029841 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 70: Brain - Nervous system development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Nucleoli, Cytosol" "HPA029841: AB_10600658" "unprognostic (1.64e-1)" "unprognostic (3.63e-1)" "unprognostic (3.13e-2)" "unprognostic (8.50e-2)" "unprognostic (9.15e-2)" "unprognostic (7.30e-2)" "unprognostic (2.43e-3)" "unprognostic (4.08e-2)" "unprognostic (3.65e-2)" "unprognostic (8.30e-3)" "unprognostic (1.21e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (5.84e-6)" "unprognostic (5.73e-3)" "unprognostic (6.54e-2)" "unprognostic (3.05e-1)" "unprognostic (1.51e-1)" 53.6 42.6 477.0 40.7 757.5 49.1 48.8 696.1 804.5 59.0 316.7 58.3 36.5 58.8 43.1 77.8 46.7 50.6 57.6 483.5 577.6 39.2 50.0 46.9 54.7 851.3 670.8 63.9 23.6 32.6 28.2 73.8 837.8 49.5 46.9 46.5 29.8 51.9 43.6 64.8 42.2 63.5 643.7 44.0 37.4 106.6 638.3 44.7 40.5 68.9 54.9 64.0 65.8 1093.8 67.3 26.2 83.2 50.7 96.0 75.0 44.6 52.0 69.8 71.0 97.8 52.7 66.9 33.7 69.1 49.4 134.3 90.4 61.6 39.9 124.3 79.3 27.5 68.3 18.6 48.1 76.2 62.7 67.3 88.4 207.6 54.0 58.7 77.6 79.1 64.7 35.4 100.6 102.9 33.4 47.8 42.8 75.1 28.7 55.9 31.9 110.6 43.4 67.7 30.0 30.1 82.6 74.6 24.4 108.5 110.5 24.5 52.8 75.1 94.6 86.2 65.3 69.3 130.8 59.8 53.9 154.9 61.0 125.2 179.8 91.0 103.9 102.1 55.4 193.5 101.5 190.3 187.1 98.9 99.3 76.6 78.1 70.2 274.0 56.7 63.9 399.7 155.1 477.0 757.5 696.1 804.5 483.5 577.6 851.3 670.8 837.8 643.7 638.3 1093.8 83.3 35.3 36.6 17.9 72.1 144.0 131.7 122.3 87.0 20.1 43.6 45.3 53.8 17.2 71.4 27.6 25.0 52.0 72.8 16.9 29.4 21.2 105.3 21.1 47.7 70.8 28.7 65.4 25.1 16.2 160.6 86.6 30.1 41.7 36.8 25.2 61.4 19.4 35.6 15.2 23.6 19.6 89.5 29.2 168.1 76.7 51.6 46.9 113.8 20.6 42.3 28.1 38.1 30.7 575.2 30.3 16.8 46.6 131.7 98.1 34.6 23.3 27.5 35.0 52.6 53.2 128.4 182.4 55.3 90.1 196.5 95.8 147.1 22.8 17.5 121.9 GPR15 ENSG00000154165 "G protein-coupled receptor 15" P49685 3 98531978-98534681 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 31.3" "Cell type enriched" "Detected in some" 8 "Plasma cells: 31.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "memory B-cell: 3.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 5.1;T-reg: 12.1" "Group enriched" "Detected in many" 26 "B-cells: 3.6;T-cells: 12.1" "Group enriched" "Detected in some" 5 "HDLM-2: 4.6;U-266/70: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA013775 Approved NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 37: Intestine - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA013775: AB_1849264" "unprognostic (8.03e-2)" "unprognostic (1.04e-2)" "unprognostic (3.72e-3)" "unprognostic (5.66e-2)" "unprognostic (9.48e-3)" "unprognostic (5.60e-5)" "unprognostic (5.17e-1)" "unprognostic (6.77e-3)" "unprognostic (3.96e-1)" "unprognostic (3.03e-2)" "unprognostic (2.82e-1)" "unprognostic (2.83e-1)" "unprognostic (4.04e-3)" "unprognostic (4.23e-3)" "unprognostic (1.89e-1)" "unprognostic (1.23e-1)" "unprognostic (1.54e-1)" 0.6 0.0 0.0 4.5 0.2 0.2 3.8 0.1 0.2 0.5 0.0 20.0 2.7 0.2 0.0 2.5 0.1 2.3 0.1 0.0 0.1 0.2 0.3 1.9 2.4 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.4 31.3 0.0 4.9 0.2 0.0 0.3 10.2 0.8 0.1 5.3 1.6 0.0 0.1 1.9 0.4 0.0 5.3 7.2 1.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 3.6 10.8 5.1 0.0 0.6 0.5 0.8 0.3 0.0 0.0 0.2 12.1 2.1 0.0 0.2 0.1 0.2 0.0 0.1 0.5 0.3 0.4 0.1 0.1 0.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 CPOX "CPO, CPX, HCP" ENSG00000080819 "Coproporphyrinogen oxidase" P36551 3 98579446-98593648 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 352.8;Extravillous trophoblasts: 75.9;Oligodendrocytes: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "HEL: 166.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015736, HPA054448" Supported Mitochondria No No 170000 "Cluster 26: Non-specific - Mitochondria" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" Mitochondria "HPA015736: AB_1847194, HPA054448: AB_2682490" "unprognostic (2.14e-1)" "unprognostic (1.04e-1)" "unprognostic (4.07e-2)" "unprognostic (6.09e-2)" "unprognostic (2.71e-1)" "unprognostic (2.34e-2)" "unprognostic (8.58e-3)" "unprognostic (7.14e-2)" "unprognostic (2.53e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (1.04e-5)" "unprognostic (1.62e-1)" "unprognostic (2.67e-2)" "unprognostic (2.15e-2)" "unprognostic (2.57e-1)" 8.1 10.0 19.7 11.4 28.2 44.1 7.2 24.0 31.7 9.1 13.5 10.0 21.2 10.1 7.2 16.1 7.4 8.1 8.6 19.5 22.4 6.5 35.3 7.5 12.3 30.8 24.9 10.7 7.2 9.5 5.4 18.0 29.8 8.4 12.0 4.5 7.6 7.9 11.2 13.1 15.2 9.0 24.5 9.5 9.4 4.7 25.1 12.8 7.1 9.8 12.3 8.1 10.9 41.8 47.9 22.9 19.9 35.4 36.5 26.9 56.6 30.0 21.7 30.7 34.7 38.2 14.7 5.0 33.1 16.2 33.6 34.1 24.9 32.8 51.9 15.4 21.6 166.4 12.9 49.9 18.5 35.7 37.8 21.2 27.0 29.0 12.0 35.9 29.6 20.2 32.2 20.9 29.1 14.8 36.2 30.4 23.4 26.6 41.0 25.4 45.0 22.1 26.2 19.8 13.1 13.0 32.0 10.9 96.2 22.1 16.7 22.5 24.9 45.1 44.0 26.1 22.4 31.6 26.8 26.7 44.6 38.3 33.7 0.0 0.6 0.0 0.3 0.3 0.7 0.5 0.6 0.8 0.5 0.5 0.2 0.8 0.0 0.6 0.2 0.3 0.3 0.2 19.7 28.2 24.0 31.7 19.5 22.4 30.8 24.9 29.8 24.5 25.1 41.8 6.4 3.2 8.7 9.1 5.6 7.4 3.9 7.3 11.4 4.3 6.0 4.6 8.0 7.2 4.2 3.7 8.4 23.9 6.5 7.9 1.9 3.7 0.1 5.2 8.6 7.4 8.4 352.8 17.7 1.7 75.9 9.4 10.2 5.0 1.3 7.0 11.7 36.4 12.7 0.0 12.3 9.1 4.1 11.3 10.0 0.2 7.5 11.4 12.4 11.2 12.7 5.8 3.1 13.0 99.1 3.2 4.1 7.9 10.4 5.2 9.4 6.3 5.0 5.0 13.1 6.4 7.2 0.3 6.1 12.2 10.2 10.7 12.7 9.7 9.9 4.2 ST3GAL6 "SIAT10, ST3GALVI" ENSG00000064225 "ST3 beta-galactoside alpha-2,3-sialyltransferase 6" Q9Y274 3 98732236-98821201 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 56.0" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 128.8;Hepatocytes: 86.8;Microglial cells: 134.0;Oligodendrocyte precursor cells: 171.4" "Cancer enriched" "Detected in many" 5 "melanoma: 17.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 49.6;neutrophil: 57.6" "Group enriched" "Detected in many" 143 "dendritic cells: 24.2;granulocytes: 57.6;monocytes: 17.4" "Group enriched" "Detected in many" 4 "RPMI-8226: 96.5;SK-MEL-30: 114.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018792 Approved NA NA 5800000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 15: Liver - Metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA018792: AB_10964349" "unprognostic (1.25e-1)" "unprognostic (1.21e-1)" "unprognostic (1.88e-3)" "unprognostic (4.17e-2)" "unprognostic (5.20e-3)" "unprognostic (3.82e-2)" "unprognostic (1.23e-2)" "unprognostic (2.30e-3)" "unprognostic (2.40e-1)" "unprognostic (2.99e-1)" "unprognostic (2.48e-1)" "unprognostic (4.32e-1)" "unprognostic (3.91e-3)" "unprognostic (6.15e-3)" "unprognostic (9.44e-2)" "unprognostic (9.47e-3)" "unprognostic (6.79e-4)" 14.6 7.9 8.2 3.8 8.9 2.4 6.3 14.0 9.9 4.8 3.0 3.8 2.0 2.2 12.0 1.9 6.3 2.2 26.5 9.3 8.5 14.0 56.0 7.8 1.6 19.5 10.1 1.2 3.5 1.1 4.1 8.5 14.3 3.3 2.7 1.5 19.5 2.0 7.9 16.7 1.9 2.0 14.8 3.2 4.5 1.6 9.2 10.6 2.9 6.4 2.8 1.6 1.4 13.1 0.3 1.3 1.8 2.7 3.3 1.1 12.5 0.4 1.5 1.2 2.2 8.7 0.5 6.4 3.3 0.0 4.6 2.1 3.9 2.0 1.1 0.0 2.7 0.2 0.6 15.1 14.0 13.2 23.7 1.5 0.1 3.5 6.6 22.4 14.2 2.6 0.0 6.3 1.3 0.0 2.1 22.6 3.5 0.0 3.5 1.3 1.5 96.5 3.4 0.0 3.8 19.2 5.1 0.5 114.2 3.6 0.4 23.1 10.8 2.9 2.4 0.8 1.3 24.1 2.0 0.0 4.6 18.6 10.3 18.5 17.4 49.6 0.0 9.6 0.0 0.1 0.0 0.0 24.2 0.0 0.2 0.0 57.6 0.1 4.9 5.5 0.0 4.7 8.2 8.9 14.0 9.9 9.3 8.5 19.5 10.1 14.3 14.8 9.2 13.1 10.1 12.8 35.2 2.3 2.3 11.5 2.6 7.0 2.2 1.2 6.4 5.7 40.4 2.8 2.8 3.7 8.4 45.2 0.0 0.0 13.7 6.8 0.3 128.8 4.2 20.2 16.1 6.6 78.5 2.0 69.5 3.8 9.2 41.0 39.1 1.8 32.5 86.8 34.4 0.0 64.2 0.1 30.5 29.5 64.2 1.0 2.8 38.4 65.8 134.0 38.0 0.9 0.0 171.4 51.6 6.2 0.1 6.8 18.0 5.2 0.0 10.0 27.5 3.5 6.6 1.7 2.2 0.1 1.0 2.1 12.8 27.0 2.0 0.3 0.3 1.8 DCBLD2 "CLCP1, ESDN" ENSG00000057019 "Discoidin, CUB and LCCL domain containing 2" Q96PD2 3 98795941-98901695 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 83.8;Oligodendrocyte precursor cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-HME1: 455.0;hTERT-RPE1: 648.9;LHCN-M2: 776.8;RPTEC TERT1: 479.0;U-87 MG: 581.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016909 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA 2200000 "Cluster 21: Non-specific - Transcription" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Plasma membrane, Cytosol" "Golgi apparatus" "HPA016909: AB_1847510" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "unprognostic (4.46e-2)" "unprognostic (2.64e-1)" "unprognostic (5.97e-3)" "unprognostic (9.29e-3)" "unprognostic (8.31e-3)" "unprognostic (1.06e-3)" "unprognostic (1.42e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (2.43e-1)" "prognostic unfavorable (3.32e-5)" "prognostic unfavorable (2.87e-4)" "unprognostic (7.76e-2)" "unprognostic (3.93e-2)" "unprognostic (1.59e-3)" 12.2 13.3 4.0 4.5 3.8 1.2 8.2 8.1 5.8 8.3 6.6 11.5 2.8 14.6 8.0 6.4 14.5 12.5 27.6 3.4 5.9 11.0 9.8 11.5 3.6 6.5 6.9 17.8 5.8 13.2 6.6 8.0 26.7 11.5 7.0 22.4 10.1 14.9 5.2 8.3 4.1 16.3 4.8 1.6 6.5 23.8 7.3 6.9 15.7 8.4 3.9 7.8 5.1 5.0 55.3 397.0 52.3 41.2 67.8 160.1 22.7 122.0 57.9 81.4 91.9 33.9 171.6 0.1 373.7 211.5 249.0 50.3 24.1 198.8 186.2 0.8 8.4 19.4 12.1 51.5 41.6 9.3 8.7 63.8 30.3 234.3 455.0 648.9 54.6 7.1 4.0 5.0 776.8 14.6 7.7 5.5 36.5 0.4 135.6 8.1 98.2 4.8 479.0 14.4 14.0 24.3 33.5 6.9 145.9 35.2 26.4 7.3 90.4 208.0 166.6 53.8 433.0 6.3 9.7 7.4 581.3 3.4 92.8 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.0 3.8 8.1 5.8 3.4 5.9 6.5 6.9 26.7 4.8 7.3 5.0 5.9 32.1 52.8 18.3 2.7 22.8 15.5 18.2 17.1 12.9 15.5 16.3 83.8 17.2 19.0 18.4 77.2 12.4 1.6 4.3 0.0 30.5 3.1 32.2 39.5 7.7 3.6 5.9 51.6 8.0 9.7 33.8 6.1 38.3 38.0 52.2 6.8 20.5 4.0 13.5 51.3 8.0 20.3 3.2 6.2 5.8 22.1 4.0 8.8 25.3 1.4 40.9 2.1 88.4 38.9 26.3 4.6 50.4 1.6 11.9 0.7 7.9 22.8 48.9 0.0 12.3 31.3 15.8 24.2 14.1 15.6 4.0 1.8 34.4 8.2 7.1 COL8A1 "C3orf7, MGC9568" ENSG00000144810 "Collagen type VIII alpha 1 chain" P27658 3 99638475-99799226 "Plasma proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 246.8;Fibroblasts: 53.3;Hepatic stellate cells: 102.8;Smooth muscle cells: 51.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 34.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 1098.3;hTERT-RPE1: 431.9;LHCN-M2: 313.0;TIME: 471.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053107 Enhanced Supported Vesicles "Secreted to extracellular matrix" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Vesicles "HPA053107: AB_2682046" "unprognostic (3.13e-2)" "unprognostic (2.92e-2)" "unprognostic (2.27e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-3)" "unprognostic (2.49e-1)" "unprognostic (2.31e-2)" "unprognostic (4.83e-2)" "unprognostic (2.62e-2)" "unprognostic (4.79e-2)" "unprognostic (3.58e-2)" "unprognostic (3.71e-1)" "prognostic unfavorable (9.39e-8)" "unprognostic (2.98e-3)" "unprognostic (1.72e-1)" "unprognostic (1.38e-2)" "unprognostic (1.32e-3)" 33.0 7.0 1.7 5.8 2.9 0.0 5.7 1.8 2.6 3.8 4.4 12.4 1.0 5.2 2.7 11.1 9.1 10.8 39.1 1.3 3.0 5.9 0.9 32.8 0.9 3.1 3.9 9.2 1.2 17.9 11.3 4.2 3.4 12.7 6.9 0.5 7.0 12.0 2.3 3.2 3.7 31.5 2.7 1.0 5.3 0.5 2.6 0.4 27.5 7.8 0.5 25.0 5.4 2.5 0.1 0.4 3.0 0.3 142.2 236.4 0.2 68.5 45.7 69.6 138.6 0.0 0.3 0.1 5.9 1098.3 1.9 0.1 0.4 88.2 157.8 0.1 0.2 0.1 7.9 0.0 26.8 0.0 0.1 142.8 3.2 52.6 82.9 431.9 129.4 0.0 0.1 0.2 313.0 0.0 0.0 0.0 2.6 0.0 0.9 0.0 0.0 0.0 144.3 0.0 0.0 0.0 0.0 0.0 0.0 20.8 0.1 0.2 471.5 31.0 24.1 1.6 34.2 0.1 0.0 0.1 58.4 0.0 241.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 2.9 1.8 2.6 1.3 3.0 3.1 3.9 3.4 2.7 2.6 2.5 4.4 246.8 22.1 0.0 0.4 0.8 0.5 2.8 14.8 0.4 1.8 5.2 4.9 4.3 3.9 9.2 0.0 0.1 0.9 0.0 0.0 0.1 1.3 0.2 2.6 14.1 0.0 0.0 1.9 0.0 0.3 53.3 2.0 0.3 5.1 0.2 102.8 0.8 0.1 0.0 0.7 0.0 0.0 1.9 2.3 1.0 2.1 0.8 1.8 4.7 0.2 0.7 2.1 9.0 0.6 0.1 0.0 9.4 0.5 0.2 0.0 1.6 1.0 0.6 0.0 1.9 51.6 0.3 0.3 1.0 0.6 0.4 0.9 0.1 0.0 0.5 CMSS1 "C3orf26, MGC4308" ENSG00000184220 "Cms1 ribosomal small subunit homolog" Q9BQ75 3 99817837-100181732 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 215.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042820 Uncertain Approved "Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoli "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA042820: AB_10795763" "unprognostic (1.50e-1)" "unprognostic (8.28e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (3.15e-6)" "unprognostic (2.13e-2)" "unprognostic (2.39e-3)" "prognostic unfavorable (5.92e-10)" "unprognostic (1.50e-1)" "unprognostic (5.92e-2)" "unprognostic (5.83e-2)" "unprognostic (6.71e-2)" "prognostic unfavorable (3.10e-4)" "unprognostic (2.18e-3)" "unprognostic (1.56e-1)" "unprognostic (2.26e-1)" "unprognostic (3.25e-1)" "unprognostic (4.04e-2)" 24.5 33.1 23.0 15.8 21.7 20.8 23.4 26.7 30.1 22.4 17.8 21.0 8.6 21.8 9.7 15.8 20.9 10.5 28.2 21.8 20.9 20.7 15.0 15.8 17.1 22.8 20.1 23.6 26.7 21.8 24.5 11.6 19.6 16.0 11.6 24.6 14.0 13.3 69.4 17.4 12.6 13.2 17.9 13.8 16.4 30.3 21.3 16.7 14.8 29.9 15.0 24.5 18.1 21.7 116.2 51.0 50.0 72.6 34.7 40.1 51.0 53.5 28.8 93.3 77.0 64.1 37.5 126.3 90.6 28.2 82.4 68.4 70.3 60.2 120.3 66.8 66.5 99.9 32.9 53.2 62.6 137.0 51.3 28.2 56.7 71.4 116.6 30.3 65.2 100.9 63.5 78.1 67.0 78.8 110.3 126.4 73.0 109.4 126.1 49.1 81.3 134.1 57.2 27.5 139.9 58.9 52.8 42.5 125.0 47.8 51.4 84.0 18.5 73.6 207.4 43.3 109.8 56.3 121.1 244.9 49.1 149.4 124.8 1.0 11.0 2.3 22.2 27.3 32.0 57.3 32.8 30.3 23.8 55.7 41.3 42.0 4.1 28.6 25.1 62.1 33.9 18.2 23.0 21.7 26.7 30.1 21.8 20.9 22.8 20.1 19.6 17.9 21.3 21.7 26.7 6.4 19.4 48.6 41.3 62.2 37.4 45.5 26.2 32.8 43.8 40.4 41.7 42.9 23.2 62.5 18.8 41.7 25.1 8.5 97.8 42.1 165.0 21.7 56.8 38.7 15.0 30.9 154.3 47.7 56.6 44.3 9.7 19.8 62.1 47.7 24.7 61.4 27.2 127.9 132.8 14.4 16.2 7.9 45.5 215.8 50.7 18.7 37.4 58.1 12.8 28.0 19.6 114.1 116.2 35.8 4.6 58.6 36.2 82.8 1.1 87.9 22.4 27.0 26.3 67.3 50.1 163.4 146.1 21.3 66.1 21.9 30.1 54.1 22.6 27.0 FILIP1L "DOC-1, GIP130" ENSG00000168386 "Filamin A interacting protein 1 like" Q4L180 3 99830141-100114513 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 210.1;Early spermatids: 376.7;Sertoli cells: 256.4;Skeletal myocytes: 184.2;Smooth muscle cells: 351.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.9" "Group enriched" "Detected in many" 4 "dendritic cells: 2.1;monocytes: 2.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 84.2;HDLM-2: 79.9;TIME: 145.8" "Region enriched" "Detected in many" 7 "olfactory bulb: 18.0" "Low region specificity" "Detected in all" HPA043133 Approved Approved "Plasma membrane" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "HPA043133: AB_10793991" "unprognostic (9.14e-2)" "unprognostic (2.16e-1)" "unprognostic (7.73e-2)" "unprognostic (5.25e-2)" "unprognostic (6.68e-2)" "unprognostic (1.06e-2)" "unprognostic (4.40e-2)" "unprognostic (1.29e-1)" "unprognostic (2.08e-2)" "unprognostic (2.18e-1)" "unprognostic (1.02e-1)" "unprognostic (3.32e-1)" "prognostic unfavorable (9.40e-4)" "unprognostic (2.46e-2)" "unprognostic (9.44e-2)" "unprognostic (5.30e-2)" "unprognostic (1.82e-3)" 77.1 21.7 4.9 52.4 6.3 0.8 32.6 4.8 6.6 63.8 4.0 57.7 28.4 117.6 23.8 56.0 31.2 90.9 54.8 6.2 4.4 24.0 28.1 30.7 30.1 9.6 4.2 76.4 35.5 17.5 3.9 43.9 9.7 67.9 29.8 4.7 9.3 54.3 140.4 16.8 41.2 151.7 3.7 42.9 46.7 22.0 3.6 11.9 20.1 161.5 22.3 101.5 21.9 4.0 59.0 0.0 22.3 0.1 35.8 30.2 2.0 29.4 58.8 50.2 56.5 17.8 0.2 0.2 5.0 84.2 13.2 7.1 0.0 14.4 59.0 79.9 0.6 4.8 0.2 23.3 17.8 1.4 0.0 24.2 5.1 5.6 0.0 32.0 22.8 0.0 3.8 0.5 7.7 0.1 5.2 1.2 1.3 3.1 0.0 0.1 26.1 0.7 33.5 1.0 2.0 3.7 0.4 0.4 0.1 11.7 0.0 10.5 145.8 8.8 0.2 1.9 15.5 4.2 0.2 0.3 6.5 0.4 0.0 0.2 0.4 0.0 0.1 1.0 0.0 0.6 0.1 0.1 2.1 0.6 0.0 0.1 0.2 0.4 2.9 0.4 0.1 0.3 4.9 6.3 4.8 6.6 6.2 4.4 9.6 4.2 9.7 3.7 3.6 4.0 92.9 16.0 23.1 9.4 4.1 27.8 56.7 7.9 2.2 11.8 12.3 6.5 145.7 35.8 2.3 5.5 8.4 1.1 1.8 2.1 1.9 210.1 376.7 2.3 60.5 77.2 3.0 0.0 42.0 109.3 0.7 145.2 21.9 2.4 34.8 16.3 41.0 0.7 3.2 106.0 25.8 5.7 6.1 36.3 98.9 180.2 83.0 86.1 17.8 25.3 17.7 0.9 0.0 22.1 21.6 43.7 0.2 104.2 3.0 5.1 5.4 2.6 1.9 6.0 256.4 184.2 351.9 40.1 2.5 1.5 22.7 3.1 8.8 41.8 3.2 3.5 TBC1D23 FLJ11046 ENSG00000036054 "TBC1 domain family member 23" Q9NUY8 3 100260992-100325251 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038151, HPA038152" Approved Enhanced "Golgi apparatus" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 44: Endometrium - Transcription" "Golgi apparatus" "HPA038151: AB_10672405, HPA038152: AB_10672620" "unprognostic (9.23e-3)" "unprognostic (6.01e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.37e-4)" "unprognostic (1.79e-2)" "unprognostic (6.18e-2)" "unprognostic (7.87e-3)" "unprognostic (6.16e-2)" "unprognostic (7.92e-2)" "unprognostic (2.02e-2)" "unprognostic (2.98e-3)" "unprognostic (3.66e-3)" "unprognostic (1.14e-1)" "unprognostic (1.83e-1)" "unprognostic (1.51e-1)" "unprognostic (5.64e-2)" "unprognostic (2.32e-1)" 15.1 17.4 4.8 12.7 7.0 23.0 14.8 10.8 6.7 13.5 5.0 15.1 17.9 14.3 10.2 16.2 9.3 13.9 14.3 5.9 6.4 17.1 22.7 12.6 12.5 6.6 5.4 16.2 18.2 17.9 5.1 21.6 7.1 11.7 15.5 16.8 15.2 9.9 17.2 13.5 18.4 14.1 7.0 12.5 15.2 17.1 6.7 14.4 14.1 15.3 15.5 15.6 8.2 10.9 72.9 15.0 17.4 9.8 34.4 44.3 17.5 40.4 45.7 46.6 53.6 28.6 13.3 18.3 20.6 46.9 26.0 25.5 64.5 29.4 72.4 9.0 15.1 49.9 16.6 19.3 33.9 23.2 39.1 35.9 23.7 23.3 38.1 39.0 25.2 14.1 41.0 26.8 30.1 16.3 17.9 11.4 20.3 26.2 27.8 14.8 37.9 21.6 27.3 16.3 24.8 13.5 23.4 18.4 29.8 22.7 19.6 22.0 24.1 32.9 30.9 15.5 26.9 25.6 28.1 31.8 42.1 21.2 27.4 27.8 17.8 22.7 12.2 20.5 12.4 12.0 11.7 10.7 18.7 12.7 10.3 10.9 10.2 21.8 24.8 8.2 17.4 17.4 4.8 7.0 10.8 6.7 5.9 6.4 6.6 5.4 7.1 7.0 6.7 10.9 24.0 41.7 12.6 19.6 24.5 31.5 18.6 14.8 16.5 18.6 17.9 11.7 26.1 11.5 20.5 12.9 14.6 20.1 19.1 24.8 31.3 26.8 46.8 17.5 28.4 22.5 7.2 54.1 50.9 29.5 19.3 31.9 13.7 31.7 29.8 19.0 13.9 19.0 13.9 35.3 42.4 17.5 18.3 17.1 20.2 44.2 20.5 21.9 24.9 48.7 14.0 18.7 12.3 41.7 56.4 36.1 16.9 14.3 34.5 22.3 21.1 19.9 19.3 30.2 13.1 27.6 25.9 20.8 15.2 20.4 38.8 65.8 21.1 21.8 14.3 30.2 NIT2 ENSG00000114021 "Nitrilase family member 2" Q9NQR4 3 100334739-100361635 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 26.4" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 705.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036999, HPA041289" Approved Supported Centrosome,Cytosol NA NA 1700000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol Centrosome "HPA036999: AB_10672105, HPA041289: " "unprognostic (3.27e-1)" "unprognostic (1.29e-1)" "unprognostic (7.06e-3)" "prognostic unfavorable (4.62e-4)" "unprognostic (6.28e-2)" "unprognostic (2.10e-1)" "unprognostic (4.56e-1)" "unprognostic (1.12e-1)" "unprognostic (6.60e-3)" "unprognostic (2.21e-1)" "unprognostic (6.68e-2)" "unprognostic (7.92e-2)" "unprognostic (1.37e-2)" "unprognostic (4.48e-2)" "unprognostic (1.29e-1)" "unprognostic (8.26e-2)" "unprognostic (1.47e-3)" 5.1 3.9 1.3 1.4 2.4 3.5 6.8 1.4 1.9 3.4 1.7 3.8 2.7 4.1 5.5 4.4 4.1 3.4 5.2 1.6 1.3 18.5 26.4 3.2 2.4 0.7 0.8 3.3 3.7 3.9 2.7 2.4 0.9 3.6 3.4 3.6 3.8 4.9 10.1 5.0 2.8 3.0 0.9 2.2 4.1 1.2 1.2 2.5 5.9 7.6 3.7 5.2 3.6 1.4 12.3 12.1 1.4 6.2 10.3 14.1 7.4 4.9 7.3 11.5 10.9 10.4 13.7 12.3 7.4 7.2 4.9 9.1 5.4 13.2 13.7 3.8 2.8 9.0 4.1 5.3 12.6 5.9 5.8 8.8 19.9 6.1 10.1 6.0 7.4 6.9 4.2 9.8 14.2 11.9 3.9 5.3 5.4 15.3 18.0 4.3 5.0 12.0 19.4 7.7 8.2 3.8 6.8 11.6 7.3 3.7 8.6 5.4 5.5 7.2 2.9 3.5 4.4 5.9 7.0 10.6 11.4 9.9 9.3 0.2 0.7 0.4 1.0 0.7 1.4 1.5 1.0 0.8 2.0 1.5 1.2 1.1 0.4 1.1 0.5 0.6 1.2 0.3 1.3 2.4 1.4 1.9 1.6 1.3 0.7 0.8 0.9 0.9 1.2 1.4 22.3 12.8 17.2 8.5 31.5 32.6 51.7 92.0 37.0 12.8 43.7 56.1 56.4 45.8 53.5 58.8 16.7 92.5 26.1 14.6 187.9 73.6 3.1 53.6 47.2 16.7 24.0 17.0 12.0 52.7 73.7 38.0 29.6 42.3 21.0 55.3 15.0 183.6 63.5 13.5 8.8 22.0 65.1 23.5 39.9 4.1 44.1 26.9 49.8 4.7 89.9 15.4 22.6 12.1 8.0 62.1 20.6 37.6 20.8 54.3 24.1 705.6 60.5 24.9 39.5 23.9 51.6 2.7 17.5 53.7 41.6 59.2 27.7 118.1 36.7 53.0 TOMM70 "KIAA0719, Tom70, TOMM70A" ENSG00000154174 "Translocase of outer mitochondrial membrane 70" O94826 3 100363431-100401089 "Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 34.9;Extravillous trophoblasts: 33.2;Proximal tubular cells: 48.6;Theca cells: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014589, CAB017156, HPA048020" Enhanced Enhanced Mitochondria NA NA "Cluster 15: NK-cells - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "CAB017156: , HPA014589: AB_1858185, HPA048020: AB_2680234" "unprognostic (2.74e-2)" "unprognostic (2.25e-1)" "unprognostic (2.57e-2)" "unprognostic (2.69e-3)" "unprognostic (2.12e-2)" "unprognostic (5.96e-2)" "unprognostic (2.06e-3)" "unprognostic (5.01e-2)" "unprognostic (9.86e-2)" "unprognostic (1.21e-1)" "unprognostic (9.73e-3)" "unprognostic (5.38e-2)" "unprognostic (2.62e-3)" "unprognostic (1.73e-1)" "unprognostic (3.53e-1)" "unprognostic (3.34e-2)" "unprognostic (6.98e-3)" 29.7 23.1 21.8 19.5 38.7 16.6 31.5 20.6 24.4 19.8 19.1 27.7 29.3 24.5 21.3 28.9 20.4 16.1 38.8 23.6 23.0 36.8 61.7 15.9 22.2 21.3 18.6 30.8 26.8 27.2 14.8 23.4 21.9 26.4 29.8 45.4 21.9 26.9 66.4 19.8 24.4 26.7 17.9 19.2 21.5 19.6 22.9 29.6 30.1 76.1 25.9 27.3 17.8 19.5 70.2 48.3 39.8 57.9 55.4 60.0 52.0 57.9 49.6 52.2 53.8 68.7 39.0 83.2 49.9 49.7 46.6 67.4 73.1 53.4 76.7 31.6 33.7 95.2 30.3 67.3 34.6 117.2 41.8 53.7 48.6 46.5 75.6 46.5 38.8 40.1 69.2 65.6 63.3 51.9 79.6 47.5 55.2 107.4 101.2 72.0 80.9 89.0 42.6 52.2 72.2 60.1 42.3 67.0 77.9 38.2 87.1 65.8 35.2 45.5 60.3 25.8 44.0 71.1 108.8 139.1 44.1 70.0 35.2 1.1 1.0 1.2 1.9 1.1 2.3 2.0 2.3 2.0 1.4 1.4 2.3 2.5 0.2 2.7 1.3 1.4 1.0 0.8 21.8 38.7 20.6 24.4 23.6 23.0 21.3 18.6 21.9 17.9 22.9 19.5 24.2 6.4 25.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 30.0 20.2 0.0 0.0 11.2 14.7 0.0 26.8 11.5 0.0 11.7 19.0 0.0 13.8 34.9 10.0 0.0 0.0 0.0 20.1 33.2 12.9 0.0 25.4 7.6 27.1 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 5.7 0.0 0.0 0.0 0.0 22.5 0.0 0.0 2.3 0.0 0.0 48.6 10.2 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 16.3 6.3 32.9 0.0 0.0 LNP1 NP3 ENSG00000206535 "Leukemia NUP98 fusion partner 1" A1A4G5 3 100401532-100456319 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "retina: 46.1;testis: 29.0" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 50.1;Early spermatids: 147.6;Horizontal cells: 257.4;Spermatocytes: 91.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "T-reg: 1.4" "Lineage enriched" "Detected in single" 4 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "PC-3: 18.7;U-266/84: 17.3" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 6.8;cerebral cortex: 8.7;hippocampal formation: 7.3;olfactory bulb: 5.0" HPA047926 Approved "Nuclear speckles,Vesicles,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 16: U-266 - Nucleosome" "Cluster 62: Horizontal cells - Visual perception" Vesicles "Nuclear speckles, Cytosol" "HPA047926: " "unprognostic (1.78e-1)" "unprognostic (3.70e-2)" "unprognostic (8.33e-3)" "unprognostic (4.40e-3)" "unprognostic (6.33e-3)" "unprognostic (1.17e-1)" "unprognostic (1.34e-1)" "unprognostic (1.66e-3)" "unprognostic (1.81e-1)" "unprognostic (1.75e-2)" "unprognostic (1.58e-2)" "unprognostic (1.74e-2)" "unprognostic (8.28e-3)" "unprognostic (1.43e-1)" "unprognostic (7.98e-2)" "unprognostic (2.11e-1)" "unprognostic (6.08e-2)" 2.2 1.9 5.1 0.8 5.9 0.1 1.9 5.3 6.1 2.6 3.0 2.5 0.6 3.1 6.7 1.3 3.0 2.0 8.5 5.2 6.0 4.3 7.7 3.1 0.9 5.2 5.1 3.9 3.3 1.7 6.1 2.7 6.4 1.9 1.5 46.1 2.0 2.3 2.9 0.7 1.2 2.7 4.6 1.2 1.5 29.0 4.7 1.3 3.6 2.1 1.1 3.1 1.7 5.3 3.2 1.7 9.9 0.9 4.1 2.9 0.7 2.0 6.3 2.7 2.8 0.9 0.9 2.4 0.9 1.9 2.8 2.1 1.8 3.2 2.9 2.6 2.1 7.1 0.5 4.0 1.8 5.4 0.8 3.5 0.8 1.2 5.0 2.5 0.3 1.0 2.7 11.6 2.1 2.7 6.2 4.3 7.6 2.1 18.7 4.6 5.4 6.1 1.9 0.4 9.5 4.9 1.6 2.7 4.5 2.3 0.6 0.6 0.7 1.0 10.4 1.0 2.2 14.9 17.3 9.5 3.3 3.3 2.1 0.0 0.0 0.0 0.4 0.0 0.9 0.3 0.3 0.2 0.2 0.1 0.4 0.4 0.0 0.1 0.0 0.0 1.4 0.1 5.1 5.9 5.3 6.1 5.2 6.0 5.2 5.1 6.4 4.6 4.7 5.3 0.9 0.0 0.5 4.2 1.8 1.0 1.3 0.7 2.2 42.2 2.2 1.9 10.5 0.0 1.5 1.8 50.1 1.5 0.3 0.6 7.9 0.8 147.6 0.9 2.3 1.2 2.4 6.1 6.9 1.0 1.9 3.2 3.1 0.7 0.0 1.2 0.0 1.7 0.6 257.4 11.3 1.6 0.0 0.3 0.3 34.2 3.4 0.3 21.4 0.0 0.7 17.1 1.0 7.5 3.7 0.6 0.5 1.2 7.5 0.8 1.1 6.0 3.3 44.3 0.0 1.9 4.6 91.8 3.3 0.6 0.6 0.4 0.7 0.7 0.8 0.5 TMEM45A "DERP7, FLJ10134" ENSG00000181458 "Transmembrane protein 45A" Q9NWC5 3 100492619-100577444 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "skin 1: 475.1" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 425.3;Club cells: 841.5;Early spermatids: 207.3;Suprabasal keratinocytes: 254.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 406.9;ASC TERT1: 118.3;HSkMC: 125.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA062101 Uncertain Approved "Endoplasmic reticulum,Vesicles" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 61: Skin - Cornification" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Endoplasmic reticulum" Vesicles "HPA062101: AB_2684682" "unprognostic (5.92e-3)" "unprognostic (5.44e-2)" "unprognostic (2.11e-1)" "unprognostic (1.43e-3)" "unprognostic (7.80e-2)" "unprognostic (1.04e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (7.42e-4)" "unprognostic (2.37e-1)" "unprognostic (2.21e-2)" "unprognostic (2.43e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (6.18e-11)" "unprognostic (1.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.02e-5)" "unprognostic (2.68e-2)" 19.4 18.1 1.4 11.7 3.3 2.0 42.8 1.7 2.5 38.4 2.3 10.3 3.6 18.3 3.2 16.5 20.9 18.9 21.9 1.5 1.8 3.7 99.0 13.1 2.6 1.9 1.9 11.9 23.3 2.7 22.9 40.9 1.8 9.1 6.6 1.7 26.9 6.3 3.2 475.1 6.4 25.4 1.7 5.0 7.0 13.3 1.9 1.6 9.1 2.5 50.7 19.5 79.5 2.1 28.6 2.0 2.7 9.6 406.9 118.3 0.3 66.9 62.0 9.4 84.8 2.5 0.6 0.0 32.6 44.1 24.6 31.9 2.4 13.0 23.4 7.2 8.4 23.9 9.3 8.0 25.7 0.4 1.5 125.4 7.4 17.1 25.4 39.0 3.5 0.0 0.6 3.2 22.6 0.3 0.1 0.7 3.2 0.0 16.8 0.0 23.3 0.4 0.6 1.0 2.9 19.4 16.4 8.5 7.3 18.2 0.8 13.6 9.3 62.9 44.3 0.5 15.2 53.8 32.9 0.1 49.7 1.9 42.6 0.0 0.9 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.6 1.4 3.3 1.7 2.5 1.5 1.8 1.9 1.9 1.8 1.7 1.9 2.1 1.6 60.9 61.4 0.7 3.0 94.6 5.4 425.3 9.6 3.2 19.1 8.9 2.5 1.5 841.5 0.0 0.0 2.6 0.4 0.2 0.0 7.5 207.3 3.0 79.1 8.9 1.2 1.3 0.8 14.9 46.3 56.3 2.0 2.0 65.0 10.7 15.0 137.1 5.8 8.4 2.4 2.0 63.1 6.5 25.4 25.4 16.1 6.6 23.2 13.1 1.1 3.5 0.0 16.1 11.8 6.5 2.6 27.8 26.8 3.1 0.3 0.2 121.0 0.9 6.6 22.8 56.6 1.5 3.3 5.4 254.9 7.5 6.4 26.7 0.1 4.4 ADGRG7 "FLJ14454, GPR128" ENSG00000144820 "Adhesion G protein-coupled receptor G7" Q96K78 3 100609601-100695479 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "intestine: 42.9;liver: 24.7" "Group enriched" "Detected in some" 4 "Hepatocytes: 23.9;Paneth cells: 14.0;Proximal enterocytes: 39.4" "Cancer enhanced" "Detected in some" "stomach cancer: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA056451 Approved "Plasma membrane" NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Plasma membrane" "HPA056451: " "unprognostic (1.65e-1)" "unprognostic (1.10e-1)" "unprognostic (2.79e-1)" "unprognostic (8.46e-3)" "unprognostic (1.26e-1)" "unprognostic (6.71e-2)" "unprognostic (9.37e-3)" "unprognostic (2.84e-5)" "unprognostic (1.17e-1)" "unprognostic (2.16e-1)" "unprognostic (6.77e-2)" 0.1 0.1 0.0 0.9 0.0 2.2 0.1 0.2 0.1 0.5 0.0 5.2 42.9 0.3 0.0 0.2 0.6 0.7 0.2 0.0 0.0 0.1 24.7 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.2 2.9 0.2 0.1 0.0 0.1 0.2 39.3 1.5 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.8 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.0 0.0 0.2 5.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.0 0.0 0.0 0.0 39.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 TFG "FLJ36137, SPG57, TF6" ENSG00000114354 "Trafficking from ER to golgi regulator" Q92734 3 100709295-100748964 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019473, HPA052206" Approved Supported Vesicles,Cytosol No No 320000 "Cluster 38: Basophils - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" Vesicles Cytosol "HPA019473: AB_1857936, HPA052206: AB_2681760" "unprognostic (1.14e-1)" "unprognostic (3.58e-2)" "unprognostic (1.46e-1)" "unprognostic (2.94e-2)" "unprognostic (1.46e-1)" "unprognostic (4.14e-2)" "prognostic unfavorable (5.48e-4)" "unprognostic (3.31e-3)" "unprognostic (1.42e-1)" "unprognostic (3.73e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (4.58e-3)" "unprognostic (3.72e-2)" "unprognostic (2.82e-1)" "unprognostic (8.55e-2)" "unprognostic (3.33e-1)" "unprognostic (8.45e-2)" 62.2 73.0 40.7 37.2 40.4 37.4 52.4 43.5 46.4 53.9 46.7 63.8 89.8 52.0 78.5 85.7 51.2 56.4 82.6 41.3 45.4 71.9 113.9 55.6 29.4 44.2 43.2 48.2 66.7 89.0 64.1 79.2 44.4 47.9 69.6 40.9 60.6 61.3 75.5 58.9 76.6 66.5 43.2 42.6 54.4 47.7 42.3 40.6 64.1 58.2 54.9 61.6 57.3 44.4 203.8 107.5 126.7 79.0 160.1 176.4 163.9 141.1 190.4 182.5 213.0 136.0 96.1 24.7 103.3 180.4 141.3 143.1 143.4 161.5 216.2 123.8 87.4 99.7 69.3 130.0 183.3 70.2 51.8 149.3 216.6 108.4 190.8 165.1 165.5 44.5 73.1 63.5 191.9 143.9 63.3 56.7 122.5 193.8 169.3 55.5 77.8 89.0 226.5 125.9 96.4 93.1 95.0 118.2 175.8 103.4 141.7 103.1 113.1 103.0 130.8 48.4 104.4 56.2 65.8 92.1 171.2 79.7 130.7 84.3 43.6 42.8 30.8 45.2 37.4 37.4 31.6 34.5 43.1 35.9 29.4 29.7 26.1 43.1 44.8 29.3 41.0 37.0 40.7 40.4 43.5 46.4 41.3 45.4 44.2 43.2 44.4 43.2 42.3 44.4 67.9 60.9 36.9 46.4 43.3 136.6 105.9 183.6 69.4 46.8 58.0 50.2 83.5 48.6 93.1 36.8 25.0 211.6 43.1 111.8 137.0 190.3 101.5 70.8 70.4 70.2 52.6 27.1 54.8 107.7 201.5 97.8 47.4 79.0 76.8 62.9 53.9 68.4 86.2 57.2 59.2 128.5 122.1 27.3 84.9 45.5 70.8 43.6 64.0 38.4 98.5 88.0 28.8 49.3 55.0 130.5 91.0 74.1 75.8 133.5 202.5 106.4 63.9 60.3 39.5 81.3 87.2 79.2 51.5 68.0 118.9 284.4 43.2 90.0 97.2 123.0 ABI3BP "DKFZP586L2024, NESHBP, TARSH" ENSG00000154175 "ABI family member 3 binding protein" Q7Z7G0 3 100749156-100993515 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 57.7;Fibroblasts: 213.8;Leydig cells: 97.3;Muller glia cells: 93.7;Skeletal myocytes: 106.8" "Cancer enhanced" "Detected in many" "renal cancer: 10.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 437.3;hTEC/SVTERT24-B: 840.8;hTERT-HME1: 818.4;TIME: 1405.8;U-2197: 311.0" "Group enriched" "Detected in many" 4 "amygdala: 4.2;basal ganglia: 15.9;cerebellum: 5.5;cerebral cortex: 13.9;olfactory bulb: 12.0" "Low region specificity" "Detected in all" HPA044127 Uncertain "Secreted in other tissues" NA NA 550000000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 50: Fibroblasts - ECM organization" "HPA044127: AB_2678823" "unprognostic (4.32e-2)" "unprognostic (3.32e-2)" "unprognostic (6.36e-2)" "unprognostic (3.41e-1)" "unprognostic (1.70e-1)" "unprognostic (7.20e-2)" "unprognostic (7.58e-2)" "unprognostic (6.25e-2)" "unprognostic (1.61e-1)" "unprognostic (2.36e-1)" "unprognostic (1.08e-1)" "unprognostic (9.46e-2)" "prognostic favorable (6.14e-4)" "unprognostic (2.27e-2)" "unprognostic (2.69e-2)" "unprognostic (6.59e-2)" "unprognostic (1.07e-3)" 41.3 9.9 3.9 57.0 9.7 0.2 23.1 0.8 4.1 56.4 3.1 36.5 5.3 49.5 10.7 35.1 46.9 97.9 44.5 3.8 26.6 12.2 7.8 68.7 25.9 3.4 5.7 89.4 12.7 3.0 4.7 51.9 7.3 8.7 56.2 57.5 13.7 12.3 6.7 14.0 15.4 72.0 5.6 12.4 25.5 17.1 6.7 7.9 25.0 41.1 39.9 96.7 23.7 9.1 1.3 0.3 0.1 0.0 37.0 437.3 0.4 91.9 90.2 171.4 79.9 0.0 0.2 0.9 0.4 25.0 0.3 0.0 0.1 1.0 278.2 0.8 0.7 2.4 1.6 0.0 23.7 0.5 0.1 26.6 1.0 840.8 818.4 3.6 267.1 0.0 0.5 1.3 158.6 0.0 0.5 0.3 0.1 0.0 87.5 0.4 0.7 0.7 54.0 0.2 0.2 0.6 0.0 0.6 0.1 0.8 0.3 0.1 1405.8 37.7 0.4 311.0 19.7 1.0 0.0 0.0 43.7 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 9.7 0.8 4.1 3.8 26.6 3.4 5.7 7.3 5.6 6.7 9.1 9.1 57.7 5.5 26.1 0.3 15.9 1.5 5.8 4.6 1.2 0.6 1.8 9.7 10.0 39.8 18.4 2.1 0.5 0.1 0.4 0.0 0.3 10.3 1.2 30.6 23.6 1.2 0.0 2.6 0.4 0.4 213.8 9.7 2.4 3.8 0.2 16.1 0.1 0.9 0.0 47.0 0.8 0.0 0.6 23.2 8.8 97.3 1.8 19.6 7.5 0.0 93.7 0.0 1.5 3.3 1.9 5.4 27.8 0.7 1.5 0.2 9.0 5.0 3.7 0.0 106.8 17.5 0.1 0.3 3.9 19.9 0.7 2.1 3.6 1.0 2.9 IMPG2 "IPM200, RP56, SPACRCAN" ENSG00000081148 "Interphotoreceptor matrix proteoglycan 2" Q9BZV3 3 101222546-101320575 "Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Heparin-binding, Receptor" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "retina: 305.4" "Group enriched" "Detected in some" 18 "Cone photoreceptor cells: 517.1;Rod photoreceptor cells: 329.1" "Cancer enriched" "Detected in single" 12 "ovarian cancer: 2.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008779, HPA015907" Enhanced "Secreted in other tissues" NA NA "Cluster 79: Retina - Phototransduction" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA008779: AB_2668138, HPA015907: AB_2669323" "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.40e-1)" "unprognostic (9.58e-3)" "unprognostic (1.28e-1)" "unprognostic (4.80e-5)" "unprognostic (6.66e-4)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (6.59e-2)" "unprognostic (7.51e-3)" "unprognostic (1.28e-1)" "unprognostic (4.50e-9)" "unprognostic (7.12e-2)" "unprognostic (2.70e-1)" "unprognostic (2.81e-2)" "unprognostic (6.08e-2)" 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.3 0.1 1.7 0.1 0.0 0.1 0.1 0.0 9.6 0.1 0.1 0.2 1.1 0.3 0.0 0.0 0.2 0.9 0.3 0.1 0.1 0.0 0.1 0.0 1.1 0.1 0.1 305.4 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.3 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.2 1.1 0.9 0.3 1.1 0.2 0.3 0.2 0.3 0.0 0.0 5.9 0.4 0.1 0.0 0.1 0.0 22.8 0.1 0.5 0.6 0.0 0.1 0.0 517.1 0.0 0.3 0.0 1.9 0.1 0.3 0.7 0.5 2.4 0.0 0.0 7.5 0.0 0.0 0.3 0.0 0.5 0.0 0.2 0.0 0.1 0.1 13.5 14.0 0.0 0.0 0.3 0.0 0.0 0.6 0.3 0.0 4.7 1.2 23.4 0.0 8.5 2.6 0.1 0.0 0.7 0.6 0.1 0.0 0.0 0.5 329.1 0.0 0.6 0.3 0.1 0.3 0.0 0.3 0.0 0.2 1.2 0.0 0.0 SENP7 ENSG00000138468 "SUMO specific peptidase 7" Q9BQF6 3 101324205-101513241 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 109.6;Oligodendrocyte precursor cells: 157.3;Oligodendrocytes: 134.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 44.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 44.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027259, HPA071998" Approved Supported "Nucleoplasm,Nuclear bodies,Centrosome,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "Nuclear bodies, Centrosome, Cytosol" "HPA027259: AB_1856679, HPA071998: " "unprognostic (1.50e-1)" "unprognostic (6.12e-2)" "unprognostic (2.78e-2)" "unprognostic (7.31e-2)" "unprognostic (2.44e-2)" "prognostic favorable (4.23e-4)" "unprognostic (1.38e-3)" "unprognostic (9.25e-3)" "unprognostic (8.80e-2)" "unprognostic (2.24e-1)" "unprognostic (7.77e-3)" "unprognostic (1.94e-1)" "unprognostic (9.85e-2)" "unprognostic (8.08e-3)" "unprognostic (3.27e-1)" "unprognostic (9.03e-2)" "unprognostic (2.23e-2)" 15.1 9.7 9.7 13.7 12.7 24.7 16.9 21.8 11.8 15.8 9.7 12.5 7.3 26.8 14.7 7.8 16.1 14.2 9.5 9.3 12.3 11.4 8.7 12.8 23.1 13.9 11.7 26.3 12.8 16.9 10.2 19.4 14.0 12.7 10.8 26.0 8.9 11.5 11.2 20.8 12.4 14.7 10.1 16.9 14.1 9.1 11.5 20.5 17.5 11.2 17.7 11.8 11.4 20.3 9.2 6.1 29.4 16.4 5.6 8.2 5.3 5.2 3.8 8.5 10.4 4.0 8.3 7.0 7.9 5.1 7.8 9.1 9.4 4.8 17.0 13.0 2.7 12.7 5.1 5.5 4.5 7.4 12.2 6.4 8.5 4.3 9.6 7.6 12.2 13.4 10.5 17.6 8.1 6.1 13.7 8.6 6.0 4.8 6.3 15.2 8.0 6.4 10.1 5.2 11.3 8.8 4.8 4.8 6.5 15.0 8.0 9.8 10.2 11.8 7.1 3.9 5.2 12.2 7.8 16.4 4.1 9.7 9.8 44.1 5.9 5.9 5.8 5.4 7.3 6.4 7.8 5.8 4.8 9.0 10.3 7.1 17.3 9.3 6.3 4.1 6.9 6.1 9.7 12.7 21.8 11.8 9.3 12.3 13.9 11.7 14.0 10.1 11.5 20.3 44.5 16.0 24.9 78.4 33.0 9.1 8.4 7.4 21.1 48.3 14.4 12.2 21.6 2.8 18.4 16.5 20.9 5.8 30.8 5.4 5.9 8.1 4.1 33.1 48.5 28.4 13.1 18.7 62.4 5.2 2.7 23.4 21.4 34.1 37.2 28.6 32.9 10.3 8.2 52.2 109.6 6.5 12.2 20.5 9.5 4.0 18.3 19.1 10.6 80.6 13.6 16.7 35.0 157.3 134.4 6.9 4.1 19.5 23.5 4.8 7.0 8.5 27.5 33.8 46.0 29.7 23.3 22.8 19.9 13.4 9.9 2.5 41.0 21.1 5.9 6.1 TRMT10C "FLJ20432, MRPP1, RG9MTD1" ENSG00000174173 "TRNA methyltransferase 10C, mitochondrial RNase P subunit" Q7L0Y3 3 101561868-101566446 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036671 Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 44: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Mitochondria Nucleoplasm "HPA036671: AB_10602085" "unprognostic (7.42e-2)" "unprognostic (2.68e-1)" "unprognostic (9.08e-3)" "unprognostic (4.47e-3)" "unprognostic (5.01e-2)" "unprognostic (5.55e-2)" "prognostic unfavorable (6.56e-5)" "unprognostic (1.67e-2)" "unprognostic (8.48e-2)" "unprognostic (5.42e-2)" "unprognostic (4.70e-2)" "unprognostic (3.28e-2)" "prognostic favorable (3.32e-5)" "unprognostic (2.77e-2)" "unprognostic (1.37e-1)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" 16.6 17.4 6.9 14.8 7.9 18.2 20.8 9.1 9.7 12.2 8.5 15.4 12.7 14.1 13.4 18.9 14.5 11.4 21.6 7.8 7.9 19.2 25.2 10.3 20.5 7.4 7.4 15.7 10.4 15.6 6.4 14.0 7.9 11.9 14.7 7.8 13.0 9.9 27.6 12.7 13.1 16.0 7.4 12.5 12.1 11.8 7.5 17.5 15.4 30.2 20.7 26.6 8.6 7.5 58.9 28.2 36.6 37.1 33.0 28.0 34.1 34.2 33.3 43.6 48.5 43.2 38.6 121.3 43.4 21.6 35.4 57.9 71.5 52.5 59.7 43.8 35.3 81.6 20.5 31.6 25.4 72.5 33.1 32.9 53.3 38.3 35.4 23.2 43.1 45.4 70.3 26.3 47.6 40.4 58.2 52.9 68.2 75.9 60.4 42.9 29.8 54.3 56.2 49.0 90.9 51.8 26.7 56.0 78.1 31.9 74.0 78.9 28.7 23.6 45.0 15.8 36.5 30.4 59.4 117.5 40.0 51.5 36.2 56.6 18.2 12.8 21.1 24.7 29.8 35.7 26.2 25.1 22.7 34.2 35.0 33.2 8.1 21.4 27.4 25.8 26.2 19.5 6.9 7.9 9.1 9.7 7.8 7.9 7.4 7.4 7.9 7.4 7.5 7.5 33.3 22.4 24.0 4.9 47.9 94.3 153.4 106.8 63.7 30.6 39.9 52.7 51.5 21.5 69.2 29.5 14.6 65.7 50.3 21.5 52.8 48.5 49.7 54.7 54.0 39.5 35.8 65.0 8.8 33.8 47.0 38.8 28.1 63.5 46.3 47.3 31.4 56.9 31.1 21.9 8.5 31.5 69.2 27.3 31.9 13.7 37.3 23.7 14.2 1.9 42.1 29.8 37.0 6.6 7.6 37.2 17.9 37.6 21.5 85.3 17.3 72.0 53.3 33.9 32.9 58.1 41.3 77.7 55.0 55.2 105.0 65.5 46.4 57.1 47.0 127.4 PCNP ENSG00000081154 "PEST proteolytic signal containing nuclear protein" Q8WW12 3 101574180-101594465 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035011, HPA063861" Supported Enhanced "Nucleoplasm,Nuclear bodies" No No 38000 "Cluster 2: Granulocytes - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm "Nuclear bodies" "HPA035011: AB_10601386, HPA063861: " "unprognostic (4.34e-2)" "unprognostic (9.65e-2)" "unprognostic (6.74e-2)" "unprognostic (2.08e-3)" "unprognostic (7.67e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.00e-5)" "unprognostic (1.91e-1)" "unprognostic (3.44e-3)" "unprognostic (1.21e-1)" "unprognostic (3.20e-2)" "unprognostic (4.99e-2)" "unprognostic (6.16e-2)" "unprognostic (2.20e-1)" "unprognostic (2.43e-1)" "unprognostic (8.32e-2)" "unprognostic (2.05e-1)" 47.0 47.6 42.6 43.5 45.3 58.7 53.5 48.6 69.1 48.2 54.5 47.8 38.8 53.8 52.6 48.1 43.8 41.0 57.7 43.1 50.6 51.9 49.6 41.0 57.3 43.7 43.9 69.7 33.3 50.0 39.3 50.5 44.0 47.6 45.2 58.3 42.5 49.1 66.5 39.0 36.1 53.4 45.8 39.8 34.8 28.4 45.8 58.0 49.8 66.4 57.5 50.7 40.0 52.9 135.0 71.1 105.2 82.9 96.1 136.8 113.4 90.0 126.3 94.1 105.1 85.8 73.1 139.4 66.5 100.0 92.8 71.4 138.0 119.6 196.9 102.6 76.6 151.1 84.9 103.4 73.6 141.1 72.1 82.4 115.5 78.0 109.6 134.8 129.6 64.1 143.7 82.6 117.2 55.8 123.8 120.2 162.4 110.8 113.9 71.8 93.2 110.0 123.7 76.7 136.1 108.0 83.4 82.0 132.6 119.3 76.7 105.4 81.5 86.5 113.8 44.1 97.1 62.1 100.2 174.0 84.1 150.9 107.4 58.3 22.4 38.6 22.1 27.0 29.1 29.8 28.9 26.9 23.9 24.1 29.1 27.3 20.2 36.4 36.0 18.9 35.9 40.9 42.6 45.3 48.6 69.1 43.1 50.6 43.7 43.9 44.0 45.8 45.8 52.9 94.9 60.9 101.4 25.5 124.2 232.6 235.2 171.7 126.9 89.5 90.3 65.8 111.5 75.8 106.2 64.4 39.6 120.3 75.0 46.6 266.1 130.3 30.1 89.1 80.4 111.0 81.9 195.9 50.4 95.0 205.7 126.9 55.5 114.6 102.6 53.8 90.3 51.7 90.3 97.6 51.3 70.8 187.2 87.3 242.1 15.0 130.8 105.0 250.8 39.4 131.0 128.4 102.0 36.2 49.1 111.2 51.6 134.6 77.8 207.5 72.2 182.6 85.8 90.5 131.5 110.8 170.3 105.7 70.1 100.6 238.5 235.9 125.1 60.9 78.8 196.3 ZBTB11 "ZNF-U69274, ZNF913" ENSG00000066422 "Zinc finger and BTB domain containing 11" O95625 3 101648889-101677132 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015328, HPA024138" Approved Enhanced Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 36: HEL - Hemostasis" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA015328: AB_1858938, HPA024138: AB_1858939" "unprognostic (3.25e-3)" "unprognostic (9.62e-2)" "unprognostic (4.92e-2)" "prognostic unfavorable (7.49e-4)" "unprognostic (2.86e-2)" "unprognostic (7.04e-2)" "unprognostic (1.17e-3)" "unprognostic (4.77e-1)" "unprognostic (6.65e-3)" "unprognostic (1.75e-1)" "unprognostic (1.41e-1)" "unprognostic (1.45e-2)" "unprognostic (5.64e-2)" "unprognostic (2.91e-1)" "unprognostic (1.89e-1)" "unprognostic (5.90e-2)" "unprognostic (2.09e-1)" 7.3 7.2 6.1 10.6 7.0 38.0 10.0 11.8 10.3 8.2 5.9 6.7 8.3 9.8 7.2 7.6 6.8 7.4 5.6 6.9 5.9 7.3 9.6 8.2 13.5 5.6 6.0 10.4 9.6 9.9 5.5 9.2 6.2 8.1 7.6 12.4 9.2 6.7 9.1 12.4 7.2 7.1 6.6 13.1 7.8 10.5 6.3 13.7 8.4 10.0 12.7 8.6 6.8 10.0 14.8 16.5 10.7 14.0 16.7 16.3 18.7 14.4 14.2 13.0 14.3 15.0 10.0 18.1 11.4 11.0 11.6 18.0 16.3 16.4 23.3 18.8 11.3 40.1 15.8 14.1 12.8 28.8 14.2 13.1 20.8 12.1 27.8 11.6 13.0 20.6 23.7 21.2 14.1 18.4 25.5 12.8 10.1 15.7 24.0 20.6 16.7 22.1 12.2 17.4 31.0 11.4 18.7 15.0 19.1 6.5 19.1 15.3 14.7 19.6 14.2 8.2 14.5 24.2 21.7 33.4 12.2 18.6 13.9 6.7 3.7 4.2 3.6 4.6 4.7 2.9 3.1 4.0 4.6 3.8 3.5 3.0 2.4 3.0 7.3 2.7 3.8 2.8 6.1 7.0 11.8 10.3 6.9 5.9 5.6 6.0 6.2 6.6 6.3 10.0 19.0 32.1 20.8 12.7 28.2 46.4 20.0 8.4 51.8 14.2 21.4 17.4 12.1 10.0 19.3 1.8 33.3 10.2 40.3 14.0 0.0 6.6 3.2 44.7 50.4 20.1 20.2 12.4 32.7 5.5 7.5 19.4 15.8 70.2 8.8 13.7 13.2 10.3 7.9 21.9 28.2 14.5 14.2 23.0 24.4 3.9 8.4 25.9 19.6 12.2 20.3 12.0 21.6 15.1 27.6 7.6 4.4 14.3 32.6 18.3 8.2 6.2 20.1 22.8 6.6 25.0 19.1 25.5 21.8 50.0 49.0 16.8 34.1 14.3 14.2 24.1 RPL24 L24 ENSG00000114391 "Ribosomal protein L24" P83731 3 101681091-101686718 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051653 Approved Enhanced "Endoplasmic reticulum,Cytosol" NA NA 44000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "HPA051653: AB_2681564" "unprognostic (7.32e-2)" "unprognostic (2.11e-1)" "unprognostic (9.46e-2)" "unprognostic (1.78e-2)" "unprognostic (2.95e-3)" "unprognostic (1.22e-1)" "unprognostic (1.79e-3)" "unprognostic (2.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.29e-2)" "unprognostic (1.55e-1)" "unprognostic (7.43e-2)" "prognostic unfavorable (2.72e-5)" "unprognostic (4.98e-2)" "unprognostic (4.08e-1)" "prognostic favorable (8.25e-4)" "unprognostic (5.37e-2)" 1220.4 963.7 1179.4 795.9 1197.2 1813.7 2016.7 1206.7 1802.8 1786.4 1168.9 1269.8 843.8 1272.5 1658.1 1155.1 1363.2 709.5 1161.8 1152.6 1190.2 1145.5 1195.3 882.4 1514.7 1190.0 1168.8 2886.8 1989.8 967.9 1101.6 889.8 1190.1 1124.9 937.9 588.3 1605.5 795.5 1501.5 1285.7 866.2 822.5 1216.9 917.6 1117.4 324.3 1203.7 1558.3 1217.1 1347.0 1338.5 1222.0 1282.4 1226.6 3341.0 1122.5 1638.4 1892.9 1823.4 3249.1 2499.1 1832.0 2161.4 2560.1 1868.3 2262.4 1480.2 3669.7 2253.5 1494.6 1002.0 1749.4 1967.8 2398.5 2584.5 1982.6 1939.0 2147.6 857.8 1715.0 1772.2 2451.8 1122.7 3142.6 3062.3 1585.9 2863.5 2474.3 2226.2 1741.3 2028.0 1830.4 2427.7 2323.0 2566.8 3835.9 2991.2 3052.1 2372.1 2332.6 1598.0 3622.8 2686.7 1508.6 3587.0 1629.7 966.3 1775.0 4454.7 1413.3 2184.7 4483.3 1579.9 1138.3 2019.4 613.4 2332.7 1512.4 2049.7 6425.0 1484.6 2643.4 1919.2 668.3 1239.3 311.8 1468.5 1083.5 2151.6 2246.8 2305.6 1787.9 1641.5 2185.0 2880.6 2249.1 194.6 1677.3 1115.5 1957.8 2261.4 4700.1 1179.4 1197.2 1206.7 1802.8 1152.6 1190.2 1190.0 1168.8 1190.1 1216.9 1203.7 1226.6 1628.0 948.7 1279.6 15.7 2074.3 2283.7 3314.0 1938.2 2129.6 268.3 2541.6 4149.7 333.2 1313.9 1327.7 610.6 85.5 2064.2 1870.1 882.2 2267.6 1579.1 885.8 1200.6 2281.6 1502.9 1364.3 1421.6 22.5 2930.3 3255.0 1518.4 813.5 1574.5 1350.0 1547.4 1509.5 1509.9 1594.8 117.8 22.0 2147.0 708.0 1759.2 2028.7 689.6 3003.4 1452.0 1378.5 30.0 2166.2 1045.3 1578.8 20.1 26.8 2412.1 1728.7 1501.5 1499.8 3372.3 1679.5 2895.9 676.1 432.6 874.4 2783.8 2675.9 498.4 345.7 2210.2 2326.7 2341.6 1952.8 2206.1 2242.3 3363.9 CEP97 "FLJ23047, LRRIQ2" ENSG00000182504 "Centrosomal protein 97" Q8IW35 3 101724593-101770562 "Predicted intracellular proteins" "Cilium biogenesis/degradation" Calmodulin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 50.8;Oligodendrocytes: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002980 Uncertain NA NA "Cluster 38: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 12: Non-specific - Cell cycle regulation" "HPA002980: AB_1848820" "unprognostic (7.36e-2)" "unprognostic (4.70e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-1)" "unprognostic (1.08e-1)" "unprognostic (3.33e-2)" "unprognostic (2.01e-3)" "unprognostic (1.00e-1)" "unprognostic (2.85e-1)" "unprognostic (4.04e-1)" "unprognostic (5.68e-2)" "unprognostic (1.34e-1)" "unprognostic (1.12e-3)" "unprognostic (1.44e-1)" "unprognostic (1.06e-1)" "unprognostic (4.79e-1)" "unprognostic (1.05e-1)" 2.1 2.7 4.6 3.6 7.7 4.9 2.6 6.0 6.4 2.3 3.1 2.1 1.7 3.5 2.5 2.0 5.3 2.2 2.0 4.5 5.8 2.2 1.3 2.3 4.6 6.1 6.4 3.2 1.1 6.1 2.7 2.7 5.9 2.4 2.3 5.5 2.0 2.2 2.6 2.7 1.8 4.2 5.7 3.0 2.3 7.3 5.6 5.9 3.3 3.5 4.5 2.4 2.0 12.7 12.0 7.0 11.7 8.7 6.5 5.2 3.6 12.6 8.8 9.6 11.8 3.0 5.5 10.6 5.6 7.1 7.7 7.9 8.8 6.9 16.1 11.5 4.3 6.0 7.6 2.2 3.2 7.6 8.9 3.0 5.6 8.2 6.9 5.1 5.4 10.4 4.9 17.9 11.8 3.6 12.4 4.0 4.2 4.3 9.1 9.0 16.1 7.2 3.3 4.5 22.4 9.2 6.8 4.5 6.1 6.1 7.4 6.8 5.4 12.9 9.5 3.8 9.4 11.3 11.0 18.3 5.3 6.8 13.0 2.1 0.1 0.6 0.7 0.0 0.5 1.0 0.6 0.4 0.1 0.5 0.4 0.3 0.9 0.3 0.4 0.4 0.8 0.2 4.6 7.7 6.0 6.4 4.5 5.8 6.1 6.4 5.9 5.7 5.6 12.7 8.7 3.2 6.2 24.5 9.1 4.7 2.4 4.7 9.1 13.6 5.2 4.3 7.0 4.3 9.6 1.8 12.5 3.7 14.6 1.6 3.9 4.4 20.7 32.7 14.3 6.4 4.2 9.1 28.6 2.1 2.9 8.8 5.1 10.4 9.5 14.5 3.9 4.1 2.8 18.5 36.0 3.7 10.2 3.1 2.7 9.1 7.8 3.0 8.8 8.4 3.4 19.6 4.1 50.8 96.5 4.0 1.0 7.5 24.0 1.8 0.9 3.1 42.5 14.6 13.1 13.1 8.6 30.4 11.9 8.0 3.7 1.9 9.2 11.0 3.3 1.5 NXPE3 "FAM55C, MGC15606" ENSG00000144815 "Neurexophilin and PC-esterase domain family member 3" Q969Y0 3 101779202-101828231 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.2;tongue: 50.5" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 177.7;Plasma cells: 59.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 92.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036259 Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 12000 "Cluster 20: T-cells - T-cell receptor" "Cluster 80: Striated muscle - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles Nucleoplasm "HPA036259: AB_10671838" "unprognostic (3.30e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-1)" "unprognostic (4.42e-5)" "unprognostic (4.98e-2)" "unprognostic (1.07e-1)" "unprognostic (1.81e-1)" "unprognostic (7.42e-2)" "unprognostic (1.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.57e-3)" "unprognostic (3.43e-1)" "prognostic unfavorable (7.76e-6)" "unprognostic (2.89e-1)" "unprognostic (5.23e-2)" "unprognostic (1.77e-1)" "unprognostic (8.75e-3)" 7.8 6.4 13.6 11.7 23.2 12.5 6.0 20.1 18.7 7.6 1.3 5.3 3.5 8.1 3.3 6.1 7.4 6.5 18.4 12.4 21.0 3.3 3.5 9.4 16.7 21.6 21.3 7.1 2.5 20.7 6.8 6.7 24.2 8.3 4.6 11.3 3.5 9.8 73.2 2.0 5.0 10.6 16.5 12.5 5.0 7.4 23.7 13.1 5.9 50.5 14.2 7.2 4.5 34.8 19.8 29.9 25.1 9.2 26.6 26.9 5.7 21.7 27.2 25.4 36.6 7.0 2.0 29.3 62.6 24.4 30.4 4.1 28.3 23.2 31.2 36.7 8.9 22.7 19.0 19.3 35.0 19.4 19.9 15.6 3.9 21.1 7.8 33.1 27.8 27.3 4.7 92.0 42.5 10.6 26.2 4.6 14.6 1.0 18.6 11.5 30.7 12.7 18.8 5.1 19.6 23.4 9.3 2.2 16.7 14.9 4.3 27.2 24.5 28.0 33.7 3.3 23.0 43.0 47.5 34.0 23.9 83.7 5.4 8.0 16.5 20.1 14.6 13.0 10.0 10.8 16.0 15.2 14.2 6.4 21.6 17.6 8.6 8.9 12.7 8.8 20.8 14.1 13.6 23.2 20.1 18.7 12.4 21.0 21.6 21.3 24.2 16.5 23.7 34.8 24.1 25.6 5.1 11.4 19.2 3.7 2.2 2.3 6.2 26.1 9.8 9.0 49.4 4.3 2.3 0.0 8.4 0.7 12.8 1.0 0.0 2.6 1.4 2.9 11.8 17.2 7.2 0.0 34.1 2.6 1.6 10.0 1.5 1.9 13.3 46.0 40.4 1.8 6.8 48.8 35.2 0.6 4.1 19.1 10.0 1.8 9.3 11.0 7.2 9.4 26.3 22.7 23.7 44.2 177.7 2.9 0.1 7.5 59.6 1.0 0.8 0.8 3.1 17.1 19.7 14.9 8.3 11.8 15.1 3.8 3.0 0.7 16.2 20.0 0.9 1.1 NFKBIZ "FLJ34463, INAP, MAIL" ENSG00000144802 "NFKB inhibitor zeta" Q9BYH8 3 101827991-101861022 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 406.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 33.9" "Group enriched" "Detected in many" 5 "granulocytes: 24.7;monocytes: 33.9" "Cell line enhanced" "Detected in many" "BJ hTERT+: 72.1;RPTEC TERT1: 71.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA010547, HPA075363" Enhanced Supported "Nuclear speckles,Cytoplasmic bodies" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 41: Macrophages - Immune response" "Nuclear speckles" "Cytoplasmic bodies" "HPA010547: AB_1854442, HPA075363: AB_2686745" "unprognostic (2.20e-2)" "unprognostic (1.11e-2)" "unprognostic (6.76e-2)" "unprognostic (1.91e-1)" "unprognostic (1.54e-2)" "unprognostic (1.68e-2)" "unprognostic (1.62e-2)" "unprognostic (1.62e-1)" "unprognostic (9.22e-2)" "unprognostic (5.96e-2)" "unprognostic (1.40e-1)" "unprognostic (8.82e-2)" "prognostic unfavorable (4.30e-8)" "unprognostic (2.69e-1)" "unprognostic (8.90e-2)" "unprognostic (3.30e-1)" "unprognostic (8.52e-3)" 57.5 12.0 2.8 44.4 5.2 406.0 31.7 4.7 6.0 13.4 19.1 24.5 52.6 36.3 3.7 26.9 64.8 51.3 23.6 3.4 4.8 29.2 52.4 48.2 27.2 6.7 4.2 19.1 27.0 3.6 12.5 22.3 5.5 26.6 30.6 8.0 80.8 7.4 4.6 45.7 23.2 54.6 6.2 26.9 30.5 3.7 6.8 18.8 24.7 10.2 22.7 71.3 18.3 5.0 6.5 5.2 3.5 4.4 9.7 16.7 5.3 26.2 72.1 11.3 10.7 6.3 7.8 12.2 32.4 7.2 34.8 20.5 2.5 11.4 29.2 35.9 2.3 11.7 10.2 3.4 14.7 0.8 0.7 11.6 17.3 30.5 13.7 27.8 8.4 0.3 2.0 24.6 16.2 8.1 0.2 6.9 6.0 2.3 15.3 1.5 15.7 1.5 71.0 42.7 1.5 1.9 4.4 5.3 29.6 7.4 6.3 4.8 10.6 18.1 18.0 6.9 8.6 20.4 7.8 8.1 32.9 2.2 2.5 11.7 5.9 1.7 1.4 13.1 1.7 2.9 2.1 1.6 3.8 4.6 6.0 4.2 24.7 0.8 33.9 6.0 1.3 2.3 2.8 5.2 4.7 6.0 3.4 4.8 6.7 4.2 5.5 6.2 6.8 5.0 199.5 86.6 266.6 10.7 91.3 281.7 61.2 123.0 103.0 9.0 108.7 105.8 20.6 84.4 143.0 66.2 2.1 19.3 98.6 157.8 0.0 213.0 4.6 116.1 221.4 135.3 73.6 21.0 23.7 132.1 41.0 214.2 277.8 291.9 381.8 17.9 82.1 65.2 56.5 10.1 20.2 69.7 59.0 150.6 291.5 1.3 20.2 318.4 71.2 16.9 79.0 25.7 12.3 17.1 79.3 127.6 115.8 0.7 128.5 88.8 91.2 5.6 117.3 8.9 19.7 218.4 131.1 0.6 2.6 136.4 251.7 25.6 134.0 19.2 111.7 70.5 ZPLD1 ENSG00000170044 "Zona pellucida like domain containing 1" Q8TCW7 3 102099244-102479841 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.6;gallbladder: 2.2;retina: 2.5" "Cell type enhanced" "Detected in some" "Cholangiocytes: 4.3;Ductal cells: 3.6;Early spermatids: 2.8;Late spermatids: 5.9;Muller glia cells: 16.0;Pancreatic endocrine cells: 4.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "RPTEC TERT1: 6.5" "Region enriched" "Detected in single" 7 "olfactory bulb: 2.8" "Low region specificity" "Detected in many" HPA077519 Approved Nucleoplasm "Intracellular and membrane" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "HPA077519: AB_2732349" "unprognostic (2.49e-1)" "unprognostic (2.83e-3)" "unprognostic (6.38e-3)" "unprognostic (1.88e-1)" "unprognostic (5.02e-2)" "unprognostic (1.37e-2)" "unprognostic (2.68e-1)" "unprognostic (2.63e-1)" "unprognostic (4.63e-1)" "unprognostic (2.89e-4)" "unprognostic (4.59e-2)" "unprognostic (1.05e-3)" "unprognostic (1.97e-2)" "unprognostic (9.65e-2)" "unprognostic (1.41e-1)" "unprognostic (1.23e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.2 1.1 0.2 0.0 0.0 0.1 0.8 0.3 0.0 0.0 0.1 2.2 0.0 0.1 0.3 0.5 0.0 0.0 0.0 1.6 0.1 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 6.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.2 1.1 0.2 0.1 0.3 1.6 0.1 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.4 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 2.8 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.5 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALCAM "CD166, MEMD" ENSG00000170017 "Activated leukocyte cell adhesion molecule" Q13740 3 105366909-105576900 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Adaptive immunity, Cell adhesion, Immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "parathyroid gland: 438.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 737.2;Oligodendrocyte precursor cells: 680.1;Oligodendrocytes: 981.1;Respiratory ciliated cells: 318.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 29.6" "Lineage enriched" "Detected in many" 6 "dendritic cells: 29.6" "Cell line enhanced" "Detected in many" "hTERT-HME1: 393.4;U-138 MG: 473.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002148, HPA010926" Enhanced Uncertain Vesicles "Secreted to blood" NA NA 1600000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "CAB002148: AB_442053, HPA010926: AB_1078449" "unprognostic (6.82e-2)" "unprognostic (2.66e-1)" "unprognostic (2.13e-1)" "unprognostic (2.19e-1)" "unprognostic (9.48e-3)" "unprognostic (2.08e-2)" "unprognostic (1.63e-3)" "unprognostic (3.89e-2)" "unprognostic (1.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "prognostic favorable (3.15e-4)" "unprognostic (3.15e-1)" "unprognostic (4.47e-2)" "unprognostic (9.57e-2)" "unprognostic (7.76e-2)" 7.7 32.7 31.3 12.2 48.1 10.5 81.0 42.4 47.2 28.0 14.4 16.6 17.0 15.5 35.4 8.2 49.1 23.3 9.6 32.4 70.6 22.2 47.9 74.1 9.9 50.7 54.9 57.6 32.7 438.9 19.2 12.1 51.7 32.7 14.5 3.6 33.8 39.6 0.8 11.0 17.4 16.2 44.9 6.3 33.4 4.5 45.7 14.2 62.4 5.0 14.5 25.6 6.4 85.0 248.4 93.7 65.9 33.7 97.6 42.7 0.6 197.7 115.1 124.9 173.8 0.8 50.5 17.3 80.3 280.6 68.8 186.5 10.6 157.4 366.1 16.6 16.6 2.4 65.8 4.6 109.6 101.3 0.8 76.0 114.9 159.9 393.4 346.8 139.3 17.9 0.3 28.6 165.9 16.9 14.5 37.0 13.7 79.3 104.8 9.4 5.9 1.0 188.9 27.2 47.5 131.9 20.6 19.6 12.9 25.9 37.7 66.3 291.6 473.7 162.3 20.9 237.2 0.3 0.6 1.8 108.0 21.1 207.4 0.0 4.7 3.5 0.6 2.1 1.9 4.7 1.5 0.9 29.6 3.0 0.3 0.2 5.3 0.6 1.2 10.5 2.4 3.2 31.3 48.1 42.4 47.2 32.4 70.6 50.7 54.9 51.7 44.9 45.7 85.0 4.5 737.2 143.6 238.6 17.9 12.1 22.8 65.8 12.0 3.0 112.4 47.9 10.1 62.9 255.3 16.5 2.1 0.7 19.5 9.1 1.9 18.5 66.5 108.6 20.1 11.9 16.8 6.3 143.0 43.0 0.7 37.0 23.4 158.1 11.4 29.5 3.6 44.1 57.5 1.7 287.0 16.3 46.8 51.0 162.6 60.1 3.7 86.4 24.9 40.3 93.4 1.3 1.0 680.1 981.1 55.2 8.5 6.4 21.8 117.5 9.6 24.2 318.3 0.8 0.0 7.9 21.8 8.1 5.5 30.1 20.2 0.8 8.9 22.8 10.4 105.4 CBLB "Cbl-b, RNF56" ENSG00000114423 "Cbl proto-oncogene B" Q13191 3 105655461-105869552 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 113.7;Inhibitory neurons: 112.5;Oligodendrocyte precursor cells: 123.1;T-cells: 111.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 32.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018327, HPA019880" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 24: Non-specific - Transcription regulation" Cytosol Nucleoplasm "HPA018327: AB_1846097, HPA019880: AB_1846099" "unprognostic (2.65e-1)" "unprognostic (9.42e-2)" "unprognostic (1.72e-2)" "unprognostic (2.38e-1)" "unprognostic (5.89e-3)" "unprognostic (2.80e-2)" "unprognostic (8.18e-2)" "unprognostic (1.10e-1)" "unprognostic (7.05e-2)" "unprognostic (1.66e-1)" "unprognostic (9.29e-2)" "unprognostic (1.50e-2)" "unprognostic (1.43e-2)" "unprognostic (8.21e-2)" "unprognostic (2.83e-1)" "unprognostic (1.20e-2)" "unprognostic (3.09e-2)" 17.3 5.8 5.6 6.7 4.6 11.9 11.0 17.4 5.9 6.8 5.8 6.3 6.2 6.3 4.3 3.5 8.8 8.4 12.2 5.2 7.3 4.3 4.4 9.9 14.5 4.4 5.3 10.0 3.6 2.3 3.8 6.5 5.7 4.7 5.1 9.2 6.7 2.3 7.8 6.8 8.2 3.0 2.0 8.5 8.3 6.4 6.5 4.3 9.1 5.1 6.9 10.0 6.5 4.0 2.4 3.2 10.7 5.4 11.8 12.1 6.8 7.6 4.0 2.3 3.7 4.1 2.6 5.2 5.4 4.2 3.6 3.9 1.5 1.4 2.8 3.8 4.0 2.8 16.1 2.7 17.7 2.0 2.0 11.9 4.3 6.2 16.7 8.5 7.9 5.2 3.0 15.5 5.0 2.8 2.9 1.3 3.6 2.9 4.4 6.1 3.1 0.9 5.9 10.2 8.2 8.9 9.5 1.1 11.9 7.3 2.4 4.3 4.8 32.0 2.6 4.5 2.0 8.8 0.7 8.3 8.6 1.7 2.1 0.7 1.4 2.8 8.9 0.9 7.9 2.1 4.6 5.1 1.3 4.8 3.9 7.0 1.0 10.2 2.0 3.1 5.7 1.7 5.6 4.6 17.4 5.9 5.2 7.3 4.4 5.3 5.7 2.0 6.5 4.0 26.0 16.0 6.1 57.8 43.1 10.8 6.9 35.6 25.6 42.6 12.0 9.7 43.7 2.8 13.7 12.9 27.1 10.1 113.7 12.8 5.9 8.4 34.1 20.9 47.0 34.0 12.6 10.8 48.9 7.8 83.2 55.2 43.8 26.4 8.8 21.3 33.2 8.1 13.9 3.3 112.5 18.8 6.1 13.5 17.1 14.4 7.5 14.6 16.0 74.9 9.0 7.5 59.8 123.1 100.3 15.5 8.6 10.9 53.1 8.9 17.6 3.9 20.2 28.9 6.6 23.6 28.9 11.1 13.3 10.3 7.0 45.4 111.5 5.5 9.9 7.0 CCDC54 "FLJ25362, NYD-SP17, SP17" ENSG00000138483 "Coiled-coil domain containing 54" Q8NEL0 3 107377439-107378635 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "testis: 117.4" "Group enriched" "Detected in some" 114 "Early spermatids: 1528.4;Late spermatids: 3824.3" "Not detected" "Not detected" "Region enhanced" "Detected in single" "white matter: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 74: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (2.83e-1)" "unprognostic (4.53e-1)" "unprognostic (9.56e-3)" "unprognostic (1.56e-1)" "unprognostic (2.16e-1)" "unprognostic (2.98e-1)" "unprognostic (5.27e-2)" "unprognostic (9.79e-2)" "unprognostic (7.38e-3)" "unprognostic (1.53e-2)" "unprognostic (7.32e-2)" "unprognostic (5.20e-2)" "unprognostic (1.87e-3)" "unprognostic (8.75e-4)" "unprognostic (5.58e-2)" "unprognostic (5.78e-2)" 0.0 0.1 0.1 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.9 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 117.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.3 0.2 0.0 0.2 0.1 0.1 0.1 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1528.4 0.1 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3824.3 9.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BBX "HBP2, HSPC339, MDS001" ENSG00000114439 "BBX high mobility group box domain containing" Q8WY36 3 107522936-107811339 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 1071.7;Late spermatids: 571.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006049, HPA050646" Enhanced Enhanced Nucleoplasm,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm Cytosol "HPA006049: AB_2667504, HPA050646: AB_2681200" "unprognostic (7.57e-3)" "unprognostic (1.49e-2)" "unprognostic (8.73e-2)" "unprognostic (3.77e-2)" "unprognostic (1.63e-1)" "unprognostic (3.49e-1)" "unprognostic (2.32e-2)" "unprognostic (2.12e-2)" "unprognostic (1.91e-1)" "unprognostic (9.84e-2)" "unprognostic (4.81e-2)" "unprognostic (8.62e-2)" "unprognostic (1.11e-3)" "unprognostic (7.22e-2)" "unprognostic (2.24e-1)" "unprognostic (3.28e-1)" "unprognostic (3.02e-1)" 13.9 25.0 19.3 12.8 39.0 18.5 14.5 23.7 22.2 17.2 18.7 11.5 9.5 19.0 38.6 12.9 16.8 16.7 16.5 17.0 29.4 19.5 10.2 13.3 13.9 31.0 26.3 27.0 12.3 46.4 10.2 24.2 32.8 22.7 9.3 20.0 13.4 31.6 6.7 8.1 9.1 16.5 25.6 18.9 12.1 58.1 28.5 16.4 26.2 16.2 13.7 14.6 8.7 59.9 40.0 39.7 31.1 47.0 26.5 35.1 25.5 38.6 36.5 33.2 35.4 4.4 31.4 20.2 46.5 23.4 37.5 26.9 34.4 44.2 45.7 29.0 16.3 31.9 30.0 9.4 31.1 43.3 18.2 31.6 31.3 32.5 62.4 44.5 26.2 23.8 14.9 29.6 27.7 13.5 25.2 4.6 15.5 0.4 30.2 35.8 30.1 22.9 20.8 32.2 22.5 22.0 69.0 6.3 31.5 30.7 25.4 8.6 38.3 38.7 30.7 15.3 26.8 12.9 10.3 25.0 36.9 21.4 23.2 76.0 19.9 50.4 47.0 20.8 54.4 75.9 42.2 48.3 28.3 75.0 52.5 43.3 32.0 58.0 42.7 36.2 30.8 27.7 19.3 39.0 23.7 22.2 17.0 29.4 31.0 26.3 32.8 25.6 28.5 59.9 76.9 64.1 84.1 106.7 123.0 85.1 145.6 103.3 80.8 92.8 72.7 79.4 112.7 85.8 72.5 95.6 64.6 208.2 87.7 18.1 49.0 92.9 1071.7 76.8 62.1 78.4 66.4 51.7 96.3 73.8 92.1 86.2 40.8 88.0 32.3 151.7 66.4 30.8 47.9 171.6 78.4 41.4 114.0 62.2 73.0 571.4 156.3 70.7 67.6 112.4 48.2 149.9 101.0 163.3 323.2 65.4 37.8 206.1 66.4 115.7 19.7 112.8 60.9 64.5 144.7 108.5 114.9 94.1 159.0 59.0 75.6 198.4 100.8 107.1 39.3 128.9 CD47 "IAP, MER6, OA3" ENSG00000196776 "CD47 molecule" Q08722 3 108043091-108091862 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ductal cells: 589.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016055, HPA044659" Approved Supported "Vesicles,Plasma membrane" NA NA 49000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 1: Pancreatic cells - Digestion" "Plasma membrane" Vesicles "CAB016055: AB_627086, HPA044659: AB_2679040" "unprognostic (3.54e-2)" "unprognostic (4.74e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (4.49e-2)" "unprognostic (2.14e-1)" "unprognostic (2.05e-3)" "unprognostic (8.77e-3)" "unprognostic (7.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.69e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (7.37e-2)" "unprognostic (3.78e-1)" "prognostic favorable (7.29e-5)" "unprognostic (1.83e-1)" 51.8 64.9 39.2 116.4 47.9 232.2 89.3 64.4 63.5 57.4 30.4 89.0 74.6 53.0 92.4 93.9 100.5 86.7 59.5 47.2 41.9 44.4 71.4 154.6 137.9 53.1 40.5 46.1 41.5 27.2 34.6 80.1 48.5 122.2 99.3 285.7 105.3 55.7 57.9 59.8 79.3 55.4 50.9 100.1 104.2 59.0 49.2 79.1 91.2 22.8 161.7 110.1 52.4 76.4 303.3 49.9 108.0 62.1 130.3 122.6 147.9 106.0 139.4 70.8 126.0 2.1 159.1 129.6 180.0 90.7 216.5 201.0 52.2 98.7 91.7 81.5 35.8 311.6 45.9 3.9 73.8 227.4 467.6 85.7 58.1 71.6 53.6 118.5 73.4 132.6 85.1 323.6 108.5 148.1 268.5 77.0 46.7 298.4 133.6 154.2 69.3 187.8 185.3 115.8 69.7 37.9 63.6 111.7 124.4 56.5 227.4 85.8 76.5 210.9 40.9 120.7 79.4 124.2 100.8 208.0 131.5 119.8 65.6 185.2 119.2 232.8 178.1 244.2 155.6 191.6 209.7 192.0 181.6 188.7 149.2 169.0 145.4 232.6 339.2 133.3 334.5 296.9 39.2 47.9 64.4 63.5 47.2 41.9 53.1 40.5 48.5 50.9 49.2 76.4 72.3 368.6 157.4 98.6 192.9 165.3 311.7 504.4 101.3 102.9 119.0 93.1 51.9 110.1 205.7 93.8 95.9 169.9 218.6 36.5 15.6 589.6 81.5 157.2 17.0 76.5 63.8 112.6 219.2 412.5 85.5 119.1 36.2 120.4 57.7 250.0 83.6 34.2 186.4 122.8 129.3 70.8 148.5 79.6 200.7 52.2 34.2 121.5 117.4 39.4 100.5 51.7 219.4 107.1 150.4 344.7 92.6 48.5 143.8 439.0 53.7 16.3 162.2 229.7 65.7 47.1 85.4 111.5 19.6 97.1 140.1 121.2 160.8 80.6 94.3 321.3 IFT57 "ESRRBL1, FLJ10147, HIPPI, MHS4R2" ENSG00000114446 "Intraflagellar transport 57" Q9NWB7 3 108160812-108222435 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" DNA-binding Ciliopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 1675.3;Late spermatids: 2795.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 41.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035514, HPA035515" Supported Approved "Nuclear speckles,Mitochondria,Cytosol" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 34: Spermatids - Unknown function" "Nuclear speckles" "Mitochondria, Cytosol" "HPA035514: AB_10601757, HPA035515: AB_10696505" "unprognostic (1.35e-2)" "unprognostic (1.37e-2)" "prognostic favorable (6.96e-5)" "unprognostic (2.98e-2)" "unprognostic (5.46e-3)" "unprognostic (1.02e-2)" "unprognostic (3.79e-2)" "unprognostic (3.61e-3)" "unprognostic (3.59e-2)" "prognostic favorable (7.63e-4)" "unprognostic (5.04e-2)" "unprognostic (2.78e-1)" "unprognostic (1.68e-3)" "unprognostic (1.86e-1)" "unprognostic (4.70e-2)" "unprognostic (8.67e-3)" "unprognostic (6.12e-2)" 8.9 15.3 11.6 8.6 11.7 13.2 13.1 10.2 15.5 11.7 14.8 13.3 6.0 13.3 45.1 8.5 32.0 13.4 10.4 11.4 11.5 21.3 4.5 40.7 17.3 12.0 12.2 14.0 13.8 23.0 16.3 7.8 11.6 27.5 14.6 24.0 9.1 17.5 4.2 8.6 9.0 10.6 11.9 12.1 9.8 42.8 12.0 8.2 26.1 4.4 16.4 13.9 8.3 11.8 35.5 17.2 12.8 23.1 26.1 26.9 7.1 10.6 25.8 15.3 13.6 12.4 6.1 39.5 13.3 17.8 22.0 13.9 11.5 17.8 25.8 6.2 12.2 13.6 8.0 3.3 19.4 28.5 30.2 16.3 16.1 19.9 34.2 24.4 17.5 6.6 6.4 6.9 17.8 18.9 9.5 25.8 13.6 2.7 21.0 6.1 11.5 6.3 31.6 12.3 21.1 14.7 15.9 5.2 9.9 7.1 11.0 8.3 7.5 19.6 10.2 10.5 12.6 8.1 6.2 20.7 28.4 2.7 7.3 0.2 3.5 3.1 3.6 6.5 5.8 41.9 7.4 4.5 10.2 34.9 6.2 3.7 1.8 6.8 12.8 2.0 5.1 4.9 11.6 11.7 10.2 15.5 11.4 11.5 12.0 12.2 11.6 11.9 12.0 11.8 36.6 471.1 291.2 18.6 98.4 41.0 114.1 72.9 34.7 25.6 42.2 50.9 33.8 58.6 201.9 51.5 68.8 22.3 16.9 51.1 117.4 158.8 1675.3 266.3 57.8 38.2 57.2 13.7 52.6 134.1 19.3 78.9 25.5 37.0 44.3 57.1 25.7 5.9 14.5 28.6 20.3 35.7 42.7 8.1 27.7 2795.4 65.3 19.3 46.2 4.7 13.1 56.8 8.2 13.0 13.5 79.4 36.6 64.3 40.2 151.4 24.3 124.5 528.7 72.7 52.6 61.7 61.3 242.2 43.6 25.4 37.2 14.9 30.2 104.9 52.3 93.0 HHLA2 "B7-H5, B7-H7, B7H7, B7y" ENSG00000114455 "HERV-H LTR-associating 2" Q9UM44 3 108296490-108378285 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 129.9" "Cell type enhanced" "Detected in some" "Distal enterocytes: 274.7;Paneth cells: 64.2;Proximal enterocytes: 186.8" "Group enriched" "Detected in many" 12 "colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;HDLM-2: 4.0;Karpas-707: 2.8" "Low region specificity" "Detected in all" HPA055478 Enhanced NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA055478: AB_2682830" "unprognostic (1.12e-2)" "unprognostic (2.29e-1)" "unprognostic (1.03e-1)" "unprognostic (3.11e-1)" "unprognostic (2.30e-1)" "unprognostic (1.59e-2)" "unprognostic (8.14e-5)" "unprognostic (1.76e-1)" "unprognostic (2.28e-1)" "unprognostic (1.08e-1)" "unprognostic (6.42e-3)" "unprognostic (1.24e-1)" "unprognostic (1.62e-3)" "unprognostic (1.47e-1)" "unprognostic (2.31e-1)" "unprognostic (2.67e-1)" "unprognostic (1.66e-2)" 0.4 0.2 0.5 5.6 0.4 1.1 0.2 0.7 1.3 0.0 0.0 87.9 86.8 0.3 0.8 0.5 3.7 29.2 0.2 0.6 0.7 7.6 0.1 5.7 0.6 0.7 0.3 0.1 2.9 0.1 0.2 0.1 0.6 0.2 83.0 1.2 0.2 0.3 0.5 0.3 129.9 2.0 0.2 0.3 9.4 3.3 0.6 0.4 0.2 0.0 0.3 0.0 0.0 0.8 0.2 0.3 0.2 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.2 1.7 0.2 0.1 0.1 0.0 0.1 0.2 0.6 0.0 0.0 4.0 0.1 0.1 1.4 0.2 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.8 0.0 0.2 0.4 1.5 0.5 0.2 0.3 0.3 0.1 0.8 0.0 0.1 0.7 0.7 0.7 0.0 0.1 0.5 0.1 0.2 0.1 0.1 0.7 0.2 0.2 1.3 0.7 0.3 0.0 0.4 0.1 0.5 0.1 0.4 0.0 0.1 0.0 0.1 0.0 0.1 1.8 0.1 0.0 0.0 0.2 0.1 0.5 0.0 0.0 0.2 0.5 0.4 0.7 1.3 0.6 0.7 0.7 0.3 0.6 0.2 0.6 0.8 0.0 0.0 2.0 0.7 0.4 0.0 0.1 0.7 0.0 0.0 0.7 0.3 0.2 27.1 1.6 0.0 0.0 0.0 0.0 274.7 0.0 8.5 3.3 3.2 0.0 0.3 1.8 0.0 1.3 37.6 0.1 0.3 2.6 0.1 2.5 0.0 0.0 0.0 0.1 0.0 0.5 12.5 2.0 0.0 0.7 4.2 0.3 0.3 0.0 0.0 1.1 0.0 0.0 0.5 0.9 35.7 64.2 0.0 0.0 0.1 186.8 20.4 19.4 0.0 0.0 0.1 0.1 0.7 0.3 0.0 0.0 0.1 0.5 0.0 17.7 0.1 MYH15 KIAA1000 ENSG00000144821 "Myosin heavy chain 15" Q9Y2K3 3 108380368-108529322 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.9;retina: 2.8;tongue: 1.8" "Cell type enhanced" "Detected in some" "Astrocytes: 14.0;Excitatory neurons: 8.8;Inhibitory neurons: 6.3;Muller glia cells: 8.0;Oligodendrocyte precursor cells: 5.0;Oligodendrocytes: 10.6;Rod photoreceptor cells: 5.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.4;Karpas-707: 2.3;PC-3: 5.1;SH-SY5Y: 1.8;U-87 MG: 1.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA034871, HPA057915" Uncertain Approved Vesicles,Cytosol NA NA "Cluster 24: B-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 5: Muller glia cells - Visual perception" Cytosol Vesicles "HPA034871: AB_10669996, HPA057915: " "unprognostic (4.37e-2)" "unprognostic (7.29e-2)" "unprognostic (2.08e-2)" "unprognostic (1.31e-3)" "unprognostic (2.62e-1)" "unprognostic (1.70e-1)" "unprognostic (2.96e-1)" "unprognostic (7.84e-3)" "unprognostic (7.32e-2)" "unprognostic (1.89e-2)" "unprognostic (5.67e-2)" "unprognostic (6.67e-2)" "unprognostic (4.42e-2)" "unprognostic (5.68e-2)" "unprognostic (5.43e-2)" "unprognostic (8.41e-2)" "unprognostic (3.57e-2)" 0.1 0.2 1.5 0.1 1.9 0.1 0.0 1.4 1.4 0.1 0.6 0.4 0.4 0.0 0.3 0.0 0.1 0.2 0.4 1.5 1.7 0.0 0.0 0.3 0.1 1.7 1.5 0.0 0.0 0.0 0.9 0.0 1.5 0.2 0.3 2.8 0.1 0.0 0.2 0.5 0.6 0.0 1.5 0.2 0.1 0.6 1.6 0.1 0.1 1.8 0.0 0.0 0.0 1.6 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.9 0.1 0.2 0.0 0.4 0.0 0.1 0.0 4.4 0.0 0.1 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.0 2.3 1.2 0.0 0.0 0.0 0.0 0.0 5.1 0.1 0.0 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.5 1.2 0.2 0.0 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.5 1.9 1.4 1.4 1.5 1.7 1.7 1.5 1.5 1.5 1.6 1.6 0.0 0.0 0.5 14.0 0.3 0.0 0.1 0.0 0.0 1.7 0.0 0.0 2.3 0.0 0.0 0.0 2.1 0.0 0.1 0.4 0.0 0.2 3.0 1.0 0.1 0.1 0.0 0.0 8.8 0.2 0.0 0.6 0.0 0.1 0.0 0.5 0.0 0.0 0.1 1.7 6.3 1.1 0.0 0.0 0.3 0.9 0.0 0.1 1.8 1.0 0.0 8.0 0.0 5.0 10.6 0.5 0.0 0.0 1.6 0.4 0.1 0.1 0.0 5.1 0.0 0.1 0.6 1.1 0.6 0.0 0.1 0.0 0.1 0.5 1.2 0.1 CIP2A KIAA1524 ENSG00000163507 "Cellular inhibitor of PP2A" Q8TCG1 3 108549864-108589644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 7.5;lymphoid tissue: 6.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 9.6;Cytotrophoblasts: 8.0;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 12.9;Granulosa cells: 25.3;Hofbauer cells: 8.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039570 Approved Supported "Plasma membrane,Cytosol" NA Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Plasma membrane" "HPA039570: AB_10796329" "unprognostic (2.02e-1)" "unprognostic (1.54e-2)" "unprognostic (2.31e-3)" "prognostic unfavorable (6.24e-5)" "unprognostic (3.10e-2)" "unprognostic (1.07e-2)" "unprognostic (1.91e-7)" "unprognostic (2.80e-3)" "unprognostic (2.53e-3)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.18e-4)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (9.11e-3)" "unprognostic (3.73e-1)" "unprognostic (2.11e-1)" "unprognostic (1.25e-1)" 1.1 1.1 0.3 3.4 0.6 7.5 1.4 0.9 0.8 0.9 0.1 1.9 1.2 1.8 0.6 1.7 0.9 1.2 0.7 0.6 0.5 1.0 0.7 1.4 6.7 0.2 0.9 1.9 0.4 0.6 0.7 2.1 0.2 1.8 2.7 2.6 0.6 0.8 0.6 1.2 1.7 1.5 0.0 2.3 1.2 5.7 0.1 6.9 1.2 0.7 5.2 2.0 0.9 0.4 42.2 12.2 33.9 21.8 1.4 3.2 13.8 31.1 14.7 36.2 41.9 15.0 18.5 27.6 10.4 11.4 27.7 20.9 11.7 11.0 65.8 8.8 11.3 33.9 17.4 11.3 0.5 21.8 23.2 1.4 2.3 28.4 11.5 5.9 16.3 12.7 21.1 44.5 36.1 8.7 26.7 19.2 35.0 15.8 20.8 30.1 31.2 15.3 11.0 11.5 16.4 21.6 22.9 9.0 12.7 19.7 15.3 15.6 12.2 37.0 41.7 11.3 38.3 10.2 12.1 46.1 16.4 23.2 38.6 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.6 0.9 0.8 0.6 0.5 0.2 0.9 0.2 0.0 0.1 0.4 1.2 9.6 1.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 2.5 3.7 0.0 8.0 1.8 0.0 1.9 2.8 0.0 2.5 2.8 2.6 0.0 0.0 0.0 7.3 12.9 3.0 0.0 2.7 3.8 25.3 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.4 0.0 0.0 2.4 1.5 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 1.4 1.7 5.4 0.0 0.0 DZIP3 "hRUL138, PPP1R66" ENSG00000198919 "DAZ interacting zinc finger protein 3" Q86Y13 3 108589705-108694840 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 327.4;Respiratory ciliated cells: 218.2;Spermatocytes: 351.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035066, HPA049232" Approved Approved Vesicles No No "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA035066: AB_10601549, HPA049232: AB_2680684" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (7.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (2.37e-2)" "unprognostic (3.33e-1)" "unprognostic (5.16e-2)" "unprognostic (2.74e-1)" "unprognostic (3.76e-2)" "unprognostic (2.59e-3)" "unprognostic (5.38e-2)" "prognostic favorable (3.65e-4)" "unprognostic (6.06e-2)" "unprognostic (2.78e-2)" "unprognostic (5.51e-3)" "unprognostic (3.81e-2)" 5.2 9.7 15.6 4.9 19.4 4.0 5.3 11.8 18.6 5.3 22.6 5.1 3.0 7.9 10.1 3.9 18.7 5.9 11.7 18.8 18.5 10.9 4.3 6.5 10.2 13.3 14.9 10.5 5.3 7.8 24.5 4.9 12.4 9.7 4.7 29.8 3.6 7.0 12.4 3.7 3.9 5.2 10.4 8.3 6.6 34.6 15.5 8.5 12.8 16.2 8.0 5.2 3.4 15.0 9.8 8.2 24.8 14.7 10.7 10.8 8.6 6.1 12.2 10.1 13.9 12.1 6.8 18.0 12.8 6.6 20.9 3.5 13.7 5.3 21.0 6.6 6.1 8.1 3.4 8.5 6.3 3.3 4.5 11.8 2.8 9.4 11.4 10.2 6.4 10.9 8.0 8.7 19.6 8.6 8.2 3.5 15.5 5.0 6.2 10.4 20.5 1.8 8.4 4.7 17.0 16.2 9.8 1.0 11.1 21.6 15.1 2.8 7.6 9.0 13.7 1.8 5.3 9.6 6.0 34.7 6.8 2.7 11.3 6.5 0.5 1.2 4.1 0.8 5.0 6.3 4.2 5.1 0.5 4.6 3.6 4.8 0.1 10.6 1.5 1.5 6.0 1.5 15.6 19.4 11.8 18.6 18.8 18.5 13.3 14.9 12.4 10.4 15.5 15.0 7.3 12.8 12.8 86.8 14.8 7.5 8.6 16.3 9.1 67.8 9.6 8.3 45.0 4.3 26.6 33.1 327.4 21.9 17.1 4.1 13.7 12.9 28.4 106.1 16.0 8.7 52.8 11.1 145.2 9.0 8.8 18.2 9.2 9.2 8.8 30.9 7.5 4.4 9.4 77.4 103.4 6.9 34.6 5.7 7.5 59.9 17.4 5.7 7.2 37.5 10.5 32.9 11.3 79.4 80.6 8.9 4.6 17.7 9.0 6.9 4.5 20.6 218.2 33.7 19.7 16.6 17.7 351.3 112.5 4.4 7.4 14.8 29.4 35.4 7.4 5.6 RETNLB "FIZZ2, HXCP2, RELMb" ENSG00000163515 "Resistin like beta" Q9BQ08 3 108743424-108757384 "Predicted secreted proteins, Transporters" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "intestine: 245.5" "Cell type enriched" "Detected in some" 38 "Intestinal goblet cells: 210.1" "Cancer enriched" "Detected in some" 10 "colorectal cancer: 16.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "OE19: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA049152 Enhanced "Secreted to blood" NA NA 123000 "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA049152: AB_2680655" "prognostic favorable (6.86e-5)" "unprognostic (1.19e-3)" "unprognostic (3.37e-2)" "unprognostic (4.69e-2)" "unprognostic (2.67e-2)" "unprognostic (5.78e-2)" "unprognostic (4.26e-1)" 0.1 0.0 0.0 4.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 75.7 16.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 245.5 0.0 0.0 0.1 0.0 0.0 34.5 0.8 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 2.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 210.1 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 5.5 0.0 TRAT1 "HSPC062, TCRIM, TRIM" ENSG00000163519 "T cell receptor associated transmembrane adaptor 1" Q6PIZ9 3 108822770-108855005 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "lymphoid tissue: 79.8" "Cell type enriched" "Detected in some" 10 "T-cells: 129.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "basophil: 395.1" "Group enriched" "Detected in many" 155 "granulocytes: 395.1;T-cells: 313.1" "Group enriched" "Detected in some" 25 "JURKAT: 29.9;MOLT-4: 76.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA002356, CAB026130, HPA072760" Enhanced Enhanced "Plasma membrane,Mitotic spindle,Centriolar satellite" Yes NA "Cluster 32: T-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" "Mitotic spindle, Centriolar satellite" "CAB026130: , HPA002356: AB_1080375, HPA072760: " "unprognostic (1.54e-4)" "unprognostic (1.41e-3)" "unprognostic (6.82e-2)" "unprognostic (4.95e-3)" "unprognostic (2.84e-2)" "unprognostic (2.19e-3)" "unprognostic (1.87e-3)" "unprognostic (2.02e-2)" "unprognostic (7.21e-3)" "unprognostic (8.96e-3)" "unprognostic (8.03e-2)" "unprognostic (4.32e-1)" "unprognostic (2.86e-5)" "unprognostic (3.12e-1)" "unprognostic (3.01e-2)" "unprognostic (2.90e-4)" "unprognostic (4.36e-2)" 1.1 0.6 0.0 11.0 0.0 2.7 0.8 0.0 0.0 0.4 0.0 1.3 1.4 0.4 0.4 1.0 0.3 2.5 0.4 0.1 0.0 0.3 1.3 2.1 23.9 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.8 1.5 0.0 0.6 0.1 0.1 0.6 3.0 0.5 0.0 8.5 2.4 0.4 0.0 79.8 0.4 0.4 12.4 2.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 2.1 0.0 0.0 76.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 395.1 0.6 0.2 57.0 0.2 116.4 1.0 229.5 119.6 0.3 0.4 313.1 77.7 3.5 2.2 0.7 0.8 111.1 139.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.2 0.0 3.3 8.4 0.1 0.0 0.0 0.0 0.4 0.3 0.3 0.0 0.0 1.8 0.0 0.0 8.9 0.1 0.0 0.0 2.3 0.1 0.1 1.1 0.0 2.7 0.1 0.0 0.0 1.7 7.7 0.1 2.5 0.0 1.8 0.6 0.2 0.0 0.2 0.0 0.0 1.0 12.2 2.2 0.0 1.8 3.6 0.0 3.2 0.0 3.1 0.0 0.2 0.0 0.0 0.0 5.1 0.2 0.0 0.5 0.0 0.0 0.0 0.3 0.8 0.0 0.1 0.0 8.0 0.1 129.3 0.6 0.0 0.2 GUCA1C GCAP3 ENSG00000138472 "Guanylate cyclase activator 1C" O95843 3 108907792-108953879 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "retina: 296.7" "Cell type enriched" "Detected in some" 4 "Cone photoreceptor cells: 125.1" "Cancer enriched" "Detected in single" 7 "pancreatic cancer: 0.5" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 85 "RPTEC TERT1: 14.0" HPA041597 Uncertain Approved "Focal adhesion sites" NA NA "Cluster 79: Retina - Phototransduction" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 9: Photoreceptor cells - Phototransduction" "Focal adhesion sites" "HPA041597: AB_10795501" "unprognostic (7.56e-2)" "unprognostic (6.56e-2)" 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.5 1.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.4 41.5 0.0 0.4 0.0 0.1 0.0 0.0 296.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 1.3 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 1.0 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 14.5 0.0 0.0 0.0 125.1 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.3 0.0 0.0 0.7 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 1.0 0.0 9.7 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 29.6 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 17.5 0.0 0.0 MORC1 "CT33, MORC, ZCW6" ENSG00000114487 "MORC family CW-type zinc finger 1" Q86VD1 3 108958248-109118134 "Predicted intracellular proteins" "Differentiation, RNA-mediated gene silencing, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 16.0" "Group enriched" "Detected in some" 6 "Early spermatids: 46.8;Late spermatids: 30.4;Microglial cells: 17.8;Spermatocytes: 51.4;Spermatogonia: 49.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "Karpas-707: 2.5;RPMI-8226: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA036413 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 25: RPMI-8226 - Immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "HPA036413: AB_10669989" "unprognostic (1.66e-1)" "unprognostic (4.30e-2)" "unprognostic (2.17e-2)" "unprognostic (2.63e-1)" "unprognostic (7.45e-6)" "unprognostic (4.80e-2)" "unprognostic (2.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.1 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.1 0.3 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.6 0.0 0.0 3.2 0.0 30.4 0.9 0.3 0.0 17.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.4 49.0 0.0 0.0 0.0 0.0 5.8 0.0 0.1 C3orf85 FLJ22763 ENSG00000241224 "Chromosome 3 open reading frame 85" A0A1B0GTC6 3 109118252-109151401 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 70.4;kidney: 13.9;liver: 19.8" "Cell type enriched" "Detected in some" 9 "Proximal tubular cells: 169.0" "Cancer enhanced" "Detected in some" "colorectal cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA 2900000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (9.10e-2)" "unprognostic (9.48e-3)" "unprognostic (3.80e-4)" "unprognostic (1.15e-1)" "unprognostic (6.70e-2)" 0.1 0.0 0.2 0.4 0.4 0.0 0.0 0.5 0.2 0.0 0.0 5.4 70.4 0.1 1.6 0.0 0.0 0.0 0.0 0.1 0.2 13.9 19.8 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.2 0.1 0.0 0.0 0.0 0.0 64.6 0.1 0.1 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.5 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 DPPA2 "CT100, PESCRG1" ENSG00000163530 "Developmental pluripotency associated 2" Q7Z7J5 3 109293788-109316517 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 3.3" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 12.0;Spermatogonia: 14.5" "Cancer enriched" "Detected in some" 41 "testis cancer: 35.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 6.0;EFO-21: 11.4;SuSa: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036134 Uncertain Approved Nucleoplasm NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "HPA036134: AB_10601547" "unprognostic (2.23e-1)" "unprognostic (2.79e-1)" "unprognostic (1.81e-2)" "unprognostic (3.50e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 6.5 0.4 0.0 0.1 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.0 0.0 1.6 0.0 0.1 0.0 0.0 DPPA4 FLJ10713 ENSG00000121570 "Developmental pluripotency associated 4" Q7L190 3 109326141-109337572 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.7;lymphoid tissue: 12.2;testis: 4.1" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 22.3;Erythroid cells: 16.4;Extravillous trophoblasts: 17.2;Spermatogonia: 11.7;Syncytiotrophoblasts: 6.2" "Cancer enriched" "Detected in single" 218 "testis cancer: 59.0" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 12 "plasmacytoid DC: 7.3" "Lineage enriched" "Detected in single" 12 "dendritic cells: 7.3" "Group enriched" "Detected in some" 4 "HAP1: 89.7;NTERA-2: 327.5;SuSa: 120.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB020678, HPA035249, HPA035250" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome,Cytosol" Yes NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 5: NTERA-2 - Transcription" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome, Cytosol" "CAB020678: , HPA035249: AB_2674535, HPA035250: AB_2674536" "unprognostic (2.07e-2)" "unprognostic (2.53e-2)" "unprognostic (3.80e-1)" "unprognostic (2.53e-1)" "unprognostic (8.57e-2)" "unprognostic (1.80e-2)" "unprognostic (1.67e-1)" "unprognostic (1.52e-1)" "unprognostic (9.83e-2)" "unprognostic (2.02e-2)" "unprognostic (6.60e-2)" "unprognostic (2.48e-2)" "unprognostic (3.03e-8)" "unprognostic (5.28e-2)" "unprognostic (5.04e-2)" "unprognostic (5.56e-2)" "unprognostic (3.85e-2)" 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.7 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.1 0.0 12.2 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 89.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 327.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.5 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 22.3 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 16.4 0.1 0.0 17.2 0.5 0.0 0.0 1.3 0.0 0.4 1.6 1.7 0.0 0.1 0.0 0.0 0.3 0.0 0.6 0.3 0.4 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.7 0.0 0.0 0.9 0.3 0.3 11.7 0.0 0.0 6.2 0.5 0.2 0.0 0.3 NECTIN3 "CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3" ENSG00000177707 "Nectin cell adhesion molecule 3" Q9NQS3 3 111070071-111275563 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 54.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 25.6;Syncytiotrophoblasts: 117.3;Theca cells: 31.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 117.4;TIME: 170.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009869, HPA011038" Approved Approved "Cell Junctions,Cytosol" NA NA 41000000 "Cluster 45: Intestine - Brush border" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" Cytosol "Cell Junctions" "CAB009869: AB_2284699, HPA011038: AB_1079719" "unprognostic (3.76e-2)" "unprognostic (3.81e-3)" "unprognostic (1.74e-1)" "unprognostic (1.97e-2)" "unprognostic (1.02e-1)" "unprognostic (9.77e-2)" "unprognostic (3.26e-3)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (3.94e-2)" "unprognostic (5.33e-2)" "unprognostic (7.04e-2)" "prognostic favorable (9.82e-7)" "unprognostic (2.01e-1)" "unprognostic (1.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.05e-1)" 8.9 4.8 3.9 4.7 6.0 0.2 4.3 6.2 7.5 7.3 0.0 23.0 32.9 7.6 1.5 4.6 9.7 8.2 5.3 6.6 5.0 12.0 29.4 10.4 3.0 10.8 5.6 16.1 7.1 4.6 1.1 22.7 6.7 11.7 23.1 7.3 5.6 8.4 1.7 1.4 21.2 13.6 7.3 3.9 24.6 54.7 12.4 1.5 42.5 7.1 3.1 6.0 3.0 8.8 0.2 36.2 117.4 7.7 45.7 85.3 7.2 78.6 82.7 47.8 39.7 33.4 16.7 0.0 25.4 112.4 26.6 0.6 33.2 11.4 87.4 0.9 8.8 0.1 12.1 2.4 77.2 5.9 1.1 43.6 4.6 31.7 30.3 42.5 40.8 1.5 0.0 30.2 104.2 0.2 7.8 0.0 33.0 11.0 12.9 0.0 58.2 0.2 26.9 19.2 2.9 20.8 1.6 0.0 15.7 38.9 1.3 0.5 170.4 58.8 24.9 11.1 47.2 17.2 0.0 0.2 37.9 0.1 56.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.9 6.0 6.2 7.5 6.6 5.0 10.8 5.6 6.7 7.3 12.4 8.8 8.3 25.6 11.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.6 3.0 0.0 0.0 3.1 12.9 0.0 3.9 4.5 0.0 0.0 6.5 0.0 9.0 11.4 4.4 0.0 0.0 0.0 18.9 9.4 9.5 0.0 13.7 1.3 6.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 2.8 0.0 0.0 7.1 0.7 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 117.3 5.3 31.5 0.0 0.0 CD96 TACTILE ENSG00000153283 "CD96 molecule" P40200 3 111292719-111665750 "CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 61.8" "Group enriched" "Detected in many" 4 "dendritic cells: 96.8;NK-cells: 58.7;T-cells: 199.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "gdT-cell: 74.0;MAIT T-cell: 117.2;memory CD4 T-cell: 67.0;memory CD8 T-cell: 85.3;naive CD4 T-cell: 68.7;naive CD8 T-cell: 81.8;NK-cell: 79.5;T-reg: 47.4" "Group enriched" "Detected in many" 5 "NK-cells: 79.5;T-cells: 117.2" "Cell line enhanced" "Detected in some" "HEL: 15.9;JURKAT: 18.2;MOLT-4: 68.7;RT4: 58.2;U-937: 59.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA066754 Enhanced NA NA 85000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA066754: AB_2685714" "unprognostic (1.06e-3)" "unprognostic (3.95e-3)" "unprognostic (4.16e-3)" "unprognostic (1.91e-5)" "unprognostic (4.72e-3)" "prognostic favorable (5.52e-4)" "unprognostic (2.12e-2)" "unprognostic (3.48e-2)" "unprognostic (6.06e-2)" "unprognostic (4.84e-3)" "unprognostic (2.44e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (2.02e-6)" "unprognostic (3.12e-1)" "unprognostic (4.42e-2)" "unprognostic (3.90e-2)" "prognostic favorable (5.23e-5)" 5.2 1.7 0.7 12.2 0.8 16.0 2.8 1.2 1.0 3.1 1.8 5.0 6.0 2.6 0.9 1.8 1.9 5.8 0.8 0.8 0.8 1.6 3.7 8.3 26.9 1.8 0.7 0.9 0.4 0.2 0.7 1.0 1.2 2.1 5.9 0.1 2.7 1.1 0.4 1.0 10.1 1.4 0.7 12.8 6.8 0.8 1.2 61.8 3.9 0.1 20.2 11.8 2.6 2.2 0.1 0.0 0.2 0.1 0.2 0.0 0.8 0.0 0.1 0.0 0.0 0.3 1.6 0.3 0.3 0.0 0.0 0.7 0.1 0.1 0.0 0.2 0.0 15.9 0.2 0.2 0.0 0.8 1.3 0.0 0.0 0.1 0.1 1.2 0.0 18.2 0.3 2.0 0.0 0.0 68.7 0.2 0.6 0.0 0.0 0.1 1.9 0.5 0.6 58.2 0.1 0.0 0.2 0.9 0.1 0.3 0.3 0.2 0.0 0.3 1.1 0.3 0.1 5.6 1.9 0.0 0.3 59.0 12.2 2.3 0.5 15.6 74.0 0.3 117.2 10.8 67.0 85.3 0.3 18.8 68.7 81.8 2.7 79.5 0.7 0.5 47.4 46.4 0.7 0.8 1.2 1.0 0.8 0.8 1.8 0.7 1.2 0.7 1.2 2.2 1.5 19.2 19.0 0.0 12.5 3.2 0.8 0.1 1.2 1.6 1.6 1.4 1.0 0.0 9.3 1.8 0.0 0.6 96.8 0.8 0.0 0.1 0.8 2.1 0.8 3.0 0.0 9.3 0.7 0.0 0.2 4.3 8.6 1.6 16.4 0.4 2.2 0.9 0.2 0.0 0.4 0.7 0.0 5.0 6.7 1.1 0.3 6.7 3.6 6.5 2.9 0.5 58.7 0.0 0.1 0.0 1.3 0.0 29.6 0.3 0.0 0.4 1.7 2.1 0.0 0.8 1.0 0.4 0.7 0.6 3.1 1.9 199.9 0.2 0.5 0.6 ZBED2 MGC10796 ENSG00000177494 "Zinc finger BED-type containing 2" Q9BTP6 3 111592900-111595346 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 47.6;thyroid gland: 71.0" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 44.8" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 64.0" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "naive B-cell: 2.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "CAPAN-2: 54.8;EFO-21: 37.4;HaCaT: 53.1;HBEC3-KT: 119.3;RPTEC TERT1: 77.6" "Not detected" "Not detected" HPA029786 Approved "Nuclear bodies,Mitochondria,Cytosol" No No "Cluster 24: B-cells - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 11: Alveolar cells - Smell perception" "Mitochondria, Cytosol" "Nuclear bodies" "HPA029786: AB_10601028" "unprognostic (7.31e-3)" "unprognostic (1.67e-1)" "unprognostic (1.98e-3)" "unprognostic (1.66e-1)" "unprognostic (2.39e-3)" "unprognostic (3.49e-1)" "unprognostic (7.61e-2)" "unprognostic (1.47e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (8.83e-4)" "unprognostic (2.59e-1)" "unprognostic (1.47e-6)" "unprognostic (3.81e-2)" "unprognostic (4.34e-1)" "unprognostic (4.69e-2)" "unprognostic (3.29e-2)" 0.2 0.0 0.0 1.7 0.4 0.3 0.2 0.0 0.1 5.4 0.0 0.1 0.1 0.1 0.2 12.8 20.0 0.3 0.1 0.0 0.0 0.2 0.0 10.4 6.9 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.1 0.0 2.8 0.4 0.0 2.2 0.5 0.0 0.0 0.3 0.5 0.0 0.0 47.6 71.0 0.0 12.9 0.4 9.9 0.0 15.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 54.8 0.5 37.4 0.0 0.0 53.1 0.0 119.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 10.8 0.0 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.3 1.2 0.2 0.1 0.0 2.1 0.6 0.8 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.8 1.1 0.0 0.6 4.5 0.3 3.1 4.6 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.6 3.8 0.0 4.5 0.0 0.1 0.2 PLCXD2 FLJ31579 ENSG00000240891 "Phosphatidylinositol specific phospholipase C X domain containing 2" Q0VAA5 3 111674676-111846447 "Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.3;retina: 14.8" "Cell type enhanced" "Detected in many" "Collecting duct cells: 60.7;Distal tubular cells: 160.4;Hepatocytes: 168.6;Proximal tubular cells: 196.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;NK-cells: 1.1;T-cells: 1.8" "Cell line enhanced" "Detected in many" "HBF TERT88: 7.1" "Low region specificity" "Detected in all" HPA055947 Uncertain Approved Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA055947: AB_2682981" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (7.26e-2)" "unprognostic (2.42e-1)" "unprognostic (3.09e-2)" "unprognostic (2.76e-2)" "unprognostic (1.36e-1)" "unprognostic (4.64e-1)" "unprognostic (3.47e-1)" "unprognostic (1.99e-2)" "unprognostic (3.38e-2)" "unprognostic (2.04e-1)" "prognostic favorable (1.23e-7)" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "prognostic favorable (2.99e-4)" 0.3 0.3 2.6 1.6 2.9 4.6 0.2 0.7 7.3 0.3 0.0 1.2 2.8 0.3 0.2 0.5 0.2 0.7 0.3 3.9 1.6 0.6 1.0 0.6 2.9 4.1 4.5 0.2 0.6 0.1 1.4 1.0 4.1 0.3 1.5 14.8 0.9 0.2 0.2 0.6 2.7 0.3 2.2 1.6 0.9 1.0 3.5 2.7 1.3 0.1 2.2 0.5 0.3 1.9 2.3 2.1 2.0 0.9 0.0 0.1 0.6 4.0 1.9 3.7 3.2 1.4 1.1 1.7 2.0 0.2 1.2 5.6 0.8 3.7 7.1 0.5 1.0 0.4 4.1 1.3 0.3 0.5 2.0 0.0 0.7 1.2 2.2 3.4 2.0 2.1 0.0 4.0 0.4 0.2 1.2 0.4 0.7 1.5 5.1 1.1 2.8 1.6 1.7 2.3 0.4 3.4 0.8 0.5 0.8 2.2 0.3 0.1 2.0 0.8 5.0 0.4 0.8 4.8 0.7 0.3 0.4 0.3 0.2 0.3 0.0 0.0 1.8 0.0 1.8 0.3 0.9 1.8 0.1 0.4 0.4 0.9 0.1 1.1 0.0 3.8 0.9 0.3 2.6 2.9 0.7 7.3 3.9 1.6 4.1 4.5 4.1 2.2 3.5 1.9 0.4 19.2 2.2 3.3 2.3 0.1 9.9 17.1 7.4 0.8 2.9 1.8 3.7 22.8 3.5 60.7 4.2 0.0 8.4 1.6 160.4 44.2 11.9 0.9 0.2 0.7 25.1 0.0 11.7 50.1 0.0 0.4 7.1 1.5 0.0 5.4 0.4 168.6 0.0 6.7 6.0 7.8 2.0 1.6 0.0 12.0 0.3 1.8 0.0 3.7 0.0 0.0 2.1 7.5 0.9 50.1 0.2 0.4 3.9 7.9 1.0 196.6 1.0 3.5 0.0 0.0 1.7 0.5 0.5 2.2 0.1 0.0 5.3 0.5 1.5 14.1 PHLDB2 "FLJ21791, LL5b, LL5beta" ENSG00000144824 "Pleckstrin homology like domain family B member 2" Q86SQ0 3 111732497-111976517 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 249.9;Basal prostatic cells: 189.9;Suprabasal keratinocytes: 114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 103.8;HaCaT: 105.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035146, HPA035147" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane, Cytosol" "HPA035146: AB_10600927, HPA035147: AB_2674492" "unprognostic (2.83e-2)" "unprognostic (4.93e-3)" "unprognostic (2.15e-2)" "unprognostic (8.01e-2)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (5.14e-2)" "unprognostic (2.20e-2)" "unprognostic (1.43e-1)" "unprognostic (9.03e-2)" "unprognostic (2.00e-2)" "unprognostic (3.53e-1)" "prognostic favorable (7.03e-8)" "unprognostic (3.24e-3)" "unprognostic (3.47e-2)" "unprognostic (1.53e-1)" "unprognostic (2.83e-1)" 25.6 7.2 2.2 15.7 2.3 1.5 11.3 0.9 4.0 10.6 10.3 29.0 6.0 20.4 7.4 11.1 13.3 15.3 42.7 0.9 0.5 31.5 35.6 17.6 5.1 1.2 1.8 8.9 10.0 1.8 5.7 40.8 1.6 16.4 8.6 0.5 10.6 25.7 4.8 7.0 7.7 24.3 1.6 16.5 11.7 2.8 3.9 5.0 6.2 8.7 3.2 26.5 10.5 2.0 103.8 11.2 62.2 0.1 19.8 32.3 25.5 58.3 28.5 37.8 44.5 32.1 7.5 0.0 59.6 22.6 38.2 105.2 0.9 37.5 68.6 1.6 1.5 0.0 26.1 10.6 21.3 0.2 0.3 38.1 21.9 26.1 48.1 42.5 61.8 1.0 0.1 0.4 11.5 0.2 4.2 0.1 25.3 1.0 19.3 9.0 80.1 0.0 22.2 24.5 1.6 4.7 57.6 1.1 5.9 34.1 2.1 0.3 54.4 10.2 85.2 27.4 14.3 5.4 0.2 0.2 10.4 0.1 19.9 0.1 0.0 0.0 2.6 0.0 1.8 0.2 1.8 2.9 0.0 0.4 0.0 1.1 0.2 1.0 0.0 0.5 0.4 0.8 2.2 2.3 0.9 4.0 0.9 0.5 1.2 1.8 1.6 1.6 3.9 2.0 30.9 80.1 7.5 2.6 1.6 249.9 189.9 33.3 33.0 0.2 11.6 9.8 95.8 25.8 16.8 33.1 2.1 27.0 13.0 0.6 23.5 62.6 12.9 3.7 15.3 44.8 10.8 2.7 51.7 20.5 51.5 40.3 14.3 26.2 7.0 1.2 35.3 35.2 3.5 0.0 9.5 3.4 8.2 2.5 20.6 5.3 14.3 2.9 23.2 39.4 1.0 0.1 23.7 4.5 1.8 45.4 0.5 22.6 2.8 60.1 0.0 30.9 6.8 0.3 13.1 21.0 95.9 0.5 3.3 17.7 114.7 66.8 6.7 2.7 1.9 84.0 ABHD10 FLJ11342 ENSG00000144827 "Abhydrolase domain containing 10, depalmitoylase" Q9NUJ1 3 111979010-111993368 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036991, HPA036992, HPA066081" Supported Approved Mitochondria "Intracellular and membrane" No No 71000 "Cluster 46: Basophils - DNA binding" "Cluster 7: Kidney - Transmembrane transport" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA036991: AB_2675420, HPA036992: AB_10672345, HPA066081: AB_2685610" "unprognostic (1.65e-1)" "prognostic favorable (7.57e-4)" "unprognostic (1.61e-1)" "unprognostic (1.63e-1)" "unprognostic (1.05e-1)" "unprognostic (1.30e-2)" "unprognostic (8.95e-2)" "unprognostic (1.14e-1)" "unprognostic (8.50e-2)" "unprognostic (1.69e-2)" "unprognostic (1.70e-1)" "unprognostic (3.91e-2)" "prognostic favorable (4.72e-9)" "unprognostic (1.59e-2)" "unprognostic (1.72e-1)" "unprognostic (4.18e-3)" "unprognostic (2.76e-2)" 11.0 21.9 23.0 10.6 25.3 10.9 15.0 24.5 29.3 11.3 22.9 14.1 11.7 11.1 50.8 8.2 14.9 10.1 25.0 23.9 24.6 49.4 34.4 10.1 17.9 23.5 23.2 19.8 13.7 16.7 27.9 10.8 23.7 20.4 14.7 27.0 25.5 13.7 14.1 10.0 10.3 10.0 24.4 14.6 14.9 16.4 26.3 21.8 31.1 19.6 16.2 9.5 8.3 25.3 40.2 34.1 36.4 12.0 20.5 27.5 19.8 41.4 21.5 33.0 31.7 35.3 22.4 36.0 22.6 17.2 22.7 21.6 16.3 23.0 44.9 12.1 20.6 29.7 15.4 30.7 16.3 60.3 30.4 16.9 16.7 17.0 42.4 22.7 35.9 42.1 13.9 14.9 36.7 13.7 56.9 27.9 23.7 43.8 53.2 50.9 23.4 16.7 34.6 17.1 24.6 17.9 33.2 23.7 39.8 14.3 26.8 21.8 20.6 19.7 25.3 14.4 21.7 23.6 9.0 61.4 20.1 32.4 21.5 29.4 16.5 25.2 9.8 21.6 16.8 26.2 12.2 11.3 28.1 21.6 15.4 13.9 2.5 11.4 17.3 17.8 13.2 16.1 23.0 25.3 24.5 29.3 23.9 24.6 23.5 23.2 23.7 24.4 26.3 25.3 9.1 0.0 7.2 11.1 19.7 7.0 10.2 12.1 14.2 21.8 12.7 10.9 26.1 7.2 12.4 11.0 8.4 19.2 16.1 7.0 35.2 5.2 1.0 11.1 10.3 8.8 12.1 24.2 16.0 7.8 14.9 12.3 12.8 6.8 9.5 9.5 10.0 26.2 14.1 42.1 16.2 13.4 6.1 19.5 7.0 3.0 10.5 11.0 10.6 15.0 10.7 20.4 12.3 14.6 15.6 5.4 4.0 7.5 25.0 5.1 7.0 42.5 19.5 16.2 0.0 7.9 8.9 29.7 37.0 13.6 8.2 5.5 14.6 19.2 12.1 4.5 TAGLN3 "NP22, NP25" ENSG00000144834 "Transgelin 3" Q9UI15 3 111998739-112013887 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 442.4;choroid plexus: 172.3;pituitary gland: 100.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 104.3;Excitatory neurons: 78.1;Horizontal cells: 297.8;Inhibitory neurons: 49.3;Rod photoreceptor cells: 50.7" "Cancer enriched" "Detected in many" 4 "glioma: 24.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 104.1;RPTEC TERT1: 41.6;SCLC-21H: 55.5;SH-SY5Y: 94.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062620 Enhanced NA NA 9000000 "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "HPA062620: AB_2684810" "unprognostic (1.55e-2)" "unprognostic (2.28e-1)" "unprognostic (1.81e-1)" "unprognostic (1.36e-3)" "unprognostic (4.28e-1)" "unprognostic (4.07e-1)" "unprognostic (1.48e-1)" "unprognostic (2.02e-1)" "unprognostic (8.92e-2)" "unprognostic (6.82e-3)" "unprognostic (2.51e-1)" "unprognostic (5.49e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (8.60e-2)" "unprognostic (7.67e-3)" 0.3 33.5 291.3 1.5 313.2 0.0 0.1 250.3 442.4 0.0 172.3 11.4 0.6 0.0 0.0 0.2 0.0 0.2 0.6 318.0 310.2 4.5 0.3 0.5 0.2 300.5 235.8 0.3 5.6 0.0 100.9 0.0 292.8 0.5 2.3 74.3 0.2 0.2 0.2 0.6 2.4 1.1 212.3 0.1 3.3 0.3 254.2 1.3 0.4 0.0 0.2 0.2 1.1 309.3 0.0 0.0 104.1 0.2 0.0 0.0 0.1 2.6 1.9 0.1 0.1 0.4 0.2 0.0 3.8 0.0 0.1 0.7 0.1 7.2 1.4 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.5 0.0 0.0 0.8 0.4 0.0 0.1 0.0 4.0 0.0 9.0 15.1 2.8 0.0 41.6 0.0 55.5 94.5 0.0 0.1 0.0 2.1 0.1 0.3 0.0 0.3 0.3 0.0 0.3 0.1 0.1 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 291.3 313.2 250.3 442.4 318.0 310.2 300.5 235.8 292.8 212.3 254.2 309.3 0.1 0.0 0.0 16.6 0.0 0.8 1.2 1.0 0.0 104.3 0.2 0.3 0.7 0.0 1.8 5.5 8.4 0.0 0.1 0.0 0.0 0.1 2.6 0.2 0.0 1.1 5.3 0.0 78.1 0.2 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 297.8 49.3 0.0 30.5 0.0 0.0 0.9 0.0 0.4 0.0 15.0 0.0 16.3 0.0 32.2 18.8 2.3 0.0 0.0 0.0 1.1 0.0 31.9 12.8 50.7 0.0 0.4 0.5 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.9 TMPRSS7 ENSG00000176040 "Transmembrane serine protease 7" Q7RTY8 3 112034843-112081269 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 4.3;Early spermatids: 6.0;Excitatory neurons: 4.0;Respiratory ciliated cells: 8.1;Urothelial cells: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA040630 Uncertain NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 49: Ciliated cells - Cilium organization" "HPA040630: AB_10796124" "unprognostic (4.02e-2)" "unprognostic (9.87e-2)" "unprognostic (9.05e-2)" "unprognostic (2.16e-2)" "unprognostic (2.24e-1)" "unprognostic (4.64e-3)" "unprognostic (6.63e-2)" "unprognostic (2.16e-1)" "unprognostic (2.29e-2)" "unprognostic (4.64e-1)" "unprognostic (1.68e-1)" "unprognostic (1.94e-1)" "unprognostic (7.23e-2)" "unprognostic (2.96e-1)" "unprognostic (2.06e-2)" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.3 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.2 1.4 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.3 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.5 4.3 0.6 0.0 0.0 0.5 0.0 0.3 0.0 1.9 0.0 0.0 0.6 0.0 1.6 0.0 0.2 6.0 1.3 0.1 0.4 0.0 0.0 4.0 0.2 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.5 0.0 0.0 0.7 2.2 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.4 2.2 0.0 0.0 1.6 2.6 0.0 8.1 0.0 0.0 0.3 0.5 0.7 0.2 0.0 0.9 0.8 0.4 0.1 0.2 3.0 C3orf52 "FLJ23186, TTMP" ENSG00000114529 "Chromosome 3 open reading frame 52" Q5BVD1 3 112086335-112131004 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 17.4;skin 1: 26.3" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 129.6;Pancreatic endocrine cells: 82.8;Prostatic glandular cells: 75.6;Syncytiotrophoblasts: 75.0;Urothelial cells: 132.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 26.4;U-698: 30.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA007678, HPA008119, HPA011968" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 31: Skin - Epidermis development" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Nuclear bodies, Cytosol" "HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826" "unprognostic (8.86e-2)" "unprognostic (1.71e-1)" "unprognostic (3.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.45e-2)" "unprognostic (3.87e-3)" "unprognostic (3.49e-4)" "unprognostic (2.54e-1)" "unprognostic (1.39e-2)" "unprognostic (2.30e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (2.71e-2)" "unprognostic (3.76e-6)" "unprognostic (3.14e-1)" "unprognostic (2.05e-1)" "unprognostic (1.75e-2)" "unprognostic (9.59e-2)" 1.2 1.0 0.1 1.2 0.2 0.6 2.7 0.2 0.3 0.7 0.2 7.5 3.3 0.9 0.0 2.6 0.7 5.0 4.0 0.2 0.1 4.8 0.3 3.8 1.2 0.0 0.1 0.2 17.4 0.0 2.0 3.3 0.1 1.7 13.7 0.1 3.8 3.4 0.5 26.3 5.2 0.9 0.1 0.7 13.7 0.9 0.3 6.6 7.6 0.1 2.0 5.8 1.6 0.1 11.0 2.0 4.2 0.0 0.6 0.0 1.8 15.5 6.7 10.1 11.3 26.4 10.1 0.4 1.9 3.1 4.4 8.7 6.1 0.3 19.4 0.0 2.8 7.9 1.8 1.9 4.6 0.0 0.1 0.6 8.7 5.2 15.0 5.4 2.2 0.0 2.8 2.8 7.5 1.7 0.3 0.0 12.3 7.9 0.6 0.3 13.2 0.0 18.1 16.5 0.5 0.9 2.4 5.2 6.3 6.8 9.5 0.0 5.8 3.6 5.5 0.0 0.0 3.9 0.0 30.1 2.7 0.1 3.6 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.4 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.2 0.2 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0.8 16.0 10.0 0.3 1.6 32.5 129.6 10.0 45.5 0.0 14.8 3.3 2.1 4.3 19.3 18.4 0.0 18.1 0.7 30.4 0.0 26.3 24.2 24.8 3.1 3.5 11.9 0.0 3.2 35.9 25.6 4.7 64.2 44.1 0.0 0.4 0.4 0.0 1.9 0.0 0.6 56.6 8.2 0.3 2.7 23.3 0.3 1.0 1.8 1.0 2.6 0.0 0.0 0.5 0.3 82.8 30.7 0.4 4.6 75.6 7.8 2.1 14.8 0.0 0.0 4.6 4.7 3.2 5.3 44.0 33.5 75.0 2.0 3.0 8.9 132.5 GCSAM "GCET2, HGAL, MGC40441" ENSG00000174500 "Germinal center associated signaling and motility" Q8N6F7 3 112120839-112133270 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 29.3;skin 1: 16.4" "Cell type enhanced" "Detected in some" "B-cells: 10.9;dendritic cells: 6.7;Langerhans cells: 5.3;monocytes: 23.3;T-cells: 9.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 7 "Daudi: 132.8;U-698: 76.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA002473 Approved NA NA "Cluster 30: Non-specific - Translation" "Cluster 3: T-cells - Adaptive immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 3: Monocytes - Immune response regulation" "HPA002473: AB_1078960" "unprognostic (8.23e-4)" "unprognostic (1.64e-2)" "unprognostic (4.00e-1)" "unprognostic (2.97e-1)" "unprognostic (2.33e-1)" "unprognostic (4.17e-3)" "unprognostic (9.20e-2)" "unprognostic (8.24e-3)" "unprognostic (3.11e-1)" "unprognostic (1.69e-3)" "unprognostic (1.97e-1)" "unprognostic (5.78e-2)" "unprognostic (3.32e-2)" "unprognostic (3.77e-1)" "unprognostic (3.43e-2)" "unprognostic (2.35e-2)" "unprognostic (2.38e-2)" 0.5 0.2 0.0 6.4 0.1 1.7 0.6 0.0 0.1 0.3 0.2 1.9 2.1 0.2 0.2 1.8 0.4 1.5 0.9 0.1 0.1 1.2 0.5 2.2 22.2 0.0 0.1 0.1 4.0 0.0 0.7 0.3 0.0 0.9 0.9 0.0 1.3 0.3 0.2 16.4 3.5 0.3 0.0 5.0 2.8 0.4 0.0 17.7 3.3 0.1 29.3 1.3 1.0 0.0 1.9 0.3 0.5 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 3.6 0.2 132.8 0.1 0.0 0.8 3.5 0.0 2.4 0.0 2.7 0.8 0.9 0.8 0.6 0.0 0.6 0.0 0.0 2.4 0.0 0.2 0.8 0.0 1.0 0.2 7.5 0.0 0.1 12.6 0.0 1.0 0.7 0.7 14.6 1.1 0.0 0.0 1.3 0.1 0.2 0.8 0.7 0.3 0.9 1.8 0.0 1.0 1.2 0.6 0.0 0.0 0.7 0.0 76.4 0.2 0.2 0.3 9.0 0.0 0.0 2.2 0.1 0.5 10.2 11.3 5.8 6.7 12.1 10.4 5.7 0.4 0.6 0.0 3.7 1.9 3.8 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 10.9 0.1 0.8 0.3 0.0 0.0 0.1 1.8 0.4 0.0 0.2 0.0 0.0 0.3 6.7 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.0 0.8 0.0 0.0 0.2 0.3 0.5 1.2 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 1.6 5.3 0.0 0.0 1.6 0.0 0.0 23.3 0.0 1.0 0.0 0.0 0.0 0.1 0.0 3.2 0.2 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.1 0.0 2.0 0.4 0.1 9.6 0.0 0.0 0.7 SLC9C1 "NHE, SLC9A10" ENSG00000172139 "Solute carrier family 9 member C1" Q4G0N8 3 112140898-112294227 "Predicted membrane proteins, Transporters" "Antiport, Differentiation, Ion transport, Sodium transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "skin 1: 2.1;testis: 8.1" "Cell type enhanced" "Detected in some" "Adipocytes: 4.1;Early spermatids: 3.3;Excitatory neurons: 4.3;Oligodendrocyte precursor cells: 5.0;Oligodendrocytes: 5.1;Spermatocytes: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (1.21e-2)" "unprognostic (3.63e-1)" "unprognostic (4.79e-2)" "unprognostic (2.92e-1)" "unprognostic (1.57e-3)" "unprognostic (9.56e-2)" "unprognostic (3.92e-2)" "unprognostic (1.24e-1)" "unprognostic (4.40e-2)" "unprognostic (2.41e-1)" "unprognostic (1.85e-1)" "unprognostic (1.98e-2)" "unprognostic (1.65e-2)" "unprognostic (8.32e-2)" "unprognostic (5.89e-2)" "unprognostic (9.62e-3)" "unprognostic (3.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 8.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 3.3 1.0 0.1 2.5 0.0 0.0 4.3 0.0 0.3 0.2 1.1 0.6 0.0 0.2 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 5.0 5.1 0.1 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.1 15.2 0.4 0.0 0.0 0.4 0.0 0.4 0.1 0.1 CD200 "MOX1, MOX2, MRC, OX-2" ENSG00000091972 "CD200 molecule" P41217 3 112332347-112362812 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endothelial cells: 97.4;Excitatory neurons: 54.5;Inhibitory neurons: 55.7;Syncytiotrophoblasts: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 16 "memory B-cell: 30.7;naive B-cell: 83.6" "Lineage enriched" "Detected in many" 23 "B-cells: 83.6" "Cell line enhanced" "Detected in some" "AF22: 75.9;HHSteC: 27.2;NTERA-2: 47.7;REH: 42.4;SK-MEL-30: 29.8;WM-115: 83.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031149 Approved NA NA 26000 "Cluster 37: B-cells - Transcription" "Cluster 10: Brain - Neuronal signaling" "Cluster 17: WM-115 - Nervous system development" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA031149: AB_10600694" "unprognostic (1.84e-1)" "unprognostic (5.08e-2)" "unprognostic (1.79e-1)" "unprognostic (2.03e-3)" "unprognostic (4.97e-1)" "unprognostic (1.21e-2)" "unprognostic (9.29e-2)" "unprognostic (2.25e-2)" "unprognostic (3.06e-1)" "unprognostic (3.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.27e-1)" "unprognostic (8.97e-2)" "unprognostic (1.06e-2)" "unprognostic (2.80e-1)" "unprognostic (4.49e-2)" "unprognostic (1.22e-2)" 25.3 12.1 27.7 15.6 27.3 2.4 11.6 13.2 34.0 20.1 2.9 6.7 3.3 28.4 7.1 8.9 26.7 13.1 9.3 27.9 41.3 8.5 1.0 9.6 26.1 11.9 16.3 11.6 4.9 10.5 26.8 28.2 18.8 12.1 8.2 15.1 9.0 16.5 1.8 4.4 6.9 18.3 15.1 6.2 5.2 2.9 30.4 23.6 18.9 3.6 24.9 27.5 5.9 18.3 0.0 0.0 75.9 0.1 0.0 0.0 0.2 0.1 0.3 0.0 0.1 0.0 0.1 0.2 4.1 0.0 0.9 0.1 8.2 0.4 0.2 0.2 0.5 0.0 0.3 0.4 27.2 0.0 0.1 0.5 0.2 1.6 0.2 0.2 10.8 0.0 0.1 0.7 0.2 0.0 1.2 0.0 47.7 0.0 0.0 42.4 0.1 0.5 0.6 0.1 19.9 23.0 0.0 0.4 29.8 14.0 0.0 0.3 0.1 0.3 2.6 0.0 0.2 0.1 0.1 0.0 0.6 0.2 83.7 3.6 0.4 0.3 0.3 0.1 3.5 30.7 2.0 0.6 1.3 83.6 2.1 1.3 1.7 1.6 0.3 2.8 1.0 3.4 27.7 27.3 13.2 34.0 27.9 41.3 11.9 16.3 18.8 15.1 30.4 18.3 15.2 3.2 9.1 10.7 27.8 4.2 12.6 0.3 0.0 26.8 0.7 13.0 0.8 1.5 1.3 1.8 0.0 3.0 1.6 0.8 0.0 0.3 25.1 20.6 4.2 97.4 38.4 0.8 54.5 0.0 12.1 13.0 3.1 41.0 2.5 0.7 1.4 0.0 1.0 3.3 55.7 8.1 0.0 0.3 6.1 30.3 0.3 1.1 8.8 6.5 14.0 7.1 0.0 29.7 38.5 0.2 10.7 0.0 1.9 15.4 0.9 0.3 2.7 2.5 0.0 13.1 2.6 0.6 0.4 0.7 3.3 75.9 2.9 9.3 7.1 21.6 BTLA "BTLA1, CD272" ENSG00000186265 "B and T lymphocyte associated" Q7Z6A9 3 112463966-112499472 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "lymphoid tissue: 28.6" "Cell type enriched" "Detected in some" 4 "B-cells: 66.2" "Cancer enhanced" "Detected in some" "testis cancer: 1.4" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "memory B-cell: 65.0;naive B-cell: 96.5;plasmacytoid DC: 24.9" "Group enriched" "Detected in many" 4 "B-cells: 96.5;dendritic cells: 24.9" "Cell line enhanced" "Detected in single" "U-698: 2.0" "Not detected" "Not detected" "HPA047211, HPA062029" Enhanced NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "HPA047211: AB_2679983, HPA062029: AB_2684665" "unprognostic (1.13e-3)" "unprognostic (2.13e-3)" "unprognostic (5.79e-4)" "unprognostic (1.01e-4)" "unprognostic (7.08e-2)" "unprognostic (7.74e-6)" "unprognostic (6.20e-3)" "unprognostic (7.59e-3)" "unprognostic (5.98e-2)" "unprognostic (1.53e-5)" "unprognostic (2.33e-2)" "unprognostic (1.23e-1)" "unprognostic (1.57e-5)" "unprognostic (2.57e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-1)" "unprognostic (1.42e-2)" 0.4 0.3 0.0 11.2 0.0 2.1 1.9 0.1 0.4 0.5 0.0 1.7 1.6 0.3 0.1 0.6 0.3 1.1 0.2 0.0 0.0 0.3 0.6 0.9 26.4 0.1 0.0 0.1 0.4 0.0 0.0 0.1 0.1 0.4 1.6 0.2 1.3 0.1 0.1 0.1 3.1 0.4 0.0 10.8 3.0 0.1 0.0 7.7 0.3 0.1 28.6 2.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.1 0.0 11.2 0.0 8.3 65.0 13.6 6.5 4.6 96.5 12.7 12.6 0.5 0.3 0.1 24.9 3.4 6.5 0.0 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 66.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 2.3 0.8 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.5 1.3 0.0 0.4 0.2 0.1 0.0 0.4 0.0 0.0 1.3 4.7 3.6 0.0 1.6 7.2 0.0 1.9 0.0 0.0 1.0 0.3 0.0 0.0 0.0 15.9 0.0 0.0 0.2 0.7 0.0 0.0 0.3 0.1 0.2 0.3 0.0 0.3 0.1 8.6 0.0 0.0 0.1 ATG3 "APG3L, DKFZp564M1178, FLJ22125, MGC15201, PC3-96" ENSG00000144848 "Autophagy related 3" Q9NT62 3 112532510-112562046 "Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 657.9;Spermatocytes: 341.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037260, HPA040471" Enhanced Supported "Plasma membrane,Cytosol" NA NA 140000 "Cluster 51: Monocytes - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" "Plasma membrane, Cytosol" "CAB037260: AB_1078236, HPA040471: AB_2677000" "unprognostic (2.77e-2)" "prognostic favorable (6.82e-4)" "unprognostic (4.90e-3)" "unprognostic (1.30e-1)" "unprognostic (2.63e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (9.35e-6)" "unprognostic (6.79e-2)" "unprognostic (6.67e-2)" "unprognostic (6.99e-2)" "unprognostic (2.56e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.52e-3)" "unprognostic (4.66e-2)" "unprognostic (6.02e-2)" "unprognostic (3.48e-2)" "unprognostic (5.25e-2)" 33.1 38.7 41.4 49.1 50.1 94.1 34.7 51.3 53.5 28.3 38.2 38.2 38.2 24.7 24.7 34.8 23.2 24.7 33.3 39.7 46.8 41.6 43.3 31.1 48.4 49.1 48.2 25.6 41.8 44.8 30.6 33.6 48.5 23.2 40.3 29.1 29.4 28.3 29.5 29.8 36.6 29.9 48.2 48.2 37.7 85.3 45.6 51.2 42.2 33.6 46.3 38.7 26.3 55.7 105.0 55.9 51.5 52.6 66.6 54.5 57.5 89.8 65.3 86.9 78.9 78.9 60.6 130.3 66.6 78.0 106.6 74.1 84.9 78.0 120.9 22.8 40.9 82.0 52.3 51.0 102.9 145.2 67.0 50.6 58.3 85.5 130.2 56.8 82.2 81.2 71.6 108.8 92.9 91.4 86.4 68.2 56.3 135.8 109.7 74.9 45.9 110.5 72.6 56.1 88.1 34.7 74.7 70.5 109.5 48.4 79.8 107.5 66.7 92.3 75.8 39.4 80.1 70.2 72.0 201.3 84.4 133.2 69.4 64.4 167.7 121.9 39.4 258.8 49.4 61.8 48.0 49.2 169.4 59.2 46.2 46.3 174.2 50.5 327.9 36.3 75.6 138.2 41.4 50.1 51.3 53.5 39.7 46.8 49.1 48.2 48.5 48.2 45.6 55.7 45.6 48.1 39.0 10.1 53.3 74.1 42.4 74.3 37.5 22.5 32.0 50.2 86.2 37.1 51.3 25.8 12.5 73.1 45.3 47.0 117.4 73.7 657.9 37.9 40.8 54.1 31.2 90.0 11.7 86.1 85.0 42.6 36.7 45.2 39.9 42.0 40.0 40.0 121.3 18.5 11.4 53.3 75.3 106.3 131.1 146.5 42.6 134.8 69.4 11.2 185.8 42.1 54.6 13.0 33.7 70.9 49.2 43.2 70.4 39.1 76.0 87.5 37.3 22.2 59.2 45.5 77.6 341.0 119.7 57.4 70.6 122.3 55.0 68.6 69.8 54.2 SLC35A5 FLJ20730 ENSG00000138459 "Solute carrier family 35 member A5" Q9BS91 3 112561709-112585579 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 156.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035519, HPA057964" Uncertain Approved "Golgi apparatus" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus" "HPA035519: AB_10601487, HPA057964: AB_2683566" "unprognostic (7.89e-2)" "unprognostic (2.33e-1)" "unprognostic (7.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-1)" "unprognostic (7.09e-2)" "unprognostic (1.45e-1)" "unprognostic (4.78e-2)" "unprognostic (8.60e-3)" "unprognostic (2.60e-1)" "unprognostic (8.21e-2)" "unprognostic (3.51e-1)" "prognostic favorable (4.10e-5)" "unprognostic (2.26e-1)" "unprognostic (1.97e-1)" "unprognostic (8.05e-2)" "unprognostic (3.42e-1)" 15.5 19.3 18.2 13.4 23.9 5.7 14.8 22.4 26.9 15.5 18.4 15.6 16.7 15.6 16.0 14.3 14.6 15.4 9.7 18.1 21.4 20.2 21.0 14.7 15.7 24.0 21.7 17.9 9.5 17.2 9.1 18.4 24.3 16.0 16.1 21.7 11.4 13.9 6.1 9.2 18.3 15.9 23.2 14.2 14.5 18.8 21.2 12.7 26.1 10.2 15.3 12.6 8.3 30.0 20.4 18.4 31.2 18.8 39.3 37.4 18.0 33.2 23.7 27.5 31.5 13.6 22.8 18.1 27.4 28.8 31.3 25.3 22.4 15.6 34.6 14.2 11.1 23.2 15.9 11.4 33.6 20.7 21.5 31.8 30.9 24.3 14.9 34.8 25.1 13.8 13.5 22.1 38.7 7.2 16.2 13.1 20.8 24.0 19.2 14.4 11.4 19.7 34.2 14.9 18.3 24.1 21.3 10.4 38.0 20.9 14.2 13.9 28.3 40.3 21.8 8.6 15.7 15.7 24.4 32.2 29.9 17.2 30.8 14.8 16.4 21.0 10.9 25.9 10.3 14.7 10.2 8.6 19.7 13.6 13.6 11.2 14.6 7.3 27.4 9.4 11.2 10.8 18.2 23.9 22.4 26.9 18.1 21.4 24.0 21.7 24.3 23.2 21.2 30.0 9.9 3.2 10.1 13.1 12.5 6.4 8.3 9.9 11.4 12.8 8.5 6.5 5.5 7.2 12.6 14.7 0.0 36.1 12.5 16.4 9.8 7.8 156.8 9.2 9.1 12.9 7.7 9.2 15.0 7.7 25.6 14.0 10.7 10.0 14.0 9.0 19.6 13.1 17.9 37.0 15.2 11.8 20.3 23.2 9.2 23.5 17.1 13.0 26.6 5.6 14.0 20.3 9.2 23.1 36.6 8.1 13.1 17.3 14.3 8.5 25.8 14.8 10.4 16.9 26.3 9.6 10.6 14.9 15.7 8.9 6.7 29.8 10.7 14.6 10.0 6.5 CCDC80 "CL2, DRO1, LINC01279, SSG1, TCONS_00006930, URB" ENSG00000091986 "Coiled-coil domain containing 80" Q76M96 3 112596797-112649530 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 450.8;Fibroblasts: 921.6;Late spermatids: 353.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 521.4;fHDF/TERT166: 1281.3;hTERT-RPE1: 2404.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002266 Approved "Secreted to extracellular matrix" NA NA 510000 "Cluster 41: Basophils - Cellular respiration" "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA002266: AB_1078423" "unprognostic (1.26e-1)" "unprognostic (1.89e-1)" "unprognostic (1.26e-2)" "unprognostic (3.19e-1)" "unprognostic (2.29e-1)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (2.53e-2)" "unprognostic (2.30e-3)" "unprognostic (1.99e-3)" "unprognostic (8.40e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (2.86e-5)" "unprognostic (5.97e-3)" "unprognostic (1.65e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.26e-4)" 244.9 15.0 6.4 83.5 6.9 1.1 218.3 9.6 8.6 305.3 24.4 74.5 8.7 276.5 76.8 92.4 82.2 234.0 218.8 6.8 10.2 17.7 6.6 74.0 18.5 12.2 11.4 62.2 28.7 12.4 10.8 26.0 9.3 67.8 73.4 9.4 34.7 78.7 13.4 79.1 25.1 360.3 11.1 34.8 47.5 42.7 9.2 17.1 87.5 34.9 30.8 194.4 131.8 13.5 26.1 11.0 127.6 5.8 521.4 411.2 6.9 359.0 108.5 118.6 171.8 2.9 2.1 1.2 13.5 1281.3 11.4 33.5 5.3 4.8 123.7 24.3 1.2 0.7 27.7 0.7 109.5 1.0 0.5 409.7 14.4 174.9 11.0 2404.9 27.8 0.6 0.4 1.0 352.7 0.5 0.3 0.7 31.6 0.7 4.2 0.3 14.0 0.6 3.3 0.5 0.4 2.5 53.5 2.3 1.8 23.0 2.1 1.0 141.7 345.6 56.6 66.6 160.1 1.6 0.8 1.2 102.4 0.7 56.8 0.9 0.3 0.2 0.3 0.1 0.3 0.4 0.3 0.3 0.1 0.6 0.4 0.4 0.3 0.3 0.2 0.7 0.2 0.0 6.4 6.9 9.6 8.6 6.8 10.2 12.2 11.4 9.3 11.1 9.2 13.5 104.5 6.4 15.9 13.1 1.5 60.9 4.2 44.7 26.7 1.1 5.9 59.7 22.5 10.0 62.7 5.5 0.0 57.9 1.0 0.3 1.9 23.7 450.8 95.4 93.2 43.9 0.0 0.0 1.0 1.2 101.5 921.6 16.8 18.4 1.3 44.3 53.6 0.9 9.4 0.0 0.3 0.8 30.5 2.2 121.5 353.6 77.0 9.7 144.1 3.7 2.0 101.4 0.0 0.0 0.0 13.5 0.0 34.6 5.8 3.6 0.0 0.1 112.4 2.5 19.7 177.7 198.4 6.9 4.9 11.9 51.7 27.9 9.0 23.0 0.1 1.9 CD200R1L "CD200R2, CD200RLa" ENSG00000206531 "CD200 receptor 1 like" Q6Q8B3 3 112815709-112846856 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "testis: 2.8" "Group enriched" "Detected in some" 34 "Early spermatids: 23.9;Late spermatids: 45.3" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 379 "basophil: 85.0" "Lineage enriched" "Detected in single" 455 "granulocytes: 85.0" "Cell line enhanced" "Detected in single" "A-431: 1.0" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 74: Testis - Spermatogenesis" "Cluster 39: CACO-2 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (3.80e-1)" "unprognostic (1.88e-1)" "unprognostic (2.37e-2)" "unprognostic (1.55e-1)" "unprognostic (1.16e-2)" "unprognostic (1.78e-1)" "unprognostic (1.40e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 85.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.9 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 45.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CD200R1 "CD200R, HCRTR2, MOX2R, OX2R" ENSG00000163606 "CD200 receptor 1" Q8TD46 3 112921205-112975103 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 7.9" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 14.8;granulocytes: 15.2;Hepatic stellate cells: 14.6;Hofbauer cells: 31.8;Langerhans cells: 19.9;T-cells: 12.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 4 "basophil: 234.9" "Lineage enriched" "Detected in all" 10 "granulocytes: 234.9" "Cell line enriched" "Detected in some" 8 "HEL: 25.5" HPA068512 Supported "Plasma membrane" "Intracellular and membrane" NA NA 2000000 "Cluster 46: Basophils - DNA binding" "Cluster 16: Immune cells - Immune response" "Cluster 36: HEL - Hemostasis" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane" "HPA068512: AB_2732784" "unprognostic (1.49e-2)" "unprognostic (1.06e-2)" "unprognostic (2.55e-1)" "unprognostic (1.97e-2)" "unprognostic (1.53e-1)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (2.06e-3)" "unprognostic (8.30e-2)" "unprognostic (1.85e-1)" "unprognostic (7.98e-2)" "unprognostic (2.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.77e-1)" "unprognostic (7.84e-3)" "unprognostic (1.25e-1)" "unprognostic (5.12e-3)" 1.7 1.2 0.3 3.0 0.4 1.7 1.4 0.2 0.6 0.7 0.7 1.5 1.6 0.7 0.3 3.8 0.5 1.9 0.6 0.4 0.3 0.5 2.4 1.9 4.4 0.3 0.2 0.3 0.5 0.5 0.2 5.3 0.3 0.6 2.3 0.1 0.6 0.7 0.1 2.6 2.0 1.1 0.2 7.9 1.5 0.7 0.2 3.4 0.5 0.9 4.6 1.9 0.5 0.2 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.3 25.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.8 0.0 0.0 1.2 0.0 234.9 2.9 53.6 4.0 1.3 7.0 9.9 13.8 7.9 22.9 5.6 13.4 6.1 0.8 2.5 0.4 0.5 4.3 5.2 0.3 0.4 0.2 0.6 0.4 0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.0 1.1 1.6 4.4 1.9 0.1 0.0 14.8 0.0 0.2 0.3 0.3 0.0 0.1 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.1 1.0 0.1 0.5 0.0 4.0 5.7 0.0 0.2 0.9 0.0 0.1 15.2 0.0 14.6 0.1 31.8 0.0 2.2 0.0 0.0 6.7 19.9 0.0 0.0 9.1 5.4 5.6 5.2 0.0 0.0 1.0 0.7 0.1 0.0 0.0 2.7 0.1 0.0 0.1 1.2 0.0 0.0 0.3 0.4 0.8 0.3 5.8 0.9 0.7 12.4 0.0 0.0 0.2 GTPBP8 HSPC135 ENSG00000163607 "GTP binding protein 8 (putative)" Q8N3Z3 3 112990984-113015060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 79.8;Spermatocytes: 79.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034831, HPA058631" Approved Enhanced Mitochondria No No "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 36: HEL - Hemostasis" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria "HPA034831: AB_10671506, HPA058631: AB_2683783" "unprognostic (1.98e-1)" "unprognostic (1.02e-2)" "unprognostic (4.36e-2)" "unprognostic (1.99e-3)" "unprognostic (4.39e-2)" "unprognostic (2.00e-2)" "unprognostic (7.18e-3)" "unprognostic (1.80e-2)" "unprognostic (1.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.35e-2)" "unprognostic (1.21e-2)" "prognostic favorable (3.07e-5)" "unprognostic (7.10e-2)" "unprognostic (7.21e-2)" "unprognostic (4.57e-1)" "unprognostic (2.69e-1)" 5.3 5.7 3.6 6.1 4.3 8.4 5.6 4.6 4.9 4.6 4.6 6.0 6.6 5.6 3.7 7.4 4.4 5.2 11.9 3.9 3.9 7.3 5.9 4.3 11.2 4.3 3.8 6.7 6.8 8.9 4.5 6.1 4.2 5.7 7.1 4.2 6.5 3.7 20.0 4.8 6.0 5.5 4.4 4.9 7.5 14.4 3.9 9.7 10.1 18.3 8.1 5.9 4.7 6.4 25.5 10.8 15.7 16.5 9.2 15.6 11.5 17.9 14.7 17.0 20.5 18.6 10.4 16.8 9.7 10.0 14.2 17.1 21.0 17.1 23.5 7.0 13.4 46.5 11.4 11.6 8.4 28.9 10.5 11.9 11.9 9.6 7.0 19.2 16.1 19.9 16.4 19.5 18.0 8.8 18.5 14.4 32.8 13.2 20.8 16.1 14.7 10.4 14.4 16.3 17.5 18.2 14.2 11.3 25.7 13.7 12.3 19.6 9.8 12.7 19.4 4.5 16.0 13.1 17.4 24.0 12.7 23.6 14.0 7.9 4.3 2.9 6.4 3.0 5.7 4.2 7.8 6.3 8.1 3.6 9.9 6.5 0.7 8.7 2.7 3.7 5.4 4.5 3.6 4.3 4.6 4.9 3.9 3.9 4.3 3.8 4.2 4.4 3.9 6.4 13.1 16.0 15.4 2.9 16.9 13.5 15.9 28.8 8.0 11.5 12.9 12.4 25.8 10.0 19.5 5.5 6.2 28.3 27.1 10.4 23.5 16.3 79.8 17.7 12.9 11.6 10.2 22.7 5.5 18.3 25.1 13.3 12.8 18.3 19.7 20.0 17.9 7.7 22.7 10.1 6.3 10.3 28.5 16.7 14.8 35.5 11.8 13.6 10.6 4.7 18.3 10.4 13.4 7.1 6.9 16.5 12.2 5.7 17.1 12.8 17.7 29.6 16.0 14.0 0.0 17.4 15.8 79.7 28.1 16.1 12.1 15.2 22.5 34.9 12.0 18.9 NEPRO "C3orf17, DKFZP434F2021, NET17" ENSG00000163608 "Nucleolus and neural progenitor protein" Q6NW34 3 113002444-113019861 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069654 Supported Nucleoplasm,Nucleoli Yes No "Cluster 15: NK-cells - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA069654: AB_2686164" "unprognostic (8.45e-3)" "unprognostic (3.84e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.29e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (4.98e-2)" "unprognostic (1.72e-2)" "unprognostic (9.29e-3)" "unprognostic (5.40e-2)" "unprognostic (1.69e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (3.28e-2)" 6.7 6.7 4.7 7.0 5.4 10.6 8.8 6.9 6.5 6.5 6.3 7.0 7.1 8.4 10.3 6.0 6.5 7.4 8.4 5.2 4.9 6.3 5.9 6.4 12.3 5.8 5.3 8.1 8.2 6.9 6.6 6.7 5.6 6.6 5.4 11.7 6.9 6.1 18.7 10.8 7.0 5.8 5.1 8.8 8.3 11.3 5.3 9.4 11.5 7.7 7.8 6.7 5.3 7.9 13.6 10.9 17.3 13.0 5.5 10.1 9.2 12.6 8.1 6.9 4.7 10.1 8.5 17.6 6.6 4.3 9.6 13.7 12.7 5.8 9.4 3.5 8.0 27.3 10.0 7.5 10.0 17.4 9.4 15.7 10.0 5.5 14.2 18.8 6.1 17.2 9.5 13.5 5.2 8.6 15.1 10.3 18.1 12.0 14.0 12.1 13.7 9.3 7.8 11.2 11.9 17.3 7.3 9.1 21.4 12.7 10.4 14.7 12.4 9.4 9.3 3.6 9.1 13.3 11.2 20.6 15.2 13.6 7.0 1.9 1.3 1.6 2.2 1.6 2.3 1.8 2.6 1.9 1.8 1.4 3.2 3.2 0.8 4.3 0.7 1.3 1.2 1.4 4.7 5.4 6.9 6.5 5.2 4.9 5.8 5.3 5.6 5.1 5.3 7.9 16.3 9.6 12.8 0.0 7.6 0.0 0.0 0.0 0.0 0.0 17.4 16.9 0.0 0.0 10.5 18.4 0.0 18.4 23.4 0.0 17.6 14.1 0.0 11.9 20.7 6.3 0.0 0.0 0.0 12.6 15.5 9.3 0.0 16.1 17.7 24.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 9.3 0.0 0.0 0.0 0.0 14.4 0.0 0.0 4.5 0.0 0.0 14.8 8.7 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 20.4 9.1 33.9 0.0 0.0 BOC CDON2 ENSG00000144857 "BOC cell adhesion associated, oncogene regulated" Q9BWV1 3 113211003-113287459 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 71.8;Basal squamous epithelial cells: 112.1;Fibroblasts: 55.4;Leydig cells: 84.8;Peritubular cells: 47.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 79.2;ASC diff: 113.6;BJ hTERT+: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025806 Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane" "Intracellular and membrane" NA No 7900000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 50: Fibroblasts - ECM organization" "Nuclear bodies, Plasma membrane" Nucleoplasm "CAB025806: " "unprognostic (6.89e-3)" "unprognostic (1.34e-2)" "unprognostic (2.62e-3)" "unprognostic (1.03e-2)" "unprognostic (5.03e-3)" "prognostic favorable (4.89e-4)" "unprognostic (8.66e-5)" "unprognostic (1.10e-1)" "unprognostic (1.19e-2)" "unprognostic (4.78e-3)" "unprognostic (3.42e-2)" "unprognostic (1.10e-1)" "unprognostic (3.65e-3)" "unprognostic (4.94e-3)" "unprognostic (1.11e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.18e-5)" 41.6 5.8 15.8 10.4 15.5 0.2 29.8 13.1 12.1 26.0 33.2 49.1 4.9 46.6 10.1 24.9 63.2 19.3 14.3 17.1 15.2 9.7 1.0 6.6 3.6 53.2 30.1 35.2 16.1 2.7 20.8 2.2 23.2 33.8 4.6 3.2 23.8 21.3 6.3 34.9 18.3 32.6 32.3 4.6 19.0 5.0 26.3 5.7 24.6 9.0 3.1 32.5 25.8 23.4 0.0 7.6 27.6 79.2 113.6 6.0 0.9 12.8 41.9 3.2 2.7 0.0 0.0 0.1 7.8 21.8 1.7 0.0 5.6 2.7 1.1 0.0 3.4 0.0 2.3 0.0 0.6 0.3 0.2 19.7 1.8 1.7 0.2 25.7 0.0 0.0 0.1 0.0 0.6 2.1 0.2 1.4 7.0 0.0 6.9 0.2 12.3 0.0 0.7 0.1 8.2 11.7 0.1 0.5 0.3 8.1 3.4 0.4 0.0 4.5 7.3 0.1 4.2 0.0 0.0 0.0 9.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 15.5 13.1 12.1 17.1 15.2 53.2 30.1 23.2 32.3 26.3 23.4 9.6 0.0 0.5 71.8 0.0 21.2 3.1 3.6 112.1 0.6 3.7 17.3 1.1 1.5 0.7 5.5 0.0 4.8 0.2 0.0 0.0 0.1 1.4 12.6 10.5 5.6 1.8 0.0 8.8 0.0 4.3 55.4 0.5 11.7 0.0 5.7 3.3 0.1 0.8 0.0 2.5 0.0 0.0 0.3 5.5 3.3 84.8 1.0 10.6 6.5 0.0 12.2 0.0 24.1 0.7 0.3 0.0 47.8 0.6 3.3 0.0 0.0 0.3 0.5 0.0 18.0 13.5 1.5 3.2 11.5 11.1 1.9 0.8 1.1 0.0 0.9 CFAP44 "FLJ11142, WDR52" ENSG00000206530 "Cilia and flagella associated protein 44" Q96MT7 3 113286930-113441610 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 57.4;Endometrial ciliated cells: 40.0;Late spermatids: 61.2;Respiratory ciliated cells: 104.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 13.7" HPA067258 Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "HPA067258: AB_2685814" "unprognostic (2.83e-1)" "unprognostic (7.07e-2)" "unprognostic (1.65e-1)" "unprognostic (1.06e-1)" "unprognostic (2.35e-1)" "unprognostic (3.39e-3)" "unprognostic (7.51e-4)" "unprognostic (6.73e-2)" "unprognostic (1.10e-1)" "unprognostic (2.89e-1)" "unprognostic (1.62e-2)" "unprognostic (2.18e-3)" "unprognostic (2.13e-6)" "unprognostic (8.77e-2)" "unprognostic (1.04e-1)" "unprognostic (1.77e-2)" "prognostic favorable (7.09e-6)" 1.6 1.2 1.1 0.9 1.2 0.8 2.5 1.2 1.0 3.7 11.9 2.7 0.7 2.7 2.6 1.6 6.8 1.0 1.7 1.3 1.4 1.9 2.1 2.5 1.3 5.5 4.8 3.3 3.7 1.9 6.3 0.7 2.6 4.2 2.3 8.7 4.9 1.1 1.3 2.3 2.9 0.7 4.4 2.0 3.0 6.1 1.4 1.4 3.2 0.4 1.0 2.4 2.6 2.0 1.1 0.7 1.6 1.4 0.9 1.5 1.5 0.5 0.3 0.3 0.7 0.1 0.6 1.4 0.1 0.2 0.3 1.5 0.9 0.5 0.6 0.3 1.0 0.8 3.4 0.3 0.0 1.5 0.9 0.4 1.4 0.3 0.3 2.0 0.2 1.3 0.2 0.7 0.3 0.7 0.8 1.3 0.5 1.9 1.8 0.8 0.2 0.0 0.8 1.8 1.5 1.4 0.7 0.1 0.8 0.8 1.0 1.1 1.1 0.5 0.8 0.4 0.5 0.9 0.6 0.1 0.7 0.9 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.2 1.2 1.0 1.3 1.4 5.5 4.8 2.6 4.4 1.4 2.0 3.8 9.6 13.7 27.4 2.9 0.0 2.1 0.0 5.7 7.5 6.7 5.2 5.1 2.8 18.6 3.7 20.9 0.9 1.1 3.2 0.0 2.6 57.4 40.0 6.3 4.2 0.0 1.3 34.8 3.0 1.0 5.2 12.2 9.5 11.4 4.3 1.8 3.7 0.5 8.4 14.0 4.7 0.0 0.6 0.0 61.2 6.2 1.8 0.0 20.6 0.9 4.0 3.1 21.1 21.9 2.1 1.9 6.8 2.5 2.2 2.2 1.1 104.9 19.0 0.0 9.7 2.5 23.6 4.9 1.8 0.0 0.8 2.9 6.2 2.7 2.2 SPICE1 "CCDC52, SPICE" ENSG00000163611 "Spindle and centriole associated protein 1" Q8N0Z3 3 113442718-113515187 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA064843 Approved Supported Centrosome NA NA "Cluster 46: Basophils - DNA binding" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Centrosome "HPA064843: AB_2685367" "unprognostic (2.66e-1)" "unprognostic (1.27e-2)" "unprognostic (1.12e-1)" "unprognostic (4.95e-3)" "unprognostic (2.69e-1)" "unprognostic (1.01e-1)" "unprognostic (4.99e-3)" "unprognostic (1.17e-1)" "unprognostic (6.30e-2)" "unprognostic (2.24e-1)" "unprognostic (1.17e-3)" "unprognostic (1.89e-2)" "unprognostic (4.75e-3)" "unprognostic (6.53e-2)" "unprognostic (4.47e-1)" "unprognostic (3.64e-3)" "unprognostic (2.95e-2)" 4.4 3.8 2.1 4.6 2.3 4.1 7.4 3.2 2.9 8.5 3.4 6.7 4.1 8.6 4.9 6.9 8.0 7.7 4.3 2.4 2.4 4.6 4.1 4.7 4.1 2.2 2.1 7.8 6.3 6.4 8.9 5.5 2.1 6.4 6.6 7.7 8.6 4.9 2.6 6.0 5.3 6.7 1.4 4.2 6.8 7.1 1.9 8.3 6.8 2.3 5.5 6.1 7.2 3.1 17.0 10.4 12.1 10.6 7.5 9.2 7.6 8.2 6.3 10.9 13.6 9.2 9.4 9.9 11.6 7.2 10.7 16.0 6.3 8.0 14.7 5.9 2.8 9.0 9.3 6.1 4.5 18.0 6.8 7.5 7.9 11.3 4.6 9.6 8.0 18.0 5.8 8.2 3.8 17.7 15.6 7.0 13.0 13.4 11.5 10.8 10.3 8.8 4.0 10.7 6.2 10.8 8.7 10.3 4.8 13.4 10.2 7.2 8.0 5.5 8.8 5.1 7.5 7.9 5.8 16.7 11.0 10.5 8.2 3.6 4.1 1.5 3.2 3.0 5.2 5.6 5.0 4.0 3.1 6.1 7.0 5.2 2.1 2.7 2.9 9.7 2.6 2.0 2.1 2.3 3.2 2.9 2.4 2.4 2.2 2.1 2.1 1.4 1.9 3.1 6.7 0.0 4.2 14.4 12.0 6.8 7.9 5.4 9.1 6.4 9.4 5.8 2.5 5.7 5.6 5.5 8.4 4.7 3.5 8.0 0.0 5.4 6.5 22.8 11.9 4.7 3.6 9.9 20.2 4.5 5.9 7.4 16.3 12.7 1.3 10.1 3.3 5.2 4.4 3.3 6.8 10.6 6.1 2.5 3.9 3.5 9.9 4.1 0.0 15.9 2.3 7.9 1.0 16.1 14.4 5.6 3.6 3.4 13.9 4.1 3.9 4.2 15.3 25.0 6.6 6.2 5.4 20.9 16.9 7.7 7.7 3.4 7.5 6.2 7.4 8.5 SIDT1 "FLJ20174, SID-1" ENSG00000072858 "SID1 transmembrane family member 1" Q9NXL6 3 113532555-113629575 "Predicted membrane proteins, Transporters" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 10.8" "Cell type enhanced" "Detected in many" "B-cells: 47.4;dendritic cells: 34.5;Excitatory neurons: 117.8;Inhibitory neurons: 86.8" "Cancer enhanced" "Detected in many" "breast cancer: 5.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 33.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 15.4;OE19: 16.2;PC-3: 21.0;RT4: 14.9;T-47d: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA035862 Approved NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 6: T47d - Mammary gland" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA035862: AB_10671110" "unprognostic (4.23e-1)" "prognostic favorable (3.78e-4)" "unprognostic (3.43e-3)" "unprognostic (1.33e-3)" "unprognostic (2.28e-1)" "unprognostic (6.64e-4)" "unprognostic (2.93e-4)" "unprognostic (1.50e-1)" "unprognostic (4.02e-1)" "unprognostic (3.29e-3)" "unprognostic (2.21e-1)" "unprognostic (1.42e-1)" "unprognostic (2.50e-1)" "unprognostic (3.02e-1)" "unprognostic (5.86e-2)" "unprognostic (1.32e-2)" "prognostic favorable (4.09e-5)" 1.2 2.8 5.2 5.2 5.6 3.4 5.4 4.7 6.4 3.1 0.0 6.2 2.0 0.7 0.2 1.4 1.9 3.7 0.4 6.4 3.6 0.8 0.6 1.8 8.8 2.8 3.5 0.2 0.7 0.5 5.4 1.0 2.1 5.1 10.2 0.4 10.8 1.5 0.3 0.5 5.4 0.7 5.7 7.1 3.5 0.9 4.9 5.2 0.4 0.4 8.8 4.5 0.9 3.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.0 1.5 0.0 0.5 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.8 0.0 4.2 0.0 15.4 4.2 0.2 0.0 16.2 21.0 6.2 0.0 0.5 0.0 14.9 0.2 0.1 0.0 4.2 0.2 0.0 13.8 1.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 7.0 0.1 7.1 7.5 4.7 5.8 1.5 6.6 5.9 5.1 0.3 9.1 0.0 33.7 3.9 3.4 5.2 5.6 4.7 6.4 6.4 3.6 2.8 3.5 2.1 5.7 4.9 3.3 1.6 6.4 3.3 7.2 47.4 0.4 1.4 1.9 0.0 1.4 9.7 4.7 1.1 4.3 4.2 1.8 0.0 0.0 34.5 17.2 0.0 0.4 5.0 3.1 0.7 1.0 10.2 0.8 117.8 1.1 0.2 0.4 8.2 6.3 3.8 0.0 0.4 0.5 11.2 0.0 86.8 23.3 2.0 3.5 1.8 1.5 0.0 10.1 5.4 23.4 2.6 0.1 21.6 4.5 4.0 0.8 3.9 0.0 14.5 3.9 2.2 0.1 9.3 0.2 0.0 0.7 0.7 0.2 0.1 0.9 0.3 0.1 16.4 0.3 7.0 1.9 USF3 KIAA2018 ENSG00000176542 "Upstream transcription factor family member 3" Q68DE3 3 113648385-113696646 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029243, HPA029245" Uncertain Uncertain Nucleoplasm,Nucleoli,Centrosome NA NA "Cluster 46: Basophils - DNA binding" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nucleoli" Centrosome "HPA029243: AB_10611114, HPA029245: AB_10600443" "unprognostic (2.80e-2)" "unprognostic (2.80e-1)" "unprognostic (4.21e-2)" "unprognostic (7.80e-2)" "unprognostic (2.25e-2)" "unprognostic (1.96e-2)" "unprognostic (3.53e-1)" "unprognostic (2.62e-2)" "unprognostic (2.93e-1)" "unprognostic (1.53e-2)" "unprognostic (8.74e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.74e-6)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (3.28e-1)" "unprognostic (5.55e-2)" 7.1 4.9 5.6 3.0 5.9 10.2 6.7 8.8 8.0 5.5 7.5 7.5 2.8 5.3 7.8 6.8 6.2 2.4 7.0 6.2 5.3 8.2 16.4 5.9 5.3 5.4 5.4 5.8 8.5 6.0 6.7 2.8 5.6 5.9 3.9 5.6 6.4 2.7 18.7 7.4 8.3 2.4 5.2 8.7 7.5 4.8 5.3 6.7 6.2 8.5 4.6 6.0 6.1 6.8 4.6 3.4 4.1 3.9 9.8 3.7 2.8 1.8 2.9 1.7 1.6 3.2 1.9 8.0 3.2 4.6 2.8 2.8 4.5 3.6 3.3 2.7 1.9 5.7 2.2 5.3 2.9 10.5 6.2 5.5 6.4 3.2 3.6 2.6 4.2 5.9 2.7 4.1 3.7 6.4 5.9 5.8 3.0 6.1 3.4 2.5 3.2 3.2 6.3 6.3 1.9 3.0 4.3 2.4 5.5 2.8 3.3 7.7 5.7 2.7 6.0 1.5 2.6 4.8 2.9 9.2 3.1 4.3 2.0 2.2 1.0 1.7 1.3 1.3 1.0 1.0 0.9 1.0 0.8 2.3 1.1 1.2 3.2 1.2 1.8 2.3 0.5 0.7 5.6 5.9 8.8 8.0 6.2 5.3 5.4 5.4 5.6 5.2 5.3 6.8 27.1 22.4 15.1 0.0 30.1 0.0 11.2 0.0 15.9 19.5 19.7 12.6 0.0 14.3 6.2 25.8 14.6 8.1 42.7 13.1 25.4 8.4 6.7 28.3 18.6 15.6 6.1 17.0 0.0 11.8 4.2 13.3 18.3 22.8 5.1 6.7 20.3 46.3 7.8 13.5 0.0 10.2 0.0 22.6 0.0 10.9 13.1 17.0 0.0 0.0 16.4 12.4 29.9 0.0 0.0 12.5 12.4 13.9 17.5 18.4 23.6 29.2 12.4 18.8 6.6 27.6 13.8 13.1 6.0 15.8 0.0 14.5 20.0 12.2 10.9 19.5 NAA50 "FLJ13194, MAK3, NAT13, NAT5, San" ENSG00000121579 "N-alpha-acetyltransferase 50, NatE catalytic subunit" Q9GZZ1 3 113716458-113746300 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 320.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074489 Approved Supported Nucleoli NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 59: Non-specific - Translation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" Nucleoli "HPA074489: " "unprognostic (9.74e-2)" "unprognostic (1.49e-1)" "unprognostic (3.19e-2)" "prognostic unfavorable (2.32e-4)" "unprognostic (4.75e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.51e-5)" "unprognostic (1.62e-3)" "unprognostic (6.82e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (7.92e-5)" "unprognostic (2.97e-3)" "unprognostic (1.09e-1)" "unprognostic (2.25e-2)" "unprognostic (9.59e-2)" "unprognostic (7.13e-3)" "unprognostic (2.43e-1)" 88.2 64.2 21.8 72.0 24.7 87.3 58.4 25.2 29.4 49.2 27.2 62.5 48.9 50.1 31.4 93.4 38.5 50.6 50.9 23.7 24.4 64.4 90.3 43.5 84.9 23.6 25.0 51.7 58.7 59.8 23.1 45.0 25.3 52.8 54.1 31.5 69.7 42.1 320.7 53.4 47.5 51.2 25.2 52.6 65.6 53.2 26.6 56.8 58.5 154.4 90.7 87.6 46.3 28.2 589.6 250.7 135.2 158.5 179.4 144.6 281.4 308.5 172.4 186.0 212.4 362.3 205.7 403.4 185.8 164.6 146.9 236.5 238.0 211.1 338.6 85.2 121.5 435.7 182.7 220.3 164.4 459.1 135.7 124.0 163.0 208.8 298.3 122.1 168.7 167.3 279.3 157.8 194.3 277.0 306.2 99.3 303.4 228.3 365.3 309.5 207.2 318.9 141.7 439.9 207.4 119.6 223.6 164.1 229.0 116.5 228.1 150.4 156.9 255.1 253.9 109.1 235.7 174.1 314.2 736.0 200.2 253.2 160.6 17.7 40.8 22.5 45.5 40.5 40.6 55.2 33.7 43.1 44.4 37.1 29.4 39.1 51.8 31.8 38.1 25.6 39.9 52.5 21.8 24.7 25.2 29.4 23.7 24.4 23.6 25.0 25.3 25.2 26.6 28.2 33.9 48.1 39.9 24.8 75.7 168.4 86.6 42.6 76.2 24.8 52.3 31.6 47.5 25.8 45.8 36.8 8.4 46.0 78.2 51.3 78.2 52.9 68.0 44.4 53.1 45.7 19.9 79.5 41.5 55.1 94.6 55.2 35.7 94.3 47.5 45.5 29.3 66.1 61.9 40.4 39.0 31.5 42.7 55.3 148.8 50.7 30.7 60.1 62.2 20.6 49.9 29.7 29.9 33.2 28.4 65.2 36.8 31.2 74.9 142.0 31.4 71.0 30.0 18.4 19.7 53.1 64.1 53.5 60.8 99.8 177.9 62.5 74.7 37.7 49.3 193.3 ATP6V1A "ATP6A1, ATP6V1A1, VA68, Vma1, VPP2" ENSG00000114573 "ATPase H+ transporting V1 subunit A" P38606 3 113747033-113812056 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Translocase "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 463.7;Late spermatids: 870.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 79.2" "Group enriched" "Detected in all" 6 "dendritic cells: 38.8;granulocytes: 79.2;monocytes: 37.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006910, HPA035084" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA 700000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 31: Spermatids - Spermatogenesis" "Vesicles, Cytosol" Nucleoplasm "CAB006910: , HPA035084: AB_2674454" "unprognostic (1.32e-1)" "unprognostic (8.68e-2)" "unprognostic (5.87e-2)" "unprognostic (4.70e-2)" "unprognostic (1.36e-1)" "unprognostic (2.00e-1)" "unprognostic (3.43e-2)" "unprognostic (2.90e-2)" "unprognostic (1.42e-1)" "unprognostic (2.25e-1)" "unprognostic (1.36e-2)" "unprognostic (5.19e-3)" "prognostic favorable (3.82e-12)" "unprognostic (8.82e-2)" "unprognostic (2.46e-3)" "unprognostic (2.43e-1)" "unprognostic (1.52e-2)" 18.1 32.2 40.1 21.6 46.4 16.6 24.5 14.7 53.0 25.3 62.4 22.1 18.5 14.2 15.1 22.7 19.0 20.9 9.0 47.5 58.5 92.7 36.4 24.5 25.1 39.6 23.0 11.3 20.9 60.1 17.1 24.5 39.0 20.9 22.5 58.7 37.5 14.9 7.9 25.0 15.9 15.8 16.9 26.5 22.1 18.1 28.4 22.9 40.8 11.0 28.0 19.6 14.2 21.9 61.7 27.4 33.9 29.7 70.0 30.9 36.0 32.7 49.4 33.7 46.1 52.4 48.3 50.4 75.5 48.0 37.3 39.1 77.5 43.2 43.8 23.1 21.4 44.8 39.3 40.6 57.6 33.2 50.0 42.0 29.1 43.7 30.2 52.0 55.7 25.1 52.0 37.0 50.5 40.5 24.4 14.9 42.8 42.9 34.3 20.8 24.6 57.4 92.5 58.0 65.4 24.1 57.3 38.6 44.9 46.4 58.5 26.6 51.4 31.1 23.1 21.7 19.8 38.4 44.5 46.2 61.1 41.2 35.3 26.8 37.0 12.8 6.3 27.7 5.9 8.2 5.6 6.0 38.8 6.8 5.4 6.2 79.2 9.2 23.9 10.8 8.1 16.7 40.1 46.4 14.7 53.0 47.5 58.5 39.6 23.0 39.0 16.9 28.4 21.9 18.8 28.9 35.0 43.4 24.2 30.3 15.9 30.3 23.9 94.1 27.9 17.1 10.4 31.5 32.9 99.3 41.7 22.0 20.8 38.3 82.2 29.5 463.7 41.7 24.5 26.8 55.8 49.6 119.4 27.5 22.6 17.9 20.9 100.6 10.8 19.4 36.0 74.3 74.3 101.0 107.7 25.4 197.4 104.7 73.3 870.3 18.0 70.9 46.2 34.7 82.8 45.6 11.3 54.3 53.2 27.1 30.5 23.0 23.6 25.6 24.1 80.8 38.3 44.4 6.6 15.3 21.6 28.7 15.7 40.8 47.9 43.9 19.0 25.8 27.2 26.8 GRAMD1C DKFZp434C0328 ENSG00000178075 "GRAM domain containing 1C" Q8IYS0 3 113828182-113947174 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 181.8;Early spermatids: 97.1;Late spermatids: 80.5;Oligodendrocyte precursor cells: 82.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 2.7;naive B-cell: 2.9;neutrophil: 2.1" "Group enriched" "Detected in many" 13 "B-cells: 2.9;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.5;HUVEC TERT2: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012316 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 64: Astrocytes - Nervous system maintenance" "Plasma membrane, Cytosol" "HPA012316: AB_1849949" "unprognostic (2.73e-3)" "unprognostic (6.16e-3)" "unprognostic (3.27e-1)" "unprognostic (1.93e-1)" "unprognostic (5.50e-2)" "unprognostic (9.81e-3)" "unprognostic (1.43e-3)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (5.49e-2)" "prognostic favorable (4.22e-15)" "unprognostic (8.48e-2)" "unprognostic (9.96e-2)" "unprognostic (3.61e-2)" "unprognostic (2.09e-2)" 1.4 1.9 13.0 1.7 12.0 0.1 8.8 11.9 15.3 3.1 9.0 5.0 7.6 2.2 2.0 5.5 10.7 2.6 0.7 11.6 12.1 24.0 27.7 4.9 2.0 13.9 15.4 0.8 12.7 10.6 8.1 6.1 11.8 2.6 3.9 14.3 12.0 2.1 0.8 12.1 16.7 0.7 12.3 1.3 9.0 16.8 14.5 1.1 3.9 3.2 3.9 2.0 3.7 10.0 1.6 0.0 4.0 3.0 0.7 1.8 5.2 3.5 3.1 0.7 2.1 0.0 13.5 0.4 1.0 2.0 1.4 1.3 0.7 1.5 1.8 1.9 0.6 0.3 0.1 0.0 1.4 0.2 0.0 3.0 1.0 0.6 0.1 7.1 10.2 4.5 0.0 0.1 1.1 0.4 1.6 0.2 0.3 1.4 0.5 0.0 0.8 2.4 4.2 1.9 0.8 1.1 1.0 5.2 3.4 1.6 3.6 0.0 2.2 1.5 2.8 0.0 0.3 2.2 1.3 1.9 2.2 0.1 1.8 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.1 0.2 0.0 2.9 0.1 0.1 2.1 0.1 0.0 0.0 0.0 0.0 13.0 12.0 11.9 15.3 11.6 12.1 13.9 15.4 11.8 12.3 14.5 10.0 4.5 12.8 10.5 181.8 15.6 1.0 6.9 3.0 5.2 0.2 9.9 7.0 0.9 15.7 7.1 14.7 37.5 17.5 0.3 10.1 31.3 4.4 97.1 33.3 8.5 4.7 4.9 2.7 29.7 2.7 3.7 1.5 6.6 51.9 0.0 1.4 5.7 17.0 1.5 11.8 4.3 5.5 4.1 0.3 0.8 80.5 2.8 0.9 1.8 9.4 0.1 13.4 0.0 82.4 1.7 2.3 9.3 1.5 6.3 2.8 34.3 14.0 27.9 19.7 0.0 1.2 1.7 28.2 6.7 6.8 4.7 42.4 1.9 5.0 5.3 7.0 ZDHHC23 MGC42530 ENSG00000184307 "Zinc finger DHHC-type palmitoyltransferase 23" Q8IYP9 3 113947901-113965401 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 26.7;Excitatory neurons: 72.2;Late spermatids: 41.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 9 "amygdala: 5.4;basal ganglia: 7.3;cerebral cortex: 9.4;hippocampal formation: 7.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016808 Uncertain Approved Nucleoplasm NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 45: Intestine - Brush border" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "HPA016808: AB_1859002" "unprognostic (2.10e-3)" "unprognostic (2.86e-1)" "unprognostic (4.48e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.49e-1)" "unprognostic (3.98e-3)" "unprognostic (1.37e-2)" "unprognostic (2.48e-1)" "unprognostic (3.19e-1)" "unprognostic (6.63e-2)" "unprognostic (1.86e-1)" "unprognostic (2.78e-2)" "prognostic favorable (1.48e-7)" "unprognostic (2.58e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (5.90e-4)" "unprognostic (3.29e-3)" 1.1 1.0 5.4 3.0 7.3 1.2 2.6 0.0 9.4 1.4 13.2 9.4 7.3 1.2 1.5 1.5 2.4 1.6 1.0 7.4 0.0 5.5 4.0 3.2 2.8 0.0 0.0 0.9 4.8 7.4 3.2 0.9 0.0 2.5 11.5 3.6 6.6 1.8 1.2 3.8 6.8 1.3 0.0 2.4 6.2 12.2 0.0 1.2 6.1 0.9 3.8 1.9 1.5 0.8 17.8 4.4 0.5 10.1 1.5 0.3 14.8 6.9 2.1 1.3 2.0 7.1 11.6 8.1 5.9 4.0 11.0 11.4 13.0 1.9 2.2 4.9 6.0 7.5 7.0 4.4 0.5 8.5 6.7 0.3 2.2 0.3 0.8 1.6 1.1 8.5 0.0 4.6 0.2 10.2 7.0 0.5 3.1 18.2 4.9 1.2 5.8 6.8 7.0 8.6 17.6 4.4 5.3 17.5 3.3 3.9 10.5 2.7 0.3 4.8 9.6 1.0 3.1 5.2 7.3 13.2 4.1 5.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 5.4 7.3 0.0 9.4 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.3 0.0 1.5 12.1 10.5 3.1 2.0 2.3 0.6 2.1 4.8 4.2 1.4 7.2 2.2 16.5 8.4 0.9 2.7 21.8 0.0 2.1 26.7 13.6 1.6 2.8 13.8 0.4 72.2 1.9 1.6 1.0 9.2 8.5 0.0 3.2 4.2 6.4 0.4 0.0 4.0 12.7 0.0 0.3 2.2 41.0 1.2 1.3 3.6 2.8 1.0 4.2 0.0 2.5 5.4 0.7 8.3 0.0 2.3 3.9 10.9 4.4 8.7 0.9 0.0 1.7 0.7 18.2 2.9 2.1 2.7 0.3 1.3 0.9 12.6 1.7 CCDC191 KIAA1407 ENSG00000163617 "Coiled-coil domain containing 191" Q8NCU4 3 113964137-114056594 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 37.5;Endometrial ciliated cells: 68.0;Respiratory ciliated cells: 104.2;Rod photoreceptor cells: 40.4;Spermatocytes: 68.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047833 Approved Approved Mitochondria NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria "HPA047833: AB_10961639" "unprognostic (2.59e-2)" "unprognostic (3.93e-2)" "unprognostic (1.86e-1)" "unprognostic (1.31e-2)" "unprognostic (2.60e-1)" "unprognostic (1.42e-2)" "unprognostic (6.57e-2)" "unprognostic (5.91e-2)" "unprognostic (1.08e-1)" "unprognostic (2.90e-1)" "unprognostic (6.33e-2)" "unprognostic (3.64e-2)" "unprognostic (2.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.62e-1)" "unprognostic (1.54e-1)" "prognostic favorable (3.45e-4)" 2.9 3.3 4.2 3.1 3.9 2.9 4.7 3.1 4.4 4.6 11.7 3.4 1.8 5.3 7.9 2.5 12.1 3.5 1.8 3.8 4.0 7.7 1.9 4.7 4.4 5.7 5.7 4.8 5.1 7.9 10.9 2.1 4.2 5.0 3.2 14.0 3.6 4.8 0.9 7.6 4.0 2.7 4.7 5.6 3.1 9.7 4.0 2.8 8.3 0.8 4.1 3.5 3.3 4.0 3.7 1.9 3.0 2.5 0.8 4.3 0.9 0.8 1.5 1.1 1.8 0.4 4.1 1.0 1.4 1.5 1.0 4.6 0.9 1.6 2.6 0.7 0.7 0.8 0.7 0.3 1.2 1.1 0.5 1.8 4.2 1.5 2.2 2.0 2.2 2.8 0.3 2.1 0.7 1.6 2.3 0.4 0.5 2.4 1.4 1.4 0.6 2.0 4.2 1.8 1.8 2.9 1.5 0.3 1.5 1.5 7.2 0.4 2.4 2.1 0.5 0.9 0.5 3.0 2.6 3.5 2.7 0.6 1.0 0.1 0.8 1.6 0.9 0.8 1.0 8.9 1.8 1.5 0.9 8.3 0.9 1.5 4.4 0.8 0.5 3.7 1.4 0.9 4.2 3.9 3.1 4.4 3.8 4.0 5.7 5.7 4.2 4.7 4.0 4.0 5.2 12.8 14.4 0.0 20.0 0.0 4.0 0.0 4.6 8.9 5.7 7.0 0.0 0.0 16.1 12.9 37.5 1.8 7.9 1.5 13.7 5.4 27.1 68.0 9.5 3.7 4.9 2.1 0.0 3.6 0.5 4.0 9.7 10.6 1.3 9.1 4.6 1.3 3.0 20.2 0.0 2.3 0.0 3.2 0.0 13.1 4.1 3.0 0.0 0.0 2.0 21.6 4.1 0.0 0.0 2.6 1.0 5.3 3.0 1.7 2.4 5.0 104.2 40.4 0.0 6.3 3.5 68.3 13.3 4.3 0.0 0.3 4.5 8.1 2.7 2.8 QTRT2 "FLJ12960, QTRTD1" ENSG00000151576 "Queuine tRNA-ribosyltransferase accessory subunit 2" Q9H974 3 114005833-114088422 "Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2;Alveolar cells type 2: 20.3;Endometrial stromal cells: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036827, HPA036828" Uncertain Approved "Nucleoplasm,Intermediate filaments" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Intermediate filaments" "HPA036827: AB_2675336, HPA036828: AB_10696788" "unprognostic (2.22e-1)" "unprognostic (1.11e-1)" "unprognostic (6.71e-3)" "unprognostic (1.01e-3)" "unprognostic (8.57e-2)" "unprognostic (4.41e-1)" "unprognostic (5.82e-3)" "unprognostic (3.58e-1)" "unprognostic (1.35e-1)" "unprognostic (6.94e-2)" "unprognostic (6.48e-3)" "prognostic unfavorable (6.95e-4)" "unprognostic (1.44e-1)" "unprognostic (8.74e-2)" "unprognostic (2.65e-2)" "unprognostic (1.98e-1)" "unprognostic (1.18e-3)" 6.9 6.5 3.6 9.4 3.9 11.2 10.1 3.2 4.0 7.4 9.0 8.4 7.7 8.4 6.4 7.0 7.5 5.3 3.4 4.3 3.6 7.5 7.2 8.6 12.0 3.8 3.6 8.1 6.7 7.3 4.4 8.5 3.8 6.9 8.9 11.3 5.9 5.9 3.8 8.2 7.6 7.4 3.4 11.8 6.9 7.1 3.7 7.7 8.9 3.9 11.6 9.6 5.2 4.4 26.8 27.1 22.2 24.6 9.6 11.7 20.9 13.7 8.6 22.9 20.9 26.0 18.8 49.4 19.5 12.7 27.3 25.9 43.5 20.6 29.9 9.4 19.6 22.2 15.9 18.6 13.7 40.8 20.0 9.3 18.2 20.8 29.4 9.3 24.0 22.5 23.7 17.1 13.1 21.4 34.3 15.9 42.6 37.6 29.3 30.6 15.6 26.6 18.0 18.2 30.1 14.2 19.9 19.4 25.1 18.4 21.6 20.4 15.9 19.9 21.6 7.9 26.9 12.0 18.7 68.1 17.4 29.6 40.9 0.6 15.3 3.8 6.4 15.8 6.0 16.8 5.4 6.3 19.4 11.0 7.4 6.0 6.5 8.6 11.4 8.1 7.6 6.5 3.6 3.9 3.2 4.0 4.3 3.6 3.8 3.6 3.8 3.4 3.7 4.4 14.0 19.2 20.3 0.0 8.4 0.0 0.0 0.0 0.0 0.0 13.8 12.4 0.0 0.0 10.5 3.7 0.0 10.9 10.0 0.0 1.9 15.7 0.0 16.3 19.7 9.9 0.0 0.0 0.0 12.4 10.9 6.2 0.0 15.1 15.2 15.7 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 8.3 0.0 0.0 0.0 0.0 16.7 0.0 0.0 3.3 0.0 0.0 8.9 4.4 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 4.9 4.3 17.4 0.0 0.0 DRD3 ENSG00000151577 "Dopamine receptor D3" P35462 3 114127580-114199407 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 8 "brain: 5.6" "Group enriched" "Detected in some" 12 "Early spermatids: 6.2;Late spermatids: 19.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "basal ganglia: 5.6;cerebral cortex: 2.8;hypothalamus: 4.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "basal ganglia: 7.4" "Region enriched" "Detected in many" 10 "basal ganglia: 17.9" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 65: Brain - Ion transport" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (2.32e-1)" 0.0 0.0 0.3 0.0 5.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 5.6 0.0 2.8 0.1 4.1 0.0 0.2 0.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF80 pT17 ENSG00000174255 "Zinc finger protein 80" P51504 3 114234631-114237578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "lymphoid tissue: 3.1" "Cell type enhanced" "Detected in some" "dendritic cells: 3.2;granulocytes: 1.3;NK-cells: 2.1;Plasma cells: 1.4;T-cells: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.2" "Lineage enriched" "Detected in single" 4 "T-cells: 1.2" "Not detected" "Not detected" HPA065484 Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 16: Immune cells - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA065484: AB_2685496" "unprognostic (6.27e-3)" "unprognostic (3.00e-2)" "unprognostic (4.42e-2)" "unprognostic (1.26e-1)" "unprognostic (4.52e-2)" "unprognostic (9.68e-5)" "unprognostic (5.36e-1)" "unprognostic (6.52e-3)" "unprognostic (2.80e-2)" "unprognostic (1.27e-2)" "unprognostic (6.25e-2)" "unprognostic (1.49e-1)" "unprognostic (6.69e-12)" "unprognostic (1.85e-1)" "unprognostic (3.10e-1)" "unprognostic (1.16e-1)" "unprognostic (1.34e-2)" 0.1 0.2 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.1 3.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 1.3 0.3 0.1 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 0.7 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 1.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.7 0.0 0.4 0.0 5.2 0.1 0.1 0.0 TIGIT "DKFZp667A205, FLJ39873, VSIG9, VSTM3" ENSG00000181847 "T cell immunoreceptor with Ig and ITIM domains" Q495A1 3 114276913-114310288 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lymphoid tissue: 38.7" "Group enriched" "Detected in some" 10 "dendritic cells: 64.2;NK-cells: 69.0;T-cells: 78.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "T-reg: 195.5" "Lineage enriched" "Detected in many" 11 "T-cells: 195.5" "Cell line enhanced" "Detected in single" "HDLM-2: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 16: Immune cells - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (1.24e-2)" "prognostic favorable (5.43e-4)" "unprognostic (1.22e-3)" "unprognostic (2.22e-6)" "unprognostic (9.84e-2)" "prognostic favorable (3.96e-4)" "unprognostic (1.18e-1)" "unprognostic (2.57e-2)" "unprognostic (5.50e-4)" "unprognostic (3.51e-3)" "unprognostic (1.78e-1)" "unprognostic (3.15e-1)" "unprognostic (2.30e-8)" "unprognostic (3.54e-2)" "unprognostic (1.33e-1)" "unprognostic (7.62e-2)" "unprognostic (6.18e-3)" 0.7 0.3 0.3 12.1 0.5 2.1 0.7 0.6 0.5 0.8 0.2 2.1 1.7 0.9 0.7 2.1 0.5 3.6 0.7 0.4 0.4 0.4 2.9 2.9 38.7 0.8 0.5 0.5 0.2 0.1 0.2 0.3 0.7 1.4 2.4 0.3 1.8 0.2 0.1 1.0 5.2 0.9 0.4 15.0 3.7 0.8 0.7 9.0 0.9 0.0 20.4 5.1 0.5 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.5 0.0 0.2 0.1 0.0 0.4 0.2 0.1 29.8 0.2 3.5 1.4 48.5 90.3 0.2 0.9 5.2 39.8 0.7 17.3 0.2 1.0 195.5 22.0 0.3 0.5 0.6 0.5 0.4 0.4 0.8 0.5 0.7 0.4 0.7 0.9 0.9 0.0 3.3 0.0 3.7 3.1 0.1 0.0 0.6 0.4 0.4 0.6 0.6 0.0 1.3 0.0 2.1 0.1 64.2 0.0 0.0 0.0 0.0 0.2 1.0 0.6 0.0 0.4 0.0 0.0 0.0 0.9 2.6 0.4 1.3 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 1.8 4.2 0.3 0.0 2.3 3.6 0.0 0.9 0.1 69.0 0.0 0.1 0.0 0.0 0.0 6.9 0.2 0.0 0.1 0.0 0.6 0.0 1.0 0.5 0.7 3.0 0.2 3.3 0.0 78.4 0.0 0.2 0.0 ZBTB20 "DKFZp566F123, DPZF, ODA-8S, ZNF288" ENSG00000181722 "Zinc finger and BTB domain containing 20" Q9HC78 3 114314500-115147288 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 66.5" "Cell type enhanced" "Detected in many" "Astrocytes: 1998.0;Microglial cells: 855.4;Oligodendrocyte precursor cells: 1908.5;Oligodendrocytes: 2090.4" "Cancer enhanced" "Detected in some" "stomach cancer: 1.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015551, HPA016815" Approved Enhanced "Nucleoplasm,Nuclear bodies" No No "Cluster 43: B-cells - Humoral immune response" "Cluster 70: Brain - Nervous system development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Nuclear bodies" "HPA015551: AB_2669217, HPA016815: AB_1858947" "unprognostic (1.79e-1)" "unprognostic (1.50e-2)" "unprognostic (5.51e-2)" "unprognostic (2.33e-3)" "unprognostic (5.72e-3)" "unprognostic (3.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (7.51e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-3)" "unprognostic (6.94e-2)" "unprognostic (1.41e-1)" "unprognostic (7.83e-3)" "unprognostic (1.81e-1)" 4.1 3.9 24.5 1.1 43.8 2.5 3.4 66.5 43.7 3.4 5.7 1.7 0.8 3.6 9.6 1.2 2.4 2.3 3.5 65.9 30.9 5.2 5.4 1.8 1.8 43.8 42.6 6.8 3.4 2.3 1.4 1.0 32.9 5.4 1.4 8.5 3.0 4.9 7.9 2.3 0.8 2.9 29.9 2.5 1.7 15.8 39.4 1.9 5.0 8.9 1.7 1.6 0.7 41.1 1.4 2.7 1.0 2.8 4.2 1.8 0.0 1.3 2.5 0.8 0.6 1.7 0.5 0.4 3.7 3.2 0.8 0.0 4.0 0.6 0.7 0.3 0.1 0.4 1.7 1.3 0.8 0.1 0.0 1.8 0.2 1.4 0.4 2.4 0.8 0.2 0.1 0.6 4.4 0.0 0.1 0.1 0.3 0.0 0.1 0.1 3.4 0.0 2.9 0.0 0.3 0.7 0.5 0.0 0.9 0.1 0.0 0.3 4.8 1.0 3.5 0.2 1.8 0.9 0.0 0.1 1.7 0.2 1.3 9.7 1.5 6.4 6.8 2.3 4.6 20.4 6.4 6.4 1.9 11.3 8.3 6.8 3.5 5.3 4.6 4.9 3.6 3.5 24.5 43.8 66.5 43.7 65.9 30.9 43.8 42.6 32.9 29.9 39.4 41.1 278.1 160.3 122.6 1998.0 115.4 25.7 38.2 11.3 22.2 123.6 103.7 81.8 48.5 108.7 25.2 294.3 60.5 0.2 56.1 10.3 49.0 231.4 450.3 109.8 628.3 106.4 31.8 20.4 72.3 82.9 0.6 174.5 36.7 170.5 80.6 194.5 56.0 106.0 4.3 80.8 462.3 14.5 40.7 20.4 28.5 111.1 105.6 36.0 32.0 855.4 29.3 127.7 36.0 1908.5 2090.4 107.8 10.5 120.7 58.4 28.0 19.2 198.4 36.4 108.6 85.5 301.2 124.6 6.9 8.7 14.2 18.5 0.5 67.4 140.7 17.2 25.0 GAP43 "B-50, GAP-43, PP46" ENSG00000172020 "Growth associated protein 43" P17677 3 115623510-115721490 "Plasma proteins, Predicted intracellular proteins, Transporters" "Differentiation, Growth regulation, Neurogenesis" "Calmodulin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "brain: 277.0" "Cell type enriched" "Detected in some" 4 "Excitatory neurons: 270.2" "Cancer enriched" "Detected in many" 43 "glioma: 245.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 37.9;NTERA-2: 81.1;SCLC-21H: 52.2;SH-SY5Y: 39.6;U-87 MG: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004417, HPA013392, HPA015600, CAB078783" Enhanced Supported Enhanced "Plasma membrane" NA NA 35000 "Cluster 32: T-cells - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466" "unprognostic (1.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.15e-2)" "unprognostic (5.72e-5)" "unprognostic (7.44e-3)" "unprognostic (2.19e-2)" "unprognostic (3.97e-3)" "unprognostic (3.15e-3)" "unprognostic (6.08e-4)" "unprognostic (3.33e-1)" "unprognostic (2.17e-2)" "unprognostic (1.62e-1)" "unprognostic (5.35e-8)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (1.29e-3)" 0.6 6.3 131.6 7.5 149.2 0.0 0.9 36.3 277.0 0.6 0.0 10.5 2.5 0.2 0.1 1.1 0.2 4.7 4.3 149.9 187.2 0.2 0.2 0.3 0.2 55.6 156.5 0.2 0.8 0.0 10.0 1.7 113.3 0.9 4.8 8.0 2.1 0.3 0.3 0.5 5.5 4.3 28.5 0.0 2.9 0.4 150.7 0.1 0.2 0.6 0.4 1.3 1.9 121.0 0.0 0.0 37.9 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.2 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 8.6 0.0 0.5 0.0 0.0 0.0 9.1 0.2 0.0 0.0 0.0 81.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.2 39.6 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 1.5 0.1 0.1 0.1 0.0 0.0 18.9 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 131.6 149.2 36.3 277.0 149.9 187.2 55.6 156.5 113.3 28.5 150.7 121.0 0.1 0.0 0.0 20.9 0.0 0.3 0.0 0.0 0.0 3.7 0.0 0.0 0.5 0.0 0.0 0.0 2.1 0.1 0.4 0.0 0.0 0.0 1.0 0.0 0.8 5.1 0.0 0.0 270.2 0.0 0.1 4.5 0.0 0.0 0.0 1.5 0.0 0.0 0.8 0.0 62.5 0.0 0.0 0.0 1.2 1.8 0.0 0.0 1.8 29.0 0.0 1.4 0.0 40.2 20.2 0.8 0.0 0.0 0.4 0.0 0.0 0.2 0.0 3.5 0.0 2.0 1.1 0.9 1.7 0.0 0.1 0.0 0.1 0.3 0.0 0.0 LSAMP "IGLON3, LAMP" ENSG00000185565 "Limbic system associated membrane protein" Q13449 3 115802363-117139389 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 73.9;retina: 41.3" "Group enriched" "Detected in many" 9 "Astrocytes: 3381.0;Excitatory neurons: 1001.8;Inhibitory neurons: 2137.4;Oligodendrocyte precursor cells: 2480.6;Oligodendrocytes: 933.9" "Cancer enhanced" "Detected in many" "glioma: 13.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 11.0;SH-SY5Y: 22.5;WM-115: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054051, HPA076122" Enhanced Cytosol NA NA 150000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 58: Brain - Synaptic function" "Cluster 17: WM-115 - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" Cytosol "HPA054051: AB_2682358, HPA076122: AB_2686779" "unprognostic (4.18e-2)" "unprognostic (2.54e-1)" "unprognostic (9.97e-3)" "unprognostic (6.03e-2)" "unprognostic (9.63e-2)" "unprognostic (4.15e-3)" "unprognostic (6.81e-2)" "unprognostic (2.70e-2)" "unprognostic (5.71e-2)" "unprognostic (6.82e-3)" "unprognostic (1.26e-1)" "unprognostic (6.03e-2)" "unprognostic (1.92e-2)" "unprognostic (1.28e-2)" "unprognostic (1.06e-1)" "unprognostic (5.23e-5)" "unprognostic (1.31e-2)" 3.1 15.7 47.8 5.6 45.4 1.0 1.7 22.6 73.9 21.8 0.0 9.9 2.0 5.0 3.1 3.9 3.1 13.5 2.3 64.2 36.3 2.6 0.8 10.6 4.9 37.5 32.2 5.5 14.4 8.9 3.8 1.0 37.8 26.1 3.8 41.3 1.2 7.3 0.2 5.1 2.6 3.8 28.5 1.9 3.8 4.6 56.4 1.2 5.0 0.2 6.7 6.5 4.8 31.9 0.2 3.2 11.0 0.3 1.1 3.4 1.1 1.0 0.5 0.4 1.1 0.2 0.7 0.8 0.2 6.0 0.3 0.2 0.2 0.1 0.5 0.5 0.1 0.3 1.0 0.3 0.2 0.8 0.5 2.8 0.0 1.3 0.1 0.2 0.1 1.3 0.4 1.2 0.0 0.3 1.3 0.8 4.1 0.1 0.9 0.2 0.2 0.2 2.8 1.1 2.4 22.5 0.0 0.2 3.5 4.5 0.3 0.8 0.0 2.0 1.5 2.7 0.6 1.3 1.2 0.3 0.4 0.3 55.9 0.9 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.3 0.2 0.1 0.4 0.0 0.1 0.1 0.1 0.0 47.8 45.4 22.6 73.9 64.2 36.3 37.5 32.2 37.8 28.5 56.4 31.9 0.5 0.0 1.1 3381.0 0.6 7.6 0.3 0.0 0.0 54.2 1.2 0.4 25.5 4.3 0.6 0.0 2.1 0.2 0.0 0.0 0.0 0.0 22.5 0.9 26.5 5.8 0.0 0.0 1001.8 3.6 0.0 25.0 2.6 1.1 0.0 20.1 4.2 0.0 0.3 220.4 2137.4 0.0 0.0 0.0 3.2 22.2 126.2 1.9 56.9 111.5 0.0 126.9 0.0 2480.6 933.9 0.4 0.0 91.7 1.0 18.3 0.0 0.2 0.0 11.3 0.0 0.1 4.0 0.9 0.5 0.6 5.1 0.0 0.4 4.9 0.0 0.6 IGSF11 "BT-IgSF, CT119, Igsf13, MGC35227, VSIG3" ENSG00000144847 "Immunoglobulin superfamily member 11" Q5DX21 3 118900557-119146068 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Growth regulation" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 46.3;ovary: 16.2;retina: 50.6;testis: 35.7" "Cell type enhanced" "Detected in many" "Astrocytes: 133.9;Early spermatids: 257.9;Inhibitory neurons: 139.1;Late spermatids: 334.0;Oligodendrocytes: 283.2" "Group enriched" "Detected in many" 9 "glioma: 9.2;melanoma: 10.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.0;HEL: 5.9;SK-MEL-30: 35.1;U-266/70: 11.9;U-266/84: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046377 Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" NA NA "Cluster 77: Retina - Visual perception" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Cell Junctions" "Nucleoplasm, Cytosol" "HPA046377: AB_10966195" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.62e-1)" "unprognostic (1.88e-1)" "unprognostic (1.17e-2)" "unprognostic (1.89e-3)" "unprognostic (2.51e-2)" "unprognostic (3.56e-2)" "unprognostic (3.91e-1)" "unprognostic (1.44e-1)" "unprognostic (2.20e-1)" "unprognostic (8.70e-2)" "unprognostic (1.08e-1)" "unprognostic (5.03e-4)" "unprognostic (1.39e-1)" "unprognostic (3.42e-2)" "unprognostic (7.57e-2)" 0.3 7.8 19.5 0.4 34.0 0.0 0.2 26.9 22.2 0.8 1.5 4.1 0.2 0.5 1.1 1.2 0.6 0.8 2.2 19.3 18.6 8.2 0.1 0.1 0.1 30.5 28.0 16.2 3.7 1.3 1.7 0.1 29.9 0.7 0.8 50.6 0.6 0.8 3.9 1.5 0.9 0.5 23.3 0.1 1.6 35.7 25.6 0.3 3.4 5.0 0.2 0.6 0.8 46.3 0.0 8.0 0.2 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.9 2.7 0.0 0.0 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.7 0.6 0.0 0.1 35.1 2.1 0.7 0.1 0.0 0.0 1.4 0.0 0.1 11.9 15.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 34.0 26.9 22.2 19.3 18.6 30.5 28.0 29.9 23.3 25.6 46.3 0.1 0.0 0.0 133.9 0.6 0.4 0.1 0.3 2.8 9.1 0.3 0.1 1.3 0.0 0.5 0.0 75.0 0.2 0.1 0.0 0.0 0.9 257.9 4.2 0.8 0.3 0.0 0.0 77.8 0.7 0.0 2.0 0.0 7.2 0.0 26.8 0.0 0.0 0.0 16.8 139.1 0.0 6.1 0.0 0.4 334.0 3.7 0.4 3.6 4.7 0.0 22.3 0.0 43.2 283.2 0.2 0.0 1.9 0.2 0.1 0.0 5.9 0.4 25.7 0.0 0.8 0.9 22.4 6.0 0.7 0.0 0.1 0.2 6.8 0.0 0.4 TEX55 "C3orf30, FLJ32859, TSCPA" ENSG00000163424 "Testis expressed 55" Q96M34 3 119146151-119160042 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 168 "testis: 53.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA062468, HPA068480" Enhanced Approved Vesicles NA NA "Cluster 74: Testis - Spermatogenesis" Vesicles "HPA062468: AB_2684772, HPA068480: " "unprognostic (4.06e-3)" "unprognostic (3.67e-2)" "unprognostic (2.66e-1)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC083800.1 ENSG00000251012 "Novel chromosome 3 open reading frame 30 (C3orf30) and uroplakin 1B (UPK1B)" 3 119147375-119187807 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UPK1B "TSPAN20, UPK1" ENSG00000114638 "Uroplakin 1B" O75841 3 119173517-119205143 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 33.8;urinary bladder: 88.8" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 32.2;Club cells: 198.3;Glandular and luminal cells: 80.9;Urothelial cells: 46.3" "Cancer enriched" "Detected in many" 4 "urothelial cancer: 147.3" "Region enhanced" "Detected in single" "basal ganglia: 1.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 17.7;CACO-2: 40.6;RPTEC TERT1: 36.5;RT4: 147.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA031799, HPA031800" Enhanced NA NA "Cluster 11: Basophils - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 15: RT4 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA031799: AB_10671579, HPA031800: AB_10671580" "unprognostic (1.20e-2)" "unprognostic (7.18e-2)" "prognostic favorable (3.87e-5)" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (8.77e-3)" "unprognostic (3.67e-1)" "unprognostic (2.71e-1)" "unprognostic (3.26e-2)" "unprognostic (2.03e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.76e-4)" "unprognostic (1.68e-1)" "unprognostic (6.76e-2)" "unprognostic (2.95e-2)" 10.2 0.0 0.4 0.1 1.6 0.2 0.2 0.3 0.6 4.8 0.0 0.0 0.1 0.5 0.0 3.5 7.9 8.0 1.8 0.4 0.0 10.2 0.1 1.2 0.0 0.1 0.0 0.0 6.5 0.0 0.2 7.6 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 33.8 0.6 0.0 3.7 0.0 0.2 17.0 88.8 1.4 0.3 0.1 17.7 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 40.6 0.0 0.0 5.4 0.0 0.0 1.1 0.0 0.5 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 36.5 147.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.4 0.1 0.1 0.2 0.0 0.0 0.4 1.6 0.3 0.6 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.0 1.5 0.0 0.2 0.3 0.6 32.2 0.0 0.5 0.2 0.4 0.5 24.3 198.3 0.0 0.0 3.5 0.4 0.1 0.0 15.6 3.5 25.1 9.4 0.9 0.0 0.0 1.9 0.7 11.1 4.0 11.2 80.9 2.5 0.5 0.0 0.5 0.5 1.7 1.2 0.2 24.4 0.3 3.1 1.5 0.0 1.1 1.8 0.0 1.1 0.2 0.0 0.5 0.5 0.8 0.2 0.0 0.4 0.9 0.2 10.9 27.8 1.2 0.0 0.5 4.6 0.2 0.5 0.3 0.0 1.5 0.7 0.1 0.0 46.3 B4GALT4 beta4Gal-T4 ENSG00000121578 "Beta-1,4-galactosyltransferase 4" O60513 3 119211732-119240946 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 76.0" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 123.6;Urothelial cells: 171.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ: 125.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046819, HPA063546" Approved Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "HPA046819: AB_2679824, HPA063546: AB_2685036" "unprognostic (4.07e-2)" "unprognostic (1.78e-2)" "unprognostic (3.27e-2)" "unprognostic (1.14e-3)" "unprognostic (4.59e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (6.30e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-1)" "unprognostic (6.10e-3)" "unprognostic (2.26e-2)" "unprognostic (2.76e-2)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (2.37e-1)" "unprognostic (1.11e-1)" 12.4 9.1 6.8 10.7 8.4 20.1 11.1 6.5 8.1 16.4 8.7 30.6 28.6 14.8 76.0 17.7 21.8 33.2 12.9 7.0 6.9 24.1 16.6 9.9 9.9 6.9 6.7 18.4 19.5 15.1 18.2 25.7 6.9 13.7 35.2 9.9 12.2 14.7 6.3 14.1 32.5 13.6 7.0 9.4 29.3 8.3 7.5 7.4 16.4 6.5 11.5 37.6 10.5 7.2 60.1 100.3 12.8 9.8 36.0 31.1 65.3 125.8 54.4 54.4 56.2 65.4 18.3 11.8 23.9 61.3 32.2 78.6 20.7 15.0 59.9 23.5 6.8 15.1 20.3 31.7 25.3 8.9 15.7 21.2 21.4 23.0 19.3 21.6 5.8 8.0 11.2 11.7 25.5 18.4 5.3 10.7 17.6 34.0 27.2 4.9 11.8 4.7 31.2 60.3 10.9 24.0 29.4 14.6 27.9 28.2 30.2 5.7 4.9 27.3 24.0 15.2 13.5 27.2 21.5 16.1 23.5 10.1 23.5 20.1 4.1 8.3 13.3 5.2 7.3 4.2 7.3 7.9 5.5 3.2 13.6 7.1 2.5 14.8 5.0 3.4 2.7 5.7 6.8 8.4 6.5 8.1 7.0 6.9 6.9 6.7 6.9 7.0 7.5 7.2 8.5 0.0 9.4 7.2 17.1 10.7 22.2 48.9 12.0 10.8 14.9 12.4 9.2 61.5 69.1 7.3 4.2 36.2 46.0 43.2 1.9 30.7 2.1 40.1 16.9 8.4 13.8 7.8 11.9 33.2 123.6 24.0 36.2 74.5 13.3 35.0 3.9 10.8 14.4 18.5 11.1 78.7 16.2 9.8 14.8 2.4 14.9 14.9 14.2 6.5 10.9 22.2 39.1 10.6 10.2 40.5 50.2 28.2 27.4 30.7 59.3 22.6 52.6 10.2 19.7 13.9 16.9 1.7 8.4 14.0 10.5 52.3 23.1 20.0 23.6 171.6 ARHGAP31 CDGAP ENSG00000031081 "Rho GTPase activating protein 31" Q2M1Z3 3 119294383-119420714 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 47.8;Astrocytes: 123.1;Endothelial cells: 46.9;Langerhans cells: 54.1;Microglial cells: 125.5;Oligodendrocyte precursor cells: 159.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 6.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 35.0;TIME: 38.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036380 Approved NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" "HPA036380: AB_10673129" "unprognostic (2.22e-2)" "unprognostic (1.93e-2)" "unprognostic (9.90e-2)" "unprognostic (1.48e-1)" "unprognostic (1.09e-2)" "unprognostic (1.11e-1)" "unprognostic (8.75e-3)" "unprognostic (3.22e-2)" "unprognostic (2.57e-1)" "unprognostic (7.18e-3)" "unprognostic (5.86e-2)" "unprognostic (1.30e-1)" "prognostic favorable (8.45e-4)" "unprognostic (3.57e-2)" "unprognostic (6.32e-2)" "unprognostic (1.38e-1)" "unprognostic (7.79e-3)" 17.0 2.1 8.3 7.6 9.3 0.8 9.0 10.1 8.3 6.0 1.1 5.4 3.0 6.2 3.1 5.9 5.1 8.6 13.0 8.3 8.9 4.9 3.6 19.5 5.6 11.6 10.4 6.1 2.9 4.0 2.1 11.2 9.4 3.0 5.4 1.5 2.8 3.4 4.2 6.4 4.7 11.8 9.0 7.1 3.2 1.3 10.8 6.9 12.7 9.2 6.8 8.1 3.8 9.9 0.4 2.5 6.2 12.2 3.5 2.9 1.9 7.5 8.6 5.8 4.2 0.1 0.5 0.1 8.7 19.5 10.0 0.2 5.9 1.9 6.7 11.0 0.8 1.7 0.8 0.0 5.8 0.4 7.0 7.8 0.2 15.1 1.7 4.5 35.0 1.2 0.0 3.0 13.1 0.2 0.1 0.3 2.1 0.0 7.6 0.0 2.9 0.0 1.7 0.0 0.0 22.7 3.8 0.0 15.6 3.3 0.7 0.6 38.5 16.0 6.4 2.0 5.9 5.1 5.6 6.2 10.9 5.6 16.4 0.0 2.6 0.0 0.4 2.8 0.8 1.6 0.3 0.5 6.0 0.6 0.3 0.2 0.0 1.1 1.1 5.2 0.8 1.2 8.3 9.3 10.1 8.3 8.3 8.9 11.6 10.4 9.4 9.0 10.8 9.9 47.8 19.2 24.6 123.1 7.3 5.2 0.7 3.1 1.8 0.6 0.5 1.7 16.0 1.5 3.1 0.0 0.0 1.2 9.8 0.2 0.0 2.1 0.4 0.4 2.1 46.9 0.0 7.4 3.4 2.0 10.3 7.3 0.0 0.4 9.5 8.4 30.7 0.6 10.1 0.0 18.4 3.9 0.0 14.5 54.1 0.7 2.8 16.7 10.6 125.5 13.8 3.9 4.1 159.8 0.9 1.9 0.3 2.6 4.9 1.1 0.0 2.1 1.4 0.4 0.0 2.5 11.3 0.3 0.7 1.3 5.1 1.0 3.7 3.3 0.4 0.7 TMEM39A "FLJ10902, SUSR2" ENSG00000176142 "Transmembrane protein 39A" Q9NV64 3 119428949-119468830 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039140 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm Vesicles "HPA039140: AB_10673303" "unprognostic (2.16e-1)" "unprognostic (8.75e-2)" "unprognostic (4.25e-2)" "unprognostic (6.86e-2)" "unprognostic (1.56e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (9.68e-2)" "unprognostic (6.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (4.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.88e-1)" "unprognostic (6.41e-2)" 12.4 10.5 2.2 14.4 4.3 12.9 10.2 4.1 3.5 19.5 10.9 9.0 10.0 13.2 10.9 9.0 11.7 12.6 11.1 2.2 3.1 6.4 13.0 12.4 10.0 4.0 3.4 13.1 28.4 12.8 15.4 18.1 4.3 9.1 9.3 5.0 13.3 14.3 7.2 8.8 8.0 9.7 3.1 9.2 9.8 7.8 4.7 12.1 16.6 11.9 13.6 14.4 10.5 6.2 28.3 15.1 24.1 17.4 56.1 54.2 24.1 26.4 54.3 37.2 50.0 26.1 21.2 12.0 27.4 28.7 37.9 28.7 29.3 12.1 38.0 12.6 11.2 15.5 13.5 25.4 37.9 27.1 23.4 29.7 20.5 25.9 61.5 37.5 23.6 18.5 16.1 35.5 19.6 14.1 13.7 7.0 20.5 29.8 31.5 16.5 11.3 25.7 9.2 10.7 10.7 15.8 26.6 15.2 33.4 17.3 14.8 23.8 18.5 20.2 17.2 13.8 17.3 39.5 12.5 28.5 27.6 18.2 26.8 12.7 10.9 7.3 11.7 5.8 11.9 7.7 7.1 9.6 12.3 9.0 5.6 6.1 3.8 11.9 4.6 17.3 8.9 9.4 2.2 4.3 4.1 3.5 2.2 3.1 4.0 3.4 4.3 3.1 4.7 6.2 8.5 9.6 15.8 9.8 14.3 22.8 16.0 21.8 8.6 4.7 14.6 10.8 10.8 7.2 16.2 7.3 6.2 26.5 24.7 7.4 5.9 11.6 22.8 8.2 26.3 10.8 10.8 9.0 12.4 14.2 57.6 28.9 13.3 17.9 1.3 13.5 7.9 12.0 13.3 1.7 14.0 18.3 6.1 15.0 54.9 6.8 17.1 17.8 10.6 12.2 31.0 3.9 9.2 25.1 21.8 10.2 6.6 13.2 57.8 20.6 8.0 3.0 14.9 6.4 6.6 15.9 25.2 26.1 18.5 9.6 21.7 59.8 17.4 9.4 11.1 20.4 POGLUT1 "9630046K23Rik, C3orf9, hCLP46, KDELCL1, KTELC1, MDS010, MDSRP, MGC32995, Rumi" ENSG00000163389 "Protein O-glucosyltransferase 1" Q8NBL1 3 119468963-119494708 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Gastrulation "Developmental protein, Glycosyltransferase, Transferase" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 81.2;monocytes: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037855, HPA037856" Approved Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 25: RPMI-8226 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "Endoplasmic reticulum" "HPA037855: AB_10672728, HPA037856: AB_2732477" "unprognostic (2.43e-1)" "unprognostic (5.94e-2)" "unprognostic (1.19e-1)" "unprognostic (1.83e-2)" "unprognostic (5.62e-2)" "unprognostic (2.00e-2)" "unprognostic (3.38e-1)" "unprognostic (2.81e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (6.52e-3)" "unprognostic (1.31e-2)" "prognostic unfavorable (7.02e-7)" "unprognostic (3.08e-2)" "unprognostic (1.89e-1)" "unprognostic (1.23e-3)" "prognostic favorable (2.23e-4)" 6.8 7.2 5.9 7.8 6.1 3.1 7.7 6.0 8.2 7.1 6.9 6.8 4.2 9.0 7.8 5.6 6.0 4.7 5.9 5.9 7.2 5.7 6.6 5.6 10.8 6.6 6.5 5.5 7.9 9.5 4.9 8.2 6.6 5.4 7.2 4.2 4.6 11.6 3.2 10.0 7.8 10.4 6.1 9.0 5.4 2.5 7.2 9.7 5.6 3.4 10.8 8.5 6.3 6.7 10.8 7.1 11.7 13.1 29.5 16.8 8.6 16.7 16.7 12.3 18.4 11.5 6.9 16.5 22.2 21.4 10.6 11.9 15.9 16.8 20.4 14.4 10.6 19.3 11.1 12.9 19.1 21.3 21.7 17.5 9.6 13.3 18.0 15.7 15.5 11.2 10.5 19.7 13.9 10.9 12.5 20.7 12.4 18.6 13.8 12.2 12.2 24.0 11.6 13.9 12.7 20.0 8.1 4.9 13.4 11.7 13.2 17.8 19.7 13.1 8.0 3.8 8.9 27.1 25.2 21.7 11.1 20.6 18.8 2.9 16.4 13.9 16.2 15.7 18.7 13.9 18.2 17.0 20.7 10.1 21.1 20.0 1.2 29.5 10.8 11.5 22.3 15.0 5.9 6.1 6.0 8.2 5.9 7.2 6.6 6.5 6.6 6.1 7.2 6.7 19.1 0.0 6.2 11.4 15.7 16.8 7.3 17.4 16.5 13.6 9.7 8.5 5.2 14.3 10.1 20.2 6.2 10.6 17.1 5.2 0.0 6.9 0.7 5.5 19.3 16.1 9.5 8.4 32.7 5.3 14.7 14.5 9.2 7.0 17.7 11.3 13.6 12.5 8.4 5.0 31.6 11.7 22.4 11.9 81.2 0.2 8.7 16.6 12.4 6.5 151.4 10.3 21.6 23.6 25.8 5.0 8.3 17.0 14.1 8.0 8.5 6.0 6.5 13.0 13.1 16.7 13.4 1.5 1.5 13.9 14.9 6.6 15.5 17.4 13.9 5.9 TIMMDC1 "C3orf1, FLJ22597" ENSG00000113845 "Translocase of inner mitochondrial membrane domain containing 1" Q9NPL8 3 119498547-119525090 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053214, HPA055846" Uncertain Enhanced Nucleoplasm,Mitochondria NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 39: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Nucleoplasm "HPA053214: AB_2682081, HPA055846: AB_2682941" "unprognostic (3.95e-2)" "unprognostic (8.85e-2)" "unprognostic (1.73e-1)" "unprognostic (2.53e-2)" "unprognostic (2.88e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (9.60e-2)" "unprognostic (6.25e-2)" "unprognostic (3.39e-1)" "unprognostic (4.67e-3)" "unprognostic (1.05e-1)" "unprognostic (3.87e-2)" "unprognostic (8.89e-2)" "unprognostic (1.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.05e-1)" 10.5 12.0 13.4 10.7 14.3 6.3 13.1 14.2 15.4 15.0 13.2 11.3 8.9 9.3 17.9 15.9 12.8 14.4 44.0 12.7 13.9 17.8 14.2 11.0 17.7 14.3 13.6 10.9 11.1 23.1 7.1 17.1 13.9 13.0 13.7 4.2 14.6 19.7 27.3 15.8 7.7 12.1 14.0 9.9 8.5 10.6 14.1 11.4 19.1 49.2 14.8 14.2 7.0 14.6 26.9 24.5 12.4 10.4 45.5 30.6 27.0 7.7 25.3 21.7 24.7 16.7 16.0 19.5 13.7 27.1 15.1 12.2 30.8 24.8 35.0 16.4 10.9 14.4 10.7 18.8 23.9 11.3 9.1 28.0 37.4 18.4 22.4 13.9 31.5 18.5 19.8 18.1 40.3 33.2 12.0 23.7 16.2 22.4 30.1 10.0 8.4 25.4 32.0 13.1 15.8 29.4 7.8 11.8 28.0 16.2 19.5 30.4 16.1 12.2 9.3 11.3 13.8 12.1 11.8 28.3 20.7 28.5 19.6 11.1 17.6 21.3 10.8 17.6 12.5 16.2 10.4 12.0 17.4 17.6 12.2 10.9 4.3 13.1 20.9 15.1 20.7 22.1 13.4 14.3 14.2 15.4 12.7 13.9 14.3 13.6 13.9 14.0 14.1 14.6 61.2 25.6 39.3 18.6 24.0 37.5 50.4 110.2 31.3 25.0 44.8 55.0 165.3 41.5 63.7 40.5 14.6 157.5 28.9 44.0 150.6 73.2 12.2 39.9 41.1 56.0 28.8 43.1 17.4 62.7 112.7 48.2 29.0 31.1 41.2 34.1 31.8 52.4 86.3 21.9 23.9 43.5 87.5 32.7 40.4 10.0 47.2 39.4 44.4 15.0 65.7 73.6 18.6 22.6 35.6 52.7 40.9 54.5 30.2 43.5 50.5 146.5 63.0 35.4 72.3 43.9 52.5 111.1 58.2 45.9 42.1 177.5 29.7 48.0 45.7 46.7 CD80 "B7-1, B7.1, CD28LG, CD28LG1" ENSG00000121594 "CD80 molecule" P33681 3 119524293-119559614 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 3.0;lymphoid tissue: 6.8" "Group enriched" "Detected in some" 4 "Langerhans cells: 17.4;monocytes: 65.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.4;T-reg: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 11.9;HDLM-2: 42.3;Karpas-707: 17.0;U-266/70: 7.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB025368, HPA050092" Enhanced "Intracellular and membrane" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "CAB025368: , HPA050092: AB_2681012" "unprognostic (2.36e-1)" "unprognostic (1.55e-2)" "unprognostic (5.91e-2)" "unprognostic (1.24e-1)" "unprognostic (3.14e-1)" "unprognostic (1.18e-1)" "unprognostic (1.86e-2)" "unprognostic (4.14e-3)" "unprognostic (1.02e-2)" "unprognostic (4.96e-3)" "unprognostic (1.16e-2)" "unprognostic (1.15e-1)" "unprognostic (9.03e-8)" "unprognostic (3.20e-1)" "unprognostic (3.65e-2)" "unprognostic (7.81e-3)" "unprognostic (1.94e-2)" 0.4 0.1 0.1 5.3 0.1 1.4 0.2 0.2 0.3 0.2 0.7 0.7 1.0 0.2 0.0 0.1 0.1 0.6 0.1 0.2 0.1 0.1 1.5 3.0 5.6 0.4 0.1 0.0 0.2 1.7 0.1 0.4 0.3 0.1 1.3 0.0 0.2 0.2 0.1 0.0 0.8 0.3 0.4 3.4 0.6 0.2 0.5 2.5 0.6 0.0 6.8 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 17.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 7.2 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.1 0.1 0.2 0.3 0.2 0.1 0.4 0.1 0.3 0.4 0.5 0.4 0.2 0.0 1.5 0.0 7.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.4 0.0 1.3 0.0 0.4 0.0 0.0 4.5 17.4 0.5 0.0 8.5 0.0 1.0 65.2 0.0 0.0 0.5 0.2 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 ADPRH ARH1 ENSG00000144843 "ADP-ribosylarginine hydrolase" P54922 3 119579268-119589945 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Macrophages: 14.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 23.9;HEL: 17.1;HMC-1: 18.5;Karpas-707: 25.3;U-266/70: 24.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001701, HPA036961" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 4: Macrophages - Innate immune response" "Nuclear membrane" Nucleoplasm "CAB001701: , HPA036961: AB_2675405" "prognostic favorable (2.42e-4)" "unprognostic (2.29e-1)" "unprognostic (4.77e-1)" "unprognostic (2.39e-2)" "unprognostic (3.38e-2)" "unprognostic (2.65e-1)" "unprognostic (3.06e-2)" "unprognostic (2.63e-1)" "unprognostic (4.24e-2)" "unprognostic (3.31e-3)" "unprognostic (1.88e-1)" "unprognostic (1.71e-1)" "unprognostic (6.04e-2)" "unprognostic (2.60e-3)" "unprognostic (8.87e-2)" "unprognostic (2.03e-1)" "unprognostic (4.35e-2)" 10.6 6.2 3.0 7.3 3.3 3.4 7.9 3.3 4.2 6.9 9.2 5.5 2.3 6.0 4.9 4.0 4.2 6.9 8.5 2.9 3.5 4.9 3.1 13.5 11.0 4.6 3.4 1.9 6.7 8.0 2.0 11.3 4.4 6.1 4.1 6.6 5.1 9.3 11.8 2.6 5.4 9.2 4.2 11.9 3.9 2.4 4.6 5.9 5.8 9.9 13.0 6.5 3.4 4.9 2.4 3.0 0.7 0.0 2.4 2.7 0.0 2.1 0.4 1.8 2.3 0.9 2.0 0.6 0.9 3.2 0.1 0.2 2.0 0.0 1.7 23.9 0.2 17.1 0.4 0.0 3.9 0.1 18.5 4.0 0.1 0.9 0.1 0.8 7.3 0.0 1.6 25.3 11.0 0.7 0.0 4.1 6.9 0.2 5.8 0.0 8.2 1.1 1.0 0.9 0.5 0.1 0.0 0.1 6.4 1.0 4.4 10.6 6.0 0.0 1.1 4.6 0.4 24.5 5.8 0.1 3.0 0.0 4.6 13.9 18.7 19.1 0.8 17.2 0.8 11.0 1.9 1.7 11.2 6.8 0.2 0.7 0.6 5.3 13.9 9.8 14.3 7.5 3.0 3.3 3.3 4.2 2.9 3.5 4.6 3.4 4.4 4.2 4.6 4.9 12.6 9.6 8.6 0.3 5.0 0.8 0.7 0.4 0.0 0.5 1.5 1.9 4.7 2.8 2.7 3.7 4.2 5.8 5.0 0.3 1.9 3.6 0.7 0.2 0.9 9.9 0.0 2.7 0.1 3.2 3.8 2.1 2.6 0.5 10.8 2.5 7.1 1.6 9.4 0.0 0.2 0.2 2.0 12.2 11.1 0.5 0.3 14.8 1.8 4.7 10.2 0.8 4.1 0.0 0.6 2.1 0.5 3.0 3.9 0.7 0.0 1.3 2.1 4.3 0.0 3.6 3.9 0.4 0.6 0.1 0.9 11.8 1.2 0.7 0.2 0.2 PLA1A ps-PLA1 ENSG00000144837 "Phospholipase A1 member A" Q53H76 3 119597875-119629811 "Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 138.4;parathyroid gland: 65.8;seminal vesicle: 67.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 14.7;Endothelial cells: 14.3;Hepatocytes: 26.0;Langerhans cells: 15.6;Peritubular cells: 14.3" "Group enriched" "Detected in many" 5 "liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "SK-MEL-30: 25.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059740 Approved "Nucleoplasm,Nuclear speckles,Cytoplasmic bodies" "Secreted in other tissues" NA NA 420000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles, Cytoplasmic bodies" Nucleoplasm "HPA059740: AB_2684118" "unprognostic (1.35e-1)" "prognostic favorable (2.81e-7)" "unprognostic (2.24e-2)" "unprognostic (3.46e-2)" "unprognostic (3.18e-2)" "unprognostic (1.94e-2)" "unprognostic (1.11e-2)" "unprognostic (2.43e-1)" "unprognostic (3.87e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" "unprognostic (9.09e-2)" "unprognostic (1.55e-3)" "unprognostic (9.53e-3)" "unprognostic (3.94e-2)" "unprognostic (1.67e-1)" "unprognostic (2.67e-1)" 4.9 0.7 12.1 3.5 11.3 0.3 3.4 11.6 16.3 4.7 26.8 2.7 1.1 4.7 138.4 1.5 5.7 2.8 4.9 12.5 12.0 7.7 39.6 21.2 15.6 13.2 12.3 1.1 3.7 65.8 1.7 9.8 13.2 9.1 2.5 1.0 3.5 67.2 16.2 0.8 3.5 8.8 13.4 1.0 4.4 3.7 14.7 1.6 6.9 3.1 8.7 3.9 1.9 12.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.8 0.3 0.5 0.1 0.0 0.2 0.0 0.0 25.0 0.0 0.0 0.0 1.3 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 12.1 11.3 11.6 16.3 12.5 12.0 13.2 12.3 13.2 13.4 14.7 12.4 6.5 0.0 1.7 0.0 0.0 0.6 0.5 0.4 0.6 0.0 0.1 0.1 2.8 2.8 1.0 14.7 0.0 0.2 0.1 0.0 1.9 4.7 6.6 0.1 0.1 14.3 1.8 0.0 0.2 2.2 0.0 1.6 0.0 0.9 1.3 0.7 7.9 26.0 1.6 0.0 0.1 0.1 0.0 1.0 15.6 3.2 0.3 5.4 1.8 4.7 4.2 0.0 0.0 0.0 0.0 1.3 0.6 14.3 0.0 0.5 0.0 5.1 7.5 0.1 0.0 0.9 5.9 0.0 0.2 0.0 0.6 1.9 0.1 0.0 0.1 0.2 POPDC2 POP2 ENSG00000121577 "Popeye domain containing 2" Q9HBU9 3 119636457-119665324 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "heart muscle: 405.4" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 272.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 10 "SH-SY5Y: 24.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA024255 Enhanced NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA024255: AB_1855545" "unprognostic (1.13e-1)" "unprognostic (1.17e-3)" "unprognostic (8.91e-3)" "unprognostic (9.48e-2)" "unprognostic (5.56e-2)" "unprognostic (7.64e-2)" "unprognostic (2.73e-2)" "unprognostic (2.43e-1)" "unprognostic (3.18e-2)" "unprognostic (1.72e-2)" "unprognostic (5.86e-3)" "unprognostic (1.80e-1)" "unprognostic (1.24e-2)" "unprognostic (6.26e-3)" "unprognostic (1.66e-2)" "unprognostic (2.12e-1)" "unprognostic (2.06e-2)" 3.6 2.1 0.6 3.8 0.5 0.3 3.3 0.8 0.9 7.9 1.3 95.3 2.8 12.5 2.6 2.0 9.6 10.9 405.4 0.5 0.5 2.4 1.0 2.5 6.7 0.6 0.6 2.0 1.3 8.4 1.3 1.4 0.6 16.3 6.2 0.9 3.3 49.2 77.7 2.8 12.2 24.0 0.5 2.8 10.7 1.0 0.6 1.5 2.4 96.9 2.5 35.3 6.0 0.5 0.1 0.2 0.5 0.0 0.2 0.2 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.4 1.0 0.0 0.3 0.1 0.1 0.0 0.1 0.4 0.2 0.2 0.0 0.3 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 24.8 0.0 0.0 0.6 2.5 0.0 0.3 0.0 0.2 0.1 0.2 0.1 1.0 0.0 0.2 0.2 0.3 0.5 0.5 0.0 0.7 0.3 0.0 0.4 0.1 0.5 0.4 0.0 0.4 0.8 0.2 0.0 0.2 1.3 0.2 0.7 0.1 0.6 0.5 0.8 0.9 0.5 0.5 0.6 0.6 0.6 0.5 0.6 0.5 4.7 0.0 0.5 1.0 0.6 0.4 0.3 0.5 0.0 3.1 0.9 3.0 272.7 0.0 0.9 0.0 0.0 0.5 2.3 0.4 0.0 0.5 0.3 0.6 0.5 6.4 3.0 0.0 0.8 0.2 0.1 8.0 0.5 0.3 1.3 1.6 1.4 0.2 1.6 1.7 1.2 0.8 0.0 1.0 2.3 0.8 1.2 1.6 0.0 2.8 1.8 1.2 0.0 1.0 1.9 0.5 0.2 1.9 0.0 0.8 0.7 0.3 1.9 2.4 59.2 5.9 11.1 1.0 0.3 0.1 0.6 1.2 1.6 0.6 0.3 0.2 COX17 ENSG00000138495 "Cytochrome c oxidase copper chaperone COX17" Q14061 3 119654513-119677454 "Cancer-related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042226, HPA048158" Supported Supported Mitochondria NA NA 220000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" Mitochondria "HPA042226: AB_2677911, HPA048158: AB_2680292" "unprognostic (1.98e-2)" "unprognostic (3.49e-2)" "unprognostic (1.96e-2)" "unprognostic (8.29e-2)" "unprognostic (2.88e-2)" "unprognostic (6.63e-3)" "unprognostic (3.49e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-1)" "unprognostic (7.11e-3)" "unprognostic (2.12e-1)" "unprognostic (4.45e-2)" "unprognostic (1.33e-2)" "unprognostic (2.15e-2)" "unprognostic (1.65e-1)" "unprognostic (9.19e-2)" "unprognostic (2.64e-2)" 81.6 178.5 106.5 77.1 111.2 113.3 68.8 117.5 122.4 50.3 149.2 90.2 90.2 41.2 114.1 55.9 47.3 59.4 279.9 105.5 123.6 94.7 172.7 62.3 110.4 115.8 115.3 31.5 102.0 412.1 119.2 63.9 115.7 78.6 78.7 120.6 80.8 90.7 401.4 43.3 88.5 62.9 112.5 64.9 107.5 44.4 113.0 106.6 94.4 363.9 89.8 75.9 35.7 118.6 219.6 257.0 122.7 33.3 53.4 53.1 45.7 130.5 84.2 127.3 133.4 226.4 157.7 164.6 158.0 72.1 174.8 84.0 138.5 154.9 74.9 205.5 155.9 145.0 195.3 180.1 63.1 205.0 246.7 56.6 142.7 77.9 106.0 82.2 87.9 200.8 122.4 370.7 155.4 410.2 212.8 283.5 133.8 212.2 413.3 88.3 82.3 273.7 203.2 141.0 210.5 86.4 153.1 137.1 189.7 76.9 180.5 313.0 66.6 91.3 144.9 59.8 168.4 257.5 348.9 361.1 129.0 157.8 164.2 591.4 241.1 630.6 218.1 357.5 208.1 378.3 241.7 230.3 252.8 320.4 189.1 187.0 174.4 213.6 487.3 538.7 352.6 260.1 106.5 111.2 117.5 122.4 105.5 123.6 115.8 115.3 115.7 112.5 113.0 118.6 194.5 157.0 167.1 5.2 161.5 94.1 132.8 267.9 46.7 108.9 153.8 147.2 622.8 238.8 202.4 498.4 43.8 137.4 116.7 385.3 716.1 264.0 115.0 282.4 64.3 164.7 214.2 162.9 3.8 413.7 193.9 99.3 150.3 178.8 309.3 70.2 116.0 779.8 216.1 75.7 5.6 327.8 427.2 181.8 281.2 39.9 91.0 190.8 277.5 11.2 345.7 178.8 137.0 8.5 8.8 459.7 512.8 136.9 176.5 198.2 434.6 786.2 280.2 174.4 184.1 112.9 171.6 286.0 159.2 85.4 125.4 211.0 129.0 49.6 151.1 199.0 CFAP91 "AAT-1, AAT1, AAT1alpha, C3orf15, CaM-IP2, MAATS1, SPATA26" ENSG00000183833 "Cilia and flagella associated protein 91" Q7Z4T9 3 119703022-119767102 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 14.1" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.6;hTERT-RPE1: 1.4;RPTEC TERT1: 2.4;SCLC-21H: 3.5;SH-SY5Y: 2.5;T-47d: 1.8;U-87 MG: 1.9" HPA074084 Supported NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" "HPA074084: " "unprognostic (6.70e-2)" "unprognostic (3.54e-2)" "unprognostic (3.31e-1)" "unprognostic (3.93e-2)" "unprognostic (2.40e-2)" "unprognostic (1.89e-2)" "unprognostic (1.36e-1)" "unprognostic (4.02e-2)" "unprognostic (1.19e-1)" "unprognostic (4.62e-2)" "unprognostic (2.10e-2)" "unprognostic (9.11e-2)" "unprognostic (4.07e-2)" "unprognostic (9.46e-2)" "unprognostic (1.69e-1)" "unprognostic (2.07e-1)" "unprognostic (4.46e-2)" 0.6 2.1 0.8 0.0 1.0 0.0 1.8 0.5 1.0 3.4 5.7 1.4 0.0 4.0 5.0 0.3 14.1 1.2 0.4 1.0 1.7 2.5 0.4 2.1 0.1 2.4 2.1 3.4 4.9 4.0 7.2 0.2 1.8 2.3 0.5 4.1 1.5 4.5 0.1 0.3 0.6 0.8 1.6 2.4 1.7 8.7 1.4 0.4 4.6 0.0 0.3 1.1 1.1 1.0 0.1 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.2 0.2 1.2 0.0 1.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 2.4 0.0 3.5 2.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.0 0.5 1.0 1.0 1.7 2.4 2.1 1.8 1.6 1.4 1.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 AC069444.2 ENSG00000285585 "Novel protein" 3 119703076-119807570 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 15 "Respiratory ciliated cells: 9.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA074084 Uncertain NA NA "Cluster 49: Ciliated cells - Cilium organization" "HPA074084: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NR1I2 "BXR, ONR1, PAR2, PXR, SXR" ENSG00000144852 "Nuclear receptor subfamily 1 group I member 2" O75469 3 119780484-119818487 "FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 31.2;liver: 47.4" "Cell type enhanced" "Detected in some" "Distal enterocytes: 26.1;Hepatocytes: 32.2;Paneth cells: 13.8;Proximal enterocytes: 51.7;Undifferentiated cells: 9.0" "Group enriched" "Detected in some" 24 "colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 15 "NK-cell: 2.8" "Lineage enriched" "Detected in single" 15 "NK-cells: 2.8" "Cell line enriched" "Detected in some" 5 "Hep G2: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA029309, HPA055121, HPA073926" Enhanced Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643" "unprognostic (6.76e-3)" "unprognostic (2.25e-1)" "unprognostic (5.84e-2)" "unprognostic (1.24e-4)" "unprognostic (4.51e-2)" "unprognostic (4.52e-2)" "unprognostic (4.03e-3)" "unprognostic (3.97e-2)" "unprognostic (5.78e-2)" "unprognostic (5.05e-2)" "unprognostic (5.21e-2)" "unprognostic (3.60e-2)" "unprognostic (5.51e-6)" "unprognostic (4.86e-1)" "unprognostic (6.95e-2)" "unprognostic (3.13e-1)" "unprognostic (6.12e-3)" 0.1 0.1 0.2 1.0 0.1 0.6 0.1 0.0 0.1 0.0 0.2 12.3 28.2 0.0 0.1 0.0 0.1 5.2 0.0 0.1 0.3 0.0 47.4 0.0 0.2 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 13.3 0.2 0.0 0.1 0.0 0.0 31.2 0.6 0.1 0.1 1.7 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 2.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.3 0.2 0.3 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.7 1.5 0.0 1.8 0.0 0.0 0.1 26.1 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.6 0.2 0.0 0.1 3.1 0.0 0.0 1.7 0.0 32.2 0.2 0.0 0.4 6.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 13.8 0.0 0.1 0.2 51.7 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.5 9.0 0.0 GSK3B ENSG00000082701 "Glycogen synthase kinase 3 beta" P49841 3 119821321-120094994 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Carbohydrate metabolism, Differentiation, Glycogen metabolism, Neurogenesis, Wnt signaling pathway" "Developmental protein, Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase" "Alzheimer disease, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 218.7;Inhibitory neurons: 246.3;Microglial cells: 197.7;Oligodendrocyte precursor cells: 241.8;Oligodendrocytes: 202.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016263, HPA028017" Approved Supported Nucleoplasm No No "Cluster 52: Eosinophils - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "CAB016263: AB_2279451, HPA028017: AB_10600708" "unprognostic (1.09e-2)" "unprognostic (2.62e-1)" "unprognostic (1.40e-1)" "unprognostic (2.17e-3)" "unprognostic (1.15e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (8.20e-5)" "unprognostic (3.39e-2)" "unprognostic (1.11e-1)" "unprognostic (1.67e-2)" "unprognostic (1.05e-3)" "unprognostic (6.79e-2)" "prognostic favorable (1.52e-4)" "unprognostic (2.39e-1)" "unprognostic (2.58e-1)" "unprognostic (1.28e-2)" "unprognostic (1.16e-1)" 11.0 13.6 9.2 11.7 9.5 15.1 11.2 16.6 16.9 10.0 0.0 11.7 12.3 10.3 11.1 13.8 10.1 11.1 18.2 8.2 13.8 12.0 14.8 13.9 10.4 15.2 15.3 9.3 10.7 17.3 7.1 16.3 16.5 10.0 12.4 23.6 13.2 9.3 17.5 16.3 15.3 13.3 4.9 12.9 12.6 23.1 9.6 20.0 15.1 18.0 11.7 12.0 9.5 12.5 59.3 22.7 46.8 25.5 31.9 29.5 50.3 36.6 57.6 28.3 29.3 25.9 23.8 24.1 19.1 43.0 33.8 46.0 22.2 59.1 45.8 15.5 6.6 42.2 18.4 16.6 35.6 31.6 49.9 34.3 39.5 27.0 56.8 27.3 31.5 29.3 13.6 34.6 40.5 25.1 44.0 10.7 25.2 23.3 28.3 16.9 41.0 22.2 25.1 45.3 37.1 22.6 38.5 29.0 44.1 41.1 30.9 27.0 40.0 45.5 55.1 12.7 20.6 31.9 35.2 44.8 29.4 22.0 33.9 1.0 1.8 6.3 0.7 1.6 1.2 0.5 1.0 1.7 1.4 0.7 0.9 0.8 6.6 0.5 2.1 1.1 1.2 0.8 9.2 9.5 16.6 16.9 8.2 13.8 15.2 15.3 16.5 4.9 9.6 12.5 39.3 32.1 26.7 113.6 28.3 50.9 37.8 22.2 46.1 63.2 21.9 17.0 39.7 20.0 21.4 18.4 60.5 27.0 29.0 37.3 11.7 26.9 138.2 25.2 31.6 31.5 26.9 15.4 218.7 32.0 49.3 25.1 46.4 32.5 17.2 18.1 25.0 22.9 21.5 143.0 246.3 22.3 20.3 27.3 29.2 48.1 13.1 33.4 35.6 197.7 35.5 31.6 22.6 241.8 202.5 49.0 23.4 19.9 29.0 28.7 35.8 17.3 16.3 42.4 13.1 24.4 38.2 38.8 29.3 50.8 41.1 43.0 36.4 32.7 25.9 41.6 GPR156 "GABABL, PGR28" ENSG00000175697 "G protein-coupled receptor 156" Q8NFN8 3 120164645-120285222 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "testis: 2.7" "Group enriched" "Detected in some" 4 "Astrocytes: 15.0;Early spermatids: 8.3;Late spermatids: 17.9;Oligodendrocyte precursor cells: 13.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1.3;PC-3: 1.3;SiHa: 3.5;U-2 OS: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA028642, HPA028644" Uncertain Supported "Plasma membrane" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 20: HeLa - Mitochondria" "Cluster 25: Spermatids - Spermatogenesis" "Plasma membrane" "HPA028642: AB_10599711, HPA028644: AB_10600441" "unprognostic (2.85e-3)" "unprognostic (1.02e-1)" "unprognostic (3.53e-3)" "unprognostic (2.02e-3)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.62e-4)" "unprognostic (2.03e-1)" "unprognostic (4.54e-4)" "unprognostic (5.03e-2)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (4.03e-5)" "unprognostic (2.43e-2)" "unprognostic (3.43e-2)" "unprognostic (4.91e-3)" "unprognostic (6.71e-2)" 0.0 0.0 0.3 0.1 0.3 0.0 0.3 0.0 0.2 0.2 0.1 0.0 0.0 0.4 0.0 0.2 1.0 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.7 0.4 0.0 0.0 0.0 0.4 0.3 0.0 0.0 2.7 0.1 0.3 0.0 0.3 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.3 0.5 0.0 0.2 0.0 0.3 1.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.6 3.5 0.0 0.4 0.1 0.4 0.0 0.1 0.1 1.9 0.0 0.1 0.4 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.2 0.1 0.3 0.3 0.1 0.3 0.1 0.3 0.0 0.0 0.0 15.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.3 0.3 0.2 0.0 0.0 0.0 1.5 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 17.9 0.0 0.1 0.0 1.0 0.0 1.3 0.0 13.0 2.9 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.1 0.6 1.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 LRRC58 ENSG00000163428 "Leucine rich repeat containing 58" Q96CX6 3 120324509-120349354 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057574 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 30: Non-specific - Translation" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA057574: AB_2683474" "unprognostic (7.87e-3)" "unprognostic (6.84e-3)" "unprognostic (3.20e-1)" "unprognostic (2.67e-3)" "unprognostic (8.73e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (4.41e-2)" "unprognostic (1.30e-2)" "unprognostic (3.67e-2)" "unprognostic (2.73e-3)" "unprognostic (1.48e-1)" "unprognostic (1.66e-2)" "unprognostic (6.43e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (6.18e-4)" "unprognostic (1.06e-1)" 10.6 22.8 8.4 8.8 11.9 9.0 12.0 11.0 9.3 9.0 9.5 7.7 7.5 10.2 8.3 9.2 6.6 7.4 5.5 7.1 8.6 14.9 11.2 7.4 10.2 11.8 11.3 14.6 10.3 13.7 4.1 9.6 12.6 9.7 7.5 7.2 8.5 8.6 5.0 10.9 7.4 9.7 10.8 9.1 7.3 4.5 9.7 12.2 14.2 5.8 8.8 7.4 6.5 14.8 52.6 18.1 12.2 15.6 27.5 26.1 19.3 18.5 16.0 19.2 23.8 17.0 15.8 34.1 22.4 19.9 27.3 22.4 22.7 18.1 36.5 13.3 14.0 36.5 23.5 19.9 18.5 59.8 18.0 19.3 22.7 23.4 29.9 12.4 11.5 21.5 21.0 42.6 20.9 23.9 47.2 19.1 12.3 23.1 32.8 10.4 32.6 22.1 14.6 19.1 15.6 20.6 32.4 21.9 46.2 8.5 24.1 26.7 17.2 32.0 35.7 21.7 23.5 36.3 44.9 70.6 32.2 44.2 27.4 1.4 2.7 1.1 1.9 2.4 2.7 2.5 2.3 2.4 2.6 2.3 3.5 2.7 1.5 1.6 1.9 2.9 2.6 1.9 8.4 11.9 11.0 9.3 7.1 8.6 11.8 11.3 12.6 10.8 9.7 14.8 26.0 73.7 59.9 18.3 30.8 50.9 20.7 15.9 32.5 32.3 34.0 25.8 17.3 24.3 29.0 18.4 56.3 17.3 33.3 17.9 11.7 22.0 7.8 24.4 48.8 24.1 16.8 34.3 23.8 31.0 28.2 50.0 18.3 27.0 35.4 33.9 27.1 43.0 28.7 25.2 27.1 24.3 12.2 49.0 33.9 7.3 55.9 34.4 33.8 14.0 42.3 46.5 30.9 25.1 34.8 28.8 18.6 73.0 33.0 37.0 24.8 39.6 32.3 26.5 26.3 52.7 33.9 19.5 22.8 31.2 57.0 13.5 28.7 94.6 32.3 17.5 FSTL1 "FRP, FSL1, OCC-1, OCC1, tsc36" ENSG00000163430 "Follistatin like 1" Q12841 3 120392293-120450993 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 352.1;Fibroblasts: 521.9;Leydig cells: 327.4;Peritubular cells: 270.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 14 "basophil: 12.0" "Lineage enriched" "Detected in single" 14 "granulocytes: 12.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 1782.4;BJ: 2156.3;fHDF/TERT166: 2692.9;HBF TERT88: 1741.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035251, HPA040815" Uncertain Approved Vesicles,Cytosol "Secreted to blood" NA NA 34000000 "Cluster 34: Basophils - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Cytosol" "HPA035251: AB_10601906, HPA040815: AB_2732489" "unprognostic (2.60e-1)" "unprognostic (1.59e-3)" "unprognostic (8.84e-2)" "unprognostic (4.54e-3)" "unprognostic (4.10e-2)" "unprognostic (1.35e-1)" "unprognostic (9.88e-2)" "unprognostic (3.05e-2)" "unprognostic (1.19e-2)" "unprognostic (3.88e-2)" "unprognostic (3.54e-2)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (4.89e-3)" "unprognostic (1.72e-2)" "unprognostic (1.05e-2)" "unprognostic (4.47e-3)" 432.4 134.3 20.5 116.3 18.1 2.2 166.1 22.8 22.7 279.9 83.0 156.4 37.1 157.5 50.8 126.1 150.6 257.0 242.7 20.6 22.8 45.4 35.7 120.7 50.3 28.5 44.6 90.3 37.3 35.5 25.7 442.0 23.1 188.3 90.4 29.8 59.3 184.4 31.8 64.2 69.1 409.6 22.7 63.1 68.6 33.5 22.7 24.2 78.8 89.8 38.8 260.4 104.3 20.6 81.0 21.2 222.9 91.8 1304.4 1782.4 1.3 2156.3 1208.9 1374.5 1211.0 0.1 178.5 0.8 178.8 2692.9 112.8 20.5 68.6 270.0 1741.5 1.1 32.5 0.4 159.8 0.3 286.0 1.2 0.9 1362.7 8.5 884.5 192.7 612.1 811.6 11.2 0.5 0.3 227.6 0.5 22.6 2.0 181.3 0.4 181.9 0.7 92.7 1.0 150.4 1.7 39.2 93.5 764.6 13.6 76.5 462.6 23.5 6.2 986.8 507.4 479.8 268.0 323.8 1.0 1.1 2.3 177.4 0.9 67.0 12.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 2.6 20.5 18.1 22.8 22.7 20.6 22.8 28.5 44.6 23.1 22.7 22.7 20.6 76.9 64.1 9.4 56.5 1.1 64.1 31.9 36.4 10.2 2.3 25.6 24.6 127.5 8.6 42.5 23.9 0.0 114.4 2.5 0.9 0.0 62.6 2.3 44.4 176.7 111.4 3.0 3.6 9.6 5.8 352.1 521.9 3.1 23.0 1.3 66.5 142.5 17.4 20.6 1.7 16.2 0.2 8.2 10.8 91.6 9.8 327.4 11.5 110.3 30.0 9.9 116.1 0.0 9.5 0.9 117.8 0.7 270.8 0.9 108.4 0.0 5.5 74.9 4.3 59.2 62.5 129.3 1.5 4.4 2.2 48.2 54.7 7.1 47.5 0.9 65.3 NDUFB4 B15 ENSG00000065518 "NADH:ubiquinone oxidoreductase subunit B4" O95168 3 120596328-120602507 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 945.3" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1493.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051739, HPA064441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Mitochondria" No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "Nucleoplasm, Nuclear membrane" "HPA051739: AB_2681585, HPA064441: " "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.95e-2)" "unprognostic (4.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.35e-3)" "unprognostic (9.66e-3)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (3.69e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-1)" "prognostic favorable (1.79e-4)" 148.6 338.4 159.7 90.3 169.1 112.4 145.1 175.9 203.2 126.2 173.2 170.0 147.8 117.9 133.8 159.5 113.0 85.7 619.5 163.5 178.4 232.4 187.4 102.9 93.8 168.3 163.0 119.8 137.4 260.3 170.2 76.8 168.6 118.1 148.7 100.2 148.4 117.4 945.3 144.5 135.6 103.4 170.7 112.1 162.3 106.5 161.7 125.6 113.1 562.2 114.2 133.5 142.1 172.8 294.8 204.3 246.7 248.5 151.0 181.4 199.2 157.0 212.1 205.4 224.5 200.9 219.8 147.8 311.6 177.8 255.6 272.5 191.3 202.7 155.7 227.5 212.6 226.1 205.7 208.1 90.4 202.7 256.8 161.3 268.5 98.9 125.8 246.0 258.5 271.7 138.5 219.2 220.9 224.1 398.6 294.8 193.9 478.9 554.7 228.8 141.0 325.8 337.3 177.9 273.8 283.4 186.5 205.7 360.0 162.0 348.0 319.9 199.8 179.0 233.2 76.9 226.5 263.2 260.1 454.3 283.6 279.8 250.8 205.0 164.8 197.2 156.0 229.5 162.2 231.6 215.2 176.8 213.9 176.3 182.2 181.8 101.6 152.7 238.2 267.9 300.6 205.7 159.7 169.1 175.9 203.2 163.5 178.4 168.3 163.0 168.6 170.7 161.7 172.8 274.1 163.5 162.6 36.9 167.0 222.3 289.0 612.6 190.6 137.8 290.1 351.3 1493.1 311.7 348.3 320.0 58.4 366.0 158.1 472.4 1226.7 556.7 999.2 259.9 188.9 235.7 298.7 196.9 22.6 620.9 421.0 213.7 175.3 293.5 174.8 139.4 183.5 513.9 330.3 84.1 22.0 526.3 451.6 240.2 247.9 164.6 275.2 196.2 434.0 15.9 339.2 340.7 186.4 13.0 31.2 567.9 581.8 277.2 283.2 243.2 613.4 1225.1 266.2 168.4 256.4 208.1 259.0 418.9 87.5 288.4 251.5 352.4 168.1 271.3 462.8 344.0 HGD "AKU, HGO" ENSG00000113924 "Homogentisate 1,2-dioxygenase" Q93099 3 120628172-120682269 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "kidney: 200.3;liver: 752.6" "Cell type enhanced" "Detected in many" "Distal tubular cells: 103.7;Endometrial ciliated cells: 113.9;Glandular and luminal cells: 127.8;Hepatocytes: 534.7;Proximal tubular cells: 477.5" "Cancer enriched" "Detected in many" 4 "liver cancer: 119.8" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in single" 6 "neutrophil: 1.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.1" "Cell line enhanced" "Detected in some" "CACO-2: 55.8;EFO-21: 82.7;Hep G2: 186.6;OE19: 328.0;RPTEC TERT1: 212.2" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.2" "HPA047374, HPA052359" Enhanced Approved "Golgi apparatus" NA NA 700000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Golgi apparatus" "HPA047374: AB_2680019, HPA052359: AB_2681798" "unprognostic (1.36e-1)" "unprognostic (9.89e-2)" "unprognostic (3.93e-2)" "prognostic favorable (1.78e-4)" "unprognostic (1.56e-1)" "unprognostic (2.05e-1)" "unprognostic (5.65e-3)" "unprognostic (7.20e-2)" "unprognostic (6.05e-2)" "unprognostic (2.41e-3)" "unprognostic (2.68e-2)" "unprognostic (1.16e-1)" "unprognostic (4.29e-3)" "unprognostic (8.57e-2)" "unprognostic (1.78e-1)" "unprognostic (3.71e-3)" "unprognostic (1.43e-1)" 0.4 0.3 0.4 2.5 1.9 0.5 12.5 0.6 0.8 27.4 1.5 16.7 31.6 3.1 13.0 0.4 4.2 61.7 0.3 0.5 0.4 200.3 752.6 0.8 0.4 0.4 0.4 0.2 31.2 7.0 0.2 0.2 0.4 44.5 20.3 0.7 4.2 4.2 0.1 0.9 25.6 0.5 0.4 0.6 25.5 0.1 0.5 0.7 55.1 0.2 0.1 0.2 0.1 0.6 0.0 12.3 4.6 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 55.8 10.7 0.1 82.7 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.2 186.6 0.0 0.4 1.0 0.0 0.2 0.1 0.0 0.1 0.1 0.4 0.0 0.3 0.5 0.0 0.0 0.2 0.3 328.0 0.0 0.1 0.3 0.1 212.2 0.0 0.2 0.2 0.2 0.9 0.0 0.0 0.2 1.0 0.6 0.1 0.9 0.2 0.1 0.0 0.3 0.5 0.2 0.8 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 2.3 0.4 1.9 0.6 0.8 0.5 0.4 0.4 0.4 0.4 0.4 0.5 0.6 0.1 0.0 2.0 0.3 5.9 0.0 0.4 0.6 0.0 0.3 7.5 1.7 0.3 81.5 4.9 27.6 2.1 0.0 0.3 18.5 103.7 7.2 0.2 113.9 17.1 1.2 43.8 24.0 3.2 17.8 0.0 0.4 19.4 127.8 1.3 0.0 16.4 534.7 0.2 0.0 0.6 16.0 2.0 16.1 0.0 0.0 0.0 21.3 0.0 1.9 2.0 4.2 0.0 0.0 0.5 12.1 35.6 0.0 0.0 12.9 54.6 477.5 4.1 0.2 0.0 0.2 1.1 0.1 0.0 0.0 0.0 0.0 3.8 0.4 9.1 0.4 RABL3 MGC23920 ENSG00000144840 "RAB, member of RAS oncogene family like 3" Q5HYI8 3 120684938-120742993 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 116.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035150, HPA035151, HPA069861" Uncertain Approved "Endoplasmic reticulum" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 9: Photoreceptor cells - Phototransduction" "Endoplasmic reticulum" "HPA035150: AB_2674493, HPA035151: AB_10601154, HPA069861: " "unprognostic (1.69e-2)" "unprognostic (5.10e-2)" "unprognostic (8.32e-2)" "unprognostic (3.96e-2)" "unprognostic (1.88e-1)" "unprognostic (7.22e-2)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (7.19e-2)" "unprognostic (2.94e-1)" "unprognostic (2.11e-3)" "unprognostic (2.78e-1)" "prognostic favorable (2.79e-5)" "unprognostic (2.33e-1)" "unprognostic (6.15e-2)" "unprognostic (8.44e-3)" "unprognostic (3.65e-1)" 10.8 16.1 2.3 5.6 2.5 5.3 8.8 2.6 4.1 7.0 2.6 8.1 5.5 7.0 2.7 7.9 5.9 5.7 7.3 2.1 3.1 9.8 9.7 5.6 5.9 3.0 2.8 9.2 6.4 11.8 6.3 6.9 2.9 6.9 8.6 5.8 6.9 6.5 13.8 6.3 6.0 6.2 2.7 5.6 7.1 4.2 2.4 6.4 12.3 11.9 7.3 7.3 7.9 3.7 20.6 17.8 12.6 3.9 11.7 17.0 11.4 18.8 13.8 10.0 8.3 12.6 6.5 17.3 8.5 15.4 17.6 7.1 14.0 9.2 18.3 14.8 5.9 16.0 12.9 15.7 8.1 31.2 9.1 8.4 11.2 8.9 10.7 11.6 15.1 9.4 14.2 9.7 12.8 20.8 18.2 3.0 6.4 19.9 8.6 7.7 17.4 6.6 9.6 10.0 5.8 4.5 9.2 5.5 5.4 4.8 10.5 9.8 22.1 6.5 7.5 4.8 17.1 5.4 7.9 13.6 16.7 25.4 8.4 3.7 3.6 2.6 4.6 5.6 3.6 3.2 4.5 5.1 6.5 2.6 3.8 4.4 3.7 5.6 3.1 3.4 5.3 3.4 2.3 2.5 2.6 4.1 2.1 3.1 3.0 2.8 2.9 2.7 2.4 3.7 17.6 9.6 11.7 14.7 11.6 6.4 17.2 17.3 11.4 39.8 13.7 10.0 14.3 12.8 16.7 9.2 116.7 13.3 7.7 13.1 7.9 15.2 25.5 22.3 11.9 12.8 5.4 10.7 11.7 16.2 18.0 13.8 9.7 14.2 8.2 10.4 8.2 18.1 14.7 8.4 10.2 12.7 16.2 10.6 7.2 9.8 5.9 12.0 10.6 2.8 11.4 19.2 9.2 7.5 17.1 14.6 15.8 6.0 11.3 12.2 9.6 26.4 15.7 20.0 0.0 16.5 10.4 26.9 8.5 10.5 11.1 22.0 10.0 16.6 12.1 15.4 GTF2E1 "FE, TFIIE-A" ENSG00000153767 "General transcription factor IIE subunit 1" P29083 3 120742637-120783069 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009884, HPA056359, HPA066881" Supported Enhanced Nucleoplasm NA NA "Cluster 38: Basophils - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "CAB009884: AB_2279381, HPA056359: AB_2683106, HPA066881: AB_2685740" "unprognostic (3.19e-1)" "unprognostic (1.40e-1)" "unprognostic (2.05e-1)" "unprognostic (1.05e-2)" "unprognostic (8.94e-2)" "unprognostic (3.23e-1)" "unprognostic (4.36e-3)" "unprognostic (2.62e-1)" "unprognostic (2.64e-2)" "unprognostic (1.59e-1)" "unprognostic (4.38e-2)" "unprognostic (9.34e-3)" "unprognostic (5.10e-2)" "unprognostic (8.29e-3)" "unprognostic (4.94e-1)" "unprognostic (3.19e-2)" "unprognostic (2.97e-1)" 5.2 7.7 4.2 6.6 4.9 4.4 5.1 4.6 5.5 4.9 7.9 5.0 4.6 4.6 4.5 4.2 4.2 3.7 5.1 4.4 4.8 4.3 5.0 4.9 9.1 5.0 4.7 5.7 4.5 4.6 2.9 6.6 4.9 4.6 5.8 5.6 4.2 5.6 7.0 3.6 4.2 5.7 4.5 7.7 4.7 9.9 4.9 8.3 5.5 9.3 9.0 5.5 4.2 5.4 13.7 18.7 23.0 14.1 16.9 7.8 20.0 9.0 8.2 13.8 14.7 22.5 9.6 22.3 15.3 6.8 10.7 16.1 21.4 11.8 19.2 15.6 5.0 28.7 12.8 19.0 13.1 26.1 16.8 10.4 12.6 10.3 14.5 9.4 21.4 18.9 20.4 11.3 14.8 15.6 21.6 13.2 22.0 13.1 17.2 17.7 27.0 16.6 13.8 8.6 4.9 15.1 13.5 11.6 12.6 20.6 14.7 19.8 18.9 12.9 14.0 4.1 10.2 9.9 11.8 31.5 13.5 26.0 12.5 18.0 7.2 11.6 6.6 11.2 8.3 9.3 8.1 9.5 8.7 7.3 8.6 8.4 5.0 10.8 10.5 4.1 10.2 7.6 4.2 4.9 4.6 5.5 4.4 4.8 5.0 4.7 4.9 4.5 4.9 5.4 4.1 3.2 4.4 3.3 6.8 1.9 3.0 4.1 3.4 5.3 4.6 1.8 4.9 8.6 6.3 7.3 0.0 9.0 4.7 3.8 5.9 5.1 7.7 8.1 6.0 5.4 1.2 5.5 3.8 4.4 8.4 3.8 3.1 6.1 12.7 9.1 7.5 5.3 9.2 16.8 4.0 3.2 6.1 8.3 2.2 2.9 2.1 7.0 3.6 8.4 12.5 5.5 14.4 4.5 7.2 4.9 2.5 4.9 5.3 3.3 3.4 5.9 5.1 4.4 0.0 3.5 3.9 14.3 22.8 2.8 2.6 8.8 5.7 9.7 3.9 3.1 STXBP5L "KIAA1006, LLGL4" ENSG00000145087 "Syntaxin binding protein 5 like" Q9Y2K9 3 120908072-121424761 "Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 69.0" "Group enriched" "Detected in some" 10 "Excitatory neurons: 1544.2;Inhibitory neurons: 529.4;Oligodendrocyte precursor cells: 390.6" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 6 "cerebellum: 69.0;cerebral cortex: 25.6;hippocampal formation: 19.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.4;HeLa: 4.7;MOLT-4: 6.6;NTERA-2: 3.5;RH-30: 3.3;SCLC-21H: 8.8;SH-SY5Y: 3.9;U-937: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (2.42e-1)" "unprognostic (9.47e-2)" "unprognostic (6.30e-2)" "unprognostic (2.85e-3)" "unprognostic (1.75e-1)" "unprognostic (2.89e-2)" "unprognostic (7.01e-2)" "unprognostic (1.41e-1)" "unprognostic (1.48e-1)" "unprognostic (6.73e-3)" "unprognostic (2.52e-1)" "unprognostic (6.52e-3)" "unprognostic (5.13e-2)" "unprognostic (3.58e-1)" "unprognostic (1.86e-3)" "unprognostic (8.61e-3)" 0.0 1.8 3.8 0.0 6.4 0.0 0.0 69.0 25.6 0.6 0.0 1.2 0.3 0.9 0.0 0.3 0.1 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 4.3 0.0 9.4 0.2 0.0 2.9 0.0 3.8 2.1 0.2 4.3 0.1 3.0 0.0 0.0 0.3 0.8 0.0 0.0 0.4 2.1 0.0 0.0 7.6 0.0 0.0 0.9 0.3 4.4 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 4.7 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 6.6 0.0 3.5 0.0 0.7 0.0 3.3 0.0 0.0 0.6 8.8 3.9 0.0 0.0 0.1 0.0 0.9 2.5 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 1.7 4.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 6.4 69.0 25.6 19.1 0.0 4.3 0.0 3.8 0.0 0.0 4.4 0.0 0.0 0.0 51.2 0.0 0.1 0.9 0.0 0.0 32.8 0.0 0.0 0.5 0.0 0.0 0.0 75.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.3 0.1 12.1 0.0 1544.2 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 10.1 529.4 0.6 0.0 0.0 0.0 12.8 2.8 0.0 0.0 24.4 0.0 0.8 0.0 390.6 27.9 0.1 0.1 0.4 0.0 0.9 0.0 0.1 0.0 1.1 0.0 0.7 0.3 11.2 7.2 0.0 0.0 0.0 0.0 3.6 0.0 0.2 POLQ POLH ENSG00000051341 "DNA polymerase theta" O75417 3 121431427-121546641 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 6.0;lymphoid tissue: 4.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 16.4;Excitatory neurons: 9.5;Granulosa cells: 12.6;Inhibitory neurons: 7.8;Plasma cells: 12.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 2.5" HPA053359 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Golgi apparatus, Cytosol" "HPA053359: " "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (2.70e-1)" "unprognostic (6.23e-3)" "unprognostic (3.09e-5)" "unprognostic (8.55e-3)" "unprognostic (1.09e-4)" "unprognostic (2.86e-1)" "unprognostic (5.59e-5)" "unprognostic (2.06e-3)" "unprognostic (0.00e+0)" "prognostic favorable (1.04e-4)" "unprognostic (1.76e-1)" "unprognostic (6.01e-2)" "unprognostic (5.76e-2)" 0.1 0.2 0.0 1.6 0.1 6.0 0.4 1.0 0.2 0.2 0.0 1.2 1.2 0.2 0.0 2.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.2 2.8 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 2.0 0.0 0.3 0.0 0.0 1.4 0.9 0.4 0.0 0.8 0.5 2.2 0.0 4.5 0.0 0.0 2.3 0.3 0.5 0.0 18.2 12.1 10.2 7.2 0.9 1.2 9.2 8.5 3.2 9.7 12.9 9.8 6.6 21.5 3.7 4.6 11.7 14.0 12.2 5.4 16.4 6.3 6.7 13.8 8.0 6.1 0.1 15.1 12.1 0.2 0.4 8.9 5.4 1.7 4.9 7.9 9.3 15.9 10.3 7.1 13.7 8.8 9.7 5.5 5.9 11.4 12.2 7.6 3.1 10.3 5.5 5.0 9.8 5.2 3.4 8.8 4.8 14.8 3.8 8.6 11.2 3.4 11.1 8.0 6.9 21.8 4.1 11.0 6.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 1.6 0.7 0.9 0.5 0.6 0.0 0.9 0.6 0.6 1.6 0.0 2.0 0.0 0.0 3.1 0.6 1.6 0.0 0.1 0.4 0.9 1.0 0.5 0.0 16.4 9.5 0.0 3.3 1.2 4.6 1.0 0.0 12.6 0.0 0.2 2.3 0.0 7.8 1.6 2.0 1.3 1.2 0.7 0.3 1.7 0.0 1.0 0.6 0.4 0.0 1.5 1.3 0.2 1.2 0.0 12.2 0.5 0.2 0.1 2.4 0.2 0.0 0.1 1.0 6.8 3.4 4.9 0.1 0.3 1.8 0.9 3.2 0.8 ARGFX ENSG00000186103 "Arginine-fifty homeobox" A6NJG6 3 121567949-121590622 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.4" "Cell type enhanced" "Detected in some" "Inhibitory neurons: 1.0;Oligodendrocyte precursor cells: 1.5" "Cancer enriched" "Detected in single" 119 "testis cancer: 6.4" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.7" HPA043049 Uncertain NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA043049: AB_2678288" "unprognostic (6.00e-2)" 0.1 0.2 0.7 0.3 0.7 1.2 0.3 2.4 1.1 0.0 0.7 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.8 0.4 0.1 0.1 0.1 0.4 0.7 0.2 0.2 0.4 0.1 0.0 0.2 0.7 0.2 0.2 0.6 0.4 0.1 0.5 0.8 0.3 0.1 0.0 0.3 0.4 0.3 0.6 0.1 0.3 0.1 0.3 0.1 0.0 1.9 0.1 0.2 0.3 0.3 0.1 0.1 0.4 0.1 0.0 0.1 0.1 0.3 0.4 0.6 0.1 0.1 0.1 0.4 0.1 0.1 0.0 0.2 0.3 0.3 0.6 0.3 0.1 0.5 0.9 0.1 0.5 0.1 0.1 0.2 0.0 0.4 0.3 0.8 0.0 0.3 0.2 0.5 0.4 0.1 0.1 0.3 0.2 0.2 0.2 0.5 0.3 0.3 0.2 1.7 0.1 0.3 0.2 0.2 0.4 0.4 0.3 0.4 0.1 0.5 0.2 0.4 0.3 0.3 0.2 1.3 0.4 0.3 0.3 0.3 0.2 0.4 0.3 0.2 0.1 0.6 0.3 0.3 1.8 0.6 0.3 0.4 0.2 0.1 0.7 0.7 2.4 1.1 0.8 0.4 0.7 0.2 0.7 0.0 0.6 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FBXO40 "Fbx40, KIAA1195" ENSG00000163833 "F-box protein 40" Q9UH90 3 121593379-121630295 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 97 "heart muscle: 90.4;skeletal muscle: 162.2;tongue: 100.3" "Cell type enriched" "Detected in some" 33 "Cardiomyocytes: 416.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "pons and medulla: 1.7" "Low region specificity" "Detected in many" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (1.67e-2)" "unprognostic (1.23e-4)" "unprognostic (9.17e-2)" "unprognostic (6.65e-2)" "unprognostic (2.62e-1)" "unprognostic (1.43e-2)" "unprognostic (1.22e-1)" "unprognostic (7.01e-2)" "unprognostic (2.91e-1)" "unprognostic (2.50e-1)" "unprognostic (3.48e-2)" "unprognostic (1.01e-1)" "unprognostic (4.14e-1)" "unprognostic (4.30e-2)" 0.2 0.1 0.3 0.0 0.7 0.6 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.0 1.2 0.1 0.0 90.4 0.5 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.1 0.8 0.0 162.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 100.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.3 0.7 0.0 0.7 0.5 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 416.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.8 0.0 0.0 2.8 0.0 0.1 9.6 0.0 0.2 0.0 12.4 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 2.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 2.3 0.0 0.0 0.0 0.1 0.0 0.2 0.6 0.0 0.0 HCLS1 "CTTNL, HS1" ENSG00000180353 "Hematopoietic cell-specific Lyn substrate 1" P14317 3 121631399-121660927 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 153.6;lymphoid tissue: 300.3" "Cell type enhanced" "Detected in many" "B-cells: 175.7;Kupffer cells: 666.3;Macrophages: 269.0;monocytes: 245.7;NK-cells: 216.3;T-cells: 181.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 265.6;HMC-1: 362.3;RPMI-8226: 256.5;THP-1: 262.8;U-266/70: 361.6;U-698: 371.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019143 Enhanced Supported "Plasma membrane,Cytosol" NA NA 870000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane, Cytosol" "HPA019143: AB_1850532" "unprognostic (2.27e-2)" "unprognostic (1.79e-3)" "unprognostic (5.38e-3)" "unprognostic (6.29e-2)" "unprognostic (1.01e-2)" "unprognostic (4.02e-3)" "unprognostic (2.35e-1)" "unprognostic (4.88e-3)" "unprognostic (1.70e-2)" "unprognostic (1.19e-1)" "unprognostic (6.76e-2)" "unprognostic (2.28e-1)" "unprognostic (1.03e-3)" "unprognostic (2.93e-1)" "unprognostic (3.46e-2)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" 67.0 32.9 14.6 147.2 14.7 153.6 25.5 15.4 18.7 20.7 15.8 29.2 21.2 13.7 6.4 15.7 21.5 37.8 18.4 14.3 17.0 21.5 39.1 52.7 207.6 21.6 17.5 9.4 11.9 7.7 14.6 51.4 20.8 15.8 31.4 2.3 16.0 11.1 7.3 11.1 68.7 34.6 18.5 300.3 27.1 4.5 18.2 140.3 15.4 18.8 242.8 53.0 13.7 23.0 0.8 0.0 0.2 0.1 20.9 11.5 5.7 4.1 4.0 0.8 1.6 0.1 0.0 265.6 124.6 0.0 0.2 0.3 6.9 9.9 1.1 120.6 0.0 172.6 0.0 0.0 11.6 192.4 362.3 2.2 0.5 0.0 1.5 0.0 153.4 106.2 35.1 235.9 0.0 0.0 137.9 162.9 0.3 0.2 4.5 137.1 0.2 256.5 0.0 68.0 0.3 0.2 0.2 0.4 0.6 0.6 0.1 262.8 203.5 0.0 2.0 0.3 0.9 361.6 118.1 371.5 1.9 181.5 0.2 357.3 713.1 1180.9 405.3 870.4 333.0 345.7 334.2 376.8 636.2 313.1 279.3 326.2 1619.2 280.0 997.1 197.4 494.2 1427.9 14.6 14.7 15.4 18.7 14.3 17.0 21.6 17.5 20.8 18.5 18.2 23.0 23.0 9.6 31.8 1.0 175.7 3.2 1.0 7.8 0.6 0.5 2.7 5.1 2.3 4.3 13.1 0.0 0.0 122.4 139.5 0.8 0.0 0.3 1.1 8.8 1.6 23.3 0.0 50.5 1.4 0.2 60.0 7.0 8.6 3.1 73.4 0.7 27.8 7.7 126.9 0.0 0.7 0.4 4.1 666.3 105.8 1.5 3.4 269.0 19.6 26.2 245.7 0.4 216.3 0.5 0.3 0.2 0.2 1.2 148.6 0.4 0.1 0.9 24.7 0.8 13.1 3.7 6.7 0.6 0.6 1.3 4.4 145.4 181.4 2.4 0.5 2.2 GOLGB1 "GCP, GCP372, giantin, GOLIM1" ENSG00000173230 "Golgin B1" Q14789 3 121663199-121749767 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011008, HPA011555" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 51: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" "HPA011008: AB_1079011, HPA011555: AB_1079010" "unprognostic (2.56e-2)" "unprognostic (7.69e-2)" "unprognostic (1.46e-1)" "unprognostic (6.57e-2)" "unprognostic (5.34e-2)" "unprognostic (5.96e-2)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (6.58e-2)" "unprognostic (7.49e-2)" "unprognostic (3.65e-3)" "unprognostic (1.31e-1)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.37e-1)" "unprognostic (9.90e-3)" "unprognostic (9.05e-2)" 19.9 25.2 11.0 7.1 12.7 14.1 24.1 15.0 12.9 21.9 26.5 18.8 12.2 17.4 32.1 15.1 15.8 13.3 18.5 13.2 10.5 18.6 17.9 15.3 8.4 8.5 9.9 21.9 27.1 20.7 25.0 13.4 9.0 25.8 17.1 31.0 25.2 19.9 14.2 20.2 19.0 10.0 9.6 16.6 19.7 14.6 9.3 11.3 21.0 11.1 9.8 16.3 15.7 11.5 19.9 15.7 15.3 9.9 28.8 31.0 9.6 12.6 27.5 11.9 13.4 13.8 7.1 4.3 10.4 23.6 11.9 9.0 9.2 13.7 14.1 6.3 17.5 12.2 20.1 19.2 17.2 13.7 16.0 25.4 31.9 7.5 18.7 25.8 15.3 7.3 5.8 9.6 12.7 14.3 4.1 9.9 9.9 19.1 16.4 5.4 12.0 10.3 17.7 20.2 10.8 12.0 15.5 11.0 16.7 17.3 13.6 15.2 21.5 11.4 6.9 4.9 9.2 17.8 11.4 7.2 15.3 6.6 4.3 1.6 4.1 4.3 4.3 2.2 3.5 3.4 3.5 3.3 2.6 2.8 3.3 3.6 15.4 3.9 1.7 5.5 3.9 1.6 11.0 12.7 15.0 12.9 13.2 10.5 8.5 9.9 9.0 9.6 9.3 11.5 118.9 291.7 233.9 101.2 97.3 51.6 89.1 62.1 96.8 101.4 110.2 130.3 274.8 74.4 179.2 53.3 123.0 78.7 134.7 148.6 11.7 104.3 56.0 247.9 186.4 102.7 91.9 36.8 72.9 111.0 53.0 135.5 144.8 284.0 115.6 220.7 74.3 68.9 34.5 69.0 80.2 176.8 65.1 47.2 48.3 23.8 198.5 82.1 33.8 68.4 76.8 82.1 54.6 50.3 72.8 100.2 95.7 199.0 176.0 74.9 79.9 29.3 165.7 193.6 85.5 165.9 120.5 155.0 66.8 70.2 45.7 150.8 102.6 197.7 101.7 88.3 IQCB1 "KIAA0036, NPHP5, SLSN5" ENSG00000173226 "IQ motif containing B1" Q15051 3 121769761-121835079 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Calmodulin-binding "Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 155.3;Spermatogonia: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 131.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042028 Approved Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 43: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA042028: AB_2677806" "unprognostic (3.82e-2)" "prognostic favorable (1.77e-4)" "unprognostic (2.16e-1)" "unprognostic (4.10e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (3.08e-5)" "prognostic favorable (3.67e-4)" "unprognostic (1.42e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "unprognostic (6.78e-3)" "unprognostic (1.50e-3)" "unprognostic (2.59e-3)" "unprognostic (2.75e-1)" "unprognostic (1.67e-1)" "unprognostic (4.75e-3)" 11.6 11.2 9.6 14.7 10.0 20.4 23.1 11.0 10.5 15.7 10.8 13.0 12.0 15.5 19.7 12.5 16.6 12.1 9.7 10.1 10.1 12.2 8.9 12.3 24.3 9.7 9.5 17.9 18.3 13.9 15.3 11.5 9.5 15.9 16.2 18.9 15.6 15.5 11.4 15.5 14.1 11.8 9.7 18.3 12.3 28.9 10.4 22.1 10.5 5.7 25.7 14.2 13.7 11.0 38.3 10.1 48.9 55.5 7.5 11.6 57.2 17.4 10.8 19.7 23.8 33.6 18.1 76.8 23.9 10.1 30.2 28.7 30.5 14.5 29.3 15.1 23.8 51.2 22.2 28.7 20.0 64.1 14.8 7.4 27.2 13.7 30.3 10.2 15.2 32.4 31.0 27.9 22.3 19.3 41.7 44.5 40.1 22.6 18.1 40.4 23.4 24.9 11.4 16.9 26.0 20.9 17.3 12.2 31.3 16.0 10.8 49.4 12.9 18.5 22.4 9.1 23.4 66.4 44.9 131.2 17.9 29.0 17.1 3.2 6.6 11.7 7.2 12.3 10.5 22.8 9.8 9.0 9.6 21.6 11.5 7.2 2.8 12.2 14.1 8.7 11.7 6.4 9.6 10.0 11.0 10.5 10.1 10.1 9.7 9.5 9.5 9.7 10.4 11.0 15.8 6.4 15.0 48.3 28.4 18.9 19.2 20.0 19.9 15.2 19.6 17.3 8.4 11.5 26.5 11.0 27.1 26.6 21.9 7.7 3.9 11.1 3.7 31.1 12.7 11.2 7.2 21.5 60.1 12.9 8.2 15.4 11.7 12.6 8.8 21.9 6.8 6.2 10.5 13.5 66.8 8.6 20.3 9.8 14.1 7.4 15.5 11.3 14.2 51.5 15.8 12.8 17.5 49.3 59.5 13.9 8.2 13.5 45.2 15.7 7.9 7.5 69.2 27.7 13.1 17.8 15.9 155.3 96.5 16.2 20.6 14.1 19.9 8.4 11.9 16.3 EAF2 "BM040, TRAITS, U19" ENSG00000145088 "ELL associated factor 2" Q96CJ1 3 121835183-121886526 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 71.8;lymphoid tissue: 53.6" "Cell type enhanced" "Detected in many" "B-cells: 73.7;Plasma cells: 144.1;Proximal tubular cells: 128.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "memory B-cell: 104.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 73.5;HL-60: 114.9;THP-1: 59.9;U-698: 93.5;U-937: 64.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA008411 Enhanced NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA008411: AB_1847950" "unprognostic (3.43e-1)" "prognostic favorable (2.25e-9)" "unprognostic (1.48e-1)" "prognostic favorable (2.66e-4)" "unprognostic (1.00e-1)" "unprognostic (3.18e-2)" "unprognostic (1.89e-3)" "unprognostic (7.04e-2)" "unprognostic (2.04e-1)" "unprognostic (2.18e-1)" "unprognostic (2.08e-1)" "unprognostic (1.14e-1)" "unprognostic (2.08e-2)" "unprognostic (2.55e-1)" "unprognostic (1.81e-1)" "unprognostic (9.04e-2)" "unprognostic (8.34e-2)" 4.3 2.6 2.3 19.5 2.0 71.8 10.0 2.1 3.1 5.5 1.5 10.3 8.9 2.0 4.9 2.7 1.4 5.0 1.7 2.7 2.4 30.2 3.5 4.3 53.6 2.1 2.4 1.0 4.2 3.1 3.3 2.9 2.2 21.0 11.6 1.7 7.6 8.4 0.8 1.0 7.7 3.5 1.4 16.9 8.2 4.6 3.0 7.7 1.7 1.3 43.4 7.8 1.4 2.0 3.5 3.0 2.0 2.5 0.7 2.1 6.0 1.3 0.8 2.4 4.4 5.8 2.0 73.5 1.5 0.3 7.7 5.7 5.0 3.0 6.0 35.8 2.9 42.4 3.0 11.1 1.0 114.9 44.7 1.0 6.9 2.8 2.6 0.0 2.3 10.0 5.0 14.2 1.1 1.0 16.3 15.1 2.9 13.8 2.5 17.1 6.4 11.2 2.4 4.3 2.5 0.6 2.1 2.0 5.7 5.5 1.8 59.9 0.7 1.5 2.4 1.4 3.4 25.4 12.2 93.5 2.8 64.0 4.7 11.9 18.8 42.8 1.4 41.2 2.8 104.4 2.2 1.5 22.5 97.4 2.9 1.6 3.5 1.8 54.7 30.5 2.7 13.1 2.3 2.0 2.1 3.1 2.7 2.4 2.1 2.4 2.2 1.4 3.0 2.0 4.5 3.2 4.2 48.0 73.7 2.4 6.9 25.0 6.2 1.3 5.9 6.6 4.3 0.0 16.5 1.8 4.2 15.5 15.3 2.9 17.6 4.4 36.4 4.3 2.0 2.5 1.2 10.3 17.3 17.6 2.2 4.9 7.7 7.7 10.1 2.5 3.9 1.6 16.5 0.0 28.6 5.7 16.2 32.4 15.7 4.6 5.0 29.8 16.0 8.4 29.5 9.4 6.2 12.1 7.7 4.2 4.7 3.0 144.1 11.1 2.4 128.0 9.1 5.3 0.0 4.5 4.6 37.6 18.1 2.3 2.4 7.7 11.1 2.2 3.5 5.9 SLC15A2 PEPT2 ENSG00000163406 "Solute carrier family 15 member 2" Q16348 3 121894401-121944188 "Metabolic proteins, Predicted membrane proteins, Transporters" "Immunity, Innate immunity, Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 50.9;epididymis: 39.2;prostate: 39.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 99.3;Astrocytes: 139.7;Club cells: 64.8;Microglial cells: 49.6;Muller glia cells: 51.4" "Cancer enhanced" "Detected in many" "prostate cancer: 12.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 5.7;U-937: 4.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 37: B-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "unprognostic (4.72e-2)" "prognostic favorable (2.37e-4)" "unprognostic (3.50e-2)" "prognostic favorable (6.96e-4)" "unprognostic (1.80e-2)" "unprognostic (1.78e-1)" "unprognostic (8.03e-3)" "prognostic favorable (6.74e-4)" "unprognostic (3.21e-1)" "unprognostic (1.28e-1)" "unprognostic (9.92e-2)" "unprognostic (1.43e-1)" "unprognostic (5.53e-3)" "unprognostic (1.63e-1)" "unprognostic (2.58e-1)" "unprognostic (2.67e-2)" "unprognostic (4.60e-2)" 1.0 1.3 14.0 3.0 15.0 5.9 4.8 10.1 15.0 50.9 2.4 2.6 2.2 2.0 39.2 3.4 11.3 6.3 2.0 12.9 11.8 11.0 0.9 20.1 6.0 9.4 13.6 0.8 5.5 1.7 3.4 2.2 12.6 39.7 2.9 20.9 24.6 22.0 0.8 0.9 2.0 1.2 9.0 6.0 1.6 4.1 17.1 1.6 6.7 0.4 6.0 4.9 2.3 7.7 1.3 0.6 0.7 0.2 0.8 0.4 0.9 0.1 0.1 0.3 0.4 1.2 2.1 2.4 0.1 0.1 0.4 1.4 0.5 1.2 0.4 2.0 0.5 3.3 1.0 0.6 0.1 3.6 3.2 0.7 3.6 0.4 0.2 0.4 0.2 0.7 0.5 1.0 0.4 1.0 0.7 5.7 3.7 1.4 0.3 0.8 0.3 0.7 0.8 0.8 0.3 0.3 0.3 0.2 0.1 1.1 0.2 3.1 0.1 0.3 0.2 0.2 0.3 1.2 0.4 3.3 0.4 4.8 0.3 0.9 0.4 0.1 0.0 0.1 0.1 1.3 0.1 0.0 0.1 1.3 0.1 0.1 0.2 0.0 1.0 0.6 0.0 0.1 14.0 15.0 10.1 15.0 12.9 11.8 9.4 13.6 12.6 9.0 17.1 7.7 0.4 99.3 22.8 139.7 5.9 0.5 2.8 22.5 1.2 1.0 5.0 2.0 2.6 4.3 64.8 11.0 0.0 2.5 3.2 1.4 3.9 0.6 0.4 8.9 2.0 1.0 0.0 1.7 15.4 8.3 0.6 1.3 0.5 21.3 3.8 1.0 1.4 0.0 2.7 0.0 22.6 1.4 14.2 13.5 3.8 0.6 6.5 5.3 0.0 49.6 3.1 51.4 1.0 16.6 5.0 2.0 1.0 5.3 7.7 14.4 0.2 1.6 28.8 2.9 0.0 0.9 2.4 0.4 0.5 10.4 0.6 1.4 1.2 0.3 1.6 12.7 ILDR1 "DFNB42, MGC50831" ENSG00000145103 "Immunoglobulin like domain containing receptor 1" Q86SU0 3 121987323-122022247 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 15.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 12.8;Club cells: 14.7;Collecting duct cells: 20.2;Cytotrophoblasts: 16.6;Distal enterocytes: 17.5;Glandular and luminal cells: 13.5;Respiratory ciliated cells: 13.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 4 "B-cells: 1.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.3;HDLM-2: 8.2;MCF7: 5.1;RT4: 7.5;T-47d: 5.3;U-266/70: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA018207 Approved "Intracellular and membrane" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 37: Intestine - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA018207: AB_1851742" "unprognostic (2.69e-1)" "unprognostic (1.28e-2)" "unprognostic (9.24e-2)" "unprognostic (4.46e-3)" "unprognostic (9.73e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-2)" "unprognostic (2.80e-2)" "unprognostic (2.00e-1)" "unprognostic (2.04e-1)" "unprognostic (7.78e-2)" "unprognostic (2.37e-1)" "prognostic favorable (5.79e-9)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "unprognostic (3.25e-3)" "unprognostic (2.21e-2)" 0.0 0.7 0.2 1.3 0.1 0.3 2.9 0.2 0.3 11.7 0.1 8.2 3.3 1.0 12.8 3.8 5.1 3.3 0.0 0.1 0.0 6.5 0.2 2.9 1.1 0.1 0.1 0.0 6.7 15.7 2.4 1.8 0.1 6.9 7.2 0.2 8.0 10.6 0.1 1.2 2.4 0.3 0.0 0.6 0.8 0.6 0.1 0.8 7.3 0.0 2.2 2.2 1.1 0.1 2.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 6.3 1.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 8.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 5.1 0.0 0.1 0.0 1.2 0.0 0.0 0.0 2.4 2.8 7.5 0.2 0.0 0.0 0.7 0.0 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.0 6.1 1.4 1.1 0.0 0.1 0.0 0.2 0.2 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.2 1.1 0.1 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.2 0.1 0.2 0.3 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 12.8 7.4 0.3 1.3 0.0 0.8 7.5 0.0 0.0 4.2 2.4 0.7 4.3 14.7 20.2 0.0 16.6 0.1 17.5 1.9 7.5 0.2 6.3 1.6 0.1 3.5 0.0 0.5 3.7 0.5 0.1 1.1 13.5 0.0 0.2 0.0 0.1 1.2 0.0 0.5 7.9 8.2 0.6 0.0 0.0 0.0 0.3 1.8 1.9 0.0 0.0 0.0 0.0 0.2 2.6 8.9 0.0 2.1 2.2 2.5 2.1 13.7 0.0 0.0 0.0 0.6 0.0 0.1 5.9 0.6 5.1 0.1 0.0 7.8 3.5 CD86 "B7-2, B7.2, CD28LG2" ENSG00000114013 "CD86 molecule" P42081 3 122055362-122121139 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 34.5" "Cell type enhanced" "Detected in many" "Hofbauer cells: 121.3;Kupffer cells: 107.8;Langerhans cells: 148.3;Macrophages: 151.8;Microglial cells: 78.7;monocytes: 489.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "classical monocyte: 79.9;intermediate monocyte: 79.0;memory B-cell: 41.0;myeloid DC: 78.8;naive B-cell: 28.5;non-classical monocyte: 85.2" "Group enriched" "Detected in many" 18 "B-cells: 41.0;dendritic cells: 78.8;monocytes: 85.2" "Cell line enriched" "Detected in some" 7 "HDLM-2: 296.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004319, HPA026802" Approved Supported "Plasma membrane,Centriolar satellite" NA NA 160000 "Cluster 7: Monocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 3: Monocytes - Immune response regulation" "Plasma membrane" "Centriolar satellite" "CAB004319: AB_627200, HPA026802: " "unprognostic (1.81e-1)" "unprognostic (3.78e-3)" "unprognostic (3.04e-2)" "unprognostic (3.52e-2)" "unprognostic (1.36e-1)" "unprognostic (2.79e-1)" "unprognostic (1.15e-1)" "unprognostic (8.56e-2)" "unprognostic (7.72e-3)" "unprognostic (1.21e-1)" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "prognostic unfavorable (9.83e-5)" "unprognostic (9.72e-2)" "unprognostic (1.70e-2)" "unprognostic (9.78e-2)" "unprognostic (8.67e-2)" 7.8 5.3 3.5 34.5 3.4 10.3 4.4 4.0 3.6 3.5 4.8 6.3 3.7 2.4 1.0 4.0 2.1 14.3 2.7 3.2 6.1 1.9 11.2 18.6 28.8 7.2 5.5 2.1 2.6 2.9 1.1 15.0 7.0 2.4 7.7 0.9 2.3 2.5 0.8 2.0 6.8 7.4 5.3 23.4 5.2 3.1 5.0 10.6 1.3 0.8 22.0 14.9 1.0 10.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 40.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 296.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.2 0.0 32.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.4 0.0 0.1 0.0 0.1 15.1 0.6 35.1 0.0 0.9 0.0 0.1 79.9 0.8 0.0 79.0 0.0 41.0 0.2 0.3 78.8 28.5 0.2 0.1 0.9 3.7 85.2 8.3 1.6 33.4 3.5 3.4 4.0 3.6 3.2 6.1 7.2 5.5 7.0 5.3 5.0 10.2 0.9 0.0 7.7 0.3 36.5 3.6 0.1 1.3 0.0 0.0 0.4 1.3 0.3 1.5 3.2 1.8 0.0 1.8 3.3 0.0 0.0 0.2 3.7 0.1 0.0 2.6 0.0 1.3 0.2 3.5 0.8 0.8 0.5 0.0 2.5 0.1 1.8 0.8 121.3 0.0 0.3 0.0 0.0 107.8 148.3 2.7 0.0 151.8 7.2 78.7 489.4 0.0 0.0 0.5 0.1 0.3 0.0 0.0 20.6 0.3 0.0 0.1 0.1 0.4 0.0 0.3 0.7 0.2 0.3 0.2 4.0 1.9 2.1 0.1 0.0 0.3 CASR "FHH, GPRC2A, HHC, HHC1, NSHPT" ENSG00000036828 "Calcium sensing receptor" P41180 3 122183668-122291629 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "parathyroid gland: 654.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 25.6;Alveolar cells type 2: 20.2;Cholangiocytes: 27.1;Distal tubular cells: 13.7;Enteroendocrine cells: 11.5;Granulosa cells: 20.7;Respiratory ciliated cells: 15.3" "Cancer enriched" "Detected in some" 7 "pancreatic cancer: 5.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA039686, HPA050335" Enhanced NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 40: Granulosa cells - Unknown function" "HPA039686: AB_10673536, HPA050335: AB_2681092" "unprognostic (1.97e-2)" "unprognostic (7.40e-2)" "unprognostic (8.20e-4)" "unprognostic (3.15e-1)" "unprognostic (8.55e-4)" "unprognostic (1.58e-1)" "unprognostic (7.32e-2)" "unprognostic (7.67e-2)" "unprognostic (1.62e-1)" "unprognostic (1.48e-1)" "unprognostic (1.91e-5)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (1.24e-2)" 0.1 0.1 1.5 0.1 1.0 0.8 0.0 1.7 1.6 0.0 0.3 0.1 0.8 0.0 0.1 0.0 0.1 4.2 0.0 1.0 0.6 22.4 0.2 0.0 0.2 0.6 1.1 0.5 9.6 654.4 0.2 0.0 0.8 0.1 0.2 1.5 0.1 0.0 0.1 0.2 0.5 0.0 0.2 0.1 2.8 0.2 1.7 0.1 0.7 0.0 0.2 0.3 0.0 1.7 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.8 0.3 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.0 0.2 0.2 0.3 0.2 0.0 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.5 1.0 1.7 1.6 1.0 0.6 0.6 1.1 0.8 0.2 1.7 1.7 0.0 25.6 20.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 27.1 5.6 3.7 0.0 0.0 0.0 0.0 13.7 4.3 0.5 0.0 0.0 0.5 11.5 0.0 0.3 0.2 0.0 1.6 0.0 0.0 1.3 20.7 0.0 0.1 0.1 0.0 0.1 0.6 0.0 1.0 0.0 1.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.4 0.0 0.0 0.0 0.2 15.3 1.0 0.0 0.0 1.5 0.0 0.5 0.0 0.0 0.0 0.9 0.8 0.0 0.0 CSTA "STF1, STFA" ENSG00000121552 "Cystatin A" P01040 3 122325248-122341969 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 5912.9;vagina: 1853.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 2493.8;Club cells: 768.0;Kupffer cells: 579.4;monocytes: 1298.6;Squamous epithelial cells: 3020.6" "Cancer enhanced" "Detected in all" "cervical cancer: 227.7;head and neck cancer: 405.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 19 "classical monocyte: 514.7;intermediate monocyte: 269.1;myeloid DC: 382.9;neutrophil: 245.6;non-classical monocyte: 161.7" "Group enriched" "Detected in all" 193 "dendritic cells: 382.9;granulocytes: 245.6;monocytes: 514.7" "Cell line enhanced" "Detected in many" "HBEC3-KT: 282.0;hTCEpi: 1218.6;THP-1: 789.0;U-698: 504.5;U-937: 250.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000469, HPA001031, CAB047315" Enhanced Approved Nucleoplasm,Cytosol No No 28000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Cytosol" "CAB000469: , CAB047315: , HPA001031: AB_1078610" "unprognostic (5.22e-3)" "unprognostic (6.10e-2)" "unprognostic (2.64e-1)" "unprognostic (6.07e-2)" "unprognostic (7.79e-3)" "prognostic favorable (5.86e-4)" "unprognostic (4.46e-1)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (7.99e-2)" "unprognostic (2.56e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (8.89e-2)" "unprognostic (3.43e-2)" "unprognostic (9.24e-3)" "unprognostic (1.99e-1)" 30.7 4.7 0.8 27.1 0.9 297.8 56.3 1.0 3.7 961.0 1.4 3.8 1.1 2.2 10.3 5912.9 4.6 7.2 5.9 0.8 1.0 2.4 38.9 26.0 25.1 1.5 0.9 21.1 3.7 0.8 5.0 19.0 1.3 19.7 3.6 0.3 996.1 9.6 4.6 369.1 5.8 6.3 1.1 20.4 30.3 1.3 1.4 46.5 2.7 2.8 941.0 39.1 1853.3 1.6 14.6 1.3 0.2 3.2 31.5 58.0 2.9 0.6 0.8 0.0 0.0 0.0 0.0 3.2 7.6 5.9 0.5 86.9 0.0 282.0 0.0 0.3 0.2 0.7 0.0 6.8 6.8 117.6 1.9 30.5 1218.6 2.9 119.1 0.0 0.0 1.5 0.8 29.9 0.5 0.8 0.2 108.3 0.0 0.5 0.0 0.0 0.9 0.0 0.0 141.3 0.0 0.0 14.1 7.5 10.4 0.1 1.6 789.0 0.5 1.7 19.7 0.2 0.9 0.0 1.7 504.5 26.4 250.3 0.3 8.8 514.7 16.4 0.6 269.1 1.5 1.5 0.7 0.6 382.9 0.5 0.5 0.7 245.6 1.9 161.7 6.9 1.0 283.2 0.8 0.9 1.0 3.7 0.8 1.0 1.5 0.9 1.3 1.1 1.4 1.6 1.1 6.4 19.8 0.0 5.0 83.5 136.5 2493.8 117.8 0.0 7.1 119.8 0.2 2.8 768.0 0.0 0.0 230.6 7.4 3.9 0.0 2.1 0.4 0.3 0.4 3.0 0.0 3.8 0.1 22.1 17.8 13.6 12.8 0.3 13.9 0.1 6.1 96.0 134.5 0.0 0.1 0.5 179.0 579.4 90.6 2.4 10.2 243.7 8.8 0.0 1298.6 0.0 20.6 0.5 0.2 46.2 1.5 3.8 2.8 30.2 0.0 0.7 115.7 0.0 32.9 8.8 24.3 0.1 0.5 3020.6 205.0 334.2 4.9 26.1 2.0 134.1 CCDC58 FLJ33273 ENSG00000160124 "Coiled-coil domain containing 58" Q4VC31 3 122359591-122383231 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 114.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051965 Approved Approved Nucleoli,Mitochondria No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Mitochondria Nucleoli "HPA051965: AB_2681676" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (5.64e-2)" "unprognostic (6.98e-3)" "prognostic unfavorable (2.94e-5)" "unprognostic (2.72e-2)" "unprognostic (1.03e-2)" "unprognostic (4.98e-3)" "unprognostic (5.26e-3)" "unprognostic (1.84e-2)" "unprognostic (7.11e-3)" "unprognostic (1.03e-3)" "unprognostic (2.58e-1)" "unprognostic (1.86e-1)" "prognostic favorable (7.29e-4)" 14.7 21.0 16.9 15.7 17.8 18.0 19.0 18.2 28.2 10.7 18.4 28.5 22.5 11.7 24.6 23.2 10.6 13.4 27.3 17.1 17.6 46.8 49.8 9.0 23.3 17.8 18.1 13.1 13.8 14.9 7.8 14.4 18.2 11.1 29.1 17.1 11.3 10.6 78.8 15.0 18.6 11.4 17.4 12.1 16.4 9.4 18.1 16.2 18.3 47.2 21.5 22.6 12.5 18.3 135.1 41.9 78.2 50.2 28.5 39.8 100.6 50.5 54.3 119.4 116.4 118.4 66.4 98.0 84.6 38.6 92.7 91.9 127.9 86.3 142.5 34.1 45.3 115.9 28.5 145.6 47.5 174.5 39.5 33.0 43.9 73.5 79.8 50.7 55.9 85.8 133.6 41.6 63.7 67.2 111.7 123.6 150.0 147.2 78.1 72.8 92.9 120.1 83.7 70.3 78.8 38.4 58.5 61.5 150.5 65.3 61.2 112.8 32.6 66.4 86.1 28.6 102.3 32.9 47.5 217.4 75.7 83.3 60.0 0.9 7.7 2.7 15.2 16.7 18.0 20.9 19.9 20.1 16.5 19.2 23.0 22.2 1.4 19.2 14.2 29.2 17.2 6.7 16.9 17.8 18.2 28.2 17.1 17.6 17.8 18.1 18.2 17.4 18.1 18.3 5.7 3.2 17.0 8.1 18.1 15.3 19.1 21.4 21.1 10.5 14.1 10.4 32.0 20.0 22.2 12.9 10.4 21.8 8.4 19.6 54.8 31.4 0.5 24.7 20.5 13.7 5.4 14.1 11.3 30.0 44.7 12.8 16.8 26.2 21.5 14.4 10.8 50.5 17.8 0.0 13.2 27.7 16.2 8.7 7.6 1.5 12.8 8.9 8.8 2.8 19.8 9.7 16.5 11.6 11.8 31.9 14.7 8.2 12.5 30.7 23.9 114.0 22.5 9.6 13.1 15.1 41.8 23.1 31.0 30.8 18.5 15.2 10.9 11.8 35.1 23.0 FAM162A "C3orf28, E2IG5" ENSG00000114023 "Family with sequence similarity 162 member A" Q96A26 3 122384176-122412334 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 625.3;Distal tubular cells: 540.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035856, HPA075611" Approved Supported Mitochondria NA NA 19000 "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 21: OE19 - Mitochondria" "Cluster 10: Non-specific - Unknown function" Mitochondria "HPA035856: AB_10611965, HPA075611: " "unprognostic (1.17e-2)" "unprognostic (1.42e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" "unprognostic (3.99e-1)" "unprognostic (7.84e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (5.91e-3)" "unprognostic (8.74e-2)" "unprognostic (1.95e-2)" "unprognostic (7.91e-3)" "unprognostic (4.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (4.10e-2)" "prognostic favorable (3.93e-4)" 49.0 105.7 54.8 31.3 60.2 39.9 43.9 57.3 82.2 84.5 57.1 145.9 56.1 49.5 59.4 207.6 49.7 46.2 174.2 57.1 58.5 107.6 200.3 32.0 32.9 55.9 57.2 84.3 133.9 116.6 51.0 17.6 55.6 74.6 149.0 83.5 59.8 49.2 141.0 89.8 56.3 44.6 56.6 31.7 93.2 43.6 58.8 34.7 44.1 142.6 42.7 76.9 131.5 55.6 132.0 27.7 40.4 75.6 72.1 66.4 20.7 52.9 46.8 49.0 123.9 69.4 58.7 142.1 89.2 18.2 40.3 89.8 73.5 128.1 130.0 74.0 55.1 115.6 44.0 125.8 47.4 114.0 39.6 77.3 65.5 46.7 97.9 164.3 66.0 137.7 79.2 55.6 71.1 52.0 116.9 137.9 59.5 294.9 144.4 69.5 57.8 186.9 144.3 314.9 60.1 48.1 39.4 92.4 114.3 59.9 57.9 55.7 47.0 48.4 34.6 28.7 55.6 108.8 39.9 144.8 143.3 109.7 22.8 9.9 25.8 75.7 58.3 68.2 86.9 75.3 79.5 74.0 84.6 68.1 85.1 88.6 8.5 50.6 75.9 70.4 80.4 38.8 54.8 60.2 57.3 82.2 57.1 58.5 55.9 57.2 55.6 56.6 58.8 55.6 55.7 28.9 46.0 41.1 68.2 128.1 155.3 625.3 82.0 31.5 80.6 109.5 338.4 84.4 188.6 130.6 47.9 51.4 47.9 477.5 540.0 148.2 102.5 82.0 30.1 49.8 106.9 47.7 33.0 177.6 47.8 78.7 84.6 79.2 85.7 59.3 44.6 280.4 92.7 38.7 30.4 374.3 240.1 66.7 108.9 33.1 134.5 61.2 104.9 7.5 108.9 79.7 45.3 22.1 21.6 141.6 313.2 148.6 61.2 121.4 186.2 466.2 95.5 29.9 105.2 83.2 315.3 146.4 68.3 315.1 132.8 47.2 66.0 121.1 358.4 210.9 WDR5B FLJ11287 ENSG00000196981 "WD repeat domain 5B" Q86VZ2 3 122411846-122416062 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 16.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042994 Approved NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 49: Ciliated cells - Cilium organization" "HPA042994: AB_10960397" "unprognostic (5.61e-2)" "unprognostic (5.66e-2)" "unprognostic (2.09e-1)" "unprognostic (3.31e-1)" "unprognostic (1.12e-1)" "unprognostic (3.97e-2)" "unprognostic (2.05e-2)" "unprognostic (2.86e-2)" "unprognostic (3.74e-2)" "unprognostic (1.05e-1)" "unprognostic (1.76e-2)" "unprognostic (2.81e-1)" "unprognostic (6.13e-2)" "unprognostic (3.47e-2)" "unprognostic (1.95e-1)" "unprognostic (6.54e-2)" "unprognostic (7.45e-3)" 2.6 3.4 2.0 3.6 2.6 1.9 6.2 2.9 2.5 4.1 2.8 2.1 3.4 3.0 9.5 2.1 7.0 2.2 2.9 2.1 2.2 3.9 5.3 2.9 5.6 2.6 2.4 4.7 6.0 3.9 3.7 2.9 2.6 4.4 2.7 7.2 4.8 3.2 1.7 3.5 3.6 2.5 2.3 5.1 4.6 3.7 2.3 4.9 6.8 1.7 5.3 2.4 2.1 3.5 5.3 3.2 4.9 5.6 8.8 7.2 3.0 3.9 5.9 5.4 4.6 2.9 4.6 3.2 5.3 3.7 4.4 7.3 3.9 2.9 7.0 2.0 3.3 4.7 3.8 2.9 5.7 2.6 5.0 4.9 7.9 4.0 9.2 6.2 4.2 5.6 2.1 2.7 4.5 6.3 4.2 4.8 2.4 7.9 5.3 4.0 4.8 2.8 5.1 2.2 5.5 5.9 4.0 2.6 8.1 5.5 7.5 5.6 3.4 4.1 5.1 2.0 2.6 2.3 1.0 6.2 5.5 2.5 5.3 3.0 2.0 1.3 1.2 2.1 1.6 1.3 1.9 1.1 1.0 1.8 2.8 2.1 0.7 1.1 4.3 0.6 2.3 1.2 2.0 2.6 2.9 2.5 2.1 2.2 2.6 2.4 2.6 2.3 2.3 3.5 2.7 3.2 4.8 4.2 2.7 0.5 2.8 4.0 2.8 4.1 5.0 3.9 2.6 5.7 4.0 12.9 6.2 5.6 1.2 0.9 7.9 4.3 14.9 5.8 3.6 3.0 0.0 6.1 1.2 4.0 1.6 3.1 4.1 2.3 0.0 3.3 6.1 4.9 2.5 6.7 1.2 3.8 0.0 4.3 0.6 1.0 4.7 1.8 0.0 0.0 2.1 6.2 9.2 3.5 7.6 2.5 2.0 3.0 1.6 3.7 3.2 6.5 16.3 7.1 0.0 3.2 3.3 11.9 4.9 1.6 2.0 2.9 2.7 2.2 2.5 1.8 KPNA1 "IPOA5, NPI-1, RCH2, SRP1" ENSG00000114030 "Karyopherin subunit alpha 1" P52294 3 122421902-122514945 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 221.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053627, HPA063426" Supported Enhanced Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA053627: AB_2682211, HPA063426: AB_2685013" "unprognostic (6.23e-2)" "unprognostic (3.83e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.30e-1)" "unprognostic (4.02e-3)" "unprognostic (2.86e-1)" "unprognostic (1.40e-1)" "unprognostic (6.77e-3)" "unprognostic (7.89e-3)" "unprognostic (5.22e-2)" "unprognostic (9.09e-2)" "unprognostic (5.43e-1)" "unprognostic (4.02e-1)" "unprognostic (4.77e-1)" 20.2 18.4 10.0 19.8 10.6 11.4 11.9 10.6 15.0 14.1 6.7 15.5 13.0 13.6 15.1 21.8 12.9 12.1 20.3 11.6 10.7 16.1 32.0 13.0 15.7 11.2 10.2 10.6 18.8 19.2 9.0 15.9 11.2 15.1 15.4 28.6 12.4 16.3 74.4 13.5 13.6 23.0 11.6 12.3 14.5 20.6 10.7 15.5 17.9 41.0 20.6 22.1 11.4 12.6 75.1 43.4 73.2 37.2 46.6 51.2 23.2 56.5 47.5 60.4 54.4 52.6 35.6 54.1 50.6 62.4 47.8 38.3 58.2 48.2 88.9 14.8 22.1 66.6 37.1 29.5 27.3 59.8 29.5 35.7 61.0 43.7 60.9 29.5 67.3 28.8 47.6 30.5 55.8 34.6 43.7 14.1 31.8 52.5 46.2 44.1 60.8 34.8 26.2 51.8 50.4 30.3 60.5 32.6 50.1 56.9 43.2 34.8 57.9 37.7 41.2 18.7 44.1 29.1 31.8 99.9 52.7 40.9 39.1 27.1 19.3 18.8 17.4 19.5 18.6 15.8 15.2 19.3 25.4 12.7 15.4 15.8 41.5 21.2 29.3 7.9 17.6 18.2 10.0 10.6 10.6 15.0 11.6 10.7 11.2 10.2 11.2 11.6 10.7 12.6 27.9 16.0 31.8 53.5 31.9 41.4 22.2 15.8 28.5 30.1 24.2 12.3 31.1 22.8 32.9 14.7 31.3 21.2 31.5 18.6 13.7 23.2 120.1 35.0 26.1 27.6 16.3 49.2 107.2 33.4 25.9 26.1 19.4 29.5 38.7 18.6 22.5 50.2 23.3 20.2 81.7 19.7 18.3 27.9 47.4 221.8 22.4 30.0 17.8 61.8 31.5 22.2 26.8 59.8 91.7 35.1 19.8 24.8 36.6 34.5 18.6 23.1 44.8 47.4 13.1 25.4 32.1 42.1 18.0 27.1 45.5 24.9 31.3 19.6 14.0 27.5 PARP9 "ARTD9, BAL, BAL1" ENSG00000138496 "Poly(ADP-ribose) polymerase family member 9" Q8IXQ6 3 122527924-122564577 "Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 95.8;BJ hTERT+ SV40 Large T+ RasG12V: 113.4;SK-MEL-30: 93.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA066708 Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Cytosol" Mitochondria "HPA066708: AB_2685707" "unprognostic (3.06e-2)" "unprognostic (4.80e-2)" "unprognostic (1.55e-3)" "unprognostic (6.70e-3)" "unprognostic (1.11e-1)" "unprognostic (6.38e-2)" "unprognostic (4.73e-3)" "unprognostic (3.39e-3)" "unprognostic (1.31e-1)" "prognostic favorable (6.65e-4)" "unprognostic (1.00e-3)" "unprognostic (5.63e-3)" "unprognostic (1.56e-3)" "unprognostic (3.06e-2)" "unprognostic (3.70e-2)" "unprognostic (9.65e-3)" "unprognostic (1.56e-2)" 20.1 29.4 14.0 35.8 15.1 20.8 17.6 13.8 17.4 20.3 14.8 22.5 21.2 19.6 19.1 24.8 20.1 28.8 18.3 13.5 15.1 22.0 68.3 36.5 30.5 21.3 15.5 12.9 22.0 23.7 18.5 20.1 16.8 18.9 19.5 5.8 39.9 12.6 13.6 11.6 21.4 29.1 17.6 44.3 20.0 6.4 17.4 30.6 16.8 17.3 25.9 26.0 16.5 16.1 23.1 7.7 2.8 1.9 16.9 34.6 2.6 7.6 41.0 95.8 113.4 12.0 24.9 5.2 16.4 15.3 60.2 24.8 6.6 13.4 19.9 40.3 4.5 24.9 7.6 6.4 18.0 8.1 15.9 28.4 12.9 13.6 3.4 19.1 20.8 15.7 2.3 20.7 3.9 10.2 26.0 10.1 1.1 4.7 21.1 27.3 27.2 1.7 37.0 13.1 1.7 6.6 20.2 3.3 93.8 1.5 10.7 9.0 12.6 4.1 11.8 0.9 4.7 12.8 7.1 9.5 14.1 8.7 7.7 41.9 29.9 36.9 19.8 41.1 18.5 15.9 20.6 22.3 27.5 11.4 15.6 19.3 87.5 30.2 45.2 3.3 24.9 23.3 14.0 15.1 13.8 17.4 13.5 15.1 21.3 15.5 16.8 17.6 17.4 16.1 37.0 41.7 44.2 13.4 18.9 7.1 10.8 13.8 12.5 0.8 10.5 6.3 5.8 10.0 35.1 20.2 0.0 5.2 14.0 32.5 1.9 30.4 1.6 23.6 28.1 37.4 10.7 19.0 0.3 39.9 19.3 19.9 22.4 23.2 10.1 19.5 21.8 50.1 42.0 0.0 1.3 11.5 10.2 32.3 9.2 4.5 18.3 41.2 7.2 45.0 50.2 12.1 32.0 17.1 3.9 36.8 11.7 24.0 13.6 8.9 17.5 19.3 48.8 1.0 19.7 18.9 16.3 0.9 1.9 15.7 6.7 1.6 23.5 17.0 8.6 14.4 DTX3L "BBAP, RNF143" ENSG00000163840 "Deltex E3 ubiquitin ligase 3L" Q8TDB6 3 122564338-122575203 "Enzymes, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+ SV40 Large T+: 91.6;BJ hTERT+ SV40 Large T+ RasG12V: 112.3;GAMG: 87.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010570 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Cytosol" "HPA010570: AB_1847877" "unprognostic (8.15e-2)" "unprognostic (7.36e-3)" "unprognostic (5.04e-2)" "unprognostic (3.74e-3)" "unprognostic (9.51e-2)" "unprognostic (9.22e-2)" "unprognostic (1.82e-1)" "unprognostic (1.11e-2)" "unprognostic (9.23e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (8.99e-4)" "unprognostic (2.76e-2)" "unprognostic (2.33e-2)" "unprognostic (7.77e-2)" "unprognostic (9.28e-2)" "unprognostic (3.33e-2)" "unprognostic (2.61e-2)" 11.1 9.2 5.5 24.4 6.0 12.8 10.8 5.0 6.4 10.1 4.8 15.5 20.6 12.3 6.5 11.4 11.4 15.3 7.3 4.6 6.1 9.9 32.1 20.8 21.8 11.1 6.6 9.4 17.8 11.1 5.3 16.3 7.4 12.3 16.2 2.6 20.3 8.6 7.8 8.1 18.7 14.8 8.3 26.6 15.9 3.6 8.3 17.4 11.9 9.2 20.9 18.2 8.2 7.2 31.2 9.4 2.6 7.9 12.0 27.6 10.2 7.9 29.3 91.6 112.3 9.2 31.2 3.6 15.1 13.2 87.8 30.5 9.2 12.8 20.1 26.3 3.4 27.1 7.2 9.8 23.7 14.0 20.2 23.8 14.8 13.7 7.8 17.4 17.6 16.9 3.5 18.8 6.9 9.6 34.3 9.9 1.7 9.7 17.2 37.5 21.0 6.0 23.4 19.8 3.8 4.1 16.6 7.4 59.5 1.8 8.5 17.5 21.6 10.4 14.5 1.0 10.2 6.8 4.0 16.4 17.9 17.9 10.9 21.4 11.3 12.0 11.6 18.1 12.5 7.5 9.5 12.4 8.7 7.9 8.4 9.3 28.2 10.5 19.4 0.9 9.9 9.9 5.5 6.0 5.0 6.4 4.6 6.1 11.1 6.6 7.4 8.3 8.3 7.2 31.3 32.1 28.1 3.9 19.7 8.9 10.2 10.4 9.1 0.3 12.9 8.1 5.1 15.7 15.0 7.3 0.0 4.1 15.3 46.3 0.0 23.1 2.5 17.2 26.7 24.1 18.5 16.2 0.0 32.5 15.2 13.3 30.5 27.5 15.8 17.5 25.4 56.7 28.4 0.0 0.3 26.6 10.2 38.6 5.8 1.1 8.4 26.1 5.4 13.1 38.2 5.1 40.2 0.5 1.1 32.4 15.0 9.1 11.8 20.1 24.2 15.1 17.0 0.4 32.9 10.0 10.7 1.8 0.5 12.4 6.0 1.8 19.2 8.3 20.6 20.1 PARP15 "ARTD7, FLJ40597, pART7" ENSG00000173200 "Poly(ADP-ribose) polymerase family member 15" Q460N3 3 122577628-122639047 "Metabolic proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 23.1;intestine: 42.1;lymphoid tissue: 67.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 19.2;B-cells: 88.4;dendritic cells: 38.6;granulocytes: 19.6;NK-cells: 21.6;Plasma cells: 18.6;T-cells: 31.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 7.6;JURKAT: 5.1;REH: 3.5;THP-1: 3.7;TIME: 8.9" "Low region specificity" "Detected in single" HPA035757 Approved Mitochondria "Intracellular and membrane" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 36: HEL - Hemostasis" "Cluster 57: B-cells - Immune response" Mitochondria "HPA035757: AB_10669656" "unprognostic (8.19e-3)" "unprognostic (2.88e-3)" "unprognostic (1.12e-1)" "unprognostic (1.18e-3)" "unprognostic (1.22e-1)" "unprognostic (9.01e-5)" "unprognostic (4.79e-2)" "unprognostic (1.83e-2)" "unprognostic (3.91e-2)" "unprognostic (5.40e-2)" "unprognostic (1.61e-1)" "unprognostic (9.63e-2)" "unprognostic (9.24e-7)" "unprognostic (9.03e-2)" "unprognostic (2.07e-2)" "unprognostic (1.52e-1)" "unprognostic (1.22e-2)" 3.7 1.2 3.1 25.7 2.7 23.1 1.8 4.2 3.8 1.7 1.2 3.8 2.6 1.9 1.3 2.0 2.0 4.4 1.7 2.1 1.2 1.7 3.2 9.0 44.4 1.8 2.3 0.7 0.8 0.2 0.7 2.5 1.7 1.8 4.8 2.2 2.2 1.1 6.0 1.2 42.1 1.9 0.7 67.2 4.1 2.5 2.0 8.3 3.0 1.9 50.3 4.5 1.6 3.6 0.3 0.2 0.3 0.3 0.1 0.2 0.3 0.2 0.1 0.0 0.0 0.2 0.7 0.3 0.4 0.1 0.2 0.3 0.0 0.0 0.0 0.7 0.1 7.6 0.5 0.3 0.1 0.5 0.3 1.5 0.1 0.3 0.1 0.2 1.7 5.1 0.2 1.3 0.0 0.3 2.3 0.4 0.4 0.1 0.1 3.5 0.2 0.3 0.0 0.6 0.5 0.3 0.1 0.1 0.1 0.3 0.5 3.7 8.9 0.2 0.6 0.3 0.2 0.6 0.4 1.6 0.4 0.2 0.1 1.8 0.2 0.1 7.2 0.3 5.8 9.4 4.4 5.4 0.8 9.3 3.8 4.8 0.5 3.9 0.7 1.0 4.2 2.2 3.1 2.7 4.2 3.8 2.1 1.2 1.8 2.3 1.7 0.7 2.0 3.6 0.8 19.2 15.9 0.0 88.4 0.5 0.0 0.0 0.0 0.0 0.6 0.6 0.7 0.0 2.1 0.0 0.0 0.1 38.6 0.1 0.0 0.0 0.2 0.3 0.1 1.2 0.0 7.4 0.1 0.0 0.1 2.7 2.6 0.3 19.6 0.0 2.2 0.6 8.3 0.0 0.2 0.0 0.0 5.1 1.4 0.2 0.0 6.4 1.8 6.5 4.7 0.0 21.6 0.0 0.1 0.1 0.0 0.0 18.6 0.0 0.0 0.1 10.5 0.0 0.0 0.7 0.4 0.1 1.6 0.4 0.0 0.3 31.1 0.0 0.0 0.0 PARP14 "ARTD8, KIAA1268, pART8" ENSG00000173193 "Poly(ADP-ribose) polymerase family member 14" Q460N5 3 122680839-122730840 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 246.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 74.7;BJ hTERT+ SV40 Large T+ RasG12V: 113.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA008846, HPA012063" Supported Supported Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 44: Endometrium - Transcription" Cytosol "HPA008846: AB_1854982, HPA012063: AB_1854981" "unprognostic (4.38e-2)" "unprognostic (1.07e-2)" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (2.56e-1)" "unprognostic (2.50e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (1.44e-1)" "unprognostic (4.20e-2)" "unprognostic (1.74e-3)" "unprognostic (1.62e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (7.87e-2)" "unprognostic (3.82e-2)" "unprognostic (1.58e-3)" "unprognostic (1.71e-2)" 14.0 12.6 4.3 24.3 5.1 20.1 11.3 3.6 2.7 11.4 5.5 11.5 15.3 8.2 2.4 9.0 10.7 15.2 11.1 2.8 5.1 14.9 24.5 33.5 24.0 15.1 5.9 9.2 7.8 7.3 7.6 17.8 8.6 13.0 8.7 1.1 11.7 7.2 5.0 5.3 17.5 10.2 10.9 37.4 11.7 2.2 8.9 15.4 14.7 8.3 26.8 13.7 9.4 7.8 15.6 13.0 8.0 8.3 9.1 26.2 0.0 6.1 40.1 74.7 113.1 6.9 28.7 0.0 24.2 13.4 41.8 11.5 11.9 11.6 15.0 24.0 1.5 14.6 5.8 8.7 20.4 6.4 6.8 14.7 4.7 13.0 4.8 16.4 32.2 12.3 7.0 22.7 2.1 7.9 24.8 1.5 1.1 2.1 11.1 34.2 8.3 4.3 9.5 16.2 0.6 0.0 15.3 3.1 14.1 0.8 5.7 9.3 22.0 4.0 9.4 2.3 5.5 8.7 1.6 2.7 12.0 13.8 7.2 13.1 10.8 5.8 8.6 13.7 7.2 12.8 4.5 5.6 5.6 20.3 3.6 4.1 29.5 9.5 14.7 0.7 9.9 4.3 4.3 5.1 3.6 2.7 2.8 5.1 15.1 5.9 8.6 10.9 8.9 7.8 111.5 246.8 98.4 17.3 115.3 16.8 17.0 35.9 13.1 2.1 19.6 15.6 14.6 24.3 65.9 25.8 4.2 14.1 64.9 43.0 3.9 36.0 0.3 118.8 59.8 94.7 10.7 18.5 0.5 41.2 28.4 37.2 24.5 149.8 32.2 69.6 67.1 32.5 36.5 0.0 3.0 18.2 26.4 61.6 39.9 2.1 28.0 83.9 16.0 124.6 132.2 15.1 58.7 47.3 1.1 44.0 20.2 17.3 50.9 31.8 29.5 11.5 73.0 1.0 13.1 32.7 30.3 1.9 1.1 13.7 10.5 4.8 51.4 42.8 16.0 25.9 HSPBAP1 "FLJ22623, PASS1" ENSG00000169087 "HSPB1 associated protein 1" Q96EW2 3 122739999-122793831 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 60.5;Microglial cells: 52.5;Syncytiotrophoblasts: 48.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044930 Approved Approved Mitochondria NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria "HPA044930: AB_10961122" "unprognostic (3.40e-3)" "unprognostic (1.22e-2)" "unprognostic (2.98e-2)" "unprognostic (6.70e-3)" "unprognostic (3.40e-3)" "unprognostic (3.40e-2)" "unprognostic (8.61e-4)" "unprognostic (2.68e-2)" "unprognostic (6.95e-2)" "unprognostic (3.35e-2)" "unprognostic (2.36e-1)" "unprognostic (8.91e-2)" "unprognostic (1.24e-3)" "unprognostic (4.29e-1)" "unprognostic (1.33e-1)" "unprognostic (3.34e-1)" "unprognostic (4.12e-3)" 4.2 5.4 2.9 4.3 3.3 3.1 3.8 3.4 4.2 3.8 4.1 3.7 2.5 3.8 1.9 2.8 3.1 3.5 3.2 3.3 3.5 4.3 3.5 4.6 6.2 4.0 3.4 3.0 3.8 3.7 2.7 6.0 4.0 3.3 3.4 4.6 3.2 3.2 15.9 4.3 3.8 3.8 3.4 7.3 3.0 10.7 3.4 6.4 6.2 8.7 5.5 4.3 3.2 3.9 5.4 4.1 5.8 5.2 6.8 5.1 11.3 2.6 6.7 6.1 8.6 5.6 4.1 6.9 4.2 1.8 15.4 6.4 9.0 5.0 7.1 4.3 2.5 4.6 4.8 3.3 15.4 4.2 6.1 7.7 18.0 5.1 16.3 5.8 5.8 6.9 3.1 5.8 5.6 3.5 6.1 5.3 6.6 4.2 8.2 6.2 7.8 6.8 6.4 2.1 6.4 6.5 6.2 2.4 23.3 5.5 2.9 8.8 5.8 7.1 4.2 2.3 3.7 5.7 6.1 8.1 4.4 6.2 7.1 23.0 16.5 12.0 6.1 12.2 7.6 11.0 8.0 6.1 13.0 8.3 8.6 8.4 30.6 6.3 24.1 4.5 10.3 8.2 2.9 3.3 3.4 4.2 3.3 3.5 4.0 3.4 4.0 3.4 3.4 3.9 10.2 6.4 5.3 10.7 20.8 10.7 3.9 5.0 6.8 6.6 3.9 5.7 5.7 4.3 3.9 5.5 60.5 16.8 11.4 4.9 3.9 5.5 35.7 7.3 5.1 6.4 0.0 7.2 15.2 6.0 11.0 6.5 5.6 4.4 6.3 6.4 11.0 3.6 12.9 8.4 24.7 3.1 4.1 24.1 14.1 8.0 9.6 20.1 5.4 52.5 29.4 3.7 14.4 8.0 22.9 4.3 3.5 4.9 6.4 3.2 6.3 4.5 5.9 12.8 6.6 7.1 4.9 36.8 8.4 5.0 7.5 48.6 10.3 7.4 3.5 1.7 SLC49A4 "DIRC2, FLJ14784, RCC4" ENSG00000138463 "Solute carrier family 49 member 4" Q96SL1 3 122795069-122881139 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 44.0;Extravillous trophoblasts: 61.2;Syncytiotrophoblasts: 226.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072579 Supported Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Vesicles "HPA072579: AB_2686536" "unprognostic (1.40e-1)" "unprognostic (8.53e-3)" "unprognostic (1.20e-1)" "unprognostic (1.09e-1)" "unprognostic (1.16e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (9.74e-2)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.87e-1)" "prognostic favorable (8.81e-11)" "unprognostic (2.36e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-1)" "unprognostic (7.13e-2)" 4.4 5.0 4.9 2.7 5.1 5.9 3.1 4.9 5.3 3.0 6.2 4.1 1.9 2.6 3.8 5.6 3.1 3.7 6.4 5.7 5.9 4.6 3.5 5.2 2.0 4.8 5.6 2.2 6.5 12.7 2.4 7.6 5.6 4.9 4.5 5.7 3.7 3.6 15.9 6.6 2.6 2.7 5.2 2.8 3.1 2.5 5.6 1.9 5.2 14.0 2.5 4.0 2.6 5.9 7.4 6.1 5.9 3.3 7.5 6.1 19.6 3.1 6.7 4.9 5.0 14.4 8.0 1.0 3.9 3.5 10.9 10.5 4.3 5.6 4.7 1.6 3.2 1.2 3.3 6.2 5.5 0.7 0.7 5.0 15.0 3.5 5.9 7.6 5.6 2.0 0.7 1.3 6.3 3.3 0.9 0.8 5.3 2.5 9.8 2.0 13.3 1.5 7.0 8.4 6.1 4.6 9.1 4.1 8.4 3.7 4.8 1.6 8.0 7.6 2.8 4.6 2.6 1.3 1.2 0.4 3.8 1.3 4.2 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.9 0.0 0.2 0.0 0.0 0.0 4.9 5.1 4.9 5.3 5.7 5.9 4.8 5.6 5.6 5.2 5.6 5.9 3.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 44.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 61.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 226.6 0.4 0.0 0.0 0.0 SEMA5B "FLJ10372, KIAA1445, SEMAG, SemG" ENSG00000082684 "Semaphorin 5B" Q9P283 3 122909082-123028605 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.2" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Excitatory neurons: 30.8;Muller glia cells: 7.3;Oligodendrocyte precursor cells: 45.2;Smooth muscle cells: 14.3" "Cancer enhanced" "Detected in many" "renal cancer: 18.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 79.7;NTERA-2: 15.7;SH-SY5Y: 21.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA066548 Enhanced Supported Cytosol NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "HPA066548: AB_2685689" "unprognostic (7.34e-2)" "unprognostic (1.84e-3)" "unprognostic (1.92e-4)" "unprognostic (3.01e-2)" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "unprognostic (4.72e-2)" "unprognostic (1.58e-2)" "unprognostic (7.66e-3)" "unprognostic (2.87e-2)" "unprognostic (4.71e-2)" "unprognostic (2.58e-1)" "prognostic unfavorable (7.57e-4)" "unprognostic (1.31e-3)" "unprognostic (5.96e-2)" "unprognostic (6.12e-2)" "unprognostic (2.12e-1)" 1.7 1.5 12.1 0.4 11.8 0.0 1.3 7.3 15.9 1.8 6.7 1.3 0.9 1.4 2.8 0.7 3.5 2.5 9.5 16.2 8.0 9.1 0.9 1.2 0.6 8.4 8.5 1.4 1.7 0.6 2.7 2.6 9.7 1.4 0.8 7.1 0.4 1.4 0.9 1.5 1.5 1.9 7.7 0.2 0.6 0.7 7.8 0.2 2.6 0.5 0.6 1.6 1.6 10.9 0.0 0.0 79.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.3 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 21.3 0.0 0.2 0.0 3.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 11.8 7.3 15.9 16.2 8.0 8.4 8.5 9.7 7.7 7.8 10.9 1.2 0.0 1.1 9.4 0.0 0.0 0.0 0.1 0.0 7.2 0.1 0.0 3.5 1.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.8 0.0 0.0 30.8 0.0 0.3 0.7 0.0 0.0 0.0 0.1 1.8 0.0 0.1 0.0 6.6 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.9 0.6 7.3 0.0 45.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 14.3 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 PDIA5 "FLJ30401, PDIR" ENSG00000065485 "Protein disulfide isomerase family A member 5" Q14554 3 123067025-123225227 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 80.2" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 133.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 12.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030353, HPA030355" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus" "Intracellular and membrane" NA NA 4700000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nucleoplasm, Golgi apparatus" "Nucleoli fibrillar center" "HPA030353: AB_10599734, HPA030355: AB_10602200" "unprognostic (8.81e-2)" "unprognostic (2.25e-2)" "unprognostic (8.93e-2)" "prognostic favorable (4.55e-4)" "unprognostic (4.34e-2)" "unprognostic (2.10e-2)" "unprognostic (7.38e-2)" "unprognostic (2.41e-1)" "unprognostic (3.21e-2)" "unprognostic (4.02e-2)" "unprognostic (1.55e-1)" "unprognostic (2.26e-3)" "prognostic unfavorable (8.09e-11)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "unprognostic (1.06e-2)" "unprognostic (4.06e-3)" 17.9 23.6 0.3 15.2 0.3 17.9 13.8 0.2 1.4 14.5 2.7 20.1 13.9 12.4 30.2 6.1 14.0 19.6 9.9 0.6 0.8 14.5 80.2 17.7 11.1 0.5 0.6 11.5 26.6 10.7 12.7 47.4 0.4 32.3 25.0 4.2 13.7 7.9 4.2 8.8 12.8 17.0 0.3 10.1 33.4 15.3 0.9 4.5 30.8 4.3 12.0 17.9 9.5 0.7 24.0 14.6 17.7 21.5 80.3 71.9 95.0 44.9 74.5 24.5 66.9 47.8 21.6 0.0 57.6 69.9 15.7 12.5 7.8 27.4 25.7 1.1 8.8 10.4 3.9 56.7 33.2 26.5 1.4 62.3 40.2 16.6 34.5 26.1 84.0 10.1 13.6 60.4 16.9 29.6 7.2 31.3 13.1 54.5 15.6 6.7 13.0 67.5 20.7 13.9 19.3 11.4 22.0 24.0 40.4 28.7 21.4 32.3 47.2 6.2 19.5 29.4 12.3 18.1 5.0 10.8 20.2 21.0 21.5 0.0 9.3 0.3 1.4 2.4 2.3 3.5 1.0 0.8 5.5 1.1 0.6 0.6 0.2 0.5 0.5 12.8 0.0 2.3 0.3 0.3 0.2 1.4 0.6 0.8 0.5 0.6 0.4 0.3 0.9 0.7 17.2 19.2 30.7 2.6 5.6 5.0 6.0 6.4 3.4 13.1 6.9 4.7 2.7 35.8 11.3 5.5 39.6 41.8 3.1 5.4 0.0 32.2 1.6 5.4 13.1 24.3 8.4 5.5 9.6 28.6 133.6 20.7 30.5 21.1 3.8 7.3 37.5 50.1 12.1 0.0 7.1 36.9 0.0 7.8 5.5 2.0 24.2 4.4 8.8 5.6 5.0 2.3 0.0 1.0 2.5 11.9 7.6 22.2 40.1 18.1 3.5 5.3 6.4 28.4 13.1 3.6 17.6 1.3 1.5 3.4 4.1 50.2 3.1 23.3 15.1 4.5 SEC22A SEC22L2 ENSG00000121542 "SEC22 homolog A, vesicle trafficking protein" Q96IW7 3 123201927-123274136 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 67.5;Inhibitory neurons: 67.5;Oligodendrocytes: 75.0;Spermatocytes: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (2.94e-2)" "unprognostic (1.09e-2)" "unprognostic (1.96e-1)" "unprognostic (8.25e-3)" "unprognostic (2.16e-1)" "unprognostic (9.04e-2)" "unprognostic (1.13e-2)" "unprognostic (4.91e-2)" "unprognostic (6.59e-2)" "unprognostic (2.16e-1)" "unprognostic (2.05e-1)" "unprognostic (2.66e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.46e-1)" "unprognostic (1.61e-1)" "unprognostic (3.03e-2)" "unprognostic (5.25e-1)" 10.4 11.2 6.6 8.1 6.9 4.6 10.9 8.6 6.9 10.5 6.8 8.9 6.8 9.6 8.8 12.3 9.6 9.0 8.0 7.5 6.8 10.5 12.9 9.2 10.3 6.2 6.8 10.6 10.1 9.5 11.3 10.1 7.2 8.9 9.5 9.9 9.6 7.3 6.1 13.7 8.5 11.6 6.1 9.8 8.4 21.5 7.0 10.2 9.9 5.5 13.1 8.9 10.0 8.0 40.4 12.5 20.2 15.6 27.1 25.4 20.2 35.3 22.2 20.4 28.8 10.3 22.0 20.9 25.8 19.9 23.8 30.5 16.0 20.8 34.0 9.1 13.6 14.1 11.7 9.0 24.7 18.3 11.6 18.2 27.2 19.4 18.7 20.5 27.6 18.3 9.4 17.4 20.6 17.6 17.0 13.5 7.1 29.2 25.0 12.9 21.5 21.2 18.6 11.0 14.6 11.3 20.8 14.5 21.0 14.6 30.2 22.5 12.6 17.8 19.5 29.4 21.5 11.4 11.4 34.6 26.5 20.5 27.3 19.3 19.9 16.7 24.1 19.3 29.8 18.7 24.7 26.4 19.9 15.7 26.3 22.0 2.9 28.9 19.5 19.2 27.6 16.9 6.6 6.9 8.6 6.9 7.5 6.8 6.2 6.8 7.2 6.1 7.0 8.0 10.5 3.2 12.1 39.8 13.9 8.4 17.9 29.7 10.8 7.5 7.9 7.4 5.6 17.2 20.4 7.3 4.2 27.5 7.3 6.1 9.8 17.8 30.5 4.7 9.0 9.8 7.8 8.6 67.5 10.4 19.5 12.5 12.2 6.4 7.0 11.6 12.1 9.0 13.6 1.7 67.5 9.4 10.2 5.0 8.0 16.5 12.2 7.8 5.4 56.2 11.7 6.7 9.2 59.3 75.0 11.3 4.6 6.8 18.4 9.9 5.7 9.5 11.1 7.6 19.7 8.8 12.3 75.6 17.0 12.1 9.5 44.1 12.9 11.2 6.8 10.9 ADCY5 AC5 ENSG00000173175 "Adenylate cyclase 5" O95622 3 123282296-123449090 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.7;heart muscle: 105.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 75.5;Inhibitory neurons: 44.0;Oligodendrocytes: 89.7;Paneth cells: 59.6;Peritubular cells: 73.7;Sertoli cells: 65.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 15.5;RPMI-8226: 2.7;RPTEC TERT1: 5.2" "Region enriched" "Detected in all" 5 "basal ganglia: 388.0" "Region enriched" "Detected in all" 6 "basal ganglia: 155.9" "HPA017730, HPA077682" Uncertain Enhanced "Intermediate filaments" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 54: Cardiomyocytes - Muscle contraction" "Intermediate filaments" "HPA017730: AB_1844595, HPA077682: AB_2686851" "unprognostic (3.55e-2)" "unprognostic (1.01e-3)" "unprognostic (7.61e-3)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.48e-1)" "unprognostic (7.61e-2)" "unprognostic (2.49e-2)" "unprognostic (2.34e-1)" "unprognostic (7.27e-3)" "unprognostic (2.64e-2)" "prognostic favorable (7.46e-6)" "unprognostic (1.81e-2)" "unprognostic (5.65e-2)" "unprognostic (3.19e-2)" "unprognostic (5.97e-4)" 18.9 3.3 25.5 4.9 97.7 0.0 10.6 13.9 43.9 9.8 0.0 35.1 5.2 14.7 5.7 18.8 12.7 10.0 105.2 25.8 15.9 12.8 3.3 4.1 2.3 20.5 18.3 13.2 7.5 0.8 14.3 6.1 17.4 19.8 5.6 4.5 4.0 21.5 2.7 2.6 13.0 18.2 10.8 6.5 21.2 8.2 34.4 1.3 1.9 5.8 3.0 23.2 7.8 30.1 0.0 0.6 1.3 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.2 2.3 0.5 0.6 0.0 0.0 0.1 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 15.5 0.0 0.0 0.8 0.0 0.1 0.0 0.3 2.7 5.2 0.5 1.8 1.6 0.0 0.5 0.1 1.7 0.0 0.1 0.0 0.1 1.2 0.1 0.2 0.1 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 97.7 13.9 43.9 25.8 15.9 20.5 18.3 17.4 10.8 34.4 30.1 0.3 0.0 0.0 8.1 0.1 0.3 0.1 0.2 0.0 21.8 0.4 5.8 75.5 8.6 0.0 7.3 0.0 1.4 0.0 2.6 0.0 15.9 0.9 1.5 7.1 1.8 0.0 0.0 34.0 6.9 4.0 5.2 0.0 4.0 0.0 4.6 3.9 0.1 0.3 0.0 44.0 0.3 0.0 0.0 0.3 3.0 20.5 0.1 0.0 6.5 1.0 1.0 0.0 19.1 89.7 0.4 59.6 73.7 0.0 0.1 0.3 0.8 0.0 2.2 65.7 0.6 21.4 0.8 6.3 0.2 0.9 12.4 0.2 1.0 2.0 0.1 HACD2 PTPLB ENSG00000206527 "3-hydroxyacyl-CoA dehydratase 2" Q6Y1H2 3 123490820-123585053 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SiHa: 249.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB019282 Approved NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 59: Non-specific - Transcription" "CAB019282: " "unprognostic (3.04e-2)" "unprognostic (2.51e-1)" "unprognostic (6.11e-2)" "unprognostic (2.65e-3)" "unprognostic (5.36e-2)" "unprognostic (6.04e-2)" "unprognostic (1.32e-2)" "unprognostic (1.95e-2)" "unprognostic (1.96e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.59e-5)" "unprognostic (6.90e-2)" "unprognostic (7.03e-3)" "unprognostic (1.48e-1)" "unprognostic (3.85e-2)" "unprognostic (1.94e-2)" "unprognostic (2.59e-2)" 68.3 11.2 16.2 16.5 23.5 8.7 22.8 19.3 20.5 14.6 8.4 26.7 29.9 16.6 17.7 18.9 13.1 16.7 10.7 16.0 19.7 24.1 48.4 19.4 21.3 19.4 17.1 12.5 17.4 21.3 7.7 15.5 21.0 29.5 27.7 13.8 16.4 12.9 5.3 32.5 25.8 16.7 17.8 12.3 21.2 19.0 16.6 14.9 19.4 8.4 28.6 14.7 17.1 33.9 76.9 42.7 28.8 21.1 88.3 19.5 106.5 53.7 22.2 54.6 39.4 87.9 66.1 44.1 37.8 51.7 63.3 162.8 52.3 67.4 57.3 28.3 17.5 30.8 37.3 68.9 28.7 41.2 29.4 27.2 169.7 26.5 73.6 85.2 29.0 30.0 6.3 42.7 33.4 59.8 19.7 12.3 37.2 92.7 37.4 29.6 31.6 46.9 66.5 48.6 50.5 15.8 249.9 52.7 34.6 41.5 54.9 21.1 22.7 56.8 42.2 57.5 53.1 25.2 34.7 35.9 25.5 28.5 31.1 0.7 1.6 1.1 1.5 1.2 2.2 1.5 1.9 1.9 2.8 2.0 1.8 1.7 0.5 1.3 1.0 1.6 2.5 1.2 16.2 23.5 19.3 20.5 16.0 19.7 19.4 17.1 21.0 17.8 16.6 33.9 19.8 6.4 43.1 8.8 17.5 0.0 28.7 0.0 23.9 9.5 27.8 21.5 13.5 22.8 15.5 46.0 6.2 21.5 18.9 29.4 7.9 15.4 19.8 22.3 14.9 17.0 15.8 15.4 34.3 18.7 16.5 17.3 25.0 35.7 3.8 17.1 16.8 47.5 22.9 1.7 29.7 16.4 0.0 24.2 0.0 10.4 11.5 25.1 0.0 12.2 19.6 14.5 19.6 25.1 32.6 19.6 16.6 17.7 15.0 40.6 33.8 17.8 2.9 13.9 6.6 14.8 11.3 10.5 24.8 35.1 0.0 6.7 14.2 11.8 19.9 33.2 MYLK "MLCK, MLCK1, MYLK1, smMLCK" ENSG00000065534 "Myosin light chain kinase" Q15746 3 123610049-123884332 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 1700.3;smooth muscle: 2137.7" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 728.5;Hepatocytes: 208.7;Peritubular cells: 690.5;Sertoli cells: 276.1;Smooth muscle cells: 448.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 7.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 200.0;BJ hTERT+: 298.2;fHDF/TERT166: 260.2;hTERT-RPE1: 202.7;RPTEC TERT1: 291.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020789, HPA031677, HPA048055" Enhanced Enhanced "Plasma membrane,Actin filaments" NA NA 1500000 "Cluster 34: Basophils - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Actin filaments" "Plasma membrane" "CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543" "unprognostic (2.80e-2)" "unprognostic (5.05e-2)" "unprognostic (5.55e-2)" "unprognostic (2.85e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-1)" "unprognostic (4.86e-2)" "unprognostic (8.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.40e-1)" "unprognostic (8.21e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (2.04e-6)" "unprognostic (5.26e-3)" "unprognostic (9.60e-2)" "unprognostic (3.00e-1)" "prognostic unfavorable (4.46e-4)" 143.6 57.4 37.6 188.7 64.8 3.3 163.4 72.1 42.4 281.3 14.1 551.5 110.9 669.2 232.9 420.6 289.8 250.4 33.6 33.6 46.7 64.4 67.2 85.2 33.6 104.6 64.8 95.9 15.3 11.6 2.6 70.2 99.3 907.6 299.1 13.6 140.1 1700.3 10.0 20.1 125.1 2137.7 55.6 89.5 122.7 50.5 52.2 8.0 22.2 14.9 19.1 505.7 84.8 112.1 14.4 38.4 10.8 7.8 10.8 1.9 4.7 200.0 298.2 137.3 92.1 8.1 7.4 0.6 42.5 260.2 67.0 4.8 5.2 1.8 149.0 0.2 0.7 102.4 0.9 28.9 56.1 0.6 9.8 36.9 3.5 24.4 34.4 202.7 8.9 1.3 1.2 0.5 90.9 1.7 0.2 2.5 12.0 0.5 5.1 13.5 6.8 36.7 291.9 8.5 1.4 6.4 21.8 1.9 3.1 25.0 1.0 0.3 33.4 39.5 13.9 10.3 30.7 3.4 4.2 0.3 104.0 1.0 9.6 7.4 1.6 0.4 0.1 0.2 0.0 0.2 0.0 0.0 3.5 0.1 0.2 0.1 5.0 0.0 0.0 3.3 0.2 20.9 37.6 64.8 72.1 42.4 33.6 46.7 104.6 64.8 99.3 55.6 52.2 112.1 45.9 16.0 38.3 43.4 2.5 20.5 27.2 24.8 1.2 2.9 19.9 728.5 25.2 37.1 5.7 27.6 125.1 0.8 3.5 88.1 3.9 6.0 40.7 45.9 46.6 56.9 11.4 3.2 25.2 3.9 0.8 40.1 3.1 54.4 2.5 3.2 45.3 208.7 4.9 3.3 3.4 3.9 8.2 7.9 37.0 33.8 104.7 20.8 19.6 8.4 1.2 4.7 0.0 5.5 37.0 4.0 18.7 690.5 3.3 8.6 14.2 17.2 17.6 19.9 276.1 5.6 448.7 4.7 4.6 1.3 20.2 2.5 3.2 4.5 4.2 3.7 CCDC14 "DKFZp434L1050, FLJ12892" ENSG00000175455 "Coiled-coil domain containing 14" Q49A88 3 123897305-123961408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA035278, HPA035279" Uncertain Enhanced "Centriolar satellite" NA Yes "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Centriolar satellite" "HPA035278: AB_2674548, HPA035279: AB_10601253" "unprognostic (7.41e-3)" "unprognostic (5.18e-2)" "unprognostic (1.86e-1)" "unprognostic (1.41e-1)" "unprognostic (9.45e-2)" "prognostic favorable (5.27e-4)" "prognostic unfavorable (4.82e-4)" "unprognostic (6.83e-2)" "unprognostic (5.50e-2)" "unprognostic (2.12e-1)" "unprognostic (3.76e-1)" "prognostic unfavorable (4.76e-4)" "prognostic unfavorable (3.50e-8)" "unprognostic (2.14e-2)" "unprognostic (2.86e-1)" "unprognostic (9.37e-2)" "prognostic favorable (2.72e-5)" 11.8 9.6 5.3 12.8 8.5 36.6 21.4 6.4 7.5 17.1 4.6 22.5 12.8 22.1 35.5 10.0 14.5 13.6 8.6 5.1 8.7 14.4 15.3 13.7 16.6 8.8 7.5 17.4 16.8 5.6 13.7 10.6 9.0 16.3 34.8 43.2 14.9 7.9 6.2 23.8 15.4 14.2 7.7 12.4 13.9 23.7 10.1 20.5 13.2 2.9 15.0 12.0 12.4 10.0 42.6 22.5 72.1 28.0 10.6 16.1 34.0 79.9 26.2 41.6 45.2 17.5 28.5 12.4 19.9 19.1 30.1 44.5 27.1 14.8 55.9 10.5 20.0 49.9 50.7 17.7 9.0 31.2 29.9 15.1 9.7 20.7 21.9 49.0 19.7 48.9 25.8 21.0 28.1 18.3 26.4 17.3 22.2 19.0 28.0 47.2 29.0 15.2 23.3 34.1 25.4 28.3 45.2 13.0 33.4 46.5 27.5 31.2 22.9 91.1 45.8 28.5 26.5 20.0 15.8 32.8 32.2 25.6 31.5 1.1 0.6 1.3 1.4 0.9 1.0 0.8 1.2 1.2 0.3 0.7 1.3 1.1 0.1 2.5 0.2 1.8 2.6 0.7 5.3 8.5 6.4 7.5 5.1 8.7 8.8 7.5 9.0 7.7 10.1 10.0 22.1 22.4 71.5 72.8 21.3 21.9 36.4 31.2 25.6 35.9 48.9 37.7 14.6 38.6 29.4 36.8 60.5 27.5 27.6 67.9 0.0 26.1 38.6 33.7 44.0 23.8 89.7 72.1 83.8 13.8 22.9 32.3 26.0 29.9 25.9 67.9 28.5 22.3 20.9 28.6 67.7 85.6 67.1 19.7 29.9 17.3 32.6 21.0 24.9 41.2 20.1 18.6 49.4 91.0 77.1 22.8 63.7 31.2 25.3 20.4 41.6 12.6 18.9 75.5 19.7 39.2 29.4 144.0 49.6 18.2 16.1 11.6 30.3 33.5 77.7 22.9 ROPN1 "CT91, ODF6, ROPN1A, ropporin" ENSG00000065371 "Rhophilin associated tail protein 1" Q9HAT0 3 123968521-123992178 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 158.8" "Group enriched" "Detected in some" 9 "Early spermatids: 1370.6;Late spermatids: 629.0;Spermatocytes: 355.0" "Cancer enriched" "Detected in some" 4 "melanoma: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "SK-MEL-30: 28.7" "Low region specificity" "Detected in single" HPA052530 Supported NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA052530: AB_2681861" "unprognostic (1.75e-5)" "unprognostic (2.24e-1)" "unprognostic (4.77e-2)" "unprognostic (7.66e-2)" "unprognostic (1.72e-1)" "unprognostic (1.95e-2)" "unprognostic (3.13e-1)" "unprognostic (2.08e-2)" "unprognostic (8.35e-4)" 0.0 0.0 0.3 0.0 0.2 0.0 20.5 0.1 0.2 0.0 0.0 0.5 0.0 0.0 3.6 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.5 0.3 6.1 0.0 0.1 1.6 0.1 0.0 0.0 0.0 0.0 158.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 28.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 49.4 81.7 7.8 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 1370.6 0.2 0.0 1.4 2.4 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 629.0 8.7 1.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 355.0 5.7 0.0 0.0 0.0 0.4 0.0 0.5 0.0 KALRN "ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD" ENSG00000160145 "Kalirin RhoGEF kinase" O60229 3 124080023-124726325 "Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.3" "Group enriched" "Detected in many" 5 "Excitatory neurons: 1434.2;Inhibitory neurons: 480.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "T-reg: 1.6" "Lineage enriched" "Detected in single" 5 "T-cells: 1.6" "Cell line enhanced" "Detected in many" "CACO-2: 57.4;HEL: 35.3;OE19: 20.1;SH-SY5Y: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011913, CAB026456" Approved Approved Nucleoplasm,Cytosol NA NA 83000 "Cluster 35: T-regs - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Cytosol" "CAB026456: , HPA011913: AB_1850494" "unprognostic (2.54e-2)" "unprognostic (3.43e-1)" "unprognostic (2.08e-1)" "unprognostic (3.12e-4)" "unprognostic (2.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (3.41e-2)" "unprognostic (8.58e-2)" "unprognostic (1.65e-1)" "unprognostic (1.04e-1)" "unprognostic (2.26e-3)" "unprognostic (5.58e-2)" "unprognostic (2.67e-1)" "unprognostic (3.70e-2)" "unprognostic (2.81e-3)" 9.4 6.3 15.0 2.2 23.4 0.3 6.7 0.0 31.3 9.1 4.9 2.0 2.5 7.7 1.9 9.5 4.6 2.9 12.8 21.3 3.4 3.8 5.8 4.4 0.9 0.0 6.6 3.1 8.8 3.5 4.1 4.2 0.0 2.8 1.8 4.5 2.8 4.9 27.2 2.0 2.0 6.2 0.0 8.5 12.1 2.6 10.7 0.5 5.1 19.3 1.6 2.6 6.0 20.9 0.7 1.1 6.2 1.3 0.9 0.2 8.1 2.5 1.5 2.4 1.1 57.4 4.5 0.2 0.8 6.4 3.9 0.4 1.4 0.0 2.0 0.0 0.7 35.3 0.4 8.9 0.1 0.0 0.0 0.4 0.0 0.5 0.1 2.6 2.9 0.1 8.3 0.2 0.7 4.2 0.0 0.0 3.5 20.1 5.4 1.8 2.8 0.0 0.2 0.5 2.1 15.9 0.7 0.5 0.5 6.0 1.2 0.1 14.4 7.0 2.8 1.0 1.1 0.0 0.6 0.0 0.8 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.7 0.2 0.2 0.0 0.0 0.0 1.6 0.4 15.0 23.4 0.0 31.3 21.3 3.4 0.0 6.6 0.0 0.0 10.7 20.9 56.2 3.2 3.9 191.3 0.6 1.7 1.5 0.3 0.6 61.2 6.1 7.1 32.1 18.6 0.5 16.5 6.2 8.0 2.5 40.5 1.9 5.0 57.0 15.0 18.8 23.2 9.6 5.3 1434.2 8.4 1.7 5.9 29.0 7.4 3.8 4.4 45.3 21.7 1.0 0.0 480.8 16.4 0.0 1.6 1.1 64.0 3.7 5.3 3.6 48.7 0.0 4.7 8.2 162.3 63.1 4.4 21.0 33.1 0.3 2.6 34.8 3.6 8.4 2.7 19.7 8.8 21.8 5.2 2.6 4.9 1.1 14.2 1.0 17.5 12.3 1.6 UMPS ENSG00000114491 "Uridine monophosphate synthetase" P11172 3 124730433-124749273 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Pyrimidine biosynthesis" "Decarboxylase, Glycosyltransferase, Lyase, Multifunctional enzyme, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 109.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036178, HPA036179" Uncertain Approved Cytosol NA NA 9200 "Cluster 26: Non-specific - Mitochondria" "Cluster 45: Intestine - Brush border" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol "HPA036178: AB_10673002, HPA036179: AB_10673615" "unprognostic (6.41e-2)" "unprognostic (6.70e-2)" "unprognostic (1.79e-2)" "unprognostic (1.13e-3)" "unprognostic (2.70e-1)" "unprognostic (1.72e-1)" "unprognostic (1.15e-3)" "unprognostic (5.51e-2)" "unprognostic (4.85e-3)" "unprognostic (1.43e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (9.20e-4)" "unprognostic (2.18e-2)" "unprognostic (1.58e-2)" "unprognostic (1.91e-1)" "unprognostic (4.61e-2)" "unprognostic (1.31e-1)" 1.3 1.4 2.5 1.2 2.5 1.3 1.8 2.8 2.9 1.0 1.1 2.3 2.0 1.3 1.0 2.0 1.8 0.7 0.8 2.6 1.8 1.8 2.6 0.9 1.4 2.8 2.1 1.9 2.1 1.5 0.8 0.7 2.3 1.4 1.6 1.8 1.3 0.7 3.1 2.3 2.1 1.1 2.0 2.6 1.8 0.9 2.3 1.8 1.1 0.7 1.7 0.8 1.0 3.5 1.4 4.4 5.1 2.1 2.9 3.4 5.4 7.9 2.4 3.1 2.6 3.8 2.1 4.0 8.2 3.0 7.9 9.0 7.1 2.4 5.0 4.4 4.2 8.2 3.0 2.7 2.6 8.7 6.0 3.8 2.3 1.8 3.9 1.9 1.2 8.2 3.7 1.9 2.3 3.5 10.8 1.7 12.1 3.9 2.7 7.4 6.0 3.3 2.4 2.5 4.0 2.6 11.3 4.2 4.3 3.7 4.1 3.1 15.4 2.5 5.2 7.4 3.2 8.0 12.5 12.1 2.8 3.4 2.6 5.9 10.3 5.5 14.0 11.3 12.4 17.0 9.2 12.1 14.6 24.3 13.9 10.8 0.7 12.8 9.3 11.0 12.4 11.9 2.5 2.5 2.8 2.9 2.6 1.8 2.8 2.1 2.3 2.0 2.3 3.5 9.6 6.4 11.5 6.5 11.2 15.8 24.5 41.3 18.8 8.3 8.9 12.3 6.2 20.0 22.8 9.2 4.2 66.8 13.2 9.0 29.4 29.8 3.2 10.9 18.2 15.2 9.6 16.2 11.0 30.5 35.0 12.7 14.3 12.1 12.0 22.8 7.9 31.4 22.0 5.0 12.0 10.3 20.3 7.0 5.9 4.4 13.7 8.3 3.6 10.3 18.0 11.0 13.4 15.6 12.2 23.4 8.6 13.9 10.4 14.6 14.0 25.9 22.1 9.1 13.1 13.3 17.1 23.2 32.1 20.6 19.0 109.2 11.0 29.5 17.8 21.1 ITGB5 ENSG00000082781 "Integrin subunit beta 5" P18084 3 124761948-124901418 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 135.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 459.9;hTERT-RPE1: 508.7;WM-115: 477.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001820, CAB022050" Approved Approved "Plasma membrane,Mitochondria" NA NA 64000 "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "Plasma membrane, Mitochondria" "CAB022050: , HPA001820: AB_1079142" "unprognostic (2.63e-1)" "unprognostic (1.04e-1)" "unprognostic (3.57e-1)" "unprognostic (4.44e-2)" "unprognostic (1.37e-2)" "unprognostic (6.07e-2)" "unprognostic (3.49e-3)" "unprognostic (3.16e-3)" "unprognostic (1.68e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.16e-1)" "unprognostic (2.16e-3)" "unprognostic (2.49e-3)" "unprognostic (1.12e-1)" "unprognostic (1.01e-1)" "unprognostic (4.38e-3)" 102.7 32.5 24.4 26.0 33.4 3.3 71.3 32.6 20.3 84.7 71.0 48.1 33.1 75.9 16.4 54.9 33.2 71.7 68.8 24.6 28.7 48.6 51.4 53.9 6.0 38.2 32.9 28.0 23.1 21.8 20.5 82.3 35.4 37.3 24.9 14.3 49.6 46.9 30.0 88.9 32.5 60.1 32.3 41.0 29.7 13.5 32.5 12.2 34.3 33.7 9.9 40.3 70.0 35.8 189.1 459.9 32.4 82.7 296.6 84.2 166.3 197.5 120.0 35.9 57.6 92.6 240.3 0.8 93.5 336.3 177.0 148.0 29.5 102.7 31.2 2.0 20.1 66.3 69.5 98.0 51.0 0.4 116.8 51.2 23.2 91.1 46.9 508.7 121.2 0.2 60.7 98.1 122.7 190.0 0.8 1.1 145.8 105.1 50.4 0.4 52.2 71.8 98.8 41.2 0.9 67.5 146.6 214.5 165.7 56.4 121.9 4.2 318.2 134.9 200.7 118.5 103.7 16.6 18.4 1.3 141.3 0.8 477.0 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.0 2.5 24.4 33.4 32.6 20.3 24.6 28.7 38.2 32.9 35.4 32.3 32.5 35.8 50.4 6.4 6.7 55.5 1.0 17.2 23.1 18.8 6.2 8.1 20.6 27.2 28.9 42.9 10.0 29.5 4.2 68.5 0.6 34.9 11.7 38.3 10.7 22.0 21.4 27.5 3.5 2.7 0.9 18.8 7.4 52.1 11.2 13.4 0.0 135.9 31.1 39.1 72.3 35.3 18.1 12.9 2.0 36.8 17.5 4.1 20.2 28.5 10.6 60.9 0.4 50.2 0.0 16.6 12.5 70.4 27.0 16.6 0.6 24.9 21.0 10.7 6.2 14.9 39.5 31.3 52.1 2.6 7.0 15.6 22.3 55.1 1.7 1.0 16.3 14.8 MUC13 DRCC1 ENSG00000173702 "Mucin 13, cell surface associated" Q9H3R2 3 124905442-124953819 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "intestine: 614.6" "Cell type enhanced" "Detected in some" "Distal enterocytes: 853.2;Intestinal goblet cells: 418.5;Paneth cells: 641.9;Proximal enterocytes: 422.5;Undifferentiated cells: 207.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 198.4;stomach cancer: 152.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "OE19: 220.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045163, HPA079663" Enhanced "Secreted to digestive system" NA NA "Cluster 9: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA045163: AB_10960396, HPA079663: " "unprognostic (8.42e-2)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (1.55e-3)" "unprognostic (2.93e-1)" "unprognostic (2.11e-2)" "unprognostic (1.26e-1)" "unprognostic (3.48e-2)" "unprognostic (2.94e-1)" "unprognostic (5.10e-2)" "unprognostic (2.02e-1)" "unprognostic (9.64e-2)" "prognostic unfavorable (9.73e-5)" "unprognostic (2.05e-3)" "unprognostic (1.10e-1)" "unprognostic (2.29e-1)" "unprognostic (1.42e-1)" 0.8 0.8 0.0 62.0 0.0 0.1 0.5 0.0 0.1 0.8 0.0 304.6 614.6 1.5 0.0 0.8 2.8 47.9 0.1 0.0 0.0 17.5 3.7 0.3 0.4 0.2 0.0 0.0 4.5 0.0 0.1 0.0 0.3 2.1 301.3 0.0 0.0 0.8 0.0 0.1 503.8 10.9 0.0 0.1 35.3 0.3 0.0 0.0 0.0 0.1 0.1 0.8 0.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 0.1 6.4 13.6 0.0 0.8 0.2 0.1 1.0 0.0 0.0 0.0 0.1 0.1 0.0 1.5 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.9 0.1 0.0 0.0 1.0 0.0 220.9 1.1 0.0 0.1 2.7 0.0 0.0 0.3 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.1 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.3 3.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 25.8 0.8 0.0 0.0 0.0 0.0 853.2 0.0 24.7 0.9 120.0 1.5 0.4 153.8 0.0 0.1 31.4 0.0 0.0 36.7 6.1 8.9 0.0 0.0 0.0 0.0 0.0 0.2 418.5 0.0 0.3 0.0 4.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 15.8 641.9 0.7 0.0 1.5 422.5 7.7 10.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 1.5 0.0 207.9 1.4 HEG1 "HEG, KIAA1237" ENSG00000173706 "Heart development protein with EGF like domains 1" Q9ULI3 3 124965710-125055997 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 90.1;Cardiomyocytes: 90.5;Cone photoreceptor cells: 264.8;Endothelial cells: 121.5;Hepatic stellate cells: 130.3;Microglial cells: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 174.1;HHSteC: 241.5;hTERT-RPE1: 351.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010952, HPA011559" Approved Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 510000000 "Cluster 15: NK-cells - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "Plasma membrane" "HPA010952: AB_2668389, HPA011559: AB_1850580" "unprognostic (1.10e-1)" "unprognostic (2.21e-1)" "unprognostic (6.52e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.48e-2)" "unprognostic (2.89e-2)" "unprognostic (2.36e-1)" "unprognostic (9.80e-2)" "unprognostic (1.69e-1)" "unprognostic (8.33e-2)" "prognostic unfavorable (1.93e-5)" "unprognostic (1.11e-2)" "unprognostic (4.99e-2)" "unprognostic (6.20e-3)" "prognostic unfavorable (1.16e-4)" 30.1 9.9 19.3 19.2 23.2 1.9 14.8 27.0 15.0 20.8 28.3 11.9 8.0 19.2 6.2 16.1 13.2 38.9 67.3 14.3 22.7 15.2 7.5 55.1 16.5 32.0 28.1 12.4 31.6 16.1 3.6 33.4 28.6 13.9 12.2 46.8 7.7 14.6 14.3 5.2 9.4 25.4 27.3 17.9 9.8 13.5 30.3 8.6 52.2 24.2 15.7 30.0 10.1 30.6 7.0 7.1 54.7 4.2 73.2 58.7 21.1 64.9 90.1 72.6 83.5 58.5 1.0 2.8 43.8 174.1 52.3 15.3 7.4 31.6 97.9 6.5 3.7 1.3 42.3 8.4 241.5 1.8 80.6 77.8 10.1 87.4 21.5 351.3 69.3 5.0 0.1 1.0 25.7 1.3 2.8 0.1 10.1 0.1 5.5 4.8 41.0 0.2 14.6 1.2 1.0 5.6 134.8 10.6 6.4 55.1 24.2 4.3 93.9 37.7 41.3 150.5 29.1 6.9 19.7 0.4 76.8 6.5 82.4 1.1 0.1 0.0 1.9 1.7 1.1 0.5 0.6 1.7 0.4 0.3 1.2 0.8 0.0 3.9 1.9 0.4 0.2 0.5 19.3 23.2 27.0 15.0 14.3 22.7 32.0 28.1 28.6 27.3 30.3 30.6 90.1 86.6 5.8 28.7 4.9 5.0 8.0 25.4 6.8 6.1 2.4 5.7 90.5 7.2 6.5 27.6 264.8 1.8 19.2 0.5 0.0 32.0 7.0 4.0 20.1 121.5 0.0 6.1 0.9 6.4 65.3 44.8 1.1 2.2 26.6 24.9 130.3 3.5 6.8 1.7 14.9 0.5 4.1 18.4 7.3 9.4 5.0 7.1 7.2 92.8 4.0 6.0 35.0 13.0 57.6 6.4 0.1 13.9 8.6 5.2 0.8 1.3 1.0 66.8 0.0 24.0 28.7 1.0 1.1 2.7 4.4 3.3 14.2 3.1 0.1 1.3 SLC12A8 CCC9 ENSG00000221955 "Solute carrier family 12 member 8" A0AV02 3 125082636-125212864 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 22.9" "Cell type enhanced" "Detected in many" "Collecting duct cells: 23.9;Excitatory neurons: 38.4;granulocytes: 17.8;Inhibitory neurons: 27.8;Intestinal goblet cells: 36.6;Oligodendrocyte precursor cells: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 19.6;HHSteC: 33.6;OE19: 27.6;U-2197: 67.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031123 Uncertain Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 18: U-2197 - ECM organization" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm "HPA031123: AB_2301872" "unprognostic (4.74e-2)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (5.91e-3)" "unprognostic (7.35e-3)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (3.76e-2)" "unprognostic (1.01e-1)" "unprognostic (7.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.13e-2)" "prognostic unfavorable (5.56e-4)" "unprognostic (7.18e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-2)" "unprognostic (1.78e-2)" 1.5 1.1 2.9 1.2 3.2 0.0 2.3 1.0 3.1 1.4 11.7 3.5 5.6 0.6 3.6 4.1 2.0 8.3 0.6 3.4 2.4 3.2 6.8 2.2 0.6 1.6 2.0 0.3 10.0 4.3 2.2 2.7 1.9 2.8 4.2 0.1 11.9 0.6 0.1 1.3 3.6 0.7 1.0 0.3 4.1 2.3 2.0 0.5 22.9 0.0 0.9 2.1 2.2 2.0 14.7 0.0 2.7 0.0 3.3 4.6 6.7 0.8 2.0 0.9 1.7 19.6 6.8 0.0 1.9 5.6 2.8 8.5 0.0 0.0 0.5 0.0 0.0 0.0 7.2 0.0 33.6 0.0 1.0 8.7 8.3 1.9 0.9 16.3 0.0 0.0 0.0 0.6 1.3 3.9 0.0 0.0 9.3 27.6 0.7 0.0 0.2 0.0 6.8 1.3 4.2 0.0 7.0 8.4 0.1 0.9 15.6 0.4 0.2 0.2 1.3 67.9 0.0 0.1 1.9 5.0 3.3 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.2 1.0 3.1 3.4 2.4 1.6 2.0 1.9 1.0 2.0 2.0 0.2 0.0 0.5 7.2 0.1 1.0 1.3 3.3 3.4 0.0 5.6 4.3 1.1 2.8 2.5 23.9 0.0 0.5 0.1 1.6 0.0 3.9 0.3 0.8 1.4 0.3 5.4 0.0 38.4 3.5 6.5 2.1 7.7 2.7 17.8 1.8 0.0 9.4 0.9 0.0 27.8 36.6 0.0 0.0 0.7 0.5 0.0 0.5 0.0 7.5 2.1 0.0 1.0 31.7 2.0 2.9 3.4 0.0 0.2 6.2 2.6 1.5 0.4 0.0 0.0 0.2 0.7 0.6 0.4 4.3 0.3 3.0 0.8 0.1 5.6 1.0 ZNF148 "BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148" ENSG00000163848 "Zinc finger protein 148" Q9UQR1 3 125225669-125375325 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001656, CAB017486" Supported Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 23: Testis - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "Golgi apparatus" "CAB017486: AB_794260, HPA001656: AB_1079995" "unprognostic (2.40e-1)" "unprognostic (1.12e-2)" "unprognostic (5.03e-2)" "unprognostic (3.94e-2)" "unprognostic (5.94e-3)" "unprognostic (5.66e-2)" "unprognostic (1.24e-2)" "unprognostic (2.36e-1)" "unprognostic (1.69e-2)" "unprognostic (1.33e-2)" "prognostic unfavorable (2.88e-4)" "unprognostic (6.36e-2)" "unprognostic (7.97e-3)" "unprognostic (1.71e-1)" "unprognostic (2.84e-1)" "unprognostic (3.63e-2)" "unprognostic (2.72e-1)" 8.9 7.5 5.6 9.4 8.9 7.9 12.1 12.9 7.8 12.6 0.0 10.8 7.6 13.9 10.2 10.3 12.4 9.5 15.5 4.5 16.4 12.9 11.7 10.3 12.3 4.2 6.5 17.4 9.5 15.8 4.7 9.7 4.2 11.1 11.5 13.1 10.0 11.1 11.1 5.8 8.9 13.7 2.3 11.9 9.8 10.5 14.5 16.9 30.0 12.0 14.4 10.6 6.1 8.3 30.6 19.8 21.1 18.9 18.4 19.7 16.0 27.2 31.5 29.9 28.4 19.1 16.6 24.4 18.5 40.3 24.1 24.4 23.2 20.5 42.4 10.9 8.9 30.1 23.3 9.8 13.6 20.9 29.1 16.1 21.0 28.0 29.4 19.7 20.7 17.7 15.0 20.2 22.3 23.9 26.1 7.7 13.6 20.6 16.8 18.6 23.2 13.9 17.1 33.6 18.2 15.3 36.2 18.2 29.7 11.7 22.7 20.8 26.6 22.6 24.1 28.5 17.5 17.4 21.5 36.6 16.9 13.1 21.3 4.4 15.3 32.0 21.8 14.5 22.5 24.5 19.2 20.9 13.0 22.2 27.9 22.0 51.4 33.2 23.4 11.3 19.6 20.1 5.6 8.9 12.9 7.8 4.5 16.4 4.2 6.5 4.2 2.3 14.5 8.3 54.7 93.0 41.3 92.7 56.7 35.6 26.0 36.2 48.9 68.0 37.0 35.7 75.2 24.3 43.0 33.1 39.6 28.7 53.7 34.7 25.4 37.5 82.0 28.8 54.3 51.6 47.9 32.0 166.7 37.4 24.3 44.5 31.1 38.1 50.6 75.7 37.9 41.0 31.1 75.7 170.3 34.4 26.4 37.1 21.2 135.2 48.1 41.2 17.8 143.4 50.1 45.7 59.8 154.3 151.4 33.7 25.6 59.0 35.8 36.6 28.2 43.9 27.5 39.4 32.9 63.4 60.7 24.4 24.2 32.5 38.4 31.6 52.0 42.0 33.6 35.6 SNX4 ATG24B ENSG00000114520 "Sorting nexin 4" O95219 3 125446650-125520202 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 163.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005709 Uncertain NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA005709: AB_1080049" "unprognostic (1.11e-1)" "unprognostic (2.08e-1)" "unprognostic (1.91e-2)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.97e-2)" "unprognostic (1.80e-1)" "unprognostic (1.19e-2)" "unprognostic (6.33e-2)" "unprognostic (4.93e-2)" "unprognostic (4.06e-1)" "unprognostic (3.42e-1)" "unprognostic (6.99e-2)" "prognostic favorable (5.01e-5)" "unprognostic (2.40e-1)" "unprognostic (1.03e-1)" "unprognostic (7.13e-3)" "unprognostic (1.05e-1)" 16.7 22.1 11.0 12.7 11.2 16.3 25.3 11.5 16.7 19.9 12.4 24.9 35.8 14.1 13.7 14.9 14.2 19.8 16.5 11.1 12.3 53.8 56.5 18.1 16.3 11.9 11.1 14.9 19.5 18.0 14.4 31.7 12.0 22.7 27.7 9.1 22.4 11.4 18.9 10.2 34.2 13.4 11.8 13.0 21.6 16.1 10.8 21.1 44.9 23.3 17.1 16.8 11.3 14.0 34.8 10.9 34.5 21.8 20.9 17.4 39.1 18.5 17.5 35.9 32.1 23.7 15.5 22.0 21.4 22.5 15.5 18.0 32.4 15.6 42.9 20.6 23.8 35.6 14.5 36.0 24.5 37.8 22.1 22.7 17.0 18.2 14.5 20.0 34.1 31.8 38.6 10.9 27.6 26.2 41.8 25.4 20.2 37.6 13.0 38.2 42.0 40.3 33.0 30.6 36.1 50.9 29.8 38.3 47.4 32.0 37.7 61.3 22.3 18.0 22.9 23.4 21.9 22.1 20.1 60.2 22.0 23.8 27.8 12.4 14.0 25.8 9.7 18.8 13.0 13.8 12.4 11.2 18.3 10.3 15.8 13.8 2.6 17.4 19.1 16.1 15.1 12.0 11.0 11.2 11.5 16.7 11.1 12.3 11.9 11.1 12.0 11.8 10.8 14.0 27.1 28.9 39.4 33.6 24.5 12.1 17.9 21.3 12.5 13.4 27.2 17.1 17.7 37.1 34.1 22.0 0.0 87.2 20.6 39.9 60.7 45.4 21.6 23.8 22.1 24.7 30.0 22.7 46.7 36.6 57.8 26.9 26.0 20.9 31.0 30.9 24.7 75.8 50.9 18.5 44.9 37.0 46.8 27.0 22.6 31.5 22.1 28.3 30.2 31.9 45.7 21.3 34.0 37.7 47.8 42.9 37.9 18.0 26.2 22.5 48.8 163.4 37.1 12.0 13.1 27.8 30.3 33.0 29.8 23.0 11.8 41.2 22.9 27.2 29.6 15.7 OSBPL11 "FLJ13012, FLJ13164, ORP-11, ORP11" ENSG00000144909 "Oxysterol binding protein like 11" Q9BXB4 3 125528858-125595497 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 57.3;tongue: 80.1" "Cell type enhanced" "Detected in many" "Kupffer cells: 74.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039144 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Nucleoplasm, Golgi apparatus" "HPA039144: AB_10794086" "unprognostic (1.14e-1)" "unprognostic (1.31e-3)" "unprognostic (2.57e-3)" "unprognostic (9.73e-3)" "unprognostic (6.38e-2)" "unprognostic (6.56e-3)" "unprognostic (7.05e-2)" "unprognostic (1.43e-1)" "unprognostic (6.68e-2)" "unprognostic (1.42e-1)" "unprognostic (9.25e-2)" "unprognostic (9.84e-2)" "unprognostic (6.43e-2)" "unprognostic (2.32e-1)" "unprognostic (1.07e-1)" "unprognostic (3.58e-2)" "unprognostic (1.13e-1)" 10.0 5.4 11.6 10.9 13.3 7.0 6.0 8.6 10.5 6.3 4.4 8.2 6.8 7.6 5.6 8.4 5.7 6.5 6.6 9.1 15.2 8.5 28.9 14.0 13.1 11.0 14.1 5.5 3.7 13.3 3.9 10.9 12.6 5.6 8.1 6.0 4.2 7.7 57.3 7.5 6.2 8.8 9.9 15.4 5.2 10.3 12.3 12.4 7.4 80.1 12.2 8.4 4.9 12.3 21.2 10.9 20.4 11.7 22.4 12.0 27.5 15.6 11.9 18.7 21.3 21.3 7.2 34.2 19.2 12.5 15.5 15.5 22.7 13.3 24.7 9.6 10.2 15.6 12.5 14.0 12.6 11.9 20.8 9.7 15.8 15.6 13.6 7.5 13.8 16.2 16.5 15.0 17.1 12.2 24.4 5.8 28.8 15.1 10.0 21.1 11.8 40.4 15.5 12.6 4.6 12.4 18.9 10.6 16.3 13.9 11.2 6.1 14.8 15.2 13.9 22.4 12.2 9.8 11.1 41.5 10.7 4.1 14.9 16.5 12.3 3.1 2.1 12.1 1.8 4.3 1.3 2.2 14.9 3.3 1.4 1.6 18.2 2.5 10.1 6.2 2.9 4.5 11.6 13.3 8.6 10.5 9.1 15.2 11.0 14.1 12.6 9.9 12.3 12.3 14.4 9.6 14.4 33.3 16.0 9.9 7.3 3.9 10.8 18.7 12.1 11.6 9.4 7.2 9.9 9.2 12.5 12.4 22.8 29.1 5.9 8.5 1.3 34.5 13.7 9.7 4.2 9.4 14.8 6.9 10.3 9.4 6.6 24.3 3.8 10.6 10.8 37.6 26.6 8.4 18.6 6.0 0.0 74.0 27.5 4.0 6.5 40.3 12.4 38.4 48.6 12.2 13.4 15.1 18.1 11.4 21.3 7.2 10.5 7.8 10.7 9.7 8.9 33.8 6.6 18.0 10.5 13.0 18.6 9.2 15.8 23.1 11.1 5.3 9.5 10.4 ALG1L ALG1L1 ENSG00000189366 "ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like" Q6GMV1 3 125929275-125937039 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 10.8;urinary bladder: 9.4" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 33.6;Club cells: 15.2;Endometrial ciliated cells: 10.5;Ionocytes: 12.2;Respiratory ciliated cells: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 15.9;CAPAN-2: 14.3;HaCaT: 15.2;MCF7: 30.1;OE19: 19.1;T-47d: 19.7" HPA036108 Uncertain NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA036108: AB_10673344" "unprognostic (7.06e-3)" "unprognostic (1.50e-3)" "unprognostic (1.47e-1)" "unprognostic (4.14e-2)" "prognostic favorable (3.00e-4)" "unprognostic (2.40e-2)" "unprognostic (1.86e-1)" "unprognostic (1.15e-1)" "unprognostic (2.10e-1)" "unprognostic (1.47e-1)" "unprognostic (4.37e-2)" "unprognostic (5.79e-2)" "unprognostic (4.50e-6)" "unprognostic (1.35e-1)" "unprognostic (3.30e-1)" "unprognostic (1.57e-2)" "prognostic favorable (6.24e-4)" 0.5 1.1 2.5 1.1 2.7 0.3 1.4 2.0 3.0 1.6 1.4 1.4 0.4 1.4 10.8 1.6 2.2 0.8 0.7 2.4 2.6 1.7 1.4 1.0 0.4 2.5 2.4 2.3 1.3 0.6 1.8 1.5 2.5 1.8 0.8 0.6 1.9 0.9 6.7 5.8 0.5 0.5 2.1 0.3 1.5 1.2 2.4 1.1 1.6 2.6 2.7 9.4 1.5 2.5 1.1 0.8 0.4 0.0 0.0 0.2 1.8 0.1 0.0 0.2 0.4 15.9 14.3 4.4 6.8 0.0 0.3 15.2 0.4 0.0 0.8 0.6 3.6 0.8 2.4 0.0 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.0 4.1 1.2 1.4 0.0 30.1 1.0 0.3 6.4 19.1 3.8 0.1 0.1 7.4 0.0 0.9 2.4 0.9 0.5 0.2 0.7 3.2 19.7 0.4 0.3 0.2 2.2 0.2 0.1 10.9 1.7 5.9 0.2 0.0 1.0 2.5 0.0 0.1 2.0 0.1 1.1 1.6 1.0 2.2 0.0 0.9 1.2 0.7 0.4 3.2 0.0 1.3 2.7 0.9 2.5 2.7 2.0 3.0 2.4 2.6 2.5 2.4 2.5 2.1 2.4 2.5 0.2 0.0 0.5 0.3 0.7 3.3 1.7 33.6 0.6 0.3 2.1 2.4 0.0 0.0 15.2 1.8 0.0 3.5 0.5 0.3 1.9 0.4 1.7 10.5 0.8 0.3 1.8 0.0 1.2 0.4 2.0 1.1 0.0 0.4 1.3 1.4 0.0 0.1 0.3 0.0 1.7 0.2 12.2 0.0 1.2 1.8 1.8 0.1 1.8 0.0 0.2 1.5 2.1 1.0 0.6 0.6 1.4 3.0 0.4 0.5 0.0 1.0 46.0 0.0 0.0 2.7 2.6 1.4 1.6 0.3 5.1 1.4 0.5 2.4 0.4 8.2 ROPN1B ENSG00000114547 "Rhophilin associated tail protein 1B" Q9BZX4 3 125969160-125983454 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 214.2" "Group enriched" "Detected in many" 4 "Early spermatids: 2012.7;Late spermatids: 1967.9" "Group enriched" "Detected in some" 5 "breast cancer: 1.3;melanoma: 4.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "SK-MEL-30: 54.6;WM-115: 18.5" HPA052530 Supported NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 34: Spermatids - Unknown function" "HPA052530: AB_2681861" "unprognostic (7.73e-3)" "unprognostic (1.35e-2)" "unprognostic (2.22e-3)" "unprognostic (2.76e-2)" "unprognostic (7.19e-2)" "unprognostic (3.39e-2)" "unprognostic (1.21e-2)" "unprognostic (2.12e-1)" "unprognostic (8.15e-2)" "unprognostic (1.96e-2)" "unprognostic (1.09e-2)" "unprognostic (8.18e-2)" "unprognostic (5.91e-2)" "unprognostic (5.01e-2)" "unprognostic (1.74e-2)" "unprognostic (6.89e-3)" "unprognostic (3.78e-2)" 0.3 0.5 1.3 0.2 1.6 0.1 38.2 2.0 1.8 0.2 0.0 0.1 0.1 0.3 22.1 0.1 0.5 0.0 3.0 1.3 1.2 0.3 1.2 0.3 0.6 0.8 1.3 0.3 0.3 0.0 3.0 0.2 0.9 0.7 0.0 1.8 14.6 0.2 0.4 7.0 0.1 0.0 0.5 0.1 0.1 214.2 0.9 0.0 0.7 0.8 0.3 0.4 0.1 2.0 0.0 0.0 0.3 0.2 0.0 0.0 2.9 0.0 0.3 0.2 0.2 0.2 2.4 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 1.4 0.0 0.1 1.1 0.2 0.0 0.8 0.0 0.0 0.0 0.5 0.0 0.3 0.9 0.3 0.1 0.0 54.6 0.1 0.7 0.7 0.0 0.0 0.5 0.2 0.2 5.4 1.1 0.3 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 1.6 2.0 1.8 1.3 1.2 0.8 1.3 0.9 0.5 0.9 2.0 0.6 0.0 0.0 1.3 0.3 3.7 0.1 1.4 0.0 0.2 60.1 86.2 18.8 0.0 3.9 0.0 0.0 0.3 2.0 0.0 0.0 0.2 2012.7 3.1 0.1 1.6 0.0 0.0 0.5 0.2 2.5 1.3 0.0 0.1 0.0 0.2 0.0 0.5 0.1 3.3 0.4 0.0 2.0 0.0 2.0 1967.9 19.0 1.5 149.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 9.8 0.0 0.6 0.0 0.1 17.8 0.2 19.7 0.0 1.0 493.4 11.8 0.0 0.6 0.1 0.5 0.0 0.0 1.2 SLC41A3 FLJ20473 ENSG00000114544 "Solute carrier family 41 member 3" Q96GZ6 3 126006357-126101561 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045847 Approved Supported "Plasma membrane" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 80: Striated muscle - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" "HPA045847: AB_2679472" "unprognostic (1.77e-1)" "unprognostic (3.35e-2)" "unprognostic (1.11e-1)" "unprognostic (3.37e-2)" "unprognostic (7.68e-3)" "unprognostic (2.20e-1)" "prognostic unfavorable (1.49e-7)" "unprognostic (1.36e-1)" "unprognostic (3.23e-2)" "unprognostic (2.82e-3)" "unprognostic (5.74e-2)" "unprognostic (3.57e-1)" "prognostic favorable (6.04e-7)" "unprognostic (1.26e-1)" "unprognostic (5.88e-2)" "unprognostic (2.85e-1)" "unprognostic (7.54e-2)" 29.5 47.2 53.3 13.3 55.6 11.3 29.5 55.0 56.1 42.4 53.0 24.8 18.1 44.4 55.1 22.2 40.2 28.6 34.3 57.7 54.9 27.7 14.3 21.4 18.1 56.8 54.0 54.5 32.7 34.9 40.0 19.7 59.6 23.1 19.2 25.7 31.1 23.7 61.8 24.6 23.8 29.4 49.8 19.6 27.8 44.7 54.7 34.4 32.0 47.9 19.3 28.9 29.6 48.4 43.7 17.4 28.5 24.1 78.7 45.3 42.4 24.4 42.1 32.9 39.0 23.3 38.7 31.4 44.8 48.9 35.7 33.3 10.8 42.1 29.0 31.1 32.0 17.2 32.1 34.2 65.3 31.4 18.4 44.0 50.8 20.0 41.1 48.7 46.5 38.2 14.7 26.2 44.0 22.2 35.1 25.7 21.7 57.4 26.3 18.6 29.3 43.5 39.6 31.6 22.1 23.8 37.8 12.3 104.0 26.6 12.2 41.9 32.2 30.8 23.2 47.1 28.0 19.4 17.2 15.8 27.7 14.0 28.9 13.0 6.3 4.6 12.0 9.4 9.6 9.4 11.1 12.2 9.8 9.0 9.6 9.1 1.2 14.9 6.1 9.6 21.8 6.1 53.3 55.6 55.0 56.1 57.7 54.9 56.8 54.0 59.6 49.8 54.7 48.4 25.6 16.0 10.9 9.8 13.5 13.8 22.3 24.9 20.5 15.4 22.9 23.5 14.4 32.9 20.5 22.0 4.2 34.6 14.6 7.5 3.9 35.8 36.7 34.1 15.3 28.5 21.1 5.0 17.0 24.7 36.1 19.7 11.7 17.9 5.7 21.2 35.0 7.2 16.1 28.6 20.7 12.1 30.5 12.8 10.3 14.7 37.6 8.6 14.2 15.0 13.5 25.9 7.2 11.6 8.0 24.3 6.8 54.9 10.3 15.3 14.7 12.6 14.8 12.1 26.3 23.1 20.7 16.7 45.4 18.2 15.3 25.3 17.7 42.4 15.6 19.0 ALDH1L1 "10-fTHF, FDH, FTHFD" ENSG00000144908 "Aldehyde dehydrogenase 1 family member L1" O75891 3 126103562-126197994 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "One-carbon metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 369.7" "Group enriched" "Detected in many" 4 "Hepatocytes: 633.3;Proximal tubular cells: 197.4" "Cancer enriched" "Detected in many" 4 "liver cancer: 40.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 36.5;Hep G2: 78.1;Karpas-707: 82.0;RPMI-8226: 45.0;RT4: 219.1;U-266/70: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036900, HPA050139" Enhanced Supported Supported Cytosol No No 3000000 "Cluster 15: Liver - Metabolism" "Cluster 15: RT4 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" Cytosol "HPA036900: AB_10672273, HPA050139: AB_2681031" "unprognostic (5.93e-2)" "unprognostic (1.22e-1)" "unprognostic (9.12e-2)" "unprognostic (2.68e-1)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (7.12e-2)" "unprognostic (1.29e-1)" "unprognostic (3.05e-2)" "unprognostic (4.73e-2)" "unprognostic (3.05e-3)" "unprognostic (8.40e-2)" "prognostic favorable (2.42e-8)" "unprognostic (3.60e-1)" "unprognostic (1.47e-1)" "unprognostic (7.03e-3)" "unprognostic (7.93e-2)" 76.4 37.2 53.4 2.0 63.2 0.4 28.8 55.9 63.6 15.6 37.7 10.1 0.2 7.2 2.5 6.6 16.0 2.3 26.5 47.5 56.2 116.6 369.7 3.1 0.3 56.7 52.9 45.3 44.3 15.1 4.5 0.0 53.0 14.6 5.4 8.7 88.6 6.9 90.7 3.5 5.6 2.0 48.4 0.4 9.5 15.0 53.9 3.7 2.6 59.9 4.6 28.3 6.4 46.0 1.3 0.0 0.0 0.0 36.5 0.0 0.4 0.3 1.5 0.4 0.6 0.0 3.2 2.6 10.2 0.0 2.1 0.4 0.6 1.5 0.7 0.0 0.2 0.1 0.3 78.1 10.6 10.6 0.2 0.3 0.8 0.0 0.0 0.3 0.0 0.0 0.0 82.0 1.6 0.0 0.0 0.2 0.3 1.1 0.0 0.1 0.2 45.0 0.7 219.1 0.4 0.3 1.3 10.6 0.0 0.6 0.1 0.0 0.3 1.4 6.2 0.0 0.1 44.8 14.8 0.4 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.4 63.2 55.9 63.6 47.5 56.2 56.7 52.9 53.0 48.4 53.9 46.0 0.8 0.0 6.0 92.7 4.6 0.1 53.5 9.1 1.8 0.2 14.4 2.2 16.1 38.6 44.0 12.9 0.0 0.0 0.1 7.2 72.4 2.9 22.3 57.2 5.2 4.6 1.2 34.7 0.6 5.6 0.2 9.1 0.0 3.6 27.8 12.4 17.2 633.3 0.1 0.0 3.0 17.6 2.0 24.5 1.9 35.0 26.4 9.3 3.6 3.7 0.0 40.0 0.0 11.1 0.2 2.2 0.4 22.6 0.0 12.2 0.8 197.4 32.2 1.4 6.6 10.5 5.3 1.6 4.3 1.7 0.0 0.1 2.8 0.9 5.6 61.7 KLF15 KKLF ENSG00000163884 "Kruppel like factor 15" Q9UIH9 3 126342635-126357408 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 92.5" "Cell type enhanced" "Detected in many" "Astrocytes: 22.9;Cardiomyocytes: 29.7;Distal tubular cells: 29.4;Hepatocytes: 66.9;Peritubular cells: 19.9;Proximal tubular cells: 22.1" "Cancer enhanced" "Detected in many" "liver cancer: 30.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 57.4;HHSteC: 34.8;RPMI-8226: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003286, HPA028866" Uncertain Supported "Nucleoplasm,Nuclear speckles,Vesicles" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 30: Mammary glandular cells - Lactation" "Nucleoplasm, Nuclear speckles" Vesicles "HPA003286: , HPA028866: AB_10600819" "unprognostic (3.77e-3)" "unprognostic (1.08e-1)" "unprognostic (1.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.72e-3)" "unprognostic (2.11e-1)" "unprognostic (4.63e-2)" "unprognostic (1.09e-2)" "unprognostic (2.91e-1)" "unprognostic (1.32e-1)" "unprognostic (3.58e-2)" "unprognostic (1.10e-1)" "prognostic favorable (3.27e-7)" "unprognostic (6.75e-2)" "unprognostic (7.65e-2)" "unprognostic (1.91e-2)" "unprognostic (5.58e-3)" 36.5 6.2 42.2 0.8 50.7 0.1 25.4 45.1 69.5 15.8 37.5 18.6 1.2 19.1 4.1 7.1 29.7 3.5 31.4 41.7 40.6 20.3 92.5 18.6 1.8 64.9 45.9 46.3 48.5 4.5 10.4 1.7 47.2 17.6 0.9 3.9 19.7 5.2 67.3 10.3 10.2 2.5 44.9 3.6 30.2 5.6 44.7 1.2 11.1 32.4 0.8 27.0 12.0 48.4 0.8 0.0 2.2 9.2 57.4 1.0 10.0 0.6 1.4 0.7 1.3 1.1 0.0 3.4 0.9 0.0 1.7 0.1 5.3 0.1 0.2 0.2 2.0 0.1 0.8 7.9 34.8 0.0 0.2 5.4 0.5 0.0 1.2 0.0 0.6 4.5 4.3 7.4 0.2 0.7 0.0 1.3 6.6 1.3 0.3 4.7 0.2 20.2 0.1 0.8 0.7 7.7 0.1 0.3 10.2 3.3 0.5 4.6 0.3 0.3 0.4 0.3 0.3 4.7 0.6 0.7 0.2 1.5 1.3 25.1 7.6 10.3 7.0 10.2 8.2 12.3 7.3 7.4 8.2 11.4 9.4 11.3 16.7 12.8 9.3 9.0 10.5 11.7 42.2 50.7 45.1 69.5 41.7 40.6 64.9 45.9 47.2 44.9 44.7 48.4 1.5 6.4 4.6 22.9 0.8 0.0 2.9 0.2 0.6 1.3 7.8 1.8 29.7 15.7 0.7 0.0 0.0 0.1 0.1 0.0 29.4 0.1 0.1 2.5 4.4 2.1 0.0 2.7 0.6 0.0 0.2 8.1 3.1 3.4 0.0 13.7 8.2 66.9 0.1 0.0 2.8 0.1 0.0 2.6 0.0 0.8 12.2 0.4 1.8 2.8 0.0 12.0 0.0 15.1 5.7 0.4 0.0 19.9 0.9 5.2 0.0 22.1 0.8 3.3 0.0 12.0 5.5 0.1 0.1 0.3 0.0 0.3 0.5 0.6 0.1 1.8 CFAP100 "CCDC37, FLJ40083, MIA1" ENSG00000163885 "Cilia and flagella associated protein 100" Q494V2 3 126394909-126436556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 23.3;choroid plexus: 30.6;fallopian tube: 27.1;testis: 32.4" "Group enriched" "Detected in some" 8 "Early spermatids: 316.1;Late spermatids: 703.3" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046354 Enhanced NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 31: Spermatids - Spermatogenesis" "HPA046354: AB_2679634" "unprognostic (1.79e-2)" "unprognostic (3.75e-3)" "unprognostic (7.17e-5)" "unprognostic (1.61e-3)" "unprognostic (6.75e-2)" "unprognostic (9.99e-3)" "unprognostic (1.47e-1)" "unprognostic (7.83e-2)" "unprognostic (1.61e-1)" "unprognostic (3.70e-1)" "unprognostic (1.45e-2)" "unprognostic (1.63e-1)" "unprognostic (2.70e-5)" "unprognostic (3.57e-2)" "unprognostic (2.80e-1)" "unprognostic (2.96e-2)" "unprognostic (3.58e-4)" 0.0 0.0 5.2 0.0 4.9 0.0 0.0 2.1 2.0 3.1 30.6 0.0 0.0 1.0 0.0 0.0 27.1 0.0 0.0 5.2 4.5 0.1 0.0 6.2 0.1 16.6 23.3 0.1 0.0 0.0 0.3 0.0 9.8 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 11.8 0.0 0.0 32.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 4.9 2.1 2.0 5.2 4.5 16.6 23.3 9.8 11.8 5.3 6.9 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 316.1 60.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 703.3 3.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.1 0.0 0.8 48.1 0.0 6.6 0.0 0.0 5.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZXDC "FLJ13861, MGC11349" ENSG00000070476 "ZXD family zinc finger C" Q2QGD7 3 126437601-126475891 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 39.4" "Cell type enhanced" "Detected in many" "Astrocytes: 84.5;Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 99.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.4" "Group enriched" "Detected in many" 4 "dendritic cells: 1.1;granulocytes: 1.7;monocytes: 4.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049593 Approved Nucleoli Yes No "Cluster 14: Monocytes - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoli "HPA049593: AB_2680828" "unprognostic (3.06e-1)" "unprognostic (2.00e-2)" "unprognostic (2.65e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (2.27e-4)" "unprognostic (3.06e-2)" "unprognostic (5.97e-2)" "unprognostic (4.34e-2)" "unprognostic (3.37e-2)" "unprognostic (2.67e-2)" "unprognostic (1.06e-1)" "unprognostic (8.13e-2)" "unprognostic (2.98e-1)" "unprognostic (4.66e-2)" "unprognostic (1.12e-3)" 6.9 5.2 6.8 6.2 9.4 39.4 6.3 8.7 9.6 8.1 9.2 5.3 5.0 7.8 5.2 7.3 8.8 6.0 5.6 6.6 5.9 6.3 7.6 7.0 7.9 9.6 8.1 10.7 14.9 10.1 3.9 7.5 8.7 7.2 5.4 7.6 8.0 6.6 16.2 9.7 5.9 6.5 6.7 8.8 6.7 6.4 8.3 10.0 8.5 9.8 6.0 6.1 5.6 14.4 15.2 7.6 9.4 8.9 10.1 7.8 16.7 6.7 7.4 9.7 8.6 11.6 6.4 11.2 11.2 6.1 8.9 12.3 12.6 7.9 7.6 6.0 10.8 8.8 9.2 7.7 10.7 13.6 13.7 6.2 15.1 6.0 10.6 9.6 10.0 13.0 9.6 14.6 8.2 8.9 13.1 7.5 13.4 10.0 7.6 14.1 6.4 14.3 6.8 10.9 17.1 9.5 13.0 9.5 18.2 6.2 12.9 11.9 10.2 8.9 11.4 13.4 8.3 12.1 6.1 14.6 9.7 10.5 10.0 1.7 0.4 0.8 0.5 0.2 0.2 0.1 0.3 0.4 0.7 0.4 0.5 0.4 1.2 0.3 4.4 1.1 0.2 0.2 6.8 9.4 8.7 9.6 6.6 5.9 9.6 8.1 8.7 6.7 8.3 14.4 10.1 25.6 15.6 84.5 11.9 6.2 8.3 4.5 10.8 30.1 6.8 6.5 5.5 12.8 7.9 5.5 45.9 7.2 10.0 8.6 7.9 4.8 1.7 8.1 7.9 7.7 3.6 12.0 51.3 6.1 2.6 7.8 9.2 12.2 2.5 16.8 7.9 14.3 5.7 13.5 44.3 6.9 0.0 5.4 4.4 0.8 7.5 9.0 1.8 47.8 7.3 23.0 7.2 67.8 99.2 4.4 5.2 7.5 12.9 6.0 8.4 9.5 7.7 30.4 0.0 13.5 8.9 3.3 9.0 9.0 4.3 6.3 11.1 10.5 6.6 6.3 UROC1 "FLJ31300, HMFN0320" ENSG00000159650 "Urocanate hydratase 1" Q96N76 3 126481166-126517773 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 336 "liver: 116.6" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 62.2" "Cancer enriched" "Detected in single" 100 "liver cancer: 12.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "NB-4: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069863 Enhanced NA NA 670000 "Cluster 62: Liver - Hemostasis" "Cluster 24: NB-4 - Immune response" "Cluster 15: Hepatocytes - Hemostasis" "HPA069863: AB_2732143" "unprognostic (1.28e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (7.43e-2)" "unprognostic (6.43e-2)" "unprognostic (1.43e-1)" "unprognostic (2.23e-3)" "unprognostic (2.95e-1)" "unprognostic (2.57e-2)" "unprognostic (7.71e-2)" "unprognostic (9.97e-2)" "unprognostic (3.04e-1)" "unprognostic (3.65e-5)" "unprognostic (3.97e-2)" "unprognostic (2.66e-1)" "unprognostic (5.52e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 116.6 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 13.5 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.1 3.3 62.2 0.3 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 CHST13 C4ST3 ENSG00000180767 "Carbohydrate sulfotransferase 13" Q8NET6 3 126524155-126543291 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "liver: 59.6;testis: 18.3" "Group enriched" "Detected in some" 5 "Early spermatids: 104.0;Hepatocytes: 40.3;Spermatocytes: 126.2" "Group enriched" "Detected in many" 4 "liver cancer: 25.0;renal cancer: 6.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in many" 5 "eosinophil: 155.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 155.2" "Group enriched" "Detected in some" 8 "CACO-2: 15.6;Hep G2: 28.4;NB-4: 19.0;THP-1: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA067960 Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 62: Liver - Hemostasis" "Cluster 39: CACO-2 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA067960: " "unprognostic (5.68e-2)" "unprognostic (1.21e-1)" "unprognostic (1.32e-2)" "unprognostic (6.42e-4)" "unprognostic (2.26e-1)" "unprognostic (1.05e-1)" "unprognostic (8.45e-3)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" "unprognostic (1.52e-1)" "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (5.75e-2)" "unprognostic (5.16e-2)" "unprognostic (6.68e-2)" "unprognostic (2.26e-1)" "unprognostic (1.59e-2)" 0.3 0.4 0.2 0.4 0.2 0.6 0.1 0.0 0.3 0.1 0.0 0.9 0.6 0.1 0.0 0.0 0.2 0.0 0.4 0.3 0.2 3.2 59.6 0.6 0.1 0.4 0.5 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 1.0 0.0 0.4 3.5 0.4 18.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.7 0.0 2.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.7 0.3 28.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.9 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.1 33.0 155.2 0.0 20.5 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 30.7 0.0 17.5 0.0 0.0 13.1 0.2 0.2 0.0 0.3 0.3 0.2 0.4 0.5 0.2 0.4 0.6 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 10.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 104.0 0.6 0.0 0.1 1.2 5.5 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.7 40.3 13.1 0.0 0.0 1.0 0.0 7.5 1.3 16.9 1.5 6.2 0.0 1.9 7.2 0.0 0.0 0.0 0.1 0.0 2.8 1.2 0.3 0.0 8.5 9.9 0.1 0.0 0.0 0.0 0.0 126.2 2.8 0.0 0.0 0.3 0.2 0.0 1.8 0.0 C3orf22 MGC34728 ENSG00000180697 "Chromosome 3 open reading frame 22" Q8N5N4 3 126526999-126558965 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 485 "testis: 48.4" "Cell type enriched" "Detected in some" 5 "Late spermatids: 1630.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA059199 Enhanced NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 25: Spermatids - Spermatogenesis" "HPA059199: AB_2683946" "unprognostic (2.10e-1)" "unprognostic (5.14e-5)" "unprognostic (2.55e-1)" "unprognostic (9.21e-2)" "unprognostic (2.01e-1)" "unprognostic (2.75e-1)" "unprognostic (1.08e-3)" "unprognostic (1.34e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 283.2 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1630.9 10.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TXNRD3 "TGR, TR2, TR2IT1, TRXR3, TXNRD3IT1, TXNRD3NB, TXNRD3NT1" ENSG00000197763 "Thioredoxin reductase 3" Q86VQ6 3 126571779-126655124 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Electron transport, Spermatogenesis, Transport" "Developmental protein, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 20.4" "Cell type enhanced" "Detected in many" "Spermatocytes: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020802, HPA036109" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm Cytosol "CAB020802: , HPA036109: AB_2674945" "unprognostic (1.41e-1)" "unprognostic (1.55e-2)" "unprognostic (3.92e-1)" "prognostic unfavorable (3.35e-4)" "unprognostic (3.90e-1)" "unprognostic (2.96e-1)" "unprognostic (3.01e-1)" "unprognostic (3.39e-2)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.86e-4)" "unprognostic (3.14e-1)" "prognostic favorable (2.72e-4)" "unprognostic (5.94e-2)" "unprognostic (1.74e-1)" "unprognostic (1.03e-2)" "unprognostic (2.51e-1)" 4.9 4.0 2.4 2.2 2.4 1.1 6.1 3.4 1.9 4.7 3.1 2.4 1.3 5.1 5.9 4.8 3.6 3.6 3.1 1.8 3.3 5.7 8.7 4.2 1.1 2.8 3.0 6.7 6.3 8.2 1.7 2.9 2.8 3.8 3.0 1.9 3.7 4.1 5.6 3.2 1.4 4.9 3.0 2.6 3.6 20.4 3.0 4.6 6.1 5.8 1.4 3.2 1.9 2.8 16.0 3.8 4.9 8.3 8.7 13.1 2.7 6.7 5.8 5.4 7.4 7.6 8.7 0.0 8.5 9.7 3.4 6.4 6.3 7.1 6.4 0.0 5.1 1.5 3.7 5.9 7.8 6.4 0.6 13.1 5.9 1.8 12.1 7.0 3.8 5.2 3.7 0.0 9.0 12.2 1.4 3.4 7.3 4.3 3.4 0.5 4.2 2.6 6.0 8.0 8.9 5.1 19.9 5.7 10.3 3.7 8.0 2.6 6.9 6.8 1.8 9.3 3.3 4.0 1.9 0.0 3.5 2.2 5.6 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 1.0 0.3 0.0 0.2 0.0 0.0 0.0 0.1 2.4 2.4 3.4 1.9 1.8 3.3 2.8 3.0 2.8 3.0 3.0 2.8 1.3 3.2 7.2 14.4 0.4 1.0 5.7 1.6 6.2 2.0 2.9 2.4 4.1 4.3 3.0 3.7 2.1 9.4 0.1 0.5 3.9 5.1 18.2 1.5 4.0 1.7 4.2 3.0 7.5 3.8 5.4 5.3 4.1 1.0 5.7 6.1 2.9 8.0 2.9 0.0 5.8 2.4 0.0 0.8 0.7 4.0 4.7 1.0 0.0 3.7 0.0 3.2 0.0 11.1 4.7 3.8 0.3 8.6 0.1 5.5 0.1 4.5 3.3 0.9 0.0 5.7 2.8 71.5 18.2 6.1 0.6 7.3 0.6 6.6 1.5 3.2 CHCHD6 "CHCM1, MGC13016, Mic25, MICOS25, PPP1R23" ENSG00000159685 "Coiled-coil-helix-coiled-coil-helix domain containing 6" Q9BRQ6 3 126704240-126960420 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.0" "Cell type enhanced" "Detected in many" "Hofbauer cells: 178.2;Late spermatids: 106.6;Melanocytes: 172.5;Spermatocytes: 119.7" "Cancer enriched" "Detected in all" 4 "melanoma: 34.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047673, HPA051975" Approved Supported Mitochondria NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 4: Macrophages - Innate immune response" Mitochondria "HPA047673: AB_10961761, HPA051975: AB_2681679" "unprognostic (3.94e-2)" "prognostic favorable (7.46e-4)" "unprognostic (6.20e-2)" "unprognostic (1.91e-2)" "unprognostic (2.60e-1)" "unprognostic (1.16e-1)" "unprognostic (6.83e-3)" "unprognostic (1.87e-1)" "unprognostic (1.47e-1)" "unprognostic (1.31e-1)" "unprognostic (6.79e-2)" "unprognostic (2.08e-1)" "prognostic favorable (6.76e-4)" "unprognostic (6.47e-2)" "unprognostic (2.27e-1)" "unprognostic (2.79e-1)" "unprognostic (3.11e-3)" 9.4 12.8 22.2 3.8 24.7 4.2 10.8 17.7 34.3 13.1 16.4 11.6 3.9 11.5 5.0 10.9 13.7 5.0 11.9 35.0 22.7 14.4 7.4 10.7 3.9 19.0 21.6 17.7 14.8 15.6 16.5 4.1 21.0 10.5 3.0 8.3 14.1 7.8 4.7 16.3 6.2 5.4 18.4 6.9 11.7 53.0 21.4 4.9 13.0 3.2 2.9 11.1 11.5 22.1 37.1 21.1 18.4 44.7 6.4 9.8 10.5 14.1 9.5 16.0 15.5 29.3 15.8 16.3 31.8 8.5 17.5 21.3 13.9 38.3 7.9 4.5 37.7 13.5 15.8 29.0 19.0 29.2 8.5 9.9 22.9 7.8 16.3 13.1 10.6 28.4 12.2 9.4 14.2 27.7 43.2 29.1 22.3 20.9 23.7 22.8 28.0 38.9 14.3 15.8 33.6 21.0 14.5 24.3 45.4 9.0 14.2 10.8 9.7 17.9 22.2 24.5 14.6 12.0 5.9 20.4 20.1 9.6 17.0 0.0 2.4 2.1 6.8 4.1 8.8 8.4 9.9 8.4 6.8 11.6 9.4 11.2 0.0 7.7 3.7 4.8 10.0 4.6 22.2 24.7 17.7 34.3 35.0 22.7 19.0 21.6 21.0 18.4 21.4 22.1 8.9 19.2 12.5 20.5 7.1 29.6 21.7 35.5 9.6 15.4 20.0 31.5 18.5 8.6 24.0 14.7 18.8 40.8 3.4 6.4 58.7 22.7 99.0 18.6 8.8 7.3 7.7 8.2 48.1 24.2 12.1 14.8 9.7 5.8 14.0 45.6 6.8 7.2 178.2 20.2 45.1 10.8 28.5 10.1 15.6 106.6 15.8 33.0 172.5 12.2 2.7 20.2 2.1 22.6 22.0 18.9 9.0 22.2 7.1 29.6 2.6 27.9 56.1 16.1 0.0 10.9 17.9 119.7 51.4 16.0 30.1 15.5 8.2 14.1 13.3 21.1 PLXNA1 "NOV, PLXN1" ENSG00000114554 "Plexin A1" Q9UIW2 3 126988594-127037392 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 48.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007499, CAB012483" Uncertain Supported Nucleoplasm,Cytosol NA NA 10000000 "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 15: RT4 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm Cytosol "CAB012483: , HPA007499: AB_1079637" "unprognostic (1.87e-1)" "unprognostic (1.11e-1)" "unprognostic (4.38e-2)" "unprognostic (1.19e-2)" "unprognostic (1.66e-2)" "unprognostic (4.17e-2)" "prognostic unfavorable (4.13e-6)" "unprognostic (1.79e-2)" "unprognostic (9.06e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (3.77e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (5.64e-5)" "unprognostic (4.50e-3)" "unprognostic (7.62e-3)" "unprognostic (1.37e-3)" "unprognostic (1.73e-1)" 11.2 7.6 13.9 7.0 13.0 1.0 9.6 0.6 16.4 11.6 0.5 9.1 3.4 10.9 2.3 11.3 10.2 4.8 15.8 14.0 7.9 8.6 3.2 14.7 6.3 5.5 5.6 13.8 9.3 24.0 5.5 8.2 5.6 9.3 1.9 1.7 12.9 6.3 10.9 15.1 7.9 5.2 1.3 13.2 7.9 9.0 14.8 6.3 9.6 6.1 4.2 9.8 10.0 5.5 45.3 21.1 22.8 18.1 29.3 32.7 36.3 26.3 22.2 14.8 14.7 70.2 20.6 5.0 38.6 28.4 20.0 68.2 11.7 51.6 6.1 7.2 18.6 0.7 13.4 18.3 19.2 5.4 3.6 32.8 35.4 27.4 21.2 14.9 7.5 14.7 26.3 9.1 16.1 26.3 10.6 9.9 22.0 14.2 18.5 14.0 58.0 14.1 12.9 89.4 20.2 22.1 19.1 17.9 24.7 14.7 28.8 33.9 28.0 23.6 30.0 43.4 28.1 5.5 3.9 9.8 33.9 10.2 25.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.9 13.0 0.6 16.4 14.0 7.9 5.5 5.6 5.6 1.3 14.8 5.5 1.9 48.1 4.1 8.8 1.8 15.8 5.6 23.4 6.2 6.7 6.6 7.4 13.0 1.5 18.6 12.9 4.2 21.8 0.8 3.6 0.0 8.9 4.4 5.0 10.0 3.8 9.6 0.4 22.1 6.9 2.5 13.8 7.1 5.6 0.0 20.8 2.2 0.9 13.1 20.2 11.3 4.0 0.0 7.4 12.8 1.0 7.8 7.4 8.8 5.6 1.0 2.5 1.0 13.6 3.6 17.0 2.3 6.4 3.1 21.3 7.4 1.5 11.2 3.3 6.6 6.4 9.9 5.3 9.5 6.7 16.1 7.3 2.2 4.7 5.1 9.5 C3orf56 FLJ40141 ENSG00000214324 "Chromosome 3 open reading frame 56" Q8N813 3 127193131-127198185 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 15 "testis cancer: 0.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA055395 Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "Centrosome, Cytosol" "HPA055395: " "unprognostic (1.12e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRR20G ENSG00000239620 "Proline rich 20G" P0DPQ3 3 127283783-127288046 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 41 "testis: 4.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "testis cancer: 2.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (4.60e-3)" "unprognostic (2.41e-3)" "unprognostic (1.45e-1)" "unprognostic (5.78e-2)" "unprognostic (4.97e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TPRA1 "FLJ32197, GPR175, TMEM227, TPRA40" ENSG00000163870 "Transmembrane protein adipocyte associated 1" Q86W33 3 127571232-127598267 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 179.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019784 Approved Approved Vesicles NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 31: Skin - Epidermis development" "Cluster 18: U-2197 - ECM organization" "Cluster 41: Macrophages - Immune response" Vesicles "HPA019784: AB_2670266" "unprognostic (1.52e-1)" "unprognostic (1.33e-2)" "unprognostic (9.41e-3)" "unprognostic (1.66e-2)" "unprognostic (6.91e-3)" "unprognostic (9.74e-2)" "prognostic unfavorable (6.46e-4)" "unprognostic (3.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.91e-1)" "unprognostic (1.17e-1)" "unprognostic (1.11e-1)" "unprognostic (2.02e-2)" "unprognostic (1.73e-2)" "unprognostic (4.42e-2)" "unprognostic (2.09e-1)" "unprognostic (4.28e-2)" 23.9 29.7 22.4 11.7 23.3 26.5 24.5 23.4 26.2 35.8 25.9 25.8 16.9 28.8 12.5 26.4 28.1 16.5 24.7 22.3 23.3 26.8 37.0 24.9 13.9 22.9 23.4 27.8 26.7 29.0 21.7 20.8 23.0 28.8 11.3 8.0 26.4 16.2 26.8 42.9 21.2 17.2 22.7 25.0 25.8 16.3 24.2 11.5 27.0 19.8 13.0 28.5 28.8 22.7 40.0 31.2 12.9 27.3 51.4 28.6 42.1 20.5 34.2 24.7 22.2 22.1 30.9 36.7 37.6 38.4 77.2 43.6 22.6 34.8 12.9 20.0 15.0 21.4 46.0 20.7 56.6 13.3 44.7 28.8 28.8 16.4 42.8 51.2 18.0 24.5 14.0 36.7 30.4 39.8 18.5 43.4 19.3 25.5 23.4 31.9 17.0 37.0 29.6 19.1 24.6 9.5 37.7 57.7 35.1 10.4 27.3 42.3 28.7 29.6 13.1 60.0 13.2 25.0 21.0 34.4 31.9 38.8 22.4 3.8 12.9 11.5 6.4 9.4 8.6 6.6 7.4 9.5 12.7 6.4 5.6 6.8 7.0 6.6 8.4 9.7 7.2 6.5 22.4 23.3 23.4 26.2 22.3 23.3 22.9 23.4 23.0 22.7 24.2 22.7 15.7 22.4 7.0 13.1 11.7 50.0 20.5 18.8 24.5 7.8 16.3 17.9 11.8 11.5 16.5 25.8 4.2 56.9 8.4 18.2 5.9 29.1 2.7 23.5 18.0 22.8 17.4 46.5 9.3 19.6 43.3 22.9 17.9 27.5 17.8 13.9 21.8 21.7 32.9 5.0 9.7 18.7 18.3 16.0 179.7 2.4 33.5 32.0 30.2 5.6 52.3 11.2 20.6 6.6 8.1 31.4 17.6 19.5 17.9 37.5 37.5 13.1 12.4 8.9 13.1 13.2 18.3 8.4 17.9 19.1 54.4 68.1 12.6 12.7 20.7 23.5 MCM2 "BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030" ENSG00000073111 "Minichromosome maintenance complex component 2" P49736 3 127598410-127622436 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 67.7;lymphoid tissue: 37.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 63.3;Erythroid cells: 65.6;Extravillous trophoblasts: 28.8;Spermatogonia: 25.9;Syncytiotrophoblasts: 33.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB000303, HPA031450, HPA031495, HPA031496" Enhanced Enhanced Nucleoplasm Yes Yes 120000 "Cluster 43: B-cells - Humoral immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905" "unprognostic (2.43e-1)" "prognostic favorable (4.66e-4)" "unprognostic (4.44e-2)" "unprognostic (3.12e-3)" "unprognostic (1.68e-1)" "unprognostic (2.25e-2)" "prognostic unfavorable (1.51e-7)" "unprognostic (8.43e-3)" "unprognostic (1.92e-2)" "unprognostic (1.79e-1)" "unprognostic (1.41e-3)" "unprognostic (1.21e-2)" "unprognostic (1.16e-2)" "unprognostic (8.16e-3)" "unprognostic (1.56e-1)" "unprognostic (3.29e-2)" "unprognostic (2.82e-1)" 3.1 3.4 2.0 16.4 1.9 67.7 6.2 2.5 1.9 5.3 0.6 9.2 8.1 5.0 2.4 11.0 7.6 2.5 6.4 1.9 1.8 3.4 6.3 3.4 26.8 2.3 1.9 6.4 3.0 3.7 2.4 17.0 2.6 5.0 10.2 3.5 4.7 2.8 9.4 10.6 8.6 5.3 2.0 9.6 5.7 12.3 2.0 37.6 4.8 5.8 26.0 4.2 5.4 2.4 133.6 110.3 122.4 102.1 7.0 14.4 110.5 65.2 42.3 129.9 146.9 177.7 84.7 136.0 65.2 32.3 113.6 105.6 204.8 76.1 79.1 127.2 127.1 227.4 134.8 131.1 4.4 214.3 102.4 8.2 8.4 86.1 13.1 15.3 40.6 160.7 116.0 123.7 47.4 169.0 229.0 156.2 172.5 108.3 90.7 242.4 165.1 203.3 26.9 97.9 143.0 106.8 175.8 48.9 16.7 45.7 111.9 165.3 20.3 104.2 87.9 128.4 91.7 127.1 163.5 362.6 73.2 159.7 41.0 0.0 0.6 0.3 4.4 1.4 5.5 9.7 3.9 5.4 2.9 8.1 3.6 4.7 0.9 6.5 0.4 3.7 11.2 3.5 2.0 1.9 2.5 1.9 1.9 1.8 2.3 1.9 2.6 2.0 2.0 2.4 1.2 3.2 2.0 0.7 8.5 4.6 2.6 4.6 2.2 2.5 4.1 5.3 8.3 0.0 3.9 0.0 0.0 63.3 1.8 4.8 0.0 5.3 0.9 5.2 3.5 2.9 3.6 65.6 0.3 1.9 28.8 4.2 6.6 4.8 1.3 18.8 1.4 1.7 18.2 0.0 0.4 8.2 0.0 1.6 3.2 0.7 1.8 2.7 1.8 0.0 9.2 2.1 0.0 0.0 0.7 2.1 1.7 1.5 20.5 0.8 1.1 0.8 7.4 2.1 0.0 2.6 4.1 8.1 25.9 7.1 3.0 33.5 6.3 3.8 13.8 2.3 PODXL2 "endoglycan, PODLX2" ENSG00000114631 "Podocalyxin like 2" Q9NZ53 3 127629185-127672802 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 65.6;pituitary gland: 59.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 96.3;Early spermatids: 73.5;Horizontal cells: 82.4;Late spermatids: 153.1;Spermatogonia: 80.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPMI-8226: 118.1;SCLC-21H: 167.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024934, HPA042265" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" Vesicles "CAB024934: , HPA042265: AB_2677920" "unprognostic (2.07e-2)" "unprognostic (2.34e-1)" "unprognostic (7.02e-2)" "unprognostic (1.07e-2)" "unprognostic (9.74e-2)" "unprognostic (1.79e-2)" "unprognostic (8.97e-3)" "unprognostic (1.81e-1)" "unprognostic (3.89e-1)" "unprognostic (2.67e-1)" "unprognostic (4.05e-3)" "unprognostic (3.48e-1)" "unprognostic (2.91e-1)" "unprognostic (1.90e-1)" "unprognostic (2.67e-2)" "unprognostic (1.94e-2)" "unprognostic (1.46e-3)" 3.8 17.3 45.0 2.7 39.9 1.8 8.8 34.1 50.9 2.9 1.9 9.4 7.2 4.4 2.3 4.2 4.3 4.5 4.1 42.3 65.6 7.2 1.6 2.0 2.2 49.2 50.9 11.2 13.5 5.3 59.0 1.0 54.6 13.1 8.2 21.6 24.9 2.0 3.2 7.6 6.7 1.8 32.9 2.0 14.1 30.8 53.6 1.9 5.5 1.8 2.7 3.1 2.8 40.5 0.3 13.8 37.5 89.2 0.0 0.0 55.2 4.3 0.2 7.9 1.6 28.7 1.5 34.0 33.3 0.6 12.1 0.2 30.9 0.0 0.7 0.2 63.3 0.7 30.9 29.3 1.2 78.1 75.7 1.5 6.6 0.2 0.0 20.9 2.2 0.2 45.6 0.2 2.9 17.6 0.3 0.3 56.2 7.9 66.6 0.2 1.0 118.1 10.9 3.9 167.0 94.0 40.9 86.3 77.2 3.7 22.0 39.2 0.4 0.2 17.2 1.5 27.3 0.2 0.0 26.9 0.9 50.1 25.1 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.6 0.1 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.6 0.5 0.1 45.0 39.9 34.1 50.9 42.3 65.6 49.2 50.9 54.6 32.9 53.6 40.5 1.6 0.0 1.1 10.4 3.4 5.5 3.7 1.3 9.1 96.3 17.5 18.4 0.5 4.3 1.7 9.2 31.3 2.2 4.4 14.3 1.9 6.8 73.5 8.7 2.5 2.2 63.5 5.5 21.3 20.1 5.9 8.2 25.0 12.3 1.3 9.5 0.7 0.7 1.3 82.4 57.7 23.2 4.1 1.3 2.8 153.1 8.7 1.6 21.4 5.6 8.1 19.0 6.2 29.1 12.5 12.9 16.7 5.7 10.4 9.9 10.8 2.9 1.7 49.9 6.6 3.8 9.8 20.4 80.4 10.0 5.5 1.5 3.3 7.5 21.8 3.1 ABTB1 "BPOZ, Btb3, BTBD21, EF1ABP" ENSG00000114626 "Ankyrin repeat and BTB domain containing 1" Q969K4 3 127672935-127680926 "Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 822.3" "Lineage enriched" "Detected in all" 13 "granulocytes: 822.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035022, HPA035023" Uncertain Supported Nucleoli,Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol Nucleoli "HPA035022: AB_10669998, HPA035023: AB_10602104" "unprognostic (6.76e-2)" "unprognostic (9.18e-3)" "unprognostic (2.11e-2)" "unprognostic (6.34e-2)" "unprognostic (6.51e-2)" "unprognostic (2.00e-3)" "unprognostic (4.43e-2)" "unprognostic (2.12e-2)" "unprognostic (9.81e-2)" "unprognostic (4.48e-3)" "unprognostic (4.55e-3)" "unprognostic (2.86e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.88e-1)" "unprognostic (1.81e-2)" "unprognostic (3.98e-2)" "unprognostic (7.92e-3)" 38.4 18.7 30.6 18.8 35.8 51.1 33.4 38.0 42.4 42.0 28.9 38.9 12.3 29.7 5.3 13.4 37.2 18.1 40.5 32.7 25.9 25.5 17.3 32.0 22.0 28.7 27.2 30.3 17.7 9.0 31.4 12.2 27.1 31.0 4.6 8.7 24.5 13.6 44.7 24.9 31.8 7.6 24.7 89.7 27.5 8.1 29.1 21.5 21.8 26.2 7.4 32.9 31.2 30.7 4.3 10.7 0.9 2.0 10.0 8.7 7.8 6.8 12.2 4.5 6.5 0.3 8.9 1.9 11.9 5.1 6.0 2.2 0.2 5.1 1.0 20.7 2.5 3.1 19.4 2.5 7.5 0.5 9.5 12.0 5.6 4.5 1.5 15.2 4.8 8.3 0.1 13.5 4.9 6.6 4.9 13.4 0.9 4.9 11.7 3.0 5.6 13.8 6.7 3.3 9.5 6.0 4.8 6.6 25.0 2.6 1.4 3.7 9.1 4.8 4.0 8.5 2.3 11.5 3.8 0.6 11.1 4.0 7.8 40.7 64.5 161.8 17.0 48.2 16.6 17.8 19.0 17.1 28.6 21.1 16.6 14.3 822.3 25.2 44.5 18.1 46.3 46.2 30.6 35.8 38.0 42.4 32.7 25.9 28.7 27.2 27.1 24.7 29.1 30.7 45.3 19.2 13.0 10.7 31.7 11.7 15.6 14.2 7.4 10.4 9.9 15.6 8.1 22.8 5.3 7.3 18.8 8.1 34.2 11.3 15.6 15.1 0.5 9.9 11.1 20.8 23.9 58.7 26.1 16.8 22.3 21.0 23.0 10.1 14.7 10.1 27.5 8.9 21.3 3.3 12.2 15.0 12.2 64.7 16.4 1.7 33.8 37.4 10.6 18.7 74.3 18.0 35.0 6.6 12.8 25.9 21.4 22.6 25.2 12.8 26.3 23.0 6.9 31.1 65.7 16.1 36.8 1.0 8.6 4.2 9.2 15.9 38.6 10.6 10.3 11.8 MGLL "HU-K5, MAGL, MGL" ENSG00000074416 "Monoglyceride lipase" Q99685 3 127689062-128052190 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 565.4;Distal enterocytes: 398.7;Pancreatic endocrine cells: 535.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 84.7;plasmacytoid DC: 89.8" "Group enriched" "Detected in all" 14 "dendritic cells: 89.8;granulocytes: 36.0;monocytes: 84.7" "Cell line enhanced" "Detected in many" "BJ: 209.1;BJ hTERT+: 238.6;LHCN-M2: 191.3;RPTEC TERT1: 170.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011348, HPA011993, HPA011994" Enhanced Enhanced Nucleoplasm NA NA 100000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 57: Non-specific - Angiogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916" "unprognostic (1.84e-2)" "unprognostic (1.80e-2)" "unprognostic (2.14e-1)" "unprognostic (8.19e-2)" "unprognostic (1.15e-2)" "unprognostic (1.69e-1)" "unprognostic (5.83e-2)" "unprognostic (3.61e-2)" "unprognostic (1.45e-1)" "unprognostic (8.83e-2)" "prognostic unfavorable (6.41e-4)" "unprognostic (7.63e-3)" "unprognostic (1.44e-1)" "unprognostic (1.68e-1)" "unprognostic (1.90e-2)" "unprognostic (2.51e-1)" "unprognostic (2.11e-3)" 174.8 16.1 100.8 22.9 91.0 18.9 92.0 87.2 123.4 26.8 48.0 81.9 36.9 17.7 9.9 139.9 34.3 44.8 101.9 96.9 75.9 71.0 106.9 72.0 13.5 72.5 86.6 6.1 7.8 3.6 12.5 41.6 70.9 25.8 60.4 6.2 102.1 27.5 66.0 38.1 50.3 27.8 63.0 44.9 38.2 6.2 107.2 10.0 18.9 64.9 21.3 42.5 39.4 88.6 52.4 46.2 0.1 0.5 76.8 90.0 6.2 209.1 238.6 45.3 72.2 1.2 21.0 14.0 56.9 71.3 13.7 2.1 0.4 27.9 25.2 23.5 0.9 1.6 31.4 0.4 27.7 0.3 1.7 34.2 16.1 85.0 92.4 25.6 97.5 1.0 0.3 3.0 191.3 5.6 0.5 0.9 0.5 33.6 71.5 0.2 24.6 109.4 170.4 5.9 26.5 2.1 36.3 70.4 12.6 2.0 3.5 2.1 125.9 49.5 14.8 121.0 29.1 0.5 0.4 43.4 102.4 3.4 156.6 20.6 8.3 36.0 0.5 84.7 2.8 4.9 0.5 1.1 9.2 0.5 0.2 0.2 1.5 2.0 57.2 89.8 0.0 17.1 100.8 91.0 87.2 123.4 96.9 75.9 72.5 86.6 70.9 63.0 107.2 88.6 565.4 195.5 108.6 83.2 8.5 22.8 11.9 14.1 5.7 22.8 25.2 19.9 53.7 118.7 32.2 42.3 0.0 84.6 16.1 398.7 168.3 99.4 4.1 100.0 36.4 207.7 88.6 30.7 39.0 160.7 154.6 71.5 47.9 132.1 8.8 0.1 17.2 148.7 123.9 0.0 48.9 239.1 63.1 32.8 86.3 5.8 32.6 77.8 21.4 52.5 235.2 54.5 2.1 43.2 5.8 535.2 201.0 69.6 36.2 18.5 134.2 102.0 48.0 7.8 85.5 22.3 141.4 0.7 1.7 64.7 22.3 72.7 9.3 1.1 74.0 6.0 KBTBD12 "FLJ46299, KLHDC6" ENSG00000187715 "Kelch repeat and BTB domain containing 12" Q3ZCT8 3 127915232-127987671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 13.8;skeletal muscle: 58.8;tongue: 25.8" "Cell type enhanced" "Detected in many" "Astrocytes: 43.4;Early spermatids: 32.0;Excitatory neurons: 29.9;Microglial cells: 74.0" "Cancer enhanced" "Detected in some" "cervical cancer: 1.9" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "cerebellum: 5.1" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: Early spermatids - Spermatogenesis" "unprognostic (3.60e-2)" "unprognostic (2.19e-2)" "unprognostic (3.37e-1)" "unprognostic (2.19e-1)" "unprognostic (9.51e-2)" "unprognostic (3.01e-1)" "unprognostic (3.35e-2)" "unprognostic (4.69e-3)" "unprognostic (3.62e-1)" "unprognostic (2.08e-1)" "unprognostic (2.28e-2)" "unprognostic (1.17e-1)" "unprognostic (1.37e-2)" "unprognostic (1.59e-1)" "unprognostic (9.41e-2)" "unprognostic (5.70e-2)" "unprognostic (9.49e-2)" 0.3 0.2 1.3 0.3 1.5 0.2 0.2 1.6 1.6 0.2 2.7 1.8 0.8 0.3 0.1 0.7 0.9 0.7 13.8 1.6 0.6 1.2 0.0 0.2 0.1 0.7 0.7 0.1 4.0 0.0 0.5 0.1 0.7 0.5 1.2 0.7 1.9 0.2 58.8 0.3 0.7 0.7 0.5 0.0 2.0 1.0 0.7 0.0 0.0 25.8 0.0 0.8 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 1.5 1.6 1.6 1.6 0.6 0.7 0.7 0.7 0.5 0.7 1.2 0.0 3.2 3.7 43.4 0.0 0.1 0.1 0.0 0.0 1.0 0.4 0.1 12.1 0.0 1.4 1.8 6.2 0.0 0.1 2.3 1.9 0.1 32.0 1.3 0.0 0.2 2.4 1.7 29.9 9.3 0.0 0.7 7.1 0.8 0.0 0.1 0.0 0.0 0.1 1.7 15.7 5.8 0.0 0.0 1.0 3.2 0.0 0.3 0.0 74.0 0.0 1.6 0.0 3.0 2.2 5.9 5.8 0.0 0.1 0.0 1.4 0.0 1.2 0.9 0.0 1.6 1.0 6.2 5.7 0.0 0.3 0.0 0.0 0.1 1.9 0.1 SEC61A1 ENSG00000058262 "SEC61 translocon subunit alpha 1" P61619 3 128051641-128071683 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022076 Supported "Endoplasmic reticulum" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Endoplasmic reticulum" "CAB022076: " "unprognostic (1.84e-1)" "unprognostic (8.00e-2)" "unprognostic (8.21e-2)" "prognostic favorable (7.82e-4)" "unprognostic (2.13e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.07e-6)" "unprognostic (2.84e-2)" "unprognostic (4.67e-1)" "unprognostic (1.23e-1)" "unprognostic (3.85e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (6.84e-9)" "unprognostic (2.73e-2)" "unprognostic (3.18e-2)" "unprognostic (8.33e-2)" "unprognostic (2.51e-2)" 82.1 100.7 31.3 88.3 33.4 79.5 75.3 33.5 34.7 144.5 52.4 90.7 81.9 88.9 128.9 88.7 78.1 81.7 74.2 32.3 39.6 64.6 134.8 93.3 60.2 40.9 37.6 67.3 272.1 111.7 93.5 112.8 36.0 90.0 90.0 37.0 176.3 97.0 70.5 66.9 75.8 110.7 36.6 73.7 105.5 38.8 46.6 61.4 104.8 59.3 80.6 97.0 68.7 35.8 272.8 136.5 132.0 240.3 367.9 317.3 256.9 426.9 470.8 349.0 371.2 259.1 186.9 184.7 259.5 534.8 266.2 232.6 209.0 291.3 334.2 168.1 126.2 213.5 143.5 273.6 542.9 264.1 225.9 348.1 345.4 329.3 422.4 265.0 314.3 122.2 136.9 415.3 412.8 237.7 135.1 87.5 184.6 231.6 202.8 144.2 125.5 349.8 181.4 229.3 155.8 162.4 216.0 193.5 270.7 152.0 184.2 215.1 327.3 278.3 164.7 333.7 201.4 386.6 210.6 265.8 456.3 166.2 369.1 160.3 88.6 67.0 89.0 79.6 120.0 43.8 62.9 78.2 82.6 26.1 38.8 46.2 22.5 65.0 84.2 114.0 45.1 116.9 31.3 33.4 33.5 34.7 32.3 39.6 40.9 37.6 36.0 36.6 46.6 35.8 31.9 32.1 33.1 18.6 46.6 37.0 25.7 44.4 30.7 17.0 63.5 41.3 15.0 37.1 43.3 49.7 35.5 64.3 59.2 107.2 3.9 81.0 42.2 28.2 72.9 45.9 73.6 19.5 12.6 154.5 136.3 57.4 77.5 68.6 26.0 55.6 49.6 118.2 75.9 26.9 18.5 150.8 38.7 34.8 32.1 25.7 41.0 38.2 33.8 26.2 32.1 22.4 28.8 19.1 17.2 104.9 50.2 43.6 192.8 69.6 63.5 26.8 31.0 15.5 32.9 25.6 47.2 12.3 18.4 42.5 29.5 127.9 32.4 52.6 100.4 44.6 RUVBL1 "ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a" ENSG00000175792 "RuvB like AAA ATPase 1" Q9Y265 3 128064778-128153914 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 147.0;Respiratory ciliated cells: 221.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019947, HPA019948" Enhanced Supported Nucleoplasm,Cytosol NA NA 81000 "Cluster 15: NK-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "HPA019947: AB_1856516, HPA019948: AB_1856514" "unprognostic (7.40e-2)" "unprognostic (2.17e-1)" "unprognostic (1.28e-1)" "unprognostic (4.73e-2)" "unprognostic (3.55e-1)" "unprognostic (2.66e-2)" "prognostic unfavorable (1.21e-8)" "unprognostic (2.43e-2)" "unprognostic (3.31e-2)" "unprognostic (1.39e-1)" "unprognostic (2.25e-2)" "unprognostic (7.39e-2)" "unprognostic (2.98e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.61e-1)" "unprognostic (9.27e-2)" 20.2 18.7 6.4 10.1 6.3 8.6 18.5 6.1 7.0 17.7 9.8 16.2 5.1 23.1 5.8 26.0 27.5 5.0 25.8 6.2 6.3 24.6 17.2 17.2 13.1 7.3 8.7 15.3 13.9 14.6 17.3 12.7 7.5 13.1 8.5 7.4 14.0 6.9 19.1 17.7 15.2 10.0 6.4 22.3 14.8 29.4 6.5 15.7 15.4 6.0 16.1 19.2 18.5 6.8 75.1 66.2 40.1 65.6 30.5 29.4 52.2 35.8 30.5 67.3 45.9 69.7 43.2 105.0 34.8 34.2 52.2 58.4 107.2 75.6 77.6 43.4 52.3 87.8 36.3 47.4 31.4 82.9 27.0 30.2 39.1 56.5 72.1 25.6 45.6 39.4 72.9 24.4 38.7 105.9 89.7 64.6 101.1 83.5 55.8 72.4 48.4 73.4 40.7 27.6 66.8 60.1 39.6 32.4 55.9 36.8 58.5 61.8 29.8 30.5 37.2 46.4 55.2 24.3 41.6 103.0 37.4 50.2 39.2 1.3 7.3 2.5 15.6 11.9 20.1 15.6 18.7 19.6 11.3 15.7 15.6 17.6 0.3 15.9 11.9 12.6 30.5 11.0 6.4 6.3 6.1 7.0 6.2 6.3 7.3 8.7 7.5 6.4 6.5 6.8 26.1 22.4 15.3 12.7 22.7 20.0 23.7 61.6 25.0 17.4 17.4 21.8 20.9 21.5 37.3 22.0 2.1 53.7 31.3 7.8 46.9 40.9 21.2 147.0 50.8 27.4 16.9 20.4 12.6 30.1 65.4 22.9 17.3 23.8 26.0 35.7 12.8 14.6 29.9 23.5 14.6 14.0 28.5 8.8 8.2 67.1 15.2 14.6 10.6 4.7 13.3 28.1 11.3 9.0 10.0 27.1 11.1 18.4 27.3 34.5 4.6 59.2 221.3 19.7 13.1 16.1 32.3 94.8 75.0 27.9 16.9 24.1 29.1 84.7 23.4 15.6 EEFSEC "EFSEC, SELB" ENSG00000132394 "Eukaryotic elongation factor, selenocysteine-tRNA specific" P57772 3 128153481-128408646 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 71.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 15.2;GAMG: 12.3;MOLT-4: 7.9;SH-SY5Y: 10.4;SK-BR-3: 17.7;SK-MEL-30: 15.4;T-47d: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035795 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" Cytosol "HPA035795: AB_10696512" "unprognostic (1.01e-1)" "prognostic favorable (2.98e-5)" "unprognostic (2.53e-1)" "unprognostic (1.32e-3)" "unprognostic (1.12e-1)" "unprognostic (3.03e-1)" "unprognostic (4.37e-3)" "unprognostic (6.06e-2)" "unprognostic (6.78e-3)" "unprognostic (2.84e-1)" "unprognostic (1.61e-2)" "unprognostic (3.83e-2)" "unprognostic (1.12e-2)" "unprognostic (4.31e-2)" "unprognostic (1.99e-1)" "unprognostic (1.70e-1)" "unprognostic (4.11e-2)" 13.5 8.2 0.2 0.2 0.2 0.1 12.5 0.2 0.6 14.2 0.1 11.3 0.0 15.6 0.0 12.3 13.9 0.1 25.5 0.2 0.3 14.3 21.8 9.6 2.2 0.4 0.2 12.3 11.7 3.0 8.8 1.6 0.3 12.1 0.6 0.5 9.7 1.9 24.0 16.5 10.7 0.0 0.2 13.4 11.0 19.3 0.4 0.1 9.9 0.0 1.2 12.7 12.3 0.2 0.5 0.1 4.1 1.7 0.1 0.2 0.5 0.0 0.3 0.2 0.2 0.3 6.9 15.2 0.1 3.8 12.3 1.1 0.4 0.1 0.1 0.3 0.3 0.0 0.1 0.1 5.7 0.3 0.3 0.1 0.1 4.0 0.1 0.2 0.3 0.0 0.1 0.2 3.5 0.2 7.9 0.4 0.4 0.1 0.1 0.3 0.2 1.0 0.0 0.0 0.3 10.4 0.0 17.7 15.4 0.3 9.6 0.7 0.0 0.1 0.0 0.2 0.2 0.4 0.7 0.4 0.1 0.4 0.2 0.4 6.3 6.1 5.0 6.0 3.9 5.4 4.4 4.4 8.7 3.9 4.0 5.0 0.0 7.5 4.8 3.7 5.7 4.3 0.2 0.2 0.2 0.6 0.2 0.3 0.4 0.2 0.3 0.2 0.4 0.2 9.4 0.0 6.0 15.0 17.2 6.4 9.3 9.1 7.4 7.8 6.9 8.6 10.1 8.6 4.4 16.5 2.1 22.3 15.7 6.4 15.6 7.9 27.7 3.1 12.5 8.2 11.4 5.9 25.3 7.1 18.3 10.0 10.2 4.5 28.5 10.0 8.9 14.8 14.6 13.5 36.6 11.7 18.3 7.9 8.2 71.6 13.1 11.4 12.4 28.1 9.8 9.3 17.5 45.8 27.1 5.6 2.7 8.6 17.1 9.4 8.6 25.7 2.7 8.2 26.3 9.0 9.1 27.9 16.9 10.8 9.9 29.7 13.7 11.9 10.6 6.0 DNAJB8 "CT156, MGC33884" ENSG00000179407 "DnaJ heat shock protein family (Hsp40) member B8" Q8NHS0 3 128462439-128467248 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 511 "testis: 51.1" "Group enriched" "Detected in some" 135 "Early spermatids: 1108.7;Late spermatids: 4086.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 25: Spermatids - Spermatogenesis" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1108.7 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4086.0 16.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 19.1 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GATA2 NFE1B ENSG00000179348 "GATA binding protein 2" P23769 3 128479427-128493201 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Phagocytosis, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 261.6;Glandular and luminal cells: 116.5;granulocytes: 638.7;Syncytiotrophoblasts: 321.4" "Group enriched" "Detected in all" 5 "endometrial cancer: 12.7;prostate cancer: 36.7;urothelial cancer: 13.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 330 "basophil: 513.2" "Lineage enriched" "Detected in single" 4344 "granulocytes: 513.2" "Cell line enhanced" "Detected in many" "BEWO: 281.0;HEL: 360.7;HMC-1: 187.4;SH-SY5Y: 325.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005633, CAB024847" Enhanced Supported Nucleoplasm NA NA "Cluster 10: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 60: Granulocytes - Receptor signaling" Nucleoplasm "CAB024847: , HPA005633: AB_1078954" "unprognostic (1.71e-1)" "unprognostic (8.90e-2)" "unprognostic (1.12e-1)" "unprognostic (8.61e-2)" "unprognostic (8.67e-2)" "unprognostic (4.17e-2)" "unprognostic (5.96e-3)" "unprognostic (7.30e-2)" "unprognostic (3.98e-2)" "unprognostic (4.12e-2)" "unprognostic (3.58e-2)" "unprognostic (3.04e-1)" "prognostic favorable (2.04e-4)" "unprognostic (2.50e-1)" "unprognostic (8.07e-2)" "unprognostic (2.08e-1)" "prognostic favorable (5.22e-5)" 16.9 9.8 7.1 2.7 5.3 5.1 12.8 3.6 4.6 32.9 2.1 6.6 4.3 42.7 7.1 4.9 49.7 10.7 19.5 3.9 3.4 20.7 1.3 34.8 2.8 8.2 12.2 4.3 13.7 6.9 9.7 22.5 7.9 54.4 2.9 0.1 4.8 52.2 6.4 9.2 8.5 10.8 4.0 11.4 6.6 2.7 8.8 0.8 7.3 5.2 1.2 33.8 23.9 4.1 24.4 5.9 1.3 15.9 2.0 0.6 281.0 53.8 45.2 18.0 6.5 10.0 10.7 0.5 14.8 31.9 1.5 25.5 14.7 0.0 7.6 0.0 8.3 360.7 42.9 16.0 4.0 36.8 187.4 0.3 0.3 0.7 0.3 2.9 28.6 0.2 96.7 0.5 0.4 9.0 0.1 74.2 1.0 0.2 1.8 0.1 7.0 0.4 0.5 21.5 21.8 325.9 13.6 70.1 2.4 14.4 13.5 15.0 52.0 1.2 0.7 12.7 7.4 0.1 0.0 0.2 0.6 2.5 3.7 513.2 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 3.9 7.1 5.3 3.6 4.6 3.9 3.4 8.2 12.2 7.9 4.0 8.8 4.1 69.0 6.4 27.7 0.0 0.9 4.8 25.5 0.0 1.2 0.2 1.5 1.5 5.7 0.0 1.8 75.4 0.0 63.4 2.3 0.5 1.9 0.2 10.1 74.2 43.2 75.4 3.0 62.4 0.0 14.2 261.6 8.8 0.5 116.5 638.7 0.9 57.5 0.2 10.8 0.0 0.0 0.3 0.0 0.3 4.6 6.4 0.6 7.9 8.8 15.9 0.7 0.1 0.0 0.0 0.0 0.9 0.0 0.4 5.4 29.5 0.0 0.2 0.7 0.2 0.0 2.2 11.0 0.6 4.7 0.9 2.4 321.4 14.0 0.2 0.3 10.5 RPN1 OST1 ENSG00000163902 "Ribophorin I" P04843 3 128619969-128681075 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 424.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009748, HPA026828, HPA051520" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA 730000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" Cytosol "CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521" "unprognostic (4.83e-2)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (7.67e-2)" "unprognostic (2.36e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (4.80e-4)" "unprognostic (2.71e-1)" "unprognostic (2.43e-1)" "unprognostic (2.28e-2)" "unprognostic (4.58e-3)" "unprognostic (2.87e-1)" "unprognostic (7.68e-2)" "unprognostic (7.86e-2)" "unprognostic (1.52e-2)" "unprognostic (1.44e-1)" "unprognostic (9.74e-2)" 97.9 88.3 56.7 94.5 65.5 97.1 105.5 69.0 63.3 142.0 96.2 124.0 97.1 92.0 352.4 76.6 124.8 90.5 82.6 56.1 71.4 119.5 226.3 112.7 76.8 72.7 65.8 80.8 118.8 143.8 83.7 139.8 69.4 100.2 134.3 46.9 120.4 113.9 89.2 63.5 94.5 111.6 66.7 85.2 115.0 90.9 68.1 86.0 177.7 77.7 102.4 117.2 64.0 77.9 358.5 190.9 156.2 289.8 412.7 273.1 351.3 300.0 393.2 391.4 452.1 399.4 328.2 221.9 274.8 437.3 363.2 349.7 255.4 268.2 374.7 158.8 160.3 392.7 127.9 332.3 454.3 322.5 198.2 229.5 307.3 258.4 377.5 260.9 308.6 164.2 164.2 289.6 260.4 327.8 179.7 353.0 198.1 476.6 170.2 193.6 209.4 540.6 272.7 212.0 238.6 137.4 246.3 253.6 313.6 199.0 271.0 329.0 203.2 200.9 154.7 297.0 226.9 306.1 259.9 234.4 329.4 235.9 296.9 178.0 171.6 137.6 129.3 147.0 154.7 91.5 104.7 117.7 159.5 60.7 63.8 99.3 233.2 90.3 159.3 192.4 114.2 250.8 56.7 65.5 69.0 63.3 56.1 71.4 72.7 65.8 69.4 66.7 68.1 77.9 82.9 60.9 74.1 13.1 72.4 49.5 83.6 102.8 55.2 13.0 53.7 26.9 42.4 51.5 91.6 112.2 8.4 113.7 59.1 126.0 15.6 111.5 19.1 85.3 73.9 72.4 43.3 63.5 11.7 93.3 199.1 91.7 113.2 126.8 43.7 40.2 96.0 180.0 135.7 20.2 16.3 158.4 73.2 154.1 70.8 29.5 94.1 87.6 58.7 11.2 77.0 30.3 39.1 18.1 21.3 104.0 83.1 64.3 424.1 93.3 109.1 90.7 110.2 13.2 46.0 43.9 53.7 65.9 62.6 67.0 53.4 156.7 65.8 54.0 130.2 78.9 RAB7A "CMT2B, RAB7" ENSG00000075785 "RAB7A, member RAS oncogene family" P51149 3 128693669-128825942 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, Host-virus interaction, Lipid degradation, Lipid metabolism, Protein transport, Transport" Hydrolase "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006964, CAB037131" Supported Supported Lysosomes NA NA 5700000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" Lysosomes "CAB037131: AB_477460, HPA006964: AB_1856015" "unprognostic (1.99e-2)" "unprognostic (9.03e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.45e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (9.89e-6)" "unprognostic (2.15e-2)" "unprognostic (2.38e-1)" "unprognostic (3.50e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (4.69e-1)" "unprognostic (6.73e-3)" "unprognostic (1.88e-1)" "unprognostic (1.97e-1)" "unprognostic (3.03e-3)" "unprognostic (5.64e-3)" 170.6 157.1 120.1 101.4 132.2 99.9 149.5 133.4 159.4 138.3 123.7 128.9 108.3 137.4 143.0 188.2 110.1 109.7 186.8 128.9 138.4 131.8 145.2 152.9 108.8 138.8 142.0 122.7 88.6 155.9 101.5 117.5 139.4 101.3 126.0 103.8 133.3 63.9 332.4 164.9 116.8 124.0 135.9 123.0 114.9 61.5 140.3 124.6 122.5 249.7 136.6 144.4 143.4 159.0 280.2 95.5 146.0 78.3 300.6 94.0 126.0 252.8 183.9 164.4 158.8 170.1 179.2 134.2 163.2 236.2 289.9 163.4 175.2 248.6 99.2 149.4 111.7 294.3 83.6 165.8 303.0 269.4 182.5 243.7 104.0 176.7 204.4 220.7 89.2 114.4 143.4 148.0 108.1 213.1 176.8 294.6 121.4 294.8 144.8 140.2 130.7 170.4 85.7 205.4 105.8 138.5 142.1 194.7 405.4 174.9 180.3 254.8 202.9 192.7 98.0 325.7 125.9 184.4 187.0 192.0 312.7 212.1 235.5 194.9 176.8 213.6 92.1 192.3 92.3 93.2 97.4 94.5 200.0 85.8 94.8 93.6 374.2 128.8 204.0 81.8 120.7 201.3 120.1 132.2 133.4 159.4 128.9 138.4 138.8 142.0 139.4 135.9 140.3 159.0 154.4 89.8 81.8 66.9 109.9 296.7 331.2 218.1 104.7 66.0 112.8 73.0 110.7 90.1 129.4 132.4 18.8 230.0 92.3 222.1 240.7 259.6 11.2 90.8 90.8 165.3 96.9 111.3 83.9 198.9 283.4 172.5 79.0 142.4 146.2 46.5 142.8 127.9 403.9 74.0 82.5 122.8 219.7 208.6 379.9 19.6 133.6 242.8 339.7 99.3 220.9 154.6 121.5 80.9 111.4 303.7 185.0 157.2 79.9 279.2 172.7 332.3 118.7 37.6 138.1 107.7 160.5 116.4 100.4 122.8 308.0 497.9 107.7 109.6 103.5 324.6 ACAD9 "MGC14452, NPD002" ENSG00000177646 "Acyl-CoA dehydrogenase family member 9" Q9H845 3 128879596-128924003 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037716, HPA046720" Supported Enhanced Mitochondria No No "Cluster 14: Monocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA037716: AB_10673638, HPA046720: AB_2679773" "unprognostic (1.04e-1)" "unprognostic (1.28e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (3.61e-1)" "unprognostic (2.83e-1)" "prognostic unfavorable (3.67e-6)" "unprognostic (1.30e-1)" "unprognostic (3.74e-1)" "unprognostic (3.25e-2)" "unprognostic (1.37e-1)" "unprognostic (6.96e-3)" "prognostic favorable (4.32e-8)" "unprognostic (1.52e-1)" "unprognostic (2.64e-2)" "unprognostic (6.56e-2)" "unprognostic (9.96e-2)" 16.7 20.5 9.0 6.1 8.5 4.7 14.5 9.6 10.2 14.4 9.1 13.6 9.0 14.6 7.7 23.2 12.9 7.3 21.9 8.3 8.7 15.6 20.6 11.0 6.6 8.2 8.7 12.9 14.4 27.7 14.6 8.4 8.4 12.1 9.4 4.1 14.2 12.0 30.4 48.0 11.2 11.1 7.4 12.2 15.9 12.5 8.7 12.1 13.6 28.7 11.2 12.9 14.5 9.0 46.2 22.6 18.0 12.6 28.7 20.7 17.5 22.4 26.2 43.6 36.8 33.3 27.1 33.3 21.1 29.5 29.0 35.5 33.8 45.9 32.8 21.2 23.1 29.3 46.8 24.4 21.6 23.9 10.6 22.5 16.8 23.6 26.7 25.1 35.8 25.2 14.4 11.4 29.5 46.5 36.7 19.0 9.9 49.3 33.8 25.5 17.4 35.1 30.9 25.1 19.0 11.6 37.0 32.9 23.2 17.4 44.5 54.8 18.2 13.2 13.4 14.2 20.3 14.5 5.8 28.3 28.3 21.4 22.7 2.4 15.1 4.9 8.3 18.3 7.8 8.1 7.6 7.3 17.5 5.4 6.2 8.0 0.7 6.8 25.2 9.9 8.3 12.1 9.0 8.5 9.6 10.2 8.3 8.7 8.2 8.7 8.4 7.4 8.7 9.0 10.4 16.0 21.7 13.1 9.3 6.2 11.4 16.7 8.6 14.1 11.9 9.5 30.5 15.7 14.8 14.7 10.4 26.2 10.5 11.7 21.5 20.6 20.2 10.4 11.5 11.2 5.4 14.3 14.3 17.8 18.8 12.9 16.8 12.9 16.5 12.0 15.7 26.7 31.5 10.1 17.7 7.4 16.2 9.5 4.0 17.3 10.2 10.8 16.0 7.5 13.4 15.0 12.3 6.0 12.2 14.1 8.7 14.7 9.5 8.1 9.4 26.3 12.0 11.9 13.1 12.7 14.9 22.6 9.6 13.5 14.2 30.6 8.2 18.1 14.3 8.4 CFAP92 "FAP92, FLJ43738, KIAA1257" ENSG00000114656 "Cilia and flagella associated protein 92 (putative)" Q9ULG3 3 128909866-129002690 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 22.1" "Group enriched" "Detected in some" 4 "Adipocytes: 1.3;Cardiomyocytes: 1.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 11 "neutrophil: 34.0" "Lineage enriched" "Detected in single" 48 "granulocytes: 34.0" "Cell line enhanced" "Detected in many" "AF22: 7.6;HL-60: 13.5;THP-1: 9.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA042811, HPA048445" Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 43: THP-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA042811: AB_2678180, HPA048445: AB_2680397" "unprognostic (4.17e-2)" "unprognostic (5.16e-2)" "unprognostic (2.46e-1)" "unprognostic (2.67e-1)" "unprognostic (9.41e-3)" "unprognostic (2.45e-1)" "unprognostic (6.74e-2)" "unprognostic (4.22e-2)" "unprognostic (6.48e-3)" "unprognostic (7.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.88e-2)" "unprognostic (1.42e-2)" "unprognostic (3.38e-1)" "unprognostic (4.69e-2)" "unprognostic (2.52e-1)" "unprognostic (5.50e-2)" 0.4 0.6 3.1 1.0 2.1 2.1 0.8 3.9 2.2 0.4 4.4 0.7 0.8 0.7 0.5 1.1 3.3 1.4 0.6 3.7 2.5 0.5 0.2 1.1 1.0 3.1 4.7 1.2 0.9 1.7 1.8 1.1 3.2 1.0 0.8 2.7 0.7 0.3 0.7 4.3 0.9 0.2 1.4 1.0 1.1 22.1 3.3 4.2 0.8 0.5 0.3 0.4 0.1 1.3 1.0 1.4 7.6 1.6 0.1 0.2 2.4 0.3 0.3 0.1 0.0 1.2 1.0 1.5 0.3 0.0 0.7 1.1 2.3 0.1 0.0 0.6 1.1 3.3 1.9 1.0 0.0 13.5 0.7 0.0 1.4 0.0 0.1 0.5 0.1 2.9 0.9 1.7 0.2 1.5 1.3 2.5 1.4 2.6 1.4 1.1 0.8 0.9 0.0 1.5 1.5 0.7 0.4 0.5 0.6 1.0 2.6 9.2 0.4 0.8 1.2 0.8 0.5 2.2 2.0 2.5 0.6 5.0 0.6 0.8 0.7 2.9 0.3 0.3 0.2 0.4 0.2 0.2 0.2 0.3 0.3 0.5 34.0 0.3 0.3 0.3 0.2 0.2 3.1 2.1 3.9 2.2 3.7 2.5 3.1 4.7 3.2 1.4 3.3 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 EFCC1 "C3orf73, CCDC48, FLJ12057" ENSG00000114654 "EF-hand and coiled-coil domain containing 1" Q9HA90 3 129001629-129040742 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 5.6" "Cell type enhanced" "Detected in some" "Adipocytes: 7.1;Endothelial cells: 6.5;Enteroendocrine cells: 9.5;Fibroblasts: 10.7;Microglial cells: 9.4;Peritubular cells: 7.5;Sertoli cells: 6.6;Theca cells: 22.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "AF22: 1.3;HL-60: 3.7;U-266/84: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042798, HPA050888" Uncertain NA NA "Cluster 14: B-cells - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" "HPA042798: AB_2678173, HPA050888: AB_2681263" "unprognostic (1.74e-1)" "unprognostic (5.16e-3)" "unprognostic (1.65e-1)" "unprognostic (1.49e-3)" "unprognostic (1.95e-1)" "unprognostic (2.54e-2)" "unprognostic (1.66e-3)" "unprognostic (7.23e-3)" "unprognostic (1.57e-2)" "unprognostic (2.04e-1)" "prognostic favorable (9.70e-4)" "unprognostic (7.79e-2)" "unprognostic (2.26e-1)" "unprognostic (1.29e-1)" "unprognostic (2.71e-1)" "unprognostic (1.82e-1)" "unprognostic (2.20e-1)" 1.7 0.4 0.8 0.4 0.2 0.1 1.8 1.8 1.0 1.2 0.0 3.5 1.9 1.9 0.1 0.9 1.6 0.5 2.3 2.2 1.4 1.2 0.5 5.6 0.1 1.7 1.0 3.4 0.5 0.1 1.3 0.3 1.8 2.0 0.4 0.0 0.7 0.2 1.0 1.1 2.5 0.1 0.5 2.7 2.1 0.4 1.1 0.2 2.2 0.5 0.0 2.0 1.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 1.8 1.0 2.2 1.4 1.7 1.0 1.8 0.5 1.1 0.0 7.1 0.0 1.1 0.3 0.2 0.3 0.0 0.0 0.0 0.0 1.3 1.0 1.5 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.1 1.4 0.2 0.3 6.5 9.5 3.6 1.3 0.6 0.0 10.7 0.0 0.2 0.0 0.4 3.6 0.0 0.1 0.0 0.4 0.0 0.0 0.3 0.8 5.3 4.7 0.1 1.8 9.4 0.0 0.0 2.1 0.0 0.1 0.1 0.0 7.5 0.0 0.1 0.0 0.2 0.0 0.0 6.6 1.1 2.4 0.2 0.4 0.0 0.4 0.1 0.3 22.0 0.2 0.1 GP9 "CD42a, GPIX" ENSG00000169704 "Glycoprotein IX platelet" P14770 3 129060779-129062406 "CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Bernard Soulier syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.1;lung: 3.2;lymphoid tissue: 8.9" "Cell type enriched" "Detected in some" 8 "Macrophages: 151.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 29.5;neutrophil: 13.9" "Lineage enriched" "Detected in many" 10 "granulocytes: 29.5" "Cell line enriched" "Detected in some" 14 "HEL: 85.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA063182 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 2600000 "Cluster 34: Basophils - Unknown function" "Cluster 2: Immune cells - Immune response" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" "Plasma membrane, Cytosol" Nucleoplasm "HPA063182: AB_2684956" "unprognostic (1.70e-1)" "unprognostic (3.97e-1)" "unprognostic (1.10e-1)" "unprognostic (3.80e-2)" "unprognostic (2.50e-2)" "unprognostic (3.24e-1)" "unprognostic (2.53e-2)" "unprognostic (8.47e-2)" "unprognostic (8.70e-2)" 0.1 0.0 0.0 0.0 0.0 5.1 0.1 0.0 0.3 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.9 0.1 1.8 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 1.2 0.2 0.2 0.7 0.3 0.0 0.0 0.3 0.6 0.1 0.1 0.0 13.9 0.0 0.2 3.0 0.0 51.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.1 0.0 0.0 14.4 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 2.9 0.1 1.7 0.0 0.0 0.6 0.0 1.3 0.0 18.3 0.0 151.9 0.0 0.0 4.1 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.7 0.3 0.0 RAB43 "ISY1, RAB11B, RAB41" ENSG00000172780 "RAB43, member RAS oncogene family" Q86YS6 3 129087569-129122801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 46.9" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 12.0;Gastric mucus-secreting cells: 5.6;Plasma cells: 9.2;Squamous epithelial cells: 2.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 11.2" "Group enriched" "Detected in many" 5 "granulocytes: 11.2;T-cells: 2.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046840, HPA060085" Enhanced Supported "Plasma membrane" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 59: Non-specific - Transcription" "Plasma membrane" "HPA046840: , HPA060085: AB_2684199" "unprognostic (3.01e-1)" "unprognostic (1.14e-2)" "unprognostic (3.08e-1)" "unprognostic (1.01e-1)" "unprognostic (5.08e-2)" "unprognostic (1.91e-1)" "unprognostic (9.36e-2)" "unprognostic (3.17e-2)" "unprognostic (4.16e-1)" "unprognostic (8.68e-2)" "unprognostic (3.14e-1)" "unprognostic (3.08e-1)" "unprognostic (2.46e-2)" "unprognostic (9.32e-2)" "unprognostic (5.82e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" 7.6 8.3 9.5 10.4 9.7 22.3 7.1 11.6 8.1 7.3 9.3 7.9 8.0 6.6 2.9 5.9 7.3 9.4 4.2 7.9 5.8 10.4 46.9 14.8 17.4 10.0 7.5 9.9 10.3 5.2 6.7 3.9 8.4 9.9 2.6 0.7 10.2 5.0 1.8 4.0 6.9 2.7 7.3 10.9 8.1 7.5 7.1 12.9 22.7 1.4 4.6 7.3 4.0 6.7 22.4 6.0 1.4 5.7 2.7 1.2 8.3 7.6 5.1 4.4 3.5 9.4 9.4 0.6 17.1 5.7 5.9 9.2 0.5 8.8 1.0 11.2 5.6 1.5 1.1 12.5 25.9 5.1 12.7 7.1 5.4 2.2 0.5 1.9 8.7 13.0 2.5 10.8 6.1 9.7 5.0 9.8 7.0 5.2 10.5 10.8 3.2 6.6 14.1 18.7 0.4 2.7 3.3 7.0 14.4 2.2 3.0 5.3 12.5 9.3 6.4 7.6 2.9 16.9 9.8 3.6 8.5 1.0 10.3 0.4 1.2 2.3 1.5 1.5 0.7 0.5 1.5 1.2 0.6 1.0 2.8 2.4 11.2 1.4 0.7 0.9 2.4 1.0 9.5 9.7 11.6 8.1 7.9 5.8 10.0 7.5 8.4 7.3 7.1 6.7 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.0 12.0 0.0 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.0 0.8 0.0 0.3 0.6 0.4 0.0 0.0 0.0 0.2 0.1 0.5 5.6 0.5 0.0 0.2 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 9.2 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.4 0.2 0.1 2.5 0.1 0.1 1.2 0.2 0.3 0.1 ISY1-RAB43 ENSG00000261796 "ISY1-RAB43 readthrough" 3 129087575-129161036 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Excitatory neurons: 1.5;granulocytes: 1.3;Oligodendrocytes: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA006312, HPA016995" Approved Enhanced "Nuclear speckles" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 11: Alveolar cells - Smell perception" "Nuclear speckles" "HPA006312: AB_1079734, HPA016995: AB_1852387" "unprognostic (1.09e-1)" "unprognostic (5.42e-2)" "unprognostic (1.52e-1)" "unprognostic (9.05e-3)" "unprognostic (2.81e-1)" "unprognostic (3.15e-1)" "unprognostic (1.63e-1)" "unprognostic (2.52e-1)" "unprognostic (1.51e-3)" "unprognostic (1.89e-1)" "unprognostic (1.40e-1)" "unprognostic (5.67e-2)" "unprognostic (1.87e-1)" 7.6 7.2 2.4 10.1 2.8 7.1 7.5 2.4 5.7 7.3 2.5 7.6 3.9 8.1 4.4 5.2 6.9 4.2 5.7 2.3 2.9 7.8 9.6 9.4 8.1 2.5 2.6 9.4 7.2 8.8 5.6 6.5 3.2 7.6 7.4 2.7 6.6 8.3 3.9 5.5 6.7 7.7 2.1 9.2 6.8 5.1 2.7 16.7 7.6 3.7 9.0 7.6 4.6 3.5 26.1 5.7 12.9 11.9 15.8 9.3 5.6 12.2 28.5 19.4 23.6 3.0 13.1 0.9 17.7 22.0 22.2 9.8 5.1 20.4 11.9 9.9 1.0 2.4 2.5 10.2 27.1 10.8 12.9 21.5 10.7 12.1 7.7 19.2 25.4 23.7 4.2 9.9 16.9 10.8 16.3 7.7 9.1 27.7 6.7 13.7 5.6 9.1 20.8 9.9 0.9 5.8 5.8 13.1 18.9 10.7 6.5 10.3 21.0 9.4 7.9 13.5 5.6 14.3 7.0 4.4 10.7 1.1 13.3 0.1 0.5 0.1 0.6 0.2 0.6 0.0 0.6 0.8 0.2 0.1 0.8 0.7 0.6 0.6 0.4 0.2 0.4 0.6 2.4 2.8 2.4 5.7 2.3 2.9 2.5 2.6 3.2 2.1 2.7 3.5 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ISY1 "fSAP33, KIAA1160" ENSG00000240682 "ISY1 splicing factor homolog" Q9ULR0 3 129127415-129161063 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA006312, HPA016995" Supported Enhanced "Nuclear speckles" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 14: REH - Unknown function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear speckles" "HPA006312: AB_1079734, HPA016995: AB_1852387" "unprognostic (2.20e-2)" "prognostic favorable (2.46e-5)" "unprognostic (1.46e-2)" "unprognostic (1.84e-3)" "unprognostic (2.19e-1)" "unprognostic (5.52e-2)" "prognostic unfavorable (7.25e-4)" "unprognostic (4.08e-1)" "unprognostic (5.94e-2)" "unprognostic (7.38e-2)" "unprognostic (1.71e-1)" "unprognostic (7.34e-2)" "unprognostic (2.23e-3)" "unprognostic (2.49e-3)" "unprognostic (1.65e-1)" "unprognostic (1.66e-1)" "unprognostic (2.54e-2)" 18.7 13.7 9.1 19.0 9.0 51.6 17.0 9.8 9.6 20.2 7.5 21.6 15.4 19.5 15.1 22.2 15.5 17.4 21.4 8.8 9.1 15.0 10.8 14.1 32.0 9.2 9.3 19.7 15.8 11.2 8.8 22.1 8.9 13.3 16.9 10.4 15.0 12.3 34.9 20.3 16.2 20.3 8.2 18.2 14.9 12.4 8.8 22.7 14.9 21.3 30.1 18.3 19.4 8.9 53.7 20.5 29.6 41.6 35.1 36.4 34.5 39.3 35.0 46.1 44.2 40.6 39.3 67.3 41.3 32.6 40.0 44.8 56.3 31.8 64.9 65.0 26.5 78.0 35.2 32.8 32.7 121.2 53.4 22.9 21.7 40.6 62.3 28.7 37.7 43.2 57.1 33.5 25.2 54.2 73.8 67.1 32.3 55.9 31.3 64.9 67.3 47.5 17.3 33.5 46.8 35.3 72.7 15.7 41.9 16.0 30.3 99.1 45.2 33.5 33.4 49.8 41.6 40.1 26.1 131.9 30.8 69.4 39.0 79.8 57.6 94.2 54.8 56.4 61.4 56.1 55.8 58.7 62.8 50.7 61.0 55.0 90.7 84.8 51.2 54.5 73.5 56.5 9.1 9.0 9.8 9.6 8.8 9.1 9.2 9.3 8.9 8.2 8.8 8.9 26.5 25.6 23.4 0.0 27.4 27.4 16.5 21.3 20.5 19.7 17.0 15.6 19.7 21.5 21.8 9.2 22.9 44.1 38.5 15.8 23.5 26.7 2.8 11.9 23.0 25.3 9.0 29.0 0.0 28.0 41.2 21.8 12.8 21.0 45.6 25.8 26.0 12.3 34.8 20.2 0.0 16.7 16.2 21.1 25.6 1.8 16.1 23.9 10.6 0.0 43.7 20.7 46.4 0.0 0.0 24.4 15.3 16.1 24.1 17.4 18.8 23.2 14.8 19.0 19.7 18.8 20.9 57.4 42.6 20.0 35.8 45.8 32.9 18.7 20.5 16.9 CNBP "CNBP1, DM2, RNF163, ZCCHC22, ZNF9" ENSG00000169714 "CCHC-type zinc finger nucleic acid binding protein" P62633 3 129167827-129183922 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063097 Approved Nucleoplasm,Cytosol NA NA 160000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "HPA063097: AB_2684939" "unprognostic (1.74e-1)" "unprognostic (3.11e-2)" "unprognostic (4.84e-1)" "unprognostic (3.35e-2)" "unprognostic (6.28e-2)" "unprognostic (7.38e-2)" "unprognostic (7.02e-3)" "unprognostic (1.23e-1)" "unprognostic (1.06e-3)" "unprognostic (6.39e-2)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.72e-3)" "unprognostic (4.62e-3)" "unprognostic (1.89e-1)" "unprognostic (2.03e-1)" "unprognostic (2.51e-1)" "unprognostic (1.58e-1)" 292.7 308.2 175.2 181.1 184.0 254.1 274.6 198.6 211.3 295.9 175.7 314.1 198.5 285.8 197.6 264.6 275.7 195.1 487.2 170.6 184.3 231.6 433.7 258.3 251.0 182.7 175.1 385.8 307.4 277.9 169.5 214.3 187.1 256.6 219.0 231.8 250.8 282.4 1207.6 288.0 199.2 234.9 195.6 200.7 262.1 131.2 181.9 254.2 261.8 797.9 250.7 317.5 269.2 211.7 452.7 266.4 369.9 294.6 355.2 303.9 294.9 344.2 535.7 362.2 412.4 389.2 305.7 589.8 292.2 318.1 269.6 328.3 484.3 396.4 484.6 404.5 357.9 569.2 251.7 420.2 355.7 622.4 314.5 295.5 449.2 254.8 897.8 247.6 324.1 328.1 437.6 391.9 384.0 538.9 578.6 454.1 452.7 399.7 439.1 502.4 343.4 707.7 379.1 425.4 501.2 402.8 271.5 263.0 766.3 214.4 305.6 421.3 347.9 268.4 266.2 374.1 353.7 367.3 365.4 932.3 277.3 419.2 362.4 1077.7 810.5 930.9 551.8 596.8 699.0 691.0 658.8 595.3 552.8 603.8 700.3 610.5 1102.3 601.1 485.5 320.4 704.3 2029.8 175.2 184.0 198.6 211.3 170.6 184.3 182.7 175.1 187.1 195.6 181.9 211.7 253.7 259.6 263.9 27.1 292.8 524.7 417.0 262.9 259.6 153.7 177.5 272.5 608.0 141.5 235.1 79.1 33.3 252.3 188.1 143.9 373.7 226.9 36.0 141.4 195.1 267.5 171.3 246.5 28.2 290.7 396.6 309.4 142.8 172.8 314.5 173.0 167.0 138.5 246.5 92.5 33.7 178.6 140.4 194.4 463.0 42.9 316.0 232.4 318.4 35.6 392.7 350.3 236.9 32.6 42.8 230.1 158.0 319.7 311.7 405.1 196.5 237.4 164.8 153.8 263.0 343.6 571.0 305.2 271.5 286.5 586.7 291.7 304.2 277.7 213.6 376.2 COPG1 COPG ENSG00000181789 "COPI coat complex subunit gamma 1" Q9Y678 3 129249606-129277773 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037866, HPA037867, HPA045712" Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No 57000 "Cluster 18: Basophils - Vesicular transport" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428" "unprognostic (8.86e-2)" "unprognostic (2.22e-2)" "unprognostic (4.22e-3)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (1.22e-6)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-3)" "unprognostic (3.29e-1)" "unprognostic (1.23e-3)" "unprognostic (2.10e-1)" "unprognostic (3.20e-1)" "unprognostic (2.99e-1)" "unprognostic (1.60e-1)" 84.7 111.0 66.6 59.0 68.2 59.4 79.8 69.5 80.7 100.4 93.0 107.6 86.7 75.5 157.4 86.8 70.0 53.8 95.5 70.3 73.7 82.7 149.5 84.4 54.8 74.3 71.5 77.9 162.4 96.3 139.0 81.9 77.4 107.7 109.8 33.4 130.7 72.7 75.7 74.4 86.7 72.2 66.4 81.9 114.0 46.5 73.2 53.5 83.3 43.2 67.1 67.2 72.2 73.2 167.8 83.2 119.1 104.0 272.8 219.0 126.9 266.3 251.8 179.5 225.2 153.9 101.2 91.1 150.8 380.7 145.6 98.4 99.5 157.2 193.6 112.0 41.4 151.9 103.2 252.6 247.9 116.4 156.4 230.9 135.6 143.8 235.0 196.1 164.3 68.9 54.2 213.6 219.2 253.4 68.7 117.7 71.3 243.6 100.9 73.3 111.8 178.3 227.3 136.7 74.1 86.1 204.2 150.3 255.9 129.8 167.1 167.6 223.9 96.9 91.7 207.2 104.2 165.7 86.1 158.9 236.4 86.9 190.0 79.1 49.9 37.2 44.1 59.2 53.6 24.9 39.8 43.9 57.0 26.9 30.0 36.2 37.2 57.0 57.3 52.2 43.8 56.2 66.6 68.2 69.5 80.7 70.3 73.7 74.3 71.5 77.4 66.4 73.2 73.2 16.6 16.0 31.5 7.8 19.2 8.8 16.9 35.4 12.0 9.2 18.9 8.6 23.3 17.2 34.6 27.6 4.2 55.6 19.7 77.0 43.0 44.5 10.4 26.2 27.7 22.8 38.6 22.9 14.1 46.5 63.1 32.5 53.0 36.9 15.2 28.6 28.9 56.5 39.0 5.0 14.8 75.1 22.4 31.2 14.8 4.7 41.0 21.6 23.2 7.5 36.5 12.7 18.6 4.5 11.8 40.8 44.6 31.2 68.4 24.4 64.5 39.5 32.6 7.1 19.7 20.2 33.3 24.3 17.0 16.4 10.2 72.2 19.4 27.7 44.6 20.6 HMCES "C3orf37, DC12, SRAPD1" ENSG00000183624 "5-hydroxymethylcytosine binding, ES cell specific" Q96FZ2 3 129278828-129306186 "Predicted intracellular proteins" "DNA damage" "DNA-binding, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 124.9;Spermatocytes: 127.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044968 Enhanced Approved Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm "HPA044968: AB_2679160" "unprognostic (9.18e-3)" "unprognostic (1.11e-3)" "unprognostic (4.16e-2)" "unprognostic (2.80e-2)" "unprognostic (2.93e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (4.41e-4)" "unprognostic (1.87e-1)" "unprognostic (2.29e-1)" "unprognostic (3.00e-1)" "unprognostic (4.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.46e-2)" "unprognostic (1.71e-2)" "unprognostic (1.74e-1)" "unprognostic (1.25e-2)" "unprognostic (9.08e-3)" 35.8 22.0 27.6 37.3 32.5 37.8 32.9 26.6 32.4 25.8 22.4 36.1 29.4 24.0 23.0 41.7 27.0 21.1 40.3 29.8 30.1 27.4 53.7 27.1 99.7 27.3 27.6 28.3 15.3 68.9 22.2 20.9 27.6 24.6 30.9 27.7 26.8 26.2 57.7 35.5 28.8 23.2 26.4 29.8 26.4 39.9 32.5 57.1 22.4 48.5 131.0 28.5 28.8 27.1 149.4 66.2 74.4 85.9 90.6 37.8 66.8 51.2 41.5 73.1 56.6 105.0 67.9 286.0 53.9 46.9 57.2 106.3 94.8 110.8 83.7 58.0 51.2 59.7 52.7 76.0 38.8 52.1 41.9 36.7 56.6 61.1 60.2 35.6 45.5 63.5 61.2 244.2 40.9 197.3 74.8 45.1 48.4 108.5 42.8 66.6 63.8 50.5 77.0 88.8 74.0 45.6 114.4 70.8 70.6 45.6 121.0 52.1 36.8 36.3 63.7 87.3 66.5 135.8 87.2 289.3 43.4 41.9 41.1 35.5 25.5 65.0 30.4 27.4 31.6 37.5 36.7 36.3 26.3 62.1 36.1 40.0 52.5 27.2 40.9 28.1 48.0 31.2 27.6 32.5 26.6 32.4 29.8 30.1 27.3 27.6 27.6 26.4 32.5 27.1 26.1 32.1 25.6 11.4 23.5 58.2 71.2 72.4 54.7 21.5 18.8 16.1 35.6 30.0 30.4 22.0 10.4 49.2 32.0 30.8 37.2 39.6 8.6 16.0 10.2 27.8 21.0 28.2 13.6 47.0 37.6 23.3 17.9 15.7 22.2 11.0 20.7 26.1 19.7 26.9 14.7 17.3 32.6 8.1 39.4 8.6 24.5 15.7 58.7 10.3 16.4 38.6 25.7 7.1 10.6 33.8 16.9 31.2 124.9 37.3 19.9 21.1 25.2 12.5 13.1 21.0 27.1 127.8 83.6 30.7 43.9 35.0 47.3 23.9 30.7 61.0 H1-10 "H1FX, H1X, MGC15959, MGC8350" ENSG00000184897 "H1.10 linker histone" Q92522 3 129314771-129316286 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 1004.3" "Cell type enhanced" "Detected in some" "Adipocytes: 188.4;Cytotrophoblasts: 66.8;dendritic cells: 73.2;Extravillous trophoblasts: 114.2;Hofbauer cells: 93.4;Plasma cells: 148.6;Syncytiotrophoblasts: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 937.8" "Low region specificity" "Detected in all" "CAB012235, HPA040099, HPA068431" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nucleoli, Nucleoli rim" "CAB012235: , HPA040099: AB_2676846, HPA068431: " "unprognostic (1.01e-2)" "unprognostic (1.12e-2)" "unprognostic (4.13e-2)" "unprognostic (8.48e-2)" "unprognostic (6.94e-2)" "unprognostic (2.23e-1)" "unprognostic (4.00e-2)" "unprognostic (1.46e-2)" "unprognostic (1.16e-1)" "unprognostic (5.51e-2)" "unprognostic (5.28e-3)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (3.24e-1)" "unprognostic (2.50e-2)" 121.4 54.7 39.9 42.6 43.9 1004.3 145.0 60.6 68.6 162.4 25.2 125.0 44.6 143.1 9.2 107.8 142.2 13.9 82.0 43.1 48.4 162.7 100.1 115.8 44.3 29.5 26.0 168.9 100.0 30.1 112.6 25.4 25.1 124.5 11.9 13.9 98.7 20.8 110.7 258.4 106.7 13.2 27.8 127.7 115.7 40.9 38.2 131.5 94.4 12.3 18.3 130.9 140.7 46.4 141.8 73.4 135.8 59.3 13.6 16.1 129.1 60.5 43.5 70.4 74.3 44.5 75.5 17.8 65.5 21.6 47.2 139.1 57.3 39.0 10.8 129.4 111.7 53.8 55.5 61.1 57.3 62.6 14.1 32.4 51.9 28.7 64.7 32.0 40.7 241.7 83.7 308.5 10.0 147.9 290.9 124.1 127.2 25.8 81.6 207.4 58.1 170.9 22.1 29.1 216.0 250.1 64.1 31.7 196.3 26.1 124.1 125.1 40.9 54.4 283.5 53.5 51.2 937.8 385.2 156.9 44.5 58.6 61.1 0.5 5.5 17.8 4.4 4.2 4.0 5.7 6.7 5.2 7.9 5.3 8.4 4.3 1.2 5.2 3.9 11.4 6.1 2.4 39.9 43.9 60.6 68.6 43.1 48.4 29.5 26.0 25.1 27.8 38.2 46.4 188.4 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 66.8 73.2 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 114.2 46.9 0.0 0.0 0.0 0.0 0.0 0.0 93.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 148.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 68.4 17.6 0.0 0.0 0.0 EFCAB12 C3orf25 ENSG00000172771 "EF-hand calcium binding domain 12" Q6NXP0 3 129401321-129428651 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 12.6;fallopian tube: 19.7" "Group enriched" "Detected in some" 4 "Early spermatids: 29.6;Endometrial ciliated cells: 31.9;Late spermatids: 20.1;Respiratory ciliated cells: 46.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;RPTEC TERT1: 1.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 8.9" "HPA037694, HPA057532" Uncertain Supported Approved "Nucleoplasm,Nuclear bodies,Midbody ring" Yes NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Nuclear bodies, Midbody ring" "HPA037694: AB_10672605, HPA057532: " "unprognostic (2.06e-3)" "unprognostic (1.87e-2)" "unprognostic (2.96e-2)" "unprognostic (4.34e-3)" "unprognostic (1.81e-1)" "unprognostic (7.59e-4)" "unprognostic (2.37e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (1.64e-1)" "unprognostic (1.81e-2)" "unprognostic (3.84e-1)" "unprognostic (1.20e-1)" "unprognostic (5.72e-2)" "unprognostic (2.27e-1)" "unprognostic (1.57e-2)" "unprognostic (4.59e-2)" 0.3 0.4 0.8 0.1 1.0 0.8 0.3 1.7 1.1 1.1 12.6 0.1 0.0 0.3 0.8 0.0 19.7 0.2 0.3 1.4 1.5 0.8 1.2 1.7 0.1 4.9 7.0 1.0 0.6 1.7 3.6 0.1 3.2 3.0 0.0 1.6 0.2 0.2 0.0 0.1 0.3 0.0 3.6 0.4 0.7 6.9 2.4 0.2 1.2 0.0 0.2 0.0 0.1 1.0 0.1 0.7 0.2 0.7 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.2 1.5 0.0 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.4 0.3 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.3 0.0 0.1 1.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 0.4 0.6 0.7 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.0 1.7 1.1 1.4 1.5 4.9 7.0 3.2 3.6 2.4 1.0 0.2 3.2 1.7 0.3 0.5 0.5 0.1 0.8 0.0 0.4 0.7 0.4 1.3 1.5 1.8 0.0 2.1 0.0 0.3 0.1 0.0 0.2 29.6 31.9 0.7 0.5 0.0 0.0 2.7 0.2 0.1 0.5 3.1 1.9 0.0 0.1 0.0 1.1 0.1 5.0 0.8 0.3 2.0 0.0 0.0 20.1 0.3 0.3 0.0 0.0 0.1 1.2 1.0 0.0 0.1 0.0 0.0 0.0 0.2 0.9 0.0 0.9 46.0 5.6 0.0 0.5 0.6 6.8 2.7 0.7 0.3 0.0 0.3 0.3 0.0 0.2 MBD4 MED1 ENSG00000129071 "Methyl-CpG binding domain 4, DNA glycosylase" O95243 3 129430947-129440179 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002031 Supported Supported "Nuclear speckles" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" "Nuclear speckles" "HPA002031: AB_1079319" "unprognostic (2.70e-2)" "unprognostic (3.48e-3)" "unprognostic (1.18e-2)" "unprognostic (6.37e-2)" "unprognostic (4.31e-2)" "unprognostic (7.11e-2)" "unprognostic (4.70e-2)" "unprognostic (3.25e-2)" "unprognostic (2.02e-2)" "unprognostic (5.73e-2)" "prognostic unfavorable (2.18e-4)" "prognostic unfavorable (4.75e-4)" "prognostic unfavorable (2.73e-6)" "unprognostic (9.27e-2)" "unprognostic (1.59e-2)" "unprognostic (8.58e-2)" "unprognostic (3.35e-2)" 18.6 18.4 16.8 34.0 18.4 44.2 21.6 19.6 20.7 33.2 16.8 19.3 23.7 23.3 24.8 16.4 19.3 21.3 25.3 17.0 17.4 25.4 38.0 22.9 66.5 17.5 17.2 30.3 22.9 18.1 19.3 19.7 17.7 18.7 22.9 19.6 19.5 17.8 25.8 23.7 27.5 19.7 17.3 39.2 27.8 17.3 18.4 30.0 19.3 22.3 74.0 18.5 17.5 20.6 46.2 27.4 32.5 36.5 36.8 32.8 37.5 39.0 36.9 36.7 43.3 33.8 30.1 64.6 31.1 24.5 33.7 40.7 25.2 24.1 44.2 37.0 16.6 38.9 32.0 24.6 58.7 71.2 49.2 39.1 33.8 31.2 27.4 36.5 35.1 37.2 43.9 47.1 27.5 43.3 41.4 50.0 28.7 38.8 23.5 38.7 19.2 44.7 40.9 22.7 36.5 20.3 49.3 25.3 42.5 28.0 32.3 62.5 23.6 34.5 26.3 37.6 26.2 31.9 20.9 111.9 29.4 40.1 29.2 80.3 25.0 35.2 31.1 23.1 24.0 116.5 33.2 30.9 21.0 110.8 40.6 33.3 43.0 28.9 30.0 25.2 31.5 25.6 16.8 18.4 19.6 20.7 17.0 17.4 17.5 17.2 17.7 17.3 18.4 20.6 36.5 19.2 52.9 15.3 111.2 17.3 32.5 38.4 29.6 37.0 26.7 29.6 35.9 27.1 36.4 44.1 18.8 49.2 61.4 22.4 45.0 32.1 19.8 49.6 41.2 33.5 33.6 46.3 18.1 69.0 46.2 35.6 55.0 45.0 58.9 33.1 31.4 32.1 71.8 21.9 12.8 27.5 40.7 41.8 24.7 10.6 32.9 48.0 21.4 24.4 62.9 21.2 54.6 14.1 22.0 39.3 23.4 36.5 75.5 31.1 29.4 55.5 39.5 46.3 39.5 39.6 30.9 49.5 71.6 30.4 19.6 37.1 54.2 33.2 26.3 35.6 IFT122 "FAP80, SPG, WDR10, WDR10p, WDR140" ENSG00000163913 "Intraflagellar transport 122" Q9HBG6 3 129440036-129520507 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Ciliopathy, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 72.8" "Cell type enhanced" "Detected in many" "Early spermatids: 81.7;Late spermatids: 70.3;Spermatocytes: 120.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041815 Uncertain Uncertain Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "HPA041815: AB_10804118" "unprognostic (7.16e-2)" "unprognostic (3.71e-3)" "unprognostic (3.67e-1)" "unprognostic (7.61e-3)" "unprognostic (5.29e-2)" "unprognostic (5.33e-3)" "unprognostic (4.68e-2)" "unprognostic (1.82e-1)" "unprognostic (7.90e-2)" "unprognostic (3.30e-1)" "unprognostic (1.67e-2)" "unprognostic (3.50e-2)" "unprognostic (1.09e-2)" "unprognostic (7.67e-2)" "unprognostic (5.33e-1)" "unprognostic (9.91e-2)" "unprognostic (4.20e-3)" 9.6 7.4 5.7 5.2 7.6 10.1 12.4 6.5 9.2 13.1 15.3 7.6 4.7 12.6 12.7 7.2 24.7 6.7 12.0 6.8 6.8 11.7 9.2 8.8 6.7 4.5 6.2 25.4 13.3 13.9 14.4 10.8 3.0 7.4 6.9 11.2 7.9 8.5 3.9 13.8 5.3 8.9 3.7 4.5 9.0 72.8 7.0 8.9 13.1 2.9 5.7 6.6 8.4 6.3 16.5 24.6 21.0 13.5 29.7 21.0 10.5 8.5 12.9 14.8 14.1 11.9 10.7 10.6 10.0 11.3 14.5 10.4 8.2 7.7 13.3 5.8 8.8 8.2 21.8 10.3 8.1 22.2 7.2 24.7 5.7 11.4 8.8 12.9 20.3 21.8 8.4 22.1 12.1 18.2 18.2 11.6 14.1 12.3 7.0 16.3 8.0 7.7 15.7 3.0 25.9 10.6 24.8 8.2 7.5 7.9 22.6 17.9 9.0 10.1 8.7 13.6 10.2 15.0 11.4 9.3 9.2 11.3 8.1 4.5 3.1 3.7 0.9 2.2 1.6 1.9 1.6 2.3 3.2 2.1 1.8 2.2 1.4 1.5 0.9 0.8 3.0 2.1 5.7 7.6 6.5 9.2 6.8 6.8 4.5 6.2 3.0 3.7 7.0 6.3 7.5 9.6 8.2 28.1 4.3 2.7 5.8 4.5 2.8 9.7 18.0 13.3 6.4 15.7 5.6 25.8 37.5 6.7 4.5 6.2 7.9 5.2 81.7 43.4 11.0 9.7 3.0 7.4 35.1 8.9 5.2 9.8 19.9 10.2 5.1 8.7 20.7 6.0 9.3 5.0 23.1 10.2 4.1 7.2 2.2 70.3 18.6 4.1 3.6 15.0 3.8 11.8 3.1 12.1 15.9 3.4 4.2 13.9 3.4 3.6 6.2 8.2 37.3 21.4 0.0 12.8 7.7 120.4 38.0 5.4 2.8 2.6 4.1 10.6 8.7 3.4 RHO "CSNBAD1, OPN2, RP4" ENSG00000163914 Rhodopsin P08100 3 129528639-129535344 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Congenital stationary night blindness, Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5994 "retina: 4062.1" "Cell type enriched" "Detected in some" 7 "Rod photoreceptor cells: 4509.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 4 "hippocampal formation: 9.7" "Region enhanced" "Detected in single" "hippocampal formation: 1.1" "HPA013440, CAB022486, CAB034887, CAB034888" Enhanced NA NA "Cluster 79: Retina - Phototransduction" "Cluster 46: Photoreceptor cells - Phototransduction" "CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: AB_2668844" "unprognostic (4.32e-2)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "unprognostic (1.83e-1)" "unprognostic (2.87e-1)" "unprognostic (1.94e-1)" "unprognostic (9.19e-11)" "unprognostic (4.24e-2)" "unprognostic (1.84e-1)" "unprognostic (2.91e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4062.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 369.9 0.0 0.0 0.6 0.0 0.0 0.0 454.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 26.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 218.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 590.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4509.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 H1-8 H1FOO ENSG00000178804 "H1.8 linker histone" Q8IZA3 3 129543214-129551467 "Predicted intracellular proteins" Meiosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 15 "testis: 7.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA037992 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "HPA037992: AB_10671517" "unprognostic (5.43e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.3 0.1 0.2 0.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLXND1 KIAA0620 ENSG00000004399 "Plexin D1" Q9Y4D7 3 129555214-129606676 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 107.3;Endothelial cells: 102.1;Hepatic stellate cells: 132.1;Hofbauer cells: 81.5;Kupffer cells: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 10.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 392.3;HSkMC: 286.1;HUVEC TERT2: 346.1;TIME: 414.4" "Group enriched" "Detected in all" 4 "amygdala: 36.6;basal ganglia: 33.1;cerebral cortex: 27.4;hippocampal formation: 26.3" "Low region specificity" "Detected in all" CAB020819 Approved NA NA 120000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 4: Macrophages - Innate immune response" "CAB020819: " "unprognostic (8.97e-3)" "unprognostic (1.95e-1)" "unprognostic (6.30e-2)" "unprognostic (8.35e-2)" "unprognostic (1.28e-2)" "unprognostic (3.00e-3)" "unprognostic (6.35e-2)" "unprognostic (4.51e-2)" "unprognostic (3.69e-1)" "unprognostic (3.02e-3)" "unprognostic (3.78e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (5.93e-7)" "unprognostic (1.30e-1)" "unprognostic (3.21e-2)" "unprognostic (3.17e-2)" "unprognostic (1.00e-2)" 72.6 22.1 32.0 37.4 38.1 26.5 47.4 36.2 35.6 58.4 26.1 19.5 6.0 33.5 17.6 21.5 35.0 39.4 39.8 29.3 34.2 24.7 18.3 67.5 34.7 48.7 43.5 16.3 13.9 18.0 11.1 112.4 43.8 19.0 16.9 3.5 13.3 27.0 12.9 19.5 20.9 52.6 38.8 33.6 15.8 10.8 49.0 62.7 29.5 39.8 23.2 37.1 26.8 43.2 10.0 57.7 47.4 16.3 392.3 167.9 98.4 42.8 123.1 25.5 29.5 13.4 8.1 2.1 179.9 152.9 13.2 0.6 25.9 0.6 7.5 1.9 3.2 40.7 30.2 61.4 44.8 13.5 11.0 286.1 1.7 26.4 2.8 36.6 346.1 2.1 14.5 1.5 34.8 31.0 2.4 44.2 11.8 2.4 8.0 47.4 32.0 51.8 10.2 2.3 27.6 1.1 11.0 3.5 15.9 107.6 15.5 59.7 414.4 21.5 28.5 0.6 32.4 1.9 2.2 19.9 7.5 29.2 19.0 0.0 10.7 0.0 1.7 5.1 6.8 0.0 1.2 1.4 2.9 0.0 0.0 0.1 0.2 3.1 5.2 3.6 0.0 1.7 32.0 38.1 36.2 35.6 29.3 34.2 48.7 43.5 43.8 38.8 49.0 43.2 107.3 3.2 27.2 12.4 3.6 8.0 0.4 2.1 0.6 0.1 7.6 3.4 10.6 5.7 3.1 0.0 0.0 7.1 16.9 0.2 0.0 1.4 1.4 3.7 52.5 102.1 13.1 12.6 10.4 3.5 16.4 19.5 5.6 6.2 22.2 1.3 132.1 7.7 81.5 0.0 0.6 3.2 6.1 75.6 31.8 1.8 38.8 41.7 8.8 27.2 29.4 6.5 10.3 0.5 27.7 2.7 0.1 13.9 12.9 0.5 0.0 0.3 1.2 0.3 32.9 14.4 37.1 0.6 4.0 1.5 4.4 5.3 14.4 49.5 0.5 0.6 TMCC1 KIAA0779 ENSG00000172765 "Transmembrane and coiled-coil domain family 1" O94876 3 129647792-129893606 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Alveolar cells type 1: 54.5;Astrocytes: 119.1;Excitatory neurons: 206.7;Inhibitory neurons: 201.5;Microglial cells: 127.4;Oligodendrocyte precursor cells: 181.0;Oligodendrocytes: 209.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "neutrophil: 9.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053894 Uncertain NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 39: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA053894: AB_2682295" "unprognostic (4.26e-2)" "unprognostic (1.38e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (2.60e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (9.15e-4)" "unprognostic (7.75e-3)" "unprognostic (1.13e-1)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.50e-2)" "prognostic unfavorable (1.77e-6)" "unprognostic (6.82e-3)" "unprognostic (2.90e-1)" "unprognostic (1.20e-1)" "unprognostic (2.32e-1)" 7.5 6.8 12.9 4.8 13.1 3.2 7.3 23.5 14.8 9.8 1.1 6.7 4.1 7.8 6.7 7.6 6.9 8.6 8.2 10.8 12.1 6.7 34.5 6.7 5.0 10.1 13.1 8.0 4.8 7.8 6.5 9.8 9.9 7.5 5.1 15.2 5.5 6.2 30.1 7.7 4.4 6.8 10.0 6.8 4.0 13.5 16.9 8.3 6.8 21.1 5.5 7.8 6.9 14.5 10.6 11.3 8.8 7.2 12.9 9.1 8.9 4.1 5.4 3.6 3.7 7.3 5.7 6.5 11.4 7.9 4.2 9.6 5.0 8.2 2.6 8.6 1.6 4.3 3.4 26.7 4.4 3.2 2.6 5.3 15.1 2.8 6.7 7.7 11.0 3.9 2.2 4.7 8.2 11.6 5.7 1.9 6.7 7.7 3.6 5.2 7.4 5.5 8.4 12.9 8.2 5.7 14.0 4.8 4.1 8.5 9.2 3.5 9.6 5.7 9.2 5.3 8.5 6.9 5.1 4.8 4.2 3.8 3.0 0.6 0.9 2.1 1.1 0.9 1.2 0.7 0.9 0.9 0.5 1.1 1.1 1.4 9.6 0.8 2.0 1.4 1.9 0.8 12.9 13.1 23.5 14.8 10.8 12.1 10.1 13.1 9.9 10.0 16.9 14.5 14.1 54.5 7.4 119.1 9.4 6.6 12.6 9.9 12.5 37.1 17.4 12.1 23.0 7.2 16.0 22.0 31.3 10.6 8.3 9.0 7.9 15.8 9.6 30.5 14.6 13.2 12.6 4.6 206.7 8.1 20.7 10.9 10.2 38.3 3.8 12.0 9.7 36.8 9.9 35.3 201.5 12.2 10.2 18.6 6.6 10.5 13.1 13.5 1.8 127.4 6.8 27.0 12.3 181.0 209.2 24.9 22.8 8.6 14.5 20.4 4.7 13.1 19.6 29.5 6.6 18.1 12.2 33.5 19.4 15.8 7.0 23.9 8.9 9.6 8.3 25.2 TRH ENSG00000170893 "Thyrotropin releasing hormone" P20396 3 129974688-129977935 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "brain: 68.7;cervix: 26.0;endometrium 1: 18.7;retina: 35.2" "Cell type enriched" "Detected in some" 10 "Muller glia cells: 234.5" "Group enriched" "Detected in some" 5 "breast cancer: 13.3;endometrial cancer: 10.2;glioma: 4.3" "Group enriched" "Detected in many" 6 "hypothalamus: 68.7;medulla oblongata: 59.4;pons: 38.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.0" "Group enriched" "Detected in many" 5 "hypothalamus: 175.6;olfactory bulb: 148.0" "Low region specificity" "Detected in many" HPA035596 Enhanced "Secreted in other tissues" NA NA "Cluster 77: Retina - Visual perception" "Cluster 6: T47d - Mammary gland" "Cluster 5: Muller glia cells - Visual perception" "HPA035596: AB_2674695" "unprognostic (1.22e-1)" "unprognostic (8.94e-2)" "unprognostic (5.82e-3)" "unprognostic (5.24e-2)" "unprognostic (2.82e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-1)" "unprognostic (4.44e-2)" "unprognostic (3.86e-2)" "unprognostic (1.50e-1)" "unprognostic (1.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.95e-1)" "unprognostic (2.57e-2)" "unprognostic (2.82e-2)" 0.2 0.0 4.9 0.1 0.9 3.7 1.9 2.2 0.8 26.0 0.1 0.0 0.1 18.7 0.0 0.0 2.5 0.0 0.5 2.3 68.7 0.5 0.0 0.6 0.0 59.4 9.1 3.8 0.0 0.0 0.2 0.2 38.2 0.1 0.0 35.2 0.5 0.1 0.1 0.4 0.0 0.3 2.8 0.1 0.0 1.2 3.7 0.4 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.9 0.9 2.2 0.8 2.3 68.7 59.4 9.1 38.2 2.8 3.7 0.7 0.3 0.0 0.0 0.3 0.2 0.8 0.7 0.0 0.0 10.4 1.6 1.4 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 7.1 9.0 0.8 0.7 0.0 0.0 0.2 0.0 0.1 0.2 0.0 22.5 0.0 0.1 0.0 0.0 0.1 5.0 0.3 0.0 0.0 0.0 11.5 2.7 0.0 2.0 0.0 0.0 0.0 234.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 9.2 0.0 0.0 0.2 0.7 1.6 0.0 0.1 0.1 0.2 0.1 0.0 4.3 ALG1L2 ENSG00000251287 "ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like 2" C9J202 3 130081831-130113227 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.4;retina: 2.5" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 6.0;Erythroid cells: 6.1;Granulosa cells: 16.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" HPA060392 Uncertain Uncertain "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 40: Granulosa cells - Unknown function" "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA060392: AB_2684273" "unprognostic (1.05e-1)" "unprognostic (5.13e-2)" "unprognostic (5.44e-3)" "unprognostic (8.15e-2)" "unprognostic (2.98e-2)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "unprognostic (4.38e-1)" "unprognostic (3.91e-1)" "prognostic favorable (7.75e-4)" "unprognostic (4.58e-2)" "unprognostic (4.17e-2)" "unprognostic (5.93e-4)" "unprognostic (1.24e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (4.28e-3)" 0.0 0.0 0.1 0.2 0.5 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.1 0.5 0.1 0.3 0.0 1.4 0.3 0.2 0.2 0.0 0.5 0.7 1.2 0.0 2.6 0.7 1.7 0.0 6.0 0.0 0.0 1.7 1.4 1.7 0.4 0.0 0.6 1.8 4.2 0.3 0.9 0.8 1.9 0.2 0.4 0.7 3.0 0.9 0.0 6.1 0.8 0.0 0.3 1.7 1.5 0.9 0.0 16.7 0.7 0.4 0.2 5.0 0.6 1.4 0.0 0.0 0.0 0.0 3.7 0.9 0.0 0.0 0.3 3.2 0.0 0.5 0.8 0.0 0.0 2.6 1.1 3.3 1.2 1.1 0.7 3.0 0.0 3.3 2.2 1.3 0.2 0.5 0.0 0.0 1.5 1.5 1.5 1.7 COL6A5 "COL29A1, FLJ35880, VWA4" ENSG00000172752 "Collagen type VI alpha 5 chain" 3 130345516-130484844 "Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "lung: 5.6;skin 1: 6.2" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 3.4;Early spermatids: 5.6;Erythroid cells: 3.8;Fibroblasts: 5.5;Langerhans cells: 5.2;Late spermatids: 3.0;Suprabasal keratinocytes: 3.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "midbrain: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 64 "HDLM-2: 15.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA043138 Uncertain "Secreted in other tissues" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 44: HDLM-2 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" "HPA043138: AB_10796687" "unprognostic (3.45e-2)" "unprognostic (4.08e-2)" "unprognostic (6.01e-3)" "unprognostic (2.32e-1)" "unprognostic (3.42e-2)" "unprognostic (1.46e-6)" "unprognostic (8.44e-2)" "unprognostic (2.07e-3)" "unprognostic (2.47e-1)" "unprognostic (1.71e-1)" "unprognostic (7.58e-8)" "unprognostic (3.85e-2)" "unprognostic (4.51e-1)" "unprognostic (1.54e-1)" "unprognostic (2.79e-2)" 0.0 0.0 0.0 0.1 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.7 0.0 0.0 0.0 1.0 0.8 0.1 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.3 0.0 3.8 0.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.2 3.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 3.4 0.0 0.2 0.0 0.0 0.0 COL6A6 ENSG00000206384 "Collagen type VI alpha 6 chain" A6NMZ7 3 130560334-130678155 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "parathyroid gland: 97.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 4.6;Fibroblasts: 20.6;Inhibitory neurons: 5.3;Oligodendrocytes: 4.6;Skeletal myocytes: 3.3" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "SuSa: 1.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 15 "spinal cord: 10.0" HPA045239 Uncertain "Secreted to extracellular matrix" NA NA 700000 "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 12: NES - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "HPA045239: AB_2679268" "unprognostic (4.86e-3)" "unprognostic (2.16e-2)" "unprognostic (9.91e-2)" "unprognostic (2.08e-4)" "unprognostic (2.79e-1)" "unprognostic (1.11e-5)" "unprognostic (3.74e-3)" "unprognostic (5.59e-2)" "unprognostic (1.42e-1)" "unprognostic (3.50e-2)" "unprognostic (8.90e-2)" "unprognostic (2.70e-1)" "unprognostic (2.96e-4)" "unprognostic (5.82e-2)" "unprognostic (1.61e-1)" "unprognostic (1.45e-2)" "unprognostic (1.07e-1)" 1.8 0.0 0.0 0.0 0.2 0.2 2.5 0.2 0.3 0.0 0.0 0.0 0.0 0.6 0.3 0.9 0.3 0.1 3.3 0.0 0.0 0.0 0.8 7.3 0.0 0.0 0.0 0.2 0.0 97.8 3.6 0.7 0.0 0.0 0.0 0.3 1.5 0.0 0.1 0.4 0.0 0.5 0.0 1.2 0.1 0.4 0.1 1.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.1 0.0 1.1 1.3 0.0 0.9 0.0 0.0 0.0 1.1 0.2 0.4 2.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 2.9 0.1 0.0 0.0 4.6 0.0 0.0 20.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 5.3 0.0 0.0 0.0 1.5 0.1 0.3 0.2 0.0 0.0 0.0 0.1 0.0 3.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 3.3 0.8 0.0 0.4 0.0 0.9 0.1 0.2 0.0 0.0 0.0 PIK3R4 "p150, VPS15" ENSG00000196455 "Phosphoinositide-3-kinase regulatory subunit 4" Q99570 3 130678934-130746829 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036032, HPA036033" Approved Approved Vesicles,Microtubules NA NA "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Vesicles Microtubules "HPA036032: AB_10610281, HPA036033: AB_2674911" "unprognostic (7.50e-2)" "unprognostic (3.90e-3)" "unprognostic (1.68e-1)" "unprognostic (4.05e-3)" "unprognostic (2.88e-1)" "unprognostic (1.28e-1)" "unprognostic (1.34e-1)" "unprognostic (1.21e-1)" "unprognostic (1.11e-1)" "unprognostic (2.67e-1)" "unprognostic (1.02e-3)" "unprognostic (7.26e-2)" "prognostic favorable (4.40e-6)" "unprognostic (8.25e-2)" "unprognostic (3.72e-1)" "unprognostic (2.27e-1)" "unprognostic (1.05e-1)" 8.8 8.5 3.7 7.8 4.2 8.9 10.0 5.2 4.9 9.4 5.6 8.2 7.5 10.1 7.9 8.0 9.1 7.2 7.6 4.1 4.5 10.5 21.2 9.6 9.4 3.2 3.6 12.4 6.9 17.6 6.1 9.7 3.8 9.8 8.1 16.5 7.6 9.6 7.3 7.8 8.0 10.4 3.8 10.0 7.5 11.4 3.2 11.4 13.1 8.6 10.4 9.0 6.5 7.1 20.7 12.9 18.5 13.4 26.6 21.1 12.8 15.0 17.9 20.2 23.3 16.7 17.1 24.2 18.4 15.2 16.1 28.7 30.7 23.3 31.6 14.7 11.3 19.7 13.8 11.7 12.2 30.3 9.5 14.7 16.4 21.7 13.6 12.6 19.0 13.8 23.3 11.9 18.1 18.1 24.9 9.2 23.3 18.6 12.4 17.2 21.4 21.9 13.2 16.7 17.0 12.4 21.6 13.4 15.3 21.5 18.6 13.1 15.2 15.5 13.3 17.6 12.2 13.8 13.5 31.2 17.0 11.3 14.7 9.7 5.3 7.0 6.3 6.0 9.3 5.6 5.7 4.7 6.9 3.5 6.6 6.0 4.4 8.5 6.6 2.4 6.8 5.3 3.7 4.2 5.2 4.9 4.1 4.5 3.2 3.6 3.8 3.8 3.2 7.1 8.3 6.4 8.7 18.6 8.8 3.8 3.9 5.7 10.8 8.1 5.7 4.7 7.7 8.6 9.6 11.0 14.6 5.6 7.2 5.5 1.9 5.0 4.4 8.9 7.5 8.9 3.0 9.2 28.5 5.8 3.4 6.9 13.3 9.9 9.5 9.5 7.5 18.2 5.9 5.0 30.3 6.8 8.2 6.4 2.6 3.1 9.6 7.3 5.4 20.6 7.1 9.0 6.2 22.1 32.9 6.6 4.3 11.7 6.9 4.8 6.2 4.2 12.6 12.6 6.6 8.9 6.2 17.0 13.9 9.5 4.4 4.2 7.5 9.6 6.1 3.4 ATP2C1 "ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1" ENSG00000017260 "ATPase secretory pathway Ca2+ transporting 1" P98194 3 130850595-131016712 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 162.6;Excitatory neurons: 172.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010207, HPA035116, HPA069684" Supported Supported "Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169" "unprognostic (1.52e-1)" "unprognostic (1.37e-1)" "unprognostic (2.74e-2)" "unprognostic (1.08e-1)" "unprognostic (2.99e-1)" "unprognostic (1.32e-2)" "prognostic unfavorable (5.06e-6)" "unprognostic (7.66e-2)" "unprognostic (6.52e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.52e-4)" "unprognostic (8.44e-2)" "prognostic favorable (1.55e-4)" "unprognostic (2.19e-1)" "unprognostic (1.95e-1)" "unprognostic (3.73e-2)" "unprognostic (3.06e-1)" 32.2 32.7 34.0 25.3 36.6 38.6 32.9 31.8 42.8 33.4 76.9 36.5 23.9 30.9 28.0 23.6 37.2 27.2 31.9 40.7 38.6 44.7 28.5 51.4 21.9 37.0 38.9 28.8 22.6 78.0 22.7 32.7 40.3 85.8 35.9 59.4 29.2 25.2 28.1 31.9 26.9 31.0 33.6 19.5 31.5 25.2 48.8 36.2 35.0 21.1 26.2 31.6 18.1 48.6 133.1 51.1 49.9 48.5 136.7 110.0 53.9 141.2 186.8 69.4 87.0 83.5 106.3 47.6 95.6 134.4 96.4 153.6 95.1 77.9 100.8 104.4 34.2 127.2 51.5 39.0 87.2 51.2 148.4 86.8 76.6 73.2 82.2 126.3 74.6 59.3 37.3 84.1 86.7 59.0 50.6 40.9 57.0 71.7 54.8 36.3 49.9 75.6 127.5 87.7 76.7 45.9 121.4 37.8 72.8 70.8 55.7 41.7 102.6 73.3 40.8 95.5 65.8 54.6 71.1 69.9 75.8 38.0 62.6 30.6 8.9 15.9 7.4 7.6 7.0 5.6 7.3 6.6 9.5 3.6 4.9 4.9 4.3 11.5 9.6 8.2 9.3 6.5 34.0 36.6 31.8 42.8 40.7 38.6 37.0 38.9 40.3 33.6 48.8 48.6 30.2 38.5 53.0 162.6 17.4 39.4 34.5 34.8 26.7 25.9 34.4 22.4 30.2 35.8 41.1 46.0 20.9 16.3 15.5 39.0 5.9 35.3 17.5 26.9 34.1 27.8 35.6 23.3 172.5 38.0 27.6 25.9 33.1 55.8 28.5 28.2 26.7 27.4 27.7 82.4 136.5 32.4 36.7 26.2 34.8 18.9 16.1 39.5 21.4 128.4 20.5 26.4 19.6 148.3 154.3 51.1 27.5 14.7 18.5 69.0 16.3 19.8 52.7 33.4 6.6 27.7 25.9 16.2 14.1 24.7 52.8 17.6 19.5 17.3 31.2 36.9 ASTE1 HT001 ENSG00000034533 "Asteroid homolog 1" Q2TB18 3 131013875-131027649 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037010, HPA037011" Supported Approved "Endoplasmic reticulum" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Endoplasmic reticulum" "HPA037010: AB_10673629, HPA037011: AB_10696929" "unprognostic (7.42e-2)" "prognostic favorable (3.09e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.34e-4)" "unprognostic (2.56e-1)" "unprognostic (1.03e-2)" "prognostic unfavorable (4.03e-5)" "unprognostic (2.27e-3)" "unprognostic (2.80e-2)" "unprognostic (1.89e-2)" "unprognostic (2.22e-1)" "unprognostic (1.38e-2)" "unprognostic (2.58e-2)" "unprognostic (1.65e-1)" "unprognostic (3.56e-1)" "unprognostic (1.41e-2)" "unprognostic (4.64e-2)" 3.4 3.2 2.9 4.9 3.3 6.7 5.5 6.1 4.8 6.0 3.4 5.4 5.8 3.8 5.9 3.7 4.5 3.9 2.9 3.2 2.5 3.7 6.1 4.1 7.0 2.5 2.8 5.7 3.3 5.0 3.3 3.9 3.0 3.8 5.8 4.7 3.1 4.2 2.3 4.1 7.1 3.4 2.9 4.4 4.7 6.1 3.3 7.2 7.0 2.8 6.8 3.9 2.9 4.6 9.7 7.1 4.5 4.7 7.7 8.4 1.9 5.4 4.6 6.4 7.0 11.4 4.2 10.8 8.2 5.5 5.5 10.5 9.1 4.4 9.6 5.8 5.3 6.4 3.6 5.4 7.9 9.9 3.6 5.3 6.1 5.2 4.9 5.7 5.4 8.7 5.9 5.3 6.7 6.6 9.0 5.2 4.1 11.6 6.8 9.4 6.4 9.4 5.2 5.9 7.7 7.2 10.5 2.4 7.6 4.3 6.3 6.9 3.8 7.2 4.8 12.1 4.3 6.6 6.5 14.0 5.6 8.5 3.6 51.2 13.0 28.4 20.4 15.3 21.3 15.5 22.0 17.7 14.5 16.5 28.3 21.2 9.4 29.4 20.9 10.7 28.2 11.8 2.9 3.3 6.1 4.8 3.2 2.5 2.5 2.8 3.0 2.9 3.3 4.6 6.5 12.8 5.8 7.5 14.6 3.2 3.7 4.8 2.2 9.2 5.1 7.4 1.8 4.3 6.3 3.7 14.6 6.0 17.5 11.1 5.9 4.9 42.1 4.5 5.8 6.9 6.7 6.1 8.3 6.0 4.8 5.1 8.6 4.6 8.8 7.0 10.0 5.6 4.8 3.3 6.3 7.0 4.1 5.7 2.0 12.6 7.2 7.2 1.8 5.6 3.9 5.8 18.6 7.5 10.5 3.6 7.8 4.9 8.7 2.9 15.6 3.5 2.1 13.9 0.0 3.6 6.1 4.4 4.9 3.6 1.4 4.0 15.7 6.1 7.1 2.8 NEK11 FLJ23495 ENSG00000114670 "NIMA related kinase 11" Q8NG66 3 131026850-131350465 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 26.2" "Cell type enhanced" "Detected in many" "Astrocytes: 60.7;Early spermatids: 156.4;Endometrial ciliated cells: 69.2;Excitatory neurons: 91.0;Late spermatids: 109.2;Respiratory ciliated cells: 102.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016908 Approved Supported Nucleoplasm NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA016908: AB_1854364" "unprognostic (9.15e-3)" "prognostic favorable (7.10e-4)" "unprognostic (1.05e-1)" "unprognostic (1.08e-1)" "unprognostic (9.96e-2)" "unprognostic (4.85e-3)" "unprognostic (2.48e-5)" "unprognostic (5.38e-2)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (2.27e-1)" "unprognostic (1.79e-1)" "prognostic favorable (5.92e-6)" "unprognostic (2.46e-2)" "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "unprognostic (1.58e-1)" 3.1 4.3 8.3 0.5 8.3 0.1 6.6 6.9 7.7 5.4 26.2 2.1 1.3 4.9 7.1 2.3 21.4 4.6 2.1 7.3 9.0 6.3 0.6 4.3 1.0 14.2 15.5 6.4 2.2 4.8 5.6 2.2 12.4 2.9 2.4 5.6 2.9 3.7 1.1 2.2 1.8 2.7 12.8 1.2 1.6 15.5 9.3 0.9 9.6 0.8 1.2 2.8 2.5 12.8 5.7 2.2 1.6 4.8 6.2 9.3 0.9 2.7 5.0 4.1 3.1 2.1 7.7 0.2 1.9 4.8 3.9 3.0 0.4 4.6 5.6 0.5 0.6 0.8 0.3 1.0 2.1 0.6 1.3 3.9 7.7 4.2 1.9 4.3 0.8 2.4 0.2 0.8 6.9 3.9 0.1 0.4 0.5 0.9 2.1 0.0 0.1 0.1 9.3 2.2 2.0 2.2 1.3 0.1 1.9 0.7 4.4 0.1 0.9 4.1 2.0 3.3 1.3 1.2 2.2 0.1 2.9 0.2 0.7 0.0 0.0 0.2 0.1 0.3 0.2 0.1 0.6 0.5 0.1 0.1 0.2 0.1 0.1 0.0 0.2 0.2 0.3 0.0 8.3 8.3 6.9 7.7 7.3 9.0 14.2 15.5 12.4 12.8 9.3 12.8 2.5 16.0 3.2 60.7 1.5 4.2 3.4 4.5 4.6 2.6 7.3 7.5 1.6 4.3 18.8 1.8 6.2 1.0 1.4 3.3 5.9 6.4 156.4 69.2 6.1 3.5 2.4 0.4 91.0 2.5 1.1 7.7 2.6 6.6 0.0 8.1 5.7 0.6 2.0 0.0 42.0 3.5 6.1 0.3 1.7 109.2 6.8 2.0 0.0 21.5 0.8 6.4 1.0 38.7 38.9 3.7 3.9 6.0 0.8 1.6 1.7 10.6 102.7 7.3 6.6 7.2 3.7 33.4 5.2 2.6 2.0 1.6 1.4 11.5 2.4 2.7 NUDT16 FLJ31265 ENSG00000198585 "Nudix hydrolase 16" Q96DE0 3 131381671-131388830 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Kupffer cells: 179.8;Proximal enterocytes: 334.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 41.7;eosinophil: 47.0;intermediate monocyte: 54.6;myeloid DC: 32.4;neutrophil: 34.0;non-classical monocyte: 63.4" "Group enriched" "Detected in all" 4 "dendritic cells: 32.4;granulocytes: 47.0;monocytes: 63.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060452, HPA062492" Uncertain Supported Nucleoplasm,Nucleoli NA NA 38000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 18: U-2197 - ECM organization" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Nucleoli" "HPA060452: AB_2684279, HPA062492: AB_2684781" "unprognostic (4.85e-3)" "prognostic favorable (9.39e-5)" "unprognostic (3.19e-3)" "unprognostic (9.21e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (9.96e-2)" "unprognostic (1.15e-1)" "unprognostic (5.16e-2)" "unprognostic (1.94e-1)" "unprognostic (1.77e-1)" "unprognostic (5.88e-2)" "prognostic favorable (1.05e-7)" "unprognostic (3.29e-1)" "unprognostic (1.62e-1)" "unprognostic (2.00e-2)" "unprognostic (9.44e-2)" 30.6 19.0 39.3 15.2 40.1 10.4 22.9 35.9 49.3 17.1 28.6 25.6 22.2 19.4 11.0 11.1 22.7 9.8 32.9 34.1 38.3 27.7 33.8 26.2 12.3 40.7 39.6 25.2 14.7 48.6 15.8 8.1 40.9 17.8 19.5 18.8 16.1 13.6 24.7 11.6 57.6 12.6 41.7 36.0 21.3 12.2 41.2 6.7 24.4 24.5 10.1 20.9 14.0 40.8 20.8 10.8 17.5 9.2 34.3 31.0 8.1 16.5 15.1 10.9 11.3 16.8 9.0 3.4 14.1 15.4 21.5 14.8 15.7 10.4 17.3 10.4 11.5 8.7 15.3 16.4 22.0 14.9 15.4 27.8 9.0 7.2 19.5 9.7 17.2 0.0 10.2 17.4 10.7 21.5 0.0 4.0 13.6 20.6 16.0 11.6 12.6 26.1 10.8 16.6 8.6 15.0 9.9 9.9 15.6 14.7 21.6 11.7 17.1 17.7 7.6 32.8 13.0 17.1 18.1 0.5 11.5 11.2 10.0 7.2 41.7 47.0 6.0 54.6 6.2 11.2 6.0 5.5 32.4 10.5 5.3 5.4 34.0 9.8 63.4 4.3 10.7 17.4 39.3 40.1 35.9 49.3 34.1 38.3 40.7 39.6 40.9 41.7 41.2 40.8 56.1 16.0 41.1 4.6 13.0 8.4 12.3 21.1 10.8 22.8 22.2 20.2 85.2 44.3 23.9 20.2 8.4 21.0 11.5 58.8 68.4 24.7 77.8 27.2 25.5 33.0 25.3 17.9 5.6 36.9 26.1 27.8 36.2 33.1 19.6 23.0 78.1 107.5 65.1 43.7 3.0 74.7 18.3 179.8 25.3 37.5 26.4 73.6 17.8 3.7 64.6 14.2 17.5 3.0 4.6 31.1 66.7 39.5 14.3 19.5 334.3 109.4 19.8 19.2 26.3 22.1 30.7 28.2 6.3 15.4 5.4 7.3 15.1 68.2 48.5 16.0 MRPL3 "MRL3, RPML3" ENSG00000114686 "Mitochondrial ribosomal protein L3" P09001 3 131462212-131502983 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043665, HPA060132" Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "HPA043665: AB_2678606, HPA060132: AB_2684209" "unprognostic (1.75e-2)" "unprognostic (7.23e-2)" "unprognostic (2.61e-2)" "unprognostic (1.61e-3)" "unprognostic (7.83e-3)" "unprognostic (1.47e-2)" "prognostic unfavorable (4.33e-7)" "unprognostic (1.54e-1)" "unprognostic (8.23e-2)" "prognostic favorable (1.36e-4)" "prognostic unfavorable (3.51e-6)" "unprognostic (2.05e-3)" "unprognostic (6.40e-2)" "unprognostic (1.56e-1)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (3.29e-1)" 46.2 44.3 22.9 45.1 24.2 32.0 65.4 23.0 28.7 47.0 29.4 60.8 48.7 40.8 71.6 51.0 59.3 34.9 48.6 24.2 28.0 75.2 65.6 29.9 51.4 22.9 23.8 47.9 61.1 80.9 38.2 39.6 24.9 45.7 65.9 33.8 57.5 48.1 78.6 34.5 41.3 50.4 25.6 29.8 46.7 51.1 25.6 53.1 64.2 78.0 60.9 65.8 35.0 26.9 263.1 108.9 119.8 135.0 110.5 142.4 216.4 139.7 122.6 177.0 156.7 241.4 148.5 212.3 184.3 140.8 138.9 168.5 205.9 200.8 269.6 138.4 160.1 197.2 112.3 204.8 129.2 399.8 121.7 112.7 163.6 136.4 241.0 96.1 116.4 159.7 183.3 113.0 148.2 200.1 201.3 199.6 255.2 278.6 193.7 79.4 153.8 326.3 176.3 182.1 194.1 130.5 125.4 141.4 206.3 100.0 165.5 211.6 105.8 127.2 132.5 181.6 196.8 107.0 116.0 380.4 135.6 189.6 178.6 12.8 79.0 19.7 58.7 105.9 91.2 71.9 71.9 70.2 147.5 76.3 82.7 75.1 4.5 98.3 80.5 51.5 77.1 124.6 22.9 24.2 23.0 28.7 24.2 28.0 22.9 23.8 24.9 25.6 25.6 26.9 32.5 25.6 26.9 22.5 54.4 45.9 89.0 106.8 49.5 28.3 54.2 52.8 35.7 37.1 63.8 31.3 8.4 100.2 37.6 26.6 152.6 115.7 86.4 39.0 58.6 31.6 30.1 57.2 38.3 101.9 135.4 53.3 42.8 65.2 28.6 55.1 31.1 50.7 65.9 30.3 30.3 76.2 67.1 54.1 37.3 24.2 55.6 51.5 42.7 19.7 55.5 35.6 49.4 33.7 30.3 92.4 31.9 51.6 72.9 97.8 47.4 167.2 38.9 21.9 32.9 59.8 54.2 149.3 85.4 67.6 47.5 63.9 42.5 95.0 81.3 84.0 CPNE4 "COPN4, CPN4" ENSG00000196353 "Copine 4" Q96A23 3 131533555-132285410 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 34.3;prostate: 25.3" "Cell type enriched" "Detected in some" 10 "Excitatory neurons: 351.2" "Cancer enriched" "Detected in some" 6 "prostate cancer: 22.4" "Group enriched" "Detected in many" 4 "basal ganglia: 34.3;cerebral cortex: 15.2;hippocampal formation: 16.8;thalamus: 12.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.2;AF22: 5.7;Karpas-707: 1.7;RT4: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA032036, HPA078300" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 10: Brain - Neuronal signaling" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoplasm, Cytosol" "HPA032036: AB_10600898, HPA078300: AB_2732377" "unprognostic (7.38e-2)" "unprognostic (2.12e-2)" "unprognostic (1.56e-1)" "unprognostic (1.22e-4)" "unprognostic (2.53e-2)" "unprognostic (1.41e-2)" "unprognostic (8.81e-3)" "unprognostic (3.40e-1)" "unprognostic (2.69e-2)" "unprognostic (1.57e-2)" "unprognostic (2.27e-2)" "unprognostic (1.29e-2)" "unprognostic (9.10e-3)" "unprognostic (1.18e-2)" "unprognostic (1.76e-2)" "unprognostic (1.35e-1)" "unprognostic (2.51e-1)" 0.6 0.5 4.8 0.1 34.3 0.0 0.2 0.0 15.2 0.2 0.0 0.3 0.7 0.2 0.6 0.3 0.4 0.0 0.9 16.8 3.7 1.0 0.1 0.4 0.0 0.0 4.2 0.0 0.2 1.9 3.0 0.0 0.1 25.3 0.2 2.0 0.4 3.7 0.0 0.2 0.5 0.3 0.5 0.8 0.5 1.4 12.1 0.0 0.3 0.1 0.0 0.1 0.4 1.2 0.0 6.2 5.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 1.7 0.8 0.4 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.8 0.4 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.7 1.4 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 4.8 34.3 0.0 15.2 16.8 3.7 0.0 4.2 0.1 0.5 12.1 1.2 0.9 0.0 0.0 8.8 0.0 0.3 0.4 0.1 0.0 0.8 0.0 0.0 17.5 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.6 0.1 0.6 4.9 0.0 351.2 0.0 0.0 0.6 3.6 0.6 0.0 0.2 0.0 0.0 0.1 1.7 33.0 0.1 0.0 0.0 0.3 5.6 0.3 1.1 0.0 8.4 0.6 0.3 0.0 8.5 7.1 0.1 0.0 0.0 0.0 17.0 0.0 2.6 0.3 0.6 0.0 0.0 0.4 1.4 1.1 0.3 0.1 0.0 0.0 0.1 0.0 0.9 ACP3 "ACP-3, ACPP, PAP, TM-PAP" ENSG00000014257 "Acid phosphatase 3" P15309 3 132317369-132368298 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 76 "prostate: 3643.7" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 13.9;Hofbauer cells: 4.7;Syncytiotrophoblasts: 8.9" "Cancer enriched" "Detected in many" 275 "prostate cancer: 1227.2" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 139.7" "Lineage enhanced" "Detected in many" "granulocytes: 139.7" "Cell line enhanced" "Detected in many" "BJ hTERT+: 17.7;OE19: 22.3;RPMI-8226: 58.0;U-698: 17.2;U-87 MG: 14.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000071, HPA004335, HPA063916" Enhanced "Secreted to blood" NA NA 460000 480000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 51: Non-specific - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 47: Cytotrophoblasts - Unknown function" "CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152" "unprognostic (6.67e-2)" "unprognostic (4.70e-2)" "unprognostic (1.76e-1)" "unprognostic (7.77e-2)" "unprognostic (1.74e-1)" "unprognostic (2.58e-2)" "unprognostic (2.46e-1)" "unprognostic (7.41e-2)" "unprognostic (1.81e-1)" "unprognostic (3.78e-3)" "unprognostic (2.14e-1)" "unprognostic (5.95e-2)" "unprognostic (9.38e-2)" "unprognostic (1.35e-1)" "unprognostic (1.18e-1)" "unprognostic (3.91e-2)" "unprognostic (1.71e-1)" 3.1 5.4 0.9 7.3 1.3 17.5 3.4 0.9 0.9 6.3 1.2 3.6 3.1 1.4 17.2 47.7 2.2 1.5 0.6 1.2 1.5 28.9 1.4 4.5 1.9 1.5 1.3 1.1 2.7 3.9 0.5 10.8 1.5 3643.7 6.5 0.4 10.6 0.8 0.2 27.0 3.4 1.8 1.0 1.8 3.2 2.4 1.0 1.0 2.4 0.2 6.5 1.8 12.1 1.7 0.5 0.1 0.0 0.0 0.2 0.9 11.7 0.3 17.7 0.1 0.0 0.4 0.4 10.6 0.8 0.0 0.1 4.8 0.0 0.1 0.0 0.1 0.5 2.0 0.4 0.2 0.2 7.3 0.1 1.1 1.6 0.1 0.0 0.2 0.0 0.0 0.1 2.7 0.2 0.1 0.0 13.5 0.7 22.3 2.1 0.1 0.0 58.0 5.0 6.5 0.0 4.1 0.1 2.0 0.6 1.7 0.3 6.5 0.0 0.1 0.1 2.5 0.1 0.8 0.4 17.2 14.9 12.7 0.2 0.1 30.2 139.7 0.2 26.9 0.2 0.7 0.0 0.0 35.3 0.0 0.0 0.0 26.4 2.6 25.8 2.4 0.0 10.1 0.9 1.3 0.9 0.9 1.2 1.5 1.5 1.3 1.5 1.0 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 DNAJC13 "KIAA0678, RME8" ENSG00000138246 "DnaJ heat shock protein family (Hsp40) member C13" O75165 3 132417502-132539032 "Human disease related genes, Predicted membrane proteins" "Protein transport, Transport" Chaperone "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036923, HPA036924" Approved Supported Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 10: Non-specific - Unknown function" Vesicles Cytosol "HPA036923: AB_10672480, HPA036924: AB_2675386" "unprognostic (3.35e-3)" "unprognostic (7.47e-2)" "unprognostic (9.16e-2)" "unprognostic (1.20e-2)" "unprognostic (9.71e-2)" "unprognostic (4.92e-2)" "prognostic unfavorable (7.49e-4)" "unprognostic (3.68e-2)" "unprognostic (3.38e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (8.36e-4)" "unprognostic (1.92e-1)" "unprognostic (4.81e-3)" "unprognostic (2.15e-1)" "unprognostic (1.71e-1)" "unprognostic (2.34e-2)" "unprognostic (1.22e-1)" 11.7 9.4 5.9 12.4 6.5 15.5 11.4 6.0 6.3 12.9 8.2 14.4 10.9 13.8 11.7 10.7 9.9 9.9 12.9 5.9 6.9 16.0 9.8 11.3 11.0 7.7 6.9 11.7 6.8 12.6 5.9 15.4 7.1 10.8 14.3 10.7 9.1 12.1 12.5 9.8 10.4 16.7 6.3 12.2 9.7 7.8 7.5 12.0 15.7 14.2 10.6 12.4 10.3 7.8 31.0 18.0 22.2 10.9 54.3 46.7 13.7 32.3 62.5 31.4 33.8 20.4 18.2 15.7 20.5 46.3 41.1 24.1 22.1 24.3 43.5 18.3 6.4 20.6 17.1 13.6 27.6 21.1 18.3 34.2 16.4 28.5 35.1 22.7 44.6 26.0 11.4 25.6 43.7 24.1 16.8 9.1 12.7 26.7 15.8 15.9 16.5 13.0 27.7 32.4 7.9 11.9 31.6 16.7 36.1 19.0 24.7 17.8 40.9 34.7 17.8 33.3 13.9 14.8 15.7 21.5 36.8 13.6 25.2 2.0 2.6 0.4 0.8 2.2 0.7 1.0 0.9 0.7 2.8 0.4 0.6 0.8 0.5 0.7 4.0 1.4 0.4 0.8 5.9 6.5 6.0 6.3 5.9 6.9 7.7 6.9 7.1 6.3 7.5 7.8 16.8 12.8 21.9 45.7 14.4 6.6 7.3 7.3 6.8 10.8 8.9 7.2 47.2 8.6 11.3 12.9 33.3 7.9 13.2 21.5 1.9 9.0 1.7 10.3 31.3 17.1 14.4 12.8 48.7 9.1 7.7 20.2 16.8 18.7 12.0 18.9 13.2 8.5 20.5 67.3 48.7 12.5 0.0 34.2 9.2 3.6 15.2 26.5 28.4 60.0 25.1 13.3 6.2 46.8 64.7 11.7 12.5 21.4 13.9 10.5 17.0 18.7 13.1 11.5 6.6 22.3 19.7 5.3 13.7 15.4 7.5 5.1 10.8 22.5 13.4 11.0 ACAD11 FLJ12592 ENSG00000240303 "Acyl-CoA dehydrogenase family member 11" Q709F0 3 132558138-132660082 "Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 64.4;liver: 103.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 6.4;Erythroid cells: 5.7;Plasma cells: 7.6;Syncytiotrophoblasts: 9.7" "Cancer enhanced" "Detected in single" "renal cancer: 1.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048317 Enhanced NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 59: Non-specific - Transcription" "HPA048317: AB_2680354" "unprognostic (5.04e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-1)" "unprognostic (3.31e-2)" "unprognostic (3.36e-1)" "unprognostic (2.69e-4)" "unprognostic (1.20e-1)" "unprognostic (2.85e-2)" "unprognostic (2.40e-1)" "unprognostic (5.90e-2)" "unprognostic (5.86e-2)" "unprognostic (5.68e-2)" "unprognostic (1.06e-3)" "unprognostic (6.01e-2)" "unprognostic (1.48e-1)" "unprognostic (2.71e-2)" "unprognostic (2.93e-1)" 16.2 7.6 8.6 2.8 11.3 7.8 6.1 9.3 13.3 8.5 23.3 7.7 17.0 8.0 6.7 4.0 8.5 4.0 15.4 8.8 9.0 64.4 103.6 5.8 3.3 10.2 9.9 9.9 8.2 8.8 9.8 9.8 10.0 6.6 3.4 11.7 5.7 6.0 4.3 6.3 15.8 6.4 9.6 4.3 4.8 8.2 10.3 4.6 6.4 2.0 3.2 5.5 6.5 11.5 5.8 5.2 10.5 13.6 23.2 17.9 10.5 13.6 21.0 8.0 10.5 19.3 2.1 3.9 7.6 7.7 9.0 4.3 8.0 11.9 12.7 6.7 5.6 4.3 5.5 18.1 23.0 4.7 4.1 12.2 8.9 11.0 27.2 18.6 7.9 5.0 2.3 8.2 11.2 7.8 3.0 3.2 6.2 2.8 5.2 3.3 8.4 6.4 18.0 3.8 4.1 6.7 10.5 5.0 28.5 10.9 10.5 3.4 6.5 6.3 3.9 3.6 4.8 6.7 2.3 4.0 8.4 1.6 5.2 0.0 0.2 0.0 0.6 0.4 0.5 0.6 0.6 0.3 0.2 0.6 1.4 0.7 0.0 0.9 0.3 0.9 0.3 0.2 8.6 11.3 9.3 13.3 8.8 9.0 10.2 9.9 10.0 9.6 10.3 11.5 1.4 6.4 3.2 0.0 2.1 0.1 0.2 0.7 2.8 0.9 0.6 0.4 0.0 0.0 0.8 0.0 0.0 4.2 0.8 0.4 0.0 0.8 0.6 1.5 2.0 1.0 4.8 5.7 0.0 1.1 0.9 1.6 0.0 0.8 1.3 1.5 0.4 3.9 0.7 0.0 0.0 0.5 0.0 0.8 0.2 0.2 0.6 0.8 0.0 0.0 2.3 0.6 4.1 0.0 0.0 0.4 0.2 0.7 7.6 0.2 4.4 1.6 1.0 2.9 0.0 0.9 1.1 0.1 0.3 0.9 0.3 9.7 2.2 1.1 0.7 0.1 NPHP3-ACAD11 ENSG00000274810 "NPHP3-ACAD11 readthrough (NMD candidate)" 3 132558142-132722459 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Astrocytes: 2.3;Microglial cells: 3.7;Oligodendrocyte precursor cells: 4.5;Oligodendrocytes: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 7.9" "Low region specificity" "Detected in many" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 22: Epithelial cell types - Mixed function" "unprognostic (1.50e-1)" "unprognostic (1.82e-1)" "unprognostic (1.04e-1)" "unprognostic (1.91e-1)" "unprognostic (2.45e-1)" "unprognostic (5.84e-2)" "unprognostic (2.07e-2)" "unprognostic (3.07e-1)" "unprognostic (2.38e-1)" "unprognostic (3.48e-1)" "unprognostic (3.63e-5)" "unprognostic (4.17e-2)" "unprognostic (3.99e-1)" "unprognostic (2.12e-1)" "unprognostic (2.59e-2)" 2.7 1.0 2.3 0.3 2.9 1.1 2.2 2.4 5.2 1.7 2.3 1.6 0.7 3.0 0.0 0.8 1.6 1.3 0.8 2.2 2.3 0.7 0.7 2.2 0.9 2.7 2.5 5.7 1.2 1.0 0.3 0.8 3.1 0.6 0.7 2.7 1.6 1.1 3.8 0.3 0.8 1.1 2.6 1.6 0.9 1.3 2.6 0.8 0.6 0.0 0.8 0.6 0.4 3.2 1.5 0.2 3.8 0.3 1.5 7.9 2.0 4.0 3.9 1.0 1.7 0.0 0.8 0.4 1.5 4.1 3.0 0.8 0.2 0.7 1.5 0.5 0.5 0.3 0.0 2.1 2.0 0.0 2.7 5.0 1.5 2.1 2.2 5.1 0.0 1.0 0.3 0.7 2.0 0.0 0.0 1.4 1.1 1.9 0.3 0.0 2.6 0.4 1.8 0.0 0.2 2.8 1.6 0.3 3.6 3.0 0.4 1.1 5.5 3.1 2.4 3.3 0.0 1.1 0.1 0.4 4.3 0.1 1.8 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 2.3 2.9 2.4 5.2 2.2 2.3 2.7 2.5 3.1 2.6 2.6 3.2 0.0 3.2 1.1 2.3 0.1 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 1.9 0.0 0.8 0.4 0.0 0.0 1.3 0.0 0.0 0.4 0.5 0.0 1.8 0.0 0.0 0.3 0.0 0.7 0.0 0.5 0.0 3.7 0.0 0.6 0.0 4.5 3.7 0.0 0.1 0.0 0.5 0.6 0.4 0.0 0.0 1.1 0.0 0.6 0.3 0.5 0.4 0.7 0.0 0.4 0.6 0.0 0.1 0.6 ACKR4 "CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1" ENSG00000129048 "Atypical chemokine receptor 4" Q9NPB9 3 132597270-132618967 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.8" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Fibroblasts: 21.4;Proximal enterocytes: 19.1;Respiratory ciliated cells: 15.7" "Cancer enhanced" "Detected in many" "stomach cancer: 2.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "BJ hTERT+: 285.1" "Group enriched" "Detected in some" 7 "cerebellum: 4.7;pons and medulla: 1.5" "Low region specificity" "Detected in all" HPA054926 Approved Vesicles,Mitochondria NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 31: Skin - Epidermis development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Vesicles, Mitochondria" "HPA054926: " "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (2.62e-2)" "unprognostic (8.27e-2)" "unprognostic (5.17e-2)" "unprognostic (4.55e-3)" "unprognostic (8.93e-2)" "unprognostic (2.26e-1)" "unprognostic (4.85e-2)" "unprognostic (4.20e-3)" "unprognostic (1.03e-3)" "unprognostic (2.69e-3)" "unprognostic (1.95e-1)" "unprognostic (2.01e-1)" "unprognostic (1.86e-1)" "unprognostic (1.18e-1)" "unprognostic (1.22e-1)" 11.1 1.4 0.6 1.0 0.2 0.8 5.5 0.3 0.3 0.7 0.9 1.9 15.8 3.7 1.7 1.4 2.0 6.5 5.7 0.4 0.0 1.1 1.0 8.0 2.1 0.3 0.5 1.0 2.6 0.0 6.7 0.2 0.3 0.5 1.3 0.6 7.1 1.9 0.5 8.9 13.0 2.2 0.3 1.6 10.2 0.4 0.1 0.5 1.4 1.0 1.6 4.6 1.1 0.2 0.2 0.0 0.2 0.2 19.9 10.7 0.1 47.7 285.1 2.8 7.9 0.2 0.4 3.3 0.0 29.9 0.2 0.1 0.0 0.0 1.8 1.1 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.2 0.0 1.3 0.0 0.0 4.9 0.1 0.2 0.6 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.2 0.0 0.5 0.1 0.7 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.3 0.4 0.0 0.3 0.5 0.3 0.3 0.1 0.2 1.6 38.5 1.1 0.7 0.1 6.5 0.6 1.3 0.0 1.6 0.3 0.3 0.7 1.5 2.3 5.5 6.2 0.2 0.1 1.1 0.0 0.2 2.9 2.9 0.6 3.9 0.0 0.0 0.6 12.1 0.1 21.4 10.7 0.6 0.0 0.7 9.7 0.2 0.4 1.7 0.5 0.8 0.0 0.3 5.1 0.4 2.1 0.3 1.8 1.9 6.8 0.9 0.0 0.0 0.3 5.1 0.1 2.6 0.5 0.4 19.1 3.0 15.7 3.4 0.0 1.3 2.6 0.1 0.1 0.6 6.5 0.3 0.5 12.5 3.7 1.2 UBA5 "FLJ23251, UBE1DC1" ENSG00000081307 "Ubiquitin like modifier activating enzyme 5" Q9GZZ9 3 132654446-132679794 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 418.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017235, HPA076042" Supported Enhanced Vesicles,Cytosol NA NA 43000 "Cluster 15: NK-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" Cytosol Vesicles "HPA017235: AB_1858507, HPA076042: " "unprognostic (4.34e-3)" "unprognostic (6.44e-2)" "unprognostic (7.70e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.06e-1)" "unprognostic (3.28e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-2)" "unprognostic (1.84e-2)" "unprognostic (3.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (1.02e-2)" "unprognostic (2.40e-2)" 18.3 29.2 15.6 18.6 17.5 21.5 23.0 15.2 16.3 18.0 30.9 21.5 24.0 17.2 30.4 17.2 16.6 16.9 23.8 16.7 15.8 31.3 31.8 17.7 22.4 12.6 13.6 16.9 52.1 31.0 22.3 25.8 14.1 24.8 22.6 25.2 48.0 20.2 31.4 22.0 24.8 17.7 13.8 21.1 26.7 17.0 14.2 19.7 31.8 24.4 24.9 17.2 11.8 16.5 67.2 24.4 42.1 35.3 28.4 31.9 44.5 57.1 57.2 34.4 39.6 44.9 24.2 52.1 41.1 40.8 23.3 39.6 41.6 43.6 49.5 51.3 18.1 63.6 39.6 50.1 27.9 79.6 36.7 28.0 24.8 32.8 48.7 31.8 38.6 28.6 41.0 76.2 38.0 59.4 44.1 29.2 38.6 56.3 22.9 38.6 37.0 99.8 31.0 50.9 40.2 35.8 33.5 32.0 51.3 37.8 40.0 39.5 35.9 36.7 36.2 17.8 29.8 71.7 51.8 98.3 40.9 28.1 33.5 8.3 7.1 7.0 12.4 8.2 14.6 15.1 13.8 19.1 15.9 10.2 16.1 16.3 1.6 26.0 9.5 19.2 15.5 10.5 15.6 17.5 15.2 16.3 16.7 15.8 12.6 13.6 14.1 13.8 14.2 16.5 23.1 35.3 25.9 37.2 24.0 17.2 18.9 26.4 21.1 22.1 26.1 13.1 36.9 22.8 24.4 7.3 14.6 63.0 28.4 8.3 68.4 30.3 124.8 17.7 22.2 20.5 21.6 10.9 37.6 44.9 48.0 24.8 28.5 17.4 24.1 16.8 13.2 22.8 22.6 21.9 35.6 22.6 34.6 10.3 11.4 418.2 16.8 13.9 17.8 16.9 21.6 26.1 16.5 37.7 28.4 23.2 16.7 27.1 85.4 23.1 35.4 43.1 20.8 23.6 32.9 23.5 28.2 49.4 23.1 15.9 18.5 99.7 20.4 29.7 18.3 18.1 NPHP3 "CFAP31, FLJ30691, FLJ36696, KIAA2000, MKS7, NPH3, SLSN3" ENSG00000113971 "Nephrocystin 3" Q7Z494 3 132680609-132722414 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Ciliopathy, Disease variant, Meckel syndrome, Nephronophthisis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009150 Uncertain NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "HPA009150: AB_1078086" "unprognostic (1.02e-2)" "unprognostic (1.22e-1)" "unprognostic (1.56e-2)" "unprognostic (2.79e-1)" "unprognostic (2.22e-1)" "unprognostic (8.24e-3)" "unprognostic (2.36e-5)" "unprognostic (8.02e-3)" "unprognostic (6.51e-2)" "unprognostic (1.96e-2)" "unprognostic (9.42e-3)" "unprognostic (2.92e-2)" "prognostic unfavorable (8.28e-9)" "unprognostic (2.61e-2)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-3)" 7.0 6.0 3.7 4.1 5.6 2.8 7.6 4.0 4.5 9.2 4.4 5.5 3.3 12.9 10.8 4.0 8.1 7.3 5.6 3.5 5.6 4.4 2.9 7.2 5.0 5.6 5.0 15.9 4.5 3.6 3.6 7.4 5.4 6.8 4.1 3.1 5.3 6.0 3.7 8.0 4.1 7.8 4.2 6.2 4.0 3.4 5.2 3.7 6.4 5.2 2.8 5.3 5.4 7.9 4.7 2.5 12.2 8.3 9.0 15.1 5.6 13.9 11.3 6.3 7.6 3.6 2.1 0.6 6.0 13.9 5.4 4.2 5.1 6.3 7.2 2.6 3.5 3.8 2.9 4.0 9.1 0.7 4.1 12.2 3.8 7.2 10.2 13.5 9.5 2.9 1.8 3.8 18.0 4.4 0.6 4.6 5.9 3.0 3.8 1.5 11.3 5.2 7.9 3.2 0.3 9.3 9.1 2.5 10.5 10.5 3.9 2.2 11.5 9.6 6.2 11.7 5.8 3.1 1.2 1.2 10.7 1.1 9.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.3 0.2 0.1 0.5 0.3 0.1 0.5 0.0 0.7 0.2 0.3 0.0 3.7 5.6 4.0 4.5 3.5 5.6 5.6 5.0 5.4 4.2 5.2 7.9 25.5 28.9 18.6 0.0 12.4 19.1 15.9 10.5 7.4 20.8 21.5 27.6 20.9 12.8 8.9 16.5 56.3 18.7 13.5 9.4 0.0 6.8 2.4 14.0 20.1 24.7 12.7 7.4 0.0 4.9 11.7 25.2 4.1 11.0 7.6 25.6 52.1 14.6 9.7 26.9 0.0 11.6 4.1 18.5 17.2 4.3 60.0 9.8 14.2 0.0 13.2 13.2 10.3 0.0 0.0 8.1 5.4 40.3 5.6 15.8 14.8 5.2 14.3 34.1 32.9 26.6 20.6 14.1 5.5 6.9 18.8 9.2 14.0 15.1 13.4 9.1 TMEM108 "CT124, MGC3040" ENSG00000144868 "Transmembrane protein 108" Q6UXF1 3 133038391-133397775 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 35.2;skeletal muscle: 23.1" "Cell type enhanced" "Detected in many" "Astrocytes: 209.9;Excitatory neurons: 357.3;Inhibitory neurons: 475.3;Oligodendrocyte precursor cells: 480.0" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 24.2;LHCN-M2: 13.8;SCLC-21H: 21.0;SH-SY5Y: 92.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063350 Enhanced Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 55000 "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane, Cytosol" "Nucleoli, Vesicles" "HPA063350: AB_2684993" "unprognostic (4.75e-2)" "unprognostic (1.73e-2)" "unprognostic (9.00e-2)" "unprognostic (1.92e-2)" "unprognostic (3.07e-3)" "unprognostic (3.17e-1)" "unprognostic (1.28e-1)" "unprognostic (3.65e-2)" "unprognostic (2.06e-4)" "unprognostic (2.08e-1)" "unprognostic (7.27e-4)" "unprognostic (1.11e-1)" "unprognostic (3.03e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-2)" "unprognostic (6.12e-2)" "unprognostic (1.36e-2)" 1.4 11.3 6.3 1.5 9.6 0.2 1.5 3.4 10.0 2.0 3.2 1.5 0.4 2.4 0.6 9.6 1.7 0.8 6.8 9.6 2.9 0.4 0.1 11.0 1.7 0.0 4.1 0.3 0.3 3.0 2.2 2.4 4.0 1.0 1.3 35.2 1.3 2.0 23.1 1.4 1.6 5.5 0.0 1.3 1.3 13.9 7.9 1.3 3.1 7.0 2.3 8.3 0.8 0.8 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.0 0.3 0.0 0.1 1.0 0.0 0.0 0.1 0.2 0.0 0.7 1.0 1.8 8.5 0.0 0.0 0.0 0.0 24.2 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 13.8 0.7 0.1 0.3 3.8 0.0 0.0 0.0 4.8 0.1 1.1 0.0 21.0 92.6 0.0 0.1 0.3 5.5 0.2 0.0 0.0 0.1 0.1 0.0 3.4 1.3 0.0 0.7 1.8 0.0 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 9.6 3.4 10.0 9.6 2.9 0.0 4.1 4.0 0.0 7.9 0.8 0.6 3.2 4.6 209.9 0.0 2.4 0.5 0.2 0.0 10.4 1.3 2.8 1.7 1.5 5.0 0.0 102.2 1.8 0.0 0.0 0.0 0.0 80.6 1.0 0.6 1.3 0.0 0.0 357.3 0.4 8.6 4.6 4.1 0.2 1.3 5.5 0.4 0.0 0.3 1.7 475.3 0.0 0.0 0.0 0.8 38.2 0.9 0.1 0.0 33.7 0.0 5.7 0.0 480.0 22.2 0.3 0.0 0.7 1.2 0.2 0.0 0.0 0.0 57.6 0.0 6.8 3.3 17.2 11.2 0.0 1.6 1.1 1.0 4.9 0.0 0.4 BFSP2 "CP47, CP49, LIFL-L, phakinin" ENSG00000170819 "Beaded filament structural protein 2" Q13515 3 133400056-133475222 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "B-cells: 6.3;Melanocytes: 5.4;Plasma cells: 10.6" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.7" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 8 "T-reg: 13.4" "Lineage enriched" "Detected in single" 43 "T-cells: 13.4" "Group enriched" "Detected in some" 6 "Daudi: 2.4;U-698: 2.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038464, HPA062959" Enhanced Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Plasma membrane, Cytosol" "HPA038464: AB_10672746, HPA062959: AB_2684912" "unprognostic (1.58e-3)" "unprognostic (7.47e-4)" "unprognostic (1.04e-2)" "unprognostic (2.32e-1)" "unprognostic (9.59e-2)" "unprognostic (4.04e-5)" "unprognostic (8.13e-2)" "unprognostic (5.57e-2)" "unprognostic (6.71e-2)" "unprognostic (1.91e-3)" "unprognostic (1.74e-2)" "unprognostic (4.70e-2)" "unprognostic (1.68e-5)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "unprognostic (8.23e-2)" "unprognostic (2.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.6 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 1.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 1.8 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.4 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.9 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.3 0.1 5.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.3 0.0 0.6 0.0 1.0 0.1 0.1 0.0 CDV3 H41 ENSG00000091527 "CDV3 homolog" Q9UKY7 3 133573686-133590261 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 559.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 1103.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029761, HPA029762, HPA029763" Enhanced Approved "Nucleoli,Plasma membrane,Cytosol" NA NA 1100000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 34: Spermatids - Unknown function" Cytosol "Nucleoli, Plasma membrane" "HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679" "unprognostic (1.17e-2)" "unprognostic (1.22e-1)" "unprognostic (4.06e-2)" "unprognostic (4.56e-2)" "unprognostic (4.04e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.21e-6)" "unprognostic (1.20e-1)" "unprognostic (3.30e-1)" "unprognostic (8.45e-3)" "unprognostic (3.29e-3)" "unprognostic (1.13e-1)" "unprognostic (2.36e-1)" "unprognostic (7.83e-2)" "unprognostic (1.48e-2)" "unprognostic (9.87e-2)" "unprognostic (7.59e-3)" 117.0 68.6 39.1 113.7 42.0 161.3 73.0 40.6 42.9 59.3 48.3 80.0 57.5 60.6 54.9 78.7 51.6 76.4 74.5 37.0 47.1 64.4 112.9 83.6 159.3 46.0 41.8 57.9 84.3 85.8 43.0 108.5 46.0 43.2 70.8 49.2 52.7 47.7 250.9 55.0 65.5 75.7 44.6 121.6 89.0 95.9 45.8 194.5 97.4 155.9 165.6 104.3 49.3 47.8 376.2 85.5 147.6 98.0 166.7 203.6 174.5 201.6 261.1 197.6 194.7 213.4 147.0 473.9 298.0 227.4 229.2 158.2 213.5 202.0 366.4 306.1 80.1 282.3 93.2 130.9 258.2 318.7 173.4 194.7 206.7 178.2 473.4 139.6 254.5 137.9 205.7 309.9 289.5 107.1 260.9 180.9 148.9 161.6 108.2 156.8 197.6 382.2 206.9 150.7 116.5 87.8 192.0 140.4 246.0 210.0 456.3 190.8 316.4 209.4 198.5 168.5 202.7 446.9 363.2 1103.9 117.0 187.8 124.7 14.3 10.5 17.6 13.0 12.3 13.5 11.1 12.2 13.2 9.7 7.0 9.7 15.2 9.7 6.4 13.7 15.9 24.0 5.7 39.1 42.0 40.6 42.9 37.0 47.1 46.0 41.8 46.0 44.6 45.8 47.8 116.3 57.7 69.8 7.2 114.9 145.9 217.3 19.5 63.7 22.6 97.6 77.2 86.2 74.4 34.4 84.6 10.4 51.6 169.7 158.0 37.2 42.1 324.7 174.0 160.5 99.5 47.2 59.5 13.2 87.6 82.0 93.7 88.7 314.4 45.0 63.0 91.1 97.2 118.5 23.5 12.3 102.4 10.2 146.8 117.7 559.5 34.2 145.0 55.2 17.8 100.4 109.5 90.6 8.0 14.5 88.1 101.2 35.7 239.4 320.2 26.9 74.4 27.4 29.9 26.3 120.9 92.5 21.2 30.9 94.0 128.3 35.2 126.5 124.4 90.1 219.5 TOPBP1 "Dpb11, KIAA0259, TOP2BP1" ENSG00000163781 "DNA topoisomerase II binding protein 1" Q92547 3 133598175-133662380 "Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 104.1;Spermatocytes: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022451, HPA036738, HPA036739" Approved Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "CAB022451: , HPA036738: AB_2675280, HPA036739: AB_2675281" "unprognostic (7.72e-2)" "unprognostic (8.54e-2)" "unprognostic (2.77e-2)" "prognostic unfavorable (5.76e-5)" "unprognostic (2.05e-1)" "unprognostic (3.05e-2)" "prognostic unfavorable (4.66e-5)" "unprognostic (8.03e-2)" "unprognostic (3.98e-2)" "unprognostic (2.59e-2)" "prognostic unfavorable (1.88e-4)" "unprognostic (2.74e-3)" "unprognostic (8.65e-3)" "unprognostic (7.97e-2)" "unprognostic (2.52e-1)" "unprognostic (7.64e-2)" "unprognostic (1.60e-1)" 7.7 4.9 3.6 13.0 4.3 33.1 10.7 5.0 4.6 6.5 3.1 9.3 8.3 8.1 5.0 8.9 5.9 6.9 6.1 4.6 3.3 5.5 7.4 7.3 19.7 3.7 3.2 7.3 7.6 6.0 3.6 12.0 3.7 6.6 11.5 8.2 7.1 5.5 6.9 11.8 9.2 8.7 3.5 10.4 8.7 22.4 3.7 29.1 7.4 7.6 18.6 8.3 7.0 4.5 44.4 27.2 43.1 35.1 8.0 10.5 32.3 33.9 26.9 41.0 52.4 37.9 27.5 80.5 29.1 24.7 49.3 50.2 62.8 22.6 62.7 48.9 28.2 75.4 38.3 23.4 7.7 81.5 57.1 12.5 13.7 40.2 23.9 15.4 28.5 46.3 47.6 55.7 32.6 30.3 79.9 43.1 35.7 50.4 23.0 53.3 53.8 58.4 14.6 30.1 40.9 45.2 41.9 22.6 35.4 41.7 37.7 74.6 19.9 43.0 38.9 43.9 37.7 33.4 53.4 150.6 25.4 42.7 38.4 1.8 0.7 2.2 0.7 0.9 1.0 0.9 0.7 0.7 0.7 0.5 0.7 0.7 0.9 1.0 0.5 1.0 1.5 0.4 3.6 4.3 5.0 4.6 4.6 3.3 3.7 3.2 3.7 3.5 3.7 4.5 17.1 22.4 21.9 10.7 22.8 12.4 8.8 7.8 20.5 15.2 14.2 14.2 10.1 12.8 19.7 11.0 2.1 20.0 33.9 11.9 9.8 12.3 69.4 8.8 16.8 16.0 7.2 42.7 24.3 13.3 19.6 14.9 16.3 13.1 7.6 34.3 7.5 9.5 11.2 3.3 19.6 13.9 6.1 16.7 8.0 104.1 10.2 18.2 8.8 11.2 27.4 10.4 28.8 16.6 13.0 14.7 11.6 9.8 37.5 10.2 6.1 6.1 8.7 9.3 13.1 20.9 12.2 81.3 43.6 22.0 11.5 14.0 23.3 17.7 14.8 10.5 TF "PRO1557, PRO2086" ENSG00000091513 Transferrin P02787 3 133746040-133796641 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Ion transport, Iron transport, Transport" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 6 "liver: 7525.8;retina: 2433.0" "Group enriched" "Detected in many" 9 "Hepatocytes: 7205.2;Muller glia cells: 12965.3" "Cancer enriched" "Detected in many" 42 "liver cancer: 783.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 48 "Hep G2: 780.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001527, HPA005692, CAB009538" Enhanced "Secreted to blood" NA NA 19800000000000 98000000000 "Cluster 17: Basophils - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 5: Muller glia cells - Visual perception" "CAB009538: AB_793365, HPA001527: AB_1080357, HPA005692: AB_1080354" "prognostic favorable (4.05e-4)" "unprognostic (2.45e-2)" "unprognostic (1.78e-1)" "unprognostic (1.50e-1)" "unprognostic (8.99e-2)" "unprognostic (5.18e-2)" "unprognostic (6.63e-2)" "unprognostic (8.46e-2)" "unprognostic (2.82e-1)" "unprognostic (3.08e-1)" "unprognostic (1.37e-1)" "unprognostic (7.60e-2)" "prognostic unfavorable (2.35e-13)" "unprognostic (2.17e-3)" "unprognostic (5.49e-2)" "unprognostic (3.47e-3)" "unprognostic (9.70e-2)" 80.9 1.2 186.3 1.0 412.5 2.4 13.3 591.8 274.2 2.0 58.9 2.3 0.9 1.7 1.4 11.0 1.4 1.9 12.1 173.7 287.7 3.4 7525.8 1.9 1.3 786.9 385.4 2.1 4.6 2.2 4.4 1.3 628.2 5.4 1.2 2433.0 55.8 1.8 2.1 4.2 1.6 1.5 484.9 2.9 1.9 14.3 398.1 1.2 2.2 2.7 3.0 1.2 2.8 862.1 1.9 1.4 1.8 1.2 5.5 3.4 0.9 1.9 2.0 1.0 0.8 3.4 1.5 1.7 1.6 1.8 1.2 2.1 1.3 1.8 1.5 1.1 0.7 16.3 2.7 780.9 1.3 4.6 2.7 2.4 3.8 1.0 1.7 1.8 2.2 0.9 6.4 2.1 2.6 1.3 1.1 1.2 1.2 1.2 1.8 1.5 2.9 1.2 1.1 3.1 1.9 1.4 2.4 2.6 7.0 1.3 1.9 1.3 2.9 2.4 1.5 1.6 1.1 1.7 3.0 1.4 2.0 1.5 1.6 0.6 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.0 186.3 412.5 591.8 274.2 173.7 287.7 786.9 385.4 628.2 484.9 398.1 862.1 0.7 16.0 32.4 36.2 11.4 1.0 5.6 0.6 0.0 101.3 5.3 4.3 2.7 117.2 22.9 0.0 91.8 0.2 0.2 0.1 1.9 0.7 5.4 0.8 1.0 16.7 0.0 56.2 34.2 1.1 0.3 3.9 0.0 0.6 17.7 1.3 87.4 7205.2 0.1 47.1 34.7 0.0 0.0 124.7 0.3 3.8 0.3 4.7 0.0 9.4 0.6 12965.3 0.0 45.2 1077.2 1.1 0.0 0.4 0.0 18.7 0.0 0.5 22.1 400.4 0.0 11.6 0.4 0.5 0.4 3.6 0.0 0.3 7.8 0.5 0.0 3.0 SRPRB "APMCF1, SR-beta" ENSG00000144867 "SRP receptor subunit beta" Q9Y5M8 3 133784023-133825772 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 146.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011173 Approved Approved "Plasma membrane" NA NA 12000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 25: Pancreas - Digestion" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Plasma membrane" "HPA011173: AB_1857484" "unprognostic (5.44e-2)" "unprognostic (1.32e-1)" "unprognostic (6.40e-2)" "unprognostic (1.58e-2)" "unprognostic (2.61e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (3.12e-5)" "unprognostic (1.99e-1)" "unprognostic (3.60e-2)" "unprognostic (6.07e-3)" "unprognostic (8.45e-2)" "unprognostic (1.31e-2)" "unprognostic (3.79e-2)" "unprognostic (5.08e-2)" "unprognostic (7.37e-2)" "unprognostic (6.47e-2)" "unprognostic (2.26e-2)" 20.4 26.8 21.1 18.4 23.3 14.1 24.7 23.2 24.6 26.6 26.4 23.1 19.0 14.4 47.9 29.9 17.9 13.3 16.9 21.1 23.7 26.6 52.9 14.8 15.3 24.5 24.4 13.8 83.2 27.6 25.4 16.0 24.5 18.2 26.1 6.8 49.9 23.7 19.0 15.4 15.4 21.0 22.4 15.5 24.4 26.8 23.1 10.7 26.1 16.5 28.9 23.7 13.8 28.9 44.8 37.5 22.6 72.7 91.8 62.3 45.6 97.4 49.4 50.2 44.3 73.7 34.6 90.4 131.5 72.4 51.2 64.8 69.8 50.9 47.7 57.8 59.6 80.6 34.9 65.2 110.8 124.5 56.7 57.3 83.3 46.2 135.9 28.1 43.5 43.6 68.1 96.9 55.5 65.6 40.9 55.5 43.8 120.3 63.8 49.1 43.5 190.8 61.9 32.1 74.7 32.7 77.3 66.6 28.3 17.0 76.9 55.1 46.0 51.9 29.0 82.8 54.0 118.8 131.5 131.4 45.3 82.9 56.9 13.1 30.5 3.9 54.3 41.1 73.0 38.9 45.4 47.9 36.3 36.7 43.3 51.9 2.2 41.5 27.5 53.8 29.1 50.3 21.1 23.3 23.2 24.6 21.1 23.7 24.5 24.4 24.5 22.4 23.1 28.9 16.8 16.0 20.6 15.3 43.4 37.7 32.0 38.2 11.4 6.5 36.4 22.0 26.6 37.1 32.8 36.8 12.5 65.4 29.1 14.2 11.7 46.0 68.9 18.7 51.2 26.3 32.2 21.7 16.0 67.4 71.2 40.6 28.5 30.1 32.4 19.8 18.9 88.4 49.4 6.7 15.7 58.8 36.7 19.7 23.1 35.9 32.0 20.6 35.6 8.4 16.4 17.2 20.6 17.6 92.6 36.0 17.7 27.8 146.0 52.3 20.0 33.0 24.3 9.4 13.1 38.2 30.2 60.1 40.6 52.1 31.5 51.7 26.1 52.9 43.9 28.5 RAB6B ENSG00000154917 "RAB6B, member RAS oncogene family" Q9NRW1 3 133824235-133895882 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 138.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 30.8;Erythroid cells: 79.2;Excitatory neurons: 60.5;Horizontal cells: 67.3;Inhibitory neurons: 54.1" "Cancer enhanced" "Detected in all" "glioma: 18.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 4 "MAIT T-cell: 7.3" "Lineage enriched" "Detected in single" 47 "T-cells: 7.3" "Cell line enriched" "Detected in many" 4 "HEL: 226.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017713, HPA059131" Uncertain Approved "Golgi apparatus" NA NA 2200000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "Golgi apparatus" "CAB017713: , HPA059131: AB_2683916" "unprognostic (2.87e-2)" "unprognostic (6.33e-3)" "unprognostic (4.53e-3)" "prognostic unfavorable (9.01e-4)" "unprognostic (3.61e-1)" "unprognostic (5.14e-2)" "unprognostic (1.73e-4)" "unprognostic (3.12e-2)" "unprognostic (4.26e-2)" "unprognostic (4.80e-2)" "prognostic favorable (3.97e-6)" "unprognostic (9.00e-2)" "unprognostic (1.26e-1)" "unprognostic (1.49e-2)" "unprognostic (8.10e-2)" "unprognostic (9.53e-2)" "unprognostic (6.05e-3)" 6.8 11.1 45.7 2.8 72.6 12.0 4.4 0.4 138.0 2.9 0.0 6.8 2.4 3.0 2.1 4.2 16.2 3.2 20.8 71.8 31.3 7.1 0.9 3.1 3.3 74.6 43.1 2.1 4.4 24.9 12.0 1.7 55.7 2.7 2.1 29.4 10.1 5.9 2.7 1.5 2.9 8.4 3.7 5.9 5.5 4.0 21.5 1.4 5.2 2.8 2.0 1.6 2.2 63.1 0.1 3.0 5.8 14.9 10.1 10.3 0.5 3.0 6.3 7.2 0.8 1.6 1.5 0.2 6.3 2.4 21.2 0.4 13.8 0.4 3.6 0.2 8.6 226.6 3.5 0.5 1.2 1.4 8.5 3.1 2.9 1.1 0.2 0.1 2.9 8.3 53.4 0.6 1.1 5.5 0.7 21.3 18.0 10.8 2.2 0.2 0.4 2.3 4.0 1.3 47.2 10.1 4.4 4.2 26.7 22.5 16.8 9.7 3.7 6.5 15.5 3.2 5.4 5.6 1.5 0.5 0.7 0.5 5.6 0.0 0.0 0.0 0.6 0.0 7.3 0.1 0.1 1.7 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.8 45.7 72.6 0.4 138.0 71.8 31.3 74.6 43.1 55.7 3.7 21.5 63.1 2.0 0.0 0.0 25.8 0.2 1.3 2.2 0.5 0.6 10.5 2.0 2.3 30.8 1.5 2.8 1.8 2.1 0.3 0.6 2.2 3.9 3.6 0.1 2.3 0.9 3.5 0.0 79.2 60.5 1.3 0.7 3.7 2.0 1.3 0.0 12.4 7.9 0.1 0.2 67.3 54.1 0.2 0.0 0.6 1.1 0.2 1.8 0.4 1.8 16.9 0.1 10.2 0.0 17.1 9.6 2.5 1.1 6.8 0.1 2.0 0.0 1.5 9.3 21.3 0.0 4.1 13.8 0.9 12.7 0.8 1.4 0.3 1.1 2.2 0.0 0.6 SLCO2A1 "MATR1, OATP2A1, PGT, SLC21A2" ENSG00000174640 "Solute carrier organic anion transporter family member 2A1" Q92959 3 133932701-134052184 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 123.7" "Group enriched" "Detected in many" 4 "Distal enterocytes: 47.1;Endothelial cells: 65.2;Hepatic stellate cells: 146.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "EFO-21: 90.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA013742 Enhanced NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA013742: AB_2668877" "unprognostic (4.39e-3)" "unprognostic (2.84e-1)" "unprognostic (1.33e-1)" "prognostic favorable (9.69e-4)" "unprognostic (8.53e-2)" "unprognostic (2.32e-3)" "prognostic favorable (9.24e-5)" "unprognostic (1.92e-1)" "unprognostic (1.29e-1)" "unprognostic (7.60e-2)" "unprognostic (2.04e-2)" "unprognostic (6.87e-2)" "unprognostic (5.63e-3)" "prognostic unfavorable (3.25e-4)" "unprognostic (2.78e-1)" "unprognostic (1.45e-1)" "unprognostic (3.07e-2)" 30.4 42.5 1.6 16.8 1.6 0.0 18.1 1.3 2.7 30.9 9.1 24.7 10.2 46.3 6.1 18.8 28.3 18.8 26.4 1.5 1.6 52.8 2.4 123.7 9.2 2.0 1.6 5.2 20.8 28.7 15.8 23.4 2.2 36.5 18.0 0.0 20.8 84.7 2.1 13.5 29.3 33.5 1.9 24.2 23.6 1.3 2.3 8.4 89.3 3.4 9.6 21.3 20.3 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.5 4.3 0.5 0.0 0.1 0.1 0.0 90.6 0.9 0.0 11.2 0.1 0.0 0.1 0.1 0.1 0.0 5.8 0.0 2.4 0.0 0.0 3.4 0.2 0.0 0.2 0.0 1.5 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.6 6.0 0.0 0.0 0.0 0.0 8.7 0.0 0.1 0.0 4.6 1.5 0.0 3.7 0.1 0.0 22.1 0.0 4.5 0.1 0.4 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 1.6 1.3 2.7 1.5 1.6 2.0 1.6 2.2 1.9 2.3 1.7 19.8 0.0 2.5 0.0 2.1 5.1 9.1 0.5 8.6 0.0 0.8 3.9 4.6 1.5 1.6 3.7 0.0 1.5 0.0 47.1 0.0 2.8 1.0 0.9 0.2 65.2 1.2 0.0 8.1 3.3 4.0 8.7 18.8 1.6 1.3 0.1 146.7 0.6 0.2 0.0 1.7 4.1 0.0 2.2 0.4 0.8 0.3 0.7 0.0 2.8 0.0 0.0 0.0 0.0 0.1 14.0 15.8 0.0 0.0 1.5 3.2 2.1 0.8 0.0 0.0 0.4 1.1 0.4 0.2 2.0 1.7 0.8 1.1 0.1 0.6 2.2 RYK "D3S3195, JTK5, JTK5A, RYK1" ENSG00000163785 "Receptor like tyrosine kinase" P34925 3 134065303-134250859 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Wnt signaling pathway" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 121.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034117, HPA045503, HPA075430" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" Cytosol "CAB034117: AB_2183048, HPA045503: AB_2679353, HPA075430: AB_2732293" "unprognostic (7.84e-2)" "unprognostic (5.82e-2)" "unprognostic (2.22e-2)" "unprognostic (2.34e-2)" "unprognostic (2.21e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.60e-4)" "unprognostic (2.60e-2)" "unprognostic (6.59e-2)" "unprognostic (1.62e-1)" "unprognostic (1.07e-3)" "unprognostic (9.66e-2)" "unprognostic (2.42e-2)" "unprognostic (5.54e-2)" "unprognostic (3.13e-1)" "unprognostic (3.43e-1)" "unprognostic (2.85e-2)" 31.8 25.2 15.7 15.7 16.2 17.1 42.8 15.4 19.8 40.2 19.9 34.5 20.1 46.1 40.0 29.6 33.4 24.3 30.3 14.5 15.3 25.4 22.3 25.3 18.9 15.9 15.6 82.1 24.5 29.7 17.0 36.6 15.5 36.3 26.2 15.9 26.9 43.9 25.3 34.7 21.4 40.6 16.3 22.9 23.2 47.0 16.5 21.2 40.9 32.2 20.5 34.7 32.6 16.4 78.8 20.6 63.3 48.7 79.8 84.4 48.8 51.0 117.7 66.4 74.2 65.6 58.8 15.3 82.4 63.1 63.7 71.6 45.5 64.3 94.5 25.9 20.5 40.6 22.4 42.4 62.2 20.0 34.4 56.1 74.0 41.2 82.2 72.5 56.5 26.4 14.5 7.5 66.0 37.6 28.0 25.9 53.4 65.2 24.3 13.7 48.4 32.4 54.5 57.3 31.0 45.6 61.7 44.5 79.1 40.5 55.7 35.8 42.1 54.8 49.6 57.8 41.8 3.1 4.2 8.3 34.8 33.1 39.6 4.6 0.8 1.6 1.1 0.8 1.3 0.6 2.0 1.3 0.3 1.2 1.9 1.5 0.3 1.6 0.8 0.0 0.5 0.5 15.7 16.2 15.4 19.8 14.5 15.3 15.9 15.6 15.5 16.3 16.5 16.4 62.5 12.8 27.9 31.6 20.6 41.3 36.6 26.3 39.3 23.1 45.4 37.2 34.9 18.6 23.7 44.1 29.2 19.4 23.1 15.9 0.0 15.9 16.2 27.6 41.7 31.0 13.9 13.2 69.5 21.1 14.7 41.3 15.8 32.7 17.7 121.2 40.7 24.1 11.3 13.5 59.7 20.9 12.2 18.6 21.6 7.4 33.2 16.1 14.2 65.6 12.8 26.8 13.4 65.9 57.9 21.7 19.7 32.7 12.9 42.8 15.4 10.5 13.9 39.8 46.0 33.8 38.1 24.6 40.9 33.7 38.1 10.8 18.4 50.8 22.2 38.9 AMOTL2 LCCP ENSG00000114019 "Angiomotin like 2" Q9Y2J4 3 134355347-134375479 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 89.2;Suprabasal keratinocytes: 130.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 259.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063027 Approved "Cell Junctions" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 28: BEWO - Transcription regulation" "Cluster 44: Endometrium - Transcription" "Cell Junctions" "HPA063027: AB_2684924" "unprognostic (2.23e-1)" "unprognostic (2.55e-2)" "unprognostic (7.01e-3)" "prognostic unfavorable (1.94e-4)" "unprognostic (6.09e-2)" "unprognostic (1.57e-2)" "unprognostic (9.84e-2)" "unprognostic (4.40e-2)" "unprognostic (2.32e-1)" "unprognostic (3.02e-1)" "unprognostic (2.85e-2)" "unprognostic (1.49e-1)" "unprognostic (8.09e-2)" "unprognostic (3.59e-1)" "unprognostic (7.67e-2)" "unprognostic (3.85e-1)" "unprognostic (1.17e-2)" 80.0 11.1 24.1 7.1 42.5 0.2 55.9 26.0 32.7 34.4 32.0 28.3 7.7 44.3 9.1 37.1 37.5 22.8 25.9 17.5 22.9 25.6 17.2 33.4 11.9 40.8 35.0 21.5 27.2 9.6 5.7 33.6 33.6 24.6 5.5 5.4 25.1 15.8 16.8 39.7 15.8 16.7 21.6 20.5 23.1 4.2 36.3 4.3 29.5 15.9 7.2 29.1 33.3 70.2 99.1 43.1 29.6 30.9 30.3 37.3 259.9 97.5 54.8 87.6 43.0 132.5 30.3 0.0 119.9 69.4 50.0 72.2 19.4 26.3 39.9 0.2 2.2 0.2 22.7 14.4 56.8 0.2 0.2 53.7 79.5 34.5 39.7 35.1 42.3 0.9 0.7 0.2 59.2 31.7 0.3 0.3 37.9 21.4 16.3 0.2 37.4 0.3 56.4 22.7 4.5 11.7 73.8 94.3 68.8 66.8 88.2 0.8 72.4 59.5 53.2 41.7 59.7 0.1 0.3 0.4 22.1 0.1 68.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 42.5 26.0 32.7 17.5 22.9 40.8 35.0 33.6 21.6 36.3 70.2 24.0 60.9 17.3 2.6 0.2 72.9 18.4 15.4 30.1 10.4 29.2 21.5 15.6 52.9 16.4 18.4 18.8 30.4 1.1 6.5 17.6 27.5 4.0 59.7 29.1 30.1 12.5 0.0 4.5 13.1 29.9 30.3 20.4 89.2 1.3 34.1 51.8 25.8 3.0 1.7 5.8 3.6 6.1 1.6 7.8 10.9 35.8 1.7 14.2 9.4 0.0 12.1 0.0 18.6 56.9 52.8 4.2 19.9 0.0 30.0 10.6 19.3 16.2 5.1 13.1 12.1 46.1 0.2 0.6 25.3 130.1 24.8 2.6 8.7 4.5 37.3 ANAPC13 "APC13, DKFZP566D193, SWM1" ENSG00000129055 "Anaphase promoting complex subunit 13" Q9BS18 3 134477706-134486716 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 463.7;Proximal tubular cells: 373.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046114 Uncertain Approved Mitochondria,Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 7: Kidney - Transmembrane transport" "Cluster 18: U-2197 - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Mitochondria, Cytosol" "HPA046114: AB_10961429" "unprognostic (2.84e-2)" "prognostic favorable (1.66e-4)" "unprognostic (2.98e-1)" "unprognostic (7.67e-2)" "unprognostic (1.65e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (1.67e-4)" "unprognostic (3.57e-1)" "unprognostic (2.90e-1)" "unprognostic (2.28e-3)" "unprognostic (6.44e-2)" "unprognostic (4.36e-1)" "prognostic favorable (2.66e-7)" "unprognostic (3.10e-1)" "unprognostic (9.90e-2)" "unprognostic (2.39e-1)" "unprognostic (1.16e-1)" 56.7 73.3 54.1 29.0 56.1 30.0 65.9 58.0 68.6 49.1 74.4 44.6 35.2 46.8 114.4 35.1 48.2 48.0 98.5 56.8 63.4 121.2 86.8 45.4 38.8 60.3 58.6 52.2 50.1 77.2 63.7 51.1 62.3 60.0 45.8 62.6 53.7 54.4 87.1 38.1 33.8 48.1 58.0 40.1 54.3 29.3 57.2 35.7 95.6 67.9 36.6 51.3 33.3 58.3 91.9 56.2 87.4 74.9 144.7 191.6 67.5 116.0 106.4 83.4 77.9 70.6 52.9 61.9 244.8 172.2 100.1 53.0 82.6 83.6 119.9 31.7 37.7 63.3 43.2 119.3 104.6 104.2 43.5 127.7 90.3 83.5 155.1 93.4 130.9 59.3 85.9 51.2 266.9 117.3 53.5 103.1 59.8 157.7 54.5 42.6 68.5 113.7 165.3 56.0 35.4 58.0 103.2 37.8 107.4 92.8 94.2 101.6 91.9 115.2 47.0 164.1 52.2 56.2 65.6 127.3 71.4 57.4 100.9 112.9 96.6 86.5 52.7 108.2 69.7 86.1 78.7 69.9 91.8 68.9 94.2 80.7 236.4 67.6 111.4 70.1 72.9 84.8 54.1 56.1 58.0 68.6 56.8 63.4 60.3 58.6 62.3 58.0 57.2 58.3 46.6 35.3 47.0 3.6 41.7 42.1 47.6 72.2 47.8 41.0 60.8 49.9 112.8 67.2 41.7 84.6 12.5 95.8 26.8 22.1 463.7 51.5 42.5 38.1 39.5 51.8 40.8 26.3 7.0 53.8 96.6 57.2 38.2 28.9 18.9 34.5 53.6 64.5 78.7 20.2 8.3 40.6 77.3 71.3 48.8 104.6 50.7 43.8 97.8 6.5 33.4 85.0 42.2 4.0 6.3 39.5 42.6 44.0 46.0 74.7 54.6 373.4 49.3 38.3 19.7 26.6 58.5 46.2 64.2 44.3 50.6 70.3 35.4 59.5 35.4 52.9 CEP63 FLJ13386 ENSG00000182923 "Centrosomal protein 63" Q96MT8 3 134485721-134575017 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Mitosis" "Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 139.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 179.4" "Lineage enriched" "Detected in all" 6 "granulocytes: 179.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058154, HPA058313" Approved Approved Nucleoplasm NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 23: Testis - Cell cycle regulation" "Cluster 25: RPMI-8226 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA058154: AB_2683624, HPA058313: " "unprognostic (1.80e-1)" "unprognostic (1.03e-2)" "unprognostic (2.13e-1)" "unprognostic (1.38e-2)" "unprognostic (1.12e-1)" "unprognostic (2.08e-1)" "unprognostic (1.60e-2)" "unprognostic (2.23e-2)" "unprognostic (2.71e-2)" "unprognostic (1.32e-1)" "unprognostic (1.71e-1)" "unprognostic (3.08e-2)" "unprognostic (5.24e-2)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (1.66e-1)" "unprognostic (1.33e-1)" 23.9 15.2 7.4 14.0 9.8 30.2 16.1 10.0 13.7 13.1 6.8 16.4 10.0 12.9 16.9 12.4 12.2 11.3 25.1 7.5 10.9 16.4 21.9 11.8 18.5 9.4 9.1 16.2 17.0 18.8 12.7 14.4 9.7 14.5 14.3 22.0 16.0 15.9 41.5 14.8 11.2 16.4 7.7 16.2 14.7 45.2 9.3 27.5 18.9 29.0 17.4 15.7 12.5 11.7 32.9 12.6 26.2 17.5 36.9 30.7 24.6 35.1 29.1 26.7 21.9 11.8 13.7 36.5 21.0 24.4 26.0 18.6 14.5 18.0 32.3 41.7 7.4 47.9 15.0 16.1 25.3 30.5 22.0 26.4 23.3 14.8 47.1 28.8 27.9 48.2 14.7 31.3 32.4 20.1 37.7 34.5 18.4 20.1 16.9 23.5 38.7 52.8 23.7 20.3 14.8 14.6 31.2 12.1 47.3 30.2 24.7 38.1 30.1 30.1 18.4 30.3 26.9 27.1 21.9 46.7 33.4 30.8 39.2 72.7 20.1 34.3 12.7 20.6 16.9 15.9 12.2 16.5 24.6 22.2 17.2 13.1 179.4 20.3 29.5 16.3 16.8 12.7 7.4 9.8 10.0 13.7 7.5 10.9 9.4 9.1 9.7 7.7 9.3 11.7 19.9 19.2 27.6 39.2 25.5 10.7 14.6 22.6 13.6 31.6 16.8 22.5 84.7 22.8 23.1 7.3 20.9 25.3 16.5 11.8 31.3 25.8 93.2 21.8 23.6 21.0 13.1 26.5 63.5 20.0 26.0 25.8 14.8 17.9 52.6 25.2 14.6 17.3 29.4 32.0 58.3 16.0 16.2 27.7 12.8 54.9 23.9 25.1 17.8 28.1 30.2 26.3 19.6 71.4 67.8 21.0 16.2 25.9 27.3 19.2 12.5 29.6 31.1 43.8 19.7 31.7 25.1 139.1 51.7 17.3 9.8 17.4 20.6 18.8 16.2 16.2 EPHB1 "EPHT2, Hek6" ENSG00000154928 "EPH receptor B1" P54762 3 134597801-135260467 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6" "Cell type enhanced" "Detected in many" "Astrocytes: 198.8;dendritic cells: 53.7;Early spermatids: 42.2;Excitatory neurons: 47.9;Inhibitory neurons: 44.3;Late spermatids: 41.2;Oligodendrocyte precursor cells: 77.9" "Cancer enriched" "Detected in many" 6 "glioma: 7.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 33 "neutrophil: 24.0;plasmacytoid DC: 23.3" "Group enriched" "Detected in many" 33 "dendritic cells: 23.3;granulocytes: 24.0" "Group enriched" "Detected in some" 5 "HDLM-2: 63.9;HMC-1: 35.5;RPTEC TERT1: 16.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067740 Enhanced Approved "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 44: HDLM-2 - Immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "Endoplasmic reticulum, Plasma membrane, Cytosol" "HPA067740: AB_2685895" "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.52e-1)" "unprognostic (1.41e-6)" "unprognostic (6.52e-2)" "unprognostic (1.31e-1)" "unprognostic (1.07e-1)" "unprognostic (8.15e-2)" "unprognostic (9.88e-2)" "unprognostic (1.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-2)" "unprognostic (1.78e-1)" "unprognostic (1.37e-3)" "unprognostic (4.88e-4)" 1.0 0.6 4.7 0.8 18.7 0.7 3.2 40.6 12.8 1.8 0.0 3.2 1.4 2.2 0.9 1.9 1.3 1.7 0.3 7.0 5.1 1.3 1.6 0.3 1.9 5.0 14.4 0.7 0.3 0.2 1.0 0.2 5.5 1.7 0.5 4.2 2.2 2.7 4.9 4.8 0.7 0.7 0.9 1.9 0.6 10.8 12.0 0.7 7.0 10.3 1.7 1.5 1.0 4.2 0.0 0.0 8.4 0.1 0.2 0.0 0.0 6.6 0.1 0.3 0.1 0.1 0.0 1.1 1.6 3.4 0.6 0.1 5.5 0.0 1.2 63.9 0.8 4.8 0.0 0.0 0.0 0.0 35.5 0.1 0.0 0.1 0.0 0.3 0.2 0.5 0.0 0.3 4.7 0.2 0.0 0.3 2.4 1.2 0.1 0.0 0.9 0.2 16.5 0.0 1.1 0.2 0.0 0.1 0.0 1.1 0.1 0.7 0.5 1.1 3.4 0.7 7.9 0.1 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 23.3 0.0 0.2 4.7 18.7 40.6 12.8 7.0 5.1 5.0 14.4 5.5 0.9 12.0 4.2 1.9 0.0 0.0 198.8 1.0 3.7 0.0 0.0 0.0 1.9 0.8 12.3 1.6 0.0 0.0 0.0 10.4 0.0 53.7 0.0 0.0 0.8 42.2 0.1 0.5 2.8 0.0 0.0 47.9 0.4 0.1 0.4 0.0 0.1 0.0 3.3 0.4 7.0 0.4 0.0 44.3 0.0 0.0 0.0 0.8 41.2 0.6 0.8 1.8 8.4 0.1 16.9 0.0 77.9 5.6 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.5 0.0 3.3 0.8 0.5 1.6 0.0 5.8 0.0 0.2 3.0 0.3 0.2 KY FLJ33207 ENSG00000174611 "Kyphoscoliosis peptidase" Q8NBH2 3 134599923-134651636 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease" "Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 16.3;skin 1: 9.6;tongue: 27.7" "Cell type enhanced" "Detected in some" "Astrocytes: 15.0;Excitatory neurons: 10.0;Inhibitory neurons: 11.6;Late spermatids: 6.4;Oligodendrocyte precursor cells: 24.6" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 5 "basophil: 5.7" "Lineage enriched" "Detected in single" 58 "granulocytes: 5.7" "Cell line enhanced" "Detected in some" "Karpas-707: 2.0;NB-4: 1.1;U-2197: 2.7;U-87 MG: 8.1" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 9.2" "HPA036492, HPA036668" Uncertain Approved Nucleoplasm NA NA "Cluster 38: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "HPA036492: AB_10672222, HPA036668: AB_2675239" "unprognostic (1.40e-2)" "unprognostic (2.05e-2)" "unprognostic (4.24e-2)" "unprognostic (2.81e-2)" "unprognostic (2.72e-2)" "unprognostic (1.65e-2)" "unprognostic (2.42e-2)" "unprognostic (2.42e-1)" "unprognostic (1.27e-1)" "unprognostic (3.86e-2)" "unprognostic (9.87e-2)" "unprognostic (2.83e-2)" "unprognostic (3.82e-1)" "unprognostic (4.62e-2)" "unprognostic (2.29e-1)" "unprognostic (8.98e-2)" "unprognostic (1.47e-1)" 0.0 2.7 1.7 0.2 1.8 0.3 0.8 1.6 2.9 0.8 0.1 0.9 0.4 1.9 0.8 2.0 1.9 0.4 3.1 1.6 1.7 0.3 0.0 0.1 0.0 1.9 2.3 0.9 0.0 2.2 3.3 0.0 2.1 2.2 0.2 1.7 0.8 1.7 16.3 9.6 0.2 4.2 1.5 0.1 0.7 0.3 2.0 0.9 3.0 27.7 0.0 0.6 0.6 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 8.1 0.7 0.0 5.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 1.7 1.8 1.6 2.9 1.6 1.7 1.9 2.3 2.1 1.5 2.0 1.9 0.0 0.0 0.0 15.0 0.0 0.6 0.1 0.0 0.0 0.4 0.1 0.8 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.0 10.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 1.0 0.0 2.5 0.0 24.6 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 PPP2R3A "PPP2R3, PR130, PR72" ENSG00000073711 "Protein phosphatase 2 regulatory subunit B''alpha" Q06190 3 135965728-136147894 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 51.2;skeletal muscle: 180.5;tongue: 117.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 115.3;Oligodendrocytes: 201.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 37.4;BJ hTERT+: 35.3;RPTEC TERT1: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035829, HPA035830, HPA065338" Uncertain Approved "Golgi apparatus" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus" "HPA035829: AB_10696513, HPA035830: AB_10670121, HPA065338: AB_2685475" "unprognostic (3.35e-1)" "unprognostic (2.37e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.71e-1)" "unprognostic (4.04e-1)" "unprognostic (1.44e-4)" "unprognostic (9.43e-2)" "unprognostic (1.27e-1)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.14e-5)" "unprognostic (8.92e-2)" "prognostic favorable (1.15e-5)" "unprognostic (4.55e-2)" "unprognostic (3.06e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (3.91e-4)" 3.1 3.4 3.3 2.3 7.2 0.2 7.1 4.3 5.0 5.2 3.9 8.0 2.0 7.7 5.1 8.3 4.1 5.0 51.2 4.2 4.9 22.0 1.1 3.9 0.6 5.7 5.5 5.6 3.4 11.7 1.8 2.8 5.3 5.9 5.4 2.6 8.9 6.5 180.5 18.9 2.3 9.6 4.3 1.1 7.4 7.2 6.0 0.6 3.1 117.6 1.2 4.5 4.0 13.7 37.4 2.0 10.3 5.0 8.1 10.2 11.9 28.5 35.3 13.2 16.3 2.4 2.4 0.1 10.7 29.3 9.5 4.7 4.3 10.0 28.3 0.1 1.4 1.6 1.0 0.1 5.8 0.0 1.4 9.3 8.5 16.8 7.8 13.3 12.8 1.0 1.0 0.1 19.2 6.2 0.3 0.2 7.2 0.4 6.9 0.1 15.1 0.1 46.2 1.4 0.7 5.7 4.7 5.7 10.9 9.2 9.1 0.5 8.4 13.7 7.5 18.8 12.7 0.4 1.0 0.1 10.1 0.8 4.9 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.0 3.3 7.2 4.3 5.0 4.2 4.9 5.7 5.5 5.3 4.3 6.0 13.7 7.9 28.9 27.6 51.6 2.8 26.4 19.5 7.1 19.4 5.7 19.9 15.5 115.3 8.6 10.0 55.2 0.0 10.9 6.7 25.3 21.5 20.6 8.4 9.9 19.0 11.4 13.1 0.4 35.2 9.9 15.4 14.8 21.9 16.1 3.8 15.7 8.6 2.9 2.5 3.3 47.2 6.9 6.1 2.4 9.8 10.7 24.5 3.2 28.4 13.1 9.6 8.9 2.1 72.4 201.1 17.2 10.6 18.4 1.5 17.8 21.7 40.1 8.1 2.6 6.6 29.0 14.0 10.1 18.6 15.3 33.2 10.4 3.4 6.7 8.9 15.6 MSL2 "FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184" ENSG00000174579 "MSL complex subunit 2" Q9HCI7 3 136148917-136197241 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003413 Uncertain Approved Nucleoplasm,Cytosol NA No "Cluster 32: T-cells - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Cytosol" "HPA003413: AB_1848659" "unprognostic (9.86e-2)" "prognostic favorable (4.80e-4)" "unprognostic (1.30e-1)" "unprognostic (2.32e-1)" "unprognostic (4.41e-2)" "unprognostic (8.11e-3)" "unprognostic (1.37e-2)" "unprognostic (4.62e-2)" "unprognostic (7.01e-2)" "unprognostic (1.36e-1)" "unprognostic (1.71e-1)" "unprognostic (2.54e-2)" "unprognostic (2.23e-1)" "unprognostic (5.79e-3)" "unprognostic (4.54e-2)" "unprognostic (3.52e-2)" "unprognostic (1.76e-3)" 11.9 9.4 6.0 21.3 8.7 57.9 13.8 18.8 8.6 14.7 5.0 12.9 13.3 15.2 9.2 12.7 15.5 12.8 9.5 6.3 7.3 11.3 14.1 14.5 33.1 6.5 7.2 20.9 11.5 15.3 8.0 13.1 9.2 12.0 12.7 14.8 13.0 11.5 12.6 11.4 14.8 12.1 6.0 25.8 14.7 17.4 7.2 60.3 17.0 17.2 31.7 13.3 10.1 12.1 26.5 7.5 20.8 23.2 14.4 15.6 33.1 16.1 16.0 14.9 14.9 19.4 15.0 52.1 21.2 14.3 17.0 20.4 24.6 16.2 23.5 25.3 11.9 59.6 19.8 11.0 14.8 51.7 26.1 12.6 17.7 11.7 34.0 14.2 15.1 48.1 22.0 47.7 12.5 15.8 93.8 26.7 25.3 14.7 13.1 40.5 33.5 35.3 7.1 21.2 25.2 16.8 37.7 16.1 26.5 16.2 14.7 28.5 20.6 19.0 15.0 17.4 15.1 47.5 28.0 78.7 15.9 20.2 13.2 5.1 2.5 4.1 5.1 2.9 6.2 3.1 4.7 6.0 2.7 5.4 9.6 6.4 5.9 5.1 2.2 1.5 3.9 4.2 6.0 8.7 18.8 8.6 6.3 7.3 6.5 7.2 9.2 6.0 7.2 12.1 15.0 19.2 11.2 18.9 30.4 28.0 15.6 5.6 23.3 12.9 15.8 9.5 15.2 8.6 7.0 12.9 4.2 8.9 47.1 9.3 3.9 5.1 4.1 9.6 15.3 13.9 18.0 23.1 28.0 5.6 6.3 14.7 9.2 12.9 7.0 12.6 16.8 23.4 8.5 16.8 31.6 14.1 2.0 24.2 25.4 3.7 9.3 18.9 21.4 37.5 21.4 8.0 30.9 39.2 55.1 6.4 5.6 8.6 27.8 14.5 7.7 7.4 5.7 9.7 6.6 18.6 12.3 16.0 12.5 22.8 26.7 4.8 36.2 8.5 12.2 14.0 PCCB ENSG00000114054 "Propionyl-CoA carboxylase subunit beta" P05166 3 136250340-136337896 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 202.1" "Cell type enhanced" "Detected in all" "Early spermatids: 316.7;Late spermatids: 159.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036939, HPA036940" Enhanced "Intracellular and membrane" NA NA 120000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 29: Early spermatids - Spermatogenesis" "HPA036939: AB_10671366, HPA036940: AB_10669779" "unprognostic (2.74e-1)" "unprognostic (7.88e-3)" "unprognostic (3.99e-2)" "unprognostic (2.89e-2)" "unprognostic (2.75e-2)" "unprognostic (1.11e-1)" "unprognostic (1.05e-2)" "unprognostic (1.50e-1)" "unprognostic (2.31e-2)" "unprognostic (2.47e-2)" "unprognostic (1.74e-1)" "unprognostic (1.05e-1)" "prognostic favorable (6.47e-7)" "unprognostic (2.43e-2)" "unprognostic (2.64e-1)" "unprognostic (3.50e-1)" "unprognostic (4.13e-1)" 34.4 75.1 23.3 15.2 33.6 37.9 27.5 31.4 29.3 17.5 35.5 43.6 38.1 13.8 13.9 26.3 19.2 17.0 94.6 23.6 28.5 88.9 202.1 14.8 16.2 31.1 29.4 12.1 32.0 57.0 15.6 19.6 30.4 23.7 41.9 17.2 23.6 21.7 83.8 15.1 27.5 22.6 27.1 12.7 26.1 38.8 29.8 21.1 37.9 91.4 20.7 20.5 11.4 47.8 64.8 45.8 42.4 64.4 30.2 34.5 75.4 33.0 35.5 49.1 69.6 67.9 44.7 80.3 89.4 46.6 44.0 35.1 50.3 44.0 69.4 47.8 43.0 140.8 49.5 101.4 66.4 107.3 60.2 40.8 41.4 31.0 69.4 30.5 56.1 131.6 104.5 41.0 38.0 123.1 109.3 63.1 36.0 96.8 40.9 29.3 34.6 116.6 89.9 69.4 84.0 62.9 84.4 48.9 77.5 35.2 98.3 62.9 42.0 24.5 26.0 69.2 29.6 78.3 70.0 66.9 34.9 41.7 29.9 7.3 29.5 7.5 22.6 30.8 25.4 21.7 14.7 23.2 44.6 19.8 15.1 18.7 2.7 25.9 28.7 38.5 14.8 22.6 23.3 33.6 31.4 29.3 23.6 28.5 31.1 29.4 30.4 27.1 29.8 47.8 5.6 9.6 14.0 16.0 9.2 4.1 9.4 37.9 3.4 16.0 12.5 5.3 51.1 8.6 28.4 20.2 10.4 57.1 8.0 15.1 39.2 24.6 316.7 14.1 9.5 8.1 9.1 53.2 16.5 14.0 27.1 13.6 14.8 14.1 29.2 18.1 9.3 76.3 35.1 11.8 22.7 15.1 24.4 11.7 5.2 159.0 13.7 11.4 19.6 16.9 16.5 11.8 10.3 22.1 50.9 14.4 16.7 10.9 22.6 10.4 19.2 97.3 23.6 13.2 13.1 13.6 13.1 11.3 29.0 16.2 3.3 50.9 9.9 52.8 25.1 12.2 STAG1 "SA-1, SA1, SCC3A" ENSG00000118007 "Stromal antigen 1" Q8WVM7 3 136336236-136752403 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 166.8;Microglial cells: 231.4;Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 188.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035015, HPA058653" Supported Enhanced "Nucleoplasm,Nuclear bodies" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Nuclear bodies" "HPA035015: AB_10603117, HPA058653: AB_2683787" "unprognostic (1.82e-1)" "unprognostic (1.11e-2)" "unprognostic (1.41e-1)" "unprognostic (5.37e-2)" "unprognostic (4.05e-2)" "unprognostic (1.92e-1)" "unprognostic (4.62e-2)" "unprognostic (5.26e-2)" "unprognostic (1.74e-1)" "unprognostic (7.22e-3)" "unprognostic (1.29e-2)" "unprognostic (1.71e-1)" "unprognostic (5.81e-2)" "unprognostic (2.70e-1)" "unprognostic (1.58e-1)" "unprognostic (5.97e-2)" "unprognostic (2.83e-2)" 13.7 9.1 7.6 12.3 8.8 15.7 15.6 17.0 8.3 16.9 9.9 13.5 9.6 19.3 10.6 10.8 13.5 10.3 10.5 6.5 8.7 12.0 10.8 11.2 14.7 9.3 7.8 21.9 12.4 13.7 5.0 17.6 9.0 10.8 14.4 13.2 11.6 12.1 15.0 13.7 11.0 16.1 8.8 11.8 10.0 8.9 7.8 22.5 15.8 15.8 15.9 12.0 11.5 11.2 34.6 17.6 29.1 25.1 21.5 36.8 15.7 37.9 48.4 35.0 33.0 30.2 14.9 26.9 23.3 39.7 28.1 23.4 31.6 17.3 47.4 33.2 14.9 28.8 25.1 16.7 16.3 50.6 27.7 23.4 19.3 25.6 28.6 20.3 27.5 28.8 18.7 52.7 22.3 29.5 33.6 16.4 19.0 23.7 13.9 29.6 31.6 35.7 19.1 24.5 14.2 22.8 40.8 16.0 17.5 15.0 22.9 21.2 23.3 40.1 29.0 36.0 33.9 39.1 28.9 59.5 24.6 17.0 26.2 4.0 3.0 4.6 4.4 3.0 4.6 6.4 3.7 4.0 2.8 4.4 4.1 3.3 8.7 5.5 3.5 4.5 4.8 2.1 7.6 8.8 17.0 8.3 6.5 8.7 9.3 7.8 9.0 8.8 7.8 11.2 44.5 25.6 24.2 95.6 42.4 40.0 31.4 18.7 38.7 43.8 24.8 26.7 10.8 22.8 23.5 16.5 39.6 29.3 39.5 42.1 11.7 20.7 2.8 23.7 59.5 34.1 18.7 29.7 161.8 22.2 26.7 33.8 23.9 39.6 22.2 30.3 31.4 21.5 18.6 28.6 166.8 27.9 8.2 16.9 22.0 4.8 49.4 25.1 16.0 231.4 27.2 25.6 42.2 223.2 188.4 27.4 17.5 32.4 53.1 27.2 24.2 13.2 14.5 68.1 26.3 67.1 36.2 54.8 50.5 27.5 36.7 31.7 39.2 16.0 23.4 24.3 SLC35G2 "DKFZp564K2464, MGC3295, TMEM22" ENSG00000168917 "Solute carrier family 35 member G2" Q8TBE7 3 136818647-136855888 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 54.2;Early spermatids: 65.4;Inhibitory neurons: 42.4;Spermatocytes: 35.5" "Cancer enhanced" "Detected in many" "glioma: 6.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 73.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052054, HPA064728" Approved Supported "Plasma membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" "HPA052054: AB_2681709, HPA064728: AB_2685336" "unprognostic (1.04e-1)" "unprognostic (1.46e-2)" "unprognostic (6.91e-4)" "unprognostic (2.56e-4)" "unprognostic (5.34e-2)" "unprognostic (6.73e-2)" "unprognostic (1.16e-5)" "unprognostic (1.83e-3)" "unprognostic (1.12e-1)" "unprognostic (6.39e-2)" "unprognostic (1.49e-2)" "unprognostic (3.32e-1)" "prognostic unfavorable (1.16e-7)" "unprognostic (1.00e-2)" "unprognostic (1.69e-1)" "unprognostic (1.07e-2)" "unprognostic (2.30e-2)" 14.9 15.4 20.9 2.1 21.2 0.5 11.1 23.1 26.4 5.1 16.5 3.8 1.0 4.3 4.6 2.6 5.7 5.3 8.1 20.0 24.4 3.9 4.4 7.0 1.9 21.4 25.0 5.5 7.6 6.7 19.3 7.4 26.9 4.1 2.0 5.3 3.1 2.6 2.4 3.7 2.9 5.1 22.1 3.2 2.9 14.4 22.6 2.8 8.5 5.4 1.2 6.5 5.0 21.0 3.9 10.7 10.6 4.8 20.8 17.1 0.0 16.9 73.1 24.7 37.0 10.1 5.7 0.0 12.7 17.5 39.3 1.3 12.7 0.7 22.8 0.1 3.5 3.2 12.0 6.3 26.6 0.1 0.0 24.2 1.8 21.5 5.9 18.0 18.8 6.8 1.8 0.1 32.1 0.0 4.7 3.3 2.3 0.0 7.9 4.2 7.1 0.2 21.1 0.9 17.5 11.7 13.7 0.0 24.0 3.6 0.0 1.8 13.1 18.4 4.7 8.2 18.6 0.0 0.0 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 20.9 21.2 23.1 26.4 20.0 24.4 21.4 25.0 26.9 22.1 22.6 21.0 22.4 12.8 7.0 54.2 2.5 3.3 4.9 12.0 7.4 4.7 0.7 0.8 2.5 1.5 7.1 1.8 12.5 1.3 2.7 0.8 1.9 3.3 65.4 1.0 1.6 30.6 4.2 4.4 34.0 10.7 1.3 12.4 0.5 1.3 2.5 3.6 27.8 2.3 0.7 6.7 42.4 1.0 0.0 2.2 7.3 30.3 9.9 2.1 3.6 17.8 3.7 7.8 15.5 15.6 6.1 10.0 0.1 3.0 3.7 4.7 0.6 0.7 1.4 4.6 6.6 4.7 4.8 35.5 16.1 1.2 3.0 2.2 3.8 3.1 0.6 2.0 NCK1 "NCK, NCKalpha" ENSG00000158092 "NCK adaptor protein 1" P16333 3 136862208-136951606 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 225.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005063, HPA030766" Supported Approved "Plasma membrane,Cytosol" NA NA 17000 "Cluster 38: Basophils - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane, Cytosol" "CAB005063: AB_562169, HPA030766: AB_2673602" "unprognostic (7.47e-2)" "unprognostic (2.07e-1)" "unprognostic (3.98e-2)" "unprognostic (3.03e-2)" "unprognostic (1.06e-2)" "unprognostic (8.77e-3)" "unprognostic (4.24e-3)" "unprognostic (8.30e-2)" "unprognostic (9.31e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.14e-5)" "unprognostic (5.96e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.64e-1)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (4.17e-2)" 34.4 17.9 12.8 26.2 13.0 32.0 28.6 17.0 15.3 27.3 20.4 27.7 15.3 23.7 17.0 38.7 20.4 20.1 20.2 12.9 14.6 16.1 30.9 27.0 41.8 14.2 14.3 23.3 17.2 24.2 13.7 30.7 14.2 21.4 27.8 18.4 24.6 19.2 27.5 30.2 15.8 23.6 12.8 28.8 18.4 19.6 13.9 52.9 26.9 29.1 44.5 29.3 36.2 15.8 50.1 22.0 28.4 23.4 65.3 62.7 31.5 36.6 65.3 41.8 43.4 32.3 49.9 49.0 74.9 43.0 54.5 37.9 40.3 37.1 54.3 35.7 16.3 43.0 31.1 25.4 106.0 31.3 28.2 57.4 47.3 40.8 80.0 41.9 64.4 46.1 26.3 42.7 44.2 28.2 71.8 25.3 26.8 45.6 27.6 37.6 26.4 47.6 38.9 34.4 19.8 19.2 66.5 28.1 62.2 34.2 42.0 33.8 32.5 27.1 17.1 38.8 21.3 42.2 36.6 62.5 27.8 27.6 29.3 61.1 22.3 24.7 32.8 50.5 33.6 13.9 25.7 33.7 24.4 14.2 20.8 24.5 12.8 21.6 26.4 9.4 27.6 23.6 12.8 13.0 17.0 15.3 12.9 14.6 14.2 14.3 14.2 12.8 13.9 15.8 58.6 9.6 15.9 25.5 41.6 74.8 77.1 225.1 79.6 20.1 23.7 19.9 11.1 27.1 144.3 9.2 6.2 45.4 54.0 29.6 15.6 50.4 11.6 27.9 31.9 61.4 13.8 17.5 28.6 27.3 52.7 42.8 9.2 31.2 9.5 14.9 31.8 37.5 48.3 25.2 37.9 17.7 46.8 36.6 62.8 8.9 44.1 38.0 42.7 70.3 49.6 20.2 88.6 42.7 36.9 37.9 25.3 26.7 36.2 98.0 15.6 23.9 75.7 14.6 13.1 24.9 32.1 55.2 36.6 66.1 83.3 61.0 70.4 21.8 18.8 142.9 IL20RB "DIRS1, FNDC6, IL-20R2, MGC34923" ENSG00000174564 "Interleukin 20 receptor subunit beta" Q6UXL0 3 136946230-137011085 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 110.7;skin 1: 163.3;vagina: 66.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 36.8;Basal respiratory cells: 115.8;Basal squamous epithelial cells: 60.9;Club cells: 43.0;Early spermatids: 57.0;Late spermatids: 28.8;Squamous epithelial cells: 56.5;Suprabasal keratinocytes: 38.1" "Group enriched" "Detected in many" 5 "cervical cancer: 54.5;head and neck cancer: 50.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 86.0;HBEC3-KT: 140.0;HHSteC: 91.8;hTCEpi: 555.6;hTERT-HME1: 102.6" "Not detected" "Not detected" HPA063914 Approved Vesicles,Cytosol NA NA "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Vesicles Cytosol "HPA063914: AB_2732709" "unprognostic (1.35e-2)" "unprognostic (1.05e-1)" "unprognostic (7.43e-4)" "unprognostic (2.48e-4)" "unprognostic (2.74e-1)" "unprognostic (3.31e-1)" "unprognostic (7.43e-4)" "unprognostic (4.08e-3)" "unprognostic (7.64e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (3.57e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.55e-1)" "unprognostic (3.55e-2)" "unprognostic (1.33e-2)" "unprognostic (5.57e-2)" 2.3 0.2 0.1 0.0 0.2 0.0 10.3 0.1 0.6 24.3 0.1 0.6 0.0 0.2 0.0 110.7 0.4 0.0 0.6 0.1 0.1 0.2 5.4 0.5 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.4 0.2 2.2 0.5 0.0 13.6 0.2 1.0 163.3 0.4 0.0 0.1 0.3 0.5 3.7 0.2 2.0 0.5 0.9 9.5 1.3 66.2 0.2 27.2 0.0 0.1 0.4 15.4 64.9 2.6 0.6 1.8 0.3 1.2 2.7 3.4 0.2 14.9 9.7 1.0 86.0 0.0 140.0 0.7 0.4 0.0 0.3 19.5 0.0 91.8 0.2 0.2 11.5 555.6 4.5 102.6 0.7 0.1 0.1 0.3 0.1 0.0 0.0 0.6 0.0 0.4 2.4 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 54.6 0.0 2.8 4.7 0.5 0.9 0.0 0.2 1.8 0.5 0.5 0.1 0.2 0.2 8.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.6 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.7 0.0 0.0 0.7 0.0 36.8 1.7 115.8 60.9 0.0 0.3 0.5 0.4 0.0 43.0 0.0 0.0 1.7 0.8 0.8 0.0 0.9 57.0 0.7 0.4 0.9 0.0 0.0 1.0 0.2 1.4 3.9 0.0 0.8 0.0 0.2 0.0 2.2 0.4 0.0 1.2 0.7 10.2 0.3 6.6 28.8 0.3 0.6 3.6 1.0 1.7 0.0 1.0 1.0 0.2 1.0 0.1 0.7 0.4 1.3 0.2 0.3 5.5 0.0 0.0 0.6 3.6 1.7 1.9 56.5 38.1 1.6 0.6 0.2 0.5 5.3 SOX14 SOX28 ENSG00000168875 "SRY-box transcription factor 14" O95416 3 137764315-137766334 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 12.5" "Cell type enriched" "Detected in some" 5 "Cytotrophoblasts: 18.4" "Cancer enhanced" "Detected in many" "prostate cancer: 2.8" "Region enhanced" "Detected in many" "thalamus: 12.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hypothalamus: 1.7;midbrain: 4.9" "Group enriched" "Detected in some" 6 "midbrain: 7.1;pons: 4.5;thalamus: 11.8" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 47: Cytotrophoblasts - Unknown function" "unprognostic (1.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.88e-2)" "unprognostic (2.49e-3)" "unprognostic (5.08e-1)" 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.0 0.0 1.7 2.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.5 0.1 0.0 2.5 0.4 4.3 2.7 0.2 12.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 CLDN18 SFTPJ ENSG00000066405 "Claudin 18" P56856 3 137998735-138033655 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 50 "lung: 252.2;stomach 1: 724.9" "Group enriched" "Detected in some" 53 "Alveolar cells type 1: 1602.5;Alveolar cells type 2: 431.2;Gastric mucus-secreting cells: 1153.4;Pancreatic endocrine cells: 442.5" "Group enriched" "Detected in some" 11 "pancreatic cancer: 113.6;stomach cancer: 186.8" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "OE19: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013010, CAB013243, HPA018446" Enhanced Approved "Cell Junctions" NA NA "Cluster 4: Stomach - Digestion" "Cluster 21: OE19 - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Cell Junctions" "CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866" "unprognostic (1.03e-1)" "unprognostic (1.49e-1)" "unprognostic (2.93e-1)" "unprognostic (1.04e-2)" "unprognostic (1.41e-1)" "unprognostic (8.51e-2)" "unprognostic (5.14e-4)" "unprognostic (2.00e-1)" "unprognostic (1.29e-1)" "unprognostic (2.60e-1)" "unprognostic (9.54e-2)" "unprognostic (1.38e-2)" "unprognostic (4.42e-5)" "unprognostic (1.66e-1)" "unprognostic (2.26e-1)" "unprognostic (8.26e-2)" "unprognostic (2.95e-1)" 0.3 0.3 0.3 0.4 0.4 0.1 0.2 1.0 0.5 0.4 2.2 0.7 1.5 0.2 0.5 0.6 0.5 3.3 9.7 0.3 0.2 0.2 0.1 252.2 0.0 0.9 0.9 0.5 0.8 0.0 0.5 0.3 0.5 0.2 0.2 0.7 0.3 0.4 0.1 1.1 0.8 0.1 0.7 0.5 724.9 1.3 0.5 0.1 0.1 0.0 0.7 0.2 0.3 0.2 0.1 0.0 0.2 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.7 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.5 15.1 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.4 0.3 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.0 0.5 0.3 0.2 0.9 0.9 0.5 0.7 0.5 0.2 0.0 1602.5 431.2 1.0 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 17.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.6 0.3 0.2 0.6 0.0 0.0 0.5 11.4 0.0 1.4 1153.4 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.7 0.0 2.0 0.0 1.9 0.0 0.1 0.0 0.0 0.2 442.5 0.0 0.0 1.3 0.0 0.0 0.1 0.7 1.3 0.0 0.9 0.1 15.3 11.9 0.0 0.0 0.0 1.3 0.0 0.0 0.1 DZIP1L "DZIP2, FLJ32844" ENSG00000158163 "DAZ interacting zinc finger protein 1 like" Q8IYY4 3 138061990-138115818 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 58.8;Respiratory ciliated cells: 74.0;Rod photoreceptor cells: 19.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030404 Approved Supported "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Cluster 45: Eosinophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 49: Ciliated cells - Cilium organization" Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA030404: AB_10601548" "unprognostic (3.65e-2)" "unprognostic (8.37e-2)" "unprognostic (2.87e-2)" "unprognostic (3.71e-2)" "unprognostic (8.22e-2)" "unprognostic (6.50e-2)" "unprognostic (6.47e-4)" "unprognostic (1.54e-1)" "unprognostic (3.21e-2)" "unprognostic (3.13e-1)" "unprognostic (3.26e-1)" "unprognostic (1.69e-1)" "unprognostic (1.51e-2)" "unprognostic (2.35e-3)" "unprognostic (2.72e-1)" "unprognostic (9.98e-2)" "unprognostic (2.77e-2)" 4.9 1.4 1.7 2.2 2.2 8.8 4.7 5.9 2.1 8.6 15.3 5.0 2.2 8.1 1.9 2.5 12.8 5.7 3.3 2.2 2.3 5.6 1.0 5.7 0.9 5.7 7.4 7.0 6.3 2.7 2.1 2.0 4.2 4.1 1.5 4.6 2.1 3.3 1.0 7.8 2.1 4.6 4.3 2.6 7.2 4.1 2.6 0.4 3.6 0.9 0.7 6.1 5.3 2.2 5.4 3.1 6.1 5.1 3.8 5.1 1.4 8.6 5.1 5.0 6.3 2.0 0.4 0.0 4.3 8.0 7.0 1.7 4.5 2.0 2.4 1.2 4.4 2.4 7.5 0.3 3.1 1.8 4.0 5.4 2.0 5.5 2.6 5.1 2.8 1.4 1.8 0.0 6.9 0.3 0.0 0.8 7.4 0.0 1.1 0.0 7.1 0.0 2.3 8.5 2.1 4.8 8.9 0.0 4.3 3.4 2.3 3.7 2.2 12.3 5.6 6.0 4.5 0.0 0.0 0.1 4.9 2.6 4.8 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 2.2 5.9 2.1 2.2 2.3 5.7 7.4 4.2 4.3 2.6 2.2 1.4 3.2 2.0 4.2 0.0 3.6 0.6 1.9 7.4 8.6 0.2 2.5 2.9 7.2 7.7 1.8 8.4 0.1 0.0 0.0 5.9 3.8 17.4 58.8 8.5 2.6 0.0 1.3 4.0 1.2 0.1 6.5 7.1 1.1 0.0 7.4 0.0 0.0 1.4 3.3 2.9 0.0 2.0 3.2 2.6 1.8 6.2 3.5 0.0 3.7 0.6 2.7 0.0 2.5 0.2 5.9 0.0 4.1 0.0 0.4 0.0 0.8 74.0 19.4 0.0 7.2 9.8 0.6 2.3 1.7 4.3 0.0 0.5 1.7 0.0 0.1 A4GNT alpha4GnT ENSG00000118017 Alpha-1,4-N-acetylglucosaminyltransferase Q9UNA3 3 138123713-138132390 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "stomach 1: 23.6" "Group enriched" "Detected in some" 25 "Cholangiocytes: 4.3;Gastric mucus-secreting cells: 16.3" "Group enriched" "Detected in some" 6 "pancreatic cancer: 2.5;stomach cancer: 3.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA008017 Enhanced "Intracellular and membrane" NA NA "Cluster 4: Stomach - Digestion" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA008017: AB_1078073" "unprognostic (1.21e-1)" "unprognostic (2.52e-1)" "unprognostic (2.14e-1)" "unprognostic (1.18e-2)" "unprognostic (1.48e-2)" "unprognostic (8.79e-2)" "unprognostic (9.35e-2)" "unprognostic (1.97e-1)" "unprognostic (1.81e-1)" "unprognostic (1.85e-1)" "unprognostic (4.03e-2)" "unprognostic (1.03e-1)" "unprognostic (7.79e-2)" "unprognostic (2.55e-2)" "unprognostic (6.48e-3)" 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.1 2.7 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.4 0.1 0.2 0.0 0.2 0.4 0.1 3.2 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.2 23.6 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DBR1 ENSG00000138231 "Debranching RNA lariats 1" Q9UK59 3 138160988-138174921 "Predicted intracellular proteins" "mRNA processing" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035365 Supported Enhanced Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA035365: AB_10611956" "unprognostic (1.20e-1)" "unprognostic (3.72e-2)" "unprognostic (8.48e-3)" "unprognostic (2.04e-2)" "unprognostic (2.83e-1)" "unprognostic (9.40e-2)" "prognostic unfavorable (1.36e-4)" "unprognostic (2.33e-1)" "unprognostic (5.24e-2)" "unprognostic (9.99e-2)" "unprognostic (2.60e-1)" "unprognostic (3.33e-2)" "prognostic favorable (1.36e-4)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (5.35e-2)" "unprognostic (4.79e-2)" 6.6 6.7 4.4 6.7 5.1 15.3 7.6 5.4 4.8 6.2 5.8 6.4 5.3 7.4 8.2 6.6 6.5 5.6 6.0 4.2 5.1 7.2 6.1 7.7 9.0 5.1 4.8 8.2 7.3 7.4 5.6 5.6 5.4 6.7 6.2 5.1 7.0 6.1 6.7 7.6 7.2 6.9 5.4 9.6 11.3 3.0 4.8 9.7 8.2 6.5 9.0 6.2 5.5 5.9 24.5 9.9 17.7 19.7 9.6 9.0 18.4 14.2 10.4 15.1 18.2 16.9 10.6 22.3 26.4 12.9 22.8 17.8 20.6 7.0 19.7 19.2 17.1 24.2 12.3 13.9 11.8 31.5 20.5 12.4 11.6 14.0 13.1 8.9 12.6 19.1 16.0 4.7 15.4 18.9 31.2 18.5 20.4 18.9 11.4 19.3 20.1 20.4 13.2 23.6 17.1 22.0 38.0 13.1 21.1 14.4 24.6 25.5 11.9 12.6 8.8 23.6 16.7 7.1 10.5 46.6 8.2 22.4 16.8 4.2 7.1 13.3 8.4 9.7 11.1 7.0 9.6 8.1 8.6 7.4 9.6 10.7 2.9 8.4 8.4 5.2 8.4 6.2 4.4 5.1 5.4 4.8 4.2 5.1 5.1 4.8 5.4 5.4 4.8 5.9 7.5 6.4 12.9 6.5 8.2 5.2 3.4 6.2 6.2 5.9 6.9 11.9 6.1 7.2 5.9 9.2 0.0 11.3 14.7 4.7 9.8 10.8 0.1 6.1 9.8 6.7 6.0 16.2 4.2 9.0 8.6 8.6 9.2 9.5 5.7 8.7 6.1 6.9 10.4 6.7 4.8 6.6 6.1 16.7 4.8 0.5 8.7 10.2 3.6 8.4 9.0 8.0 6.2 8.5 7.8 8.2 5.6 8.2 7.0 3.7 3.9 5.3 5.5 5.1 0.0 10.0 8.7 4.3 2.1 5.6 4.1 4.5 12.9 6.5 7.3 2.9 ARMC8 "DKFZP434A043, GID5, HSPC056, VID28" ENSG00000114098 "Armadillo repeat containing 8" Q8IUR7 3 138187248-138298384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 128.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036996, HPA044869" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 3: HMC-1 - Innate immune response" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "Vesicles, Cytosol" "HPA036996: AB_10672786, HPA044869: AB_2679123" "unprognostic (2.04e-1)" "unprognostic (1.60e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (3.51e-2)" "unprognostic (2.39e-2)" "prognostic unfavorable (8.90e-5)" "unprognostic (1.96e-1)" "unprognostic (2.04e-2)" "unprognostic (7.48e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (2.15e-4)" "unprognostic (3.27e-2)" "unprognostic (2.03e-1)" "unprognostic (4.06e-2)" "unprognostic (5.51e-2)" "unprognostic (1.18e-1)" 20.8 14.3 14.6 18.0 16.6 60.6 16.4 41.2 18.5 14.7 25.6 16.8 12.0 17.6 12.2 21.0 15.7 15.3 17.4 13.3 16.9 18.9 16.9 16.3 21.2 16.0 15.8 16.0 14.2 21.3 12.3 19.8 17.5 16.5 18.3 26.2 12.5 17.5 38.7 12.8 13.5 24.4 15.9 15.9 15.4 18.4 16.7 22.2 21.3 34.8 22.9 22.2 13.4 19.4 46.2 22.0 28.5 23.2 35.2 30.7 37.9 34.8 33.4 46.7 45.3 34.3 23.7 43.2 35.0 30.2 54.6 23.5 37.1 33.9 57.4 29.3 25.7 77.2 14.3 23.9 44.3 60.6 82.5 46.2 21.2 30.0 42.9 25.4 37.0 37.0 29.3 23.8 58.6 40.5 42.7 28.6 39.2 34.8 19.1 33.0 45.7 34.6 30.7 42.3 33.0 24.0 50.0 17.2 29.1 36.8 33.8 31.6 40.4 24.8 20.2 33.1 25.9 45.0 37.5 65.2 22.4 28.4 25.2 79.7 39.7 74.8 38.6 43.5 44.6 48.8 35.2 41.1 45.9 43.3 41.1 40.6 27.9 48.8 46.0 20.3 50.4 37.4 14.6 16.6 41.2 18.5 13.3 16.9 16.0 15.8 17.5 15.9 16.7 19.4 25.0 28.9 14.1 56.2 38.2 31.0 31.9 29.0 25.0 34.9 17.7 14.9 23.1 24.3 27.2 12.9 33.3 29.9 35.6 25.1 11.7 20.2 7.3 16.2 22.3 23.4 23.4 59.6 101.9 14.6 27.6 23.4 31.1 19.5 35.4 24.1 24.3 24.6 22.5 43.7 93.6 16.9 30.5 32.7 39.2 7.3 30.4 35.2 19.6 70.3 27.2 25.0 39.1 128.2 120.8 14.8 17.2 22.2 26.8 28.1 17.0 26.1 17.4 47.0 13.1 30.2 31.5 43.4 32.2 22.3 28.4 34.1 30.9 19.6 17.4 28.3 NME9 "NM23-H9, TXL-2, TXNDC6" ENSG00000181322 "NME/NM23 family member 9" Q86XW9 3 138261437-138329886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 14.6;fallopian tube: 17.6" "Group enriched" "Detected in some" 6 "Astrocytes: 27.4;Endometrial ciliated cells: 20.0;Excitatory neurons: 26.6;Inhibitory neurons: 17.9;Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 36.6;Respiratory ciliated cells: 48.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020943, HPA040000, HPA043881" Enhanced Approved "Centriolar satellite,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 3: HMC-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "Centriolar satellite" "CAB020943: , HPA040000: AB_2676793, HPA043881: AB_2678712" "unprognostic (2.71e-5)" "unprognostic (1.68e-1)" "unprognostic (5.09e-2)" "unprognostic (3.01e-3)" "unprognostic (3.67e-1)" "unprognostic (1.69e-3)" "unprognostic (4.58e-2)" "unprognostic (5.19e-2)" "unprognostic (1.66e-1)" "unprognostic (1.12e-2)" "unprognostic (1.03e-2)" "unprognostic (1.72e-2)" "unprognostic (3.82e-2)" "unprognostic (1.39e-2)" "unprognostic (9.14e-2)" "unprognostic (4.89e-2)" "unprognostic (7.17e-3)" 0.7 0.7 4.1 0.4 4.0 2.9 0.7 8.8 5.5 1.1 14.6 0.6 0.2 0.6 0.7 0.4 17.6 0.4 0.5 3.4 4.1 1.0 0.4 2.2 0.3 6.9 7.0 0.7 1.3 0.9 3.7 0.2 4.2 0.8 0.0 7.4 1.6 0.7 2.7 0.8 0.8 0.2 5.2 0.5 0.6 4.3 5.0 0.5 1.1 0.0 0.2 0.5 0.5 4.4 0.3 0.2 0.4 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.3 0.6 0.2 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.2 0.7 0.8 0.1 0.0 1.0 1.7 0.3 0.0 0.0 0.0 0.7 0.0 0.7 0.2 0.4 0.0 0.1 0.1 1.0 0.2 0.1 0.3 0.3 0.0 0.3 0.5 0.9 0.9 0.2 0.6 0.1 0.1 0.3 0.3 0.0 1.1 0.3 0.2 0.3 0.1 0.3 0.4 0.4 0.2 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.3 0.0 0.1 0.2 0.4 0.1 0.1 0.1 0.0 0.2 0.2 0.0 4.1 4.0 8.8 5.5 3.4 4.1 6.9 7.0 4.2 5.2 5.0 4.4 0.2 0.0 0.5 27.4 0.0 0.0 0.2 1.1 0.0 1.5 0.1 0.0 1.5 2.8 2.3 1.8 0.0 0.1 0.0 0.0 0.0 0.2 3.1 20.0 0.2 0.3 0.0 0.0 26.6 0.0 0.0 0.4 0.0 0.5 0.0 0.3 0.4 0.0 0.0 3.3 17.9 0.0 0.0 0.3 0.0 1.4 0.3 0.0 0.0 1.0 0.0 2.7 0.0 67.8 36.6 0.0 0.0 0.0 0.3 0.2 0.0 0.5 48.4 2.3 0.0 0.5 0.7 5.0 0.7 0.0 0.0 0.3 0.2 0.4 0.0 0.1 MRAS "M-RAs, R-RAS3, RRAS3" ENSG00000158186 "Muscle RAS oncogene homolog" O14807 3 138347648-138405534 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 202.3;heart muscle: 132.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 121.7;Distal tubular cells: 58.7;Theca cells: 59.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "non-classical monocyte: 25.0" "Lineage enriched" "Detected in many" 9 "monocytes: 25.0" "Cell line enhanced" "Detected in many" "BJ: 92.9;EFO-21: 113.7;fHDF/TERT166: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042728 Approved Approved Vesicles,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol Vesicles "HPA042728: AB_10796582" "unprognostic (1.96e-1)" "unprognostic (2.95e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.73e-4)" "unprognostic (1.69e-1)" "unprognostic (5.32e-2)" "unprognostic (8.96e-2)" "unprognostic (3.85e-3)" "unprognostic (1.70e-1)" "unprognostic (1.86e-1)" "unprognostic (1.71e-1)" "unprognostic (2.59e-1)" "unprognostic (3.18e-3)" "unprognostic (1.78e-2)" "unprognostic (6.25e-2)" "unprognostic (2.21e-1)" "unprognostic (4.23e-2)" 91.9 67.7 112.7 10.8 130.6 1.7 46.7 118.2 105.5 17.3 48.9 24.2 3.3 28.7 7.1 7.9 26.4 12.0 132.9 105.6 132.8 22.9 5.5 18.4 5.2 126.1 135.9 48.6 5.7 8.2 17.7 10.6 112.9 15.3 4.1 15.9 13.4 15.0 80.4 12.2 8.7 23.2 110.3 12.2 12.0 9.6 202.3 4.9 26.4 48.0 3.3 29.1 12.1 97.8 0.8 7.9 15.8 24.5 59.6 29.2 40.0 92.9 16.0 7.3 8.2 3.3 3.1 0.3 113.7 70.4 18.6 0.1 9.0 1.8 6.1 7.7 3.1 0.5 4.8 20.1 15.9 0.0 1.9 41.5 5.9 0.7 1.4 13.6 1.3 0.0 10.7 0.8 31.4 3.7 0.0 20.4 19.1 0.0 2.7 1.1 33.8 0.2 30.4 2.0 18.6 42.0 62.8 0.7 45.9 10.9 16.1 37.7 0.6 23.7 25.3 24.3 2.4 0.1 1.0 1.2 21.4 0.1 11.4 0.2 2.1 0.0 0.0 4.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.3 0.8 25.0 0.1 0.0 0.8 112.7 130.6 118.2 105.5 105.6 132.8 126.1 135.9 112.9 110.3 202.3 97.8 8.9 9.6 1.5 54.2 0.8 2.2 3.0 3.4 1.2 5.6 28.8 34.8 121.7 2.8 3.5 9.2 10.4 20.1 0.2 0.0 58.7 8.6 11.6 1.0 21.4 14.5 1.8 0.0 25.5 3.2 3.2 23.0 2.0 1.5 6.3 35.2 12.8 1.6 26.3 28.6 20.6 0.0 2.0 15.1 18.4 40.0 23.3 18.2 28.4 20.6 12.2 24.3 0.0 28.6 11.0 3.8 0.0 34.3 0.1 3.3 0.0 27.5 1.3 9.6 6.6 20.8 18.9 7.3 18.6 0.4 1.0 14.4 0.8 59.1 0.0 0.6 ESYT3 "CHR3SYT, FAM62C" ENSG00000158220 "Extended synaptotagmin 3" A0FGR9 3 138434586-138481686 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.1;skin 1: 7.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Alveolar cells type 2: 37.7;Excitatory neurons: 9.4;Inhibitory neurons: 9.7" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "JURKAT: 1.4;NTERA-2: 3.3;SCLC-21H: 3.5;SK-MEL-30: 1.7;SuSa: 1.4" "Region enhanced" "Detected in many" "hypothalamus: 7.3" "Low region specificity" "Detected in all" HPA039200 Approved NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 11: Alveolar cells - Smell perception" "HPA039200: AB_10805356" "unprognostic (4.48e-2)" "unprognostic (3.07e-2)" "unprognostic (1.21e-2)" "unprognostic (1.38e-4)" "unprognostic (2.23e-1)" "unprognostic (8.22e-2)" "unprognostic (3.55e-3)" "prognostic favorable (8.30e-4)" "unprognostic (3.38e-1)" "unprognostic (5.57e-2)" "unprognostic (6.19e-3)" "unprognostic (4.88e-3)" "unprognostic (3.16e-5)" "unprognostic (3.46e-1)" "unprognostic (1.12e-1)" "unprognostic (2.13e-1)" "unprognostic (6.43e-2)" 0.1 0.1 2.5 0.0 2.0 0.0 0.7 5.1 2.2 0.8 0.2 3.8 0.0 2.2 0.0 0.4 0.2 0.3 0.5 2.1 2.3 0.9 0.0 4.7 0.0 2.2 2.1 0.5 1.0 0.8 1.9 0.3 2.5 0.2 0.2 0.1 0.3 0.0 0.4 7.7 0.3 1.5 1.3 0.0 1.7 0.5 2.4 0.0 4.7 0.0 0.4 1.0 0.7 1.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.8 0.8 0.1 0.2 1.3 0.0 0.0 0.2 0.0 0.1 0.4 0.5 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.2 3.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 3.5 0.0 1.2 0.1 1.7 1.4 0.3 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 2.0 5.1 2.2 2.1 2.3 2.2 2.1 2.5 1.3 2.4 1.5 0.1 38.5 37.7 4.2 0.1 0.8 0.8 0.5 1.2 1.9 0.9 1.3 2.5 1.5 4.5 1.8 4.2 0.8 0.0 0.1 0.0 1.0 0.2 1.5 0.8 0.7 0.0 0.0 9.4 0.9 0.4 0.9 3.6 2.2 0.0 0.5 0.4 0.1 0.2 0.0 9.7 0.0 0.0 0.0 0.4 0.2 0.3 0.2 1.8 1.0 0.0 0.3 0.0 2.0 0.5 0.7 0.1 0.0 0.0 1.1 0.0 0.3 0.8 3.9 0.0 1.4 0.3 1.5 1.7 0.5 1.6 0.7 0.1 0.7 0.2 0.1 CEP70 "BITE, FLJ13036" ENSG00000114107 "Centrosomal protein 70" Q8NHQ1 3 138494344-138594538 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 222.5;Late spermatids: 299.3;Spermatocytes: 163.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "gdT-cell: 2.8;MAIT T-cell: 3.3;memory B-cell: 1.7;memory CD4 T-cell: 2.1;memory CD8 T-cell: 2.3;naive B-cell: 1.4;naive CD4 T-cell: 4.1;naive CD8 T-cell: 4.0;NK-cell: 2.3;T-reg: 1.3" "Group enriched" "Detected in many" 10 "B-cells: 1.7;NK-cells: 2.3;T-cells: 4.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036941, HPA036942" Enhanced Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 6: T47d - Mammary gland" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Cytosol" Centrosome "HPA036941: AB_10670567, HPA036942: AB_10670957" "unprognostic (1.61e-1)" "prognostic favorable (2.93e-4)" "unprognostic (2.27e-2)" "unprognostic (3.59e-2)" "unprognostic (3.31e-2)" "unprognostic (3.44e-2)" "unprognostic (1.95e-2)" "unprognostic (9.92e-3)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (5.01e-3)" "prognostic unfavorable (9.60e-5)" "unprognostic (8.90e-3)" "unprognostic (8.07e-3)" "unprognostic (1.46e-1)" "unprognostic (8.71e-3)" "unprognostic (6.43e-2)" 7.5 12.0 20.1 6.3 20.9 5.9 13.3 24.1 22.3 30.6 16.2 17.6 56.2 20.9 21.6 12.0 30.6 13.1 15.8 18.1 25.4 21.4 29.4 14.7 5.5 22.1 21.8 18.5 24.1 21.8 15.6 3.9 21.8 21.0 18.1 35.8 8.7 21.7 18.0 6.8 19.0 11.7 20.5 6.1 13.1 69.0 23.9 42.4 39.2 20.8 6.9 12.1 11.7 22.7 53.7 11.1 25.3 30.8 15.2 16.9 23.5 10.4 19.4 14.0 20.5 15.5 27.9 12.5 24.0 19.2 53.1 23.0 23.2 20.6 31.1 22.2 15.3 35.7 26.0 20.1 24.2 1.6 12.5 92.3 11.7 10.6 26.2 37.0 20.5 40.1 26.6 40.5 23.1 20.1 38.4 2.1 15.0 13.9 24.6 41.7 32.9 32.3 26.9 23.8 30.7 19.8 54.5 12.7 60.8 28.4 64.3 17.7 12.1 10.3 19.0 21.3 12.9 37.2 22.1 42.6 22.9 3.3 35.7 0.2 0.0 0.1 2.8 0.1 3.3 1.7 2.1 2.3 0.0 1.4 4.1 4.0 0.2 2.3 0.0 0.1 1.3 1.2 20.1 20.9 24.1 22.3 18.1 25.4 22.1 21.8 21.8 20.5 23.9 22.7 7.0 32.1 69.3 44.1 4.8 9.7 46.3 14.0 22.2 15.8 11.8 9.8 34.3 22.8 27.4 20.2 35.5 8.1 4.6 10.5 72.4 24.9 222.5 114.0 14.9 7.7 15.6 13.7 51.8 17.6 4.4 11.8 16.3 52.6 20.8 21.9 6.1 14.7 2.4 21.9 48.5 11.1 8.2 0.3 3.0 299.3 9.9 2.3 10.6 19.7 0.6 26.4 2.1 60.8 30.5 12.7 8.1 12.8 9.2 29.5 3.3 21.1 34.5 31.1 6.6 17.5 12.4 163.6 9.5 18.6 8.1 9.6 8.9 9.5 23.9 28.6 FAIM "FAIM1, FLJ10582" ENSG00000158234 "Fas apoptotic inhibitory molecule" Q9NVQ4 3 138608606-138633376 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "retina: 235.0" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 173.3;Rod photoreceptor cells: 228.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 135.7" "Low region specificity" "Detected in all" "HPA042440, HPA052209" Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 79: Retina - Phototransduction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Plasma membrane, Cytosol" "HPA042440: AB_2677999, HPA052209: AB_2681761" "unprognostic (6.45e-2)" "unprognostic (8.21e-3)" "unprognostic (5.97e-2)" "unprognostic (1.11e-1)" "unprognostic (3.24e-1)" "unprognostic (8.31e-2)" "prognostic unfavorable (3.96e-5)" "unprognostic (4.84e-2)" "unprognostic (4.15e-2)" "unprognostic (9.23e-3)" "unprognostic (2.29e-1)" "unprognostic (2.63e-2)" "prognostic favorable (6.63e-4)" "unprognostic (4.76e-2)" "unprognostic (3.51e-1)" "unprognostic (3.43e-1)" "unprognostic (6.98e-2)" 18.3 8.6 16.8 6.9 17.9 4.1 15.6 17.5 21.3 31.7 14.9 9.3 6.4 12.6 19.5 12.2 38.2 12.1 6.4 16.2 18.6 15.3 8.2 10.5 10.8 18.9 17.7 10.8 38.1 8.5 10.4 8.4 19.4 14.9 7.9 235.0 9.6 21.7 5.4 8.5 6.1 9.7 19.2 4.9 9.8 7.3 17.1 19.8 20.3 5.5 13.7 13.5 10.4 19.9 80.8 15.5 1.7 13.9 14.7 27.2 55.4 24.4 14.7 25.2 21.5 26.8 23.2 0.2 21.0 32.0 29.0 20.9 66.8 13.9 28.2 66.2 69.8 15.1 42.9 39.1 16.3 0.0 4.8 38.4 26.5 9.4 14.4 15.4 27.5 5.7 10.0 20.0 15.8 30.7 0.4 68.3 30.1 2.5 15.3 81.4 18.0 2.1 40.4 39.5 26.0 22.1 43.2 23.8 64.6 16.4 40.1 20.0 16.9 5.1 11.9 25.9 12.0 0.0 0.4 135.7 20.8 0.2 21.0 16.8 2.9 2.2 10.5 3.3 9.6 17.0 5.8 8.4 6.3 12.0 3.8 9.8 0.4 18.8 2.2 4.3 6.9 4.3 16.8 17.9 17.5 21.3 16.2 18.6 18.9 17.7 19.4 19.2 17.1 19.9 16.4 19.2 22.9 9.1 12.7 10.8 30.3 35.2 14.2 31.9 14.3 21.5 5.3 68.6 32.4 25.8 66.7 42.0 14.7 5.9 31.3 63.1 12.0 173.3 29.8 14.5 21.1 7.2 7.7 50.0 33.3 16.8 8.2 41.3 41.2 17.2 8.9 9.4 25.2 15.2 6.1 8.8 14.2 3.2 5.7 16.5 17.4 6.5 16.0 1.9 15.6 45.3 21.6 11.1 16.5 31.3 4.4 19.9 14.2 22.1 2.2 28.1 77.5 228.3 0.0 25.0 22.6 14.1 4.2 16.6 13.1 14.6 10.8 14.6 11.7 21.6 PIK3CB PIK3C1 ENSG00000051382 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta" P42338 3 138652698-138834928 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Autophagy, Cell adhesion, Endocytosis" "Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 96.5;Inhibitory neurons: 92.4;Oligodendrocytes: 88.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 115.2;HMC-1: 185.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB031938, HPA042288, HPA064207" Approved Supported Nucleoplasm,Nucleoli,Vesicles,Midbody Yes No "Cluster 52: Eosinophils - Transcription" "Cluster 7: Kidney - Transmembrane transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Nucleoli, Vesicles, Midbody" "CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212" "unprognostic (4.89e-2)" "unprognostic (1.42e-2)" "unprognostic (5.97e-2)" "unprognostic (7.85e-2)" "unprognostic (4.89e-2)" "unprognostic (6.01e-2)" "prognostic unfavorable (6.42e-4)" "unprognostic (3.98e-2)" "unprognostic (1.35e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.99e-5)" "unprognostic (2.15e-1)" "unprognostic (6.18e-3)" "unprognostic (9.33e-2)" "unprognostic (7.82e-2)" "unprognostic (2.79e-1)" "unprognostic (4.59e-2)" 11.6 7.4 4.3 12.4 5.0 23.7 11.9 8.6 8.6 12.4 14.4 17.8 17.8 8.2 7.0 18.0 12.1 10.3 15.8 5.4 4.4 26.4 11.0 11.2 12.3 5.1 3.3 9.2 22.3 19.3 2.7 18.6 6.1 15.0 18.1 23.0 19.8 12.0 19.5 23.7 17.9 9.1 3.5 10.8 13.0 8.0 4.0 17.0 43.2 13.2 13.2 9.9 5.4 7.9 64.1 21.9 11.7 9.4 10.6 13.0 79.2 14.2 14.5 15.1 16.7 26.0 25.2 25.0 38.0 13.7 29.1 27.5 15.1 24.1 27.3 31.8 12.5 115.2 14.8 17.3 11.8 30.1 185.1 12.4 17.6 10.2 21.9 26.4 21.5 12.3 43.0 19.0 18.1 28.6 17.8 20.7 16.6 49.2 19.5 11.5 12.2 19.6 24.5 35.5 9.8 7.4 37.6 18.0 56.2 34.7 44.8 73.0 20.3 8.4 11.7 21.2 21.1 30.3 22.1 23.7 22.8 27.7 14.0 4.4 5.1 6.9 2.4 2.8 1.6 2.8 2.8 1.8 5.9 2.6 3.5 2.4 6.4 0.8 2.8 1.0 1.5 2.0 4.3 5.0 8.6 8.6 5.4 4.4 5.1 3.3 6.1 3.5 4.0 7.9 19.7 9.6 21.3 40.1 12.1 19.1 18.7 12.5 14.2 16.2 13.1 7.7 37.3 12.8 18.3 18.4 25.0 35.5 6.9 30.3 5.9 11.1 1.1 18.3 4.0 13.9 16.3 8.0 96.5 19.4 61.1 7.3 21.4 18.8 14.5 6.7 9.7 19.1 14.4 21.9 92.4 17.1 4.1 33.3 23.1 1.7 3.7 28.1 7.2 37.5 29.5 8.9 11.3 48.2 88.2 20.0 25.9 6.8 10.2 25.8 21.9 23.4 17.4 19.5 6.6 8.6 5.9 16.0 19.9 22.1 23.3 47.9 11.6 4.2 15.1 17.5 FOXL2 "BPES, BPES1" ENSG00000183770 "Forkhead box L2" P58012 3 138944224-138947137 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix: 12.8;ovary: 44.8;parathyroid gland: 12.5" "Cell type enriched" "Detected in some" 4 "Granulosa cells: 208.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 4.9;fHDF/TERT166: 5.6;HEL: 8.1;hTCEpi: 7.1;K-562: 8.4;SiHa: 5.6;THP-1: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA069613 Enhanced Supported Nucleoplasm NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA069613: AB_2686160" "unprognostic (1.46e-1)" "unprognostic (3.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.05e-1)" "unprognostic (5.16e-4)" "unprognostic (3.55e-2)" "unprognostic (2.35e-3)" "unprognostic (5.08e-2)" "unprognostic (3.79e-2)" "unprognostic (2.19e-1)" "unprognostic (9.63e-8)" "unprognostic (2.16e-2)" "unprognostic (4.65e-1)" "unprognostic (2.90e-2)" "unprognostic (1.61e-2)" 0.0 2.6 1.0 0.0 0.8 0.0 0.0 0.6 0.8 12.8 0.3 0.0 0.0 7.3 0.4 0.0 11.9 0.0 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.8 0.8 44.8 0.1 12.5 10.0 0.1 0.8 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.8 0.8 0.0 0.0 0.7 1.2 0.0 0.0 0.1 0.0 0.0 2.1 0.7 4.9 1.8 0.2 3.4 0.0 0.0 1.4 0.1 0.0 0.4 0.0 0.0 0.3 0.0 2.2 5.6 0.2 1.1 0.0 0.0 0.1 0.0 0.0 8.1 0.9 0.0 0.0 0.1 0.0 0.0 7.1 0.0 0.0 1.1 0.0 0.0 8.4 0.0 2.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.6 0.0 0.0 5.6 0.0 0.0 0.3 0.0 5.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.6 0.8 0.6 0.6 0.8 0.8 0.8 0.8 1.2 0.7 0.2 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 41.8 1.6 0.0 0.0 0.0 0.2 0.3 20.9 0.0 1.0 0.0 208.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 6.2 1.8 1.4 0.0 1.0 0.0 0.3 48.4 0.0 0.0 FOXL2NB "C3orf72, FLJ43329" ENSG00000206262 "FOXL2 neighbor" Q6ZUU3 3 138947217-138953990 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ovary: 50.1;parathyroid gland: 32.7" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 2.0;Granulosa cells: 3.6" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.4;fHDF/TERT166: 9.2;HEL: 8.7;hTCEpi: 4.4;SiHa: 6.6" "HPA061017, HPA071790" Enhanced "Nucleoli fibrillar center" NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 36: HEL - Hemostasis" "Cluster 40: Granulosa cells - Unknown function" "Nucleoli fibrillar center" "HPA061017: AB_2684415, HPA071790: AB_2686447" "unprognostic (3.32e-1)" "unprognostic (1.13e-1)" "unprognostic (3.86e-2)" "unprognostic (4.07e-2)" "unprognostic (4.40e-5)" "unprognostic (3.30e-2)" "unprognostic (2.27e-2)" "unprognostic (1.28e-1)" "unprognostic (5.16e-1)" "unprognostic (1.60e-1)" "unprognostic (1.41e-10)" "unprognostic (2.07e-1)" "unprognostic (1.09e-1)" "unprognostic (2.77e-1)" "unprognostic (1.22e-2)" 0.1 1.8 1.2 0.3 1.0 0.8 0.2 2.0 1.6 16.4 0.6 0.2 0.2 17.9 2.0 0.4 14.9 0.2 0.1 1.1 1.0 0.1 0.1 0.1 0.7 0.9 0.9 50.1 0.9 32.7 8.4 0.4 1.2 0.2 0.2 0.6 0.2 1.1 0.3 0.8 0.2 4.2 0.3 0.4 0.2 0.8 1.2 0.1 0.2 0.1 0.5 0.0 3.4 1.2 1.8 1.1 0.5 4.4 0.2 0.1 2.0 0.1 0.0 0.2 0.0 0.2 0.4 0.2 0.9 9.2 0.1 0.5 0.2 0.0 0.2 0.1 0.2 8.7 3.0 0.2 0.0 0.2 0.3 0.1 4.4 0.1 0.1 0.4 0.0 0.2 3.4 0.3 2.5 0.3 0.1 0.3 0.3 0.1 0.1 0.1 0.0 0.1 0.4 1.2 0.2 0.1 6.6 0.2 0.1 0.7 0.2 2.6 0.2 0.3 0.2 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.0 1.2 1.0 2.0 1.6 1.1 1.0 0.9 0.9 1.2 0.3 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 PRR23A ENSG00000206260 "Proline rich 23A" A6NEV1 3 139003962-139006268 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 17 "testis cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 78: Testis - Spermatogenesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.48e-1)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.2 0.1 0.0 0.2 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRPS22 "C3orf5, GIBT, GK002, MRP-S22" ENSG00000175110 "Mitochondrial ribosomal protein S22" P82650 3 139005806-139357223 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006083, HPA007830" Enhanced Supported Mitochondria "Intracellular and membrane" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria "HPA006083: AB_1854122, HPA007830: AB_1854123" "unprognostic (8.38e-2)" "unprognostic (1.52e-2)" "unprognostic (3.04e-2)" "prognostic unfavorable (1.35e-5)" "unprognostic (5.22e-3)" "unprognostic (5.45e-3)" "unprognostic (4.85e-2)" "unprognostic (2.18e-2)" "unprognostic (2.78e-2)" "unprognostic (4.49e-3)" "prognostic unfavorable (1.55e-5)" "prognostic unfavorable (1.85e-4)" "unprognostic (3.22e-3)" "unprognostic (2.56e-2)" "unprognostic (1.49e-1)" "unprognostic (1.77e-1)" "unprognostic (3.40e-1)" 25.5 55.6 23.1 20.7 24.2 37.9 25.2 27.2 31.5 21.9 22.2 35.0 37.0 20.2 19.3 37.4 20.5 17.3 61.3 23.4 27.3 38.0 57.4 17.0 22.8 24.9 23.4 22.6 32.0 31.7 13.7 25.6 26.0 17.1 31.9 17.9 22.0 20.2 83.0 21.8 33.1 23.9 25.8 17.0 25.0 35.4 24.4 23.5 22.8 77.3 24.4 27.3 21.6 27.4 101.2 40.4 40.0 44.5 49.1 41.7 79.1 58.9 72.3 97.1 80.7 130.0 68.3 66.5 106.9 67.1 98.9 109.9 64.6 76.5 96.4 39.0 64.1 105.2 35.8 97.2 56.2 99.3 58.1 45.2 59.6 58.3 61.8 49.2 61.0 76.2 149.2 41.7 61.2 72.4 51.9 85.9 64.4 102.3 73.3 65.0 61.3 98.9 75.0 61.4 43.4 40.4 94.2 141.4 154.6 37.0 97.1 93.7 47.5 42.4 42.3 82.4 55.9 66.3 38.5 119.5 56.9 70.6 42.3 42.8 38.4 36.1 34.9 53.4 43.0 40.3 37.5 39.4 45.8 36.1 41.0 38.9 9.2 38.1 53.6 29.7 47.6 36.3 23.1 24.2 27.2 31.5 23.4 27.3 24.9 23.4 26.0 25.8 24.4 27.4 30.7 19.2 13.4 8.8 21.8 22.8 29.7 63.3 19.4 19.9 15.3 18.0 50.3 25.8 33.3 18.4 14.6 62.9 24.9 26.5 68.4 47.5 84.3 19.9 30.5 26.6 15.6 31.2 8.7 60.3 48.0 27.7 16.3 22.0 27.3 24.9 18.2 38.9 48.6 20.2 13.8 26.5 32.6 21.9 16.1 14.3 23.3 22.5 16.0 4.7 38.0 21.8 24.7 10.1 10.1 42.0 27.1 23.7 38.4 16.6 45.4 59.4 35.5 26.2 39.5 32.2 39.1 102.2 51.4 34.8 20.5 75.4 24.7 74.1 46.5 31.2 PRR23B FLJ46116 ENSG00000184814 "Proline rich 23B" Q6ZRT6 3 139019031-139020926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 1.3" "Group enriched" "Detected in some" 8 "Spermatocytes: 6.4;Spermatogonia: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047473 Uncertain Uncertain "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 83: Testis - Spermatogenesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (7.57e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 PRR23C FLJ46210 ENSG00000233701 "Proline rich 23C" Q6ZRP0 3 139042102-139044892 "Predicted intracellular proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Early spermatids: 3.5;Late spermatids: 2.0;Spermatocytes: 1.6;Spermatogonia: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" "Not detected" "Not detected" HPA047473 Uncertain Approved "Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 17: Basophils - Unknown function" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Microtubules" "Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol" "HPA047473: AB_2680062" "unprognostic (1.00e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 COPB2 "beta'-COP, betaprime-COP" ENSG00000184432 "COPI coat complex subunit beta 2" P35606 3 139353946-139389736 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036867, HPA058180" Approved Approved "Endoplasmic reticulum,Golgi apparatus" NA NA 63000 "Cluster 18: Basophils - Vesicular transport" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "Golgi apparatus" "HPA036867: AB_10672271, HPA058180: AB_2683630" "unprognostic (3.37e-2)" "unprognostic (2.04e-1)" "unprognostic (9.38e-2)" "unprognostic (6.93e-2)" "unprognostic (1.31e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.41e-7)" "unprognostic (5.59e-2)" "unprognostic (2.14e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (8.11e-2)" "unprognostic (1.51e-2)" "unprognostic (6.44e-2)" "unprognostic (1.14e-1)" "unprognostic (6.05e-2)" "unprognostic (4.95e-2)" 46.7 58.2 17.9 50.5 19.7 22.3 60.4 20.4 21.0 76.5 35.9 62.5 57.4 48.5 62.5 55.0 47.5 48.4 47.9 17.4 21.8 52.9 71.1 44.3 44.8 20.5 18.9 38.9 89.7 68.2 60.0 68.9 20.4 72.2 71.7 37.0 71.1 57.0 33.5 37.4 53.4 63.5 20.8 42.8 60.7 35.0 20.2 54.4 64.3 31.2 61.5 56.2 42.2 25.0 192.1 84.0 111.2 99.0 247.2 214.9 96.8 223.9 235.9 158.2 204.7 143.4 83.5 90.2 203.0 287.1 145.1 110.9 136.2 141.0 210.6 139.0 85.2 138.2 114.9 152.3 152.7 121.9 139.7 160.1 114.7 132.2 138.5 178.6 161.6 76.5 86.7 105.7 199.4 138.6 59.4 59.7 102.2 215.0 99.5 75.8 93.6 149.5 141.2 133.4 85.2 61.7 254.6 212.0 147.2 168.6 193.2 123.2 185.1 90.3 66.4 122.8 83.7 148.0 80.8 129.7 115.2 61.0 138.0 74.4 49.8 52.0 36.0 56.3 35.8 35.3 31.0 37.6 57.7 23.8 24.2 31.1 45.0 44.1 57.2 30.2 38.1 44.2 17.9 19.7 20.4 21.0 17.4 21.8 20.5 18.9 20.4 20.8 20.2 25.0 36.6 57.7 46.6 18.3 45.8 19.6 39.5 61.2 29.6 38.0 41.3 29.3 58.5 32.9 74.5 20.2 31.3 83.3 34.9 52.4 41.1 83.4 40.8 64.9 62.9 45.2 63.9 51.1 25.1 82.1 76.1 66.6 75.4 54.8 45.0 50.4 36.4 48.5 52.7 42.1 25.5 86.7 46.8 34.6 21.3 8.6 54.7 42.8 21.4 13.1 60.1 62.0 29.9 20.1 30.8 79.7 34.8 50.0 118.6 46.6 46.9 42.4 108.6 51.1 19.7 47.3 69.6 83.1 45.6 36.5 14.9 133.1 37.5 74.4 44.7 52.9 RBP2 "CRABP-II, CRBP2, CRBPII, RBPC2" ENSG00000114113 "Retinol binding protein 2" P50120 3 139452884-139480747 "Metabolic proteins, Predicted intracellular proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 294 "intestine: 2713.5" "Cell type enriched" "Detected in some" 26 "Proximal enterocytes: 6095.4" "Group enriched" "Detected in many" 4 "colorectal cancer: 7.1;pancreatic cancer: 4.5;stomach cancer: 8.4;testis cancer: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "CACO-2: 78.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA035866 Enhanced Approved "Golgi apparatus" NA NA 140000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA035866: AB_10672232" "unprognostic (1.74e-1)" "unprognostic (2.66e-2)" "unprognostic (3.34e-2)" "unprognostic (6.72e-6)" "unprognostic (2.33e-1)" "unprognostic (4.10e-2)" "unprognostic (1.56e-2)" "unprognostic (2.24e-1)" "unprognostic (8.51e-3)" "unprognostic (3.92e-2)" "unprognostic (7.35e-2)" "unprognostic (1.24e-3)" "unprognostic (5.57e-3)" "unprognostic (1.10e-1)" "unprognostic (9.23e-2)" "unprognostic (1.78e-2)" "unprognostic (2.21e-1)" 0.4 1.1 4.6 1.1 3.2 0.7 0.5 0.3 3.2 0.2 0.0 4.0 2713.5 2.0 0.0 0.2 0.3 1.8 0.2 3.3 5.0 2.6 0.0 7.6 2.2 8.1 9.2 0.3 3.0 0.0 0.1 0.1 3.4 0.4 2.4 2.2 0.1 0.0 0.2 1.1 1886.7 1.0 3.4 0.1 3.6 1.0 9.0 0.0 0.5 0.0 0.0 0.0 0.0 5.3 0.0 0.2 0.2 0.2 0.0 0.0 7.1 0.0 0.0 0.0 0.0 78.8 0.1 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.9 0.1 0.2 0.1 0.1 0.0 11.7 0.0 0.0 4.0 10.1 0.0 0.1 0.0 0.5 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 3.2 0.3 3.2 3.3 5.0 8.1 9.2 3.4 3.4 9.0 5.3 0.0 9.6 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.1 12.9 8.4 0.0 0.0 14.0 0.0 0.6 0.0 0.0 0.0 0.2 1.2 0.0 1.0 6.1 0.0 3.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 185.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.5 0.9 6.1 226.3 0.0 0.0 0.0 6095.4 0.0 0.7 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 142.6 0.1 RBP1 "CRABP-I, CRBP, CRBP1, CRBPI, RBPC" ENSG00000114115 "Retinol binding protein 1" P09455 3 139517434-139539829 "Metabolic proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 1366.7;pancreas: 632.7" "Group enriched" "Detected in many" 4 "Granulosa cells: 5988.6;Theca cells: 3228.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "SH-SY5Y: 835.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 64.4" "HPA007338, CAB018603, CAB019276" Enhanced Approved Nucleoplasm,Cytosol NA NA 41000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" Cytosol Nucleoplasm "CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814" "unprognostic (9.62e-3)" "unprognostic (7.67e-2)" "unprognostic (9.53e-3)" "unprognostic (5.17e-1)" "unprognostic (7.48e-3)" "unprognostic (2.27e-2)" "unprognostic (6.29e-2)" "unprognostic (1.16e-1)" "unprognostic (7.12e-2)" "unprognostic (3.91e-3)" "unprognostic (2.74e-2)" "unprognostic (8.86e-2)" "unprognostic (1.11e-3)" "unprognostic (2.60e-2)" "unprognostic (1.71e-1)" "unprognostic (4.50e-2)" "unprognostic (1.28e-3)" 23.7 377.1 64.6 18.4 65.2 1.3 49.5 64.9 72.7 53.8 251.4 30.3 32.3 180.2 64.2 35.4 390.2 182.9 60.1 65.5 67.8 46.9 140.8 26.8 18.6 83.1 69.0 1366.7 632.7 46.8 257.8 63.6 64.7 44.8 14.2 23.2 50.2 41.3 15.2 31.3 26.2 119.3 68.2 47.0 29.3 56.1 75.2 9.4 23.0 15.5 12.0 65.7 24.3 67.5 7.8 2.9 7.4 164.2 0.3 0.0 0.9 0.1 0.0 0.0 0.1 0.4 76.1 0.0 53.8 0.1 2.6 0.1 38.2 0.5 0.0 0.1 5.3 0.1 2.7 75.5 155.1 0.2 0.1 3.0 0.0 0.1 0.0 160.9 0.0 0.0 0.2 29.9 0.2 0.0 0.2 0.5 18.4 0.2 0.0 0.1 32.0 0.5 0.1 0.1 19.6 835.4 35.3 0.1 0.1 13.9 3.2 1.1 0.0 0.3 120.0 0.2 0.3 0.6 0.5 0.5 1.3 0.0 2.3 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 64.6 65.2 64.9 72.7 65.5 67.8 83.1 69.0 64.7 68.2 75.2 67.5 24.8 32.1 5.9 8.8 3.5 17.6 53.5 91.9 2.8 26.3 70.4 47.8 21.4 77.2 30.3 23.9 2.1 3.2 1.0 0.1 13.7 1013.0 4.8 199.6 961.4 103.8 43.1 13.5 0.5 1042.7 6.2 158.8 19.9 58.1 0.0 5988.6 343.7 6.9 16.5 3.3 0.3 2.3 42.7 10.6 3.4 16.2 27.1 25.1 8.8 5.6 13.5 159.9 0.0 4.0 16.0 563.0 0.0 4.5 2.9 56.6 2.6 4.7 10.3 7.2 26.3 220.9 534.7 11.6 4.9 6.2 34.9 3.8 10.2 3228.5 2.7 32.7 NMNAT3 PNAT3 ENSG00000163864 "Nicotinamide nucleotide adenylyltransferase 3" Q96T66 3 139560180-139678017 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 50.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 567.3;Alveolar cells type 2: 566.9;Club cells: 217.6;granulocytes: 278.8;Late spermatids: 223.3;Respiratory ciliated cells: 250.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 31.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039077, HPA057402" Approved Supported Mitochondria NA NA "Cluster 11: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" Mitochondria "HPA039077: AB_2676336, HPA057402: AB_2683427" "unprognostic (9.45e-3)" "prognostic favorable (9.67e-4)" "unprognostic (2.29e-1)" "unprognostic (1.56e-3)" "unprognostic (2.33e-2)" "unprognostic (2.33e-1)" "unprognostic (2.77e-3)" "unprognostic (6.22e-2)" "unprognostic (9.69e-2)" "unprognostic (1.92e-1)" "prognostic favorable (7.29e-5)" "unprognostic (4.57e-2)" "prognostic favorable (1.95e-5)" "unprognostic (4.13e-2)" "unprognostic (1.63e-1)" "unprognostic (1.44e-1)" "unprognostic (3.07e-1)" 7.5 7.4 17.7 4.9 26.7 19.3 8.3 46.5 45.4 6.7 8.2 6.9 9.2 9.4 8.1 5.4 13.6 5.4 11.6 21.5 10.9 9.2 6.6 4.3 4.8 8.6 5.3 20.1 12.0 8.9 5.5 2.2 15.1 6.5 7.5 30.6 9.3 5.5 29.6 19.0 7.8 5.6 2.5 5.4 5.6 11.3 14.6 3.0 7.6 20.3 5.3 5.5 6.8 50.1 9.2 3.6 4.0 4.6 0.9 0.9 5.0 3.7 0.4 0.6 0.5 5.1 6.4 5.9 10.8 0.7 4.3 4.5 3.0 1.2 0.7 5.8 5.3 31.4 9.1 6.9 2.4 5.6 5.5 1.4 7.8 1.0 1.7 9.3 0.5 3.6 5.0 13.1 0.6 6.2 5.3 4.6 9.0 16.5 3.7 4.4 4.5 4.3 1.2 6.3 9.2 5.4 9.2 4.8 3.3 7.3 12.6 15.6 5.6 5.7 12.6 7.2 5.5 23.1 11.0 4.2 3.8 9.0 5.4 11.4 3.6 2.2 2.8 3.4 1.9 2.7 2.4 2.4 2.8 4.5 3.4 3.6 7.0 4.0 3.4 2.9 1.6 1.7 17.7 26.7 46.5 45.4 21.5 10.9 8.6 5.3 15.1 2.5 14.6 50.1 5.5 567.3 566.9 34.9 1.9 4.1 6.3 6.6 6.2 2.7 8.2 7.1 9.7 8.6 217.6 9.2 4.2 0.4 0.8 2.3 11.7 3.3 128.2 2.1 2.4 38.8 6.7 27.1 37.2 3.1 0.2 38.3 3.1 1.7 278.8 9.7 2.5 2.7 2.0 1.7 26.0 6.5 8.2 4.1 2.9 223.3 7.8 31.8 7.2 12.2 1.8 12.3 0.0 46.8 16.9 0.8 2.9 6.4 0.7 6.1 3.5 16.1 250.6 18.5 6.6 13.2 3.8 67.1 3.5 4.4 9.7 0.1 21.5 5.9 10.6 4.8 CLSTN2 "CDHR13, CS2, CSTN2, FLJ39113" ENSG00000158258 "Calsyntenin 2" Q9H4D0 3 139935185-140577397 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 18.2;brain: 26.7;ovary: 64.7" "Cell type enriched" "Detected in many" 4 "Excitatory neurons: 552.2" "Cancer enriched" "Detected in many" 7 "breast cancer: 15.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 32.7;SCLC-21H: 14.5;SuSa: 42.7;THP-1: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031342, HPA061800" Approved Uncertain "Vesicles,Cytokinetic bridge" Yes No 130000 "Cluster 35: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "Cytokinetic bridge" "HPA031342: AB_10602800, HPA061800: AB_2684615" "unprognostic (7.58e-2)" "unprognostic (2.64e-2)" "unprognostic (8.02e-2)" "unprognostic (1.51e-3)" "unprognostic (5.52e-3)" "unprognostic (8.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "unprognostic (5.58e-1)" "unprognostic (6.25e-2)" "unprognostic (2.24e-1)" "unprognostic (1.81e-1)" "unprognostic (1.71e-1)" "unprognostic (2.52e-2)" "unprognostic (3.16e-2)" "unprognostic (7.63e-5)" "unprognostic (7.22e-5)" 18.2 4.8 17.3 0.3 15.3 0.0 8.8 0.0 26.7 4.2 0.0 1.4 0.5 5.1 0.7 1.0 4.7 2.1 6.1 23.4 0.0 4.3 0.8 1.1 2.7 13.3 3.1 64.7 1.6 0.8 0.9 0.9 9.1 5.3 0.8 2.7 1.3 1.1 1.6 2.0 1.3 6.8 0.0 0.1 1.0 0.6 0.0 0.7 2.8 2.2 0.2 1.6 3.2 15.6 0.0 0.0 5.1 0.0 2.2 0.6 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.1 0.0 32.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 2.1 0.0 0.0 0.0 42.7 2.2 9.4 0.0 1.0 0.5 1.4 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 15.3 0.0 26.7 23.4 0.0 13.3 3.1 9.1 0.0 0.0 15.6 2.1 0.0 0.0 18.3 0.0 0.5 0.3 0.0 8.6 1.8 10.9 2.2 8.0 0.0 0.6 3.7 0.0 0.2 0.1 0.0 1.9 0.2 39.8 0.5 8.9 0.8 0.0 0.0 552.2 0.2 0.0 9.1 0.0 0.2 0.0 25.0 2.2 0.0 0.1 0.0 111.5 0.0 0.0 0.3 1.5 31.1 28.0 0.8 0.0 5.6 0.0 0.8 0.0 108.6 29.4 0.0 0.0 0.7 0.0 5.0 0.0 32.3 3.0 3.8 0.0 28.3 13.7 0.8 0.8 0.4 0.0 0.0 0.7 0.5 0.0 0.3 TRIM42 "FLJ40097, PPP1R40, T4A1" ENSG00000155890 "Tripartite motif containing 42" Q8IWZ5 3 140678064-140701150 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 41 "testis: 16.7" "Group enriched" "Detected in some" 118 "Early spermatids: 245.8;Late spermatids: 157.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA003581, HPA022481" Uncertain Nucleoplasm,Mitochondria NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Mitochondria" "HPA003581: AB_1080383, HPA022481: AB_1858301" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 245.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.9 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC25A36 "FLJ10618, PNC2" ENSG00000114120 "Solute carrier family 25 member 36" Q96CQ1 3 140941830-140980995 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027036 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" "Mitochondria, Cytosol" Nucleoplasm "HPA027036: AB_1857048" "unprognostic (4.12e-2)" "unprognostic (9.98e-2)" "unprognostic (2.86e-1)" "unprognostic (1.37e-1)" "unprognostic (6.52e-2)" "unprognostic (3.46e-1)" "unprognostic (9.00e-2)" "unprognostic (1.71e-2)" "unprognostic (1.99e-2)" "unprognostic (2.47e-2)" "unprognostic (3.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.20e-1)" "unprognostic (2.34e-1)" "unprognostic (6.03e-2)" "prognostic favorable (1.55e-4)" 27.1 22.2 16.6 14.3 16.2 61.6 33.5 16.2 22.7 31.9 13.9 25.7 30.9 34.4 47.7 15.0 32.6 18.4 39.8 16.1 20.1 38.7 4.2 27.5 21.3 17.0 16.4 39.0 45.2 28.9 26.9 26.4 17.5 27.1 19.5 42.6 23.4 20.8 38.4 22.5 22.9 19.2 16.9 20.1 34.0 23.8 18.2 20.6 31.8 20.8 17.6 23.0 23.9 21.5 52.3 11.5 36.0 30.8 33.0 40.7 46.2 19.4 23.6 18.2 27.3 28.6 24.0 42.1 46.9 17.3 31.2 34.9 40.1 15.2 40.6 33.8 36.5 33.9 29.8 20.9 45.9 48.8 21.3 44.1 61.1 15.4 45.8 44.4 22.0 32.0 17.6 27.4 29.2 22.8 30.6 34.1 37.8 12.8 18.4 34.2 32.0 59.6 23.5 17.7 22.4 38.2 26.7 45.1 80.9 30.3 32.6 29.2 24.1 29.5 17.1 52.2 19.0 56.4 36.8 51.2 36.0 21.1 15.0 10.7 9.2 15.1 9.6 11.5 11.8 16.3 9.6 10.2 14.0 15.1 13.5 12.6 1.7 18.3 13.5 9.7 9.9 9.8 16.6 16.2 16.2 22.7 16.1 20.1 17.0 16.4 17.5 16.9 18.2 21.5 60.3 99.3 143.0 85.5 47.6 68.2 68.0 38.1 116.7 106.0 72.2 77.5 90.3 38.6 52.0 71.7 133.5 58.8 58.2 22.7 64.6 26.4 10.6 113.4 78.0 45.8 59.3 27.3 127.7 38.3 38.0 73.9 58.1 106.3 65.9 92.8 35.7 0.5 26.5 92.5 115.6 32.5 30.5 38.2 45.8 16.0 59.7 38.4 56.9 46.9 36.9 68.2 25.7 108.6 109.1 29.3 22.8 59.5 48.2 88.9 44.9 57.5 98.8 121.8 59.2 80.0 59.2 59.4 68.8 61.3 54.4 49.4 49.1 83.2 46.8 78.9 SPSB4 SSB-4 ENSG00000175093 "SplA/ryanodine receptor domain and SOCS box containing 4" Q96A44 3 141051347-141148611 "Predicted intracellular proteins" "Biological rhythms, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 2.9;pancreas: 7.0;pituitary gland: 3.0;testis: 2.9" "Group enriched" "Detected in some" 4 "Early spermatids: 23.6;Late spermatids: 11.7;Oligodendrocyte precursor cells: 41.7;Spermatocytes: 22.1" "Group enriched" "Detected in some" 5 "glioma: 4.6;testis cancer: 2.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.5;NTERA-2: 3.5;RH-30: 4.2;SH-SY5Y: 3.6;U-2 OS: 2.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA062793 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Golgi apparatus" "HPA062793: AB_2732689" "unprognostic (5.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.12e-1)" "unprognostic (1.23e-3)" "prognostic favorable (3.72e-4)" "unprognostic (7.49e-2)" "unprognostic (6.58e-2)" "unprognostic (1.76e-1)" "unprognostic (8.48e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-1)" "unprognostic (2.36e-1)" "unprognostic (1.06e-2)" "unprognostic (1.47e-3)" "unprognostic (2.30e-2)" "unprognostic (2.46e-4)" "unprognostic (9.80e-3)" 0.3 0.3 0.5 0.0 0.9 0.0 0.1 0.8 1.2 0.0 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.3 2.0 0.3 0.0 0.4 0.0 2.8 2.1 0.0 7.0 0.2 3.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 1.5 1.1 0.0 2.9 1.1 0.2 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 12.5 0.2 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.4 0.9 0.0 3.5 0.0 0.0 0.0 4.2 0.6 0.0 0.0 1.1 3.6 0.0 0.0 0.0 2.0 0.2 0.3 0.0 0.0 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.8 1.2 0.3 2.0 2.8 2.1 1.6 1.5 1.1 0.9 0.4 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.1 4.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 23.6 0.0 0.1 0.1 0.0 0.0 2.8 0.5 0.0 3.2 0.0 0.0 0.0 0.4 0.4 0.1 0.2 0.0 5.6 0.0 0.0 5.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.3 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.4 22.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 PXYLP1 "ACPL2, FLJ23751" ENSG00000155893 "2-phosphoxylose phosphatase 1" Q8TE99 3 141228726-141367753 "Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 148.2" "Cell type enhanced" "Detected in many" "Early spermatids: 196.8;Late spermatids: 131.1;Spermatocytes: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017243 Uncertain "Intracellular and membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA017243: AB_1844509" "unprognostic (9.55e-2)" "unprognostic (3.48e-3)" "unprognostic (1.81e-1)" "unprognostic (2.06e-1)" "unprognostic (8.45e-2)" "unprognostic (8.04e-3)" "unprognostic (4.05e-3)" "unprognostic (5.43e-2)" "unprognostic (1.27e-1)" "unprognostic (6.95e-2)" "unprognostic (5.07e-3)" "unprognostic (4.67e-2)" "unprognostic (1.29e-2)" "unprognostic (5.20e-2)" "unprognostic (1.37e-1)" "unprognostic (8.56e-2)" "unprognostic (8.17e-3)" 4.2 6.3 5.6 4.3 6.4 5.0 8.3 1.7 13.5 7.3 0.3 5.4 5.5 8.8 148.2 2.6 6.4 8.2 13.8 6.3 6.5 7.5 5.1 4.9 9.1 1.0 3.0 8.6 9.2 16.2 7.4 18.2 1.1 10.1 5.6 18.3 6.6 28.9 2.9 4.6 6.4 7.2 3.4 5.3 5.0 8.9 3.4 53.3 5.9 2.0 9.9 7.0 4.7 6.6 5.3 5.5 23.3 18.5 9.0 7.7 5.6 3.6 9.0 9.1 12.5 9.2 1.8 0.3 4.9 8.2 1.9 1.2 24.7 2.3 8.7 17.4 16.3 1.9 7.5 7.4 19.2 4.8 1.0 7.3 10.4 2.8 1.0 11.3 0.6 17.8 0.9 2.1 4.1 4.5 25.8 6.0 9.7 13.2 3.1 3.5 13.6 3.2 6.5 22.8 10.1 17.8 9.3 2.9 7.6 4.2 9.7 2.8 1.1 11.6 6.9 8.0 3.5 4.9 0.4 0.7 10.7 6.5 10.4 15.2 6.0 9.4 13.4 4.0 8.6 0.7 7.5 8.9 5.3 0.5 21.6 17.6 3.8 19.3 2.0 1.9 4.3 8.9 5.6 6.4 1.7 13.5 6.3 6.5 1.0 3.0 1.1 3.4 3.4 6.6 1.1 9.6 8.7 14.0 2.2 0.0 4.6 0.0 6.2 3.3 9.5 6.7 7.6 2.8 1.8 46.0 6.2 2.1 3.4 2.1 0.0 3.2 196.8 1.0 9.3 1.4 4.2 4.4 41.3 3.7 8.2 7.9 1.1 1.8 2.5 5.4 1.4 3.8 0.7 6.7 31.8 3.9 0.0 1.8 0.0 131.1 20.2 2.0 0.0 1.0 3.5 8.0 3.1 32.6 6.5 3.0 8.6 15.1 2.7 7.6 4.2 11.7 2.9 5.2 13.1 6.6 4.2 95.9 13.8 2.2 0.0 1.1 4.9 0.9 4.7 6.6 ZBTB38 "CIBZ, FLJ35036, PPP1R171, ZNF921" ENSG00000177311 "Zinc finger and BTB domain containing 38" Q8NAP3 3 141324213-141449792 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 284.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 261.2;RPMI-8226: 395.1;U-266/70: 259.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014865, HPA059378" Enhanced Nucleoplasm No No "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "HPA014865: AB_2732412, HPA059378: AB_2683998" "unprognostic (1.78e-1)" "unprognostic (3.18e-1)" "unprognostic (2.97e-3)" "unprognostic (1.93e-1)" "unprognostic (2.78e-1)" "unprognostic (2.84e-2)" "unprognostic (4.01e-2)" "unprognostic (7.99e-2)" "unprognostic (8.45e-2)" "unprognostic (1.38e-1)" "unprognostic (2.01e-3)" "unprognostic (4.53e-1)" "unprognostic (5.07e-3)" "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (1.29e-2)" "unprognostic (1.04e-1)" 27.1 42.3 7.7 30.4 14.4 11.3 25.4 34.1 18.1 47.8 11.9 39.1 28.8 65.5 20.3 26.8 32.3 47.3 42.1 9.8 9.6 34.1 24.2 31.7 34.4 11.8 12.8 38.2 33.6 53.5 8.3 34.8 13.9 28.1 40.8 39.0 33.0 33.9 55.1 16.7 31.5 56.0 8.0 23.9 29.2 30.1 14.0 14.3 38.0 31.0 38.7 35.0 11.6 28.3 56.4 82.0 9.3 18.7 84.8 79.4 12.5 89.0 106.7 84.6 122.8 43.0 32.4 1.9 36.1 78.1 65.7 15.5 10.8 75.4 191.5 54.5 15.2 15.8 74.4 25.2 94.0 1.0 22.4 60.1 43.8 89.9 180.6 137.8 65.6 1.5 16.9 261.2 96.9 6.0 1.0 3.5 9.7 15.7 10.1 1.1 27.5 395.1 54.3 34.3 3.6 13.7 130.7 12.4 46.0 16.4 26.8 13.8 159.5 68.5 17.5 134.9 42.2 259.7 163.4 19.8 116.7 1.8 38.5 27.9 5.5 15.2 25.9 8.2 19.3 16.6 16.7 26.4 8.1 7.2 12.9 21.0 6.3 24.1 7.2 3.9 24.4 11.5 7.7 14.4 34.1 18.1 9.8 9.6 11.8 12.8 13.9 8.0 14.0 28.3 70.7 76.9 64.6 38.2 48.0 20.4 33.8 36.3 24.5 89.8 44.0 41.1 114.8 64.3 61.2 58.8 75.0 32.6 66.5 57.8 29.4 39.3 284.2 63.4 107.9 81.2 36.0 17.7 115.4 31.8 17.0 59.3 35.2 125.9 68.9 40.0 59.3 34.9 32.6 141.3 107.9 37.0 24.4 23.4 43.1 118.6 70.5 37.9 39.2 65.6 70.8 59.3 55.6 56.8 105.3 69.6 37.0 103.0 221.9 36.8 38.9 51.1 46.6 73.3 118.3 71.9 106.9 9.4 11.4 19.0 18.6 124.9 88.4 35.6 82.5 43.5 RASA2 GAP1M ENSG00000155903 "RAS p21 protein activator 2" Q15283 3 141487027-141615344 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 196.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035374, HPA035375" Approved Approved Vesicles "Intracellular and membrane" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 44: Endometrium - Transcription" Vesicles "HPA035374: AB_10602122, HPA035375: AB_2674596" "unprognostic (1.85e-1)" "unprognostic (8.11e-2)" "unprognostic (1.48e-1)" "unprognostic (2.38e-2)" "unprognostic (1.18e-1)" "unprognostic (3.36e-3)" "unprognostic (9.62e-3)" "unprognostic (2.57e-1)" "unprognostic (1.38e-1)" "unprognostic (9.21e-2)" "unprognostic (4.23e-2)" "unprognostic (8.93e-2)" "prognostic unfavorable (7.62e-7)" "unprognostic (1.17e-1)" "unprognostic (2.56e-1)" "unprognostic (1.61e-1)" "prognostic favorable (4.34e-5)" 7.3 4.7 5.1 15.4 6.0 21.9 10.0 7.1 6.4 9.8 3.2 6.6 5.3 8.4 7.3 7.3 7.8 6.7 4.6 5.3 4.9 5.8 5.1 9.7 21.3 4.0 3.6 9.7 5.2 4.4 6.2 8.3 3.5 6.5 7.2 14.6 8.1 5.0 3.8 11.2 8.5 6.0 3.1 12.4 5.4 4.7 4.7 13.3 6.0 3.3 17.2 8.8 8.8 5.6 24.6 4.5 9.5 7.2 10.2 12.6 13.5 17.4 34.0 11.0 13.5 10.5 7.9 15.6 11.7 15.2 10.6 10.0 6.8 7.5 20.0 8.5 6.7 8.4 3.8 3.8 5.4 16.1 21.0 7.3 6.6 10.0 11.8 13.3 14.1 13.1 7.7 19.7 11.0 3.6 21.2 13.0 11.1 8.1 3.2 7.9 16.0 19.5 10.9 8.7 3.3 6.9 13.8 12.1 13.0 9.8 6.0 12.0 11.9 12.9 5.9 18.1 7.8 31.9 10.0 20.9 11.3 10.8 6.4 12.8 4.9 5.3 14.8 5.0 14.8 8.9 13.2 15.3 4.6 13.5 21.6 17.2 19.2 15.7 8.9 3.6 13.2 8.0 5.1 6.0 7.1 6.4 5.3 4.9 4.0 3.6 3.5 3.1 4.7 5.6 24.2 44.8 23.6 59.4 55.1 21.5 52.0 15.8 21.1 16.2 22.0 17.5 7.4 8.6 21.4 12.9 37.5 20.0 104.9 21.7 1.9 16.8 120.3 26.3 19.7 22.7 15.7 17.5 196.9 16.5 6.6 20.4 11.2 60.7 31.6 29.6 20.3 9.6 12.5 30.3 123.1 15.2 8.2 32.5 24.6 12.7 13.7 34.3 12.4 94.6 19.8 15.3 68.0 112.1 94.4 31.8 21.7 14.3 94.9 53.4 10.4 9.1 15.5 50.7 6.6 26.4 27.2 28.2 15.3 17.5 27.4 13.1 88.3 4.6 18.7 62.5 RNF7 "CKBBP1, ROC2, SAG" ENSG00000114125 "Ring finger protein 7" Q9UBF6 3 141738249-141747560 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 898.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA036995 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 38: EFO-21 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA036995: AB_10673627" "unprognostic (5.68e-2)" "unprognostic (4.94e-3)" "unprognostic (1.83e-1)" "unprognostic (3.24e-1)" "unprognostic (9.11e-2)" "unprognostic (3.45e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (4.53e-2)" "unprognostic (1.24e-2)" "unprognostic (3.98e-3)" "unprognostic (5.17e-3)" "unprognostic (8.58e-3)" "prognostic unfavorable (1.54e-9)" "unprognostic (4.60e-1)" "unprognostic (2.20e-1)" "unprognostic (3.69e-2)" "unprognostic (2.36e-2)" 67.1 114.5 62.7 40.8 65.6 65.0 63.5 63.4 80.0 69.5 72.2 98.2 69.7 58.7 70.8 86.5 61.0 46.1 102.8 64.2 67.2 92.3 83.9 58.4 44.5 64.4 64.8 73.8 80.3 44.0 81.5 51.2 65.7 77.6 59.8 37.6 59.8 43.8 142.0 72.0 64.1 47.8 65.1 58.7 68.3 71.2 66.3 45.4 52.6 113.1 44.1 77.9 71.9 65.9 172.6 67.4 98.1 80.0 91.6 125.7 65.5 94.6 87.5 78.2 82.6 79.4 82.5 57.7 214.5 104.7 192.7 80.8 61.5 88.1 98.3 56.0 119.1 56.6 64.8 116.4 122.6 89.7 52.9 118.2 96.9 63.4 105.5 104.3 112.3 96.1 61.6 77.0 117.2 131.0 56.6 100.1 105.1 170.7 113.3 61.1 63.1 124.0 169.2 74.0 54.8 68.1 108.7 108.8 161.4 126.4 102.4 114.8 86.2 78.1 75.6 139.2 80.5 73.7 66.5 121.2 122.4 98.4 90.3 119.0 128.2 87.7 78.0 116.4 77.7 82.6 82.8 83.2 112.9 74.1 79.6 83.7 45.5 61.8 125.7 103.4 108.8 121.6 62.7 65.6 63.4 80.0 64.2 67.2 64.4 64.8 65.7 65.1 66.3 65.9 128.7 60.9 55.2 7.5 81.4 132.4 143.0 290.5 150.2 34.3 159.7 207.3 104.1 105.8 151.1 101.2 27.1 183.8 133.2 262.0 254.3 225.1 348.9 99.3 112.0 134.9 125.7 41.4 12.9 247.3 249.1 114.2 73.9 100.0 72.9 206.4 129.9 132.0 214.4 28.6 12.6 195.2 134.3 126.7 123.5 898.4 117.8 137.6 144.1 18.7 174.1 111.7 140.1 10.6 19.6 233.2 261.4 121.9 102.0 181.8 295.1 324.1 105.7 56.7 85.5 84.3 126.2 212.2 129.1 183.7 144.6 129.8 112.7 281.4 174.5 185.9 GRK7 GPRK7 ENSG00000114124 "G protein-coupled receptor kinase 7" Q8WTQ7 3 141778148-141818490 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 19 "retina: 11.3" "Cell type enriched" "Detected in some" 73 "Cone photoreceptor cells: 329.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA075093, HPA078232" Enhanced Approved Mitochondria NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 79: Retina - Phototransduction" "Cluster 9: Photoreceptor cells - Phototransduction" Mitochondria "HPA075093: , HPA078232: " "unprognostic (1.11e-1)" "unprognostic (1.70e-2)" "unprognostic (3.35e-3)" "unprognostic (1.22e-2)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-2)" "unprognostic (5.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-2)" "unprognostic (3.46e-2)" "unprognostic (1.20e-1)" "unprognostic (2.53e-8)" "unprognostic (3.08e-1)" "unprognostic (1.99e-1)" "unprognostic (3.11e-1)" "unprognostic (2.91e-1)" 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 3.9 0.1 0.4 0.2 0.0 0.6 1.0 0.1 0.1 0.2 0.0 0.0 0.0 329.4 0.0 0.2 0.0 0.0 0.0 1.0 0.1 0.1 0.1 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.4 2.4 0.0 0.1 0.0 1.9 0.1 1.1 0.0 4.5 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.5 0.1 0.1 0.0 0.2 0.3 0.0 0.1 0.3 0.1 0.0 ATP1B3 "CD298, FLJ29027" ENSG00000069849 "ATPase Na+/K+ transporting subunit beta 3" P54709 3 141876124-141926549 "CD markers, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 982.6;Late spermatids: 930.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020697, HPA048963" Enhanced Supported "Plasma membrane" NA NA 33000 "Cluster 51: Monocytes - Innate immune response" "Cluster 31: Skin - Epidermis development" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 41: Macrophages - Immune response" "Plasma membrane" "CAB020697: , HPA048963: AB_2680574" "unprognostic (2.31e-1)" "unprognostic (1.11e-3)" "unprognostic (2.75e-1)" "prognostic favorable (5.19e-5)" "unprognostic (2.60e-2)" "unprognostic (3.31e-2)" "prognostic unfavorable (6.32e-6)" "unprognostic (8.11e-3)" "unprognostic (6.99e-2)" "unprognostic (5.37e-3)" "unprognostic (1.48e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.29e-5)" "unprognostic (5.14e-2)" "unprognostic (2.04e-1)" "unprognostic (7.19e-3)" "unprognostic (6.15e-2)" 229.4 349.6 62.2 81.0 62.8 63.0 87.0 78.5 78.8 98.4 100.5 146.7 112.7 75.7 37.6 182.3 96.2 55.4 102.8 63.6 74.7 128.4 24.5 191.0 41.3 71.1 66.6 180.0 36.7 20.3 168.7 96.7 76.5 102.0 168.0 43.6 85.8 46.2 26.7 259.3 125.0 71.4 68.7 65.7 66.3 75.8 70.6 51.4 75.8 16.0 57.1 101.0 161.2 62.2 280.8 170.1 155.5 145.6 411.7 118.0 354.7 322.2 287.6 224.2 252.1 253.7 136.5 223.3 278.2 243.5 328.4 595.8 157.0 152.2 253.4 120.4 190.0 195.7 161.4 156.8 161.7 164.9 149.1 126.5 355.1 179.1 169.7 162.4 245.7 156.3 135.9 193.7 233.8 114.6 165.6 275.0 213.6 384.5 76.1 225.0 116.4 227.1 191.1 186.7 127.6 86.0 413.2 188.5 455.9 270.7 145.6 197.2 170.7 196.4 76.3 298.8 189.8 138.0 197.6 367.5 259.5 176.5 165.2 69.7 104.1 35.4 70.4 174.3 51.7 39.7 56.3 74.8 103.3 30.4 32.6 59.6 6.7 32.0 260.4 64.8 68.4 103.7 62.2 62.8 78.5 78.8 63.6 74.7 71.1 66.6 76.5 68.7 70.6 62.2 114.7 57.7 41.9 38.2 143.4 492.8 428.3 535.9 326.7 35.9 53.0 46.4 19.7 17.2 177.6 220.7 25.0 281.3 464.5 982.6 41.1 73.9 465.9 86.0 72.2 199.2 56.1 147.1 107.5 60.6 226.8 164.1 24.5 127.2 130.7 94.3 100.6 9.0 305.9 25.2 91.2 65.2 164.8 148.0 678.3 930.5 84.8 455.3 222.3 37.5 364.8 46.3 75.2 46.3 54.7 70.6 321.1 68.4 153.1 396.5 413.3 41.5 33.3 28.4 124.9 99.5 265.2 69.0 200.2 178.4 414.4 391.4 216.1 122.2 134.9 370.2 TFDP2 Dp-2 ENSG00000114126 "Transcription factor Dp-2" Q14188 3 141944428-142149544 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 169.7" "Cell type enhanced" "Detected in all" "Early spermatids: 986.1;Late spermatids: 397.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "JURKAT: 216.4;MOLT-4: 423.3;REH: 222.7;U-698: 366.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018396, HPA070399" Supported Supported "Nucleoplasm,Vesicles,Mitotic spindle" Yes No "Cluster 49: Eosinophils - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "Vesicles, Mitotic spindle" "CAB018396: AB_2287284, HPA070399: " "unprognostic (1.35e-2)" "prognostic favorable (6.32e-4)" "unprognostic (8.08e-3)" "unprognostic (2.90e-2)" "unprognostic (4.69e-2)" "unprognostic (1.18e-1)" "unprognostic (1.14e-3)" "unprognostic (2.60e-3)" "unprognostic (5.42e-2)" "unprognostic (1.46e-1)" "unprognostic (5.04e-2)" "unprognostic (2.04e-1)" "prognostic favorable (9.84e-4)" "unprognostic (6.04e-2)" "unprognostic (3.91e-2)" "unprognostic (2.45e-1)" "unprognostic (1.08e-1)" 18.8 15.1 7.8 9.2 8.9 50.3 18.9 21.2 12.7 12.1 8.2 14.8 22.7 15.3 15.9 13.7 14.7 19.4 26.0 9.0 7.0 29.5 17.3 11.8 10.5 12.5 10.6 23.3 12.4 16.7 13.0 28.4 12.4 19.4 14.0 13.2 12.3 13.7 28.5 11.9 21.3 14.4 7.4 9.5 12.4 69.9 8.2 169.7 21.6 21.3 10.6 11.2 10.2 10.0 32.8 14.7 61.6 49.4 20.3 21.9 134.0 16.3 18.8 25.5 40.2 19.2 32.2 115.8 73.7 18.7 44.6 19.5 15.8 31.2 35.8 46.9 28.5 140.4 21.5 26.0 19.6 43.1 47.8 20.6 22.8 27.8 26.9 23.5 18.3 216.4 53.5 6.8 44.3 25.4 423.3 16.1 49.6 17.2 20.0 222.7 42.2 27.0 29.4 16.5 26.9 25.0 54.5 19.5 29.0 45.3 46.7 21.9 12.0 24.2 21.9 19.8 20.7 20.7 20.5 366.5 19.4 11.4 11.6 69.3 4.0 48.0 28.0 6.9 10.9 14.7 12.8 14.9 9.8 18.7 18.6 22.2 4.4 37.4 10.0 33.7 12.8 12.5 7.8 8.9 21.2 12.7 9.0 7.0 12.5 10.6 12.4 7.4 8.2 10.0 29.7 32.1 30.6 64.0 24.2 25.1 52.1 30.4 43.3 33.0 45.1 36.8 87.6 45.8 30.7 47.8 33.3 235.4 98.5 23.1 93.9 36.8 986.1 63.9 51.1 26.8 38.6 171.9 194.6 26.4 125.2 44.0 15.8 35.8 33.5 84.8 27.8 39.8 27.8 37.0 166.7 27.1 40.7 13.5 15.4 397.5 77.0 27.0 5.4 51.5 14.9 26.1 128.8 61.9 116.6 27.2 25.7 75.2 25.2 36.3 87.5 98.4 43.1 34.5 26.3 96.7 38.6 75.4 75.6 31.3 20.0 99.2 42.9 72.4 42.0 36.0 GK5 MGC40579 ENSG00000175066 "Glycerol kinase 5" Q6ZS86 3 142157527-142225592 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycerol metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 127.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042606, HPA057998" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 51: Non-specific - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Cytosol" "HPA042606: AB_10795509, HPA057998: AB_2683573" "unprognostic (7.79e-2)" "unprognostic (5.15e-2)" "unprognostic (2.02e-2)" "unprognostic (1.33e-1)" "unprognostic (3.07e-2)" "unprognostic (3.60e-2)" "unprognostic (9.89e-3)" "unprognostic (3.13e-1)" "unprognostic (2.77e-2)" "unprognostic (1.76e-2)" "unprognostic (7.76e-2)" "unprognostic (2.03e-1)" "unprognostic (1.12e-2)" "unprognostic (2.10e-3)" "unprognostic (4.49e-2)" "unprognostic (1.32e-1)" "unprognostic (5.59e-3)" 4.6 7.0 2.3 3.8 2.4 7.8 6.8 4.8 2.7 5.0 7.0 6.8 9.4 5.4 9.0 4.3 6.0 3.2 2.4 2.3 2.4 3.6 2.1 3.8 2.2 4.4 3.1 8.6 4.0 3.1 5.8 1.7 4.0 8.4 7.3 4.7 11.0 4.0 2.5 5.9 8.0 3.3 2.9 2.2 5.2 3.2 3.0 2.1 4.6 1.5 2.4 4.2 4.4 4.6 11.2 2.7 3.9 2.6 8.0 15.2 6.7 3.6 2.5 3.9 2.5 4.2 6.0 7.9 3.2 3.5 4.3 4.6 4.5 3.5 5.2 2.9 4.3 5.2 7.1 3.1 4.3 6.1 6.7 6.2 3.0 2.6 3.4 2.5 2.3 9.1 4.6 4.7 7.2 7.2 5.3 5.0 2.5 7.5 3.1 4.9 4.2 2.9 4.1 6.8 3.8 2.8 10.1 10.5 3.3 2.3 14.8 4.0 2.5 3.1 2.6 6.9 4.1 4.9 5.1 8.1 5.6 3.8 5.3 2.0 0.4 0.3 1.5 0.3 0.7 0.2 0.5 0.5 0.3 0.4 0.3 0.6 1.1 1.5 2.6 0.4 0.2 0.2 2.3 2.4 4.8 2.7 2.3 2.4 4.4 3.1 4.0 2.9 3.0 4.6 13.7 38.5 30.7 31.6 6.8 4.0 12.3 3.7 15.9 30.6 26.6 13.6 10.5 17.2 17.3 27.6 29.2 13.1 80.5 37.4 7.9 14.9 2.8 32.7 22.5 9.7 27.9 8.8 37.6 20.4 7.3 15.2 25.0 39.2 8.8 23.2 5.0 11.8 5.6 15.2 44.1 42.0 0.0 10.0 3.9 5.2 33.8 20.2 3.6 15.9 9.3 10.2 127.7 27.6 75.6 19.3 31.6 46.6 34.6 21.5 69.5 6.1 14.1 33.0 26.3 16.0 9.0 4.0 5.9 19.4 4.0 6.8 21.0 21.1 34.5 17.3 XRN1 SEP1 ENSG00000114127 "5'-3' exoribonuclease 1" Q8IZH2 3 142306607-142448062 "Predicted intracellular proteins" "DNA-binding, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "RH-30: 119.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035005, HPA035006" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 59: Non-specific - Transcription" "Plasma membrane, Cytosol" "HPA035005: AB_10670695, HPA035006: AB_10672750" "unprognostic (3.52e-1)" "unprognostic (2.35e-2)" "unprognostic (2.49e-1)" "unprognostic (1.35e-2)" "unprognostic (2.40e-2)" "unprognostic (1.68e-2)" "unprognostic (1.24e-1)" "unprognostic (2.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (9.43e-4)" "unprognostic (7.68e-2)" "unprognostic (6.16e-2)" "unprognostic (1.23e-1)" "unprognostic (2.41e-1)" "unprognostic (2.43e-2)" "unprognostic (6.32e-2)" 9.0 6.8 2.9 12.2 4.5 21.2 10.7 11.4 5.5 8.4 6.4 8.2 11.0 9.8 7.8 7.0 6.2 8.0 5.5 3.2 4.0 6.8 16.2 8.6 13.1 3.8 3.2 10.1 8.1 8.8 6.0 10.5 4.2 8.8 9.4 14.6 7.4 6.1 11.7 9.4 12.4 6.6 4.5 12.8 9.0 9.3 3.9 14.4 8.7 9.7 11.3 7.7 8.2 6.8 22.1 3.9 9.6 8.6 11.1 17.0 5.9 9.9 12.9 12.3 15.2 3.6 6.1 8.9 10.3 13.3 10.0 8.6 8.6 5.2 19.2 21.4 6.5 12.7 7.3 3.5 9.6 12.8 12.7 14.0 6.1 8.8 11.7 12.1 11.4 9.7 8.0 20.4 11.7 4.5 11.2 7.6 3.0 3.4 4.4 9.0 119.2 11.4 6.5 10.8 5.7 7.3 17.3 10.4 8.2 5.9 11.9 10.8 16.0 9.0 4.7 10.3 8.7 29.1 14.2 13.7 8.4 7.2 7.9 31.0 5.8 17.2 10.0 5.4 7.1 9.8 7.7 9.1 2.9 7.2 10.1 7.0 21.2 5.9 5.0 8.0 6.2 3.1 2.9 4.5 11.4 5.5 3.2 4.0 3.8 3.2 4.2 4.5 3.9 6.8 66.1 54.5 33.3 74.7 55.9 25.6 33.7 22.7 33.6 33.7 27.2 21.0 26.5 18.6 30.2 46.0 50.1 22.9 80.8 46.5 11.7 16.5 49.9 31.9 50.7 40.6 28.2 43.6 101.6 12.5 7.8 41.8 48.4 29.0 21.5 33.7 33.9 48.0 16.3 26.9 114.2 22.5 14.2 28.9 23.0 19.1 24.8 38.8 14.2 81.5 41.4 21.0 50.4 126.7 120.4 18.6 41.9 29.0 111.7 44.0 43.4 13.2 34.2 53.9 6.6 56.0 39.9 61.8 20.5 27.6 28.3 53.5 69.8 37.1 15.0 43.8 ATR "FRP1, MEC1, SCKL, SCKL1" ENSG00000175054 "ATR serine/threonine kinase" Q13535 3 142449007-142578733 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "DNA damage, DNA repair" "DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 93.0;Inhibitory neurons: 94.4;Microglial cells: 73.1;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 71.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054320 Supported "Nucleoplasm,Golgi apparatus" No No "Cluster 15: NK-cells - Transcription" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "Golgi apparatus" "HPA054320: AB_2682448" "unprognostic (1.47e-1)" "unprognostic (8.90e-2)" "unprognostic (2.90e-1)" "unprognostic (4.23e-2)" "unprognostic (2.25e-2)" "unprognostic (6.42e-2)" "prognostic unfavorable (8.39e-5)" "unprognostic (3.44e-1)" "unprognostic (1.67e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (1.94e-1)" "unprognostic (5.61e-2)" "unprognostic (1.06e-1)" "unprognostic (3.55e-1)" "unprognostic (1.69e-2)" "unprognostic (1.43e-1)" 3.0 8.6 0.7 4.1 1.1 1.2 3.2 0.9 1.4 3.8 3.7 2.7 1.7 3.3 2.3 3.1 3.3 3.4 2.3 1.2 1.9 3.7 3.6 2.9 4.8 1.5 1.2 2.7 3.8 5.2 3.7 3.1 1.4 3.0 2.9 2.9 3.5 2.5 2.9 2.7 3.1 3.2 1.0 4.2 2.8 5.2 1.2 4.9 5.0 1.4 4.6 4.1 2.7 1.2 28.6 13.2 7.1 7.0 9.6 13.6 8.8 14.8 8.4 10.1 9.7 6.4 6.8 19.9 14.6 10.1 14.6 16.1 10.9 12.8 15.0 7.5 7.9 11.9 8.2 4.1 4.2 20.5 5.3 9.8 4.8 9.5 10.3 5.8 11.6 8.7 8.2 7.5 9.6 7.5 13.9 2.6 7.3 15.6 9.6 11.8 12.5 13.5 6.3 11.1 5.2 5.1 28.6 8.3 8.0 7.8 12.0 5.4 14.6 10.5 4.9 12.3 15.2 10.8 7.4 18.5 13.8 6.5 8.5 0.0 0.3 0.0 0.5 0.4 1.0 0.1 0.3 0.5 0.7 0.3 0.4 0.4 0.0 1.3 0.2 0.2 0.4 0.2 0.7 1.1 0.9 1.4 1.2 1.9 1.5 1.2 1.4 1.0 1.2 1.2 11.5 6.4 10.6 39.2 22.4 4.0 7.2 8.8 14.2 14.1 9.2 6.5 7.6 5.7 10.1 3.7 37.5 7.7 14.9 3.5 0.0 5.9 16.4 18.8 18.6 10.2 7.7 14.5 93.0 4.9 3.6 8.3 14.8 10.3 1.3 16.3 7.9 7.3 6.4 8.4 94.4 4.8 14.2 9.4 4.0 8.7 6.5 12.8 10.6 73.1 12.0 6.0 9.2 65.4 71.9 6.4 1.8 7.2 23.1 8.1 1.9 6.5 25.4 23.6 0.0 14.6 9.8 50.1 18.5 14.7 4.5 5.1 15.1 13.8 7.6 6.1 PLS1 "I-plastin, Plastin-1" ENSG00000120756 "Plastin 1" Q14651 3 142596393-142713664 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Actin-binding "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "intestine: 315.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 471.4;Intestinal goblet cells: 147.9;Paneth cells: 200.5;Proximal enterocytes: 335.1" "Cancer enhanced" "Detected in many" "colorectal cancer: 36.0" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.6;NK-cells: 3.2;T-cells: 2.6" "Cell line enhanced" "Detected in many" "A-431: 90.0;BEWO: 112.3;OE19: 166.4;RPTEC TERT1: 143.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055744, HPA061936" Enhanced NA NA 56000000 "Cluster 15: NK-cells - Transcription" "Cluster 9: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA055744: AB_2682903, HPA061936: " "unprognostic (1.29e-1)" "unprognostic (2.61e-1)" "unprognostic (3.15e-3)" "unprognostic (2.22e-2)" "unprognostic (1.20e-1)" "unprognostic (1.41e-2)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.33e-1)" "unprognostic (7.78e-2)" "prognostic unfavorable (4.84e-4)" "unprognostic (3.14e-2)" "prognostic favorable (8.76e-6)" "unprognostic (1.99e-2)" "unprognostic (8.64e-2)" "unprognostic (7.22e-2)" "unprognostic (3.82e-2)" 1.6 3.9 0.8 18.8 1.3 7.4 5.7 2.7 2.2 10.1 11.7 144.2 191.6 3.3 3.1 9.6 7.7 27.7 1.2 1.1 1.4 26.7 27.5 14.8 1.7 3.3 0.3 0.9 12.2 15.7 6.2 1.5 3.2 3.1 139.1 24.9 9.1 1.9 0.9 3.6 315.6 4.3 0.3 0.9 45.8 7.5 0.4 5.9 7.7 0.9 2.9 19.6 3.7 1.4 90.0 69.2 4.8 10.4 0.7 0.0 112.3 1.7 2.3 9.4 20.1 31.7 68.8 15.2 35.8 0.1 31.9 18.9 18.8 28.7 20.0 5.5 27.0 27.2 10.2 11.4 0.9 13.0 1.7 0.1 4.7 17.8 11.4 14.8 4.5 16.4 11.8 1.7 1.1 21.0 21.4 7.0 18.9 166.4 25.9 8.7 20.3 12.7 143.6 81.7 24.1 9.7 10.0 7.0 7.8 13.3 55.6 2.2 1.2 1.1 11.3 3.5 21.3 12.7 12.6 18.1 3.2 12.8 3.5 1.9 0.2 2.6 1.5 0.2 2.0 0.3 1.8 2.0 0.4 0.3 2.2 2.6 1.8 3.2 0.2 0.5 1.3 1.0 0.8 1.3 2.7 2.2 1.1 1.4 3.3 0.3 3.2 0.3 0.4 1.4 0.6 54.5 38.0 1.3 1.6 2.9 4.1 23.2 2.8 3.4 9.7 4.2 3.1 54.3 46.8 44.1 16.7 5.8 0.7 471.4 21.5 21.8 64.3 22.2 1.8 0.7 53.9 5.9 18.7 34.0 1.9 1.1 50.0 26.8 8.9 32.3 1.1 31.5 0.6 5.0 25.2 147.9 24.4 1.6 1.0 20.5 1.2 1.4 1.8 5.6 0.8 2.8 0.0 4.0 3.1 70.2 200.5 0.0 2.8 6.8 335.1 40.6 42.2 13.4 0.0 1.2 1.9 4.6 4.1 7.6 3.3 1.4 1.8 1.3 85.2 20.7 TRPC1 HTRP-1 ENSG00000144935 "Transient receptor potential cation channel subfamily C member 1" P48995 3 142724034-142807888 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 7 "Astrocytes: 93.7;Excitatory neurons: 144.6;Granulosa cells: 91.8;Inhibitory neurons: 184.4;Microglial cells: 49.6;Oligodendrocyte precursor cells: 154.8;Oligodendrocytes: 164.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009387, HPA021130" Supported Approved Vesicles NA NA "Cluster 21: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Vesicles "CAB009387: AB_2240941, HPA021130: AB_1858361" "unprognostic (1.66e-1)" "unprognostic (7.38e-2)" "unprognostic (1.56e-2)" "unprognostic (4.37e-5)" "unprognostic (5.53e-1)" "unprognostic (1.40e-2)" "unprognostic (5.90e-3)" "unprognostic (1.59e-2)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (8.46e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (2.72e-5)" "unprognostic (1.44e-3)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (2.49e-2)" 5.2 4.7 7.3 1.9 7.9 0.3 4.7 10.9 7.5 9.1 5.8 7.6 1.2 11.1 5.2 3.6 8.6 5.4 10.1 7.9 7.0 3.2 0.8 3.3 1.9 7.1 5.6 14.2 1.4 6.5 10.3 3.5 7.7 7.0 2.5 22.8 2.9 7.8 1.2 3.6 3.9 10.6 6.1 2.8 3.2 4.8 6.1 1.5 5.1 3.6 1.0 6.3 6.9 7.9 4.2 5.7 10.8 1.2 9.7 23.9 4.8 6.8 10.5 8.4 12.2 1.7 1.1 0.0 2.1 7.0 14.2 0.3 3.0 3.2 12.2 1.0 4.1 6.8 2.6 2.9 4.0 0.4 0.0 11.4 3.2 7.9 9.4 14.2 4.9 0.0 0.2 0.0 12.1 2.6 0.4 0.5 6.0 0.1 3.1 0.0 5.0 0.0 5.9 0.1 6.7 4.8 8.1 0.0 1.5 9.9 3.3 0.1 4.3 10.1 1.6 14.0 9.1 3.9 1.8 2.1 7.7 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 7.3 7.9 10.9 7.5 7.9 7.0 7.1 5.6 7.7 6.1 6.1 7.9 6.2 3.2 0.5 93.7 2.9 2.9 1.6 1.2 7.4 17.9 0.9 1.8 12.0 1.5 0.6 5.5 16.7 0.2 0.3 0.0 0.0 0.3 3.6 0.5 10.8 4.6 1.8 0.4 144.6 0.2 0.2 13.2 0.0 0.9 0.0 91.8 3.6 0.0 0.1 13.5 184.4 0.0 0.0 0.0 1.6 2.9 8.4 0.5 1.8 49.6 0.1 7.7 0.0 154.8 164.8 0.1 0.0 10.9 1.5 0.9 0.0 0.7 3.0 16.0 0.0 10.4 12.0 9.8 2.8 0.7 1.1 0.3 2.2 1.7 0.0 0.3 PCOLCE2 PCPE2 ENSG00000163710 "Procollagen C-endopeptidase enhancer 2" Q9UKZ9 3 142815922-142889206 "Predicted secreted proteins" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 87.6;heart muscle: 123.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 138.0;Extravillous trophoblasts: 63.1;Fibroblasts: 225.8;Syncytiotrophoblasts: 241.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 65.5;RPMI-8226: 36.8;U-2197: 77.9;U-266/70: 68.6;U-266/84: 34.3" "Low region specificity" "Detected in many" HPA013203 Uncertain Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 580000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Cytosol" "HPA013203: AB_1855084" "unprognostic (1.31e-1)" "unprognostic (3.75e-2)" "unprognostic (5.71e-6)" "unprognostic (8.36e-6)" "unprognostic (3.03e-2)" "unprognostic (1.06e-3)" "unprognostic (2.78e-2)" "unprognostic (9.39e-2)" "unprognostic (1.60e-2)" "unprognostic (1.67e-1)" "unprognostic (1.36e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.96e-5)" "unprognostic (1.85e-4)" "unprognostic (1.43e-1)" "unprognostic (1.74e-4)" "prognostic unfavorable (1.08e-4)" 87.6 2.8 0.8 4.0 0.9 14.9 29.1 0.4 1.0 21.5 0.8 6.9 0.1 4.2 2.2 7.8 3.9 1.5 123.2 1.3 1.9 17.9 18.3 16.4 2.3 0.7 1.1 3.9 1.4 0.7 23.7 48.1 0.6 21.5 5.1 0.7 3.1 8.9 2.4 5.3 2.8 8.7 0.5 3.0 3.4 2.4 1.5 0.7 6.4 22.1 1.9 25.7 26.0 0.8 1.4 11.0 3.4 0.0 65.5 18.1 0.0 1.0 0.2 2.9 3.6 0.7 1.2 0.0 3.3 4.9 14.8 0.1 13.7 0.0 3.4 0.0 21.0 2.5 6.8 0.0 0.0 1.5 0.0 6.9 0.0 6.9 1.7 14.5 0.2 2.2 0.5 0.0 1.4 2.0 4.5 1.2 5.5 0.2 21.9 0.0 8.1 36.8 3.2 0.1 7.6 4.6 17.8 0.0 6.5 4.7 0.0 4.5 0.0 5.8 12.8 77.9 6.0 68.6 34.3 0.0 16.6 1.9 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.4 1.0 1.3 1.9 0.7 1.1 0.6 0.5 1.5 0.8 17.3 0.0 3.2 0.7 0.2 7.4 0.7 0.9 0.6 18.0 0.5 0.6 37.3 0.0 0.9 12.9 25.0 138.0 0.2 0.2 0.0 0.0 0.6 2.1 2.2 4.5 0.0 0.0 1.6 0.0 63.1 225.8 0.5 3.7 1.3 29.0 0.4 11.8 15.3 6.7 2.2 0.2 0.0 0.6 12.4 1.0 0.6 6.7 3.6 1.9 0.0 13.8 0.0 29.7 1.6 0.5 0.4 0.0 0.0 2.1 0.0 0.0 0.0 12.6 0.0 6.1 16.9 25.8 47.7 1.0 7.4 241.6 1.1 19.1 0.0 0.4 PAQR9 FLJ41938 ENSG00000188582 "Progestin and adipoQ receptor family member 9" Q6ZVX9 3 142949164-142963674 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 13.5;retina: 9.6;testis: 20.4" "Cell type enhanced" "Detected in some" "Early spermatids: 42.1;Erythroid cells: 28.2;Hepatocytes: 18.4;Late spermatids: 98.3;Syncytiotrophoblasts: 36.5" "Cancer enriched" "Detected in single" 15 "liver cancer: 5.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.0;AF22: 1.0;U-266/70: 3.3;U-266/84: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA052798 Uncertain NA NA "Cluster 77: Retina - Visual perception" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "HPA052798: AB_2681955" "unprognostic (4.13e-2)" "unprognostic (2.54e-1)" "unprognostic (2.81e-1)" "unprognostic (3.09e-2)" "unprognostic (1.21e-2)" "unprognostic (5.98e-2)" "unprognostic (1.12e-1)" "unprognostic (3.56e-2)" "unprognostic (1.23e-2)" "unprognostic (1.09e-1)" "unprognostic (6.91e-2)" 0.0 0.0 1.9 0.0 1.7 5.2 0.0 0.9 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 2.3 1.5 0.0 13.5 0.0 0.0 1.1 1.9 0.0 0.0 0.2 0.9 0.2 1.1 0.0 0.0 9.6 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 20.4 3.3 0.1 0.0 1.4 0.0 0.1 0.0 2.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.2 0.0 3.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.7 0.9 5.5 2.3 1.5 1.1 1.9 1.1 0.2 3.3 2.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 5.8 0.0 0.0 6.7 1.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 42.1 0.7 0.0 0.2 0.0 28.2 0.8 0.0 0.1 0.3 0.0 0.2 0.0 1.0 0.0 18.4 0.1 0.0 0.7 0.0 0.0 0.0 0.0 98.3 1.2 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.2 0.1 0.0 1.9 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.0 0.1 2.6 5.4 0.0 0.1 36.5 0.0 0.1 0.0 0.0 U2SURP "fSAPa, SR140" ENSG00000163714 "U2 snRNP associated SURP domain containing" O15042 3 142964497-143060725 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037545, HPA037546, HPA061407" Enhanced Supported Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA037545: AB_10672598, HPA037546: AB_2675535, HPA061407: AB_2684506" "unprognostic (2.01e-1)" "unprognostic (9.78e-2)" "unprognostic (8.09e-2)" "prognostic unfavorable (8.44e-4)" "unprognostic (3.11e-2)" "unprognostic (4.30e-2)" "prognostic unfavorable (3.15e-5)" "unprognostic (3.72e-2)" "unprognostic (1.98e-2)" "unprognostic (9.61e-2)" "prognostic unfavorable (8.92e-4)" "unprognostic (2.85e-3)" "prognostic unfavorable (8.86e-7)" "unprognostic (6.71e-2)" "unprognostic (2.19e-1)" "unprognostic (3.12e-1)" "prognostic favorable (6.78e-4)" 22.1 18.2 16.6 19.3 17.1 57.6 23.4 21.9 25.1 25.0 15.9 21.3 12.9 22.6 20.8 21.5 23.9 12.3 18.1 16.2 16.8 23.2 24.3 18.8 29.9 16.4 16.1 31.7 25.2 22.5 21.5 17.8 16.6 19.8 20.1 51.8 18.5 14.5 27.4 21.9 22.0 17.5 15.1 25.7 19.9 20.4 16.2 31.3 22.5 17.7 26.1 20.9 21.9 20.8 165.4 54.2 59.7 40.1 30.9 28.3 103.9 72.8 46.4 82.2 61.2 72.7 49.7 189.2 76.0 47.5 157.0 58.2 124.0 66.1 93.2 51.8 88.0 205.1 49.9 58.3 31.7 202.1 75.3 34.4 32.0 64.3 81.9 36.4 45.4 118.5 129.5 59.1 39.0 46.3 100.4 86.8 96.7 52.8 50.4 101.9 116.2 79.0 40.8 102.8 76.5 44.5 146.1 48.2 87.1 61.2 85.3 84.8 49.5 44.1 52.2 35.1 118.0 69.4 97.5 319.8 34.9 72.1 63.1 40.2 32.7 33.3 40.9 31.7 35.1 60.1 37.1 37.0 27.0 60.7 42.4 36.6 33.3 35.5 48.2 53.9 40.5 21.6 16.6 17.1 21.9 25.1 16.2 16.8 16.4 16.1 16.6 15.1 16.2 20.8 124.4 118.6 129.4 116.2 94.8 60.8 85.7 140.5 68.9 124.2 64.4 90.3 123.8 52.9 115.6 62.5 66.7 78.9 109.9 50.0 52.8 77.2 35.1 91.5 129.4 96.4 55.2 126.0 71.7 79.8 83.7 103.8 58.1 99.1 98.1 165.5 62.8 58.5 61.3 92.5 80.7 74.7 85.5 60.2 54.6 22.0 108.7 78.4 51.6 63.7 115.9 98.1 110.2 104.5 145.8 89.6 55.7 79.7 108.7 81.9 48.0 60.6 100.2 125.4 78.9 122.8 139.4 243.6 235.6 76.9 64.8 79.1 98.6 111.6 80.7 78.4 CHST2 C6ST ENSG00000175040 "Carbohydrate sulfotransferase 2" Q9Y4C5 3 143119771-143124014 "Metabolic proteins, Predicted membrane proteins" "Carbohydrate metabolism, Inflammatory response" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.4" "Cell type enhanced" "Detected in many" "Muller glia cells: 114.4;NK-cells: 233.8;Plasma cells: 79.3;Sertoli cells: 92.1;Theca cells: 58.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "intermediate monocyte: 4.3;NK-cell: 4.9;non-classical monocyte: 11.4" "Group enriched" "Detected in many" 5 "monocytes: 11.4;NK-cells: 4.9" "Cell line enhanced" "Detected in many" "ASC diff: 57.7;ASC TERT1: 58.8;HEL: 48.2;HHSteC: 118.4;HMC-1: 55.4;HSkMC: 62.3;U-266/70: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013620 Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 5: Muller glia cells - Visual perception" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA013620: AB_2668861" "unprognostic (1.55e-2)" "unprognostic (2.20e-1)" "unprognostic (7.64e-3)" "unprognostic (2.75e-1)" "unprognostic (8.97e-3)" "unprognostic (2.83e-1)" "unprognostic (2.70e-2)" "unprognostic (2.06e-1)" "unprognostic (2.76e-1)" "unprognostic (4.11e-2)" "unprognostic (8.96e-3)" "unprognostic (9.15e-2)" "unprognostic (1.31e-2)" "unprognostic (7.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.58e-3)" "unprognostic (1.34e-1)" 7.7 2.7 17.8 8.1 13.7 16.8 6.3 16.7 14.6 5.7 6.0 3.0 2.1 8.4 1.4 1.1 2.1 1.7 5.6 9.7 13.4 8.4 1.3 7.5 7.7 31.0 18.4 4.9 1.3 0.9 6.9 10.3 28.1 7.4 1.1 11.0 2.7 9.9 1.6 4.4 7.5 3.7 21.4 18.2 3.4 1.7 28.7 14.5 6.7 0.8 5.4 7.1 7.6 48.4 0.0 0.3 3.1 2.6 57.7 58.8 0.2 3.3 9.5 2.3 2.1 0.0 0.0 0.6 2.0 2.3 3.1 0.1 2.3 8.2 1.2 0.8 1.5 48.2 0.1 0.0 118.4 1.2 55.4 62.3 9.7 3.1 10.1 3.6 3.6 7.2 5.5 2.9 15.4 0.0 9.1 12.2 16.5 0.0 8.0 0.5 1.0 0.1 1.7 2.2 3.7 0.0 0.7 0.0 5.6 2.9 0.0 1.9 12.3 7.0 4.1 9.5 13.9 52.4 0.8 3.3 13.8 9.3 37.4 0.7 0.5 0.7 0.3 4.3 0.0 1.1 0.1 0.2 1.6 0.8 0.6 0.5 0.3 4.9 11.4 0.1 0.5 0.9 17.8 13.7 16.7 14.6 9.7 13.4 31.0 18.4 28.1 21.4 28.7 48.4 11.3 0.0 0.0 3.6 17.7 2.4 7.3 2.5 0.0 25.0 2.8 2.7 1.4 0.0 1.8 3.7 2.1 0.6 41.9 0.0 0.0 0.4 0.2 5.7 29.8 9.4 0.0 39.1 6.8 0.2 0.6 14.4 2.0 6.5 11.4 12.5 3.6 0.4 2.8 1.7 8.1 0.0 0.0 10.3 32.2 1.3 12.8 20.2 17.8 1.0 13.6 114.4 233.8 2.5 6.1 5.9 0.0 2.2 79.3 13.1 0.0 0.0 0.1 23.8 92.1 0.8 20.2 0.0 2.2 0.1 0.6 1.0 9.8 58.1 1.3 14.8 SLC9A9 "FLJ35613, NHE9" ENSG00000181804 "Solute carrier family 9 member A9" Q8IVB4 3 143265222-143848485 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Astrocytes: 149.8;Inhibitory neurons: 159.5;Microglial cells: 396.3;Oligodendrocyte precursor cells: 272.9;Oligodendrocytes: 431.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.3;ASC TERT1: 24.9;HSkMC: 17.6;Karpas-707: 62.8;RPMI-8226: 30.4;U-266/70: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058234 Approved NA NA 280000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA058234: AB_2683648" "unprognostic (8.22e-2)" "unprognostic (6.88e-2)" "unprognostic (7.23e-3)" "unprognostic (1.65e-1)" "unprognostic (3.65e-2)" "unprognostic (7.05e-2)" "unprognostic (1.24e-1)" "prognostic favorable (8.18e-4)" "unprognostic (2.66e-1)" "unprognostic (1.35e-3)" "unprognostic (7.73e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (5.57e-7)" "unprognostic (5.01e-2)" "unprognostic (4.69e-2)" "unprognostic (1.56e-1)" "unprognostic (4.28e-2)" 12.8 5.1 9.7 8.8 14.4 2.0 5.3 12.5 11.3 6.9 6.9 7.3 3.0 4.2 3.7 12.8 6.8 9.6 5.4 9.9 16.3 2.3 7.1 5.9 14.7 20.4 13.5 7.9 1.0 3.0 3.4 15.9 19.5 8.8 5.8 1.3 4.5 8.5 2.1 7.7 7.0 8.0 14.4 13.1 5.0 1.8 13.8 15.5 3.5 5.0 13.5 11.4 7.7 18.2 0.5 0.5 0.8 1.0 19.3 24.9 0.3 1.0 6.6 0.5 3.1 0.0 0.2 3.0 0.2 2.9 1.5 0.7 0.9 1.9 0.8 12.8 0.2 1.6 0.4 0.0 2.2 0.8 1.3 17.6 5.2 0.7 0.9 1.1 0.3 2.3 0.0 62.8 4.2 0.0 1.5 0.0 0.2 0.0 0.5 2.6 0.1 30.4 0.0 0.5 0.4 0.0 1.5 0.0 0.0 0.4 0.2 0.6 0.0 2.4 0.6 2.8 1.4 29.1 0.1 0.1 4.3 0.4 1.2 0.2 6.2 0.7 4.7 10.6 4.0 3.3 4.9 7.5 8.4 3.7 2.7 4.0 0.5 4.2 9.0 0.6 9.3 4.8 9.7 14.4 12.5 11.3 9.9 16.3 20.4 13.5 19.5 14.4 13.8 18.2 4.5 0.0 1.1 149.8 13.2 3.7 10.4 8.7 22.8 0.2 0.6 1.3 1.5 0.0 3.4 3.7 2.1 0.5 10.4 0.0 0.0 1.0 4.8 0.8 10.1 4.4 0.0 9.9 25.6 0.2 0.5 26.5 7.1 0.8 0.0 0.7 21.8 0.0 55.4 0.0 159.5 0.0 6.1 30.5 9.9 4.4 9.3 31.0 7.2 396.3 24.3 2.8 13.4 272.9 431.8 0.8 0.1 7.2 10.9 11.1 0.0 0.4 1.6 0.1 0.0 18.0 7.0 0.3 0.4 23.9 5.1 1.1 19.7 3.7 0.1 3.9 DIPK2A "C3orf58, DIA1, HASF, MGC33365" ENSG00000181744 "Divergent protein kinase domain 2A" Q8NDZ4 3 143971823-144048719 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 23.5;Cardiomyocytes: 19.6;dendritic cells: 11.3;Fibroblasts: 22.6;Hofbauer cells: 22.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 147.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048992 Approved "Secreted in other tissues" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 33: Fibroblasts - ECM organization" "HPA048992: AB_2680591" "unprognostic (5.96e-2)" "unprognostic (8.54e-2)" "unprognostic (1.17e-1)" "unprognostic (2.24e-1)" "unprognostic (2.43e-1)" "unprognostic (2.85e-2)" "unprognostic (3.74e-2)" "unprognostic (2.31e-2)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (3.44e-1)" "unprognostic (3.98e-1)" "prognostic unfavorable (2.92e-7)" "unprognostic (4.82e-3)" "unprognostic (2.87e-1)" "unprognostic (1.70e-1)" "unprognostic (1.50e-2)" 9.8 7.4 10.3 10.5 14.5 32.4 15.7 24.5 17.9 13.6 3.8 8.2 6.8 14.2 6.0 14.1 12.7 14.2 7.0 9.1 10.9 6.8 18.9 12.9 11.3 12.6 11.0 20.2 4.5 15.0 3.4 38.1 11.9 11.5 8.8 5.8 9.0 12.6 4.6 24.4 5.9 15.1 9.7 10.7 8.4 8.0 10.6 16.6 12.7 7.2 11.0 11.5 9.7 23.9 24.9 9.9 24.8 147.9 22.6 20.4 13.5 17.7 17.2 16.6 17.6 6.7 9.8 15.5 13.6 6.8 11.9 13.9 37.2 14.3 25.9 7.3 13.5 23.0 9.4 10.1 9.8 21.3 10.3 17.0 7.5 10.2 15.4 16.7 26.1 7.0 4.1 43.9 21.2 6.7 7.7 10.4 15.7 10.3 6.2 11.3 12.8 17.2 10.3 29.1 16.5 0.0 12.7 5.8 5.8 6.7 15.5 11.5 12.5 14.6 7.0 22.9 20.6 17.4 6.5 22.1 23.6 10.0 19.3 24.9 11.9 20.1 3.5 7.8 5.8 8.2 4.2 3.7 14.9 7.1 3.6 3.6 3.3 9.5 10.6 9.3 3.9 6.0 10.3 14.5 24.5 17.9 9.1 10.9 12.6 11.0 11.9 9.7 10.6 23.9 23.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 1.6 11.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 2.1 22.6 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 3.4 2.6 0.0 0.0 0.0 PLOD2 LH2 ENSG00000152952 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2" O00469 3 146069440-146163653 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 130.9;Basal respiratory cells: 115.1;Distal enterocytes: 143.7;Extravillous trophoblasts: 130.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBF TERT88: 636.0;hTERT-RPE1: 723.8;U-87 MG: 566.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025898, HPA069126" Approved Uncertain Nucleoli,Cytosol "Intracellular and membrane" NA NA 21000 "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Nucleoli, Cytosol" "CAB025898: , HPA069126: " "unprognostic (8.68e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (2.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.34e-2)" "unprognostic (1.29e-3)" "prognostic unfavorable (7.64e-10)" "prognostic unfavorable (1.42e-4)" "unprognostic (2.97e-2)" "unprognostic (3.36e-2)" "unprognostic (6.27e-3)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.99e-11)" "prognostic unfavorable (2.83e-4)" "unprognostic (6.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.41e-3)" 63.1 20.1 13.4 35.6 14.5 1.1 18.6 15.1 17.2 10.2 19.4 36.2 42.2 23.5 13.4 18.2 11.4 41.5 22.1 13.3 15.1 26.1 57.3 12.9 3.8 23.1 18.1 20.5 18.7 16.5 7.9 80.6 16.3 13.2 29.9 56.6 9.5 16.2 3.0 3.9 35.0 46.8 17.8 5.4 20.1 8.5 20.6 10.5 90.0 3.9 5.5 25.7 10.0 17.6 134.5 94.3 29.0 9.5 102.5 109.6 73.2 465.5 141.6 247.7 463.0 7.2 13.4 0.0 88.8 79.5 113.1 27.8 34.0 400.5 636.0 0.6 53.5 33.3 84.3 66.9 262.5 0.1 0.6 192.9 56.5 215.2 104.1 723.8 347.7 0.1 45.1 1.8 441.6 48.8 0.3 0.6 18.5 0.3 40.0 0.2 19.2 0.6 105.0 6.5 14.5 0.5 370.3 39.4 39.9 135.1 107.5 4.2 440.4 304.2 92.2 97.8 280.7 138.9 20.9 0.5 566.5 0.4 55.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 13.4 14.5 15.1 17.2 13.3 15.1 23.1 18.1 16.3 17.8 20.6 17.6 29.1 16.0 11.4 130.9 0.4 7.0 6.4 115.1 30.1 17.1 23.7 10.2 14.3 44.3 47.0 27.6 35.5 9.2 0.3 143.7 9.8 64.5 0.5 35.4 13.8 24.3 19.8 4.6 22.8 53.1 130.6 68.1 19.9 38.7 0.0 42.7 21.0 65.2 5.1 0.0 46.4 19.5 22.4 1.0 2.5 1.2 13.1 3.0 14.2 21.5 0.7 53.8 0.0 64.3 6.0 82.4 48.8 4.9 1.3 8.9 50.5 8.2 33.0 24.7 19.7 36.9 47.2 11.0 18.0 27.5 5.5 18.7 1.0 24.5 25.1 5.6 PLSCR4 ENSG00000114698 "Phospholipid scramblase 4" Q9NRQ2 3 146192335-146251179 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 77.3;Astrocytes: 151.1;Endothelial cells: 63.4;Hepatic stellate cells: 110.3;Oligodendrocyte precursor cells: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 60.5;ASC TERT1: 48.2;hTERT-RPE1: 62.1;HUVEC TERT2: 50.8;TIME: 106.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002276 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 15: Liver - Metabolism" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nuclear bodies" "HPA002276: AB_1855479" "unprognostic (3.73e-3)" "unprognostic (4.03e-2)" "unprognostic (9.83e-2)" "prognostic unfavorable (3.90e-4)" "unprognostic (2.62e-1)" "unprognostic (6.77e-3)" "unprognostic (1.19e-1)" "unprognostic (4.36e-2)" "unprognostic (7.33e-2)" "unprognostic (2.49e-1)" "unprognostic (2.50e-1)" "unprognostic (4.17e-2)" "prognostic unfavorable (4.13e-4)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" "unprognostic (8.13e-3)" "unprognostic (2.97e-3)" 60.2 43.8 30.2 9.4 28.2 2.3 41.9 30.9 32.5 28.9 11.6 27.4 6.8 30.1 15.7 23.2 41.2 45.6 28.0 28.7 38.5 25.3 69.0 37.4 10.5 39.3 44.0 36.4 20.5 4.3 11.2 56.4 32.6 13.8 25.2 13.7 23.6 25.8 7.4 16.1 13.6 33.7 36.9 30.1 14.4 21.6 41.8 6.6 31.2 18.8 6.7 19.8 25.5 32.2 0.0 9.9 1.7 0.0 60.5 48.2 0.3 11.5 15.7 5.0 10.9 1.0 12.6 0.0 12.3 21.0 5.0 1.4 2.4 1.1 2.8 0.1 0.1 5.0 7.9 1.3 28.1 0.1 1.3 29.6 1.6 10.4 3.0 62.1 50.8 0.0 0.2 0.9 7.4 0.3 0.0 0.1 2.1 5.1 3.4 0.0 0.8 0.0 0.1 0.0 0.6 0.0 20.1 0.1 3.9 2.5 0.7 0.6 106.4 10.4 2.6 23.6 2.1 0.3 0.0 0.0 2.6 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 30.2 28.2 30.9 32.5 28.7 38.5 39.3 44.0 32.6 36.9 41.8 32.2 77.3 3.2 10.3 151.1 1.0 10.8 5.6 0.8 12.0 0.6 10.2 8.6 4.1 25.8 6.0 3.7 0.0 0.7 0.3 27.4 0.0 8.2 1.1 3.6 11.6 63.4 10.3 15.6 1.7 11.6 0.5 57.1 2.0 1.5 1.3 7.0 110.3 44.1 0.8 0.0 0.6 11.7 0.0 7.1 11.8 3.8 42.9 1.1 3.6 40.3 0.1 51.4 0.0 61.3 0.6 4.7 13.3 32.4 2.8 2.6 6.4 28.3 6.4 1.5 0.0 18.9 23.6 1.2 0.9 4.8 8.7 0.8 1.8 20.0 8.1 2.7 PLSCR2 ENSG00000163746 "Phospholipid scramblase 2" Q9NRY7 3 146391421-146495991 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 13.2" "Group enriched" "Detected in some" 30 "Early spermatids: 195.5;Late spermatids: 246.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051352 Approved "Nucleoplasm,Endoplasmic reticulum,Vesicles" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "Endoplasmic reticulum, Vesicles" "HPA051352: " "unprognostic (1.11e-1)" "unprognostic (9.83e-2)" "unprognostic (8.94e-3)" "unprognostic (7.53e-3)" "unprognostic (3.81e-2)" "unprognostic (1.51e-2)" "unprognostic (3.67e-2)" "unprognostic (1.84e-2)" "unprognostic (4.11e-1)" "unprognostic (5.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.16e-1)" "unprognostic (1.88e-4)" "unprognostic (4.06e-1)" "unprognostic (9.71e-2)" "unprognostic (3.02e-1)" "unprognostic (1.23e-2)" 0.2 0.1 0.4 0.3 0.2 1.1 0.3 0.2 0.7 0.1 0.2 0.3 0.2 0.1 1.8 0.2 0.7 0.5 0.0 0.1 0.7 0.6 0.2 0.2 0.1 0.9 0.6 0.1 0.9 0.2 0.1 0.2 0.7 0.3 0.4 0.5 0.3 0.5 0.0 0.0 0.2 0.2 0.6 0.1 0.4 13.2 0.6 0.2 0.5 0.0 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.5 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.1 0.4 0.2 0.2 0.7 0.1 0.7 0.9 0.6 0.7 0.6 0.6 0.6 0.4 0.0 0.0 0.3 0.2 0.3 0.1 0.1 0.6 0.0 1.3 0.6 0.0 1.5 0.2 7.3 0.0 0.2 1.5 0.7 1.9 1.6 195.5 1.4 0.1 0.4 1.8 0.0 1.0 0.6 0.1 0.5 1.5 0.7 0.0 0.4 0.4 0.1 0.1 0.0 1.1 0.3 2.0 0.0 1.1 246.0 1.8 0.6 0.0 1.0 0.0 1.2 0.0 0.0 0.2 0.5 1.0 1.5 0.0 0.3 0.1 1.5 1.4 0.3 0.0 0.7 0.3 5.4 2.6 0.1 0.1 0.0 0.2 0.2 0.9 0.3 PLSCR1 MMTRA1B ENSG00000188313 "Phospholipid scramblase 1" O15162 3 146515180-146544856 "Predicted intracellular proteins, Transporters" "Antiviral defense, Host-virus interaction" "DNA-binding, Host cell receptor for virus entry, Hydrolase, Nuclease, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 291.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 319.8;BJ hTERT+ SV40 Large T+ RasG12V: 418.6;HHSteC: 292.9;SK-MEL-30: 569.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068923, CAB070421" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane" NA Yes "Cluster 25: Monocytes - Inflammatory response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB070421: AB_11153452, HPA068923: AB_2686059" "unprognostic (7.88e-2)" "unprognostic (1.10e-1)" "unprognostic (5.34e-2)" "prognostic unfavorable (1.35e-4)" "unprognostic (1.12e-1)" "unprognostic (3.35e-1)" "unprognostic (5.22e-2)" "unprognostic (7.73e-3)" "unprognostic (9.19e-3)" "unprognostic (6.93e-3)" "unprognostic (3.07e-3)" "unprognostic (1.10e-1)" "unprognostic (1.09e-3)" "unprognostic (5.26e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-1)" "unprognostic (1.63e-1)" 60.6 23.0 11.4 86.7 12.5 64.4 45.9 12.7 17.6 25.9 11.9 65.0 39.8 28.2 31.0 47.9 40.0 66.1 24.3 12.1 13.5 71.9 49.2 49.3 40.6 17.4 14.2 34.9 38.3 16.8 15.4 56.3 15.3 23.7 59.5 9.8 49.1 49.6 10.8 13.6 45.4 41.9 16.2 64.5 44.0 17.1 14.7 30.0 27.8 17.6 39.4 68.1 29.5 14.0 106.2 41.5 26.4 12.1 40.9 65.0 40.5 32.6 88.4 319.8 418.6 34.0 88.1 8.4 75.6 20.6 245.9 86.2 21.2 32.7 56.6 32.9 21.6 66.1 12.5 25.2 292.9 40.3 35.4 106.3 53.3 36.6 182.3 52.6 49.4 19.1 44.7 104.0 66.9 41.0 30.6 16.1 25.8 71.6 37.6 27.4 28.1 2.9 95.9 29.6 16.3 0.0 42.6 20.9 569.9 35.8 20.7 46.8 30.6 26.9 22.7 59.1 55.8 79.2 15.6 0.4 27.0 29.0 23.3 41.1 157.6 44.3 20.8 159.6 30.0 25.2 13.5 18.5 105.8 19.7 9.3 13.9 100.0 57.8 94.8 28.5 8.3 79.3 11.4 12.5 12.7 17.6 12.1 13.5 17.4 14.2 15.3 16.2 14.7 14.0 191.4 35.3 43.0 12.7 28.2 37.0 106.5 92.1 26.2 0.7 36.0 22.6 7.3 124.4 110.4 95.6 0.0 53.7 25.4 134.2 74.3 291.6 2.0 56.1 24.5 135.2 33.1 18.3 7.1 217.4 114.1 74.8 47.9 58.2 28.4 60.5 100.6 29.7 139.9 0.0 9.0 71.5 79.3 86.2 162.9 6.8 114.9 185.5 48.0 35.6 72.3 64.3 32.0 7.1 0.3 157.6 110.3 45.9 18.2 79.6 40.7 75.0 133.5 1.6 39.5 63.4 59.2 1.5 2.4 21.8 28.6 44.5 25.9 42.6 69.4 211.9 PLSCR5 ENSG00000231213 "Phospholipid scramblase family member 5" A0PG75 3 146576555-146605346 "Predicted membrane proteins" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.0" "Cell type enriched" "Detected in single" 6 "Inhibitory neurons: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "SuSa: 1.6" "Region enhanced" "Detected in single" "midbrain: 1.0" "Low region specificity" "Detected in some" HPA047249 Uncertain NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA047249: AB_2679997" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.6 0.3 1.0 0.2 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZIC4 ENSG00000174963 "Zic family member 4" Q8N9L1 3 147386046-147406809 "Human disease related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 68.5" "Cell type enhanced" "Detected in some" "Early spermatids: 5.0;Late spermatids: 13.5;Microglial cells: 6.5;Muller glia cells: 5.5;Oligodendrocytes: 6.9;Skeletal myocytes: 6.2" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Region enriched" "Detected in all" 4 "cerebellum: 68.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 16.5;ASC diff: 4.7;BEWO: 3.5;MCF7: 4.7;SH-SY5Y: 4.9;U-2197: 3.9" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 8 "cerebellum: 67.3" HPA030194 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 12: NES - Nervous system development" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA030194: AB_2673367" "unprognostic (1.12e-1)" "unprognostic (9.95e-2)" "unprognostic (5.59e-3)" "unprognostic (1.02e-1)" "unprognostic (6.83e-2)" "unprognostic (1.10e-1)" "unprognostic (2.20e-1)" "unprognostic (9.13e-2)" "unprognostic (1.10e-10)" "unprognostic (3.50e-2)" "unprognostic (8.69e-2)" 0.6 0.0 1.9 0.0 6.6 0.0 0.0 68.5 4.7 0.0 5.5 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.7 5.5 0.0 0.3 0.0 0.0 10.6 5.8 0.0 0.0 0.0 0.1 0.0 9.0 0.0 0.0 4.8 0.0 0.0 1.3 1.2 0.1 0.0 2.7 0.0 0.0 0.5 10.5 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 16.5 0.0 4.7 1.9 3.5 1.8 0.4 0.2 0.5 0.0 0.0 0.0 2.1 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 2.2 0.0 0.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 4.9 0.0 0.0 2.1 0.0 0.0 0.0 0.0 1.1 0.0 3.9 1.8 0.0 0.0 0.0 1.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 6.6 68.5 4.7 1.7 5.5 10.6 5.8 9.0 2.7 10.5 15.3 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.9 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.0 6.5 0.0 5.5 0.0 0.5 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 6.2 0.1 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZIC1 "ZIC, ZNF201" ENSG00000152977 "Zic family member 1" Q15915 3 147393422-147510293 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Craniosynostosis, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "brain: 616.8" "Group enriched" "Detected in some" 4 "Microglial cells: 25.3;Skeletal myocytes: 61.0" "Cancer enhanced" "Detected in many" "glioma: 9.5" "Region enriched" "Detected in all" 5 "cerebellum: 616.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 174.0;MCF7: 43.9;U-2197: 28.5" "Region enhanced" "Detected in all" "cerebellum: 207.4" "Region enriched" "Detected in all" 8 "cerebellum: 638.1" HPA004098 Supported Supported Nucleoplasm NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 12: NES - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "HPA004098: AB_1859065" "unprognostic (1.33e-2)" "unprognostic (1.82e-1)" "unprognostic (4.01e-2)" "unprognostic (2.36e-1)" "unprognostic (9.32e-2)" "unprognostic (1.52e-2)" "unprognostic (1.68e-2)" "unprognostic (2.19e-1)" "unprognostic (5.01e-1)" "unprognostic (2.61e-7)" "unprognostic (2.95e-3)" "unprognostic (1.67e-2)" "unprognostic (3.01e-1)" 3.4 0.7 25.0 0.0 50.7 0.0 0.2 616.8 30.3 0.0 39.0 0.1 0.2 0.0 1.8 0.2 0.0 0.1 0.1 13.6 39.5 0.1 12.8 0.1 0.1 66.8 55.3 0.2 0.1 0.0 2.4 0.0 67.3 0.0 0.1 10.7 0.5 0.0 6.9 2.5 0.8 0.0 23.8 0.0 0.2 0.3 112.1 0.0 0.0 0.8 0.0 0.0 0.0 44.8 0.0 0.0 174.0 0.0 17.9 19.6 9.8 11.4 13.5 12.1 9.9 0.0 0.0 0.0 9.1 0.9 9.2 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.4 0.0 0.7 0.0 0.0 3.1 0.0 10.9 43.9 0.0 0.0 0.5 0.9 0.0 0.0 17.1 0.0 0.0 0.0 0.0 8.1 0.0 0.0 10.7 0.0 0.0 0.0 0.0 17.9 0.0 28.5 11.0 0.0 0.0 0.0 13.5 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.0 50.7 616.8 30.3 13.6 39.5 66.8 55.3 67.3 23.8 112.1 44.8 0.2 0.0 0.0 8.5 0.0 0.1 0.0 0.0 0.0 0.3 0.9 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.1 0.0 25.3 0.0 4.3 0.0 2.0 9.5 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 61.0 0.3 0.4 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 AGTR1 "AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R" ENSG00000144891 "Angiotensin II receptor type 1" P30556 3 148697784-148743008 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 96.6;placenta: 141.6" "Cell type enhanced" "Detected in some" "Fibroblasts: 53.1;Hepatocytes: 30.9;Leydig cells: 145.1;Sertoli cells: 144.7;Smooth muscle cells: 71.2" "Group enriched" "Detected in many" 8 "breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8" "Region enhanced" "Detected in some" "midbrain: 8.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 176.8;ASC TERT1: 24.4;BJ hTERT+ SV40 Large T+: 34.8;HBF TERT88: 53.9;HSkMC: 32.2" "Low region specificity" "Detected in all" HPA003596 Enhanced Uncertain Vesicles NA NA "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Vesicles "HPA003596: AB_1845163" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.48e-4)" "unprognostic (5.28e-3)" "unprognostic (1.55e-1)" "unprognostic (3.46e-1)" "unprognostic (1.28e-2)" "unprognostic (3.26e-2)" "unprognostic (3.08e-2)" "unprognostic (9.25e-3)" "unprognostic (4.11e-2)" "unprognostic (4.79e-2)" "unprognostic (3.21e-3)" "unprognostic (1.46e-1)" "unprognostic (2.54e-1)" "unprognostic (5.41e-3)" 65.9 38.2 0.3 1.8 0.7 0.0 39.9 0.2 0.4 3.4 0.4 21.1 0.8 3.5 2.7 2.8 9.8 6.2 10.9 0.4 1.4 18.4 96.6 10.4 0.7 2.1 8.1 3.8 3.5 2.8 3.8 141.6 0.9 5.3 4.4 0.9 4.7 4.2 11.6 15.8 4.3 4.6 0.2 9.1 6.5 2.2 0.7 3.0 14.2 13.8 0.2 14.6 6.1 0.2 0.0 1.0 0.8 0.0 176.8 24.4 0.0 0.2 3.9 34.8 20.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 53.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 32.2 0.0 3.4 1.8 1.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.2 0.4 0.4 1.4 2.1 8.1 0.9 0.2 0.7 0.2 20.5 0.0 0.6 0.0 0.0 3.4 0.2 0.0 0.0 0.0 1.3 0.9 6.3 2.8 0.0 0.0 0.0 0.5 0.3 0.1 0.0 0.1 0.8 0.0 0.3 3.8 23.5 0.0 0.1 7.6 0.3 53.1 0.5 0.0 0.0 0.0 17.5 30.9 0.7 0.0 0.0 0.2 0.0 0.3 3.5 1.7 145.1 0.5 1.8 2.8 0.0 5.7 0.0 0.0 0.1 0.5 0.0 7.5 0.4 1.1 0.0 0.1 0.0 0.1 144.7 7.6 71.2 0.0 1.8 0.3 1.7 0.3 0.5 0.3 0.0 0.1 CPB1 ENSG00000153002 "Carboxypeptidase B1" P15086 3 148791102-148860187 "Enzymes, Plasma proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1970 "pancreas: 226925.8" "Cell type enriched" "Detected in some" 12 "Exocrine glandular cells: 7306.0" "Group enriched" "Detected in some" 312 "breast cancer: 293.8;pancreatic cancer: 641.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "basophil: 4.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 1.0;U-2 OS: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026158, HPA038069, HPA046340" Enhanced "Secreted to digestive system" NA NA 88000000 "Cluster 17: Basophils - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 9: U-2 OS - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "CAB026158: , HPA038069: AB_2675816, HPA046340: AB_2679628" "unprognostic (6.90e-2)" "unprognostic (3.79e-2)" "unprognostic (3.34e-2)" "unprognostic (2.64e-2)" "unprognostic (5.58e-2)" "unprognostic (3.27e-2)" "unprognostic (6.26e-4)" "unprognostic (1.90e-1)" "unprognostic (1.82e-1)" "unprognostic (1.07e-1)" "unprognostic (7.59e-2)" "unprognostic (4.51e-2)" "unprognostic (5.50e-8)" "unprognostic (3.08e-1)" "unprognostic (1.60e-1)" "unprognostic (4.93e-2)" 15.7 83.0 0.4 5.1 1.7 2.5 78.3 0.6 1.4 6.0 0.1 2.6 31.2 4.7 0.3 3.5 1.8 0.1 40.8 0.6 0.8 2.0 7.1 1.7 8.1 1.0 1.2 115.1 226925.8 0.0 2.1 13.7 1.1 4.7 4.5 0.0 36.3 0.0 2.2 2.8 17.2 0.0 0.4 19.2 28.3 2.9 1.2 0.1 1.6 0.0 0.0 1.4 2.0 3.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.9 0.2 0.0 0.0 0.0 4.0 0.3 0.5 1.3 0.4 0.9 0.4 0.5 1.1 0.1 0.7 0.3 1.4 1.9 1.4 0.5 0.5 0.3 0.4 0.4 1.7 0.6 1.4 0.6 0.8 1.0 1.2 1.1 0.4 1.2 3.3 2.2 0.0 0.0 1.0 0.0 0.6 0.5 0.0 0.0 0.0 8.7 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 11.6 11.2 0.0 0.1 1.1 164.9 1.3 0.3 7306.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.2 0.0 0.0 1.0 2.5 0.6 1.5 0.0 0.0 18.1 0.0 0.0 0.0 29.8 590.0 0.1 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 4.2 2.5 0.0 1.1 0.1 0.3 0.3 0.3 1.1 0.2 0.2 CPA3 ENSG00000163751 "Carboxypeptidase A3" P15088 3 148865296-148897203 "Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 112.0;lung: 86.3" "Cell type enriched" "Detected in some" 26 "granulocytes: 4422.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 1534 "basophil: 1115.4" "Lineage enriched" "Detected in single" 5518 "granulocytes: 1115.4" "Cell line enriched" "Detected in some" 45 "HEL: 303.3" "Not detected" "Not detected" "HPA006479, HPA008689, CAB020712" Enhanced Approved "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 36: HEL - Hemostasis" "Cluster 60: Granulocytes - Receptor signaling" "Golgi apparatus" Nucleoplasm "CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (2.66e-3)" "unprognostic (9.13e-3)" "unprognostic (3.50e-1)" "unprognostic (1.18e-3)" "unprognostic (2.47e-1)" "unprognostic (1.57e-2)" "unprognostic (2.14e-1)" "unprognostic (9.51e-2)" "unprognostic (1.89e-1)" "unprognostic (5.30e-3)" "unprognostic (3.50e-3)" "unprognostic (5.18e-3)" "unprognostic (3.24e-2)" "unprognostic (1.74e-1)" "unprognostic (1.69e-3)" 18.2 2.6 0.0 19.9 0.4 25.7 20.9 0.0 0.0 59.4 0.3 39.2 27.3 26.1 19.3 41.1 6.6 112.0 6.2 0.0 0.0 3.3 2.7 86.3 11.2 0.0 0.0 0.9 21.0 2.8 0.9 1.7 0.0 18.5 56.6 0.0 12.1 15.1 1.6 17.7 45.9 25.7 0.0 1.1 45.3 3.8 0.0 14.9 0.9 10.2 15.1 54.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 303.3 0.0 0.0 0.2 0.2 6.7 0.2 0.0 0.1 0.3 0.5 3.8 0.0 0.1 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1115.4 0.0 0.7 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 2.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.1 163.9 0.0 0.5 1.7 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.7 0.0 16.0 0.0 1.6 0.0 3.5 0.5 0.0 4422.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 5.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 6.7 0.3 0.0 0.0 8.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 1.3 0.0 41.7 0.0 0.0 0.3 GYG1 GYG ENSG00000163754 "Glycogenin 1" P46976 3 148991408-149031775 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 560.0;tongue: 357.6" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 229.8;Early spermatids: 251.2;Late spermatids: 368.8;Spermatocytes: 296.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030497, HPA073229" Supported Approved Vesicles NA NA 30000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles "HPA030497: AB_10602326, HPA073229: " "unprognostic (2.68e-2)" "unprognostic (6.31e-3)" "unprognostic (3.21e-1)" "unprognostic (1.81e-1)" "unprognostic (6.19e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (1.10e-1)" "unprognostic (7.75e-3)" "unprognostic (1.29e-1)" "unprognostic (3.56e-2)" "unprognostic (1.27e-2)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" 40.3 31.1 30.1 31.3 32.2 219.8 33.8 33.1 39.4 36.5 28.7 152.2 16.7 64.1 38.7 53.6 52.6 23.9 117.8 29.9 44.0 29.0 18.6 41.1 24.8 37.0 39.7 43.8 42.7 25.2 31.5 23.0 39.0 47.3 25.6 34.3 39.7 64.4 560.0 21.2 37.7 68.1 35.9 59.2 50.7 115.1 33.6 18.0 21.1 357.6 23.0 86.1 30.8 38.3 62.7 39.8 29.0 32.6 78.5 81.7 39.5 90.2 74.4 128.3 119.2 52.3 62.2 0.1 43.5 105.1 68.4 18.8 76.7 39.8 128.6 21.1 33.3 47.6 16.7 59.9 70.7 49.1 68.8 45.1 63.8 42.7 53.3 66.8 74.7 30.7 29.8 109.8 74.7 110.3 9.6 38.9 34.9 48.3 32.2 26.7 43.8 89.3 35.7 57.6 23.7 11.3 47.6 64.6 54.4 27.3 64.4 51.4 62.9 65.4 19.4 47.4 66.9 98.7 59.1 44.4 55.1 74.3 21.7 22.7 58.1 42.4 39.4 59.6 73.1 15.9 25.7 41.3 64.0 14.0 13.8 23.5 27.0 44.3 67.9 25.3 39.4 50.1 30.1 32.2 33.1 39.4 29.9 44.0 37.0 39.7 39.0 35.9 33.6 38.3 27.7 12.8 11.1 16.3 28.3 12.1 22.4 27.7 12.5 9.4 22.5 17.1 229.8 15.7 21.9 33.1 18.8 36.5 50.4 9.9 27.4 43.4 251.2 7.9 15.2 32.6 14.4 12.2 9.8 77.6 47.2 45.0 17.3 9.5 18.3 19.7 45.3 13.5 95.3 6.7 11.3 19.0 26.4 87.1 26.3 368.8 53.1 56.2 40.9 6.5 56.2 132.1 36.0 11.6 5.4 31.6 14.3 76.8 104.1 45.9 15.0 17.3 16.1 7.0 65.7 35.8 50.3 296.7 52.2 23.1 14.9 29.3 61.2 33.8 15.2 19.6 HLTF "HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3" ENSG00000071794 "Helicase like transcription factor" Q14527 3 149030127-149086554 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 143.4;Spermatogonia: 113.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015284, HPA049001" Uncertain Enhanced Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 21: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA015284: AB_1857263, HPA049001: AB_2680594" "unprognostic (3.21e-2)" "unprognostic (3.46e-2)" "unprognostic (6.81e-2)" "unprognostic (1.95e-3)" "unprognostic (4.29e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (3.01e-2)" "unprognostic (2.13e-2)" "unprognostic (2.27e-1)" "unprognostic (4.78e-2)" "unprognostic (9.00e-3)" "unprognostic (1.39e-1)" "unprognostic (2.94e-1)" "unprognostic (3.42e-1)" "unprognostic (2.83e-2)" "unprognostic (1.07e-2)" 12.2 23.6 10.3 7.4 11.9 11.5 13.8 20.7 12.0 11.1 17.6 9.9 5.3 13.6 10.2 7.5 11.5 9.3 19.0 10.3 13.4 16.9 18.5 7.8 11.9 13.1 12.6 18.8 13.6 17.2 12.4 8.2 13.9 15.7 7.5 27.6 11.1 11.6 11.6 5.6 6.8 12.1 15.1 8.7 9.9 44.7 12.2 15.8 21.0 11.4 11.2 8.3 6.0 17.5 66.7 31.8 44.3 34.6 29.0 37.3 4.3 44.1 26.2 32.0 37.0 25.8 45.1 42.7 52.3 20.6 62.3 1.9 60.1 17.5 52.9 23.7 29.1 102.6 23.6 10.5 18.1 27.2 40.7 23.7 9.3 23.9 13.9 48.4 18.7 68.1 36.5 26.9 44.2 33.5 56.4 40.9 33.5 33.3 39.3 64.2 49.8 6.6 26.2 21.1 43.5 25.6 66.9 30.4 60.8 23.3 91.5 25.9 13.2 37.1 22.4 53.1 48.5 39.3 23.5 55.4 36.2 36.3 14.6 8.2 1.0 3.5 4.3 1.7 8.0 6.9 3.8 5.8 3.4 4.9 5.6 5.7 0.0 4.7 1.9 7.8 3.9 2.8 10.3 11.9 20.7 12.0 10.3 13.4 13.1 12.6 13.9 15.1 12.2 17.5 19.5 25.6 20.4 56.8 15.6 5.6 8.5 12.9 10.8 99.3 20.1 16.5 46.4 18.6 18.5 31.3 41.7 10.2 29.9 1.9 35.2 10.1 9.9 36.7 31.1 14.3 4.9 71.5 67.5 8.4 10.1 27.6 12.8 11.7 55.7 55.8 13.2 17.2 8.7 47.1 88.7 6.9 18.3 4.6 3.1 12.3 33.8 11.9 5.4 28.1 5.2 35.4 12.3 66.4 68.7 7.4 3.6 32.4 19.3 8.2 2.0 19.2 26.2 76.2 13.1 37.5 23.8 143.4 113.2 11.5 4.3 1.6 22.1 100.6 7.5 6.6 HPS3 "BLOC2S1, SUTAL" ENSG00000163755 "HPS3 biogenesis of lysosomal organelles complex 2 subunit 1" Q969F9 3 149129638-149173732 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 115.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046281, HPA052778" Approved Approved "Golgi apparatus,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus, Plasma membrane" "HPA046281: AB_10961641, HPA052778: AB_2681943" "unprognostic (1.47e-2)" "unprognostic (7.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.11e-3)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (6.04e-4)" "unprognostic (1.33e-1)" "unprognostic (1.75e-1)" "unprognostic (1.08e-1)" "unprognostic (1.82e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (3.06e-2)" 7.6 9.2 4.2 11.4 4.7 5.6 7.9 4.8 4.2 7.5 8.3 7.5 11.0 9.9 4.9 5.6 8.6 9.0 5.0 3.7 6.0 12.0 8.0 9.7 17.6 6.7 5.6 14.0 6.7 5.7 3.7 10.6 6.8 9.3 9.1 9.6 6.6 8.5 2.8 4.7 10.8 10.3 5.6 16.0 9.2 6.9 5.2 16.8 8.8 3.9 16.4 8.4 5.2 8.5 49.1 26.5 15.7 16.3 21.4 27.4 11.7 19.7 38.4 25.3 32.4 9.1 31.8 12.4 23.8 23.7 115.3 16.5 17.4 13.4 32.4 30.6 13.9 5.8 11.8 9.9 19.1 15.7 9.1 18.0 13.5 24.4 10.0 51.6 26.2 20.2 6.5 29.4 32.5 30.3 11.3 22.1 37.7 26.3 21.1 13.4 10.3 33.7 13.9 24.1 4.7 12.4 16.8 17.7 35.9 33.4 19.2 20.5 13.2 25.2 4.5 26.0 29.0 24.0 10.0 30.6 37.7 30.1 6.3 20.7 12.5 12.1 12.0 15.2 14.5 15.4 10.9 12.9 19.5 12.2 8.4 10.9 5.7 9.8 10.3 11.0 10.7 10.9 4.2 4.7 4.8 4.2 3.7 6.0 6.7 5.6 6.8 5.6 5.2 8.5 9.9 12.8 19.5 17.6 28.6 3.7 3.9 11.5 6.8 6.7 9.1 7.4 2.5 5.7 22.9 7.3 2.1 21.0 24.3 8.0 5.9 10.7 3.0 10.6 11.6 9.9 9.0 7.4 13.3 18.1 14.6 10.8 16.8 10.4 15.2 18.0 17.5 6.9 19.8 3.3 16.5 8.8 14.2 29.3 23.8 4.8 11.5 33.1 14.2 38.4 14.4 25.1 19.6 19.1 27.3 12.9 4.9 30.1 15.4 6.8 13.6 22.8 20.7 5.2 0.0 7.4 8.4 4.4 8.4 8.7 5.3 14.1 18.9 5.4 7.5 5.1 CP ENSG00000047457 Ceruloplasmin P00450 3 149162410-149221829 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Copper transport, Ion transport, Transport" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 1871.4" "Cell type enhanced" "Detected in many" "Club cells: 558.1;Glandular and luminal cells: 406.0;Hepatocytes: 1687.2;Muller glia cells: 720.5;Respiratory ciliated cells: 318.4" "Cancer enhanced" "Detected in many" "liver cancer: 98.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "EFO-21: 318.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001834, CAB008591" Supported "Secreted to blood" NA NA 160000000000 440000000000 "Cluster 62: Liver - Hemostasis" "Cluster 38: EFO-21 - Unknown function" "Cluster 15: Hepatocytes - Hemostasis" "CAB008591: AB_1613734, HPA001834: AB_1078502" "unprognostic (3.58e-1)" "unprognostic (4.24e-1)" "unprognostic (9.61e-2)" "unprognostic (1.80e-2)" "unprognostic (4.14e-2)" "unprognostic (1.02e-2)" "unprognostic (1.06e-1)" "unprognostic (2.97e-2)" "unprognostic (2.07e-1)" "unprognostic (8.75e-2)" "unprognostic (6.03e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (1.14e-7)" "unprognostic (2.68e-2)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (2.70e-1)" 13.0 2.3 17.9 2.2 18.1 0.9 20.8 18.7 29.8 70.2 129.2 13.0 9.8 14.8 0.0 5.6 8.3 1.1 39.2 17.5 33.0 9.5 1871.4 13.4 18.9 28.1 20.3 0.8 6.5 3.9 28.6 3.4 24.9 7.9 16.4 246.5 39.9 0.9 2.6 13.0 20.8 2.4 19.2 23.1 3.0 1.5 20.1 0.5 16.1 8.3 20.0 23.9 2.3 29.0 0.2 18.8 15.6 0.0 3.3 0.1 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 318.8 0.0 29.4 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.4 32.7 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.2 2.5 5.4 0.0 0.0 0.0 0.4 6.7 16.2 0.0 0.2 0.3 1.0 0.1 0.4 0.0 0.4 0.0 0.2 1.7 0.2 0.2 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.9 18.1 18.7 29.8 17.5 33.0 28.1 20.3 24.9 19.2 20.1 29.0 2.3 19.2 76.6 3.3 10.6 3.3 8.3 28.6 0.6 6.9 14.0 0.6 0.6 65.8 558.1 9.2 6.2 0.1 0.3 0.1 0.0 83.4 0.9 190.5 51.0 12.6 0.0 34.7 1.5 21.4 0.2 16.3 0.0 406.0 2.5 0.1 34.6 1687.2 0.6 5.0 1.4 0.2 8.2 44.6 6.9 1.2 0.3 4.0 0.0 6.5 1.6 720.5 1.0 0.5 2.0 69.3 0.0 0.4 0.3 19.5 0.0 0.3 318.4 24.8 0.0 0.8 15.3 0.0 0.1 0.8 2.6 0.3 4.9 0.1 0.1 79.0 TM4SF18 L6D ENSG00000163762 "Transmembrane 4 L six family member 18" Q96CE8 3 149318498-149334414 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.9" "Group enriched" "Detected in many" 4 "Adipocytes: 226.1;Endothelial cells: 188.9;Hepatic stellate cells: 151.0" "Cancer enhanced" "Detected in all" "renal cancer: 17.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 94.8;EFO-21: 194.9;GAMG: 38.7;HUVEC TERT2: 65.9;NTERA-2: 47.2" "Low region specificity" "Detected in many" "HPA053639, HPA069378" Approved Supported Vesicles,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles Cytosol "HPA053639: , HPA069378: AB_2686133" "unprognostic (2.25e-1)" "unprognostic (3.68e-1)" "unprognostic (4.76e-2)" "unprognostic (1.08e-1)" "unprognostic (9.11e-3)" "unprognostic (1.05e-2)" "prognostic favorable (8.63e-4)" "unprognostic (2.84e-1)" "unprognostic (6.13e-3)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (1.75e-1)" "unprognostic (5.71e-2)" "unprognostic (3.56e-3)" "unprognostic (1.65e-1)" "unprognostic (3.01e-1)" "unprognostic (1.97e-1)" 21.3 5.2 9.4 4.9 9.6 0.1 16.3 9.2 11.5 8.3 10.4 3.4 3.9 7.6 4.7 3.4 6.4 10.6 8.4 9.1 10.3 19.1 7.9 9.2 6.6 12.2 9.6 3.2 9.8 6.8 3.1 17.4 11.5 4.0 3.3 1.1 4.0 6.5 5.9 2.4 3.6 14.9 10.0 33.9 3.4 1.9 12.1 2.1 12.7 5.7 5.0 6.7 2.5 10.4 0.1 94.8 3.5 0.2 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.2 1.2 0.0 194.9 0.0 38.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.3 0.1 0.7 0.0 0.0 0.0 24.7 65.9 0.0 0.0 0.0 6.2 0.7 0.0 0.2 47.2 0.0 0.0 0.1 2.6 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.5 1.5 0.1 0.1 8.4 0.1 1.2 0.0 0.5 0.1 0.1 0.5 0.0 0.1 15.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 9.4 9.6 9.2 11.5 9.1 10.3 12.2 9.6 11.5 10.0 12.1 10.4 226.1 0.0 4.4 0.3 1.6 3.2 0.2 0.0 0.6 0.2 41.4 23.9 2.8 4.3 0.0 1.8 0.0 0.0 1.0 0.0 9.8 35.2 0.4 0.7 1.1 188.9 0.0 0.0 0.0 0.2 0.0 6.2 0.0 0.9 1.3 0.3 151.0 1.1 0.1 0.0 0.1 0.0 0.0 9.1 3.0 1.8 2.1 1.2 1.8 33.7 0.6 0.4 0.0 0.5 0.6 0.9 0.0 6.8 2.5 1.3 0.0 35.8 0.7 0.0 0.0 1.5 2.5 0.2 0.5 0.2 2.8 0.0 1.1 5.2 0.0 0.6 TM4SF1 "L6, M3S1" ENSG00000169908 "Transmembrane 4 L six family member 1" P30408 3 149369022-149377692 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 5463.1;Endothelial cells: 1843.0;Pancreatic endocrine cells: 2557.3;Prostatic glandular cells: 2717.0;Urothelial cells: 4902.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 703.8;hTERT-RPE1: 925.5;HUVEC TERT2: 633.3;LHCN-M2: 687.7;OE19: 672.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002760, HPA002823" Uncertain NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "CAB002760: , HPA002823: AB_1079221" "unprognostic (1.94e-1)" "unprognostic (2.25e-2)" "unprognostic (5.20e-2)" "unprognostic (4.79e-2)" "unprognostic (2.89e-2)" "unprognostic (2.47e-3)" "unprognostic (3.85e-3)" "unprognostic (2.74e-2)" "unprognostic (5.09e-1)" "unprognostic (3.23e-1)" "prognostic unfavorable (4.01e-4)" "unprognostic (4.06e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (4.67e-2)" "unprognostic (2.10e-1)" "unprognostic (2.67e-1)" "prognostic unfavorable (3.43e-6)" 365.9 71.3 41.9 50.5 43.1 2.6 192.8 44.1 68.2 82.6 65.6 61.6 38.3 74.9 58.2 210.9 74.7 237.6 181.7 42.2 45.2 155.1 92.6 229.8 25.2 45.1 43.9 49.7 211.7 19.9 20.2 194.6 47.7 79.9 59.9 6.0 180.9 32.0 50.2 63.5 62.2 94.6 45.4 120.5 129.7 19.5 53.5 17.0 72.5 64.2 60.2 150.9 115.5 45.9 367.9 401.9 0.0 1.0 108.4 422.2 0.6 115.2 455.5 23.9 8.8 159.7 703.8 0.1 351.3 23.5 545.5 434.0 1.9 80.0 22.9 0.9 0.0 3.9 391.8 521.8 39.4 0.0 0.5 40.0 19.1 169.7 81.5 925.5 633.3 0.0 0.3 0.8 687.7 0.5 0.0 0.7 1.5 672.9 170.7 0.2 0.9 0.8 449.3 54.8 0.2 0.5 46.8 25.1 4.4 6.0 0.8 1.7 404.7 233.6 38.9 4.8 244.3 0.5 0.7 1.1 337.4 0.4 62.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.9 43.1 44.1 68.2 42.2 45.2 45.1 43.9 47.7 45.4 53.5 45.9 1131.0 576.9 342.3 0.3 7.5 278.0 5463.1 668.3 272.6 0.1 956.5 363.1 24.0 274.5 984.3 57.0 0.0 0.8 17.0 176.6 0.0 1383.5 5.2 514.1 168.0 1843.0 39.2 15.6 0.0 1600.9 0.9 297.2 147.8 1807.5 31.5 0.2 1263.6 21.8 1.9 0.0 0.0 15.9 382.5 27.8 222.1 11.3 255.7 35.6 300.6 30.9 26.4 0.0 0.0 0.0 0.3 2557.3 251.8 176.0 11.1 2717.0 0.3 1.2 238.5 0.0 322.1 37.7 311.0 6.6 1.4 925.8 253.7 1.4 44.1 44.2 46.6 4902.9 TM4SF4 il-TMP ENSG00000169903 "Transmembrane 4 L six family member 4" P48230 3 149474697-149503394 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "gallbladder: 945.8;intestine: 650.8;liver: 703.8" "Group enriched" "Detected in some" 17 "Cholangiocytes: 2070.3;Hepatocytes: 578.1" "Group enriched" "Detected in many" 10 "liver cancer: 249.4;pancreatic cancer: 130.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "A549: 22.7;OE19: 20.3;RPTEC TERT1: 36.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046430 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 2: Hepatocytes - Metabolism" "Plasma membrane" Cytosol "HPA046430: AB_2679662" "unprognostic (1.91e-2)" "unprognostic (1.71e-1)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.98e-1)" "unprognostic (7.60e-2)" "unprognostic (1.83e-1)" "unprognostic (4.66e-2)" "unprognostic (1.91e-2)" "unprognostic (4.97e-1)" 0.3 1.2 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.0 650.8 0.6 2.3 0.7 0.5 945.8 0.3 0.0 0.0 0.8 703.8 0.3 0.8 0.0 0.0 0.0 72.5 0.0 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 514.8 0.9 0.0 0.1 21.3 0.6 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 1.5 1.1 0.0 0.0 0.0 0.6 0.3 0.2 4.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.8 0.1 20.3 0.0 0.0 0.5 1.4 36.5 0.0 0.6 1.2 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.1 0.1 0.5 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.5 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 4.1 2070.3 0.6 0.0 0.0 0.0 0.0 0.8 0.0 25.9 1.1 3.1 0.3 0.6 3.0 13.5 0.1 2.0 0.2 0.1 10.7 3.3 0.0 0.0 7.1 578.1 0.1 0.0 0.1 41.6 0.0 11.6 0.0 0.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 8.2 17.5 0.0 0.3 0.0 76.6 4.8 0.1 0.0 0.0 0.0 0.7 4.1 0.3 0.0 0.0 0.1 0.5 5.6 2.0 0.2 WWTR1 "DKFZp586I1419, TAZ" ENSG00000018408 "WW domain containing transcription regulator 1" Q9GZV5 3 149517235-149736714 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 229.3;Endothelial cells: 221.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 212.1;RPTEC TERT1: 151.1;SK-MEL-30: 160.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007415, CAB017483, CAB068248" Enhanced Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nuclear bodies" Cytosol "CAB017483: AB_2216639, CAB068248: AB_2665648, HPA007415: AB_1080602" "unprognostic (1.85e-2)" "unprognostic (2.24e-2)" "unprognostic (3.41e-3)" "unprognostic (1.33e-2)" "unprognostic (7.94e-2)" "unprognostic (1.37e-1)" "unprognostic (2.41e-2)" "unprognostic (2.22e-1)" "unprognostic (1.74e-2)" "unprognostic (2.34e-1)" "unprognostic (1.63e-2)" "unprognostic (3.32e-1)" "unprognostic (1.17e-3)" "unprognostic (2.76e-2)" "unprognostic (2.53e-1)" "unprognostic (3.98e-2)" "unprognostic (1.01e-3)" 41.6 13.8 19.2 22.4 20.8 0.2 37.2 18.9 19.6 41.8 32.6 74.9 8.0 42.1 13.4 35.8 33.7 39.6 36.4 20.7 53.9 45.9 19.0 41.2 7.2 52.6 39.9 43.9 31.8 14.1 13.6 44.0 35.9 34.5 13.5 4.2 27.6 32.1 13.2 24.8 21.6 43.7 37.1 19.5 32.7 7.2 23.0 4.7 31.6 15.0 6.1 59.2 34.3 41.0 58.9 80.5 40.6 48.7 48.6 86.8 43.0 32.6 57.5 17.7 17.8 46.7 53.2 0.1 212.1 45.0 53.3 36.1 28.4 28.5 17.9 22.0 19.3 0.0 18.6 37.8 27.3 0.0 0.1 45.3 7.4 61.8 26.6 65.4 136.3 0.0 0.0 0.2 61.7 9.2 0.2 0.2 8.2 0.2 96.6 0.0 50.6 0.4 151.1 9.4 0.0 0.4 21.1 17.2 160.2 31.5 26.5 1.6 94.2 29.0 16.2 24.8 67.4 0.6 0.5 0.8 66.8 0.1 78.8 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.1 19.2 20.8 18.9 19.6 20.7 53.9 52.6 39.9 35.9 37.1 23.0 41.0 125.7 64.1 89.7 60.4 1.1 51.7 229.3 34.6 60.9 2.2 58.1 56.8 46.8 141.5 87.8 49.7 4.2 12.2 2.0 0.5 7.9 72.0 21.9 136.3 89.1 221.2 0.0 3.2 8.7 27.1 82.3 77.9 10.2 144.4 7.6 45.0 111.4 21.9 4.1 0.0 6.1 1.2 10.2 6.0 32.3 7.9 57.8 4.6 30.2 94.6 2.1 11.0 0.0 7.5 12.7 45.8 0.0 126.4 2.9 86.7 1.2 59.8 53.9 2.0 59.2 76.1 58.0 2.2 0.8 46.3 35.5 14.8 6.5 48.4 2.4 93.5 COMMD2 HSPC042 ENSG00000114744 "COMM domain containing 2" Q86X83 3 149738472-149752495 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 187.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044190 Uncertain NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 5: Breast - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA044190: AB_10966289" "unprognostic (2.17e-1)" "unprognostic (8.34e-3)" "unprognostic (6.28e-2)" "unprognostic (1.55e-3)" "unprognostic (1.53e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (1.45e-1)" "unprognostic (1.02e-2)" "unprognostic (4.93e-2)" "prognostic unfavorable (3.69e-6)" "unprognostic (1.31e-1)" "unprognostic (4.03e-3)" "unprognostic (1.76e-1)" "unprognostic (1.89e-1)" "unprognostic (6.25e-2)" "unprognostic (4.86e-2)" 8.6 7.4 8.5 7.5 9.4 8.9 15.2 9.3 10.6 11.6 8.3 7.3 7.9 13.4 7.3 8.9 8.2 7.7 8.5 8.4 8.5 10.5 9.1 12.6 10.8 9.0 9.0 12.4 6.4 10.3 4.3 13.8 9.0 9.3 8.4 10.6 8.4 8.4 6.4 9.6 6.7 12.3 9.0 10.1 7.2 5.2 8.9 12.3 14.0 8.0 10.4 7.5 7.4 10.2 27.4 7.8 25.2 14.7 21.6 24.7 16.6 16.8 17.6 25.6 25.6 13.9 16.6 22.0 18.6 16.5 16.0 17.1 24.4 20.6 29.7 16.2 22.9 19.8 9.8 9.4 22.9 28.6 8.6 18.8 22.3 12.7 22.5 17.3 18.3 13.6 9.8 12.0 18.5 8.6 20.0 14.0 27.9 16.6 10.4 18.2 25.6 29.6 24.5 7.2 11.5 17.6 19.7 15.6 37.0 20.0 28.9 18.7 16.0 14.9 5.9 15.1 20.2 21.5 9.0 35.8 14.6 25.5 6.3 16.9 6.3 11.2 5.8 9.6 8.5 6.6 7.1 7.1 8.0 6.1 7.4 7.9 4.7 9.7 12.5 4.9 6.3 7.3 8.5 9.4 9.3 10.6 8.4 8.5 9.0 9.0 9.0 9.0 8.9 10.2 48.5 64.1 25.7 11.8 41.8 20.9 37.0 60.9 26.7 55.5 39.1 47.9 16.5 31.5 58.7 22.0 187.7 55.2 41.9 18.6 43.0 55.4 3.2 26.1 37.7 42.7 24.6 26.9 21.6 39.7 60.8 36.8 25.5 23.9 46.3 35.3 40.7 16.9 45.5 28.6 16.2 17.5 52.9 29.2 52.8 4.8 36.4 30.1 33.8 16.9 91.0 33.0 36.0 21.1 25.4 55.0 22.2 36.1 32.0 28.7 26.5 31.7 33.0 116.8 52.6 29.3 35.3 65.2 47.9 35.9 21.6 31.9 37.2 45.7 20.8 23.9 ANKUB1 C3orf16 ENSG00000206199 "Ankyrin repeat and ubiquitin domain containing 1" A6NFN9 3 149761100-149968385 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 5.1;choroid plexus: 6.9;fallopian tube: 5.9" "Group enriched" "Detected in some" 5 "Endometrial ciliated cells: 124.3;Respiratory ciliated cells: 118.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 7 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.5" "Cell line enhanced" "Detected in single" "OE19: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA053749 Uncertain NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "HPA053749: AB_2682248" "unprognostic (1.71e-2)" "unprognostic (1.89e-4)" "unprognostic (1.01e-1)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (1.18e-1)" "unprognostic (2.42e-1)" "unprognostic (1.61e-2)" "unprognostic (1.48e-1)" "unprognostic (9.61e-2)" "unprognostic (1.52e-2)" "unprognostic (2.35e-1)" "unprognostic (2.18e-9)" "unprognostic (3.06e-1)" "unprognostic (2.96e-1)" "unprognostic (3.17e-1)" "unprognostic (7.07e-4)" 0.0 0.0 0.8 0.1 0.6 0.3 0.0 0.3 0.3 0.6 6.9 0.0 0.1 0.2 0.0 0.0 5.9 0.0 0.0 0.7 0.5 0.0 0.0 1.1 0.0 2.9 5.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 1.4 0.1 0.1 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.3 0.3 0.7 0.5 2.9 5.1 2.5 1.4 0.3 1.3 0.0 0.0 1.7 0.3 0.0 0.5 0.8 7.3 0.0 0.0 0.0 0.0 0.2 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 124.3 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 10.2 1.6 0.3 5.4 0.3 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 118.9 0.0 0.0 0.2 1.4 4.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.7 RNF13 RZF ENSG00000082996 "Ring finger protein 13" O43567 3 149812770-149962139 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 591.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 462.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064784 Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 21: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Vesicles" Cytosol "HPA064784: AB_2685350" "unprognostic (1.27e-1)" "unprognostic (2.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.93e-2)" "unprognostic (1.80e-1)" "unprognostic (9.64e-2)" "unprognostic (8.49e-2)" "unprognostic (4.36e-3)" "unprognostic (1.72e-1)" "unprognostic (1.25e-1)" "unprognostic (6.94e-3)" "unprognostic (1.13e-1)" "prognostic favorable (2.00e-8)" "unprognostic (2.95e-1)" "unprognostic (4.11e-2)" "unprognostic (2.17e-1)" "unprognostic (1.79e-1)" 48.2 41.2 58.1 40.4 95.2 19.9 53.9 88.1 91.5 33.6 63.7 35.0 28.9 33.3 57.2 32.6 30.2 40.6 34.4 55.0 77.3 67.9 73.8 64.1 38.0 101.8 83.9 35.6 36.1 52.3 18.3 64.1 100.8 46.6 37.1 40.4 75.5 39.3 36.5 32.5 30.5 36.9 85.6 53.0 34.3 25.2 75.9 32.0 64.0 42.6 33.2 42.3 28.9 131.0 60.6 39.4 24.4 29.0 92.2 55.2 40.3 32.2 86.2 32.3 47.4 33.4 84.4 26.6 48.7 42.0 58.7 58.0 37.5 41.5 42.9 34.1 24.6 35.8 17.3 31.2 61.5 35.0 41.8 59.9 73.1 26.5 71.8 37.3 37.0 24.9 10.1 49.7 28.0 34.5 26.2 18.8 16.8 58.6 29.1 19.0 26.7 108.5 54.2 29.6 12.6 37.6 28.5 39.9 110.3 19.2 79.2 34.0 37.8 40.8 16.5 45.6 23.4 89.9 61.9 51.5 35.9 30.1 23.6 98.2 130.1 106.5 37.4 153.8 48.8 51.9 41.5 44.8 93.1 48.4 38.0 42.4 462.3 46.3 207.8 68.3 48.7 104.5 58.1 95.2 88.1 91.5 55.0 77.3 101.8 83.9 100.8 85.6 75.9 131.0 100.9 109.0 72.3 78.7 55.3 73.5 68.2 84.3 74.0 44.5 54.5 51.1 27.3 48.6 68.1 47.8 29.2 101.2 61.9 30.2 43.0 63.0 2.5 32.5 34.5 69.4 20.3 32.4 122.1 70.6 83.5 84.8 31.6 39.7 60.8 14.6 80.3 53.7 201.2 21.9 98.8 27.7 67.1 183.9 173.7 6.7 76.1 177.6 103.2 92.8 93.5 98.5 38.1 115.6 591.2 58.7 33.6 88.0 62.4 71.9 38.5 71.5 40.4 37.2 92.1 76.3 55.5 23.6 32.5 52.3 72.5 52.5 49.8 38.2 27.7 55.8 PFN2 ENSG00000070087 "Profilin 2" P35080 3 149964904-150050788 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 461.8;Ionocytes: 231.9;Muller glia cells: 289.3;Proximal tubular cells: 198.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035611, CAB037073" Enhanced NA NA 19000 "Cluster 32: T-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 39: Non-specific - Basic cellular processes" "CAB037073: AB_1079600, HPA035611: AB_10672870" "unprognostic (1.27e-1)" "unprognostic (9.08e-2)" "unprognostic (2.07e-3)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.77e-2)" "prognostic unfavorable (3.42e-4)" "prognostic unfavorable (2.19e-7)" "unprognostic (4.11e-2)" "unprognostic (1.00e-1)" "unprognostic (1.42e-2)" "unprognostic (2.96e-3)" "unprognostic (4.86e-3)" "unprognostic (6.82e-2)" "unprognostic (1.25e-2)" "unprognostic (1.24e-1)" "unprognostic (1.35e-1)" "unprognostic (1.99e-1)" 27.3 39.1 188.0 19.8 205.1 3.1 35.9 147.7 261.5 42.4 165.3 44.3 25.2 60.9 151.8 25.0 97.1 35.8 45.7 268.1 182.4 116.0 25.0 20.2 7.2 162.1 154.4 60.5 37.8 79.3 61.7 21.4 164.3 66.2 27.4 154.9 49.0 64.7 255.3 14.1 34.4 58.8 165.3 16.3 38.4 27.4 166.3 28.4 99.5 89.9 10.2 52.1 32.5 192.3 556.7 189.8 446.3 184.0 97.5 330.3 119.1 174.0 262.9 268.3 310.1 71.2 435.7 0.1 357.8 383.1 457.2 5.7 187.0 247.5 386.7 17.8 111.3 6.5 94.7 206.0 130.1 31.3 8.8 209.1 205.4 263.9 341.5 285.9 159.3 87.9 1.6 21.3 282.9 206.0 27.3 1.5 195.0 3.7 248.1 31.1 321.7 2.6 200.8 278.6 241.6 248.8 86.4 41.1 239.6 306.6 65.3 4.5 116.1 127.2 177.3 214.1 228.4 28.5 2.3 14.7 275.3 1.8 159.2 1.7 0.2 0.4 2.2 0.1 4.7 2.0 4.8 4.1 0.1 1.0 7.3 4.4 1.2 1.4 0.0 0.2 1.4 2.1 188.0 205.1 147.7 261.5 268.1 182.4 162.1 154.4 164.3 165.3 166.3 192.3 16.2 6.4 6.9 26.4 4.5 9.8 52.4 106.0 100.2 52.1 54.3 37.0 48.3 32.9 47.3 136.1 18.8 11.9 1.9 12.8 461.8 42.1 57.6 75.5 28.3 22.6 121.2 0.0 65.0 27.3 11.5 54.7 7.7 10.6 8.2 39.5 25.4 12.3 3.2 26.9 33.8 27.9 231.9 1.2 9.3 27.2 74.0 2.9 35.6 15.9 4.8 289.3 1.0 21.6 30.3 14.9 19.4 96.7 3.4 57.9 103.2 198.2 116.4 42.2 13.1 52.7 71.8 28.5 19.2 51.5 7.5 10.3 5.0 55.8 30.5 37.7 TSC22D2 "KIAA0669, TILZ4a, TILZ4b, TILZ4c" ENSG00000196428 "TSC22 domain family member 2" O75157 3 150408335-150466431 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004926 Approved Approved Cytosol NA NA 100000 "Cluster 39: Non-specific - mRNA processing" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 44: Endometrium - Transcription" Cytosol "HPA004926: AB_1080401" "unprognostic (4.65e-2)" "unprognostic (1.54e-1)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.74e-4)" "unprognostic (2.49e-1)" "unprognostic (2.65e-2)" "unprognostic (1.89e-1)" "unprognostic (1.09e-2)" "unprognostic (7.63e-2)" "unprognostic (2.59e-1)" "unprognostic (2.28e-3)" "unprognostic (8.32e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (1.10e-2)" "unprognostic (4.86e-1)" "unprognostic (1.10e-2)" "unprognostic (3.49e-1)" 20.9 11.8 8.1 10.7 8.9 34.9 13.2 9.9 15.2 18.9 3.3 14.9 6.0 23.4 14.4 23.8 15.4 22.6 21.5 9.1 9.0 15.9 29.6 15.0 10.3 8.5 8.8 15.2 11.4 10.8 9.8 16.9 9.0 11.4 12.4 16.7 10.6 7.3 17.0 11.1 11.9 26.3 6.1 13.8 16.3 17.8 6.6 11.8 12.9 14.4 9.9 20.6 23.3 11.1 45.7 6.2 19.6 18.8 25.1 12.2 56.4 44.6 16.9 32.1 39.5 25.0 22.4 14.9 25.1 33.7 65.7 18.9 19.8 16.2 63.7 11.8 11.1 16.0 11.6 12.7 28.5 9.8 10.6 22.6 12.4 20.9 31.4 19.4 20.4 7.1 27.7 23.9 22.6 16.1 10.5 12.1 25.1 13.6 12.3 11.0 35.8 17.7 20.7 26.6 11.3 10.1 20.5 10.8 45.8 23.5 10.3 13.0 33.0 21.1 21.9 25.3 41.6 31.9 6.6 20.6 14.3 29.2 12.7 0.5 1.7 2.0 1.1 1.6 1.8 1.1 1.4 1.2 1.1 1.4 1.1 1.1 2.2 2.0 2.9 1.2 0.6 1.5 8.1 8.9 9.9 15.2 9.1 9.0 8.5 8.8 9.0 6.1 6.6 11.1 97.4 64.1 30.8 160.3 52.5 148.9 81.5 12.6 111.0 18.6 65.1 28.4 46.9 20.0 18.2 12.9 29.2 28.6 53.7 77.6 17.6 13.8 23.2 85.5 107.6 48.3 31.6 10.3 78.7 13.8 33.0 59.6 50.0 166.6 65.4 10.9 29.3 40.1 18.4 16.8 70.9 45.4 22.4 24.1 94.9 29.6 18.6 58.9 42.7 86.2 20.2 31.8 16.5 59.3 86.5 26.0 82.2 15.1 37.3 42.6 16.0 10.6 10.8 21.3 13.1 79.0 48.9 51.6 29.3 77.0 108.3 54.9 48.7 17.9 34.8 83.5 SERP1 "FLJ43424, RAMP4" ENSG00000120742 "Stress associated endoplasmic reticulum protein 1" Q9Y6X1 3 150541998-150603228 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 542.5;U-266/70: 735.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038970 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA038970: AB_2676296" "unprognostic (8.81e-3)" "unprognostic (2.35e-3)" "unprognostic (1.91e-1)" "unprognostic (7.29e-3)" "unprognostic (3.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.57e-2)" "unprognostic (2.35e-3)" "unprognostic (6.16e-2)" "unprognostic (1.77e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.12e-1)" "unprognostic (1.61e-3)" "unprognostic (2.55e-2)" "unprognostic (2.75e-2)" "unprognostic (4.75e-2)" "unprognostic (1.78e-1)" 74.6 94.0 52.9 64.4 56.5 86.8 103.9 51.5 67.7 104.3 55.1 78.5 63.4 51.0 158.0 80.6 80.2 48.2 39.0 54.2 56.1 73.9 157.7 82.3 66.1 54.3 51.2 80.7 255.6 57.2 84.6 60.2 53.2 92.4 67.8 26.1 185.5 69.8 16.9 52.8 64.2 45.0 56.1 87.8 114.8 37.5 56.0 66.4 113.3 17.0 74.5 64.6 64.2 58.8 216.1 46.3 68.9 52.5 99.7 116.0 152.9 150.4 98.7 82.2 96.5 121.6 93.7 175.8 274.8 111.7 67.7 102.2 113.6 79.5 108.6 104.7 93.3 187.1 38.4 123.9 193.9 170.8 117.4 69.6 139.4 47.7 236.7 89.2 97.7 118.1 92.7 241.0 70.8 95.3 144.5 143.3 128.1 138.5 115.1 181.2 52.5 542.5 100.4 69.7 116.8 99.3 57.8 128.4 244.5 83.2 112.8 165.0 93.8 38.9 69.6 84.4 117.0 735.1 230.5 236.0 70.9 165.2 36.8 347.2 410.6 375.2 237.4 399.6 304.5 239.7 250.3 238.5 317.6 222.1 244.0 227.3 299.9 188.5 456.8 321.1 268.0 508.0 52.9 56.5 51.5 67.7 54.2 56.1 54.3 51.2 53.2 56.1 56.0 58.8 168.0 67.3 162.7 66.0 468.4 538.0 677.4 277.8 363.7 74.5 500.8 451.2 44.5 158.7 246.5 172.9 58.4 284.6 337.7 351.1 365.9 231.3 361.1 246.5 198.9 189.5 254.0 157.5 51.6 304.3 553.8 213.0 218.2 359.7 219.7 135.4 249.5 480.7 373.5 42.1 48.0 563.2 168.9 662.6 477.8 627.0 219.6 512.6 348.6 25.3 558.1 174.5 279.1 63.3 60.6 349.0 564.2 190.3 923.0 744.8 326.1 293.7 218.5 69.6 111.7 98.1 192.4 208.0 91.3 347.4 592.7 944.7 335.5 94.2 404.3 1101.9 EIF2A EIF-2A ENSG00000144895 "Eukaryotic translation initiation factor 2A" Q9BY44 3 150546678-150586016 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036256 Approved Uncertain Mitochondria,Cytosol No No 16000 "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" Mitochondria Cytosol "HPA036256: AB_10611961" "unprognostic (1.72e-1)" "unprognostic (2.09e-2)" "unprognostic (2.71e-3)" "unprognostic (3.36e-2)" "unprognostic (3.96e-3)" "unprognostic (7.05e-3)" "prognostic unfavorable (2.36e-5)" "unprognostic (2.11e-1)" "unprognostic (7.92e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.57e-6)" "unprognostic (6.30e-2)" "unprognostic (3.08e-2)" "unprognostic (3.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.48e-1)" "unprognostic (3.39e-1)" 57.0 54.0 14.5 47.8 18.5 86.8 103.4 27.2 25.4 63.9 21.9 57.8 65.5 69.7 46.9 64.7 62.7 55.8 72.3 16.6 18.4 72.2 75.2 47.7 68.4 17.1 15.3 94.9 107.2 62.8 32.8 52.4 18.5 52.8 70.8 52.3 77.2 47.0 87.3 74.0 55.3 68.4 18.1 47.4 59.7 24.3 15.1 68.7 92.1 76.7 83.4 67.5 43.4 22.8 158.0 69.4 76.6 79.9 100.8 234.3 105.0 97.3 158.0 134.1 143.0 202.5 168.9 212.0 142.4 134.3 160.1 125.1 149.9 152.9 193.5 81.3 91.6 129.4 76.1 130.9 101.1 155.0 113.0 151.4 153.6 97.2 221.9 200.7 180.3 112.3 109.8 116.5 105.5 121.3 109.6 70.6 108.4 161.3 98.7 97.5 101.1 238.8 119.9 116.9 93.7 102.1 62.6 88.0 144.5 91.6 130.9 127.3 99.9 76.3 69.3 109.2 186.6 194.9 119.6 195.0 96.4 130.5 39.5 23.6 47.2 10.4 27.9 49.5 46.1 36.2 40.6 35.7 54.2 34.7 51.5 41.6 3.7 46.1 56.9 26.5 37.0 44.4 14.5 18.5 27.2 25.4 16.6 18.4 17.1 15.3 18.5 18.1 15.1 22.8 77.7 35.3 67.1 14.4 91.4 140.1 157.3 109.8 109.3 30.6 86.0 76.5 102.4 58.6 69.2 35.0 27.1 84.1 85.7 43.1 137.0 76.1 21.5 39.6 64.3 67.5 56.8 80.3 30.4 108.3 113.6 63.8 64.7 51.4 75.5 45.0 60.0 30.6 62.4 23.5 33.1 81.7 54.9 96.4 82.8 6.6 61.5 72.7 69.4 19.7 97.4 37.2 73.2 32.6 34.7 64.0 57.7 56.4 112.1 79.6 77.0 138.4 41.7 31.2 78.9 95.4 77.9 40.4 41.9 102.3 122.9 120.3 95.0 55.1 99.0 130.4 SELENOT SELT ENSG00000198843 "Selenoprotein T" P62341 3 150602875-150630445 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 215.1;Extravillous trophoblasts: 230.6;Hofbauer cells: 238.8;Pancreatic endocrine cells: 206.0;Proximal tubular cells: 176.8;Syncytiotrophoblasts: 489.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039780 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA039780: AB_10805594" "unprognostic (1.13e-1)" "unprognostic (4.03e-2)" "unprognostic (2.78e-1)" "unprognostic (1.92e-1)" "unprognostic (3.31e-1)" "unprognostic (1.34e-2)" "unprognostic (2.65e-3)" "unprognostic (1.49e-1)" "unprognostic (8.96e-2)" "unprognostic (5.79e-3)" "unprognostic (6.30e-3)" "unprognostic (1.99e-1)" "unprognostic (3.08e-3)" "unprognostic (4.91e-2)" "unprognostic (4.08e-2)" "unprognostic (1.58e-1)" "unprognostic (3.41e-2)" 49.2 73.5 44.0 56.4 47.2 100.0 47.8 49.8 58.9 44.0 44.8 49.1 51.2 39.2 62.7 41.0 49.1 38.9 51.9 46.0 52.2 75.4 72.4 51.0 80.5 46.9 46.9 36.0 45.4 84.2 45.6 60.6 49.9 49.5 56.6 69.7 45.5 48.8 44.9 28.3 50.3 54.1 50.5 46.4 45.1 39.7 47.7 58.3 67.2 54.0 73.2 63.4 32.0 53.9 232.1 94.9 57.1 51.8 86.7 84.0 111.3 174.3 127.3 120.7 79.6 145.9 129.1 125.6 192.2 128.7 107.5 76.1 89.6 110.3 177.7 124.8 77.3 130.9 48.4 68.1 94.6 77.1 102.5 74.1 86.5 107.6 92.1 86.7 132.2 58.2 31.0 359.9 173.4 137.6 107.5 46.1 65.4 134.2 99.0 79.0 73.8 215.4 102.6 132.7 64.2 39.8 106.4 64.4 74.8 71.2 133.6 96.2 125.7 65.1 41.1 121.1 172.6 261.3 151.4 176.1 88.8 142.1 56.9 218.1 163.8 142.5 133.7 138.4 148.5 119.6 111.3 125.4 126.5 102.3 87.4 110.1 198.8 106.3 155.7 90.7 132.3 324.7 44.0 47.2 49.8 58.9 46.0 52.2 46.9 46.9 49.9 50.5 47.7 53.9 80.6 60.9 67.9 0.0 53.4 0.0 0.0 0.0 0.0 0.0 97.2 66.5 0.0 0.0 29.1 108.5 0.0 215.1 114.7 0.0 97.8 166.8 0.0 63.9 46.8 35.5 0.0 0.0 0.0 135.0 230.6 30.9 0.0 64.7 45.4 31.5 0.0 0.0 238.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.5 0.0 0.0 123.5 0.0 0.0 0.0 0.0 206.0 0.0 0.0 21.0 0.0 0.0 176.8 32.8 0.0 0.0 0.0 37.1 0.0 0.0 0.0 0.0 489.3 48.1 63.4 0.0 0.0 ERICH6 "C3orf44, ERICH6A, FAM194A, MGC39662" ENSG00000163645 "Glutamate rich 6" Q7L0X2 3 150659885-150703971 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 29.7" "Group enriched" "Detected in some" 25 "Early spermatids: 96.1;Late spermatids: 56.0;Spermatocytes: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 1.5;SH-SY5Y: 1.6;U-266/70: 1.7;U-266/84: 2.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA048373 Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA048373: AB_2680375" "unprognostic (7.38e-2)" "unprognostic (3.89e-3)" "unprognostic (7.02e-3)" "unprognostic (2.52e-2)" "unprognostic (7.38e-3)" "unprognostic (1.86e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (4.44e-1)" "unprognostic (1.96e-1)" "unprognostic (8.44e-2)" "unprognostic (1.71e-2)" "unprognostic (1.80e-2)" "unprognostic (7.27e-2)" "unprognostic (2.21e-1)" "unprognostic (1.49e-2)" "unprognostic (3.16e-2)" 0.3 0.2 0.1 0.2 0.4 0.3 0.1 0.1 0.3 0.0 0.9 0.1 0.5 0.4 1.7 0.2 0.3 0.3 0.3 0.3 0.6 0.6 0.1 0.2 0.6 0.1 0.4 0.4 0.0 0.0 0.2 0.0 0.1 0.4 0.0 0.1 0.3 0.0 0.1 0.1 0.3 0.0 0.1 0.3 0.3 29.7 0.4 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.7 0.6 0.0 0.9 0.0 0.5 0.1 0.0 0.0 0.0 0.7 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.2 0.4 0.0 0.4 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.7 1.6 0.0 0.1 0.0 0.0 0.3 0.5 0.0 0.2 0.5 0.6 0.1 1.7 2.8 0.3 0.2 0.0 0.0 0.0 0.1 0.1 2.6 0.0 5.1 1.9 1.6 2.0 0.1 2.0 2.2 2.3 0.0 4.2 0.0 2.4 1.9 1.4 0.1 0.4 0.1 0.3 0.3 0.6 0.1 0.4 0.1 0.1 0.4 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 96.1 0.3 0.2 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 56.0 2.1 0.2 0.0 1.9 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 25.0 1.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 SIAH2 ENSG00000181788 "Siah E3 ubiquitin protein ligase 2" O43255 3 150741125-150763477 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 226.7;Syncytiotrophoblasts: 389.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA061293, CAB069930" Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 85: Liver - Metabolism" "Cluster 29: U-266 - Adaptive immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm Vesicles "CAB069930: AB_1217916, HPA061293: AB_2684470" "prognostic favorable (1.17e-4)" "unprognostic (1.04e-3)" "unprognostic (3.83e-2)" "unprognostic (9.15e-2)" "unprognostic (1.69e-1)" "unprognostic (6.91e-2)" "unprognostic (1.86e-2)" "unprognostic (5.68e-3)" "unprognostic (6.26e-2)" "unprognostic (1.95e-2)" "prognostic unfavorable (8.21e-5)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (2.38e-2)" "unprognostic (5.56e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-2)" 15.8 78.6 16.4 20.8 19.0 44.7 17.1 17.4 24.9 48.0 17.3 17.7 13.5 33.4 18.6 46.1 27.2 14.3 16.2 16.9 16.7 12.1 61.2 13.2 35.8 15.8 15.5 24.4 20.9 15.9 11.0 43.1 17.9 19.4 15.4 7.8 16.4 34.7 12.3 30.4 12.9 29.4 15.5 24.4 17.9 8.0 16.5 25.1 8.0 12.8 45.3 23.5 39.6 26.0 54.0 13.4 10.5 20.1 35.4 26.4 41.7 22.9 26.5 27.3 32.4 28.4 24.7 31.3 31.0 24.1 22.8 31.4 28.6 20.7 25.6 24.4 19.5 61.5 16.0 94.7 50.4 34.3 16.0 24.1 47.0 16.3 36.9 21.7 21.5 60.2 15.5 110.8 17.4 66.4 58.7 17.4 33.1 52.3 26.0 44.0 22.7 110.4 17.4 17.9 38.4 19.1 17.4 15.4 39.8 23.8 99.5 50.0 15.0 17.7 15.8 40.1 31.0 130.6 55.9 42.0 17.6 48.6 9.2 8.9 2.2 8.6 1.6 1.2 2.5 2.2 2.8 2.5 2.0 2.2 1.4 1.4 4.7 1.4 1.3 2.6 1.6 0.9 16.4 19.0 17.4 24.9 16.9 16.7 15.8 15.5 17.9 15.5 16.5 26.0 15.9 6.4 4.8 6.8 99.0 146.7 82.3 11.8 153.1 47.0 32.3 22.2 17.8 25.8 11.7 22.0 37.5 192.0 62.6 30.2 13.7 8.5 3.4 56.0 29.2 22.5 38.3 226.7 14.1 6.6 23.4 28.8 44.4 96.5 10.2 18.7 20.7 54.4 32.6 35.3 11.0 39.9 14.2 115.5 102.7 2.1 44.1 70.4 44.4 14.0 22.7 32.7 32.0 5.0 11.5 10.5 17.9 30.9 128.7 56.7 20.7 17.9 16.5 2.8 13.1 11.8 29.9 0.7 10.8 154.1 142.4 389.4 86.1 28.6 34.5 81.8 MINDY4B "C3orf76, FAM188B2" ENSG00000214237 "MINDY family member 4B" A8MYZ0 3 150870376-150905439 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "basal ganglia: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "T-47d: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 6: T47d - Mammary gland" "unprognostic (1.91e-4)" "unprognostic (6.32e-3)" "unprognostic (6.09e-3)" "unprognostic (3.14e-1)" "unprognostic (3.96e-1)" "unprognostic (1.01e-2)" "unprognostic (3.25e-2)" "unprognostic (2.07e-3)" "unprognostic (3.36e-1)" "unprognostic (8.66e-3)" "unprognostic (1.43e-1)" "unprognostic (2.22e-1)" "unprognostic (4.70e-1)" "unprognostic (2.54e-1)" "unprognostic (4.77e-1)" "unprognostic (2.16e-1)" 0.0 0.2 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CLRN1 "RP61, USH3, USH3A" ENSG00000163646 "Clarin 1" P58418 3 150926163-150972727 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hearing, Sensory transduction, Vision" "Deafness, Disease variant, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 4.9;retina: 12.8" "Cell type enriched" "Detected in some" 6 "Muller glia cells: 165.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 30 "NTERA-2: 3.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 77: Retina - Visual perception" "Cluster 5: NTERA-2 - Transcription" "Cluster 5: Muller glia cells - Visual perception" "unprognostic (1.00e-3)" "unprognostic (1.26e-1)" "unprognostic (5.54e-1)" "unprognostic (9.68e-2)" 0.0 4.9 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 165.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MED12L "KIAA1635, TNRC11L, TRALP, TRALPUSH" ENSG00000144893 "Mediator complex subunit 12L" Q86YW9 3 151085697-151437072 "Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Autism spectrum disorder, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "choroid plexus: 24.1" "Group enriched" "Detected in many" 4 "Astrocytes: 383.3;Excitatory neurons: 302.4;Inhibitory neurons: 120.7;Oligodendrocyte precursor cells: 225.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 1.3;plasmacytoid DC: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 18.5;HEL: 20.9;JURKAT: 13.0;MOLT-4: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036807 Enhanced Approved Nucleoli NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 36: HEL - Hemostasis" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoli "HPA036807: AB_10670242" "unprognostic (1.01e-2)" "unprognostic (5.82e-2)" "unprognostic (5.12e-2)" "unprognostic (8.14e-4)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (1.23e-2)" "unprognostic (5.90e-3)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" "unprognostic (1.38e-3)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (4.36e-3)" "unprognostic (3.84e-1)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" 0.7 1.5 0.7 0.4 2.6 4.3 0.2 0.3 5.6 1.0 24.1 0.2 1.0 0.4 1.9 0.1 0.3 0.5 0.2 2.4 0.7 0.1 0.0 0.2 1.0 0.2 0.9 0.2 0.1 0.2 1.7 1.2 0.0 0.6 0.0 3.0 0.3 0.3 0.3 0.1 0.4 0.3 0.0 0.4 0.2 4.5 3.6 0.5 0.4 0.0 1.0 0.3 0.4 0.6 0.9 0.4 2.9 0.2 0.1 0.1 18.5 0.0 0.3 0.7 0.8 1.0 0.3 0.0 0.2 0.1 2.1 0.1 3.8 0.3 0.8 0.0 1.8 20.9 0.1 0.1 0.0 0.7 7.1 0.0 0.1 0.1 0.1 0.1 0.0 13.0 0.0 3.1 0.0 3.1 9.9 0.0 3.4 0.1 0.7 0.1 1.1 0.5 0.3 3.0 4.9 0.7 0.4 0.2 0.0 5.2 1.0 0.1 0.0 0.0 2.2 0.0 1.5 5.9 0.0 7.3 0.2 1.8 1.1 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.7 2.6 0.3 5.6 2.4 0.7 0.2 0.9 0.0 0.0 3.6 0.6 0.1 0.0 0.0 383.3 1.0 1.1 1.1 0.3 2.8 11.1 0.5 0.4 1.2 0.0 1.3 1.8 4.2 18.6 0.4 0.2 0.0 0.1 13.2 1.1 0.4 0.4 0.0 13.0 302.4 0.6 1.5 0.9 0.0 0.3 0.0 0.2 0.4 0.2 1.9 33.7 120.7 0.0 0.0 1.6 1.1 7.3 0.9 1.7 0.0 52.5 1.3 26.2 0.0 225.7 9.6 0.2 0.0 0.4 1.3 1.1 0.0 0.5 0.9 1.9 0.0 0.3 0.5 8.2 4.3 0.4 0.1 27.0 0.2 1.1 0.0 0.4 GPR171 H963 ENSG00000174946 "G protein-coupled receptor 171" O14626 3 151197832-151203216 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.3" "Cell type enriched" "Detected in some" 4 "T-cells: 107.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 110.3" "Lineage enriched" "Detected in many" 15 "T-cells: 110.3" "Cell line enriched" "Detected in some" 25 "U-266/70: 27.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA067323 Supported NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA067323: " "unprognostic (6.82e-6)" "unprognostic (4.90e-3)" "unprognostic (7.10e-2)" "unprognostic (6.85e-4)" "unprognostic (2.80e-3)" "unprognostic (1.04e-3)" "unprognostic (4.19e-4)" "unprognostic (6.09e-2)" "unprognostic (4.93e-3)" "unprognostic (1.01e-3)" "unprognostic (8.84e-2)" "unprognostic (1.08e-1)" "unprognostic (4.72e-6)" "unprognostic (1.31e-1)" "unprognostic (4.17e-2)" "unprognostic (4.58e-2)" "unprognostic (1.02e-2)" 3.7 1.6 0.5 21.3 1.5 1.2 1.9 1.7 3.8 4.3 12.3 4.3 4.5 1.5 0.5 2.5 3.0 6.2 0.9 1.1 0.4 1.3 4.3 6.4 17.4 2.5 0.7 0.8 0.7 0.2 0.5 0.5 0.7 1.9 4.6 0.0 1.7 0.8 0.2 0.9 12.9 1.1 0.1 13.0 5.9 0.3 1.1 13.0 1.8 0.1 11.3 9.3 2.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.1 0.0 0.0 0.2 0.0 0.2 0.3 3.5 27.9 0.2 110.3 0.0 40.2 53.5 2.3 0.5 24.1 21.1 0.8 7.3 0.5 2.2 21.4 9.4 0.5 1.5 1.7 3.8 1.1 0.4 2.5 0.7 0.7 0.1 1.1 1.2 0.4 0.0 2.2 0.3 2.3 1.1 0.4 0.0 0.6 4.8 0.3 0.3 1.0 0.0 1.3 0.0 2.1 0.4 25.8 0.1 0.0 0.0 0.2 0.1 0.6 0.5 0.0 2.7 0.8 0.0 0.0 2.3 4.6 0.1 2.5 0.0 1.8 1.6 0.1 21.9 0.3 0.5 0.0 2.2 8.1 0.1 0.0 4.8 0.0 0.0 14.0 5.7 6.2 0.5 0.0 0.0 0.0 0.0 14.9 0.2 0.0 0.5 0.0 0.1 0.0 0.5 1.2 0.8 0.7 0.1 0.6 0.7 107.6 0.1 0.0 0.3 P2RY14 "GPR105, KIAA0001" ENSG00000174944 "Purinergic receptor P2Y14" Q15391 3 151212117-151278542 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 24.6;placenta: 31.7" "Cell type enhanced" "Detected in many" "Astrocytes: 31.0;dendritic cells: 54.4;Endometrial stromal cells: 35.5;Excitatory neurons: 41.2;granulocytes: 45.7;Langerhans cells: 61.3;Oligodendrocyte precursor cells: 29.1;Sertoli cells: 26.3;Smooth muscle cells: 29.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "eosinophil: 230.1;plasmacytoid DC: 98.0" "Group enriched" "Detected in many" 9 "dendritic cells: 98.0;granulocytes: 230.1" "Cell line enriched" "Detected in single" 68 "HMC-1: 67.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022646 Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 19: Lung - Lung function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "CAB022646: " "unprognostic (9.78e-2)" "unprognostic (7.47e-4)" "unprognostic (3.89e-2)" "unprognostic (4.52e-4)" "unprognostic (1.69e-2)" "unprognostic (2.57e-5)" "unprognostic (2.68e-2)" "unprognostic (1.55e-2)" "unprognostic (2.65e-1)" "unprognostic (1.64e-3)" "unprognostic (6.30e-2)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.72e-5)" "unprognostic (3.79e-2)" "unprognostic (6.89e-2)" "unprognostic (1.58e-1)" "unprognostic (2.58e-2)" 7.9 0.8 2.6 10.8 3.8 0.7 7.0 3.4 7.1 5.9 24.6 11.7 6.9 8.0 0.6 20.2 1.1 5.2 5.3 3.2 1.8 2.0 1.0 7.2 9.6 1.3 2.2 1.5 0.6 2.4 0.9 31.7 1.1 0.7 9.7 0.4 1.2 1.3 2.5 1.9 12.0 4.1 1.0 5.7 11.2 0.5 3.8 4.8 2.5 6.4 6.7 9.2 1.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 67.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 10.3 0.4 230.1 1.1 0.3 19.0 3.7 0.6 2.2 13.8 17.0 0.1 0.0 8.9 11.7 0.1 98.0 1.1 2.0 2.6 3.8 3.4 7.1 3.2 1.8 1.3 2.2 1.1 1.0 3.8 3.3 5.8 3.2 0.5 31.0 13.9 2.3 0.0 0.0 0.0 2.1 0.1 0.3 1.8 0.0 0.0 0.0 0.0 0.1 54.4 0.0 0.0 0.0 0.4 1.0 35.5 5.9 0.0 0.4 41.2 0.0 0.2 3.9 0.0 0.7 45.7 0.0 0.0 0.0 0.6 0.0 16.4 0.0 0.0 0.8 61.3 0.5 0.0 22.7 3.6 5.6 1.2 0.4 1.0 29.1 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.7 0.4 26.3 1.6 29.3 0.0 0.1 0.2 1.7 0.3 4.8 1.5 0.1 0.1 GPR87 GPR95 ENSG00000138271 "G protein-coupled receptor 87" Q9BY21 3 151294086-151316820 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.9;skin 1: 32.8;vagina: 23.8" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 139.2;Basal respiratory cells: 150.0;Suprabasal keratinocytes: 68.2;Syncytiotrophoblasts: 205.0;Urothelial cells: 211.4" "Group enriched" "Detected in many" 6 "cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 110.8;CAPAN-2: 40.8;HaCaT: 90.6;HBEC3-KT: 116.7;hTCEpi: 152.8;hTERT-HME1: 62.2;RT4: 46.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066313 Approved "Nucleoplasm,Lipid droplets,Mitochondria" No No "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Lipid droplets, Mitochondria" Nucleoplasm "HPA066313: AB_2685656" "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (4.07e-3)" "unprognostic (8.60e-2)" "unprognostic (1.28e-2)" "unprognostic (4.61e-3)" "unprognostic (3.28e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (4.62e-6)" "unprognostic (8.64e-2)" "unprognostic (1.50e-3)" "unprognostic (3.66e-4)" "unprognostic (8.73e-2)" "unprognostic (3.80e-2)" "unprognostic (2.17e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 3.3 0.1 0.8 10.0 2.9 0.0 0.0 0.0 3.2 35.9 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 9.6 0.0 4.3 0.0 0.0 13.7 5.5 0.1 32.8 0.0 0.0 0.0 0.0 0.5 0.0 0.1 3.5 0.0 0.0 12.4 13.2 23.8 0.4 110.8 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.9 0.2 0.0 40.8 0.0 0.0 0.0 0.6 90.6 0.0 116.7 1.1 0.0 0.1 0.0 1.1 0.0 0.8 0.0 0.0 0.0 152.8 0.1 62.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.1 6.1 0.0 0.0 0.0 3.8 46.7 0.0 0.0 19.0 0.5 0.0 3.1 0.4 0.1 0.0 0.0 10.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 1.1 1.0 0.0 59.3 139.2 150.0 46.7 0.0 2.8 1.8 0.1 0.0 49.9 3.7 0.0 59.0 0.4 0.0 0.0 1.2 0.7 3.3 0.0 1.5 0.0 0.0 1.1 0.7 8.7 1.1 0.0 2.4 1.3 0.0 0.0 0.0 4.2 0.0 0.4 0.0 28.5 0.0 3.6 0.1 0.0 0.6 10.6 0.0 0.0 0.0 0.0 1.0 0.0 12.9 0.0 0.0 0.0 60.6 0.0 0.1 19.6 0.0 0.0 0.0 4.1 0.0 0.0 52.7 68.2 205.0 0.9 0.0 0.0 211.4 P2RY13 "FKSG77, GPR86, GPR94, P2Y13" ENSG00000181631 "Purinergic receptor P2Y13" Q9BPV8 3 151326312-151329549 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.1;lymphoid tissue: 36.9" "Group enriched" "Detected in some" 9 "Kupffer cells: 124.4;Macrophages: 53.2;Microglial cells: 66.5;monocytes: 63.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 581.5" "Group enriched" "Detected in many" 6 "granulocytes: 581.5;monocytes: 185.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049047 Enhanced NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "HPA049047: AB_2680611" "unprognostic (1.09e-3)" "unprognostic (7.51e-4)" "unprognostic (1.68e-2)" "unprognostic (2.37e-3)" "unprognostic (3.95e-2)" "unprognostic (8.66e-3)" "unprognostic (7.66e-2)" "unprognostic (5.48e-3)" "unprognostic (2.84e-3)" "unprognostic (1.83e-1)" "unprognostic (4.97e-2)" "unprognostic (1.17e-1)" "unprognostic (4.05e-1)" "unprognostic (4.46e-1)" "unprognostic (5.95e-2)" "unprognostic (2.21e-3)" "unprognostic (3.78e-1)" 4.8 3.8 1.6 20.6 1.6 25.1 4.2 1.6 2.2 2.6 2.7 4.5 4.6 1.9 0.8 3.2 3.1 3.9 1.4 1.9 2.0 1.6 8.2 7.6 18.2 3.1 2.4 1.6 1.2 1.6 0.5 3.3 2.8 1.4 6.2 0.1 2.9 3.2 0.7 2.1 11.0 5.3 3.7 36.9 3.1 0.7 4.2 4.5 1.3 3.8 8.4 4.1 0.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 152.5 137.2 0.3 155.4 0.3 1.5 0.2 0.2 66.4 0.6 0.2 0.3 581.5 0.1 185.6 1.1 0.2 77.6 1.6 1.6 1.6 2.2 1.9 2.0 3.1 2.4 2.8 3.7 4.2 4.0 0.9 0.0 6.1 0.0 1.3 0.0 0.1 0.0 0.0 0.8 0.6 0.6 0.4 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 3.6 0.3 0.0 0.2 0.6 0.5 0.0 2.5 0.0 0.7 0.4 7.7 1.7 0.2 0.0 0.0 124.4 4.5 0.0 0.0 53.2 0.0 66.5 63.3 1.1 2.1 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.0 P2RY12 "HORK3, P2Y12, SP1999" ENSG00000169313 "Purinergic receptor P2Y12" Q9H244 3 151336843-151384753 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.8;lymphoid tissue: 9.8" "Cell type enriched" "Detected in some" 27 "Microglial cells: 421.6" "Cancer enriched" "Detected in many" 14 "glioma: 17.3" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 8.3" "Group enriched" "Detected in many" 11 "dendritic cells: 3.2;monocytes: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013796, HPA014518" Enhanced NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 68: Oligodendrocytes - Mixed function" "HPA013796: AB_1854884, HPA014518: AB_2669027" "unprognostic (2.39e-2)" "unprognostic (1.60e-3)" "unprognostic (5.93e-2)" "unprognostic (1.77e-1)" "unprognostic (2.41e-2)" "unprognostic (2.52e-2)" "unprognostic (8.09e-2)" "unprognostic (1.72e-3)" "unprognostic (6.46e-2)" "unprognostic (8.64e-4)" "unprognostic (4.84e-2)" "unprognostic (5.96e-2)" "unprognostic (2.03e-1)" "unprognostic (8.92e-2)" "unprognostic (1.65e-1)" "unprognostic (3.52e-2)" "unprognostic (4.04e-1)" 8.6 4.0 4.8 1.9 5.1 0.5 3.7 5.1 6.1 1.3 2.4 1.6 1.2 0.7 0.6 1.2 2.5 2.2 1.3 5.7 6.9 0.6 2.5 2.5 9.8 10.2 8.1 1.6 0.8 1.6 0.3 2.3 11.8 0.9 1.4 0.3 2.9 2.0 0.1 0.4 2.8 1.6 11.5 5.5 1.1 0.2 8.5 0.9 0.5 0.6 8.7 1.1 0.4 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 8.3 0.0 0.3 0.0 0.0 3.2 0.5 0.0 0.0 0.3 0.0 2.2 0.3 0.0 1.3 4.8 5.1 5.1 6.1 5.7 6.9 10.2 8.1 11.8 11.5 8.5 13.8 0.2 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.5 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 2.6 0.0 0.0 0.0 3.1 0.0 421.6 0.7 0.4 0.0 15.6 4.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 IGSF10 "CMF608, FLJ25972" ENSG00000152580 "Immunoglobulin superfamily member 10" Q6WRI0 3 151425384-151458709 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Osteogenesis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 17.7" "Cell type enhanced" "Detected in many" "Early spermatids: 170.5;Horizontal cells: 60.6;Late spermatids: 34.1;Microglial cells: 61.8;Syncytiotrophoblasts: 30.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HeLa: 44.1;HL-60: 23.3;REH: 17.2;RPMI-8226: 55.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA012655, HPA012921" Uncertain Approved Vesicles "Secreted - unknown location" NA NA 540000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 25: RPMI-8226 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles "HPA012655: , HPA012921: AB_1851526" "unprognostic (1.78e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.47e-7)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (9.82e-2)" "unprognostic (8.84e-4)" "unprognostic (9.38e-3)" "unprognostic (1.96e-1)" "unprognostic (5.70e-2)" "unprognostic (2.04e-1)" "unprognostic (7.52e-4)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (4.59e-3)" "unprognostic (7.57e-4)" 3.9 4.0 1.4 0.9 0.7 0.6 6.1 0.3 1.0 0.5 3.2 1.3 0.5 1.4 1.6 2.9 4.3 9.7 4.3 2.8 1.1 0.2 0.3 8.6 1.4 0.1 1.0 17.7 0.7 1.3 1.7 0.7 0.3 0.1 1.3 0.2 5.2 0.2 0.1 1.9 1.2 1.5 0.0 0.9 0.7 0.9 3.6 1.3 1.5 0.5 2.5 2.2 0.3 0.3 0.0 0.1 0.3 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.1 0.0 0.4 0.0 0.0 0.3 0.3 7.5 44.1 0.0 1.6 23.3 0.1 0.4 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.2 0.1 55.1 0.1 0.1 1.0 0.0 5.9 0.0 0.0 0.2 0.0 0.2 0.0 0.1 1.1 0.0 0.0 2.4 0.0 0.0 0.2 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.7 0.3 1.0 2.8 1.1 0.1 1.0 0.3 0.0 3.6 0.3 2.0 0.0 0.5 1.0 0.6 2.4 1.2 0.5 2.8 15.8 0.6 0.9 1.6 2.8 6.3 1.8 4.2 21.7 2.7 0.2 0.0 0.1 170.5 11.4 4.0 0.9 6.0 3.4 2.4 1.3 2.9 20.4 0.5 0.5 0.0 0.0 0.0 0.1 1.3 60.6 2.8 0.7 4.1 0.8 3.2 34.1 6.8 2.9 3.6 61.8 1.1 25.6 0.0 0.5 0.7 0.4 0.1 1.2 0.3 0.7 0.0 0.3 12.5 2.4 0.0 0.5 2.2 10.7 7.9 0.8 2.4 30.9 0.6 2.5 0.1 0.2 AADACL2 MGC72001 ENSG00000197953 "Arylacetamide deacetylase like 2" Q6P093 3 151733916-151761339 "Predicted secreted proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 19 "skin 1: 35.6" "Cell type enriched" "Detected in some" 7 "Suprabasal keratinocytes: 30.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "Cluster 61: Skin - Cornification" "Cluster 28: Keratinocytes - Keratinization" "unprognostic (2.20e-2)" "unprognostic (3.10e-3)" "unprognostic (2.63e-2)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (3.00e-1)" "unprognostic (2.91e-4)" 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 35.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.1 30.7 0.1 0.1 0.0 0.0 0.0 AADAC "CES5A1, DAC" ENSG00000114771 "Arylacetamide deacetylase" P22760 3 151814073-151828488 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 224.9;intestine: 241.7;liver: 946.7" "Group enriched" "Detected in some" 8 "Hepatocytes: 687.7;Proximal enterocytes: 460.5" "Cancer enriched" "Detected in many" 22 "liver cancer: 153.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 9.5;ASC diff: 4.2;EFO-21: 4.6;HBEC3-KT: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA002911 Approved NA NA "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 2: Hepatocytes - Metabolism" "HPA002911: AB_1078074" "unprognostic (1.26e-1)" "unprognostic (1.82e-2)" "unprognostic (8.11e-2)" "unprognostic (4.41e-2)" "unprognostic (9.23e-2)" "unprognostic (7.82e-2)" "unprognostic (2.15e-1)" "unprognostic (9.89e-2)" "prognostic favorable (5.58e-6)" "prognostic unfavorable (5.02e-4)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.22e-1)" "unprognostic (1.27e-1)" 8.2 224.9 0.0 0.4 0.0 0.0 5.0 0.0 0.1 0.1 0.2 0.3 220.9 0.2 0.0 2.7 0.6 27.4 0.7 0.0 0.0 0.2 946.7 9.1 0.3 0.0 0.1 0.1 36.7 0.0 0.0 1.5 0.0 0.1 0.2 0.0 1.3 0.0 0.0 13.8 241.7 0.0 0.0 0.2 52.3 0.8 0.1 0.4 0.3 0.0 2.5 0.7 0.4 0.0 0.0 9.5 0.0 0.0 4.2 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 4.6 0.0 0.0 0.2 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.5 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 1.0 0.4 0.1 0.3 1.7 0.0 1.7 0.1 1.2 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.0 0.9 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 6.5 0.0 14.3 0.0 0.7 0.3 0.0 4.4 0.0 0.0 0.0 0.0 1.1 71.4 8.7 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.3 1.8 0.1 0.7 0.0 2.7 0.0 51.9 0.0 39.3 53.5 0.2 0.0 0.0 5.0 687.7 0.2 0.0 0.0 9.6 0.0 14.8 0.3 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 10.0 0.0 0.1 0.2 460.5 0.0 2.9 0.0 0.0 0.0 3.4 0.0 0.1 1.4 3.4 0.3 0.7 0.3 18.4 0.2 SUCNR1 GPR91 ENSG00000198829 "Succinate receptor 1" Q9BXA5 3 151873643-151884619 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "kidney: 39.9" "Cell type enhanced" "Detected in some" "Distal tubular cells: 19.6;Hofbauer cells: 22.0;Kupffer cells: 32.0;Macrophages: 11.8;Proximal tubular cells: 46.3;Smooth muscle cells: 11.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEL: 53.3;NB-4: 31.0;U-937: 52.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB022745 Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 32: U-937 - Innate immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "CAB022745: " "unprognostic (1.54e-1)" "unprognostic (2.65e-2)" "unprognostic (3.45e-2)" "unprognostic (6.94e-2)" "unprognostic (1.58e-1)" "unprognostic (6.01e-2)" "unprognostic (3.17e-1)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" "unprognostic (1.04e-1)" "unprognostic (8.92e-2)" "unprognostic (2.59e-1)" "unprognostic (1.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.14e-2)" "unprognostic (7.49e-2)" "unprognostic (1.58e-1)" 3.5 0.8 0.0 1.3 0.1 8.1 1.0 0.0 0.2 0.2 0.0 0.5 1.2 0.1 0.1 0.2 0.1 0.5 0.7 0.0 0.2 39.9 5.2 2.6 1.9 0.2 0.2 0.1 0.0 3.4 0.0 0.2 0.3 0.1 0.8 0.0 0.6 0.1 0.0 1.0 1.0 0.7 0.1 7.0 7.8 0.1 0.4 0.9 9.3 0.1 0.6 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.3 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 8.7 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.8 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.2 0.2 0.3 0.1 0.4 0.2 8.4 0.0 1.1 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.5 1.5 0.1 3.7 0.0 0.1 1.4 0.0 19.6 0.0 0.5 0.0 0.0 0.8 0.0 2.1 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 4.3 22.0 0.0 0.0 0.2 8.2 32.0 8.1 0.4 0.0 11.8 0.0 8.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 46.3 1.5 0.0 0.0 0.1 11.2 0.0 0.1 0.0 0.3 0.1 0.3 0.0 0.0 0.1 MBNL1 "EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL" ENSG00000152601 "Muscleblind like splicing regulator 1" Q9NR56 3 152243828-152465780 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 537.7;Oligodendrocytes: 471.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016398, HPA035098" Enhanced Enhanced Nucleoplasm,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "CAB016398: AB_784435, HPA035098: AB_2674461" "unprognostic (5.46e-3)" "unprognostic (6.01e-3)" "unprognostic (1.94e-3)" "unprognostic (1.99e-1)" "unprognostic (3.44e-2)" "unprognostic (5.82e-3)" "unprognostic (2.75e-2)" "unprognostic (9.49e-3)" "unprognostic (5.18e-2)" "unprognostic (1.70e-2)" "unprognostic (2.78e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.90e-7)" "unprognostic (7.53e-3)" "unprognostic (6.15e-2)" "unprognostic (1.77e-1)" "unprognostic (2.98e-1)" 116.4 35.8 18.2 105.0 24.9 90.4 48.1 22.9 22.3 76.9 18.9 69.0 43.6 68.0 30.1 65.3 38.4 75.2 63.2 18.7 23.0 31.5 47.6 78.1 138.4 25.5 20.1 45.1 24.3 26.5 11.8 29.9 26.0 55.1 71.1 17.7 32.3 66.0 188.8 61.5 58.3 116.5 25.0 92.3 40.5 14.9 25.2 108.4 31.8 131.0 135.1 78.4 32.7 32.5 133.8 107.8 17.3 38.9 132.5 135.8 12.7 163.3 131.5 105.6 87.8 48.0 76.3 136.3 81.3 230.8 32.8 59.7 32.1 94.5 155.0 106.9 43.7 149.3 52.2 22.7 73.8 180.5 104.5 63.8 50.2 121.9 94.0 80.8 219.5 54.1 77.3 180.5 103.6 45.9 169.0 66.0 7.2 38.9 85.4 170.5 53.0 171.6 53.7 66.3 13.8 15.7 71.1 38.2 69.8 6.2 53.1 270.5 186.6 143.6 55.1 96.4 142.7 186.9 115.9 154.6 83.8 220.6 79.1 95.3 53.7 90.1 79.4 61.7 84.4 56.2 64.5 66.5 70.1 49.7 80.6 70.7 78.4 79.6 54.7 24.9 62.6 104.3 18.2 24.9 22.9 22.3 18.7 23.0 25.5 20.1 26.0 25.0 25.2 32.5 175.5 150.6 193.7 179.2 252.1 213.6 49.0 25.9 156.0 28.5 51.8 48.0 179.8 52.9 89.5 38.6 64.6 26.1 266.0 164.7 21.5 36.0 2.6 64.0 92.2 142.9 47.3 160.2 258.6 63.6 9.2 122.9 78.0 68.5 162.6 31.5 90.0 91.5 60.9 32.0 185.5 68.8 14.2 216.4 195.5 9.7 89.5 235.0 103.2 537.7 249.4 18.2 230.7 224.7 471.9 57.3 90.3 71.5 181.3 61.2 121.4 42.2 63.1 84.1 98.6 102.7 145.6 4.3 12.7 149.4 243.6 14.8 340.1 46.8 80.7 50.1 P2RY1 "P2Y1, SARCC" ENSG00000169860 "Purinergic receptor P2Y1" P47900 3 152835131-152841439 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 25.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 23.3;Cholangiocytes: 21.5;Distal enterocytes: 25.4;Kupffer cells: 21.1;Squamous epithelial cells: 45.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 6.0;non-classical monocyte: 2.6" "Group enriched" "Detected in many" 9 "granulocytes: 6.0;monocytes: 2.6" "Cell line enriched" "Detected in many" 5 "HEL: 45.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA015577 Enhanced NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" "HPA015577: AB_1854882" "unprognostic (3.30e-1)" "unprognostic (4.52e-2)" "unprognostic (2.68e-2)" "unprognostic (4.76e-2)" "unprognostic (9.70e-2)" "unprognostic (1.40e-3)" "unprognostic (3.32e-2)" "unprognostic (2.53e-1)" "unprognostic (5.14e-1)" "unprognostic (2.58e-1)" "unprognostic (4.68e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (2.04e-7)" "unprognostic (1.36e-1)" "unprognostic (8.98e-2)" "unprognostic (7.33e-2)" "unprognostic (3.20e-2)" 1.6 1.4 6.2 2.3 14.2 5.7 1.4 3.1 6.4 4.5 1.0 9.1 3.2 6.5 0.5 19.2 2.1 2.0 2.9 5.9 6.7 0.8 1.5 7.0 0.8 3.3 4.2 8.8 3.3 0.3 1.6 25.4 8.4 7.7 6.7 9.0 3.2 2.2 7.7 8.9 6.1 4.5 4.9 2.2 0.9 1.1 8.2 1.6 1.3 3.4 2.7 2.4 8.0 4.1 0.0 0.7 7.0 0.0 1.1 0.1 0.0 0.0 0.1 0.2 0.6 9.0 0.1 0.0 0.7 0.0 1.1 1.5 3.9 1.3 0.3 0.0 3.4 45.9 0.1 0.0 0.0 5.4 4.0 0.5 8.7 0.0 0.4 3.5 0.0 1.5 1.4 0.0 0.0 0.1 0.8 0.1 6.4 0.0 5.5 0.0 0.2 1.3 0.0 3.1 1.1 0.0 0.0 0.0 0.9 1.6 0.0 2.4 0.0 0.7 1.8 0.0 3.9 0.0 0.0 0.0 4.5 0.0 5.2 6.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.6 0.5 0.0 0.1 6.2 14.2 3.1 6.4 5.9 6.7 3.3 4.2 8.4 4.9 8.2 4.1 1.0 0.0 0.5 12.7 0.8 1.9 6.7 3.3 15.9 23.3 0.5 0.1 7.1 21.5 1.0 0.0 0.0 0.2 1.6 25.4 0.0 1.3 0.2 1.9 12.0 7.1 0.0 10.8 0.0 0.0 0.3 5.6 0.0 2.7 10.1 0.1 11.7 0.3 7.4 0.0 0.2 8.9 0.0 21.1 0.3 0.8 14.9 15.9 0.0 1.0 1.8 19.1 0.0 0.0 0.6 0.9 12.3 6.0 0.0 6.3 13.4 0.2 0.2 1.5 0.0 1.2 1.0 0.4 2.2 45.4 2.0 0.1 0.5 3.5 8.3 4.9 RAP2B ENSG00000181467 "RAP2B, member of RAS oncogene family" P61225 3 153162226-153170627 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 236.8;Squamous epithelial cells: 259.0;Urothelial cells: 269.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 160000 "Cluster 7: Monocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" "unprognostic (2.44e-2)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "unprognostic (3.51e-2)" "unprognostic (3.04e-2)" "unprognostic (2.87e-2)" "prognostic unfavorable (1.65e-4)" "unprognostic (2.40e-1)" "unprognostic (2.00e-1)" "prognostic favorable (9.21e-4)" "unprognostic (2.48e-2)" "unprognostic (1.67e-1)" "unprognostic (5.97e-2)" "unprognostic (2.96e-1)" "unprognostic (2.32e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-2)" 5.2 2.5 4.9 6.0 7.2 15.6 3.4 1.4 7.4 6.0 2.1 3.8 2.6 3.4 2.9 14.9 2.7 6.3 2.1 12.1 5.2 2.7 4.4 5.0 6.3 2.5 4.8 3.6 2.4 2.3 1.2 8.6 2.1 2.4 3.5 0.9 4.8 2.3 1.3 5.0 3.6 3.1 2.9 7.5 8.7 1.4 8.2 4.7 2.1 1.6 5.0 8.2 7.0 5.4 29.0 10.4 5.0 7.4 10.7 9.7 13.7 7.3 10.8 4.9 5.4 5.5 16.6 2.0 8.0 6.8 8.1 28.5 3.9 13.3 5.7 11.7 7.5 11.7 5.6 10.2 5.6 10.9 17.8 10.5 11.1 7.3 13.6 8.6 11.9 5.5 6.8 23.9 9.3 11.5 10.3 15.7 10.4 6.0 16.1 8.9 13.7 26.3 7.7 27.8 0.1 2.7 7.6 6.9 23.5 8.9 5.1 5.6 23.9 7.5 11.6 8.1 18.5 15.3 2.7 5.2 10.0 12.0 7.9 28.0 17.9 7.5 19.5 27.8 14.7 6.4 16.6 17.2 13.1 3.8 9.3 14.7 7.2 14.1 27.6 9.5 12.7 13.8 4.9 7.2 1.4 7.4 12.1 5.2 2.5 4.8 2.1 2.9 8.2 5.4 39.7 12.8 16.5 1.6 26.0 193.0 145.8 61.1 236.8 3.7 41.3 22.4 4.8 30.0 39.4 16.5 2.1 17.3 94.4 135.3 3.9 31.3 0.6 107.8 40.4 21.5 48.6 40.8 8.9 21.7 49.4 30.7 120.8 173.4 26.6 51.3 25.4 14.7 132.1 3.3 3.0 53.5 40.7 170.6 159.9 1.5 19.3 117.0 35.6 4.7 120.1 7.9 110.2 4.5 1.9 60.6 121.3 14.7 27.8 102.1 31.1 12.3 22.1 5.9 0.0 11.1 18.0 3.8 6.1 259.0 195.2 15.2 52.6 12.3 33.6 269.2 ARHGEF26 "DKFZP434D146, SGEF" ENSG00000114790 "Rho guanine nucleotide exchange factor 26" Q96DR7 3 154121003-154257827 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 339.7;Astrocytes: 248.8" "Cancer enhanced" "Detected in all" "prostate cancer: 19.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017722, HPA049195" Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 30: Mammary glandular cells - Lactation" "Plasma membrane" "Nucleoplasm, Cytosol" "HPA017722: AB_1856800, HPA049195: AB_2680671" "unprognostic (1.41e-1)" "unprognostic (1.43e-3)" "unprognostic (3.55e-1)" "unprognostic (7.99e-3)" "unprognostic (2.82e-1)" "unprognostic (9.42e-3)" "prognostic favorable (9.74e-4)" "unprognostic (7.06e-2)" "unprognostic (1.16e-1)" "unprognostic (6.01e-5)" "unprognostic (1.44e-3)" "unprognostic (4.36e-2)" "unprognostic (2.22e-1)" "unprognostic (5.53e-3)" "unprognostic (3.11e-1)" "unprognostic (1.07e-1)" "unprognostic (5.24e-3)" 8.0 2.1 5.8 1.8 5.7 0.3 6.0 4.1 5.3 5.0 7.7 18.3 7.3 4.3 1.2 7.4 6.2 5.5 3.2 4.6 5.0 1.7 15.5 16.3 0.3 5.9 7.3 3.9 6.0 9.9 1.7 3.4 5.8 3.4 2.6 7.1 3.1 4.8 0.4 6.2 6.6 7.1 5.4 0.8 8.7 5.1 6.1 0.8 3.1 1.4 0.9 5.1 6.4 4.8 8.5 3.7 10.6 6.8 5.1 1.4 0.3 0.3 0.0 3.1 4.3 6.5 0.8 5.0 0.5 0.6 4.9 8.9 6.7 4.4 3.9 0.0 8.8 0.1 2.6 1.5 4.7 1.6 0.2 1.3 0.4 4.0 0.5 1.8 0.6 5.4 0.0 0.0 2.0 8.1 2.0 0.1 6.7 2.4 3.0 0.0 12.9 0.0 0.7 4.1 3.2 1.1 1.7 14.4 1.5 4.6 10.1 0.5 0.0 1.1 5.3 0.1 26.6 4.5 0.7 0.0 2.5 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.7 4.1 5.3 4.6 5.0 5.9 7.3 5.8 5.4 6.1 4.8 5.0 339.7 26.8 248.8 1.7 19.5 9.0 2.7 17.6 11.6 54.2 6.6 1.8 20.0 10.8 3.7 4.2 1.8 4.3 1.5 0.0 2.2 11.9 4.7 4.5 4.3 0.0 2.7 4.2 2.5 1.1 12.0 14.3 2.1 5.1 3.6 8.6 60.8 0.6 5.0 10.1 7.9 6.1 2.5 3.4 3.4 10.5 1.3 3.6 7.5 2.7 58.1 12.3 41.7 5.1 2.0 6.9 18.8 0.7 7.5 21.4 0.1 14.9 47.8 0.0 14.1 3.7 4.7 37.0 11.7 23.7 6.2 4.7 2.5 8.1 5.7 DHX36 "DDX36, KIAA1488, MLEL1, RHAU" ENSG00000174953 "DEAH-box helicase 36" Q9H2U1 3 154272546-154324487 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 547.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035398, HPA035399" Approved Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Mitochondria, Cytosol" "HPA035398: , HPA035399: AB_10670115" "unprognostic (8.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.86e-1)" "unprognostic (3.50e-3)" "unprognostic (2.67e-2)" "unprognostic (3.22e-1)" "unprognostic (8.80e-3)" "unprognostic (1.03e-1)" "unprognostic (7.51e-2)" "unprognostic (1.26e-1)" "unprognostic (3.94e-2)" "unprognostic (3.90e-2)" "unprognostic (2.72e-1)" "unprognostic (5.09e-2)" "unprognostic (5.27e-1)" "unprognostic (4.96e-2)" "unprognostic (1.37e-1)" 17.7 14.4 5.6 17.3 8.6 16.3 16.4 8.9 7.3 13.9 6.3 12.0 12.6 18.3 11.6 14.8 14.4 15.5 16.9 5.6 8.1 18.6 20.0 13.7 21.7 7.0 7.5 19.0 16.0 29.1 14.9 19.0 7.2 17.3 13.7 17.0 11.7 16.4 58.9 12.0 12.8 17.1 6.9 15.2 16.0 34.4 6.9 21.7 23.1 31.6 20.5 17.2 11.0 10.0 63.8 42.6 56.6 32.7 26.1 36.3 28.1 40.6 40.5 45.2 53.5 43.7 49.7 61.3 64.0 35.8 41.7 40.1 53.8 34.4 70.6 59.3 35.6 44.5 34.8 25.0 44.2 62.7 37.4 41.3 28.5 48.6 59.1 24.5 39.4 37.3 42.6 34.3 42.2 31.0 52.2 13.7 75.4 33.6 40.5 53.4 47.6 88.8 32.1 44.4 52.7 56.1 42.3 44.4 59.7 38.3 45.5 31.5 44.9 47.1 29.6 44.6 82.1 63.6 43.9 87.5 38.1 32.2 51.1 1.2 1.5 1.8 3.7 1.5 2.3 2.6 3.2 2.5 1.3 3.1 2.9 3.1 0.6 2.6 3.5 3.3 3.1 0.6 5.6 8.6 8.9 7.3 5.6 8.1 7.0 7.5 7.2 6.9 6.9 10.0 95.6 57.7 92.9 45.4 123.6 92.9 146.6 56.6 81.4 152.2 61.8 62.6 60.8 67.2 83.5 60.7 129.3 138.0 179.3 43.8 39.2 71.2 547.0 73.4 147.9 82.0 92.0 68.5 53.5 62.8 69.9 97.6 66.8 104.2 103.8 86.7 72.8 80.5 62.0 154.8 60.2 57.4 73.2 73.7 85.2 335.5 110.6 83.0 53.4 37.5 88.5 86.4 113.3 59.3 55.4 66.5 49.9 121.5 97.6 132.2 40.4 54.4 52.3 128.6 78.9 130.6 88.8 197.4 135.1 65.3 83.1 370.1 152.0 114.2 58.1 128.4 GPR149 "IEDA, PGR10, R35" ENSG00000174948 "G protein-coupled receptor 149" Q86SP6 3 154334943-154430190 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 6.9" "Cell type enriched" "Detected in some" 22 "Inhibitory neurons: 48.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 15.0" "Low region specificity" "Detected in many" HPA018020 Uncertain NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA018020: AB_1849334" 0.0 0.0 0.5 0.0 6.9 0.0 0.0 1.2 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 1.9 2.9 0.0 0.0 0.0 0.9 0.0 4.4 0.0 0.0 0.7 0.0 1.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 6.9 1.2 2.6 0.1 3.0 1.9 2.9 4.4 0.6 6.6 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 48.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 MME "CALLA, CD10, NEP" ENSG00000196549 "Membrane metalloendopeptidase" P08473 3 155024124-155183704 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 333.5;kidney: 302.5" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 273.3;Proximal enterocytes: 372.4;Proximal tubular cells: 125.7;Syncytiotrophoblasts: 126.0" "Cancer enhanced" "Detected in many" "prostate cancer: 17.6" "Group enriched" "Detected in many" 5 "basal ganglia: 17.3;medulla oblongata: 9.3;pons: 10.9;thalamus: 4.6" "Immune cell enriched" "Detected in some" 122 "neutrophil: 139.4" "Lineage enriched" "Detected in many" 122 "granulocytes: 139.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 684.4;BJ hTERT+: 1116.9;HSkMC: 651.1" "Region enhanced" "Detected in many" "basal ganglia: 28.1" "Group enriched" "Detected in many" 4 "basal ganglia: 32.3;olfactory bulb: 8.5;spinal cord: 15.9" "CAB000013, HPA052583, HPA056072" Enhanced NA NA 320000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 45: Enterocytes - Digestion" "CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027" "unprognostic (1.36e-1)" "unprognostic (1.02e-3)" "unprognostic (8.52e-2)" "unprognostic (2.95e-1)" "unprognostic (2.78e-2)" "unprognostic (6.52e-3)" "unprognostic (1.20e-1)" "unprognostic (1.67e-2)" "unprognostic (8.67e-2)" "unprognostic (1.96e-1)" "unprognostic (7.30e-3)" "unprognostic (1.31e-1)" "unprognostic (2.71e-3)" "unprognostic (1.50e-1)" "unprognostic (7.29e-2)" "unprognostic (1.06e-2)" "unprognostic (1.37e-2)" 103.9 1.0 0.7 4.5 17.3 11.5 38.5 1.5 1.9 22.7 0.3 1.9 333.5 13.3 22.5 2.3 1.9 13.4 4.3 0.1 0.6 302.5 56.1 27.6 10.3 9.3 2.3 0.9 1.2 0.5 0.6 73.0 10.9 79.6 3.4 0.1 6.1 44.5 20.3 1.9 289.7 1.5 0.9 7.9 1.6 1.3 4.6 16.6 1.2 23.5 12.3 6.0 7.6 0.4 0.1 0.0 0.9 0.3 280.1 684.4 1.6 160.3 1116.9 82.2 209.8 0.0 0.3 172.9 0.1 130.1 107.4 0.5 5.2 6.1 201.3 0.0 0.8 0.0 0.1 0.2 229.6 0.0 0.0 651.1 1.0 40.4 308.1 89.4 59.5 0.4 0.2 0.3 135.1 0.7 0.4 1.0 6.1 0.5 1.1 303.3 139.9 1.6 5.2 1.9 0.5 1.5 0.1 0.5 31.9 68.3 0.2 0.2 165.8 356.4 0.8 115.7 27.9 0.1 0.0 217.3 42.5 0.1 7.3 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 139.4 0.0 0.0 1.1 0.0 0.0 0.7 17.3 1.5 1.9 0.1 0.6 9.3 2.3 10.9 0.9 4.6 0.4 5.9 9.6 13.0 0.3 2.3 0.8 74.1 2.5 0.0 0.0 1.5 64.1 1.6 21.5 11.2 22.0 0.0 82.1 6.9 0.0 9.8 0.2 0.5 6.2 273.3 6.6 0.0 0.0 2.2 0.0 57.8 40.6 0.0 5.7 2.5 0.0 2.9 53.2 8.9 0.0 8.1 9.9 2.0 3.1 1.2 0.5 4.1 10.7 0.0 0.0 0.2 0.0 0.0 0.5 0.3 0.6 13.8 1.2 0.1 40.0 372.4 125.7 1.6 0.0 0.0 17.4 11.1 0.2 0.5 0.1 0.3 126.0 2.5 0.1 12.6 33.6 STRIT1 DWORF ENSG00000240045 "Small transmembrane regulator of ion transport 1" P0DN84 3 155290227-155293683 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 79 "skeletal muscle: 1711.3;tongue: 698.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.1;prostate cancer: 1.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "basophil: 1.0" "Lineage enriched" "Detected in single" 10 "granulocytes: 1.0" "Not detected" "Not detected" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" "unprognostic (6.77e-4)" "unprognostic (1.60e-2)" "unprognostic (6.62e-2)" "unprognostic (1.58e-1)" "unprognostic (7.82e-3)" "unprognostic (1.33e-2)" 0.6 0.1 3.5 0.2 15.2 0.2 0.5 4.5 3.5 0.0 2.8 0.2 6.3 0.2 0.5 14.1 0.1 0.4 5.5 3.3 2.8 5.9 0.3 0.2 0.3 3.1 4.1 0.1 0.3 0.1 0.1 0.1 4.2 12.1 0.2 0.3 8.7 0.1 1711.3 2.2 3.6 0.0 1.7 0.2 0.2 0.2 7.5 0.0 0.4 698.4 0.1 0.0 0.1 5.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.3 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.2 0.4 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 15.2 4.5 3.5 3.3 2.8 3.1 4.1 4.2 1.7 7.5 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PLCH1 "DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3" ENSG00000114805 "Phospholipase C eta 1" Q4KWH8 3 155375580-155745071 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.6;retina: 12.4" "Group enriched" "Detected in many" 4 "Astrocytes: 93.7;Early spermatids: 206.2;Excitatory neurons: 126.0;Inhibitory neurons: 131.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 12.3;AF22: 39.0;HEL: 10.1;NTERA-2: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036176, HPA057978" Uncertain Enhanced Vesicles NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles "HPA036176: AB_10671837, HPA057978: AB_2683569" "unprognostic (1.08e-2)" "unprognostic (3.68e-1)" "unprognostic (2.17e-2)" "unprognostic (1.55e-2)" "unprognostic (3.50e-4)" "unprognostic (6.41e-2)" "unprognostic (2.94e-5)" "unprognostic (5.04e-2)" "unprognostic (2.41e-1)" "unprognostic (2.24e-3)" "unprognostic (4.84e-2)" "unprognostic (1.76e-2)" "prognostic favorable (3.03e-5)" "unprognostic (3.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-1)" "unprognostic (1.37e-2)" 0.0 0.0 5.5 0.3 4.8 0.2 2.6 4.5 6.0 1.2 9.3 2.5 2.5 0.7 8.2 0.1 8.1 1.5 1.8 3.8 1.4 1.2 0.1 4.0 0.0 1.3 4.6 0.1 1.4 0.4 1.5 0.4 1.5 0.3 2.4 12.4 1.3 1.9 0.2 0.1 2.5 0.1 1.6 0.0 3.8 11.3 1.3 16.6 5.7 0.0 0.0 0.4 0.1 2.0 0.0 12.3 39.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.2 2.4 9.8 0.0 0.8 0.0 0.1 0.0 7.0 0.0 0.0 0.0 3.6 10.1 0.0 1.4 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.3 0.0 0.0 4.4 2.4 9.4 20.8 1.3 1.6 0.9 0.0 0.0 2.4 0.2 3.6 0.9 0.0 9.4 0.0 5.7 4.2 0.0 0.0 0.0 0.2 0.0 1.7 0.4 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.5 4.8 4.5 6.0 3.8 1.4 1.3 4.6 1.5 1.6 1.3 2.0 0.0 3.2 13.6 93.7 0.3 0.0 0.4 0.5 0.6 10.5 4.0 5.0 0.8 4.3 2.3 1.8 4.2 0.0 0.1 2.7 0.0 2.2 206.2 34.6 1.3 0.6 3.0 0.0 126.0 2.3 0.3 0.3 15.3 13.6 0.0 0.1 0.0 0.0 0.2 25.2 131.5 4.0 0.0 0.3 0.4 21.4 1.2 0.4 0.0 12.2 0.1 16.1 0.0 5.5 5.7 1.5 4.6 0.4 0.0 0.4 2.8 2.1 23.4 3.0 0.0 0.0 0.2 2.4 1.2 0.7 0.1 0.0 0.3 0.1 4.4 0.4 C3orf33 "AC3-33, FLJ31139" ENSG00000174928 "Chromosome 3 open reading frame 33" Q6P1S2 3 155762617-155806278 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA037663 Uncertain "Secreted in other tissues" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 50: Fibroblasts - ECM organization" "HPA037663: AB_10672610" "unprognostic (1.18e-1)" "unprognostic (9.39e-3)" "unprognostic (1.48e-1)" "unprognostic (1.66e-3)" "unprognostic (1.31e-1)" "unprognostic (7.27e-2)" "unprognostic (6.31e-3)" "unprognostic (3.28e-2)" "unprognostic (1.56e-1)" "unprognostic (5.47e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic favorable (6.48e-7)" "unprognostic (3.19e-1)" "unprognostic (1.79e-1)" "unprognostic (2.24e-2)" "unprognostic (1.56e-1)" 2.7 10.7 5.2 1.3 5.6 2.0 4.2 5.3 7.8 4.0 6.2 3.1 2.6 3.7 5.8 1.7 3.9 2.3 6.1 5.5 5.5 6.2 3.1 3.3 1.6 5.4 5.5 4.5 6.7 7.5 4.9 1.3 5.4 4.4 2.3 2.7 3.2 3.9 4.9 1.3 2.2 3.3 5.4 2.3 3.1 4.1 5.8 1.5 8.7 4.4 1.0 2.7 2.5 5.4 5.5 7.5 3.6 4.9 0.3 4.4 1.5 2.4 3.5 2.2 5.2 2.6 6.9 0.9 5.3 2.3 3.3 0.8 3.7 0.0 3.9 2.7 5.4 3.3 1.0 7.0 6.0 4.8 1.1 3.4 4.0 2.4 4.6 2.8 3.8 5.5 5.4 2.4 3.8 4.1 4.9 4.0 4.6 5.2 1.8 4.8 1.8 5.2 12.2 2.7 2.6 3.6 5.3 6.7 4.6 1.8 9.8 5.7 2.3 2.5 1.8 5.5 5.9 4.1 4.3 0.0 1.8 4.4 2.6 2.1 1.2 0.2 4.0 1.1 5.1 1.8 3.1 3.6 2.1 1.4 3.9 4.1 0.1 4.0 0.8 1.7 2.2 2.1 5.2 5.6 5.3 7.8 5.5 5.5 5.4 5.5 5.4 5.4 5.8 5.4 1.6 3.2 6.7 13.7 1.5 1.3 5.2 4.7 5.2 8.5 3.1 2.7 11.9 5.7 6.7 0.0 6.2 4.2 0.9 1.8 5.9 3.7 6.6 1.5 2.7 2.3 3.6 3.8 14.9 3.3 3.1 4.8 1.1 1.4 7.0 2.8 2.5 3.3 2.4 6.7 14.9 3.8 4.1 0.3 2.0 5.4 6.2 1.4 1.8 3.7 0.6 15.6 6.2 11.6 10.7 1.4 2.5 7.9 2.2 5.1 1.0 7.0 3.5 7.6 0.0 8.4 4.1 14.5 14.8 2.7 1.4 3.7 2.8 3.8 3.7 2.5 SLC33A1 "ACATN, AT-1, AT1, SPG42" ENSG00000169359 "Solute carrier family 33 member 1" O00400 3 155821024-155854456 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Cataract, Deafness, Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042430 Uncertain Approved Vesicles,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Vesicles, Cytosol" "HPA042430: AB_10806238" "unprognostic (5.12e-3)" "unprognostic (7.78e-2)" "unprognostic (1.13e-2)" "unprognostic (7.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.73e-2)" "unprognostic (9.57e-2)" "unprognostic (5.65e-2)" "unprognostic (6.61e-2)" "unprognostic (4.36e-2)" "unprognostic (1.19e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-2)" "unprognostic (2.92e-1)" "unprognostic (4.73e-2)" "unprognostic (5.74e-2)" 8.8 11.0 3.9 4.9 4.8 2.9 8.4 4.6 4.7 12.3 9.2 7.2 6.9 8.8 12.9 8.0 9.5 7.8 7.6 4.6 5.3 10.4 17.2 8.4 5.0 4.4 4.2 8.0 30.9 11.6 5.9 6.6 4.6 8.3 6.4 6.8 11.2 11.0 4.7 6.4 7.7 7.1 5.2 5.8 8.8 5.4 5.2 7.1 18.8 4.8 6.2 6.8 7.9 7.3 18.9 17.7 7.3 8.3 24.4 23.5 12.9 13.1 21.2 19.8 18.7 8.5 22.0 9.9 24.1 13.1 19.8 17.1 14.3 15.2 20.8 16.5 13.3 11.3 6.5 15.8 41.5 13.3 8.9 18.4 26.7 9.7 49.5 20.5 19.8 12.4 8.6 27.8 14.3 14.3 5.0 3.7 6.8 17.7 14.9 5.6 8.1 29.1 9.7 11.8 7.9 5.9 11.1 24.5 21.4 11.3 8.1 11.2 21.4 10.1 4.9 17.9 13.1 33.2 14.4 12.3 14.6 8.8 14.0 12.7 8.4 6.2 8.9 6.3 9.6 5.4 6.0 6.8 10.4 3.5 5.4 5.5 1.7 6.6 6.5 16.1 5.7 5.9 3.9 4.8 4.6 4.7 4.6 5.3 4.4 4.2 4.6 5.2 5.2 7.3 9.0 22.4 25.0 16.0 14.8 8.9 11.7 20.8 18.2 17.5 16.0 9.0 23.8 18.6 21.5 11.0 27.1 18.2 21.1 14.2 5.9 15.3 13.7 11.2 20.3 13.7 12.5 8.4 17.9 15.4 28.3 19.7 20.9 16.6 12.0 12.8 16.4 64.3 19.5 18.5 17.4 18.1 12.2 14.7 15.8 13.2 18.6 15.2 12.4 10.3 19.0 15.4 12.3 11.1 20.8 14.4 5.3 21.4 33.3 19.5 18.9 17.1 23.4 23.0 13.1 16.0 16.0 19.5 9.2 12.2 9.5 37.6 15.3 10.2 13.9 10.9 GMPS GATD7 ENSG00000163655 "Guanine monophosphate synthase" P49915 3 155870650-155944020 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "GMP biosynthesis, Purine biosynthesis" Ligase Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 100.3" "Cell type enhanced" "Detected in all" "Early spermatids: 272.7;Late spermatids: 193.6;Spermatocytes: 171.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046630 Approved Cytosol No No 50000 "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Cytosol "HPA046630: AB_2679727" "unprognostic (3.89e-2)" "unprognostic (2.02e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (5.54e-5)" "unprognostic (2.30e-1)" "unprognostic (1.35e-2)" "prognostic unfavorable (8.73e-7)" "unprognostic (1.71e-2)" "unprognostic (3.52e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (2.58e-2)" "unprognostic (2.79e-2)" "unprognostic (2.89e-2)" "unprognostic (3.78e-1)" "unprognostic (3.55e-3)" "unprognostic (8.79e-2)" 18.8 20.7 7.2 20.0 7.7 44.6 24.1 22.7 11.0 21.2 7.9 19.7 15.8 20.6 16.0 22.1 17.1 14.0 17.9 6.8 8.5 15.9 22.6 18.2 27.0 7.8 6.8 17.0 26.4 23.1 11.5 20.8 8.3 17.4 22.5 10.1 20.9 17.5 20.0 25.0 16.7 23.4 6.3 19.2 18.0 100.3 8.0 32.3 20.3 16.7 29.4 23.3 19.9 8.8 241.0 93.1 123.0 101.1 49.0 77.0 118.9 99.8 91.6 128.2 128.8 170.5 156.2 171.7 116.1 77.1 98.1 114.6 105.7 104.2 175.0 101.1 81.8 183.2 63.7 92.8 55.9 188.5 68.7 57.3 62.9 99.4 150.5 68.2 79.9 91.3 131.7 63.8 96.8 160.1 153.9 99.4 118.5 130.4 68.3 149.2 145.8 207.5 66.3 103.5 73.3 68.0 111.0 156.0 101.8 83.9 163.6 122.3 56.9 84.4 68.5 121.0 204.3 88.8 58.5 288.5 84.8 137.4 77.0 23.7 16.1 11.5 24.7 20.2 29.1 16.0 23.6 22.3 26.1 11.6 23.3 22.3 2.2 29.3 29.5 14.2 27.1 17.5 7.2 7.7 22.7 11.0 6.8 8.5 7.8 6.8 8.3 6.3 8.0 8.8 23.8 19.2 20.2 19.6 21.5 39.9 47.4 43.9 22.8 22.0 19.5 18.5 16.4 15.7 28.4 7.3 2.1 44.1 21.6 8.3 25.4 33.8 272.7 14.3 37.5 29.9 7.2 68.5 40.9 29.5 56.2 32.4 19.9 18.4 28.6 34.0 22.1 11.6 29.9 21.9 41.6 19.7 26.4 18.5 27.1 193.6 23.0 25.2 23.2 22.5 31.7 17.8 30.9 30.2 31.6 21.3 11.9 24.8 21.9 50.6 17.8 22.8 17.3 8.7 19.7 28.6 65.2 171.2 65.5 29.0 38.2 30.8 30.4 63.2 26.8 42.4 KCNAB1 "AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3" ENSG00000169282 "Potassium voltage-gated channel subfamily A member regulatory beta subunit 1" Q14722 3 156037701-156539138 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Oxidoreductase, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 52.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 85.8;Excitatory neurons: 108.6;Inhibitory neurons: 605.4;Oligodendrocyte precursor cells: 206.6;Oligodendrocytes: 97.5;Sertoli cells: 78.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 3.4;hTEC/SVTERT24-B: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036110, HPA044550" Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "Nucleoplasm, Plasma membrane" "HPA036110: , HPA044550: AB_10797032" "unprognostic (1.52e-1)" "unprognostic (3.73e-1)" "unprognostic (1.33e-1)" "unprognostic (2.98e-4)" "unprognostic (1.24e-2)" "unprognostic (1.64e-1)" "unprognostic (1.81e-1)" "unprognostic (2.83e-2)" "unprognostic (8.51e-2)" "unprognostic (3.72e-2)" "unprognostic (5.87e-2)" "unprognostic (9.70e-2)" "unprognostic (2.17e-3)" "unprognostic (2.60e-1)" "unprognostic (1.95e-1)" "unprognostic (1.06e-1)" "unprognostic (4.00e-1)" 15.8 6.3 12.7 1.2 52.7 1.6 7.3 15.5 17.3 8.4 4.2 4.1 1.7 5.4 12.8 2.2 4.3 2.9 5.5 25.9 11.6 1.8 2.6 3.3 0.9 7.2 12.1 2.9 4.0 2.0 1.8 1.3 7.2 22.4 1.8 12.8 3.9 19.2 2.0 2.2 2.7 2.7 8.4 5.2 1.6 3.1 14.1 1.8 28.7 5.1 0.3 2.9 5.0 15.4 0.5 0.5 0.7 0.2 0.0 0.0 1.4 1.2 0.0 0.0 0.1 0.9 0.1 0.4 0.7 0.0 0.3 0.3 0.0 0.0 0.0 0.4 1.0 3.4 0.6 1.6 0.0 1.0 0.2 0.0 0.0 5.2 0.0 1.1 2.1 0.5 0.1 0.3 0.2 0.1 0.3 0.6 1.1 1.5 0.2 0.6 0.7 2.8 0.0 0.2 0.8 0.8 0.3 0.6 0.7 0.5 0.8 0.5 2.2 0.8 0.5 1.4 1.2 1.8 0.4 0.4 2.6 1.1 1.0 0.8 0.1 0.0 0.4 0.2 0.8 0.2 0.4 0.3 0.2 0.2 0.3 0.3 0.0 0.3 0.3 1.2 0.5 0.1 12.7 52.7 15.5 17.3 25.9 11.6 7.2 12.1 7.2 8.4 14.1 15.4 7.2 0.0 0.0 7.5 0.7 0.8 0.3 0.0 0.0 85.8 1.4 1.4 4.3 0.0 0.7 0.0 31.3 0.1 0.5 0.1 0.0 0.4 13.7 0.6 2.4 2.8 0.0 0.0 108.6 0.0 0.0 3.8 0.0 2.1 0.0 0.4 0.7 0.0 4.6 0.0 605.4 0.0 0.0 11.1 1.0 7.0 0.0 1.2 1.8 24.4 0.0 2.7 0.0 206.6 97.5 0.0 0.0 2.6 2.3 0.2 0.0 0.1 0.0 6.7 78.9 1.3 73.3 0.3 4.2 1.2 0.9 0.1 0.5 0.2 0.0 0.2 SSR3 TRAPG ENSG00000114850 "Signal sequence receptor subunit 3" Q9UNL2 3 156539553-156555149 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 894.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014906 Approved NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "HPA014906: AB_2195736" "unprognostic (4.11e-1)" "unprognostic (3.50e-1)" "unprognostic (5.49e-2)" "unprognostic (5.46e-2)" "unprognostic (5.74e-2)" "prognostic unfavorable (3.43e-4)" "prognostic unfavorable (4.46e-7)" "unprognostic (1.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.87e-2)" "unprognostic (2.19e-3)" "unprognostic (6.68e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (3.23e-2)" "unprognostic (2.92e-2)" "unprognostic (1.39e-2)" "unprognostic (8.29e-2)" 84.9 72.0 36.2 74.2 39.3 52.9 106.2 40.2 44.8 144.4 35.5 84.8 61.7 84.5 173.0 51.8 106.8 59.0 116.0 34.9 44.0 75.3 100.9 60.3 64.0 45.5 39.9 93.8 195.3 72.1 58.7 60.4 46.0 73.9 91.1 29.0 181.2 137.1 61.6 34.2 56.5 113.6 44.9 61.9 82.6 57.9 46.4 48.7 113.9 45.0 87.9 73.5 53.0 51.0 449.0 92.9 113.3 143.4 377.4 354.9 118.1 641.9 363.2 320.6 444.6 184.9 209.1 148.4 277.3 432.9 290.1 203.4 192.5 760.2 762.3 178.7 91.9 264.4 58.5 185.9 402.2 279.9 122.0 318.1 278.3 545.3 1081.7 309.6 400.6 129.0 151.9 528.2 930.8 131.1 96.8 63.1 138.7 253.6 181.5 136.1 185.7 969.9 300.6 105.2 91.2 76.8 166.0 246.3 358.9 176.4 252.3 143.2 508.5 424.0 204.9 325.3 721.8 485.5 207.3 249.0 254.0 231.9 248.1 111.1 88.7 71.6 60.6 104.1 95.7 76.1 64.0 75.4 115.5 46.8 42.6 52.0 30.5 66.7 136.0 162.1 81.1 72.4 36.2 39.3 40.2 44.8 34.9 44.0 45.5 39.9 46.0 44.9 46.4 51.0 103.4 109.0 167.3 22.2 205.3 83.7 132.7 182.6 41.5 33.7 157.8 263.4 153.4 117.2 151.1 73.5 31.3 113.1 142.1 85.1 109.5 238.4 98.1 89.7 281.2 124.9 71.1 91.9 10.7 229.8 470.0 174.0 103.0 160.0 95.7 145.4 123.5 219.0 388.2 25.2 14.3 247.0 69.2 218.1 224.3 38.0 214.9 196.2 145.9 10.3 241.5 89.6 73.2 17.1 18.5 233.2 81.5 223.0 894.2 257.5 90.3 214.7 81.0 37.1 72.3 96.3 178.4 177.1 69.0 74.0 78.7 188.9 109.8 119.5 148.9 157.8 TIPARP "ARTD14, DDF1, DKFZP434J214, DKFZp686N0351, PARP-1, PARP-7, PARP7, pART14, RM1" ENSG00000163659 "TCDD inducible poly(ADP-ribose) polymerase" Q7Z3E1 3 156673235-156706770 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 302.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 53.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 53.5" "Cell line enhanced" "Detected in all" "HBEC3-KT: 168.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036796 Approved Microtubules NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" Microtubules "HPA036796: AB_10672268" "prognostic favorable (2.00e-5)" "unprognostic (3.50e-1)" "unprognostic (7.62e-2)" "unprognostic (5.21e-2)" "unprognostic (2.62e-1)" "unprognostic (4.56e-2)" "unprognostic (9.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.23e-1)" "unprognostic (1.43e-1)" "unprognostic (4.27e-3)" "unprognostic (2.01e-1)" "unprognostic (4.69e-2)" "unprognostic (7.26e-2)" "unprognostic (1.73e-1)" "unprognostic (6.16e-3)" "unprognostic (4.90e-3)" 67.5 56.6 16.5 16.0 19.3 74.1 39.7 17.7 22.3 29.8 15.2 15.1 13.5 30.6 14.7 55.1 39.5 27.9 34.6 16.4 21.2 28.2 44.3 27.4 13.7 33.4 27.9 40.2 29.6 99.2 15.1 12.5 22.9 25.9 14.4 18.3 10.3 27.8 17.6 39.5 23.1 43.7 19.9 10.9 21.9 50.3 25.7 21.7 17.0 9.6 18.1 65.0 24.0 21.9 42.8 29.6 9.8 8.4 35.7 25.9 8.0 70.0 56.4 34.9 48.2 17.2 86.9 12.7 22.2 79.9 46.5 42.1 25.1 168.0 51.4 27.3 18.5 21.0 29.0 11.7 15.2 7.4 38.1 21.3 103.0 35.6 84.9 93.8 32.3 9.4 16.9 49.9 122.5 8.2 6.4 9.8 11.2 53.5 24.5 10.5 22.5 43.6 36.7 20.1 29.5 7.5 55.2 16.9 11.9 22.5 26.2 12.5 70.2 15.1 4.9 28.5 25.1 53.9 10.6 11.3 25.7 11.3 51.4 53.5 5.0 7.5 6.1 3.3 8.6 2.9 5.9 8.2 3.6 5.4 3.6 4.9 15.9 11.6 9.2 5.0 7.4 3.3 16.5 19.3 17.7 22.3 16.4 21.2 33.4 27.9 22.9 19.9 25.7 21.9 112.8 86.6 98.3 27.7 43.9 196.0 117.3 51.7 185.5 5.0 62.0 57.7 29.9 31.5 66.5 7.3 39.6 5.1 97.0 38.3 21.5 35.2 302.3 114.6 118.7 45.6 54.5 7.0 3.6 23.5 10.3 109.0 57.6 169.4 115.0 12.2 20.3 18.9 19.2 21.9 8.7 32.4 18.3 18.5 97.5 28.0 19.6 101.7 37.4 12.2 17.3 10.1 16.5 22.1 20.4 36.9 40.1 19.2 60.5 83.9 40.4 16.2 43.5 10.4 13.1 138.0 87.7 58.0 33.4 100.1 121.5 7.5 105.4 7.3 18.2 187.8 LEKR1 FLJ16641 ENSG00000197980 "Leucine, glutamate and lysine rich 1" 3 156825481-157046129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 12.8" "Cell type enhanced" "Detected in many" "Early spermatids: 96.8;Late spermatids: 47.7;Respiratory ciliated cells: 28.0;Spermatocytes: 65.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.3;U-266/70: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044039, HPA047774" Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Nucleoli "HPA044039: AB_10794288, HPA047774: " "unprognostic (5.42e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (8.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.94e-1)" "unprognostic (2.29e-3)" "unprognostic (1.98e-2)" "unprognostic (7.55e-2)" "unprognostic (2.20e-1)" "unprognostic (5.66e-3)" "unprognostic (3.50e-2)" "unprognostic (5.99e-2)" "unprognostic (6.59e-2)" "unprognostic (3.28e-1)" "unprognostic (2.17e-3)" "unprognostic (1.80e-2)" 0.9 1.0 0.7 0.3 1.0 0.2 1.6 0.9 0.7 0.5 1.9 0.6 1.0 0.7 3.4 0.3 3.8 0.4 0.9 0.9 1.1 1.4 0.7 0.6 1.0 1.9 1.7 0.9 1.0 1.5 1.5 0.2 1.5 0.9 0.6 1.8 0.6 0.6 0.2 0.4 0.6 0.4 1.6 0.5 0.9 12.8 1.1 0.7 2.3 0.2 0.4 0.5 0.2 1.0 3.3 1.2 0.0 0.7 0.4 0.2 0.1 0.1 0.5 0.6 0.5 0.1 1.7 0.0 0.9 0.4 1.2 1.2 0.0 0.3 1.3 0.5 0.3 1.0 0.1 0.0 0.0 1.0 0.2 1.5 0.8 0.1 0.9 0.3 0.3 0.0 0.7 0.6 1.2 1.2 0.0 0.7 1.0 0.9 0.7 0.0 0.8 0.8 1.0 0.2 1.9 0.7 1.0 0.7 0.0 0.2 2.2 1.8 0.0 0.1 0.3 0.2 0.5 2.9 0.5 0.0 0.5 0.7 1.0 0.6 0.0 0.0 0.2 0.0 0.4 0.8 0.4 0.0 0.3 0.9 0.4 0.2 0.0 0.7 0.0 0.5 0.6 0.1 0.7 1.0 0.9 0.7 0.9 1.1 1.9 1.7 1.5 1.6 1.1 1.0 0.5 0.0 1.1 19.9 6.3 1.3 1.1 1.4 2.8 1.2 2.7 3.9 1.5 1.5 2.8 3.7 2.1 0.3 0.7 1.5 3.9 0.7 96.8 20.7 1.4 0.6 0.0 2.1 6.5 1.6 0.1 1.1 9.7 2.8 1.3 1.4 0.0 1.8 0.2 3.3 11.8 0.9 0.0 1.6 1.3 47.7 1.5 1.8 1.8 3.7 1.1 1.7 0.0 8.0 8.0 1.0 0.6 1.9 2.5 0.7 1.2 5.4 28.0 4.8 0.0 0.6 1.4 65.2 4.3 2.2 0.9 0.1 2.3 1.1 0.9 0.8 CCNL1 ania-6a ENSG00000163660 "Cyclin L1" Q9UK58 3 157146508-157160760 "Predicted intracellular proteins" "Transcription, Transcription regulation" Cyclin Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057911 Supported "Nucleoplasm,Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 18: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies" "HPA057911: AB_2683553" "unprognostic (1.03e-2)" "unprognostic (3.66e-2)" "unprognostic (1.38e-1)" "unprognostic (6.90e-3)" "unprognostic (1.79e-1)" "unprognostic (6.58e-2)" "unprognostic (3.16e-3)" "unprognostic (7.50e-2)" "unprognostic (5.54e-3)" "unprognostic (3.37e-1)" "unprognostic (3.06e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.01e-6)" "unprognostic (3.71e-1)" "unprognostic (2.24e-1)" "unprognostic (5.62e-2)" "prognostic favorable (6.96e-7)" 52.1 25.2 12.4 11.6 12.9 56.6 27.3 14.2 21.2 21.9 12.6 22.5 13.5 19.4 5.7 22.1 30.5 13.5 23.1 13.0 13.2 31.8 45.3 30.2 14.1 15.1 12.8 31.2 33.5 8.3 21.8 10.3 13.1 23.8 6.6 5.3 18.7 6.2 21.3 25.3 29.7 9.1 11.9 35.6 29.1 9.1 13.0 20.0 23.7 10.3 9.8 19.4 22.9 14.7 19.2 11.4 16.8 11.6 16.1 10.9 16.0 12.0 14.4 13.9 13.0 19.7 14.8 20.3 10.0 8.9 9.7 14.7 12.4 14.6 12.8 18.2 14.1 12.6 12.2 17.2 13.2 8.8 7.7 13.3 25.1 13.2 17.7 13.9 11.1 11.4 8.7 12.7 10.2 13.8 17.8 16.7 13.9 14.7 12.5 16.2 13.6 31.7 8.9 11.4 8.9 16.5 9.1 8.4 26.1 12.5 8.7 26.1 9.1 12.8 7.1 13.8 15.9 25.3 21.5 26.7 12.8 13.1 12.6 5.9 10.3 16.0 13.5 8.4 14.1 13.4 12.5 14.0 13.1 15.2 17.1 14.2 28.6 17.4 11.3 14.0 15.4 8.2 12.4 12.9 14.2 21.2 13.0 13.2 15.1 12.8 13.1 11.9 13.0 14.7 367.4 218.0 392.4 33.0 222.5 268.0 499.2 203.8 310.7 73.7 279.3 247.0 54.3 177.3 259.0 68.0 133.5 139.2 253.6 389.6 23.5 189.4 41.0 379.7 426.5 287.1 247.7 86.5 30.6 127.8 152.9 302.7 268.1 761.2 222.2 281.6 167.8 90.4 164.6 40.4 32.3 294.6 154.6 241.5 251.4 20.9 128.0 292.5 140.5 42.2 160.1 69.5 122.6 35.7 66.3 143.2 378.2 75.2 258.5 408.2 415.6 21.2 188.9 183.3 131.5 460.0 276.4 46.5 25.0 252.6 276.9 209.1 282.8 182.6 244.1 503.2 VEPH1 "FLJ12604, KIAA1692" ENSG00000197415 "Ventricular zone expressed PH domain containing 1" Q14D04 3 157259742-157533619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 20.2;kidney: 27.0;lung: 29.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 266.0;Alveolar cells type 2: 175.9;Distal tubular cells: 46.9;Early spermatids: 64.5;Late spermatids: 84.7" "Cancer enhanced" "Detected in many" "melanoma: 4.3;renal cancer: 4.2" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 92.0;hTERT-RPE1: 96.7;HUVEC TERT2: 245.1;TIME: 147.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA026645 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Nucleoli, Cytosol" "HPA026645: AB_1858741" "unprognostic (4.35e-2)" "unprognostic (1.42e-2)" "unprognostic (2.44e-1)" "unprognostic (3.58e-1)" "unprognostic (5.17e-2)" "unprognostic (3.30e-3)" "unprognostic (2.87e-3)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (1.75e-3)" "unprognostic (3.57e-3)" "unprognostic (1.99e-2)" "prognostic favorable (7.75e-9)" "unprognostic (2.03e-1)" "unprognostic (2.57e-1)" "unprognostic (1.15e-4)" "unprognostic (7.49e-2)" 0.4 20.2 0.2 0.1 0.3 2.2 1.9 0.8 0.1 3.1 11.1 0.8 0.7 0.3 17.6 0.0 5.4 0.9 0.2 0.7 0.4 27.0 0.5 29.4 0.0 2.7 1.1 0.2 13.1 2.1 17.1 1.3 2.9 1.4 0.8 0.4 2.5 2.8 0.1 1.5 0.1 0.2 0.4 4.0 0.9 2.9 0.4 0.1 2.0 0.1 0.0 0.4 0.3 0.2 7.3 0.8 16.0 0.0 9.2 33.8 0.0 41.9 92.0 12.2 17.7 1.1 6.4 0.0 16.0 45.3 1.9 0.3 0.5 1.0 67.2 0.2 0.0 7.3 0.8 0.0 2.9 0.0 0.1 9.9 0.7 51.9 10.3 96.7 245.1 0.0 2.5 0.0 33.4 0.9 0.0 0.0 6.6 1.9 6.2 0.0 1.2 0.0 6.1 3.6 0.6 0.0 1.3 1.9 17.0 0.2 70.7 0.1 147.2 48.0 1.6 16.8 58.0 0.0 0.0 0.0 38.6 0.0 11.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.7 0.2 0.3 0.8 0.1 0.7 0.4 2.7 1.1 2.9 0.4 0.4 0.2 0.1 266.0 175.9 1.6 0.5 1.8 0.2 0.0 0.0 0.2 4.5 3.7 0.5 22.8 14.3 31.3 2.1 1.8 0.2 1.2 46.9 6.9 64.5 11.1 0.5 0.9 0.0 0.0 2.8 10.1 0.1 0.9 0.0 4.4 0.0 0.8 0.0 0.0 0.2 0.0 3.3 0.4 0.0 0.0 0.3 84.7 1.5 2.3 28.4 0.0 0.7 1.5 0.0 0.0 0.9 1.8 3.2 0.4 0.0 0.3 0.0 28.7 8.1 0.5 0.0 0.1 1.3 0.3 0.9 0.0 0.4 0.0 0.6 0.9 0.8 0.2 PTX3 "TNFAIP5, TSG-14" ENSG00000163661 "Pentraxin 3" P26022 3 157436850-157443633 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 231.5;urinary bladder: 191.7" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 16.2;Fibroblasts: 44.7;Glandular and luminal cells: 24.0;Langerhans cells: 23.6;Macrophages: 27.0;Melanocytes: 14.2" "Cancer enhanced" "Detected in many" "glioma: 22.5" "Group enriched" "Detected in some" 4 "cerebral cortex: 1.9;thalamus: 4.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 1219.3;ASC TERT1: 1751.7;BJ hTERT+: 1201.8;HHSteC: 2261.1;HSkMC: 2364.2;hTEC/SVTERT24-B: 1276.5;TIME: 1761.1;U-2197: 1605.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA069320 Approved Approved "Plasma membrane" "Secreted to blood" NA NA 1090000 970000 "Cluster 52: Eosinophils - Transcription" "Cluster 82: Adipose tissue - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "HPA069320: AB_2686118" "unprognostic (1.93e-2)" "unprognostic (4.96e-3)" "unprognostic (1.35e-1)" "prognostic unfavorable (8.35e-9)" "unprognostic (5.79e-3)" "prognostic unfavorable (6.36e-4)" "unprognostic (6.03e-3)" "prognostic unfavorable (8.75e-6)" "unprognostic (2.45e-1)" "unprognostic (6.69e-2)" "unprognostic (7.60e-2)" "unprognostic (2.63e-1)" "unprognostic (2.76e-9)" "unprognostic (6.03e-3)" "unprognostic (5.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.92e-3)" 231.5 11.1 0.4 38.8 0.4 89.0 57.9 0.6 1.9 2.8 1.1 13.0 0.8 2.5 0.5 2.9 21.4 7.7 46.8 0.6 0.5 6.8 2.6 83.2 0.9 0.7 0.6 1.4 41.6 1.1 4.4 11.4 0.6 6.9 2.3 0.4 5.4 0.5 5.2 25.4 9.7 5.7 0.3 23.6 24.8 0.7 4.0 1.6 5.8 0.5 0.3 191.7 3.1 0.4 1.2 0.0 752.4 0.2 1219.3 1751.7 0.3 132.3 1201.8 56.2 60.9 0.7 7.9 0.2 460.6 157.4 87.6 0.0 0.3 1.1 110.5 0.8 0.3 2.0 0.1 0.0 2261.1 2.5 0.0 2364.2 0.8 1276.5 429.8 110.2 266.4 0.1 0.3 0.0 380.1 0.0 0.3 2.9 11.2 0.0 4.6 0.2 0.0 0.2 5.3 53.1 6.0 0.8 7.6 1.0 0.9 0.1 0.6 2.4 1761.1 252.2 12.2 1605.1 23.0 0.2 0.5 0.9 52.8 6.4 74.2 0.0 0.3 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.4 0.6 1.9 0.6 0.5 0.7 0.6 0.6 0.3 4.0 0.4 2.3 0.0 1.7 0.0 0.1 1.7 1.7 0.3 0.0 1.8 3.6 0.6 0.6 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 7.2 2.4 16.2 10.3 5.1 0.0 0.0 0.5 0.0 0.1 44.7 0.0 24.0 0.0 0.7 3.3 0.0 2.6 0.0 1.0 0.0 0.0 10.0 23.6 1.2 0.3 27.0 14.2 0.0 2.3 0.5 0.0 0.0 0.3 0.3 0.0 0.0 0.3 1.0 0.0 0.2 0.0 0.8 0.0 4.0 7.2 0.0 0.4 0.4 1.0 0.3 0.4 0.0 0.0 0.4 SHOX2 "OG12, OG12X, SHOT" ENSG00000168779 "Short stature homeobox 2" O60902 3 158095905-158106420 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 7.8;brain: 26.4" "Cell type enriched" "Detected in some" 6 "Early spermatids: 90.3" "Cancer enhanced" "Detected in many" "glioma: 3.4" "Region enhanced" "Detected in many" "thalamus: 26.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 24.2;THP-1: 38.7" "Group enriched" "Detected in many" 5 "midbrain: 36.0;thalamus: 54.8" "Group enriched" "Detected in some" 6 "midbrain: 10.6;pons: 16.3;thalamus: 32.1" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 43: THP-1 - Innate immune response" "Cluster 29: Early spermatids - Spermatogenesis" "unprognostic (2.62e-1)" "unprognostic (6.32e-2)" "unprognostic (3.32e-2)" "unprognostic (1.08e-3)" "unprognostic (1.51e-1)" "unprognostic (1.69e-3)" "unprognostic (2.28e-3)" "unprognostic (7.66e-2)" "unprognostic (7.35e-2)" "unprognostic (2.23e-1)" "unprognostic (6.31e-2)" "unprognostic (8.75e-3)" "unprognostic (0.00e+0)" "unprognostic (4.20e-3)" "unprognostic (2.12e-1)" "unprognostic (3.95e-2)" "unprognostic (2.76e-3)" 7.8 0.1 8.9 0.0 0.5 0.1 5.4 0.0 1.1 3.9 0.0 0.1 0.0 0.4 0.1 0.0 0.2 0.2 3.4 0.1 6.1 0.0 0.0 0.2 1.7 10.6 13.0 0.2 0.1 0.3 0.2 0.2 7.0 0.1 0.0 0.0 2.2 0.4 1.3 2.2 0.1 0.0 0.5 0.0 0.2 3.4 26.4 0.0 0.5 0.4 0.3 0.4 1.0 0.2 5.5 0.6 0.3 8.1 24.2 15.3 1.5 8.9 3.4 4.8 8.2 1.8 0.7 1.2 0.2 12.8 9.5 0.1 10.1 0.0 1.9 5.1 2.9 13.7 2.7 0.0 0.0 1.2 10.7 6.9 0.3 4.4 0.5 14.8 0.0 0.7 3.8 0.9 2.1 0.3 0.0 0.7 0.0 0.1 0.5 6.2 7.4 1.4 0.0 0.0 2.7 20.5 1.0 0.2 5.2 0.1 0.2 38.7 0.5 15.0 3.1 16.6 14.8 1.1 2.9 0.9 14.5 7.3 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 8.9 0.5 0.0 1.1 0.1 6.1 10.6 13.0 7.0 0.5 26.4 0.2 3.0 0.0 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.2 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 90.3 0.1 1.7 0.9 0.0 0.0 0.0 0.2 0.7 9.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 1.9 1.2 13.9 2.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 13.1 1.1 8.5 5.7 2.8 0.0 0.4 0.3 0.1 0.0 0.2 0.0 RSRC1 "BM-011, MGC12197, SFRS21, SRrp53" ENSG00000174891 "Arginine and serine rich coiled-coil 1" Q96IZ7 3 158105855-158545730 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044792 Supported Approved "Nuclear speckles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear speckles" "HPA044792: AB_10794502" "unprognostic (1.06e-2)" "unprognostic (8.83e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (7.40e-5)" "unprognostic (5.18e-1)" "unprognostic (1.17e-1)" "unprognostic (3.60e-3)" "unprognostic (2.91e-2)" "unprognostic (2.86e-2)" "unprognostic (5.71e-2)" "unprognostic (2.53e-3)" "unprognostic (8.84e-2)" "unprognostic (7.98e-3)" "unprognostic (3.48e-2)" "unprognostic (9.71e-2)" "unprognostic (2.71e-1)" "unprognostic (2.15e-1)" 18.5 17.1 13.2 11.8 12.0 15.1 16.4 16.9 17.2 16.0 6.2 14.8 8.7 14.2 11.6 12.7 10.7 10.2 16.0 8.0 12.7 15.9 16.5 10.6 13.7 14.5 15.5 12.8 15.6 15.6 11.6 11.8 12.6 13.1 13.5 18.7 13.5 12.3 19.3 12.9 10.2 13.8 11.0 11.8 12.1 11.3 17.6 13.2 17.0 11.0 14.2 13.6 13.4 13.8 73.6 37.3 24.1 32.1 60.7 41.4 34.1 36.2 29.3 37.8 41.5 51.8 56.8 68.6 66.9 42.9 47.2 32.8 48.4 31.8 58.3 107.6 40.4 71.0 30.4 41.3 9.3 61.5 43.2 32.3 30.0 32.4 29.1 43.4 17.7 38.8 45.4 50.2 31.6 63.7 43.2 41.5 21.4 44.3 33.4 54.7 45.4 86.1 29.5 23.8 47.4 51.7 40.7 26.6 44.6 27.1 59.2 51.7 20.3 52.6 31.6 63.3 69.4 41.0 51.0 72.6 48.5 79.5 61.2 40.4 36.3 20.3 25.1 38.6 25.9 49.5 25.6 24.3 22.0 45.5 23.9 25.7 25.4 17.7 37.2 62.3 22.4 12.9 13.2 12.0 16.9 17.2 8.0 12.7 14.5 15.5 12.6 11.0 17.6 13.8 36.0 32.1 23.1 51.6 51.1 37.3 36.1 32.3 15.4 78.1 39.4 28.7 44.9 45.8 27.0 82.8 33.3 37.5 41.1 33.2 74.3 52.6 49.9 32.8 48.4 35.5 33.0 68.8 71.3 60.5 52.8 47.5 26.0 29.9 76.5 44.0 32.2 74.5 38.3 63.9 82.4 54.9 40.7 45.6 67.6 11.0 46.3 42.4 44.4 80.6 50.0 52.2 44.3 46.3 142.2 45.8 34.2 35.7 35.4 27.7 21.8 67.8 29.7 95.6 19.7 34.8 49.5 39.5 40.4 27.4 27.4 29.6 37.4 39.8 35.9 29.3 MLF1 ENSG00000178053 "Myeloid leukemia factor 1" P58340 3 158571163-158607252 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Differentiation" "Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 182.3;testis: 393.7" "Group enriched" "Detected in many" 10 "Early spermatids: 4964.0;Late spermatids: 12837.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 8.7" "Lineage enriched" "Detected in single" 9 "T-cells: 8.7" "Cell line enhanced" "Detected in many" "A-431: 84.0" "Low region specificity" "Detected in all" "HPA069479, HPA079339" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 43: Testis - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA069479: AB_2686140, HPA079339: " "unprognostic (6.49e-2)" "unprognostic (1.98e-3)" "unprognostic (1.98e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (1.72e-2)" "unprognostic (2.65e-2)" "unprognostic (8.55e-2)" "unprognostic (4.11e-2)" "unprognostic (2.01e-1)" "unprognostic (2.07e-1)" "unprognostic (7.21e-2)" "unprognostic (1.07e-1)" "unprognostic (7.82e-2)" "prognostic unfavorable (5.54e-4)" "unprognostic (9.34e-3)" "unprognostic (2.47e-3)" "unprognostic (3.36e-2)" 10.9 6.8 16.8 3.0 19.8 3.2 17.4 17.3 22.0 9.8 34.5 10.0 1.8 15.9 14.8 10.2 67.9 15.1 138.9 19.1 19.3 21.2 3.6 17.9 2.9 25.1 25.2 12.8 9.6 20.2 18.1 2.7 24.0 6.2 4.7 46.9 5.1 4.6 182.3 6.2 4.0 14.2 22.0 3.5 6.2 393.7 19.4 2.3 16.5 107.2 4.8 14.1 4.2 24.2 84.0 7.7 28.4 0.1 13.8 18.1 7.8 6.8 8.4 31.9 30.5 0.0 44.8 0.0 29.3 13.1 42.8 16.3 0.3 14.2 44.5 0.0 15.3 3.9 6.3 0.9 10.2 0.0 6.4 10.5 22.3 13.8 8.8 28.2 7.3 0.0 6.3 0.1 22.2 12.5 0.0 0.2 7.6 46.4 21.3 0.0 15.4 0.7 25.0 6.4 34.8 21.7 38.1 13.7 43.9 27.7 41.1 8.9 3.8 27.2 27.2 35.4 31.0 15.6 8.2 0.1 20.0 0.1 20.6 0.0 0.0 0.0 2.8 0.0 1.4 0.5 6.9 6.9 0.2 0.3 1.5 3.2 0.3 0.9 0.3 0.1 8.7 2.0 16.8 19.8 17.3 22.0 19.1 19.3 25.1 25.2 24.0 22.0 19.4 24.2 42.0 25.6 28.2 11.8 6.0 44.7 143.4 35.3 27.3 14.9 52.8 68.7 231.2 17.2 55.2 20.2 33.3 0.7 12.0 12.8 72.4 26.9 4964.0 203.9 29.3 28.4 33.9 3.6 20.2 7.6 5.0 56.3 18.8 24.0 43.8 10.0 18.5 0.2 8.0 10.1 14.1 29.3 28.5 4.1 19.7 12837.2 69.9 11.5 23.2 3.7 1.0 28.5 3.1 9.0 12.7 10.2 14.3 50.4 3.4 37.4 1.3 36.6 329.7 71.1 19.7 131.0 40.5 854.2 192.2 10.4 34.2 1.6 25.3 55.9 14.7 83.1 GFM1 "EFGM, EGF1, GFM, mtEF-G1" ENSG00000168827 "G elongation factor mitochondrial 1" Q96RP9 3 158644527-158695581 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034764, HPA034765, HPA061405" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Mitochondria Nucleoplasm "HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (5.48e-3)" "unprognostic (4.48e-3)" "unprognostic (1.84e-1)" "unprognostic (3.40e-1)" "unprognostic (4.75e-2)" "unprognostic (6.05e-2)" "unprognostic (2.48e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (9.20e-4)" "unprognostic (2.79e-1)" "prognostic favorable (1.16e-7)" "unprognostic (1.62e-1)" "unprognostic (4.78e-1)" "unprognostic (3.32e-2)" "unprognostic (8.78e-2)" 26.7 25.0 12.3 21.7 13.2 24.1 27.8 18.1 21.3 14.1 16.8 30.1 24.9 17.2 20.8 24.1 13.4 17.5 39.0 13.0 15.5 43.7 49.6 18.8 20.7 14.5 13.2 12.7 26.4 40.1 12.0 25.7 15.3 19.6 31.5 46.4 21.0 21.9 63.0 15.2 19.8 20.9 13.7 16.4 23.9 23.5 14.1 16.6 32.1 60.2 20.7 23.5 12.9 15.7 92.2 55.9 25.5 32.0 41.8 30.6 34.2 42.6 49.8 75.9 57.4 73.2 58.7 73.9 54.7 39.2 32.0 55.9 62.5 47.8 84.3 40.6 33.7 56.1 34.6 34.3 48.6 76.7 35.9 37.3 55.7 43.8 41.0 17.6 50.2 43.0 71.7 50.3 67.9 56.9 49.6 30.6 55.7 97.0 29.8 49.8 28.0 132.6 51.0 38.3 48.9 42.8 63.8 96.1 79.1 19.9 132.1 60.0 28.0 46.4 21.0 69.4 74.1 82.7 61.4 138.9 41.8 65.0 52.4 18.9 19.3 13.8 22.2 27.2 28.6 17.0 19.3 23.0 23.3 16.4 22.1 23.9 3.0 25.4 22.0 11.2 17.4 18.4 12.3 13.2 18.1 21.3 13.0 15.5 14.5 13.2 15.3 13.7 14.1 15.7 31.4 19.2 19.0 17.0 26.1 21.5 26.0 20.9 20.5 57.3 23.0 11.9 54.8 22.8 18.9 12.9 31.3 31.6 20.1 22.2 11.7 19.9 15.4 12.4 20.2 36.6 19.3 29.0 39.8 25.0 17.6 20.9 22.4 14.8 19.0 17.7 22.5 61.6 29.0 15.2 43.9 24.5 30.5 20.4 21.5 7.6 22.7 21.7 17.8 18.7 33.8 27.3 16.5 22.6 43.3 20.3 10.5 17.0 19.2 21.7 22.1 37.9 25.1 51.6 13.1 21.5 23.4 34.4 31.6 20.1 21.0 30.8 22.3 41.4 28.9 22.0 LXN ENSG00000079257 Latexin Q9BS40 3 158645822-158672648 "Predicted intracellular proteins" "Inflammatory response" "Heparin-binding, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 97.7" "Cell type enhanced" "Detected in many" "granulocytes: 123.0;Respiratory ciliated cells: 120.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "hTERT-RPE1: 1196.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014179, CAB025128" Enhanced Approved Nucleoplasm,Cytosol No NA 4700000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 60: Granulocytes - Receptor signaling" "Nucleoplasm, Cytosol" "CAB025128: , HPA014179: AB_1853404" "unprognostic (4.46e-2)" "unprognostic (2.59e-1)" "unprognostic (1.80e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-1)" "unprognostic (3.20e-2)" "unprognostic (3.20e-1)" "unprognostic (5.82e-3)" "unprognostic (4.70e-3)" "unprognostic (1.98e-1)" "unprognostic (7.13e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.86e-5)" "unprognostic (8.45e-2)" "unprognostic (3.48e-2)" "unprognostic (3.18e-1)" "unprognostic (8.84e-2)" 59.0 47.0 3.7 21.5 6.4 27.1 22.4 7.3 4.4 20.3 14.1 42.0 30.3 13.7 23.7 9.9 34.3 40.5 23.1 4.5 5.4 21.6 5.6 26.3 18.6 3.9 4.3 49.7 14.1 14.0 16.0 22.0 4.1 36.9 44.0 3.6 42.4 17.9 5.4 12.4 26.1 22.9 3.6 10.2 15.0 4.5 6.2 13.8 18.3 7.8 14.3 97.7 14.4 4.2 0.1 40.7 3.1 0.5 17.0 58.2 3.4 31.3 80.4 7.6 15.2 0.1 91.3 0.3 28.2 8.7 0.2 14.1 8.1 12.7 11.2 0.1 40.2 19.6 33.0 0.4 19.5 5.0 0.5 131.5 2.3 14.5 2.4 1196.4 296.5 0.1 0.3 0.9 0.0 167.0 2.1 0.0 3.6 7.3 10.5 5.5 0.0 40.0 27.6 113.4 5.1 0.1 0.0 42.5 10.4 9.4 0.3 0.1 42.8 0.3 0.3 42.3 0.1 0.6 0.0 0.2 14.8 1.6 0.5 28.8 5.8 8.6 5.6 5.8 5.8 10.3 11.7 9.3 7.3 6.9 12.9 7.2 36.7 9.8 3.6 7.6 29.8 6.5 3.7 6.4 7.3 4.4 4.5 5.4 3.9 4.3 4.1 3.6 6.2 4.2 71.0 16.0 9.2 0.3 4.4 5.6 84.1 27.0 4.6 0.3 17.3 21.2 3.8 11.5 38.7 16.5 4.2 13.4 5.5 34.1 15.6 18.5 3.9 20.7 16.5 88.5 35.2 86.3 0.5 26.4 16.2 28.8 6.1 7.6 123.0 3.6 77.8 0.8 22.9 0.0 0.3 73.1 22.4 6.3 18.1 7.9 8.4 8.0 19.6 4.7 17.7 8.9 6.2 0.0 0.3 15.1 58.4 2.6 2.8 49.8 48.6 15.5 120.3 1.2 13.1 1.3 29.4 0.9 10.8 8.6 8.2 4.0 6.5 5.9 30.8 77.0 RARRES1 "LXNL, TIG1" ENSG00000118849 "Retinoic acid receptor responder 1" P49788 3 158696892-158732489 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 221.9;fallopian tube: 206.4" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 217.1;Club cells: 621.4;Prostatic glandular cells: 312.9;Urothelial cells: 737.7" "Cancer enhanced" "Detected in all" "urothelial cancer: 93.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 10 "CAPAN-2: 1319.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003892 Uncertain Approved "Endoplasmic reticulum,Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" "Endoplasmic reticulum" "HPA003892: AB_1856079" "unprognostic (5.76e-3)" "unprognostic (2.13e-1)" "unprognostic (8.85e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (9.29e-4)" "unprognostic (7.09e-2)" "unprognostic (8.93e-2)" "unprognostic (3.86e-1)" "unprognostic (7.16e-3)" "unprognostic (1.47e-2)" "unprognostic (6.42e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.88e-6)" "unprognostic (3.49e-1)" "unprognostic (1.33e-1)" "unprognostic (7.73e-2)" "unprognostic (1.15e-1)" 221.9 21.3 1.0 65.1 1.5 0.6 44.6 1.5 1.7 74.6 11.3 31.7 5.1 25.9 27.0 11.3 206.4 19.7 81.5 1.5 0.8 25.1 4.2 52.7 18.9 0.6 0.4 60.5 10.0 0.2 27.7 3.5 0.4 78.6 36.2 0.9 165.3 37.2 5.6 8.3 38.5 51.2 0.4 2.7 23.7 4.5 1.0 1.8 20.4 2.8 6.2 92.1 32.2 1.4 19.2 6.9 0.2 1.0 4.0 12.6 0.3 1.8 5.7 1.0 1.4 1.4 1319.3 0.0 1.2 0.9 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 2.0 0.1 12.0 0.0 0.0 131.3 0.0 0.5 0.0 8.9 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.2 1.7 5.8 0.0 0.0 0.0 0.1 0.3 22.9 0.5 1.7 16.7 1.3 0.3 0.0 1.9 2.3 1.3 1.1 0.0 4.6 0.0 0.0 0.0 0.0 1.5 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.0 1.5 1.5 1.7 1.5 0.8 0.6 0.4 0.4 0.4 1.0 1.4 5.2 0.0 0.6 2.3 0.9 0.5 217.1 92.7 11.4 0.4 99.7 35.6 0.9 11.5 621.4 14.7 0.0 2.9 1.6 59.0 0.0 10.5 29.5 14.4 98.4 18.1 37.5 3.6 14.2 4.7 0.8 101.3 1.1 16.9 29.9 0.3 31.8 6.0 10.8 0.0 10.6 102.3 40.7 1.6 1.7 33.1 10.8 11.0 5.4 1.9 0.0 4.2 0.0 4.5 7.6 2.3 106.1 1.2 1.2 312.9 140.7 19.7 149.3 0.7 0.0 7.7 46.7 3.8 0.7 7.8 0.4 11.4 3.3 0.1 88.3 737.7 MFSD1 "FLJ14153, Minerva, UG0581B09" ENSG00000118855 "Major facilitator superfamily domain containing 1" Q9H3U5 3 158732198-158829719 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 214.4;Kupffer cells: 289.7;Macrophages: 212.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 254.5;granulocytes: 246.0;monocytes: 288.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065858 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 32: U-937 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane" Cytosol "HPA065858: AB_2685569" "unprognostic (9.94e-2)" "unprognostic (3.12e-3)" "unprognostic (3.54e-2)" "unprognostic (1.00e-1)" "unprognostic (2.16e-2)" "unprognostic (7.37e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (2.52e-1)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (2.92e-1)" "prognostic favorable (5.60e-5)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (4.66e-2)" "unprognostic (2.57e-1)" 39.7 27.4 11.0 38.1 12.9 35.9 26.9 20.2 15.8 22.5 23.8 31.1 25.7 16.1 19.4 35.0 21.4 32.3 17.2 15.7 14.5 30.3 39.5 40.5 34.5 15.8 12.2 17.9 31.5 36.0 7.5 30.7 16.4 26.8 22.2 8.4 48.4 23.4 11.1 23.4 23.2 26.2 11.5 42.0 36.1 18.0 16.1 16.1 27.9 16.9 21.5 40.0 19.6 17.3 83.3 28.9 9.1 26.3 51.0 45.0 35.9 109.7 61.8 46.5 45.9 10.3 82.8 19.7 73.5 81.9 24.1 37.0 22.0 26.7 40.9 68.2 33.7 57.2 24.0 6.7 52.1 206.0 135.7 59.3 38.5 39.7 9.5 15.9 38.0 14.0 39.9 32.9 85.1 19.2 11.3 83.2 8.5 29.9 50.9 19.8 11.3 170.9 18.1 16.3 18.2 29.8 76.7 70.0 25.0 8.3 56.9 100.1 102.8 58.6 23.2 87.3 60.5 98.3 94.4 9.6 74.1 162.0 39.7 102.4 288.8 246.0 36.6 223.4 35.3 54.2 30.3 33.9 254.5 44.5 32.2 35.5 97.1 32.9 187.8 81.8 38.9 252.1 11.0 12.9 20.2 15.8 15.7 14.5 15.8 12.2 16.4 11.5 16.1 17.3 28.5 19.2 34.0 12.1 39.6 21.4 46.2 38.4 33.0 11.8 33.3 19.7 22.2 20.0 51.6 22.0 6.2 27.5 24.1 33.3 19.6 34.0 5.3 13.6 22.7 28.2 22.8 56.0 14.6 28.5 33.6 33.7 23.9 17.2 48.8 8.9 37.1 34.4 214.4 18.5 15.2 28.6 34.6 289.7 90.7 6.7 12.2 212.3 32.0 16.9 88.7 26.0 25.7 15.1 29.4 29.0 29.9 11.3 32.9 30.0 27.1 31.8 59.3 10.5 13.1 11.8 23.8 11.6 8.7 61.2 26.0 56.0 22.3 19.4 28.3 58.4 IQCJ-SCHIP1 ENSG00000283154 "IQCJ-SCHIP1 readthrough" B3KU38 3 158962235-159897366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 165.9" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 7.3;Basal squamous epithelial cells: 12.5;Bipolar cells: 11.5;Excitatory neurons: 11.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA003243, HPA003445" Approved Approved Cytosol NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "HPA003243: AB_1079877, HPA003445: AB_1079875" 22.0 5.1 82.3 9.7 90.6 2.2 15.4 84.9 165.9 9.2 56.6 49.8 4.5 19.6 6.3 15.4 18.2 12.5 57.2 83.9 73.9 17.8 14.3 19.6 2.2 93.5 88.0 4.4 2.7 1.1 7.3 23.6 92.0 17.7 6.8 14.2 6.5 20.4 27.6 5.7 12.8 25.9 81.5 4.3 18.3 4.7 87.2 2.5 5.7 3.2 1.8 35.8 10.8 110.5 87.9 14.8 28.9 34.4 6.6 6.3 25.1 73.6 17.3 59.4 40.5 55.6 20.9 4.4 46.4 24.6 22.6 34.8 11.3 24.9 48.5 72.7 27.6 0.1 31.2 2.8 7.7 4.2 0.5 6.5 20.8 26.5 31.1 49.3 44.5 4.9 0.0 0.3 27.7 3.9 0.3 0.0 24.2 7.0 31.9 10.2 58.4 0.0 57.6 4.7 5.8 26.8 39.8 16.7 21.8 32.9 9.8 0.8 37.6 34.0 47.5 22.9 101.5 0.3 0.5 0.4 19.1 12.4 92.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 82.3 90.6 84.9 165.9 83.9 73.9 93.5 88.0 92.0 81.5 87.2 110.5 4.7 6.4 0.0 1.0 0.1 1.5 7.3 0.8 12.5 11.5 0.3 0.9 0.6 0.0 1.4 1.8 6.2 0.0 0.1 0.3 0.0 0.9 2.0 2.1 0.8 5.7 0.0 0.0 11.3 0.6 0.0 3.1 0.0 2.3 2.5 0.0 1.8 0.6 0.0 0.0 4.7 0.2 0.0 0.3 1.2 0.6 0.3 1.2 0.0 0.0 0.6 0.5 0.0 0.0 0.6 1.2 0.0 1.2 0.0 1.3 0.0 4.2 2.4 0.6 0.0 2.5 5.4 0.1 0.4 3.5 0.9 0.0 0.5 0.0 0.2 1.6 IQCJ ENSG00000214216 "IQ motif containing J" Q1A5X6 3 158962928-159266307 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "brain: 5.8" "Group enriched" "Detected in some" 97 "Early spermatids: 27.3;Late spermatids: 50.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "amygdala: 5.8;basal ganglia: 3.9;cerebral cortex: 4.8;hippocampal formation: 5.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 21 "Daudi: 5.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA052835 Uncertain NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "HPA052835: AB_2681970" "unprognostic (1.99e-2)" 0.0 0.0 5.8 0.0 3.9 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.1 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 3.9 0.0 4.8 5.3 0.1 0.3 1.1 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 SCHIP1 SCHIP-1 ENSG00000151967 "Schwannomin interacting protein 1" P0DPB3 3 159839861-159897360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 81.0;choroid plexus: 28.9;heart muscle: 80.4;skeletal muscle: 101.3;tongue: 92.8" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 14.2;Horizontal cells: 15.2;Skeletal myocytes: 7.0" "Cancer enriched" "Detected in single" 7 "glioma: 2.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 6.9" "Group enriched" "Detected in many" 46 "dendritic cells: 6.9;granulocytes: 2.1" "Cell line enhanced" "Detected in many" "AF22: 27.0;AN3-CA: 49.2;HUVEC TERT2: 58.3;NTERA-2: 29.8;SH-SY5Y: 167.0" "HPA003243, HPA069824" Uncertain Approved "Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 37: Myocytes - Muscle contraction" "Plasma membrane, Cell Junctions, Cytosol" "Nucleoplasm, Nuclear bodies" "HPA003243: AB_1079877, HPA069824: AB_2732142" "unprognostic (1.07e-1)" "unprognostic (3.27e-2)" "unprognostic (1.37e-2)" "unprognostic (2.36e-5)" "prognostic favorable (2.80e-4)" "unprognostic (6.25e-2)" "unprognostic (4.56e-3)" "unprognostic (1.11e-1)" "unprognostic (7.81e-2)" "unprognostic (1.38e-1)" "unprognostic (6.45e-3)" "unprognostic (4.67e-2)" "unprognostic (2.12e-1)" "unprognostic (4.66e-4)" "unprognostic (2.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.96e-1)" 6.1 2.9 46.5 0.2 56.3 0.8 1.2 52.6 55.0 2.5 28.9 11.1 1.0 3.9 0.7 3.4 2.3 1.9 80.4 50.0 48.7 2.5 0.7 2.9 0.5 51.0 48.2 0.5 0.4 0.2 11.8 10.9 52.6 5.6 1.1 3.6 1.9 1.4 101.3 0.4 3.6 5.4 55.6 4.8 4.6 1.9 46.9 0.8 0.8 92.8 0.2 0.7 1.2 81.0 0.1 0.0 27.0 49.2 0.0 0.2 0.0 0.2 0.1 0.1 1.1 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.0 2.4 0.0 1.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 2.7 1.1 0.3 11.2 0.4 58.3 0.0 0.0 0.1 3.5 0.0 0.0 0.0 29.8 0.0 0.0 0.0 5.5 0.0 1.3 0.0 0.0 167.0 0.0 0.0 0.2 7.0 0.0 3.1 10.9 0.6 1.5 0.4 2.5 2.1 0.0 0.0 0.7 2.0 1.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 46.5 56.3 52.6 55.0 50.0 48.7 51.0 48.2 52.6 55.6 46.9 81.0 4.5 6.4 1.7 0.0 0.1 0.4 4.8 2.5 1.2 5.4 0.6 0.8 14.2 0.0 2.2 3.7 2.1 1.5 2.7 0.1 0.0 0.3 0.0 4.4 0.4 6.0 0.0 2.1 0.0 0.2 0.5 1.6 0.0 3.1 0.0 0.1 2.2 0.5 0.2 15.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 3.6 0.0 0.0 3.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.6 0.0 1.4 3.7 0.6 0.0 7.0 2.9 0.0 0.4 0.4 0.6 0.8 0.2 0.2 0.0 1.4 IL12A "CLMF, IL-12A, NFSK, NKSF1, p35" ENSG00000168811 "Interleukin 12A" P29459 3 159988835-159996019 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 4.1" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 3.9;Ionocytes: 4.1;Oligodendrocyte precursor cells: 4.0;Respiratory ciliated cells: 6.1;Sertoli cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "naive B-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 8.1;HDLM-2: 13.2;SK-BR-3: 17.6" "Region enhanced" "Detected in single" "cerebral cortex: 2.8" "Not detected" "Not detected" HPA001886 Uncertain "Secreted to blood" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA001886: AB_1079132" "unprognostic (6.23e-2)" "unprognostic (7.82e-5)" "unprognostic (1.25e-1)" "unprognostic (3.10e-2)" "unprognostic (4.22e-1)" "unprognostic (7.18e-2)" "unprognostic (4.18e-5)" "unprognostic (2.22e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (9.57e-10)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.16e-1)" "unprognostic (9.61e-2)" 0.3 0.4 0.9 0.6 0.9 1.5 0.7 0.9 2.0 0.2 0.3 0.8 0.5 0.3 0.1 4.1 2.1 0.2 0.8 0.8 0.8 0.4 0.1 2.1 0.8 0.9 1.1 0.5 0.5 0.0 0.5 0.1 1.0 0.3 0.4 0.1 0.3 0.1 0.2 0.1 0.8 0.2 0.7 1.2 0.5 0.3 0.9 0.4 0.2 0.7 0.5 0.7 0.6 1.1 3.1 0.3 0.4 2.6 0.0 0.2 0.2 3.3 2.1 3.9 8.1 1.2 0.1 0.0 0.2 0.5 4.5 0.3 0.8 0.5 3.6 13.2 4.1 0.1 0.2 0.9 2.5 0.7 6.1 0.6 1.0 6.9 2.7 2.7 1.2 0.3 0.0 2.1 2.4 0.1 0.1 0.0 0.4 0.1 1.8 2.4 0.0 0.4 0.4 0.2 0.1 1.2 0.0 17.6 0.5 0.6 0.9 1.4 0.9 0.8 0.8 2.3 6.3 1.4 0.0 0.0 1.5 5.9 0.8 0.0 0.0 0.5 0.3 0.1 0.5 0.5 0.1 0.6 0.0 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.9 0.9 0.9 2.0 0.8 0.8 0.9 1.1 1.0 0.7 0.9 1.1 1.0 0.0 0.6 1.0 3.4 0.1 2.1 1.0 1.2 0.0 1.6 2.2 0.4 0.0 1.1 0.0 0.0 0.1 0.7 0.3 0.0 1.5 0.0 3.9 0.2 1.4 2.4 0.8 0.1 0.0 0.0 0.4 0.0 1.5 0.0 0.1 0.0 0.0 0.1 0.0 1.9 0.9 4.1 0.3 0.3 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 4.0 1.3 0.4 0.2 0.0 2.1 2.9 0.1 0.0 6.1 0.0 6.6 1.5 0.3 0.4 2.9 2.6 0.1 0.0 0.7 0.1 0.5 1.3 C3orf80 ENSG00000180044 "Chromosome 3 open reading frame 80" F5H4A9 3 160225422-160228213 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 5.5;esophagus: 4.6;intestine: 8.0" "Cell type enhanced" "Detected in some" "Early spermatids: 5.6;Excitatory neurons: 23.6;Hepatic stellate cells: 6.1;Horizontal cells: 6.7;Inhibitory neurons: 6.3;Oligodendrocytes: 5.9;Spermatocytes: 7.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HMC-1: 140.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA047439 Uncertain NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA047439: AB_10965171" "unprognostic (5.34e-2)" "unprognostic (2.31e-1)" "unprognostic (6.35e-2)" "unprognostic (6.62e-3)" "unprognostic (1.92e-3)" "unprognostic (6.70e-3)" "unprognostic (4.28e-3)" "unprognostic (1.69e-1)" "unprognostic (4.64e-3)" "unprognostic (1.51e-1)" "unprognostic (9.20e-2)" "unprognostic (2.65e-1)" "unprognostic (6.09e-10)" "unprognostic (1.32e-2)" "unprognostic (1.78e-2)" "unprognostic (4.11e-3)" "unprognostic (5.00e-2)" 0.9 0.1 2.8 0.6 4.2 0.6 0.4 1.2 5.5 0.4 0.0 8.0 0.7 0.4 0.1 4.6 0.2 0.5 0.4 4.9 0.0 0.3 0.6 0.8 0.0 0.0 0.1 0.1 0.2 0.3 0.6 0.0 0.0 0.6 1.3 0.1 0.4 0.2 0.0 0.1 0.5 0.7 0.0 1.2 1.1 0.9 0.0 0.0 0.2 0.1 0.1 1.0 1.4 2.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.8 0.1 0.1 0.3 0.0 0.2 2.9 1.7 12.2 3.3 0.1 0.0 2.4 140.5 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.3 0.1 0.0 2.3 0.0 1.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 1.3 0.0 0.0 0.1 0.4 29.8 0.0 0.1 0.5 0.0 3.7 0.3 0.0 0.0 1.0 21.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4.2 1.2 5.5 4.9 0.0 0.0 0.1 0.0 0.0 0.0 2.6 1.2 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.2 0.0 1.3 4.2 3.0 23.6 0.4 0.0 0.4 0.0 0.1 0.0 0.0 6.1 0.3 0.1 6.7 6.3 0.0 0.0 0.0 0.4 1.8 0.3 0.0 0.0 1.9 0.0 0.0 0.0 1.5 5.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 2.3 7.1 1.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 IFT80 "FAP167, KIAA1374, WDR56" ENSG00000068885 "Intraflagellar transport 80" Q9P2H3 3 160256986-160399880 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 254.5;Respiratory ciliated cells: 71.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035868 Uncertain NA NA "Cluster 46: Basophils - DNA binding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA035868: AB_10959463" "unprognostic (2.71e-2)" "unprognostic (4.47e-3)" "unprognostic (2.13e-1)" "unprognostic (5.29e-2)" "unprognostic (3.03e-1)" "unprognostic (7.25e-2)" "unprognostic (4.08e-3)" "unprognostic (1.29e-2)" "unprognostic (5.95e-2)" "unprognostic (6.70e-2)" "unprognostic (8.31e-2)" "unprognostic (4.24e-3)" "unprognostic (4.52e-2)" "unprognostic (4.32e-2)" "unprognostic (2.20e-1)" "unprognostic (2.07e-1)" "unprognostic (5.60e-3)" 7.5 10.0 17.2 8.3 25.6 6.2 11.5 17.0 26.2 13.3 20.6 7.7 6.1 14.6 16.9 8.9 17.3 11.6 10.0 17.6 20.0 17.9 7.6 14.5 12.1 18.7 21.0 16.5 10.2 27.5 25.7 7.6 18.7 9.8 9.9 25.1 7.3 10.8 4.7 12.3 8.3 10.8 15.4 9.4 11.2 24.1 19.7 18.2 18.2 6.8 11.6 8.9 8.9 40.1 23.9 16.3 36.9 16.9 34.0 59.8 9.1 20.0 29.3 15.1 19.8 13.3 33.9 15.5 25.7 18.9 22.9 20.3 13.1 19.3 33.7 23.1 14.5 20.7 23.4 9.5 33.8 9.9 17.4 33.2 13.0 17.2 18.4 68.1 17.1 19.7 8.9 28.8 23.8 11.5 18.4 11.7 11.6 15.0 9.5 16.3 19.3 26.3 31.5 6.9 22.0 23.2 21.9 20.6 26.1 23.9 34.5 11.3 15.3 15.5 10.5 21.2 19.9 41.7 28.9 28.5 26.7 17.8 15.6 0.9 0.5 0.5 0.6 0.2 0.6 0.8 0.7 0.7 0.7 0.7 1.0 0.7 0.4 0.9 0.5 1.4 1.0 0.6 17.2 25.6 17.0 26.2 17.6 20.0 18.7 21.0 18.7 15.4 19.7 40.1 6.5 41.7 33.0 42.7 7.0 3.3 5.9 7.5 15.4 16.7 6.4 3.8 7.2 18.6 14.4 23.9 16.7 3.1 7.3 3.8 7.9 5.6 30.5 39.0 19.0 7.0 11.4 11.6 61.7 1.8 2.9 13.8 5.6 9.6 2.5 13.3 6.8 4.0 2.9 1.7 44.9 5.2 2.0 4.1 2.7 9.5 16.4 4.4 1.8 27.2 2.5 8.0 7.2 46.3 254.5 2.6 2.6 21.8 10.9 2.4 1.9 6.7 71.7 18.1 6.6 8.3 8.3 43.2 10.4 8.5 3.8 0.7 8.8 11.6 5.1 3.6 SMC4 "CAP-C, hCAP-C, SMC4L1" ENSG00000113810 "Structural maintenance of chromosomes 4" Q9NTJ3 3 160399274-160434954 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 60.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 305.8;Spermatocytes: 339.8;Spermatogonia: 239.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "basophil: 74.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029449, CAB055509" Approved Supported "Nuclear speckles,Cytosol" NA Yes 25000 "Cluster 18: Basophils - Vesicular transport" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear speckles, Cytosol" "CAB055509: , HPA029449: AB_10603891" "unprognostic (2.63e-1)" "unprognostic (1.01e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (7.63e-4)" "unprognostic (2.22e-1)" "unprognostic (1.28e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (9.54e-2)" "unprognostic (2.18e-2)" "unprognostic (5.47e-2)" "prognostic unfavorable (4.20e-5)" "prognostic unfavorable (9.00e-4)" "prognostic unfavorable (8.05e-7)" "unprognostic (3.03e-2)" "unprognostic (4.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.98e-2)" 6.8 6.5 1.0 21.2 2.0 36.3 6.8 1.2 1.7 6.3 1.5 13.2 14.0 7.4 2.3 23.5 4.5 7.6 7.3 0.9 1.9 5.9 7.8 11.8 37.1 1.7 1.4 5.9 7.8 3.8 2.0 16.2 1.6 5.8 14.9 7.7 4.6 5.0 3.6 11.0 15.4 10.1 1.3 14.7 11.8 32.5 1.9 60.6 9.0 6.8 31.6 9.6 4.3 3.2 386.3 72.8 155.0 73.0 31.5 30.9 72.1 181.2 88.8 206.0 176.8 94.4 209.7 236.6 101.9 81.1 140.0 212.5 183.0 95.0 332.4 297.9 113.8 234.7 123.3 33.6 17.3 158.3 182.6 14.6 13.3 114.4 96.5 78.5 94.8 103.2 130.3 272.2 133.9 78.3 183.2 44.4 91.8 106.7 149.3 180.1 238.8 177.3 43.4 54.8 93.7 94.0 141.4 135.1 65.5 76.6 156.9 128.6 84.8 132.2 105.2 119.9 349.8 181.1 192.2 412.0 96.7 166.9 151.9 74.4 6.0 23.6 11.5 8.9 11.4 17.2 18.2 14.3 6.6 15.0 11.4 10.2 10.8 15.3 15.9 11.7 30.3 9.5 1.0 2.0 1.2 1.7 0.9 1.9 1.7 1.4 1.6 1.3 1.9 3.2 24.6 105.8 174.0 3.9 43.7 40.8 18.2 33.1 30.7 14.9 21.5 21.0 41.3 25.8 35.0 35.0 8.4 74.6 54.4 41.4 3.9 20.9 48.6 35.2 27.0 44.8 30.1 305.8 3.5 14.7 138.1 50.7 32.6 36.1 79.1 77.3 38.2 20.4 61.3 0.0 2.9 44.5 24.4 29.7 43.5 28.3 25.1 36.4 17.8 17.8 39.3 9.3 46.4 3.5 30.1 13.5 26.5 48.2 95.9 14.1 25.9 8.6 25.4 25.8 131.5 21.7 73.2 339.8 239.4 58.1 35.7 34.1 58.4 34.6 69.7 19.1 TRIM59 "Mrf1, RNF104, TRIM57, TSBF1" ENSG00000213186 "Tripartite motif containing 59" Q8IWR1 3 160432445-160485773 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 68.4" "Cell type enriched" "Detected in many" 12 "Oligodendrocytes: 391.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017750 Uncertain Approved "Rods & Rings" NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Rods & Rings" "HPA017750: AB_1858312" "unprognostic (3.74e-1)" "prognostic favorable (4.36e-4)" "unprognostic (1.76e-1)" "unprognostic (1.03e-1)" "unprognostic (1.10e-1)" "unprognostic (3.02e-1)" "unprognostic (8.00e-4)" "unprognostic (1.88e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (1.15e-5)" "unprognostic (1.02e-3)" "unprognostic (2.44e-11)" "unprognostic (7.92e-2)" "unprognostic (2.42e-1)" "unprognostic (4.03e-2)" "unprognostic (5.91e-3)" 0.7 0.8 9.0 5.1 38.8 17.6 2.1 18.0 20.4 1.4 0.0 2.7 2.8 3.0 0.9 4.9 2.0 2.7 0.8 12.3 15.2 1.2 1.0 2.0 12.1 19.4 23.6 1.3 1.5 1.8 1.2 2.0 19.9 2.0 2.6 1.4 1.7 1.0 1.2 5.4 2.9 2.8 9.3 5.1 2.5 8.7 24.6 13.6 2.0 0.1 12.1 3.1 2.2 68.4 20.4 15.8 19.8 1.3 7.8 10.6 26.0 31.5 27.3 38.5 36.9 1.9 34.8 54.5 22.9 23.7 12.1 34.1 0.0 12.9 50.7 49.1 19.2 2.0 5.4 2.4 10.9 24.3 3.2 9.0 3.8 18.7 13.4 23.6 27.1 8.0 25.8 22.6 36.7 21.9 15.0 1.9 52.5 13.2 26.1 20.7 17.2 24.6 13.8 6.6 13.0 2.8 9.0 26.3 0.7 26.5 31.2 22.4 20.9 2.8 8.9 4.5 3.1 37.0 14.5 13.4 3.4 31.0 3.1 29.1 2.8 5.4 10.9 3.1 12.7 10.4 17.9 15.0 4.5 9.3 12.0 14.5 2.2 12.4 1.5 6.7 22.0 3.7 9.0 38.8 18.0 20.4 12.3 15.2 19.4 23.6 19.9 9.3 24.6 68.4 0.6 0.0 6.5 0.3 7.8 4.8 4.7 2.1 3.4 0.4 2.8 1.8 2.5 2.8 1.4 1.8 6.2 7.2 6.1 1.2 0.0 2.0 31.2 1.9 2.1 2.5 10.8 29.5 0.4 2.0 11.7 2.1 5.1 2.9 1.3 10.1 2.2 0.1 2.9 0.0 0.5 2.9 2.0 2.2 2.3 12.5 0.3 1.8 3.6 0.0 2.1 0.5 3.1 0.0 391.8 1.9 2.8 0.7 6.4 3.3 1.2 2.3 2.1 1.7 0.0 2.4 2.7 14.0 15.1 5.6 4.4 2.5 10.9 2.7 4.8 3.6 KPNA4 "IPOA3, MGC12217, MGC26703, QIP1, SRP3" ENSG00000186432 "Karyopherin subunit alpha 4" O00629 3 160495007-160565571 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 124.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034336, HPA043154, HPA045500" Enhanced Enhanced Nucleoplasm NA NA 110000 "Cluster 18: Basophils - Vesicular transport" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351" "unprognostic (1.58e-1)" "unprognostic (7.65e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (8.59e-4)" "unprognostic (7.56e-2)" "unprognostic (4.46e-2)" "prognostic unfavorable (6.24e-7)" "unprognostic (7.71e-3)" "unprognostic (1.57e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (1.20e-1)" "unprognostic (1.21e-1)" "unprognostic (3.98e-2)" "unprognostic (2.21e-1)" "unprognostic (2.17e-3)" "unprognostic (1.48e-1)" 20.2 8.1 4.4 12.0 5.4 15.2 11.1 7.2 10.8 11.1 2.7 16.9 8.8 12.7 8.5 16.5 9.0 9.7 23.3 5.8 7.3 11.1 12.2 11.0 10.4 6.2 5.5 9.0 13.2 11.0 6.3 11.9 6.5 11.6 8.5 13.2 10.5 12.4 124.6 11.3 9.8 13.5 5.9 11.2 12.1 12.2 5.5 11.2 10.3 59.8 12.0 14.3 11.8 6.9 103.4 29.9 20.0 32.7 30.3 27.8 39.7 70.7 39.6 41.0 33.0 38.5 32.1 52.6 73.8 59.9 52.5 45.8 27.4 38.2 50.2 77.0 20.5 52.8 15.2 9.0 37.7 49.3 33.8 22.0 18.5 38.5 76.6 27.5 53.9 26.5 44.2 33.5 45.5 13.8 38.0 17.7 53.9 33.7 31.4 33.9 41.6 50.4 21.9 22.9 23.3 24.8 60.8 29.7 55.7 22.8 33.7 14.4 72.9 39.4 36.0 37.3 87.9 80.4 50.4 96.3 30.9 45.4 31.6 7.7 2.3 2.9 1.8 3.5 2.5 2.3 1.6 2.6 1.7 1.5 1.3 2.0 4.2 4.0 5.7 1.5 2.7 1.8 4.4 5.4 7.2 10.8 5.8 7.3 6.2 5.5 6.5 5.9 5.5 6.9 70.5 38.5 25.1 40.1 62.8 123.6 87.3 24.3 60.3 58.6 59.4 48.1 158.8 30.0 38.4 11.0 79.2 26.1 54.5 65.0 35.2 36.5 24.3 71.2 63.2 60.7 28.7 38.1 48.5 37.7 25.3 55.1 45.9 92.1 31.6 57.6 37.5 34.7 39.2 53.8 52.9 38.1 28.5 47.9 97.2 18.4 33.8 80.0 44.4 49.6 43.2 57.5 28.8 45.8 69.2 77.4 44.3 34.6 65.2 86.5 32.0 40.2 40.6 69.6 32.9 102.4 67.4 38.2 25.3 85.3 126.0 40.6 60.6 36.1 43.7 104.4 ARL14 "ARF7, FLJ22595" ENSG00000179674 "ADP ribosylation factor like GTPase 14" Q8N4G2 3 160677160-160678448 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 129.2;intestine: 51.2;stomach 1: 77.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 588.3;Gastric mucus-secreting cells: 377.7;Intestinal goblet cells: 154.6;Paneth cells: 519.2;Proximal enterocytes: 174.5" "Group enriched" "Detected in many" 5 "colorectal cancer: 6.6;pancreatic cancer: 26.0;stomach cancer: 14.3;urothelial cancer: 8.1" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 15 "memory B-cell: 1.8" "Lineage enriched" "Detected in single" 18 "B-cells: 1.8" "Cell line enhanced" "Detected in some" "A-431: 9.7;CAPAN-2: 36.2;HaCaT: 9.0;OE19: 25.3;RT4: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (2.65e-1)" "unprognostic (7.26e-3)" "unprognostic (2.64e-2)" "unprognostic (3.70e-3)" "unprognostic (6.36e-2)" "unprognostic (2.47e-3)" "prognostic unfavorable (2.64e-5)" "unprognostic (2.30e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (6.71e-4)" "unprognostic (4.74e-2)" "unprognostic (4.91e-2)" "unprognostic (2.36e-1)" "unprognostic (1.35e-1)" "unprognostic (1.62e-1)" "unprognostic (1.70e-2)" 0.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 42.9 51.2 0.1 0.0 1.0 0.1 129.2 0.0 0.0 0.0 0.4 1.4 0.0 0.2 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.1 36.0 0.0 0.1 0.0 0.0 0.2 34.2 2.8 0.0 0.1 77.2 0.0 0.0 0.3 0.6 0.0 3.2 23.8 0.3 0.0 9.7 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 36.2 0.0 0.8 0.0 4.2 9.0 0.0 0.9 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 0.0 25.3 2.0 0.0 0.0 0.3 2.9 17.7 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.0 1.9 4.5 2.6 0.0 0.0 0.2 0.1 0.0 18.6 1.2 0.0 0.0 0.0 0.0 588.3 0.0 12.6 0.0 5.6 0.4 0.1 89.1 0.0 0.0 41.4 0.1 0.5 377.7 10.7 8.9 0.0 0.0 0.0 0.0 0.0 0.0 154.6 2.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.3 519.2 0.0 1.0 1.2 174.5 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.9 0.0 1.4 0.0 112.0 25.9 PPM1L PP2CE ENSG00000163590 "Protein phosphatase, Mg2+/Mn2+ dependent 1L" Q5SGD2 3 160755602-161078902 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 126.7;Excitatory neurons: 344.6;Inhibitory neurons: 175.7;Oligodendrocyte precursor cells: 111.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 4.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "HDLM-2: 79.8;U-266/70: 75.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019891, HPA019953" Approved Approved Nucleoplasm,Cytosol NA NA 26000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol Nucleoplasm "HPA019891: AB_1855631, HPA019953: AB_2170360" "prognostic unfavorable (4.90e-4)" "unprognostic (7.29e-3)" "unprognostic (2.01e-1)" "unprognostic (2.59e-2)" "unprognostic (8.03e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "unprognostic (1.63e-2)" "unprognostic (2.49e-2)" "unprognostic (1.92e-1)" "unprognostic (4.51e-2)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.81e-1)" "unprognostic (2.39e-1)" "unprognostic (9.13e-3)" "unprognostic (2.07e-1)" 6.0 5.9 7.6 2.2 8.5 2.4 3.2 11.0 13.4 7.3 0.0 5.9 1.9 4.2 1.9 6.2 4.1 5.9 6.6 9.2 5.6 5.8 3.2 3.0 1.0 11.3 7.6 2.2 3.7 15.5 10.1 8.6 13.1 4.0 3.9 11.3 15.2 2.2 21.8 6.0 2.5 4.1 0.0 2.2 6.1 1.7 12.7 3.5 10.7 17.8 2.2 10.8 4.0 0.8 2.6 1.7 8.7 4.6 5.1 0.1 5.4 0.3 0.2 0.9 0.3 0.5 0.6 0.5 0.8 0.4 2.0 8.1 7.4 0.5 0.3 79.8 7.9 7.7 7.0 0.9 0.2 4.7 8.6 0.9 3.5 0.2 0.5 0.6 0.5 3.8 0.3 12.0 0.1 4.2 1.8 0.5 5.1 14.2 1.7 9.5 1.5 1.8 0.4 8.4 10.5 9.0 4.5 5.2 0.3 3.0 5.7 4.7 0.4 0.9 0.9 0.7 2.9 75.6 0.3 4.3 1.1 3.9 1.9 0.4 1.6 3.2 1.5 3.5 0.1 0.1 0.3 1.0 0.8 0.6 0.5 1.0 0.1 0.6 4.9 0.4 0.0 1.6 7.6 8.5 11.0 13.4 9.2 5.6 11.3 7.6 13.1 0.0 12.7 0.8 2.6 6.4 2.7 126.7 1.5 8.7 5.7 3.0 8.6 59.4 4.7 3.0 33.9 8.6 10.9 1.8 35.5 3.8 11.6 12.5 0.0 2.1 1.2 3.2 17.5 5.3 13.8 3.4 344.6 4.3 3.4 6.5 11.7 6.8 0.0 2.2 2.5 18.1 7.1 6.7 175.7 8.0 14.2 15.4 7.2 1.2 5.0 14.0 3.6 53.4 6.6 10.2 26.8 111.6 77.4 2.2 8.3 5.3 2.9 5.9 2.2 3.7 9.5 10.4 0.0 42.5 21.4 2.6 3.4 13.1 8.7 2.6 3.8 2.6 5.6 21.2 B3GALNT1 "B3GALT3, beta3Gal-T3, galT3, GLOB, P1" ENSG00000169255 "Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)" O75752 3 161083883-161105411 "Blood group antigen proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 53.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 56.3;Cardiomyocytes: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 8.8;NK-cell: 22.1" "Group enriched" "Detected in many" 7 "granulocytes: 8.8;NK-cells: 22.1" "Cell line enhanced" "Detected in many" "RT4: 128.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041204 Approved Vesicles NA NA 400000 "Cluster 48: NK-cells - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 15: RT4 - Unknown function" "Cluster 56: Bipolar cells - Visual perception" Vesicles "HPA041204: AB_10795585" "unprognostic (3.85e-2)" "unprognostic (5.11e-3)" "unprognostic (3.02e-1)" "unprognostic (1.06e-2)" "unprognostic (7.83e-2)" "unprognostic (4.07e-2)" "unprognostic (9.26e-5)" "unprognostic (1.49e-2)" "unprognostic (1.12e-2)" "unprognostic (1.88e-2)" "unprognostic (3.44e-2)" "unprognostic (3.24e-1)" "unprognostic (2.09e-3)" "unprognostic (1.32e-1)" "unprognostic (4.90e-2)" "unprognostic (3.66e-2)" "unprognostic (3.19e-3)" 5.3 7.2 20.7 3.9 21.5 4.8 9.8 14.7 19.6 20.1 8.0 2.7 1.9 9.9 8.5 6.8 14.2 9.9 53.3 21.7 26.7 19.4 1.2 14.6 4.9 12.8 21.7 18.8 11.1 8.6 9.8 13.9 18.0 11.6 2.4 26.6 22.3 8.5 1.4 2.5 2.4 9.9 14.1 6.2 10.7 8.4 25.7 2.8 27.0 3.2 5.4 12.3 5.4 13.0 17.3 0.3 7.5 0.1 1.0 2.8 0.1 9.3 8.7 22.3 7.3 11.3 13.2 0.0 35.7 8.0 12.7 3.9 0.0 16.9 7.5 0.0 0.0 9.0 5.7 0.0 11.2 0.2 0.0 23.3 5.4 6.1 1.4 15.6 31.6 0.0 0.0 0.0 8.3 29.4 0.1 0.0 17.4 0.2 38.9 0.1 0.0 0.2 9.3 128.3 15.1 0.1 23.7 8.8 6.3 3.0 35.6 13.3 0.0 0.2 15.5 0.5 0.2 3.6 0.1 0.2 14.7 0.0 0.0 8.8 0.2 0.0 0.4 0.2 0.4 2.3 0.2 0.4 1.7 0.2 0.4 0.9 0.4 22.1 0.1 1.1 0.0 0.7 20.7 21.5 14.7 19.6 21.7 26.7 12.8 21.7 18.0 14.1 25.7 13.0 5.0 19.2 2.2 10.1 2.1 5.0 5.2 5.7 6.2 56.3 7.5 6.2 56.9 0.0 8.0 14.7 12.5 21.2 1.2 0.1 11.7 3.5 0.7 4.9 5.8 7.7 1.8 17.0 22.3 8.5 13.0 13.3 4.6 8.7 10.2 13.0 6.1 0.2 9.8 6.7 27.5 0.1 6.1 2.1 6.8 2.2 7.2 3.4 10.6 9.4 4.3 12.6 1.0 14.6 3.2 9.8 0.1 5.3 0.2 6.2 0.1 15.8 3.1 8.4 0.0 5.3 13.2 6.5 20.7 8.4 2.6 5.1 1.2 4.6 0.7 4.5 NMD3 CGI-07 ENSG00000169251 "NMD3 ribosome export adaptor" Q96D46 3 161104696-161253532 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035019 Supported Nucleoplasm,Nucleoli NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli" "HPA035019: AB_10600922" "unprognostic (1.37e-2)" "unprognostic (2.71e-1)" "unprognostic (9.50e-2)" "unprognostic (9.39e-3)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.03e-1)" "unprognostic (4.41e-2)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.03e-5)" "unprognostic (7.97e-2)" "unprognostic (5.57e-2)" "unprognostic (6.17e-2)" "unprognostic (8.71e-2)" "unprognostic (2.26e-2)" "unprognostic (5.86e-3)" 26.9 21.5 13.1 18.1 13.8 64.7 32.3 19.3 14.1 27.0 12.8 18.6 17.6 26.3 15.3 24.4 20.2 22.6 40.0 11.2 14.2 29.2 77.7 19.7 22.3 10.8 13.4 26.4 34.9 21.9 12.7 25.6 11.8 27.7 21.2 17.0 32.8 20.0 60.3 17.2 15.4 28.3 12.1 21.1 42.5 16.0 13.0 18.7 25.2 34.5 24.7 39.3 16.5 13.9 68.7 39.2 37.8 38.6 46.3 63.1 51.9 76.3 57.9 55.9 64.8 66.5 54.9 86.4 94.8 53.8 39.3 43.8 60.9 56.1 86.4 90.2 37.4 89.0 31.4 41.7 50.7 108.0 51.7 53.2 40.9 39.7 129.1 59.4 61.4 29.9 66.3 46.3 66.8 155.7 49.6 41.3 47.4 82.1 61.7 59.8 54.5 87.9 53.1 153.2 59.8 37.3 43.5 105.2 63.9 40.9 78.3 49.0 54.2 44.1 31.5 51.3 93.4 75.6 54.5 87.1 55.5 69.5 61.5 30.5 16.6 8.9 16.5 17.6 25.9 17.3 19.2 20.4 19.8 15.6 25.3 20.1 3.6 35.4 11.4 11.0 26.8 20.7 13.1 13.8 19.3 14.1 11.2 14.2 10.8 13.4 11.8 12.1 13.0 13.9 30.6 19.2 14.6 22.9 25.3 64.9 52.9 23.8 34.7 24.7 26.8 16.5 43.9 21.5 25.1 11.0 14.6 33.3 25.2 14.0 35.2 25.6 19.3 13.8 29.6 30.1 13.8 32.2 16.6 38.9 48.8 34.0 31.1 19.3 25.4 20.3 22.1 41.6 23.4 30.3 15.3 19.4 26.4 33.1 47.0 7.0 25.4 21.6 24.9 12.2 26.1 12.8 21.6 19.6 18.2 33.0 13.9 27.4 20.9 46.7 19.7 39.9 18.5 20.8 26.3 29.1 87.5 39.2 27.4 33.4 74.3 56.6 25.8 24.4 21.2 72.7 SPTSSB "ADMP, C3orf57, ssSPTb" ENSG00000196542 "Serine palmitoyltransferase small subunit B" Q8NFR3 3 161344792-161372880 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 45.5;stomach 1: 61.4;urinary bladder: 49.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 28.5;Exocrine glandular cells: 46.0;Gastric mucus-secreting cells: 37.2;Melanocytes: 46.2;Prostatic glandular cells: 74.6;Suprabasal keratinocytes: 36.4;Urothelial cells: 65.6" "Cancer enhanced" "Detected in many" "urothelial cancer: 24.0" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 13 "NK-cell: 353.6" "Lineage enriched" "Detected in many" 13 "NK-cells: 353.6" "Group enriched" "Detected in some" 10 "MCF7: 1167.1;RT4: 304.2" HPA047712 Uncertain "Nuclear speckles" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 35: Glandular cells - Unknown function" "Nuclear speckles" "HPA047712: AB_2680127" "unprognostic (2.09e-1)" "unprognostic (4.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-1)" "unprognostic (1.34e-2)" "unprognostic (4.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (5.10e-2)" "unprognostic (6.37e-3)" "unprognostic (2.72e-1)" "unprognostic (4.08e-2)" "unprognostic (5.37e-4)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (9.51e-3)" 1.9 0.1 3.7 0.6 1.9 0.3 8.3 5.2 7.9 4.8 3.0 0.8 0.3 1.0 0.1 8.7 0.4 1.3 0.4 2.2 1.3 1.2 0.5 0.1 1.2 2.8 5.6 0.2 0.8 0.1 0.4 0.0 4.8 14.7 0.7 2.5 11.4 0.1 0.1 45.5 0.3 0.2 0.2 1.3 61.4 0.0 6.7 0.4 0.3 1.5 2.0 49.5 11.1 3.7 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.9 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.4 0.0 0.0 0.1 0.1 2.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1167.1 0.0 0.0 4.3 71.5 13.4 0.0 0.0 0.5 0.0 304.2 1.9 11.9 0.0 40.6 0.0 0.1 64.7 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.1 0.2 26.2 0.1 0.9 2.5 0.0 0.1 0.3 0.4 0.9 353.6 0.0 0.2 0.0 2.5 3.7 1.9 5.2 7.9 2.2 1.3 2.8 5.6 4.8 0.2 6.7 3.7 0.2 0.0 0.0 4.2 0.1 3.8 16.6 19.6 1.8 1.4 16.6 8.4 0.4 1.5 22.5 3.7 0.0 0.0 3.6 0.1 0.0 1.3 0.0 0.5 0.2 0.8 0.0 0.0 28.5 46.0 0.0 0.7 37.2 1.2 0.0 4.3 0.0 0.0 0.2 0.0 14.2 2.5 6.1 0.0 0.8 0.0 0.0 0.4 46.2 1.0 0.1 0.6 7.2 5.0 1.5 27.6 0.0 0.0 0.4 74.6 0.0 0.0 4.1 1.4 0.0 0.1 2.2 0.0 0.0 6.8 36.4 0.1 3.2 0.0 0.0 65.6 OTOL1 "C1QTNF15, C1QTNF16" ENSG00000182447 "Otolin 1" A6NHN0 3 161496808-161503942 "Predicted secreted proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041030 Uncertain "Secreted in other tissues" NA NA "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA041030: AB_10795000" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 SI ENSG00000090402 Sucrase-isomaltase P14410 3 164978898-165078496 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Glycosidase, Hydrolase, Multifunctional enzyme" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 150 "intestine: 545.1" "Cell type enriched" "Detected in some" 8 "Proximal enterocytes: 1083.9" "Cancer enhanced" "Detected in some" "stomach cancer: 6.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;CACO-2: 1.5;HeLa: 1.2;NB-4: 1.3;RPMI-8226: 2.0;SH-SY5Y: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA011897 Enhanced NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 24: NB-4 - Immune response" "Cluster 45: Enterocytes - Digestion" "HPA011897: AB_1856840" "unprognostic (2.71e-2)" "unprognostic (1.62e-2)" "unprognostic (2.68e-1)" "unprognostic (2.05e-1)" "unprognostic (4.41e-2)" 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 545.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 31.0 0.0 0.0 0.0 0.0 0.0 448.2 0.8 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 9.7 0.0 0.0 0.1 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 123.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 124.7 0.0 0.0 0.3 1083.9 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 77.8 0.0 SLITRK3 KIAA0848 ENSG00000121871 "SLIT and NTRK like family member 3" O94933 3 165186720-165197109 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.0;fallopian tube: 9.6;liver: 7.9" "Group enriched" "Detected in some" 6 "Bipolar cells: 8.4;Excitatory neurons: 11.0;Inhibitory neurons: 15.9;Oligodendrocyte precursor cells: 21.1" "Cancer enriched" "Detected in single" 22 "glioma: 7.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.6;HAP1: 2.2;SCLC-21H: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017636, HPA048042" Enhanced Approved Mitochondria No NA 2600000 "Cluster 15: Liver - Metabolism" "Cluster 12: NES - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" Mitochondria "HPA017636: AB_1857232, HPA048042: AB_2732542" "unprognostic (8.91e-2)" "unprognostic (1.44e-1)" "unprognostic (4.08e-2)" "unprognostic (1.96e-1)" "unprognostic (5.16e-2)" "unprognostic (1.76e-1)" "unprognostic (9.59e-2)" "unprognostic (2.95e-2)" "unprognostic (1.03e-1)" "unprognostic (2.22e-1)" "unprognostic (6.74e-3)" "unprognostic (5.03e-1)" "unprognostic (2.38e-1)" "unprognostic (8.03e-4)" 0.1 0.1 3.4 1.0 3.1 0.0 0.1 4.1 8.4 5.4 0.0 2.6 0.4 7.3 0.9 4.4 9.6 0.2 0.4 9.0 2.8 0.1 7.9 0.3 0.0 0.2 0.1 0.9 0.0 0.0 0.1 0.0 0.5 1.7 1.6 3.1 0.2 5.4 0.3 0.0 1.1 3.7 0.9 0.0 0.4 0.4 0.7 0.0 0.1 0.0 0.0 0.5 0.9 1.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.1 4.1 8.4 9.0 2.8 0.2 0.1 0.5 0.9 0.7 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 2.2 0.0 0.0 15.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 21.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BCHE "CHE1, CHE2, E1" ENSG00000114200 Butyrylcholinesterase P06276 3 165772904-165837462 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Serine esterase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "liver: 525.1" "Group enriched" "Detected in many" 9 "Hepatocytes: 420.3;Oligodendrocyte precursor cells: 210.1" "Group enriched" "Detected in many" 6 "glioma: 24.0;liver cancer: 13.7;melanoma: 18.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 9 "Karpas-707: 785.6" "Low region specificity" "Detected in all" HPA001560 Approved "Secreted to blood" NA NA 9400000000 "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 2: Karpas-707 - Immune response" "Cluster 2: Hepatocytes - Metabolism" "HPA001560: AB_1078271" "unprognostic (4.74e-2)" "unprognostic (2.00e-1)" "unprognostic (9.21e-4)" "unprognostic (8.19e-8)" "unprognostic (2.66e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (1.44e-1)" "unprognostic (5.04e-2)" "unprognostic (6.15e-2)" "unprognostic (9.59e-2)" "unprognostic (5.15e-2)" "unprognostic (3.65e-2)" "unprognostic (3.18e-3)" "unprognostic (4.46e-5)" "unprognostic (2.17e-2)" "unprognostic (5.92e-2)" "unprognostic (4.26e-4)" 30.4 11.6 9.3 2.7 7.4 0.0 4.7 7.5 12.0 22.0 5.0 36.1 4.7 41.0 24.3 25.8 36.2 6.0 9.7 7.9 7.3 4.9 525.1 10.9 0.2 7.9 9.4 3.7 2.3 0.1 1.8 0.0 7.8 12.5 16.1 8.8 1.9 32.3 2.7 8.7 10.6 29.7 7.4 5.9 3.5 1.3 12.2 2.9 1.3 5.1 0.1 11.3 5.1 9.4 0.0 2.1 82.1 0.1 0.2 0.0 0.1 0.0 1.5 0.6 7.3 0.0 0.1 0.3 30.7 0.0 0.0 0.5 5.7 0.4 5.8 0.4 0.8 0.0 0.0 0.0 6.3 0.2 0.4 23.5 1.4 0.0 8.1 25.3 3.6 30.0 0.0 785.6 0.0 0.0 0.0 0.1 2.1 0.0 0.8 0.0 28.4 67.3 0.7 0.0 0.0 0.8 0.1 0.0 46.5 0.0 34.0 0.2 0.0 19.3 0.5 0.0 8.3 3.5 0.0 1.6 8.2 0.2 84.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 7.4 7.5 12.0 7.9 7.3 7.9 9.4 7.8 7.4 12.2 9.4 5.8 0.0 0.0 1.0 0.7 5.5 0.9 0.0 1.8 1.4 0.0 0.1 9.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.6 0.0 0.7 3.4 0.0 8.0 3.0 0.0 0.0 22.0 0.5 0.0 0.0 0.2 8.9 420.3 0.1 1.7 10.5 0.4 0.0 4.7 1.5 8.7 2.1 0.3 19.6 3.7 0.0 31.7 0.0 210.1 16.1 0.0 0.0 0.0 0.0 0.2 0.0 3.7 0.0 1.2 0.0 0.8 6.5 0.3 0.3 0.6 3.4 0.0 1.1 0.1 0.0 0.1 ZBBX FLJ23049 ENSG00000169064 "Zinc finger B-box domain containing" A8MT70 3 167239843-167407874 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 13.5;choroid plexus: 28.9;fallopian tube: 23.2;testis: 35.9" "Cell type enhanced" "Detected in some" "Early spermatids: 423.4;Endometrial ciliated cells: 107.4;Excitatory neurons: 80.1;Late spermatids: 232.4;Respiratory ciliated cells: 226.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 1.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA036327, HPA036328" Enhanced Approved "Golgi apparatus" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA036327: AB_10672240, HPA036328: AB_2675063" "unprognostic (2.68e-3)" "unprognostic (4.49e-2)" "unprognostic (6.94e-2)" "unprognostic (3.99e-1)" "unprognostic (4.08e-2)" "unprognostic (7.61e-2)" "unprognostic (1.24e-1)" "unprognostic (1.75e-3)" "unprognostic (1.29e-1)" "unprognostic (2.30e-3)" "unprognostic (1.15e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-1)" 0.0 0.2 3.7 0.0 2.6 0.0 0.0 0.7 1.5 0.7 28.9 0.0 0.0 0.8 0.1 0.0 23.2 0.0 0.0 2.4 2.7 0.2 0.0 3.5 0.0 13.5 11.1 0.0 0.0 0.3 2.0 0.0 6.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 35.9 3.5 0.1 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 2.6 0.7 1.5 2.4 2.7 13.5 11.1 6.6 10.5 3.5 6.1 0.0 0.0 1.1 7.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 25.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 423.4 107.4 0.6 0.6 0.0 0.0 80.1 0.0 0.0 0.5 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 23.8 0.0 6.1 0.0 0.0 232.4 1.5 0.4 0.0 1.9 0.0 0.0 0.0 4.5 1.1 0.1 0.0 1.5 0.0 0.1 0.0 0.2 226.2 0.0 0.0 0.0 1.2 37.4 11.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 SERPINI2 "MEPI, PANCPIN, PI14, TSA2004" ENSG00000114204 "Serpin family I member 2" O75830 3 167441789-167479004 "Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 133 "pancreas: 1370.0" "Cell type enhanced" "Detected in some" "Astrocytes: 37.5;Exocrine glandular cells: 93.4;Respiratory ciliated cells: 22.9" "Cancer enriched" "Detected in some" 6 "pancreatic cancer: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "THP-1: 9.0" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 8.7" "Secreted to digestive system" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 25: Pancreas - Digestion" "Cluster 43: THP-1 - Innate immune response" "Cluster 1: Pancreatic cells - Digestion" "unprognostic (1.88e-2)" "unprognostic (2.23e-3)" "unprognostic (1.14e-1)" "unprognostic (5.27e-2)" "unprognostic (1.17e-2)" "unprognostic (1.29e-2)" "unprognostic (1.11e-2)" "unprognostic (2.04e-1)" "unprognostic (3.13e-1)" "unprognostic (1.76e-5)" "unprognostic (5.35e-2)" "unprognostic (4.16e-2)" 0.1 0.1 3.7 0.0 2.9 0.4 0.1 4.4 1.5 0.2 10.2 0.1 1.0 0.2 0.2 0.2 3.9 0.0 0.5 2.5 3.7 0.2 0.0 1.0 0.1 9.6 7.7 0.5 1370.0 0.0 0.4 0.0 7.1 0.2 0.0 0.0 0.4 0.0 0.0 0.1 1.9 0.1 9.4 0.2 0.3 0.1 4.3 0.0 0.0 0.2 0.1 0.1 0.1 5.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 9.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.7 2.9 4.4 1.5 2.5 3.7 9.6 7.7 7.1 9.4 4.3 5.8 0.0 0.0 1.1 37.5 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 5.9 0.1 0.1 0.0 0.0 3.6 93.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.1 0.0 0.5 0.0 0.0 1.2 0.0 0.0 2.0 0.9 4.8 0.0 0.0 0.0 0.0 0.7 0.0 22.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 WDR49 FLJ33620 ENSG00000174776 "WD repeat domain 49" Q8IV35 3 167478684-167653983 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 31.3;choroid plexus: 29.3;fallopian tube: 10.0" "Group enriched" "Detected in some" 5 "Astrocytes: 79.0;Endometrial ciliated cells: 43.4;Respiratory ciliated cells: 47.7" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 2.7;myeloid DC: 2.2;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 24 "dendritic cells: 2.9;monocytes: 2.7" "Cell line enhanced" "Detected in some" "AF22: 2.7;NTERA-2: 3.0;THP-1: 14.5;U-937: 7.8" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 9.5" "HPA036225, HPA036226" Uncertain Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 43: THP-1 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nuclear bodies" Cytosol "HPA036225: AB_10696652, HPA036226: AB_2675007" "unprognostic (1.68e-3)" "unprognostic (1.24e-3)" "unprognostic (2.48e-2)" "unprognostic (1.96e-1)" "unprognostic (5.67e-2)" "unprognostic (5.11e-3)" "unprognostic (1.66e-1)" "unprognostic (6.02e-2)" "unprognostic (9.28e-3)" "unprognostic (1.34e-1)" "unprognostic (4.60e-9)" "unprognostic (1.79e-4)" "unprognostic (3.50e-2)" "unprognostic (3.57e-2)" "unprognostic (2.07e-1)" 0.1 0.1 10.2 0.4 8.2 2.0 0.1 16.6 3.4 0.3 29.3 0.1 2.0 0.4 0.0 0.9 10.0 0.2 2.1 7.0 15.6 0.3 0.0 1.9 0.3 30.1 27.0 0.1 0.3 0.0 0.5 0.0 23.8 0.2 0.1 0.0 0.2 0.0 0.0 0.1 4.6 0.1 31.3 0.4 0.2 0.6 15.5 0.4 0.0 0.2 0.3 0.2 0.2 23.4 0.1 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.8 0.0 0.0 2.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.5 10.2 8.2 16.6 3.4 7.0 15.6 30.1 27.0 23.8 31.3 15.5 23.4 0.2 0.0 0.6 79.0 0.1 0.0 0.9 1.7 9.1 0.0 0.1 0.1 1.1 0.0 10.9 0.0 0.0 0.0 1.6 0.1 0.0 0.1 2.4 43.4 0.3 0.2 0.0 1.7 4.5 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 4.1 1.6 2.5 0.8 0.0 1.8 0.0 0.0 4.0 0.0 0.0 2.5 3.0 0.0 0.0 0.0 0.1 0.4 3.3 0.0 47.7 0.0 6.6 0.3 0.6 0.1 0.2 1.0 0.1 0.0 0.1 0.0 0.2 0.8 PDCD10 "CCM3, TFAR15" ENSG00000114209 "Programmed cell death 10" Q9BUL8 3 167683298-167734939 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Angiogenesis, Apoptosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027095 Approved NA NA 190000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "HPA027095: AB_1855101" "unprognostic (3.39e-2)" "unprognostic (2.75e-1)" "unprognostic (4.98e-2)" "prognostic unfavorable (9.34e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.89e-4)" "prognostic unfavorable (2.30e-4)" "unprognostic (4.98e-3)" "unprognostic (2.41e-2)" "unprognostic (9.95e-3)" "prognostic unfavorable (5.22e-5)" "unprognostic (3.08e-2)" "prognostic favorable (5.88e-4)" "unprognostic (1.98e-1)" "unprognostic (2.45e-1)" "unprognostic (3.14e-1)" "unprognostic (5.58e-2)" 34.4 30.4 24.0 39.2 27.1 61.7 41.3 28.4 34.3 24.9 22.6 50.9 48.7 27.3 29.1 50.4 24.4 29.5 35.9 25.6 28.0 43.5 36.4 31.4 53.0 26.9 25.6 25.6 25.7 41.5 21.9 44.4 27.3 31.0 48.7 20.3 31.4 24.7 21.8 27.6 43.4 30.3 27.9 33.1 41.3 44.1 25.9 50.9 37.9 29.6 52.6 50.2 32.3 32.2 133.1 49.3 61.6 39.6 56.7 62.1 67.7 78.5 82.7 89.8 89.9 92.3 153.3 107.5 150.0 73.2 156.5 86.0 73.1 91.1 108.0 172.2 52.9 164.8 59.3 61.1 80.3 109.8 93.0 47.9 92.7 56.9 92.6 64.3 73.3 89.1 129.6 105.2 82.1 117.2 88.4 67.7 79.3 119.3 67.9 51.3 46.9 157.9 112.7 53.5 58.9 52.1 75.2 80.8 148.5 76.8 149.0 92.4 70.5 63.5 41.2 68.9 113.5 113.4 170.9 187.6 75.3 114.6 53.2 224.8 81.7 196.5 82.4 107.0 100.1 136.2 111.2 100.2 79.4 136.4 92.0 95.3 175.0 107.1 138.9 73.2 181.9 133.8 24.0 27.1 28.4 34.3 25.6 28.0 26.9 25.6 27.3 27.9 25.9 32.2 103.3 44.8 42.6 18.6 74.8 108.1 91.0 227.1 69.4 20.2 49.1 57.4 71.1 32.9 120.9 33.1 6.2 106.2 76.9 100.1 105.7 101.4 76.0 58.8 48.3 69.8 34.6 123.3 48.0 122.0 112.3 52.9 62.7 61.4 62.7 34.8 45.3 41.5 91.2 20.2 33.8 75.4 120.1 53.8 73.6 33.5 49.7 89.0 49.8 27.2 100.5 52.9 88.6 19.1 49.7 121.7 103.0 39.5 51.2 97.2 72.0 123.5 92.8 24.1 32.9 37.9 128.4 119.5 103.7 66.6 129.0 103.0 77.9 38.9 55.9 122.7 SERPINI1 PI12 ENSG00000163536 "Serpin family I member 1" Q99574 3 167735243-167825569 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 301.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 219.4;Excitatory neurons: 176.9;Inhibitory neurons: 228.8;Oligodendrocytes: 174.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 29.2;Karpas-707: 29.1;U-266/84: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001565, HPA056092" Enhanced Uncertain Cytosol "Secreted in brain" NA NA 750000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 65: Brain - Ion transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 56: Bipolar cells - Visual perception" Cytosol "HPA001565: AB_1079924, HPA056092: AB_2683036" "unprognostic (1.61e-1)" "unprognostic (1.06e-1)" "unprognostic (4.09e-3)" "unprognostic (1.35e-1)" "unprognostic (6.97e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.48e-1)" "unprognostic (2.61e-1)" "unprognostic (6.07e-3)" "unprognostic (2.18e-2)" "unprognostic (1.01e-1)" "unprognostic (1.58e-3)" "unprognostic (1.41e-1)" "unprognostic (2.89e-1)" "unprognostic (1.22e-1)" "unprognostic (1.11e-1)" 13.1 15.8 138.8 4.1 157.7 2.3 11.7 115.9 301.4 8.4 82.1 5.1 2.2 8.6 8.2 5.5 7.9 6.3 14.0 162.0 129.1 32.1 4.1 6.4 4.6 122.8 153.6 6.9 39.5 6.9 42.8 6.7 123.9 11.8 4.4 84.4 23.0 7.4 3.2 3.1 4.4 6.1 134.6 8.7 10.8 15.8 134.5 4.4 11.2 8.1 8.2 4.9 6.0 164.8 0.8 3.5 5.5 0.4 10.3 2.2 0.3 1.9 2.7 1.3 2.2 1.5 5.9 29.2 9.5 1.3 4.5 1.3 3.9 3.8 1.5 7.7 6.5 8.9 22.5 10.7 0.7 1.4 1.1 3.8 1.4 0.8 1.3 2.9 0.4 10.5 18.9 29.1 1.2 2.7 0.8 1.9 3.3 4.2 4.5 2.7 0.4 3.2 11.2 1.0 2.2 13.4 3.6 6.8 8.3 12.4 10.6 4.4 1.0 5.5 0.5 0.5 10.3 23.0 28.4 18.8 4.2 7.7 3.2 1.5 0.3 0.8 9.3 0.7 6.9 22.1 9.7 10.2 0.5 25.2 6.9 8.1 0.9 9.5 0.5 7.2 27.2 5.2 138.8 157.7 115.9 301.4 162.0 129.1 122.8 153.6 123.9 134.6 134.5 164.8 49.8 6.4 1.5 43.1 10.7 3.7 13.2 6.4 14.2 219.4 3.6 14.1 8.2 1.5 6.7 5.5 14.6 6.1 6.2 0.7 7.9 1.8 0.4 2.0 1.0 16.0 4.8 7.4 176.9 18.0 6.0 8.9 2.6 1.7 2.5 2.3 3.9 0.6 2.3 5.0 228.8 0.3 73.2 0.6 3.2 2.4 4.1 0.9 7.2 25.3 1.2 78.0 2.1 31.2 174.7 3.0 0.0 2.6 14.6 6.7 0.0 39.9 13.6 35.4 26.3 5.2 54.7 3.0 27.4 0.5 1.7 5.1 6.2 1.1 0.3 2.3 GOLIM4 "GIMPC, GOLPH4, GPP130, P138" ENSG00000173905 "Golgi integral membrane protein 4" O00461 3 168008689-168095924 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 370.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 10.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001677, HPA002315" Enhanced Enhanced "Golgi apparatus" NA NA 1000000 "Cluster 49: Eosinophils - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA001677: AB_1079017, HPA002315: AB_1079018" "unprognostic (6.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.19e-1)" "unprognostic (6.27e-2)" "unprognostic (2.11e-1)" "unprognostic (4.76e-2)" "unprognostic (2.44e-1)" "unprognostic (5.17e-2)" "unprognostic (1.39e-1)" "unprognostic (6.46e-2)" "unprognostic (1.10e-1)" "unprognostic (6.31e-2)" "unprognostic (1.84e-3)" "unprognostic (9.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" "unprognostic (9.62e-3)" 24.8 12.6 25.4 21.4 23.0 9.0 12.9 24.7 32.1 16.8 13.9 53.4 65.8 21.9 8.9 15.7 15.7 28.5 54.6 27.7 34.8 31.3 59.2 29.1 11.3 39.5 29.5 19.9 11.9 12.8 9.6 22.4 40.1 15.2 51.1 53.0 17.3 13.6 32.4 9.3 85.2 26.6 35.1 23.0 24.3 9.0 27.5 6.5 19.0 30.7 9.5 16.8 10.7 33.6 23.7 34.5 47.8 30.4 79.7 58.6 14.5 135.8 72.4 36.3 33.2 38.7 28.4 51.6 159.1 82.4 58.4 42.5 44.4 39.9 54.9 81.3 57.0 83.8 100.2 48.1 32.1 80.5 45.8 61.5 20.9 33.4 32.8 32.2 42.1 0.0 43.7 146.2 41.9 39.2 0.1 21.8 46.9 44.2 36.6 0.1 48.1 72.2 20.6 8.5 42.9 55.5 83.5 25.1 28.4 31.7 30.9 36.1 79.0 114.9 44.2 81.3 110.1 56.4 43.4 109.4 57.1 47.4 52.4 3.2 2.5 10.8 0.6 2.8 0.2 1.2 0.1 0.5 3.3 2.0 0.0 0.2 0.0 5.5 2.3 4.0 0.0 0.7 25.4 23.0 24.7 32.1 27.7 34.8 39.5 29.5 40.1 35.1 27.5 33.6 74.9 48.1 124.8 141.0 11.1 41.4 24.4 18.3 41.5 16.2 21.3 20.6 157.3 67.2 23.3 36.8 37.5 11.4 33.5 184.5 17.6 21.8 1.7 20.6 51.5 70.9 63.3 33.9 18.1 29.6 17.2 119.2 34.1 30.9 58.3 23.3 45.3 178.8 39.1 16.8 84.2 136.5 12.2 50.7 57.5 3.3 39.7 42.2 37.4 38.4 22.0 370.3 14.4 145.8 44.7 23.6 181.2 51.1 28.9 26.0 195.2 31.6 9.2 62.8 46.0 108.2 82.5 5.5 37.6 20.1 35.9 5.5 16.5 20.4 167.6 8.4 MECOM "EVI1, KMT8E, MDS1, MDS1-EVI1, PRDM3" ENSG00000085276 "MDS1 and EVI1 complex locus" Q03112 3 169083499-169663775 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 73.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 184.8;Collecting duct cells: 125.0;Gastric mucus-secreting cells: 111.1;Glandular and luminal cells: 107.7;Microglial cells: 346.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 55.5;RPTEC TERT1: 71.2;RT4: 119.6;TIME: 53.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046537 Supported Supported "Nuclear speckles" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 46: Fibroblasts - ECM organization" "Cluster 15: RT4 - Unknown function" "Cluster 44: Endometrium - Transcription" "Nuclear speckles" "HPA046537: AB_2679689" "unprognostic (4.09e-2)" "unprognostic (1.96e-1)" "unprognostic (3.24e-3)" "unprognostic (7.29e-2)" "unprognostic (2.87e-2)" "unprognostic (2.53e-1)" "unprognostic (1.83e-2)" "unprognostic (4.77e-3)" "unprognostic (1.53e-2)" "unprognostic (3.27e-3)" "prognostic unfavorable (2.59e-4)" "unprognostic (1.87e-1)" "unprognostic (2.60e-3)" "unprognostic (6.54e-2)" "unprognostic (1.03e-1)" "unprognostic (2.81e-2)" "unprognostic (3.37e-3)" 16.0 0.9 7.3 7.3 7.2 1.4 12.3 8.5 7.3 21.3 2.4 24.9 19.8 17.3 4.4 13.5 23.4 8.3 13.0 4.9 6.3 41.3 1.4 25.5 1.5 9.1 7.2 2.3 23.3 1.7 4.2 17.4 8.9 6.9 30.0 1.8 8.8 8.0 4.3 2.6 10.2 8.0 4.1 6.2 73.3 3.0 8.1 2.0 5.7 12.0 5.3 30.4 7.5 6.3 25.8 0.7 0.9 0.2 3.7 2.7 1.1 3.7 4.2 1.1 2.2 10.7 26.1 0.9 39.1 0.6 5.5 13.4 10.2 15.7 3.1 1.4 16.6 16.7 7.6 1.1 0.4 0.3 5.1 5.7 2.2 1.0 12.1 12.0 55.5 1.4 13.0 1.8 10.3 9.8 0.9 0.4 1.7 13.5 6.6 9.8 13.1 0.3 71.2 119.6 1.0 3.1 1.3 6.7 0.3 1.5 7.1 1.1 53.4 9.7 6.6 2.5 16.9 1.4 0.7 0.9 4.8 1.0 1.6 0.9 0.4 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.5 0.2 0.0 0.0 0.3 0.4 0.5 1.6 0.1 0.0 7.3 7.2 8.5 7.3 4.9 6.3 9.1 7.2 8.9 4.1 8.1 6.3 80.2 60.9 184.8 16.0 0.6 2.2 33.3 29.4 10.2 0.0 1.2 0.9 11.4 2.8 69.6 125.0 0.0 1.1 0.1 25.5 52.8 1.6 10.4 71.9 5.8 70.5 19.9 7.4 10.3 75.4 0.2 4.8 111.1 107.7 9.5 0.8 69.3 0.2 0.0 0.0 9.1 29.0 20.3 0.6 1.9 3.2 0.3 2.6 1.8 346.6 1.0 0.0 0.0 6.0 13.8 49.8 19.3 0.0 0.3 13.9 6.2 0.7 53.2 0.1 0.0 1.4 5.7 3.0 1.2 39.4 1.4 0.4 1.3 0.5 53.9 45.4 ACTRT3 ARPM1 ENSG00000184378 "Actin related protein T3" Q9BYD9 3 169766921-169769561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 47.5" "Cell type enriched" "Detected in many" 6 "Early spermatids: 1021.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 18.1;HSkMC: 11.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA035817, HPA035818" Approved Approved Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "HPA035817: AB_10671938, HPA035818: AB_2674801" "unprognostic (2.35e-1)" "unprognostic (9.39e-2)" "unprognostic (2.10e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (1.89e-2)" "unprognostic (1.75e-1)" "unprognostic (3.29e-1)" "unprognostic (1.24e-1)" "unprognostic (7.31e-4)" "unprognostic (2.64e-1)" "unprognostic (9.16e-2)" "unprognostic (4.41e-2)" "unprognostic (8.03e-2)" "unprognostic (8.49e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-3)" "unprognostic (2.22e-1)" 1.6 0.9 1.7 0.7 2.1 0.4 1.1 2.6 4.5 1.4 2.0 0.9 1.1 1.1 0.8 1.0 2.0 0.9 1.2 2.2 2.0 2.4 2.7 1.1 0.8 2.1 3.5 1.6 0.6 1.2 1.3 1.0 2.2 1.2 0.8 0.8 0.6 1.9 0.7 0.4 0.8 1.6 1.8 0.4 1.2 47.5 2.5 0.8 1.5 0.7 0.9 1.7 0.7 2.6 4.0 2.5 0.2 1.1 18.1 5.5 0.0 4.7 3.0 3.1 2.6 0.0 5.2 0.0 6.5 5.9 2.0 2.5 1.5 2.5 3.3 2.9 1.7 9.3 1.9 0.5 3.0 1.1 0.9 11.8 0.6 3.8 0.7 2.0 5.8 0.9 0.0 0.0 5.7 2.0 0.2 0.1 4.5 3.5 5.3 0.6 0.0 0.1 3.3 1.0 3.1 2.1 5.9 1.4 0.1 0.6 2.5 4.1 2.4 0.0 0.0 2.5 0.0 0.4 0.2 0.2 1.1 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.9 0.3 0.0 0.3 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 1.7 2.1 2.6 4.5 2.2 2.0 2.1 3.5 2.2 1.8 2.5 2.6 0.9 0.0 1.5 0.3 0.1 0.4 1.3 1.6 1.2 1.6 0.4 0.4 0.7 0.0 2.0 0.0 2.1 1.7 0.1 0.2 1.9 2.3 1021.8 1.1 0.6 1.8 0.0 0.4 0.2 2.1 1.3 1.7 0.5 0.9 1.3 1.3 2.2 2.1 1.5 3.3 0.2 1.3 0.0 0.8 0.7 161.0 9.6 2.2 1.8 0.0 0.0 1.5 0.0 0.0 0.0 2.1 0.1 5.7 0.2 0.7 0.5 2.8 2.1 1.3 13.1 1.1 1.4 24.6 4.6 1.2 0.0 0.8 1.3 3.8 1.2 0.4 MYNN "SBBIZ1, ZBTB31, ZNF902" ENSG00000085274 Myoneurin Q9NPC7 3 169773396-169789716 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045149 Approved Supported Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA045149: AB_10960839" "unprognostic (7.13e-2)" "unprognostic (2.28e-2)" "unprognostic (3.67e-2)" "unprognostic (2.19e-2)" "unprognostic (1.17e-2)" "unprognostic (2.02e-1)" "unprognostic (3.09e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-2)" "unprognostic (2.77e-1)" "unprognostic (8.25e-3)" "unprognostic (1.25e-3)" "unprognostic (1.34e-3)" "unprognostic (1.05e-1)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.36e-3)" 6.0 5.3 3.4 6.5 4.1 14.8 9.7 7.2 4.5 7.9 4.4 5.7 5.1 10.3 6.3 7.1 6.8 6.2 5.8 3.1 3.4 6.8 7.9 6.4 8.7 3.0 3.5 10.0 7.3 8.4 3.6 7.1 3.3 7.2 7.0 15.3 6.3 6.3 7.9 7.8 6.8 8.4 3.5 7.9 7.0 9.9 3.4 7.6 8.5 10.8 9.8 7.4 5.5 5.2 13.1 6.0 6.9 13.6 14.2 12.2 8.7 8.6 12.4 13.0 14.3 7.3 13.1 19.7 15.3 9.4 10.3 10.2 12.5 10.9 17.2 17.7 9.8 18.4 9.1 7.2 12.0 17.1 12.9 10.8 13.9 7.9 22.8 10.5 11.7 8.6 7.9 18.9 13.0 11.0 10.1 8.8 10.4 16.1 6.6 11.1 9.7 21.4 8.6 22.1 9.6 11.3 10.4 23.5 14.8 9.0 29.0 12.5 8.7 11.9 5.4 11.1 16.6 21.6 16.4 26.8 9.5 10.6 11.7 22.2 4.8 11.2 7.3 5.2 10.0 8.1 8.4 7.1 5.5 7.9 10.0 7.7 6.7 10.8 4.5 5.5 9.1 7.7 3.4 4.1 7.2 4.5 3.1 3.4 3.0 3.5 3.3 3.5 3.4 5.2 25.8 28.9 21.6 10.7 25.2 41.3 31.1 21.4 46.7 9.0 14.9 12.1 14.7 14.3 20.3 11.0 22.9 14.6 20.1 9.8 13.7 10.4 46.3 15.8 14.8 20.3 14.3 14.5 15.6 9.4 17.0 16.6 19.4 20.3 7.6 12.7 11.4 7.3 8.2 10.1 15.0 8.4 20.3 7.5 14.0 12.6 17.1 12.3 16.0 13.1 12.7 13.3 19.6 12.5 14.0 9.9 9.4 18.8 31.6 18.1 12.2 12.3 18.3 31.7 6.6 15.7 14.7 34.9 18.8 27.3 38.4 20.8 25.5 12.0 9.6 25.7 LRRC34 MGC27085 ENSG00000171757 "Leucine rich repeat containing 34" Q8IZ02 3 169793003-169812986 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 12.8" "Cell type enhanced" "Detected in many" "Early spermatids: 137.9;Respiratory ciliated cells: 129.6;Spermatocytes: 104.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 8.1;HL-60: 8.9;JURKAT: 7.1;NTERA-2: 7.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA035747 Approved Approved "Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 36: HEL - Hemostasis" "Cluster 49: Ciliated cells - Cilium organization" "Cell Junctions, Microtubules" "Cytokinetic bridge, Mitotic spindle" "HPA035747: AB_10670120" "unprognostic (1.04e-2)" "unprognostic (5.71e-2)" "unprognostic (5.67e-2)" "unprognostic (5.64e-2)" "unprognostic (9.74e-3)" "unprognostic (5.46e-2)" "unprognostic (9.74e-2)" "unprognostic (8.24e-2)" "unprognostic (6.39e-3)" "unprognostic (2.57e-1)" "unprognostic (6.05e-2)" "unprognostic (1.23e-1)" "unprognostic (8.39e-2)" "unprognostic (1.16e-2)" "unprognostic (3.48e-1)" "unprognostic (3.37e-1)" "unprognostic (2.79e-1)" 1.5 0.4 1.6 0.6 2.1 1.4 1.1 1.6 2.7 0.9 2.8 0.5 0.2 0.7 0.3 0.2 5.5 0.3 1.1 1.2 2.1 0.7 0.2 1.0 0.8 2.1 2.5 0.8 0.2 0.3 2.8 0.2 2.2 0.6 0.1 5.6 0.3 0.7 0.4 0.5 0.4 0.2 2.1 0.7 0.4 12.8 1.9 0.6 0.9 0.4 0.3 0.4 0.4 1.8 2.3 0.4 0.5 0.0 0.9 3.0 0.0 0.9 1.9 2.4 2.1 0.1 0.0 1.5 0.1 0.6 3.1 0.0 1.8 0.0 0.8 0.4 5.6 8.1 0.2 0.0 0.6 8.9 1.8 0.9 0.4 0.8 0.0 0.1 1.6 7.1 0.2 0.0 0.9 0.0 0.8 1.1 7.7 0.0 2.6 4.0 0.0 0.4 2.1 0.2 4.0 3.1 0.5 0.3 0.0 0.2 0.0 4.2 0.5 0.4 0.0 0.3 0.1 0.1 0.1 1.9 3.5 0.1 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.1 1.6 2.1 1.6 2.7 1.2 2.1 2.1 2.5 2.2 2.1 1.9 1.8 3.9 3.2 2.6 8.5 1.5 0.4 0.9 5.3 0.0 6.9 0.4 0.9 3.2 0.0 12.9 5.5 37.5 0.2 1.6 0.1 1.9 0.5 137.9 33.8 5.8 3.0 4.2 4.2 15.1 0.2 0.3 5.0 0.5 1.0 1.3 1.0 10.4 0.3 2.4 11.8 12.5 0.4 6.1 0.8 1.2 36.3 10.5 1.2 0.0 3.7 3.8 7.4 0.0 9.5 3.6 0.3 0.0 10.5 0.7 0.4 0.0 3.6 129.6 18.8 0.0 3.6 3.7 104.4 9.2 0.1 0.3 0.5 0.9 1.9 0.2 0.4 LRRIQ4 LRRC64 ENSG00000188306 "Leucine rich repeats and IQ motif containing 4" A6NIV6 3 169821922-169837775 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 2.9" "Group enriched" "Detected in some" 17 "Early spermatids: 42.8;Late spermatids: 27.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RT4: 1.6;T-47d: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036271, HPA036706" Uncertain Approved Mitochondria NA NA "Cluster 45: Intestine - Brush border" "Cluster 6: T47d - Mammary gland" "Cluster 29: Early spermatids - Spermatogenesis" Mitochondria "HPA036271: , HPA036706: AB_2675264" "unprognostic (5.09e-2)" "unprognostic (8.85e-2)" "unprognostic (2.55e-1)" "unprognostic (1.30e-4)" "unprognostic (5.26e-3)" "unprognostic (2.32e-2)" "unprognostic (2.04e-1)" "unprognostic (2.31e-1)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (9.72e-2)" "unprognostic (1.42e-1)" "unprognostic (2.12e-1)" "unprognostic (7.47e-2)" "unprognostic (1.55e-1)" "unprognostic (6.74e-2)" "unprognostic (4.56e-3)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 2.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.5 0.0 0.2 0.0 0.1 0.7 0.0 0.9 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.2 0.3 0.0 0.0 0.0 1.6 0.6 0.2 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 42.8 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 27.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 LRRC31 FLJ23259 ENSG00000114248 "Leucine rich repeat containing 31" Q6UY01 3 169839172-169869935 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 21.7;salivary gland: 6.5;stomach 1: 10.1" "Cell type enhanced" "Detected in some" "Distal enterocytes: 8.9;Enteroendocrine cells: 10.3;Intestinal goblet cells: 23.5;Paneth cells: 6.0;Undifferentiated cells: 5.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 4.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.9;HAP1: 1.4;OE19: 8.8;RPTEC TERT1: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA058013 Approved Nucleoplasm,Cytosol NA NA "Cluster 9: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm Cytosol "HPA058013: " "unprognostic (5.15e-2)" "unprognostic (5.75e-2)" "unprognostic (2.68e-2)" "unprognostic (1.49e-1)" "unprognostic (1.00e-1)" "unprognostic (9.90e-2)" "unprognostic (4.40e-2)" "unprognostic (7.90e-3)" "unprognostic (2.49e-2)" "unprognostic (1.64e-2)" "unprognostic (3.20e-4)" "unprognostic (3.14e-1)" "unprognostic (2.61e-1)" "unprognostic (2.27e-1)" "unprognostic (5.96e-3)" 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 1.4 0.0 17.5 8.4 0.1 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.1 5.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 21.7 0.1 6.5 0.0 0.0 0.0 9.6 0.4 0.0 0.1 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.8 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 1.0 0.3 0.0 10.3 0.0 0.3 0.0 0.0 0.0 3.1 3.0 0.0 0.0 0.0 2.4 0.1 0.0 0.2 23.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 6.0 0.0 0.0 0.1 2.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.4 SAMD7 DKFZp686E1583 ENSG00000187033 "Sterile alpha motif domain containing 7" Q7Z3H4 3 169911572-169939175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 646 "retina: 134.1" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 47.9;Rod photoreceptor cells: 124.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 79: Retina - Phototransduction" "Cluster 46: Photoreceptor cells - Phototransduction" "unprognostic (1.27e-3)" "unprognostic (5.46e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 134.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 1.0 0.1 0.0 0.0 6.2 0.0 0.0 0.1 0.0 0.0 0.0 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.3 0.0 0.0 0.0 7.6 0.1 0.0 0.0 0.0 124.9 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.0 0.0 0.2 SEC62 "Dtrp1, HTP1, TLOC1" ENSG00000008952 "SEC62 homolog, preprotein translocation factor" Q99442 3 169966635-169998373 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014059, HPA061450" Approved Approved "Endoplasmic reticulum,Intermediate filaments" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 6: Erythroid cells - Oxygen transport" "Endoplasmic reticulum" "Intermediate filaments" "HPA014059: AB_1858029, HPA061450: AB_2684524" "unprognostic (8.15e-2)" "unprognostic (6.84e-2)" "unprognostic (2.72e-1)" "unprognostic (4.93e-3)" "unprognostic (5.13e-1)" "unprognostic (1.10e-3)" "unprognostic (1.24e-1)" "unprognostic (4.04e-1)" "unprognostic (6.78e-2)" "unprognostic (5.97e-2)" "unprognostic (6.36e-2)" "unprognostic (3.15e-1)" "unprognostic (2.83e-2)" "unprognostic (4.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.20e-1)" "unprognostic (2.02e-1)" 104.9 86.5 82.9 58.6 94.3 94.4 64.5 88.1 120.6 74.4 74.6 60.9 58.5 74.7 131.9 44.4 52.3 58.5 49.1 81.8 108.1 118.6 193.7 67.6 63.3 94.9 97.7 75.9 116.5 109.7 41.5 71.0 97.9 82.5 56.6 128.9 130.4 83.5 55.3 27.4 59.4 68.3 95.5 83.5 91.1 34.6 92.3 51.1 120.9 60.2 67.0 63.7 31.7 99.9 140.4 96.6 74.2 66.3 217.9 114.7 46.7 175.5 128.3 80.0 82.5 104.0 143.9 156.8 190.7 125.9 132.5 130.3 92.3 84.8 124.7 123.1 89.2 108.6 57.2 105.6 157.9 111.6 68.5 115.0 79.7 88.0 85.3 108.8 80.1 47.3 68.0 147.2 96.3 117.2 58.9 59.0 76.4 110.8 62.5 77.6 107.6 212.8 115.1 88.5 76.1 71.9 143.7 155.8 125.3 71.3 233.5 101.0 107.8 113.1 51.0 95.6 143.1 168.8 134.9 240.8 118.5 85.1 108.0 17.2 34.8 62.3 44.2 37.1 49.2 77.6 40.6 43.5 30.9 82.1 50.9 46.6 52.0 31.8 29.0 35.1 39.1 27.6 82.9 94.3 88.1 120.6 81.8 108.1 94.9 97.7 97.9 95.5 92.3 99.9 419.0 237.2 291.5 64.6 362.7 254.4 252.8 511.1 144.0 362.0 223.3 278.5 582.1 320.3 431.7 680.5 277.3 218.7 209.5 144.7 195.6 256.4 31.6 302.9 424.8 363.7 261.1 874.1 79.3 347.6 215.0 396.3 104.5 455.3 293.5 105.2 463.7 1081.6 214.7 452.6 86.8 285.4 364.2 237.2 268.0 43.4 560.1 208.4 279.3 48.7 280.0 486.8 183.4 47.3 103.1 283.4 217.4 435.6 469.8 223.5 233.7 416.9 385.8 418.4 295.9 358.9 423.4 206.5 142.2 90.2 172.3 434.1 205.5 175.9 182.2 176.8 GPR160 "GPCR1, GPCR150" ENSG00000173890 "G protein-coupled receptor 160" Q9UJ42 3 170037995-170085392 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 107.9;parathyroid gland: 216.6" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 194.8;Proximal enterocytes: 362.1;Proximal tubular cells: 151.4;Rod photoreceptor cells: 153.2;Undifferentiated cells: 199.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 123.9;SK-BR-3: 95.8;THP-1: 197.2;U-266/70: 206.2;U-266/84: 127.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006970 Approved Supported "Plasma membrane" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 29: U-266 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "HPA006970: AB_1849275" "unprognostic (1.70e-1)" "unprognostic (5.08e-3)" "unprognostic (2.96e-2)" "unprognostic (2.39e-3)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (5.21e-2)" "prognostic favorable (1.21e-4)" "unprognostic (5.71e-3)" "unprognostic (1.35e-1)" "unprognostic (4.35e-2)" "unprognostic (1.77e-1)" "prognostic favorable (4.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.25e-1)" "unprognostic (1.43e-1)" "prognostic favorable (3.61e-4)" 12.2 1.7 0.7 15.9 1.0 107.9 22.5 1.0 1.6 11.2 0.9 72.0 73.8 5.8 57.9 2.9 5.4 18.6 1.0 0.6 0.7 59.8 4.1 15.0 27.9 1.4 0.9 0.6 18.4 216.6 1.4 4.1 1.1 26.7 72.6 104.7 19.3 6.3 1.3 1.2 98.6 4.4 0.8 25.2 43.0 5.2 0.9 9.5 6.7 2.7 30.4 26.8 1.0 1.2 64.2 1.5 0.3 0.5 0.3 0.4 15.6 0.4 0.5 0.4 1.9 11.7 8.1 29.4 12.9 0.6 4.0 0.7 8.8 0.5 1.0 45.9 17.7 19.1 1.0 24.3 0.2 38.2 24.8 0.2 0.9 2.0 2.3 2.8 1.4 13.7 6.4 73.9 0.4 41.5 2.9 8.4 10.3 39.1 2.4 5.3 1.1 123.9 32.3 86.8 6.1 1.8 0.8 95.8 4.5 8.2 55.9 197.2 1.9 0.2 0.4 7.1 4.8 206.2 127.9 51.4 0.8 40.3 2.8 2.9 1.1 9.3 0.5 0.4 1.0 8.0 1.0 0.4 2.4 12.3 3.0 1.1 11.3 0.4 0.2 3.2 0.3 1.2 0.7 1.0 1.0 1.6 0.6 0.7 1.4 0.9 1.1 0.8 0.9 1.2 35.2 9.6 51.1 0.7 25.9 0.4 3.2 4.1 0.0 9.5 48.5 18.3 1.0 28.6 22.7 62.5 39.6 3.1 11.6 88.9 54.8 10.3 33.7 20.6 4.4 8.7 194.8 0.4 1.5 72.0 21.1 1.0 50.0 54.0 1.3 0.1 20.0 0.9 7.4 15.2 0.6 133.9 18.3 11.7 11.2 36.3 0.6 17.0 28.4 7.5 62.3 16.6 0.0 1.0 0.9 60.3 118.6 0.4 56.8 25.4 362.1 151.4 27.9 153.2 0.0 0.8 1.4 7.4 13.1 0.9 0.9 27.2 4.2 1.2 199.7 35.5 PHC3 "EDR3, FLJ12729, FLJ12967, HPH3" ENSG00000173889 "Polyhomeotic homolog 3" Q8NDX5 3 170086732-170181749 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 156.5;Rod photoreceptor cells: 126.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039162, HPA062031" Approved Supported Nucleoplasm NA NA "Cluster 24: B-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA039162: AB_10671038, HPA062031: AB_2684666" "unprognostic (4.57e-2)" "unprognostic (1.03e-1)" "unprognostic (2.60e-1)" "unprognostic (4.85e-3)" "unprognostic (2.48e-1)" "unprognostic (1.18e-1)" "unprognostic (5.04e-2)" "unprognostic (1.19e-2)" "unprognostic (8.71e-2)" "unprognostic (2.28e-1)" "unprognostic (1.34e-3)" "unprognostic (3.26e-2)" "unprognostic (3.70e-1)" "unprognostic (1.54e-1)" "unprognostic (1.92e-1)" "unprognostic (9.58e-3)" "unprognostic (2.76e-2)" 9.1 7.4 3.7 12.7 9.1 50.8 10.5 29.3 8.9 9.0 6.3 10.5 11.2 12.2 8.1 12.4 10.2 12.9 8.1 2.0 14.3 9.7 8.7 9.7 18.1 6.5 2.9 14.9 11.3 15.1 5.4 8.4 7.8 11.6 11.3 42.0 8.9 8.6 8.7 8.5 12.3 13.5 0.0 13.9 11.8 11.5 5.5 16.8 16.6 14.0 14.1 11.8 7.4 14.0 35.0 32.3 6.9 11.6 19.2 19.4 12.8 14.6 16.5 14.8 18.2 21.6 17.0 16.5 34.8 20.5 19.7 17.1 15.3 14.1 26.6 38.3 14.2 28.5 30.2 10.0 11.3 35.4 14.8 14.0 8.1 22.1 31.0 10.9 11.1 12.7 6.9 45.0 14.6 32.3 16.2 7.4 7.2 11.3 11.9 12.0 29.5 24.0 7.4 38.7 7.5 4.6 48.1 29.8 9.8 4.5 34.6 27.0 22.3 20.5 12.1 17.1 25.4 43.0 37.6 48.1 12.8 13.1 12.6 9.5 7.0 25.7 16.2 11.2 13.8 16.8 15.2 14.1 7.8 21.6 15.6 13.8 10.2 13.3 7.3 26.0 20.2 7.5 3.7 9.1 29.3 8.9 2.0 14.3 6.5 2.9 7.8 0.0 5.5 14.0 26.8 22.4 31.9 77.4 46.2 14.1 16.9 16.1 19.9 36.3 16.4 12.1 22.7 18.6 18.7 27.6 60.5 15.5 45.9 11.1 0.0 8.9 5.5 18.7 34.5 21.3 7.8 28.8 108.2 7.5 9.6 25.1 25.0 19.0 12.7 35.9 19.6 17.8 11.1 53.8 103.2 14.1 16.2 21.6 22.6 3.8 29.5 22.5 19.6 105.9 25.5 21.9 32.0 103.0 156.5 10.4 16.7 27.8 45.6 22.8 16.4 10.7 24.1 126.2 6.6 29.8 26.4 21.0 19.3 17.8 15.9 18.3 40.4 25.7 14.4 19.6 PRKCI "DXS1179E, PKCI" ENSG00000163558 "Protein kinase C iota" P41743 3 170222424-170305977 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026574, HPA038635" Approved Supported "Microtubules,Cytokinetic bridge,Cytosol" Yes No "Cluster 15: NK-cells - Transcription" "Cluster 46: Fibroblasts - ECM organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Cytosol "Microtubules, Cytokinetic bridge" "HPA026574: AB_1855428, HPA038635: AB_2676124" "unprognostic (2.26e-1)" "unprognostic (6.75e-2)" "unprognostic (4.57e-2)" "prognostic unfavorable (3.93e-6)" "unprognostic (1.59e-1)" "unprognostic (1.84e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (2.52e-1)" "unprognostic (7.10e-2)" "unprognostic (1.73e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (5.32e-3)" "prognostic favorable (3.10e-4)" "unprognostic (1.16e-1)" "unprognostic (2.65e-1)" "unprognostic (1.06e-1)" "unprognostic (9.73e-2)" 6.7 5.0 2.0 6.9 2.4 2.6 10.4 2.0 3.2 12.7 0.3 12.4 11.6 11.0 8.2 15.1 15.9 11.4 6.9 3.4 1.1 13.5 7.3 16.6 4.6 0.4 0.2 13.6 7.0 13.0 3.1 10.9 0.5 17.3 13.1 6.2 17.5 12.7 6.2 6.9 10.8 11.0 0.2 5.2 34.5 12.5 0.9 10.9 24.5 9.8 10.4 16.1 6.2 1.1 81.6 20.2 20.0 21.6 17.3 23.9 32.2 20.4 29.9 26.4 28.3 29.7 38.6 24.7 65.3 28.8 36.4 37.3 37.9 40.0 44.8 18.2 23.5 22.9 24.3 16.6 27.9 20.9 10.0 21.8 27.5 22.6 35.1 42.8 20.9 13.3 25.8 19.8 27.4 28.0 30.5 8.5 42.3 86.4 22.1 21.8 30.7 41.2 42.3 24.4 31.5 25.8 44.1 57.7 20.0 29.5 63.0 14.5 22.4 27.5 21.1 26.0 34.3 33.9 34.9 35.2 19.8 16.4 11.0 0.0 0.6 0.4 1.1 0.6 1.7 0.9 1.5 2.0 0.8 1.2 1.6 0.9 0.3 2.6 0.5 0.8 1.1 0.7 2.0 2.4 2.0 3.2 3.4 1.1 0.4 0.2 0.5 0.2 0.9 1.1 17.6 73.7 82.1 23.2 5.8 57.1 49.5 39.8 30.7 16.4 29.0 19.7 16.2 24.3 45.3 49.7 14.6 30.2 15.0 29.0 25.4 16.5 8.4 42.0 29.7 20.5 29.3 10.5 77.2 22.0 26.6 32.2 59.7 72.3 8.8 20.4 17.5 17.7 10.0 15.2 55.2 28.3 50.8 18.6 26.8 6.8 23.3 11.6 17.8 22.5 12.7 8.8 6.2 33.2 33.5 55.2 18.6 28.6 29.4 99.4 18.7 20.4 31.9 9.4 19.7 23.7 18.7 15.8 20.6 38.5 63.6 20.7 14.8 14.3 28.5 80.1 SKIL "SNO, SnoA, SnoN" ENSG00000136603 "SKI like proto-oncogene" P12757 3 170357678-170396835 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008472, HPA014233" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA008472: AB_1856933, HPA014233: " "unprognostic (5.50e-2)" "unprognostic (1.71e-2)" "unprognostic (3.95e-2)" "unprognostic (3.51e-3)" "unprognostic (7.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.21e-2)" "unprognostic (1.68e-2)" "unprognostic (2.52e-2)" "unprognostic (7.79e-2)" "unprognostic (2.26e-3)" "unprognostic (3.25e-2)" "prognostic unfavorable (1.19e-7)" "unprognostic (2.94e-2)" "unprognostic (7.34e-2)" "unprognostic (8.73e-2)" "unprognostic (3.34e-1)" 11.9 12.0 6.1 18.8 7.3 23.1 9.0 8.5 10.0 9.4 8.3 10.4 13.8 12.0 8.2 9.2 6.4 21.1 12.0 6.6 10.9 10.3 15.6 16.1 13.8 10.7 10.8 9.2 9.6 5.7 11.0 13.9 10.5 11.6 9.7 9.6 7.4 8.9 11.0 5.8 14.2 10.5 12.0 7.2 15.9 13.0 11.4 9.2 11.3 21.4 18.4 14.6 8.8 13.2 19.9 24.0 15.6 10.4 20.0 8.7 29.1 19.6 13.6 13.8 10.6 4.9 42.2 24.9 60.5 18.2 23.1 44.8 9.9 9.0 21.3 43.6 9.2 32.8 24.8 11.0 17.8 13.7 17.4 15.3 8.8 19.9 15.0 42.9 34.1 2.4 14.7 27.9 28.4 21.3 5.9 4.5 61.2 21.8 8.1 13.6 52.8 5.0 20.8 31.7 11.5 14.1 48.3 47.4 10.3 31.6 32.2 14.2 66.1 38.2 35.9 33.0 37.1 36.2 18.6 47.3 14.3 7.1 18.3 3.1 3.4 1.8 1.3 8.3 1.8 3.6 1.1 1.7 2.4 4.4 1.9 2.0 4.0 2.8 10.3 1.6 0.5 1.9 6.1 7.3 8.5 10.0 6.6 10.9 10.7 10.8 10.5 12.0 11.4 13.2 104.1 73.7 72.8 21.2 142.1 72.7 88.8 52.5 67.7 25.6 79.3 38.1 12.4 21.5 70.4 35.0 54.2 14.8 124.9 45.9 15.6 56.7 115.7 118.4 80.9 86.0 23.8 3.0 48.6 111.4 58.3 100.6 93.8 102.0 204.8 46.3 72.5 32.0 26.3 53.8 21.6 62.4 22.4 65.4 85.2 35.8 37.9 121.7 35.6 60.0 42.1 12.7 14.4 26.2 27.5 176.5 29.1 68.1 104.3 43.5 41.3 45.9 82.1 30.5 26.3 143.6 63.6 53.9 37.6 61.3 96.0 41.2 81.5 17.5 31.3 117.8 CLDN11 "OSP, OTM" ENSG00000013297 "Claudin 11" O75508 3 170418868-170454733 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 130.1;ovary: 95.4;testis: 116.9" "Cell type enhanced" "Detected in many" "Fibroblasts: 56.4;Leydig cells: 105.3;Oligodendrocytes: 394.5;Peritubular cells: 67.7" "Cancer enhanced" "Detected in many" "glioma: 11.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 141.3;ASC TERT1: 174.2;EFO-21: 91.8;HUVEC TERT2: 162.2;TIME: 252.1" "Region enriched" "Detected in all" 5 "white matter: 2084.8" "CAB009789, HPA013166, HPA013657" Enhanced Supported "Lipid droplets,Cell Junctions" NA NA "Cluster 21: Non-specific - Transcription" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 33: Fibroblasts - ECM organization" "Cell Junctions" "Lipid droplets" "CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: " "prognostic favorable (6.31e-4)" "unprognostic (3.18e-1)" "unprognostic (2.32e-2)" "unprognostic (5.28e-4)" "unprognostic (3.45e-2)" "unprognostic (4.60e-1)" "unprognostic (5.25e-2)" "unprognostic (5.40e-2)" "unprognostic (2.52e-1)" "unprognostic (1.40e-1)" "unprognostic (1.03e-1)" "unprognostic (5.48e-2)" "unprognostic (8.70e-11)" "unprognostic (2.50e-3)" "unprognostic (1.93e-1)" "unprognostic (6.68e-3)" "unprognostic (2.29e-1)" 29.9 5.4 18.8 0.0 51.7 0.0 15.3 48.7 36.5 6.7 4.4 7.6 0.1 8.1 1.5 5.1 18.0 8.7 7.8 22.7 34.6 6.4 2.2 4.8 0.2 130.1 44.2 95.4 0.8 0.0 20.9 1.2 88.6 11.2 0.3 0.2 5.2 1.0 1.5 6.5 6.6 0.4 52.5 1.2 3.1 116.9 47.4 0.0 1.8 0.7 0.1 13.2 13.2 94.6 0.0 0.0 0.1 0.0 141.3 174.2 0.0 1.2 8.5 11.0 19.6 0.0 19.2 0.0 91.8 14.2 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 10.6 42.8 0.0 0.0 61.0 0.0 60.9 0.0 0.4 162.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 4.6 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 252.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 51.7 48.7 36.5 22.7 34.6 130.1 44.2 88.6 52.5 47.4 94.6 16.4 0.0 0.6 2.3 0.4 14.4 15.6 1.0 0.0 0.5 5.7 27.7 1.4 1.5 0.1 1.8 0.0 0.9 0.8 0.3 0.0 0.1 8.3 0.5 0.2 37.3 0.0 2.7 1.5 0.0 1.6 56.4 0.0 0.6 0.0 27.2 49.2 1.1 0.9 0.0 2.8 0.0 0.0 1.2 23.8 24.3 105.3 1.1 14.2 24.4 0.0 0.4 0.0 3.5 394.5 0.7 0.0 67.7 0.0 15.4 0.2 0.2 0.2 0.1 0.0 2.9 6.6 11.6 4.1 1.0 10.2 0.8 0.6 1.6 0.1 2.0 AC026316.4 ENSG00000285218 "Novel protein" 3 170418868-170860380 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 11 "brain: 43.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 5.1" "Low region specificity" "Detected in all" NA NA "Cluster 7: SCLC-21H - Neuronal signaling" 1.2 1.3 8.3 1.3 18.3 4.0 0.9 13.8 15.1 0.2 2.3 0.6 1.0 1.1 1.2 1.1 0.6 1.2 1.0 9.9 10.2 0.9 0.8 0.8 1.1 20.8 12.7 3.1 0.5 0.4 0.7 20.9 1.6 0.4 1.6 1.8 0.7 0.9 2.2 1.1 0.7 14.9 0.8 0.6 3.7 14.8 0.1 0.6 0.1 0.6 0.3 43.0 0.7 1.1 0.7 1.0 0.4 0.4 0.9 1.3 0.7 0.3 0.0 0.2 3.0 0.9 3.0 0.6 0.4 1.2 0.0 0.0 0.2 0.9 0.7 1.4 1.7 1.4 0.0 0.7 1.2 0.5 0.1 0.5 0.1 0.4 0.3 0.7 0.5 0.8 0.2 0.2 0.3 1.1 2.4 1.0 1.4 0.6 0.2 0.2 0.3 0.8 5.1 0.5 0.6 0.6 0.4 0.8 0.5 0.2 1.9 0.5 1.0 3.4 0.2 0.6 0.7 0.5 0.4 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.0 8.3 18.3 13.8 15.1 9.9 10.2 20.8 12.7 20.9 14.9 14.8 43.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC7A14 "KIAA1613, PPP1R142" ENSG00000013293 "Solute carrier family 7 member 14" Q8TBB6 3 170459548-170586075 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 15.9;pituitary gland: 7.3;retina: 6.1" "Group enriched" "Detected in some" 5 "Bipolar cells: 28.4;Excitatory neurons: 61.9;Horizontal cells: 28.6;Inhibitory neurons: 90.2;Oligodendrocytes: 67.4" "Group enriched" "Detected in some" 11 "glioma: 0.8;pancreatic cancer: 0.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 3.2;SCLC-21H: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045929 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Vesicles, Cytosol" "Nucleoplasm, Plasma membrane" "HPA045929: AB_2679501" "unprognostic (1.00e-1)" "unprognostic (9.56e-2)" "unprognostic (1.03e-1)" "unprognostic (4.15e-2)" "unprognostic (1.43e-2)" "unprognostic (7.46e-2)" "unprognostic (9.16e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-1)" "unprognostic (6.68e-3)" "unprognostic (6.36e-2)" "unprognostic (3.03e-6)" "unprognostic (1.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.71e-2)" "unprognostic (3.24e-3)" 0.0 2.3 8.9 0.4 8.1 0.1 0.0 5.5 8.8 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 0.0 7.9 15.9 0.1 0.0 0.0 0.0 15.6 6.4 0.1 0.7 0.0 7.3 0.0 14.9 0.1 0.4 6.1 0.0 0.0 0.1 0.1 0.3 0.1 4.0 0.0 0.2 0.1 8.9 0.0 0.0 0.0 0.0 0.0 0.1 7.7 0.0 0.0 0.1 0.0 0.5 0.9 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.9 8.1 5.5 8.8 7.9 15.9 15.6 6.4 14.9 4.0 8.9 7.7 0.8 3.2 2.2 4.6 0.1 0.4 0.3 0.1 0.0 28.4 0.1 0.0 1.0 0.0 2.5 0.0 2.1 0.1 0.1 0.0 0.0 0.0 0.6 0.2 0.2 0.5 1.8 0.0 61.9 0.0 0.1 0.4 0.0 0.1 2.5 0.1 0.4 0.9 0.0 28.6 90.2 0.1 0.0 0.0 1.2 0.6 2.1 0.4 3.6 6.5 0.0 1.8 0.0 9.5 67.4 0.1 1.2 2.6 0.1 0.3 0.1 0.2 3.0 4.3 0.0 0.7 0.5 0.0 0.2 0.0 0.6 0.0 0.4 0.1 0.0 0.2 RPL22L1 ENSG00000163584 "Ribosomal protein L22 like 1" Q6P5R6 3 170864875-170870208 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 651.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC TERT1: 912.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048060, HPA056207, HPA068294" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA048060: AB_2732544, HPA056207: AB_2683065, HPA068294: AB_2732781" "unprognostic (1.99e-1)" "unprognostic (3.45e-1)" "unprognostic (2.59e-1)" "unprognostic (1.45e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-3)" "unprognostic (1.01e-2)" "unprognostic (9.50e-2)" "unprognostic (1.97e-1)" "prognostic favorable (8.60e-5)" "unprognostic (1.17e-3)" "unprognostic (4.52e-2)" "prognostic unfavorable (5.13e-12)" "unprognostic (5.12e-2)" "unprognostic (3.55e-1)" "unprognostic (1.23e-1)" "unprognostic (6.96e-2)" 41.4 32.0 10.4 64.2 12.0 93.6 46.7 10.7 20.6 25.6 9.8 36.1 19.0 24.8 17.8 75.3 32.3 17.2 23.5 10.4 11.6 27.4 47.9 25.9 75.3 11.9 11.5 34.0 47.5 8.3 22.4 17.2 12.1 25.1 33.0 7.7 34.2 15.7 9.9 46.6 32.9 26.5 11.4 67.4 38.6 13.7 11.8 39.8 16.9 6.2 63.2 61.3 38.0 16.4 153.8 169.2 54.4 632.1 156.8 912.4 165.5 152.9 349.5 121.7 78.4 72.8 34.8 472.8 34.5 143.1 379.6 39.3 136.4 390.2 67.7 28.8 24.7 43.2 21.4 166.4 632.4 88.7 60.1 670.6 775.2 38.9 409.7 189.0 418.9 257.7 30.4 29.8 672.0 194.3 650.6 49.7 849.1 58.6 31.0 857.7 19.4 72.7 305.4 337.4 9.2 45.7 15.4 75.6 72.1 29.2 105.6 77.2 196.3 23.3 175.9 47.2 216.8 47.1 36.0 76.2 420.5 53.7 489.4 2.2 9.5 4.3 13.2 12.6 26.9 47.1 19.4 17.9 10.7 34.8 12.9 14.5 2.1 28.8 17.8 51.2 13.1 6.9 10.4 12.0 10.7 20.6 10.4 11.6 11.9 11.5 12.1 11.4 11.8 16.4 153.2 9.6 43.7 4.6 379.6 197.6 240.2 260.8 198.6 13.9 185.1 397.2 18.1 55.8 111.4 20.2 4.2 89.8 241.9 111.5 66.5 160.8 37.6 128.4 279.6 138.5 144.6 266.7 3.3 232.3 297.4 169.0 146.3 116.8 106.5 202.8 103.9 129.5 184.7 8.4 4.5 240.7 93.6 187.4 101.4 36.3 139.4 148.9 78.2 2.8 108.7 54.2 69.0 7.5 10.1 400.8 137.1 89.1 651.0 421.5 99.1 94.1 60.5 21.0 46.0 189.5 472.0 67.2 58.9 511.7 247.8 98.4 173.7 260.4 197.5 356.3 EIF5A2 ENSG00000163577 "Eukaryotic translation initiation factor 5A2" Q9GZV4 3 170888418-170908644 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport" "Elongation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 28.3" "Group enriched" "Detected in many" 12 "Early spermatids: 353.0;Late spermatids: 977.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029090 Approved Supported Vesicles NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 78: Testis - Spermatogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 34: Spermatids - Unknown function" Vesicles "HPA029090: AB_10671359" "unprognostic (2.41e-1)" "unprognostic (2.42e-1)" "unprognostic (4.05e-1)" "unprognostic (5.75e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (7.42e-4)" "unprognostic (1.11e-3)" "unprognostic (1.47e-1)" "unprognostic (3.72e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" "unprognostic (1.79e-1)" "unprognostic (2.66e-2)" "unprognostic (3.45e-2)" "unprognostic (5.92e-2)" "unprognostic (1.64e-2)" "unprognostic (4.29e-3)" 4.1 2.7 1.9 3.1 2.8 4.2 2.9 5.8 6.1 3.1 1.9 3.4 1.7 4.5 1.3 2.9 2.4 3.5 4.0 1.9 5.4 5.0 1.6 2.2 2.8 7.2 4.6 4.4 3.3 3.7 1.8 1.8 8.2 2.6 2.6 2.8 1.9 3.0 1.3 1.9 1.6 7.2 4.1 2.3 9.1 28.3 5.5 4.3 2.2 3.1 3.1 3.5 2.0 7.2 22.7 11.6 4.2 5.9 21.7 14.2 10.0 17.1 22.3 17.4 25.1 23.6 14.4 14.2 30.9 23.4 38.9 7.4 13.4 6.0 21.9 15.8 5.8 6.9 4.6 7.5 14.6 18.2 19.9 16.6 8.7 26.3 21.4 24.2 9.1 3.7 5.8 0.1 28.7 7.6 8.1 7.9 8.1 17.5 7.8 0.0 12.0 0.0 7.3 4.0 3.4 6.4 17.7 4.6 14.4 6.5 10.0 11.9 12.0 21.2 15.0 44.8 38.9 21.6 0.3 33.3 7.2 6.2 15.4 14.9 1.4 1.5 12.4 1.5 8.7 2.2 8.4 11.9 1.0 3.5 5.0 8.3 0.7 8.8 1.4 1.0 11.3 5.0 1.9 2.8 5.8 6.1 1.9 5.4 7.2 4.6 8.2 4.1 5.5 7.2 16.6 0.0 0.5 4.9 4.4 17.1 8.5 7.8 10.8 2.5 2.1 2.7 9.5 0.0 1.8 1.8 0.0 1.2 18.1 1.6 1.9 6.4 353.0 0.9 7.7 12.8 4.9 2.1 7.1 7.5 1.9 11.7 8.6 0.6 2.5 2.6 3.3 2.5 8.9 0.0 8.8 0.8 2.0 3.8 7.2 977.9 12.8 4.5 10.6 3.7 7.9 8.0 28.8 4.0 10.1 19.6 6.1 11.3 3.7 8.2 1.7 21.1 3.4 2.7 46.0 9.6 11.6 54.3 10.0 2.3 21.6 0.7 15.7 2.2 1.8 5.7 SLC2A2 GLUT2 ENSG00000163581 "Solute carrier family 2 member 2" P11168 3 170996347-171026743 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "liver: 836.1" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 457.6" "Cancer enriched" "Detected in some" 12 "liver cancer: 105.2" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 55 "CACO-2: 7.7;Hep G2: 27.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB010444, HPA028997" Enhanced Supported "Plasma membrane" NA NA "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "Plasma membrane" "CAB010444: AB_641068, HPA028997: AB_2672860" "unprognostic (9.56e-2)" "unprognostic (1.24e-1)" "prognostic favorable (2.63e-5)" "unprognostic (3.10e-1)" "unprognostic (1.02e-1)" "unprognostic (2.95e-2)" "unprognostic (6.31e-2)" 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.2 0.4 0.0 0.2 0.0 66.1 0.0 0.0 0.0 0.0 5.2 0.0 0.3 0.3 30.8 836.1 0.0 0.0 0.5 0.4 0.0 2.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 27.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.2 0.4 0.3 0.3 0.5 0.4 0.8 0.4 0.4 2.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 90.1 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.2 6.7 0.0 0.0 0.1 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 457.6 0.0 0.0 0.1 3.0 0.0 10.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 2.5 0.0 0.0 0.0 105.4 63.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 1.8 0.0 TNIK KIAA0551 ENSG00000154310 "TRAF2 and NCK interacting kinase" Q9UKE5 3 171058414-171460408 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Neurogenesis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.7" "Cell type enhanced" "Detected in many" "Astrocytes: 1074.4;Excitatory neurons: 248.4;Inhibitory neurons: 360.8;Oligodendrocyte precursor cells: 374.5;Oligodendrocytes: 205.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 65.2;HMC-1: 71.3;WM-115: 52.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012128, HPA012297" Approved Supported Nucleoplasm,Cytosol NA NA 160000 "Cluster 52: Eosinophils - Transcription" "Cluster 10: Brain - Neuronal signaling" "Cluster 3: HMC-1 - Innate immune response" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm Cytosol "HPA012128: AB_1858226, HPA012297: AB_1858225" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (1.32e-1)" "unprognostic (5.90e-2)" "unprognostic (5.25e-2)" "unprognostic (9.23e-2)" "unprognostic (4.91e-2)" "unprognostic (2.41e-3)" "unprognostic (1.91e-1)" "unprognostic (7.81e-2)" "unprognostic (5.91e-2)" "unprognostic (1.96e-2)" "unprognostic (3.34e-3)" "unprognostic (2.41e-1)" "unprognostic (1.64e-1)" "unprognostic (2.13e-2)" "unprognostic (3.97e-2)" 1.4 4.4 25.7 6.2 33.7 4.4 2.1 4.1 17.5 1.3 0.0 8.2 21.0 3.4 0.9 4.1 2.8 5.1 9.4 20.8 15.7 3.8 3.1 8.9 6.7 25.5 18.7 1.5 3.7 0.5 8.4 1.9 6.3 3.5 6.7 19.4 1.9 4.6 23.2 1.0 21.3 4.3 19.0 4.5 7.0 7.7 20.1 7.0 6.3 23.6 5.3 4.8 2.1 10.7 0.9 1.2 43.4 4.7 0.8 0.1 10.4 9.3 2.5 7.3 4.8 41.5 16.9 0.0 3.4 9.0 6.9 14.1 6.3 2.6 7.3 0.3 9.8 65.2 3.7 0.0 19.0 13.0 71.3 6.1 5.9 4.3 0.9 15.7 43.6 10.5 23.3 0.1 1.1 1.1 4.1 13.5 18.2 30.6 17.9 0.0 11.8 16.6 12.0 0.1 2.1 2.3 5.8 0.4 9.6 4.1 20.4 2.9 0.5 0.0 7.9 20.5 7.1 0.1 0.0 0.1 1.8 13.8 52.1 4.6 0.1 10.5 3.5 0.0 4.4 0.0 4.2 3.2 0.0 0.2 5.8 3.1 0.1 2.4 0.1 0.0 5.3 1.0 25.7 33.7 4.1 17.5 20.8 15.7 25.5 18.7 6.3 19.0 20.1 10.7 0.7 6.4 50.4 1074.4 4.9 2.5 1.6 1.3 9.1 19.2 8.4 6.5 28.6 21.5 7.1 9.2 14.6 6.3 32.5 19.6 5.9 12.1 48.6 1.1 2.5 1.6 13.2 13.5 248.4 7.7 1.3 9.1 21.4 0.3 83.5 0.4 2.5 8.1 2.9 0.0 360.8 10.3 0.0 6.5 1.9 38.0 2.5 10.4 1.8 57.1 1.6 65.0 51.5 374.5 205.5 7.1 21.6 6.4 11.7 0.7 56.2 17.3 1.8 28.7 0.0 12.4 6.2 3.1 1.0 10.3 1.6 2.5 47.4 9.9 16.6 3.2 PLD1 ENSG00000075651 "Phospholipase D1" Q13393 3 171600404-171810950 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 86.8" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 519.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 57.5;SK-MEL-30: 31.1;TIME: 50.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004527, HPA042396, HPA066938" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 10: Basophils - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles Nucleoplasm "CAB004527: AB_677324, HPA042396: AB_2677977, HPA066938: " "unprognostic (3.23e-1)" "unprognostic (3.27e-1)" "unprognostic (5.82e-2)" "unprognostic (5.13e-2)" "unprognostic (4.58e-1)" "unprognostic (4.76e-2)" "unprognostic (9.03e-2)" "unprognostic (1.46e-1)" "unprognostic (6.23e-2)" "unprognostic (8.02e-2)" "unprognostic (2.06e-2)" "unprognostic (2.95e-2)" "unprognostic (1.23e-1)" "unprognostic (1.29e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.76e-6)" 7.8 26.4 9.2 6.6 24.7 7.8 7.5 18.4 13.6 10.4 4.5 14.6 46.9 6.2 2.8 33.0 6.4 86.8 24.4 10.5 14.3 12.0 33.7 4.7 9.1 24.8 22.0 24.2 21.2 1.6 2.3 10.7 23.5 3.4 14.7 0.5 13.8 6.0 2.5 29.2 43.9 4.8 14.7 15.7 8.2 5.0 19.0 4.1 3.7 6.8 10.8 5.1 12.4 41.4 4.5 7.2 3.7 1.4 11.2 12.6 7.7 2.3 9.9 3.5 4.3 1.1 6.4 0.0 17.0 0.9 24.0 15.2 0.6 2.0 5.7 3.6 3.2 4.2 11.5 26.1 4.9 7.3 18.9 4.9 10.9 4.2 2.0 10.0 57.5 1.2 2.8 0.0 0.9 1.3 0.0 6.4 0.8 11.9 5.1 0.2 1.5 0.1 8.9 1.8 0.1 0.1 7.9 4.7 31.1 5.1 9.0 9.7 50.7 1.5 5.7 4.0 2.5 9.6 8.2 0.1 6.7 8.6 1.9 8.3 1.8 2.3 0.3 1.1 2.6 0.0 0.2 0.6 0.6 0.0 0.0 0.1 1.0 2.2 0.4 0.0 0.8 0.6 9.2 24.7 18.4 13.6 10.5 14.3 24.8 22.0 23.5 14.7 19.0 41.4 7.7 0.0 4.7 2.0 0.9 7.1 3.4 11.0 10.8 0.4 4.9 5.6 33.6 57.2 11.1 1.8 0.0 3.0 1.9 37.5 3.9 8.4 13.1 1.0 4.8 7.4 4.2 6.3 8.9 3.4 3.7 15.7 27.0 1.3 27.9 10.4 6.4 15.9 20.0 0.0 12.1 23.6 6.1 13.2 2.4 9.5 10.5 10.2 12.4 98.4 5.4 0.0 1.0 12.5 519.6 2.4 18.3 4.5 3.4 0.7 38.3 48.0 9.9 0.1 19.7 3.8 8.4 6.1 5.3 93.5 34.9 2.3 2.3 12.1 17.8 4.7 TMEM212 FLJ23172 ENSG00000186329 "Transmembrane protein 212" A6NML5 3 171843349-171938715 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 15.8;fallopian tube: 30.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 35.3;Alveolar cells type 2: 30.9;Club cells: 25.8;granulocytes: 15.2;Respiratory ciliated cells: 102.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045736 Approved "Nucleoli fibrillar center,Endoplasmic reticulum" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA045736: AB_2679436" "unprognostic (3.39e-2)" "unprognostic (1.78e-2)" "unprognostic (3.05e-1)" "unprognostic (5.54e-2)" "unprognostic (3.06e-1)" "unprognostic (2.87e-1)" 1.0 0.9 2.6 1.5 5.7 3.8 0.9 15.8 12.9 0.9 0.8 1.9 1.0 1.7 1.6 0.6 30.2 1.1 0.9 4.9 0.6 0.8 6.5 4.2 1.6 0.6 1.7 1.4 0.9 0.8 0.0 1.2 1.3 1.1 1.9 7.9 1.4 0.6 2.6 2.7 1.4 0.5 0.0 1.5 1.2 2.8 3.1 0.6 1.3 0.3 1.0 0.6 0.0 10.8 2.1 1.5 1.5 1.5 0.4 0.1 3.0 1.2 0.5 0.6 0.6 1.3 1.7 3.0 1.5 0.9 1.4 1.4 1.0 0.8 1.4 4.3 1.4 2.7 4.5 1.5 0.2 2.4 2.2 0.7 0.6 0.8 0.6 0.7 0.8 1.8 2.2 4.5 0.5 1.7 1.7 2.2 2.4 0.9 1.3 1.4 2.1 2.2 0.6 2.2 1.9 1.6 2.1 1.6 1.1 1.4 1.6 1.6 3.6 2.0 2.4 3.4 1.5 2.7 2.3 1.8 1.1 1.4 1.1 3.2 0.7 0.6 0.8 0.6 0.6 0.5 0.5 0.5 0.3 1.1 0.6 0.7 1.5 1.2 0.7 1.1 0.4 0.2 2.6 5.7 15.8 12.9 4.9 0.6 0.6 1.7 1.3 0.0 3.1 10.8 0.0 35.3 30.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 25.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 9.2 0.2 3.6 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.1 15.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.5 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 102.7 0.0 0.0 0.3 0.3 0.7 0.5 0.0 0.1 0.0 1.8 0.0 0.0 0.1 FNDC3B "DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421" ENSG00000075420 "Fibronectin type III domain containing 3B" Q53EP0 3 172039578-172401669 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 283.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebral cortex: 29.4;hypothalamus: 8.2;pons: 9.4;thalamus: 14.4" "Immune cell enhanced" "Detected in many" "neutrophil: 37.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 37.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007859 Uncertain Approved "Endoplasmic reticulum" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA007859: AB_1078900" "unprognostic (7.18e-2)" "prognostic unfavorable (2.41e-5)" "unprognostic (6.03e-2)" "unprognostic (6.38e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (3.25e-2)" "prognostic unfavorable (9.85e-4)" "unprognostic (2.17e-3)" "unprognostic (1.98e-1)" "unprognostic (2.46e-2)" "prognostic unfavorable (9.06e-5)" "unprognostic (3.50e-2)" "prognostic unfavorable (5.65e-7)" "unprognostic (4.35e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-2)" "unprognostic (3.00e-2)" 34.4 25.5 1.1 26.3 1.1 37.0 16.6 0.6 29.4 26.0 11.9 19.8 13.0 21.9 18.2 9.2 12.5 19.4 24.4 3.5 8.2 17.5 28.5 21.8 8.9 3.3 3.4 22.8 28.3 15.0 8.5 52.7 9.4 12.9 19.6 4.4 21.3 15.6 21.2 7.0 11.4 25.4 0.7 14.7 20.6 9.3 14.4 6.8 32.4 18.5 11.0 38.6 9.5 1.9 47.4 55.9 36.0 43.5 107.6 73.6 87.6 68.3 73.1 43.3 58.3 30.5 100.5 4.2 178.9 99.0 85.6 27.4 12.4 53.2 74.9 27.5 9.2 6.0 34.8 78.6 109.2 62.1 100.1 75.5 24.9 80.8 75.9 102.8 116.7 8.1 10.9 32.6 44.3 14.8 2.4 24.9 20.8 18.0 22.0 5.4 37.5 21.9 44.8 42.1 2.2 10.8 62.2 30.6 53.9 49.3 31.1 28.5 182.6 60.5 28.5 78.9 52.2 67.3 84.0 9.3 63.5 32.7 61.0 13.5 8.3 20.4 4.2 5.3 1.8 1.1 1.3 2.3 4.7 0.1 1.4 2.5 37.5 4.6 2.7 0.7 1.2 3.4 1.1 1.1 0.6 29.4 3.5 8.2 3.3 3.4 9.4 0.7 14.4 1.9 54.8 86.6 49.0 115.2 19.2 63.9 51.4 61.1 39.3 7.5 27.4 31.9 51.0 41.5 47.9 46.0 12.5 41.4 29.2 53.1 15.6 69.8 16.2 73.7 73.4 61.5 16.8 16.4 37.9 45.6 99.6 103.7 32.6 179.5 15.2 95.2 58.2 68.9 47.1 0.0 43.9 30.7 12.2 59.2 53.3 9.3 57.5 65.1 69.4 155.5 52.2 17.4 39.1 115.6 31.4 78.5 44.8 54.5 283.6 67.8 16.1 35.7 33.6 11.5 52.6 89.4 69.1 2.3 3.2 18.6 33.5 34.8 23.1 26.0 26.2 88.4 GHSR ENSG00000121853 "Growth hormone secretagogue receptor" Q92847 3 172443291-172448456 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "hippocampal formation: 3.8;hypothalamus: 15.1;thalamus: 3.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hypothalamus: 3.3" "Low region specificity" "Detected in all" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (1.27e-1)" "unprognostic (3.31e-2)" 0.0 0.2 0.7 0.1 0.5 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 15.1 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 3.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.6 3.8 15.1 1.3 0.2 0.8 0.3 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TNFSF10 "Apo-2L, CD253, TL2, TRAIL" ENSG00000121858 "TNF superfamily member 10" P50591 3 172505508-172523475 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 732.8;Exocrine glandular cells: 424.6;Proximal tubular cells: 556.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 265.4;classical monocyte: 133.4;intermediate monocyte: 203.5;neutrophil: 257.1;non-classical monocyte: 213.2" "Group enriched" "Detected in all" 5 "granulocytes: 265.4;monocytes: 213.2" "Cell line enhanced" "Detected in many" "BEWO: 73.1;CAPAN-2: 53.7;HaCaT: 51.5;HMC-1: 244.5;RPTEC TERT1: 122.1" "Low region specificity" "Detected in all" HPA054938 Uncertain "Secreted to blood" NA NA 67400 18000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 3: HMC-1 - Innate immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA054938: AB_2682643" "unprognostic (9.16e-2)" "unprognostic (2.79e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-3)" "unprognostic (2.52e-1)" "unprognostic (2.67e-1)" "unprognostic (1.55e-1)" "unprognostic (2.01e-1)" "unprognostic (1.99e-1)" "unprognostic (1.71e-2)" "prognostic unfavorable (9.43e-4)" "unprognostic (1.04e-1)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (3.68e-2)" "unprognostic (1.32e-1)" "unprognostic (6.27e-2)" 51.0 49.9 9.5 55.4 9.8 14.8 84.5 9.8 17.0 37.3 17.3 76.8 100.3 47.1 19.6 66.4 39.1 45.3 31.7 9.0 9.9 145.1 209.0 177.2 54.7 12.0 10.2 27.1 22.2 77.7 10.4 167.9 11.0 86.7 91.4 1.4 127.9 42.7 20.7 54.6 95.2 26.3 11.0 70.9 47.3 4.8 10.3 34.2 29.3 61.7 46.8 70.3 62.4 10.6 12.4 0.6 0.1 0.2 8.2 6.6 73.1 0.0 0.5 3.7 5.9 0.3 53.7 7.9 34.7 0.0 3.2 51.5 0.3 6.3 0.7 19.6 0.2 0.2 1.5 1.1 0.4 14.7 244.5 8.2 8.0 1.3 0.2 0.0 25.6 1.6 0.3 8.7 0.0 0.1 1.9 19.4 0.3 0.2 0.5 2.9 0.2 3.5 122.1 4.6 0.3 0.5 27.2 1.0 0.6 0.4 15.3 8.0 1.1 0.1 0.2 0.1 0.7 9.3 1.1 9.5 0.6 8.0 0.2 265.4 133.4 14.7 10.9 203.5 15.0 16.7 30.4 16.8 49.1 18.2 21.6 8.5 257.1 49.3 213.2 2.9 36.8 73.6 9.5 9.8 9.8 17.0 9.0 9.9 12.0 10.2 11.0 11.0 10.3 10.6 326.5 70.5 114.4 0.0 26.2 22.0 169.5 398.4 69.4 0.3 146.5 97.3 7.9 84.4 281.1 66.2 0.0 6.6 20.7 294.2 45.0 732.8 4.5 60.5 18.2 247.5 48.3 9.7 0.1 424.6 189.4 69.2 44.9 121.0 257.0 2.4 186.7 75.2 23.5 1.7 0.1 111.3 175.0 79.8 23.7 3.8 18.3 70.5 7.2 52.5 160.3 18.7 52.5 0.0 0.1 244.0 216.4 4.9 23.2 82.7 317.0 556.7 114.5 1.5 0.0 6.5 22.3 0.1 0.3 103.1 25.6 10.9 51.8 19.7 74.3 170.1 NCEH1 "AADACL1, KIAA1363, NCEH" ENSG00000144959 "Neutral cholesterol ester hydrolase 1" Q6PIU2 3 172630249-172711218 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 83.2;Pancreatic endocrine cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 287.7;LHCN-M2: 133.1;U-251 MG: 132.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026888, HPA043873" Enhanced Approved "Endoplasmic reticulum" "Intracellular and membrane" No No "Cluster 25: Monocytes - Inflammatory response" "Cluster 58: Brain - Synaptic function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" "Endoplasmic reticulum" "HPA026888: AB_10601557, HPA043873: " "unprognostic (3.19e-1)" "unprognostic (9.67e-2)" "unprognostic (5.74e-2)" "unprognostic (1.27e-1)" "unprognostic (6.88e-3)" "unprognostic (5.41e-2)" "unprognostic (3.29e-2)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (8.25e-5)" "unprognostic (5.29e-2)" "unprognostic (2.96e-2)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (2.81e-2)" "unprognostic (2.28e-1)" 3.8 16.2 8.7 8.7 15.8 8.3 5.6 2.3 27.5 4.3 0.0 11.6 4.2 4.6 3.2 3.9 3.4 6.9 14.2 12.5 4.3 21.5 4.9 19.9 14.3 9.3 4.9 1.5 4.7 8.0 3.2 6.7 9.6 6.7 12.0 19.6 10.3 4.4 6.1 1.4 4.8 3.4 3.5 11.2 12.8 1.6 7.8 4.9 4.5 7.4 11.2 8.5 2.1 6.9 98.1 55.3 1.9 3.0 3.3 3.4 7.8 71.8 47.5 46.5 27.2 14.0 287.7 8.1 105.4 43.4 44.4 19.2 2.0 35.1 107.0 27.1 4.5 5.6 8.5 10.8 3.9 14.8 19.9 1.7 3.5 32.3 47.5 43.6 31.5 4.4 1.4 6.9 133.1 8.0 2.5 5.1 2.6 27.4 43.5 2.3 5.2 10.0 83.0 12.6 1.6 0.8 43.6 45.2 9.6 3.1 15.4 6.8 86.9 71.3 10.7 34.1 132.0 8.2 16.4 6.8 53.3 14.1 55.4 6.8 17.9 0.7 2.6 11.6 1.7 3.3 1.6 1.9 12.8 2.2 1.6 2.0 0.6 3.4 7.8 0.7 1.7 6.4 8.7 15.8 2.3 27.5 12.5 4.3 9.3 4.9 9.6 3.5 7.8 6.9 6.6 48.1 17.9 35.9 6.6 6.8 18.3 5.2 1.8 14.8 11.5 3.7 31.6 22.8 20.1 16.5 22.9 9.0 4.7 43.0 3.9 64.1 7.5 41.2 6.4 8.5 7.8 50.5 83.2 31.0 5.2 6.6 25.0 64.1 5.1 5.5 6.8 2.4 49.7 5.0 68.2 11.5 4.1 42.8 15.2 4.1 0.9 32.8 5.4 22.5 12.2 5.4 3.1 15.6 5.4 72.9 13.0 2.6 2.9 30.6 7.3 24.6 27.4 20.5 6.6 8.6 7.0 0.0 1.1 4.3 3.4 10.5 4.6 9.3 7.8 27.3 ECT2 ARHGEF31 ENSG00000114346 "Epithelial cell transforming 2" Q9H8V3 3 172750682-172821474 "Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport" "Guanine-nucleotide releasing factor" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Spermatocytes: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA036363, HPA053261" Enhanced Nucleoplasm,Cytosol No Yes "Cluster 1: Neutrophils - Mixed function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "HPA036363: AB_2732472, HPA053261: AB_2682094" "unprognostic (3.83e-2)" "unprognostic (4.34e-1)" "unprognostic (1.27e-2)" "unprognostic (4.22e-3)" "unprognostic (4.49e-2)" "unprognostic (5.02e-3)" "prognostic unfavorable (6.82e-6)" "prognostic unfavorable (1.13e-4)" "unprognostic (1.82e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (2.44e-2)" "prognostic unfavorable (1.19e-5)" "unprognostic (1.08e-2)" "unprognostic (1.46e-1)" "unprognostic (1.29e-1)" "unprognostic (1.33e-1)" 3.6 3.3 2.1 8.2 1.9 19.8 7.5 3.4 3.4 8.1 1.4 11.5 9.3 4.4 1.8 8.9 3.3 5.3 3.2 2.4 1.4 4.3 2.6 5.2 10.5 2.1 1.7 1.3 2.9 3.6 1.2 8.8 2.7 3.2 15.8 12.5 5.6 2.6 2.1 7.1 7.6 7.5 0.7 4.3 9.4 15.9 2.3 23.3 3.9 2.7 11.4 6.9 4.2 3.5 192.0 133.6 103.2 54.0 10.6 21.8 51.6 81.5 67.5 121.4 116.9 74.7 196.9 47.2 122.1 48.8 116.0 81.8 84.2 53.1 164.3 67.8 46.6 29.6 70.0 38.5 4.6 46.2 32.8 7.1 9.0 72.2 73.2 34.0 53.0 68.6 31.3 67.2 97.2 67.6 47.5 34.6 84.4 156.7 72.0 33.7 101.1 60.7 92.2 43.7 68.6 44.1 104.5 117.4 42.2 51.5 195.4 34.1 46.5 58.5 55.7 79.6 174.9 32.8 47.2 88.2 51.6 39.7 78.0 6.0 2.0 0.7 1.0 1.7 1.1 1.4 1.4 0.9 1.6 1.3 0.6 0.9 6.3 0.7 0.7 1.6 2.5 0.7 2.1 1.9 3.4 3.4 2.4 1.4 2.1 1.7 2.7 0.7 2.3 3.5 6.7 6.4 3.2 4.2 3.8 19.5 4.9 6.2 9.1 3.4 10.1 6.5 3.6 5.7 5.7 3.7 64.6 12.0 2.9 10.7 0.0 9.5 3.3 20.1 6.6 7.7 4.8 25.2 6.5 9.2 14.9 6.0 17.9 20.5 0.0 17.9 5.3 2.9 7.3 0.0 2.5 13.5 10.2 4.7 6.3 2.8 0.9 5.1 7.2 15.0 2.8 3.1 2.1 3.0 4.9 20.7 3.8 1.5 9.6 12.8 1.5 3.7 11.0 16.3 0.0 2.9 5.2 42.6 30.4 16.9 12.8 3.8 4.1 3.3 13.5 8.8 SPATA16 NYD-SP12 ENSG00000144962 "Spermatogenesis associated 16" Q9BXB7 3 172889357-173141235 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 595 "testis: 59.5" "Group enriched" "Detected in some" 49 "Early spermatids: 288.6;Late spermatids: 129.3;Spermatocytes: 192.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA037884 Enhanced NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA037884: AB_2675717" "unprognostic (3.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 288.6 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 129.3 4.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 192.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NLGN1 KIAA1070 ENSG00000169760 "Neuroligin 1" Q8N2Q7 3 173396284-174286644 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Biological rhythms, Cell adhesion" "Autism, Autism spectrum disorder, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.0;retina: 13.8" "Group enriched" "Detected in many" 31 "Excitatory neurons: 1484.7;Inhibitory neurons: 1700.0;Oligodendrocyte precursor cells: 4004.1;Oligodendrocytes: 1261.9" "Group enriched" "Detected in some" 9 "glioma: 3.8;melanoma: 2.2;renal cancer: 3.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 25.9;HUVEC TERT2: 24.9;RH-30: 26.2;WM-115: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006572, HPA006680, CAB033261" Enhanced Uncertain "Nuclear bodies,Plasma membrane" "Intracellular and membrane" NA NA 82000 "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 17: WM-115 - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "Nuclear bodies" "CAB033261: AB_2151659, HPA006572: , HPA006680: AB_1854400" "unprognostic (2.81e-1)" "unprognostic (9.86e-2)" "unprognostic (3.08e-5)" "unprognostic (7.52e-5)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (6.67e-2)" "unprognostic (6.65e-2)" "unprognostic (1.78e-1)" "unprognostic (8.07e-2)" "unprognostic (3.21e-3)" "unprognostic (1.86e-2)" "unprognostic (1.97e-1)" "unprognostic (4.08e-2)" "unprognostic (8.81e-2)" "unprognostic (2.41e-3)" "unprognostic (5.37e-2)" 2.0 1.0 12.6 0.5 10.8 0.0 0.7 31.0 12.1 3.1 0.0 2.0 0.2 2.1 2.5 2.5 3.0 1.6 3.2 12.5 15.2 2.9 0.0 0.4 0.2 5.3 5.4 1.3 0.8 0.7 1.8 0.5 4.0 2.2 0.9 13.8 0.3 3.0 0.2 0.3 0.6 2.7 4.4 0.0 0.8 7.0 20.5 0.2 0.9 1.0 0.1 2.9 1.3 7.2 0.1 0.0 6.1 0.0 11.8 12.4 0.0 5.2 12.8 0.6 0.8 0.0 0.5 0.0 0.2 25.9 4.7 0.0 3.7 0.0 1.3 0.0 6.0 1.7 0.1 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.0 10.0 24.9 0.0 0.0 1.7 0.1 0.0 0.0 0.0 7.2 0.0 1.7 0.0 26.2 6.4 4.7 0.1 2.5 1.7 0.0 0.0 12.3 1.1 0.6 0.0 3.1 13.5 1.3 9.9 11.6 11.7 0.0 0.0 4.6 0.0 27.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 10.8 31.0 12.1 12.5 15.2 5.3 5.4 4.0 4.4 20.5 7.2 0.3 0.0 0.5 66.6 0.0 0.8 0.4 0.0 0.6 14.3 0.1 0.0 4.4 0.0 0.0 3.7 4.2 0.3 0.0 0.0 0.0 0.3 55.9 0.6 12.4 0.8 0.0 0.0 1484.7 0.0 0.2 8.2 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 1700.0 0.0 0.0 0.0 0.3 12.5 25.7 0.4 14.2 60.9 0.0 24.9 0.0 4004.1 1261.9 0.1 0.0 14.3 0.0 2.6 0.0 8.5 0.0 10.3 6.6 2.9 2.1 0.4 1.6 0.1 0.9 0.1 0.1 1.6 0.0 0.3 NAALADL2 ENSG00000177694 "N-acetylated alpha-linked acidic dipeptidase like 2" Q58DX5 3 174438573-175810548 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 311.5;Inhibitory neurons: 135.1;Microglial cells: 155.5;Oligodendrocyte precursor cells: 468.0;Oligodendrocytes: 532.9" "Cancer enhanced" "Detected in many" "prostate cancer: 5.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.5;BJ hTERT+: 5.4;fHDF/TERT166: 6.4;WM-115: 5.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA012413, HPA017425, CAB025586" Approved Enhanced Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275" "unprognostic (7.28e-3)" "unprognostic (1.10e-1)" "unprognostic (6.28e-2)" "unprognostic (1.60e-1)" "unprognostic (2.56e-1)" "unprognostic (2.56e-1)" "unprognostic (2.29e-4)" "unprognostic (3.44e-3)" "unprognostic (5.70e-2)" "unprognostic (7.42e-2)" "unprognostic (7.85e-3)" "unprognostic (9.49e-2)" "unprognostic (3.66e-6)" "unprognostic (7.11e-2)" "unprognostic (1.48e-1)" "unprognostic (9.05e-2)" "unprognostic (2.22e-2)" 2.4 1.1 1.1 1.0 2.3 0.2 5.8 1.2 1.4 6.3 1.1 3.0 1.7 3.7 5.5 1.5 3.8 4.2 2.6 1.4 0.6 3.3 2.9 2.0 0.5 2.2 1.3 3.9 2.2 10.2 0.5 1.2 1.8 4.9 2.4 1.6 5.8 3.7 1.0 0.8 1.6 3.5 1.4 1.9 2.7 0.9 1.5 1.2 2.3 1.7 0.5 3.8 1.2 3.3 0.0 0.0 0.3 0.0 4.4 14.5 0.1 3.1 5.4 0.7 0.9 0.2 1.7 0.0 0.6 6.4 0.2 0.1 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 4.1 0.8 0.1 0.0 3.8 0.5 0.0 0.0 0.1 3.1 0.6 0.2 0.0 0.0 2.2 0.0 0.0 0.2 0.1 2.2 0.3 0.1 0.1 0.3 0.3 1.2 0.3 4.0 0.2 0.7 2.9 0.1 0.1 0.6 0.0 0.0 0.0 1.9 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 2.3 1.2 1.4 1.4 0.6 2.2 1.3 1.8 1.4 1.5 3.3 5.1 0.0 11.5 311.5 0.1 2.3 8.9 2.7 1.2 7.7 35.1 13.7 3.0 12.8 9.1 12.9 12.5 19.6 0.3 11.1 7.9 10.1 74.9 23.7 8.7 2.8 9.0 2.7 113.4 2.5 1.4 15.0 23.9 30.2 4.5 3.4 2.9 4.5 1.8 0.0 135.1 2.6 10.2 0.3 3.0 39.6 15.2 1.1 3.6 155.5 0.0 6.7 0.0 468.0 532.9 3.6 4.4 12.0 0.0 13.6 13.2 2.4 21.9 6.2 0.0 23.4 4.9 3.2 2.8 5.3 1.8 12.3 0.8 5.7 16.4 16.0 TBL1XR1 "C21, DC42, FLJ12894, IRA1, TBLR1" ENSG00000177565 "TBL1X receptor 1" Q9BZK7 3 177019340-177228000 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 280.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019182 Supported Approved Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA019182: AB_1857800" "unprognostic (4.11e-2)" "unprognostic (3.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.27e-3)" "prognostic favorable (5.16e-5)" "unprognostic (4.44e-2)" "prognostic unfavorable (1.08e-7)" "unprognostic (3.75e-1)" "unprognostic (4.84e-2)" "unprognostic (3.04e-1)" "unprognostic (3.13e-3)" "unprognostic (2.50e-1)" "prognostic unfavorable (4.25e-5)" "unprognostic (5.83e-2)" "unprognostic (1.69e-1)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" 18.8 20.3 7.2 24.4 12.7 30.2 21.7 13.9 11.8 24.9 8.5 31.0 24.6 16.9 9.2 21.2 22.4 23.2 32.6 16.0 3.3 22.3 24.5 19.6 31.3 8.1 8.5 20.9 12.1 27.3 2.9 21.0 4.9 25.6 24.4 42.7 16.1 14.8 12.9 17.1 18.7 19.4 8.6 22.9 22.3 19.1 8.4 45.5 47.1 25.3 36.3 25.3 10.3 15.0 96.8 41.2 61.1 39.7 56.2 65.8 44.2 26.1 52.3 30.3 36.3 48.9 76.2 98.9 132.9 43.6 58.4 61.2 42.9 63.2 58.7 97.5 14.5 56.2 66.8 30.3 49.7 91.0 29.6 95.3 35.9 37.3 90.6 53.8 48.5 68.5 44.8 189.9 42.8 31.0 81.7 14.0 38.1 59.8 32.2 53.9 72.6 124.6 33.1 119.5 24.8 38.7 43.3 35.9 49.8 37.3 113.0 74.3 60.5 48.9 35.3 28.8 65.6 89.8 117.6 280.7 32.9 66.2 56.1 14.3 3.7 3.8 5.6 6.2 5.9 7.5 6.9 7.3 4.6 7.3 5.9 7.4 12.9 7.4 5.5 12.4 8.3 5.3 7.2 12.7 13.9 11.8 16.0 3.3 8.1 8.5 4.9 8.6 8.4 15.0 55.1 73.7 60.7 128.0 56.5 91.5 55.1 90.6 62.0 113.6 69.2 42.2 101.9 47.1 80.3 104.8 125.1 28.9 70.0 84.7 29.4 52.2 7.4 90.9 59.0 65.5 85.3 60.4 228.9 43.8 35.1 81.8 44.4 134.5 25.3 65.9 48.5 66.6 37.8 116.1 167.6 72.6 59.0 91.1 75.0 9.0 64.0 69.4 65.8 184.6 55.8 47.6 41.2 241.8 269.4 66.7 43.7 73.0 75.1 144.9 41.5 67.3 83.9 81.6 46.0 76.3 54.4 12.9 61.4 88.1 111.8 27.5 66.0 41.6 84.6 83.6 KCNMB2 ENSG00000197584 "Potassium calcium-activated channel subfamily M regulatory beta subunit 2" Q9Y691 3 178272932-178844429 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 35.4;fallopian tube: 13.9;ovary: 12.7" "Group enriched" "Detected in some" 4 "Inhibitory neurons: 791.1;Oligodendrocyte precursor cells: 1982.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.4;SCLC-21H: 3.3" CAB022649 Uncertain NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB022649: " "unprognostic (9.52e-2)" "unprognostic (1.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.07e-1)" "unprognostic (2.19e-2)" "unprognostic (1.04e-2)" "unprognostic (2.43e-2)" "unprognostic (6.97e-2)" "unprognostic (6.74e-2)" "unprognostic (2.15e-1)" "unprognostic (3.58e-3)" "unprognostic (3.57e-2)" "unprognostic (1.71e-2)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-4)" "unprognostic (7.85e-2)" 0.3 5.1 2.5 0.0 3.0 0.0 0.7 1.5 4.0 1.4 0.9 1.2 0.5 2.9 35.4 0.4 13.9 0.5 5.8 4.0 2.3 3.4 0.2 1.1 0.0 3.0 2.7 12.7 4.0 0.2 1.7 0.1 2.3 0.5 0.3 0.2 0.2 1.1 0.2 0.3 0.5 1.9 2.2 1.3 3.0 0.2 2.1 0.0 0.3 0.2 0.0 0.2 0.7 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.6 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.5 3.3 0.0 0.0 0.1 0.0 0.2 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.0 1.5 4.0 4.0 2.3 3.0 2.7 2.3 2.2 2.1 2.1 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 3.3 0.0 0.8 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.1 8.7 0.2 0.0 13.8 0.0 311.8 0.0 0.0 2.7 0.0 1.9 0.0 12.7 1.8 0.0 0.0 0.0 791.1 0.0 4.1 0.0 0.0 0.1 2.8 0.1 0.0 12.2 0.0 0.0 0.0 1982.5 6.8 0.1 0.0 0.0 0.0 0.0 0.0 1.3 10.0 0.0 0.0 0.8 0.4 0.0 0.0 0.1 0.0 0.0 0.1 1.7 0.0 0.1 AC117457.1 ENSG00000275163 "Potassium large conductance calcium-activated channel, subfamily M, beta member 2 (KCNMB2-IT1 - KCNMB2 readthrough transcript)" 3 178419123-178843300 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "fallopian tube: 5.6;kidney: 1.5" "Group enriched" "Detected in some" 5 "Distal tubular cells: 1.9;Endometrial ciliated cells: 7.1;Proximal tubular cells: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "HSkMC: 1.3" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.6 0.1 0.1 0.2 0.2 1.5 0.1 0.2 0.0 0.7 0.7 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.2 0.2 0.7 0.7 0.3 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZMAT3 "FLJ12296, MGC10613, PAG608, WIG-1, WIG1" ENSG00000172667 "Zinc finger matrin-type 3" Q9HA38 3 178960121-179072215 "Predicted intracellular proteins" "Apoptosis, DNA damage, Growth regulation, Protein transport, Translocation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HSkMC: 76.0;LHCN-M2: 87.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027569, HPA028671, HPA054356" Enhanced Supported Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 65: Brain - Ion transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "HPA027569: AB_2732438, HPA028671: AB_2672725, HPA054356: AB_2682460" "unprognostic (3.53e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-1)" "unprognostic (1.46e-1)" "unprognostic (1.46e-1)" "unprognostic (1.88e-1)" "unprognostic (4.81e-2)" "unprognostic (3.57e-2)" "unprognostic (1.45e-1)" "unprognostic (4.37e-2)" "unprognostic (6.88e-2)" "unprognostic (1.60e-1)" "unprognostic (1.85e-2)" "unprognostic (7.09e-2)" "unprognostic (2.51e-1)" "unprognostic (3.91e-2)" "unprognostic (1.46e-2)" 5.2 7.9 9.9 5.2 10.9 3.4 5.9 4.4 14.5 5.8 3.4 6.3 3.4 5.2 6.2 6.8 5.8 8.9 6.1 12.1 11.0 6.3 12.6 5.9 7.4 10.5 12.1 4.4 4.1 8.8 4.9 5.6 11.9 5.9 8.5 6.1 4.3 7.7 3.1 6.1 3.4 11.2 9.9 6.9 5.1 4.1 12.5 10.2 7.5 4.4 6.4 6.1 3.7 11.7 5.9 4.0 12.8 8.4 57.4 64.2 28.3 23.1 33.9 3.3 4.3 5.1 3.5 24.2 11.1 36.2 5.1 5.4 4.6 24.6 7.6 20.7 7.0 10.7 7.8 16.2 45.7 11.7 16.0 76.0 45.2 8.1 16.7 51.2 48.5 6.8 5.7 3.3 87.7 5.8 9.3 2.1 5.7 8.3 3.3 10.7 11.1 5.2 19.2 11.3 3.0 12.7 7.1 6.4 7.7 23.8 8.0 4.9 53.2 49.9 19.2 8.3 11.0 3.2 2.9 10.2 29.6 1.7 34.9 2.1 0.7 1.7 1.8 0.6 1.0 0.9 1.3 1.4 0.7 1.8 2.2 1.5 0.8 1.6 1.4 0.8 1.0 0.6 9.9 10.9 4.4 14.5 12.1 11.0 10.5 12.1 11.9 9.9 12.5 11.7 11.2 54.5 105.8 38.2 24.6 39.6 10.6 26.1 34.1 19.5 22.2 22.9 21.0 24.3 53.8 35.0 25.0 10.7 25.1 14.0 7.9 16.1 1.1 12.0 15.7 14.6 20.9 14.5 40.7 20.7 2.9 28.2 19.9 12.2 39.8 19.8 17.2 32.1 18.2 62.2 36.7 9.5 30.5 40.2 16.6 2.2 20.2 24.4 51.6 41.2 49.7 15.5 32.0 87.4 18.9 28.6 11.9 29.0 11.1 17.3 14.0 20.2 45.1 11.1 39.5 25.0 23.8 9.5 13.1 25.2 36.7 4.4 29.8 42.8 10.4 11.1 PIK3CA PI3K ENSG00000121879 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha" P42336 3 179148114-179240093 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Lipid metabolism, Phagocytosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 126.7;Inhibitory neurons: 122.0;Oligodendrocyte precursor cells: 130.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009985, CAB017804" Approved Supported Mitochondria,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol Mitochondria "CAB017804: , HPA009985: AB_1079610" "unprognostic (1.81e-1)" "unprognostic (2.77e-1)" "unprognostic (2.18e-1)" "unprognostic (2.69e-3)" "unprognostic (6.49e-3)" "unprognostic (1.43e-1)" "unprognostic (2.65e-2)" "unprognostic (1.00e-2)" "unprognostic (1.03e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-3)" "unprognostic (5.21e-2)" "unprognostic (4.50e-2)" "unprognostic (1.16e-2)" "unprognostic (2.48e-1)" "unprognostic (9.74e-2)" "unprognostic (3.82e-2)" 14.7 7.9 3.1 8.1 3.7 12.4 8.5 9.7 8.3 8.7 0.3 6.7 4.2 8.3 4.8 7.9 5.7 8.4 9.5 3.7 3.6 8.2 7.1 7.9 9.2 5.1 4.2 10.3 4.3 11.5 3.4 11.1 5.1 7.3 5.8 12.4 4.5 7.1 7.1 5.5 5.3 8.9 2.3 8.8 5.8 6.1 3.7 13.7 7.9 13.0 9.2 8.6 5.8 6.4 19.9 6.5 9.6 9.2 22.7 27.7 6.5 10.8 16.5 10.9 16.0 5.1 13.0 16.1 21.7 10.8 14.1 5.9 8.4 9.8 16.5 32.0 6.2 22.4 5.2 4.4 10.7 13.1 12.6 16.8 10.6 12.4 15.0 13.4 15.8 12.9 10.6 17.3 18.9 6.9 10.9 8.5 8.0 8.8 7.8 13.9 10.0 16.7 8.5 10.0 5.2 9.9 13.1 10.8 16.1 9.1 19.0 11.1 21.1 10.4 6.5 18.1 13.3 9.3 13.8 29.0 11.3 9.6 5.4 1.3 1.2 0.4 1.2 1.0 0.8 1.5 0.8 0.6 0.8 1.6 1.0 0.8 2.2 0.7 0.9 0.9 0.8 0.3 3.1 3.7 9.7 8.3 3.7 3.6 5.1 4.2 5.1 2.3 3.7 6.4 31.3 32.1 26.8 60.7 28.3 14.7 17.9 11.2 2.2 27.9 14.4 15.2 18.5 5.7 15.9 7.3 31.3 10.2 17.9 8.7 1.9 10.7 2.0 14.1 21.7 25.6 2.4 9.2 126.7 13.9 6.1 23.5 8.6 21.6 31.6 19.9 33.5 21.9 11.1 38.7 122.0 10.3 14.2 23.5 24.3 3.4 32.6 20.9 14.2 75.9 24.5 17.4 18.6 130.2 84.2 16.9 10.8 39.5 15.1 34.6 9.5 14.8 20.1 27.1 26.3 25.7 28.6 11.8 10.2 9.8 14.9 8.8 19.9 19.6 9.2 32.0 KCNMB3 "KCNMB2, KCNMBL" ENSG00000171121 "Potassium calcium-activated channel subfamily M regulatory beta subunit 3" Q9NPA1 3 179236691-179267002 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Early spermatids: 11.2;Late spermatids: 13.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 4.8;HEL: 8.1;NB-4: 5.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA015665, HPA019185" Approved Approved Nucleoplasm,Mitochondria NA NA "Cluster 15: NK-cells - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 32: U-937 - Innate immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Mitochondria "HPA015665: AB_1852142, HPA019185: AB_1852144" "unprognostic (2.50e-1)" "unprognostic (1.32e-1)" "unprognostic (6.76e-5)" "unprognostic (2.65e-2)" "unprognostic (2.22e-2)" "unprognostic (2.08e-1)" "unprognostic (4.59e-3)" "unprognostic (1.14e-1)" "unprognostic (9.15e-3)" "unprognostic (5.09e-2)" "unprognostic (1.87e-2)" "unprognostic (1.95e-5)" "unprognostic (5.93e-10)" "unprognostic (7.22e-2)" "unprognostic (4.72e-1)" "unprognostic (8.69e-2)" "unprognostic (3.49e-2)" 4.9 3.6 1.5 2.2 1.8 1.1 4.6 1.7 1.9 3.5 1.6 4.0 1.5 3.2 1.5 2.0 2.9 1.7 3.5 1.5 1.7 4.8 5.5 3.0 2.2 1.9 1.7 3.2 5.3 1.2 3.3 4.2 1.8 4.2 1.5 2.3 3.1 1.1 1.3 2.4 3.5 1.4 1.3 7.5 3.7 3.9 1.7 0.9 3.2 0.5 1.9 3.7 2.7 1.7 2.2 0.5 0.8 0.0 0.9 0.8 1.3 0.6 0.3 0.9 0.4 4.8 1.9 0.1 2.1 0.4 1.8 0.8 0.0 0.1 1.0 2.7 0.3 8.1 2.6 1.8 0.8 0.1 2.5 1.3 0.4 0.6 0.0 0.7 0.8 0.0 0.3 0.0 1.1 1.5 0.1 5.7 0.0 0.9 1.6 2.4 0.0 0.1 0.7 1.5 1.1 0.2 0.7 0.8 0.5 0.7 2.1 4.4 0.5 0.4 0.7 0.2 0.6 0.7 0.3 2.6 0.4 3.1 0.6 0.8 0.1 0.1 0.3 0.1 0.2 1.2 0.2 0.3 0.0 0.6 0.2 0.2 0.6 1.1 0.0 0.1 0.4 0.0 1.5 1.8 1.7 1.9 1.5 1.7 1.9 1.7 1.8 1.3 1.7 1.7 4.2 0.0 3.6 3.9 2.9 0.3 1.4 0.3 0.0 2.5 2.1 1.3 1.1 2.8 1.5 0.0 14.6 1.2 0.6 3.8 0.0 5.0 11.2 1.5 2.3 5.3 4.9 0.8 3.4 3.6 1.3 1.5 0.5 2.0 2.5 3.4 2.9 1.4 1.1 0.0 4.6 1.4 0.0 2.1 1.9 13.3 2.8 1.4 0.0 5.6 1.4 1.8 1.0 4.0 6.4 3.3 0.8 3.0 0.9 1.7 1.9 0.3 1.1 7.8 6.6 1.6 1.6 2.0 2.6 0.3 0.1 1.2 1.0 2.3 1.4 1.0 ZNF639 "ANC-2H01, ZASC1" ENSG00000121864 "Zinc finger protein 639" Q9UID6 3 179323031-179338583 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049023, HPA052163" Uncertain Supported Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA049023: AB_2680603, HPA052163: AB_2681747" "unprognostic (5.64e-2)" "unprognostic (6.16e-2)" "unprognostic (8.15e-2)" "unprognostic (1.33e-2)" "prognostic favorable (5.45e-5)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.13e-4)" "unprognostic (7.74e-2)" "unprognostic (1.05e-2)" "unprognostic (2.16e-3)" "unprognostic (4.70e-3)" "unprognostic (4.58e-2)" "unprognostic (2.48e-2)" "unprognostic (1.59e-1)" "unprognostic (7.82e-2)" "unprognostic (1.33e-2)" "unprognostic (1.56e-1)" 20.8 19.5 16.5 18.0 17.5 59.2 28.0 22.1 19.3 27.6 15.0 26.6 17.4 31.5 25.6 20.9 26.0 19.8 27.4 16.4 16.6 25.1 23.9 21.9 26.6 16.4 16.8 32.7 24.6 38.6 18.2 22.5 15.9 26.3 22.1 40.0 24.5 27.0 27.3 16.9 18.6 31.0 16.8 23.7 20.6 19.1 17.3 26.6 41.4 30.3 24.6 21.5 18.3 18.0 81.3 18.7 35.5 43.9 31.7 38.4 35.2 37.8 56.4 61.0 54.8 31.7 31.3 94.2 56.4 46.6 74.1 30.1 55.2 50.5 76.0 86.7 43.1 96.1 26.8 31.8 55.0 76.1 34.5 31.1 51.9 31.3 72.5 45.7 42.1 61.3 59.4 48.6 48.6 41.2 79.5 33.7 59.9 56.9 43.5 75.4 37.1 112.1 37.8 32.4 65.3 39.9 37.9 41.1 49.2 29.8 104.9 59.4 34.5 41.3 43.7 33.1 98.7 19.7 19.0 174.2 30.3 58.5 28.9 2.5 1.1 1.2 1.6 0.7 1.5 1.8 2.6 2.6 0.9 2.0 2.2 2.2 0.7 2.2 0.5 0.3 2.4 0.8 16.5 17.5 22.1 19.3 16.4 16.6 16.4 16.8 15.9 16.8 17.3 18.0 16.9 19.2 11.7 9.4 24.2 20.9 34.0 7.0 32.5 21.5 21.6 13.2 19.4 10.0 8.8 14.7 54.2 14.7 18.3 8.6 33.2 12.2 29.8 21.6 22.4 19.4 18.7 29.0 8.7 10.0 11.3 21.8 11.2 30.3 10.1 18.5 18.5 17.0 9.9 16.8 10.6 15.6 6.1 13.2 17.2 8.8 24.5 13.8 14.2 4.7 13.5 19.6 13.4 8.5 9.6 11.5 9.4 24.0 27.5 36.1 11.2 22.2 7.2 44.9 26.3 27.1 22.7 29.9 21.3 29.9 17.5 3.4 23.2 19.8 12.2 24.9 MFN1 FLJ20693 ENSG00000171109 "Mitofusin 1" Q8IWA4 3 179347709-179394936 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 92.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033437, HPA059230" Approved Supported Mitochondria NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 44: Endometrium - Transcription" Mitochondria "CAB033437: AB_2250540, HPA059230: AB_2683952" "unprognostic (2.94e-2)" "unprognostic (5.56e-2)" "unprognostic (5.44e-3)" "prognostic unfavorable (6.70e-4)" "prognostic favorable (6.11e-4)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.08e-5)" "unprognostic (6.37e-2)" "unprognostic (1.86e-2)" "unprognostic (3.70e-2)" "unprognostic (3.76e-3)" "unprognostic (7.91e-2)" "unprognostic (7.90e-2)" "unprognostic (1.58e-1)" "unprognostic (3.83e-1)" "unprognostic (6.24e-2)" "unprognostic (9.79e-2)" 9.5 9.0 5.6 9.4 6.6 8.4 11.0 8.8 8.5 9.5 8.8 12.5 8.9 11.4 14.9 14.1 10.2 9.6 23.4 5.6 5.5 10.4 8.8 8.8 12.8 6.3 5.8 9.1 17.9 13.3 6.7 7.9 6.0 12.4 10.5 10.3 14.1 9.6 14.0 14.5 9.8 11.4 5.2 9.9 10.8 9.0 5.7 8.6 10.4 16.4 11.9 12.7 8.9 9.5 32.2 9.4 17.9 29.1 25.1 23.2 23.6 19.6 20.2 20.2 23.9 23.5 13.0 10.8 20.0 29.1 40.9 18.5 25.4 19.4 35.3 17.2 19.5 17.8 19.4 13.1 20.5 9.5 16.3 16.2 16.7 21.9 15.4 16.8 26.0 17.9 13.2 14.1 28.6 17.1 14.0 7.1 21.3 32.1 17.3 9.7 28.1 40.4 19.1 33.4 16.8 23.9 18.3 48.5 26.6 18.2 66.6 6.8 22.0 17.6 19.4 27.6 29.0 18.6 21.9 18.0 19.7 15.8 19.5 4.2 2.5 5.8 2.6 3.1 4.5 5.1 3.0 2.7 2.3 6.2 2.7 3.2 5.8 2.9 2.4 2.8 2.9 1.4 5.6 6.6 8.8 8.5 5.6 5.5 6.3 5.8 6.0 5.2 5.7 9.5 21.3 25.6 36.8 39.8 27.3 16.7 12.3 12.6 20.5 18.8 19.1 14.4 29.3 14.3 23.7 18.4 39.6 11.2 20.9 18.2 9.8 12.6 6.6 36.9 28.5 16.3 10.2 24.0 77.2 17.4 11.0 22.6 26.0 43.4 8.8 22.1 14.6 18.3 7.8 11.8 92.5 18.2 12.2 11.7 11.4 3.3 13.4 14.9 12.4 28.1 12.2 11.2 18.6 56.8 85.1 16.5 11.8 17.7 21.2 20.0 10.4 13.4 31.9 16.5 6.6 26.8 21.2 33.2 13.7 24.9 27.0 13.1 15.1 25.3 16.6 20.7 GNB4 ENSG00000114450 "G protein subunit beta 4" Q9HAV0 3 179396088-179451476 "Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 81.1;Kupffer cells: 98.1;Macrophages: 66.8;Microglial cells: 91.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 143.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018383, CAB018737, HPA040736" Supported Supported "Plasma membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 44: HDLM-2 - Immune response" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane" "CAB018383: AB_631542, CAB018737: AB_640712, HPA040736: AB_2677106" "unprognostic (2.56e-2)" "unprognostic (1.95e-1)" "unprognostic (1.62e-1)" "unprognostic (1.01e-1)" "unprognostic (5.97e-3)" "unprognostic (2.12e-1)" "unprognostic (1.44e-2)" "unprognostic (8.28e-2)" "unprognostic (1.16e-1)" "unprognostic (3.44e-1)" "unprognostic (1.56e-1)" "unprognostic (2.32e-2)" "prognostic unfavorable (1.39e-6)" "unprognostic (1.90e-3)" "unprognostic (3.13e-2)" "unprognostic (8.90e-2)" "unprognostic (2.80e-3)" 14.9 6.3 8.7 21.9 19.2 33.7 12.4 7.3 11.2 11.5 2.9 9.5 5.9 9.2 3.7 21.9 7.0 15.2 13.9 9.6 8.7 5.9 7.8 16.0 17.7 15.5 8.5 5.8 2.8 2.7 3.0 21.8 14.5 4.5 8.6 2.0 4.7 4.0 3.1 34.1 6.4 23.5 14.5 18.1 7.4 4.3 10.9 7.9 6.3 5.7 11.5 13.2 6.8 19.7 33.4 15.4 37.7 0.8 23.8 41.5 44.1 46.7 33.1 54.1 61.3 0.8 3.7 61.6 9.9 54.3 49.7 0.6 36.4 43.1 56.7 143.6 29.2 71.3 54.9 0.7 23.4 62.3 16.2 32.9 6.6 42.4 21.6 12.0 59.3 13.7 18.7 0.8 42.8 1.3 32.8 24.3 18.9 0.2 19.3 61.4 49.2 25.3 34.9 1.9 7.0 20.5 37.5 33.0 61.1 23.0 67.5 26.1 45.3 45.1 27.4 13.6 61.6 0.3 0.9 0.8 24.7 52.8 35.4 5.6 21.3 11.0 0.2 27.8 0.1 6.7 0.4 0.3 24.9 13.6 0.4 0.3 14.5 3.4 23.5 12.8 0.6 8.8 8.7 19.2 7.3 11.2 9.6 8.7 15.5 8.5 14.5 14.5 10.9 19.7 40.0 25.6 12.8 17.9 20.1 18.7 1.8 2.5 13.6 1.7 14.3 12.3 15.6 0.0 12.3 3.7 6.2 13.8 11.5 0.1 3.9 1.1 1.2 15.6 22.9 42.9 0.0 22.9 18.6 1.6 18.7 26.6 3.6 10.8 10.8 16.2 53.2 0.9 81.1 1.7 18.4 0.0 2.0 98.1 17.4 1.4 10.2 66.8 14.2 91.8 59.9 0.8 2.1 11.6 7.7 2.8 0.0 15.8 8.1 2.6 0.2 0.2 11.3 4.0 26.3 9.9 41.8 2.3 16.8 23.4 25.4 4.1 2.9 14.7 0.0 1.3 ACTL6A "Actl6, Arp4, BAF53A, INO80K" ENSG00000136518 "Actin like 6A" O96019 3 179562886-179588407 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 243.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012188, HPA018671, HPA063149" Supported Enhanced Nucleoplasm,Cytosol NA NA 18000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: " "unprognostic (2.13e-1)" "unprognostic (5.33e-2)" "unprognostic (1.54e-2)" "unprognostic (2.24e-3)" "unprognostic (7.79e-3)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.89e-5)" "unprognostic (3.36e-2)" "unprognostic (1.09e-3)" "unprognostic (2.13e-2)" "prognostic unfavorable (5.44e-5)" "unprognostic (1.03e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (4.21e-2)" "unprognostic (1.96e-1)" "unprognostic (4.21e-3)" "unprognostic (5.20e-2)" 19.7 20.4 8.3 23.5 9.8 17.8 33.0 10.1 12.4 24.6 11.0 31.1 24.7 27.6 25.9 25.3 25.0 15.6 18.6 7.9 9.5 22.3 21.8 19.0 32.0 10.4 9.8 31.9 20.6 24.3 13.1 23.5 10.8 21.3 37.8 16.3 21.3 21.4 12.3 26.8 23.8 26.3 9.4 19.9 22.3 62.5 8.9 46.0 20.5 13.9 41.4 24.8 20.7 11.9 196.4 59.5 142.2 75.7 53.4 58.0 111.7 78.1 60.2 142.3 119.8 126.6 94.8 154.0 136.8 73.5 164.7 88.7 126.3 95.7 174.6 156.7 105.0 125.5 58.2 101.9 61.0 157.4 75.2 40.7 96.1 91.5 76.6 44.5 82.5 90.7 100.1 85.1 103.6 135.6 140.1 96.8 127.6 178.0 129.5 128.7 118.0 284.4 113.4 76.2 116.9 83.2 119.1 118.5 125.2 71.2 231.5 128.8 62.5 101.0 87.1 104.1 237.8 54.6 86.5 231.3 55.6 165.0 113.5 5.7 19.3 14.7 24.5 25.5 32.4 29.2 27.8 28.5 34.1 24.1 30.2 31.3 2.6 26.7 30.1 19.3 39.1 24.3 8.3 9.8 10.1 12.4 7.9 9.5 10.4 9.8 10.8 9.4 8.9 11.9 31.1 22.4 23.1 6.2 27.1 47.2 48.0 60.4 29.0 6.1 24.5 23.9 6.7 30.0 38.1 27.6 8.4 51.2 21.6 13.4 35.2 51.1 53.5 27.1 28.8 26.7 30.5 62.3 2.8 44.7 67.5 28.1 23.4 20.8 14.5 31.0 13.6 16.8 34.9 0.0 3.8 26.7 48.8 17.1 18.7 17.7 32.3 15.4 30.2 3.7 27.1 16.7 18.6 6.6 19.0 38.8 18.8 30.1 25.8 45.4 18.2 25.8 35.6 14.9 26.3 25.0 49.0 243.2 92.1 42.7 45.9 30.6 21.6 35.1 40.4 38.5 MRPL47 "CGI-204, NCM1" ENSG00000136522 "Mitochondrial ribosomal protein L47" Q9HD33 3 179588285-179604649 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 399.7;Spermatocytes: 301.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037553, HPA047779" Approved Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria "HPA037553: AB_10671375, HPA047779: AB_2680154" "unprognostic (6.37e-2)" "prognostic favorable (6.44e-4)" "unprognostic (7.21e-2)" "prognostic unfavorable (3.15e-4)" "unprognostic (1.53e-1)" "unprognostic (8.55e-3)" "unprognostic (1.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.58e-1)" "unprognostic (8.03e-3)" "unprognostic (1.70e-2)" "unprognostic (1.29e-2)" "unprognostic (5.64e-2)" "unprognostic (3.06e-1)" "unprognostic (1.75e-1)" "unprognostic (1.71e-1)" "unprognostic (8.84e-2)" 27.2 34.8 30.6 24.0 31.7 48.8 27.2 34.2 41.1 19.4 34.2 32.1 23.7 23.0 22.8 31.8 18.9 18.5 54.9 29.4 34.7 44.4 35.5 20.1 30.0 32.0 31.8 16.6 17.4 33.9 24.0 22.2 32.6 20.6 31.8 26.6 21.1 18.9 52.5 21.5 22.6 24.7 33.3 24.3 26.2 53.1 32.6 33.3 21.0 56.9 30.4 32.0 21.7 34.2 128.6 48.6 83.0 76.7 51.5 53.5 95.2 73.2 65.1 112.3 93.2 198.6 51.8 104.7 140.6 62.5 137.2 94.5 103.5 76.9 120.5 121.0 90.9 99.8 46.1 112.5 99.8 182.2 54.2 49.6 65.7 83.4 84.7 53.1 77.2 95.9 59.5 81.4 88.1 98.9 98.4 168.4 144.3 115.4 114.6 102.7 81.1 175.3 120.4 79.6 71.8 83.5 80.7 128.6 151.2 61.9 198.6 136.6 61.6 60.7 87.4 77.1 204.5 102.1 182.4 229.3 70.7 147.4 75.8 38.2 32.4 44.2 31.7 43.8 32.2 35.1 35.1 34.7 48.4 31.8 30.4 31.7 8.5 41.5 54.4 41.9 48.9 35.8 30.6 31.7 34.2 41.1 29.4 34.7 32.0 31.8 32.6 33.3 32.6 34.2 45.3 22.4 21.7 5.5 51.4 74.9 82.0 179.7 38.7 20.2 36.4 33.4 89.7 54.3 78.6 57.0 10.4 100.0 61.2 46.3 258.2 112.3 399.7 72.8 56.0 55.5 54.9 62.9 7.1 115.9 109.6 51.8 36.2 50.0 56.4 34.0 44.3 62.5 99.3 10.1 9.2 52.8 105.8 42.4 55.7 95.4 42.9 53.5 48.0 4.7 80.3 43.4 39.1 7.1 12.4 118.7 53.6 49.2 54.6 72.6 45.2 201.7 85.5 26.0 59.2 57.9 68.2 301.2 54.0 52.2 70.5 104.1 57.8 102.3 71.9 83.8 NDUFB5 "CI-SGDH, MGC12314, SGDH" ENSG00000136521 "NADH:ubiquinone oxidoreductase subunit B5" O43674 3 179604690-179627647 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 241.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005640 Enhanced Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Nucleoplasm "HPA005640: AB_1079461" "unprognostic (6.76e-2)" "unprognostic (1.09e-2)" "unprognostic (6.33e-2)" "unprognostic (3.51e-3)" "unprognostic (1.38e-1)" "unprognostic (7.35e-3)" "unprognostic (1.33e-2)" "unprognostic (1.63e-1)" "unprognostic (4.46e-2)" "unprognostic (5.96e-3)" "unprognostic (4.83e-2)" "unprognostic (7.11e-2)" "prognostic favorable (3.32e-5)" "unprognostic (3.05e-1)" "unprognostic (1.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.95e-1)" 61.0 88.4 35.6 29.0 38.5 19.5 47.8 39.4 57.3 37.7 52.8 64.0 75.1 30.2 15.6 56.7 33.4 28.8 217.0 38.4 40.0 93.5 74.0 34.4 36.1 37.1 36.6 41.9 52.3 66.6 40.2 27.0 37.4 32.6 36.1 22.7 43.7 20.2 241.4 43.6 57.0 22.3 35.4 46.3 63.8 42.2 39.8 31.4 41.6 166.9 24.8 46.2 41.5 38.9 96.5 23.2 51.2 66.8 52.3 66.0 75.6 58.5 42.0 48.1 50.7 79.8 53.4 72.7 193.4 32.7 119.5 89.9 48.9 47.4 38.9 182.5 43.1 90.4 31.2 44.8 52.3 97.9 64.0 64.9 60.7 31.2 51.0 61.0 62.8 62.1 71.2 98.7 51.8 68.8 55.8 60.5 80.2 138.7 80.8 64.2 63.3 205.1 82.5 46.8 41.1 62.4 34.9 169.9 126.7 36.2 265.9 151.2 64.5 46.6 47.8 61.7 139.9 158.0 193.6 122.5 75.8 91.7 67.9 94.6 104.5 49.9 43.8 127.8 64.5 90.2 60.0 51.6 145.5 67.2 59.8 62.9 18.9 48.1 154.8 81.0 84.0 105.6 35.6 38.5 39.4 57.3 38.4 40.0 37.1 36.6 37.4 35.4 39.8 38.9 113.6 48.1 48.5 17.3 90.2 85.1 115.2 374.4 73.4 45.9 121.0 138.6 362.3 88.6 164.3 88.3 33.3 234.0 54.5 115.9 508.7 132.5 162.6 118.4 79.0 89.2 117.5 75.3 16.1 105.7 150.0 87.1 77.5 62.9 93.8 120.1 105.7 118.3 253.5 40.4 22.6 196.0 266.5 261.3 133.0 28.9 81.1 133.6 135.2 15.9 180.0 107.2 70.0 19.6 25.8 81.5 163.4 70.0 75.0 89.8 293.5 462.8 157.9 73.4 72.3 87.1 98.5 265.7 128.3 105.9 88.7 230.0 72.9 257.4 268.8 163.4 USP13 IsoT-3 ENSG00000058056 "Ubiquitin specific peptidase 13" Q92995 3 179653032-179804366 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 149.2;tongue: 108.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 208.5;Inhibitory neurons: 52.2;Theca cells: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 15.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 93.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004827 Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Cytosol" "HPA004827: AB_1080497" "unprognostic (1.00e-2)" "unprognostic (2.09e-1)" "unprognostic (5.82e-2)" "unprognostic (7.14e-2)" "unprognostic (9.94e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (2.40e-5)" "unprognostic (1.76e-1)" "unprognostic (4.55e-2)" "unprognostic (7.79e-2)" "unprognostic (1.69e-3)" "unprognostic (2.22e-2)" "prognostic unfavorable (3.46e-6)" "unprognostic (4.93e-2)" "unprognostic (9.79e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (3.06e-4)" 6.2 11.9 3.9 2.8 13.6 1.5 5.3 8.6 12.0 3.3 0.0 2.9 1.2 5.7 3.4 4.0 3.4 4.5 42.5 3.7 4.7 3.0 4.6 5.4 3.6 11.3 10.5 12.5 4.1 4.0 5.8 2.6 12.7 4.3 2.2 7.1 6.2 2.7 149.2 2.2 1.9 6.3 6.4 2.1 1.7 6.0 8.1 2.4 9.7 108.9 3.5 3.5 2.2 34.4 27.6 11.3 20.0 14.8 8.9 14.1 11.6 18.6 17.4 23.7 18.8 17.1 9.6 35.6 18.0 17.2 27.6 2.6 21.4 9.1 26.4 93.3 14.8 9.0 23.6 14.4 6.3 26.5 1.1 10.5 3.0 18.8 18.5 9.1 16.6 11.9 4.7 43.0 15.7 15.0 22.5 3.0 17.9 1.3 13.1 29.3 20.2 27.4 11.7 7.9 13.0 14.5 14.1 16.9 7.2 5.4 37.0 12.7 24.1 28.6 27.6 23.7 64.1 29.5 21.2 78.3 13.0 15.0 27.2 0.1 0.3 0.0 2.6 0.5 15.6 3.2 1.8 3.8 1.5 0.9 1.2 1.3 0.0 0.0 0.7 4.5 0.7 1.3 3.9 13.6 8.6 12.0 3.7 4.7 11.3 10.5 12.7 6.4 8.1 34.4 45.0 9.6 35.9 14.0 5.3 2.5 1.9 1.4 0.6 13.7 7.1 5.2 208.5 5.7 5.4 1.8 6.2 10.7 5.6 1.4 15.6 1.1 2.6 13.9 11.4 10.1 9.6 5.5 23.2 4.4 2.4 12.0 4.1 2.5 2.5 35.5 22.1 7.6 4.3 16.8 52.2 2.9 0.0 4.8 3.5 3.6 9.3 5.0 14.2 16.9 1.7 7.0 3.1 36.2 42.5 1.0 12.2 9.4 4.5 4.4 0.1 2.7 3.7 10.2 13.1 17.8 12.0 6.1 2.8 4.8 1.6 5.1 4.1 58.8 4.5 1.4 PEX5L "PEX5R, PXR2, TRIP8b" ENSG00000114757 "Peroxisomal biogenesis factor 5 like" Q8IYB4 3 179794958-180037053 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 185.5" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 252.3;Excitatory neurons: 848.2;Inhibitory neurons: 475.2;Oligodendrocyte precursor cells: 215.1;Oligodendrocytes: 2006.1" "Cancer enhanced" "Detected in some" "glioma: 0.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HDLM-2: 7.8;MOLT-4: 27.9;RPMI-8226: 21.8;SCLC-21H: 12.8;U-266/70: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058026 Enhanced NA NA "Cluster 70: Brain - Nervous system development" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA058026: AB_2683582" "unprognostic (5.21e-2)" "unprognostic (1.52e-1)" "unprognostic (1.53e-1)" "unprognostic (1.36e-2)" "unprognostic (2.93e-1)" "unprognostic (1.82e-3)" "unprognostic (2.68e-2)" "unprognostic (1.52e-2)" "unprognostic (2.10e-1)" "unprognostic (3.33e-4)" "unprognostic (9.67e-5)" "unprognostic (3.84e-1)" "unprognostic (2.66e-10)" "unprognostic (2.27e-3)" "unprognostic (1.45e-2)" "unprognostic (1.69e-2)" "unprognostic (4.03e-3)" 0.7 0.3 26.2 0.1 85.5 0.0 0.1 60.1 53.9 0.1 0.0 0.0 0.1 0.1 0.3 0.1 0.2 0.0 0.2 34.1 26.5 0.1 0.0 0.2 0.0 72.2 64.0 1.8 10.2 30.1 5.3 0.0 71.6 0.2 0.0 15.3 0.2 0.0 1.3 0.1 0.1 0.0 42.1 0.0 0.1 4.8 56.5 2.7 0.2 0.4 0.0 0.0 0.0 185.5 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 2.4 0.0 7.8 0.1 0.0 0.2 0.0 0.0 1.5 0.1 0.1 0.0 0.0 1.3 0.7 0.0 0.7 0.0 3.8 0.0 0.0 27.9 0.0 1.6 0.0 0.3 0.2 0.0 21.8 0.0 0.0 12.8 0.7 0.0 0.0 0.0 0.0 0.1 2.1 0.0 2.7 0.1 0.0 0.7 16.7 0.5 0.1 0.4 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 85.5 60.1 53.9 34.1 26.5 72.2 64.0 71.6 42.1 56.5 185.5 0.0 0.0 0.0 65.6 0.0 0.0 0.2 0.0 0.0 11.3 0.1 0.1 3.2 0.0 0.0 0.0 252.3 0.1 0.0 0.0 0.0 0.0 29.6 0.2 0.6 0.4 0.0 0.0 848.2 0.6 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.1 10.1 475.2 0.2 0.0 0.0 0.4 18.0 0.3 0.1 0.0 35.6 0.7 2.3 0.0 215.1 2006.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 9.5 0.0 2.4 0.2 0.7 1.1 0.0 0.3 0.0 0.1 1.9 0.0 0.1 TTC14 "FLJ00166, KIAA1980" ENSG00000163728 "Tetratricopeptide repeat domain 14" Q96N46 3 180602163-180617828 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009295 Uncertain Approved Nucleoplasm NA NA "Cluster 6: Non-specific - Transcription" "Cluster 51: Non-specific - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA009295: AB_1858425" "unprognostic (2.72e-1)" "unprognostic (4.85e-1)" "unprognostic (1.11e-1)" "unprognostic (1.59e-2)" "unprognostic (1.48e-2)" "unprognostic (1.54e-1)" "unprognostic (2.43e-2)" "unprognostic (1.39e-1)" "unprognostic (1.91e-2)" "unprognostic (2.01e-1)" "unprognostic (3.63e-1)" "unprognostic (2.22e-3)" "unprognostic (2.27e-3)" "unprognostic (1.95e-1)" "unprognostic (2.08e-1)" "unprognostic (8.07e-2)" "unprognostic (2.33e-3)" 25.9 23.3 18.2 28.5 20.1 30.7 27.7 13.7 22.7 40.6 27.9 33.7 23.4 35.2 43.7 17.9 38.7 19.5 25.0 20.2 16.2 36.8 21.6 28.0 41.3 17.8 16.2 56.1 35.3 27.3 57.9 21.5 17.1 36.3 22.0 68.6 22.0 23.8 13.7 22.2 31.2 19.7 15.9 33.4 28.0 20.5 16.6 24.1 49.4 7.2 28.9 29.6 32.4 25.2 18.6 15.2 22.7 12.9 29.6 25.9 21.4 26.1 21.0 18.8 30.8 20.3 24.3 27.9 27.4 18.9 43.0 26.2 21.3 13.9 25.4 52.0 21.5 26.5 37.0 46.2 21.8 28.7 23.3 32.9 26.3 18.9 9.4 31.1 15.2 35.2 11.3 5.4 21.1 5.4 21.9 2.1 16.1 23.0 29.6 25.5 14.0 29.9 10.6 14.0 19.4 18.8 24.8 12.5 25.8 22.7 47.0 26.9 24.3 37.6 19.3 17.4 48.7 40.2 66.2 62.0 18.4 35.1 16.7 23.8 9.4 10.6 10.6 10.4 12.7 14.7 11.0 10.6 7.1 10.7 13.3 10.9 7.5 13.9 14.6 17.6 10.7 6.3 18.2 20.1 13.7 22.7 20.2 16.2 17.8 16.2 17.1 15.9 16.6 25.2 33.8 9.6 35.6 135.2 82.1 17.7 33.5 33.6 23.9 98.2 25.8 15.9 14.0 41.5 38.9 66.2 116.7 33.4 114.3 27.8 3.9 28.4 6.2 19.0 41.7 38.7 39.0 41.8 173.1 32.7 19.6 41.8 30.5 19.6 59.6 112.6 45.0 30.4 24.5 80.8 169.9 24.8 30.5 31.7 23.0 11.0 92.6 37.5 30.2 111.5 61.0 49.8 121.5 120.1 160.0 31.9 38.9 81.3 61.5 23.9 42.7 9.4 40.7 123.5 85.5 47.1 40.2 59.6 29.9 16.8 15.3 24.6 68.8 72.2 23.4 23.1 CCDC39 "CFAP59, CILD14, DKFZp434A128, FAP59" ENSG00000284862 "Coiled-coil domain containing 39" Q9UFE4 3 180602858-180684942 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.7;retina: 21.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Early spermatids: 106.9;Endometrial ciliated cells: 38.7;Late spermatids: 58.3;Respiratory ciliated cells: 159.7;Rod photoreceptor cells: 40.3;Spermatocytes: 56.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035363, HPA035364" Enhanced NA NA "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" "HPA035363: AB_2674588, HPA035364: AB_10601095" 2.3 4.2 0.4 9.3 0.7 5.6 0.2 1.0 2.6 0.5 4.9 1.8 6.9 5.1 0.4 3.5 11.3 7.9 3.6 0.6 0.9 1.4 0.5 4.4 21.7 2.8 2.2 7.6 2.7 0.0 1.5 1.6 2.8 0.0 21.9 4.4 0.0 2.9 20.3 7.0 0.1 1.7 10.8 4.2 9.3 0.3 0.0 8.0 0.0 0.0 2.5 2.1 5.1 2.9 11.5 2.6 0.0 0.0 3.5 2.9 0.0 0.0 0.0 3.7 4.3 13.9 4.3 0.0 2.6 4.6 0.1 0.0 0.0 7.6 6.4 6.7 10.7 7.9 0.0 10.4 6.0 0.0 0.0 0.0 0.0 11.9 0.0 13.7 4.5 1.0 0.4 1.3 5.8 0.2 6.6 2.3 6.4 7.4 3.7 16.5 0.0 6.9 5.3 5.8 3.0 2.6 2.2 5.5 7.4 6.9 8.1 8.5 3.6 3.7 9.0 8.5 6.9 13.5 5.6 9.4 1.6 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 1.0 2.6 0.6 0.9 2.8 2.2 1.6 1.7 0.3 2.1 0.1 0.0 0.0 1.3 0.2 0.5 0.0 3.3 0.0 7.0 0.0 0.0 0.0 0.0 9.6 0.0 64.6 0.0 0.1 0.0 0.0 0.0 106.9 38.7 0.3 0.4 0.0 0.0 21.8 0.2 0.0 4.0 0.0 0.5 0.0 0.1 12.8 0.1 0.0 1.7 6.8 0.0 0.0 0.9 0.7 58.3 13.4 0.3 1.8 0.0 0.0 2.8 0.0 4.0 1.3 0.0 0.0 9.8 2.4 0.2 0.0 0.0 159.7 40.3 6.6 4.1 1.3 56.0 6.9 0.2 0.6 0.0 0.2 0.2 0.0 0.1 FXR1 ENSG00000114416 "FMR1 autosomal homolog 1" P51114 3 180868141-180982753 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Myogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 788.7;tongue: 451.3" "Group enriched" "Detected in all" 4 "Early spermatids: 986.2;Late spermatids: 1759.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018246, HPA055475" Approved Enhanced Cytosol NA NA 15000 "Cluster 35: T-regs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA018246: AB_1849204, HPA055475: AB_2682828" "unprognostic (1.38e-1)" "unprognostic (1.59e-2)" "unprognostic (5.23e-2)" "prognostic unfavorable (5.96e-4)" "unprognostic (1.04e-2)" "unprognostic (1.90e-3)" "prognostic unfavorable (2.70e-4)" "unprognostic (7.77e-3)" "unprognostic (9.20e-2)" "unprognostic (2.75e-2)" "prognostic unfavorable (7.30e-4)" "unprognostic (3.28e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (7.85e-2)" "unprognostic (2.06e-1)" "unprognostic (2.02e-1)" "unprognostic (2.84e-2)" 35.8 40.1 54.8 22.4 65.0 48.1 31.9 62.9 76.0 36.6 54.2 49.1 21.2 41.4 26.3 40.0 33.3 25.6 118.9 51.5 66.1 26.8 33.9 24.6 30.0 63.7 60.6 49.2 34.3 32.5 25.5 39.0 64.9 38.0 20.1 42.2 29.7 32.6 788.7 21.9 22.4 36.2 60.5 23.1 32.3 132.4 60.8 50.5 31.4 451.3 30.5 38.5 28.3 93.2 144.2 65.8 138.8 108.5 104.6 118.4 62.7 111.9 114.0 123.1 120.5 97.5 70.9 73.3 179.8 77.7 193.9 67.6 113.3 68.8 171.0 97.4 76.1 74.3 88.9 112.7 110.8 46.6 58.5 125.7 77.0 62.3 147.8 183.7 126.1 70.5 60.7 86.0 157.1 52.2 89.4 78.3 156.8 88.8 71.2 61.0 177.5 78.6 95.4 44.6 58.4 74.6 96.8 110.9 149.9 193.7 154.7 88.5 101.3 92.0 102.3 58.1 223.3 79.0 108.9 86.9 96.0 65.9 120.2 9.4 12.6 10.0 11.7 13.7 12.2 12.9 12.3 10.6 14.4 9.1 15.5 12.9 10.9 11.6 10.4 10.2 22.2 9.6 54.8 65.0 62.9 76.0 51.5 66.1 63.7 60.6 64.9 60.5 60.8 93.2 89.1 64.1 75.0 58.1 81.1 78.4 97.6 68.5 78.6 72.6 67.7 72.3 224.6 48.6 74.8 35.0 56.3 96.8 93.5 28.9 58.7 84.5 986.2 158.2 132.1 78.1 53.8 105.6 75.6 75.8 99.5 78.6 33.6 114.8 126.6 106.3 62.4 70.2 67.9 87.5 87.8 36.1 40.7 76.6 58.7 1759.0 84.2 73.2 49.8 48.7 138.5 97.5 52.5 86.5 137.5 73.3 39.2 76.0 74.3 68.8 62.1 106.8 104.1 86.5 32.9 116.3 89.1 318.6 113.5 57.9 70.6 61.2 87.3 97.4 42.8 67.1 DNAJC19 "Pam18, Tim14, TIMM14" ENSG00000205981 "DnaJ heat shock protein family (Hsp40) member C19" Q96DA6 3 180983709-180989774 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone Cardiomyopathy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 471.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037782 Approved NA NA "Cluster 44: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "HPA037782: AB_10672611" "unprognostic (4.52e-2)" "unprognostic (3.55e-3)" "unprognostic (3.08e-2)" "unprognostic (2.45e-3)" "unprognostic (1.41e-1)" "unprognostic (5.54e-2)" "unprognostic (1.39e-1)" "unprognostic (1.14e-1)" "unprognostic (4.01e-2)" "prognostic favorable (8.53e-5)" "unprognostic (6.19e-2)" "unprognostic (1.76e-2)" "unprognostic (2.14e-2)" "unprognostic (1.75e-1)" "unprognostic (4.66e-1)" "unprognostic (3.33e-1)" "unprognostic (4.20e-3)" 22.7 44.1 26.1 11.1 27.1 10.8 26.4 27.2 39.7 19.4 28.8 27.5 21.4 18.9 33.0 22.9 21.3 11.8 73.4 27.2 28.0 50.2 48.9 14.7 16.3 26.4 29.3 26.5 27.9 34.7 30.9 14.2 26.3 22.6 17.7 27.2 28.1 18.2 65.8 15.0 18.1 11.8 27.6 18.5 26.2 11.6 26.8 20.7 25.6 77.8 13.4 23.5 18.4 28.1 53.9 14.0 38.8 29.6 45.6 27.0 35.4 30.2 18.2 29.1 25.5 49.0 26.2 23.0 63.9 25.5 70.9 26.8 37.8 36.5 35.9 36.5 49.1 27.0 24.5 48.3 48.9 64.9 27.5 25.9 29.8 24.4 43.0 37.9 34.0 55.2 42.8 35.8 23.0 44.2 48.5 54.6 51.2 75.9 44.8 31.4 26.9 69.6 43.3 24.8 38.7 20.6 30.8 75.8 82.3 44.0 85.2 45.2 16.8 18.5 27.1 26.3 54.4 47.7 60.7 80.1 19.0 49.9 22.9 33.6 20.4 31.5 33.3 22.3 39.8 34.7 38.5 34.7 28.6 29.8 39.8 40.6 4.4 26.8 27.3 36.4 35.0 30.8 26.1 27.1 27.2 39.7 27.2 28.0 26.4 29.3 26.3 27.6 26.8 28.1 68.3 38.5 52.5 11.1 66.3 56.6 68.6 105.4 56.9 31.7 138.6 183.0 151.7 120.1 70.1 77.3 14.6 116.6 67.4 57.9 471.6 83.9 9.1 57.4 50.4 61.4 45.2 48.8 18.7 109.3 111.2 71.7 30.1 42.7 110.7 79.7 68.6 167.0 68.0 48.8 20.5 90.7 91.6 35.5 59.8 13.2 85.1 42.8 74.7 9.4 58.6 91.4 74.2 13.0 21.4 79.9 66.1 72.6 47.7 91.5 101.0 216.8 58.7 67.6 85.5 80.3 108.8 82.1 56.3 73.9 60.1 68.7 68.4 121.4 86.7 69.2 SOX2 ENSG00000181449 "SRY-box transcription factor 2" P48431 3 181711925-181714436 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.2;esophagus: 24.5" "Group enriched" "Detected in some" 6 "Basal squamous epithelial cells: 362.0;Muller glia cells: 383.5;Squamous epithelial cells: 229.1" "Cancer enhanced" "Detected in many" "glioma: 136.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 277.0;HAP1: 118.6;NTERA-2: 226.2;U-251 MG: 54.0" "Low region specificity" "Detected in all" "HPA045725, HPA062851, HPA071379, CAB079745" Enhanced Supported Enhanced Nucleoplasm NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: " "unprognostic (1.80e-2)" "unprognostic (3.18e-3)" "unprognostic (5.69e-2)" "unprognostic (6.96e-2)" "unprognostic (2.74e-3)" "unprognostic (1.60e-1)" "unprognostic (1.79e-2)" "unprognostic (4.48e-3)" "unprognostic (1.71e-1)" "unprognostic (4.38e-3)" "unprognostic (1.83e-1)" "unprognostic (7.68e-2)" "unprognostic (3.81e-9)" "unprognostic (1.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.12e-2)" 0.3 0.9 58.0 0.5 58.5 0.0 0.2 47.1 56.6 2.1 8.6 5.5 0.4 0.1 0.2 24.5 3.1 0.2 0.5 46.5 59.0 0.0 0.1 1.8 0.0 50.5 58.9 0.3 0.1 0.0 13.6 0.0 45.2 2.5 0.4 15.0 18.4 0.3 0.1 0.6 1.4 0.2 59.8 0.0 7.9 1.9 59.2 0.4 0.1 0.1 5.3 1.3 4.8 62.2 0.1 9.0 277.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.6 0.3 0.0 0.1 0.0 0.2 0.7 118.6 3.2 0.0 0.1 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 226.2 12.4 0.5 0.0 0.6 0.0 31.0 0.4 0.5 1.2 0.0 0.0 0.1 45.7 1.7 0.1 0.0 0.0 4.2 0.0 54.0 0.0 0.0 0.0 0.2 0.0 35.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.0 58.5 47.1 56.6 46.5 59.0 50.5 58.9 45.2 59.8 59.2 62.2 0.2 0.0 6.0 0.0 0.0 0.3 35.5 28.5 362.0 4.9 0.2 0.4 0.5 0.0 48.4 3.7 0.0 0.2 0.0 1.1 0.0 0.0 0.9 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.1 1.6 19.4 0.0 1.3 0.2 0.7 0.1 0.1 0.0 0.0 0.5 38.7 0.0 0.4 0.4 0.6 0.8 3.6 0.0 0.0 383.5 0.0 0.0 0.0 0.0 0.0 0.0 6.1 5.8 0.0 0.1 52.8 13.1 0.0 0.2 1.6 3.9 0.4 229.1 0.4 0.3 0.6 0.2 0.0 7.5 ATP11B "ATPIF, ATPIR, KIAA0956" ENSG00000058063 "ATPase phospholipid transporting 11B (putative)" Q9Y2G3 3 182793503-182921629 "Enzymes, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036237, HPA036238" Uncertain Approved "Centriolar satellite,Cytosol" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 29: U-266 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "Centriolar satellite, Cytosol" "HPA036237: AB_10673123, HPA036238: AB_10670792" "unprognostic (4.52e-2)" "unprognostic (1.81e-1)" "unprognostic (3.37e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.50e-1)" "unprognostic (1.50e-1)" "unprognostic (6.73e-2)" "unprognostic (2.03e-3)" "unprognostic (7.28e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.02e-1)" "unprognostic (1.71e-1)" "unprognostic (1.62e-1)" "unprognostic (3.22e-1)" "unprognostic (8.66e-2)" "unprognostic (1.35e-1)" 20.6 10.7 4.7 24.9 6.9 70.6 17.4 15.9 7.6 19.1 13.8 26.3 24.3 18.7 14.6 45.4 13.7 21.1 14.1 6.0 6.3 18.0 18.3 16.5 27.9 7.5 6.1 20.5 21.0 29.4 10.3 14.5 7.3 28.3 29.0 30.8 19.4 13.4 11.4 28.2 24.0 19.5 5.6 21.8 51.1 31.6 6.6 44.6 16.8 16.8 28.4 25.7 22.5 15.8 69.7 9.7 20.5 28.7 42.6 46.1 19.3 32.8 41.6 23.2 27.1 23.7 34.0 31.3 53.5 44.0 48.2 40.4 24.6 31.3 40.2 73.9 20.9 76.7 13.1 5.2 24.8 62.3 47.3 31.5 34.7 26.1 37.4 34.1 37.0 48.7 27.7 94.3 37.8 22.9 50.3 19.1 14.5 38.1 19.2 21.2 59.8 37.8 28.1 55.8 12.5 22.0 86.2 10.7 36.9 18.3 11.9 43.7 36.6 35.0 38.7 30.5 56.2 131.0 125.5 58.1 24.1 25.3 20.9 5.5 1.0 4.3 1.7 1.0 1.7 2.1 1.4 1.7 1.1 1.3 1.2 1.8 3.8 1.8 1.0 2.4 1.2 0.8 4.7 6.9 15.9 7.6 6.0 6.3 7.5 6.1 7.3 5.6 6.6 15.8 26.8 16.0 13.2 34.6 27.8 34.3 25.7 15.9 26.2 12.2 13.8 9.7 15.6 18.6 16.5 20.2 14.6 12.8 43.0 44.6 0.0 12.5 34.1 19.0 22.9 15.7 6.7 26.1 81.6 16.5 3.8 19.5 46.4 22.1 11.4 14.0 16.1 16.4 10.4 38.7 64.3 30.5 16.2 19.4 26.4 23.8 19.3 29.3 14.2 45.9 19.9 8.4 27.8 67.8 132.6 25.2 27.0 21.1 55.5 35.8 24.3 7.8 19.8 31.4 19.7 24.1 17.7 18.7 11.4 43.8 44.6 9.6 40.9 7.0 27.3 45.4 DCUN1D1 "DCUN1L1, RP42, SCCRO, SCRO, Tes3" ENSG00000043093 "Defective in cullin neddylation 1 domain containing 1" Q96GG9 3 182938074-182985953 "Predicted intracellular proteins" "Ubl conjugation pathway" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 246.2" "Cell type enriched" "Detected in all" 5 "Late spermatids: 13031.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035911 Uncertain Approved Nucleoplasm,Cytosol NA NA 130000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 83: Testis - Spermatogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA035911: AB_10673489" "unprognostic (2.13e-1)" "unprognostic (2.36e-1)" "unprognostic (4.83e-3)" "unprognostic (1.94e-3)" "unprognostic (1.44e-3)" "unprognostic (6.06e-2)" "unprognostic (5.93e-2)" "unprognostic (1.72e-2)" "unprognostic (9.34e-2)" "unprognostic (9.25e-3)" "unprognostic (4.98e-3)" "unprognostic (7.26e-2)" "unprognostic (1.01e-3)" "unprognostic (1.52e-1)" "unprognostic (2.12e-1)" "unprognostic (5.01e-2)" "unprognostic (3.52e-1)" 14.7 12.3 10.5 12.3 13.9 22.4 13.0 13.2 16.3 11.6 4.0 14.0 13.7 12.9 9.4 18.1 10.4 12.8 15.7 10.0 10.6 19.2 31.5 10.6 15.4 11.0 12.3 12.4 10.2 12.0 8.4 12.6 13.0 13.6 13.1 11.3 11.0 13.9 34.5 14.4 14.4 15.4 11.6 12.5 11.4 246.2 12.0 13.6 17.7 38.1 17.5 14.9 10.2 18.3 54.3 23.5 31.0 13.1 32.4 30.8 26.3 33.9 37.8 37.4 36.2 34.9 39.0 63.6 72.5 32.2 56.4 29.4 27.6 28.5 49.8 52.2 14.3 61.1 17.2 14.8 20.2 36.6 44.3 23.3 32.6 22.3 20.7 28.3 26.7 38.0 20.6 32.6 27.9 28.8 36.2 19.0 25.3 40.4 21.7 27.9 32.4 41.6 27.5 37.6 22.4 22.3 59.7 41.9 33.1 32.6 86.0 29.0 25.6 22.9 22.2 31.7 40.3 26.5 53.3 64.0 29.0 33.8 33.8 10.2 8.5 16.3 6.7 9.2 6.6 6.4 5.6 6.6 10.0 4.1 6.2 6.8 13.7 10.5 6.2 7.5 7.4 5.5 10.5 13.9 13.2 16.3 10.0 10.6 11.0 12.3 13.0 11.6 12.0 18.3 23.5 22.4 29.5 54.2 22.3 43.3 26.0 28.3 23.3 13.2 26.6 15.4 32.5 21.5 30.1 47.8 10.4 18.8 36.3 29.1 37.2 28.3 2437.8 24.0 29.9 23.7 26.9 98.1 52.7 30.5 18.7 29.0 18.3 26.3 29.8 22.1 17.9 52.6 28.6 18.5 40.9 19.6 30.5 45.9 54.2 13031.2 86.6 39.5 12.4 30.0 45.9 18.1 20.6 37.7 91.9 31.9 24.1 64.3 20.2 42.0 27.3 42.3 24.0 22.6 78.9 35.9 37.4 124.6 58.7 25.7 42.5 20.0 27.1 15.3 20.7 43.6 MCCC1 MCCA ENSG00000078070 "Methylcrotonoyl-CoA carboxylase 1" Q96RQ3 3 183015218-183116075 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 153.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008310 Approved Supported Mitochondria "Intracellular and membrane" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 6: T47d - Mammary gland" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Mitochondria "HPA008310: AB_1853620" "unprognostic (4.01e-2)" "unprognostic (1.83e-3)" "unprognostic (2.05e-2)" "unprognostic (2.59e-3)" "unprognostic (3.46e-2)" "unprognostic (4.16e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-3)" "unprognostic (2.57e-3)" "unprognostic (9.82e-2)" "unprognostic (9.74e-2)" "unprognostic (7.65e-2)" "prognostic favorable (3.68e-4)" "unprognostic (4.73e-1)" "unprognostic (2.21e-1)" "unprognostic (2.95e-1)" "unprognostic (1.36e-1)" 37.9 22.6 9.5 9.5 10.9 13.9 33.2 9.9 13.4 12.3 13.8 17.4 16.1 10.1 14.6 17.6 12.2 11.9 34.2 9.2 9.3 58.8 59.3 17.9 11.7 9.5 9.1 17.2 31.2 18.7 8.4 6.3 10.6 15.1 18.6 10.8 18.0 13.4 21.9 12.2 13.8 10.6 9.3 11.8 21.7 9.1 11.1 16.0 18.9 26.3 15.5 26.5 9.4 13.3 43.1 16.5 10.3 10.6 42.6 19.1 20.4 19.5 26.4 21.1 23.5 22.9 17.1 47.6 31.0 17.2 35.8 22.0 15.4 12.9 26.4 16.6 17.0 40.0 18.3 23.9 28.7 27.5 22.0 21.6 14.5 10.0 23.3 14.0 28.6 40.7 22.7 24.7 23.6 35.4 27.1 15.9 11.2 66.3 17.9 22.4 22.6 60.1 32.2 67.2 22.0 16.4 75.3 100.1 21.1 10.7 153.9 37.8 14.0 15.8 12.5 12.8 28.6 24.3 48.8 48.2 16.8 38.4 15.2 14.4 13.3 25.0 10.7 15.6 12.3 17.9 14.1 11.8 26.6 15.4 14.7 13.1 2.1 25.4 16.8 17.3 9.6 10.7 9.5 10.9 9.9 13.4 9.2 9.3 9.5 9.1 10.6 9.3 11.1 13.3 6.2 9.6 53.9 44.7 14.6 7.0 20.1 17.9 15.9 13.0 10.6 9.5 32.8 31.5 20.2 27.6 10.4 35.4 6.3 7.2 33.2 25.3 5.4 11.0 10.2 6.6 6.0 10.9 66.6 17.2 5.4 10.3 21.4 21.9 7.6 19.0 6.1 36.5 16.5 8.4 56.9 13.6 16.2 11.1 8.6 5.5 8.7 10.5 7.2 44.0 10.5 12.0 4.1 47.7 61.6 13.4 15.8 10.5 12.5 10.4 13.5 40.6 21.4 11.2 6.6 11.6 9.6 8.1 4.4 22.3 5.8 28.3 10.1 24.3 20.5 21.7 LAMP3 "CD208, DC-LAMP, DCLAMP, LAMP, TSC403" ENSG00000078081 "Lysosomal associated membrane protein 3" Q9UQV4 3 183122215-183163839 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "lung: 219.7" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 486.7;monocytes: 339.6" "Cancer enhanced" "Detected in many" "lung cancer: 27.6" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "eosinophil: 5.6" "Group enriched" "Detected in many" 8 "granulocytes: 5.6;T-cells: 4.8" "Group enriched" "Detected in many" 4 "EFO-21: 169.5;HDLM-2: 46.6;HHSteC: 60.4;hTCEpi: 59.1;JURKAT: 52.7" "CAB025133, HPA051467" Enhanced Enhanced Vesicles NA NA 59000 "Cluster 13: T-cells - Unknown function" "Cluster 19: Lung - Lung function" "Cluster 38: EFO-21 - Unknown function" "Cluster 3: Monocytes - Immune response regulation" Vesicles "CAB025133: , HPA051467: AB_2681495" "unprognostic (1.43e-3)" "unprognostic (2.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.99e-3)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (7.67e-2)" "unprognostic (8.64e-2)" "unprognostic (4.95e-2)" "prognostic favorable (9.90e-4)" "unprognostic (1.80e-3)" "unprognostic (5.80e-2)" "prognostic unfavorable (1.89e-7)" "unprognostic (3.12e-1)" "unprognostic (4.13e-2)" "unprognostic (8.35e-2)" "unprognostic (1.29e-1)" 0.7 0.6 0.2 33.1 0.4 0.8 1.3 0.3 0.2 1.4 0.0 3.2 2.7 0.7 2.6 4.4 1.1 3.9 0.3 0.2 0.1 0.6 0.9 219.7 16.1 0.2 0.1 0.3 7.8 1.9 0.5 1.9 0.1 2.7 6.8 0.6 27.2 2.5 0.2 7.0 3.1 4.3 0.2 9.0 4.1 22.7 0.3 28.1 7.5 0.2 21.5 11.2 0.9 0.0 10.7 0.3 0.2 1.7 0.1 0.1 8.7 0.2 2.8 1.8 0.5 2.8 5.3 0.1 169.5 0.9 18.9 1.5 3.7 6.4 0.2 46.6 5.9 0.0 0.3 0.4 60.4 0.0 1.4 0.9 59.1 0.1 7.4 0.0 7.6 52.7 0.4 9.9 0.2 0.2 2.5 0.4 0.3 0.9 2.7 0.0 0.0 0.8 0.2 3.4 0.7 0.4 0.8 0.3 5.0 2.1 3.4 0.4 8.3 0.0 3.0 0.4 0.2 3.5 13.2 0.5 0.0 0.1 0.1 0.3 0.0 5.6 0.2 0.0 2.4 0.1 1.8 1.1 0.0 0.2 2.3 1.3 1.3 0.6 0.0 0.0 4.8 0.7 0.2 0.4 0.3 0.2 0.2 0.1 0.2 0.1 0.1 0.2 0.3 0.0 0.2 64.1 486.7 0.0 2.0 6.0 2.9 2.4 8.6 0.0 0.3 0.6 1.2 1.5 9.5 1.8 0.0 2.9 0.1 0.1 0.0 0.6 34.3 1.3 0.2 0.5 0.0 0.4 0.7 6.1 0.4 1.0 1.5 0.8 18.9 0.4 0.0 0.0 1.3 0.0 0.6 0.2 0.0 0.0 41.1 84.9 0.6 4.8 1.8 0.0 339.6 0.0 0.0 0.0 0.1 0.6 0.0 0.0 4.1 1.6 0.1 0.0 11.5 0.0 0.0 0.4 0.3 14.0 0.5 4.0 5.7 1.2 2.3 0.0 0.5 2.2 MCF2L2 "ARHGEF22, KIAA0861" ENSG00000053524 "MCF.2 cell line derived transforming sequence-like 2" Q86YR7 3 183178043-183428778 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 33.5;retina: 28.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 79.0;Cone photoreceptor cells: 221.0;Early spermatids: 92.9;Excitatory neurons: 177.2;Inhibitory neurons: 149.9;Oligodendrocyte precursor cells: 185.5;Oligodendrocytes: 69.1;Rod photoreceptor cells: 124.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "T-reg: 1.6" "Lineage enriched" "Detected in single" 15 "T-cells: 1.6" "Cell line enhanced" "Detected in some" "HDLM-2: 6.0;Karpas-707: 5.0;REH: 3.4" "Low region specificity" "Detected in all" "HPA038946, HPA038947, HPA061485" Uncertain Approved "Centriolar satellite,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 2: Karpas-707 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Centriolar satellite, Cytosol" "HPA038946: AB_10670914, HPA038947: AB_10672655, HPA061485: " "unprognostic (2.17e-2)" "unprognostic (4.42e-1)" "unprognostic (3.08e-1)" "unprognostic (1.95e-3)" "unprognostic (1.98e-1)" "unprognostic (2.87e-2)" "unprognostic (3.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (5.08e-2)" "unprognostic (4.80e-4)" "unprognostic (1.32e-1)" "unprognostic (8.75e-6)" "unprognostic (1.09e-1)" "unprognostic (5.47e-2)" "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" 0.1 7.7 9.4 0.3 16.5 0.2 0.1 0.3 33.5 0.3 0.0 0.5 0.0 0.2 0.2 0.2 0.2 0.3 0.2 13.5 6.5 0.4 0.0 0.2 0.5 6.9 6.1 0.2 0.2 3.8 5.4 0.0 7.2 0.6 0.3 28.2 0.1 0.4 0.3 0.2 0.3 0.3 0.0 2.5 0.2 2.6 5.6 0.3 0.1 0.2 0.7 0.4 0.3 19.8 0.0 0.4 0.1 1.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.7 0.1 1.0 0.1 0.0 1.2 0.0 0.2 0.1 0.0 6.0 0.9 2.5 0.2 0.0 0.1 0.8 0.5 0.1 0.0 0.0 0.4 0.0 0.4 1.5 0.8 5.0 0.3 0.7 0.8 0.5 0.8 0.0 1.0 3.4 0.0 0.9 0.2 0.1 1.5 0.5 0.6 0.0 1.3 0.3 0.3 0.5 0.3 0.0 0.5 0.0 0.0 2.0 2.3 1.1 0.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.6 0.0 9.4 16.5 0.3 33.5 13.5 6.5 6.9 6.1 7.2 0.0 5.6 19.8 12.3 0.0 2.2 17.0 0.2 0.4 0.5 0.2 8.6 79.0 0.3 0.6 1.8 0.0 0.1 5.5 221.0 0.2 0.8 2.1 0.0 0.1 92.9 4.6 2.1 2.0 0.0 0.4 177.2 0.2 0.1 2.0 5.1 4.3 1.3 7.7 1.8 0.4 0.5 8.4 149.9 0.3 2.0 0.8 1.2 16.4 0.9 4.3 1.8 43.1 1.6 3.8 1.0 185.5 69.1 0.1 2.2 0.4 0.6 0.3 0.4 0.1 2.8 124.0 0.0 4.1 0.9 1.4 4.2 11.2 0.4 1.4 2.9 2.9 0.2 1.1 B3GNT5 "B3GN-T5, beta3Gn-T5" ENSG00000176597 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5" Q9BYG0 3 183253253-183298504 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 76.5" "Cell type enhanced" "Detected in many" "Adipocytes: 151.2;Distal enterocytes: 150.4;Squamous epithelial cells: 169.9;Syncytiotrophoblasts: 157.9;Urothelial cells: 144.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 6 "neutrophil: 5.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 5.6" "Cell line enhanced" "Detected in many" "GAMG: 82.4;HBEC3-KT: 70.3;hTCEpi: 83.5" "Region enriched" "Detected in many" 4 "cerebellum: 14.7" "Low region specificity" "Detected in all" HPA017292 Uncertain Approved Nucleoli NA NA 28000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoli "HPA017292: AB_1845237" "unprognostic (2.17e-1)" "unprognostic (5.73e-2)" "unprognostic (1.07e-2)" "unprognostic (4.83e-3)" "unprognostic (1.89e-1)" "unprognostic (3.08e-2)" "prognostic unfavorable (5.09e-4)" "unprognostic (7.10e-3)" "unprognostic (7.78e-2)" "unprognostic (8.48e-2)" "prognostic unfavorable (7.23e-6)" "unprognostic (4.20e-1)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.18e-2)" "unprognostic (2.71e-1)" "unprognostic (3.53e-2)" "unprognostic (8.10e-3)" 11.9 2.4 3.3 13.7 3.5 76.5 5.5 2.3 3.2 6.0 0.9 22.6 38.2 5.1 9.1 37.5 9.6 21.3 3.5 3.7 4.0 3.8 3.3 15.0 1.1 5.6 3.8 4.6 7.5 3.5 5.7 13.9 4.6 7.9 19.6 1.2 10.1 3.3 7.4 10.3 42.0 6.7 4.3 1.6 11.3 7.3 3.5 7.6 5.2 4.5 5.3 24.2 13.8 5.5 46.2 4.4 23.8 14.7 19.5 57.0 21.5 0.7 1.1 4.6 3.8 9.0 23.6 0.0 2.7 0.1 82.4 20.6 24.7 70.3 3.9 0.1 15.3 2.4 1.9 0.0 24.8 23.4 10.9 27.0 83.5 3.7 62.1 6.2 43.4 0.1 26.6 0.1 38.1 0.0 0.1 7.6 10.1 26.9 38.5 7.3 12.0 0.1 14.4 12.7 1.0 22.6 12.7 0.1 5.3 10.6 0.0 28.0 64.6 1.1 9.0 1.4 11.0 0.0 0.0 0.0 8.8 54.1 23.8 0.0 1.0 1.0 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.2 0.3 3.3 3.5 2.3 3.2 3.7 4.0 5.6 3.8 4.6 4.3 3.5 5.5 151.2 6.4 17.5 2.3 1.2 65.1 70.2 35.8 101.3 10.0 18.4 10.4 2.2 21.5 40.5 5.5 22.9 31.0 1.9 150.4 1.9 18.0 13.4 58.0 13.1 26.3 38.2 6.3 1.8 11.8 10.7 9.2 70.3 55.3 14.0 2.4 2.2 0.6 29.6 3.3 1.5 88.2 34.6 15.6 123.2 26.5 1.5 76.8 12.4 80.6 9.4 3.1 0.0 4.5 0.8 35.7 126.4 0.4 1.4 43.1 74.9 4.8 118.5 13.1 0.0 23.6 5.4 7.9 0.8 169.9 84.8 157.9 4.3 0.2 36.2 144.4 KLHL6 FLJ00029 ENSG00000172578 "Kelch like family member 6" Q8WZ60 3 183487551-183555706 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lymphoid tissue: 31.0" "Cell type enhanced" "Detected in many" "B-cells: 35.7;Endometrial ciliated cells: 28.3;granulocytes: 51.1;Hofbauer cells: 24.1;Macrophages: 33.3;Plasma cells: 63.6;Respiratory ciliated cells: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 41.3;HEL: 26.6;HMC-1: 26.7;U-266/70: 82.1;U-266/84: 45.5;U-698: 121.3" "Low region specificity" "Detected in all" HPA024512 Uncertain Approved "Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite" Yes NA "Cluster 2: Granulocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Centriolar satellite" "Plasma membrane, Microtubules, Mitotic spindle" "HPA024512: AB_2131015" "unprognostic (8.46e-2)" "unprognostic (3.67e-4)" "unprognostic (1.48e-2)" "unprognostic (6.03e-4)" "unprognostic (5.15e-2)" "unprognostic (1.30e-3)" "unprognostic (1.39e-1)" "unprognostic (5.05e-2)" "unprognostic (7.43e-2)" "unprognostic (9.62e-2)" "unprognostic (8.24e-2)" "unprognostic (2.68e-1)" "prognostic unfavorable (3.53e-4)" "unprognostic (1.81e-1)" "unprognostic (3.68e-2)" "unprognostic (2.42e-1)" "unprognostic (5.73e-2)" 1.5 0.7 0.7 11.8 0.8 3.5 0.9 1.0 1.0 0.8 0.7 2.5 2.5 0.6 0.2 0.6 4.8 2.1 0.7 0.6 1.4 0.4 1.0 4.2 29.3 2.6 1.4 0.3 0.6 0.2 0.2 1.9 2.0 0.5 2.3 0.1 1.3 0.1 0.2 0.1 4.8 0.7 1.5 6.3 4.1 0.2 3.1 10.0 0.6 0.3 31.0 1.8 0.3 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 21.9 0.0 26.6 0.0 0.0 0.0 7.3 26.7 0.0 0.0 0.0 0.0 0.0 4.6 0.5 0.4 18.4 0.0 0.0 8.8 4.1 0.0 0.0 0.0 14.8 0.1 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 2.5 0.0 0.1 0.0 0.1 82.1 45.5 121.3 0.0 8.0 0.0 7.8 2.8 11.8 0.6 2.2 0.7 3.6 2.4 1.0 2.0 2.4 2.9 1.8 2.4 2.2 2.7 4.6 4.2 2.6 0.7 0.8 1.0 1.0 0.6 1.4 2.6 1.4 2.0 1.5 3.1 3.7 4.0 6.4 6.5 0.7 35.7 1.1 1.7 0.6 0.6 0.6 0.3 0.4 4.8 0.0 5.4 0.0 2.1 0.2 16.6 0.2 0.0 0.1 2.0 28.3 0.5 4.6 0.0 7.6 0.3 0.0 0.3 1.7 2.0 0.8 51.1 8.1 1.1 0.2 24.1 0.0 0.3 0.0 0.0 20.7 22.4 0.8 0.3 33.3 8.8 14.0 10.1 0.3 5.2 1.0 0.3 0.0 0.1 0.0 63.6 1.2 0.0 0.4 24.4 0.7 0.0 1.8 1.5 0.3 0.4 0.1 0.6 0.5 16.8 0.0 0.2 1.2 KLHL24 "DRE1, FLJ20059" ENSG00000114796 "Kelch like family member 24" Q6TFL4 3 183635610-183684519 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Epidermolysis bullosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 185.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 54.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056337 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 21: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "HPA056337: AB_2683103" "unprognostic (3.68e-1)" "unprognostic (1.37e-3)" "unprognostic (1.62e-1)" "unprognostic (1.53e-3)" "unprognostic (8.56e-3)" "unprognostic (3.85e-1)" "unprognostic (2.09e-1)" "unprognostic (1.02e-2)" "unprognostic (1.32e-1)" "unprognostic (1.20e-1)" "unprognostic (4.80e-3)" "unprognostic (3.31e-1)" "unprognostic (1.39e-3)" "unprognostic (1.08e-1)" "unprognostic (7.85e-2)" "unprognostic (8.40e-2)" "unprognostic (1.02e-2)" 16.5 13.1 8.4 10.5 22.4 41.0 16.1 71.6 33.2 13.7 0.0 14.9 16.0 15.3 10.3 11.5 10.3 13.4 41.3 8.4 9.0 18.5 20.3 18.8 15.8 18.4 17.6 20.0 15.3 41.7 10.4 13.9 21.0 13.9 14.0 16.1 17.8 11.5 48.5 11.2 14.6 11.3 5.1 16.2 15.1 9.0 21.2 17.8 23.3 46.4 14.7 14.0 11.9 28.3 4.4 4.3 9.9 10.5 22.1 12.0 20.6 2.2 16.9 2.7 4.8 2.8 8.0 8.9 30.1 6.1 25.2 6.2 5.7 2.6 4.8 10.1 7.9 5.4 6.9 2.9 18.9 4.7 7.1 24.7 14.0 2.9 9.2 16.7 14.4 13.8 3.5 28.5 3.7 2.1 7.9 6.0 6.4 6.7 6.5 10.0 7.5 28.7 7.8 13.6 17.5 24.5 10.3 32.1 23.5 14.4 11.8 10.4 12.5 3.4 4.4 5.4 2.9 54.1 38.4 37.7 6.0 7.5 2.2 43.1 20.3 25.0 17.3 22.7 14.7 25.7 14.3 15.8 13.8 27.7 20.7 14.8 40.9 16.3 22.5 10.7 20.5 15.3 8.4 22.4 71.6 33.2 8.4 9.0 18.4 17.6 21.0 5.1 21.2 28.3 44.5 112.2 72.3 88.8 73.4 43.6 30.7 21.8 77.4 39.8 33.2 24.8 137.8 27.1 33.4 31.3 70.9 12.1 63.2 32.0 13.7 28.1 16.1 35.5 42.0 39.5 42.3 26.1 99.5 18.9 18.0 44.5 29.6 49.3 26.0 110.1 33.2 47.7 27.1 60.6 104.3 28.5 46.8 51.9 31.4 7.0 30.7 46.5 35.6 68.4 31.3 24.4 41.2 92.0 185.2 18.1 29.3 24.5 48.5 51.9 52.3 27.7 35.8 45.8 32.9 59.7 48.8 27.9 12.4 46.1 43.9 43.8 49.5 45.1 26.0 44.8 YEATS2 "FLJ10201, FLJ12841, FLJ13308, KIAA1197" ENSG00000163872 "YEATS domain containing 2" Q9ULM3 3 183697797-183812624 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Epilepsy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 95.6;Inhibitory neurons: 62.1;Oligodendrocyte precursor cells: 71.9;Oligodendrocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045891 Uncertain Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA045891: AB_10961271" "unprognostic (1.57e-2)" "unprognostic (1.10e-1)" "unprognostic (3.56e-2)" "unprognostic (3.40e-3)" "unprognostic (1.14e-1)" "unprognostic (7.49e-2)" "prognostic unfavorable (4.82e-6)" "unprognostic (2.44e-1)" "unprognostic (3.91e-2)" "unprognostic (1.32e-1)" "unprognostic (8.33e-3)" "unprognostic (1.65e-3)" "prognostic unfavorable (6.90e-9)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "unprognostic (2.08e-2)" 7.4 4.8 5.4 8.9 7.4 14.5 7.9 8.1 8.8 8.5 0.0 9.1 5.4 9.0 4.7 8.2 10.3 6.5 6.6 6.4 5.2 6.1 3.4 10.0 12.9 2.4 3.7 15.1 5.4 9.9 8.6 11.2 3.0 8.2 6.8 15.6 8.0 7.3 5.5 8.5 7.0 11.9 1.9 8.9 5.8 8.0 4.2 16.9 9.7 4.8 11.8 8.7 8.4 7.0 38.1 11.3 32.4 14.5 15.5 22.8 35.8 22.1 17.0 32.1 37.5 27.8 13.3 34.7 39.8 19.5 49.9 23.9 31.8 21.2 32.7 28.5 18.8 35.0 12.2 13.7 23.9 26.3 19.4 15.6 16.3 23.1 27.8 32.1 33.1 35.2 14.0 28.3 24.5 10.2 38.3 20.2 29.3 13.8 22.0 53.5 30.5 42.0 12.9 16.6 31.3 22.3 16.4 55.4 29.2 27.1 27.5 17.8 28.2 29.5 21.3 15.1 25.0 26.9 22.6 57.6 22.9 25.8 21.3 0.1 4.6 1.2 1.9 2.0 1.3 1.9 1.7 1.4 1.6 1.3 1.3 1.5 8.5 1.3 7.1 2.1 0.7 1.8 5.4 7.4 8.1 8.8 6.4 5.2 2.4 3.7 3.0 1.9 4.2 7.0 13.8 35.3 2.3 41.4 7.0 2.0 3.3 7.0 8.6 19.5 5.6 7.5 10.1 5.7 5.9 5.5 10.4 4.8 7.4 4.4 0.0 5.7 2.4 10.5 18.3 15.3 8.5 6.3 95.6 4.0 9.7 9.2 7.1 9.8 7.0 42.1 7.5 3.0 7.1 13.5 62.1 6.0 6.1 8.7 6.7 3.3 9.9 10.1 1.8 40.3 6.6 5.8 5.2 71.9 80.0 7.1 3.1 9.4 9.5 5.3 4.7 1.0 11.2 15.8 0.0 10.1 10.4 3.1 12.3 8.7 3.4 2.1 8.8 9.7 4.8 2.8 AC131160.1 ENSG00000283765 "Presenilin associated rhomboid like" 3 183815568-183884889 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.2;skeletal muscle: 5.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 15.8" HPA019545 Uncertain Approved Mitochondria NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 6: T47d - Mammary gland" "Cluster 11: Alveolar cells - Smell perception" Mitochondria "HPA019545: AB_1855796" 0.5 0.5 5.0 0.4 7.2 0.5 0.3 7.7 9.2 0.2 3.1 0.5 0.1 0.1 0.0 0.6 0.2 0.0 0.6 5.0 5.7 0.2 0.2 0.3 0.2 7.0 6.6 0.3 2.0 0.4 0.1 0.2 6.7 0.2 0.5 1.0 0.3 0.4 5.5 0.6 0.3 0.4 5.2 0.2 0.4 1.3 6.1 1.7 0.3 1.6 0.2 0.4 0.2 8.3 1.0 0.4 1.3 0.4 0.3 0.3 0.1 0.9 0.4 1.3 0.5 3.3 0.1 1.1 0.3 0.8 1.7 0.0 4.2 0.8 2.1 1.4 1.5 1.6 0.9 0.8 0.0 1.0 0.3 0.6 0.6 1.0 0.0 0.8 0.0 2.7 0.3 1.1 2.0 2.5 3.1 0.7 3.2 0.0 0.5 2.2 1.1 2.1 0.3 1.6 2.3 1.4 0.7 1.2 1.4 0.2 15.8 0.2 0.0 0.1 1.6 0.3 1.5 2.0 2.6 2.1 0.5 2.2 0.6 0.0 0.2 0.6 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.0 0.1 5.0 7.2 7.7 9.2 5.0 5.7 7.0 6.6 6.7 5.2 6.1 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MAP6D1 "FLJ12748, SL21" ENSG00000180834 "MAP6 domain containing 1" Q9H9H5 3 183815922-183825594 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 102.6;choroid plexus: 24.9;skeletal muscle: 26.9" "Cell type enriched" "Detected in some" 13 "Oligodendrocytes: 101.3" "Cancer enhanced" "Detected in many" "glioma: 9.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "T-47d: 63.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037991 Enhanced Supported Approved Cytosol NA NA "Cluster 70: Brain - Nervous system development" "Cluster 6: T47d - Mammary gland" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "HPA037991: AB_10672503" "unprognostic (9.23e-3)" "unprognostic (2.70e-1)" "unprognostic (1.65e-1)" "unprognostic (1.27e-3)" "unprognostic (1.32e-1)" "unprognostic (3.67e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-1)" "unprognostic (2.42e-1)" "unprognostic (1.28e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (8.81e-12)" "unprognostic (1.08e-1)" "unprognostic (2.96e-3)" "unprognostic (1.86e-1)" "unprognostic (5.72e-2)" 0.8 0.9 40.9 0.3 66.1 0.2 0.9 60.3 73.2 1.1 24.9 1.3 0.7 1.0 0.9 1.4 1.1 0.4 1.8 40.9 44.5 1.2 1.2 0.7 0.7 67.1 59.1 1.1 4.7 0.4 2.2 0.3 60.4 3.4 0.3 1.0 1.2 0.7 26.9 3.6 1.0 0.4 53.0 1.3 0.7 1.3 56.3 3.6 1.0 14.3 0.4 1.0 1.2 102.6 3.5 2.1 3.6 0.7 0.9 1.2 2.8 4.2 0.8 7.3 5.3 2.5 0.1 0.3 5.4 6.1 3.6 2.7 6.9 1.6 4.5 2.3 11.8 0.5 0.0 0.0 2.3 4.5 1.5 0.5 0.6 1.7 0.8 0.4 1.7 5.5 0.5 0.0 0.7 14.8 10.0 5.8 2.2 2.0 6.7 5.0 5.7 0.0 0.4 0.0 11.7 2.1 2.9 2.2 4.4 2.5 63.9 4.2 0.8 1.8 2.5 2.7 6.1 2.4 1.6 1.4 0.6 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 40.9 66.1 60.3 73.2 40.9 44.5 67.1 59.1 60.4 53.0 56.3 102.6 0.0 0.0 0.0 4.9 0.1 1.1 0.7 0.9 0.6 2.5 0.0 0.0 2.4 0.0 0.4 0.0 2.1 0.3 0.0 0.9 0.0 0.0 3.4 0.0 0.0 0.3 2.4 0.4 7.4 0.0 0.5 0.4 1.1 0.0 0.0 0.0 0.7 0.4 0.9 1.7 3.5 0.4 4.1 0.0 0.7 2.2 0.9 0.3 0.0 0.0 0.5 0.8 1.0 7.1 101.3 0.0 0.1 0.0 0.2 2.4 0.2 0.0 0.3 1.9 0.0 1.6 0.4 2.9 2.1 1.0 1.4 0.7 0.3 0.0 0.3 0.7 PARL "PRO2207, PSARL, PSARL1, RHBDS1" ENSG00000175193 "Presenilin associated rhomboid like" Q9H300 3 183829271-183884933 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA019545 Approved Approved Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Mitochondria "HPA019545: AB_1855796" "unprognostic (2.10e-1)" "unprognostic (1.53e-3)" "unprognostic (5.88e-2)" "unprognostic (1.17e-2)" "unprognostic (5.76e-2)" "unprognostic (9.55e-2)" "unprognostic (3.17e-3)" "unprognostic (8.97e-2)" "unprognostic (1.81e-1)" "unprognostic (3.62e-3)" "unprognostic (1.52e-1)" "unprognostic (2.13e-2)" "unprognostic (4.28e-2)" "unprognostic (5.49e-2)" "unprognostic (2.58e-1)" "unprognostic (1.73e-1)" "prognostic favorable (9.11e-5)" 38.4 35.8 46.5 26.6 48.2 33.8 40.3 47.4 66.2 33.8 50.7 47.7 29.2 31.9 57.7 36.7 30.2 19.7 54.1 46.6 48.2 39.6 45.0 28.4 32.0 47.7 48.7 31.7 49.9 39.7 32.0 25.5 47.4 37.1 41.9 32.7 40.5 30.3 54.9 37.1 34.7 29.7 47.2 36.2 42.6 26.7 47.6 34.5 31.4 51.6 33.8 38.9 31.5 48.4 115.1 55.6 39.7 33.0 38.8 42.1 80.2 39.2 59.4 80.5 65.0 172.0 59.0 47.8 90.0 56.7 73.5 49.2 64.1 68.0 90.0 71.6 76.1 73.9 35.5 96.9 57.3 73.9 61.6 60.0 85.4 58.0 70.7 38.5 59.0 82.4 42.6 45.0 69.2 131.0 148.3 194.3 105.5 100.6 53.3 64.7 72.8 92.0 79.0 97.6 37.9 52.0 47.6 162.9 107.8 48.1 159.2 143.5 31.8 29.3 63.0 60.9 108.2 89.2 65.7 116.0 56.6 75.1 35.5 97.5 143.1 133.4 51.3 107.8 60.9 62.4 57.3 59.9 132.4 59.1 68.7 54.2 41.3 67.1 83.3 79.7 73.7 116.1 46.5 48.2 47.4 66.2 46.6 48.2 47.7 48.7 47.4 47.2 47.6 48.4 30.3 22.4 19.7 17.9 37.6 30.3 54.9 93.5 26.7 35.9 31.8 31.5 41.2 35.8 44.5 31.3 31.3 58.9 38.4 24.4 117.4 63.9 24.0 15.2 18.3 30.2 33.7 23.3 23.4 84.7 49.0 35.1 28.1 13.7 69.8 33.1 33.2 30.4 77.7 33.7 24.1 42.0 77.3 56.2 55.7 9.7 28.9 57.5 42.7 33.7 79.3 55.9 50.4 17.1 28.0 60.3 35.1 27.1 42.3 55.4 47.3 86.0 30.5 51.1 6.6 44.8 96.6 47.8 47.4 40.2 30.0 42.1 40.9 49.0 49.2 58.8 ABCC5 "EST277145, MOAT-C, MRP5, SMRP" ENSG00000114770 "ATP binding cassette subfamily C member 5" O15440 3 183919934-184017939 "Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "choroid plexus: 167.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 196.0;Inhibitory neurons: 122.8;Rod photoreceptor cells: 121.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 136.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044067, HPA052295" Uncertain Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 54: Non-specific - Microtubule organization" "Cluster 15: RT4 - Unknown function" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA044067: AB_2678797, HPA052295: AB_2681789" "unprognostic (9.39e-2)" "unprognostic (6.23e-3)" "unprognostic (3.83e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.78e-8)" "unprognostic (4.46e-2)" "unprognostic (6.07e-3)" "unprognostic (1.02e-1)" "unprognostic (5.91e-3)" "prognostic unfavorable (3.40e-4)" "unprognostic (1.10e-1)" "unprognostic (9.05e-3)" "unprognostic (1.64e-1)" "unprognostic (3.33e-2)" "unprognostic (1.24e-2)" 15.4 23.2 42.5 16.3 44.2 22.4 13.1 48.4 50.0 30.9 167.1 24.4 10.8 21.6 10.4 44.5 16.1 17.9 47.2 45.5 43.6 41.6 7.9 15.6 13.1 44.0 39.5 23.4 13.0 24.0 41.7 17.2 44.7 27.8 22.1 126.2 18.4 13.7 117.5 24.1 23.2 16.1 34.0 37.1 82.3 16.5 46.3 15.3 13.8 40.3 11.8 34.8 35.2 43.2 21.5 11.5 25.9 30.8 25.7 28.3 40.0 16.8 13.3 14.8 16.2 17.9 15.8 22.5 38.6 16.2 22.6 83.3 32.1 18.6 19.3 24.4 31.1 48.1 32.5 18.0 10.3 14.8 36.5 45.6 18.3 15.9 10.6 30.3 17.8 65.6 45.6 30.8 25.7 56.7 40.7 17.1 26.7 38.4 21.7 28.1 8.7 13.4 54.4 136.4 46.6 27.8 17.1 93.5 29.3 33.3 56.6 4.9 20.4 17.4 16.6 22.3 23.8 11.7 24.3 21.1 12.5 29.2 17.9 11.7 4.6 8.3 6.9 2.2 4.4 3.1 3.8 3.1 3.6 4.5 4.3 6.0 16.4 5.6 4.2 1.3 5.7 4.5 42.5 44.2 48.4 50.0 45.5 43.6 44.0 39.5 44.7 34.0 46.3 43.2 8.3 9.6 5.3 39.2 6.4 8.9 14.4 18.3 35.3 39.1 10.5 11.3 37.2 2.8 37.2 44.1 196.0 3.2 7.7 23.3 7.9 5.7 6.0 10.4 18.0 9.5 59.3 21.2 101.3 4.5 5.0 12.5 91.3 20.8 5.1 31.0 6.8 3.3 49.7 33.7 122.8 6.4 20.3 32.7 6.5 3.5 8.1 29.3 12.4 32.8 8.3 13.8 9.2 82.4 62.7 7.9 20.2 7.9 7.5 9.3 5.1 4.8 44.9 121.1 0.0 27.4 15.4 6.8 18.8 41.3 12.1 4.5 8.6 14.9 7.5 61.5 HTR3D ENSG00000186090 "5-hydroxytryptamine receptor 3D" Q70Z44 3 184031544-184039369 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.08e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR3C ENSG00000178084 "5-hydroxytryptamine receptor 3C" Q8WXA8 3 184053047-184060673 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "lung: 2.4" "Cell type enhanced" "Detected in single" "Enteroendocrine cells: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 19: Lung - Lung function" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (4.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.39e-1)" "unprognostic (1.61e-1)" "unprognostic (2.88e-2)" "unprognostic (1.68e-2)" "unprognostic (8.72e-2)" "unprognostic (1.75e-1)" "unprognostic (3.88e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 HTR3E ENSG00000186038 "5-hydroxytryptamine receptor 3E" A5X5Y0 3 184097064-184106995 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 3.5;Inhibitory neurons: 1.1;Microglial cells: 1.0;Oligodendrocyte precursor cells: 2.5;Paneth cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "RH-30: 1.3" HPA049764 Enhanced NA NA "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "HPA049764: AB_2680869" "unprognostic (4.12e-2)" "unprognostic (5.86e-2)" "unprognostic (2.15e-1)" "unprognostic (4.57e-4)" "unprognostic (3.61e-3)" "unprognostic (1.15e-1)" "unprognostic (3.16e-1)" "unprognostic (4.47e-1)" "unprognostic (3.32e-1)" "unprognostic (2.67e-1)" "unprognostic (4.16e-2)" 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 2.5 0.9 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 EIF2B5 "EIF-2B, EIF2Bepsilon" ENSG00000145191 "Eukaryotic translation initiation factor 2B subunit epsilon" Q13144 3 184135038-184146127 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015412, HPA064370, HPA069303" Approved Enhanced Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "CAB015412: AB_831253, HPA064370: AB_2685249, HPA069303: AB_2686114" "unprognostic (3.28e-1)" "unprognostic (1.14e-2)" "unprognostic (9.05e-3)" "unprognostic (3.33e-2)" "unprognostic (1.15e-2)" "unprognostic (9.33e-2)" "prognostic unfavorable (3.38e-8)" "unprognostic (8.07e-2)" "unprognostic (1.32e-1)" "unprognostic (5.21e-2)" "unprognostic (3.80e-1)" "unprognostic (1.32e-2)" "unprognostic (9.97e-3)" "unprognostic (1.82e-1)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (5.32e-2)" 16.1 18.9 10.1 8.2 10.1 5.3 17.6 11.2 12.5 17.2 13.0 19.6 9.4 15.3 5.6 24.7 14.9 6.5 22.3 9.8 11.7 15.5 20.1 15.8 9.7 11.2 10.1 14.9 19.0 22.1 18.0 11.8 10.6 18.1 13.8 2.3 23.9 11.2 53.9 24.7 19.4 11.6 10.9 20.3 21.0 10.1 10.8 18.2 16.7 33.6 19.0 18.8 19.6 9.3 60.7 25.4 24.3 25.4 32.4 23.4 28.0 29.1 36.2 51.7 42.4 41.5 24.5 48.6 37.8 32.5 65.0 34.7 56.6 39.1 47.7 39.7 55.4 75.6 28.4 42.4 24.8 61.8 32.9 19.6 32.1 28.7 24.1 19.5 37.3 49.7 46.7 29.2 35.2 49.5 49.5 34.3 39.9 76.1 49.3 45.1 37.6 61.3 43.1 38.6 35.2 34.2 27.9 91.9 41.5 20.3 83.6 60.8 33.6 22.9 35.4 28.5 62.7 24.3 61.2 69.6 33.0 58.8 35.2 9.5 10.0 14.7 8.7 9.1 11.5 15.4 12.2 13.3 11.8 16.9 18.1 11.5 1.3 14.3 9.8 5.1 11.6 7.6 10.1 10.1 11.2 12.5 9.8 11.7 11.2 10.1 10.6 10.9 10.8 9.3 19.8 25.6 22.7 8.8 31.6 30.8 36.6 18.2 29.6 18.5 33.1 30.1 25.8 17.2 28.4 36.8 8.4 39.3 25.4 32.0 52.8 27.5 3.7 20.5 17.7 24.0 45.9 27.6 14.6 36.0 28.8 17.8 35.2 23.3 16.5 21.3 13.6 27.1 24.9 35.3 18.6 28.0 24.4 18.5 22.6 2.7 18.3 18.2 19.6 12.2 30.8 14.5 22.6 18.1 15.3 26.3 17.9 14.7 19.0 34.6 27.2 30.0 21.9 16.7 13.1 17.5 22.8 17.7 17.0 31.2 29.0 38.6 26.5 34.2 34.7 44.9 DVL3 KIAA0208 ENSG00000161202 "Dishevelled segment polarity protein 3" Q92997 3 184155377-184173614 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046486, HPA058265" Approved Approved "Intermediate filaments,Midbody ring,Centrosome" Yes No "Cluster 45: Eosinophils - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 6: T47d - Mammary gland" "Cluster 25: Spermatids - Spermatogenesis" "Midbody ring, Centrosome" "Intermediate filaments" "CAB046486: AB_10610845, HPA058265: AB_2683658" "unprognostic (2.20e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.88e-2)" "unprognostic (1.64e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (8.41e-4)" "unprognostic (8.61e-2)" "unprognostic (5.34e-2)" "unprognostic (2.49e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (4.77e-5)" "prognostic unfavorable (1.53e-8)" "unprognostic (1.87e-1)" "unprognostic (4.10e-1)" "unprognostic (8.41e-2)" "unprognostic (3.95e-1)" 35.2 28.1 16.4 18.7 17.4 18.6 29.8 17.4 18.9 39.0 15.9 46.0 17.2 44.7 16.1 30.3 34.5 22.6 35.0 16.4 17.1 25.7 20.0 31.7 13.9 18.1 17.3 42.0 25.6 17.9 24.4 38.3 17.6 29.1 16.1 22.8 25.6 25.8 34.9 33.8 27.1 31.7 16.6 25.6 27.9 15.1 17.0 12.4 30.0 22.3 15.9 36.6 31.6 18.3 47.9 13.6 36.4 41.4 37.5 37.8 95.0 28.4 28.9 32.7 27.6 43.6 18.3 33.6 73.3 37.0 32.4 40.8 29.6 22.2 23.4 54.0 32.2 38.1 21.3 28.2 56.6 21.2 27.8 38.4 39.9 23.4 27.3 55.9 24.6 21.6 38.9 44.2 35.5 46.5 28.3 25.2 32.8 34.6 22.1 49.9 42.7 30.0 31.7 36.2 36.3 51.0 34.9 39.8 67.4 35.8 98.7 26.8 25.0 29.5 28.5 31.0 43.8 48.3 38.8 37.0 30.0 22.4 23.6 0.1 0.6 1.3 0.6 1.0 0.8 0.7 0.4 0.7 0.6 0.5 0.5 0.3 0.9 0.4 0.3 0.8 0.2 0.4 16.4 17.4 17.4 18.9 16.4 17.1 18.1 17.3 17.6 16.6 17.0 18.3 15.9 25.6 14.1 16.6 10.8 18.7 15.7 12.9 15.9 20.1 23.5 16.5 26.9 12.8 17.2 22.0 27.1 34.4 14.6 40.8 23.5 13.3 12.8 23.2 30.9 15.9 34.3 6.9 11.4 16.6 21.6 22.6 32.6 27.7 17.1 29.7 19.2 20.5 20.3 62.2 11.8 22.3 12.2 16.2 14.4 47.5 33.5 17.4 12.4 14.0 10.8 19.7 14.4 9.0 11.5 20.7 18.9 37.2 13.9 20.8 25.2 18.3 13.4 18.5 19.7 23.6 27.1 10.6 12.4 20.4 21.7 52.1 10.3 21.9 21.5 25.7 AP2M1 "AP50, CLAPM1, mu2" ENSG00000161203 "Adaptor related protein complex 2 subunit mu 1" Q96CW1 3 184174689-184184091 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036849, HPA069870" Uncertain Supported "Plasma membrane" NA NA 7500 "Cluster 31: Non-specific - Inflammatory response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Plasma membrane" "HPA036849: AB_10672101, HPA069870: AB_2686217" "unprognostic (1.16e-1)" "unprognostic (1.35e-2)" "unprognostic (5.28e-3)" "unprognostic (4.96e-3)" "unprognostic (1.79e-1)" "unprognostic (2.88e-2)" "prognostic unfavorable (9.12e-4)" "unprognostic (3.80e-3)" "unprognostic (2.09e-1)" "unprognostic (5.53e-2)" "unprognostic (4.11e-2)" "unprognostic (9.18e-2)" "prognostic unfavorable (7.45e-6)" "unprognostic (2.61e-2)" "unprognostic (4.09e-2)" "unprognostic (1.60e-2)" "unprognostic (1.28e-1)" 191.8 364.2 233.5 164.7 250.3 231.3 164.6 211.3 257.3 222.8 196.3 232.4 167.5 216.4 104.2 218.1 178.6 166.5 366.2 261.1 249.0 196.0 140.9 180.0 148.2 234.8 211.1 198.6 106.4 224.8 224.9 243.3 248.9 183.2 141.1 230.4 167.2 231.8 181.2 157.2 156.2 243.7 200.9 162.5 156.3 106.4 235.4 158.4 148.0 194.0 157.6 223.7 192.4 225.6 436.3 327.5 275.7 311.8 432.1 450.8 284.3 714.3 412.5 788.5 550.5 355.1 309.9 198.2 851.3 1076.1 516.1 480.0 376.3 482.9 647.1 409.8 470.4 512.2 365.8 317.9 508.9 254.8 311.5 577.0 269.4 501.1 318.5 711.0 595.3 258.3 250.0 377.1 750.1 993.6 330.1 151.2 674.1 388.1 484.7 302.7 351.5 393.7 489.7 389.3 292.0 212.6 561.3 696.4 335.1 427.5 934.4 305.7 645.0 497.1 400.1 492.4 960.2 336.9 318.7 441.6 937.1 369.9 331.7 194.4 294.8 244.9 137.5 238.8 136.2 114.3 127.6 134.0 268.7 112.7 107.7 111.8 127.7 170.2 206.8 134.1 185.4 441.0 233.5 250.3 211.3 257.3 261.1 249.0 234.8 211.1 248.9 200.9 235.4 225.6 146.8 54.5 50.7 41.4 84.8 124.9 177.2 275.1 97.9 174.2 108.0 98.2 195.9 112.9 133.5 114.0 70.9 400.9 117.3 155.9 375.6 243.7 326.6 69.3 131.2 172.2 140.8 277.8 62.0 161.3 327.1 161.5 71.4 78.5 149.1 173.6 182.4 78.0 576.9 277.6 63.4 119.0 201.4 137.1 162.9 347.8 164.7 185.1 199.3 34.7 369.4 199.4 130.7 26.2 46.1 232.1 153.1 214.8 100.2 138.8 253.8 290.7 58.3 125.9 197.2 106.9 278.0 83.3 101.7 128.5 126.6 513.6 102.6 278.1 154.1 185.1 ABCF3 EST201864 ENSG00000161204 "ATP binding cassette subfamily F member 3" Q9NUQ8 3 184186023-184194012 "Predicted intracellular proteins, Transporters" "Antiviral defense" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036332 Approved Approved Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 39: Non-specific - Basic cellular processes" Cytosol Nucleoli "HPA036332: AB_10603571" "unprognostic (1.70e-2)" "unprognostic (1.16e-1)" "unprognostic (3.10e-2)" "unprognostic (3.81e-2)" "unprognostic (4.11e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.16e-5)" "unprognostic (5.18e-2)" "unprognostic (5.97e-2)" "unprognostic (2.67e-1)" "unprognostic (1.01e-1)" "unprognostic (5.52e-2)" "unprognostic (1.85e-2)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.94e-2)" "unprognostic (6.53e-2)" 16.1 56.1 10.9 13.3 10.9 16.8 15.8 11.8 13.4 18.2 9.6 15.5 15.7 15.5 12.3 20.0 17.0 12.7 28.5 10.9 12.7 19.2 22.7 14.4 17.0 13.9 12.3 20.0 23.6 43.5 21.0 16.4 12.8 16.2 13.6 14.2 26.9 19.6 46.8 19.6 16.3 12.4 9.2 17.8 17.5 16.5 12.4 14.6 17.9 41.3 16.1 17.1 17.6 11.6 49.9 30.2 16.9 32.8 48.1 26.9 33.3 35.2 39.1 46.7 36.5 52.0 19.3 29.8 69.5 38.1 54.9 46.4 26.5 37.1 24.1 38.4 25.5 25.7 26.6 30.8 40.4 29.2 25.2 39.7 33.5 33.1 32.7 27.4 33.8 25.7 24.1 34.9 33.5 60.0 28.7 18.8 25.7 51.1 41.2 28.5 28.1 50.4 25.4 29.6 29.1 16.9 36.5 69.1 33.8 18.3 93.7 25.3 33.5 24.9 27.1 39.5 53.1 39.2 40.5 38.2 38.8 28.7 31.3 8.1 29.1 22.7 32.9 30.4 34.7 23.6 29.0 27.5 25.6 23.8 36.0 29.5 14.6 24.0 32.4 15.8 27.2 37.2 10.9 10.9 11.8 13.4 10.9 12.7 13.9 12.3 12.8 9.2 12.4 11.6 10.2 9.6 2.0 6.2 17.4 14.5 10.0 29.8 9.6 16.7 10.8 6.7 11.6 17.2 19.7 14.7 14.6 36.9 16.2 19.8 29.4 22.5 9.5 11.2 12.0 11.6 11.4 8.6 7.1 22.4 25.5 12.5 13.3 12.0 9.5 16.0 16.8 20.0 21.6 20.2 9.9 13.4 30.5 9.4 6.9 10.2 12.5 12.9 16.0 3.7 22.8 14.7 17.5 6.6 7.3 20.5 9.8 11.7 19.4 9.0 28.6 37.3 14.4 22.3 6.6 11.9 9.5 12.8 17.1 14.5 10.2 43.8 16.6 18.1 14.7 11.7 VWA5B2 "DKFZp761K032, LOC90113" ENSG00000145198 "Von Willebrand factor A domain containing 5B2" Q8N398 3 184230429-184242329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 40.7;brain: 16.4" "Group enriched" "Detected in some" 7 "Enteroendocrine cells: 112.4;Excitatory neurons: 39.2;Inhibitory neurons: 29.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.9;pancreatic cancer: 3.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SCLC-21H: 31.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 22.9" "HPA036823, HPA036824, HPA061412" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Golgi apparatus" Nucleoplasm "HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507" "unprognostic (3.92e-4)" "unprognostic (1.70e-1)" "unprognostic (1.69e-2)" "unprognostic (2.56e-3)" "unprognostic (3.37e-1)" "unprognostic (1.60e-1)" "unprognostic (1.70e-2)" "unprognostic (1.21e-1)" "unprognostic (3.80e-1)" "unprognostic (1.21e-1)" "unprognostic (4.32e-3)" "unprognostic (3.73e-2)" "unprognostic (1.12e-4)" "unprognostic (3.13e-1)" "unprognostic (3.65e-2)" "unprognostic (2.36e-1)" "unprognostic (1.83e-1)" 0.0 40.7 7.8 0.0 1.7 0.1 0.0 0.7 16.4 0.5 0.0 0.4 1.8 0.2 0.1 0.0 1.3 0.0 0.0 6.5 0.7 0.2 0.0 0.1 0.0 7.4 0.5 0.4 5.6 1.4 8.3 0.0 5.0 0.5 0.3 0.2 0.6 2.4 0.0 0.0 1.1 0.0 0.0 0.0 2.8 1.0 2.6 0.0 0.3 0.0 0.0 0.1 0.1 2.0 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 1.9 0.3 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.7 0.4 0.3 0.0 0.0 31.7 2.2 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.1 0.1 0.0 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 1.7 0.7 16.4 6.5 0.7 7.4 0.5 5.0 0.0 2.6 2.0 0.4 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 7.6 0.1 0.1 112.4 0.0 39.2 0.2 0.0 0.0 6.1 0.8 0.0 0.2 1.1 0.0 0.2 3.3 29.2 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 1.7 0.2 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.1 ALG3 "CDGS4, D16Ertd36e, Not56, NOT56L" ENSG00000214160 "ALG3 alpha-1,3- mannosyltransferase" Q92685 3 184242301-184249548 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 211.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045103 Enhanced NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA045103: AB_10960547" "unprognostic (3.63e-2)" "unprognostic (2.60e-1)" "unprognostic (2.36e-2)" "unprognostic (1.80e-3)" "unprognostic (3.63e-1)" "unprognostic (7.93e-3)" "prognostic unfavorable (1.58e-5)" "prognostic unfavorable (8.67e-5)" "unprognostic (6.18e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-3)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (9.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.64e-1)" "unprognostic (5.02e-2)" 22.0 32.6 9.3 15.0 9.3 15.7 19.7 10.8 11.1 18.1 13.9 23.8 16.9 17.5 12.5 30.5 15.1 11.6 19.6 8.8 9.7 18.7 58.0 18.1 13.0 10.6 10.1 12.7 37.1 23.1 14.6 19.6 11.2 19.8 18.3 6.0 26.8 13.7 30.2 24.9 20.4 16.4 10.0 20.8 23.1 25.7 10.7 12.2 18.4 14.8 14.1 22.5 19.8 10.3 77.2 67.6 18.0 59.5 70.2 39.4 59.3 40.6 46.0 54.9 47.3 102.8 50.9 67.6 108.4 50.8 112.0 90.8 64.1 90.0 34.5 49.0 76.7 60.8 49.3 84.7 64.3 99.5 52.4 47.0 74.7 64.8 90.9 29.4 30.0 46.0 60.7 132.6 36.1 95.8 48.5 83.1 55.9 153.3 85.8 49.9 27.5 269.7 63.2 25.7 44.3 36.7 37.6 147.0 67.5 21.8 140.2 54.8 24.3 57.2 36.0 51.2 88.4 72.3 137.8 71.3 51.5 129.2 52.9 0.6 60.9 14.6 35.8 61.1 40.5 31.6 38.3 36.8 71.4 30.8 33.9 33.2 2.0 48.9 51.3 65.3 44.6 41.7 9.3 9.3 10.8 11.1 8.8 9.7 10.6 10.1 11.2 10.0 10.7 10.3 14.2 6.4 18.1 4.6 24.5 25.0 28.3 61.0 26.2 10.4 24.1 20.8 11.7 21.5 43.0 20.2 10.4 79.2 21.0 24.9 7.9 62.3 95.7 9.1 17.7 18.7 14.5 24.4 5.6 63.1 100.4 22.3 25.0 13.5 12.7 16.3 12.5 51.7 69.8 8.4 5.9 33.3 50.8 24.9 15.5 211.5 12.5 25.8 21.4 7.5 21.2 13.7 16.5 7.1 6.3 44.6 22.0 15.1 63.8 47.2 39.4 31.8 16.7 13.0 19.7 9.0 34.6 29.7 34.3 39.4 27.0 65.8 17.6 23.1 45.6 29.1 EEF1AKMT4 ENSG00000284753 "EEF1A lysine methyltransferase 4" P0DPD7 3 184249672-184258759 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Breast glandular cells: 9.9;Breast myoepithelial cells: 11.7;Distal tubular cells: 15.6;Ductal cells: 14.7;Exocrine glandular cells: 15.3;Pancreatic endocrine cells: 9.2;Proximal tubular cells: 21.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 2.4 3.0 1.0 4.1 1.0 5.0 4.3 3.9 1.6 3.1 1.3 5.6 5.3 1.6 1.4 6.1 1.8 2.2 2.0 0.9 1.7 2.9 14.0 2.0 4.3 1.4 1.2 0.7 12.7 4.8 6.0 1.3 1.9 5.3 0.4 6.6 2.0 2.3 5.3 3.4 3.2 1.2 2.0 3.8 11.4 1.4 4.5 7.2 5.4 5.0 6.2 1.0 50.8 29.9 5.1 17.3 9.9 6.8 41.2 6.4 12.5 10.0 9.4 56.9 7.9 63.7 40.2 7.2 41.8 19.5 31.1 32.2 5.6 23.8 36.9 17.1 18.1 36.8 12.1 43.8 12.8 8.5 39.0 10.8 19.1 3.3 8.2 20.8 33.0 54.7 4.8 84.2 18.6 54.9 11.7 71.0 52.1 32.6 7.0 53.4 11.8 11.2 26.8 9.7 10.8 95.1 24.6 9.2 76.0 21.4 5.8 7.5 11.5 22.4 30.2 33.1 74.5 64.6 7.0 74.9 10.0 0.0 22.9 2.5 8.0 19.1 8.8 8.8 8.4 7.8 19.4 6.5 5.8 9.2 0.5 7.3 13.3 17.5 15.5 10.9 1.0 1.0 3.9 1.6 0.9 1.7 1.4 1.2 1.3 1.2 1.4 1.0 3.8 0.0 2.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.9 11.7 0.0 0.0 3.1 7.3 0.0 0.0 1.7 0.0 15.6 14.7 0.0 1.8 3.5 2.1 0.0 0.0 0.0 15.3 0.0 1.5 0.0 2.0 1.3 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.8 0.0 0.0 21.2 1.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.0 6.7 0.0 0.0 EEF1AKMT4-ECE2 ENSG00000284917 "EEF1AKMT4-ECE2 readthrough" P0DPD8 3 184249695-184293031 "Enzymes, Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062215 Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA062215: AB_2684714" 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CAMK2N2 CaM-KIIN ENSG00000163888 "Calcium/calmodulin dependent protein kinase II inhibitor 2" Q96S95 3 184259213-184261553 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 104.3;pancreas: 33.6;pituitary gland: 39.6" "Group enriched" "Detected in some" 4 "Horizontal cells: 62.2;Inhibitory neurons: 45.3" "Cancer enhanced" "Detected in many" "glioma: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 21.2;REH: 33.4;SCLC-21H: 33.2;U-138 MG: 32.1" "Low region specificity" "Detected in all" "HPA050835, HPA075200" Approved Supported Nucleoplasm,Centrosome NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 62: Horizontal cells - Visual perception" "Nucleoplasm, Centrosome" "HPA050835: AB_2681253, HPA075200: " "unprognostic (7.28e-2)" "prognostic favorable (9.77e-4)" "unprognostic (1.24e-1)" "unprognostic (4.69e-2)" "unprognostic (1.32e-1)" "unprognostic (6.09e-2)" "unprognostic (2.20e-1)" "unprognostic (1.29e-2)" "unprognostic (1.88e-1)" "unprognostic (4.21e-2)" "unprognostic (5.98e-2)" "unprognostic (9.72e-3)" "unprognostic (5.17e-9)" "unprognostic (3.47e-1)" "unprognostic (2.39e-1)" "unprognostic (1.07e-1)" "unprognostic (1.76e-3)" 0.1 14.6 60.0 0.2 29.5 0.0 0.1 45.8 49.8 0.1 0.0 0.6 0.2 0.2 0.0 0.1 0.1 0.1 0.1 36.0 69.1 0.2 0.7 0.1 0.0 95.7 70.7 0.1 33.6 0.8 39.6 0.1 79.5 0.3 0.0 5.5 0.2 0.1 0.0 0.2 0.2 0.1 50.7 0.1 0.5 0.2 104.3 0.0 0.1 0.0 0.0 0.1 0.1 29.7 21.2 0.5 3.2 1.7 0.5 0.5 2.2 0.5 6.2 4.0 4.1 1.2 1.1 2.0 5.4 0.3 13.0 2.8 1.1 0.7 2.2 16.1 1.4 0.7 0.5 0.9 0.1 1.4 3.0 0.5 1.0 0.6 2.8 1.4 0.0 0.9 0.3 7.5 0.6 14.5 0.4 1.1 13.3 1.5 8.4 33.4 9.4 3.2 0.9 5.0 33.2 7.3 3.9 1.7 0.3 0.3 13.3 0.2 0.2 32.1 15.0 4.3 6.7 4.1 8.1 6.8 8.1 3.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.0 29.5 45.8 49.8 36.0 69.1 95.7 70.7 79.5 50.7 104.3 29.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 12.2 0.3 0.5 0.4 0.0 0.0 0.0 2.1 0.0 0.5 0.0 0.0 0.1 0.3 0.1 0.4 0.2 3.6 0.0 7.8 4.3 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.8 0.0 62.2 45.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 2.8 0.0 2.0 0.0 7.5 2.0 0.7 0.0 0.0 0.0 0.1 0.0 0.2 0.0 7.2 0.0 0.1 0.6 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 ECE2 "KIAA0604, MGC2408" ENSG00000145194 "Endothelin converting enzyme 2" P0DPD6 3 184276011-184293031 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 57.8;pancreas: 25.2;pituitary gland: 19.8" "Cell type enhanced" "Detected in many" "Early spermatids: 79.5;Extravillous trophoblasts: 51.1;Inhibitory neurons: 63.8;Late spermatids: 119.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "REH: 10.3" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 14: REH - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (2.70e-2)" "unprognostic (1.44e-2)" "unprognostic (1.91e-2)" "prognostic unfavorable (8.41e-5)" "unprognostic (1.37e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (5.80e-4)" "unprognostic (1.47e-2)" "unprognostic (3.69e-1)" "unprognostic (2.65e-3)" "unprognostic (1.70e-2)" "unprognostic (5.95e-2)" "unprognostic (1.63e-9)" "unprognostic (3.66e-2)" "unprognostic (6.16e-2)" "unprognostic (2.19e-1)" "unprognostic (1.25e-2)" 0.0 9.3 24.8 0.2 24.6 0.0 0.0 22.2 28.0 0.0 8.5 1.3 0.0 0.0 0.5 0.0 0.1 0.0 1.9 16.1 57.8 0.0 0.0 0.0 0.0 29.0 52.5 0.0 25.2 4.2 19.8 0.0 36.1 0.6 0.2 5.5 0.3 0.3 0.0 0.0 0.3 0.2 21.5 0.0 0.7 0.2 54.7 0.0 0.0 0.0 0.0 0.0 0.2 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.8 24.6 22.2 28.0 16.1 57.8 29.0 52.5 36.1 21.5 54.7 15.2 0.0 0.0 0.0 5.2 3.8 38.2 18.2 15.5 20.5 5.5 0.0 0.0 2.2 10.0 7.2 0.0 2.1 21.6 2.7 6.7 0.0 0.0 79.5 0.0 0.0 3.3 12.2 6.3 5.1 0.0 51.1 3.5 9.2 0.0 0.0 0.0 3.3 35.3 17.2 26.9 63.8 12.8 16.2 4.4 5.7 119.8 3.1 4.1 8.8 1.0 4.6 2.4 5.2 30.2 1.1 0.0 5.9 2.2 12.5 35.1 13.5 0.0 2.2 2.3 6.6 2.6 5.1 43.4 9.7 16.9 39.1 21.5 2.3 0.0 13.8 16.2 PSMD2 "MGC14274, P97, Rpn1, S2, TRAP2" ENSG00000175166 "Proteasome 26S subunit, non-ATPase 2" Q13200 3 184299198-184309050 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 332.9" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 349.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045192, HPA062363" Enhanced NA NA 430000 "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 10: Non-specific - Unknown function" "HPA045192: AB_10961324, HPA062363: " "unprognostic (1.06e-2)" "unprognostic (1.69e-2)" "unprognostic (6.82e-2)" "unprognostic (2.43e-2)" "unprognostic (2.96e-1)" "prognostic unfavorable (9.98e-4)" "prognostic unfavorable (6.63e-7)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.69e-1)" "unprognostic (4.68e-2)" "unprognostic (1.51e-2)" "unprognostic (1.32e-1)" "unprognostic (4.25e-3)" "unprognostic (1.53e-1)" "unprognostic (9.12e-2)" "unprognostic (1.13e-2)" "unprognostic (2.74e-3)" 64.1 102.6 65.0 61.9 67.6 77.8 53.3 68.3 71.7 58.4 65.1 73.2 49.4 69.1 45.5 84.3 53.5 41.3 116.3 67.6 73.7 62.7 68.8 59.3 57.9 74.8 81.1 50.3 48.0 82.9 58.8 58.4 84.6 52.2 63.2 46.9 60.6 59.8 332.9 79.7 55.8 76.7 68.9 59.1 63.4 101.9 73.2 73.4 55.3 183.3 77.1 64.5 58.8 65.2 800.0 248.6 194.3 328.7 226.2 129.6 238.8 478.3 363.6 580.3 327.6 349.1 163.4 251.5 643.4 393.8 467.1 254.3 290.3 516.4 725.0 383.6 234.1 268.4 229.6 211.9 123.7 191.9 211.8 147.3 156.8 549.5 339.0 219.1 353.6 188.9 201.1 226.9 476.0 310.7 199.4 110.1 279.4 290.8 438.1 217.6 287.8 262.9 240.4 248.7 174.5 134.7 376.2 321.3 174.7 208.4 446.5 145.1 463.6 361.2 383.9 293.3 1049.9 219.7 501.3 412.9 438.7 204.2 256.7 48.8 86.0 82.2 61.9 74.5 56.7 59.0 60.1 68.0 103.1 53.5 58.5 56.3 26.6 76.7 79.6 48.3 66.9 96.3 65.0 67.6 68.3 71.7 67.6 73.7 74.8 81.1 84.6 68.9 73.2 65.2 49.0 67.3 61.7 13.4 53.4 71.1 66.2 101.1 58.1 66.9 38.7 31.5 113.3 38.6 81.8 57.0 20.9 153.8 60.6 67.3 90.1 183.2 161.8 56.1 55.0 63.0 79.6 105.9 21.0 130.8 117.9 60.3 45.3 61.3 40.5 111.3 35.0 60.5 83.8 72.3 20.0 40.0 79.3 38.8 54.0 90.3 48.7 58.5 53.4 15.9 94.1 117.1 51.5 12.5 16.6 349.2 33.3 65.8 84.4 63.1 59.1 97.0 71.5 60.5 32.9 48.2 183.0 184.6 138.9 65.2 67.1 222.9 53.0 94.3 55.8 57.7 EIF4G1 "EIF4F, EIF4G, p220, PARK18" ENSG00000114867 "Eukaryotic translation initiation factor 4 gamma 1" Q04637 3 184314495-184335358 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding, Translational shunt" "Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 348.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014774, HPA028487, HPA043866" Approved Enhanced Cytosol NA NA 330000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "CAB014774: , HPA028487: AB_10602219, HPA043866: AB_2678705" "unprognostic (4.14e-3)" "unprognostic (2.10e-2)" "unprognostic (6.01e-2)" "unprognostic (3.01e-2)" "unprognostic (2.25e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (4.27e-3)" "unprognostic (2.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.55e-3)" "unprognostic (7.06e-3)" "unprognostic (2.42e-1)" "unprognostic (7.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.33e-3)" 86.2 91.8 24.8 75.7 22.2 84.0 69.0 17.9 22.2 66.6 34.1 81.8 62.0 71.3 32.7 126.8 59.6 50.9 90.8 23.3 29.8 53.9 113.0 74.2 55.7 38.5 36.1 57.5 96.2 99.3 57.4 59.4 32.4 62.2 56.5 22.3 93.1 59.2 348.3 116.7 67.2 74.7 24.4 58.2 79.9 64.8 37.4 49.1 71.3 177.0 63.2 76.0 85.3 16.6 559.0 232.3 173.1 205.7 196.9 192.5 322.5 298.6 204.1 315.4 238.8 486.5 173.7 348.4 381.9 367.6 358.5 292.7 322.6 365.8 230.5 375.1 345.8 321.3 226.1 206.4 173.4 321.4 212.2 199.6 206.8 292.4 268.8 152.8 278.3 128.8 239.6 267.2 205.7 403.4 219.7 105.3 368.9 241.3 180.8 221.7 183.4 281.9 156.8 331.8 197.7 174.6 258.1 415.6 187.6 144.6 445.2 206.5 364.1 227.2 228.9 297.3 567.9 203.8 263.2 629.0 260.5 271.4 258.3 8.3 16.0 6.7 11.7 14.4 10.8 7.7 7.8 9.6 12.8 9.2 6.9 7.6 5.6 8.7 21.0 18.1 6.0 12.7 24.8 22.2 17.9 22.2 23.3 29.8 38.5 36.1 32.4 24.4 37.4 16.6 63.9 76.9 72.6 23.8 41.7 59.1 78.2 58.0 70.6 24.2 69.3 46.2 109.4 50.1 72.3 62.5 14.6 64.0 37.6 135.5 13.7 98.8 151.6 53.0 67.1 69.3 55.7 82.7 10.8 135.3 74.8 64.5 75.4 85.6 48.0 163.8 43.5 152.8 66.8 21.9 12.9 97.2 50.8 40.8 39.9 202.7 73.0 48.9 33.8 14.0 53.0 23.2 30.9 4.0 10.1 149.0 69.0 56.1 112.9 96.8 77.0 45.4 51.4 23.2 78.9 81.6 78.9 24.8 41.4 120.7 91.8 79.6 46.0 94.8 108.4 95.6 FAM131A "C3orf40, MGC21688" ENSG00000175182 "Family with sequence similarity 131 member A" Q6UXB0 3 184335926-184348421 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042800 Uncertain Approved "Nucleoli rim,Mitotic chromosome" Yes No "Cluster 7: Monocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" "Nucleoli rim" "Mitotic chromosome" "HPA042800: AB_10797023" "unprognostic (1.02e-2)" "unprognostic (1.44e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (2.22e-4)" "unprognostic (2.88e-1)" "unprognostic (4.84e-2)" "unprognostic (2.92e-3)" "unprognostic (1.57e-1)" "unprognostic (7.54e-2)" "unprognostic (7.02e-2)" "unprognostic (6.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" "unprognostic (3.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (1.28e-2)" 15.6 22.7 42.8 5.4 51.1 3.2 13.5 25.0 57.6 17.3 20.5 26.4 7.5 19.1 5.0 13.2 20.6 10.2 29.6 68.2 39.2 13.3 5.5 16.9 4.4 29.5 27.5 24.1 13.7 14.5 54.8 5.8 29.9 17.0 3.7 4.8 10.8 12.3 17.3 30.1 13.8 10.0 22.5 10.7 16.6 16.4 38.8 3.1 12.8 18.0 2.9 17.1 15.2 40.1 14.5 6.1 9.5 16.3 12.1 10.2 8.8 6.5 13.7 9.6 7.5 4.7 5.1 2.1 25.9 6.0 20.7 13.5 0.0 11.8 5.8 15.7 16.0 0.1 9.4 10.2 12.4 0.3 10.8 7.3 1.9 8.4 19.2 9.2 19.4 9.7 3.2 2.1 3.3 11.3 5.6 0.3 16.1 8.7 11.8 10.4 4.0 14.0 9.8 0.5 28.2 29.3 4.1 10.5 14.7 5.9 31.9 3.3 20.2 12.1 9.3 9.9 20.0 22.9 15.4 1.5 38.5 2.1 8.3 1.5 3.8 4.8 1.1 4.9 1.2 1.4 0.8 1.1 4.2 1.4 0.9 1.1 8.3 1.2 2.7 1.7 1.7 2.2 42.8 51.1 25.0 57.6 68.2 39.2 29.5 27.5 29.9 22.5 38.8 40.1 15.5 6.4 5.0 13.7 5.5 11.1 20.0 6.1 5.7 24.0 8.0 11.0 7.6 14.3 4.1 14.7 14.6 9.0 4.6 11.6 1.9 6.0 4.4 6.5 10.5 11.5 9.6 6.1 30.8 3.5 3.5 9.7 5.1 11.0 7.0 55.9 13.6 1.4 7.9 23.5 16.6 7.5 6.1 5.7 14.2 2.5 18.6 7.7 1.8 11.2 9.6 13.1 6.2 6.6 11.9 10.7 9.6 20.7 2.5 15.2 15.7 3.4 15.8 15.9 6.6 13.0 14.4 12.9 7.1 3.5 14.6 33.2 5.0 20.0 8.7 15.9 CLCN2 "ClC-2, CLC2, EJM6" ENSG00000114859 "Chloride voltage-gated channel 2" P51788 3 184346185-184361650 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 16.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 81.7;Proximal enterocytes: 27.4;Theca cells: 62.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009397, HPA014545, HPA024108" Approved Approved Cytosol NA NA "Cluster 45: Intestine - Brush border" "Cluster 39: CACO-2 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883" "unprognostic (1.13e-1)" "unprognostic (4.01e-2)" "unprognostic (6.48e-2)" "unprognostic (5.11e-3)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (4.67e-8)" "unprognostic (1.72e-2)" "unprognostic (2.26e-1)" "unprognostic (1.23e-1)" "unprognostic (2.10e-1)" "unprognostic (2.50e-3)" "unprognostic (1.19e-1)" "unprognostic (4.40e-2)" "unprognostic (5.88e-2)" "unprognostic (4.60e-2)" "unprognostic (1.35e-1)" 1.4 5.1 2.2 1.8 3.1 1.0 1.6 3.1 3.0 3.0 1.6 16.2 9.2 3.6 3.8 1.7 2.4 7.5 1.2 2.0 2.4 3.0 1.7 1.2 0.7 3.4 3.0 4.0 4.5 3.4 2.8 1.0 2.7 2.3 10.8 0.6 2.8 2.9 0.9 1.6 8.4 1.6 2.9 1.5 2.2 10.6 3.3 1.3 2.7 0.5 0.9 2.1 2.0 4.3 8.9 3.2 2.5 6.9 2.2 1.8 5.8 2.9 1.7 3.1 2.0 16.8 3.0 3.0 8.2 1.6 8.0 15.1 3.6 3.5 0.9 2.8 4.2 2.7 7.0 7.7 1.3 1.2 2.6 3.6 2.7 2.6 3.0 1.5 2.9 3.3 1.0 1.6 1.1 5.9 0.8 1.6 3.7 7.6 4.4 5.4 2.3 10.7 3.8 6.9 4.0 2.4 3.3 11.4 5.2 1.6 9.4 1.2 1.4 1.5 4.5 7.7 7.7 3.6 5.5 2.1 2.7 5.3 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 3.1 3.1 3.0 2.0 2.4 3.4 3.0 2.7 2.9 3.3 4.3 2.2 3.2 4.1 16.6 0.4 1.0 0.9 0.8 1.2 2.1 2.5 2.8 1.2 14.3 1.1 0.0 0.0 1.0 1.9 81.7 0.0 3.7 2.3 2.5 4.5 1.9 3.0 0.8 4.1 2.0 0.6 2.6 2.6 4.4 1.3 11.3 2.5 0.6 0.7 1.7 8.1 3.7 0.0 1.0 0.3 2.7 5.3 1.1 0.0 1.9 0.6 1.7 0.0 6.0 15.1 2.2 16.0 4.9 0.8 0.6 27.4 2.3 2.6 2.5 0.0 0.9 2.1 3.3 1.7 1.1 0.4 1.5 1.2 62.5 9.0 0.5 POLR2H RPB8 ENSG00000163882 "RNA polymerase II, I and III subunit H" P52434 3 184361718-184368596 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037745, HPA055813" Supported Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA037745: AB_10672914, HPA055813: AB_2797254" "unprognostic (3.21e-1)" "unprognostic (4.96e-3)" "unprognostic (3.61e-3)" "unprognostic (7.15e-2)" "unprognostic (1.17e-2)" "unprognostic (6.72e-2)" "prognostic unfavorable (2.01e-4)" "unprognostic (8.82e-3)" "unprognostic (2.84e-1)" "unprognostic (4.02e-3)" "unprognostic (4.24e-2)" "unprognostic (1.27e-3)" "prognostic unfavorable (1.65e-10)" "unprognostic (1.34e-1)" "unprognostic (4.01e-1)" "unprognostic (1.71e-1)" "unprognostic (2.93e-3)" 41.6 60.6 50.4 32.5 51.0 31.1 42.2 53.5 60.1 48.8 51.8 54.4 57.6 36.3 39.7 52.1 39.8 30.0 34.8 50.7 49.9 77.5 63.8 37.6 41.1 50.8 50.6 40.2 52.1 35.5 32.9 34.9 50.9 42.9 57.8 14.6 44.2 26.3 37.3 37.8 55.5 35.0 49.8 41.9 51.2 32.3 51.3 39.8 48.3 30.0 40.8 43.4 41.5 52.9 225.2 77.3 81.7 121.4 89.0 62.8 101.2 82.8 86.3 110.8 141.6 199.6 104.6 126.0 201.7 65.0 168.4 88.8 147.4 148.7 98.1 124.4 194.7 121.4 89.8 126.2 80.1 129.3 67.9 81.6 83.3 72.6 129.8 99.4 116.3 124.6 95.3 81.0 89.0 265.6 128.7 172.3 89.0 279.0 159.3 74.3 74.9 171.2 133.9 100.3 122.8 87.3 69.7 214.0 126.9 78.6 267.9 102.4 61.5 52.5 82.9 70.9 224.3 161.7 181.3 237.3 83.4 136.2 71.5 8.3 17.6 15.9 26.8 30.7 32.9 32.9 31.6 29.1 34.0 33.9 45.8 34.8 1.3 29.8 19.2 34.7 36.7 21.6 50.4 51.0 53.5 60.1 50.7 49.9 50.8 50.6 50.9 49.8 51.3 52.9 45.1 38.5 43.8 23.8 39.4 113.4 74.1 113.7 61.5 22.0 70.1 77.0 17.4 47.1 70.2 44.1 16.7 103.2 45.8 132.8 140.8 73.0 21.0 62.3 62.3 57.9 55.7 53.8 12.9 91.2 146.0 52.8 53.5 83.7 31.1 50.4 43.2 58.5 61.4 25.2 15.8 80.2 93.6 21.4 57.5 14.3 46.0 29.9 51.6 9.4 29.0 26.7 32.0 8.5 11.5 97.6 90.9 27.8 52.1 139.7 94.5 150.5 55.1 24.9 39.5 48.0 69.6 92.9 111.0 66.0 74.2 122.3 38.0 71.6 83.1 92.5 THPO "MGDF, MPLLG, TPO" ENSG00000090534 Thrombopoietin P40225 3 184371935-184381968 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Hormone" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 35.4" "Cell type enhanced" "Detected in some" "Early spermatids: 2.3;Hepatocytes: 12.7;Late spermatids: 4.0;Proximal tubular cells: 9.7" "Cancer enriched" "Detected in many" 5 "liver cancer: 8.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 6.0;Hep G2: 15.6;K-562: 2.8;RPMI-8226: 4.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 1070000 "Cluster 15: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (5.57e-2)" "unprognostic (3.15e-2)" "unprognostic (1.75e-1)" "unprognostic (2.21e-2)" "unprognostic (6.20e-2)" "unprognostic (1.97e-1)" "unprognostic (1.37e-2)" "unprognostic (2.75e-1)" "unprognostic (1.00e-1)" "unprognostic (1.81e-1)" "unprognostic (8.40e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (2.48e-6)" "unprognostic (1.40e-3)" "unprognostic (4.13e-1)" "unprognostic (1.11e-1)" "unprognostic (2.25e-2)" 1.8 2.5 5.2 0.5 3.9 0.0 1.4 4.7 4.8 3.9 2.4 0.7 0.2 3.8 1.3 0.4 2.0 0.4 1.2 4.5 2.8 4.5 35.4 0.8 0.2 3.3 2.9 2.8 1.7 0.1 0.7 0.5 3.0 1.3 0.3 0.0 0.5 0.5 1.9 0.6 0.7 1.5 3.0 1.3 0.9 3.9 2.8 0.0 0.8 0.9 0.1 0.9 1.9 3.6 0.0 0.0 0.0 0.0 0.5 0.0 2.0 0.0 0.0 0.1 0.0 6.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 15.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.3 0.6 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.1 1.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 3.9 4.7 4.8 4.5 2.8 3.3 2.9 3.0 3.0 2.8 3.6 0.1 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.1 1.6 0.1 0.0 0.0 2.2 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 12.7 0.6 0.0 1.3 0.0 0.0 0.8 0.0 4.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 1.1 0.8 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CHRD ENSG00000090539 Chordin Q9H2X0 3 184380073-184390736 "Plasma proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 130.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 31.2;Excitatory neurons: 28.2;Fibroblasts: 16.4;Hepatocytes: 36.4;Inhibitory neurons: 37.5;Skeletal myocytes: 19.1;Smooth muscle cells: 16.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 2.8;Hep G2: 11.8;MCF7: 2.5;SuSa: 4.0;U-2 OS: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA035827 Approved "Secreted in other tissues" NA NA 350000 "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 36: Stromal cells - Cell proliferation" "HPA035827: AB_10669657" "unprognostic (2.26e-1)" "unprognostic (3.25e-2)" "unprognostic (1.63e-2)" "unprognostic (2.21e-1)" "unprognostic (6.52e-2)" "unprognostic (3.16e-1)" "unprognostic (2.88e-1)" "unprognostic (9.58e-2)" "unprognostic (1.87e-1)" "unprognostic (1.12e-1)" "unprognostic (3.12e-2)" "unprognostic (6.55e-2)" "prognostic unfavorable (6.09e-7)" "unprognostic (5.53e-3)" "unprognostic (1.85e-1)" "unprognostic (9.84e-2)" "unprognostic (7.99e-3)" 11.1 12.2 13.9 2.1 13.9 0.0 9.9 19.0 21.2 40.0 9.1 7.6 1.6 32.9 3.2 3.3 15.0 2.5 11.2 15.1 9.4 18.8 130.0 7.2 1.5 10.1 9.9 16.3 17.1 1.1 6.0 2.4 10.2 9.7 0.8 0.0 3.8 5.2 4.4 5.4 6.0 4.6 10.3 9.7 7.8 1.1 9.7 0.2 7.7 2.7 0.3 7.2 15.4 13.6 0.0 0.0 0.3 1.1 0.1 0.1 1.4 0.3 0.0 0.2 0.1 2.8 0.0 0.0 1.1 0.3 1.0 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 11.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.0 0.0 0.0 0.6 0.0 0.1 0.1 0.1 4.0 1.4 0.0 0.0 0.0 3.8 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 13.9 19.0 21.2 15.1 9.4 10.1 9.9 10.2 10.3 9.7 13.6 2.6 0.0 0.0 11.8 0.4 2.7 0.0 0.0 0.6 2.9 2.1 1.8 3.1 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.1 0.1 3.6 31.2 2.6 0.0 0.0 28.2 3.1 0.0 16.4 1.1 4.5 0.0 0.9 3.3 36.4 0.7 0.0 37.5 0.2 0.0 3.2 3.1 0.0 3.7 0.4 1.8 4.7 0.0 0.0 0.0 7.1 2.5 1.1 0.0 2.2 0.0 0.1 0.0 4.0 0.0 0.5 6.6 19.1 16.4 0.3 0.3 0.3 1.1 0.1 0.7 0.1 0.0 0.3 EPHB3 "ETK2, Hek2, Tyro6" ENSG00000182580 "EPH receptor B3" P54753 3 184561785-184582408 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins" "Angiogenesis, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 51.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 38.1;Breast myoepithelial cells: 50.8;Enteroendocrine cells: 71.5;Intestinal goblet cells: 43.3;Squamous epithelial cells: 44.3;Undifferentiated cells: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 28.8;HaCaT: 40.2;OE19: 28.3;SK-BR-3: 30.9;T-47d: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007698, HPA008184, CAB034350" Enhanced NA NA 100000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "CAB034350: AB_2262377, HPA007698: AB_1848205, HPA008184: AB_1848206" "unprognostic (2.94e-2)" "unprognostic (5.88e-2)" "unprognostic (2.17e-2)" "unprognostic (7.80e-2)" "unprognostic (1.52e-1)" "unprognostic (9.19e-2)" "unprognostic (8.35e-2)" "unprognostic (1.94e-1)" "unprognostic (5.51e-2)" "unprognostic (1.76e-1)" "unprognostic (7.42e-2)" "unprognostic (3.31e-1)" "prognostic unfavorable (7.88e-5)" "unprognostic (8.83e-3)" "unprognostic (3.03e-2)" "unprognostic (9.59e-3)" "unprognostic (2.10e-3)" 1.7 0.7 3.0 3.7 2.7 0.1 10.4 5.8 4.1 22.7 1.0 10.3 6.4 10.1 1.8 30.6 4.0 2.8 1.9 2.9 2.4 5.8 0.9 3.4 0.9 5.7 3.4 8.3 14.9 1.1 2.0 5.7 6.1 10.0 10.9 0.5 31.7 3.5 0.5 51.5 6.3 3.8 2.3 1.0 22.8 0.9 4.0 0.7 0.9 0.4 2.4 4.0 20.9 2.7 6.6 2.3 14.8 1.6 4.5 0.3 28.8 1.1 1.9 2.2 1.2 2.0 0.2 0.0 2.8 6.3 1.0 40.2 5.4 1.9 0.6 0.2 1.1 0.0 0.3 0.0 0.3 0.0 0.2 1.2 13.0 1.8 0.2 0.7 0.0 0.0 0.0 0.0 1.0 17.6 0.0 6.4 1.4 28.3 2.5 1.5 9.0 0.0 0.0 5.8 1.9 2.2 1.2 30.9 1.3 7.8 20.5 0.1 0.0 3.6 5.1 1.8 2.5 0.0 0.0 0.1 0.3 0.0 14.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 2.7 5.8 4.1 2.9 2.4 5.7 3.4 6.1 2.3 4.0 2.7 0.9 3.2 2.7 11.1 0.2 24.1 7.6 5.3 17.1 0.9 38.1 50.8 1.8 2.8 4.6 0.0 0.0 10.1 1.1 21.5 1.9 0.5 0.6 3.7 4.0 1.4 71.5 0.0 4.6 1.6 18.7 6.9 27.0 7.5 4.5 2.1 1.8 0.0 23.5 15.2 5.8 43.3 10.2 0.3 9.8 0.4 2.8 2.4 0.0 1.0 0.8 0.1 0.0 5.0 0.3 3.2 7.2 6.0 0.0 6.0 1.7 0.2 1.4 1.0 0.0 4.5 2.9 0.4 0.6 44.3 35.8 16.3 0.8 1.6 55.0 20.7 MAGEF1 ENSG00000177383 "MAGE family member F1" Q9HAY2 3 184710364-184712064 "Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 146.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046899, HPA054190" Uncertain Approved "Actin filaments" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 35: Non-specific - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Actin filaments" "HPA046899: AB_2679859, HPA054190: AB_2682411" "unprognostic (7.36e-3)" "unprognostic (3.79e-2)" "unprognostic (3.81e-2)" "unprognostic (1.10e-2)" "unprognostic (4.27e-2)" "unprognostic (4.46e-3)" "unprognostic (2.34e-3)" "unprognostic (1.37e-1)" "unprognostic (2.42e-1)" "unprognostic (2.80e-3)" "unprognostic (1.82e-1)" "unprognostic (8.51e-3)" "prognostic favorable (7.59e-4)" "unprognostic (7.65e-2)" "unprognostic (8.97e-2)" "unprognostic (3.15e-3)" "unprognostic (1.19e-1)" 16.8 26.9 28.9 16.4 29.3 2.7 24.0 29.6 33.4 33.7 31.3 28.2 17.4 32.4 35.9 20.7 26.1 15.5 26.2 29.1 37.7 36.3 25.4 20.3 21.3 29.0 29.8 27.4 29.3 35.5 56.3 23.1 29.2 30.3 17.1 27.0 25.9 26.8 32.6 22.7 20.3 19.1 29.7 19.1 27.0 12.3 31.8 21.7 29.7 21.7 17.6 27.3 21.7 27.9 86.3 22.3 89.8 56.1 32.0 12.9 61.8 32.1 34.9 53.2 53.3 54.8 31.3 59.1 65.2 29.2 88.1 60.0 46.2 27.7 49.0 96.2 65.1 17.3 32.9 77.4 31.5 27.4 27.4 29.7 34.4 33.9 10.7 25.4 13.0 19.3 30.3 40.0 31.5 108.8 10.4 60.8 56.9 54.6 38.4 29.9 72.6 18.4 39.5 56.4 99.0 94.6 49.5 83.1 77.4 50.0 132.4 10.1 9.1 35.0 61.6 41.1 62.9 82.9 65.6 78.7 27.6 9.8 46.3 0.1 1.4 2.5 1.6 0.3 0.6 2.8 2.2 1.8 5.7 4.7 6.1 3.1 0.2 1.2 0.2 0.4 2.3 0.9 28.9 29.3 29.6 33.4 29.1 37.7 29.0 29.8 29.2 29.7 31.8 27.9 6.5 32.1 25.8 10.4 22.1 18.7 52.7 56.9 30.1 60.3 37.5 33.7 19.2 48.6 33.0 42.3 10.4 103.2 6.0 9.2 146.8 54.3 1.2 27.0 22.3 16.0 49.3 13.2 14.6 41.3 56.4 37.3 27.5 19.0 5.7 36.1 20.3 26.2 68.6 63.9 15.1 46.1 71.2 8.1 36.3 3.9 55.3 10.1 24.9 6.5 32.3 67.3 20.6 13.6 12.6 30.0 22.4 57.2 26.5 44.3 11.2 64.8 30.1 49.2 32.9 30.7 33.4 21.3 8.9 29.6 13.8 60.5 11.4 56.8 32.5 72.3 VPS8 "FLJ32099, KIAA0804" ENSG00000156931 "VPS8 subunit of CORVET complex" Q8N3P4 3 184812143-185052614 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 154.1;Granulosa cells: 124.3;Inhibitory neurons: 132.2;Oligodendrocytes: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036871 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 40: Granulosa cells - Unknown function" Cytosol "Plasma membrane" "HPA036871: AB_10672103" "unprognostic (4.36e-2)" "unprognostic (3.97e-3)" "unprognostic (1.53e-1)" "unprognostic (7.95e-2)" "unprognostic (5.11e-2)" "unprognostic (4.43e-2)" "unprognostic (1.27e-3)" "unprognostic (1.74e-1)" "unprognostic (3.21e-2)" "unprognostic (5.98e-3)" "unprognostic (1.98e-1)" "unprognostic (8.82e-2)" "unprognostic (4.74e-2)" "unprognostic (3.15e-1)" "unprognostic (2.56e-1)" "unprognostic (8.10e-3)" "unprognostic (4.97e-2)" 10.9 9.6 18.7 10.0 22.1 23.2 10.6 24.2 24.0 12.7 29.1 11.4 8.3 12.3 16.3 10.1 9.0 11.1 19.6 20.4 23.6 10.6 8.5 10.7 10.5 25.1 21.4 14.3 8.9 15.8 16.3 12.1 26.3 10.9 14.7 16.4 7.9 10.1 28.6 12.9 9.3 12.9 17.1 13.3 13.0 16.9 26.1 11.6 14.9 15.3 10.7 10.4 10.3 36.4 18.0 10.7 15.9 15.9 32.5 28.8 10.6 17.7 18.8 12.3 17.0 13.6 9.0 19.1 29.3 26.9 50.4 20.8 17.3 21.0 23.6 34.8 15.4 20.4 13.0 8.1 20.0 14.3 27.0 20.6 19.4 17.6 17.5 22.6 31.4 17.7 10.9 13.5 22.7 12.8 11.6 8.5 10.5 18.4 10.1 14.1 30.6 15.0 12.2 30.8 16.2 10.6 19.9 20.8 15.6 23.6 33.2 7.5 27.9 18.8 10.5 19.6 15.3 16.5 21.5 25.9 21.6 17.7 15.5 19.0 6.6 22.9 5.0 5.2 4.9 4.4 5.4 5.2 8.1 5.5 8.0 5.4 23.9 5.7 6.6 2.3 4.8 4.3 18.7 22.1 24.2 24.0 20.4 23.6 25.1 21.4 26.3 17.1 26.1 36.4 11.8 12.8 11.5 66.3 17.9 10.5 9.2 8.3 11.4 24.5 8.7 8.3 24.6 11.5 9.7 9.2 18.8 12.8 10.8 17.3 7.9 7.7 22.2 11.0 17.5 12.8 18.0 11.6 154.1 4.6 6.7 14.7 21.9 14.3 2.5 124.3 12.5 7.7 20.2 11.8 132.2 16.6 12.2 19.1 16.7 16.5 10.5 21.2 10.6 89.9 32.0 10.1 32.0 86.5 149.2 6.4 12.7 12.8 14.4 9.4 9.2 8.8 14.4 17.3 6.6 13.0 10.0 94.3 27.8 15.8 16.1 7.7 17.8 11.8 13.2 13.0 C3orf70 ENSG00000187068 "Chromosome 3 open reading frame 70" A6NLC5 3 185076838-185153060 "Cancer-related genes, Predicted intracellular proteins" Neurogenesis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.9;smooth muscle: 14.8" "Cell type enhanced" "Detected in many" "Astrocytes: 45.7;Bipolar cells: 76.8;Melanocytes: 39.2;Oligodendrocyte precursor cells: 143.2;Peritubular cells: 49.7" "Cancer enhanced" "Detected in many" "glioma: 10.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 3.9;SCLC-21H: 16.4;SK-BR-3: 7.2;WM-115: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041861 Uncertain Approved Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 68: Oligodendrocytes - Mixed function" Cytosol "HPA041861: AB_10804119" "unprognostic (1.45e-1)" "unprognostic (2.17e-3)" "unprognostic (3.92e-3)" "unprognostic (2.77e-1)" "unprognostic (2.31e-1)" "unprognostic (6.62e-4)" "unprognostic (5.56e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (1.32e-1)" "unprognostic (5.98e-3)" "unprognostic (9.91e-2)" "prognostic unfavorable (6.40e-6)" "unprognostic (1.06e-1)" "unprognostic (8.48e-2)" "unprognostic (6.57e-2)" "unprognostic (7.84e-2)" 2.2 0.8 10.8 2.4 8.5 0.1 1.3 7.2 8.8 3.1 0.0 11.1 2.6 9.8 2.6 5.1 5.2 2.2 2.0 9.9 9.1 0.5 0.3 0.9 0.4 15.9 11.5 2.3 0.2 2.1 0.8 1.3 10.1 5.1 4.1 3.9 3.0 8.4 0.5 1.5 3.6 14.8 13.6 2.1 2.8 4.0 12.0 0.3 1.1 0.6 0.6 4.9 2.0 14.0 0.0 0.1 1.9 0.0 0.0 0.0 0.1 2.6 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.3 0.1 0.0 0.9 0.0 0.1 0.0 0.6 2.2 0.1 0.5 0.0 0.3 3.6 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.8 2.0 0.1 0.0 3.9 0.0 0.0 0.4 16.4 0.1 0.8 7.2 0.4 0.0 0.4 1.8 0.6 0.0 1.9 0.0 1.2 0.0 0.0 0.0 0.0 0.0 8.9 0.6 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.1 0.1 0.0 0.0 10.8 8.5 7.2 8.8 9.9 9.1 15.9 11.5 10.1 13.6 12.0 14.0 5.1 0.0 0.0 45.7 1.0 4.1 0.3 0.0 0.6 76.8 1.0 0.5 1.6 0.0 0.0 0.0 0.0 10.8 0.0 9.1 0.0 0.1 1.2 0.1 2.3 4.4 1.2 0.0 13.8 0.2 0.6 3.8 0.0 0.1 0.0 3.9 6.8 0.0 4.0 3.3 19.4 8.8 0.0 0.6 0.7 1.5 3.4 0.3 39.2 6.5 0.6 2.5 0.0 143.2 10.1 0.5 2.2 49.7 0.1 0.3 4.6 0.1 0.0 7.3 6.6 1.3 15.4 6.8 12.5 0.2 1.8 0.8 0.2 1.8 6.3 0.3 EHHADH ECHD ENSG00000113790 "Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase" Q08426 3 185190624-185281990 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 11 "kidney: 144.3;liver: 344.5" "Group enriched" "Detected in many" 10 "Hepatocytes: 289.0;Proximal tubular cells: 147.1" "Group enriched" "Detected in all" 7 "liver cancer: 42.2;renal cancer: 25.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036401, HPA042021" Enhanced NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA036401: AB_10670165, HPA042021: AB_2677801" "unprognostic (1.20e-1)" "unprognostic (5.99e-2)" "unprognostic (2.17e-3)" "unprognostic (2.69e-2)" "unprognostic (6.82e-2)" "unprognostic (1.48e-1)" "unprognostic (4.79e-3)" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (3.89e-2)" "unprognostic (3.19e-3)" "unprognostic (1.87e-1)" "prognostic favorable (1.28e-5)" "unprognostic (1.93e-1)" "unprognostic (1.53e-1)" "unprognostic (2.96e-2)" "unprognostic (2.80e-1)" 10.8 4.3 2.1 3.0 2.9 1.2 4.1 3.9 2.7 3.5 9.2 14.2 21.5 2.8 3.5 5.5 3.6 4.4 10.7 2.1 3.1 144.3 344.5 4.3 2.1 3.2 4.1 2.6 9.9 7.8 1.5 3.2 3.0 6.3 10.8 1.6 5.7 2.2 1.7 4.5 12.9 3.7 2.5 3.7 10.4 2.7 3.1 2.1 6.5 5.6 2.8 3.6 2.1 2.8 12.3 5.0 1.4 0.0 7.3 6.1 1.5 5.7 1.8 3.7 4.1 21.9 7.5 0.0 22.1 5.7 1.4 5.8 0.0 4.8 7.6 16.2 5.2 8.6 1.3 22.5 4.7 1.0 0.2 8.7 6.0 3.7 3.4 5.0 5.5 0.0 5.7 6.1 7.2 6.4 0.2 5.1 3.0 4.3 6.3 0.0 9.9 0.5 15.4 6.8 4.4 6.4 11.2 6.4 10.5 12.1 23.7 10.1 2.6 2.4 3.6 1.9 0.5 1.7 5.6 0.5 0.8 3.9 4.0 0.1 0.9 0.0 0.6 0.8 0.4 0.5 0.4 0.9 2.4 0.0 0.6 1.0 0.0 1.2 0.8 1.0 0.6 0.4 2.1 2.9 3.9 2.7 2.1 3.1 3.2 4.1 3.0 2.5 3.1 2.8 4.9 16.0 10.9 20.9 4.5 1.5 1.4 1.9 1.2 0.7 3.2 2.3 19.2 17.2 3.9 20.2 4.2 8.9 0.4 17.8 19.6 2.1 0.2 6.5 5.1 3.9 7.7 9.7 4.9 6.8 2.9 1.6 8.6 3.1 0.0 6.1 13.6 289.0 4.4 0.0 5.7 12.8 0.0 10.5 1.0 0.7 0.6 2.7 3.6 4.7 9.4 1.9 0.0 3.5 8.0 3.7 9.3 0.4 0.8 2.5 15.0 147.1 4.0 1.2 0.0 1.1 2.4 3.7 4.2 4.9 0.4 1.4 2.2 3.6 10.8 1.8 MAP3K13 "LZK, MEKK13" ENSG00000073803 "Mitogen-activated protein kinase kinase kinase 13" O43283 3 185282941-185489094 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016497, HPA036691, HPA036692" Uncertain Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 22: Epithelial cell types - Mixed function" "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845" "unprognostic (8.95e-2)" "unprognostic (6.72e-3)" "unprognostic (9.46e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (5.16e-2)" "unprognostic (2.81e-1)" "unprognostic (2.61e-1)" "unprognostic (1.23e-2)" "unprognostic (9.04e-2)" "prognostic favorable (1.11e-4)" "prognostic unfavorable (7.27e-5)" "unprognostic (2.70e-3)" "unprognostic (1.54e-2)" "unprognostic (2.94e-2)" "unprognostic (2.82e-1)" "unprognostic (6.64e-2)" "unprognostic (9.31e-3)" 14.7 34.0 18.5 13.0 19.8 15.8 21.0 23.2 25.8 17.0 18.5 24.6 24.3 17.9 56.8 19.7 20.2 18.1 10.4 19.7 20.4 30.9 29.6 17.5 11.7 20.7 21.7 22.2 25.9 34.6 20.7 13.1 21.1 19.7 26.2 36.2 26.2 14.9 4.7 14.0 25.0 17.0 21.2 13.1 23.9 18.8 21.5 11.1 25.7 6.8 15.0 23.2 15.8 23.5 73.9 14.5 27.4 0.7 24.4 29.9 16.1 16.5 11.2 26.2 31.5 27.9 27.0 0.6 55.1 30.4 43.7 41.1 0.8 38.4 46.5 82.1 36.8 0.3 18.9 23.3 26.5 39.2 20.1 27.2 32.8 22.6 28.1 27.1 29.6 0.7 0.9 57.5 23.8 23.0 4.6 18.2 31.5 56.5 33.4 0.6 32.8 40.5 46.9 18.8 44.7 29.8 28.0 41.5 59.9 29.8 62.8 21.5 19.7 21.5 27.8 39.4 36.5 29.3 40.8 24.4 31.4 19.5 36.1 14.0 21.6 9.4 16.6 22.1 25.7 42.8 19.6 21.0 37.4 34.9 27.2 26.6 35.9 20.8 15.9 16.4 8.6 12.4 18.5 19.8 23.2 25.8 19.7 20.4 20.7 21.7 21.1 21.2 21.5 23.5 69.5 54.5 82.7 80.0 41.8 141.6 219.1 196.7 100.7 117.9 144.0 115.1 25.2 144.4 131.6 79.1 91.8 139.5 22.9 96.1 287.6 106.6 134.8 76.5 50.7 65.9 106.4 43.8 170.7 127.5 38.9 49.0 72.4 73.1 29.8 96.6 93.5 99.4 64.9 45.4 184.5 130.9 138.4 53.2 193.0 213.0 43.2 52.7 85.4 28.1 283.9 137.5 22.6 102.1 89.8 137.5 95.1 54.2 40.6 322.2 111.6 283.9 125.7 88.8 46.0 38.5 62.7 119.5 39.1 94.6 145.6 203.4 32.2 50.0 109.3 279.4 TMEM41A MGC15397 ENSG00000163900 "Transmembrane protein 41A" Q96HV5 3 185476496-185499057 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 200.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059101, HPA059790" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "Golgi apparatus, Cytosol" "HPA059101: AB_2683905, HPA059790: AB_2684125" "unprognostic (2.17e-2)" "unprognostic (7.94e-2)" "unprognostic (1.99e-2)" "prognostic unfavorable (6.70e-6)" "unprognostic (2.67e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (2.84e-1)" "unprognostic (1.39e-1)" "unprognostic (1.79e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (3.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.73e-1)" "unprognostic (3.68e-1)" "unprognostic (1.46e-2)" "unprognostic (1.02e-2)" 9.0 27.2 9.6 5.4 9.3 11.0 10.2 9.7 11.0 10.0 8.9 7.9 26.4 8.7 11.2 23.6 9.2 7.6 9.9 9.0 9.4 14.7 20.5 10.6 7.4 9.4 11.6 14.1 9.7 8.7 5.7 8.4 9.2 10.2 8.9 7.5 12.0 8.3 9.8 19.9 24.1 7.4 9.8 12.5 10.3 9.3 12.1 7.8 7.0 16.4 12.6 10.8 14.6 10.9 43.6 15.4 10.1 12.5 15.6 16.8 29.6 16.3 14.3 20.2 14.6 40.5 16.7 13.4 30.5 15.3 28.5 29.4 28.1 17.5 20.4 22.6 25.8 23.3 8.6 41.2 17.5 25.3 12.5 15.7 25.6 18.3 20.9 12.7 15.6 16.8 42.1 32.4 13.0 16.8 15.6 14.5 16.8 34.1 24.1 15.5 15.6 24.6 17.4 31.4 10.1 13.1 14.1 35.8 25.7 14.4 42.8 19.6 11.4 11.9 15.0 25.2 34.5 47.2 78.0 26.5 18.2 15.1 14.6 14.0 8.2 7.2 16.3 9.4 21.0 17.5 16.7 18.1 9.3 15.6 18.2 19.8 2.8 12.2 12.2 21.7 15.3 9.2 9.6 9.3 9.7 11.0 9.0 9.4 9.4 11.6 9.2 9.8 12.1 10.9 12.1 9.6 30.5 7.2 16.7 53.0 42.8 29.5 50.7 22.4 38.2 20.6 12.6 24.3 24.9 20.2 18.8 27.5 18.3 23.3 7.9 33.4 0.7 17.7 14.5 19.8 18.6 16.4 8.1 56.0 23.5 18.0 36.2 38.0 8.8 50.2 17.2 40.9 19.6 16.8 9.8 28.3 16.2 14.2 17.3 2.8 14.3 12.5 8.8 2.8 65.9 11.4 11.3 20.1 7.6 50.3 17.0 13.5 20.9 64.2 200.8 23.2 9.6 28.6 19.7 16.8 16.5 22.1 14.3 113.0 84.7 46.0 18.5 82.6 45.6 93.4 LIPH "LPDLR, mPA-PLA1, mPA-PLA1alpha, PLA1B" ENSG00000163898 "Lipase H" Q8WWY8 3 185506262-185552588 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease variant, Hypotrichosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 37.7;stomach 1: 48.2" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 144.2;Club cells: 135.5;Distal enterocytes: 312.3;Gastric mucus-secreting cells: 236.5;Intestinal goblet cells: 139.8;Proximal enterocytes: 226.1;Urothelial cells: 158.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 74.1;OE19: 17.2;RPTEC TERT1: 36.7;T-47d: 17.6;U-266/84: 18.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA049079 Approved "Secreted to blood" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA049079: AB_2680623" "unprognostic (4.50e-3)" "unprognostic (2.07e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (9.40e-4)" "unprognostic (3.38e-1)" "unprognostic (1.01e-1)" "unprognostic (8.59e-2)" "unprognostic (1.44e-1)" "unprognostic (8.67e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (7.88e-2)" "prognostic favorable (9.20e-5)" "unprognostic (1.84e-1)" "unprognostic (1.97e-1)" "prognostic favorable (4.21e-4)" "unprognostic (1.15e-1)" 0.3 0.3 0.3 2.8 0.6 0.1 3.8 0.1 0.6 2.8 6.9 36.3 11.1 0.2 7.1 14.7 1.1 12.3 0.4 0.4 1.6 7.8 0.4 18.3 0.1 0.1 0.1 0.5 5.5 0.0 0.3 0.1 0.1 6.8 37.7 0.2 13.2 2.0 0.5 7.4 11.8 0.6 0.0 0.4 48.2 2.7 0.2 0.3 0.2 0.1 3.0 12.2 4.3 0.1 10.3 13.5 0.1 0.1 0.0 0.2 2.9 0.3 0.0 0.3 0.3 1.3 74.1 0.0 7.5 0.2 2.9 3.6 5.6 0.1 0.4 0.1 1.6 1.8 1.8 1.4 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 5.4 0.1 0.0 1.3 0.5 0.1 0.7 17.2 1.1 0.0 0.0 1.0 36.7 9.2 0.0 0.0 1.1 12.2 0.3 0.6 17.6 0.3 0.0 0.1 1.1 0.1 0.2 1.2 18.9 0.1 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.3 0.3 0.6 0.1 0.6 0.4 1.6 0.1 0.1 0.1 0.0 0.2 0.1 0.1 144.2 38.5 2.0 0.8 0.8 16.3 76.5 0.6 0.7 55.6 12.7 0.4 94.4 135.5 68.0 0.0 0.2 1.0 312.3 1.9 57.8 0.2 7.0 0.5 1.8 22.2 0.0 1.7 24.9 0.1 1.1 236.5 5.7 7.0 36.0 1.1 0.3 0.0 0.0 0.9 139.8 38.7 0.3 0.3 0.1 0.0 2.4 16.0 0.0 0.8 0.3 2.1 2.5 0.4 60.4 102.7 0.0 0.3 72.8 226.1 1.6 105.6 0.9 0.0 0.1 5.5 1.1 0.3 6.9 2.0 0.3 0.8 12.0 102.1 158.0 SENP2 "AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2" ENSG00000163904 "SUMO specific peptidase 2" Q9HC62 3 185582496-185633551 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 249.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029247, HPA029248" Approved Supported Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 5: NTERA-2 - Transcription" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol "HPA029247: AB_10599305, HPA029248: AB_10601855" "unprognostic (4.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.80e-2)" "prognostic unfavorable (7.98e-5)" "unprognostic (7.85e-2)" "unprognostic (2.90e-2)" "unprognostic (4.41e-3)" "unprognostic (1.45e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (1.85e-1)" "unprognostic (8.41e-3)" "unprognostic (5.12e-2)" "unprognostic (6.92e-2)" "unprognostic (1.60e-1)" "unprognostic (1.92e-1)" "unprognostic (1.56e-1)" 7.4 7.3 13.4 4.4 15.8 10.7 7.5 13.3 16.2 6.0 12.0 7.8 6.0 6.1 9.7 6.5 7.2 4.5 8.3 13.9 13.1 7.3 9.5 6.4 6.2 12.9 13.6 10.0 7.4 9.6 10.5 9.0 12.4 6.6 6.1 12.8 7.6 6.3 18.9 9.2 6.6 4.8 12.2 6.7 8.0 15.1 14.2 8.1 7.2 13.0 6.0 7.1 6.3 14.4 24.4 4.6 11.6 13.4 20.6 13.8 15.1 10.9 12.6 13.8 14.6 18.3 7.5 13.2 20.3 10.2 23.6 12.6 24.3 9.0 20.3 9.7 11.6 8.9 9.8 11.0 10.9 13.2 5.6 8.6 13.3 7.8 9.5 10.2 9.6 12.5 10.8 18.1 12.0 12.0 11.4 14.7 42.4 12.3 8.1 13.1 15.8 22.1 7.7 7.9 11.9 13.4 9.3 20.4 18.3 23.0 27.8 17.5 6.1 9.0 9.8 16.4 17.7 20.9 26.8 23.8 14.9 13.9 12.5 5.1 1.3 2.6 1.6 1.3 1.6 1.3 1.3 1.3 1.0 1.9 1.5 1.5 3.4 2.3 1.6 2.0 1.3 0.9 13.4 15.8 13.3 16.2 13.9 13.1 12.9 13.6 12.4 12.2 14.2 14.4 12.3 28.9 27.4 17.9 21.2 10.8 23.7 12.6 6.2 22.8 21.6 15.4 24.2 11.5 26.2 9.2 31.3 25.0 22.6 15.7 5.9 12.9 249.6 26.3 12.0 12.8 5.4 11.1 42.9 15.2 19.9 16.1 15.3 25.2 10.8 21.3 17.2 20.5 13.2 11.8 43.0 15.1 14.2 12.5 9.1 43.0 22.7 11.1 17.8 26.2 13.6 17.8 21.6 41.2 41.3 17.9 6.6 17.7 25.7 17.0 24.2 18.2 28.8 38.1 19.7 23.2 16.3 84.2 31.8 13.4 12.5 39.7 18.2 33.7 15.8 22.5 IGF2BP2 IMP-2 ENSG00000073792 "Insulin like growth factor 2 mRNA binding protein 2" Q9Y6M1 3 185643130-185825042 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 126.6;Glandular and luminal cells: 117.7;Rod photoreceptor cells: 176.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 263.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017126, HPA035145" Enhanced Enhanced Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 44: Endometrium - Transcription" Cytosol "CAB017126: , HPA035145: AB_2674491" "unprognostic (7.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.32e-1)" "prognostic unfavorable (5.12e-5)" "unprognostic (2.46e-3)" "unprognostic (8.25e-3)" "unprognostic (4.17e-1)" "unprognostic (3.45e-2)" "prognostic unfavorable (7.37e-5)" "unprognostic (1.77e-1)" "unprognostic (1.25e-1)" "unprognostic (9.45e-2)" "unprognostic (2.46e-1)" "unprognostic (1.71e-2)" "unprognostic (4.94e-3)" 8.0 9.0 0.9 4.1 1.1 11.9 5.3 6.4 2.0 7.2 1.3 12.6 15.0 5.0 0.7 3.3 11.2 7.5 9.0 1.0 2.1 8.2 1.6 11.7 1.3 2.2 2.1 6.6 4.9 6.4 1.4 15.1 1.3 1.9 14.9 22.3 9.3 1.1 2.0 4.4 16.0 4.6 1.5 4.4 13.2 6.1 1.9 2.2 7.3 3.4 1.8 3.8 5.5 1.2 129.4 11.0 124.2 22.5 64.8 102.5 73.2 68.5 94.2 102.2 121.6 94.1 36.2 0.0 98.2 56.9 130.1 57.7 58.4 97.3 163.9 0.2 58.2 37.7 0.6 64.1 140.2 1.2 0.2 75.0 50.4 67.6 263.9 53.2 95.3 10.1 37.6 0.1 75.2 1.1 0.3 27.8 87.3 22.1 45.7 13.5 48.1 38.8 63.7 0.4 7.7 1.2 5.0 0.2 113.5 120.5 10.1 82.1 144.8 34.8 74.8 44.6 78.2 0.4 0.2 0.3 34.7 0.1 50.3 0.4 1.4 0.2 0.0 1.4 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.7 1.7 0.4 0.0 0.6 0.9 1.1 6.4 2.0 1.0 2.1 2.2 2.1 1.3 1.5 1.9 1.2 6.2 12.8 11.6 2.3 0.6 19.8 20.1 48.1 1.2 5.2 18.4 6.2 15.7 44.3 49.2 25.8 16.7 2.8 0.9 82.0 3.9 38.9 126.6 86.4 13.8 18.9 35.6 46.9 0.7 25.4 18.0 25.3 20.9 117.7 2.5 64.5 39.7 0.5 16.4 1.7 1.1 44.7 46.8 8.8 16.9 81.7 5.3 10.5 14.2 13.1 11.3 21.2 6.2 4.5 0.2 61.1 80.1 0.4 1.5 63.0 68.8 11.4 74.8 176.7 0.0 2.0 18.8 4.7 14.4 1.2 14.6 6.3 1.1 0.8 45.9 77.8 TRA2B "Htra2-beta, PPP1R156, SFRS10" ENSG00000136527 "Transformer 2 beta homolog" P62995 3 185914558-185938103 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 444.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011692, HPA063597, HPA064972" Supported Enhanced Nucleoplasm,Cytosol NA NA 62000 "Cluster 6: Non-specific - Transcription" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396" "unprognostic (9.37e-2)" "unprognostic (1.42e-2)" "unprognostic (1.22e-2)" "unprognostic (7.58e-3)" "unprognostic (1.48e-1)" "unprognostic (2.10e-2)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.92e-1)" "unprognostic (2.65e-3)" "prognostic favorable (2.15e-4)" "unprognostic (1.07e-1)" "unprognostic (3.22e-3)" "unprognostic (1.71e-3)" "unprognostic (1.28e-2)" "unprognostic (2.64e-1)" "unprognostic (4.38e-1)" "unprognostic (4.36e-2)" 38.2 41.3 18.1 35.2 19.1 46.3 30.2 23.0 31.1 25.2 25.7 41.7 21.5 31.3 26.3 38.7 27.1 16.0 31.7 19.6 22.3 41.6 37.5 21.5 38.7 19.8 17.2 25.5 28.3 28.9 20.3 26.3 20.4 25.8 24.9 18.5 27.0 18.4 34.1 25.5 27.0 25.2 17.4 36.2 31.1 22.4 19.5 47.6 23.2 23.2 43.9 28.7 26.8 26.3 145.0 44.2 135.0 67.8 30.3 27.3 78.2 101.5 71.1 117.5 90.2 75.3 67.6 124.5 134.4 53.2 79.5 94.1 140.9 104.5 120.9 117.5 89.6 122.0 40.1 92.7 42.4 133.3 101.1 26.5 44.3 75.1 51.0 36.5 90.4 63.5 120.4 81.6 79.6 66.4 344.9 164.1 191.3 113.0 85.5 201.1 109.4 147.5 94.3 58.9 98.0 104.0 73.3 90.1 117.8 66.5 101.1 138.0 52.7 81.3 110.8 68.2 170.1 159.6 444.0 272.0 78.0 151.0 130.6 84.1 39.2 33.0 36.3 33.1 32.8 71.2 36.1 34.0 35.3 64.0 45.0 40.9 44.0 41.3 39.6 73.2 36.4 21.5 18.1 19.1 23.0 31.1 19.6 22.3 19.8 17.2 20.4 17.4 19.5 26.3 236.3 64.1 122.0 46.4 201.7 258.4 196.9 136.6 157.1 107.8 206.0 148.2 67.2 140.2 104.0 69.9 196.0 188.9 196.6 156.2 72.4 126.8 156.9 152.7 284.5 181.6 227.6 233.4 49.7 109.5 230.7 147.2 92.2 274.6 197.6 155.9 189.9 93.0 174.6 72.3 53.7 259.8 85.5 280.7 283.1 46.6 127.7 228.1 135.2 74.0 196.9 115.5 167.9 78.4 67.0 97.5 129.1 117.4 152.1 218.3 121.2 59.1 66.7 219.5 105.2 177.0 214.7 168.2 151.5 141.3 260.7 214.9 212.6 89.4 232.4 163.7 ETV5 ERM ENSG00000244405 "ETS variant transcription factor 5" P41161 3 186046314-186110318 "Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 94.0;Oligodendrocyte precursor cells: 169.9;Syncytiotrophoblasts: 88.8" "Cancer enhanced" "Detected in all" "melanoma: 50.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-MEL-30: 178.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009590, HPA063065, HPA073889" Approved Enhanced Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "CAB009590: AB_2101008, HPA063065: AB_2684936, HPA073889: " "unprognostic (3.85e-1)" "unprognostic (5.81e-2)" "unprognostic (1.54e-2)" "unprognostic (3.30e-1)" "unprognostic (9.00e-2)" "unprognostic (2.56e-3)" "prognostic unfavorable (7.85e-9)" "unprognostic (3.52e-3)" "unprognostic (2.97e-1)" "unprognostic (1.22e-2)" "unprognostic (4.18e-2)" "unprognostic (1.48e-1)" "unprognostic (1.57e-3)" "unprognostic (6.80e-2)" "unprognostic (1.57e-1)" "unprognostic (3.58e-2)" "unprognostic (3.84e-3)" 6.8 39.3 17.1 6.9 22.4 1.4 15.0 17.7 24.4 4.9 9.4 3.4 6.1 8.1 7.3 4.2 5.1 5.6 11.5 17.8 16.8 8.9 7.9 29.6 5.2 20.5 17.1 2.2 17.5 42.2 25.4 17.1 17.7 7.4 3.2 15.9 6.5 5.8 11.9 6.4 3.0 7.4 14.7 10.9 14.8 9.3 17.2 4.8 21.9 7.0 4.2 4.3 4.1 19.6 42.4 28.6 36.1 79.2 21.9 22.7 2.6 35.7 39.7 27.7 29.6 31.7 25.4 1.1 46.4 34.7 41.3 7.1 0.8 27.2 40.7 9.3 1.0 12.4 1.0 36.4 36.3 31.2 22.1 19.9 4.4 44.3 53.7 32.9 41.0 4.4 11.6 14.6 47.5 19.8 4.1 47.7 54.2 12.1 32.4 86.6 36.0 28.7 23.0 9.9 1.6 45.8 8.7 0.4 178.3 14.4 0.1 17.3 40.0 15.0 24.3 38.2 70.5 11.1 49.9 0.3 45.8 24.6 91.6 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.4 0.4 0.0 0.1 17.1 22.4 17.7 24.4 17.8 16.8 20.5 17.1 17.7 14.7 17.2 19.6 5.7 3.2 68.5 26.1 5.6 15.7 10.6 8.2 45.5 17.8 9.4 30.4 5.7 17.2 2.4 0.0 12.5 57.6 3.1 0.6 3.9 9.4 24.6 2.0 4.3 9.2 10.7 1.7 94.0 9.4 18.8 12.5 15.8 4.7 8.2 0.8 10.4 9.0 56.4 5.0 43.7 2.8 0.0 64.4 19.4 49.0 9.0 27.1 16.0 45.9 2.1 60.4 1.0 169.9 47.5 12.5 1.1 15.4 4.9 3.6 1.5 22.9 1.3 18.8 0.0 25.4 13.6 16.9 14.4 8.7 5.3 88.8 1.9 3.1 1.5 2.7 DGKG DAGK3 ENSG00000058866 "Diacylglycerol kinase gamma" P49619 3 186105668-186362234 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.2" "Cell type enhanced" "Detected in many" "Astrocytes: 223.0;Excitatory neurons: 111.0;Inhibitory neurons: 63.5;Oligodendrocyte precursor cells: 334.8" "Cancer enhanced" "Detected in some" "glioma: 2.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "classical monocyte: 2.1;eosinophil: 1.2;intermediate monocyte: 1.2;myeloid DC: 1.5;neutrophil: 2.6;non-classical monocyte: 1.5" "Group enriched" "Detected in many" 7 "dendritic cells: 1.5;granulocytes: 2.6;monocytes: 2.1" "Cell line enhanced" "Detected in some" "HDLM-2: 23.9;HL-60: 7.7;U-266/84: 9.4;U-87 MG: 14.3;U-937: 7.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036577 Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 6: Brain - Smell perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Vesicles, Plasma membrane" "HPA036577: AB_10672358" "unprognostic (2.23e-1)" "unprognostic (1.97e-1)" "unprognostic (1.56e-2)" "unprognostic (3.24e-5)" "unprognostic (2.70e-1)" "unprognostic (6.09e-4)" "unprognostic (1.21e-3)" "unprognostic (3.80e-2)" "unprognostic (5.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.94e-1)" "unprognostic (5.09e-2)" "unprognostic (8.05e-7)" "unprognostic (3.47e-3)" "unprognostic (7.19e-2)" "unprognostic (1.41e-1)" "unprognostic (9.16e-3)" 1.6 4.2 14.2 0.8 17.4 9.3 1.1 28.2 11.9 2.2 0.0 3.2 1.4 1.2 8.0 4.6 4.1 0.9 9.1 20.4 3.6 1.3 0.8 3.8 0.9 20.1 6.5 1.2 0.5 5.7 6.0 7.8 20.8 1.3 0.8 1.7 0.8 1.8 1.8 0.8 1.7 2.4 0.6 0.9 2.1 0.3 9.6 0.5 1.8 1.0 0.8 3.4 1.7 13.2 3.2 4.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 2.7 0.0 3.3 0.2 0.0 0.0 0.0 23.9 0.0 3.2 0.0 3.5 0.0 7.7 0.3 0.0 0.0 1.4 0.0 0.1 0.0 0.6 0.0 0.4 0.4 0.1 0.1 2.6 0.4 0.0 1.4 1.7 0.0 2.6 0.0 0.0 0.6 0.0 0.9 0.0 2.0 0.0 0.1 4.9 0.0 0.0 0.8 2.4 2.9 0.0 9.4 0.0 14.3 7.0 2.6 0.0 2.1 1.2 0.0 1.2 0.0 0.3 0.0 0.0 1.5 0.1 0.0 0.0 2.6 0.0 1.5 0.2 0.0 0.7 14.2 17.4 28.2 11.9 20.4 3.6 20.1 6.5 20.8 0.6 9.6 13.2 0.1 0.0 1.7 223.0 3.1 0.4 0.2 0.0 0.6 0.1 0.1 0.4 19.4 1.5 0.0 1.8 0.0 0.1 0.0 0.0 0.0 1.4 2.6 0.3 0.1 5.0 0.0 0.4 111.0 1.2 0.0 0.5 0.5 0.1 0.0 0.3 22.1 0.0 2.1 1.7 63.5 0.1 0.0 3.2 1.4 4.2 1.8 3.4 0.0 12.2 5.2 6.8 0.0 334.8 7.8 1.0 0.1 0.4 0.2 0.4 0.1 0.9 0.0 0.1 13.1 1.8 14.5 0.0 0.2 0.4 0.4 0.1 0.1 0.9 0.1 0.4 CRYGS CRYG8 ENSG00000213139 "Crystallin gamma S" P22914 3 186538441-186546702 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Eye lens protein" "Cataract, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.5" "Cell type enhanced" "Detected in many" "Astrocytes: 5.2;Excitatory neurons: 5.4;Inhibitory neurons: 6.0;Microglial cells: 5.6;Oligodendrocyte precursor cells: 6.0;Oligodendrocytes: 7.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA035103, HPA063539" Supported Uncertain Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 43: Cardiomyocytes - Nuclear processes" Cytosol "HPA035103: AB_10696367, HPA063539: " "unprognostic (5.52e-4)" "unprognostic (1.29e-3)" "unprognostic (1.44e-2)" "unprognostic (5.45e-2)" "unprognostic (4.90e-2)" "unprognostic (5.85e-2)" "unprognostic (4.79e-2)" "unprognostic (1.73e-2)" "unprognostic (4.76e-2)" "unprognostic (1.12e-1)" "unprognostic (5.84e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.72e-9)" "unprognostic (1.10e-1)" "unprognostic (9.53e-2)" "unprognostic (3.67e-1)" "prognostic favorable (2.73e-4)" 1.1 2.0 6.5 1.0 6.9 2.8 1.6 8.0 10.5 1.8 6.9 1.7 1.1 1.6 1.5 1.2 1.5 0.8 2.1 6.5 7.2 2.3 2.1 1.5 2.2 6.5 6.8 1.2 2.1 0.7 1.4 0.9 7.0 1.5 2.0 8.1 1.2 1.4 1.1 1.1 1.9 1.3 6.3 2.8 1.5 2.1 6.8 4.8 1.2 0.6 1.7 1.7 1.6 7.3 0.3 0.7 1.5 1.1 1.5 1.7 0.0 0.2 0.4 0.5 1.0 0.2 0.6 1.5 1.3 1.2 0.6 1.0 0.8 1.1 1.6 1.0 1.8 1.7 0.2 1.1 0.6 1.1 1.3 1.9 1.2 0.3 0.8 1.7 1.5 1.6 0.4 0.8 1.2 0.4 0.8 0.5 0.0 0.5 0.3 1.7 0.2 0.8 0.5 1.0 0.5 0.6 0.2 0.7 0.3 1.0 0.9 0.9 2.2 0.4 0.3 0.5 1.0 1.7 1.1 1.8 0.7 0.5 0.6 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.5 6.9 8.0 10.5 6.5 7.2 6.5 6.8 7.0 6.3 6.8 7.3 1.2 0.0 1.7 5.2 0.7 0.3 0.3 0.7 0.6 1.1 0.9 1.5 3.0 1.5 0.9 0.0 2.1 0.2 0.6 0.5 0.0 0.6 0.2 0.3 0.6 1.0 0.0 3.2 5.4 0.2 0.2 0.9 2.6 0.5 1.3 0.9 2.5 1.3 0.4 1.7 6.0 0.8 2.0 0.3 1.2 1.3 0.3 1.1 0.0 5.6 0.1 0.5 1.0 6.0 7.6 0.2 0.4 0.7 0.1 0.3 0.8 0.2 0.5 3.2 0.0 0.8 0.8 2.4 0.9 0.4 0.1 0.3 0.8 0.9 1.2 0.2 TBCCD1 FLJ10560 ENSG00000113838 "TBCC domain containing 1" Q9NVR7 3 186546067-186570543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "unprognostic (1.15e-1)" "unprognostic (7.41e-3)" "unprognostic (6.36e-2)" "unprognostic (2.62e-2)" "unprognostic (8.79e-2)" "unprognostic (7.14e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.10e-2)" "unprognostic (1.42e-2)" "unprognostic (2.72e-2)" "unprognostic (2.59e-3)" "unprognostic (1.14e-1)" "unprognostic (1.43e-1)" "unprognostic (2.91e-1)" "unprognostic (1.62e-1)" "unprognostic (1.15e-1)" "unprognostic (2.27e-1)" 6.7 5.9 4.7 7.5 5.6 7.5 6.7 6.4 5.3 6.4 6.8 6.5 6.4 7.1 7.5 7.7 5.7 6.2 5.4 4.5 5.6 6.2 9.5 5.4 9.4 5.3 5.3 6.3 7.5 8.5 4.2 7.6 5.8 5.2 7.3 12.5 6.4 5.3 6.1 6.9 6.1 6.3 5.3 6.6 6.1 19.2 5.3 10.9 8.4 7.4 9.2 6.6 6.5 6.8 12.5 8.7 13.8 13.7 11.6 12.4 9.8 9.5 6.9 12.2 12.9 15.3 9.6 15.3 24.5 6.9 9.5 13.2 21.3 9.0 15.6 22.2 10.9 19.5 7.7 9.5 6.6 18.4 12.7 7.4 9.5 10.8 12.5 8.0 17.3 19.9 15.9 14.3 10.8 15.0 17.9 10.6 8.6 28.4 15.1 20.3 13.8 17.1 8.0 7.7 16.2 10.4 17.0 18.9 10.1 10.8 24.7 11.6 10.7 8.4 10.7 10.5 15.0 19.8 36.9 37.0 9.0 16.4 16.5 17.3 9.7 11.7 11.7 9.7 15.3 11.8 12.9 13.2 12.8 11.3 10.2 13.0 4.2 14.6 11.3 7.5 18.0 9.1 4.7 5.6 6.4 5.3 4.5 5.6 5.3 5.3 5.8 5.3 5.3 6.8 5.6 16.0 3.7 8.5 8.8 6.4 2.8 2.6 9.1 6.5 3.2 2.4 2.6 4.3 1.9 1.8 2.1 4.0 2.9 4.1 11.7 7.1 3.0 3.7 4.9 5.3 3.6 5.9 11.5 6.5 6.0 4.7 12.2 3.5 12.0 4.2 6.8 5.2 4.7 0.0 13.2 6.6 0.0 3.8 6.4 2.8 5.9 4.2 5.4 7.5 4.6 5.2 9.2 12.5 14.1 4.8 5.0 3.8 11.5 2.2 5.4 3.5 7.0 6.7 6.6 4.2 4.8 42.1 20.8 9.7 4.1 4.1 7.2 3.3 5.5 1.9 DNAJB11 "EDJ, ERdj3, HEDJ" ENSG00000090520 "DnaJ heat shock protein family (Hsp40) member B11" Q9UBS4 3 186567403-186585800 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010814, HPA017051" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 100000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA010814: AB_1078691, HPA017051: AB_1847792" "unprognostic (4.29e-1)" "unprognostic (1.07e-1)" "unprognostic (2.98e-2)" "unprognostic (2.24e-2)" "unprognostic (8.53e-2)" "unprognostic (1.07e-3)" "unprognostic (3.86e-2)" "unprognostic (6.52e-2)" "unprognostic (7.95e-2)" "unprognostic (2.14e-3)" "unprognostic (2.58e-2)" "unprognostic (1.05e-3)" "prognostic unfavorable (3.44e-9)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" "unprognostic (1.82e-1)" 36.1 26.3 17.3 51.5 18.8 50.1 28.2 20.1 19.8 30.3 21.0 38.9 35.2 31.5 36.7 33.2 28.7 28.1 42.9 17.9 20.1 33.0 81.8 35.8 34.5 21.1 19.8 20.5 62.3 31.7 27.0 46.2 20.2 23.3 37.2 16.1 34.3 23.1 22.9 23.9 38.4 30.9 19.3 41.7 37.8 27.1 20.0 30.7 53.2 15.8 36.5 40.6 26.1 21.6 154.5 60.5 87.5 150.5 69.6 53.1 142.4 166.5 98.5 138.6 145.9 187.0 100.5 109.4 326.7 113.3 199.6 139.1 96.0 88.0 135.6 123.7 81.7 97.8 57.0 128.8 150.8 116.8 149.0 46.6 85.5 78.0 130.6 76.4 116.7 59.0 55.8 263.9 93.6 117.4 77.6 85.7 83.1 211.8 76.3 78.1 96.8 187.8 87.7 66.4 73.3 101.3 108.2 181.4 123.2 103.2 209.3 177.6 89.5 76.6 97.1 100.7 244.5 202.9 159.0 175.8 102.3 141.6 169.8 37.4 37.3 39.8 44.0 45.9 37.2 37.2 22.9 36.5 46.2 21.8 21.8 29.2 17.2 50.2 35.4 84.8 33.9 38.4 17.3 18.8 20.1 19.8 17.9 20.1 21.1 19.8 20.2 19.3 20.0 21.6 42.2 19.2 20.9 12.1 78.1 145.3 212.5 104.3 48.9 22.9 38.3 22.7 152.0 67.2 61.4 14.7 18.8 88.7 75.0 93.5 3.9 109.2 41.5 58.2 44.9 63.6 142.1 37.6 10.8 85.7 173.0 63.3 41.3 77.5 54.7 29.4 61.1 105.0 149.4 23.5 11.6 122.8 67.1 65.3 130.3 10.8 31.4 59.4 103.2 14.0 33.3 48.5 63.8 12.1 24.5 86.9 88.2 25.9 251.1 136.6 74.6 18.9 47.3 28.4 65.7 63.7 61.3 190.6 100.7 51.1 112.2 195.1 61.7 28.4 106.8 155.8 AC068631.2 ENSG00000283149 "Novel protein" 3 186581995-186597103 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA010814 Uncertain Uncertain "Endoplasmic reticulum" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "Endoplasmic reticulum" "HPA010814: AB_1078691" 9.2 10.1 5.2 11.6 5.4 9.8 7.9 5.4 15.4 6.7 4.9 18.2 12.1 5.9 13.9 8.6 5.9 7.6 13.4 5.2 5.2 14.7 32.7 9.7 4.5 5.2 5.3 6.0 22.7 7.9 8.3 6.0 5.4 8.6 5.9 8.9 9.2 4.2 4.6 6.5 9.9 3.0 4.9 13.4 10.6 8.5 5.2 6.0 18.6 0.0 5.2 7.6 6.8 5.1 36.3 28.9 35.7 42.8 29.6 12.9 9.3 71.3 16.4 25.1 16.4 102.9 15.0 21.6 82.1 46.3 40.5 24.3 31.8 25.1 22.6 18.7 0.0 23.6 52.7 102.2 22.7 46.0 11.6 14.0 8.0 32.0 50.5 21.3 13.4 10.6 12.8 81.1 10.7 83.7 23.7 2.0 9.7 93.6 0.0 14.2 37.2 26.9 12.4 69.5 0.3 0.6 30.9 62.2 18.4 35.9 40.0 57.9 7.3 17.9 21.3 13.0 62.9 31.5 88.4 66.5 26.3 33.7 35.2 7.5 6.4 8.6 10.3 8.6 7.0 7.8 6.4 8.8 9.9 4.8 4.2 8.3 1.6 10.2 7.2 15.3 8.4 7.3 5.2 5.4 5.4 15.4 5.2 5.2 5.2 5.3 5.4 4.9 5.2 5.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AHSG "A2HS, FETUA, HSGA" ENSG00000145192 "Alpha 2-HS glycoprotein" P02765 3 186613060-186621318 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Mineral balance" "Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4302 "liver: 5817.6" "Cell type enriched" "Detected in some" 38 "Hepatocytes: 1242.5" "Cancer enriched" "Detected in some" 284 "liver cancer: 1231.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 78 "Hep G2: 2287.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001524, HPA001525, CAB026209" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 864000000000 110000000000 "Cluster 48: NK-cells - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849" "unprognostic (6.40e-2)" "unprognostic (1.31e-1)" "unprognostic (2.03e-2)" "unprognostic (3.20e-2)" "unprognostic (1.07e-2)" "unprognostic (1.16e-2)" "unprognostic (7.47e-3)" "unprognostic (3.05e-1)" "unprognostic (5.27e-2)" "unprognostic (8.64e-2)" "unprognostic (3.99e-7)" "unprognostic (5.21e-2)" "unprognostic (5.21e-2)" "unprognostic (1.04e-1)" 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 1.3 5817.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.7 0.7 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.9 1.0 2287.3 0.0 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 3.5 0.0 0.0 1.1 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.4 0.0 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.2 0.0 0.0 0.0 0.2 0.0 0.1 3.9 0.2 4.3 0.2 0.1 0.9 0.0 32.0 0.6 0.6 2.4 0.1 0.0 0.1 0.0 0.0 28.2 1242.5 1.3 0.0 0.1 0.0 0.0 32.4 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.9 2.0 0.0 0.0 0.1 FETUB ENSG00000090512 "Fetuin B" Q9UGM5 3 186635969-186653141 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "liver: 234.6" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 47.2" "Cancer enriched" "Detected in some" 12 "liver cancer: 44.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035132, HPA035133" Supported Approved Vesicles "Secreted to blood" NA NA 47500000000 3600000000 "Cluster 62: Liver - Hemostasis" "Cluster 15: Hepatocytes - Hemostasis" Vesicles "HPA035132: AB_10601650, HPA035133: " "unprognostic (9.01e-2)" "unprognostic (1.95e-1)" "unprognostic (4.62e-1)" "unprognostic (8.74e-2)" "unprognostic (6.28e-3)" "unprognostic (1.24e-2)" "unprognostic (7.55e-2)" "unprognostic (9.78e-2)" "unprognostic (1.73e-2)" "unprognostic (9.18e-2)" "unprognostic (1.79e-1)" "unprognostic (8.39e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 1.6 0.0 0.1 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.1 0.0 0.4 234.6 0.0 0.0 0.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.8 0.0 2.4 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.9 0.0 5.3 0.2 0.2 0.1 0.0 2.7 0.2 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.7 47.2 0.0 0.0 0.0 0.2 0.0 2.9 0.0 5.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 HRG "HPRG, HRGP" ENSG00000113905 "Histidine rich glycoprotein" P04196 3 186660216-186678234 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis" Heparin-binding "Disease variant, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 173 "liver: 5433.2" "Cell type enriched" "Detected in some" 29 "Hepatocytes: 479.7" "Cancer enriched" "Detected in some" 262 "liver cancer: 406.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 2.7;RH-30: 3.0;SiHa: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA050269, HPA054598" Supported "Secreted to blood" NA NA 120000000000 28000000000 "Cluster 62: Liver - Hemostasis" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 15: Hepatocytes - Hemostasis" "HPA050269: AB_2681068, HPA054598: AB_2682539" "unprognostic (2.67e-1)" "unprognostic (1.74e-2)" "unprognostic (7.58e-5)" "prognostic favorable (9.64e-5)" "unprognostic (1.44e-1)" "unprognostic (2.98e-3)" "unprognostic (2.22e-1)" "unprognostic (1.55e-2)" "unprognostic (1.14e-1)" "unprognostic (5.50e-2)" "unprognostic (1.05e-1)" "unprognostic (1.46e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 31.4 5433.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 3.0 0.0 0.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.7 0.0 3.7 0.0 0.0 0.0 0.0 5.9 0.0 0.1 0.0 0.0 0.6 0.0 10.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.7 479.7 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.1 KNG1 "BDK, BK, KNG" ENSG00000113889 "Kininogen 1" P01042 3 186717348-186744410 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis, Inflammatory response" "Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 3195.2" "Group enriched" "Detected in some" 25 "Distal tubular cells: 655.4;Hepatocytes: 1816.9" "Cancer enriched" "Detected in some" 126 "liver cancer: 608.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.6;Hep G2: 1.7;RH-30: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001616, HPA001645, CAB009809" Enhanced "Secreted to blood" NA NA 90000000000 47000000000 "Cluster 85: Liver - Metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" "CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215" "unprognostic (3.88e-1)" "unprognostic (1.63e-1)" "unprognostic (2.82e-1)" "unprognostic (3.27e-1)" "unprognostic (8.30e-3)" "unprognostic (2.04e-1)" "prognostic favorable (1.28e-6)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "unprognostic (1.97e-2)" "unprognostic (9.96e-2)" "unprognostic (1.65e-1)" "unprognostic (3.45e-3)" "unprognostic (5.20e-2)" "unprognostic (2.46e-1)" "unprognostic (4.52e-2)" 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 464.1 3195.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.7 5.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 48.6 0.0 33.1 0.0 0.0 0.0 1.8 655.4 0.0 0.4 0.0 0.0 1.5 0.0 40.2 1.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 30.0 1816.9 0.1 0.0 0.8 0.1 0.0 47.2 0.0 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.5 0.1 1.1 0.0 0.0 0.0 0.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 2.7 0.0 0.1 0.1 EIF4A2 "BM-010, DDX2B, EIF4A, EIF4F" ENSG00000156976 "Eukaryotic translation initiation factor 4A2" Q14240 3 186783205-186789897 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Helicase, Hydrolase, Initiation factor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011690, HPA068286" Uncertain Approved Cytosol NA NA 1600000 "Cluster 44: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "CAB011690: AB_732123, HPA068286: AB_2685968" "unprognostic (1.49e-1)" "unprognostic (9.62e-2)" "unprognostic (3.78e-2)" "unprognostic (9.50e-3)" "unprognostic (2.82e-2)" "unprognostic (1.10e-2)" "unprognostic (4.46e-2)" "unprognostic (6.27e-2)" "unprognostic (4.32e-3)" "unprognostic (1.00e-1)" "unprognostic (6.39e-2)" "unprognostic (3.99e-2)" "unprognostic (6.36e-2)" "unprognostic (3.22e-1)" "unprognostic (3.03e-1)" "unprognostic (4.67e-2)" "unprognostic (2.62e-2)" 178.4 288.5 277.5 105.8 302.9 7.3 243.4 328.0 388.2 274.5 251.6 282.5 143.3 325.0 196.3 178.1 322.0 205.3 383.9 309.0 331.3 287.8 202.6 156.2 192.3 275.4 254.5 606.8 272.1 189.2 292.5 218.8 290.2 249.7 179.7 310.3 213.5 262.9 675.3 93.7 165.7 252.8 270.6 159.0 196.0 155.3 316.9 178.0 293.8 553.2 170.0 224.3 186.8 275.6 95.4 44.6 179.1 30.2 624.9 589.3 59.3 158.9 138.5 159.1 202.1 159.9 34.2 200.0 812.8 213.7 283.4 146.8 255.2 66.5 272.0 182.6 134.8 304.8 54.4 214.5 249.6 68.3 209.0 402.5 291.8 47.8 368.3 764.1 275.2 161.6 109.6 311.9 496.8 14.2 112.5 31.2 183.7 337.0 199.4 143.3 124.1 122.2 305.9 110.4 331.8 71.9 241.4 175.4 356.9 427.3 269.6 244.3 205.6 122.8 63.0 123.9 87.7 252.1 374.8 85.9 86.9 71.0 63.9 233.4 78.5 88.5 125.8 87.5 200.8 245.4 183.2 154.5 91.0 203.0 273.4 224.2 50.5 169.6 125.3 85.4 187.3 282.3 277.5 302.9 328.0 388.2 309.0 331.3 275.4 254.5 290.2 270.6 316.9 275.6 265.3 118.6 220.2 68.6 416.9 690.3 770.9 595.8 412.6 267.4 396.7 308.2 271.3 327.5 447.9 261.1 64.6 450.1 370.8 306.7 661.2 254.3 33.0 287.9 297.5 319.2 407.8 221.4 146.8 94.5 251.2 367.8 250.2 344.2 312.1 267.2 258.1 142.4 226.6 390.3 138.0 372.9 455.7 228.6 385.2 56.8 385.8 242.9 345.1 92.8 318.1 383.9 256.4 73.9 118.7 136.0 410.8 472.8 235.7 737.4 567.9 665.2 337.8 192.8 236.7 409.7 489.9 223.8 165.4 314.8 618.0 615.5 449.2 345.6 380.1 879.5 RFC4 "A1, RFC37" ENSG00000163918 "Replication factor C subunit 4" P35249 3 186789880-186807058 "Plasma proteins, Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 55.7;Spermatocytes: 86.7;Spermatogonia: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004557, HPA049123, HPA058507" Enhanced Enhanced Nucleoplasm NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736" "unprognostic (2.45e-1)" "prognostic favorable (7.41e-5)" "unprognostic (2.84e-1)" "unprognostic (1.81e-3)" "unprognostic (1.03e-1)" "unprognostic (6.69e-3)" "prognostic unfavorable (6.75e-7)" "unprognostic (5.29e-3)" "unprognostic (1.15e-2)" "unprognostic (2.34e-3)" "prognostic unfavorable (7.38e-4)" "unprognostic (5.92e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (1.80e-2)" "unprognostic (4.98e-1)" "unprognostic (6.15e-2)" "unprognostic (2.16e-1)" 7.0 6.0 7.3 19.3 7.6 41.5 13.8 8.9 11.9 8.8 7.4 15.4 10.9 14.1 6.6 11.8 10.8 7.7 9.1 7.5 7.5 7.3 10.7 7.2 31.5 7.3 7.4 15.0 11.0 8.0 5.7 14.5 7.6 7.7 20.4 11.2 8.6 7.0 8.3 11.7 11.7 17.6 7.5 14.3 10.4 22.7 8.1 35.7 7.3 6.7 34.5 7.8 8.2 8.3 167.3 56.2 130.8 83.6 18.8 20.1 103.0 78.9 49.9 123.6 135.8 84.8 77.9 119.5 177.4 38.0 118.0 86.1 116.5 77.5 151.1 180.5 102.5 123.3 86.3 86.3 14.6 131.8 79.5 17.3 27.5 84.9 66.1 27.6 42.0 183.8 97.9 165.4 85.3 79.7 167.2 122.8 116.0 148.1 76.0 129.9 112.5 164.3 44.9 60.7 126.3 63.3 97.3 107.6 90.3 97.6 183.0 123.7 19.6 74.4 93.3 125.8 239.9 91.9 216.9 398.9 65.3 142.8 100.0 0.0 2.8 9.7 11.5 4.2 11.1 13.1 11.4 12.0 5.0 15.1 11.2 10.2 0.6 9.8 14.7 9.6 21.8 7.7 7.3 7.6 8.9 11.9 7.5 7.5 7.3 7.4 7.6 7.5 8.1 8.3 5.1 0.0 2.2 3.3 14.0 6.0 15.3 18.1 5.2 16.1 4.1 8.1 7.5 5.7 9.3 11.0 0.0 43.0 9.7 4.4 5.9 15.3 27.3 5.6 7.0 6.1 1.2 46.3 5.2 16.6 55.7 8.3 6.6 6.0 8.2 25.3 6.1 3.0 23.9 8.4 4.4 7.1 10.2 2.6 4.9 10.0 10.5 6.2 1.8 4.7 12.2 14.9 9.2 2.5 4.3 9.2 4.1 7.9 23.8 3.8 2.8 7.9 7.9 14.4 6.6 10.2 13.1 86.7 50.5 7.9 3.0 11.2 9.6 8.8 13.9 4.7 ADIPOQ "ACDC, ACRP30, adiponectin, apM1, GBP28" ENSG00000181092 "Adiponectin, C1Q and collagen domain containing" Q15848 3 186842704-186858463 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Hormone "Diabetes mellitus, Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 28 "adipose tissue: 898.8;breast: 248.9" "Cell type enhanced" "Detected in single" "Distal tubular cells: 1.9" "Group enriched" "Detected in some" 8 "breast cancer: 6.5;pancreatic cancer: 1.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 672 "ASC diff: 312.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB046467, HPA051767" Uncertain "Secreted to blood" NA NA 8360000000 910000000 "Cluster 17: Basophils - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "CAB046467: AB_1078104, HPA051767: AB_2681598" "unprognostic (1.76e-2)" "unprognostic (1.53e-1)" "unprognostic (2.20e-2)" "unprognostic (6.99e-3)" "unprognostic (1.87e-1)" 898.8 8.9 0.1 2.4 0.1 0.2 248.9 0.2 0.1 0.0 0.0 7.7 0.1 0.1 0.0 1.2 0.1 7.6 6.5 0.0 0.0 0.8 0.1 0.1 1.3 0.1 0.0 0.0 6.2 0.1 0.1 0.0 0.1 0.3 6.1 0.1 18.8 0.0 2.3 6.6 8.5 1.2 0.0 0.0 3.9 0.1 0.1 2.2 2.9 20.2 0.0 2.4 0.9 0.3 0.0 0.0 0.0 0.1 312.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ST6GAL1 SIAT1 ENSG00000073849 "ST6 beta-galactoside alpha-2,6-sialyltransferase 1" P15907 3 186930325-187078553 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 495.9;lymphoid tissue: 148.1" "Cell type enhanced" "Detected in many" "Collecting duct cells: 237.3;Hepatic stellate cells: 258.5;Hepatocytes: 608.7;Microglial cells: 602.4" "Cancer enhanced" "Detected in all" "liver cancer: 70.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 250.6;U-266/70: 628.0;U-266/84: 887.9;U-698: 334.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015018, CAB016122" Supported "Secreted to blood" NA NA 15000000 3300000 "Cluster 21: B-cells - Adaptive immune response" "Cluster 85: Liver - Metabolism" "Cluster 29: U-266 - Adaptive immune response" "Cluster 15: Hepatocytes - Hemostasis" "CAB015018: AB_629203, CAB016122: AB_627178" "unprognostic (5.85e-3)" "unprognostic (4.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.62e-1)" "unprognostic (2.64e-1)" "unprognostic (2.44e-2)" "unprognostic (1.38e-3)" "unprognostic (3.43e-2)" "unprognostic (3.17e-1)" "unprognostic (2.20e-1)" "unprognostic (3.99e-1)" "unprognostic (1.43e-1)" "unprognostic (1.91e-2)" "unprognostic (7.30e-3)" "unprognostic (1.25e-1)" "unprognostic (1.16e-1)" "unprognostic (1.93e-2)" 24.5 12.5 27.0 50.2 26.2 15.2 32.5 29.8 24.8 61.4 33.3 38.1 13.9 16.1 5.9 13.5 27.0 17.8 36.0 25.8 33.9 60.0 495.9 30.1 101.7 44.0 37.5 10.1 8.1 45.5 9.8 18.5 50.3 48.8 45.4 2.6 39.3 14.6 12.8 8.3 29.1 18.9 44.1 67.5 28.8 3.5 39.2 66.6 64.8 20.2 148.1 28.0 8.9 48.3 4.3 5.0 20.6 17.1 1.1 0.0 36.3 1.6 3.0 1.4 2.0 1.9 2.0 250.6 19.5 0.1 8.8 10.1 132.7 15.4 1.6 11.3 7.4 10.1 0.8 119.0 1.3 22.8 75.0 1.7 28.3 0.0 11.5 19.9 77.5 24.2 52.2 20.3 5.2 8.7 17.0 14.7 49.9 11.3 7.6 38.2 0.4 8.1 9.9 0.5 36.4 4.1 1.5 26.6 64.6 29.1 38.9 16.8 32.6 0.2 3.3 0.6 2.1 628.0 887.9 334.0 0.5 45.4 84.7 22.6 8.9 3.6 46.9 16.2 42.9 87.9 51.3 39.7 14.2 83.3 80.4 58.4 4.2 26.9 29.3 11.9 43.8 58.7 27.0 26.2 29.8 24.8 25.8 33.9 44.0 37.5 50.3 44.1 39.2 48.3 34.6 44.8 27.4 13.4 110.0 4.0 13.8 68.0 4.6 0.3 5.1 4.1 26.2 75.8 55.9 237.3 0.0 0.3 26.3 20.7 0.0 17.1 0.5 8.9 5.0 56.0 94.1 24.8 47.2 0.9 3.5 3.7 7.7 16.1 10.8 7.3 258.5 608.7 20.3 0.0 31.5 10.9 34.6 61.3 16.4 1.1 0.3 18.2 7.2 602.4 17.2 0.1 26.8 145.3 2.8 6.0 17.8 0.7 124.3 103.6 0.6 0.5 39.8 1.1 0.0 2.2 6.8 0.0 0.5 0.8 1.6 0.7 28.4 0.3 37.3 39.0 RPL39L RPL39L1 ENSG00000163923 "Ribosomal protein L39 like" Q96EH5 3 187120948-187180908 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 10 "testis: 210.5" "Cell type enhanced" "Detected in many" "Early spermatids: 545.6;Late spermatids: 245.5;Spermatocytes: 785.0;Spermatogonia: 161.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA047105 Approved NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 83: Testis - Spermatogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA047105: AB_2679933" "unprognostic (1.01e-1)" "unprognostic (3.96e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (6.05e-4)" "prognostic unfavorable (1.30e-6)" "unprognostic (6.94e-2)" "unprognostic (9.75e-3)" "unprognostic (1.66e-3)" "unprognostic (8.02e-2)" "prognostic favorable (1.94e-4)" "unprognostic (1.19e-2)" "unprognostic (2.06e-1)" "unprognostic (2.27e-3)" "unprognostic (9.51e-2)" "unprognostic (1.61e-1)" "unprognostic (8.21e-3)" "unprognostic (2.60e-1)" 7.8 3.0 9.6 7.9 10.4 19.4 12.8 12.8 12.0 11.2 8.5 12.5 3.4 8.7 4.6 8.9 12.0 3.6 11.6 9.5 12.7 6.9 4.5 5.4 13.2 8.4 8.9 4.7 20.2 5.9 4.8 6.0 8.6 9.9 4.5 6.8 8.3 7.1 2.1 12.0 6.2 8.2 6.6 7.0 6.8 210.5 10.0 16.5 4.0 2.3 14.1 8.5 10.7 12.5 213.2 67.3 22.4 35.9 10.2 15.3 20.9 56.6 44.0 51.0 54.8 5.6 33.3 78.7 203.7 32.7 98.2 64.7 56.4 10.8 77.5 136.5 9.1 1.5 69.7 1.3 19.3 18.7 20.3 12.7 8.2 42.2 35.9 38.9 52.6 95.4 42.8 90.3 19.4 62.7 2.1 66.0 162.8 65.0 122.7 69.5 31.0 58.9 17.0 4.8 54.6 56.8 47.3 120.2 138.0 94.1 118.8 55.4 24.8 1.4 59.6 48.5 59.2 118.6 138.1 153.4 30.8 69.9 117.0 6.1 10.7 2.6 25.1 10.4 12.3 33.1 25.1 22.5 10.8 22.7 17.2 26.1 2.2 16.5 7.3 12.2 47.5 30.9 9.6 10.4 12.8 12.0 9.5 12.7 8.4 8.9 8.6 6.6 10.0 12.5 3.0 3.2 7.1 2.3 21.0 25.0 37.0 32.5 19.4 3.4 30.4 35.9 48.4 14.3 10.7 3.7 0.0 26.0 9.1 3.3 7.9 13.0 545.6 16.4 14.7 8.1 0.0 8.8 1.8 2.6 95.7 16.8 5.1 9.2 7.0 21.1 23.6 50.4 40.3 6.7 1.6 4.5 16.2 19.1 25.5 245.5 21.8 9.9 23.2 1.0 4.3 16.6 34.0 3.0 1.3 10.5 2.2 11.7 27.2 31.6 0.7 2.3 10.2 2.2 6.6 8.5 26.4 785.0 161.7 12.7 21.2 14.9 16.0 14.5 8.4 30.4 RTP1 "MGC35450, Z3CXXC1" ENSG00000175077 "Receptor transporter protein 1" P59025 3 187197486-187201462 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 5 "brain: 2.8" "Cell type enhanced" "Detected in some" "Early spermatids: 3.3;Late spermatids: 1.9;Spermatocytes: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 32 "SuSa: 4.0;T-47d: 2.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "Cluster 65: Brain - Ion transport" "Cluster 12: NES - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (2.90e-1)" "unprognostic (1.60e-1)" "unprognostic (3.29e-1)" "unprognostic (1.91e-1)" "unprognostic (2.63e-1)" "unprognostic (2.89e-1)" 0.0 0.0 1.2 0.0 1.2 0.0 0.0 0.1 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.9 2.7 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.2 0.1 1.1 0.9 2.7 0.4 0.9 0.4 0.5 2.8 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MASP1 "CRARF, MASP, PRSS5" ENSG00000127241 "Mannan binding lectin serine peptidase 1" P48740 3 187217282-187291980 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Complement activation lectin pathway, Immunity, Innate immunity" "Hydrolase, Protease, Serine protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 120.0;heart muscle: 116.1;liver: 183.4" "Cell type enhanced" "Detected in some" "Astrocytes: 28.1;Cardiomyocytes: 38.1;Cholangiocytes: 20.0;Endometrial stromal cells: 30.6;Fibroblasts: 16.4;Hepatic stellate cells: 23.2;Hepatocytes: 65.8" "Group enriched" "Detected in some" 9 "glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BJ: 133.3;BJ hTERT+: 498.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001617, HPA009641" Supported Enhanced Nucleoplasm,Cytosol "Secreted to blood" No NA 8670000000 1900000000 "Cluster 85: Liver - Metabolism" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Cytosol" "HPA001617: AB_1079314, HPA009641: AB_1079313" "unprognostic (1.67e-1)" "unprognostic (1.02e-2)" "unprognostic (1.99e-1)" "unprognostic (5.20e-2)" "unprognostic (1.02e-2)" "unprognostic (1.25e-6)" "prognostic favorable (2.20e-4)" "unprognostic (9.92e-2)" "unprognostic (3.22e-1)" "unprognostic (2.29e-1)" "unprognostic (4.18e-1)" "unprognostic (1.29e-1)" "unprognostic (2.82e-3)" "unprognostic (3.56e-3)" "unprognostic (1.97e-1)" "unprognostic (7.85e-2)" "unprognostic (4.29e-1)" 6.3 3.6 9.4 1.3 9.4 0.0 2.8 12.9 7.0 120.0 4.9 57.5 1.9 88.4 3.3 11.1 17.7 5.1 116.1 10.4 27.0 4.8 183.4 6.0 1.0 19.2 16.5 2.7 0.2 0.3 1.0 9.0 15.3 46.0 5.6 0.0 2.3 52.2 37.5 6.3 7.5 44.4 22.2 0.8 1.6 0.5 14.6 0.2 3.2 18.9 4.3 9.9 61.5 32.0 0.0 0.0 0.3 0.4 15.7 17.3 0.1 133.3 498.3 1.8 0.9 0.0 0.0 0.1 0.0 40.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 2.6 0.0 0.0 2.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.2 0.0 0.0 5.4 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 9.4 12.9 7.0 10.4 27.0 19.2 16.5 15.3 22.2 14.6 32.0 1.1 0.0 1.8 28.1 0.2 2.9 0.1 0.2 0.0 0.0 0.0 0.0 38.1 20.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.9 0.7 30.6 2.0 0.0 0.0 0.2 0.0 0.3 16.4 0.0 0.7 0.0 0.2 23.2 65.8 0.4 0.0 0.9 0.0 0.0 1.9 3.7 7.5 2.5 0.3 1.8 1.0 0.0 0.0 0.0 10.1 0.2 0.0 0.0 0.7 0.1 0.1 0.0 2.4 0.0 0.0 0.0 5.4 4.5 0.0 0.0 0.2 1.7 0.1 0.5 5.1 0.0 0.1 RTP4 "IFRG28, Z3CXXC4" ENSG00000136514 "Receptor transporter protein 4" Q96DX8 3 187368385-187372076 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 33.2;Ductal cells: 46.4;Urothelial cells: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 10.9;GAMG: 14.2;HDLM-2: 12.3;Karpas-707: 9.7;REH: 9.9;SK-MEL-30: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064887, HPA071189" Uncertain Supported Nucleoplasm NA NA "Cluster 15: NK-cells - Transcription" "Cluster 9: Intestine - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "HPA064887: AB_2685383, HPA071189: AB_2686357" "unprognostic (1.45e-2)" "unprognostic (2.46e-2)" "unprognostic (1.30e-1)" "unprognostic (1.44e-2)" "unprognostic (6.35e-2)" "unprognostic (3.24e-1)" "unprognostic (2.32e-1)" "unprognostic (3.78e-1)" "unprognostic (1.18e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (6.83e-4)" "unprognostic (1.34e-1)" "unprognostic (5.49e-2)" "unprognostic (3.44e-2)" "unprognostic (2.95e-2)" "prognostic favorable (4.35e-4)" "prognostic favorable (1.45e-4)" 2.1 2.7 2.4 5.1 2.5 1.1 6.0 2.3 3.0 4.8 2.0 5.9 9.1 4.3 3.2 1.9 10.8 6.2 3.2 2.1 2.4 4.4 6.1 7.0 8.1 3.1 2.4 4.0 2.5 0.6 1.1 2.2 2.8 4.0 6.0 0.2 10.7 5.2 1.0 2.4 8.2 4.5 3.5 8.5 8.1 1.0 2.5 9.2 1.9 2.3 5.8 8.2 2.7 2.7 3.1 0.0 0.0 0.0 1.4 4.9 0.1 0.0 1.2 2.0 1.8 0.0 10.9 1.4 0.0 1.3 14.2 3.6 0.0 0.1 0.0 12.3 0.0 0.0 0.0 0.1 1.8 0.0 2.7 1.2 0.0 0.4 0.0 0.4 0.4 0.3 0.0 9.7 0.0 0.0 7.3 0.0 0.0 0.0 0.0 9.9 0.0 8.0 2.6 7.9 0.0 0.0 0.0 0.2 19.7 0.1 0.0 4.9 0.2 0.1 0.2 0.0 0.1 7.8 2.6 0.1 0.0 2.7 6.0 7.0 8.3 5.9 11.5 10.2 11.5 6.2 9.1 10.5 7.1 5.3 6.9 8.2 2.3 14.9 13.2 0.2 19.8 6.7 2.4 2.5 2.3 3.0 2.1 2.4 3.1 2.4 2.8 3.5 2.5 2.7 7.4 6.4 4.5 0.3 4.3 1.7 33.2 10.5 1.8 0.0 4.0 5.5 0.7 11.5 11.3 5.5 0.0 0.1 4.2 6.0 15.6 46.4 0.0 13.6 4.3 9.6 9.1 0.4 0.0 9.8 0.5 4.2 10.7 6.1 1.3 1.6 10.8 4.5 5.5 0.0 0.1 9.6 6.1 7.8 2.5 0.0 2.1 6.4 1.8 1.9 8.9 3.7 25.7 1.0 0.7 16.9 9.4 4.9 2.0 12.9 17.9 3.1 24.6 0.1 0.0 1.3 3.0 0.1 0.1 1.3 1.3 0.3 8.3 12.0 7.8 52.6 SST SMST ENSG00000157005 Somatostatin P61278 3 187668912-187670394 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 10 "brain: 449.5;intestine: 386.6;pancreas: 479.4;stomach 1: 418.0" "Group enriched" "Detected in some" 4 "Enteroendocrine cells: 1404.1;Intestinal goblet cells: 460.2" "Cancer enriched" "Detected in many" 4 "pancreatic cancer: 1039.3" "Region enhanced" "Detected in all" "hypothalamus: 449.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 22.4;U-2 OS: 44.7;U-251 MG: 7.6;U-698: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000075, HPA019472, CAB034105" Enhanced Supported "Secreted to blood" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 9: U-2 OS - Unknown function" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360" "unprognostic (2.44e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (5.12e-3)" "unprognostic (1.54e-2)" "unprognostic (4.69e-1)" "unprognostic (3.31e-2)" "unprognostic (8.16e-3)" "unprognostic (1.63e-1)" "unprognostic (1.07e-3)" "unprognostic (8.47e-2)" "unprognostic (4.19e-1)" "unprognostic (3.27e-1)" "unprognostic (1.45e-1)" 5.5 43.0 59.9 4.6 52.1 4.2 0.5 1.3 67.8 0.6 2.5 31.8 386.6 0.7 0.1 1.6 0.4 1.1 1.3 30.6 449.5 6.2 0.3 0.3 1.5 96.9 48.1 2.4 479.4 0.0 9.3 0.1 50.3 1.3 23.8 6.3 0.1 21.6 0.1 8.9 133.3 2.8 137.8 0.2 418.0 0.2 117.2 1.1 1.0 0.0 0.0 7.3 1.8 18.7 0.0 0.0 0.8 0.1 0.0 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.5 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 44.7 0.4 7.6 0.0 2.9 11.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.9 52.1 1.3 67.8 30.6 449.5 96.9 48.1 50.3 137.8 117.2 18.7 0.0 0.0 0.0 9.1 0.5 0.0 0.0 3.3 0.0 0.0 0.2 0.1 0.0 0.0 0.1 5.5 0.0 0.1 0.0 4.3 0.0 0.0 0.3 0.3 0.5 0.1 1404.1 0.0 1.7 0.0 0.2 0.7 0.0 4.2 0.0 0.0 0.0 0.0 0.3 0.0 146.2 460.2 215.7 0.0 0.0 0.1 0.0 0.0 0.0 9.4 3.6 0.0 0.0 3.0 9.1 0.0 0.6 0.0 0.0 0.0 11.9 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.9 13.8 0.2 RTP2 "MGC78665, Z3CXXC2" ENSG00000198471 "Receptor transporter protein 2" Q5QGT7 3 187698259-187702557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "skeletal muscle: 2.0;testis: 1.2" "Group enriched" "Detected in some" 5 "Early spermatids: 15.8;Late spermatids: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "SK-BR-3: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (5.86e-2)" "unprognostic (1.12e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 BCL6 "BCL5, BCL6A, LAZ3, ZBTB27, ZNF51" ENSG00000113916 "BCL6 transcription repressor" P41182 3 187721377-187745725 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Immunity, Inflammatory response, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 485.9" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 205.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "neutrophil: 269.1;non-classical monocyte: 76.4" "Group enriched" "Detected in all" 7 "granulocytes: 269.1;monocytes: 76.4" "Cell line enhanced" "Detected in many" "Daudi: 166.4;HSkMC: 113.9;U-698: 231.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000307, HPA004899, HPA050645" Enhanced Supported Nucleoplasm NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 59: Non-specific - Translation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "CAB000307: AB_2063451, HPA004899: AB_1078273, HPA050645: AB_2681199" "unprognostic (5.36e-2)" "unprognostic (3.29e-2)" "unprognostic (1.63e-3)" "unprognostic (2.49e-1)" "unprognostic (2.85e-1)" "unprognostic (6.34e-3)" "unprognostic (2.62e-2)" "unprognostic (3.33e-3)" "unprognostic (8.75e-2)" "unprognostic (2.04e-2)" "unprognostic (1.63e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.27e-9)" "unprognostic (5.22e-2)" "unprognostic (7.82e-2)" "unprognostic (5.67e-2)" "unprognostic (2.58e-2)" 143.0 49.4 54.3 53.9 53.4 123.7 126.9 85.9 57.9 100.0 35.0 87.1 7.5 68.1 16.4 44.6 140.7 45.6 72.1 50.9 68.7 37.0 65.3 110.5 56.0 104.1 69.4 65.6 49.2 11.3 44.8 15.3 74.2 57.5 10.3 34.2 70.3 22.2 485.9 160.7 34.4 43.0 55.9 106.3 58.4 18.6 69.0 43.2 50.4 96.6 47.7 90.6 81.5 64.1 5.1 13.8 14.4 3.2 98.1 78.0 14.9 16.5 39.2 18.4 19.4 9.4 7.6 166.4 11.5 21.0 11.7 7.7 4.4 10.6 15.3 33.8 5.1 0.2 6.7 22.5 51.5 2.1 0.9 113.9 68.8 22.7 32.9 60.1 10.2 4.2 1.6 27.6 18.2 5.7 5.5 1.3 1.4 3.0 10.3 45.4 7.0 0.8 13.6 23.2 3.1 0.2 18.8 8.1 11.0 30.2 35.3 5.9 21.2 43.7 7.1 16.6 7.5 21.2 7.2 231.6 24.2 6.0 31.7 8.8 33.0 18.9 5.5 37.3 5.4 6.6 3.4 5.0 24.6 15.3 2.1 2.3 269.1 3.9 76.4 4.0 3.1 30.7 54.3 53.4 85.9 57.9 50.9 68.7 104.1 69.4 74.2 55.9 69.0 64.1 35.7 19.2 67.4 66.0 22.7 47.3 14.7 18.8 205.5 10.9 55.3 54.6 71.4 14.3 28.9 16.5 20.9 1.4 36.0 3.5 0.0 12.2 13.3 36.2 26.7 25.0 4.8 3.2 7.6 12.5 2.7 57.3 12.2 51.4 11.4 9.4 15.0 51.2 11.9 0.0 19.6 2.3 16.2 67.5 74.4 8.6 28.9 48.1 35.6 7.5 16.8 39.1 1.0 50.8 7.8 7.9 0.3 18.8 14.2 27.9 1.2 1.5 29.5 9.7 32.9 77.0 84.9 0.4 1.2 72.4 61.5 4.1 30.0 10.3 2.8 29.7 AC072022.2 ENSG00000285938 "BCL6 antisense 1" 3 187743686-187746028 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "bone marrow: 6.9;brain: 17.6;skeletal muscle: 22.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 11 "neutrophil: 10.3" "Lineage enriched" "Detected in single" 12 "granulocytes: 10.3" "Cell line enhanced" "Detected in some" "Daudi: 3.0;U-698: 6.8" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" 3.0 1.8 2.2 3.2 1.4 6.9 0.0 3.5 1.9 0.0 0.0 0.1 0.3 0.7 0.0 0.7 0.2 1.6 1.0 1.0 6.1 0.2 0.4 0.5 1.3 17.6 3.8 0.7 1.7 0.1 0.3 5.8 0.2 0.0 0.8 1.2 0.0 22.9 1.8 0.5 0.0 3.7 1.3 0.2 2.2 4.9 0.0 0.4 0.4 0.1 0.4 3.8 0.0 0.5 1.1 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.1 0.0 3.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 1.0 0.2 0.0 0.2 0.0 0.1 1.1 0.9 0.0 0.0 0.9 0.2 0.3 0.2 0.9 0.6 6.8 0.4 0.2 0.4 0.0 0.8 0.9 0.1 0.3 0.8 0.2 0.2 0.3 0.2 0.1 0.0 0.1 10.3 0.1 0.2 0.1 0.1 0.1 2.2 1.4 3.5 1.9 1.0 6.1 17.6 3.8 5.8 3.7 4.9 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LPP ENSG00000145012 "LIM domain containing preferred translocation partner in lipoma" Q93052 3 188153284-188890671 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 566.5;Late spermatids: 1737.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 18.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 97.0;EFO-21: 115.2;U-698: 200.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011133, HPA017342" Enhanced Supported "Focal adhesion sites,Cytosol" NA NA 2700000 "Cluster 1: Neutrophils - Mixed function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "Focal adhesion sites, Cytosol" "HPA011133: AB_1853247, HPA017342: AB_1853249" "unprognostic (1.50e-1)" "unprognostic (4.97e-3)" "unprognostic (1.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.86e-1)" "unprognostic (4.05e-1)" "unprognostic (2.43e-3)" "unprognostic (7.97e-2)" "unprognostic (2.17e-1)" "unprognostic (5.56e-2)" "unprognostic (3.44e-3)" "unprognostic (2.10e-1)" "unprognostic (2.57e-3)" "unprognostic (2.25e-2)" "unprognostic (6.86e-2)" "unprognostic (2.82e-3)" "unprognostic (1.48e-1)" 29.3 10.8 6.7 28.4 8.9 9.9 18.8 9.1 9.7 27.5 27.3 73.3 13.8 61.9 11.8 49.4 32.2 21.3 16.7 6.1 11.2 11.5 12.1 19.1 17.2 15.6 7.9 14.7 8.8 9.9 2.9 11.5 12.6 39.0 31.7 2.4 12.0 53.1 12.4 12.0 23.0 81.3 6.6 10.8 32.7 18.6 13.8 8.0 8.8 9.1 21.4 57.0 22.1 7.8 25.6 23.3 16.7 11.3 35.3 36.0 17.9 16.0 20.9 11.8 7.8 42.2 12.1 97.0 115.2 37.3 14.7 10.7 5.2 11.0 29.5 10.7 5.7 4.6 18.4 11.1 15.0 2.0 5.5 25.7 15.3 26.4 22.5 16.9 20.1 5.2 0.2 2.0 21.0 8.1 5.1 2.1 6.6 16.3 7.6 6.2 12.3 0.5 13.1 26.8 1.1 0.3 35.3 11.4 19.2 27.3 9.0 8.8 43.7 27.1 20.8 19.6 41.1 0.2 4.0 200.0 13.6 4.3 24.9 0.8 4.9 2.2 5.1 4.5 3.3 3.3 4.5 3.8 2.6 5.6 2.4 2.9 18.9 4.8 4.6 5.3 1.8 1.9 6.7 8.9 9.1 9.7 6.1 11.2 15.6 7.9 12.6 6.6 13.8 7.8 104.7 89.8 69.8 357.5 48.5 78.0 84.9 65.0 70.0 9.5 141.8 111.5 143.0 100.1 86.2 69.9 14.6 44.7 65.7 207.1 29.4 139.7 566.5 49.3 134.4 91.8 77.5 12.0 132.8 90.9 24.1 124.9 97.9 93.6 18.3 136.6 126.4 94.8 42.5 5.0 191.2 91.7 44.7 65.1 121.0 1737.1 225.3 75.8 80.0 308.2 55.8 24.8 54.6 395.6 214.9 120.2 158.1 476.9 24.6 172.5 127.5 80.2 60.9 7.1 335.2 159.2 368.2 9.8 8.0 64.2 68.2 18.6 55.3 46.8 151.3 149.3 TPRG1 "FAM79B, FLJ41238, FLJ43694" ENSG00000188001 "Tumor protein p63 regulated 1" Q6ZUI0 3 188947214-189325304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 50.6;vagina: 32.3" "Cell type enriched" "Detected in many" 5 "Early spermatids: 199.7" "Cancer enriched" "Detected in many" 4 "breast cancer: 7.0" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 9.6;Karpas-707: 4.7;OE19: 23.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044751, HPA060187" Uncertain Supported Nucleoplasm NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA044751: AB_2679073, HPA060187: AB_2684217" "prognostic favorable (5.43e-4)" "unprognostic (8.71e-3)" "unprognostic (2.10e-3)" "unprognostic (2.36e-2)" "unprognostic (3.84e-3)" "unprognostic (1.33e-3)" "unprognostic (1.55e-2)" "unprognostic (9.88e-2)" "unprognostic (2.66e-1)" "unprognostic (2.71e-1)" "unprognostic (1.40e-2)" "unprognostic (3.79e-1)" "unprognostic (3.52e-8)" "unprognostic (8.50e-2)" "unprognostic (9.53e-2)" "unprognostic (1.38e-1)" "unprognostic (3.73e-2)" 10.6 1.9 0.5 1.8 0.6 0.0 23.3 0.6 0.7 23.3 3.5 0.5 0.3 3.0 2.8 50.6 8.4 2.9 2.0 0.4 0.7 0.4 9.0 4.4 0.9 2.2 0.7 2.2 0.6 0.1 0.2 1.2 1.0 1.2 0.3 0.4 6.1 1.3 9.1 25.1 0.7 3.0 0.6 0.7 0.5 4.8 3.6 1.5 1.3 0.4 9.0 1.0 32.3 2.0 0.9 0.2 0.3 0.0 2.0 1.7 0.0 0.0 0.0 0.1 0.1 1.1 2.2 1.3 3.4 0.1 0.6 0.2 0.0 0.0 0.0 9.6 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.5 0.4 0.0 0.0 0.5 0.0 0.0 0.0 4.7 0.2 0.4 0.0 0.0 0.6 23.4 0.3 0.0 0.0 1.7 0.0 1.8 0.0 0.0 0.2 0.5 0.0 0.7 4.1 0.6 0.0 0.1 0.3 0.0 0.3 4.3 3.7 0.4 0.1 0.0 0.1 0.0 1.5 0.0 3.8 1.2 0.5 0.1 3.0 4.0 0.4 0.0 0.6 1.5 0.7 0.0 1.1 0.0 3.8 0.9 0.5 0.6 0.6 0.7 0.4 0.7 2.2 0.7 1.0 0.6 3.6 2.0 0.9 38.5 1.7 3.6 0.9 5.6 19.9 10.5 13.6 1.3 9.8 31.1 0.8 0.0 6.4 0.0 0.0 0.4 5.3 0.2 0.0 0.3 199.7 1.2 1.1 1.0 0.0 2.7 2.8 0.6 0.2 5.5 0.5 0.2 1.3 0.3 0.0 8.4 4.8 0.0 7.9 0.3 2.0 3.5 2.7 24.4 7.2 2.5 0.0 3.7 0.6 0.2 2.1 9.5 2.1 4.5 0.1 3.0 5.6 1.7 0.2 0.2 1.0 0.2 0.0 30.7 5.3 5.1 1.1 4.3 5.8 0.3 14.4 1.2 0.2 5.7 TP63 "EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L" ENSG00000073282 "Tumor protein p63" Q9H3D4 3 189631389-189897276 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 69.6;skin 1: 137.3" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 275.4;Basal squamous epithelial cells: 335.2;Squamous epithelial cells: 173.4;Suprabasal keratinocytes: 283.1" "Group enriched" "Detected in many" 11 "cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 87.1;HBEC3-KT: 167.3;hTCEpi: 124.0;hTERT-HME1: 117.3;RT4: 185.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000083, HPA006288, HPA006289, HPA007009, HPA007010" Enhanced Enhanced Nucleoplasm NA NA "Cluster 17: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 15: RT4 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336" "prognostic favorable (1.07e-4)" "unprognostic (1.30e-1)" "unprognostic (1.44e-1)" "unprognostic (3.02e-1)" "unprognostic (4.38e-2)" "unprognostic (3.50e-1)" "unprognostic (1.29e-1)" "unprognostic (5.17e-2)" "unprognostic (2.78e-1)" "unprognostic (5.37e-2)" "unprognostic (2.09e-3)" "unprognostic (1.54e-1)" "unprognostic (1.87e-5)" "unprognostic (1.86e-1)" "unprognostic (1.05e-1)" "unprognostic (1.62e-1)" "unprognostic (2.74e-3)" 0.5 0.3 0.3 0.6 0.3 0.4 18.0 0.9 0.5 23.5 0.3 0.3 0.1 0.3 10.5 69.6 1.0 0.3 0.6 0.5 0.5 0.3 0.4 1.9 1.0 0.4 0.6 0.1 0.3 0.0 0.5 10.8 0.7 17.4 0.2 0.0 20.8 18.0 42.4 137.3 0.2 0.3 0.2 0.2 0.4 3.4 0.4 23.1 0.3 12.4 17.7 18.6 54.4 0.4 2.3 4.6 0.0 0.1 0.2 0.1 1.2 0.1 0.0 0.0 0.0 0.0 0.0 16.6 0.6 0.1 0.2 87.1 0.0 167.3 0.0 1.4 0.0 1.9 1.3 0.4 0.0 0.0 0.3 0.2 124.0 0.2 117.3 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.2 0.3 0.2 0.0 1.0 0.3 0.0 0.2 185.1 0.2 0.1 0.2 0.0 0.0 2.5 0.9 0.2 0.3 0.2 0.1 0.2 0.0 25.3 0.3 1.1 0.5 0.1 0.8 0.6 0.0 0.2 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.3 0.1 0.1 0.4 0.2 0.0 0.2 0.1 0.0 0.3 0.3 0.9 0.5 0.5 0.5 0.4 0.6 0.7 0.2 0.4 0.4 0.2 0.0 5.3 1.0 0.9 275.4 26.8 61.9 335.2 0.0 0.9 30.1 0.7 0.0 8.5 0.0 0.0 24.9 0.1 0.1 0.0 0.2 1.8 0.0 0.1 1.1 0.0 0.0 1.3 0.2 2.8 1.4 0.0 0.1 0.0 0.0 0.0 0.1 2.4 0.0 4.8 0.0 2.0 0.0 11.9 0.4 0.3 0.7 8.8 14.0 0.6 0.0 0.0 0.5 1.4 1.6 0.0 1.2 1.6 5.6 0.0 0.0 2.8 0.0 0.0 5.3 0.9 0.5 2.4 173.4 283.1 8.9 0.6 0.2 0.0 15.2 P3H2 "FLJ10718, LEPREL1, MLAT4" ENSG00000090530 "Prolyl 3-hydroxylase 2" Q8IVL5 3 189956728-190122437 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 80.3;Granulosa cells: 124.1;Microglial cells: 91.8;Theca cells: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 22 "plasmacytoid DC: 28.9" "Lineage enriched" "Detected in single" 90 "dendritic cells: 28.9" "Cell line enhanced" "Detected in many" "GAMG: 120.2;HaCaT: 109.9;RPTEC TERT1: 109.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007890, HPA013355, HPA013611" Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles,Cytosol" "Intracellular and membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "Nucleoplasm, Vesicles, Cytosol" "HPA007890: AB_1852796, HPA013355: AB_1852798, HPA013611: " "unprognostic (4.90e-2)" "unprognostic (1.57e-1)" "unprognostic (3.76e-1)" "unprognostic (4.32e-3)" "unprognostic (1.97e-2)" "unprognostic (7.75e-2)" "unprognostic (9.68e-2)" "unprognostic (2.17e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-1)" "unprognostic (1.03e-3)" "unprognostic (1.60e-1)" "unprognostic (1.15e-2)" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" 4.9 41.6 2.8 4.9 3.1 1.0 6.5 3.0 3.1 17.0 1.8 24.0 2.7 17.6 18.5 11.0 8.0 4.8 8.8 3.3 4.8 51.3 7.0 28.7 2.4 7.6 4.7 16.1 3.6 2.3 8.2 9.2 6.7 37.6 10.4 19.3 4.9 26.5 1.2 17.8 6.7 32.4 5.2 54.8 23.9 4.2 4.9 5.2 3.0 1.7 2.0 11.9 19.9 8.3 46.9 18.2 35.1 0.2 0.6 1.4 42.1 48.7 19.3 7.8 12.6 15.0 18.0 0.1 27.1 8.6 120.2 109.9 0.1 65.3 16.3 0.4 6.2 0.1 12.1 0.3 35.4 0.2 0.3 16.9 21.4 15.2 5.4 73.5 1.4 0.1 0.1 0.4 12.3 1.1 0.1 0.4 11.0 31.3 3.7 0.1 7.1 2.8 109.8 77.5 2.5 0.3 66.1 3.7 29.3 51.1 0.1 0.7 24.4 45.9 16.8 0.4 8.9 3.4 0.2 0.5 10.6 0.2 60.2 0.3 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.1 0.0 28.9 0.0 0.2 2.8 3.1 3.0 3.1 3.3 4.8 7.6 4.7 6.7 5.2 4.9 8.3 5.7 48.1 80.3 19.2 1.0 0.0 7.7 0.0 13.6 2.3 1.6 9.9 1.0 2.8 3.1 44.1 4.2 42.0 9.5 19.8 5.9 4.7 19.6 2.0 27.3 10.5 0.0 2.7 55.6 0.8 14.7 10.3 8.6 1.5 1.3 124.1 32.5 0.8 11.4 10.1 60.4 0.5 0.0 3.2 0.0 14.9 4.7 5.6 0.0 91.8 0.8 44.5 0.0 43.7 4.4 30.6 1.9 0.0 0.2 15.1 0.0 26.2 0.0 1.2 0.0 10.9 45.2 0.5 0.9 13.5 0.0 38.6 0.7 74.3 2.1 3.9 CLDN1 "ILVASC, SEMP1" ENSG00000163347 "Claudin 1" O95832 3 190305707-190322446 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 309.8;skin 1: 288.2" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 440.1;Basal prostatic cells: 291.1;Prostatic glandular cells: 501.6;Squamous epithelial cells: 298.2;Suprabasal keratinocytes: 836.1;Urothelial cells: 562.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "EFO-21: 658.6;HaCaT: 236.5;hTCEpi: 288.6;RPTEC TERT1: 414.9;RT4: 267.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in some" 12 "spinal cord: 25.4" "CAB002602, HPA048319" Enhanced NA NA "Cluster 85: Liver - Metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "CAB002602: , HPA048319: AB_2680355" "unprognostic (5.89e-2)" "unprognostic (4.58e-3)" "unprognostic (1.56e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (7.92e-3)" "unprognostic (2.43e-1)" "unprognostic (3.54e-1)" "unprognostic (2.04e-1)" "unprognostic (1.48e-1)" "unprognostic (5.25e-2)" "prognostic unfavorable (5.23e-4)" "unprognostic (3.06e-1)" "unprognostic (1.13e-1)" "unprognostic (4.43e-2)" "unprognostic (9.20e-2)" "unprognostic (1.09e-3)" "unprognostic (1.22e-1)" 40.8 47.9 1.5 1.2 1.1 0.2 22.7 0.8 1.3 17.7 20.7 1.7 1.1 64.2 31.9 40.9 56.6 15.5 2.5 1.5 1.2 10.5 309.8 9.1 0.5 1.2 2.8 6.3 34.3 0.4 2.4 5.3 1.7 13.6 1.6 0.9 34.0 46.0 1.1 288.2 0.7 126.6 0.7 1.5 1.0 4.3 1.1 9.4 36.2 4.9 44.2 40.4 35.9 1.0 34.0 29.7 0.2 0.1 0.0 0.1 0.0 2.5 52.7 1.1 2.1 17.7 69.1 0.0 658.6 0.3 58.5 236.5 1.5 77.7 6.2 0.9 1.4 0.1 9.3 41.5 49.6 0.4 0.2 0.5 288.6 6.0 87.0 2.4 0.6 0.0 0.1 0.1 0.1 6.5 0.1 0.1 1.5 2.3 5.5 0.0 0.6 0.2 414.9 267.0 0.2 0.0 31.0 5.7 18.4 3.5 53.5 0.5 12.9 0.6 9.9 0.2 1.4 0.7 0.6 1.2 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.1 0.8 1.3 1.5 1.2 1.2 2.8 1.7 0.7 1.1 1.0 0.4 12.8 34.7 0.0 0.5 440.1 291.1 217.3 84.2 0.0 35.6 2.0 1.0 170.1 143.2 31.3 0.0 2.4 0.6 0.6 0.0 203.3 0.1 44.4 10.0 7.0 1.8 0.0 0.7 56.3 0.3 29.2 2.0 100.0 1.3 0.4 1.4 188.2 1.0 0.0 1.6 0.3 54.9 3.8 66.5 1.7 15.5 8.5 32.0 0.0 5.7 0.0 0.0 24.6 0.0 139.9 0.0 35.3 0.0 501.6 0.1 4.1 144.6 0.0 0.0 0.3 11.2 0.3 0.8 298.2 836.1 33.8 2.6 5.0 1.0 562.9 CLDN16 "HOMG3, PCLN1" ENSG00000113946 "Claudin 16" Q9Y5I7 3 190322541-190412138 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease variant, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "kidney: 63.6" "Cell type enriched" "Detected in some" 8 "Distal tubular cells: 187.9" "Group enriched" "Detected in many" 15 "ovarian cancer: 39.8;thyroid cancer: 29.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 153 "EFO-21: 691.6;RPTEC TERT1: 233.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA056020 Enhanced NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "HPA056020: AB_2683011" "unprognostic (5.01e-2)" "unprognostic (7.83e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.99e-5)" "unprognostic (6.06e-4)" "unprognostic (1.30e-1)" "unprognostic (2.07e-1)" "unprognostic (2.39e-2)" "unprognostic (3.31e-1)" "unprognostic (4.20e-1)" "unprognostic (2.76e-3)" "unprognostic (3.70e-1)" "unprognostic (1.96e-1)" "unprognostic (5.76e-2)" "unprognostic (8.08e-2)" "unprognostic (1.62e-2)" "unprognostic (1.15e-1)" 0.1 0.7 0.3 0.2 0.4 0.0 0.2 0.0 0.5 0.1 1.5 0.0 0.0 0.3 0.6 0.5 2.9 0.7 0.0 0.2 0.2 63.6 2.2 0.4 1.5 0.2 0.1 0.0 0.2 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.4 0.9 0.0 3.2 0.0 0.4 0.1 0.1 0.1 0.1 0.3 0.3 9.7 0.0 1.0 0.3 0.2 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 691.6 0.0 0.3 0.7 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.8 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 233.2 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 2.2 0.0 0.3 1.4 1.2 3.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.5 0.2 0.2 0.2 0.1 0.2 0.1 0.3 0.6 0.1 0.0 0.0 0.3 0.0 7.0 5.8 2.6 0.6 0.3 0.8 0.3 0.4 4.3 1.6 9.2 0.0 0.4 0.0 0.0 187.9 3.4 2.0 3.0 0.1 0.2 0.0 0.0 5.0 0.4 0.2 0.9 0.0 0.5 1.3 0.3 0.0 1.6 0.1 3.3 3.6 0.0 0.0 0.3 1.2 0.2 0.0 0.4 5.4 2.8 0.0 0.2 0.0 4.0 0.1 0.5 0.0 0.4 0.0 6.7 0.0 0.9 22.1 0.2 0.0 0.8 0.6 0.3 0.3 0.9 12.6 6.2 0.2 0.2 0.0 3.1 TMEM207 ENSG00000198398 "Transmembrane protein 207" Q6UWW9 3 190428655-190449901 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 115 "kidney: 17.8" "Cell type enriched" "Detected in some" 18 "Distal tubular cells: 68.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA014332 Uncertain NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 39: Non-specific - Basic cellular processes" "HPA014332: AB_2204907" "unprognostic (4.81e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 68.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IL1RAP "C3orf13, IL-1RAcP, IL1R3" ENSG00000196083 "Interleukin 1 receptor accessory protein" Q9NPH3 3 190514051-190659750 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 225.8" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 109.2;Hepatocytes: 295.8;Oligodendrocyte precursor cells: 298.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "eosinophil: 23.8;neutrophil: 95.0" "Lineage enriched" "Detected in many" 15 "granulocytes: 95.0" "Cell line enriched" "Detected in many" 4 "SK-MEL-30: 247.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035293 Uncertain Approved Vesicles,Cytosol "Secreted to blood" NA NA 350000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 2: Hepatocytes - Metabolism" "Vesicles, Cytosol" "HPA035293: AB_10671511" "unprognostic (6.48e-2)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (8.84e-3)" "unprognostic (2.35e-2)" "unprognostic (6.60e-2)" "unprognostic (2.62e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.16e-7)" "unprognostic (4.02e-3)" "unprognostic (9.06e-2)" "unprognostic (5.72e-2)" "prognostic unfavorable (6.29e-4)" 6.2 2.9 4.0 11.4 1.1 20.3 4.3 0.0 8.7 4.4 0.5 2.2 1.8 4.0 2.6 13.1 5.4 12.1 3.9 4.6 3.1 3.3 225.8 8.2 2.7 2.4 3.7 3.0 3.9 1.5 1.2 37.0 3.3 3.9 2.2 2.4 5.2 3.4 1.3 11.9 2.2 6.4 1.5 5.4 4.5 1.3 5.5 4.6 4.0 2.1 4.8 9.4 5.5 3.3 13.3 3.0 5.5 0.8 9.5 7.7 10.0 5.8 11.9 13.4 13.2 5.8 29.3 2.2 59.2 16.4 31.1 34.1 3.0 57.6 18.7 2.5 3.6 2.9 5.3 14.5 19.6 20.2 9.5 10.3 23.1 19.7 59.2 27.8 6.0 5.9 0.4 0.2 6.4 6.5 1.7 9.4 8.5 6.0 6.0 9.5 8.2 4.8 5.3 14.8 1.0 0.0 26.3 15.0 247.1 5.2 9.6 14.6 7.9 10.3 10.4 32.1 26.6 5.0 0.2 0.5 17.2 18.0 60.9 11.7 3.8 23.8 1.8 4.3 3.3 2.1 2.1 2.3 3.8 2.1 2.0 1.3 95.0 0.3 6.3 0.6 2.1 1.4 4.0 1.1 0.0 8.7 4.6 3.1 2.4 3.7 3.3 1.5 5.5 3.3 3.5 0.0 14.7 6.5 6.8 44.7 16.5 45.8 68.9 6.5 2.5 4.7 5.5 40.0 22.8 3.7 8.4 8.5 3.6 1.8 0.0 7.7 4.4 8.6 3.8 8.0 5.4 4.4 44.3 7.5 109.2 7.3 7.1 12.3 7.6 0.7 7.5 295.8 7.8 0.0 63.3 1.4 4.1 33.7 17.7 0.6 4.4 28.8 8.8 53.4 5.0 1.0 6.2 298.6 1.5 19.7 0.8 2.6 5.3 11.5 0.7 1.1 8.7 0.6 0.0 18.0 5.1 0.1 0.6 30.9 37.2 24.2 5.2 1.4 1.1 14.3 GMNC GEMC1 ENSG00000205835 "Geminin coiled-coil domain containing" A6NCL1 3 190852737-190892429 "Predicted intracellular proteins" "Cell cycle, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 2.8;fallopian tube: 8.1;liver: 4.1" "Cell type enhanced" "Detected in some" "Early spermatids: 14.6;Endometrial ciliated cells: 5.9;Hepatocytes: 6.1;Proximal tubular cells: 11.5;Respiratory ciliated cells: 4.4" "Cancer enriched" "Detected in some" 5 "ovarian cancer: 4.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 45 "SCLC-21H: 4.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA043663 Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA043663: AB_10959313" "unprognostic (1.85e-3)" "unprognostic (1.17e-1)" "unprognostic (1.96e-1)" "unprognostic (1.14e-1)" "unprognostic (5.45e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (2.22e-3)" "unprognostic (2.73e-2)" "unprognostic (2.55e-3)" 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.2 0.1 0.2 2.8 0.0 0.0 0.8 0.0 0.0 8.1 0.0 0.1 0.3 1.7 1.9 4.1 0.0 0.0 0.6 0.7 0.1 0.4 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.2 0.1 0.3 1.7 0.6 0.7 0.5 0.7 0.7 2.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 14.6 5.9 0.1 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 6.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 11.5 4.4 0.2 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OSTN ENSG00000188729 Osteocrin P61366 3 191199241-191265615 "Predicted secreted proteins" Differentiation "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Early spermatids: 4.2;Excitatory neurons: 1.0;Inhibitory neurons: 5.9;Late spermatids: 1.4;Oligodendrocyte precursor cells: 2.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 6 "memory B-cell: 4.0;naive B-cell: 1.3" "Lineage enriched" "Detected in single" 9 "B-cells: 4.0" "Cell line enriched" "Detected in some" 24 "U-2197: 39.1" "Region enriched" "Detected in single" 4 "cerebellum: 1.0" "Low region specificity" "Detected in single" "CAB024997, CAB025649, HPA030878" Uncertain "Secreted in other tissues" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB024997: , CAB025649: , HPA030878: AB_2673642" "unprognostic (2.35e-2)" "unprognostic (9.12e-2)" "unprognostic (6.30e-2)" "unprognostic (2.34e-1)" "unprognostic (2.51e-1)" "unprognostic (3.01e-2)" "unprognostic (2.52e-1)" "unprognostic (8.11e-3)" "unprognostic (2.90e-1)" "unprognostic (1.45e-1)" 0.3 0.1 0.6 0.7 0.9 0.0 0.1 0.1 1.2 1.2 0.2 0.1 0.0 0.1 1.6 0.0 0.7 0.8 0.4 0.8 0.8 0.1 0.6 0.2 0.6 0.5 0.2 0.2 0.0 0.0 0.0 0.4 0.5 0.6 0.0 0.1 0.2 0.1 0.8 1.2 0.1 0.0 0.4 0.2 0.3 0.4 0.3 0.1 0.1 1.0 0.0 1.3 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.1 0.0 1.6 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.9 0.1 1.2 0.8 0.8 0.5 0.2 0.5 0.4 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 5.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UTS2B "U2B, URP, UTS2D" ENSG00000188958 "Urotensin 2B" Q765I0 3 191267168-191330536 "Predicted secreted proteins" Hormone "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "retina: 14.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;B-cells: 2.6;Early spermatids: 8.3;Late spermatids: 2.3;Oligodendrocyte precursor cells: 3.0;Spermatocytes: 2.6;Spermatogonia: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 4 "memory B-cell: 2.8;naive B-cell: 1.8" "Lineage enriched" "Detected in single" 5 "B-cells: 2.8" "Cell line enhanced" "Detected in some" "PC-3: 3.3" "Region enriched" "Detected in some" 9 "pons and medulla: 11.3" "Region enriched" "Detected in single" 46 "spinal cord: 6.0" HPA026992 Uncertain "Secreted - unknown location" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 77: Retina - Visual perception" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA026992: AB_1858703" "unprognostic (1.73e-2)" "unprognostic (4.38e-2)" "unprognostic (1.22e-1)" "unprognostic (3.41e-1)" "unprognostic (1.92e-1)" "unprognostic (2.17e-2)" "unprognostic (2.77e-2)" "unprognostic (2.14e-2)" "unprognostic (3.09e-1)" "unprognostic (2.63e-2)" "unprognostic (3.39e-2)" "unprognostic (2.63e-1)" "unprognostic (1.11e-1)" "unprognostic (7.58e-2)" "unprognostic (2.08e-1)" "unprognostic (1.29e-1)" "unprognostic (3.10e-2)" 1.0 1.2 0.8 0.8 0.5 0.5 1.2 4.1 1.4 0.2 0.0 0.5 5.3 0.7 0.5 0.7 1.0 1.2 0.7 0.7 0.5 0.6 3.2 0.5 1.0 0.7 0.4 1.0 0.5 0.2 0.0 0.4 1.1 0.6 0.4 14.9 0.6 0.2 0.5 1.1 3.2 0.5 0.1 0.6 1.6 2.3 0.6 0.1 0.5 0.0 0.3 0.4 0.1 0.9 0.4 1.0 1.3 0.6 0.3 1.6 0.4 1.0 0.5 0.3 0.2 0.7 0.5 0.7 0.5 0.4 2.6 0.5 0.4 0.0 1.6 0.6 0.5 0.6 1.4 2.9 0.3 0.8 0.4 0.6 0.2 0.2 0.3 0.9 0.3 0.6 0.4 0.6 0.5 0.6 0.2 0.5 0.7 1.3 3.3 0.9 1.5 0.2 0.2 1.6 0.7 0.5 0.6 0.7 0.4 0.5 0.5 0.5 1.4 0.7 0.4 1.3 0.4 1.1 0.6 0.6 0.9 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.5 4.1 1.4 0.7 0.5 0.7 0.4 1.1 0.1 0.6 0.9 0.2 3.2 1.1 0.7 2.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 8.3 1.4 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.2 0.1 0.0 0.7 1.6 0.0 0.2 0.1 1.5 0.0 0.0 0.1 0.2 2.6 2.1 0.0 0.3 0.3 0.0 0.1 0.0 0.1 CCDC50 "C3orf6, DFNA44, Ymer" ENSG00000152492 "Coiled-coil domain containing 50" Q8IVM0 3 191329085-191398659 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "dendritic cells: 363.7;Oligodendrocyte precursor cells: 365.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "plasmacytoid DC: 630.7" "Lineage enriched" "Detected in all" 5 "dendritic cells: 630.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001336 Approved Supported Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA001336: AB_1078421" "unprognostic (5.01e-2)" "unprognostic (1.44e-1)" "unprognostic (7.84e-2)" "unprognostic (8.77e-3)" "unprognostic (1.73e-2)" "unprognostic (8.29e-2)" "prognostic unfavorable (2.48e-5)" "unprognostic (3.03e-2)" "unprognostic (2.51e-2)" "unprognostic (4.48e-2)" "unprognostic (3.17e-3)" "unprognostic (2.05e-2)" "unprognostic (7.79e-2)" "unprognostic (1.01e-1)" "unprognostic (6.19e-2)" "unprognostic (7.57e-2)" "unprognostic (4.19e-1)" 63.2 28.3 19.6 34.3 20.7 10.3 30.6 21.5 19.1 24.1 18.8 26.9 24.2 33.0 24.8 27.9 24.3 34.8 39.7 17.6 23.3 32.4 56.5 31.6 42.2 24.1 22.0 46.2 35.1 27.6 13.5 34.9 24.1 26.2 25.4 11.8 23.7 33.3 19.0 18.4 25.8 48.1 23.2 45.0 24.3 29.6 21.3 17.7 27.4 26.1 41.0 36.7 18.6 24.7 74.9 24.5 93.6 24.7 82.3 72.1 32.3 135.4 135.2 95.4 95.0 52.6 28.9 14.6 163.0 76.8 70.6 83.6 75.6 60.5 141.9 109.0 37.8 10.0 31.7 60.3 120.8 36.8 37.8 58.2 79.3 75.6 169.7 82.2 148.7 0.0 33.9 77.3 85.4 26.0 0.2 23.1 33.2 7.6 103.0 56.3 51.9 73.1 104.3 31.9 21.8 33.2 48.2 51.6 95.8 67.3 35.6 32.9 153.3 93.4 78.4 68.4 176.3 118.6 54.9 0.9 50.5 0.1 76.9 0.1 22.1 2.1 5.9 20.8 2.4 128.5 6.1 3.9 44.3 76.5 1.3 1.5 2.2 24.0 12.1 630.7 22.1 18.0 19.6 20.7 21.5 19.1 17.6 23.3 24.1 22.0 24.1 23.2 21.3 24.7 143.5 25.6 54.5 40.5 134.5 46.9 52.5 30.7 30.7 27.2 32.5 37.5 48.4 58.6 34.7 51.5 27.1 28.1 363.7 44.1 31.3 120.4 183.0 97.3 58.1 134.0 22.8 11.2 15.8 78.5 36.3 66.6 41.8 79.0 2.5 58.5 175.6 79.5 84.4 25.2 41.3 33.8 38.7 59.4 78.3 92.1 69.3 61.4 53.4 98.4 101.4 32.1 5.2 365.4 28.9 174.7 33.9 75.6 102.7 69.8 37.6 71.8 26.3 14.4 59.2 74.1 65.7 73.2 26.6 24.0 32.5 33.5 22.4 49.5 33.7 62.4 PYDC2 POP2 ENSG00000253548 "Pyrin domain containing 2" Q56P42 3 191461163-191461456 "Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "brain: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 2.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "A549: 1.1" "Not detected" "Not detected" HPA055895 Uncertain NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 40: Non-specific - Basic cellular processes" "HPA055895: AB_2682962" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 FGF12 "FGF12B, FHF1" ENSG00000114279 "Fibroblast growth factor 12" P61328 3 192139390-192767764 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Growth factor" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 35.8;heart muscle: 131.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 413.7;Excitatory neurons: 1213.5;Inhibitory neurons: 1925.1;Oligodendrocyte precursor cells: 1668.3" "Cancer enhanced" "Detected in many" "glioma: 3.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 15.1;NTERA-2: 10.3;SCLC-21H: 23.9;U-251 MG: 14.7;WM-115: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071557 Approved Nucleoplasm,Cytosol NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Cytosol "HPA071557: AB_2686417" "unprognostic (1.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.26e-2)" "unprognostic (2.50e-5)" "unprognostic (1.75e-1)" "unprognostic (5.66e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "unprognostic (8.03e-2)" "unprognostic (2.11e-2)" "unprognostic (4.00e-2)" "unprognostic (9.19e-2)" "unprognostic (1.87e-7)" "unprognostic (2.41e-2)" "unprognostic (5.36e-2)" "unprognostic (5.59e-2)" "unprognostic (5.99e-2)" 1.9 35.8 8.5 0.2 14.1 0.0 1.3 0.5 21.3 0.5 0.0 1.1 0.7 1.0 0.2 1.7 1.5 0.5 131.3 17.5 14.2 2.5 0.6 1.1 0.2 11.1 1.0 0.8 7.7 1.6 5.3 0.4 9.9 1.3 0.3 15.4 5.9 6.0 1.1 0.3 0.3 0.7 0.0 11.6 0.6 2.1 3.5 0.1 1.5 0.8 0.2 0.5 0.7 2.8 0.1 1.1 15.1 0.0 0.0 0.0 0.1 0.0 0.1 1.4 1.7 0.0 0.1 0.8 7.2 0.3 0.3 0.2 0.0 0.0 1.6 0.1 0.2 3.2 6.3 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 3.7 0.2 0.0 0.1 0.1 0.0 4.4 0.0 0.0 10.3 7.1 0.3 0.0 0.1 0.0 4.7 1.8 23.9 0.0 0.0 0.6 0.0 1.7 1.1 0.2 0.4 6.2 3.2 0.0 14.7 0.2 2.5 0.0 1.3 0.0 17.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 14.1 0.5 21.3 17.5 14.2 11.1 1.0 9.9 0.0 3.5 2.8 17.8 0.0 0.0 42.7 0.1 0.6 4.2 0.0 0.6 100.2 0.9 1.7 413.7 0.0 1.9 5.5 4.2 0.2 0.0 0.0 7.9 0.7 20.9 1.6 1.6 13.2 0.0 0.0 1213.5 13.1 0.4 18.6 0.5 0.5 0.0 9.0 16.4 0.0 0.1 33.7 1925.1 0.0 0.0 0.3 0.3 38.5 6.8 0.1 1.8 46.9 0.0 3.8 0.0 1668.3 28.2 2.7 1.2 1.2 0.5 1.1 0.0 0.4 0.8 14.2 0.0 0.7 4.8 4.0 8.0 0.4 0.1 0.0 0.1 38.7 0.1 1.7 MB21D2 C3orf59 ENSG00000180611 "Mab-21 domain containing 2" Q8IYB1 3 192796815-192917856 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 63.8;Inhibitory neurons: 53.0;Langerhans cells: 85.0;Oligodendrocyte precursor cells: 68.9;Syncytiotrophoblasts: 110.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory CD4 T-cell: 4.2;T-reg: 3.9" "Lineage enriched" "Detected in single" 9 "T-cells: 4.2" "Cell line enhanced" "Detected in many" "HDLM-2: 114.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044026 Approved Approved Cytosol NA Yes "Cluster 13: T-cells - Unknown function" "Cluster 28: Placenta - Pregnancy" "Cluster 44: HDLM-2 - Immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol "HPA044026: AB_10962840" "unprognostic (3.52e-2)" "unprognostic (1.02e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (3.74e-5)" "unprognostic (2.42e-2)" "prognostic unfavorable (9.94e-4)" "unprognostic (2.76e-2)" "unprognostic (3.50e-2)" "unprognostic (1.53e-1)" "unprognostic (2.46e-1)" "unprognostic (2.84e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-3)" "unprognostic (5.94e-3)" "unprognostic (1.95e-1)" "unprognostic (3.80e-2)" "unprognostic (3.28e-2)" 3.7 4.2 2.5 3.2 2.8 1.3 3.4 3.3 3.1 2.8 1.6 3.0 8.8 5.1 1.9 2.0 3.6 4.7 4.0 2.8 2.3 4.2 1.5 3.6 1.2 2.1 2.0 4.1 1.9 2.3 3.5 13.3 1.8 1.9 2.9 2.0 1.5 1.9 2.7 4.7 9.3 5.6 1.5 2.2 3.5 7.1 1.9 1.4 1.7 1.6 1.7 8.8 2.4 2.3 26.6 3.7 6.3 19.0 3.9 5.8 11.2 18.8 17.5 33.4 19.9 17.0 4.2 0.0 11.0 46.6 13.8 11.5 14.6 4.8 36.2 114.8 8.1 3.3 1.8 2.0 7.4 0.4 1.6 7.6 7.4 9.4 5.8 2.7 6.6 3.3 0.2 1.5 5.8 19.8 0.3 0.0 13.1 14.4 45.9 0.6 10.5 5.6 7.8 15.1 9.8 5.0 4.1 12.8 1.9 12.9 19.9 0.4 2.1 6.3 18.4 11.1 36.3 48.1 41.0 0.0 4.4 4.0 8.6 0.0 0.2 0.0 0.2 0.3 1.9 0.1 4.2 1.0 0.4 0.0 2.6 0.7 0.0 0.0 0.0 0.0 3.9 0.9 2.5 2.8 3.3 3.1 2.8 2.3 2.1 2.0 1.8 1.5 1.9 2.3 2.9 6.4 0.5 16.6 1.2 9.2 0.9 2.0 1.2 10.9 4.6 3.2 1.8 1.5 3.2 0.0 2.1 63.8 0.3 2.4 0.0 6.5 0.2 12.4 2.0 7.7 10.2 0.0 28.6 0.2 9.5 5.9 1.5 15.9 0.0 5.8 9.7 0.2 5.6 8.4 53.0 2.8 4.1 3.8 85.0 1.4 3.1 10.4 14.2 17.8 13.4 1.1 0.0 68.9 30.6 2.2 6.1 6.0 4.2 0.8 15.4 9.6 2.8 1.3 13.1 3.3 4.5 1.8 16.5 1.8 8.7 110.4 3.3 5.4 3.7 2.6 PLAAT1 "A-C1, H-REV107, HRASLS, HRASLS1, PLA/AT1, PLAAT-1" ENSG00000127252 "Phospholipase A and acyltransferase 1" Q9HDD0 3 193241128-193277738 "Enzymes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "skeletal muscle: 90.1;testis: 73.6;tongue: 44.5" "Cell type enriched" "Detected in some" 11 "Cardiomyocytes: 12.5" "Cancer enhanced" "Detected in many" "glioma: 8.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 12.9;NTERA-2: 11.0;PC-3: 23.8;RH-30: 10.7;SCLC-21H: 22.0;U-2 OS: 13.3;U-251 MG: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051179 Uncertain Approved "Focal adhesion sites,Cytosol" No No "Cluster 9: Neutrophils - Innate immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 54: Cardiomyocytes - Muscle contraction" "Focal adhesion sites" Cytosol "HPA051179: AB_2681375" "unprognostic (3.01e-2)" "unprognostic (4.21e-2)" "unprognostic (7.93e-3)" "unprognostic (4.82e-3)" "unprognostic (2.79e-1)" "unprognostic (1.87e-1)" "unprognostic (9.97e-3)" "unprognostic (9.68e-3)" "unprognostic (1.84e-1)" "unprognostic (3.55e-1)" "unprognostic (1.77e-4)" "unprognostic (5.09e-2)" "unprognostic (1.38e-5)" "unprognostic (1.61e-2)" "prognostic favorable (4.36e-4)" "unprognostic (2.98e-3)" "unprognostic (1.13e-2)" 0.9 2.5 4.6 0.2 4.9 0.1 1.8 3.5 6.0 0.4 0.8 0.6 0.0 0.9 5.9 6.5 0.5 0.2 9.3 5.1 6.0 0.7 0.1 0.2 0.0 4.5 4.3 0.2 1.4 2.1 2.2 0.1 4.2 0.1 0.1 9.0 2.0 0.7 90.1 3.3 0.3 1.3 2.3 0.2 0.8 73.6 3.9 2.2 7.0 44.5 0.3 0.3 0.4 4.5 0.0 0.1 2.6 0.0 0.0 0.0 0.0 0.2 0.0 2.3 0.4 0.0 0.1 0.0 0.2 0.0 5.3 0.0 12.9 0.4 0.6 0.0 5.6 6.9 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.0 0.4 23.8 0.0 10.7 0.0 3.7 0.0 22.0 4.1 1.5 3.3 0.0 2.1 6.5 0.1 0.1 0.0 13.3 0.0 18.6 0.1 0.0 0.0 7.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 4.6 4.9 3.5 6.0 5.1 6.0 4.5 4.3 4.2 2.3 3.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 ATP13A5 FLJ16025 ENSG00000187527 "ATPase 13A5" Q4VNC0 3 193274789-193378820 "Predicted membrane proteins" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "breast: 17.3;choroid plexus: 38.5;salivary gland: 11.7" "Group enriched" "Detected in some" 5 "Astrocytes: 37.9;Oligodendrocyte precursor cells: 26.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.3" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "neutrophil: 1.0" "Lineage enriched" "Detected in single" 9 "granulocytes: 1.0" "Cell line enhanced" "Detected in single" "SK-BR-3: 1.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA031771, HPA031772, HPA031774" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" "Plasma membrane" Nucleoplasm "HPA031771: AB_2674038, HPA031772: , HPA031774: AB_2674039" "unprognostic (7.98e-2)" "unprognostic (3.01e-4)" "unprognostic (2.06e-3)" "unprognostic (2.72e-3)" "unprognostic (3.93e-1)" "unprognostic (1.67e-4)" "unprognostic (3.03e-1)" "unprognostic (2.31e-1)" "unprognostic (2.14e-2)" "unprognostic (1.73e-1)" "unprognostic (7.15e-2)" "unprognostic (1.10e-1)" "unprognostic (8.10e-2)" 0.0 0.1 2.3 0.0 1.9 0.2 17.3 1.5 2.7 0.0 38.5 0.0 0.0 0.1 0.8 0.7 0.1 0.0 0.2 3.1 1.8 0.2 0.0 0.5 0.1 1.6 2.3 0.2 0.1 0.2 0.3 0.0 1.5 0.0 0.0 0.8 11.7 0.0 1.3 3.9 0.0 0.0 0.8 0.0 1.6 0.4 2.4 0.0 1.3 0.1 0.2 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 2.3 1.9 1.5 2.7 3.1 1.8 1.6 2.3 1.5 0.8 2.4 1.8 0.1 0.0 0.5 37.9 0.0 0.0 0.0 0.3 0.0 0.0 5.8 5.8 0.7 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.5 0.1 0.0 0.1 0.0 0.0 1.1 0.2 0.0 0.4 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 1.9 0.0 0.0 0.0 26.2 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ATP13A4 "DKFZp761I1011, FLJ37958" ENSG00000127249 "ATPase 13A4" Q4VNC1 3 193398967-193593111 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 64.5;parathyroid gland: 58.4;thyroid gland: 51.9" "Group enriched" "Detected in many" 4 "Astrocytes: 409.4;Oligodendrocyte precursor cells: 163.3" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 23.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051932 Approved Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm "HPA051932: " "unprognostic (4.97e-2)" "unprognostic (1.50e-3)" "unprognostic (4.86e-3)" "unprognostic (2.52e-3)" "unprognostic (2.72e-2)" "prognostic favorable (3.91e-4)" "unprognostic (1.55e-1)" "unprognostic (3.99e-3)" "unprognostic (2.65e-1)" "unprognostic (1.36e-1)" "unprognostic (4.39e-2)" "unprognostic (1.34e-1)" "unprognostic (4.29e-5)" "unprognostic (1.91e-1)" "unprognostic (1.70e-1)" "unprognostic (5.75e-3)" "unprognostic (2.00e-1)" 0.1 0.3 19.5 0.2 20.9 0.2 22.7 18.1 20.1 2.8 28.2 2.0 0.3 0.1 64.5 20.1 2.4 4.6 0.1 18.0 17.0 0.7 0.6 27.3 0.4 18.5 21.5 0.3 5.3 58.4 4.8 0.1 17.9 0.1 3.4 2.5 7.2 2.4 0.5 16.9 0.3 0.1 15.2 0.3 9.6 0.5 21.6 0.3 51.9 0.0 4.8 0.1 6.7 15.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.6 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.5 20.9 18.1 20.1 18.0 17.0 18.5 21.5 17.9 15.2 21.6 15.8 0.2 64.1 30.5 409.4 1.1 0.1 0.0 1.7 0.0 1.6 6.1 3.6 0.4 11.5 15.3 0.0 0.0 1.2 0.5 1.6 0.0 3.3 0.4 4.0 0.7 0.1 0.0 0.0 5.8 0.2 0.1 0.2 17.3 6.4 1.3 0.3 1.4 0.1 0.2 1.7 10.9 1.9 0.0 0.3 0.5 1.0 0.0 0.5 1.8 13.1 0.0 0.5 0.0 163.3 20.6 1.3 1.7 0.4 0.2 0.0 0.0 0.4 8.5 1.0 0.0 0.1 0.2 0.7 1.5 2.2 1.6 0.7 0.9 0.1 2.2 0.1 OPA1 "FLJ12460, KIAA0567, MGM1, NPG, NTG" ENSG00000198836 "OPA1 mitochondrial dynamin like GTPase" O60313 3 193593144-193697811 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Apoptosis, Sensory transduction, Vision" Hydrolase "Cardiomyopathy, Deafness, Disease variant, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 135.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036926, HPA036927" Supported Supported Nucleoplasm,Mitochondria NA NA 10000 "Cluster 14: Monocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Mitochondria" "HPA036926: AB_10671247, HPA036927: AB_2675388" "unprognostic (2.10e-2)" "unprognostic (9.23e-3)" "unprognostic (7.98e-2)" "prognostic unfavorable (8.61e-4)" "unprognostic (1.62e-2)" "unprognostic (4.59e-2)" "unprognostic (2.24e-1)" "unprognostic (1.86e-2)" "unprognostic (1.57e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.44e-5)" "unprognostic (3.48e-2)" "prognostic favorable (1.84e-4)" "unprognostic (2.92e-1)" "unprognostic (4.75e-1)" "unprognostic (4.50e-3)" "unprognostic (3.21e-1)" 15.0 12.0 14.3 7.6 17.4 25.6 12.8 15.2 19.5 10.4 9.4 18.9 16.8 10.9 9.1 14.6 8.1 10.2 39.3 18.6 17.4 18.3 20.9 8.5 11.8 16.4 15.4 8.4 10.1 23.1 3.8 11.7 16.8 12.3 16.6 9.6 11.7 13.3 24.2 11.9 13.8 13.5 12.4 9.3 14.6 6.3 15.2 12.7 13.9 44.5 12.4 13.0 5.1 13.7 58.9 18.8 18.2 20.2 15.8 25.0 19.3 27.5 26.2 30.0 29.0 45.2 19.3 38.6 58.1 27.0 27.3 37.3 32.7 31.7 53.5 46.5 25.7 67.9 16.7 23.1 24.9 55.8 29.8 28.4 27.6 30.0 40.9 18.5 26.2 15.7 28.4 37.0 30.2 46.5 21.9 30.9 25.8 33.9 59.9 27.8 40.1 41.6 22.7 36.1 39.8 24.2 41.8 46.3 29.5 14.1 60.3 43.5 26.3 27.7 20.8 29.3 58.7 33.1 41.3 74.0 30.5 43.7 28.4 9.7 7.3 7.1 5.8 8.2 5.5 6.8 5.5 5.6 7.8 5.1 5.6 6.0 2.7 4.7 17.3 4.0 6.6 5.2 14.3 17.4 15.2 19.5 18.6 17.4 16.4 15.4 16.8 12.4 15.2 13.7 24.8 16.0 24.0 72.1 27.5 15.9 16.4 17.4 24.5 19.5 20.9 13.5 135.2 22.8 20.1 18.4 31.3 19.0 24.6 31.4 17.6 19.3 7.7 20.3 25.2 23.8 23.4 86.3 106.8 24.0 14.9 24.6 31.1 26.1 19.6 25.6 14.3 39.1 17.9 21.9 106.7 20.6 10.2 25.6 14.7 13.5 15.8 28.1 21.4 58.1 22.9 14.6 11.3 87.4 98.1 28.9 12.1 14.7 29.3 18.7 24.6 34.1 19.6 23.4 6.6 21.3 26.2 15.1 16.6 34.3 22.4 17.9 22.3 28.2 26.7 22.1 HES1 "bHLHb39, FLJ20408, HES-1, HRY" ENSG00000114315 "Hes family bHLH transcription factor 1" Q14469 3 194136148-194138732 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 850.6;Muller glia cells: 1146.0;Paneth cells: 1137.2;Undifferentiated cells: 882.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 8 "eosinophil: 15.6" "Lineage enriched" "Detected in many" 8 "granulocytes: 15.6" "Cell line enhanced" "Detected in many" "hTCEpi: 94.1;OE19: 95.8;SK-BR-3: 78.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066929 Supported Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA066929: AB_2732753" "unprognostic (1.79e-2)" "unprognostic (2.41e-1)" "unprognostic (1.79e-2)" "unprognostic (4.44e-2)" "unprognostic (1.00e-1)" "unprognostic (1.46e-1)" "unprognostic (3.01e-2)" "unprognostic (1.05e-1)" "unprognostic (4.64e-1)" "unprognostic (2.62e-2)" "unprognostic (2.04e-2)" "unprognostic (1.40e-2)" "unprognostic (1.71e-2)" "unprognostic (1.44e-1)" "unprognostic (1.74e-1)" "unprognostic (1.85e-1)" "prognostic favorable (2.04e-5)" 64.2 32.2 13.6 7.9 14.9 0.9 87.0 12.5 15.0 66.0 11.8 44.1 31.2 22.5 9.0 127.8 22.4 17.7 65.6 14.7 16.8 87.3 68.7 47.1 7.0 15.3 17.4 25.3 34.8 22.6 42.7 27.5 13.5 90.1 35.7 66.5 79.9 31.5 69.9 184.5 23.9 9.8 13.5 23.4 42.1 12.8 14.5 11.9 93.2 22.4 11.8 59.8 136.6 11.6 9.3 2.6 20.8 27.1 6.1 0.0 5.2 4.3 12.2 0.9 0.5 36.4 26.1 1.3 74.6 1.6 12.6 51.4 3.9 24.2 0.3 7.7 44.0 33.1 3.5 9.4 0.1 0.2 30.1 2.2 94.1 0.8 10.9 14.3 28.6 1.7 16.1 1.2 0.0 43.9 47.5 45.7 19.4 95.8 17.8 0.1 1.5 1.0 28.0 71.2 1.2 1.6 21.0 78.9 38.9 23.6 22.2 2.6 22.3 2.3 21.8 0.3 31.3 0.2 0.1 0.2 1.6 0.1 43.7 0.0 0.0 15.6 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 13.6 14.9 12.5 15.0 14.7 16.8 15.3 17.4 13.5 13.5 14.5 11.6 684.0 25.6 96.0 70.2 54.2 122.9 498.5 736.7 159.4 15.9 352.0 164.1 128.8 517.6 355.1 196.8 16.7 41.1 4.7 696.8 189.8 268.9 2.2 231.9 37.6 401.8 160.1 19.2 1.2 199.1 6.0 274.1 105.0 257.4 303.4 16.1 850.6 163.1 24.4 10.1 0.4 579.7 213.6 95.3 76.2 8.7 58.7 74.6 80.0 5.6 22.8 1146.0 0.0 4.5 0.1 227.1 1137.2 18.8 5.0 231.1 297.5 126.6 190.2 54.9 164.3 76.8 291.7 1.2 13.2 367.8 296.5 209.2 24.1 31.4 882.7 358.1 CPN2 ACBP ENSG00000178772 "Carboxypeptidase N subunit 2" P22792 3 194339768-194351328 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "liver: 218.6" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 171.8" "Cancer enriched" "Detected in some" 32 "liver cancer: 72.7" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 29 "Hep G2: 61.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA004732 Uncertain "Secreted to blood" NA NA 25000000000 "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "HPA004732: AB_1078561" "unprognostic (4.27e-2)" "unprognostic (3.04e-1)" "unprognostic (1.42e-1)" "unprognostic (4.12e-2)" "prognostic favorable (2.05e-4)" "unprognostic (1.27e-1)" "unprognostic (8.65e-2)" "unprognostic (8.56e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (2.91e-2)" "unprognostic (2.40e-1)" "unprognostic (6.90e-5)" "unprognostic (8.42e-2)" 0.4 3.0 0.7 0.4 0.6 1.5 0.2 0.6 1.1 0.2 0.0 0.2 0.0 0.4 0.4 0.1 0.2 0.4 1.0 0.7 0.8 14.7 218.6 0.2 0.3 0.2 0.2 0.3 0.1 0.1 0.0 0.4 0.2 0.2 0.2 1.1 0.2 0.1 0.1 0.6 0.2 0.2 0.0 1.2 0.4 0.7 0.4 0.1 0.3 0.0 0.2 0.1 0.0 1.1 0.2 0.1 0.3 0.3 0.1 0.8 0.2 0.3 0.1 0.0 0.0 0.4 0.2 0.2 0.3 0.8 0.4 0.5 0.1 0.0 0.2 0.1 0.2 0.3 0.6 61.8 0.0 0.3 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.3 0.5 0.6 0.0 0.3 0.2 0.3 0.3 0.1 0.1 0.1 0.5 0.0 0.1 0.4 0.3 0.2 0.3 0.2 0.4 0.3 0.2 1.4 1.6 0.2 2.1 0.2 0.1 0.2 0.2 0.1 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.6 0.6 1.1 0.7 0.8 0.2 0.2 0.2 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 171.8 0.2 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 LRRC15 LIB ENSG00000172061 "Leucine rich repeat containing 15" Q8TF66 3 194355249-194369743 "Plasma proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 4.9;skin 1: 7.3" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 1.9;Endothelial cells: 1.0;Fibroblasts: 2.3;Hepatic stellate cells: 1.8;Langerhans cells: 3.0;Suprabasal keratinocytes: 1.4" "Cancer enhanced" "Detected in many" "breast cancer: 25.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "fHDF/TERT166: 120.6;U-87 MG: 62.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA035503 Uncertain Approved "Vesicles,Plasma membrane" NA NA 1700000 "Cluster 31: Skin - Epidermis development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "Plasma membrane" "HPA035503: AB_10961253" "unprognostic (3.20e-2)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (6.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (3.53e-2)" "unprognostic (3.97e-2)" "unprognostic (1.88e-3)" "unprognostic (1.22e-8)" "unprognostic (5.81e-2)" "unprognostic (1.11e-1)" "unprognostic (5.62e-3)" "unprognostic (7.54e-3)" 1.1 0.1 0.0 1.3 0.0 0.0 3.7 0.0 0.0 2.9 0.0 1.7 0.5 1.9 0.0 0.5 1.1 1.6 0.2 0.0 0.0 0.0 0.1 2.0 0.8 0.0 0.1 0.2 0.1 0.1 0.0 2.2 0.0 0.1 3.0 0.0 1.0 0.0 0.1 7.3 0.4 0.6 0.0 1.3 1.5 0.0 0.1 0.2 1.3 0.2 4.9 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.7 0.1 0.1 0.4 0.0 0.0 1.0 120.6 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 22.5 3.7 3.0 0.0 0.0 0.0 0.0 62.7 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 GP5 CD42d ENSG00000178732 "Glycoprotein V platelet" P40197 3 194394821-194398354 "CD markers, Plasma proteins, Predicted membrane proteins" "Blood coagulation, Cell adhesion, Hemostasis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.1" "Cell type enhanced" "Detected in single" "Paneth cells: 1.1" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "HEL: 16.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA072646 Approved Cytosol NA NA 270000000 "Cluster 32: T-cells - Unknown function" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 36: HEL - Hemostasis" "Cluster 58: T-cells - T-cell receptor" Cytosol "HPA072646: " "unprognostic (3.74e-2)" "unprognostic (3.40e-1)" "unprognostic (5.22e-2)" "unprognostic (2.96e-2)" "unprognostic (1.74e-2)" "unprognostic (1.35e-3)" "unprognostic (1.69e-3)" "unprognostic (1.68e-1)" "unprognostic (3.41e-1)" "unprognostic (2.80e-2)" "unprognostic (1.65e-1)" "unprognostic (5.51e-2)" "unprognostic (1.21e-2)" "unprognostic (4.18e-2)" "unprognostic (3.14e-1)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" 0.1 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.3 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 ATP13A3 AFURS1 ENSG00000133657 "ATPase 13A3" Q9H7F0 3 194402672-194498364 "Predicted membrane proteins" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 384.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029471 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 18: U-2197 - ECM organization" "Cluster 41: Macrophages - Immune response" Nucleoli "Plasma membrane, Cytosol" "HPA029471: AB_10600784" "unprognostic (5.07e-2)" "unprognostic (3.53e-2)" "unprognostic (2.94e-1)" "unprognostic (5.31e-2)" "unprognostic (3.20e-2)" "unprognostic (3.55e-1)" "unprognostic (1.57e-1)" "unprognostic (9.87e-2)" "unprognostic (1.32e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.60e-4)" "unprognostic (2.70e-2)" "prognostic unfavorable (1.63e-4)" "unprognostic (1.22e-1)" "unprognostic (1.65e-1)" "unprognostic (1.34e-2)" "unprognostic (3.77e-1)" 38.0 22.5 8.5 32.0 9.3 36.9 22.8 12.2 14.8 17.0 18.4 21.2 20.2 18.9 17.0 18.0 17.4 24.2 55.7 10.4 9.3 36.2 87.0 35.5 20.8 9.7 8.4 15.9 16.4 50.3 15.3 54.8 9.1 15.5 22.0 11.6 21.8 15.2 17.0 11.5 16.6 16.9 9.5 16.9 24.4 9.6 12.8 16.3 46.0 14.4 19.4 40.1 16.3 10.1 184.6 19.3 33.0 35.2 49.7 64.9 96.8 62.7 75.4 74.9 132.5 114.1 45.2 74.2 161.1 89.4 197.9 64.2 37.5 66.9 171.4 175.5 31.4 43.1 24.8 31.7 77.1 139.7 91.6 32.6 36.8 127.8 89.0 105.0 38.0 34.9 46.2 139.1 90.7 41.0 53.9 34.8 41.1 64.5 33.5 40.0 77.1 48.8 71.6 53.4 52.4 30.5 64.1 77.9 52.9 31.2 127.7 92.4 37.1 81.2 64.2 162.1 116.5 93.4 141.2 116.6 149.3 80.6 55.7 0.2 0.4 0.4 0.4 0.6 0.5 0.4 0.4 0.7 0.6 0.2 0.5 0.5 0.0 0.6 0.2 0.3 1.0 0.2 8.5 9.3 12.2 14.8 10.4 9.3 9.7 8.4 9.1 9.5 12.8 10.1 56.6 51.3 34.1 51.6 22.3 82.5 49.1 42.1 21.1 25.9 32.1 16.6 50.0 78.6 35.9 49.7 20.9 29.6 26.6 43.7 3.9 66.6 2.0 52.3 65.4 50.5 30.6 23.5 61.8 71.4 19.0 53.2 42.8 181.8 8.8 27.9 68.9 153.2 37.2 15.2 80.6 24.1 26.4 31.1 384.4 2.3 10.2 110.1 62.2 76.8 27.0 8.4 18.6 64.3 49.6 87.8 23.7 13.2 37.8 94.3 11.6 41.4 31.7 13.6 13.1 35.8 42.4 15.2 6.8 36.5 71.2 64.6 24.4 14.1 24.7 69.9 TMEM44 DKFZp686O18124 ENSG00000145014 "Transmembrane protein 44" Q2T9K0 3 194587673-194633689 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 31.2;Hepatic stellate cells: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "basophil: 3.7;NK-cell: 8.1" "Group enriched" "Detected in many" 10 "granulocytes: 3.7;NK-cells: 8.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043718 Uncertain Approved Cytosol "Intracellular and membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 10: Brain - Neuronal signaling" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA043718: AB_10794662" "unprognostic (8.94e-2)" "unprognostic (1.01e-1)" "unprognostic (8.31e-3)" "unprognostic (4.53e-2)" "unprognostic (2.78e-3)" "unprognostic (9.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.17e-2)" "unprognostic (1.70e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (6.55e-13)" "unprognostic (1.23e-2)" "unprognostic (3.36e-1)" "unprognostic (1.65e-3)" "unprognostic (5.66e-2)" 10.3 2.9 9.8 2.3 11.7 5.2 8.9 7.8 12.4 6.9 7.1 11.0 2.7 5.6 13.7 5.6 5.4 4.5 9.6 10.3 10.1 6.0 3.4 11.3 3.0 9.9 9.7 4.9 3.5 0.9 2.6 7.4 10.0 5.2 7.2 0.6 7.7 2.2 3.2 3.6 6.8 3.2 8.8 9.3 4.9 2.2 10.5 2.0 5.6 2.3 1.6 5.3 5.9 9.2 11.1 9.1 13.4 14.2 4.8 16.2 11.8 8.2 15.3 6.8 10.8 5.0 21.8 2.0 38.9 10.0 20.3 12.6 4.5 6.4 4.6 18.1 6.3 12.4 10.6 3.8 8.7 3.9 18.9 10.0 6.8 15.4 6.8 32.8 28.2 12.1 3.4 0.5 22.9 10.1 5.9 9.9 6.9 11.1 14.8 11.5 8.4 0.3 7.2 6.3 3.7 7.7 6.1 1.9 12.6 5.6 9.0 8.5 33.7 20.8 7.6 6.4 11.2 1.5 1.2 4.0 31.4 15.0 10.4 3.7 0.2 0.2 0.4 0.1 0.0 0.1 0.1 0.6 0.0 0.2 0.0 0.2 0.4 8.1 0.3 0.4 0.0 0.0 9.8 11.7 7.8 12.4 10.3 10.1 9.9 9.7 10.0 8.8 10.5 9.2 22.0 0.0 2.3 3.3 2.1 0.5 3.3 4.9 1.8 0.9 2.8 2.3 1.7 1.5 6.0 5.5 2.1 9.5 1.7 31.2 0.0 5.7 0.6 2.3 3.7 23.8 6.0 4.0 12.7 4.9 4.0 6.0 22.4 2.0 17.7 10.6 53.2 0.6 3.5 0.0 5.4 25.2 6.1 1.3 3.4 0.3 3.1 1.5 1.8 12.2 0.1 0.5 2.1 2.5 1.5 14.9 21.0 1.9 1.3 6.0 3.9 0.4 7.5 0.6 6.6 1.8 3.6 0.5 6.5 2.4 0.6 8.8 1.9 6.0 21.0 6.3 LSG1 FLJ11301 ENSG00000041802 "Large 60S subunit nuclear export GTPase 1" Q9H089 3 194640791-194672463 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037704, HPA037705" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 60: Granulocytes - Receptor signaling" "Nuclear bodies, Cytosol" Nucleoplasm "HPA037704: AB_10672912, HPA037705: AB_2675621" "unprognostic (5.72e-3)" "unprognostic (9.38e-3)" "unprognostic (2.63e-1)" "unprognostic (1.23e-2)" "unprognostic (3.74e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (3.21e-7)" "unprognostic (4.63e-2)" "unprognostic (1.59e-1)" "unprognostic (2.07e-1)" "unprognostic (1.60e-2)" "unprognostic (4.86e-3)" "unprognostic (1.42e-1)" "unprognostic (3.00e-2)" "unprognostic (2.70e-1)" "unprognostic (6.77e-2)" "unprognostic (2.07e-1)" 14.9 12.8 13.2 15.8 13.8 28.1 15.8 13.9 15.9 12.8 14.0 15.1 17.2 15.2 19.8 15.9 14.5 12.6 14.0 13.1 14.5 16.6 21.7 12.8 18.7 14.7 16.4 14.2 15.5 16.8 11.1 17.2 15.8 14.6 18.1 14.0 13.8 13.9 23.0 19.3 14.9 14.5 14.0 15.4 13.6 14.4 14.4 17.2 15.5 18.9 21.3 18.2 14.3 15.4 55.6 36.0 21.2 35.3 32.3 17.8 43.1 31.0 30.1 42.9 37.6 47.9 25.1 43.1 93.5 29.4 75.5 39.5 68.2 35.0 52.1 56.3 32.5 46.8 38.4 27.6 22.9 51.1 42.4 17.3 31.5 44.4 41.7 16.0 47.1 29.4 39.5 46.2 36.0 76.6 46.3 30.8 57.7 73.5 65.6 56.2 35.0 49.3 23.7 46.9 40.5 27.9 39.9 38.2 40.0 39.7 90.3 32.9 36.5 32.4 37.3 46.2 66.6 50.6 71.1 97.7 26.2 64.7 52.4 3.5 10.1 13.6 15.3 13.2 17.1 16.6 12.5 13.9 17.2 14.3 14.4 12.9 1.3 21.0 8.9 9.0 15.4 10.6 13.2 13.8 13.9 15.9 13.1 14.5 14.7 16.4 15.8 14.0 14.4 15.4 25.0 19.2 29.6 10.4 22.5 16.2 13.4 8.9 25.0 18.3 12.1 11.9 17.2 18.6 27.9 9.2 12.5 25.1 21.2 14.0 5.9 23.3 12.0 22.1 24.5 23.7 7.8 16.2 10.5 22.4 19.4 17.7 21.9 24.0 53.7 21.9 11.7 14.0 13.0 15.2 8.3 14.2 12.2 4.4 10.2 8.9 15.5 15.5 12.4 8.4 14.0 18.2 12.3 12.5 12.2 19.7 8.0 14.7 23.8 11.5 10.8 9.7 34.3 18.6 19.7 22.1 14.6 26.4 35.7 30.5 16.1 28.5 24.0 23.2 17.6 9.0 FAM43A FLJ90022 ENSG00000185112 "Family with sequence similarity 43 member A" Q8N2R8 3 194685883-194689037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 54.9" "Cell type enhanced" "Detected in many" "Adipocytes: 89.2;Endothelial cells: 102.4;Extravillous trophoblasts: 83.3;Hepatic stellate cells: 97.1;NK-cells: 75.2;Syncytiotrophoblasts: 162.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 123.7;NB-4: 72.8;PC-3: 56.9;TIME: 66.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048345 Uncertain Approved Vesicles NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 64: Macrophages - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "HPA048345: AB_2680367" "unprognostic (1.61e-1)" "unprognostic (1.11e-1)" "unprognostic (9.18e-2)" "unprognostic (1.90e-2)" "unprognostic (5.71e-3)" "unprognostic (5.13e-3)" "unprognostic (9.80e-2)" "unprognostic (8.28e-2)" "unprognostic (4.96e-2)" "unprognostic (1.38e-1)" "unprognostic (3.92e-3)" "unprognostic (1.74e-1)" "unprognostic (2.14e-1)" "unprognostic (1.15e-1)" "unprognostic (1.45e-1)" "unprognostic (2.91e-3)" "prognostic unfavorable (9.96e-4)" 25.2 4.8 8.3 5.1 5.6 3.7 15.7 6.9 14.1 16.1 4.0 15.7 1.4 13.0 1.2 15.4 15.1 4.0 30.3 11.7 6.5 41.4 5.8 9.7 10.0 33.2 9.6 4.5 3.0 1.4 8.7 11.2 34.8 22.1 2.3 0.8 8.0 2.7 6.0 25.2 11.6 3.7 7.3 54.9 8.3 4.4 8.3 1.3 8.0 4.0 6.3 17.2 25.1 6.9 0.3 1.8 1.4 1.1 23.3 11.4 10.4 3.8 8.6 0.1 0.0 0.8 0.3 1.3 37.4 11.6 8.5 3.8 2.3 1.0 0.1 0.9 6.4 4.7 10.8 1.3 1.8 1.2 13.5 3.0 4.8 0.5 0.1 0.6 123.7 0.2 2.8 2.5 0.3 1.9 0.0 72.8 6.0 12.8 56.9 6.0 0.4 0.6 0.1 0.2 35.6 3.0 2.4 2.3 7.5 2.4 1.5 15.7 66.3 1.2 1.9 1.6 0.8 0.2 1.5 3.5 0.7 34.3 24.0 2.2 0.6 1.3 0.5 0.5 0.7 1.2 0.3 0.5 0.8 2.5 0.0 0.2 0.9 1.6 0.5 4.5 0.2 0.3 8.3 5.6 6.9 14.1 11.7 6.5 33.2 9.6 34.8 7.3 8.3 6.9 89.2 0.0 2.5 0.0 26.7 4.0 21.4 6.7 4.6 16.0 10.6 7.0 35.1 0.0 4.0 1.8 8.4 21.1 38.3 39.6 7.9 7.8 0.3 3.2 19.5 102.4 6.6 0.4 3.5 1.8 83.3 30.1 8.6 4.0 15.2 3.8 97.1 1.4 6.0 0.0 7.3 8.0 24.4 13.1 3.9 1.3 16.4 9.3 12.4 28.1 7.7 2.2 75.2 0.0 2.6 7.0 19.1 9.8 8.5 20.3 1.0 0.4 1.4 2.8 26.3 5.2 20.8 0.6 14.2 6.5 4.0 162.4 16.0 3.0 11.0 12.6 XXYLT1 "C3orf21, FLJ35155" ENSG00000173950 "Xyloside xylosyltransferase 1" Q8NBI6 3 195068284-195271159 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 10.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 110000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (1.39e-2)" "unprognostic (2.31e-2)" "unprognostic (3.42e-2)" "unprognostic (2.32e-3)" "unprognostic (9.57e-2)" "unprognostic (2.34e-1)" "unprognostic (6.29e-3)" "unprognostic (5.67e-2)" "unprognostic (5.50e-2)" "unprognostic (6.57e-2)" "unprognostic (3.13e-2)" "unprognostic (4.13e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.07e-1)" "unprognostic (2.23e-2)" "unprognostic (8.20e-2)" "unprognostic (1.07e-2)" 6.8 4.4 5.3 6.9 4.9 5.8 5.5 4.4 5.7 8.3 5.5 6.2 4.4 9.2 3.7 11.3 5.8 5.4 4.4 4.5 6.5 5.1 1.9 5.1 6.2 6.2 4.7 4.3 2.9 5.8 5.8 10.4 6.3 5.3 4.7 2.7 4.6 5.5 1.9 9.2 4.4 8.6 4.2 5.3 4.2 2.5 6.6 5.2 4.4 1.7 5.0 6.2 8.1 4.7 16.1 13.5 39.7 65.2 22.1 19.2 14.1 24.9 17.0 24.1 20.8 14.3 11.0 18.9 26.1 19.7 18.5 18.8 16.8 14.7 12.7 10.7 26.6 18.9 10.7 15.5 10.2 23.9 29.2 13.8 19.0 8.6 9.4 13.4 51.3 12.4 23.5 5.4 8.3 40.0 16.0 30.6 30.7 15.1 23.5 27.0 16.2 20.5 17.8 5.3 36.4 33.6 15.5 12.1 15.5 21.0 36.6 13.2 34.2 14.0 3.5 13.7 25.8 4.6 14.8 45.9 9.1 30.4 15.2 0.9 3.8 1.8 1.5 2.6 1.2 1.4 1.3 1.4 2.6 2.2 1.3 1.3 1.2 1.5 2.3 10.0 0.7 1.2 5.3 4.9 4.4 5.7 4.5 6.5 6.2 4.7 6.3 4.2 6.6 4.7 11.8 3.2 4.4 15.0 4.0 4.2 4.8 5.6 4.0 6.8 4.1 6.2 3.9 2.8 5.8 7.3 4.2 10.9 7.8 2.2 3.9 10.3 0.3 4.2 11.6 10.8 8.4 9.7 25.1 5.3 13.9 11.9 3.1 4.5 2.5 15.9 11.7 1.6 8.3 0.0 30.9 4.0 8.2 13.8 3.2 1.9 6.5 11.8 0.0 26.2 9.9 4.4 10.3 20.6 17.4 8.4 0.5 10.5 2.6 6.6 1.4 5.3 4.8 3.2 6.6 5.0 8.6 1.0 6.1 13.0 7.1 4.8 4.4 10.3 4.3 4.9 ACAP2 "CENTB2, CNT-B2, KIAA0041" ENSG00000114331 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 2" Q15057 3 195274745-195443044 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 215.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034807, HPA034808" Supported Approved Endosomes NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 57: B-cells - Immune response" Endosomes "HPA034807: AB_10669896, HPA034808: AB_10673103" "unprognostic (9.13e-2)" "unprognostic (1.75e-3)" "unprognostic (7.05e-2)" "unprognostic (2.16e-2)" "unprognostic (2.90e-2)" "unprognostic (5.64e-2)" "unprognostic (3.08e-3)" "unprognostic (7.17e-2)" "unprognostic (3.18e-2)" "unprognostic (1.57e-1)" "unprognostic (5.49e-2)" "unprognostic (2.36e-2)" "unprognostic (1.01e-2)" "unprognostic (1.05e-1)" "unprognostic (1.58e-1)" "unprognostic (3.77e-2)" "unprognostic (8.54e-2)" 15.9 10.2 10.7 22.2 10.3 39.6 13.5 21.4 14.5 14.3 1.8 17.0 14.0 14.4 10.9 21.7 12.2 14.2 8.3 14.1 6.4 10.3 11.8 15.7 26.9 2.5 4.2 19.0 9.0 13.2 8.5 15.5 6.1 10.7 17.3 29.4 9.5 10.4 5.3 15.5 15.3 14.5 3.3 23.6 14.0 15.1 5.0 21.0 21.7 9.7 27.9 13.5 11.5 7.7 34.6 13.5 21.5 21.1 34.3 41.9 31.6 28.0 37.2 20.5 21.4 18.5 19.8 38.7 65.7 25.8 20.0 21.6 16.5 14.0 29.4 43.4 9.7 38.5 14.2 7.6 33.5 52.5 26.7 32.3 24.0 20.4 46.1 17.6 22.7 21.4 19.1 37.0 30.3 20.3 33.7 19.1 13.0 19.8 18.1 39.7 24.8 27.8 14.1 32.2 23.8 11.5 30.7 27.4 32.9 18.2 51.7 30.6 40.3 25.9 14.7 34.6 32.7 21.8 50.2 84.0 19.1 56.2 27.5 62.8 55.2 55.3 27.5 49.0 21.2 39.3 26.1 21.3 32.9 45.6 22.0 22.4 215.8 17.6 59.0 34.4 26.2 25.4 10.7 10.3 21.4 14.5 14.1 6.4 2.5 4.2 6.1 3.3 5.0 7.7 110.7 44.8 40.9 103.8 103.1 44.5 28.8 45.1 88.2 58.7 43.1 50.3 17.9 22.8 43.4 31.3 77.2 20.2 101.9 75.8 19.6 24.1 11.1 49.7 60.4 74.1 51.6 50.1 141.2 24.3 22.2 62.2 44.4 49.7 39.9 33.5 57.5 32.5 65.4 121.1 143.1 44.4 22.4 115.7 67.5 9.7 46.6 110.8 35.6 143.4 122.3 29.1 68.0 132.7 130.1 31.7 70.7 37.6 67.6 41.5 39.3 28.6 45.1 92.6 59.2 43.8 61.4 39.6 26.7 143.7 51.7 29.0 85.1 43.0 37.6 38.6 PPP1R2 "IPP2, PPP1R2A" ENSG00000184203 "Protein phosphatase 1 regulatory inhibitor subunit 2" P41236 3 195514428-195543386 "Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 431.9;Spermatocytes: 354.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 142.1;U-266/70: 224.2" "Low region specificity" "Detected in all" "HPA043729, HPA059420" Approved Nucleoplasm,Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "HPA043729: AB_2678639, HPA059420: AB_2684009" "unprognostic (1.85e-2)" "unprognostic (3.71e-3)" "unprognostic (6.26e-2)" "unprognostic (3.58e-1)" "unprognostic (5.66e-2)" "unprognostic (1.44e-1)" "unprognostic (4.17e-2)" "unprognostic (3.92e-1)" "unprognostic (4.20e-2)" "unprognostic (2.00e-1)" "unprognostic (6.73e-2)" "unprognostic (8.32e-2)" "unprognostic (4.99e-2)" "unprognostic (2.28e-1)" "unprognostic (3.74e-1)" "unprognostic (2.71e-1)" "unprognostic (2.13e-1)" 18.3 15.0 15.4 21.3 16.2 68.1 22.6 12.9 16.9 18.0 16.5 22.8 25.8 21.2 25.2 22.4 18.3 19.7 24.7 16.6 21.0 21.0 15.0 17.4 29.1 15.1 15.4 13.9 13.5 16.8 15.6 17.5 17.2 20.9 19.8 16.0 16.9 19.1 85.8 17.2 22.3 21.6 14.3 21.5 17.7 29.2 15.2 28.2 23.1 56.2 25.2 21.1 18.2 15.0 43.8 9.8 14.7 17.0 24.1 25.8 29.1 25.8 36.6 26.4 22.6 142.1 18.0 17.3 99.2 31.1 27.8 18.1 15.1 25.6 32.1 33.0 30.3 18.6 14.0 47.5 37.2 20.5 18.8 31.4 19.4 19.7 39.6 20.8 23.0 17.1 14.7 33.4 23.4 32.3 34.4 22.9 15.6 49.2 42.1 16.6 25.6 50.4 31.8 32.1 34.9 20.0 31.6 33.1 46.5 27.0 52.5 19.9 27.9 16.9 19.3 28.8 36.7 224.2 105.7 79.5 23.9 37.0 33.3 120.6 64.7 257.5 71.8 68.2 98.2 100.3 149.3 99.1 68.8 95.8 178.6 122.8 152.3 94.2 69.0 103.5 168.4 129.2 15.4 16.2 12.9 16.9 16.6 21.0 15.1 15.4 17.2 14.3 15.2 15.0 106.9 22.4 47.8 13.1 165.7 94.2 138.6 70.1 89.4 51.5 80.6 61.5 53.5 38.6 56.3 22.0 58.4 67.7 148.2 48.6 125.2 69.5 431.9 119.5 65.0 99.6 57.4 33.6 30.8 66.3 43.0 62.5 45.3 67.9 111.0 26.7 51.0 27.1 61.0 52.2 41.7 48.5 69.2 73.3 170.6 243.8 51.6 103.4 97.8 25.3 120.9 50.5 74.2 23.1 19.1 74.5 65.1 63.6 188.4 123.0 77.3 106.0 80.3 91.1 26.3 48.7 71.1 354.3 92.4 88.2 77.6 103.2 230.1 58.0 54.7 186.2 APOD ENSG00000189058 "Apolipoprotein D" P05090 3 195568705-195584033 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 5037.8" "Cell type enhanced" "Detected in many" "Fibroblasts: 4485.3;Leydig cells: 2077.4;Melanocytes: 1028.1;Peritubular cells: 994.5" "Cancer enriched" "Detected in all" 4 "melanoma: 925.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 14 "memory B-cell: 5.0" "Lineage enriched" "Detected in single" 14 "B-cells: 5.0" "Group enriched" "Detected in many" 6 "ASC diff: 3507.4;ASC TERT1: 1918.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040520 Enhanced Approved "Plasma membrane" "Secreted to blood" NA NA 98900000000 90000000000 "Cluster 37: B-cells - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "HPA040520: AB_2677020" "prognostic favorable (5.51e-4)" "unprognostic (7.62e-3)" "unprognostic (7.85e-3)" "unprognostic (3.34e-3)" "unprognostic (2.20e-1)" "unprognostic (1.02e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-3)" "unprognostic (1.26e-1)" "unprognostic (3.45e-1)" "unprognostic (3.38e-1)" "unprognostic (3.19e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.38e-1)" "prognostic unfavorable (4.12e-4)" "unprognostic (1.71e-3)" 2071.8 84.8 949.6 13.9 1157.3 0.9 5037.8 1174.9 1364.1 620.2 1370.1 144.7 56.0 496.7 155.7 160.0 750.6 213.3 1007.8 952.8 1010.4 49.7 7.1 183.5 24.6 1148.3 1040.5 131.2 212.4 61.9 192.2 350.5 1122.0 419.8 57.2 0.8 1272.3 183.8 1154.9 970.1 88.4 96.2 1027.5 8.2 402.6 75.7 1070.2 113.5 828.8 625.3 20.8 434.4 591.7 1347.6 0.0 2.2 0.5 0.7 3507.4 1918.1 6.1 31.3 7.6 0.1 0.2 222.4 0.4 0.4 0.9 1.8 0.0 0.9 0.4 10.5 0.3 0.3 2.4 0.3 0.2 0.1 12.5 0.3 0.5 91.4 21.0 0.2 17.0 0.3 4.3 0.2 0.2 0.9 5.3 1.3 0.1 0.7 0.5 38.9 0.5 0.1 0.0 0.6 0.0 2.8 0.7 0.5 0.0 34.8 31.8 1.3 67.2 0.1 0.4 0.5 1.4 0.4 0.1 0.2 0.3 9.2 1.0 0.4 420.3 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 949.6 1157.3 1174.9 1364.1 952.8 1010.4 1148.3 1040.5 1122.0 1027.5 1070.2 1347.6 543.2 0.0 11.0 2.9 7.5 145.0 16.0 25.4 46.7 0.0 121.6 138.7 26.9 1.5 81.8 5.5 0.0 5.4 15.9 1.4 0.0 0.4 9.7 16.3 393.7 114.1 46.3 0.0 3.3 0.0 4.2 4485.3 7.7 7.0 0.0 0.0 21.4 0.0 13.3 0.0 2.1 0.7 10.2 0.3 193.2 51.0 2077.4 31.8 1028.1 279.2 1.0 0.0 0.0 300.6 221.5 2.3 0.3 994.5 19.2 25.7 0.0 0.2 128.9 0.0 19.7 100.3 210.7 10.5 4.0 24.1 102.6 5.9 23.5 7.0 0.6 47.3 MUC20 "FLJ14408, KIAA1359" ENSG00000176945 "Mucin 20, cell surface associated" Q8N307 3 195720884-195741123 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 58.5;kidney: 69.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 53.2;Ductal cells: 55.5;Ionocytes: 152.5;Respiratory ciliated cells: 66.5;Urothelial cells: 84.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SK-BR-3: 28.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042249 Approved "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 170000 "Cluster 7: Kidney - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA042249: " "unprognostic (1.85e-1)" "unprognostic (4.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.83e-3)" "unprognostic (2.12e-1)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.41e-1)" "unprognostic (3.99e-4)" "unprognostic (7.66e-2)" "unprognostic (2.84e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.57e-4)" "unprognostic (2.05e-1)" "unprognostic (2.56e-1)" "unprognostic (3.98e-3)" "unprognostic (1.17e-1)" 6.7 5.1 4.3 1.3 5.0 0.9 7.9 7.0 6.7 23.0 3.0 30.0 3.0 5.0 4.5 58.5 20.0 6.4 6.3 3.6 3.4 69.7 21.1 7.9 0.8 4.1 2.7 11.8 16.1 2.0 16.5 0.5 4.0 20.9 7.2 8.1 40.3 1.1 7.0 8.0 14.7 0.8 1.4 6.1 9.8 8.5 4.2 0.8 16.2 1.0 1.4 21.0 26.0 5.0 0.9 0.0 0.2 0.7 0.4 0.0 0.7 0.0 0.2 0.0 0.1 0.0 3.7 0.1 0.7 0.0 0.2 1.5 0.1 0.0 0.1 1.3 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.4 0.1 0.7 3.9 0.1 1.0 0.1 1.1 0.1 3.6 1.3 0.4 0.0 28.1 0.2 0.5 0.2 0.0 0.0 0.2 0.8 1.0 0.1 1.3 1.7 0.0 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.3 5.0 7.0 6.7 3.6 3.4 4.1 2.7 4.0 1.4 4.2 5.0 0.9 35.3 16.7 16.6 0.5 1.8 10.0 6.4 0.6 19.9 3.2 1.5 0.7 14.3 43.7 22.0 35.5 0.1 0.2 53.2 1.9 55.5 0.1 3.5 1.3 1.7 13.8 5.3 7.5 9.9 0.1 1.8 13.3 6.2 1.3 5.3 3.3 7.3 0.5 11.8 7.7 7.3 152.5 1.0 0.8 0.4 5.3 1.1 3.6 1.0 0.0 4.7 0.0 5.0 3.0 12.2 16.9 6.4 1.7 14.2 16.9 3.3 66.5 20.5 0.0 8.8 3.3 1.3 1.3 4.3 1.8 0.0 1.7 1.0 15.2 84.4 MUC4 ENSG00000145113 "Mucin 4, cell surface associated" Q99102 3 195746765-195811973 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 19.2;intestine: 31.1;prostate: 14.8;vagina: 15.0" "Cell type enhanced" "Detected in many" "Club cells: 193.7;Distal enterocytes: 185.1;Gastric mucus-secreting cells: 163.1;Intestinal goblet cells: 193.3;Respiratory ciliated cells: 336.1;Undifferentiated cells: 174.5;Urothelial cells: 319.4" "Cancer enhanced" "Detected in many" "cervical cancer: 16.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 16 "basal ganglia: 3.4" "HPA005895, CAB013536" Approved "Secreted in other tissues" NA NA "Cluster 37: Intestine - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "CAB013536: , HPA005895: AB_1079427" "unprognostic (4.16e-3)" "unprognostic (1.00e-2)" "unprognostic (6.79e-2)" "unprognostic (1.11e-2)" "unprognostic (3.03e-2)" "unprognostic (5.16e-2)" "unprognostic (5.49e-2)" "unprognostic (2.74e-1)" "unprognostic (3.19e-1)" "unprognostic (4.22e-3)" "unprognostic (6.68e-3)" "unprognostic (5.30e-2)" "unprognostic (2.43e-3)" "unprognostic (3.19e-1)" "unprognostic (6.78e-2)" "unprognostic (3.46e-3)" "unprognostic (9.97e-3)" 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.1 5.4 0.0 31.1 0.0 0.0 0.0 19.2 2.1 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.8 0.0 7.8 0.0 0.0 0.0 3.4 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.2 1.2 15.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 6.4 15.6 0.3 2.1 0.0 18.5 82.1 0.6 0.0 25.7 2.9 2.5 0.0 193.7 0.0 0.0 0.1 0.3 185.1 0.0 1.6 3.5 6.2 0.2 0.7 16.4 0.0 0.9 5.2 4.3 0.6 163.1 5.1 2.5 0.1 0.0 0.0 0.1 0.0 1.0 193.3 40.7 0.0 0.0 0.7 0.0 1.8 0.0 1.0 0.0 0.0 0.0 0.0 0.2 37.5 64.3 0.4 0.8 12.4 1.1 0.2 336.1 0.0 0.0 0.5 11.1 2.1 1.9 0.4 0.0 0.1 1.2 2.3 174.5 319.4 TNK2 "ACK, ACK1, p21cdc42Hs" ENSG00000061938 "Tyrosine kinase non receptor 2" Q07912 3 195863364-195911945 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Endocytosis "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 102.9" "Cell type enhanced" "Detected in many" "Horizontal cells: 99.3;Oligodendrocyte precursor cells: 245.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041954, HPA069561" Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Plasma membrane" Vesicles "HPA041954: AB_10794164, HPA069561: " "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (1.15e-3)" "prognostic unfavorable (8.96e-4)" "unprognostic (1.34e-1)" "unprognostic (8.92e-2)" "unprognostic (1.45e-1)" "unprognostic (1.30e-1)" "unprognostic (8.89e-3)" "unprognostic (1.13e-1)" "unprognostic (8.92e-3)" "unprognostic (4.49e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (6.82e-2)" "unprognostic (9.76e-2)" "unprognostic (1.44e-1)" "prognostic favorable (1.00e-4)" 14.2 10.0 77.1 24.7 64.1 72.2 15.0 40.0 102.9 18.0 11.8 18.5 9.4 13.8 11.1 19.1 17.1 10.5 18.4 75.6 51.4 7.7 10.5 14.1 30.0 77.5 59.8 13.4 12.1 6.1 36.4 12.7 70.1 21.1 6.3 9.3 26.3 11.8 54.8 62.3 16.1 9.2 45.5 27.0 19.7 12.0 57.0 16.0 10.0 16.7 20.1 19.4 19.3 60.6 93.4 16.3 15.4 13.4 15.3 11.5 80.0 17.7 16.7 11.7 9.4 15.6 79.3 25.9 55.1 24.2 17.4 34.1 14.9 22.2 3.5 61.8 15.4 22.0 36.2 10.4 7.9 13.5 10.2 7.8 30.7 11.7 17.9 26.7 13.3 9.2 11.3 30.6 9.4 67.1 5.3 39.7 12.3 24.6 29.1 13.8 15.6 26.0 7.2 51.2 16.2 16.5 9.5 37.6 21.3 11.3 71.4 11.9 18.9 19.1 13.0 11.4 48.6 70.8 9.2 17.0 22.1 38.0 15.4 1.4 1.2 0.3 0.9 1.5 0.4 1.3 0.8 0.4 0.5 2.5 0.5 0.5 2.7 0.4 1.4 1.5 0.1 0.7 77.1 64.1 40.0 102.9 75.6 51.4 77.5 59.8 70.1 45.5 57.0 60.6 9.3 6.4 7.7 44.4 14.6 6.9 8.1 6.0 4.6 30.6 13.0 12.6 16.1 7.2 8.9 0.0 50.1 13.4 11.0 18.0 1.9 4.0 1.0 4.1 5.4 11.1 6.1 12.8 42.7 5.3 3.3 4.6 14.3 4.1 1.3 4.5 11.7 19.2 8.1 99.3 45.3 2.3 6.1 16.0 11.7 1.2 6.5 13.7 5.4 20.6 16.2 5.9 21.6 245.3 25.1 29.5 9.6 6.4 10.7 8.2 0.9 1.6 7.6 20.3 0.0 4.8 5.7 6.4 11.2 11.0 10.5 4.2 12.5 1.7 6.4 19.0 TFRC "CD71, p90, TFR1" ENSG00000072274 "Transferrin receptor" P02786 3 196027183-196082096 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Endocytosis, Host-virus interaction" "Host cell receptor for virus entry, Receptor, Transducer" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 254.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 556.4;Syncytiotrophoblasts: 502.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 860.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000153, HPA028598" Enhanced Supported Endosomes,Lysosomes "Secreted to blood" NA NA 1310000000 38000000 "Cluster 27: Non-specific - Gene expression" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "Endosomes, Lysosomes" "CAB000153: AB_2533029, HPA028598: AB_10601599" "unprognostic (2.95e-2)" "prognostic unfavorable (3.67e-4)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" "unprognostic (6.75e-2)" "unprognostic (7.88e-3)" "prognostic unfavorable (1.15e-4)" "unprognostic (6.92e-2)" "unprognostic (3.30e-3)" "unprognostic (4.35e-2)" "unprognostic (1.34e-2)" "unprognostic (1.14e-2)" "unprognostic (3.63e-3)" "unprognostic (3.65e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (2.96e-4)" "unprognostic (2.62e-2)" 44.6 28.7 21.6 63.4 18.3 254.5 20.2 18.5 32.3 31.3 15.7 77.2 35.9 23.8 11.1 36.0 25.9 24.9 31.0 21.9 19.0 26.4 27.8 78.0 23.0 24.2 19.9 93.9 15.9 44.8 13.1 103.2 26.3 13.2 55.6 47.3 15.7 13.4 76.2 21.8 32.1 31.5 20.8 15.5 21.4 21.6 25.3 22.0 20.1 68.7 28.1 68.5 17.4 20.7 175.3 155.0 69.8 142.1 151.7 87.3 438.7 242.5 183.7 168.1 276.3 384.6 156.6 178.5 446.3 91.0 363.5 261.8 243.3 81.1 204.2 860.4 82.4 677.4 120.2 179.2 119.4 561.8 130.4 99.1 78.6 144.5 129.0 47.8 56.9 95.6 287.3 164.1 132.8 161.7 185.8 116.8 214.9 228.6 314.0 97.3 103.9 214.1 148.3 435.3 159.3 65.9 234.4 613.9 55.2 115.9 595.0 115.8 72.5 198.4 159.7 175.3 369.7 46.3 387.8 276.7 232.3 149.2 122.3 0.0 1.6 2.2 2.2 7.3 1.4 5.1 2.4 1.5 3.5 3.1 2.1 1.7 0.2 1.9 13.2 7.1 6.4 2.1 21.6 18.3 18.5 32.3 21.9 19.0 24.2 19.9 26.3 20.8 25.3 20.7 25.4 44.8 32.1 43.1 46.6 60.3 37.2 33.6 21.1 53.1 37.1 34.9 103.0 41.5 38.8 20.2 148.0 122.5 53.2 156.6 0.0 49.4 3.5 35.3 20.3 23.6 56.1 556.4 24.7 41.8 25.3 32.4 77.5 56.1 23.4 40.2 8.6 93.2 73.4 13.5 28.3 67.8 22.4 37.1 77.6 5.3 11.5 161.7 17.8 44.0 49.4 22.0 9.2 11.6 8.2 52.0 50.8 8.6 42.1 25.6 48.3 13.1 32.1 44.4 26.3 36.3 29.3 23.8 18.2 51.3 35.8 502.7 42.6 16.6 103.5 23.7 ZDHHC19 MGC33345 ENSG00000163958 "Zinc finger DHHC-type palmitoyltransferase 19" Q8WVZ1 3 196197452-196211437 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 50.1" "Group enriched" "Detected in some" 17 "Early spermatids: 332.1;Late spermatids: 810.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "eosinophil: 1.2;memory B-cell: 2.5;naive B-cell: 2.4;neutrophil: 1.5" "Group enriched" "Detected in many" 20 "B-cells: 2.5;granulocytes: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 37: B-cells - Transcription" "Cluster 74: Testis - Spermatogenesis" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (1.15e-1)" "unprognostic (7.50e-4)" "unprognostic (2.87e-3)" "unprognostic (6.72e-3)" "unprognostic (3.79e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (3.66e-3)" "unprognostic (4.63e-2)" "unprognostic (6.52e-2)" "unprognostic (2.86e-2)" "unprognostic (3.46e-7)" "unprognostic (8.05e-4)" "unprognostic (4.71e-1)" "unprognostic (7.08e-3)" "unprognostic (4.28e-2)" 0.1 0.8 0.1 0.3 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.6 0.3 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 50.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.5 0.0 0.0 0.0 2.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 5.3 0.3 0.1 0.0 0.0 0.2 0.0 0.4 0.4 1.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 332.1 0.1 0.1 0.6 0.0 0.0 0.9 0.0 0.5 0.5 0.0 0.1 0.0 9.7 0.0 3.6 1.4 0.0 0.8 0.0 0.0 1.0 0.4 810.2 16.4 1.2 0.0 2.8 0.1 0.3 0.0 0.5 0.1 0.0 0.0 32.0 0.0 0.0 0.1 0.8 0.8 0.1 0.0 0.0 0.8 5.5 3.3 0.0 0.0 2.5 0.3 6.5 0.0 0.0 SLC51A OSTalpha ENSG00000163959 "Solute carrier family 51 subunit alpha" Q86UW1 3 196211487-196243178 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "intestine: 64.5;liver: 71.3" "Cell type enhanced" "Detected in many" "Hepatocytes: 49.1;Leydig cells: 61.5;Peritubular cells: 101.5;Proximal enterocytes: 271.8;Sertoli cells: 144.7" "Cancer enriched" "Detected in many" 7 "liver cancer: 15.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "REH: 3.9;U-266/84: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA045488 Enhanced NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 29: U-266 - Adaptive immune response" "Cluster 45: Enterocytes - Digestion" "HPA045488: " "unprognostic (1.63e-2)" "unprognostic (1.27e-3)" "unprognostic (2.80e-1)" "unprognostic (7.66e-2)" "unprognostic (5.16e-2)" "unprognostic (2.40e-2)" "prognostic favorable (7.54e-4)" "unprognostic (5.02e-2)" "unprognostic (1.07e-1)" "unprognostic (5.98e-3)" "unprognostic (5.41e-2)" "unprognostic (2.90e-2)" "unprognostic (2.73e-2)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.58e-5)" 1.3 5.2 0.2 1.3 0.2 5.9 1.2 0.1 0.7 2.0 0.0 11.3 30.5 0.8 0.8 1.4 1.6 0.6 1.3 0.2 0.4 5.5 71.3 2.0 0.6 0.2 0.1 1.4 0.9 2.7 1.2 0.2 0.3 1.1 0.7 0.7 1.2 0.0 1.6 2.5 64.5 0.2 0.0 1.8 0.9 4.1 0.7 0.1 1.5 0.0 0.5 1.0 1.8 0.5 0.5 0.7 0.6 0.7 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.8 0.5 0.0 0.4 0.0 0.0 0.0 0.3 1.3 0.5 0.4 0.8 0.1 0.6 0.6 0.1 0.0 0.0 0.0 0.6 0.1 0.1 0.1 1.5 0.0 0.3 0.0 0.6 0.0 0.1 0.9 3.9 0.0 0.2 0.0 0.4 0.1 0.2 0.2 1.4 0.1 0.1 1.1 0.2 0.2 0.7 0.3 0.6 0.4 1.5 2.0 0.2 0.5 0.2 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.7 0.2 0.4 0.2 0.1 0.3 0.0 0.7 0.5 1.1 0.0 0.5 0.3 1.0 3.3 2.5 10.9 0.0 0.5 0.6 0.3 4.1 1.5 18.2 0.0 4.2 0.7 3.0 43.5 3.9 0.2 20.7 2.7 1.6 1.6 0.0 2.7 1.0 0.2 0.4 2.4 0.0 1.6 0.0 2.3 3.9 49.1 0.6 1.7 0.7 8.4 22.4 4.4 7.3 12.9 61.5 1.3 3.6 1.0 0.8 0.4 1.0 0.5 0.2 0.1 12.1 101.5 0.8 1.5 271.8 11.5 18.0 1.1 144.7 2.3 2.6 2.4 1.3 0.0 2.6 1.0 3.0 13.6 11.8 2.8 PCYT1A "CT, CTPCT, PCYT1" ENSG00000161217 "Phosphate cytidylyltransferase 1, choline, alpha" P49585 3 196214222-196287957 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Cone-rod dystrophy, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 215.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035428 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 38: EFO-21 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Cytosol "HPA035428: AB_10602045" "unprognostic (8.58e-3)" "unprognostic (2.63e-1)" "unprognostic (8.45e-2)" "unprognostic (8.61e-3)" "unprognostic (2.87e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (8.65e-5)" "unprognostic (8.52e-2)" "unprognostic (5.99e-2)" "unprognostic (1.65e-2)" "unprognostic (6.72e-3)" "unprognostic (1.74e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (1.47e-2)" "unprognostic (7.16e-3)" "unprognostic (2.41e-2)" 31.4 24.4 15.2 30.0 16.0 45.3 21.0 16.6 15.8 16.7 17.8 25.7 60.3 19.1 13.9 31.0 15.6 20.7 46.4 15.5 21.1 18.3 20.7 22.5 22.9 18.8 18.0 15.8 16.8 22.7 12.9 20.1 18.5 16.6 22.9 14.4 19.3 18.6 73.8 43.0 49.1 23.0 17.5 25.9 24.2 22.4 18.1 18.1 17.2 42.1 26.8 21.0 19.8 17.1 92.6 36.6 25.8 37.2 52.2 53.9 37.0 68.2 47.1 59.2 51.8 92.3 32.8 23.9 215.2 78.1 60.2 71.4 40.5 52.1 50.4 42.1 28.6 68.6 40.6 39.5 45.2 34.3 56.7 47.4 40.0 55.9 39.6 35.4 63.0 21.0 38.3 53.3 58.1 79.6 19.9 17.3 21.4 55.7 53.0 34.5 31.0 37.5 35.7 53.6 25.4 18.3 44.5 79.5 44.2 32.8 114.1 37.2 88.5 45.5 25.2 61.8 92.7 45.8 101.1 44.1 69.6 43.8 56.9 9.6 9.2 10.4 8.8 9.3 7.5 7.2 6.5 9.7 9.1 6.3 4.2 6.3 21.0 9.4 11.0 5.9 14.9 5.2 15.2 16.0 16.6 15.8 15.5 21.1 18.8 18.0 18.5 17.5 18.1 17.1 24.7 16.0 25.7 15.3 19.9 14.5 9.4 19.7 14.2 15.9 14.1 9.4 70.1 20.0 17.5 14.7 25.0 11.9 27.3 36.4 13.7 24.8 76.3 17.8 22.9 23.2 22.1 12.2 20.4 22.9 17.7 17.0 23.4 15.6 20.8 16.1 26.7 35.6 37.4 8.4 22.7 24.2 6.1 34.6 27.1 67.6 19.9 33.9 19.6 20.6 39.4 13.1 39.1 16.1 17.6 24.6 21.1 28.2 27.2 12.0 67.2 23.2 33.9 12.8 26.3 15.0 19.0 46.0 13.2 30.0 21.5 18.6 25.6 25.5 23.8 12.2 DYNLT2B "MGC33212, TCTEX1D2" ENSG00000213123 "Dynein light chain Tctex-type 2B" Q8WW35 3 196291219-196318299 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 5.5;Cardiomyocytes: 6.2;Cytotrophoblasts: 29.4;Extravillous trophoblasts: 9.9;Hofbauer cells: 16.8;Syncytiotrophoblasts: 6.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 21.9;dendritic cells: 16.2;T-cells: 25.1" "Cell line enhanced" "Detected in many" "T-47d: 101.7" HPA049555 Approved Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA049555: AB_2680816" "unprognostic (1.16e-1)" "prognostic favorable (7.83e-4)" "unprognostic (5.34e-2)" "unprognostic (1.59e-2)" "unprognostic (1.47e-1)" "unprognostic (5.63e-2)" "unprognostic (2.65e-2)" "unprognostic (4.61e-1)" "unprognostic (9.98e-3)" "unprognostic (3.99e-2)" "unprognostic (3.44e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (6.23e-4)" "unprognostic (3.73e-2)" "unprognostic (1.05e-1)" "unprognostic (1.39e-1)" "unprognostic (2.32e-1)" 5.0 7.9 15.2 4.5 15.7 5.1 6.5 14.6 18.6 8.7 15.0 9.1 3.4 7.1 7.9 13.0 36.2 5.1 6.3 15.2 16.0 16.9 2.3 7.0 8.8 15.2 16.8 7.3 5.1 7.9 13.8 3.1 17.0 7.0 4.2 15.0 5.2 3.9 3.0 8.4 4.0 3.7 15.7 4.3 5.0 30.9 16.6 14.7 10.1 1.5 6.0 6.7 9.4 15.0 33.1 23.9 45.3 28.0 11.1 22.3 5.4 13.8 9.3 16.8 18.8 7.9 45.0 21.0 23.0 12.1 7.0 33.7 17.8 14.5 16.3 18.4 13.3 8.6 22.3 3.4 12.7 6.4 0.9 12.1 38.2 14.7 17.1 30.5 10.2 44.0 13.3 10.8 32.6 79.0 28.9 29.4 29.6 36.6 41.5 37.3 7.7 8.7 38.9 13.4 50.9 39.7 29.2 17.2 28.0 18.7 101.7 18.3 19.2 15.0 5.8 6.1 18.0 16.9 38.0 48.8 45.0 11.4 25.8 0.0 3.1 1.4 11.7 1.2 7.1 21.9 13.9 9.0 8.8 13.7 9.1 9.4 1.8 4.6 0.8 16.2 25.1 6.3 15.2 15.7 14.6 18.6 15.2 16.0 15.2 16.8 17.0 15.7 16.6 15.0 5.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 29.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 9.9 3.3 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 6.2 0.5 0.0 0.0 0.0 TM4SF19 ENSG00000145107 "Transmembrane 4 L six family member 19" Q96DZ7 3 196319342-196338503 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adipose tissue: 6.0;testis: 4.6" "Cell type enriched" "Detected in some" 8 "Hofbauer cells: 74.6" "Group enriched" "Detected in some" 4 "cervical cancer: 1.4;head and neck cancer: 3.4;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 0.9" "Region enhanced" "Detected in single" "thalamus: 2.5" "Group enriched" "Detected in some" 6 "gdT-cell: 14.8;memory CD8 T-cell: 3.9;naive CD8 T-cell: 4.9" "Lineage enriched" "Detected in single" 16 "T-cells: 14.8" "Cell line enriched" "Detected in many" 12 "GAMG: 427.6" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 71: Testis - DNA repair" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 4: Macrophages - Innate immune response" "unprognostic (9.90e-2)" "unprognostic (1.17e-2)" "unprognostic (3.60e-2)" "unprognostic (1.89e-2)" "unprognostic (1.67e-1)" "unprognostic (7.19e-2)" "unprognostic (8.90e-5)" "unprognostic (8.86e-3)" "unprognostic (1.30e-1)" "unprognostic (3.21e-2)" "unprognostic (1.85e-1)" "unprognostic (2.86e-1)" "unprognostic (1.06e-3)" "unprognostic (4.23e-2)" "unprognostic (4.20e-3)" "unprognostic (2.60e-1)" "unprognostic (1.18e-3)" 6.0 0.3 0.1 0.5 0.2 0.6 2.9 0.3 0.5 1.5 0.0 0.3 0.2 0.3 0.0 3.4 0.3 0.1 0.1 0.2 0.1 0.2 0.5 3.5 0.5 0.1 0.2 0.7 0.3 0.0 0.1 0.8 0.4 0.5 0.2 0.5 1.5 0.0 1.6 1.8 0.2 0.1 0.2 0.6 0.5 4.6 2.5 0.2 0.7 0.5 0.7 0.3 1.7 0.8 15.6 7.2 0.2 0.4 0.9 4.6 0.3 0.0 4.4 1.6 2.9 0.0 8.2 0.2 2.6 0.0 427.6 2.2 0.0 1.7 1.1 0.6 0.0 0.3 2.1 0.0 1.0 0.5 0.4 0.5 1.4 18.8 31.3 0.0 0.0 0.9 9.8 0.9 4.8 1.2 0.1 0.8 0.0 0.2 36.2 0.2 3.2 0.9 0.0 0.4 0.3 0.0 2.5 0.1 0.7 0.4 0.6 0.2 1.4 18.6 15.6 2.9 9.1 0.5 5.6 0.3 20.2 0.7 0.3 0.9 0.3 0.4 14.8 0.4 0.1 0.1 1.3 3.9 0.1 0.3 0.7 4.9 0.6 0.7 0.1 0.6 0.4 1.6 0.1 0.2 0.3 0.5 0.2 0.1 0.1 0.2 0.4 0.2 2.5 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 2.9 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 74.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 9.3 4.9 4.9 0.0 0.4 0.9 0.1 0.0 0.0 UBXN7 "KIAA0794, UBXD7" ENSG00000163960 "UBX domain protein 7" O94888 3 196347662-196432430 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048441, HPA049442" Supported Enhanced Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA048441: AB_2680394, HPA049442: AB_2680769" "unprognostic (8.36e-3)" "unprognostic (4.89e-2)" "unprognostic (1.01e-1)" "unprognostic (1.90e-3)" "unprognostic (1.05e-1)" "unprognostic (6.64e-2)" "unprognostic (5.12e-3)" "unprognostic (1.49e-1)" "unprognostic (9.60e-2)" "unprognostic (6.45e-2)" "unprognostic (2.11e-2)" "unprognostic (2.91e-2)" "unprognostic (2.52e-2)" "unprognostic (1.78e-1)" "unprognostic (3.40e-1)" "unprognostic (7.58e-2)" "unprognostic (1.32e-1)" 6.5 7.5 5.3 7.5 7.5 21.7 8.2 17.5 7.1 8.3 7.4 6.9 5.5 10.1 8.1 6.6 8.4 5.7 4.9 5.4 9.3 6.8 6.4 6.7 9.0 6.3 7.3 12.8 7.4 10.8 7.3 9.5 6.9 7.3 6.8 18.1 6.6 6.7 5.0 10.7 6.3 7.9 5.8 8.9 6.6 11.9 7.6 13.9 8.1 7.0 8.7 6.2 7.0 10.9 25.2 7.7 29.8 15.8 15.2 26.6 13.0 20.3 13.4 11.4 10.4 19.9 10.5 23.0 41.6 13.7 15.4 20.0 22.5 12.0 21.2 9.5 13.8 36.9 16.5 11.3 11.6 18.8 11.5 16.0 13.5 16.0 20.0 20.4 18.7 17.2 17.8 15.5 13.5 10.8 19.6 9.9 17.3 10.2 9.7 22.7 22.3 15.8 9.4 10.9 20.0 15.4 32.6 9.0 15.7 23.7 24.2 15.7 23.5 13.0 11.6 11.8 21.7 21.6 31.3 33.5 12.0 21.0 9.9 9.9 4.7 7.0 4.4 3.7 4.0 6.9 3.8 2.9 5.0 5.9 6.5 5.9 8.4 6.2 5.4 2.2 6.6 2.5 5.3 7.5 17.5 7.1 5.4 9.3 6.3 7.3 6.9 5.8 7.6 10.9 27.1 44.8 18.8 29.7 31.4 47.3 14.3 16.2 40.5 38.0 22.2 16.0 16.8 12.8 21.1 20.2 70.9 18.0 32.9 14.8 5.9 10.8 38.3 47.8 46.3 27.8 46.5 34.0 35.3 10.0 10.5 30.7 18.8 35.1 8.8 46.0 21.8 12.0 12.5 32.0 41.3 15.9 12.2 25.4 41.0 24.7 29.8 24.7 23.2 27.2 28.4 21.5 33.0 36.7 47.8 12.2 11.8 28.2 34.3 31.7 13.3 11.7 30.5 46.5 32.9 37.3 25.6 34.7 23.8 38.6 54.7 18.9 29.8 33.2 15.8 25.3 RNF168 FLJ35794 ENSG00000163961 "Ring finger protein 168" Q8IYW5 3 196468783-196503768 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 199.9;Late spermatids: 459.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046109 Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA046109: AB_2679540" "unprognostic (6.15e-3)" "prognostic favorable (8.21e-4)" "unprognostic (3.11e-1)" "unprognostic (1.11e-2)" "unprognostic (4.22e-1)" "unprognostic (5.04e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (6.81e-3)" "unprognostic (5.30e-2)" "unprognostic (1.63e-1)" "prognostic unfavorable (8.31e-4)" "unprognostic (4.83e-3)" "unprognostic (2.80e-3)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (1.95e-2)" "unprognostic (6.65e-2)" 8.6 4.8 3.9 6.0 4.2 20.6 6.8 5.9 4.3 9.3 4.4 6.1 6.1 6.0 4.0 7.9 5.9 4.5 6.8 3.2 6.3 4.7 10.4 8.1 7.2 6.1 5.2 7.4 4.8 4.0 3.5 5.4 6.5 5.3 5.7 4.9 5.8 4.1 13.1 11.5 5.6 5.3 4.9 6.8 5.8 10.7 6.0 7.7 4.9 8.3 8.7 6.7 9.3 6.0 21.6 8.5 14.8 19.5 13.6 9.8 21.1 12.9 8.1 8.5 13.3 16.6 10.4 22.7 29.1 10.8 11.9 21.3 21.0 15.4 13.0 10.9 10.3 43.0 22.2 20.7 7.0 13.3 10.3 9.8 5.8 13.3 11.7 6.0 12.6 18.4 13.1 23.1 8.7 36.4 44.6 7.8 17.6 11.6 10.8 19.7 17.2 18.4 7.2 29.2 12.3 12.4 14.6 17.7 11.1 10.9 26.8 11.7 12.4 14.6 11.4 15.7 17.2 19.6 19.7 33.2 14.3 15.8 11.9 30.0 7.3 8.8 12.2 8.0 10.9 6.3 10.1 8.8 6.6 6.6 8.8 9.4 8.0 8.7 12.2 6.2 7.0 7.5 3.9 4.2 5.9 4.3 3.2 6.3 6.1 5.2 6.5 4.9 6.0 6.0 34.4 16.0 37.5 16.0 37.7 100.1 49.8 30.8 52.3 36.0 17.3 15.0 21.7 12.8 20.0 14.7 60.5 14.6 76.4 25.3 17.6 14.0 199.9 17.0 20.8 33.3 14.4 14.1 33.5 8.9 26.6 27.9 23.9 24.0 50.1 24.0 24.3 25.9 17.9 15.2 36.0 18.5 28.5 32.4 98.8 459.7 20.2 33.9 26.6 28.1 38.2 12.7 42.2 25.1 27.4 10.5 17.3 20.7 37.9 27.7 11.4 10.3 17.1 39.8 13.1 23.6 25.7 13.8 54.9 55.5 126.6 10.7 63.7 20.3 22.4 50.3 SMCO1 "C3orf43, DKFZp313B0440, FLJ41923" ENSG00000214097 "Single-pass membrane protein with coiled-coil domains 1" Q147U7 3 196506879-196515346 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 41 "heart muscle: 41.5;skeletal muscle: 149.2;tongue: 107.0" "Cell type enriched" "Detected in some" 34 "Cardiomyocytes: 89.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061937 Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "Golgi apparatus" "Endoplasmic reticulum" "HPA061937: AB_2684642" "unprognostic (4.86e-2)" "unprognostic (1.62e-1)" "unprognostic (1.51e-2)" "unprognostic (6.08e-2)" "unprognostic (1.72e-2)" "unprognostic (1.73e-1)" "unprognostic (3.25e-1)" "unprognostic (1.64e-1)" "unprognostic (1.94e-2)" "unprognostic (2.95e-1)" "unprognostic (2.72e-1)" "unprognostic (3.07e-2)" "unprognostic (2.88e-3)" 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.6 2.4 0.0 0.0 41.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.7 0.0 0.1 0.7 0.0 149.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 107.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 89.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.5 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WDR53 "MGC12928, MGC64882" ENSG00000185798 "WD repeat domain 53" Q7Z5U6 3 196554177-196568674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 74.2" "Group enriched" "Detected in many" 9 "Early spermatids: 313.9;Late spermatids: 118.8;Spermatocytes: 135.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016420 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 78: Testis - Spermatogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Plasma membrane, Cytosol" "HPA016420: AB_1858812" "unprognostic (3.29e-2)" "unprognostic (4.24e-3)" "unprognostic (9.89e-2)" "unprognostic (2.29e-3)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "prognostic unfavorable (1.57e-6)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.57e-1)" "unprognostic (2.10e-3)" "unprognostic (4.48e-3)" "unprognostic (8.01e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" 7.8 7.4 9.4 6.9 10.3 14.7 9.0 10.3 12.1 7.7 9.7 8.1 4.3 8.1 11.0 9.0 7.1 6.3 8.1 9.5 10.0 8.8 10.0 6.9 10.6 9.6 9.7 7.0 5.9 10.0 6.7 6.3 11.2 7.2 7.1 8.9 7.0 6.1 13.0 11.9 7.9 7.4 9.4 10.8 7.2 74.2 9.8 12.1 7.1 12.6 11.9 7.2 7.6 11.3 39.4 8.5 14.6 13.6 15.0 13.2 23.8 20.1 16.2 23.0 21.7 22.8 20.2 18.9 66.4 13.0 21.2 22.3 18.9 18.4 28.8 30.0 16.3 19.4 21.2 14.6 18.5 26.9 14.3 10.7 25.9 20.6 22.2 11.4 18.7 23.6 18.8 34.5 17.7 36.4 22.5 27.5 19.5 25.7 24.4 26.5 25.3 40.5 12.8 13.4 15.0 15.2 15.0 20.8 32.2 19.8 53.0 24.2 17.2 18.9 18.0 21.5 40.6 29.5 63.8 56.6 12.7 34.2 19.4 13.1 5.5 15.7 8.8 4.7 14.1 7.8 12.2 8.5 4.7 7.5 10.2 6.1 4.7 7.4 7.8 6.2 16.5 5.0 9.4 10.3 10.3 12.1 9.5 10.0 9.6 9.7 11.2 9.4 9.8 11.3 3.9 0.0 2.8 6.8 3.8 4.2 3.2 8.1 2.8 3.7 3.4 3.4 5.6 2.8 5.8 3.7 0.0 5.7 3.5 1.7 5.9 5.0 313.9 3.3 3.5 4.7 0.0 7.4 5.5 4.2 6.1 3.9 0.5 2.7 9.5 3.2 3.9 2.5 4.3 3.3 4.8 1.6 10.2 3.8 3.0 118.8 5.0 3.9 5.4 10.3 7.3 4.0 4.1 6.0 7.1 3.7 1.9 3.4 3.7 2.9 1.5 5.0 3.1 2.8 19.7 4.0 5.5 135.6 13.9 3.5 4.7 4.7 6.3 4.1 2.7 2.6 FBXO45 Fbx45 ENSG00000174013 "F-box protein 45" P0C2W1 3 196568611-196589059 "Predicted intracellular proteins" "Neurogenesis, Ubl conjugation pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040730 Uncertain Approved Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA040730: AB_10959311" "unprognostic (7.17e-3)" "unprognostic (1.14e-1)" "unprognostic (8.37e-2)" "unprognostic (1.01e-2)" "unprognostic (8.14e-2)" "unprognostic (2.89e-1)" "prognostic unfavorable (7.61e-5)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.13e-2)" "unprognostic (9.48e-3)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.16e-5)" "prognostic unfavorable (4.93e-5)" "unprognostic (5.18e-2)" "unprognostic (1.66e-1)" "unprognostic (6.93e-2)" "unprognostic (1.65e-1)" 5.1 4.2 10.7 6.1 11.5 13.9 7.3 11.8 14.8 4.5 6.8 6.9 5.3 4.7 3.0 8.9 3.6 4.4 3.6 11.0 10.9 3.7 6.9 4.5 6.7 10.7 10.9 5.0 4.6 7.2 3.1 5.4 10.4 5.1 7.0 8.2 4.0 4.3 13.8 12.7 5.1 5.0 11.6 5.1 5.5 12.2 11.5 8.8 3.7 11.5 10.0 6.8 5.0 11.7 45.5 8.5 17.6 22.4 11.6 11.4 20.9 19.7 9.0 15.3 15.6 23.9 15.1 19.1 33.1 12.8 22.8 19.0 33.9 22.5 28.1 27.7 15.3 34.8 15.5 15.1 11.1 46.9 17.1 5.8 24.9 17.3 31.8 8.0 16.9 30.5 42.4 39.2 17.2 45.3 27.5 21.9 27.4 40.3 32.5 23.1 23.0 46.2 12.9 18.3 35.6 24.4 21.4 36.8 23.5 15.4 63.3 31.1 16.8 17.7 19.1 25.7 53.8 38.3 68.5 52.6 15.4 59.6 17.3 1.3 0.9 1.1 0.8 0.9 1.4 0.5 0.8 0.5 1.2 0.8 0.8 0.9 0.4 0.6 1.1 1.4 1.6 0.4 10.7 11.5 11.8 14.8 11.0 10.9 10.7 10.9 10.4 11.6 11.5 11.7 10.2 12.8 4.1 6.5 6.6 9.8 10.2 5.6 4.6 20.1 10.5 7.7 10.8 4.3 4.2 3.7 14.6 2.6 11.5 7.9 0.0 4.4 15.5 8.0 12.9 8.0 17.4 6.1 13.8 7.7 4.6 7.8 10.7 8.8 1.3 6.9 7.9 9.9 5.8 13.5 15.0 8.2 4.1 9.1 11.0 18.9 5.6 7.6 5.4 8.4 8.3 9.3 4.1 6.6 12.4 8.3 4.8 6.4 8.0 14.8 4.0 3.4 6.8 10.7 0.0 10.5 7.5 32.4 24.4 9.4 13.5 1.9 8.2 7.1 9.8 14.5 NRROS "ELLP3030, GARPL1, LRRC33, MGC50789, UNQ3030" ENSG00000174004 "Negative regulator of reactive oxygen species" Q86YC3 3 196639694-196662004 "Disease related genes, Predicted membrane proteins" "Growth factor binding" "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 32.7" "Cell type enhanced" "Detected in many" "B-cells: 40.2;Erythroid cells: 27.5;Hofbauer cells: 76.9;Kupffer cells: 35.5;Langerhans cells: 59.9;Macrophages: 33.3;Microglial cells: 31.9;NK-cells: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 4.2" "Group enriched" "Detected in many" 6 "dendritic cells: 1.3;granulocytes: 4.2;monocytes: 1.1" "Cell line enhanced" "Detected in many" "HEL: 53.1;HMC-1: 106.4;Karpas-707: 66.7;MOLT-4: 59.8;NB-4: 138.5;RPMI-8226: 68.9;THP-1: 60.5;U-937: 76.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031586 Uncertain NA NA "Cluster 46: Basophils - DNA binding" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 24: NB-4 - Immune response" "Cluster 57: B-cells - Immune response" "HPA031586: AB_10601543" "unprognostic (5.28e-2)" "unprognostic (8.92e-3)" "unprognostic (1.02e-1)" "unprognostic (3.05e-2)" "unprognostic (2.23e-1)" "unprognostic (1.41e-3)" "unprognostic (1.05e-1)" "unprognostic (9.67e-2)" "unprognostic (3.20e-2)" "prognostic unfavorable (9.63e-4)" "unprognostic (2.32e-2)" "unprognostic (2.81e-1)" "unprognostic (6.73e-3)" "unprognostic (1.47e-1)" "unprognostic (7.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" 7.8 2.6 1.9 8.6 1.5 32.7 5.1 1.5 1.6 2.5 1.6 2.7 2.4 2.9 0.5 2.0 2.8 4.2 2.9 1.8 3.0 2.8 2.5 7.7 10.5 2.7 1.9 1.2 1.1 0.9 1.2 9.9 2.7 2.0 1.6 0.3 2.4 1.6 1.3 2.0 5.1 4.1 2.7 15.7 2.3 1.3 3.4 7.7 2.2 2.5 3.6 4.5 2.1 4.4 0.1 0.0 0.3 0.0 0.4 1.0 0.1 0.4 2.1 0.4 0.3 0.1 0.2 0.0 6.7 0.4 0.3 0.1 1.1 0.0 0.1 4.0 0.1 53.1 0.0 0.0 0.5 43.7 106.4 0.4 0.0 1.7 0.7 2.1 4.3 48.6 5.5 66.7 1.2 0.1 59.8 138.5 4.4 0.0 0.1 15.7 0.1 68.9 0.1 0.4 0.3 0.0 0.1 0.1 28.0 0.9 0.1 60.5 0.5 0.5 0.2 1.9 0.1 26.5 43.1 12.1 3.4 76.1 0.7 4.2 1.0 1.8 0.3 1.0 0.1 0.3 0.2 0.2 1.3 0.2 0.1 0.2 0.0 0.3 1.1 0.2 0.3 0.7 1.9 1.5 1.5 1.6 1.8 3.0 2.7 1.9 2.7 2.7 3.4 4.4 5.6 0.0 0.5 0.0 40.2 1.5 0.1 0.0 2.2 0.4 0.4 0.3 0.3 0.0 0.6 0.0 4.2 0.3 15.5 0.0 0.0 0.0 1.4 0.0 0.4 10.1 0.0 27.5 1.8 0.0 0.7 0.7 0.5 0.1 14.5 0.1 15.4 0.2 76.9 0.0 2.7 0.0 0.0 35.5 59.9 0.4 0.6 33.3 8.8 31.9 24.1 0.1 33.0 1.0 0.3 0.0 0.0 0.7 25.7 0.0 0.0 0.1 0.0 0.4 6.6 0.3 0.3 2.7 0.4 0.2 0.9 0.5 10.8 0.5 0.0 0.0 PIGX FLJ20522 ENSG00000163964 "Phosphatidylinositol glycan anchor biosynthesis class X" Q8TBF5 3 196639775-196736007 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 87.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 87.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029409, HPA073301" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "Plasma membrane" "HPA029409: AB_10610280, HPA073301: " "unprognostic (8.83e-2)" "prognostic favorable (2.12e-4)" "unprognostic (2.14e-1)" "unprognostic (2.42e-3)" "unprognostic (9.25e-2)" "unprognostic (2.00e-1)" "prognostic unfavorable (7.45e-5)" "unprognostic (1.91e-1)" "unprognostic (3.97e-2)" "unprognostic (1.11e-2)" "unprognostic (3.18e-2)" "unprognostic (4.02e-1)" "unprognostic (1.30e-1)" "unprognostic (1.15e-1)" "unprognostic (1.53e-1)" "unprognostic (1.46e-1)" "unprognostic (2.01e-1)" 10.5 10.3 14.4 10.4 15.6 9.0 9.9 14.7 16.7 7.5 19.5 10.8 9.1 8.3 12.4 10.3 7.9 8.3 9.6 15.2 16.7 12.2 8.2 7.2 7.1 15.1 15.8 6.8 9.0 19.6 12.7 8.3 14.8 12.8 10.1 17.4 9.9 10.5 17.1 10.4 9.1 11.2 16.0 6.8 7.6 6.0 16.2 11.6 9.2 14.1 10.9 8.7 7.6 16.7 39.4 18.7 21.4 18.1 22.7 15.3 12.6 18.1 20.7 19.3 20.5 13.7 25.6 20.3 63.6 15.4 25.1 22.2 19.5 16.6 23.1 18.6 19.6 21.0 12.8 12.6 19.2 20.6 34.6 15.1 25.7 17.1 15.7 16.3 12.7 36.5 11.7 38.6 21.0 30.1 59.2 32.1 12.8 30.7 18.3 31.1 27.6 29.5 24.6 11.5 24.4 29.2 31.8 23.9 29.7 16.9 71.8 20.3 8.2 18.1 9.2 25.6 29.5 57.0 70.4 41.1 20.7 26.9 21.5 39.6 7.5 87.5 3.3 10.8 3.0 4.6 3.1 4.6 7.7 5.5 3.7 3.2 18.8 8.7 11.6 3.3 4.4 4.1 14.4 15.6 14.7 16.7 15.2 16.7 15.1 15.8 14.8 16.0 16.2 16.7 14.2 19.2 16.3 13.7 16.4 17.1 30.1 5.5 31.9 34.9 28.3 19.2 12.6 21.5 8.4 29.5 47.9 21.4 31.6 20.8 35.2 7.9 30.5 17.2 23.5 16.9 15.7 15.8 17.7 5.6 20.9 22.0 9.2 17.9 12.0 19.3 17.5 16.6 20.1 33.7 23.7 17.0 8.2 21.4 25.4 22.7 28.0 18.1 21.4 15.9 25.0 50.0 32.0 12.1 14.5 5.2 12.5 35.0 20.1 33.8 27.1 32.5 10.2 39.1 26.3 23.6 28.1 27.1 36.0 29.3 15.9 11.6 21.2 22.7 25.7 23.0 CEP19 "C3orf34, MGC14126" ENSG00000174007 "Centrosomal protein 19" Q96LK0 3 196706277-196712250 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 54.8;Spermatocytes: 66.3;Spermatogonia: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "basophil: 51.5;eosinophil: 59.0;neutrophil: 144.2" "Lineage enriched" "Detected in all" 13 "granulocytes: 144.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047614, HPA071138" Enhanced Supported Centrosome NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Centrosome "HPA047614: AB_2680103, HPA071138: AB_2686348" "unprognostic (3.00e-1)" "unprognostic (5.45e-2)" "unprognostic (5.11e-2)" "unprognostic (9.31e-2)" "unprognostic (5.51e-3)" "unprognostic (4.66e-2)" "unprognostic (3.56e-4)" "unprognostic (1.16e-1)" "unprognostic (1.33e-2)" "unprognostic (2.10e-1)" "unprognostic (1.01e-1)" "unprognostic (1.02e-1)" "unprognostic (2.36e-2)" "unprognostic (1.91e-1)" "unprognostic (3.06e-2)" "unprognostic (2.01e-1)" "unprognostic (2.33e-2)" 1.6 2.6 5.1 3.1 5.3 1.2 1.1 4.7 6.3 1.7 5.7 1.4 0.9 1.6 3.0 1.5 4.1 1.9 1.4 5.4 5.9 2.6 1.1 1.6 2.9 5.2 5.3 1.8 0.7 3.4 3.8 2.0 5.1 1.6 1.0 6.6 1.2 2.1 0.6 1.6 1.2 1.4 5.0 3.4 0.9 9.9 5.8 7.6 2.2 1.8 3.5 1.8 1.5 5.5 6.0 4.1 5.6 3.5 12.6 9.6 1.6 4.8 9.0 5.1 6.6 2.1 3.9 4.4 13.3 2.4 11.1 2.6 3.8 1.1 5.9 6.2 3.8 6.8 2.0 0.6 5.0 3.1 8.3 4.4 5.5 6.6 1.8 9.3 2.0 5.4 3.8 5.4 5.2 3.1 7.8 5.6 2.9 2.6 6.9 9.0 3.4 2.9 5.4 0.5 5.6 4.0 6.4 0.8 7.6 4.7 5.0 5.9 1.7 5.8 1.3 9.1 3.2 16.2 16.6 9.1 8.4 7.9 5.8 51.5 4.0 59.0 5.4 3.2 6.0 3.8 8.0 7.3 2.6 4.4 10.3 6.6 144.2 7.3 3.7 11.0 4.8 3.9 5.1 5.3 4.7 6.3 5.4 5.9 5.2 5.3 5.1 5.0 5.8 5.5 2.6 0.0 2.0 3.6 4.5 2.0 1.3 2.2 5.2 5.8 2.7 3.0 2.0 2.8 2.1 1.8 0.0 1.8 5.1 0.6 5.9 2.0 54.8 14.8 5.2 3.7 0.0 1.3 8.4 0.8 1.5 3.4 0.0 1.3 1.3 5.0 5.0 0.3 3.1 5.0 6.6 0.4 4.1 2.2 4.7 6.3 6.5 2.4 0.0 1.0 15.3 9.5 14.4 1.5 1.4 0.8 0.0 5.3 7.1 0.8 0.1 4.9 21.4 8.3 0.0 2.9 2.2 66.3 39.6 2.1 0.9 0.4 3.9 8.8 0.4 0.5 PAK2 "PAK65, PAKgamma" ENSG00000180370 "P21 (RAC1) activated kinase 2" Q13177 3 196739857-196832647 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Growth regulation, Host-virus interaction" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB007794 Approved Approved Nucleoplasm,Vesicles NA NA 1700000 "Cluster 5: Granulocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Nucleoplasm, Vesicles" "CAB007794: AB_562363" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" "unprognostic (2.52e-1)" "unprognostic (2.50e-2)" "unprognostic (1.32e-1)" "unprognostic (1.80e-1)" "unprognostic (5.18e-3)" "unprognostic (1.85e-2)" "unprognostic (7.97e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.36e-4)" "prognostic unfavorable (9.58e-4)" "unprognostic (1.30e-3)" "unprognostic (4.57e-2)" "unprognostic (1.25e-2)" "unprognostic (1.70e-2)" "unprognostic (3.39e-1)" 31.8 18.1 21.2 34.6 24.9 28.1 19.5 25.0 21.7 21.1 19.8 25.6 23.0 21.9 16.0 26.5 20.5 23.8 24.0 19.5 24.6 22.1 33.8 26.3 40.9 26.7 23.4 19.8 18.5 32.6 8.4 33.3 27.7 20.1 26.6 17.4 14.5 18.9 28.3 16.6 22.5 27.0 24.8 43.5 20.9 15.1 23.0 45.1 19.7 25.9 39.4 34.1 16.0 34.1 140.7 49.1 67.6 49.8 47.1 61.9 100.0 69.1 57.0 73.7 66.8 117.5 70.1 89.4 192.7 70.8 75.1 70.2 72.5 66.2 113.6 39.9 35.2 132.2 52.1 92.5 95.0 130.2 122.0 49.6 53.1 66.2 139.2 78.1 74.3 97.3 65.0 107.5 72.9 146.7 124.8 67.2 40.5 74.7 73.4 112.4 38.6 80.9 64.8 96.7 39.6 44.7 92.8 64.7 52.7 51.9 227.0 92.6 76.9 60.9 33.6 64.3 103.1 72.5 138.9 216.4 50.4 127.6 59.1 37.3 20.0 48.0 10.9 23.2 14.7 11.2 12.7 12.6 25.4 11.3 9.1 10.9 47.6 12.2 21.2 9.3 20.7 14.9 21.2 24.9 25.0 21.7 19.5 24.6 26.7 23.4 27.7 24.8 23.0 34.1 164.9 80.1 40.2 37.9 142.8 97.4 89.2 41.8 96.2 42.6 59.7 47.5 59.3 62.9 45.1 82.8 52.1 50.3 135.1 69.6 33.2 71.5 57.1 107.9 112.6 104.0 44.9 72.3 32.2 59.0 101.4 68.9 58.1 96.1 148.8 70.9 66.0 138.6 104.3 55.5 38.9 46.4 57.0 160.5 115.9 75.5 60.9 169.6 33.8 46.9 183.2 63.7 140.1 37.2 61.3 100.4 52.1 45.5 100.0 149.4 58.2 85.2 76.4 45.0 39.5 86.0 75.9 24.5 43.0 103.2 86.2 34.9 139.1 96.3 51.0 124.1 SENP5 MGC27076 ENSG00000119231 "SUMO specific peptidase 5" Q96HI0 3 196867856-196934714 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 16: U-266 - Nucleosome" "Cluster 44: Endometrium - Transcription" "unprognostic (4.07e-2)" "unprognostic (4.91e-3)" "unprognostic (7.63e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (4.13e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (2.95e-1)" "unprognostic (2.20e-1)" "unprognostic (2.88e-1)" "unprognostic (2.89e-1)" "unprognostic (9.57e-3)" "prognostic unfavorable (2.14e-5)" "unprognostic (2.02e-1)" "unprognostic (1.62e-1)" "unprognostic (1.62e-2)" "unprognostic (6.71e-2)" 8.1 7.0 12.3 8.3 12.2 15.8 8.1 14.4 14.0 10.6 9.9 10.3 5.8 8.4 7.9 8.5 9.1 7.3 9.3 13.0 14.6 7.8 10.1 9.9 9.0 13.3 13.1 10.4 8.1 8.9 10.2 9.1 14.3 9.3 7.0 17.5 7.7 7.4 11.9 9.4 8.3 7.8 11.3 10.5 8.2 20.8 12.7 10.6 8.3 12.2 11.5 9.0 9.8 15.9 26.0 11.1 18.1 16.4 15.0 17.8 14.7 16.2 17.1 17.1 27.2 20.2 10.0 24.3 44.1 17.6 29.1 17.8 18.9 8.6 27.5 13.1 13.3 32.8 17.1 14.3 17.4 27.1 14.8 15.5 22.7 17.4 18.4 12.4 16.9 21.0 22.2 36.1 20.2 22.1 26.1 16.0 14.2 14.0 23.4 16.5 14.7 16.6 8.4 14.5 11.3 15.0 18.9 20.1 19.8 18.0 33.8 20.5 19.3 16.5 17.2 23.0 33.5 38.6 73.6 51.4 22.4 21.7 19.3 16.3 6.5 6.3 7.1 7.1 6.4 7.4 6.8 7.0 4.3 7.0 6.3 6.7 12.5 6.5 8.1 6.9 5.9 3.6 12.3 12.2 14.4 14.0 13.0 14.6 13.3 13.1 14.3 11.3 12.7 15.9 25.7 22.4 12.6 43.4 27.7 60.8 28.4 8.6 16.5 28.6 22.7 13.0 14.6 12.8 13.2 9.2 16.7 18.3 33.4 19.9 11.7 16.0 42.9 22.1 26.9 21.6 21.6 19.3 71.2 14.2 15.7 21.1 18.8 27.5 26.6 25.9 22.5 17.6 13.4 28.6 69.1 16.6 8.2 20.4 41.4 48.0 16.1 17.4 14.2 48.7 18.7 13.8 27.8 50.8 57.3 27.4 19.4 16.6 24.4 21.4 13.3 20.5 11.2 30.5 26.3 25.8 23.9 67.5 56.8 14.3 62.1 22.8 25.7 13.7 13.8 36.1 NCBP2 "Cbc2, CBP20, NIP1" ENSG00000114503 "Nuclear cap binding protein subunit 2" P52298 3 196935402-196942594 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044850, HPA062483" Supported Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA044850: AB_10961012, HPA062483: AB_2684779" "unprognostic (1.82e-2)" "unprognostic (1.09e-1)" "unprognostic (4.04e-2)" "unprognostic (5.12e-3)" "unprognostic (3.17e-1)" "unprognostic (5.13e-3)" "prognostic unfavorable (2.37e-7)" "unprognostic (2.86e-2)" "unprognostic (9.63e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.75e-4)" "prognostic unfavorable (2.27e-4)" "unprognostic (3.28e-3)" "unprognostic (6.38e-2)" "unprognostic (1.97e-1)" "unprognostic (4.30e-2)" "unprognostic (5.04e-3)" 38.3 44.0 40.3 38.7 41.4 17.2 36.0 39.7 46.6 34.5 38.6 35.4 29.4 32.6 41.1 29.0 30.1 28.8 31.3 41.5 45.8 41.7 30.1 27.1 43.5 42.7 42.1 35.7 25.7 38.2 26.0 33.9 42.3 36.4 35.2 46.2 24.4 35.5 38.6 27.2 27.8 33.8 43.6 34.2 29.6 25.8 43.8 49.9 37.7 38.6 42.2 45.6 26.1 43.1 144.3 44.6 105.5 131.8 118.6 102.8 74.1 106.1 80.9 66.4 69.7 99.5 51.2 97.0 229.7 76.3 85.4 84.6 136.1 113.0 104.7 50.8 85.0 125.2 55.3 87.5 103.9 146.4 85.3 84.1 101.2 48.7 134.1 99.5 104.3 103.2 71.6 99.7 113.7 165.5 111.3 88.4 134.5 137.2 139.5 86.9 78.6 92.9 99.3 101.9 57.3 153.1 63.8 126.4 189.4 85.4 279.1 112.4 97.5 67.1 71.4 85.0 193.0 155.6 149.4 162.1 93.8 162.5 103.2 9.9 37.7 20.9 37.5 44.5 56.6 53.2 46.2 44.8 40.1 43.5 52.8 48.1 4.0 43.1 47.0 32.2 45.0 40.4 40.3 41.4 39.7 46.6 41.5 45.8 42.7 42.1 42.3 43.6 43.8 43.1 38.5 25.6 43.5 9.1 71.1 52.5 83.6 55.9 36.5 55.7 48.9 36.8 40.5 25.8 51.6 42.3 58.4 59.1 58.9 44.0 97.8 64.3 116.2 39.5 66.6 50.2 45.0 35.1 12.8 49.8 81.8 47.1 30.5 35.9 52.6 54.7 30.0 31.1 65.4 45.4 14.0 44.9 54.9 54.1 60.7 66.2 37.6 38.6 32.0 2.8 68.2 91.0 51.5 10.6 10.4 69.1 45.9 51.6 42.0 81.9 37.0 82.5 44.6 60.3 26.3 40.9 51.3 52.9 59.5 33.5 44.8 53.2 49.8 58.8 52.1 84.2 NCBP2AS2 "HIAR, KRASIM, NCBP2-AS2" ENSG00000270170 "NCBP2 antisense 2 (head to head)" Q69YL0 3 196942674-196943543 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 50.3;Cytotrophoblasts: 53.1;dendritic cells: 22.6;Extravillous trophoblasts: 42.3;Hofbauer cells: 43.0;Syncytiotrophoblasts: 34.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (3.48e-1)" "unprognostic (4.33e-3)" "unprognostic (4.51e-2)" "unprognostic (1.74e-3)" "unprognostic (4.77e-2)" "unprognostic (2.49e-1)" "unprognostic (2.61e-3)" "unprognostic (1.30e-1)" "unprognostic (1.71e-1)" "unprognostic (2.67e-1)" "unprognostic (5.07e-2)" "unprognostic (3.21e-2)" "prognostic favorable (8.92e-4)" "unprognostic (4.19e-2)" "unprognostic (1.65e-1)" "unprognostic (1.19e-1)" "unprognostic (8.66e-3)" 19.0 22.6 32.7 9.7 32.3 38.4 18.8 33.7 33.7 12.6 27.2 31.6 15.9 21.7 13.2 22.5 16.2 6.0 27.9 31.7 34.9 24.9 23.5 14.9 13.9 32.0 31.8 11.5 21.9 20.1 21.4 9.6 33.0 18.7 16.6 13.1 19.8 13.0 45.1 29.5 23.9 10.2 31.2 23.7 23.8 14.0 32.4 18.2 16.9 35.2 10.5 20.7 16.3 32.3 52.7 15.3 26.0 31.3 20.5 18.7 50.0 24.4 16.8 33.2 22.1 29.7 18.7 49.1 87.8 18.3 25.9 41.0 42.8 21.6 26.0 17.5 64.1 39.0 19.3 49.0 23.1 36.4 23.5 30.8 39.4 19.4 24.0 15.1 21.7 45.7 39.7 38.1 14.5 93.9 45.8 65.7 56.9 58.8 74.0 40.7 22.7 60.9 28.0 29.7 59.9 68.0 26.1 39.4 61.3 26.8 80.9 41.4 16.5 15.3 45.4 24.5 52.2 57.1 71.4 119.5 18.0 62.3 20.7 87.4 120.6 116.5 91.6 97.9 99.2 98.3 115.7 106.5 110.0 123.3 141.8 115.3 47.6 127.2 89.7 129.0 118.3 109.7 32.7 32.3 33.7 33.7 31.7 34.9 32.0 31.8 33.0 31.2 32.4 32.3 10.8 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 0.0 0.0 0.0 53.1 22.6 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 42.3 10.4 0.0 0.0 0.0 0.0 0.0 0.0 43.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 34.3 2.9 0.0 0.0 0.0 PIGZ "FLJ12768, MGC52163, SMP3" ENSG00000119227 "Phosphatidylinositol glycan anchor biosynthesis class Z" Q86VD9 3 196946356-196969060 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 39.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 205.1;Intestinal goblet cells: 61.3;Paneth cells: 129.7;Proximal enterocytes: 50.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "HPA058599, HPA059920" Approved NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA058599: AB_2683771, HPA059920: AB_2684162" "unprognostic (1.46e-1)" "unprognostic (3.18e-3)" "unprognostic (1.06e-2)" "unprognostic (3.31e-2)" "unprognostic (3.90e-2)" "unprognostic (8.16e-2)" "unprognostic (4.25e-3)" "unprognostic (4.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.44e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (1.02e-1)" "unprognostic (3.93e-2)" "unprognostic (8.38e-5)" "unprognostic (5.02e-3)" 6.7 1.6 8.2 2.0 8.5 1.0 5.4 8.6 9.6 4.3 4.4 39.1 1.6 3.4 0.7 4.2 3.4 2.0 6.9 8.1 9.2 2.1 2.6 3.7 1.1 7.6 8.6 0.8 2.7 3.0 4.1 1.0 10.0 6.1 16.7 3.1 4.7 2.6 7.4 4.7 11.7 2.7 5.3 1.9 4.6 1.6 8.6 1.2 1.9 3.2 0.5 10.4 4.6 7.7 1.8 1.2 0.7 2.8 7.7 3.7 0.7 2.6 7.3 2.0 1.6 1.7 1.5 0.3 5.1 5.9 1.3 3.0 0.1 0.4 0.5 0.5 0.3 0.8 0.6 6.5 3.6 0.0 2.9 3.7 5.6 0.3 0.9 2.2 2.4 4.7 0.2 2.2 1.9 3.2 0.3 1.5 0.1 2.2 0.9 0.4 0.1 0.6 3.0 3.3 1.1 1.2 3.7 0.3 1.5 0.3 7.2 2.6 6.0 1.6 0.4 4.7 0.9 1.0 0.1 0.1 0.4 1.1 0.6 0.0 0.3 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.1 8.2 8.5 8.6 9.6 8.1 9.2 7.6 8.6 10.0 5.3 8.6 7.7 8.9 0.0 1.1 20.5 1.7 7.8 9.1 3.8 6.8 7.1 22.6 33.9 8.0 1.5 2.8 9.2 2.1 0.0 2.8 205.1 5.9 2.3 2.1 5.1 3.0 5.5 13.8 3.0 31.3 3.6 0.0 5.0 1.5 6.5 5.7 0.3 12.1 10.3 1.8 15.2 21.9 61.3 10.2 4.4 3.4 5.0 4.1 2.2 8.8 5.6 4.1 4.6 2.1 12.5 2.7 3.2 129.7 6.4 1.9 7.4 50.0 5.4 2.7 7.0 0.0 7.7 6.5 1.2 0.2 11.5 5.1 0.1 1.7 0.0 44.4 14.7 MELTF "CD228, FLJ38863, MAP97, MFI2, MGC4856, MTf, MTF1" ENSG00000163975 Melanotransferrin P08582 3 196988621-197029817 "CD markers, Plasma proteins, Predicted intracellular proteins" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 35.1;salivary gland: 68.7" "Cell type enhanced" "Detected in some" "Breast glandular cells: 21.1;Breast myoepithelial cells: 20.6;Collecting duct cells: 14.7;Ductal cells: 28.3;Hofbauer cells: 15.4;Pancreatic endocrine cells: 66.4" "Cancer enhanced" "Detected in all" "melanoma: 32.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 162.1;SK-MEL-30: 201.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA004880 Approved "Intracellular and membrane" NA NA 41000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA004880: AB_1853844" "unprognostic (8.68e-3)" "unprognostic (3.68e-2)" "unprognostic (1.75e-2)" "unprognostic (7.68e-3)" "unprognostic (1.06e-2)" "unprognostic (1.08e-2)" "unprognostic (5.53e-2)" "unprognostic (1.64e-3)" "unprognostic (1.20e-2)" "unprognostic (1.23e-1)" "unprognostic (3.68e-3)" "unprognostic (8.14e-2)" "prognostic unfavorable (6.99e-11)" "unprognostic (2.29e-1)" "unprognostic (2.11e-1)" "unprognostic (5.75e-2)" "unprognostic (2.09e-2)" 10.0 1.7 2.3 3.8 1.7 2.3 7.4 2.1 3.8 8.1 27.2 4.0 2.4 6.8 0.7 2.9 8.6 1.6 7.5 2.5 1.9 35.1 1.6 1.9 1.9 0.6 2.8 1.2 4.6 10.3 2.9 1.5 0.4 4.1 2.1 0.3 68.7 5.5 1.1 16.4 9.9 1.2 0.5 1.1 1.7 3.4 6.5 2.9 3.1 1.0 1.6 3.2 7.3 2.0 162.1 34.6 0.4 1.2 4.8 6.0 4.0 2.8 1.5 5.2 6.3 9.8 23.6 4.5 33.3 5.6 4.5 49.6 1.8 0.1 2.3 7.4 10.8 5.6 7.9 4.1 30.5 0.8 30.8 33.0 4.3 4.3 0.4 0.2 0.8 8.9 4.3 30.5 3.1 9.8 9.3 0.0 3.6 6.9 22.5 13.4 5.3 2.0 0.8 1.5 3.1 11.3 32.5 2.8 201.4 3.8 9.5 4.8 1.2 1.2 26.8 5.5 19.9 5.3 46.0 4.5 3.9 9.5 0.2 0.0 0.1 0.0 0.2 0.2 0.8 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 2.3 1.7 2.1 3.8 2.5 1.9 0.6 2.8 0.4 0.5 6.5 2.0 0.8 0.0 1.7 0.0 1.0 0.0 0.0 0.0 0.0 0.0 21.1 20.6 0.0 0.0 1.8 14.7 0.0 0.2 1.0 0.0 0.0 28.3 0.0 3.2 6.1 0.6 0.0 0.0 0.0 5.7 0.3 3.7 0.0 4.4 0.0 3.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.6 0.0 0.0 0.0 0.0 66.4 0.0 0.0 1.7 0.0 0.0 0.5 1.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.0 0.0 DLG1 "dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97" ENSG00000075711 "Discs large MAGUK scaffold protein 1" Q12959 3 197042560-197299330 "Predicted intracellular proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 422.9;Oligodendrocytes: 1542.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016307, HPA069593" Supported Uncertain "Vesicles,Plasma membrane" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 38: EFO-21 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Vesicles "Plasma membrane" "CAB016307: AB_2092015, HPA069593: " "unprognostic (2.04e-2)" "unprognostic (1.37e-1)" "unprognostic (7.79e-2)" "unprognostic (4.56e-3)" "unprognostic (3.54e-2)" "unprognostic (8.56e-2)" "unprognostic (8.90e-3)" "unprognostic (2.97e-1)" "unprognostic (5.98e-2)" "unprognostic (2.33e-1)" "unprognostic (2.41e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-3)" "unprognostic (3.56e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (3.07e-1)" 20.7 14.5 26.4 14.7 57.0 16.2 18.4 33.2 36.4 23.8 15.4 24.2 24.0 19.7 11.6 37.6 16.1 17.1 19.4 25.4 29.3 27.6 25.9 18.0 14.7 36.9 43.3 23.3 17.2 31.7 14.4 21.3 34.8 15.9 26.3 38.8 20.2 18.6 25.2 18.8 25.4 21.2 19.9 13.0 22.9 15.5 50.3 27.1 43.3 28.2 20.6 20.3 20.5 73.5 128.0 20.0 40.3 75.7 34.2 36.2 40.7 52.2 46.2 49.2 59.0 60.4 59.8 41.5 127.1 47.7 95.7 86.4 39.3 76.4 97.7 10.9 22.5 35.2 31.1 40.5 35.2 35.0 33.3 27.8 43.3 49.1 101.3 163.1 64.8 32.2 26.7 51.4 125.6 41.5 51.3 12.9 35.3 71.1 35.4 26.7 51.6 26.8 51.9 55.3 19.7 32.3 72.9 49.5 49.4 46.7 108.8 26.0 62.5 127.5 33.5 36.1 79.9 76.0 50.6 50.6 50.3 51.8 40.0 2.5 0.7 1.2 0.8 0.7 1.3 1.6 1.3 0.9 0.8 1.2 1.3 1.3 2.4 1.1 0.4 1.1 1.0 0.8 26.4 57.0 33.2 36.4 25.4 29.3 36.9 43.3 34.8 19.9 50.3 73.5 24.0 25.6 25.7 113.3 28.5 53.3 52.3 45.5 40.5 42.0 29.6 23.0 25.6 35.8 44.6 49.7 95.9 48.9 25.2 72.4 5.9 22.8 12.9 51.8 37.4 28.1 28.9 17.5 422.9 20.2 19.5 27.7 51.5 68.5 12.0 29.9 27.8 54.6 14.9 37.0 117.8 34.4 28.5 26.4 26.0 19.2 28.6 19.2 37.4 165.8 18.3 71.9 43.3 257.3 1542.2 30.3 48.0 25.6 34.1 52.3 50.6 20.8 66.3 101.7 13.1 40.5 25.5 31.2 37.9 66.7 70.8 25.0 30.6 29.3 38.8 106.8 BDH1 "BDH, SDR9C1" ENSG00000161267 "3-hydroxybutyrate dehydrogenase 1" Q02338 3 197509783-197573323 "Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Allosteric enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 324.0" "Cell type enhanced" "Detected in many" "Hepatocytes: 112.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 44.2;U-937: 75.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA030947, HPA058709" Enhanced Approved Mitochondria NA NA "Cluster 30: Non-specific - Translation" "Cluster 85: Liver - Metabolism" "Cluster 32: U-937 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "HPA030947: AB_10669548, HPA058709: AB_2683797" "unprognostic (2.72e-2)" "prognostic favorable (1.09e-4)" "unprognostic (1.13e-1)" "unprognostic (3.93e-1)" "unprognostic (3.35e-2)" "unprognostic (1.07e-1)" "prognostic favorable (9.86e-7)" "unprognostic (2.08e-1)" "unprognostic (3.85e-2)" "unprognostic (4.53e-2)" "unprognostic (5.17e-3)" "unprognostic (5.85e-3)" "prognostic favorable (7.12e-8)" "unprognostic (5.62e-2)" "unprognostic (1.74e-1)" "unprognostic (6.22e-2)" "unprognostic (1.02e-1)" 9.6 6.8 14.4 4.1 17.9 7.3 9.7 18.4 19.8 6.8 30.8 45.1 17.4 6.3 3.9 48.0 9.7 3.8 52.4 16.5 14.3 19.2 324.0 5.2 3.9 14.3 13.8 8.2 7.0 15.5 12.6 0.3 14.4 16.2 19.8 9.3 25.3 4.1 21.5 30.4 28.1 2.2 12.9 7.9 16.6 4.5 16.3 6.1 17.7 22.8 7.1 9.9 14.7 14.2 23.7 2.9 1.2 11.3 1.9 0.1 0.0 2.8 2.2 11.4 6.3 20.5 7.5 0.2 33.0 0.7 0.9 10.3 10.0 5.4 4.2 0.3 0.0 12.0 8.3 7.0 8.3 27.0 12.3 3.4 6.0 4.4 9.4 1.2 2.8 13.7 0.0 8.4 0.2 40.9 20.5 18.8 8.2 44.2 4.2 19.6 4.1 31.5 12.3 9.9 20.1 8.8 8.2 1.1 4.5 0.5 26.3 22.7 0.3 0.7 3.9 0.1 21.6 10.4 20.5 0.3 0.7 75.8 1.5 2.9 1.3 0.6 4.6 0.2 6.4 5.1 5.1 4.2 3.5 4.6 7.6 4.7 0.0 4.5 0.2 3.8 3.7 3.4 14.4 17.9 18.4 19.8 16.5 14.3 14.3 13.8 14.4 12.9 16.3 14.2 0.4 3.2 9.4 27.7 7.0 9.3 8.5 10.0 16.5 21.3 20.3 14.7 36.7 17.2 13.8 12.9 20.9 2.0 7.1 68.9 52.8 6.6 9.5 34.1 3.6 2.2 27.2 6.7 60.5 5.6 5.1 2.8 17.3 16.5 1.3 6.6 5.0 112.3 8.9 18.5 58.0 43.2 10.2 5.4 8.5 13.9 5.6 3.5 16.0 8.4 1.0 17.5 11.3 27.2 12.5 3.0 36.4 4.1 5.4 6.5 62.8 30.2 48.0 33.6 0.0 2.4 3.7 16.8 4.9 36.3 10.9 1.9 8.5 10.0 68.7 13.1 RUBCN "KIAA0226, rubicon, rundataxin" ENSG00000145016 "Rubicon autophagy regulator" Q92622 3 197668867-197749727 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Endocytosis, Immunity, Phagocytosis" Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 67.5;Plasma cells: 48.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 87.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050908, HPA054497" Approved Supported Vesicles,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Vesicles, Cytosol" "HPA050908: , HPA054497: AB_2682507" "unprognostic (2.91e-2)" "unprognostic (1.61e-2)" "prognostic unfavorable (6.65e-4)" "unprognostic (1.34e-3)" "unprognostic (1.46e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (9.91e-5)" "unprognostic (1.99e-1)" "unprognostic (6.71e-2)" "unprognostic (2.86e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (2.22e-2)" "unprognostic (2.92e-2)" "unprognostic (1.75e-1)" "unprognostic (2.43e-1)" "unprognostic (1.23e-1)" 8.3 7.5 16.2 11.6 16.3 8.5 7.2 10.5 17.0 9.2 4.4 10.4 7.3 8.8 4.0 12.0 8.5 7.2 11.4 17.0 19.0 7.7 5.6 11.8 15.3 20.0 17.8 10.7 9.1 6.8 15.8 5.8 15.9 7.4 5.7 10.9 7.3 7.2 8.9 9.1 13.1 7.8 14.5 19.2 8.1 14.6 23.7 8.8 7.1 8.1 16.1 8.9 8.4 17.4 30.9 7.4 8.2 16.2 14.4 8.3 8.6 13.8 9.2 17.0 14.2 12.7 8.4 33.6 26.7 15.8 16.1 17.0 15.0 8.0 13.6 9.3 13.9 21.6 13.4 4.9 8.4 12.0 18.0 7.0 9.6 14.8 17.6 7.9 10.7 14.4 12.3 87.7 11.5 24.4 15.7 7.5 7.1 8.8 23.2 14.9 8.6 22.6 9.6 13.9 34.3 7.9 10.2 19.8 10.8 5.5 29.2 8.1 13.7 9.9 9.9 27.8 18.9 36.5 34.2 27.0 13.6 22.4 8.7 0.8 2.6 17.5 3.7 3.9 2.4 7.7 3.1 4.7 1.6 8.5 2.2 3.2 2.9 1.8 4.8 16.6 4.4 1.7 16.2 16.3 10.5 17.0 17.0 19.0 20.0 17.8 15.9 14.5 23.7 17.4 8.5 6.4 11.2 0.0 33.9 0.0 6.0 0.0 8.0 21.0 7.3 7.0 0.0 7.2 4.3 12.9 18.8 1.8 28.9 3.8 1.9 5.8 21.7 4.8 6.2 6.7 0.0 5.7 0.0 6.4 3.7 4.8 7.1 9.8 2.5 6.1 9.3 3.5 9.2 21.9 0.0 3.7 0.0 16.3 0.0 16.4 5.0 18.7 0.0 0.0 67.5 15.0 14.4 0.0 0.0 8.5 1.5 6.4 48.3 8.9 5.8 2.7 0.7 14.3 6.6 9.7 6.8 34.1 21.3 5.6 0.0 6.4 15.9 4.9 2.8 12.3 FYTTD1 "DKFZp761B1514, UIF" ENSG00000122068 "Forty-two-three domain containing 1" Q96QD9 3 197737179-197787596 "Predicted intracellular proteins" "mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054474, HPA074880" Enhanced Supported "Nuclear speckles" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nuclear speckles" "HPA054474: , HPA074880: " "unprognostic (3.61e-2)" "unprognostic (6.01e-2)" "unprognostic (4.88e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (2.33e-2)" "unprognostic (3.80e-1)" "unprognostic (3.69e-2)" "unprognostic (9.57e-3)" "unprognostic (4.44e-2)" "unprognostic (1.66e-1)" "unprognostic (5.04e-3)" "unprognostic (8.74e-2)" "unprognostic (8.49e-3)" "unprognostic (3.40e-2)" "unprognostic (3.36e-1)" "unprognostic (3.29e-1)" "unprognostic (3.15e-1)" 29.7 20.9 12.1 27.1 12.6 39.2 26.6 16.1 14.6 24.8 9.1 19.9 16.7 30.4 19.6 43.9 19.1 24.4 41.3 12.1 14.9 25.7 28.9 23.6 32.4 12.4 13.9 27.5 36.4 28.7 12.6 33.5 13.0 25.1 21.6 33.8 18.2 28.8 92.6 27.1 19.3 34.9 12.8 26.3 18.2 41.1 13.3 34.1 29.6 67.0 37.7 33.6 16.9 14.9 104.5 22.6 43.7 41.7 50.1 55.3 13.4 50.0 50.8 75.4 61.4 35.3 34.8 66.4 177.1 59.3 40.0 36.7 55.5 51.0 79.8 14.5 24.9 99.8 32.9 16.1 48.9 75.1 46.5 40.0 64.6 40.8 58.3 52.1 60.4 36.8 45.9 139.0 67.6 86.9 82.2 18.1 9.6 45.1 41.2 74.9 53.6 47.4 54.8 67.3 82.4 35.7 76.8 60.0 56.4 31.8 141.2 39.1 54.0 38.5 38.1 49.0 53.6 83.5 137.2 79.3 40.8 106.4 40.6 59.2 26.9 26.5 32.4 31.8 40.7 20.0 30.7 35.9 29.9 18.9 33.4 32.2 8.5 64.6 31.0 16.9 30.2 45.7 12.1 12.6 16.1 14.6 12.1 14.9 12.4 13.9 13.0 12.8 13.3 14.9 60.6 35.3 27.2 14.7 78.5 82.3 46.6 24.3 42.7 35.1 47.0 34.4 109.7 25.8 30.1 47.8 31.3 24.4 63.9 19.0 90.1 35.5 21.7 27.3 58.9 55.2 56.4 25.2 23.7 36.1 27.5 53.7 30.1 42.6 66.6 29.4 36.4 50.7 38.0 45.4 19.6 23.7 28.5 48.6 67.8 18.3 32.0 54.8 51.6 22.5 108.6 41.8 82.4 19.6 23.0 34.3 16.5 37.2 65.4 74.5 17.1 51.1 44.6 45.2 39.5 45.8 63.1 96.3 90.7 54.0 91.1 50.1 60.7 51.9 20.0 63.6 LRCH3 MGC4126 ENSG00000186001 "Leucine rich repeats and calponin homology domain containing 3" Q96II8 3 197791226-197888436 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 139.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 38.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 38.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012380, HPA017299" Uncertain Enhanced Cytosol "Intracellular and membrane" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 52: Non-specific - Transcription" Cytosol "HPA012380: AB_1853260, HPA017299: AB_2669576" "unprognostic (1.25e-1)" "unprognostic (4.92e-1)" "unprognostic (1.43e-1)" "unprognostic (2.69e-3)" "unprognostic (1.05e-1)" "unprognostic (8.26e-2)" "prognostic unfavorable (2.95e-4)" "unprognostic (3.29e-1)" "unprognostic (4.13e-1)" "unprognostic (9.85e-2)" "unprognostic (1.64e-1)" "unprognostic (2.06e-2)" "unprognostic (1.79e-3)" "unprognostic (3.29e-2)" "unprognostic (2.67e-1)" "unprognostic (5.59e-2)" "unprognostic (1.32e-1)" 13.1 10.2 7.7 12.0 11.9 8.0 11.4 18.7 9.1 16.2 7.3 16.3 7.0 15.5 7.7 10.7 13.7 10.2 14.6 7.7 12.5 8.2 10.3 11.9 17.0 9.8 8.1 18.8 9.5 12.2 12.3 10.1 8.5 13.9 10.2 19.2 12.0 12.1 19.3 10.8 12.8 14.8 6.0 13.9 11.2 13.1 10.1 15.5 9.7 11.5 18.7 14.8 13.8 15.7 30.5 10.0 28.8 17.5 28.9 35.2 11.0 21.5 25.6 25.3 31.5 26.0 15.5 16.1 33.5 24.9 40.7 19.1 25.7 21.2 34.5 13.3 14.4 29.8 16.2 19.2 18.9 21.4 19.3 25.0 10.9 24.7 31.9 23.0 30.7 14.7 18.1 27.5 23.4 25.1 15.9 7.8 19.3 15.8 22.3 16.0 17.6 10.6 11.3 19.4 14.2 14.4 28.5 18.5 20.1 26.4 39.0 17.1 30.1 19.4 12.0 24.4 22.2 24.5 26.9 15.2 19.8 28.0 20.3 38.9 4.7 10.1 7.4 6.9 6.0 9.3 5.8 6.3 4.1 6.6 5.3 7.5 2.3 7.1 6.9 3.5 6.1 5.4 7.7 11.9 18.7 9.1 7.7 12.5 9.8 8.1 8.5 6.0 10.1 15.7 19.2 32.1 27.0 64.6 29.7 10.6 18.1 11.4 8.0 56.0 11.6 8.5 15.4 14.3 17.0 9.2 56.3 8.5 25.8 10.4 1.9 10.1 12.8 12.2 22.9 20.8 6.0 11.1 69.8 9.9 6.6 23.8 10.7 16.4 11.4 23.0 34.6 14.2 9.0 38.7 86.1 11.0 8.2 17.6 17.9 9.6 25.1 14.6 17.8 66.5 30.8 19.8 27.8 102.1 139.2 14.1 9.5 28.6 15.1 15.9 7.1 5.2 15.1 43.1 19.7 31.7 22.8 18.0 17.2 9.4 10.5 6.0 19.9 17.0 11.0 14.7 IQCG "CFAP122, DKFZp434B227, DRC9" ENSG00000114473 "IQ motif containing G" Q9H095 3 197889077-197960142 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 52.8;testis: 43.9" "Cell type enhanced" "Detected in all" "Early spermatids: 255.0;Endometrial ciliated cells: 176.3;Late spermatids: 489.4;Respiratory ciliated cells: 322.2;Spermatocytes: 122.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042787, HPA051981" Enhanced Approved "Actin filaments,Cytosol" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Actin filaments" Cytosol "HPA042787: AB_10797021, HPA051981: AB_2732572" "unprognostic (1.50e-2)" "unprognostic (6.20e-3)" "unprognostic (6.20e-2)" "unprognostic (1.10e-2)" "unprognostic (2.51e-2)" "unprognostic (9.20e-2)" "unprognostic (1.05e-1)" "unprognostic (4.89e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (7.54e-2)" "unprognostic (1.79e-1)" "unprognostic (2.94e-2)" "unprognostic (9.15e-2)" "unprognostic (1.73e-1)" "unprognostic (2.72e-3)" "unprognostic (7.75e-2)" 6.0 5.2 8.9 3.3 9.7 3.2 5.8 8.4 9.5 5.9 25.2 3.2 2.6 4.6 10.0 4.0 52.8 4.6 4.4 8.7 10.6 6.4 3.7 9.1 3.8 15.0 19.8 3.6 2.0 4.4 6.1 3.5 14.1 3.9 3.7 18.1 2.5 4.5 2.0 2.7 2.7 4.3 14.3 3.4 3.7 43.9 10.9 2.9 8.1 2.1 4.2 3.6 2.2 14.6 5.3 5.8 7.3 7.1 15.6 15.7 2.9 6.4 7.1 7.5 7.6 1.2 5.0 1.9 7.0 5.2 9.6 4.9 5.4 5.0 12.0 4.4 3.8 3.2 3.3 2.9 3.6 4.4 5.0 8.1 6.1 8.1 2.6 6.1 3.6 8.8 3.5 7.2 5.8 12.2 2.4 2.1 4.6 7.8 7.6 6.8 4.8 2.6 7.2 2.2 6.4 7.7 10.6 4.3 4.4 6.4 32.2 3.0 3.7 4.8 3.3 14.5 6.7 6.2 18.4 3.1 18.1 6.1 7.8 2.0 3.8 4.3 3.4 2.7 2.2 4.3 2.9 2.3 3.3 1.6 2.7 3.7 2.3 3.3 2.6 2.9 3.1 2.3 8.9 9.7 8.4 9.5 8.7 10.6 15.0 19.8 14.1 14.3 10.9 14.6 7.4 6.4 7.7 16.6 8.5 9.3 3.3 14.8 2.2 13.1 27.9 15.2 11.0 5.7 31.8 5.5 75.0 6.4 10.1 3.1 15.6 7.1 255.0 176.3 15.0 8.2 4.2 4.8 10.1 4.2 5.8 13.1 5.6 16.3 8.8 30.9 5.3 4.2 6.6 10.1 8.8 2.9 26.4 6.0 24.9 489.4 22.7 10.3 14.2 14.0 2.9 13.5 11.3 10.6 13.2 11.9 1.9 23.7 5.7 2.2 1.4 10.4 322.2 43.8 6.6 6.8 18.7 122.7 31.6 5.9 8.9 5.2 10.8 46.5 2.9 2.5 RPL35A "eL33, GIG33, L35A" ENSG00000182899 "Ribosomal protein L35a" P18077 3 197950190-197956610 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, tRNA-binding" "Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 11000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 32: Non-specific - Translation" "unprognostic (9.48e-3)" "unprognostic (1.69e-2)" "unprognostic (1.78e-1)" "unprognostic (5.01e-2)" "unprognostic (5.51e-2)" "unprognostic (5.89e-3)" "prognostic unfavorable (9.89e-4)" "unprognostic (2.51e-1)" "unprognostic (3.41e-2)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.43e-4)" "unprognostic (2.54e-2)" "prognostic unfavorable (1.37e-6)" "unprognostic (1.03e-2)" "unprognostic (4.65e-2)" "unprognostic (3.85e-2)" "unprognostic (7.72e-2)" 1060.9 919.0 554.5 548.3 560.9 1161.6 1209.1 556.6 875.5 1438.4 549.5 971.4 520.6 971.4 599.3 1071.3 1200.8 252.4 966.5 543.8 571.1 753.4 643.4 725.7 776.3 560.9 550.3 2394.5 1789.9 502.8 697.1 374.5 562.3 950.7 463.3 326.6 899.8 418.6 879.5 1311.5 830.6 379.1 574.1 927.0 1025.4 358.9 568.7 907.9 754.4 616.9 736.3 892.3 1148.1 574.3 2272.2 669.9 1091.7 982.0 737.1 1529.0 1215.9 1067.3 916.3 1121.8 841.4 2189.3 934.5 1922.7 3792.9 680.8 669.3 1163.5 924.8 990.5 1121.2 439.8 1629.0 1117.0 1082.0 1513.0 1173.4 1973.2 899.3 1383.4 1121.0 605.3 1672.3 1389.3 1085.5 810.5 1049.2 2182.5 1071.6 3132.8 1295.6 2533.4 1729.9 1681.6 1618.3 1221.8 942.7 2976.8 1286.5 1394.9 1052.5 969.8 676.7 2283.5 3031.5 1176.3 3953.6 3116.9 1031.2 652.8 872.6 979.3 2042.8 1709.4 2192.8 2579.9 934.9 3009.7 1045.6 461.7 737.7 233.9 705.6 543.2 1155.3 1223.1 1275.3 970.1 796.3 1105.2 1645.4 1249.0 118.2 741.6 513.4 929.9 878.3 2092.3 554.5 560.9 556.6 875.5 543.8 571.1 560.9 550.3 562.3 574.1 568.7 574.3 1882.9 1060.9 1722.6 24.5 4121.3 5337.3 4473.1 3629.9 3843.2 320.9 5257.9 6722.9 541.7 2116.1 2284.9 941.7 100.1 2684.9 2686.7 1217.3 3470.9 2107.4 1845.9 1520.8 2914.9 2334.0 1638.9 2465.7 23.1 4595.8 4411.0 2262.0 1398.1 1765.7 2045.0 2514.8 3040.2 1877.8 2449.5 156.5 25.7 3361.4 1184.0 3417.8 4894.1 1595.8 4527.5 2304.4 2968.6 28.1 3705.1 1155.2 2747.7 13.6 30.9 3218.5 2744.3 2315.1 2374.0 4080.9 2776.5 3992.3 1300.9 435.6 1610.6 4280.8 2712.8 850.7 723.4 3869.4 6022.9 2692.1 3610.9 2182.6 3544.4 4170.3 LMLN "Gp63, LMNL1, Msp" ENSG00000185621 "Leishmanolysin like peptidase" Q96KR4 3 197960200-198043720 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 39.7;Endometrial ciliated cells: 35.2;Respiratory ciliated cells: 37.5;Spermatocytes: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016481, HPA028844" Uncertain Supported "Focal adhesion sites,Cytosol" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 16: U-266 - Nucleosome" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "Focal adhesion sites" "HPA016481: AB_1852955, HPA028844: AB_10602347" "unprognostic (2.54e-1)" "unprognostic (3.15e-1)" "unprognostic (7.63e-2)" "prognostic favorable (6.77e-4)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (1.30e-1)" "unprognostic (4.07e-2)" "unprognostic (1.94e-1)" "unprognostic (2.31e-1)" "unprognostic (6.36e-2)" "unprognostic (2.98e-1)" "unprognostic (4.82e-3)" "unprognostic (8.78e-2)" "unprognostic (7.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.63e-1)" 2.1 2.6 2.7 1.2 3.4 1.2 2.2 3.6 4.7 3.1 4.7 2.1 1.0 2.2 10.7 2.2 4.9 2.6 3.3 2.7 3.7 3.4 2.2 2.5 1.3 4.2 3.3 3.3 3.8 3.8 6.5 2.0 4.5 2.3 2.0 9.7 2.4 3.4 2.4 3.4 1.4 2.0 3.0 1.5 2.0 10.1 4.0 1.1 4.1 2.0 1.2 1.9 2.3 3.2 7.7 2.8 3.3 4.0 6.4 9.0 2.9 3.9 3.6 6.9 5.6 2.8 2.7 2.4 17.7 2.8 14.9 2.8 3.1 3.1 10.0 0.3 2.3 1.4 2.3 2.1 4.0 4.4 2.0 4.3 6.8 8.6 5.5 4.0 3.0 6.0 7.5 4.5 6.7 5.7 2.6 3.8 3.8 5.5 6.7 3.0 0.8 2.6 7.1 2.0 5.4 1.5 5.4 4.8 3.9 3.7 12.5 3.2 6.6 8.4 1.3 10.3 6.7 8.0 16.7 0.7 12.0 7.4 7.8 0.0 0.1 0.1 0.2 0.4 0.3 0.4 0.1 0.3 0.4 0.2 0.4 0.5 0.1 0.3 0.2 0.1 0.0 0.2 2.7 3.4 3.6 4.7 2.7 3.7 4.2 3.3 4.5 3.0 4.0 3.2 4.4 16.0 14.8 24.5 1.7 2.0 1.5 2.6 4.0 8.1 6.4 4.8 11.6 2.8 9.2 9.2 16.7 3.6 1.2 2.2 0.0 3.5 39.7 35.2 11.5 3.2 4.8 0.8 25.3 2.7 2.2 5.5 1.5 11.5 2.5 6.3 4.2 3.1 5.0 8.4 23.1 3.6 0.0 1.9 2.3 21.9 4.7 2.3 3.6 9.4 1.1 5.9 1.0 6.6 13.7 2.1 1.0 5.7 2.1 1.8 0.7 3.5 37.5 17.7 0.0 6.6 3.8 33.2 23.6 3.7 1.7 2.9 2.1 10.6 2.8 1.1